PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Autier, P; Dore, JF; Breitbart, E; Greinert, R; Pasterk, M; Boniol, M				Autier, Philippe; Dore, Jean Francois; Breitbart, Eckhard; Greinert, Ruediger; Pasterk, Markus; Boniol, Mathieu			The indoor tanning industry's double game	LANCET			English	Editorial Material									[Autier, Philippe; Pasterk, Markus; Boniol, Mathieu] Int Prevent Res Inst, F-69006 Lyon, France; [Dore, Jean Francois] INSERM, U590, F-69008 Lyon, France; [Breitbart, Eckhard; Greinert, Ruediger] Elbekliniken Klinikum Buxtehude, EUROSKIN, Buxtehude, Germany	Institut National de la Sante et de la Recherche Medicale (Inserm)	Autier, P (corresponding author), Int Prevent Res Inst, F-69006 Lyon, France.	philippe.autier@i-pri.org	Autier, Philippe/A-4402-2014; Ferris, Laura/I-7689-2012; Boniol, Mathieu/F-9623-2011; Pasterk, Markus/A-6588-2011	Autier, Philippe/0000-0003-1538-5321; Boniol, Mathieu/0000-0003-1052-5604; Pasterk, Markus/0000-0002-6127-3323				El Ghissassi F, 2009, LANCET ONCOL, V10, P751, DOI 10.1016/S1470-2045(09)70213-X; *EUROSKIN, 2008, PROP COD PRACT ART T; *FTC, 2010, FTC CONS AL; Green A, 2007, INT J CANCER, V120, P1116, DOI 10.1002/ijc.22453; Greenman J, 2010, J AM ACAD DERMATOL, V62, P685; Greinert R, 2001, EUR J CANCER PREV, V10, P157, DOI 10.1097/00008469-200104000-00007; International Agency for Research on Cancer, 2008, IARC WORK GROUP REP, V5; International Agency for Research on Cancer, 2006, IARC WORK GROUP REP, V1; Levine JA, 2005, J AM ACAD DERMATOL, V53, P1038, DOI 10.1016/j.jaad.2005.07.066; *PROS, 2010, NEWSL; *PROS, 2009, JOINT ACT SUNB 2008; *US FDA, 2010, FDA CONS HLTH INF IN; IS SUNLIGHT GOOD YOU; VITAMIN D IS ESSENTI	14	13	13	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	APR 16	2011	377	9774					1299	1301		10.1016/S0140-6736(10)61966-6	http://dx.doi.org/10.1016/S0140-6736(10)61966-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	755UE	21324519				2022-12-28	WOS:000289962900009
J	Drucker, DJ; Goldfine, AB				Drucker, Daniel J.; Goldfine, Allison B.			Cardiovascular safety and diabetes drug development	LANCET			English	Editorial Material							EXENATIDE TWICE; OPEN-LABEL; TYPE-2; LIRAGLUTIDE; THERAPIES; OUTCOMES; WEIGHT; RISK		[Drucker, Daniel J.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med, Toronto, ON M5G 1X5, Canada; [Goldfine, Allison B.] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02115 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.	Drucker, DJ (corresponding author), Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Med, Toronto, ON M5G 1X5, Canada.	d.drucker@utoronto.ca	Drucker, Daniel J/A-4092-2010	Goldfine, Allison/0000-0002-0345-1048				Ban K, 2009, J AM SOC HYPERTENS, V3, P245, DOI 10.1016/j.jash.2009.04.001; Best JH, 2009, DIABETIC MED, V26, P722, DOI 10.1111/j.1464-5491.2009.02752.x; Best JH, 2011, DIABETES CARE, V34, P90, DOI 10.2337/dc10-1393; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; Chatterjee DJ, 2009, J CLIN PHARMACOL, V49, P1353, DOI 10.1177/0091270009339189; Drucker DJ, 2008, LANCET, V372, P1240, DOI 10.1016/S0140-6736(08)61206-4; Frederich R, 2010, POSTGRAD MED, V122, P16, DOI 10.3810/pgm.2010.05.2138; Goldfine AB, 2008, NEW ENGL J MED, V359, P1092, DOI 10.1056/NEJMp0805758; James WPT, 2010, NEW ENGL J MED, V363, P905, DOI 10.1056/NEJMoa1003114; Kim D, 2007, DIABETES CARE, V30, P1487, DOI 10.2337/dc06-2375; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Ong KL, 2008, ANN EPIDEMIOL, V18, P222, DOI 10.1016/j.annepidem.2007.10.007; Orexigen, 2011, FDA ISS COMPL RESP N; US Food and Drug Administration, 2008, GUID IND DIAB MELL E	14	30	31	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 19	2011	377	9770					977	979		10.1016/S0140-6736(10)62299-4	http://dx.doi.org/10.1016/S0140-6736(10)62299-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	740FA	21316097				2022-12-28	WOS:000288775800009
J	Wang, JB; Feringa, BL				Wang, Jiaobing; Feringa, Ben L.			Dynamic Control of Chiral Space in a Catalytic Asymmetric Reaction Using a Molecular Motor	SCIENCE			English	Article							MICHAEL ADDITION	Enzymes and synthetic chiral catalysts have found widespread application to produce single enantiomers, but in situ switching of the chiral preference of a catalytic system is very difficult to achieve. Here, we report on a light-driven molecular motor with integrated catalytic functions in which the stepwise change in configuration during a 360 degrees unidirectional rotary cycle governs the catalyst performance both with respect to activity and absolute stereocontrol in an asymmetric transformation. During one full rotary cycle, catalysts are formed that provide either racemic (R,S) or preferentially the R or the S enantiomer of the chiral product of a conjugate addition reaction. This catalytic system demonstrates how different molecular tasks can be performed in a sequential manner, with the sequence controlled by the directionality of a rotary cycle.	[Feringa, Ben L.] Univ Groningen, Ctr Syst Chem, Stratingh Inst Chem, NL-9747 AG Groningen, Netherlands; Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen	Feringa, BL (corresponding author), Univ Groningen, Ctr Syst Chem, Stratingh Inst Chem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	b.l.feringa@rug.nl	Feringa, Ben L./C-1665-2013; Institute, Zernike/W-7033-2019		Netherlands Organization for Scientific Research (NWO-CW); European Research Council (ERC) [227897]	Netherlands Organization for Scientific Research (NWO-CW)(Netherlands Organization for Scientific Research (NWO)); European Research Council (ERC)(European Research Council (ERC))	We thank G. Caroli for assistance with the molecular modeling studies and W. R. Browne for discussion. This project was supported by the Netherlands Organization for Scientific Research (NWO-CW) and European Research Council (ERC grant 227897).	Anslyn E. V., 2006, MODERN PHYS ORGANIC; Doyle AG, 2007, CHEM REV, V107, P5713, DOI 10.1021/cr068373r; Eelkema R, 2006, NATURE, V440, P163, DOI 10.1038/440163a; Gotor V., 2008, ASYMMETRIC ORGANIC S; HIEMSTRA H, 1981, J AM CHEM SOC, V103, P417, DOI 10.1021/ja00392a029; Jacobsen E. N., 1999, COMPREHENSIVE ASYMME, V1-3; Knowles W.S., 2004, ASYMMETRIC CATALYSIS, P21; Koumura N, 1999, NATURE, V401, P152, DOI 10.1038/43646; MacMillan DWC, 2008, NATURE, V455, P304, DOI 10.1038/nature07367; Okino T, 2003, J AM CHEM SOC, V125, P12672, DOI 10.1021/ja036972z; Penning TM, 2001, CHEM REV, V101, P3027, DOI 10.1021/cr000049n; Pollard MM, 2008, ORG BIOMOL CHEM, V6, P507, DOI 10.1039/b715652a; Rabalakos C, 2008, J AM CHEM SOC, V130, P13524, DOI 10.1021/ja805390k; Rana NK, 2010, J ORG CHEM, V75, P2089, DOI 10.1021/jo902634a; SCHLIWA M, 2003, MOL MOTORS; Sibi MP, 2001, CURR ORG CHEM, V5, P719, DOI 10.2174/1385272013375265; Sohtome Y, 2010, ANGEW CHEM INT EDIT, V49, P9254, DOI 10.1002/anie.201005109; Stoll RS, 2010, ANGEW CHEM INT EDIT, V49, P5054, DOI 10.1002/anie.201000146; Wang JB, 2010, J AM CHEM SOC, V132, P4191, DOI 10.1021/ja910829b	19	415	417	2	314	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 18	2011	331	6023					1429	1432		10.1126/science.1199844	http://dx.doi.org/10.1126/science.1199844			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21310964				2022-12-28	WOS:000288504000039
J	Margo, KL				Margo, Katherine L.			Review: Corticosteroids improve short-term outcomes but worsen longer-term outcomes in some types of tendinopathy	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Penn, Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania	Margo, KL (corresponding author), Univ Penn, Sch Med, Philadelphia, PA 19104 USA.							Buchbinder R., 2003, COCHRANE DB SYST REV, V2003, pCD004016, DOI [DOI 10.1002/14651858.CD004016, 10.1002/14651858.CD004016]; Gaujoux-Viala C, 2009, ANN RHEUM DIS, V68, P1843, DOI 10.1136/ard.2008.099572	2	3	3	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4							JC2-5	10.7326/0003-4819-154-4-201102150-02005	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-02005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720VF	21320932				2022-12-28	WOS:000287310000004
J	Fortes, AD; Suard, E; Knight, KS				Fortes, A. Dominic; Suard, Emmanuelle; Knight, Kevin S.			Negative Linear Compressibility and Massive Anisotropic Thermal Expansion in Methanol Monohydrate	SCIENCE			English	Article							NEUTRON-DIFFRACTION; CRYSTAL-STRUCTURE; D2O ICE; INTERSTELLAR; CONSTANTS	The vast majority of materials shrink in all directions when hydrostatically compressed; exceptions include certain metallic or polymer foam structures, which may exhibit negative linear compressibility (NLC) (that is, they expand in one or more directions under hydrostatic compression). Materials that exhibit this property at the molecular level-crystalline solids with intrinsic NLC-are extremely uncommon. With the use of neutron powder diffraction, we have discovered and characterized both NLC and extremely anisotropic thermal expansion, including negative thermal expansion (NTE) along the NLC axis, in a simple molecular crystal (the deuterated 1:1 compound of methanol and water). Apically linked rhombuses, which are formed by the bridging of hydroxyl-water chains with methyl groups, extend along the axis of NLC/NTE and lead to the observed behavior.	[Fortes, A. Dominic] UCL, Dept Earth Sci, London WC1E 6BT, England; [Fortes, A. Dominic] UCL Birkbeck, Ctr Planetary Sci, London WC1E 6BT, England; [Suard, Emmanuelle] ILL, F-38042 Grenoble 9, France; [Knight, Kevin S.] Rutherford Appleton Lab, STFC, ISIS Facil, Didcot OX11 0QX, Oxon, England; [Knight, Kevin S.] Nat Hist Museum, London SW7 5BD, England	University of London; University College London; University of London; Birkbeck University London; University College London; Institut Laue-Langevin (ILL); UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Natural History Museum London	Fortes, AD (corresponding author), UCL, Dept Earth Sci, Gower St, London WC1E 6BT, England.	andrew.fortes@ucl.ac.uk	Fortes, A Dominic/C-1349-2011; SUARD, Emmanuelle/E-9579-2012; Knight, Kevin/N-9278-2019	Fortes, A Dominic/0000-0001-5907-2285; SUARD, Emmanuelle/0000-0001-5966-5929; Knight, Kevin/0000-0002-4826-0739	STFC (ex Particle Physics and Astronomy Research Council, PPARC) [PPA/P/S/2003/00247, PP/E006515/1]; STFC [PP/E006515/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/E006515/1] Funding Source: researchfish	STFC (ex Particle Physics and Astronomy Research Council, PPARC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank I. Wood for useful discussions; the Institut Laue Langevin and the ISIS facility for beam time; and J.-L. Laborier, C. Payre, and L. Gendrin for invaluable technical assistance in carrying out the high-pressure measurements at the ILL. This work was funded under fellowships from STFC (ex Particle Physics and Astronomy Research Council, PPARC) grant nos. PPA/P/S/2003/00247 and PP/E006515/1.	Allamandola LJ, 1999, SPACE SCI REV, V90, P219, DOI 10.1023/A:1005210417396; Baughman RH, 1998, SCIENCE, V279, P1522, DOI 10.1126/science.279.5356.1522; BERNSTEIN MP, 1995, ASTROPHYS J, V454, P327, DOI 10.1086/176485; Cruikshank DP, 2005, SPACE SCI REV, V116, P421, DOI 10.1007/s11214-005-1964-0; Das D, 2010, NAT MATER, V9, P36, DOI [10.1038/nmat2583, 10.1038/NMAT2583]; Fortes AD, 2006, CHEM PHYS LETT, V431, P283, DOI 10.1016/j.cplett.2006.09.077; Fortes AD, 2010, J APPL CRYSTALLOGR, V43, P328, DOI 10.1107/S0021889810005595; Fortes AD, 2009, J APPL CRYSTALLOGR, V42, P1054, DOI 10.1107/S0021889809035705; Fortes AD, 2009, J APPL CRYSTALLOGR, V42, P846, DOI 10.1107/S0021889809027897; Fortes AD, 2010, SPACE SCI REV, V153, P185, DOI 10.1007/s11214-010-9633-3; Goodwin A. L., 2009, Z KRIST S30, V1, P1; Grima JN, 2008, PHYS STATUS SOLIDI B, V245, P2405, DOI 10.1002/pssb.200880267; HEWAT AW, 1976, NUCL INSTRUM METHODS, V137, P463, DOI 10.1016/0029-554X(76)90469-9; Ibberson R. M., 1992, RAL92031; KARGEL JS, 1992, ICARUS, V100, P556, DOI 10.1016/0019-1035(92)90118-Q; Lakes R, 2008, PHYS STATUS SOLIDI B, V245, P545, DOI 10.1002/pssb.200777708; MCCANN DR, 1972, J APPL PHYS, V43, P1432, DOI 10.1063/1.1661336; MITZDORF U, 1971, J ACOUST SOC AM, V49, P723, DOI 10.1121/1.1912408; Nakayama H., 1997, AM CHEM SOC DIV FUEL, V42, P516; OTT JB, 1979, J CHEM THERMODYN, V11, P739; ROTTGER K, 1994, ACTA CRYSTALLOGR B, V50, P644, DOI 10.1107/S0108768194004933; Sloan E. D., 1990, CLATHRATE HYDRATES N; Yukhnevich GV, 1998, J MOL STRUCT, V447, P257, DOI 10.1016/S0022-2860(98)00330-5	24	178	179	5	128	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					742	746		10.1126/science.1198640	http://dx.doi.org/10.1126/science.1198640			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21311017				2022-12-28	WOS:000287205700063
J	Reichman, OJ; Jones, MB; Schildhauer, MP				Reichman, O. J.; Jones, Matthew B.; Schildhauer, Mark P.			Challenges and Opportunities of Open Data in Ecology	SCIENCE			English	Editorial Material								Ecology is a synthetic discipline benefiting from open access to data from the earth, life, and social sciences. Technological challenges exist, however, due to the dispersed and heterogeneous nature of these data. Standardization of methods and development of robust metadata can increase data access but are not sufficient. Reproducibility of analyses is also important, and executable workflows are addressing this issue by capturing data provenance. Sociological challenges, including inadequate rewards for sharing data, must also be resolved. The establishment of well-curated, federated data repositories will provide a means to preserve data while promoting attribution and acknowledgement of its use.	[Reichman, O. J.; Jones, Matthew B.; Schildhauer, Mark P.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA	National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara	Reichman, OJ (corresponding author), Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, 735 State St,Suite 300, Santa Barbara, CA 93101 USA.	ojreichman@gmail.com	Jones, Matthew/J-9310-2013	Jones, Matthew/0000-0003-0077-4738; Newman, Gregory/0000-0003-0503-5782; Schildhauer, Mark/0000-0003-0632-7576	Div Of Biological Infrastructure [0753138] Funding Source: National Science Foundation; Office of Advanced Cyberinfrastructure (OAC) [0830944] Funding Source: National Science Foundation	Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Office of Advanced Cyberinfrastructure (OAC)(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))		Andelman SJ, 2004, BIOSCIENCE, V54, P240, DOI 10.1641/0006-3568(2004)054[0240:UECTAD]2.0.CO;2; Bizer C., 2008, P 17 INT C WORLD WID, P1265, DOI DOI 10.1145/1367497.1367760; Buneman P, 2000, LECT NOTES COMPUT SC, V1974, P87; Carpenter SR, 2009, BIOSCIENCE, V59, P699, DOI 10.1525/bio.2009.59.8.11; Chavan V. S., 2010, STATE OF THE NETWORK; Crone TJ, 2010, SCIENCE, V330, P634, DOI 10.1126/science.1195840; Hackett EJ., 2008, SCI COLLABORATION IN, P277; Heidorn PB, 2008, LIBR TRENDS, V57, P280; Jones MB, 2006, ANNU REV ECOL EVOL S, V37, P519, DOI 10.1146/annurev.ecolsys.37.091305.110031; Madin JS, 2008, TRENDS ECOL EVOL, V23, P159, DOI 10.1016/j.tree.2007.11.007; Michener WK, 2006, ECOL INFORM, V1, P3, DOI 10.1016/j.ecoinf.2005.08.004; Missier P., 2010, WORKS 2010 5 WORKSH; Piwowar HA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000308; San Gil I., 2010, J LIB METADATA, V10, P99; Savage CJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007078; Sutherland WJ, 2004, TRENDS ECOL EVOL, V19, P305, DOI 10.1016/j.tree.2004.03.018; Thebeau L.C., 1981, INT OIL SPILL C P, V1981, P467; Vision TJ, 2010, BIOSCIENCE, V60, P330, DOI 10.1525/bio.2010.60.5.2; White H., 2008, DUBL C, P157	19	405	437	11	247	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					703	705		10.1126/science.1197962	http://dx.doi.org/10.1126/science.1197962			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21311007	Green Submitted			2022-12-28	WOS:000287205700050
J	Riley, RD; Higgins, JPT; Deeks, JJ				Riley, Richard D.; Higgins, Julian P. T.; Deeks, Jonathan J.			Interpretation of random effects meta-analyses	BMJ-BRITISH MEDICAL JOURNAL			English	Article												r.d.riley@bham.ac.uk	Deeks, Jon/AAV-5745-2020; Riley, Richard David/ABE-5877-2020; Riley, Richard/G-2406-2011; Higgins, Julian PT/H-4008-2011	Deeks, Jon/0000-0002-8850-1971; Riley, Richard David/0000-0001-8699-0735; Higgins, Julian PT/0000-0002-8323-2514	Medical Research Council [MC_U105285807, G0800808] Funding Source: Medline; MRC [MC_U105285807, G0800808] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; Bachmann S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1718; Hauser W, 2009, JAMA-J AM MED ASSOC, V301, P198, DOI 10.1001/jama.2008.944; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Higgins Julian, 2002, J Health Serv Res Policy, V7, P51, DOI 10.1258/1355819021927674; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; King J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001992.pub2; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Riley RD, 2009, BRIT J CANCER, V100, P1219, DOI 10.1038/sj.bjc.6604999; Riley RD, 2010, J CLIN EPIDEMIOL; Riley RD, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c221; Sutton AJAK, 2000, METHODS METAANALYSIS; THOMPSON SG, 1994, BMJ-BRIT MED J, V309, P1351, DOI 10.1136/bmj.309.6965.1351; Thompson SG, 2002, STAT MED, V21, P1559, DOI 10.1002/sim.1187	15	1388	1397	5	40	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 10	2011	342								d549	10.1136/bmj.d549	http://dx.doi.org/10.1136/bmj.d549			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V41KS	21310794				2022-12-28	WOS:000209545700001
J	Smith, SR				Smith, Stephen R.			A Recipe for Medical Schools to Produce Primary Care Physicians.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA	Brown University	Smith, SR (corresponding author), Brown Univ, Warren Alpert Med Sch, Providence, RI 02912 USA.							Fisher ES, 2009, NEW ENGL J MED, V360, P849, DOI 10.1056/NEJMp0809794; Jeffe DB, 2010, ACAD MED, V85, P947, DOI 10.1097/ACM.0b013e3181dbe77d; Phillips RL, 2009, SPECIALTY GEOGRAPHIC	3	27	27	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2011	364	6					496	497		10.1056/NEJMp1012495	http://dx.doi.org/10.1056/NEJMp1012495			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	718QH	21306236				2022-12-28	WOS:000287139900002
J	Zilberberg, MD				Zilberberg, Marya D.			The Clinical Research Enterprise Time to Change Course?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		[Zilberberg, Marya D.] EviMed Res Grp, Goshen, MA 01032 USA; [Zilberberg, Marya D.] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Amherst, MA 01003 USA; [Zilberberg, Marya D.] Thomas Jefferson Univ, Jefferson Sch Populat Hlth, Philadelphia, PA 19107 USA	University of Massachusetts System; University of Massachusetts Amherst; Jefferson University	Zilberberg, MD (corresponding author), EviMed Res Grp, POB 303, Goshen, MA 01032 USA.	evimedgroup@gmail.com						Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Cabana MD, 1999, JAMA-J AM MED ASSOC, V282, P1458, DOI 10.1001/jama.282.15.1458; Gabler NB, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-43; Guyatt GH, 2000, JAMA-J AM MED ASSOC, V284, P1290, DOI 10.1001/jama.284.10.1290; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Landrigan C, 2010, NEW ENGL J MED, V363, P2573; Landrigan CP, 2010, NEW ENGL J MED, V363, P2124, DOI 10.1056/NEJMsa1004404; PISANI E, PROSPECT; Starfield B, 2000, JAMA-J AM MED ASSOC, V284, P483, DOI 10.1001/jama.284.4.483; BMJ CLIN EVIDENCE	11	12	12	0	4	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2011	305	6					604	605		10.1001/jama.2011.104	http://dx.doi.org/10.1001/jama.2011.104			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	717XI	21304086				2022-12-28	WOS:000287080500027
J	Ranpura, V; Hapani, S; Wu, SH				Ranpura, Vishal; Hapani, Sanjaykumar; Wu, Shenhong			Treatment-Related Mortality With Bevacizumab in Cancer Patients A Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PHASE-III TRIAL; METASTATIC COLORECTAL-CANCER; ENDOTHELIAL GROWTH-FACTOR; ADVERSE DRUG-REACTIONS; RENAL-CELL CARCINOMA; 1ST-LINE THERAPY; TUMOR-GROWTH; COMBINATION; FLUOROURACIL; LEUCOVORIN	Context Fatal adverse events (FAEs) have been reported in cancer patients treated with the widely used angiogenesis inhibitor bevacizumab in combination with chemotherapy. Currently, the role of bevacizumab in treatment-related mortality is not clear. Objective To perform a systematic review and meta-analysis of published randomized controlled trials (RCTs) to determine the overall risk of FAEs associated with bevacizumab. Data Sources PubMed, EMBASE, and Web of Science databases as well as abstracts presented at American Society of Clinical Oncology conferences from January 1966 to October 2010 were searched to identify relevant studies. Study Selection and Data Extraction Eligible studies included prospective RCTs in which bevacizumab in combination with chemotherapy or biological therapy was compared with chemotherapy or biological therapy alone. Summary incidence rates, relative risks (RRs), and 95% confidence intervals (CIs) were calculated using fixed-or random-effects models. Data Synthesis A total of 10 217 patients with a variety of advanced solid tumors from 16 RCTs were included in the analysis. The overall incidence of FAEs with bevacizumab was 2.5% (95% CI, 1.7%-3.9%). Compared with chemotherapy alone, the addition of bevacizumab was associated with an increased risk of FAEs, with an RR of 1.46 (95% CI, 1.09-1.94; P=.01; incidence, 2.5% vs 1.7%). This association varied significantly with chemotherapeutic agents (P=.045) but not with tumor types (P=.13) or bevacizumab doses (P=.16). Bevacizumab was associated with an increased risk of FAEs in patients receiving taxanes or platinum agents (RR, 3.49; 95% CI, 1.82-6.66; incidence, 3.3% vs 1.0%) but was not associated with increased risk of FAEs when used in conjunction with other agents (RR, 0.85; 95% CI, 0.25-2.88; incidence, 0.8% vs 0.9%). The most common causes of FAEs were hemorrhage (23.5%), neutropenia (12.2%), and gastrointestinal tract perforation (7.1%). Conclusion In a meta-analysis of RCTs, bevacizumab in combination with chemotherapy or biological therapy, compared with chemotherapy alone, was associated with increased treatment-related mortality. JAMA. 2011;305(5):487-494 www.jama.com	[Hapani, Sanjaykumar; Wu, Shenhong] SUNY Stony Brook, Ctr Canc, Div Hematol & Med Oncol, Stony Brook, NY 11794 USA; [Ranpura, Vishal] SUNY Stony Brook, Ctr Canc, Dept Med, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Wu, SH (corresponding author), SUNY Stony Brook, Ctr Canc, Div Hematol & Med Oncol, 9447 SUNY, Stony Brook, NY 11794 USA.	shenhong.wu@stonybrook.edu			Research Foundation of the State University of New York at Stony Brook	Research Foundation of the State University of New York at Stony Brook	Partial funding was provided by the Research Foundation of the State University of New York at Stony Brook.	[Anonymous], 2006, NAT CANC I COMM TOX; Buajordet I, 2001, J INTERN MED, V250, P327, DOI 10.1046/j.1365-2796.2001.00892.x; Cavallaro U, 2000, J NEURO-ONCOL, V50, P63, DOI 10.1023/A:1006414621286; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Ebbesen J, 2001, ARCH INTERN MED, V161, P2317, DOI 10.1001/archinte.161.19.2317; Escudier B, 2007, LANCET, V370, P2103, DOI 10.1016/S0140-6736(07)61904-7; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Folkman J, 2002, SEMIN ONCOL, V29, P15, DOI 10.1053/sonc.2002.37263; *GEN, 2009, AV BEV PROD INS; Giantonio BJ, 2007, J CLIN ONCOL, V25, P1539, DOI 10.1200/JCO.2006.09.6305; Gordon MS, 2005, ONCOLOGY-BASEL, V69, P25, DOI 10.1159/000088481; Gressett SM, 2009, ANN PHARMACOTHER, V43, P490, DOI 10.1345/aph.1L426; Hapani S, 2009, LANCET ONCOL, V10, P559, DOI 10.1016/S1470-2045(09)70112-3; Herbst RS, 2007, J CLIN ONCOL, V25, P4743, DOI 10.1200/JCO.2007.12.3026; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jadad AR, 1996, CONTROL CLIN TRIALS, V17, P1, DOI 10.1016/0197-2456(95)00134-4; Johnson DH, 2004, J CLIN ONCOL, V22, P2184, DOI 10.1200/JCO.2004.11.022; Kabbinavar F, 2003, J CLIN ONCOL, V21, P60, DOI 10.1200/JCO.2003.10.066; Kabbinavar FF, 2005, J CLIN ONCOL, V23, P3697, DOI 10.1200/JCO.2005.05.112; Kelly WK, 2010, J CLIN ONCOL, V28, DOI 10.1200/jco.2010.28.18_suppl.lba4511; Lazarou J, 1998, JAMA-J AM MED ASSOC, V279, P1200, DOI 10.1001/jama.279.15.1200; Miles D., 2008, J CLIN ONCOLOGY, V26, p43s; Miles DW, 2010, J CLIN ONCOL, V28, P3239, DOI 10.1200/JCO.2008.21.6457; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Miller KD, 2005, J CLIN ONCOL, V23, P792, DOI 10.1200/JCO.2005.05.098; Mol L, 2010, ANN ONCOL, V21, P415, DOI 10.1093/annonc/mdp330; Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Rini BI, 2008, J CLIN ONCOL, V26, P5422, DOI 10.1200/JCO.2008.16.9847; Saltz LB, 2008, J CLIN ONCOL, V26, P2013, DOI 10.1200/JCO.2007.14.9930; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Van Cutsem E, 2009, J CLIN ONCOL, V27, P2231, DOI 10.1200/JCO.2008.20.0238; Wester K, 2008, BRIT J CLIN PHARMACO, V65, P573, DOI 10.1111/j.1365-2125.2007.03064.x; Wu SH, 2010, J AM SOC NEPHROL, V21, P1381, DOI 10.1681/ASN.2010020167; Zhu XL, 2007, AM J KIDNEY DIS, V49, P186, DOI 10.1053/j.ajkd.2006.11.039	36	322	340	1	34	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2011	305	5					487	494		10.1001/jama.2011.51	http://dx.doi.org/10.1001/jama.2011.51			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	714LI	21285426	Bronze			2022-12-28	WOS:000286810700022
J	Sandset, EC; Bath, PMW; Boysen, G; Jatuzis, D; Korv, J; Luders, S; Murray, GD; Richter, PS; Roine, RO; Terent, A; Thijs, V; Berge, E				Sandset, Else Charlotte; Bath, Philip M. W.; Boysen, Gudrun; Jatuzis, Dalius; Korv, Janika; Lueders, Stephan; Murray, Gordon D.; Richter, Przemyslaw S.; Roine, Risto O.; Terent, Andreas; Thijs, Vincent; Berge, Eivind		SCAST Study Grp	The angiotensin-receptor blocker candesartan for treatment of acute stroke (SCAST): a randomised, placebo-controlled, double-blind trial	LANCET			English	Article							CEREBRAL-HEMORRHAGE TRIAL; BLOOD-PRESSURE REDUCTION; ACUTE ISCHEMIC STROKE; INTRAVENOUS NIMODIPINE; MANAGEMENT; OUTCOMES; INTERVENTION; GUIDELINES; DESIGN; HYPERTENSION	Background Raised blood pressure is common in acute stroke, and is associated with an increased risk of poor outcomes. We aimed to examine whether careful blood-pressure lowering treatment with the angiotensin-receptor blocker candesartan is beneficial in patients with acute stroke and raised blood pressure. Methods Participants in this randomised, placebo-controlled, double-blind trial were recruited from 146 centres in nine north European countries. Patients older than 18 years with acute stroke (ischaemic or haemorrhagic) and systolic blood pressure of 140 mm Hg or higher were included within 30 h of symptom onset. Patients were randomly allocated to candesartan or placebo (1:1) for 7 days, with doses increasing from 4 mg on day 1 to 16 mg on days 3 to 7. Randomisation was stratified by centre, with blocks of six packs of candesartan or placebo. Patients and investigators were masked to treatment allocation. There were two co-primary effect variables: the composite endpoint of vascular death, myocardial infarction, or stroke during the first 6 months; and functional outcome at 6 months, as measured by the modified Rankin Scale. Analyses were by intention to treat. The study is registered, number NCT00120003 (ClinicalTrials.gov), and ISRCTN13643354. Findings 2029 patients were randomly allocated to treatment groups (1017 candesartan, 1012 placebo), and data for status at 6 months were available for 2004 patients (99%; 1000 candesartan, 1004 placebo). During the 7-day treatment period, blood pressures were significantly lower in patients allocated candesartan than in those on placebo (mean 147/82 mm Hg [SD 23/14] in the candesartan group on day 7 vs 152/84 mm Hg [22/14] in the placebo group; p<0.0001). During 6 months' follow-up, the risk of the composite vascular endpoint did not differ between treatment groups (candesartan, 120 events, vs placebo, 111 events; adjusted hazard ratio 1.09, 95% CI 0.84-1.41; p=0.52). Analysis of functional outcome suggested a higher risk of poor outcome in the candesartan group (adjusted common odds ratio 1.17, 95% CI 100-138; p=0.048 [not significant at p <= 0.025 level]). The observed effects were similar for all prespecified secondary endpoints (including death from any cause, vascular death, ischaemic stroke, haemorrhagic stroke, myocardial infarction, stroke progression, symptomatic hypotension, and renal failure) and outcomes (Scandinavian Stroke Scale score at 7 days and Barthel index at 6 months), and there was no evidence of a differential effect in any of the prespecified subgroups. During follow-up, nine (1%) patients on candesartan and five (<1%) on placebo had symptomatic hypotension, and renal failure was reported for 18 (2%) patients taking candesartan and 13 (1%) allocated placebo. Interpretation There was no indication that careful blood-pressure lowering treatment with the angiotensin-receptor blocker candesartan is beneficial in patients with acute stroke and raised blood pressure. If anything, the evidence suggested a harmful effect.	[Sandset, Else Charlotte; Berge, Eivind] Univ Oslo, Ulleval Hosp, Dept Internal Med, NO-0407 Oslo, Norway; [Sandset, Else Charlotte] Univ Oslo, Ulleval Hosp, Dept Haematol, NO-0407 Oslo, Norway; [Berge, Eivind] Univ Oslo, Ulleval Hosp, Dept Cardiol, NO-0407 Oslo, Norway; [Sandset, Else Charlotte] Univ Oslo, Inst Clin Med, NO-0407 Oslo, Norway; [Bath, Philip M. W.] Univ Nottingham, Stroke Trials Unit, Div Stroke, Nottingham NG7 2RD, England; [Boysen, Gudrun] Bispebjerg Hosp, Dept Neurol, DK-2400 Copenhagen, Denmark; [Boysen, Gudrun] Univ Copenhagen, Copenhagen, Denmark; [Jatuzis, Dalius] Vilnius Univ, Fac Med, Vilnius, Lithuania; [Jatuzis, Dalius] Vilnius Univ, Santariskiu Klinikos Hosp, Dept Neurol, Vilnius, Lithuania; [Korv, Janika] Tartu Univ Hosp, Dept Neurol, Tartu, Estonia; [Lueders, Stephan] St Josefs Hosp, Dept Internal Med, Cloppenburg, Germany; [Murray, Gordon D.] Univ Edinburgh, Ctr Populat Hlth Sci, Edinburgh, Midlothian, Scotland; [Richter, Przemyslaw S.] Inst Psychiat & Neurol, Dept Neurol, Warsaw, Poland; [Roine, Risto O.] Turku Univ Hosp, Dept Neurol, FIN-20520 Turku, Finland; [Terent, Andreas] Uppsala Univ, Dept Med Sci, Uppsala, Sweden; [Thijs, Vincent] Univ Hosp Leuven, Dept Neurol, Louvain, Belgium; [Thijs, Vincent] VIB, Vesalius Res Ctr, Louvain, Belgium	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Nottingham; University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Vilnius University; Vilnius University; University of Edinburgh; Institute of Psychiatry & Neurology; University of Turku; Uppsala University; KU Leuven; University Hospital Leuven; Flanders Institute for Biotechnology (VIB)	Berge, E (corresponding author), Univ Oslo, Ulleval Hosp, Dept Internal Med, Kirkeveien 166, NO-0407 Oslo, Norway.	eivind.berge@medisin.uio.no	Vanhooren, Geert/H-4433-2011; Kõrv, Janika/I-4395-2015; Thijs, Vincent/C-3647-2009; Jatuzis, Dalius/I-2048-2016; Brola, Waldemar/D-8813-2014; Jatužis, Dalius/U-8125-2019; Bath, Philip/F-9020-2011	Vanhooren, Geert/0000-0001-6818-9346; Kõrv, Janika/0000-0002-6074-0727; Thijs, Vincent/0000-0002-6614-8417; Jatuzis, Dalius/0000-0001-6159-4795; Brola, Waldemar/0000-0002-7955-3454; Jatužis, Dalius/0000-0001-6159-4795; Thorud, Hanne-Mari Schiotz/0000-0002-4045-0909; Brin, Vadim/0000-0001-8382-3210; Iversen, Helle Klingenberg/0000-0002-5880-6352; Andersen, Grethe/0000-0001-6807-2500; Luders, Stephan/0000-0003-3007-9015; Ronning, Ole Morten/0000-0001-5080-5788; Bath, Philip/0000-0003-2734-5132; Laska, Ann Charlotte/0000-0002-7330-940X; Murray, Gordon/0000-0001-9866-4734; Roine, Risto/0000-0002-3824-3003	Boehringer Ingelheim; Sanofi-Aventis; Novartis; Solvay MSD; AstraZeneca; Abbott; Takeda; Oslo University Hospital Ulleval; South-Eastern Norway Regional Health Authority; MRC [G0800803] Funding Source: UKRI; Medical Research Council [G0800803] Funding Source: researchfish	Boehringer Ingelheim(Boehringer Ingelheim); Sanofi-Aventis(Sanofi-Aventis); Novartis(Novartis); Solvay MSD(Solvay SA); AstraZeneca(AstraZeneca); Abbott(Abbott Laboratories); Takeda(Takeda Pharmaceutical Company Ltd); Oslo University Hospital Ulleval; South-Eastern Norway Regional Health Authority; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Some of the authors have previously received payment from pharmaceutical companies, but all of these activities were unrelated to the submitted work. PMWB has received payment for lectures from Boehringer Ingelheim, payment for board membership and expenses related to meetings from Boehringer Ingelheim and Lundbeck, and has accepted support to his institution for academic trials from Boehringer Ingelheim. SL has received payment for lectures from Sanofi-Aventis, Novartis, Solvay MSD, and AstraZeneca. AT has accepted support to his institutions for academic trials from AstraZeneca. VT has received payment for lectures from Abbott and Takeda, payment to his institution for board membership from Shire, Boehringer Ingelheim, Sygnis, and MSD Belgium, and expenses related to meetings from Shire and Boehringer Ingelheim. EB has received payment for lectures from AstraZeneca and payment for board membership and expenses related to meetings from Bayer Healthcare. All other authors declare that they have no conflicts of interest.; The sponsor of the trial was Oslo University Hospital Ulleval. We thank all patients who participated in the trial and the many collaborators at the participating centres; AstraZeneca for study drugs and economic grants; the South-Eastern Norway Regional Health Authority and Takeda for economic grants; P Hasvold and A Ljunggren for continuous support; and 5 Berge, T Hamre, I Hedegaard, E Jonsson, E Marcelis, and M Torp for secretarial assistance.	Adams HP, 2007, CIRCULATION, V115, pE478, DOI 10.1161/CIRCULATIONAHA.107.181486; Ahmed N, 2000, STROKE, V31, P1250, DOI 10.1161/01.STR.31.6.1250; Anderson CS, 2008, LANCET NEUROL, V7, P391, DOI 10.1016/S1474-4422(08)70069-3; [Anonymous], 2006, INT J STROKE, V1, P245; AZCONA A, 1990, DRUGS, V40, P52, DOI 10.2165/00003495-199000402-00013; BARER DH, 1988, BRIT MED J, V296, P737, DOI 10.1136/bmj.296.6624.737; Bath PMW, 2007, STROKE, V38, P1911, DOI 10.1161/STROKEAHA.106.474080; Berge E, 2002, CEREBROVASC DIS, V13, P73, DOI 10.1159/000047752; BONITA R, 1988, STROKE, V19, P1497, DOI 10.1161/01.STR.19.12.1497; Broderick J, 2007, CIRCULATION, V116, pE391, DOI 10.1161/CIRCULATIONAHA.107.183689; Dahlof B, 2002, LANCET, V359, P995, DOI 10.1016/S0140-6736(02)08089-3; Delcourt C, 2010, INT J STROKE, V5, P110, DOI 10.1111/j.1747-4949.2010.00415.x; Fagan SC, 2006, J HYPERTENS, V24, P535, DOI 10.1097/01.hjh.0000209990.41304.43; Geeganage C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002839.pub2; Gray LJ, 2009, J STROKE CEREBROVASC, V18, P466, DOI 10.1016/j.jstrokecerebrovasdis.2009.02.003; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; KASTE M, 1994, STROKE, V25, P1348, DOI 10.1161/01.STR.25.7.1348; Kozak W, 2008, J PHARMACOL EXP THER, V326, P773, DOI 10.1124/jpet.108.139618; Lees KR, 2004, LANCET, V363, P439, DOI 10.1016/S0140-6736(04)15490-1; Leonardi-Bee J, 2002, STROKE, V33, P1315, DOI 10.1161/01.STR.0000014509.11540.66; Limburg M, 1995, STROKE, V26, P353; LINDENSTROM E, 1991, CEREBROVASC DIS, V1, P103, DOI 10.1159/000108825; Lithell H, 2003, J HYPERTENS, V21, P875, DOI 10.1097/00004872-200305000-00011; LOEWEN SC, 1990, STROKE, V21, P78, DOI 10.1161/01.STR.21.1.78; McHugh GS, 2010, CLIN TRIALS, V7, P44, DOI 10.1177/1740774509356580; Murray GD, 2005, J NEUROTRAUM, V22, P511, DOI 10.1089/neu.2005.22.511; NORRIS JW, 1994, CEREBROVASC DIS, V4, P194, DOI 10.1159/000108481; Qureshi AI, 2008, CIRCULATION, V118, P176, DOI 10.1161/CIRCULATIONAHA.107.723874; Qureshi AI, 2007, AM J EMERG MED, V25, P32, DOI 10.1016/j.ajem.2006.07.008; Sandset EC, 2010, INT J STROKE, V5, P423, DOI 10.1111/j.1747-4949.2010.00473.x; Schrader J, 2005, STROKE, V36, P1218, DOI 10.1161/01.STR.0000166048.35740.a9; Schrader J, 2003, STROKE, V34, P1699, DOI 10.1161/01.STR.0000075777.18006.89; Squire IB, 1996, CEREBROVASC DIS, V6, P156, DOI 10.1159/000108016; Strandgaard S, 1978, STAND, V57, P1; WAHLGREN NG, 1994, CEREBROVASC DIS, V4, P204, DOI 10.1159/000108483; Willmot M, 2004, HYPERTENSION, V43, P18, DOI 10.1161/01.HYP.0000105052.65787.35; World Medical Association Inc. Declaration of Helsinki, 2009, J INDIAN MED ASSOC, V107, P403; Yusuf S, 2000, NEW ENGL J MED, V342, P145	39	363	376	2	36	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2011	377	9767					741	750		10.1016/S0140-6736(11)60104-9	http://dx.doi.org/10.1016/S0140-6736(11)60104-9			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729JQ	21316752				2022-12-28	WOS:000287946000031
J	Piazza, G; Goldhaber, SZ				Piazza, Gregory; Goldhaber, Samuel Z.			CURRENT CONCEPTS Chronic Thromboembolic Pulmonary Hypertension	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							INTENSITY WARFARIN THERAPY; LONG-TERM; ARTERIAL-HYPERTENSION; ENDARTERECTOMY; EMBOLISM; ECHOCARDIOGRAPHY; TREPROSTINIL; PREVENTION; PERSISTENT; RISK		[Piazza, Gregory] Brigham & Womens Hosp, Div Cardiovasc Med, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Piazza, G (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, Dept Med, 75 Francis St, Boston, MA 02115 USA.	gpiazza@partners.org						AUGER WR, 1992, RADIOLOGY, V182, P393, DOI 10.1148/radiology.182.2.1732955; Barst RJ, 2006, J AM COLL CARDIOL, V47, P2049, DOI 10.1016/j.jacc.2006.01.057; Becattini C, 2006, CHEST, V130, P172, DOI 10.1378/chest.130.1.172; Bonderman D, 2005, THROMB HAEMOSTASIS, V93, P512, DOI 10.1160/TH04-10-0657; Bonderman D, 2009, EUR RESPIR J, V33, P325, DOI 10.1183/09031936.00087608; Bonderman D, 2008, ARTERIOSCL THROM VAS, V28, P678, DOI 10.1161/ATVBAHA.107.156000; Bonderman D, 2007, CIRCULATION, V115, P2153, DOI 10.1161/CIRCULATIONAHA.106.661041; Casaclang-Verzosa G, 2006, MAYO CLIN PROC, V81, P777, DOI 10.4065/81.6.777; Condliffe R, 2008, AM J RESP CRIT CARE, V177, P1122, DOI 10.1164/rccm.200712-1841OC; Corsico AG, 2008, AM J RESP CRIT CARE, V178, P419, DOI 10.1164/rccm.200801-101OC; de Perrot M, 2007, CHEST, V132, P780, DOI 10.1378/chest.06-2493; Dentali F, 2009, THROMB RES, V124, P256, DOI 10.1016/j.thromres.2009.01.003; DICARLO LA, 1982, AM HEART J, V104, P879, DOI 10.1016/0002-8703(82)90030-8; Feinstein JA, 2001, CIRCULATION, V103, P10; Galie N, 2009, CIRCULATION, V119, P2894, DOI 10.1161/CIRCULATIONAHA.108.839274; Iino M, 2008, EUR RADIOL, V18, P792, DOI 10.1007/s00330-007-0829-1; Jais X, 2008, J AM COLL CARDIOL, V52, P2127, DOI 10.1016/j.jacc.2008.08.059; Jensen KW, 2009, CIRCULATION, V120, P1248, DOI 10.1161/CIRCULATIONAHA.109.865881; Kearon C, 2003, NEW ENGL J MED, V349, P631, DOI 10.1056/NEJMoa035422; Keogh AM, 2009, J AM COLL CARDIOL, V54, pS67, DOI 10.1016/j.jacc.2009.04.016; Kim NH, 2010, EUR RESPIR REV, V19, P68, DOI 10.1183/09059180.00007909; Kline JA, 2009, CHEST, V136, P1202, DOI 10.1378/chest.08-2988; Kominami S, 2009, J HUM GENET, V54, P108, DOI 10.1038/jhg.2008.15; Kreitner KF, 2007, EUR RADIOL, V17, P11, DOI 10.1007/s00330-006-0327-x; Lang IM, 2008, CURR OPIN CARDIOL, V23, P555, DOI 10.1097/HCO.0b013e328311f254; Li JH, 2007, CHEST, V132, P793, DOI 10.1378/chest.07-0366; Matsuda H, 2006, ANN THORAC SURG, V82, P1338, DOI 10.1016/j.athoracsur.2006.03.105; Morris TA, 2007, THROMB RES, V119, P257, DOI 10.1016/j.thromres.2006.02.010; Morris TA, 2006, AM J RESP CRIT CARE, V173, P1270, DOI 10.1164/rccm.200506-916OC; Morris TA, 2009, BLOOD, V114, P1929, DOI 10.1182/blood-2009-03-208264; MOSER KM, 1973, CHEST, V64, P29, DOI 10.1378/chest.64.1.29; Oudiz RJ, 2009, J AM COLL CARDIOL, V54, P1971, DOI 10.1016/j.jacc.2009.07.033; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Piazza G, 2010, CIRCULATION, V122, P1124, DOI 10.1161/CIRCULATIONAHA.110.961136; Piovella F, 2006, SEMIN THROMB HEMOST, V32, P848, DOI 10.1055/s-2006-955467; Reesink HJ, 2007, J THORAC CARDIOV SUR, V133, P510, DOI 10.1016/j.jtcvs.2006.10.020; Reesink HJ, 2007, J THORAC CARDIOV SUR, V133, P58, DOI 10.1016/j.jtcvs.2006.09.032; Reesink HJ, 2006, CIRC J, V70, P1058, DOI 10.1253/circj.70.1058; Reichelt A, 2009, EUR J RADIOL, V71, P49, DOI 10.1016/j.ejrad.2008.03.016; Reichenberger F, 2007, EUR RESPIR J, V30, P922, DOI 10.1183/09031936.00039007; Ribeiro A, 1999, CIRCULATION, V99, P1325, DOI 10.1161/01.CIR.99.10.1325; Ridker PM, 2003, NEW ENGL J MED, V348, P1425, DOI 10.1056/NEJMoa035029; Simonneau G, 2009, J AM COLL CARDIOL, V54, pS43, DOI [10.1016/j.jacc.2009.04.012, 10.1016/j.jacc.2013.10.029]; Skoro-Sajer N, 2007, J THROMB HAEMOST, V5, P483, DOI 10.1111/j.1538-7836.2007.02394.x; Skoro-Sajer N, 2009, CIRCULATION, V119, P298, DOI 10.1161/CIRCULATIONAHA.108.794610; Stein PD, 2010, ANN INTERN MED, V152, P434, DOI 10.7326/0003-4819-152-7-201004060-00008; Tunariu N, 2007, J NUCL MED, V48, P680, DOI 10.2967/jnumed.106.039438; Ulrich S, 2006, CHEST, V130, P841, DOI 10.1378/chest.130.3.841; Vizza CD, 2006, CARDIOLOGY, V106, P168, DOI 10.1159/000092920; Voswinckel R, 2006, J AM COLL CARDIOL, V48, P1672, DOI 10.1016/j.jacc.2006.06.062	50	232	241	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2011	364	4					351	360		10.1056/NEJMra0910203	http://dx.doi.org/10.1056/NEJMra0910203			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711LH	21268727				2022-12-28	WOS:000286592600010
J	Coombes, R				Coombes, Rebecca			Briefing Health and Social Care Bill	BRITISH MEDICAL JOURNAL			English	Editorial Material												rcoombes@bmjgroup.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2011	342								d507	10.1136/bmj.d507	http://dx.doi.org/10.1136/bmj.d507			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	715ME	21270085				2022-12-28	WOS:000286887800007
J	Iannuzzi, MC; Fontana, JR				Iannuzzi, Michael C.; Fontana, Joseph R.			Sarcoidosis Clinical Presentation, Immunopathogenesis, and Therapeutics	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PROGRESSIVE PULMONARY SARCOIDOSIS; POSITRON-EMISSION-TOMOGRAPHY; LUNG LYMPHOCYTES-T; ALVEOLAR MACROPHAGES; AFRICAN-AMERICANS; PENTOXIFYLLINE; SUSCEPTIBILITY; NEUROSARCOIDOSIS; HYPERTENSION; METHOTREXATE	Sarcoidosis is a multisystem granulomatous disorder that most often affects the lungs and may cause significant morbidity. Sarcoidosis can manifest as neurological disease, uveitis, blindness, end-stage pulmonary fibrosis, pulmonary hypertension, dysrhythmias, cardiomyopathy, hypercalcemia, and renal failure. Sarcoidosis persists as chronic disease in approximately one-third of those affected. Clinical pitfalls and misconceptions about the course of disease place this population at risk for delayed or inadequate care. While noncaseating granulomas are the histopathological hallmark of sarcoidosis, they also are nonspecific. No pathognomonic diagnostic test exists for sarcoidosis, so the diagnosis remains one of exclusion. While the etiology of sarcoidosis is still unknown, recent insights into its immunopathogenesis have moved investigators closer to finding more effective treatments. Corticosteroids remain the standard of care when treatment is indicated, despite their adverse effect profile. Clinical investigations of novel drugs and biological agents targeting mechanisms involving CD4 type 1 helper T cells may provide more effective, better tolerated therapies. JAMA. 2011;305(4):391-399 www.jama.com	[Fontana, Joseph R.] NHLBI, Cardiovasc & Pulm Branch, NIH, Bethesda, MD 20892 USA; [Iannuzzi, Michael C.] SUNY Syracuse, Dept Med, Syracuse, NY USA; [Iannuzzi, Michael C.] Upstate Med Univ, Syracuse, NY USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); State University of New York (SUNY) System; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Fontana, JR (corresponding author), NHLBI, Cardiovasc & Pulm Branch, NIH, 9000 Rockville Pike,CRC,Room 5-1421,MSC 1507, Bethesda, MD 20892 USA.	fontanaj@nhlbi.nih.gov			National Institutes of Health	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and Dr Iannuzzi reported none. Dr Fontana reported receiving funding from the National Institutes of Health for research on 2 of the pharmacological agents discussed in this article.	Agostini C, 2002, CURR OPIN PULM MED, V8, P435, DOI 10.1097/00063198-200209000-00016; [Anonymous], 1999, AM J RESP CRIT CARE, V160, P736; Baughman RP, 2006, AM J RESP CRIT CARE, V174, P795, DOI 10.1164/rccm.200603-402OC; Baughman RP, 2001, AM J RESP CRIT CARE, V164, P1885, DOI 10.1164/ajrccm.164.10.2104046; Baughman RP, 2000, SARCOIDOSIS VASC DIF, V17, P60; Bihan H, 2007, MEDICINE, V86, P259, DOI 10.1097/MD.0b013e31815585aa; Boeck C, 1899, J CUTAN GENITOURINDI, V17, P543; Bonfioli Adriana A, 2005, Semin Ophthalmol, V20, P177, DOI 10.1080/08820530500231938; Chan ESL, 2002, ARTHRITIS RES, V4, P266, DOI 10.1186/ar419; Chen ES, 2008, CLIN CHEST MED, V29, P365, DOI 10.1016/j.ccm.2008.03.011; Chen ES, 2010, AM J RESP CRIT CARE, V181, P360, DOI 10.1164/rccm.200905-0696OC; Co DO, 2004, IMMUNOL LETT, V92, P135, DOI 10.1016/j.imlet.2003.11.023; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Fisher KA, 2006, CHEST, V130, P1481, DOI 10.1378/chest.130.5.1481; Garwood S, 2007, CHEST, V132, P1298, DOI 10.1378/chest.07-0998; Giembycz Mark A, 2005, Proc Am Thorac Soc, V2, P326, DOI 10.1513/pats.200504-041SR; Hofmann S, 2008, NAT GENET, V40, P1103, DOI 10.1038/ng.198; Iannuzzi M C, 1998, Monaldi Arch Chest Dis, V53, P609; Iannuzzi MC, 2005, GENES IMMUN, V6, P509, DOI 10.1038/sj.gene.6364235; Iannuzzi MC, 2007, NEW ENGL J MED, V357, P2153, DOI 10.1056/NEJMra071714; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Judson MA, 2003, CHEST, V123, P406, DOI 10.1378/chest.123.2.406; Kellinghaus C, 2004, EUR NEUROL, V51, P84, DOI 10.1159/000076534; Kim JS, 2009, AM HEART J, V157, P9, DOI 10.1016/j.ahj.2008.09.009; Kinlay S, 2003, CIRCULATION, V108, P1560, DOI 10.1161/01.CIR.0000091404.09558.AF; Kwak B, 2000, NAT MED, V6, P1399, DOI 10.1038/82219; Lower EE, 2008, CLIN CHEST MED, V29, P475, DOI 10.1016/j.ccm.2008.03.016; Marques LJ, 1999, AM J RESP CRIT CARE, V159, P508, DOI 10.1164/ajrccm.159.2.9804085; MARTINET Y, 1988, AM REV RESPIR DIS, V138, P1242, DOI 10.1164/ajrccm/138.5.1242; Mehta D, 2008, CHEST, V133, P1426, DOI 10.1378/chest.07-2784; Muller-Quernheim J, 2008, CLIN CHEST MED, V29, P391, DOI 10.1016/j.ccm.2008.03.007; Newman LS, 2004, AM J RESP CRIT CARE, V170, P1324, DOI 10.1164/rccm.200402-249OC; Ohira H, 2008, EUR J NUCL MED MOL I, V35, P933, DOI 10.1007/s00259-007-0650-8; Park MK, 2009, SARCOIDOSIS VASC DIF, V26, P121; Patel MR, 2009, CIRCULATION, V120, P1969, DOI 10.1161/CIRCULATIONAHA.109.851352; PINKSTON P, 1983, NEW ENGL J MED, V308, P793, DOI 10.1056/NEJM198304073081401; ROBINSON BWS, 1985, J CLIN INVEST, V75, P1488, DOI 10.1172/JCI111852; Rybicki BA, 1997, AM J EPIDEMIOL, V145, P234, DOI 10.1093/oxfordjournals.aje.a009096; Rybicki BA, 2005, AM J HUM GENET, V77, P491, DOI 10.1086/444435; Rybicki BA, 2001, AM J RESP CRIT CARE, V164, P2085, DOI 10.1164/ajrccm.164.11.2106001; Schutt AC, 2010, RESP MED, V104, P717, DOI 10.1016/j.rmed.2009.12.009; Shigehara K, 2001, J IMMUNOL, V166, P642, DOI 10.4049/jimmunol.166.1.642; Shorr AF, 2005, EUR RESPIR J, V25, P783, DOI 10.1183/09031936.05.00083404; Song ZM, 2005, J EXP MED, V201, P755, DOI 10.1084/jem.20040429; Teirtein AS, 2007, CHEST, V132, P1949, DOI 10.1378/chest.07-1178; Utz JP, 2003, CHEST, V124, P177, DOI 10.1378/chest.124.1.177; Valentonyte R, 2005, NAT GENET, V37, P357, DOI 10.1038/ng1519; Wyser CP, 1997, AM J RESP CRIT CARE, V156, P1371, DOI 10.1164/ajrccm.156.5.9506031; Yeager H, 2005, SARCOIDOSIS VASC DIF, V22, P147; Zabel P, 1997, AM J RESP CRIT CARE, V155, P1665, DOI 10.1164/ajrccm.155.5.9154873	50	215	226	0	30	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2011	305	4					391	399		10.1001/jama.2011.10	http://dx.doi.org/10.1001/jama.2011.10			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711MH	21266686				2022-12-28	WOS:000286595200024
J	Oberlander, J				Oberlander, Jonathan			Under Siege - The Individual Mandate for Health Insurance and Its Alternatives	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ N Carolina, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Oberlander, J (corresponding author), Univ N Carolina, Chapel Hill, NC 27515 USA.							Chandra A, 2011, NEW ENGL J MED, V364, P293, DOI 10.1056/NEJMp1013067; Coburn T., INDIVIDUAL AUTO ENRO; Gruber J., 2011, HLTH CARE REFORM IND; [Kaiser Family Foundation Harvard School of Public Health], 2011, PUBL HLTH CAR AG 112; Romney M, 2006, WALL STREET J   0411	5	11	11	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 24	2011	364	12					1085	1087		10.1056/NEJMp1101240	http://dx.doi.org/10.1056/NEJMp1101240			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	739FY	21323536				2022-12-28	WOS:000288701100001
J	Kamiya, D; Banno, S; Sasai, N; Ohgushi, M; Inomata, H; Watanabe, K; Kawada, M; Yakura, R; Kiyonari, H; Nakao, K; Jakt, LM; Nishikawa, S; Sasai, Y				Kamiya, Daisuke; Banno, Satoe; Sasai, Noriaki; Ohgushi, Masatoshi; Inomata, Hidehiko; Watanabe, Kiichi; Kawada, Masako; Yakura, Rieko; Kiyonari, Hiroshi; Nakao, Kazuki; Jakt, Lars Martin; Nishikawa, Shin-ichi; Sasai, Yoshiki			Intrinsic transition of embryonic stem-cell differentiation into neural progenitors	NATURE			English	Article							ZINC-FINGER PROTEIN; IN-VITRO; DIRECTED DIFFERENTIATION; NERVOUS-SYSTEM; MOTOR-NEURONS; MOUSE EMBRYO; ES CELLS; INDUCTION; EXPRESSION; SIGNALS	The neural fate is generally considered to be the intrinsic direction of embryonic stem (ES) cell differentiation. However, little is known about the intracellular mechanism that leads undifferentiated cells to adopt the neural fate in the absence of extrinsic inductive signals. Here we show that the zinc-finger nuclear protein Zfp521 is essential and sufficient for driving the intrinsic neural differentiation of mouse ES cells. In the absence of the neural differentiation inhibitor BMP4, strong Zfp521 expression is intrinsically induced in differentiating ES cells. Forced expression of Zfp521 enables the neural conversion of ES cells even in the presence of BMP4. Conversely, in differentiation culture, Zfp521-depleted ES cells do not undergo neural conversion but tend to halt at the epiblast state. Zfp521 directly activates early neural genes by working with the co-activator p300. Thus, the transition of ES cell differentiation from the epiblast state into neuroectodermal progenitors specifically depends on the cell-intrinsic expression and activator function of Zfp521.	[Kamiya, Daisuke; Banno, Satoe; Sasai, Noriaki; Ohgushi, Masatoshi; Inomata, Hidehiko; Watanabe, Kiichi; Kawada, Masako; Yakura, Rieko; Sasai, Yoshiki] RIKEN Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan; [Kamiya, Daisuke; Sasai, Yoshiki] Kyoto Univ, Grad Sch Med, Dept Med Embryol, Kyoto 6068501, Japan; [Kiyonari, Hiroshi; Nakao, Kazuki] RIKEN Ctr Dev Biol, Lab Anim Resource & Genet Engn, Kobe, Hyogo 6500047, Japan; [Jakt, Lars Martin; Nishikawa, Shin-ichi] RIKEN Ctr Dev Biol, Lab Stem Cell Res, Kobe, Hyogo 6500047, Japan	RIKEN; Kyoto University; RIKEN; RIKEN	Sasai, Y (corresponding author), RIKEN Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan.	yoshikisasai@cdb.riken.jp	Kiyonari, Hiroshi/N-7936-2015; Inomata, Hidehiko/N-7390-2015; Watanabe, Kiichi/ABA-4854-2020	Jakt, Lars Martin/0000-0002-3787-8138; Sasai, Noriaki/0000-0003-0360-1138; zhong wei, he gui/0000-0002-3066-3564	MEXT; Kobe Cluster Project; Leading Project	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kobe Cluster Project; Leading Project	We are grateful to H. Niwa for comments; M. Okada for advice on the GeneChip study; Y. Toyooka-Kamiya for constant encouragement and technical advice; H. Akimaru for advice on the shRNA knockdown study; and members of the Sasai laboratory for discussion and advice. This work was supported by grants-in-aid from MEXT, the Kobe Cluster Project and the Leading Project (Y.S.).	Abranches E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006286; Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Benchabane H, 2003, MOL CELL BIOL, V23, P6646, DOI 10.1128/MCB.23.18.6646-6661.2003; Bond HM, 2008, INT J BIOCHEM CELL B, V40, P848, DOI 10.1016/j.biocel.2007.04.006; Brunelli S, 2003, GENESIS, V36, P12, DOI 10.1002/gene.10193; Chan HM, 2001, J CELL SCI, V114, P2363; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Ding JX, 1998, NATURE, V395, P702, DOI 10.1038/27215; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Gajovic S, 1997, DIFFERENTIATION, V62, P187; Ikeya M, 2005, INT J DEV BIOL, V49, P807, DOI 10.1387/ijdb.051975mi; JAKT LM, 2003, GENOME INFORM, V14, P276; Jorgensen HF, 2009, DEVELOPMENT, V136, P715, DOI 10.1242/dev.028548; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kuhlbrodt K, 1998, J BIOL CHEM, V273, P16050, DOI 10.1074/jbc.273.26.16050; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; LAMB TM, 1993, SCIENCE, V262, P713, DOI 10.1126/science.8235591; Lin AC, 2004, J BIOL CHEM, V279, P55017, DOI 10.1074/jbc.M411240200; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Nagy A., 2003, MANIPULATING MOUSE E; Reversade B, 2005, DEVELOPMENT, V132, P3381, DOI 10.1242/dev.01901; SASAI Y, 1995, NATURE, V376, P333, DOI 10.1038/376333a0; Smukler SR, 2006, J CELL BIOL, V172, P79, DOI 10.1083/jcb.200508085; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Tanaka S, 2004, MOL CELL BIOL, V24, P8834, DOI 10.1128/MCB.24.20.8834-8846.2004; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tsai RYL, 1998, MOL CELL BIOL, V18, P6447, DOI 10.1128/MCB.18.11.6447; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; von Bubnoff A, 2005, DEV BIOL, V281, P210, DOI 10.1016/j.ydbio.2005.02.014; Warming S, 2003, BLOOD, V101, P1934, DOI 10.1182/blood-2002-08-2652; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wu M, 2009, BONE, V44, P528, DOI 10.1016/j.bone.2008.11.011; Zhao SL, 2004, MOL CELL NEUROSCI, V27, P332, DOI 10.1016/j.mcn.2004.08.002; Zwart R, 1996, MECH DEVELOP, V54, P185, DOI 10.1016/0925-4773(95)00472-6	38	159	168	2	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					503	U92		10.1038/nature09726	http://dx.doi.org/10.1038/nature09726			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21326203				2022-12-28	WOS:000287652900035
J	Klein, C; Ziegler, A				Klein, Christine; Ziegler, Andreas			From GWAS to clinical utility in Parkinson's disease	LANCET			English	Editorial Material							POLYMORPHISMS		[Klein, Christine] Med Univ Lubeck, Dept Neurol, Sect Clin & Mol Neurogenet, D-23538 Lubeck, Germany; [Ziegler, Andreas] Med Univ Lubeck, Inst Med Biometry & Stat, D-23538 Lubeck, Germany	University of Lubeck; University of Lubeck	Klein, C (corresponding author), Med Univ Lubeck, Dept Neurol, Sect Clin & Mol Neurogenet, D-23538 Lubeck, Germany.	christine.klein@neuro.uni-luebeck.de	Klein, Christine/AGK-8003-2022; Ziegler, Andreas/G-4246-2012	Klein, Christine/0000-0003-2102-3431; Ziegler, Andreas/0000-0002-8386-5397				Gail MH, 2008, J NATL CANCER I, V100, P1037, DOI 10.1093/jnci/djn180; Hardy J, 2010, NEURON, V68, P201, DOI 10.1016/j.neuron.2010.10.014; Jakobsdottir J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000337; Janssens ACJW, 2007, GENET MED, V9, P528, DOI 10.1097/GIM.0b013e31812eece0; Janssens ACJW, 2008, HUM MOL GENET, V17, pR166, DOI 10.1093/hmg/ddn250; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; Nalls MA, 2011, LANCET, V377, P641, DOI 10.1016/S0140-6736(10)62345-8; Sanderson S, 2005, GENET MED, V7, P495, DOI 10.1097/01.gim.0000179941.44494.73; Wickremaratchi MM, 2009, J NEUROL NEUROSUR PS, V80, P805, DOI 10.1136/jnnp.2008.162222	9	19	20	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2011	377	9766					613	614		10.1016/S0140-6736(11)60062-7	http://dx.doi.org/10.1016/S0140-6736(11)60062-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	727DB	21292316				2022-12-28	WOS:000287776600004
J	Rettig, RA				Rettig, Richard A.			Special Treatment - The Story of Medicare's ESRD Entitlement	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									RAND Washington, Washington, DC USA		Rettig, RA (corresponding author), RAND Washington, Washington, DC USA.							Alexander S, 1962, LIFE, P124; Alexander S, 1962, LIFE, P118; Alexander S., 1962, LIFE, P102; Alexander Shana, 1962, LIFE, P110; Alexander Shana, 1962, LIFE, P106; Alexander Shana, 1962, LIFE, P108; Alexander Shana, 1962, LIFE, P123; Alexander Shana, 1962, LIFE, P115; Alexander Shana, 1962, LIFE, P117; Bobbitt P., 1978, TRAGIC CHOICES; Knauf F, 2009, J AM SOC NEPHROL, V20, P2093, DOI 10.1681/ASN.2009070715; Moss AH, 2010, CLIN J AM SOC NEPHRO, V5, P2380, DOI 10.2215/CJN.07170810; *NIH, 2010, USRDS 2010 ANN DAT R, V2	13	56	56	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2011	364	7					596	598		10.1056/NEJMp1014193	http://dx.doi.org/10.1056/NEJMp1014193			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	722BW	21323539				2022-12-28	WOS:000287406000002
J	Williamson, OD				Williamson, Owen D.			Review: Topical nitroglycerin reduces pain during ADL in patients with chronic tendinopathies	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							NITRIC-OXIDE		Monash Univ, Melbourne, Vic 3004, Australia	Monash University	Williamson, OD (corresponding author), Monash Univ, Melbourne, Vic 3004, Australia.							Kane TPC, 2008, AM J SPORT MED, V36, P1160, DOI 10.1177/0363546508314423; Miclescu A, 2009, ACTA ANAESTH SCAND, V53, P1107, DOI 10.1111/j.1399-6576.2009.02054.x; Murrell GAC, 2007, BRIT J SPORT MED, V41, P227, DOI 10.1136/bjsm.2006.034447; Webborn ADJ, 2008, DISABIL REHABIL, V30, P1572, DOI 10.1080/09638280701786377	4	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4							JC2-6	10.7326/0003-4819-154-4-201102150-02006	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-02006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720VF	21320933				2022-12-28	WOS:000287310000005
J	Coker, RJ; Hunter, BM; Rudge, JW; Liverani, M; Hanvoravongchai, P				Coker, Richard J.; Hunter, Benjamin M.; Rudge, James W.; Liverani, Marco; Hanvoravongchai, Piya			Health in Southeast Asia 3 Emerging infectious diseases in southeast Asia: regional challenges to control	LANCET			English	Article							TO-PERSON TRANSMISSION; JAPANESE ENCEPHALITIS; PANDEMIC INFLUENZA; NIPAH VIRUS; LAO PDR; SURVEILLANCE; EMERGENCE; THAILAND; ORIGIN; OUTBREAK	Southeast Asia is a hotspot for emerging infectious diseases, including those with pandemic potential. Emerging infectious diseases have exacted heavy public health and economic tolls. Severe acute respiratory syndrome rapidly decimated the region's tourist industry. Influenza A H5N1 has had a profound effect on the poultry industry. The reasons why southeast Asia is at risk from emerging infectious diseases are complex. The region is home to dynamic systems in which biological, social, ecological, and technological processes interconnect in ways that enable microbes to exploit new ecological niches. These processes include population growth and movement, urbanisation, changes in food production, agriculture and land use, water and sanitation, and the effect of health systems through generation of drug resistance. Southeast Asia is home to about 600 million people residing in countries as diverse as Singapore, a city state with a gross domestic product (GDP) of US$37 500 per head, and Laos, until recently an overwhelmingly rural economy, with a GDP of US$890 per head. The regional challenges in control of emerging infectious diseases are formidable and range from influencing the factors that drive disease emergence, to making surveillance systems fit for purpose, and ensuring that regional governance mechanisms work effectively to improve control interventions.	[Coker, Richard J.; Hunter, Benjamin M.; Rudge, James W.; Liverani, Marco; Hanvoravongchai, Piya] Mahidol Univ, Fac Trop Med, London Sch Hyg & Trop Med, CDPRG, Bangkok 10400, Thailand	Mahidol University	Coker, RJ (corresponding author), Mahidol Univ, Fac Trop Med, London Sch Hyg & Trop Med, CDPRG, Anek Prasong Bldg,420-6 Rajvithi Rd, Bangkok 10400, Thailand.	richard.coker@lshtm.ac.uk	Hanvoravongchai, Piya/A-1569-2012	Hanvoravongchai, Piya/0000-0003-4256-1271; Hunter, Benjamin/0000-0002-5848-5245	China Medical Board; Rockefeller Foundation; Atlantic Philanthropies	China Medical Board; Rockefeller Foundation; Atlantic Philanthropies	The paper is part of a Series funded by the China Medical Board, the Rockefeller Foundation, and Atlantic Philanthropies.	Adisasmito W, 2010, OUTBREAK SURVEILLANC, V1, P1; AFRIMS, 2008, ARM FORC RES I MED S; [Anonymous], 2009, CAMB ROUND 9 PROP FO; [Anonymous], 2010, MULTIDRUG EXTENSIVEL; [Anonymous], HIGHLY PATHOGENIC AV; ASEANWEB, TOUR ARR ASEAN; Asian Development Bank, 2003, AS DEV OUTL 2003 UPD; Azly E, 2008, ANTARA NEWS     0627; Bloom EA, 2005, POTENTIAL EC IMPACT; Bodhidatta L., 2002, Southeast Asian Journal of Tropical Medicine and Public Health, V33, P752; Brahmbhatt M, 2006, 1 INT C AV INFL HUM; Butler D, 2006, NATURE, V440, P6, DOI 10.1038/440006a; Calain P, 2007, HEALTH POLICY PLANN, V22, P13, DOI 10.1093/heapol/czl035; Chongsuvivatwong V, 2011, LANCET, V377, P429, DOI 10.1016/S0140-6736(10)61507-3; Chua KB, 1999, LANCET, V354, P1257, DOI 10.1016/S0140-6736(99)04299-3; Cummings DAT, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000139; de Sa J, 2010, SE ASIAN J TROP MED, V41, P1104; Delacollette C, 2009, SE ASIAN J TROP MED, V40, P674; Dondorp AM, 2010, NAT REV MICROBIOL, V8, P272, DOI 10.1038/nrmicro2331; Dry S., 2010, EPIDEMICS SCI GOVERN; Erlanger TE, 2009, EMERG INFECT DIS, V15, P1, DOI 10.3201/eid1501.080311; FAO, 2005, LIV POL POV RED AFR; Fedson DS, 2009, EMERG INFECT DIS, V15, P365, DOI 10.3201/eid1503.080857; Fidler DP, 2008, EMERG INFECT DIS, V14, P88, DOI 10.3201/eid1401.070700; Fidler DP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000247; Food and Agriculture Organisation of the United Nations, FAOSTAT; Gilbert M, 2008, P NATL ACAD SCI USA, V105, P4769, DOI 10.1073/pnas.0710581105; Hanvoravongchai P, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-322; [International Federation of Red Cross Red Crescent Societies International Disaster Response Laws Rules and Principles Programme], 2009, LEG PREP RESP DIS CO; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Kanchanachitra C, 2011, LANCET, V377, P769, DOI 10.1016/S0140-6736(10)62035-1; Karesh WB, 2005, EMERG INFECT DIS, V11, P1000; Kimball AM, 2008, MED CLIN N AM, V92, P1459, DOI 10.1016/j.mcna.2008.06.001; Krumkamp R, 2011, EPIDEMIOL INFECT, V139, P59, DOI 10.1017/S0950268810002220; Leo YS, 2009, EMERG INFECT DIS, V15, P836, DOI 10.3201/eid1505.081390; Li KS, 2004, NATURE, V430, P209, DOI 10.1038/nature02746; Lo MK, 2008, J CLIN VIROL, V43, P396, DOI 10.1016/j.jcv.2008.08.007; Mackenzie JS, 2004, NAT MED, V10, pS98, DOI 10.1038/nm1144; McKibben W.J., 2006, GLOBAL MACROECONOMIC; Mekong Basin Disease Surveillance, REG PAND INFL TABL T; Mekong Basin Disease Surveillance, ACT PLAN 2008 2013 M; Murray CJL, 2006, LANCET, V368, P2211, DOI 10.1016/S0140-6736(06)69895-4; Narain JP, 2010, B WORLD HEALTH ORGAN, V88, P162, DOI 10.2471/BLT.09.065169; Newton PN, 2003, LANCET, V362, P169, DOI 10.1016/S0140-6736(03)13872-X; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Patz JA, 2004, ENVIRON HEALTH PERSP, V112, P1092, DOI 10.1289/ehp.6877; Peiris JSM, 2003, NEW ENGL J MED, V349, P2431, DOI 10.1056/NEJMra032498; Pimentel D, 2007, HUM ECOL, V35, P653, DOI 10.1007/s10745-007-9128-3; Putthasri W, 2009, EMERG INFECT DIS, V15, P423, DOI 10.3201/eid1503.080872; Reintjes R., 2008, HLTH SYSTEMS CHALLEN, P141; Rushton J, 2005, WORLD POULTRY SCI J, V61, P491, DOI 10.1079/WPS200570; Scoones I., 2010, AVIAN INFLUENZA SCI; Scoones I, 2008, INT RESPONSE HIGHLY; Shiffman J, 2006, HEALTH POLICY PLANN, V21, P411, DOI 10.1093/heapol/czl028; Smith GJD, 2009, NATURE, V459, P1122, DOI 10.1038/nature08182; Solomon T, 2003, J VIROL, V77, P3091, DOI 10.1128/JVI.77.5.3091-3098.2003; Srivirojana N, 2008, PUBLIC HLTH; Thai KTD, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000747; Tipayamongkholgul M, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-422; Touch S, 2009, B WORLD HEALTH ORGAN, V87, P320, DOI 10.2471/BLT.08.052951; Twiddy SS, 2003, INFECT GENET EVOL, V3, P87, DOI 10.1016/S1567-1348(02)00153-3; [UN World Bank], 2010, INT MIN C AN PAND IN; UNAIDS, 2008, REP GLOB AIDS EP; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; [United Nations Department of Economics and Social Affairs Population division], 2009, WORLD POP PROSP 2008; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; Wertheim HFL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005973; WHO, EM ZOON; WHO, PAND H1N1 2009 UPD 5; [WHO SEARO WHO WPRO], 2010, MAL GREAT MEK SUBR R; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997; World Health Organization, 2008, GLOB BURD DIS 2004 U; World Health Organization, 2010, AS PAC STRAT EM DIS; World Health Organization, CUM NUMB CONF HUM CA; World Health Organization, SUMM PROB SARS CAS O; World Health Organization (WHO), 2007, 6 WORLD HLTH ASS RES; World Organisation for Animal Health, WORLD AN HLTH INF DA	78	257	268	1	28	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2011	377	9765					599	609		10.1016/S0140-6736(10)62004-1	http://dx.doi.org/10.1016/S0140-6736(10)62004-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724DQ	21269678	Bronze, Green Published			2022-12-28	WOS:000287556700030
J	Harismendy, O; Notani, D; Song, XY; Rahim, NG; Tanasa, B; Heintzman, N; Ren, B; Fu, XD; Topol, EJ; Rosenfeld, MG; Frazer, KA				Harismendy, Olivier; Notani, Dimple; Song, Xiaoyuan; Rahim, Nazli G.; Tanasa, Bogdan; Heintzman, Nathaniel; Ren, Bing; Fu, Xiang-Dong; Topol, Eric J.; Rosenfeld, Michael G.; Frazer, Kelly A.			9p21 DNA variants associated with coronary artery disease impair interferon-gamma signalling response	NATURE			English	Article							GENOME-WIDE ASSOCIATION; NEGATIVE REGULATOR; RAPID EVOLUTION; NONCODING RNA; PROTEIN CTCF; LOCUS; SUSCEPTIBILITY; SEQUENCE; PROJECT; ANRIL	Genome-wide association studies have identified single nucleotide polymorphisms (SNPs) in the 9p21 gene desert associated with coronary artery disease (CAD)(1-4) and type 2 diabetes(5-7). Despite evidence for a role of the associated interval in neighbouring gene regulation(8-10), the biological underpinnings of these genetic associations with CAD or type 2 diabetes have not yet been explained. Here we identify 33 enhancers in 9p21; the interval is the second densest gene desert for predicted enhancers and six times denser than the whole genome (P < 6.55 x 10(-33)). The CAD risk alleles of SNPs rs10811656 and rs10757278 are located in one of these enhancers and disrupt a binding site for STAT1. Lymphoblastoid cell lines homozygous for the CAD risk haplotype show no binding of STAT1, and in lymphoblastoid cell lines homozygous for the CAD non-risk haplotype, binding of STAT1 inhibits CDKN2BAS (also known as CDKN2B-AS1) expression, which is reversed by short interfering RNA knockdown of STAT1. Using a new, open-ended approach to detect long-distance interactions, we find that in human vascular endothelial cells the enhancer interval containing the CAD locus physically interacts with the CDKN2A/B locus, the MTAP gene and an interval downstream of IFNA21. In human vascular endothelial cells, interferon-c activation strongly affects the structure of the chromatin and the transcriptional regulation in the 9p21 locus, including STAT1-binding, long-range enhancer interactions and altered expression of neighbouring genes. Our findings establish a link between CAD genetic susceptibility and the response to inflammatory signalling in a vascular cell type and thus demonstrate the utility of genome-wide association study findings in directing studies to novel genomic loci and biological processes important for disease aetiology.	[Rahim, Nazli G.; Topol, Eric J.] Scripps Res Inst, Scripps Translat Sci Inst, La Jolla, CA 92037 USA; [Harismendy, Olivier; Frazer, Kelly A.] Univ Calif San Diego, Sch Med, Dept Pediat, La Jolla, CA 92093 USA; [Harismendy, Olivier; Frazer, Kelly A.] Univ Calif San Diego, Sch Med, Radys Childrens Hosp, La Jolla, CA 92093 USA; [Harismendy, Olivier; Frazer, Kelly A.] Univ Calif San Diego, Moores UCSD Canc Ctr, La Jolla, CA 92093 USA; [Notani, Dimple; Song, Xiaoyuan; Tanasa, Bogdan; Rosenfeld, Michael G.] Univ Calif San Diego, Sch Med, Howard Hughes Med Inst, Dept Med, La Jolla, CA 92093 USA; [Tanasa, Bogdan] Scripps Res Inst, Kellogg Sch Sci & Technol, La Jolla, CA 92037 USA; [Heintzman, Nathaniel; Ren, Bing] Univ Calif San Diego, Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Fu, Xiang-Dong] Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Frazer, Kelly A.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	Scripps Research Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Scripps Research Institute; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Topol, EJ (corresponding author), Scripps Res Inst, Scripps Translat Sci Inst, 3344 N Torrey Pines Court, La Jolla, CA 92037 USA.	etopol@scripps.edu; mrosenfeld@ucsd.edu; kafrazer@ucsd.edu	Harismendy, Olivier/AAM-2072-2021; , songxy/P-1094-2014; Stefanadis, Christodoulos/ABH-2232-2020	Harismendy, Olivier/0000-0002-8098-9888; , songxy/0000-0002-9011-5033; Topol, Eric/0000-0002-1478-4729; Frazer, Kelly/0000-0002-6060-8902; Stefanadis, Christodoulos/0000-0001-5974-6454; Notani, Dimple/0000-0002-9460-8070	National Center for Research Resources [1U54RR025204, 1UL1RR025774, 1UL1RR031980-01]; National Institutes of Health [HL065445, DK39949, DK018477, DK074868, L65445, CA97134, DK74686, NS34934, 1R21CA152613-01]; Department of Defence [BC075019]; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R21CA152613, R01CA097134] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR031980, UL1RR025774] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065445, U01HL107442] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK074868, R01DK018477, R37DK039949, R01DK039949] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG025204] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defence; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank X. Wang, K. Trevarthen and M. Nakano for experimental assistance. We thank the Scripps Genomic Medicine Clinical team for sample collection. This work was partially supported by National Center for Research Resources grants 1U54RR025204, 1UL1RR025774 and 1UL1RR031980-01 and National Institutes of Health grants HL065445, DK39949, DK018477, DK074868, L65445, CA97134, DK74686, NS34934 and 1R21CA152613-01, the Department of Defence grant BC075019 and the Prostate Cancer Foundation. M. G. R. is an Investigator with the Howard Hughes Medical Institute.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Battle TE, 2006, CANCER RES, V66, P3649, DOI 10.1158/0008-5472.CAN-05-3612; Bell AC, 1999, CELL, V98, P387, DOI 10.1016/S0092-8674(00)81967-4; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Feingold EA, 2004, SCIENCE, V306, P636, DOI 10.1126/science.1105136; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hindorff LA, CATALOG PUBLISHED GE; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kwon YS, 2007, P NATL ACAD SCI USA, V104, P4852, DOI 10.1073/pnas.0700715104; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Liu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005027; Lomvardas S, 2006, CELL, V126, P403, DOI 10.1016/j.cell.2006.06.035; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Najjar I, 2005, J VIROL, V79, P4936, DOI 10.1128/JVI.79.8.4936-4943.2005; Nesterova TB, 2001, GENOME RES, V11, P833, DOI 10.1101/gr.174901; Newton-Cheh C, 2009, CIRCULATION, V120, P2062, DOI 10.1161/CIRCULATIONAHA.109.879049; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; SOLOMON MJ, 1985, P NATL ACAD SCI USA, V82, P6470, DOI 10.1073/pnas.82.19.6470; Song JS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r178; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Thijs G, 2002, J COMPUT BIOL, V9, P447, DOI 10.1089/10665270252935566; Tousoulis D, 2008, TRENDS MOL MED, V14, P441, DOI 10.1016/j.molmed.2008.08.004; Visel A, 2010, NATURE, V464, P409, DOI 10.1038/nature08801; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yu WQ, 2008, NATURE, V451, P202, DOI 10.1038/nature06468; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zheng M, 2007, BIOMETRICS, V63, P787, DOI 10.1111/j.1541-0420.2007.00768.x	45	454	476	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					264	+		10.1038/nature09753	http://dx.doi.org/10.1038/nature09753			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307941	Green Accepted			2022-12-28	WOS:000287144200045
J							Heart Protection Study	C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20536 patients in the Heart Protection Study	LANCET			English	Article							ANTIOXIDANT VITAMIN SUPPLEMENTATION; PLACEBO-CONTROLLED TRIAL; ACUTE CORONARY SYNDROMES; HIGH-RISK INDIVIDUALS; RANDOMIZED-TRIALS; RELIABLE ASSESSMENT; MAJOR MORBIDITY; CHOLESTEROL; METAANALYSIS; DISEASE	Background lit has been suggested that inflammation status, as assessed by C-reactive protein (CRP) concentration, modifies the vascular protective effects of statin therapy. In particular, there have been claims that statins might be more beneficial in people with raised CRP concentrations, and might even be ineffective in people with low concentrations of both CRP and LDL cholesterol. This study aimed to test this hypothesis. Methods In 69 UK hospitals, 20 536 men and women aged 40-80 years at high risk of vascular events were randomly assigned to simvastatin 40 mg daily versus matching placebo for a mean of 5.0 years. Patients were categorised into six baseline CRP groups (<1.25, 1.25-1.99, 2.00-2.99, 3.00-4.99, 5.00-7.99, and >= 8.00 mg/L). The primary endpoint for subgroup analyses was major vascular events, defined as the composite of coronary death, myocardial infarction, stroke, or revascularisation. Analysis was by intention to treat. This study is registered, number ISRCTN48489393. Findings Overall, allocation to simvastatin resulted in a significant 24% (95% CI 19-28) proportional reduction in the incidence of first major vascular event after randomisation (2033 [19.8%] allocated simvastatin vs 2585 [25.2%] allocated placebo). There was no evidence that the proportional reduction in this endpoint, or its components, varied with baseline CRP concentration (trend p=0.41). Even in participants with baseline CRP concentration less than 1.25 mg/L, major vascular events were significantly reduced by 29% (99% CI 12-43, p<0.0001; 239 [14.1%] vs 329 [19.4%]). No significant heterogeneity in the relative risk reduction was recorded between the four subgroups defined by the combination of low or high baseline concentrations of LDL cholesterol and CRP (p=0.72). In particular, there was clear evidence of benefit in those with both low LDL cholesterol and low CRP (27% reduction, 99% CI 11-40, p<0.0001; 295 [15.6%] vs 400 [20.9%]). Interpretation Evidence from this large-scale randomised trial does not lend support to the hypothesis that baseline CRP concentration modifies the vascular benefits of statin therapy materially.						Emberson, Jonathan/0000-0001-7792-9422	MRC [MC_EX_G0801669, MC_U137686853] Funding Source: UKRI; British Heart Foundation [RG/08/014/24067, RE/08/04] Funding Source: Medline; Medical Research Council [MC_U137686853, MC_EX_G0801669] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Baigent C, 2010, LANCET, V376, P1670, DOI 10.1016/S0140-6736(10)61350-5; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; *C REACT PROT COR, IN PRESS BMJ; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Collins R, 2001, LANCET, V357, P373, DOI 10.1016/S0140-6736(00)03651-5; Collins R, 2002, LANCET, V360, P23, DOI 10.1016/S0140-6736(02)09328-5; de Lemos JA, 2004, JAMA-J AM MED ASSOC, V292, P1307, DOI 10.1001/jama.292.11.1307; Delahoy PJ, 2009, CLIN THER, V31, P236, DOI 10.1016/j.clinthera.2009.02.017; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kaul S, 2010, ARCH INTERN MED, V170, P1073, DOI 10.1001/archinternmed.2010.189; Kinlay S, 2007, J AM COLL CARDIOL, V49, P2003, DOI 10.1016/j.jacc.2007.01.083; Libby P, 2001, CIRCULATION, V104, P365, DOI 10.1161/01.CIR.104.3.365; MacMahon S, 2001, LANCET, V357, P455, DOI 10.1016/S0140-6736(00)04017-4; McMurray JJV, 2009, CIRCULATION, V120, P2188, DOI 10.1161/CIRCULATIONAHA.109.849117; Meade T, 1999, EUR HEART J, V20, P725; Parish S, 2010, J INTERN MED, V268, P348, DOI 10.1111/j.1365-2796.2010.02258.x; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2010, AM J CARDIOL, V106, P204, DOI 10.1016/j.amjcard.2010.03.018; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Ridker PM, 1998, CIRCULATION, V98, P839, DOI 10.1161/01.CIR.98.9.839; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601; Ridker PM, 1999, CIRCULATION, V100, P230, DOI 10.1161/01.CIR.100.3.230; Ridker PM, 2005, NEW ENGL J MED, V352, P20, DOI 10.1056/NEJMoa042378; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Schachter M, 2005, FUND CLIN PHARMACOL, V19, P117, DOI 10.1111/j.1472-8206.2004.00299.x	28	96	96	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 5	2011	377	9764					469	476		10.1016/S0140-6736(10)62174-5	http://dx.doi.org/10.1016/S0140-6736(10)62174-5			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721TX	21277016	Green Published			2022-12-28	WOS:000287381800027
J	Gill, CJ; Phiri-Mazala, G; Guerina, NG; Kasimba, J; Mulenga, C; MacLeod, WB; Waitolo, N; Knapp, AB; Mirochnick, M; Mazimba, A; Fox, MP; Sabin, L; Seidenberg, P; Simon, JL; Hamer, DH				Gill, Christopher J.; Phiri-Mazala, Grace; Guerina, Nicholas G.; Kasimba, Joshua; Mulenga, Charity; MacLeod, William B.; Waitolo, Nelson; Knapp, Anna B.; Mirochnick, Mark; Mazimba, Arthur; Fox, Matthew P.; Sabin, Lora; Seidenberg, Philip; Simon, Jonathon L.; Hamer, Davidson H.			Effect of training traditional birth attendants on neonatal mortality (Lufwanyama Neonatal Survival Project): randomised controlled study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LOW-RESOURCE SETTINGS; RESUSCITATION; CARE; METAANALYSIS; MANAGEMENT; SEPSIS	Objective To determine whether training traditional birth attendants to manage several common perinatal conditions could reduce neonatal mortality in the setting of a resource poor country with limited access to healthcare. Design Prospective, cluster randomised and controlled effectiveness study. Setting Lufwanyama, an agrarian, poorly developed district located in the Copperbelt province, Zambia. All births carried out by study birth attendants occurred at mothers' homes, in rural village settings. Participants 127 traditional birth attendants and mothers and their newborns (3559 infants delivered regardless of vital status) from Lufwanyama district. Interventions Using an unblinded design, birth attendants were cluster randomised to intervention or control groups. The intervention had two components: training in a modified version of the neonatal resuscitation protocol, and single dose amoxicillin coupled with facilitated referral of infants to a health centre. Control birth attendants continued their existing standard of care (basic obstetric skills and use of clean delivery kits). Main outcome measures The primary outcome was the proportion of liveborn infants who died by day 28 after birth, with rate ratios statistically adjusted for clustering. Secondary outcomes were mortality at different time points; and comparison of causes of death based on verbal autopsy data. Results Among 3497 deliveries with reliable information, mortality at day 28 after birth was 45% lower among liveborn infants delivered by intervention birth attendants than control birth attendants (rate ratio 0.55, 95% confidence interval 0.33 to 0.90). The greatest reductions in mortality were in the first 24 hours after birth: 7.8 deaths per 1000 live births for infants delivered by intervention birth attendants compared with 19.9 per 1000 for infants delivered by control birth attendants (0.40, 0.19 to 0.83). Deaths due to birth asphyxia were reduced by 63% among infants delivered by intervention birth attendants (0.37, 0.17 to 0.81) and by 81% within the first two days after birth (0.19, 0.07 to 0.52). Stillbirths and deaths from serious infection occurred at similar rates in both groups. Conclusions Training traditional birth attendants to manage common perinatal conditions significantly reduced neonatal mortality in a rural African setting. This approach has high potential to be applied to similar settings with dispersed rural populations.	[Gill, Christopher J.; Guerina, Nicholas G.; MacLeod, William B.; Knapp, Anna B.; Fox, Matthew P.; Sabin, Lora; Seidenberg, Philip; Simon, Jonathon L.; Hamer, Davidson H.] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA; [Phiri-Mazala, Grace] Lufwanyama Dist Hlth Management Team, Zambian Anglican Council, Natl Programmes, Kalulushi, Zambia; [Guerina, Nicholas G.] Tufts Univ, Sch Med, Dept Publ Hlth & Community Med, Boston, MA 02111 USA; [Guerina, Nicholas G.] Brown Univ, Women & Infants Hosp, Dept Paediat, Providence, RI USA; [MacLeod, William B.; Waitolo, Nelson; Sabin, Lora; Simon, Jonathon L.; Hamer, Davidson H.] Boston Univ, Sch Publ Hlth, Dept Int Hlth, Boston, MA USA; [Mirochnick, Mark] Boston Univ, Sch Med, Dept Pediat, Boston, MA 02118 USA; [Hamer, Davidson H.] Boston Univ, Sch Med, Dept Med, Infect Dis Sect, Boston, MA 02118 USA; [Kasimba, Joshua; Mazimba, Arthur; Seidenberg, Philip] CIHDZ, Lusaka, Zambia; [Fox, Matthew P.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA	Boston University; Massachusetts Department of Public Health; Tufts University; Brown University; Women & Infants Hospital Rhode Island; Boston University; Boston University; Boston University; Boston University	Gill, CJ (corresponding author), Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA.	cgill@bu.edu	Fox, Matthew/K-2004-2019; Hamer, Davidson Howes/J-2020-2019	Hamer, Davidson Howes/0000-0002-4700-1495; Fox, Matthew/0000-0001-9887-0634; Simon, Jonathon/0000-0001-6740-549X; MacLeod, William/0000-0001-8003-8874; gill, christopher/0000-0003-3353-0617	Boston University [GHS-A-00-03-00020-00]; Office of Health and Nutrition of the United States Agency for International Development [GHS-A-00-03-00020-00]; NIH/NIAIDS [K23 AI 62208]; American Academy of Pediatrics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI062208] Funding Source: NIH RePORTER	Boston University; Office of Health and Nutrition of the United States Agency for International Development(United States Agency for International Development (USAID)); NIH/NIAIDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Academy of Pediatrics; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a cooperative agreement between Boston University and the Office of Health and Nutrition of the United States Agency for International Development, GHS-A-00-03-00020-00. NIH/NIAIDS K23 AI 62208 supported CJG's effort. Additional support for the neonatal resuscitation protocol intervention was provided by a neonatal resuscitation programme grant from the American Academy of Pediatrics, which also defrayed some of the costs of NGG's travels to Zambia, some of the field office expenditures, and purchase of some of the safe delivery kits. UNICEF kindly provided some of the other safe delivery kits. None of the funding agencies played any role in the analysis or reporting of these results.	[Anonymous], 2000, TXB NEON RES; [Anonymous], 1999, PEDIAT INFECT DI S10, V18, P1; Azad K, 2010, LANCET, V375, P1193, DOI 10.1016/S0140-6736(10)60142-0; Bang AT, 1999, LANCET, V354, P1955, DOI 10.1016/S0140-6736(99)03046-9; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Carlo WA, 2010, NEW ENGL J MED, V362, P614, DOI 10.1056/NEJMsa0806033; Carlo WA, 2009, J PEDIATR-US, V154, P504, DOI 10.1016/j.jpeds.2008.10.005; *CENTR STAT OFF ZA, 2003, ZAMB DEM HLTH SURV 2; Central Statistical Office, 2004, REP ZAMB 2000 CENS P; Central Statistical Office (Zambia), 2007, ZAMB DEM HLTH SURV 2; Darmstadt GL, 2009, INT J GYNECOL OBSTET, V107, pS89, DOI 10.1016/j.ijgo.2009.07.010; Hayes RJ, 2009, INTERD STAT, P3; Jokhio AH, 2005, NEW ENGL J MED, V352, P2091, DOI 10.1056/NEJMsa042830; Kidane G, 2000, LANCET, V356, P550, DOI 10.1016/S0140-6736(00)02580-0; Kinney MV, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000294; Kumar V, 2009, J PERINATOL, V29, P401, DOI 10.1038/jp.2008.233; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Manandhar DS, 2004, LANCET, V364, P970, DOI 10.1016/S0140-6736(04)17021-9; Newton O, 2006, T ROY SOC TROP MED H, V100, P899, DOI 10.1016/j.trstmh.2006.02.012; Niermeyer S, 2000, PEDIATRICS, V106; Sazawal S, 2003, LANCET INFECT DIS, V3, P547, DOI 10.1016/S1473-3099(03)00737-0; Sibley L, 2004, MIDWIFERY, V20, P51, DOI 10.1016/S0266-6138(03)00053-6; Sibley LM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005460; Sorensen BL, 2010, INT J GYNECOL OBSTET, V111, P8, DOI 10.1016/j.ijgo.2010.04.031; Sorensen BL, TROP MED INT HLTH, V15, P894; Wall SN, 2009, INT J GYNECOL OBSTET, V107, pS47, DOI 10.1016/j.ijgo.2009.07.013; Weber MW, 2003, PEDIATR INFECT DIS J, V22, P711, DOI 10.1097/01.inf.0000078163.80807.88; *WHO, 2001, WHO GLOB STRAT CONT, P1; World Health Organization, 1999, STAND VERB AUT METH	29	95	97	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2011	342								d346	10.1136/bmj.d346	http://dx.doi.org/10.1136/bmj.d346			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718PW	21292711	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000287138500004
J	O'Neill, JS; van Ooijen, G; Dixon, LE; Troein, C; Corellou, F; Bouget, FY; Reddy, AB; Millar, AJ				O'Neill, John S.; van Ooijen, Gerben; Dixon, Laura E.; Troein, Carl; Corellou, Florence; Bouget, Francois-Yves; Reddy, Akhilesh B.; Millar, Andrew J.			Circadian rhythms persist without transcription in a eukaryote	NATURE			English	Article							CLOCK; PHOSPHORYLATION; OSTREOCOCCUS; SYSTEM; PLANTS	Circadian rhythms are ubiquitous in eukaryotes, and coordinate numerous aspects of behaviour, physiology and metabolism, from sleep/wake cycles in mammals to growth and photosynthesis in plants(1,2). This daily timekeeping is thought to be driven by transcriptional-translational feedback loops, whereby rhythmic expression of 'clock' gene products regulates the expression of associated genes in approximately 24-hour cycles. The specific transcriptional components differ between phylogenetic kingdoms(3). The unicellular pico-eukaryotic alga Ostreococcus tauri possesses a naturally minimized clock, which includes many features that are shared with plants, such as a central negative feedback loop that involves the morning-expressed CCA1 and evening-expressed TOC1 genes(4). Given that recent observations in animals and plants have revealed prominent post-translational contributions to time-keeping(5), a reappraisal of the transcriptional contribution to oscillator function is overdue. Here we show that non-transcriptional mechanisms are sufficient to sustain circadian timekeeping in the eukaryotic lineage, although they normally function in conjunction with transcriptional components. We identify oxidation of peroxiredoxin proteins as a transcription-independent rhythmic biomarker, which is also rhythmic in mammals(6). Moreover we show that pharmacological modulators of the mammalian clock mechanism have the same effects on rhythms in Ostreococcus. Post-translational mechanisms, and at least one rhythmic marker, seem to be better conserved than transcriptional clock regulators. It is plausible that the oldest oscillator components are non-transcriptional in nature, as in cyanobacteria(7), and are conserved across kingdoms.	[O'Neill, John S.; Reddy, Akhilesh B.] Univ Cambridge, Metab Res Labs, Addenbrookes Hosp, Inst Metab Sci,Dept Clin Neurosci, Cambridge CB2 0QQ, England; [O'Neill, John S.; van Ooijen, Gerben; Dixon, Laura E.; Millar, Andrew J.] Ctr Syst Biol Edinburgh, Edinburgh EH9 3JD, Midlothian, Scotland; [Troein, Carl; Millar, Andrew J.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JH, Midlothian, Scotland; [Corellou, Florence; Bouget, Francois-Yves] Univ Paris 06, UMR7621, Lab Oceanog Microbienne, Observ Oceanol, F-66651 Banyuls Sur Mer, France; [Corellou, Florence; Bouget, Francois-Yves] CNRS, UMR7621, Lab Observ Oceanog Microbienne, Observ Oceanol, F-66651 Banyuls Sur Mer, France	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Edinburgh; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Reddy, AB (corresponding author), Univ Cambridge, Metab Res Labs, Addenbrookes Hosp, Inst Metab Sci,Dept Clin Neurosci, Cambridge CB2 0QQ, England.	areddy@cantab.net; Andrew.Millar@ed.ac.uk	van Ooijen, Gerben/E-9371-2013; Millar, Andrew J/G-2423-2012; Corellou, Florence/E-1378-2011	van Ooijen, Gerben/0000-0001-7967-0637; Millar, Andrew J/0000-0003-1756-3654; Corellou, Florence/0000-0001-8026-2120; O'Neill, John Stuart/0000-0003-2204-6096	BBSRC; EPSRC [D019621]; BBSRC/ANR [F005466]; HFSP; Wellcome Trust [083643/Z/07/Z]; MRC Centre for Obesity and Related metabolic Disorders (MRC CORD); BBSRC [BB/D019621/1, BB/F005466/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F005466/1, BB/D019621/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC/ANR(French National Research Agency (ANR)UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); HFSP(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); MRC Centre for Obesity and Related metabolic Disorders (MRC CORD)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	CSBE is a Centre for Integrative Systems Biology funded by BBSRC and EPSRC award D019621. C.T. is supported by a BBSRC/ANR joint project F005466 awarded to F.-Y.B. and A.J.M. and by the HFSP. A.B.R. is supported by the Wellcome Trust (083643/Z/07/Z) and the MRC Centre for Obesity and Related metabolic Disorders (MRC CORD).	Baier M, 1997, PLANT J, V12, P179, DOI 10.1046/j.1365-313X.1997.12010179.x; Corellou F, 2009, PLANT CELL, V21, P3436, DOI 10.1105/tpc.109.068825; Dodd AN, 2007, SCIENCE, V318, P1789, DOI 10.1126/science.1146757; Edwards KD, 2006, PLANT CELL, V18, P639, DOI 10.1105/tpc.105.038315; Edwards KD, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.81; Eelderink-Chen Z, 2010, P NATL ACAD SCI USA, V107, P2043, DOI 10.1073/pnas.0907902107; Eide EJ, 2005, MOL CELL BIOL, V25, P2795, DOI 10.1128/MCB.25.7.2795-2807.2005; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Hastings MH, 2008, CURR BIOL, V18, pR805, DOI 10.1016/j.cub.2008.07.021; Hirota T, 2008, P NATL ACAD SCI USA, V105, P20746, DOI 10.1073/pnas.0811410106; Isojima Y, 2009, P NATL ACAD SCI USA, V106, P15744, DOI 10.1073/pnas.0908733106; Johnson CH, 2008, CURR BIOL, V18, pR816, DOI 10.1016/j.cub.2008.07.012; Khalsa SBS, 1996, AM J PHYSIOL-CELL PH, V271, pC1646, DOI 10.1152/ajpcell.1996.271.5.C1646; KONOPKA RJ, 1979, FED PROC, V38, P2602; Lakin-Thomas PL, 2006, J BIOL RHYTHM, V21, P83, DOI 10.1177/0748730405286102; McClung CR, 2006, PLANT CELL, V18, P792, DOI 10.1105/tpc.106.040980; Mehra A, 2009, TRENDS BIOCHEM SCI, V34, P483, DOI 10.1016/j.tibs.2009.06.006; Merrow M, 2006, GENE DEV, V20, P2629, DOI 10.1101/gad.1479706; Monnier A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-192; MORSE DS, 1990, TRENDS BIOCHEM SCI, V15, P262, DOI 10.1016/0968-0004(90)90050-L; Moulager M, 2007, PLANT PHYSIOL, V144, P1360, DOI 10.1104/pp.107.096149; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Reddy AB, 2010, TRENDS CELL BIOL, V20, P36, DOI 10.1016/j.tcb.2009.10.005; Roenneberg T, 2005, NAT REV MOL CELL BIO, V6, P965, DOI 10.1038/nrm1766; Ueda HR, 2006, MOL SYST BIOL, V2, DOI 10.1038/mbs4100105; WOOLUM JC, 1991, J BIOL RHYTHM, V6, P129, DOI 10.1177/074873049100600203	29	361	370	2	129	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 27	2011	469	7331					554	558		10.1038/nature09654	http://dx.doi.org/10.1038/nature09654			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270895	Green Accepted			2022-12-28	WOS:000286596500037
J	Aufderheide, TP; Frascone, RJ; Wayne, MA; Mahoney, BD; Swor, RA; Domeier, RM; Olinger, ML; Holcomb, RG; Tupper, DE; Yannopoulos, D; Lurie, KG				Aufderheide, Tom P.; Frascone, Ralph J.; Wayne, Marvin A.; Mahoney, Brian D.; Swor, Robert A.; Domeier, Robert M.; Olinger, Michael L.; Holcomb, Richard G.; Tupper, David E.; Yannopoulos, Demetris; Lurie, Keith G.			Standard cardiopulmonary resuscitation versus active compression-decompression cardiopulmonary resuscitation with augmentation of negative intrathoracic pressure for out-of-hospital cardiac arrest: a randomised trial	LANCET			English	Article							IMPEDANCE THRESHOLD DEVICE; CHEST-WALL DECOMPRESSION; INSPIRATORY IMPEDANCE; PORCINE MODEL; VALVE; INSTRUCTOR; SURVIVAL; STUDENT; CPR	Background Active compression-decompression cardiopulmonary resuscitation (CPR) with decreased intrathoracic pressure in the decompression phase can lead to improved haemodynamics compared with standard CPR. We aimed to assess effectiveness and safety of this intervention on survival with favourable neurological function after out-of-hospital cardiac arrest. Methods In our randomised trial of 46 emergency medical service agencies (serving 2.3 million people) in urban, suburban, and rural areas of the USA, we assessed outcomes for patients with out-of-hospital cardiac arrest according to Utstein guidelines. We provisionally enrolled patients to receive standard CPR or active compression-decompression CPR with augmented negative intrathoracic pressure (via an impedance-threshold device) with a computer-generated block randomisation weekly schedule in a one-to-one ratio. Adults (presumed age or age a:18 years) who had a nontraumatic arrest of presumed cardiac cause and met initial and final selection criteria received designated CPR and were included in the final analyses. The primary endpoint was survival to hospital discharge with favourable neurological function (modified Rankin scale score of <= 3). All investigators apart from initial rescuers were masked to treatment group assignment. This trial is registered with ClinicalTrials.gov, number NCT00189423. Findings 2470 provisionally enrolled patients were randomly allocated to treatment groups. 813 (68%) of 1201 patients assigned to the standard CPR group (controls) and 840 (66%) of 1269 assigned to intervention CPR received designated CPR and were included in the final analyses. 47 (6%) of 813 controls survived to hospital discharge with favourable neurological function compared with 75 (9%) of 840 patients in the intervention group (odds ratio 1.58, 95% CI 1.07-2.36; p=0.019]. 74 (9%) of 840 patients survived to 1 year in the intervention group compared with 48 (6%) of 813 controls (p=0.03), with equivalent cognitive skills, disability ratings, and emotional-psychological statuses in both groups. The overall major adverse event rate did not differ between groups, but more patients had pulmonary oedema in the intervention group (94 [11%] of 840) than did controls (62 [7%] of 813; p=0.015). Interpretation On the basis of our findings showing increased effectiveness and generalisability of the study intervention, active compression-decompression CPR with augmentation of negative intrathoracic pressure should be considered as an alternative to standard CPR to increase long-term survival after cardiac arrest.	[Aufderheide, Tom P.] Med Coll Wisconsin, Dept Emergency Med, Milwaukee, WI 53226 USA; [Frascone, Ralph J.] Reg Hosp, Dept Emergency Med, St Paul, MN USA; [Wayne, Marvin A.] St Joseph Med Ctr, Dept Emergency Med, Whatcom Cty Emergency Med Serv, Bellingham, WA USA; [Mahoney, Brian D.; Lurie, Keith G.] Hennepin Cty Med Ctr, Dept Emergency Med, Minneapolis, MN 55415 USA; [Swor, Robert A.] William Beaumont Hosp, Dept Emergency Med, Royal Oak, MI 48072 USA; [Domeier, Robert M.] St Joseph Mercy Hosp, Dept Emergency Med, Ann Arbor, MI 48104 USA; [Olinger, Michael L.] Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN USA; [Holcomb, Richard G.] Quintiles Consulting, Rockville, MD USA; [Tupper, David E.; Yannopoulos, Demetris; Lurie, Keith G.] Univ Minnesota, Med Ctr, Div Cardiovasc, Dept Neurol, Minneapolis, MN 55455 USA; [Tupper, David E.; Yannopoulos, Demetris; Lurie, Keith G.] Univ Minnesota, Med Ctr, Div Cardiovasc, Dept Med, Minneapolis, MN 55455 USA	Medical College of Wisconsin; Hennepin County Medical Center; Beaumont Health; Saint Joseph Mercy Health System (SJMHS); Indiana University System; Indiana University Bloomington; IQVIA; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Aufderheide, TP (corresponding author), Med Coll Wisconsin, Dept Emergency Med, 9200 W Wisconsin Ave,Pavil 1P, Milwaukee, WI 53226 USA.	taufderh@mcw.edu			US National Institutes of Health; federal grant [R44-HL065851-03]; NIH Immediate Trial; NIH Resuscitation Outcomes Consortium; NIH Neurological Emergency Treatment Trials Network; NIH Medical College of Wisconsin; Predict HD study [NINDS-6375, NINDS-40068, NIMH-01579]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R44HL065851] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); federal grant; NIH Immediate Trial(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Resuscitation Outcomes Consortium(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Neurological Emergency Treatment Trials Network; NIH Medical College of Wisconsin; Predict HD study; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank the many first responders, firefighters, emergency medical technicians, and paramedics at all sites who took care of the patients, and without whom survival from out-of-hospital cardiac arrest would not be possible (see webappendix pp 5-9). The study was funded by the US National Institutes of Health and the federal grant (R44-HL065851-03) was used by Advanced Circulatory Systems to fund the study.; TPA, RJF, MAW, BDM, RAS, RMD, and MLO all received grant funds to their respective institutions for services related to patient enrolment, follow-up and data management for this clinical study; RGH received consulting fees for statistical analyses (US National Institutes of Health [NIH] R44-HL065851-03). KGL was co-inventor of the impedance-threshold device and active compression-decompression cardiopulmonary resuscitation device, and founded Advanced Circulatory Systems in 1997 after the University of Minnesota (MN, USA) declined the opportunity to apply for patent protection on the impedance threshold device. All investigators feel KGL contributed substantially to this study and therefore should be listed as an author rather than incorporating his role within the activities of the sponsor, Advanced Circulatory Systems. In his role as the Chief Medical Officer of Advanced Circulatory Systems, KGL participated with the other investigators in obtaining the NIH grant funding (KG L was the principal investigator on the Small Business Innovation Research grant), the study design, data interpretation, writing and the decision to submit the paper for publication. KGL was not involved in any patient care or assessment of patient neurological status during the 1-year follow-up. Outside the present study, TPA has board membership for Take Heart America and Citizen CPR Foundation, has consulted for JoLife Medical and Medtronic Foundation, and has received grants/grants pending from the NIH Immediate Trial, NIH Resuscitation Outcomes Consortium, NIH Neurological Emergency Treatment Trials Network, and NIH Medical College of Wisconsin K12 Research Career Development Program. RJF has received payment for one lecture from Advanced Circulatory Systems. MAW has consulted for Baxter and Vitacare, has received grants/grants pending from the NIH Immediate Trial, payment for lectures or speakers' bureau membership from Vitacare and Sub Zero, and royalties from Cook Critical Care. BDM has board membership for Take Heart Minnesota and has received grants/grants pending from the NIH Neurological Emergency Treatment Trials Network. DET has received grants/grants pending from the Predict HD study, NINDS-6375, NINDS-40068 and NIMH-01579, and royalties as a textbook editor.	Andreka P, 2006, CURR OPIN CRIT CARE, V12, P198, DOI 10.1097/01.ccx.0000224861.70958.59; [Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Aufderheide TP, 2008, CRIT CARE MED, V36, pS397, DOI 10.1097/CCM.0b013e31818a7e56; Aufderheide TP, 2005, RESUSCITATION, V64, P353, DOI 10.1016/j.resuscitation.2004.10.007; Bahlmann L, 2003, RESUSCITATION, V59, P255, DOI 10.1016/S0300-9572(03)00211-9; Cabrini L, 2008, CRIT CARE MED, V36, P1625, DOI 10.1097/CCM.0b013e318170ba80; CRAVEN JL, 1988, INT J PSYCHIAT MED, V18, P365; CUMMINS RO, 1991, ANN EMERG MED, V20, P861; Hollenberg J, 2008, CIRCULATION, V118, P389, DOI 10.1161/CIRCULATIONAHA.107.734137; Lai SM, 2001, NEUROEPIDEMIOLOGY, V20, P26, DOI 10.1159/000054754; Langhelle A, 2002, RESUSCITATION, V52, P39, DOI 10.1016/S0300-9572(01)00442-7; Lurie K, 2000, RESUSCITATION, V44, P219, DOI 10.1016/S0300-9572(00)00160-X; LURIE KG, 1995, CIRCULATION, V91, P1629, DOI 10.1161/01.CIR.91.6.1629; Lurie KG, 1997, J CARDIOVASC ELECTR, V8, P584, DOI 10.1111/j.1540-8167.1997.tb00827.x; McCurry SM, 1999, INT J GERIATR PSYCH, V14, P882, DOI 10.1002/(SICI)1099-1166(199910)14:10<882::AID-GPS42>3.0.CO;2-D; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; OBRIEN PC, 1979, BIOMETRICS, V35, P549, DOI 10.2307/2530245; Plaisance P, 2000, CIRCULATION, V101, P989, DOI 10.1161/01.CIR.101.9.989; Plaisance P, 2005, CRIT CARE MED, V33, P990, DOI 10.1097/01.CCM.0000163235.18990.F6; Plaisance P, 2004, RESUSCITATION, V61, P265, DOI 10.1016/j.resuscitation.2004.01.032; Raedler C, 2002, ANESTH ANALG, V95, P1496, DOI 10.1097/00000539-200212000-00007; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Schneider T, 1996, RESUSCITATION, V32, P203, DOI 10.1016/0300-9572(96)00946-X; SHULTZ JJ, 1994, CIRCULATION, V89, P684, DOI 10.1161/01.CIR.89.2.684; Srinivasan V, 2006, J AM COLL CARDIOL, V47, P835, DOI 10.1016/j.jacc.2005.09.062; Voelckel WG, 2002, PEDIATR RES, V51, P523, DOI 10.1203/00006450-200204000-00020; Wik L, 1996, RESUSCITATION, V32, P206, DOI 10.1016/0300-9572(96)82051-X; Wolcke BB, 2003, CIRCULATION, V108, P2201, DOI 10.1161/01.CIR.0000095787.99180.B5; Yannopoulos D, 2005, RESUSCITATION, V64, P363, DOI 10.1016/j.resuscitation.2004.10.009; Yannopoulos D, 2006, CRIT CARE MED, V34, pS495, DOI 10.1097/01.CCM.0000246082.10422.7E	31	178	201	0	18	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 22	2011	377	9762					301	311		10.1016/S0140-6736(10)62103-4	http://dx.doi.org/10.1016/S0140-6736(10)62103-4			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	714ZO	21251705	Green Accepted			2022-12-28	WOS:000286850400027
J	Nagele, P				Nagele, Peter			Augmented CPR: rescue after the ResQ trial	LANCET			English	Editorial Material							DECOMPRESSION CARDIOPULMONARY-RESUSCITATION; IMPEDANCE THRESHOLD DEVICE; INSPIRATORY IMPEDANCE; GUIDELINES		Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA	Washington University (WUSTL)	Nagele, P (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	nagelep@wustl.edu	Nagele, Peter/ABA-5189-2020; Nagele, Peter/AAW-1651-2020; Nagele, Peter/A-2922-2008	Nagele, Peter/0000-0001-8369-3858; Nagele, Peter/0000-0001-8369-3858				Aufderheide TP, 2011, LANCET, V377, P301, DOI 10.1016/S0140-6736(10)62103-4; Aufderheide TP, 2010, CIRCULATION, V122, P2215; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Cabrini L, 2008, CRIT CARE MED, V36, P1625, DOI 10.1097/CCM.0b013e318170ba80; Cave DM, 2010, CIRCULATION, V122, pS720, DOI 10.1161/CIRCULATIONAHA.110.970970; Deakin CD, 2010, RESUSCITATION, V81, P1305, DOI 10.1016/j.resuscitation.2010.08.017; Kitamura T, 2010, NEW ENGL J MED, V362, P994, DOI 10.1056/NEJMoa0906644; Lafuente-Lafuente C, 2002, COCHRANE DB SYST REV, V3; LINDNER KH, 1993, CIRCULATION, V88, P1254, DOI 10.1161/01.CIR.88.3.1254; Lurie KG, 1998, CHEST, V113, P1084, DOI 10.1378/chest.113.4.1084; LURIE KG, 1995, CIRCULATION, V91, P1629, DOI 10.1161/01.CIR.91.6.1629; Plaisance P, 2000, CIRCULATION, V101, P989, DOI 10.1161/01.CIR.101.9.989; Plaisance P, 2004, RESUSCITATION, V61, P265, DOI 10.1016/j.resuscitation.2004.01.032; Wolcke BB, 2003, CIRCULATION, V108, P2201, DOI 10.1161/01.CIR.0000095787.99180.B5	14	3	3	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 22	2011	377	9762					276	278		10.1016/S0140-6736(10)62309-4	http://dx.doi.org/10.1016/S0140-6736(10)62309-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	714ZO	21251706				2022-12-28	WOS:000286850400005
J	Daar, ES; Tierney, C; Fischl, MA; Sax, PE; Mollan, K; Budhathoki, C; Godfrey, C; Jahed, NC; Myers, L; Katzenstein, D; Farajallah, A; Rooney, JF; Pappa, KA; Woodward, WC; Patterson, K; Bolivar, H; Benson, CA; Collier, AC				Daar, Eric S.; Tierney, Camlin; Fischl, Margaret A.; Sax, Paul E.; Mollan, Katie; Budhathoki, Chakra; Godfrey, Catherine; Jahed, Nasreen C.; Myers, Laurie; Katzenstein, David; Farajallah, Awny; Rooney, James F.; Pappa, Keith A.; Woodward, William C.; Patterson, Kristine; Bolivar, Hector; Benson, Constance A.; Collier, Ann C.		AIDS Clinical Trials Grp Study A52	Atazanavir Plus Ritonavir or Efavirenz as Part of a 3-Drug Regimen for Initial Treatment of HIV-1	ANNALS OF INTERNAL MEDICINE			English	Article							TWICE-DAILY LOPINAVIR/RITONAVIR; ONCE-DAILY ATAZANAVIR/RITONAVIR; NAIVE HIV-1-INFECTED PATIENTS; RENAL-FUNCTION; ANTIRETROVIRAL TREATMENT; TENOFOVIR DF; THERAPY; LAMIVUDINE; ABACAVIR; EMTRICITABINE	Background: Limited data compare once-daily options for initial therapy for HIV-1. Objective: To compare time to virologic failure; first grade-3 or -4 sign, symptom, or laboratory abnormality (safety); and change or discontinuation of regimen (tolerability) for atazanavir plus ritonavir with efavirenz-containing initial therapy for HIV-1. Design: A randomized equivalence trial accrued from September 2005 to November 2007, with median follow-up of 138 weeks. Regimens were assigned by using a central computer, stratified by screening HIV-1 RNA level less than 100 000 copies/mL or 100 000 copies/mL or greater; blinding was known only to the site pharmacist. (ClinicalTrials.gov registration number: NCT00118898) Setting: 59 AIDS Clinical Trials Group sites in the United States and Puerto Rico. Patients: Antiretroviral-naive patients. Intervention: Open-label atazanavir plus ritonavir or efavirenz, each given with with placebo-controlled abacavir-lamivudine or tenofovir disoproxil fumarate (DF)-emtricitabine. Measurements: Primary outcomes were time to virologic failure, safety, and tolerability events. Secondary end points included proportion of patients with HIV-1 RNA level less than 50 copies/mL, emergence of drug resistance, changes in CD4 cell counts, calculated creatinine clearance, and lipid levels. Results: 463 eligible patients were randomly assigned to receive atazanavir plus ritonavir and 465 were assigned to receive efavirenz, both with abacavir-lamivudine; 322 (70%) and 324 (70%), respectively, completed follow-up. The respective numbers of participants in each group who received tenofovir DF-emtricitabine were 465 and 464; 342 (74%) and 343 (74%) completed follow-up. Primary efficacy was similar in the group that received atazanavir plus ritonavir and and the group that received efavirenz and did not differ according to whether abacavir-lamivudine or tenofovir DF-emtricitabine was also given. Hazard ratios for time to virologic failure were 1.13 (95% CI, 0.82 to 1.56) and 1.01 (CI, 0.70 to 1.46), respectively, although CIs did not meet prespecified criteria for equivalence. The time to safety (P = 0.048) and tolerability (P < 0.001) events was longer in persons given atazanavir plus ritonavir than in those given efavirenz with abacavir-lamivudine but not with tenofovir DF-emtricitabine. Limitations: Neither HLA-B*5701 nor resistance testing was the standard of care when A5202 enrolled patients. The third drugs, atazanavir plus ritonavir and efavirenz, were open-label; the nucleoside reverse transcriptase inhibitors were prematurely unblinded in the high viral load stratum; and 32% of patients modified or discontinued treatment with their third drug. Conclusion: Atazanavir plus ritonavir and efavirenz have similar antiviral activity when used with abacavir-lamivudine or tenofovir DF-emtricitabine.	Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Los Angeles, CA USA; Univ Calif Los Angeles, Los Angeles, CA USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Univ Miami, Sch Med, Miami, FL 33136 USA; Brigham & Womens Hosp, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA; NIAID, Bethesda, MD 20892 USA; Social & Sci Syst, Silver Spring, MD 20910 USA; Frontier Sci & Technol Res Fdn Inc, Amherst, NY 14226 USA; Stanford Univ, Palo Alto, CA 94304 USA; Bristol Myers Squibb Co, Plainsboro, NJ USA; Gilead Sci Inc, Foster City, CA 94404 USA; GlaxoSmithKline, Res Triangle Pk, NC 27709 USA; Abbott Labs, Abbott Pk, IL 60064 USA; Univ N Carolina, Chapel Hill, NC USA; Univ Calif San Diego, San Diego, CA 92103 USA; Univ Washington, Harborview Med Ctr, Seattle, WA 98104 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; University of California System; University of California Los Angeles; Harvard University; Harvard T.H. Chan School of Public Health; University of Miami; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Social & Scientific Systems; Frontier Science Foundation; Stanford University; Bristol-Myers Squibb; Gilead Sciences; GlaxoSmithKline; Abbott Laboratories; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; Harborview Medical Center; University of Washington; University of Washington Seattle	Daar, ES (corresponding author), Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, 1124 W Carson St,N-24, Torrance, CA 90502 USA.	EDaar@LABioMed.org	Budhathoki, Chakra/AAC-3180-2021; Pahwa, Savita/AAA-4900-2019	Pahwa, Savita/0000-0002-4470-4216; Yin, Michael T/0000-0002-9346-9056; Budhathoki, Chakra/0000-0002-1886-7847; katzenstein, david/0000-0002-8593-4560; Stapleton, Jack/0000-0002-2302-9055; Meier, Jeffery/0000-0001-9491-1697	National Institutes of Health; National Institute of Allergy and Infectious Diseases [U01AI068636]; AIDS Clinical Trials Group Central Group [AI38858]; Statistical Data Management Center [AI38855, AI68634]; National Center for Research Resources; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124, UL1TR000454] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156, M01RR000046, UL1RR024996, UL1RR025747, UL1RR025777, UL1RR025008, UL1RR025780, UL1RR024160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069556, UM1AI069472, U01AI027675, U01AI025859, P30AI073961, U01AI027666, U01AI069432, U01AI069501, U01AI069494, U01AI069511, U01AI038858, UM1AI069434, U01AI069418, U01AI046376, UM1AI068634, U01AI069452, UM1AI069513, U01AI069424, U01AI027661, N01AI072626, U01AI069502, U01AI025868, U01AI069415, U01AI027658, UM1AI069424, UM1AI069474, U01AI069495, U01AI038855, P30AI045008, UM1AI069532, U01AI068634, U01AI069513, U01AI069471, UM1AI069511, UM1AI069556, U01AI069532, U01AI069465, U01AI069477, U01AI069467, U01AI069434, U01AI046370, UM1AI069471, U01AI069472, U01AI069423, P30AI027757, UM1AI069423, U01AI069470, U01AI069428, P30AI050409, U01AI069474, UM1AI069439, R01AI058740, U01AI069447, UM1AI069432, U01AI034853, U01AI068636, UM1AI069465, UM1AI069501, P30AI050410, UM1AI069495, U01AI069419, UM1AI069419, UM1AI069477, U01AI069484, U01AI032782, U01AI069439] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AIDS Clinical Trials Group Central Group; Statistical Data Management Center; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health.; By award U01AI068636 from the National Institute of Allergy and Infectious Diseases, along with the previous grant for the AIDS Clinical Trials Group Central Group (AI38858) and the Statistical Data Management Center grants (AI38855 and AI68634). The study was supported in part by the General Clinical Research Center Units, funded by the National Center for Research Resources.	[Anonymous], GUID US ANT AG HIV 1; Bartlett JA, 2006, JAIDS-J ACQ IMM DEF, V43, P284, DOI 10.1097/01.qai.0000243092.40490.26; Buchacz K, 2006, JAIDS-J ACQ IMM DEF, V43, P626, DOI 10.1097/01.qai.0000242461.35768.45; Chesney MA, 2000, AIDS CARE, V12, P255, DOI 10.1080/09540120050042891; DeJesus E, 2004, CLIN INFECT DIS, V39, P1038, DOI 10.1086/424009; Gallant JE, 2006, NEW ENGL J MED, V354, P251, DOI 10.1056/NEJMoa051871; Gallant JE, 2004, JAMA-J AM MED ASSOC, V292, P191, DOI 10.1001/jama.292.2.191; Gallant JE, 2009, AIDS, V23, P1971, DOI 10.1097/QAD.0b013e32832c96e9; Goicoechea M, 2008, J INFECT DIS, V197, P102, DOI 10.1086/524061; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Gulick RM, 2004, NEW ENGL J MED, V350, P1850, DOI 10.1056/NEJMoa031772; Johnson Victoria A, 2008, Top HIV Med, V16, P62; LIN DY, 1993, BIOMETRIKA, V80, P557, DOI 10.2307/2337177; MacManus S, 2004, AIDS, V18, P651, DOI 10.1097/00002030-200403050-00009; Malik Amyn, 2005, J Infect, V51, pE61, DOI 10.1016/j.jinf.2004.08.031; McIntyre J, 2010, 17 C RETR OPP INF SA; Mills AM, 2009, AIDS, V23, P1679, DOI 10.1097/QAD.0b013e32832d7350; Molina JM, 2008, LANCET, V372, P646, DOI 10.1016/S0140-6736(08)61081-8; Molina JM, 2010, JAIDS-J ACQ IMM DEF, V53, P323, DOI 10.1097/QAI.0b013e3181c990bf; Puls RL, 2010, CLIN INFECT DIS, V51, P855, DOI 10.1086/656363; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; Sax PE, 2009, NEW ENGL J MED, V361, P2230, DOI 10.1056/NEJMoa0906768; Schemper M, 2009, STAT MED, V28, P2473, DOI 10.1002/sim.3623; Smith KY, 2009, AIDS, V23, P1547, DOI 10.1097/QAD.0b013e32832cbcc2; Soriano V, 2009, 5 INT AIDS SOC C HIV; Thompson MA, 2010, JAMA-J AM MED ASSOC, V304, P321, DOI 10.1001/jama.2010.1004	26	252	253	0	22	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 5	2011	154	7							445	10.7326/0003-4819-154-7-201104050-00316	http://dx.doi.org/10.7326/0003-4819-154-7-201104050-00316			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	744EX	21320923	Green Accepted			2022-12-28	WOS:000289078700001
J	Butler, CD				Butler, Colin D.			A stormy future for population health in southeast Asia?	LANCET			English	Editorial Material							CLIMATE-CHANGE		Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia	Australian National University	Butler, CD (corresponding author), Australian Natl Univ, Natl Ctr Epidemiol & Populat Hlth, GPO Box 4, Canberra, ACT 0200, Australia.	colin.butler@anu.edu.au	Butler, Colin D./H-2267-2019	Butler, Colin D./0000-0002-2942-5294				Allan RP, 2008, SCIENCE, V321, P1481, DOI 10.1126/science.1160787; Bryant L, 2009, B WORLD HEALTH ORGAN, V87, P852, DOI 10.2471/BLT.08.062562; Butler C. D., 2010, SCN News, P18; Butler CD, 2010, POSTGRAD MED J, V86, P230, DOI 10.1136/pgmj.2009.082727; Campbell M, 2007, SCIENCE, V315, P1501, DOI 10.1126/science.1140057; Dear K, 2005, ARCH ENVIRON OCCUP H, V60, P205, DOI 10.3200/AEOH.60.4.205-212; Hull TH, 2009, B INDONES ECON STUD, V45, P61, DOI 10.1080/00074910902836197; Owen NA, 2010, ENERG POLICY, V38, P4743, DOI 10.1016/j.enpol.2010.02.026; Pan CJ, 2010, ANN GEOPHYS-GERMANY, V28, P11, DOI 10.5194/angeo-28-11-2010; Pasricha SR, 2010, J PAEDIATR CHILD H, V46, P497, DOI 10.1111/j.1440-1754.2010.01839.x; Shang CS, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000775	12	1	1	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 12	2011	377	9769					885	886		10.1016/S0140-6736(10)62140-X	http://dx.doi.org/10.1016/S0140-6736(10)62140-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	738GR	21269679				2022-12-28	WOS:000288628800009
J	Connolly, SJ; Eikelboom, J; Joyner, C; Diener, HC; Hart, R; Golitsyn, S; Flaker, G; Avezum, A; Hohnloser, SH; Diaz, R; Talajic, M; Zhu, J; Pais, P; Budaj, A; Parkhomenko, A; Jansky, P; Commerford, P; Tan, RS; Sim, KH; Lewis, BS; Van Mieghem, W; Lip, GYH; Kim, JH; Lanas-Zanetti, F; Gonzalez-Hermosillo, A; Dans, AL; Munawar, M; O'Donnell, M; Lawrence, J; Lewis, G; Afzal, R; Yusuf, S				Connolly, Stuart J.; Eikelboom, John; Joyner, Campbell; Diener, Hans-Christoph; Hart, Robert; Golitsyn, Sergey; Flaker, Greg; Avezum, Alvaro; Hohnloser, Stefan H.; Diaz, Rafael; Talajic, Mario; Zhu, Jun; Pais, Prem; Budaj, Andrzej; Parkhomenko, Alexander; Jansky, Petr; Commerford, Patrick; Tan, Ru San; Sim, Kui-Hian; Lewis, Basil S.; Van Mieghem, Walter; Lip, Gregory Y. H.; Kim, Jae Hyung; Lanas-Zanetti, Fernando; Gonzalez-Hermosillo, Antonio; Dans, Antonio L.; Munawar, Muhammad; O'Donnell, Martin; Lawrence, John; Lewis, Gayle; Afzal, Rizwan; Yusuf, Salim			Apixaban in Patients with Atrial Fibrillation	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANTITHROMBOTIC THERAPY; PREVENT STROKE; WARFARIN; MANAGEMENT; THROMBOPROPHYLAXIS; ANTICOAGULATION; METAANALYSIS; ENOXAPARIN; ASPIRIN; EVENTS	BACKGROUND Vitamin K antagonists have been shown to prevent stroke in patients with atrial fibrillation. However, many patients are not suitable candidates for or are unwilling to receive vitamin K antagonist therapy, and these patients have a high risk of stroke. Apixaban, a novel factor Xa inhibitor, may be an alternative treatment for such patients. METHODS In a double-blind study, we randomly assigned 5599 patients with atrial fibrillation who were at increased risk for stroke and for whom vitamin K antagonist therapy was unsuitable to receive apixaban (at a dose of 5 mg twice daily) or aspirin (81 to 324 mg per day), to determine whether apixaban was superior. The mean follow up period was 1.1 years. The primary outcome was the occurrence of stroke or systemic embolism. RESULTS Before enrollment, 40% of the patients had used a vitamin K antagonist. The data and safety monitoring board recommended early termination of the study because of a clear benefit in favor of apixaban. There were 51 primary outcome events (1.6% per year) among patients assigned to apixaban and 113 (3.7% per year) among those assigned to aspirin (hazard ratio with apixaban, 0.45; 95% confidence interval [CI], 0.32 to 0.62; P<0.001). The rates of death were 3.5% per year in the apixaban group and 4.4% per year in the aspirin group (hazard ratio, 0.79; 95% CI, 0.62 to 1.02; P = 0.07). There were 44 cases of major bleeding (1.4% per year) in the apixaban group and 39 (1.2% per year) in the aspirin group (hazard ratio with apixaban, 1.13; 95% CI, 0.74 to 1.75; P = 0.57); there were 11 cases of intracranial bleeding with apixaban and 13 with aspirin. The risk of a first hospitalization for cardiovascular causes was reduced with apixaban as compared with aspirin (12.6% per year vs. 15.9% per year, P<0.001). The treatment effects were consistent among important subgroups. CONCLUSIONS In patients with atrial fibrillation for whom vitamin K antagonist therapy was unsuitable, apixaban reduced the risk of stroke or systemic embolism without significantly increasing the risk of major bleeding or intracranial hemorrhage.	[Connolly, Stuart J.; Eikelboom, John; Lewis, Gayle; Afzal, Rizwan; Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada; [Connolly, Stuart J.; Eikelboom, John; Lewis, Gayle; Afzal, Rizwan; Yusuf, Salim] Hamilton Hlth Sci, Hamilton, ON, Canada; [Joyner, Campbell] Univ Toronto, Toronto, ON, Canada; [Diener, Hans-Christoph] Univ Duisburg Essen, Essen, Germany; [Hart, Robert] Univ Texas San Antonio, San Antonio, TX USA; [Golitsyn, Sergey] Russian Cardiol Res & Prod Ctr, Moscow, Russia; [Flaker, Greg] Univ Missouri, Columbia, MO 65211 USA; [Avezum, Alvaro] Inst Dante Pazzanese Cardiol, Sao Paulo, Brazil; [Hohnloser, Stefan H.] Goethe Univ Frankfurt, Frankfurt, Germany; [Diaz, Rafael] Estudios Clin Latinoamer, Rosario, Argentina; [Talajic, Mario] Univ Montreal, Montreal Heart Inst, Montreal, PQ, Canada; [Zhu, Jun] Chinese Acad Med Sci, FuWai Hosp, Beijing 100037, Peoples R China; [Zhu, Jun] Peking Union Med Coll, Beijing 100021, Peoples R China; [Pais, Prem] St Johns Med Coll & Res Inst, Bangalore, Karnataka, India; [Budaj, Andrzej] Grochowski Hosp, Postgrad Med Sch, Warsaw, Poland; [Parkhomenko, Alexander] Inst Cardiol, Kiev, Ukraine; [Jansky, Petr] Univ Hosp Motol, Prague, Czech Republic; [Commerford, Patrick] Univ Cape Town, Dept Med, ZA-7925 Cape Town, South Africa; [Sim, Kui-Hian] Clin Res Ctr, Sarawak, Malaysia; [Tan, Ru San] Natl Heart Ctr, Singapore, Singapore; [Lewis, Basil S.] Lady Davis Carmel Med Ctr, Haifa, Israel; [Van Mieghem, Walter] Ziekenhuis Oost Limburg Campus, St Jan, Genk, Belgium; [Lip, Gregory Y. H.] City Hosp, Birmingham, W Midlands, England; [Kim, Jae Hyung] Catholic Univ Korea, St Pauls Hosp, Seoul, South Korea; [Lanas-Zanetti, Fernando] Univ La Frontera, Temuco, Chile; [Gonzalez-Hermosillo, Antonio] Inst Nacl Cardiol Ignacio Chavez, Mexico City, DF, Mexico; [Dans, Antonio L.] Univ Philippines, Coll Med, Manila, Philippines; [Munawar, Muhammad] Harapan Kita Hosp, Jakarta, Indonesia; [O'Donnell, Martin] HRB Clin Res Facil, Galway, Ireland; [Lawrence, John] Bristol Myers Squibb Co, Princeton, NJ USA	McMaster University; Population Health Research Institute; McMaster University; University of Toronto; University of Duisburg Essen; University of Texas System; University of Texas at San Antonio (UTSA); National Medical Research Center of Cardiology; University of Missouri System; University of Missouri Columbia; Instituto Dante Pazzanese de Cardiologia; Goethe University Frankfurt; Universite de Montreal; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; St. John's National Academy of Health Sciences; St. John's Medical College; Centre of Postgraduate Medical Education - Poland; National Academy of Medical Sciences of Ukraine; National Scientific Center M.D. Strazhesko Institute of Cardiology of the National Academy of Medical Sciences of Ukraine; Motol University Hospital; University of Cape Town; National Heart Centre Singapore; Clalit Health Services; Carmel Medical Center; East Limburg Hospital; University of Birmingham; Catholic University of Korea; Universidad de La Frontera; National Institute of Cardiology - Mexico; University of the Philippines System; University of the Philippines Manila; Health Research Board - Ireland; Ollscoil na Gaillimhe-University of Galway; Bristol-Myers Squibb	Connolly, SJ (corresponding author), McMaster Univ, Populat Hlth Res Inst, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	stuart.connolly@phri.ca	Eikelboom, John/AAG-6117-2019; Reshetko, Olga/I-7011-2013; Avezum, Alvaro/AAP-7687-2020; Okoshi, Marina/M-7592-2019; Tanne, David/F-2560-2010; Leung, Thomas W/AAU-6475-2021; Larina, Vera N/E-6211-2016; Avezum, Alvaro AA/K-6137-2016; Vanhooren, Geert/H-4433-2011; Golitsyn, Sergey/ABH-2143-2020; Khasanov, Niiaz/W-7678-2019; Diener, Hans-Christoph/AAF-7275-2019; Urina-Triana, Miguel A/H-2605-2016; O'Donnell, Martin/ABE-7459-2020; De Caterina, Raffaele/K-3857-2016; Lanas, Fernando/AAE-8842-2022; Rabuñal, Ramón/K-2795-2013; Furman, Nikolay V/M-1527-2014; Schulman, Sam/I-7559-2019; Colquhoun, David M/F-9078-2013; Hankey, Graeme J/H-4968-2014; Beghi, Ettore/AAA-7426-2020	Eikelboom, John/0000-0003-4126-1285; Reshetko, Olga/0000-0003-3107-7636; Okoshi, Marina/0000-0001-7728-4505; Tanne, David/0000-0002-6699-2220; Leung, Thomas W/0000-0001-8193-0709; Larina, Vera N/0000-0001-7825-5597; Avezum, Alvaro AA/0000-0002-3073-6890; Vanhooren, Geert/0000-0001-6818-9346; Golitsyn, Sergey/0000-0001-9913-9974; Khasanov, Niiaz/0000-0002-7760-0763; Urina-Triana, Miguel A/0000-0001-6003-4622; O'Donnell, Martin/0000-0002-7347-7761; De Caterina, Raffaele/0000-0003-1637-574X; Rabuñal, Ramón/0000-0001-5106-5005; Furman, Nikolay V/0000-0002-5686-6431; Schulman, Sam/0000-0002-8512-9043; Hankey, Graeme J/0000-0002-6044-7328; Beghi, Ettore/0000-0003-2542-0469; Tan, Ru San/0000-0003-2086-6517; Yusuf, Salim/0000-0003-4776-5601; Farnoud, Reza/0000-0001-5097-2041; Pasco, Paul Matthew/0000-0002-1533-2214; Lanas, Fernando/0000-0003-3595-9759; Talajic, Mario/0000-0001-8469-4748; Harenberg, Job/0000-0003-4590-4225; Budaj, Andrzej/0000-0002-6395-2098; Abizanda Soler, Pedro/0000-0002-4707-2963; Gonzalez-Hermosillo, Jesus Antonio/0000-0002-3563-3081	Boehringer Ingelheim; Sanofi-Aventis; Portola; Merck; Eli Lilly; AstraZeneca; Novartis; Bristol-Myers Squibb; Abbott; Bayer Vital; CoAxia; D-Pharm; Fresenius; GlaxoSmithKline; Janssen-Cilag; Knoll; Merck Sharpe and Dohme; Medtronic; MindFrame; Neurobiological Technologies; Novo-Nordisk; Paion; Parke-Davis; Pfizer; Sankyo; Schering-Plough; Servier; Solvay; Thrombogenics; Wyeth; Yamaguchi; Takeda; Bayer; Borschagovskiy; Astellas; Orion; Daiichi; Biotronic; St. Jude Medical	Boehringer Ingelheim(Boehringer Ingelheim); Sanofi-Aventis(Sanofi-Aventis); Portola; Merck(Merck & Company); Eli Lilly(Eli Lilly); AstraZeneca(AstraZeneca); Novartis(Novartis); Bristol-Myers Squibb(Bristol-Myers Squibb); Abbott(Abbott Laboratories); Bayer Vital(Bayer AG); CoAxia; D-Pharm; Fresenius; GlaxoSmithKline(GlaxoSmithKline); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Knoll; Merck Sharpe and Dohme(Merck & Company); Medtronic(Medtronic); MindFrame; Neurobiological Technologies; Novo-Nordisk(Novo Nordisk); Paion; Parke-Davis; Pfizer(Pfizer); Sankyo; Schering-Plough(Merck & CompanySchering Plough Corporation); Servier(Servier); Solvay(Solvay SA); Thrombogenics; Wyeth(Wyeth); Yamaguchi; Takeda(Takeda Pharmaceutical Company Ltd); Bayer(Bayer AG); Borschagovskiy; Astellas(Astellas Pharmaceuticals); Orion; Daiichi(Daiichi Sankyo Company Limited); Biotronic; St. Jude Medical(St. Jude Medical)	Dr. Connolly reports receiving payment for serving on the boards of Boehringer Ingelheim, Sanofi-Aventis, Portola, and Merck, consulting fees from Boehringer Ingelheim, Sanofi-Aventis, Portola, and Merck, grant support on behalf of his institution, McMaster University, from Boehringer Ingelheim, Sanofi-Aventis, Portola, and Bristol-Myers Squibb, and lecture fees from Boehringer Ingelheim, Sanofi-Aventis, and Portola; Dr. Eikelboom, receiving consulting fees from Bristol-Myers Squibb, Sanofi-Aventis, Eli Lilly, AstraZeneca, and Novartis and lecture fees from Bristol-Myers Squibb, Sanofi-Aventis, Eli Lilly, and AstraZeneca; Dr. Joyner, receiving honoraria from Hamilton Health Sciences as the cochair of the RELY adjudication committee; Dr. Diener, receiving payment for serving on the boards of Abbott, AstraZeneca, Boehringer Ingelheim, CoAxia, D-Pharm, GlaxoSmithKline, Janssen-Cilag, Medtronic, MindFrame, Neurobiological Technologies, Novartis, Sanofi-Aventis, Servier, and Solvay, consulting fees from Abbott, AstraZeneca, Bayer Vital, Bristol-Myers Squibb, Boehringer Ingelheim, CoAxia, D-Pharm, Fresenius, GlaxoSmithKline, Janssen-Cilag, Knoll, Merck Sharpe and Dohme, Medtronic, MindFrame, Neurobiological Technologies, Novartis, Novo-Nordisk, Paion, Parke-Davis, Pfizer, Sanofi-Aventis, Sankyo, Schering-Plough, Servier, Solvay, Thrombogenics, Wyeth, and Yamaguchi, grant support on behalf of his institution, University Duisburg-Essen, from AstraZeneca, GlaxoSmithKline, Boehringer Ingelheim, Novartis, Janssen-Cilag, and Sanofi-Aventis, lecture fees from Abbott, AstraZeneca, Bristol-Myers Squibb, Bayer Vital, Boehringer Ingelheim, CoAxia, D-Pharm, GlaxoSmithKline, Merck Sharpe and Dohme, MindFrame, Neurobiological Technologies, Novartis, Sanofi-Aventis, Servier, Solvay, and Thrombogenics, payment from Boehringer Ingelheim and Sanofi-Aventis for manuscript preparation, and payment from Boehringer Ingelheim for developing educational presentations; Dr. Flaker, receiving payment for serving as a consultant on Bristol-Myers Squibb's advisory board; Dr. Avezum, receiving payment from Boehringer Ingelheim for giving lectures in the Satellite Symposium; Dr. Hohnloser, receiving consulting fees from Boehringer Ingelheim, St. Jude Medical, Sanofi-Aventis, and Cardiome, and lecture fees from Boehringer Ingelheim, St. Jude Medical, Sanofi-Aventis, and Cardiome; Dr. Talajic, receiving consulting fees from Boehringer Ingelheim and Bristol-Myers Squibb, grant support on behalf of his institution, the Montreal Heart Institute, from Boehringer Ingelheim, and lecture fees from Boehringer Ingelheim and Bristol-Myers Squibb; Dr. Budaj, receiving consulting fees from Sanofi-Aventis, Eli Lilly, Novartis, and AstraZeneca, grant support both for himself and on behalf of his institution, Grochowski Hospital, from Sanofi-Aventis, Boehringer Ingelheim, GlaxoSmithKline, Bristol-Myers Squibb, and AstraZeneca, lecture fees from Sanofi-Aventis, Boehringer Ingelheim, GlaxoSmithKline, and AstraZeneca, and reimbursement for travel, accommodations, or meeting expenses from Sanofi-Aventis, Boehringer Ingelheim, GlaxoSmithKline, and AstraZeneca; Dr. Parkhomenko, receiving consulting fees from AstraZeneca, Merck Sharpe and Dohme, Bayer, Takeda, GlaxoSmithKline, Borschagovskiy, Servier, Sanofi-Aventis, Astellas, and Boehringer Ingelheim, lecture fees from Servier, Orion, GlaxoSmithKline, and Pfizer, and payment from Servier and Pfizer for developing educational presentations; Dr.; r Commerford, having testified as an expert witness on the importance of anticoagulation in atrial fibrllation, receiving consulting fees from UpToDate and reimbursement for committee meeting expenses on behalf of his institution, the Cardiac Clinic, from Boehringer Ingelheim, Sanofi-Aventis, and Bristol-Myers Squibb; Dr. Tan, receiving payment for serving on a regional advisory board for Bayer; Dr. Lewis, receiving consulting fees from Bristol-Myers Squibb; Dr. Lip, receiving consulting fees from Astellas, Boehringer Ingelheim, Bayer, Daiichi, Merck, Portola, Biotronic, Sanofi-Aventis, and AstraZeneca, grant support on behalf of his institution, City Hospital, from Bayer, lecture fees from Boehringer Ingelheim, Bayer, Merck, and Sanofi-Aventis, and payment from Boehringer Ingelheim for developing educational presentations; Dr. Lawrence, being an employee of Bristol-Myers Squibb; and Dr. Yusuf, receiving consulting fees from Boehringer Ingelheim, Sanofi-Aventis, Novartis, AstraZeneca, Bristol-Myers Squibb, and Glaxo-SmithKline, and grant support from Boehringer Ingelheim, Sanofi-Aventis, Novartis, AstraZeneca, GlaxoSmithKline, and Bristol-Myers Squibb. No other potential conflict of interest relevant to this article was reported.r Supported by Bristol-Myers Squibb and Pfizer.	Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Baker WL, 2009, J MANAGE CARE PHARM, V15, P244, DOI 10.18553/jmcp.2009.15.3.244; Birman-Deych E, 2006, STROKE, V37, P1070, DOI 10.1161/01.STR.0000208294.46968.a4; Connolly S, 2006, LANCET, V367, P1903, DOI 10.1016/s0140-6736(06)68845-4; Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Eikelboom JW, 2010, CIRCULATION, V121, P1523, DOI 10.1161/CIRCULATIONAHA.109.853119; Eikelboom JW, 2010, AM HEART J, V159, P348, DOI 10.1016/j.ahj.2009.08.026; Fang MC, 2010, CIRC-CARDIOVASC QUAL, V3, P624, DOI 10.1161/CIRCOUTCOMES.110.937680; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Glader EL, 2010, STROKE, V41, P397, DOI 10.1161/STROKEAHA.109.566950; Go AS, 2003, JAMA-J AM MED ASSOC, V290, P2685, DOI 10.1001/jama.290.20.2685; Hart RG, 2005, STROKE, V36, P1588, DOI 10.1161/01.STR.0000170642.39876.f2; Hart RG, 2007, ANN INTERN MED, V147, P590, DOI 10.7326/0003-4819-147-8-200710160-00018; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Lassen MR, 2009, NEW ENGL J MED, V361, P1814; Lassen MR, 2010, LANCET, V375, P807, DOI 10.1016/S0140-6736(09)62125-5; Lassen MR, 2009, NEW ENGL J MED, V361, P594, DOI 10.1056/NEJMoa0810773; Lip GYH, 2007, LANCET, V370, P604, DOI 10.1016/S0140-6736(07)61300-2; Lopes RD, 2010, AM HEART J, V159, P331, DOI 10.1016/j.ahj.2009.07.035; Nieuwlaat R, 2005, EUR HEART J, V26, P2422, DOI 10.1093/eurheartj/ehi505; RD Lopes, 2010, AM HEART J, V159, P1162; Wyse DG, 2004, HEART RHYTHM, V1, P531, DOI 10.1016/j.hrthm.2004.07.007	23	1723	1817	1	168	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2011	364	9					806	817		10.1056/NEJMoa1007432	http://dx.doi.org/10.1056/NEJMoa1007432			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729DJ	21309657				2022-12-28	WOS:000287928400006
J	Eltzschig, HK; Carmeliet, P				Eltzschig, Holger K.; Carmeliet, Peter			Mechanisms of Disease: Hypoxia and Inflammation.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							NF-KAPPA-B; INDUCIBLE FACTOR-I; TOLL-LIKE RECEPTOR; NUCLEOTIDE PHOSPHOHYDROLYSIS; HIF-1-DEPENDENT REPRESSION; ECTO-5'-NUCLEOTIDASE CD73; DEPENDENT INDUCTION; OXYGEN SENSORS; ADENOSINE; HIF-1-ALPHA		[Eltzschig, Holger K.] Univ Colorado Denver, Dept Anesthesiol, Aurora, CO 80045 USA; [Eltzschig, Holger K.] Univ Tubingen Hosp, Dept Anesthesiol & Intens Care Med, Tubingen, Germany; [Carmeliet, Peter] Vesalius Res Ctr VIB, Louvain, Belgium; [Carmeliet, Peter] Katholieke Univ Leuven, Vesalius Res Ctr, Louvain, Belgium	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Flanders Institute for Biotechnology (VIB); KU Leuven	Eltzschig, HK (corresponding author), Univ Colorado Denver, Dept Anesthesiol, 12700 E 19th Ave,Mailstop B112,Res Complex 2,Rm 7, Aurora, CO 80045 USA.	holger.eltzschig@ucdenver.edu	Carmeliet, Peter/AAQ-5140-2020; varesio, luigi/J-8261-2016; Wilcox, Ian/E-8360-2015	Carmeliet, Peter/0000-0001-7961-1821; varesio, luigi/0000-0001-5659-2218; Wilcox, Ian/0000-0002-6414-7453	NHLBI NIH HHS [R01 HL098294, R01 HL092188] Funding Source: Medline; NIDDK NIH HHS [R01 DK083385] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092188, R01HL098294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK083385] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Andrade CF, 2006, J HEART LUNG TRANSPL, V25, P1317, DOI 10.1016/j.healun.2006.09.017; Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Ben-Shoshan J, 2008, EUR J IMMUNOL, V38, P2412, DOI 10.1002/eji.200838318; Ben-Shoshan J, 2009, ARTERIOSCL THROM VAS, V29, P665, DOI 10.1161/ATVBAHA.108.183319; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Cash TP, 2007, FREE RADICAL BIO MED, V43, P1219, DOI 10.1016/j.freeradbiomed.2007.07.001; Chen LW, 2003, NAT MED, V9, P575, DOI 10.1038/nm849; Coleman ML, 2009, CURR PHARM DESIGN, V15, P3904, DOI 10.2174/138161209789649448; Colgan SP, 2010, NAT REV GASTRO HEPAT, V7, P281, DOI 10.1038/nrgastro.2010.39; Cramer T, 2003, CELL, V113, P419; Cramer T, 2003, CELL, V112, P645, DOI 10.1016/S0092-8674(03)00154-5; Cummins EP, 2008, GASTROENTEROLOGY, V134, P156, DOI 10.1053/j.gastro.2007.10.012; Cummins EP, 2006, P NATL ACAD SCI USA, V103, P18154, DOI 10.1073/pnas.0602235103; D'Alessio FR, 2009, J CLIN INVEST, V119, P2898, DOI 10.1172/JCI36498; De Bock K, 2009, J MOL MED, V87, P561, DOI 10.1007/s00109-009-0482-z; De Perrot M, 2002, AM J RESP CRIT CARE, V165, P211, DOI 10.1164/ajrccm.165.2.2011151; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2008, CIRCULATION, V118, P166, DOI 10.1161/CIRCULATIONAHA.107.758516; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Eltzschig HK, 2009, ANESTHESIOLOGY, V111, P904, DOI 10.1097/ALN.0b013e3181b060f2; Eltzschig HK, 2009, BLOOD, V113, P224, DOI 10.1182/blood-2008-06-165746; Fraisl P, 2009, NAT REV DRUG DISCOV, V8, P139, DOI 10.1038/nrd2761; Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003; Friedman DJ, 2009, P NATL ACAD SCI USA, V106, P16788, DOI 10.1073/pnas.0902869106; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Giatromanolaki A, 2003, J CLIN PATHOL, V56, P209, DOI 10.1136/jcp.56.3.209; Grenz A, 2008, PLOS MED, V5, P968, DOI 10.1371/journal.pmed.0050137; Grocott MPW, 2009, NEW ENGL J MED, V360, P140, DOI 10.1056/NEJMoa0801581; Hackett PH, 2001, NEW ENGL J MED, V345, P107, DOI 10.1056/NEJM200107123450206; Haeberle HA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003352; Hart ML, 2008, FASEB J, V22, P2784, DOI 10.1096/fj.07-103911; Hart ML, 2009, J IMMUNOL, V182, P3965, DOI 10.4049/jimmunol.0802193; Hartmann G, 2000, CYTOKINE, V12, P246, DOI 10.1006/cyto.1999.0533; Hartmann H, 2008, GASTROENTEROLOGY, V134, P756, DOI 10.1053/j.gastro.2007.12.008; Jain RK, 2009, NEW ENGL J MED, V360, P2669, DOI 10.1056/NEJMcibr0902054; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Karhausen J, 2004, J CLIN INVEST, V114, P1098, DOI 10.1172/JCI200421086; Kempf VAJ, 2005, CIRCULATION, V111, P1054, DOI 10.1161/01.CIR.0000155608.07691.B7; Knowles HJ, 2006, CANCER RES, V66, P2600, DOI 10.1158/0008-5472.CAN-05-2351; Kohler, 2007, CIRCULATION, V116, pE514, DOI 10.1161/CIRCULATIONAHA.107.187466; Kohler D, 2007, CIRCULATION, V116, P1784, DOI 10.1161/CIRCULATIONAHA.107.690180; Kojima H, 2002, P NATL ACAD SCI USA, V99, P2170, DOI 10.1073/pnas.052706699; Kong TQ, 2006, FASEB J, V20, P2242, DOI 10.1096/fj.06-6419com; Kruger B, 2009, P NATL ACAD SCI USA, V106, P3390, DOI 10.1073/pnas.0810169106; Kuhlicke J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001364; Ladroue C, 2008, NEW ENGL J MED, V359, P2685, DOI 10.1056/NEJMoa0806277; Liao D, 2007, CANCER METAST REV, V26, P281, DOI 10.1007/s10555-007-9066-y; Louis N, 2005, FASEB J, V19, pA778; Mazzone M, 2009, CELL, V136, P839, DOI 10.1016/j.cell.2009.01.020; Morote-Garcia JC, 2008, BLOOD, V111, P5571, DOI 10.1182/blood-2007-11-126763; Morote-Garcia JC, 2009, GASTROENTEROLOGY, V136, P607, DOI 10.1053/j.gastro.2008.10.037; Nanni S, 2009, J CLIN INVEST, V119, P1093, DOI 10.1172/JCI35079; Naugler WE, 2008, CURR OPIN GENET DEV, V18, P19, DOI 10.1016/j.gde.2008.01.020; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Ohta A, 2001, NATURE, V414, P916, DOI 10.1038/414916a; Pasparakis M, 2008, MUCOSAL IMMUNOL, V1, pS54, DOI 10.1038/mi.2008.53; Patel NJ, 2007, AM J PHYSIOL-GASTR L, V292, pG134, DOI 10.1152/ajpgi.00276.2006; Percy MJ, 2008, NEW ENGL J MED, V358, P162, DOI 10.1056/NEJMoa073123; Peyssonnaux C, 2005, J CLIN INVEST, V115, P1806, DOI 10.1172/JCI23865; Reutershan J, 2009, FASEB J, V23, P473, DOI 10.1096/fj.08-119701; Ripoli M, 2010, J VIROL, V84, P647, DOI 10.1128/JVI.00769-09; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Robinson A, 2008, GASTROENTEROLOGY, V134, P145, DOI 10.1053/j.gastro.2007.09.033; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Schingnitz U, 2010, J IMMUNOL, V184, P5271, DOI 10.4049/jimmunol.0903035; Semenza GL, 2010, ONCOGENE, V29, P625, DOI 10.1038/onc.2009.441; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Semenza GL, 2007, SCIENCE, V318, P62, DOI 10.1126/science.1147949; Sitkovsky M, 2005, NAT REV IMMUNOL, V5, P712, DOI 10.1038/nri1685; Sitkovsky MV, 2009, TRENDS IMMUNOL, V30, P102, DOI 10.1016/j.it.2008.12.002; Sitkovsky MV, 2004, ANNU REV IMMUNOL, V22, P657, DOI 10.1146/annurev.immunol.22.012703.104731; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; TAMBUWALA MM, 2010, GASTROENTEROLOG 0630; Taylor CT, 2008, J PHYSIOL-LONDON, V586, P4055, DOI 10.1113/jphysiol.2008.157669; Taylor CT, 2007, J MOL MED, V85, P1295, DOI 10.1007/s00109-007-0277-z; Thiel M, 2005, PLOS BIOL, V3, P1088, DOI 10.1371/journal.pbio.0030174; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Vallabhapurapu S, 2009, ANNU REV IMMUNOL, V27, P693, DOI 10.1146/annurev.immunol.021908.132641; Walmsley SR, 2006, BLOOD, V108, P3176, DOI 10.1182/blood-2006-04-018796; Walmsley SR, 2005, J EXP MED, V201, P105, DOI 10.1084/jem.20040624; Werth N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011576; Ye J, 2009, INT J OBESITY, V33, P54, DOI 10.1038/ijo.2008.229	90	1317	1378	8	218	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2011	364	7					656	665		10.1056/NEJMra0910283	http://dx.doi.org/10.1056/NEJMra0910283			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722BW	21323543	Green Accepted			2022-12-28	WOS:000287406000011
J	Pettitt, DA; McArthur, P				Pettitt, DA; McArthur, P			Case Report: A boy with a painful arm The most likely diagnosis is an acute compartment syndrome.	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							TIBIAL FRACTURES; CHILDREN; RISK		[Pettitt, DA] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [McArthur, P] Whiston Hosp, Prescot, Merseyside, England	University of Liverpool; Whiston Hospital	Pettitt, DA (corresponding author), Univ Liverpool, Liverpool L69 3BX, Merseyside, England.	d.pettitt@liv.ac.uk						Balakrishnan G, 2006, INDIAN J PLAST SURG, V39, P94, DOI 10.4103/0970-0358.26917; *BRIT ASS PLAST RE, 2009, RECONSTRUCTIVE AESTH; Burkhart KJ, 2007, EUR J TRAUMA EMERG S, V33, P584, DOI 10.1007/s00068-007-7162-x; Cannada LK, 2008, J BONE JOINT SURG AM, V90A, P1760; Cheng J C, 1993, J Orthop Trauma, V7, P15, DOI 10.1097/00005131-199302000-00004; Cheng JCY, 1999, J PEDIATR ORTHOPED, V19, P344, DOI 10.1097/00004694-199905000-00011; Choi PD, 2010, J PEDIATR ORTHOPED, V30, P50, DOI 10.1097/BPO.0b013e3181c6b3a8; Chuang DCC, 1996, PLAST RECONSTR SURG, V98, P1023, DOI 10.1097/00006534-199611000-00015; McQueen MM, 2000, J BONE JOINT SURG BR, V82B, P200, DOI 10.1302/0301-620X.82B2 .9799; McQueen MM, 1999, CURR ORTHOPAED, V13, P113, DOI 10.1016/S0268-0890(99)90095-6; McQueen MM, 1996, J BONE JOINT SURG BR, V78B, P99, DOI 10.1302/0301-620X.78B1.0780099; Omid R, 2008, J BONE JOINT SURG AM, V90A, P1121, DOI 10.2106/JBJS.G.01354; Reurings JC, 2007, EUR J TRAUMA EMERG S, V33, P539, DOI 10.1007/s00068-007-6142-5	13	9	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 16	2011	342								c5972	10.1136/bmj.c5972	http://dx.doi.org/10.1136/bmj.c5972			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725OZ	21325378				2022-12-28	WOS:000287656500026
J	Bates, ER				Bates, Eric R.			Adding colchicine to standard therapy after cardiac surgery reduced risk for the postpericardiotomy syndrome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							PERICARDITIS; TRIAL		Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bates, ER (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.							Finkelstein Y, 2002, HERZ, V27, P791, DOI 10.1007/s00059-002-2376-5; Imazio M, 2005, CIRCULATION, V112, P2012, DOI 10.1161/CIRCULATIONAHA.105.542738; Imazio M, 2005, ARCH INTERN MED, V165, P1987, DOI 10.1001/archinte.165.17.1987	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4							JC2-10	10.7326/0003-4819-154-4-201102150-02010	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-02010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720VF	21320925				2022-12-28	WOS:000287310000009
J	Acuin, J; Firestone, R; Htay, TT; Khor, GL; Thabrany, H; Saphonn, V; Wibulpolprasert, S				Acuin, Jose; Firestone, Rebecca; Htay, Thein Thein; Khor, Geok Lin; Thabrany, Hasbullah; Saphonn, Vonthanak; Wibulpolprasert, Suwit			Southeast Asia: an emerging focus for global health	LANCET			English	Editorial Material									[Firestone, Rebecca] China Med Board, Cambridge, MA 02138 USA; [Acuin, Jose] De la Salle Hlth Sci Inst, Damarinas, Cavite, Philippines; [Htay, Thein Thein] Minist Hlth, Nay Pyi Taw, Myanmar; [Khor, Geok Lin] Int Med Univ, Kuala Lumpur 57000, Malaysia; [Thabrany, Hasbullah] Univ Indonesia, Sch Publ Hlth, Depok, Indonesia; [Saphonn, Vonthanak] Natl Inst Publ Hlth, Phnom Penh, Cambodia; [Wibulpolprasert, Suwit] Minist Publ Hlth, Nonthaburi, Thailand	De La Salle University; De La Salle University Dasmarinas; International Medical University Malaysia; University of Indonesia; Ministry of Public Health - Thailand	Firestone, R (corresponding author), China Med Board, Cambridge, MA 02138 USA.	rfirestone@cmbfound.org		Khor, Geok Lin/0000-0002-4691-6319				Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Garrett L, 2009, LANCET, V374, P1294, DOI 10.1016/S0140-6736(09)61503-8; Kanchanachitra C, 2011, LANCET, DOI [10.1016/50140-6736(10)62035-1, DOI 10.1016/50140-6736(10)62035-1]; Kuek V, 2010, GLOB PUBLIC HLTH, P1; Sedyaningsih ER, 2008, ANN ACAD MED SINGAP, V37, P482; Smith RD, 2009, LANCET, V373, P593, DOI 10.1016/S0140-6736(08)61778-X; Tangcharoensathien V, 2011, LANCET, V377, P863, DOI 10.1016/S0140-6736(10)61890-9; World Health Organization, WHO GLOB HLTH OBS	8	19	19	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2011	377	9765					534	535		10.1016/S0140-6736(10)61426-2	http://dx.doi.org/10.1016/S0140-6736(10)61426-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	724DQ	21269684				2022-12-28	WOS:000287556700006
J	Anand, SS; Yusuf, S				Anand, Sonia S.; Yusuf, Salim			Stemming the global tsunami of cardiovascular disease	LANCET			English	Editorial Material							RISK-FACTORS; COUNTRIES; INDIVIDUALS; POLYPILL; MIDDLE		[Yusuf, Salim] McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; Hamilton Hlth Sci, Hamilton, ON, Canada; McMaster Univ, Dept Med, Hamilton, ON L8L 2X2, Canada; McMaster Univ, Dept Epidemiol, Hamilton, ON L8L 2X2, Canada	McMaster University; Population Health Research Institute; McMaster University; McMaster University; McMaster University	Yusuf, S (corresponding author), McMaster Univ, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada.	yusufs@mcmaster.ca		Yusuf, Salim/0000-0003-4776-5601				Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; Beaglehole R, 2010, LANCET, V376, P1619, DOI 10.1016/S0140-6736(10)61929-0; Capewell S, 2010, B WORLD HEALTH ORGAN, V88, P120; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; International Diabetes Federation, 2009, WORLD DIAB ATL; Lonn E, 2010, CIRCULATION, V122, P2078, DOI 10.1161/CIRCULATIONAHA.109.873232; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Oshinsky DM., 2005, POLIO AM STORY; Reddy KS, 2004, NEW ENGL J MED, V350, P2438, DOI 10.1056/NEJMp048024; Rose G, 2001, INT J EPIDEMIOL, V30, P427, DOI 10.1093/ije/30.3.427; Stuckler D, 2008, MILBANK Q, V86, P273, DOI 10.1111/j.1468-0009.2008.00522.x; Teo K, 2009, AM HEART J, V158, P1, DOI 10.1016/j.ahj.2009.04.019; World Health Organization, 2009, WHO REP GLOB TOB EP; Yusuf S, 2009, LANCET, V373, P1341, DOI 10.1016/S0140-6736(09)60611-5; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	18	156	164	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2011	377	9765					529	532		10.1016/S0140-6736(10)62346-X	http://dx.doi.org/10.1016/S0140-6736(10)62346-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	724DQ	21295845				2022-12-28	WOS:000287556700004
J	Tutu, D				Tutu, Desmond			A Celebration of the Genome, Part II - My Genome	SCIENCE			English	Editorial Material																			0	0	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					689	689		10.1126/science.1203150	http://dx.doi.org/10.1126/science.1203150			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21310994				2022-12-28	WOS:000287205700038
J	Ghuman, JK				Ghuman, Jaswinder Kaur			Restricted elimination diet for ADHD: the INCA study	LANCET			English	Editorial Material							CHILDREN; HYPERACTIVITY; BEHAVIOR		Univ Arizona, Tucson, AZ 85724 USA	University of Arizona	Ghuman, JK (corresponding author), Univ Arizona, Tucson, AZ 85724 USA.	jkghuman@email.arizona.edu			NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH001883] Funding Source: NIH RePORTER; NIMH NIH HHS [K23 MH001883-06] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Bateman B, 2004, ARCH DIS CHILD, V89, P506, DOI 10.1136/adc.2003.031435; Dulcan M, 1997, J AM ACAD CHILD PSY, V36, pS85, DOI 10.1097/00004583-199710001-00007; Feingold B F, 1975, Am J Nurs, V75, P797, DOI 10.2307/3423460; Ghuman JK, 2008, J CHILD ADOL PSYCHOP, V18, P413, DOI 10.1089/cap.2008.022; McCann D, 2007, LANCET, V370, P1560, DOI 10.1016/S0140-6736(07)61306-3; Pelsser LM, 2011, LANCET, V377, P494, DOI 10.1016/S0140-6736(10)62227-1; Stevens LJ, 2011, CLIN PEDIATR, V50, P279, DOI 10.1177/0009922810384728	7	5	5	0	20	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2011	377	9764					446	448		10.1016/S0140-6736(11)60133-5	http://dx.doi.org/10.1016/S0140-6736(11)60133-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	721TX	21296224				2022-12-28	WOS:000287381800007
J	Snyder, A				Snyder, Alison			Richard Bing Obituary	LANCET			English	Biographical-Item												amsnyder@alum.mit.edu							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 5	2011	377	9764					462	462		10.1016/S0140-6736(11)60151-7	http://dx.doi.org/10.1016/S0140-6736(11)60151-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721TX	21300596				2022-12-28	WOS:000287381800016
J	Giuliano, AR; Palefsky, JM; Goldstone, S; Moreira, ED; Penny, ME; Aranda, C; Vardas, E; Moi, H; Jessen, H; Hillman, R; Chang, YH; Ferris, D; Rouleau, D; Bryan, J; Marshall, JB; Vuocolo, S; Barr, E; Radley, D; Haupt, RM; Guris, D				Giuliano, Anna R.; Palefsky, Joel M.; Goldstone, Stephen; Moreira, Edson D., Jr.; Penny, Mary E.; Aranda, Carlos; Vardas, Eftyhia; Moi, Harald; Jessen, Heiko; Hillman, Richard; Chang, Yen-Hwa; Ferris, Daron; Rouleau, Danielle; Bryan, Janine; Marshall, J. Brooke; Vuocolo, Scott; Barr, Eliav; Radley, David; Haupt, Richard M.; Guris, Dalya			Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HUMAN-PAPILLOMAVIRUS INFECTION; AGED 16-26 YEARS; PARTICLE VACCINE; UNITED-STATES; MEN; PREVALENCE; WOMEN; TYPE-16; COHORT; IMPACT	BACKGROUND Infection with human papillomavirus (HPV) and diseases caused by HPV are common in boys and men. We report on the safety of a quadrivalent vaccine (active against HPV types 6, 11, 16, and 18) and on its efficacy in preventing the development of external genital lesions and anogenital HPV infection in boys and men. METHODS We enrolled 4065 healthy boys and men 16 to 26 years of age, from 18 countries in a randomized, placebo-controlled, double-blind trial. The primary efficacy objective was to show that the quadrivalent HPV vaccine reduced the incidence of external genital lesions related to HPV-6, 11, 16, or 18. Efficacy analyses were conducted in a per-protocol population, in which subjects received all three vaccinations and were negative for relevant HPV types at enrollment, and in an intention-to-treat population, in which subjects received vaccine or placebo, regardless of baseline HPV status. RESULTS In the intention-to-treat population, 36 external genital lesions were seen in the vaccine group as compared with 89 in the placebo group, for an observed efficacy of 60.2% (95% confidence interval [CI], 40.8 to 73.8); the efficacy was 65.5% (95% CI, 45.8 to 78.6) for lesions related to HPV-6, 11, 16, or 18. In the per-protocol population, efficacy against lesions related to HPV-6, 11, 16, or 18 was 90.4% (95% CI, 69.2 to 98.1). Efficacy with respect to persistent infection with HPV-6, 11, 16, or 18 and detection of related DNA at any time was 47.8% (95% CI, 36.0 to 57.6) and 27.1% (95% CI, 16.6 to 36.3), respectively, in the intention-to-treat population and 85.6% (97.5% CI, 73.4 to 92.9) and 44.7% (95% CI, 31.5 to 55.6) in the per-protocol population. Injection-site pain was significantly more frequent among subjects receiving quadrivalent HPV vaccine than among those receiving placebo (57% vs. 51%, P<0.001). CONCLUSIONS Quadrivalent HPV vaccine prevents infection with HPV-6, 11, 16, and 18 and the development of related external genital lesions in males 16 to 26 years of age.	[Giuliano, Anna R.] H Lee Moffitt Canc Ctr & Res Inst, Risk Assessment Detect & Intervent Program, MRC CANCONT, Tampa, FL 33612 USA; [Palefsky, Joel M.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Goldstone, Stephen] Mt Sinai Sch Med, New York, NY USA; [Penny, Mary E.] Inst Invest Nutr, Lima, Peru; [Vardas, Eftyhia] Univ Witwatersrand, Fac Hlth Sci, Ndlela Res & Clin Trials Unit, Johannesburg, South Africa; [Moi, Harald] Oslo Univ Hosp, Olafia Sexually Transmitted Infect Clin, Oslo, Norway; [Moi, Harald] Univ Oslo, Fac Med, Oslo, Norway; [Jessen, Heiko] Private Clin Infect Dis, Berlin, Germany; [Hillman, Richard] Univ Sydney, Sexually Transmitted Infect Res Ctr, Sydney, NSW 2006, Australia; [Chang, Yen-Hwa] Taipei Vet Gen Hosp, Dept Surg, Div Urol, Taipei, Taiwan; [Ferris, Daron] Med Coll Georgia, Augusta, GA 30912 USA; [Rouleau, Danielle; Radley, David] CHU Montreal, Ctr Rech, Montreal, PQ, Canada; [Bryan, Janine; Marshall, J. Brooke; Vuocolo, Scott; Barr, Eliav; Haupt, Richard M.; Guris, Dalya] Merck, N Wales, PA USA	H Lee Moffitt Cancer Center & Research Institute; University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai; University of Witwatersrand; University of Oslo; University of Oslo; University of Sydney; Taipei Veterans General Hospital; University System of Georgia; Augusta University; Universite de Montreal	Giuliano, AR (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Risk Assessment Detect & Intervent Program, MRC CANCONT, 12902 Magnolia Dr, Tampa, FL 33612 USA.	anna.giuliano@moffitt.org	Moreira Jr, Edson Duarte/GRF-5620-2022; Moreira, Edson D/J-1758-2012; Penny, Mary/J-2286-2017; Moreira, Edson/W-7437-2019; Jessen, Heiko/P-2192-2019; Hillman, Richard/AAM-1177-2020; Marshall, Brooke/ABD-2070-2020	Moreira Jr, Edson Duarte/0000-0002-7081-8348; Moreira, Edson D/0000-0002-7081-8348; Penny, Mary/0000-0001-5501-9399; Moreira, Edson/0000-0002-7081-8348; Hillman, Richard/0000-0002-1859-0761; Vardas, Eftyhia/0000-0002-7804-878X; Bryan, Janine/0000-0002-4923-6247	Merck; National Center for Research Resources [M01-RR-00079, UL1 RR024131]; National Institutes of Health [RO1 CA098803]; GlaxoSmithKline; Qiagen; NATIONAL CANCER INSTITUTE [R01CA098803] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079, UL1RR024131] Funding Source: NIH RePORTER	Merck(Merck & Company); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline(GlaxoSmithKline); Qiagen; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by Merck and by grants (M01-RR-00079 and UL1 RR024131, to Dr. Palefsky) from the National Center for Research Resources and by a grant (RO1 CA098803, to Dr. Giuliano) from the National Institutes of Health.; Drs. Giuliano, Ferris, Moreira, Penny, and Palefsky report receiving grant support from Merck, either personally or through their institution; Dr. Penny reports receiving grant support from GlaxoSmithKline; Dr. Goldstone reports receiving grant support from Qiagen; Drs. Giuliano, Ferris, Moreira, Hillman, and Chang report receiving speaking fees or fees for board membership from Merck; Dr. Moi reports that his institution has received funding from Merck; Dr. Penny reports having stock or stock options in AstraZeneca; Dr. Palefsky reports receiving consulting fees from GlaxoSmithKline; Drs. Giuliano, Palefsky, Goldstone, Moreira, Moi, and Chang report receiving travel reimbursement from Merck; Dr. Bryan reports having an approved, filed, or pending patent related to subject matter discussed in this article; and Dr. Bryan, Dr. Marshall, Dr. Vuocolo, Dr. Barr, Dr. Haupt, Mr. Radley, and Dr. Guris are employees of Merck and own Merck stock or stock options. No other potential conflict of interest relevant to this article was reported.	Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Bryan JT, 2006, J MED VIROL, V78, P117, DOI 10.1002/jmv.20512; Dunne EF, 2006, J INFECT DIS, V194, P1044, DOI 10.1086/507432; FAIRLEY C, 2009, RAPID DECLINE GENITA; Garland SM, 2007, NEW ENGL J MED, V356, P1928, DOI 10.1056/NEJMoa061760; Giuliano AR, 2008, J INFECT DIS, V198, P827, DOI 10.1086/591095; Giuliano AR, 2008, CANCER EPIDEM BIOMAR, V17, P2036, DOI 10.1158/1055-9965.EPI-08-0151; GIULIANO AR, LANCET IN PRESS; Insinga RP, 2003, CLIN INFECT DIS, V36, P1397, DOI 10.1086/375074; *INT AG RES CANC, 2007, IARC MON EV CARC RIS, V90; Palefsky JM, 2007, DIS MARKERS, V23, P261, DOI 10.1155/2007/159137; Partridge JM, 2007, J INFECT DIS, V196, P1128, DOI 10.1086/521192; Stone KM, 2002, J INFECT DIS, V186, P1396, DOI 10.1086/344354; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; Villa LL, 2007, NEW ENGL J MED, V356, P1915, DOI 10.1056/NEJMoa061741; Wheeler CM, 2009, J INFECT DIS, V199, P936, DOI 10.1086/597309	16	695	714	0	88	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2011	364	5					401	411		10.1056/NEJMoa0909537	http://dx.doi.org/10.1056/NEJMoa0909537			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715LL	21288094	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000286885900005
J	Iheanacho, I				Iheanacho, Ike			Drug Tales and Other Stories Definitely not acceptable: drug company sues journal over review	BRITISH MEDICAL JOURNAL			English	Editorial Material												iiheanacho@bmjgroup.com							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2011	342								d602	10.1136/bmj.d602	http://dx.doi.org/10.1136/bmj.d602			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	718PR	21285186				2022-12-28	WOS:000287138000009
J	Spielhagen, RF; Werner, K; Sorensen, SA; Zamelczyk, K; Kandiano, E; Budeus, G; Husum, K; Marchitto, TM; Hald, M				Spielhagen, Robert F.; Werner, Kirstin; Sorensen, Steffen Aagaard; Zamelczyk, Katarzyna; Kandiano, Evguenia; Budeus, Gereon; Husum, Katrine; Marchitto, Thomas M.; Hald, Morten			Enhanced Modern Heat Transfer to the Arctic by Warm Atlantic Water	SCIENCE			English	Article							NORTH-ATLANTIC; FRAM STRAIT; OCEAN; SEA; ICE; TEMPERATURE; VARIABILITY; AMPLIFICATION; FORAMINIFERA; MARGIN	The Arctic is responding more rapidly to global warming than most other areas on our planet. Northward-flowing Atlantic Water is the major means of heat advection toward the Arctic and strongly affects the sea ice distribution. Records of its natural variability are critical for the understanding of feedback mechanisms and the future of the Arctic climate system, but continuous historical records reach back only similar to 150 years. Here, we present a multidecadal-scale record of ocean temperature variations during the past 2000 years, derived from marine sediments off Western Svalbard (79 degrees N). We find that early-21st-century temperatures of Atlantic Water entering the Arctic Ocean are unprecedented over the past 2000 years and are presumably linked to the Arctic amplification of global warming.	[Spielhagen, Robert F.] Acad Sci Humanities & Literature, D-53151 Mainz, Germany; [Spielhagen, Robert F.; Werner, Kirstin; Kandiano, Evguenia] IFM GEOMAR, Leibniz Inst Marine Sci, D-24148 Kiel, Germany; [Sorensen, Steffen Aagaard; Zamelczyk, Katarzyna; Husum, Katrine; Hald, Morten] Univ Tromso, Dept Geol, N-9037 Tromso, Norway; [Budeus, Gereon] Alfred Wegener Inst Polar & Marine Res, D-27515 Bremerhaven, Germany; [Marchitto, Thomas M.] Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA; [Marchitto, Thomas M.] Univ Colorado, Inst Arctic & Alpine Res, Boulder, CO 80309 USA	Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; UiT The Arctic University of Tromso; Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Spielhagen, RF (corresponding author), Acad Sci Humanities & Literature, D-53151 Mainz, Germany.	rspielhagen@ifm-geomar.de	Zamelczyk, Katarzyna/AGK-4975-2022; Werner, Kirstin/AAG-7386-2020; Husum, Katrine/HGD-4711-2022	Zamelczyk, Katarzyna/0000-0002-9876-5807; Werner, Kirstin/0000-0001-5260-0348; Husum, Katrine/0000-0003-1380-5900; Kandiano, Evgenia/0000-0003-1783-9999	German Research Foundation (Deutsche Forschungsgemeinschaft) [1266]; Academy of Sciences, Humanities, and Literature, Mainz; Norwegian Research Council	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Academy of Sciences, Humanities, and Literature, Mainz; Norwegian Research Council(Research Council of NorwayEuropean Commission)	We thank the captains, crews, and shipboard scientific parties of research vessels Jan Mayen and Maria S. Merian for assistance during cruises JM06-WP and MSM5/5. R.F.S. and K.W. acknowledge support from the German Research Foundation (Deutsche Forschungsgemeinschaft Priority Core Program 1266 INTERDYNAMIK, project HOVAG); R.F.S. received support from the Academy of Sciences, Humanities, and Literature, Mainz; and S.A.S., K.Z., K.H., and M.H. acknowledge support from the Norwegian Research Council (projects SciencePub and WARMPAST). All data are available at www.pangaea.de (doi: 10.1594/PANGAEA.755114).	Bonnet S, 2010, MAR MICROPALEONTOL, V74, P59, DOI 10.1016/j.marmicro.2009.12.001; Carstens J, 1997, MAR MICROPALEONTOL, V29, P257, DOI 10.1016/S0377-8398(96)00014-X; Chylek P, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038777; Comiso JC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL031972; Dickson RR, 2000, J CLIMATE, V13, P2671, DOI 10.1175/1520-0442(2000)013<2671:TAORTT>2.0.CO;2; Divine DV, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2004JC002851; Dmitrenko IA, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004158; Dmitrenko IA, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC006020; Dokken TM, 1996, GEOLOGY, V24, P599, DOI 10.1130/0091-7613(1996)024<0599:RCSDIS>2.3.CO;2; Goosse H, 2005, J CLIMATE, V18, P3552, DOI 10.1175/JCLI3476.1; Graversen RG, 2008, NATURE, V451, P53, DOI 10.1038/nature06502; Hald M, 2007, QUATERNARY SCI REV, V26, P3423, DOI 10.1016/j.quascirev.2007.10.005; HEBBELN D, 1994, NATURE, V370, P357, DOI 10.1038/370357a0; Johannessen T, 1994, CARBON CYCLING GLACI, P61; Karcher MJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2001JC001265; Kaufman DS, 2009, SCIENCE, V325, P1236, DOI 10.1126/science.1173983; Koc N, 2002, CLIMATE DEVELOPMENT AND HISTORY OF THE NORTH ATLANTIC REALM, P165; Kozdon R, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002169; Kristensen DK, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000960; Lamb HH., 1977, CLIMATE PRESENT FUTU; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Pflaumann U, 1996, PALEOCEANOGRAPHY, V11, P15, DOI 10.1029/95PA01743; Polyakov IV, 2004, J CLIMATE, V17, P4485, DOI 10.1175/JCLI-3224.1; Rudels B, 1994, POLAR OCEANS THEIR R, P33, DOI [10.1029/GM085, DOI 10.1029/GM085P0033]; Schauer U, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001823; Screen JA, 2010, NATURE, V464, P1334, DOI 10.1038/nature09051; Semenov VA, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL038911; Serreze MC, 2006, CLIMATIC CHANGE, V76, P241, DOI 10.1007/s10584-005-9017-y; Spielhagen RF, 2004, QUATERNARY SCI REV, V23, P1455, DOI 10.1016/j.quascirev.2003.12.015; Steele M, 1998, J GEOPHYS RES-OCEANS, V103, P10419, DOI 10.1029/98JC00580; Volkmann R, 2000, J FORAMIN RES, V30, P157, DOI 10.2113/0300157	31	304	318	4	105	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					450	453		10.1126/science.1197397	http://dx.doi.org/10.1126/science.1197397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273485				2022-12-28	WOS:000286635900050
J	Cusack, JC; Clark, JW; Curley, SA; Sahani, DV; Zukerberg, LR				Cusack, James C., Jr.; Clark, Jeffrey W.; Curley, Steven A.; Sahani, Dushyant V.; Zukerberg, Lawrence R.			A Woman with a Mass in the Liver Poorly differentiated neuroendocrine carcinoma arising in a tubulovillous adenoma of the cecum, with metastasis to the liver	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SMALL-CELL CARCINOMA; UNKNOWN PRIMARY; TUMORS; RECTUM; MANAGEMENT; SURGERY; COLON		[Cusack, James C., Jr.] Massachusetts Gen Hosp, Dept Surg, Div Surg Oncol, Boston, MA 02114 USA; [Clark, Jeffrey W.] Massachusetts Gen Hosp, Dept Med, Div Med Oncol, Boston, MA 02114 USA; [Sahani, Dushyant V.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Zukerberg, Lawrence R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Curley, Steven A.] MD Anderson Hosp, Dept Surg Oncol, Houston, TX USA; [Curley, Steven A.] Univ Texas Med Sch, Dept Surg, Houston, TX USA; [Cusack, James C., Jr.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Clark, Jeffrey W.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Sahani, Dushyant V.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Zukerberg, Lawrence R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Cusack, JC (corresponding author), Massachusetts Gen Hosp, Dept Surg, Div Surg Oncol, Boston, MA 02114 USA.				Department of Continuing Education, Harvard Medical School	Department of Continuing Education, Harvard Medical School	This case was presented at the postgraduate course Advances in Cancer Management for the Surgeon, 2009, sponsored by the Department of Continuing Education, Harvard Medical School.	Bernick PE, 2004, DIS COLON RECTUM, V47, P163, DOI 10.1007/s10350-003-0038-1; Cebrian J, 1999, DIS COLON RECTUM, V42, P274, DOI 10.1007/BF02237142; Chan JA, 2009, CURR ONCOL REP, V11, P193, DOI 10.1007/s11912-009-0028-0; Clark OH, 2009, J NATL COMPR CANC NE, V7, P712; Elias D, 2009, EJSO-EUR J SURG ONC, V35, P1092, DOI 10.1016/j.ejso.2009.02.017; Gurusamy KS, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007060.pub2; Ispas C, 2005, ARCH PATHOL LAB MED, V129, P412; Landry CS, 2008, J SURG ONCOL, V97, P253, DOI 10.1002/jso.20957; Li AFY, 2010, J CLIN PATHOL, V63, P620, DOI 10.1136/jcp.2010.077024; Lobins R, 2007, SEMIN ONCOL, V34, P39, DOI 10.1053/j.seminoncol.2006.10.027; Martin R, 2003, J AM COLL SURGEONS, V197, P233, DOI 10.1016/S1072-7515(03)00390-9; Mignon M, 2000, DIGESTION, V62, P51, DOI 10.1159/000051856; Norton JA, 2003, SURGERY, V134, P1057, DOI 10.1016/j.surg.2003.07.025; Poultsides GA, 2009, J CLIN ONCOL, V27, P3379, DOI 10.1200/JCO.2008.20.9817; Rinke A, 2009, J CLIN ONCOL, V27, P4656, DOI 10.1200/JCO.2009.22.8510; Scigliano S, 2009, ENDOCR-RELAT CANCER, V16, P977, DOI 10.1677/ERC-08-0247; Spigel DR, 2009, SEMIN ONCOL, V36, P52, DOI 10.1053/j.seminoncol.2008.10.003; Varadhachary GR, 2009, SEMIN ONCOL, V36, P75, DOI 10.1053/j.seminoncol.2008.10.008; VILOR M, 1995, PATHOL INT, V45, P605, DOI 10.1111/j.1440-1827.1995.tb03510.x	19	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2011	364	4					362	370		10.1056/NEJMcpc1000965	http://dx.doi.org/10.1056/NEJMcpc1000965			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711LH	21268729				2022-12-28	WOS:000286592600013
J	Wedemeyer, H; Yurdaydin, C; Dalekos, GN; Erhardt, A; Cakaloglu, Y; Degertekin, H; Gurel, S; Zeuzem, S; Zachou, K; Bozkaya, H; Koch, A; Bock, T; Dienes, HP; Manns, MP				Wedemeyer, Heiner; Yurdaydin, Cihan; Dalekos, George N.; Erhardt, Andreas; Cakaloglu, Yilmaz; Degertekin, Halil; Gurel, Selim; Zeuzem, Stefan; Zachou, Kalliopi; Bozkaya, Hakan; Koch, Armin; Bock, Thomas; Dienes, Hans Peter; Manns, Michael P.		HIDIT Study Grp	Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							D VIRUS-INFECTION; B-VIRUS; COMBINATION THERAPY; VANISHING DISEASE; INTERFERON; LAMIVUDINE; RIBAVIRIN; HBEAG; PREVALENCE; DIPIVOXIL	BACKGROUND Chronic infection with hepatitis B virus and hepatitis delta virus (HDV) results in the most severe form of viral hepatitis. There is no currently approved treatment. We investigated the safety and efficacy of 48 weeks of treatment with peginterferon alfa-2a plus adefovir dipivoxil, peginterferon alfa-2a alone, and adefovir dipivoxil alone. METHODS We conducted a randomized trial in which 31 patients with HDV infection received treatment with 180 mu g of peginterferon alfa-2a weekly plus 10 mg of adefovir daily, 29 received 180 mu g of peginterferon alfa-2a weekly plus placebo, and 30 received 10 mg of adefovir alone weekly for 48 weeks. Follow-up was conducted for an additional 24 weeks. Efficacy end points included clearance of HDV RNA, normalization of alanine aminotransferase levels, and a decline in levels of hepatitis B surface antigen (HBsAg). RESULTS The primary end point - normalization of alanine aminotransferase levels and clearance of HDV RNA at week 48 - was achieved in two patients in the group receiving peginterferon alfa-2a plus adefovir and two patients in the group receiving peginterferon alfa-2a plus placebo but in none of the patients in the group receiving adefovir alone. At week 48, the test for HDV RNA was negative in 23% of patients in the first group, 24% of patients in the second, and none of those in the third (P=0.006 for the comparison of the first and third groups; P=0.004 for the comparison of the second and third). The efficacy of peginterferon alfa-2a was sustained for 24 weeks after treatment, with 28% of the patients receiving peginterferon alfa-2a plus adefovir or peginterferon alfa-2a alone having negative results on HDV-RNA tests; none of the patients receiving adefovir alone had negative results. A decline in HBsAg levels of more than 1 log(10) IU per milliliter from baseline to week 48 was observed in 10 patients in the first group, 2 in the second, and none in the third (P<0.001 for the comparison of the first and third groups and P=0.01 for the comparison of the first and second). CONCLUSIONS Treatment with peginterferon alfa-2a for 48 weeks, with or without adefovir, resulted in sustained HDV RNA clearance in about one quarter of patients with HDV infection.	[Manns, Michael P.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany; [Erhardt, Andreas] Univ Dusseldorf, Dusseldorf, Germany; [Zeuzem, Stefan] Goethe Univ Frankfurt, Frankfurt, Germany; [Bock, Thomas] Robert Koch Inst, D-1000 Berlin, Germany; [Dienes, Hans Peter] Univ Cologne, Cologne, Germany; [Yurdaydin, Cihan; Bozkaya, Hakan] Ankara Univ, Sch Med, TR-06100 Ankara, Turkey; [Degertekin, Halil] Ufuk Univ, Sch Med, Ankara, Turkey; [Cakaloglu, Yilmaz] Mem Hosp Istanbul, Istanbul, Turkey; [Gurel, Selim] Uludag Univ, Sch Med, Bursa, Turkey; [Dalekos, George N.; Zachou, Kalliopi] Univ Larissa, Larisa, Greece	Hannover Medical School; Heinrich Heine University Dusseldorf; Goethe University Frankfurt; Robert Koch Institute; University of Cologne; Ankara University; Ufuk University; Memorial Healthcare Group; Uludag University	Manns, MP (corresponding author), Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	manns.michael@mh-hannover.de	Zeuzem, Stefan/AAE-7435-2019; Bock, C.-Thomas/A-3518-2012	Bock, C.-Thomas/0000-0002-2773-486X	German Ministry for Education and Research, BMBF-Forderkennzeichen; Hoffmann-La Roche; Gilead Sciences	German Ministry for Education and Research, BMBF-Forderkennzeichen; Hoffmann-La Roche(Hoffmann-La Roche); Gilead Sciences(Gilead Sciences)	Supported by Hep-Net (a national network sponsored by the German Ministry for Education and Research, BMBF-Forderkennzeichen), F. Hoffmann-La Roche, and Gilead Sciences.	Buster EHCJ, 2008, GASTROENTEROLOGY, V135, P459, DOI 10.1053/j.gastro.2008.05.031; Castellares C, 2008, J VIRAL HEPATITIS, V15, P165, DOI 10.1111/j.1365-2893.2007.00903.x; Castelnau C, 2006, HEPATOLOGY, V44, P728, DOI 10.1002/hep.21325; Cooksley WGE, 2003, J VIRAL HEPATITIS, V10, P298, DOI 10.1046/j.1365-2893.2003.00450.x; Degertekin Halil, 2006, Turk J Gastroenterol, V17, P25; Erhardt A, 2006, LIVER INT, V26, P805, DOI 10.1111/j.1478-3231.2006.01279.x; Farci P, 2007, J VIRAL HEPATITIS, V14, P58, DOI 10.1111/j.1365-2893.2007.00917.x; FARCI P, 1994, NEW ENGL J MED, V330, P88, DOI 10.1056/NEJM199401133300202; Farci P, 2004, GASTROENTEROLOGY, V126, P1740, DOI 10.1053/j.gastro.2004.03.017; Ferenci P, 2005, AM J GASTROENTEROL, V100, P1626, DOI 10.1111/j.1572-0241.2005.50006_10.x; Gaeta GB, 2000, HEPATOLOGY, V32, P824, DOI 10.1053/jhep.2000.17711; GARRIPOLI A, 1994, LIVER, V14, P154; Gunsar F, 2005, ANTIVIR THER, V10, P721; Heidrich B, 2009, J VIRAL HEPATITIS, V16, P883, DOI 10.1111/j.1365-2893.2009.01144.x; Kaymakoglu S, 2005, ANTIMICROB AGENTS CH, V49, P1135, DOI 10.1128/AAC.49.3.1135-1138.2005; Kiesslich D, 2009, J INFECT DIS, V199, P1608, DOI 10.1086/598955; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Lai CL, 2006, NEW ENGL J MED, V354, P1863; Makuwa M, 2008, J CLIN MICROBIOL, V46, P754, DOI 10.1128/JCM.02142-07; Manns MP, 2006, GUT, V55, P1350, DOI 10.1136/gut.2005.076646; Manns MP, 2003, HEPATOLOGY, V38, P543, DOI 10.1002/hep.510380302; Marcellin P, 2004, NEW ENGL J MED, V351, P1206, DOI 10.1056/NEJMoa040431; Marcellin P, 2008, NEW ENGL J MED, V359, P2442, DOI 10.1056/NEJMoa0802878; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; Moucari R, 2009, J HEPATOL, V50, P1084, DOI 10.1016/j.jhep.2009.01.016; Niro GA, 2006, J HEPATOL, V44, pS188, DOI 10.1016/S0168-8278(06)80506-4; Niro GA, 2005, ALIMENT PHARM THERAP, V22, P227, DOI 10.1111/j.1365-2036.2005.02542.x; Radjef N, 2004, J VIROL, V78, P2537, DOI 10.1128/JVI.78.5.2537-2544.2004; RIZZETTO M, 1977, GUT, V18, P997, DOI 10.1136/gut.18.12.997; Rizzetto M, 2000, ACTA GASTRO-ENT BELG, V63, P221; Romeo R, 2009, GASTROENTEROLOGY, V136, P1629, DOI 10.1053/j.gastro.2009.01.052; Shakil AO, 1997, VIROLOGY, V234, P160, DOI 10.1006/viro.1997.8644; Sheng WH, 2007, CLIN INFECT DIS, V44, P988, DOI 10.1086/511867; Su CW, 2006, GASTROENTEROLOGY, V130, P1625, DOI 10.1053/j.gastro.2006.01.035; Wedemeyer H, 2007, HEPATOLOGY, V45, P1331, DOI 10.1002/hep.21590; Wedemeyer H, 2010, NAT REV GASTRO HEPAT, V7, P31, DOI 10.1038/nrgastro.2009.205; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Wolters LMM, 2000, J VIRAL HEPATITIS, V7, P428, DOI 10.1046/j.1365-2893.2000.00254.x; Yurdaydin C, 2008, J VIRAL HEPATITIS, V15, P314, DOI 10.1111/j.1365-2893.2007.00936.x; Yurdaydin C, 2002, J HEPATOL, V37, P266, DOI 10.1016/S0168-8278(02)00162-9	40	296	315	1	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2011	364	4					322	331		10.1056/NEJMoa0912696	http://dx.doi.org/10.1056/NEJMoa0912696			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711LH	21268724	Bronze			2022-12-28	WOS:000286592600007
J	Koehlmoos, TP; Smith, R				Koehlmoos, Tracey Perez; Smith, Richard			Big publishers cut access to journals in poor countries	LANCET			English	Editorial Material									[Smith, Richard] Patients Know Best, Cambridge CB4 0WS, England; [Koehlmoos, Tracey Perez] ICDDR B, Hlth & Family Planning Syst Programme, Dhaka, Bangladesh	International Centre for Diarrhoeal Disease Research (ICDDR)	Smith, R (corresponding author), Patients Know Best, Cambridge CB4 0WS, England.	richardswsmith@yahoo.co.uk						[Anonymous], 2007, LANCET, V369, P1902, DOI 10.1016/S0140-6736(07)60858-7; [Anonymous], 2005, LANCET, V366, P868, DOI 10.1016/S0140-6736(05)67292-3; Villafuerte-Galvez J, 2007, PLOS MED, V4, P1133, DOI 10.1371/journal.pmed.0040220	3	19	19	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 22	2011	377	9762					273	276		10.1016/S0140-6736(11)60067-6	http://dx.doi.org/10.1016/S0140-6736(11)60067-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	714ZO	21322840				2022-12-28	WOS:000286850400004
J	Yazawa, M; Hsueh, B; Jia, XL; Pasca, AM; Bernstein, JA; Hallmayer, J; Dolmetsch, RE				Yazawa, Masayuki; Hsueh, Brian; Jia, Xiaolin; Pasca, Anca M.; Bernstein, Jonathan A.; Hallmayer, Joachim; Dolmetsch, Ricardo E.			Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome	NATURE			English	Article							GATING MECHANISMS; SYNDROME MUTATION; SUDDEN-DEATH; CHANNELS; CARDIOMYOCYTES; ROSCOVITINE; ARRHYTHMIA; INHIBITOR; MYOCYTES	Individuals with congenital or acquired prolongation of the QT interval, or long QT syndrome (LQTS), are at risk of life-threatening ventricular arrhythmia(1,2). LQTS is commonly genetic in origin but can also be caused or exacerbated by environmental factors(1,3). A missense mutation in the L-type calcium channel Ca(V)1.2 leads to LQTS in patients with Timothy syndrome(4,5). To explore the effect of the Timothy syndrome mutation on the electrical activity and contraction of human cardiomyocytes, we reprogrammed human skin cells from Timothy syndrome patients to generate induced pluripotent stem cells, and differentiated these cells into cardiomyocytes. Electrophysiological recording and calcium (Ca2+) imaging studies of these cells revealed irregular contraction, excess Ca2+ influx, prolonged action potentials, irregular electrical activity and abnormal calcium transients in ventricular-like cells. We found that roscovitine, a compound that increases the voltage-dependent inactivation of Ca(V)1.2 (refs 6-8), restored the electrical and Ca2+ signalling properties of cardiomyocytes from Timothy syndrome patients. This study provides new opportunities for studying the molecular and cellular mechanisms of cardiac arrhythmias in humans, and provides a robust assay for developing new drugs to treat these diseases.	[Yazawa, Masayuki; Hsueh, Brian; Jia, Xiaolin; Pasca, Anca M.; Dolmetsch, Ricardo E.] Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA; [Bernstein, Jonathan A.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Hallmayer, Joachim] Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Dolmetsch, RE (corresponding author), Stanford Univ, Sch Med, Dept Neurobiol, Stanford, CA 94305 USA.	ricardo.dolmetsch@stanford.edu		Jia, Xiaolin/0000-0002-2172-4716	Japan Society for the Promotion for Science; American Heart Association Western States; National Institutes of Health; Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [DP1MH099904, R21MH087898] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003889] Funding Source: NIH RePORTER	Japan Society for the Promotion for Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); American Heart Association Western States(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Simons Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank K. Timothy and the Timothy syndrome patients who participated in this study; U. Francke for discussion and for providing karyotyping expertise; A. Cherry and D. Bangs for fibroblast isolation; K. C. Chan for iPSC cultures; O. Shcheglovitov for help with electrophysiological recordings; and A. Olson for help with the confocal microscope. Funding was provided by grants from the Japan Society for the Promotion for Science and the American Heart Association Western States to M.Y., and a National Institutes of Health Director's Pioneer Award, a grant from the Simons Foundation to R.E.D and gifts from L. Miller, B. and F. Horowitz and M. McCaffery.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Barrett CF, 2008, P NATL ACAD SCI USA, V105, P2157, DOI 10.1073/pnas.0710501105; Brunner M, 2008, J CLIN INVEST, V118, P2246, DOI 10.1172/JCI33578; Chen L, 2007, P NATL ACAD SCI USA, V104, P20990, DOI 10.1073/pnas.0710527105; Flucher BE, 1996, P NATL ACAD SCI USA, V93, P8101, DOI 10.1073/pnas.93.15.8101; He JQ, 2003, CIRC RES, V93, P32, DOI 10.1161/01.RES.0000080317.92718.99; Huikuri HV, 2001, NEW ENGL J MED, V345, P1473, DOI 10.1056/NEJMra000650; Keating MT, 1996, MEDICINE, V75, P1, DOI 10.1097/00005792-199601000-00001; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Paakkari I, 2002, TOXICOL LETT, V127, P279, DOI 10.1016/S0378-4274(01)00510-0; REUTER H, 1984, ANNU REV PHYSIOL, V46, P473; Roden DM, 2008, NEW ENGL J MED, V358, P169, DOI 10.1056/NEJMcp0706513; Roden DM, 2005, J CLIN INVEST, V115, P2025, DOI 10.1172/JCI25539; Seisenberger C, 2000, J BIOL CHEM, V275, P39193, DOI 10.1074/jbc.M006467200; Splawski I, 2004, CELL, V119, P19, DOI 10.1016/j.cell.2004.09.011; Splawski I, 2005, P NATL ACAD SCI USA, V102, P8089, DOI 10.1073/pnas.0502506102; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takeshima H, 1998, EMBO J, V17, P3309, DOI 10.1093/emboj/17.12.3309; Thiel WH, 2008, CIRCULATION, V118, P2225, DOI 10.1161/CIRCULATIONAHA.108.788067; Tran TH, 2009, STEM CELLS, V27, P1869, DOI 10.1002/stem.95; Yarotskyy V, 2007, BRIT J PHARMACOL, V152, P386, DOI 10.1038/sj.bjp.0707414; Yarotskyy V, 2010, J BIOL CHEM, V285, P43, DOI 10.1074/jbc.M109.076448; Yarotskyy V, 2009, J PHYSIOL-LONDON, V587, P551, DOI 10.1113/jphysiol.2008.161737; Yazawa M, 2007, NATURE, V448, P78, DOI 10.1038/nature05928; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	27	474	489	0	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					230	U120		10.1038/nature09855	http://dx.doi.org/10.1038/nature09855			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21307850	Green Accepted			2022-12-28	WOS:000288170200040
J	Chan, HS; Hsieh, ZM; Liang, WH; Kung, AH; Lee, CK; Lai, CJ; Pan, RP; Peng, LH				Chan, Han-Sung; Hsieh, Zhi-Ming; Liang, Wei-Hong; Kung, A. H.; Lee, Chao-Kuei; Lai, Chien-Jen; Pan, Ru-Pin; Peng, Lung-Han			Synthesis and Measurement of Ultrafast Waveforms from Five Discrete Optical Harmonics	SCIENCE			English	Article							PULSE GENERATION; LASER	Achieving the control of light fields in a manner similar in sophistication to the control of electromagnetic fields in the microwave and radiofrequency regimes has been a major challenge in optical physics research. We manipulated the phase and amplitude of five discrete harmonics spanning the blue to mid-infrared frequencies to produce instantaneous optical fields in the shape of square, sawtooth, and subcycle sine and cosine pulses at a repetition rate of 125 terahertz. Furthermore, we developed an all-optical shaper-assisted linear cross-correlation technique to retrieve these fields and thereby verified their shapes and confirmed the critical role of carrier-envelope phase in Fourier synthesis of optical waveforms.	[Chan, Han-Sung; Hsieh, Zhi-Ming; Liang, Wei-Hong; Kung, A. H.] Acad Sinica, Inst Atom & Mol Sci, Taipei, Taiwan; [Chan, Han-Sung; Kung, A. H.] Natl Tsing Hua Univ, Inst Photon Technol, Hsinchu, Taiwan; [Lee, Chao-Kuei] Natl Sun Yat Sen Univ, Dept Photon, Kaohsiung 80424, Taiwan; [Lai, Chien-Jen] MIT, Dept EECS, Cambridge, MA 02139 USA; [Pan, Ru-Pin] Natl Chiao Tung Univ, Dept Electrophys, Hsinchu 30050, Taiwan; [Peng, Lung-Han] Natl Taiwan Univ, Dept Elect Engn, Taipei 10764, Taiwan; [Peng, Lung-Han] Natl Taiwan Univ, Grad Inst Photon & Optoelect, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Tsing Hua University; National Sun Yat Sen University; Massachusetts Institute of Technology (MIT); National Yang Ming Chiao Tung University; National Taiwan University; National Taiwan University	Kung, AH (corresponding author), Acad Sinica, Inst Atom & Mol Sci, Taipei, Taiwan.	akung@ee.nthu.edu.tw	Kung, Andrew/AHD-9153-2022; Kung, Andy/F-7909-2012; chen, zuyu/D-2851-2012		Academia Sinica [AS-98-TP-A10]; National Science Council of Taiwan [NSC 97-2120-M-001-002, NSC 98-2112-M-001-008-MY3, NSC 96-2221-E-009-131-MY3]	Academia Sinica(Academia Sinica - Taiwan); National Science Council of Taiwan(Ministry of Science and Technology, Taiwan)	We are indebted to S. E. Harris for inspiring us to work on this project and for his comments during manuscript preparation. We thank S.-Y. Wu, W.-J. Chen, and S.-L. Wang for helpful assistance and S. Goda, F.-G. Yee, C.-B. Huang, and C.-L. Pan for discussions. This work was supported by the Academia Sinica (AS-98-TP-A10) and the National Science Council (NSC 97-2120-M-001-002 and NSC 98-2112-M-001-008-MY3) of Taiwan. R.-P. P. was supported by the National Science Council (NSC 96-2221-E-009-131-MY3) of Taiwan.	Chen WJ, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.163906; Couny F, 2007, SCIENCE, V318, P1118, DOI 10.1126/science.1149091; Galler A, 2008, APPL PHYS B-LASERS O, V90, P427, DOI 10.1007/s00340-007-2924-z; Goda SN, 2005, OPT LETT, V30, P1222, DOI 10.1364/OL.30.001222; Goulielmakis E, 2007, SCIENCE, V317, P769, DOI 10.1126/science.1142855; Green JT, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.011805; HANSCH TW, 1990, OPT COMMUN, V80, P71, DOI 10.1016/0030-4018(90)90509-R; Harris SE, 1998, PHYS REV LETT, V81, P2894, DOI 10.1103/PhysRevLett.81.2894; Hsieh ZM, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.213902; Huang SW, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.063825; Jiang Z, 2007, NAT PHOTONICS, V1, P463, DOI 10.1038/nphoton.2007.139; Keusters D, 2003, J OPT SOC AM B, V20, P2226, DOI 10.1364/JOSAB.20.002226; Liang JQ, 2000, PHYS REV LETT, V85, P2474, DOI 10.1103/PhysRevLett.85.2474; Matos L, 2004, OPT LETT, V29, P1683, DOI 10.1364/OL.29.001683; Sansone G, 2006, SCIENCE, V314, P443, DOI 10.1126/science.1132838; Shelton RK, 2001, SCIENCE, V293, P1286, DOI 10.1126/science.1061754; Sokolov AV, 2000, PHYS REV LETT, V85, P562, DOI 10.1103/PhysRevLett.85.562; Suzuki T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.243602; Weiner A. M., 2009, ULTRAFAST OPTICS, P92; Weiner AM, 2000, REV SCI INSTRUM, V71, P1929, DOI 10.1063/1.1150614; Yavuz DD, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.233602	21	153	156	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1165	1168		10.1126/science.1198397	http://dx.doi.org/10.1126/science.1198397			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21252316				2022-12-28	WOS:000287971200034
J	Checkley, W				Checkley, William			New insights into the treatment of persistent asthma	LANCET			English	Editorial Material							CHILDREN		Johns Hopkins Univ, Dept Med, Div Pulm & Crit Care, Baltimore, MD 21205 USA	Johns Hopkins University	Checkley, W (corresponding author), Johns Hopkins Univ, Dept Med, Div Pulm & Crit Care, Baltimore, MD 21205 USA.	wcheckl1@jhmi.edu		Checkley, William/0000-0003-1106-8812				Barnes PJ, 2010, TRENDS PHARMACOL SCI, V31, P335, DOI 10.1016/j.tips.2010.04.009; British Thoracic Society Scottish Intercollegiate Guidelines Network, 2008, Thorax, V63 Suppl 4, piv1, DOI 10.1136/thx.2008.097741; Becker AB, 2006, ANN ALLERG ASTHMA IM, V96, P800, DOI 10.1016/S1081-1206(10)61342-7; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; Martinez FD, 2011, LANCET, V377, P650, DOI 10.1016/S0140-6736(10)62145-9; Masoli M, 2004, ALLERGY, V59, P469, DOI 10.1111/j.1398-9995.2004.00526.x; *NAT ASTHM ED PREV, 2007, 3 NAT HEART LUNG BLO, P373; Rabe KF, 2004, J ALLERGY CLIN IMMUN, V114, P40, DOI 10.1016/j.jaci.2004.04.042; Simons FER, 1997, NEW ENGL J MED, V337, P1659, DOI 10.1056/NEJM199712043372304; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Verberne AAPH, 1998, AM J RESP CRIT CARE, V158, P213, DOI 10.1164/ajrccm.158.1.9706048	11	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2011	377	9766					614	616		10.1016/S0140-6736(10)62313-6	http://dx.doi.org/10.1016/S0140-6736(10)62313-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	727DB	21324521				2022-12-28	WOS:000287776600005
J	Kastor, JA				Kastor, John A.			Accountable Care Organizations at Academic Medical Centers.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Maryland, Sch Med, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Kastor, JA (corresponding author), Univ Maryland, Sch Med, Baltimore, MD 21201 USA.							Fisher ES, 2010, JAMA-J AM MED ASSOC, V304, P1715, DOI 10.1001/jama.2010.1513; KASTOR JA, 2004, GOVT TEACHING HOSP T; KASTOR JA, 2001, MERGERS TEACHING HOS	3	23	23	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2011	364	7								10.1056/NEJMp1013221	http://dx.doi.org/10.1056/NEJMp1013221			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	722BW	21288087				2022-12-28	WOS:000287406000004
J	Vijayan, S; Chase, A				Vijayan, Sethumadhavan; Chase, Alexander			Lingual Hematoma after Thrombolytic Therapy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Vijayan, Sethumadhavan; Chase, Alexander] Morriston Hosp, Swansea, W Glam, Wales	Morriston Hospital	Vijayan, S (corresponding author), Morriston Hosp, Swansea, W Glam, Wales.	sethu@doctors.org.uk							0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2011	364	7					E13	E13		10.1056/NEJMicm1005647	http://dx.doi.org/10.1056/NEJMicm1005647			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722BW	21323537				2022-12-28	WOS:000287406000013
J	Janes, H; Pepe, MS; Bossuyt, PM; Barlow, WE				Janes, Holly; Pepe, Margaret S.; Bossuyt, Patrick M.; Barlow, William E.			Measuring the Performance of Markers for Guiding Treatment Decisions	ANNALS OF INTERNAL MEDICINE			English	Article							GROWTH-FACTOR RECEPTOR; GENE-EXPRESSION; VALIDATION; CANCER; PREDICTIVENESS; CHEMOTHERAPY	Treatment selection markers, sometimes called predictive markers, are factors that help clinicians select therapies that maximize good outcomes and minimize adverse outcomes for patients. Existing statistical methods for evaluating a treatment selection marker include assessing its prognostic value, evaluating treatment effects in patients with a restricted range of marker values, and testing for a statistical interaction between marker value and treatment. These methods are inadequate, because they give misleading measures of performance that do not answer key clinical questions about how the marker might help patients choose treatment, how treatment decisions should be made on the basis of a continuous marker measurement, what effect using the marker to select treatment would have on the population, or what proportion of patients would have treatment changes on the basis of marker measurement. Marker-by-treatment predictiveness curves are proposed as a more useful aid to answering these clinically relevant questions, because they illustrate treatment effects as a function of marker value, outcomes when using or not using the marker to select treatment, and the proportion of patients for whom treatment recommendations change after marker measurement. Randomized therapeutic clinical trials, in which entry criteria and treatment regimens are not restricted by the marker, are also proposed as the basis for constructing the curves and evaluating and comparing markers.	[Janes, Holly] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	Fred Hutchinson Cancer Center; University of Amsterdam; Academic Medical Center Amsterdam	Janes, H (corresponding author), Fred Hutchinson Canc Res Ctr, 1100 Fairview Ave N,M2 C200, Seattle, WA 98109 USA.	hjanes@fhcrc.org	Bossuyt, Patrick M/AAR-1183-2021; Bossuyt, Patrick M./B-4557-2016	Bossuyt, Patrick M/0000-0003-4427-0128; Bossuyt, Patrick M./0000-0003-4427-0128	National Institutes of Health [R01CA152089]; NATIONAL CANCER INSTITUTE [R01CA152089] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant Support: By the National Institutes of Health (grant R01CA152089).	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Albain KS, 2009, LANCET, V374, P2055, DOI 10.1016/S0140-6736(09)61523-3; Albain KS, 2010, LANCET ONCOL, V11, P55, DOI 10.1016/S1470-2045(09)70314-6; Buyse M, 2007, EJC SUPPL, V5, P89, DOI 10.1016/S1359-6349(07)70028-9; Chung KY, 2005, J CLIN ONCOL, V23, P1803, DOI 10.1200/JCO.2005.08.037; Cook NR, 2007, CIRCULATION, V115, P928, DOI 10.1161/CIRCULATIONAHA.106.672402; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Dahabreh IJ, 2011, ANN INTERN MED, V154, P37, DOI 10.7326/0003-4819-154-1-201101040-00006; Dowsett M, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1798; Freidlin B, 2005, CLIN CANCER RES, V11, P7872, DOI 10.1158/1078-0432.CCR-05-0605; Huang Y, 2007, BIOMETRICS, V63, P1181, DOI 10.1111/j.1541-0420.2007.00814.x; Lazar AA, 2010, J CLIN ONCOL, V28, P4539, DOI 10.1200/JCO.2009.27.9182; NCCN, 2010, NCCN CLIN PRACT GUID; Oratz R, 2007, J ONCOL PRACT, V3, P182, DOI 10.1200/JOP.0742001; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Pepe M. S., 2003, STAT EVALUATION MED; Pepe MS, 2008, AM J EPIDEMIOL, V167, P362, DOI 10.1093/aje/kwm305; Sargent DJ, 2005, J CLIN ONCOL, V23, P2020, DOI 10.1200/JCO.2005.01.112; Simon R, 2008, CLIN CANCER RES, V14, P5984, DOI 10.1158/1078-0432.CCR-07-4531; Simon R, 2008, J STAT PLAN INFER, V138, P308, DOI 10.1016/j.jspi.2007.06.010; Simon RM, 2009, J NATL CANCER I, V101, P1446, DOI 10.1093/jnci/djp335; Song XY, 2004, ACTA CRYSTALLOGR E, V60, pO1919, DOI 10.1107/S1600536804024250; Stern RH, 2008, J CLIN HYPERTENS, V10, P485, DOI 10.1111/j.1751-7176.2008.07814.x; Vickers AJ, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-14; Zhou X.H., 2002, STAT METHODS DIAGNOS, DOI 10.1002/9780470317082	25	100	100	0	23	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4					253	W80		10.7326/0003-4819-154-4-201102150-00006	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-00006			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720VF	21320940	Green Accepted			2022-12-28	WOS:000287310000017
J	Chretien, KC; Azar, J; Kind, T				Chretien, Katherine C.; Azar, Justin; Kind, Terry			Physicians on Twitter	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Chretien, Katherine C.] Washington DC VA Med Ctr, Med Serv, Washington, DC USA; [Azar, Justin] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA; [Kind, Terry] Childrens Natl Med Ctr, Dept Med Educ, Washington, DC 20010 USA	George Washington University; Children's National Health System	Chretien, KC (corresponding author), Washington DC VA Med Ctr, Med Serv, Washington, DC USA.	katherine.chretien@va.gov	Roundtree, Aimee/B-8838-2012	Kind, Terry/0000-0002-3017-5683				American Medical Association, AMA POL PROF US SOC; Chretien KC, 2009, JAMA-J AM MED ASSOC, V302, P1309, DOI 10.1001/jama.2009.1387; Greysen SR, 2010, J GEN INTERN MED, V25, P1227, DOI 10.1007/s11606-010-1447-1; Grossman Lev, 2009, TIME            0617; Kind T, 2010, MED EDUC ONLINE, V15, DOI 10.3402/meo.v15i0.5324; WAUTERS R, 2010, TECHCRUNCH TWITTER G	6	165	169	0	27	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2011	305	6					566	568		10.1001/jama.2011.68	http://dx.doi.org/10.1001/jama.2011.68			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	717XI	21304081				2022-12-28	WOS:000287080500020
J	Bardeen, C				Bardeen, Christopher			Exciton Quenching and Migration in Single Conjugated Polymers	SCIENCE			English	Editorial Material							ORGANIC SOLAR-CELLS; ENERGY-TRANSFER; POLY(3-HEXYLTHIOPHENE)		Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside	Bardeen, C (corresponding author), Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA.	christopher.bardeen@ucr.edu						Athanasopoulos S, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.195209; Baldo MA, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.035321; Beljonne D, 2002, P NATL ACAD SCI USA, V99, P10982, DOI 10.1073/pnas.172390999; Bolinger JC, 2011, SCIENCE, V331, P565, DOI 10.1126/science.1199140; Collini E, 2009, SCIENCE, V323, P369, DOI 10.1126/science.1164016; Ferguson AJ, 2008, J PHYS CHEM C, V112, P9865, DOI 10.1021/jp7113412; Gunes S, 2007, CHEM REV, V107, P1324, DOI 10.1021/cr050149z; Lunt RR, 2009, J APPL PHYS, V105, DOI 10.1063/1.3079797; Nguyen TQ, 2000, SCIENCE, V288, P652, DOI 10.1126/science.288.5466.652; Palacios RE, 2006, J AM CHEM SOC, V128, P9028, DOI 10.1021/ja062848e; Peet J, 2009, ACCOUNTS CHEM RES, V42, P1700, DOI 10.1021/ar900065j; Scully SR, 2007, ADV MATER, V19, P2961, DOI 10.1002/adma.200700917; Shaw PE, 2008, ADV MATER, V20, P3516, DOI 10.1002/adma.200800982; Yang M, 2003, BIOPHYS J, V85, P140, DOI 10.1016/S0006-3495(03)74461-0; Yu J, 2000, SCIENCE, V289, P1327, DOI 10.1126/science.289.5483.1327	15	26	26	3	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					544	545		10.1126/science.1201660	http://dx.doi.org/10.1126/science.1201660			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292961				2022-12-28	WOS:000286933600035
J	Clark, AL; Johnson, MJ; Squire, I				Clark, Andrew L.; Johnson, Miriam J.; Squire, Iain			Uncertainties Page Does home oxygen benefit people with chronic heart failure?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EXERCISE CAPACITY; BREATHLESSNESS; THERAPY; DYSPNEA					a.l.clark@hull.ac.uk		Johnson, Miriam/0000-0001-6204-9158	National Institute for Health Research [06/80/01] Funding Source: researchfish; Department of Health [06/80/01] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); Department of Health		Abernethy AP, 2010, LANCET, V376, P784, DOI 10.1016/S0140-6736(10)61115-4; Booth S, 2004, RESP MED, V98, P66, DOI 10.1016/j.rmed.2003.08.008; Bradley TD, 2005, NEW ENGL J MED, V353, P2025, DOI 10.1056/NEJMoa051001; CLARK A, 1994, BRIT HEART J, V71, P528; Cranston JM, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001744.pub2; Cranston JM, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004769.pub2; Currow DC, 2009, PALLIATIVE MED, V23, P309, DOI 10.1177/0269216309104058; Mak S, 2001, CHEST, V120, P467, DOI 10.1378/chest.120.2.467; MOORE DP, 1992, LANCET, V339, P850, DOI 10.1016/0140-6736(92)90288-E; Oldenburg O, 2007, EUR J HEART FAIL, V9, P251, DOI 10.1016/j.ejheart.2006.08.003; RUBIN SA, 1982, CIRCULATION, V66, P143, DOI 10.1161/01.CIR.66.1.143; Russell SD, 1999, AM J CARDIOL, V84, P1412, DOI 10.1016/S0002-9149(99)00587-1; Sasayama S, 2009, CIRC J, V73, P1255, DOI 10.1253/circj.CJ-08-1210; Scottish Intercollegiate Guidelines Network, 2003, 73 SCOTT INT GUID NE; THOMAS M, 1965, BRIT HEART J, V27, P401; Toyama T, 2009, CIRC J, V73, P299, DOI 10.1253/circj.CJ-07-0297	16	15	15	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2011	342								d234	10.1136/bmj.d234	http://dx.doi.org/10.1136/bmj.d234			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718PX	21296836				2022-12-28	WOS:000287138600005
J	Odde, D				Odde, David			Getting Cells and Tissues into Shape	CELL			English	Editorial Material							FORCE	Cells of all shapes and sizes are able to calculate the location of their middles in order to divide into two during mitosis. Minc et al. (2011) and Gibson et al. (2011) now show that simple mechanical models accurately predict cleavage-plane positioning, and that geometrical interactions between neighboring cells are sufficient to generate ordered patterns of mitosis in growing epithelia.	Univ Minnesota, Dept Biomed Engn, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Odde, D (corresponding author), Univ Minnesota, Dept Biomed Engn, 7-132 Nils Hasselmo Hall,312 Church St SE, Minneapolis, MN 55455 USA.	oddex002@umn.edu	Odde, David/AAY-1720-2020; Odde, David/H-4925-2011	Odde, David/0000-0001-7731-2799; 				Aegerter-Wilmsen T, 2010, DEVELOPMENT, V137, P499, DOI 10.1242/dev.041731; Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Gibson WT, 2011, CELL, V144, P427, DOI 10.1016/j.cell.2010.12.035; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; HAYS TS, 1982, J CELL BIOL, V93, P374, DOI 10.1083/jcb.93.2.374; Hofmeister W, 1863, JB WISS BOT, V3, P259; Meyers J, 2006, CURR BIOL, V16, P1685, DOI 10.1016/j.cub.2006.07.056; Minc N, 2011, CELL, V144, P414, DOI 10.1016/j.cell.2011.01.016; Patel AB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000412	10	15	16	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 4	2011	144	3					325	326		10.1016/j.cell.2011.01.022	http://dx.doi.org/10.1016/j.cell.2011.01.022			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295695	Bronze			2022-12-28	WOS:000286973100005
J	Ron, D; Ito, K				Ron, David; Ito, Koreaki			A Translational Pause to Localize	SCIENCE			English	Editorial Material							UNFOLDED PROTEIN RESPONSE; MESSENGER-RNA; TRANSCRIPTION FACTOR; ER STRESS; IRE1; SITE; SECM		[Ron, David] Univ Cambridge, Inst Metab Sci, Cambridge CB2 0QQ, England; [Ito, Koreaki] Kyoto Sangyo Univ, Fac Life Sci, Kyoto 6038555, Japan	University of Cambridge; Kyoto Sangyo University	Ron, D (corresponding author), Univ Cambridge, Inst Metab Sci, Cambridge CB2 0QQ, England.	dr360@medschl.cam.ac.uk; kito@cc.kyoto-su.ac.jp		Ron, David/0000-0002-3014-5636	Grants-in-Aid for Scientific Research [20247020] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Murakami A, 2004, P NATL ACAD SCI USA, V101, P12330, DOI 10.1073/pnas.0404907101; Muto H, 2006, MOL CELL, V22, P545, DOI 10.1016/j.molcel.2006.03.033; Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9; Pavlov MY, 2009, P NATL ACAD SCI USA, V106, P50, DOI 10.1073/pnas.0809211106; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Stephens SB, 2005, MOL BIOL CELL, V16, P5819, DOI 10.1091/mbc.E05-07-0685; Yanagitani K, 2011, SCIENCE, V331, P586, DOI 10.1126/science.1197142; Yanagitani K, 2009, MOL CELL, V34, P191, DOI 10.1016/j.molcel.2009.02.033; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2006, J CELL BIOL, V172, P565, DOI 10.1083/jcb.200508145	14	3	3	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					543	544		10.1126/science.1202075	http://dx.doi.org/10.1126/science.1202075			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292960				2022-12-28	WOS:000286933600034
J	Wojchowski, D				Wojchowski, Don			Eugene Goldwasser (1922-2010) OBITUARY	NATURE			English	Biographical-Item									Maine Med Ctr, Res Inst, COBRE Ctr Excellence Stem Cell Biol & Regenerat M, Scarborough, ME 04074 USA	Maine Medical Center	Wojchowski, D (corresponding author), Maine Med Ctr, Res Inst, COBRE Ctr Excellence Stem Cell Biol & Regenerat M, Scarborough, ME 04074 USA.	wojchd@mmc.org			NHLBI NIH HHS [R01 HL044491] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL044491] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))			0	4	4	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2011	470	7332					40	40		10.1038/470040a	http://dx.doi.org/10.1038/470040a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293362	Bronze			2022-12-28	WOS:000286886400023
J	Schmajuk, G; Trivedi, AN; Solomon, DH; Yelin, E; Trupin, L; Chakravarty, EF; Yazdany, J				Schmajuk, Gabriela; Trivedi, Amal N.; Solomon, Daniel H.; Yelin, Edward; Trupin, Laura; Chakravarty, Eliza F.; Yazdany, Jinoos			Receipt of Disease-Modifying Antirheumatic Drugs Among Patients With Rheumatoid Arthritis in Medicare Managed Care Plans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-CARE; HEALTH PLANS; DISPARITIES; OUTCOMES; DATABASE; COST; BENEFICIARIES; NEIGHBORHOOD; MEDICATIONS; AMERICAN	Context In 2005, the Healthcare Effectiveness Data and Information Set (HEDIS) introduced a quality measure to assess the receipt of disease-modifying antirheumatic drugs (DMARDs) among patients with rheumatoid arthritis (RA). Objective To identify sociodemographic, community, and health plan factors associated with DMARD receipt among Medicare managed care enrollees. Design, Setting, and Participants We analyzed individual-level HEDIS data for 93 143 patients who were at least 65 years old with at least 2 diagnoses of RA within a measurement year (during 2005-2008). Logistic regression models with generalized estimating equations were used to determine factors associated with DMARD receipt and logistic regression was used to adjust health plan performance for case mix. Main Outcome Measures Receipt or nonreceipt of DMARD. Results The mean age of patients was 74 years; 75% were women and 82% were white. Overall performance on the HEDIS measure for RA was 59% in 2005, increasing to 67% in 2008 (P for trend <.001). The largest difference in performance was based on age: patients aged 85 years and older had a 30 percentage point lower rate of DMARD receipt (95% confidence interval [CI], -29 to -32 points; P<.001), compared with patients 65 to 69 years of age, even after adjusting for other factors. Lower percentage point rates were also found for patients who were men (-3 points; 95% CI, -5 to -2 points; P<.001), of black race (-4 points; 95% CI, -6 to -2 points; P<.001), with low personal income (-6 points; 95% CI, -8 to -5 points; P<.001), with the lowest zip code-based socioeconomic status (-4 points; 95% CI, -6 to 2 points; P<.001), or enrolled in for-profit health plans (-4 points; 95% CI, -7 to 0 points; P<.001); and in the Middle Atlantic region (-7 points; 95% CI, -13 to -2 points; P<.001) and South Atlantic regions (-11 points; 95% CI, -20 to -3 points; P<.001) as compared with the Pacific region. Performance varied widely by health plan, ranging from 16% to 87%. Conclusions Among Medicare managed care enrollees carrying a diagnosis of RA between 2005 and 2008, 63% received a DMARD. Receipt of DMARDs varied based on demographic factors, socioeconomic status, geographic location, and health plan. JAMA. 2011;305(5):480-486 www.jama.com	[Schmajuk, Gabriela; Chakravarty, Eliza F.] Stanford Univ, Dept Med, Div Rheumatol, Stanford, CA 94304 USA; [Trivedi, Amal N.] Brown Univ, Dept Community Hlth & Med, Providence, RI 02912 USA; [Solomon, Daniel H.] Harvard Univ, Brigham & Womens Hosp, Dept Med, Div Rheumatol, Boston, MA 02115 USA; [Yelin, Edward; Trupin, Laura; Yazdany, Jinoos] Univ Calif San Francisco, Dept Med, Div Rheumatol, San Francisco, CA USA	Stanford University; Brown University; Harvard University; Brigham & Women's Hospital; University of California System; University of California San Francisco	Schmajuk, G (corresponding author), Stanford Univ, Dept Med, Div Rheumatol, 1000 Welch Rd,Ste 203, Stanford, CA 94304 USA.	schmajuk@gmail.com			Merck; Pzifer (Pzifer Foundation); American College of Rheumatology/Research and Education Foundation; National Center for Research Resources [5-M01-RR-00079]; Rosalind Russell Medical Research Center for Arthritis; National Institutes of Health [R01-AR-44804]; State of California Lupus Fund; Arthritis Foundation; Agency for Healthcare Research and Quality; National Institute of Arthritis and Musculoskeletal and Skin Diseases [1-R01-HS-013893, P60-AR-053308, K24-AR-AR055989, R01-AR-056215]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS013893] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000079] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044804, P60AR053308, R01AR056215, R01AR056476, K24AR055989, K23AR060259] Funding Source: NIH RePORTER	Merck(Merck & Company); Pzifer (Pzifer Foundation); American College of Rheumatology/Research and Education Foundation; National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Rosalind Russell Medical Research Center for Arthritis; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); State of California Lupus Fund; Arthritis Foundation; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Trivedi reports receipt of compensation from Merck (for editing a chapter of the Merck Manual) and from the Pzifer (for receiving a Health Policy Scholars Award from the Pzifer Foundation). Other authors reported no potential conflicts.; Funding was provided by the American College of Rheumatology/Research and Education Foundation Physician-Scientist Development Award; National Center for Research Resources (5-M01-RR-00079); Rosalind Russell Medical Research Center for Arthritis; National Institutes of Health (R01-AR-44804); State of California Lupus Fund; Arthritis Foundation; Agency for Healthcare Research and Quality; and National Institute of Arthritis and Musculoskeletal and Skin Diseases (grant numbers: 1-R01-HS-013893, P60-AR-053308, K24-AR-AR055989, and R01-AR-056215).	Agency for Healthcare Research and Quality, RHEUM ARTHR PERC MEM; [Anonymous], 2001, INTERSTUDY COMPETITI; [Anonymous], 2008, AHRQ PUBL, V08-0034 (1-4), P1; Arday SL, 2000, HEALTH CARE FINANC R, V21, P107; Baker LC, 2010, INT J QUAL HEALTH C, V22, P210, DOI 10.1093/intqhc/mzq011; Best A E, 1999, J Med Syst, V23, P175, DOI 10.1023/A:1020515419714; Brown AF, 2007, AM J PUBLIC HEALTH, V97, P926, DOI 10.2105/AJPH.2005.069443; Bruce B, 2007, J RHEUMATOL, V34, P1475; Brunner HI, 2006, ARTHRIT RHEUM-ARTHR, V55, P378, DOI 10.1002/art.21991; Edwards CJ, 2005, RHEUMATOLOGY, V44, pI2; GABRIEL SE, 1994, ARTHRITIS RHEUM, V37, P821, DOI 10.1002/art.1780370607; Gleason PP, 2009, J MANAGE CARE PHARM, V15, P648, DOI 10.18553/jmcp.2009.15.8.648; Grijalva CG, 2008, RHEUMATOLOGY, V47, P1061, DOI 10.1093/rheumatology/ken193; Groessl EJ, 2006, PHARMACOECONOMICS, V24, P109, DOI 10.2165/00019053-200624020-00002; Health Care Financing Administration, MED HE DIS DAT AUD M; Iren UT, 2005, J RHEUMATOL, V32, P602; Keenan PS, 2010, MED CARE, V48, P260, DOI 10.1097/MLR.0b013e3181ca410a; Khanna R, 2007, CLIN THER, V29, P2456, DOI 10.1016/j.clinthera.2007.11.009; Koroukian SM, 2010, HEALTH SERV RES, V45, P265, DOI 10.1111/j.1475-6773.2009.01051.x; Kwoh CK, 2002, ARTHRITIS RHEUM-US, V46, P328; Lacaille D, 2005, ARTHRIT RHEUM-ARTHR, V53, P241, DOI 10.1002/art.21077; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Pincus T, 1999, ANN INTERN MED, V131, P768, DOI 10.7326/0003-4819-131-10-199911160-00009; Pisetsky DS, 2001, JAMA-J AM MED ASSOC, V286, P2787, DOI 10.1001/jama.286.22.2787; Polinski JM, 2009, ARTHRIT RHEUM-ARTHR, V61, P745, DOI 10.1002/art.24560; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; Schmajuk G, 2007, ARTHRIT RHEUM-ARTHR, V57, P928, DOI 10.1002/art.22890; Schneider EC, 2005, AM J MED, V118, P1392, DOI 10.1016/j.amjmed.2005.05.032; Sequist TD, 2006, HEALTH SERV RES, V41, P1451, DOI 10.1111/j.1475-6773.2006.00549; Sokka T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2591; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Strand V, 2008, AM J MANAG CARE, V14, P239; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; Trupin L, 2008, J RHEUMATOL, V35, P1782; Tutuncu Z, 2006, ANN RHEUM DIS, V65, P1226, DOI 10.1136/ard.2005.051144; Widdifield J, 2011, ARTHRIT CARE RES, V63, P53, DOI 10.1002/acr.20304; Zaslavsky AM, 2005, INT J QUAL HEALTH C, V17, P67, DOI 10.1093/intqhc/mzi005; Ziegler S, 2010, ANN RHEUM DIS, V69, P1803, DOI 10.1136/ard.2009.122101; Zuckerman S, 2010, NEW ENGL J MED, V363, P54, DOI 10.1056/NEJMsa0909253	39	101	102	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2011	305	5					480	486		10.1001/jama.2011.67	http://dx.doi.org/10.1001/jama.2011.67			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	714LI	21285425	Green Accepted, Bronze			2022-12-28	WOS:000286810700021
J	Enright, MC; Spratt, BG				Enright, Mark C.; Spratt, Brian G.			The Genomic View of Bacterial Diversification	SCIENCE			English	Editorial Material							RECOMBINATION; EVOLUTION		[Enright, Mark C.] Biocontrol Ltd, Sharnbrook MK44 1LQ, Beds, England; [Spratt, Brian G.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Enright, MC (corresponding author), Biocontrol Ltd, Sharnbrook MK44 1LQ, Beds, England.	b.spratt@imperial.ac.uk		Enright, Mark/0000-0001-5273-8750	Wellcome Trust [089472] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Coffey TJ, 1998, MOL MICROBIOL, V27, P73, DOI 10.1046/j.1365-2958.1998.00658.x; Croucher NJ, 2011, SCIENCE, V331, P430, DOI 10.1126/science.1198545; Feil EJ, 2000, GENETICS, V154, P1439; Feil EJ, 2001, ANNU REV MICROBIOL, V55, P561, DOI 10.1146/annurev.micro.55.1.561; Feng L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004053; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Hiller NL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001108; Holmes EC, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000505; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Morelli G, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001036; Pybus OG, 2009, NAT REV GENET, V10, P540, DOI 10.1038/nrg2583; SMITH JM, 1991, NATURE, V349, P29, DOI 10.1038/349029a0; Wilson DJ, 2009, MOL BIOL EVOL, V26, P385, DOI 10.1093/molbev/msn264	14	6	6	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					407	409		10.1126/science.1201690	http://dx.doi.org/10.1126/science.1201690			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273474				2022-12-28	WOS:000286635900037
J	Lin, JZ; Lai, SM; Jia, R; Xu, AB; Zhang, LM; Lu, J; Ye, KQ				Lin, Jinzhong; Lai, Shaomei; Jia, Ru; Xu, Anbi; Zhang, Liman; Lu, Jing; Ye, Keqiong			Structural basis for site-specific ribose methylation by box C/D RNA protein complexes	NATURE			English	Article							CRYSTAL-STRUCTURE; SOLUBLE-RNA; CORE; 2'-O-METHYLATION; REQUIREMENT; RNPS	Box C/D RNA protein complexes (RNPs) direct site-specific 2'-O-methylation of RNA and ribosome assembly(1-4). The guide RNA in C/D RNP forms base pairs with complementary substrates and selects the modification site using a molecular ruler(5-7). Despite many studies of C/D RNP structure(8-25), the fundamental questions of how C/D RNAs assemble into RNPs and how they guide modification remain unresolved. Here we report the crystal structure of an entire catalytically active archaeal C/D RNP consisting of a bipartite C/D RNA associated with two substrates and two copies each of Nop5, L7Ae and fibrillarin at 3.15-angstrom resolution. The substrate pairs with the second through the eleventh nucleotide of the 12-nucleotide guide, and the resultant duplex is bracketed in a channel with flexible ends. The methyltransferase fibrillarin binds to an undistorted A-form structure of the guide-substrate duplex and specifically loads the target ribose into the active site. Because interaction with the RNA duplex alone does not determine the site specificity, fibrillarin is further positioned by non-specific and specific protein interactions. Compared with the structure of the inactive C/D RNP, extensive domain movements are induced by substrate loading. Our results reveal the organization of a monomeric C/D RNP and the mechanism underlying its site-specific methylation activity.	[Lin, Jinzhong; Lai, Shaomei; Jia, Ru; Xu, Anbi; Zhang, Liman; Lu, Jing; Ye, Keqiong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Zhang, Liman; Lu, Jing] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Zhang, Liman; Lu, Jing] Peking Union Med Coll, Beijing 100730, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Ye, KQ (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	yekeqiong@nibs.ac.cn	Lin, Jinzhong/I-9131-2016	Lin, Jinzhong/0000-0001-5666-8526	Chinese Ministry of Science and Technology [2008AA022310]; Beijing Municipal Government	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Beijing Municipal Government	We are grateful to the staff at the Shanghai Synchrotron Radiation Facility beamline BL17U for assistance in data collection and to B. Zhu for help with the methylation assay. This research was supported by the Chinese Ministry of Science and Technology (863 grant 2008AA022310) and the Beijing Municipal Government.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aittaleb M, 2003, NAT STRUCT BIOL, V10, P256, DOI 10.1038/nsb905; Appel CD, 2007, RNA, V13, P899, DOI 10.1261/rna.517307; Bleichert F, 2009, SCIENCE, V325, P1384, DOI 10.1126/science.1176099; Cahill NM, 2002, EMBO J, V21, P3816, DOI 10.1093/emboj/cdf376; Cavaille J, 1996, NATURE, V383, P732, DOI 10.1038/383732a0; Chen CL, 2007, J MOL BIOL, V369, P771, DOI 10.1016/j.jmb.2007.03.052; DeLano WL, 2002, PYMOL USERS MANUAL; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hardin JW, 2006, NUCLEIC ACIDS RES, V34, P5039, DOI 10.1093/nar/gkl644; Henras AK, 2008, CELL MOL LIFE SCI, V65, P2334, DOI 10.1007/s00018-008-8027-0; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Klein DJ, 2001, EMBO J, V20, P4214, DOI 10.1093/emboj/20.15.4214; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moore T, 2004, STRUCTURE, V12, P807, DOI 10.1016/j.str.2004.02.033; Murshudov GN, 1999, ACTA CRYSTALLOGR D, V55, P247, DOI 10.1107/S090744499801405X; Omer AD, 2002, P NATL ACAD SCI USA, V99, P5289, DOI 10.1073/pnas.082101999; Omer AD, 2006, RNA, V12, P1708, DOI 10.1261/rna.31506; Oruganti S, 2007, J MOL BIOL, V371, P1141, DOI 10.1016/j.jmb.2007.06.029; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PRICE SR, 1995, J MOL BIOL, V249, P398, DOI 10.1006/jmbi.1995.0305; Rashid R, 2003, J MOL BIOL, V333, P295, DOI 10.1016/j.jmb.2003.08.012; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; Tran E, 2005, RNA, V11, P285, DOI 10.1261/rna.7223405; Tran EJ, 2003, EMBO J, V22, P3930, DOI 10.1093/emboj/cdg368; Tycowski KT, 1996, P NATL ACAD SCI USA, V93, P14480, DOI 10.1073/pnas.93.25.14480; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Venema J, 1999, ANNU REV GENET, V33, P261, DOI 10.1146/annurev.genet.33.1.261; Vidovic I, 2000, MOL CELL, V6, P1331, DOI 10.1016/S1097-2765(00)00131-3; Wang HM, 2000, EMBO J, V19, P317, DOI 10.1093/emboj/19.3.317; Watkins NJ, 2000, CELL, V103, P457, DOI 10.1016/S0092-8674(00)00137-9; Watkins NJ, 2002, MOL CELL BIOL, V22, P8342, DOI 10.1128/MCB.22.23.8342-8352.2002; Xue S, 2010, MOL CELL, V39, P939, DOI 10.1016/j.molcel.2010.08.022; Ye KQ, 2009, P NATL ACAD SCI USA, V106, P13808, DOI 10.1073/pnas.0905128106; Zhang XX, 2006, RNA, V12, P1092, DOI 10.1261/rna.2230106	37	91	95	1	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					559	U140		10.1038/nature09688	http://dx.doi.org/10.1038/nature09688			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270896				2022-12-28	WOS:000286596500038
J	Chapman, S				Chapman, Simon			Personal View Should the spectacle of surgery be sold to the highest bidder?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Sydney, Sydney, NSW 2006, Australia	University of Sydney	Chapman, S (corresponding author), Univ Sydney, Sydney, NSW 2006, Australia.	simon.chapman@sydney.edu.au	Chapman, Simon/D-4114-2009						0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2011	342								d237	10.1136/bmj.d237	http://dx.doi.org/10.1136/bmj.d237			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	715ME	21270082				2022-12-28	WOS:000286887800013
J	Spence, D				Spence, Des			From the Frontline Greed isn't good	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2011	342								d524	10.1136/bmj.d524	http://dx.doi.org/10.1136/bmj.d524			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	715ME	21270089				2022-12-28	WOS:000286887800006
J	de Kort, H; de Koning, EJ; Rabelink, TJ; Bruijn, JA; Bajema, IM				de Kort, Hanneke; de Koning, Eelco J.; Rabelink, Ton J.; Bruijn, Jan A.; Bajema, Ingeborg M.			Islet transplantation in type 1 diabetes	BMJ-BRITISH MEDICAL JOURNAL			English	Review							GRAFT-SURVIVAL; DISEASE					e.dekoning@lumc.nl	Rabelink, Ton J./A-5316-2008; de Kort, Hanneke/N-3898-2014; de Koning, Eelco JP/H-6030-2011	Rabelink, Ton J./0000-0001-6780-5186; de Kort, Hanneke/0000-0003-3601-532X; de Koning, Eelco JP/0000-0002-1232-7022				Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; Brandhorst H, 2010, TRANSPLANTATION, V89, P155, DOI 10.1097/TP.0b013e3181c9266c; Campbell PM, 2007, AM J TRANSPLANT, V7, P2311, DOI 10.1111/j.1600-6143.2007.01923.x; Chatenoud L, 2008, NEW ENGL J MED, V358, P1192, DOI 10.1056/NEJMcibr0708067; Daly Barry, 2004, Semin Intervent Radiol, V21, P335, DOI 10.1055/s-2004-861568; Fiorina P, 2005, DIABETES CARE, V28, P1358, DOI 10.2337/diacare.28.6.1358; Fiorina P, 2005, DIABETES CARE, V28, P1303, DOI 10.2337/diacare.28.6.1303; Hansson M, 2010, CURR OPIN INVEST DR, V11, P417; Harlan DM, 2009, DIABETES, V58, P2175, DOI 10.2337/db09-0476; Khan MH, 2009, DIABETES CARE, V32, P1570, DOI 10.2337/dc09-0611; Korsgren O, 2005, TRANSPLANTATION, V79, P1289, DOI 10.1097/01.TP.0000157273.60147.7C; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; Medarova Z, 2008, DIABETES OBES METAB, V10, P88, DOI 10.1111/j.1463-1326.2008.00942.x; Merani S, 2008, BRIT J SURG, V95, P1449, DOI 10.1002/bjs.6391; Naftanel MA, 2004, PLOS MED, V1, P198, DOI 10.1371/journal.pmed.0010058; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Papas KK, 2009, CURR OPIN ORGAN TRAN, V14, P674, DOI 10.1097/MOT.0b013e328332a489; Robertson RP, 2010, DIABETES, V59, P1285, DOI 10.2337/db09-1846; Ryan EA, 2005, DIABETES, V54, P2060, DOI 10.2337/diabetes.54.7.2060; Serup P, 2001, BRIT MED J, V322, P29, DOI 10.1136/bmj.322.7277.29; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Vantyghem MC, 2009, DIABETES CARE, V32, P1473, DOI 10.2337/dc08-1685; Warnock GL, 2008, TRANSPLANTATION, V86, P1762, DOI 10.1097/TP.0b013e318190b052	24	39	39	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2011	342								d217	10.1136/bmj.d217	http://dx.doi.org/10.1136/bmj.d217			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711PJ	21257658				2022-12-28	WOS:000286603600007
J	Sergio, F; Blas, J; Blanco, G; Tanferna, A; Lopez, L; Lemus, JA; Hiraldo, F				Sergio, F.; Blas, J.; Blanco, G.; Tanferna, A.; Lopez, L.; Lemus, J. A.; Hiraldo, F.			Raptor Nest Decorations Are a Reliable Threat Against Conspecifics	SCIENCE			English	Article							BOWERBIRDS; COST; REPEATABILITY; DISPLAY; BIRD	Individual quality is often signaled by phenotypic flags, such as bright plumage patches in birds. Extended phenotype signals can similarly show quality, but in these cases the signals are external to the individual, often taking the form of objects scavenged from the environment. Through multiple manipulative experiments, we showed that objects used for nest decoration by a territorial raptor, the black kite (Milvus migrans), act as reliable threats to conspecifics, revealing the viability, territory quality, and conflict dominance of the signaler. Our results suggest that animal-built structures may serve as signaling devices much more frequently than currently recognized.	[Sergio, F.; Blas, J.; Tanferna, A.; Lopez, L.; Lemus, J. A.; Hiraldo, F.] CSIC, Estn Biol Donana, Dept Conservat Biol, Seville 41092, Spain; [Blanco, G.] CSIC, Museum Nat Sci, Dept Evolutionary Ecol, E-28006 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC)	Sergio, F (corresponding author), CSIC, Estn Biol Donana, Dept Conservat Biol, C Amer Vespucio, Seville 41092, Spain.	fsergio@ebd.csic.es	López, Lidia/HGE-0751-2022; Sergio, Fabrizio/B-3952-2015; Tanferna, Alessandro/L-6648-2015; Blanco, Guillermo/L-3170-2014; Hiraldo, Fernando/AAA-8314-2019; Blas, Julio/A-2487-2012	Sergio, Fabrizio/0000-0002-8024-1773; Tanferna, Alessandro/0000-0003-0799-301X; Blanco, Guillermo/0000-0001-5742-4929; Blas, Julio/0000-0003-0589-3322; Lopez-Jimenez, Lidia/0000-0002-4109-3034	Junta de Andalucia [CGL2008-01781, JA-58, RNM 1790, RNM 03822]; Ministerio de Ciencia e Innovacion; Natural Research Limited	Junta de Andalucia(Junta de Andalucia); Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Natural Research Limited	We thank F. J. Chicano, J. Giralt, and F. G. Vilches for help in the field. S. N. Vignieri and three anonymous reviewers greatly improved a previous draft of the manuscript. The study was funded by the research projects CGL2008-01781, JA-58, RNM 1790, and RNM 03822 granted by the Junta de Andalucia, Ministerio de Ciencia e Innovacion, and Natural Research Limited.	ADAMS ES, 1995, J THEOR BIOL, V175, P405, DOI 10.1006/jtbi.1995.0151; Berglund A, 1996, BIOL J LINN SOC, V58, P385, DOI 10.1111/j.1095-8312.1996.tb01442.x; BORGIA G, 1993, AM NAT, V141, P729, DOI 10.1086/285502; Bradbury Jack W., 1998, pi; Coleman SW, 2004, NATURE, V428, P742, DOI 10.1038/nature02419; COLLIAS ELSIE C., 1964, AUK, V81, P42; DIAMOND J, 1986, P NATL ACAD SCI USA, V83, P3042, DOI 10.1073/pnas.83.9.3042; Doerr NR, 2010, ANIM BEHAV, V79, P747, DOI 10.1016/j.anbehav.2009.12.032; Enquist M, 1998, ANIM BEHAV, V56, P749, DOI 10.1006/anbe.1998.0820; Hansell M., 2005, OXF ANIMAL BIOL SER; Hansell M.H., 2000, BIRD NESTS CONSTRUCT, DOI [10.1017/CBO9781139106788, DOI 10.1017/CBO9781139106788]; JOHNSTONE RA, 1993, BEHAV ECOL SOCIOBIOL, V32, P127, DOI 10.1007/BF00164045; Levey DJ, 2004, NATURE, V431, P39, DOI 10.1038/431039a; Madden J, 2001, P ROY SOC B-BIOL SCI, V268, P833, DOI 10.1098/rspb.2000.1425; Madden JR, 2008, ANIM COGN, V11, P1, DOI 10.1007/s10071-007-0092-5; Madden JR, 2002, P ROY SOC B-BIOL SCI, V269, P1347, DOI 10.1098/rspb.2002.1988; MAYNARD-SMITH J., 2003, ANIMAL SIGNALS; MORENO J, 1994, ANIM BEHAV, V47, P1297, DOI 10.1006/anbe.1994.1178; Ostlund-Nilsson S, 2003, BEHAV ECOL SOCIOBIOL, V53, P214, DOI 10.1007/s00265-002-0574-z; Rushbrook BJ, 2008, ANIM BEHAV, V75, P547, DOI 10.1016/j.anbehav.2007.06.011; Schaedelin FC, 2009, BIOL REV, V84, P293, DOI 10.1111/j.1469-185X.2008.00075.x; Schuetz JG, 2005, BEHAV ECOL, V16, P133, DOI 10.1093/beheco/arh139; Searcy W., 2005, EVOLUTION ANIMAL COM; Sergio F, 2009, OECOLOGIA, V160, P507, DOI 10.1007/s00442-009-1314-0; Sergio F, 2009, J ANIM ECOL, V78, P109, DOI 10.1111/j.1365-2656.2008.01484.x; Walsh PT, 2010, BIOL LETTERS, V6, P149, DOI 10.1098/rsbl.2009.0664; WIMBERGER PH, 1984, AUK, V101, P615, DOI 10.1093/auk/101.3.615; Wojcieszek JM, 2007, BEHAV ECOL, V18, P689, DOI 10.1093/beheco/arm031	28	97	104	4	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					327	330		10.1126/science.1199422	http://dx.doi.org/10.1126/science.1199422			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252345	Green Submitted			2022-12-28	WOS:000286636300036
J	Haines, A; Flahault, A; Horton, R				Haines, Andy; Flahault, Antoine; Horton, Richard			European academic institutions for global health	LANCET			English	Editorial Material							DIPLOMACY		[Haines, Andy] Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, London WC1E 7HT, England; [Haines, Andy] Univ London London Sch Hyg & Trop Med, Dept Nutr & Publ Hlth, London WC1E 7HT, England; [Flahault, Antoine] EHESP Sch Publ Hlth, Rennes, France; [Horton, Richard] The Lancet, London NW1 7BY, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Haines, A (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, Keppel St, London WC1E 7HT, England.	Andy.Haines@lshtm.ac.uk		Haines, Andy/0000-0002-8053-4605				Balabanova D, 2010, HEALTH RES POLICY SY, V8, DOI 10.1186/1478-4505-8-22; Drager N, 2007, B WORLD HEALTH ORGAN, V85, P162, DOI 10.2471/BLT.07.041079; European Commission, 2010, EU ROL GLOB HLTH; Fried LP, 2010, LANCET, V375, P535, DOI 10.1016/S0140-6736(10)60203-6; *GLOB HLTH ED CONS, GLOB VS INT HLTH WHA; Kickbusch I, 2007, B WORLD HEALTH ORGAN, V85, P230, DOI 10.2471/BLT.06.039222; Koplan JP, 2009, LANCET, V373, P1993, DOI 10.1016/S0140-6736(09)60332-9; LEE K, 2005, GLOBAL CHANGE HLTH	8	6	9	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2011	377	9763					363	365		10.1016/S0140-6736(11)60108-6	http://dx.doi.org/10.1016/S0140-6736(11)60108-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	721ES	21277428				2022-12-28	WOS:000287337000009
J	Summerskill, W; Horton, R				Summerskill, William; Horton, Richard			Health in southeast Asia	LANCET			English	Editorial Material									[Summerskill, William; Horton, Richard] The Lancet, London NW1 7BY, England		Summerskill, W (corresponding author), The Lancet, London NW1 7BY, England.							ACUIN CS, 2011, LANCET          0125; CHONGSUVIVATWON.V, 2011, LANCET          0125, DOI DOI 10.1016/50140-6736(10)61507-3; COKER RJ, 2011, LANCET          0125, DOI DOI 10.1016/50140-6736(10)62004-1; DANS A, 2011, LANCET          0125, DOI DOI 10.1016/50140-6736(10)61506-1; KANCHANACHITRA C, 2011, LANCET          0125, DOI DOI 10.1016/50140-6736(10)62035-1; TANGCHAROENSATH.V, 2011, LANCET          0125, DOI DOI 10.1016/50140-6736(10)61890-9	6	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2011	377	9763					355	356		10.1016/S0140-6736(10)62192-7	http://dx.doi.org/10.1016/S0140-6736(10)62192-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	721ES	21269686				2022-12-28	WOS:000287337000004
J	Pape, KA; Taylor, JJ; Maul, RW; Gearhart, PJ; Jenkins, MK				Pape, Kathryn A.; Taylor, Justin J.; Maul, Robert W.; Gearhart, Patricia J.; Jenkins, Marc K.			Different B Cell Populations Mediate Early and Late Memory During an Endogenous Immune Response	SCIENCE			English	Article							INDUCED CYTIDINE DEAMINASE; SUBSETS; RECOMBINATION; HYPERMUTATION; EXPRESSION; ANTIGENS; AID	Memory B cells formed in response to microbial antigens provide immunity to later infections; however, the inability to detect rare endogenous antigen-specific cells limits current understanding of this process. Using an antigen-based technique to enrich these cells, we found that immunization with a model protein generated B memory cells that expressed isotype-switched immunoglobulins (swIg) or retained IgM. The more numerous IgM(+) cells were longer lived than the swIg(+) cells. However, swIg(+) memory cells dominated the secondary response because of the capacity to become activated in the presence of neutralizing serum immunoglobulin. Thus, we propose that memory relies on swIg(+) cells until they disappear and serum immunoglobulin falls to a low level, in which case memory resides with durable IgM(+) reserves.	[Pape, Kathryn A.; Taylor, Justin J.; Jenkins, Marc K.] Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA; [Maul, Robert W.; Gearhart, Patricia J.] NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA	University of Minnesota System; University of Minnesota Twin Cities; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Jenkins, MK (corresponding author), Univ Minnesota, Sch Med, Ctr Immunol, Dept Microbiol, Minneapolis, MN 55455 USA.	jenki002@umn.edu	Maul, Robert W./Y-6818-2019; Jenkins, Marc K/G-1063-2012; Gearhart, Patricia/Y-7227-2019	Jenkins, Marc K/0000-0001-8009-7655; Maul, Robert/0000-0002-6958-8514	NIH [R01 AI036914, R37 AI027998, F32 AI091033, T32 CA009138]; NIH, National Institute on Aging; NATIONAL CANCER INSTITUTE [T32CA009138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI027998, F32AI091033, R01AI039614] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [ZIAAG000732] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Walter and R. Speier for expert technical assistance and all members of the Jenkins lab for helpful discussions. This work was supported by grants from the NIH (R01 AI036914 and R37 AI027998 to M.K.J., F32 AI091033 and T32 CA009138 to J.T.), and the Intramural Research Program of the NIH, National Institute on Aging (R.W.M. and P.J.G.).	Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Anderson SM, 2007, J EXP MED, V204, P2103, DOI 10.1084/jem.20062571; Bell J, 2003, J EXP MED, V197, P1233, DOI 10.1084/jem.20020270; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Freund J, 1937, P SOC EXP BIOL MED, V37, P509; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Hasham MG, 2010, NAT IMMUNOL, V11, P820, DOI 10.1038/ni.1909; HAYAKAWA K, 1987, P NATL ACAD SCI USA, V84, P1379, DOI 10.1073/pnas.84.5.1379; Le TVL, 2008, J IMMUNOL, V181, P6027, DOI 10.4049/jimmunol.181.9.6027; Liu JY, 1999, J BIOL CHEM, V274, P16945, DOI 10.1074/jbc.274.24.16945; Mackay F, 2006, SEMIN IMMUNOL, V18, P261, DOI 10.1016/j.smim.2006.07.003; Martin F, 2001, IMMUNITY, V14, P617, DOI 10.1016/S1074-7613(01)00129-7; Maul RW, 2010, ADV IMMUNOL, V105, P159, DOI 10.1016/S0065-2776(10)05006-6; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Newman J, 2003, J IMMUNOL METHODS, V272, P177, DOI 10.1016/S0022-1759(02)00499-4; Ravetch JV, 1997, CURR OPIN IMMUNOL, V9, P121, DOI 10.1016/S0952-7915(97)80168-9; Ridderstad A, 1998, J IMMUNOL, V160, P4688; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; Seshasayee D, 2003, IMMUNITY, V18, P279, DOI 10.1016/S1074-7613(03)00025-6; Tangye SG, 2007, J IMMUNOL, V179, P13, DOI 10.4049/jimmunol.179.1.13; Tarlinton D, 2006, NAT REV IMMUNOL, V6, P785, DOI 10.1038/nri1938; Tarlinton DM, 2008, IMMUNOL CELL BIOL, V86, P133, DOI 10.1038/sj.icb.7100148; Todd DJ, 2009, J EXP MED, V206, P2151, DOI 10.1084/jem.20090738; Tomayko MM, 2010, J IMMUNOL, V185, P7146, DOI 10.4049/jimmunol.1002163; Yoshida T, 2010, IMMUNOL REV, V237, P117, DOI 10.1111/j.1600-065X.2010.00938.x	26	372	379	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1203	1207		10.1126/science.1201730	http://dx.doi.org/10.1126/science.1201730			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21310965	Green Accepted			2022-12-28	WOS:000287971200045
J	van Breugel, M; Hirono, M; Andreeva, A; Yanagisawa, H; Yamaguchi, S; Nakazawa, Y; Morgner, N; Petrovich, M; Ebong, IO; Robinson, CV; Johnson, CM; Veprintsev, D; Zuber, B				van Breugel, Mark; Hirono, Masafumi; Andreeva, Antonina; Yanagisawa, Haru-aki; Yamaguchi, Shoko; Nakazawa, Yuki; Morgner, Nina; Petrovich, Miriana; Ebong, Ima-Obong; Robinson, Carol V.; Johnson, Christopher M.; Veprintsev, Dmitry; Zuber, Benoit			Structures of SAS-6 Suggest Its Organization in Centrioles	SCIENCE			English	Article							CRYSTAL-STRUCTURE; BASAL BODY; CENTROSOME DUPLICATION; 9-FOLD SYMMETRY; PROTEIN; PROCENTRIOLE; CARTWHEEL; CHLAMYDOMONAS; BIOGENESIS; MECHANISMS	Centrioles are cylindrical, ninefold symmetrical structures with peripheral triplet microtubules strictly required to template cilia and flagella. The highly conserved protein SAS-6 constitutes the center of the cartwheel assembly that scaffolds centrioles early in their biogenesis. We determined the x-ray structure of the amino-terminal domain of SAS-6 from zebrafish, and we show that recombinant SAS-6 self-associates in vitro into assemblies that resemble cartwheel centers. Point mutations are consistent with the notion that centriole formation in vivo depends on the interactions that define the self-assemblies observed here. Thus, these interactions are probably essential to the structural organization of cartwheel centers.	[van Breugel, Mark; Andreeva, Antonina; Petrovich, Miriana; Johnson, Christopher M.; Veprintsev, Dmitry; Zuber, Benoit] MRC, Mol Biol Lab, Cambridge CB2 2QH, England; [Hirono, Masafumi; Yanagisawa, Haru-aki; Yamaguchi, Shoko; Nakazawa, Yuki] Univ Tokyo, Dept Biol Sci, Tokyo 1130033, Japan; [Morgner, Nina; Ebong, Ima-Obong; Robinson, Carol V.] Univ Oxford, Chem Res Lab, Oxford, England	MRC Laboratory Molecular Biology; University of Tokyo; University of Oxford	van Breugel, M (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 2QH, England.	vanbreug@mrc-lmb.cam.ac.uk	Morgner, Nina/O-7021-2018; Zuber, Benoît/U-1952-2019; HIRONO, MASAFUMI/G-4948-2014; Morgner, Nina/I-7975-2012; Hirono, Masafumi/G-5140-2013; Veprintsev, Dmitry B/H-2228-2012	Morgner, Nina/0000-0002-1872-490X; Zuber, Benoît/0000-0001-7725-5579; HIRONO, MASAFUMI/0000-0002-2497-4227; Hirono, Masafumi/0000-0002-2497-4227; Veprintsev, Dmitry B/0000-0002-3583-5409; Andreeva, Antonina/0000-0002-0450-0091; robinson, carol/0000-0001-7829-5505; Yanagisawa, Haruaki/0000-0003-0313-2343	MRC; Ministry of Education, Culture, Science and Technology of Japan [21370088]; European Molecular Biology Organization; MRC [MC_U105192716, MC_U105184294] Funding Source: UKRI; Medical Research Council [MC_U105184294, MC_U105192716] Funding Source: researchfish; Grants-in-Aid for Scientific Research [23657046] Funding Source: KAKEN	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Ministry of Education, Culture, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The structure factors and coordinates of D. rerio N-SAS-6<SUP>1-156</SUP> and D. rerio N-SAS-6<SUP>1-179</SUP> F131D have been deposited at the Protein Data Bank Europe under wwPDB ID codes 2y3v and 2y3w. We gratefully acknowledge P. Evans (MRC-LMB, Cambridge, UK) for his modeling of SAS-6 ring assemblies and our beamline support team, M. Nanao at ID29 and H. Belrhali at BM14UK at the European Synchrotron Radiation Facility (Grenoble, France). We thank L. Rey (MRC-LMB) for the kind gift of U2OS cells and S. Munro (MRC-LMB) for the kind gift of a construct expressing the red fluorescent protein (RFP)-tagged C-terminal PACT domain of pericentrin. This work was supported by a MRC Career Development Fellowship (to M.v.B.); Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Science and Technology of Japan (21370088) (to M.H.); and a European Molecular Biology Organization long-term fellowship (to B.Z.). Material will be provided to academic and not-for-profit research organizations under the MRC's standard academic Material Transfer Agreement. The UltraSpin software will be provided by MRC under an academic license.	ALLEN RD, 1969, J CELL BIOL, V40, P716, DOI 10.1083/jcb.40.3.716; ANDERSON RG, 1971, J CELL BIOL, V50, P10, DOI 10.1083/jcb.50.1.10; Andres SN, 2007, MOL CELL, V28, P1093, DOI 10.1016/j.molcel.2007.10.024; Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180; Carvalho-Santos Z, 2010, J CELL SCI, V123, P1414, DOI 10.1242/jcs.064931; CAVALIER.T, 1974, J CELL SCI, V16, P529; Culver BP, 2009, MOL BIOL CELL, V20, P1865, DOI 10.1091/mbc.E08-08-0838; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224; Gillingham AK, 2000, EMBO REP, V1, P524; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gopalakrishnan J, 2010, J BIOL CHEM, V285, P8759, DOI 10.1074/jbc.M109.092627; Guichard P, 2010, EMBO J, V29, P1565, DOI 10.1038/emboj.2010.45; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hiraki M, 2007, CURR BIOL, V17, P1778, DOI 10.1016/j.cub.2007.09.021; Jerka-Dziadosz M, 2010, CYTOSKELETON, V67, P161, DOI 10.1002/cm.20433; Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Li Y, 2008, EMBO J, V27, P290, DOI 10.1038/sj.emboj.7601942; Lo Conte L, 1999, J MOL BIOL, V285, P2177; Loncarek J, 2009, MOL CELLS, V27, P135, DOI 10.1007/s10059-009-0017-z; Matsuura K, 2004, J CELL BIOL, V165, P663, DOI 10.1083/jcb.200402022; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Sibanda BL, 2001, NAT STRUCT BIOL, V8, P1015, DOI 10.1038/nsb725; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; Vladar EK, 2007, J CELL BIOL, V178, P31, DOI 10.1083/jcb.200703064; Yabe T, 2007, DEV BIOL, V312, P44, DOI 10.1016/j.ydbio.2007.08.054	34	219	223	1	19	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1196	1199		10.1126/science.1199325	http://dx.doi.org/10.1126/science.1199325			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21273447				2022-12-28	WOS:000287971200043
J	Lipska, KJ; Ross, JS				Lipska, Kasia J.; Ross, Joseph S.			Switching From Rosiglitazone Thinking Outside the Class	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TYPE-2 DIABETES-MELLITUS		[Lipska, Kasia J.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT 06520 USA; [Ross, Joseph S.] Yale Univ, Sch Med, Dept Med, Gen Internal Med Sect, New Haven, CT 06520 USA	Yale University; Yale University	Lipska, KJ (corresponding author), Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, 333 Cedar St,SHM IE-60, New Haven, CT 06520 USA.	kasia.lipska@yale.edu		Ross, Joseph/0000-0002-9218-3320	NIA NIH HHS [K08 AG032886] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K08AG032886] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alexander GC, 2008, ARCH INTERN MED, V168, P2088, DOI 10.1001/archinte.168.19.2088; Bolen S, 2007, ANN INTERN MED, V147, P386, DOI 10.7326/0003-4819-147-6-200709180-00178; Cohen A, 2010, DIABETES CARE, V33, P823, DOI 10.2337/dc09-1834; Erdmann E, 2007, DIABETES CARE, V30, P2773, DOI 10.2337/dc07-0717; Erdmann E, 2010, J DIABETES, V2, P212, DOI 10.1111/j.1753-0407.2010.00082.x; McEvoy B, 2010, PIOGLITAZONE ROSIGLI; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; US Food and Drug Administration, 2008, GUID IND DIAB MELL E; WILSON D, ACTOS ADS JUMP AVAND	10	6	6	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 23	2011	305	8					820	821		10.1001/jama.2011.193	http://dx.doi.org/10.1001/jama.2011.193			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724RQ	21304068				2022-12-28	WOS:000287594300026
J	Evans, M				Evans, Mihail			Circumcision in boys and girls: why the double standard?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ W England, Bristol BS16 1QY, Avon, England	University of West England	Evans, M (corresponding author), Univ W England, Bristol BS16 1QY, Avon, England.	mihail@riseup.net						2010, COMP MATH MATH PHYS, V340, pC2987	1	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2011	342								d978	10.1136/bmj.d978	http://dx.doi.org/10.1136/bmj.d978			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	725OZ	21325390				2022-12-28	WOS:000287656500007
J	Ding, ZH; Wu, CJ; Chu, GC; Xiao, YH; Ho, D; Zhang, JF; Perry, SR; Labrot, ES; Wu, XQ; Lis, R; Hoshida, Y; Hiller, D; Hu, BL; Jiang, S; Zheng, HW; Stegh, AH; Scott, KL; Signoretti, S; Bardeesy, N; Wang, YA; Hill, DE; Golub, TR; Stampfer, MJ; Wong, WH; Loda, M; Mucci, L; Chin, L; DePinho, RA				Ding, Zhihu; Wu, Chang-Jiun; Chu, Gerald C.; Xiao, Yonghong; Ho, Dennis; Zhang, Jingfang; Perry, Samuel R.; Labrot, Emma S.; Wu, Xiaoqiu; Lis, Rosina; Hoshida, Yujin; Hiller, David; Hu, Baoli; Jiang, Shan; Zheng, Hongwu; Stegh, Alexander H.; Scott, Kenneth L.; Signoretti, Sabina; Bardeesy, Nabeel; Wang, Y. Alan; Hill, David E.; Golub, Todd R.; Stampfer, Meir J.; Wong, Wing H.; Loda, Massimo; Mucci, Lorelei; Chin, Lynda; DePinho, Ronald A.			SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression	NATURE			English	Article							TGF-BETA; EXPRESSION; PTEN; SMAD4; INACTIVATION; OSTEOPONTIN; PROMOTER; ROLES; MODEL; LEADS	Effective clinical management of prostate cancer (PCA) has been challenged by significant intratumoural heterogeneity on the genomic and pathological levels and limited understanding of the genetic elements governing disease progression(1). Here, we exploited the experimental merits of the mouse to test the hypothesis that pathways constraining progression might be activated in indolent Pten-null mouse prostate tumours and that inactivation of such progression barriers in mice would engender a metastasis-prone condition. Comparative transcriptomic and canonical pathway analyses, followed by biochemical confirmation, of normal prostate epithelium versus poorly progressive Pten-null prostate cancers revealed robust activation of the TGF beta/BMP-SMAD4 signalling axis. The functional relevance of SMAD4 was further supported by emergence of invasive, metastatic and lethal prostate cancers with 100% penetrance upon genetic deletion of Smad4 in the Pten-null mouse prostate. Pathological and molecular analysis as well as transcriptomic knowledge-based pathway profiling of emerging tumours identified cell proliferation and invasion as two cardinal tumour biological features in the metastatic Smad4/Pten-null PCA model. Follow-on pathological and functional assessment confirmed cyclin D1 and SPP1 as key mediators of these biological processes, which together with PTEN and SMAD4, form a four-gene signature that is prognostic of prostate-specific antigen (PSA) biochemical recurrence and lethal metastasis in human PCA. This model-informed progression analysis, together with genetic, functional and translational studies, establishes SMAD4 as a key regulator of PCA progression in mice and humans.	[Ding, Zhihu; Wu, Chang-Jiun; Chu, Gerald C.; Xiao, Yonghong; Ho, Dennis; Perry, Samuel R.; Labrot, Emma S.; Hu, Baoli; Jiang, Shan; Zheng, Hongwu; Stegh, Alexander H.; Scott, Kenneth L.; Wang, Y. Alan; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Ding, Zhihu; Wu, Chang-Jiun; Chu, Gerald C.; Xiao, Yonghong; Ho, Dennis; Perry, Samuel R.; Labrot, Emma S.; Wu, Xiaoqiu; Lis, Rosina; Hu, Baoli; Jiang, Shan; Zheng, Hongwu; Stegh, Alexander H.; Scott, Kenneth L.; Wang, Y. Alan; Loda, Massimo; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Ding, Zhihu; Wu, Chang-Jiun; Ho, Dennis; Zheng, Hongwu; Stegh, Alexander H.; Scott, Kenneth L.; Hill, David E.; Chin, Lynda; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Ding, Zhihu; Wu, Chang-Jiun; Ho, Dennis; Zheng, Hongwu; Stegh, Alexander H.; Scott, Kenneth L.; Chin, Lynda; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Chu, Gerald C.; Loda, Massimo] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Zhang, Jingfang] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Wu, Xiaoqiu; Lis, Rosina; Loda, Massimo] Dana Farber Canc Inst, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Hoshida, Yujin; Golub, Todd R.] MIT, Eli & Edythe L Broad Inst, Cambridge, MA 02142 USA; [Hoshida, Yujin; Golub, Todd R.] Harvard Univ, Cambridge, MA 02142 USA; [Hiller, David; Wong, Wing H.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Signoretti, Sabina] Dana Farber Harvard Canc Ctr, Renal Canc Program, Boston, MA 02115 USA; [Bardeesy, Nabeel] Massachusetts Gen Hosp, Ctr Canc, Dept Med, Boston, MA 02114 USA; [Hill, David E.] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Hill, David E.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Chin, Lynda] Brigham & Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Stampfer, Meir J.; Mucci, Lorelei] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Stampfer, Meir J.] Harvard Univ, Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Stampfer, Meir J.; Mucci, Lorelei] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; University of Wisconsin System; University of Wisconsin Madison; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Stanford University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Massachusetts General Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital	DePinho, RA (corresponding author), Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA.	lynda_chin@dfci.harvard.edu; ron_depinho@dfci.harvard.edu	Hill, David E/B-6617-2011; Hoshida, Yujin/R-7513-2019	Zheng, Hongwu/0000-0002-5823-4913; DePinho, Ronald/0000-0002-5625-577X	Damon Runyon Cancer Research Foundation; National Science Foundation; Helen Hay Whitney Foundation; Multiple Myeloma Research Foundation; Belfer Institute for Applied Cancer Science (NCI) [U01-CA84313]; DF/HCC SPORE in Prostate Cancer [P50 CA090381-08]; National Cancer Institute [RO1CA131945, P50 CA90381, RO1 5R01CA136578, R01CA141298]; Linda and Arthur Gelb Center for Translational Research; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA141298, U01CA084313, R01CA136578, P50CA090381, R01CA131945] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; National Science Foundation(National Science Foundation (NSF)); Helen Hay Whitney Foundation; Multiple Myeloma Research Foundation; Belfer Institute for Applied Cancer Science (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); DF/HCC SPORE in Prostate Cancer; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Linda and Arthur Gelb Center for Translational Research; Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors are grateful to the late W. Gerald for providing the primary gene expression data and clinical outcome files<SUP>13</SUP>. We thank S. Zhou for excellent mouse husbandry and care, B. Xiong and G. Tonon for bioinformatic assistance, and S. Jia, J. M. Stommel, J. Paik, M. Kim and A. C. Kimmelman for helpful discussion. We thank M. Vidal, the Ellison Foundation and DFCI ISR for support of ORF cloning efforts, R. Maser for MSCV-puro-v5 gateway vector, W. Hahn for shRNA constructs. We thank the DF/HCC Specialized Histopathology Core and the DF/HCC Tissue Microarray and Imaging core for the TMA IHC staining; the DFCI/BWH Center for Molecular Oncologic Pathology (CMOP) for the quantification of the IHC. Z.D was supported by the Damon Runyon Cancer Research Foundation. D. H. was supported by a graduate fellowship from the National Science Foundation. H.Z. was supported by the Helen Hay Whitney Foundation. Y.A.W. was supported by the Multiple Myeloma Research Foundation. This work is supported by the Belfer Institute for Applied Cancer Science, NCI U01-CA84313 (L. C. and R. A. D.), DF/HCC SPORE in Prostate Cancer P50 CA090381-08 (Z.D.), the National Cancer Institute (M. L. RO1CA131945 and P50 CA90381, L. M. RO1 5R01CA136578, M. S. R01CA141298), and the Linda and Arthur Gelb Center for Translational Research (M. L.). R. A. D. was supported by an American Cancer Society Research Professorship and L. M. was supported by the Prostate Cancer Foundation.	Aitchison AA, 2008, PROSTATE, V68, P661, DOI 10.1002/pros.20730; Andreoiu M, 2010, HUM PATHOL, V41, P781, DOI 10.1016/j.humpath.2010.02.011; Bardeesy N, 2006, GENE DEV, V20, P3130, DOI 10.1101/gad.1478706; Berger R, 2004, CANCER RES, V64, P8867, DOI 10.1158/0008-5472.CAN-04-2938; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Christen WG, 2000, ANN EPIDEMIOL, V10, P125, DOI 10.1016/S1047-2797(99)00042-3; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Haibe-Kains B, 2008, BIOINFORMATICS, V24, P2200, DOI 10.1093/bioinformatics/btn374; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hullinger TG, 2001, EXP CELL RES, V262, P69, DOI 10.1006/excr.2000.5074; Jeet V, 2010, CANCER METAST REV, V29, P123, DOI 10.1007/s10555-010-9212-9; JEMAL A, 2010, CA CANC J CLIN; Johansson JE, 2004, JAMA-J AM MED ASSOC, V291, P2713, DOI 10.1001/jama.291.22.2713; Ma XQ, 2005, CANCER RES, V65, P5730, DOI 10.1158/0008-5472.CAN-04-4519; Marino S, 2000, GENE DEV, V14, P994; Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705; Packer L, 2006, CARCINOGENESIS, V27, P1778, DOI 10.1093/carcin/bgl016; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Rubin MA, 2008, MODERN PATHOL, V21, pS44, DOI 10.1038/modpathol.2008.11; Sboner A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-8; Shi XM, 2001, J BIOL CHEM, V276, P850, DOI 10.1074/jbc.M005955200; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Trotman LC, 2003, PLOS BIOL, V1, P385, DOI 10.1371/journal.pbio.0000059; Walsh PC, 2007, NEW ENGL J MED, V357, P2696, DOI 10.1056/NEJMcp0706784; Wang SY, 2003, CANCER CELL, V4, P209, DOI 10.1016/S1535-6108(03)00215-0; Wang YZ, 2001, CANCER RES, V61, P6064; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zeng L, 2004, HUM PATHOL, V35, P290, DOI 10.1016/j.humpath.2003.11.001; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	33	373	389	3	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					269	+		10.1038/nature09677	http://dx.doi.org/10.1038/nature09677			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21289624	Green Accepted			2022-12-28	WOS:000287144200046
J	Shapiro, ND; Rauniyar, V; Hamilton, GL; Wu, J; Toste, FD				Shapiro, Nathan D.; Rauniyar, Vivek; Hamilton, Gregory L.; Wu, Jeffrey; Toste, F. Dean			Asymmetric additions to dienes catalysed by a dithiophosphoric acid	NATURE			English	Article							O,O-DIETHYLDITHIOPHOSPHORIC ACID; PHOSPHORIC-ACID; HYDROAMINATION; ALKENES	Chiral Bronsted acids (proton donors) have been shown to facilitate a broad range of asymmetric chemical transformations under catalytic conditions without requiring additional toxic or expensive metals(1-8). Although the catalysts developed thus far are remarkably effective at activating polarized functional groups, it is not clear whether organic Bronsted acids can be used to catalyse highly enantioselective transformations of unactivated carbon-carbon multiple bonds. This deficiency persists despite the fact that racemic acid-catalysed 'Markovnikov' additions to alkenes are well known chemical transformations. Here we show that chiral dithiophosphoric acids can catalyse the intramolecular hydroamination and hydroarylation of dienes and allenes to generate heterocyclic products in exceptional yield and enantiomeric excess. We present a mechanistic hypothesis that involves the addition of the acid catalyst to the diene, followed by nucleophilic displacement of the resulting dithiophosphate intermediate; we also report mass spectroscopic and deuterium labelling studies in support of the proposed mechanism. The catalysts and concepts revealed in this study should prove applicable to other asymmetric functionalizations of unsaturated systems.	[Shapiro, Nathan D.; Rauniyar, Vivek; Hamilton, Gregory L.; Wu, Jeffrey; Toste, F. Dean] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Toste, FD (corresponding author), Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA.	fdtoste@berkeley.edu	Toste, F. Dean/Y-2556-2019	Toste, F. Dean/0000-0001-8018-2198	Office of Science of the US Department of Energy [DE-AC02-05CH11231]; NIHGMS [R01 GM074774]; Natural Sciences and Engineering Research Council of Canada (NSERC); Bristol-Myers/Squibb; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074774] Funding Source: NIH RePORTER	Office of Science of the US Department of Energy(United States Department of Energy (DOE)); NIHGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Bristol-Myers/Squibb(Bristol-Myers Squibb); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to D. Benitez and E. Tkatchouk (Goddard Group, California Institute of Technology) for performing DFT calculations, to U. Anderson and T. Iavarone of the QB3/Chemistry Mass Spectrometry Facility, and to A. DiPasquale of the X-ray Crystallography Facility. We acknowledge funding from the Director, Office of Science of the US Department of Energy (contract no. DE-AC02-05CH11231) and from NIHGMS (R01 GM074774). V. R. is grateful for a Natural Sciences and Engineering Research Council of Canada (NSERC) postdoctoral fellowship. G. L. H. is grateful for a Bristol-Myers/Squibb graduate fellowship.	Ackermann L, 2008, SYNLETT, P995, DOI 10.1055/s-2008-1072505; Aillaud I, 2007, DALTON T, P5105, DOI 10.1039/b711126f; Akiyama T, 2004, ANGEW CHEM INT EDIT, V43, P1566, DOI 10.1002/anie.200353240; Akiyama T, 2007, CHEM REV, V107, P5744, DOI 10.1021/cr068374j; Borrmann T, 1996, LIEBIGS ANN, P1593; Cheng XC, 2008, BIOORGAN MED CHEM, V16, P7932, DOI 10.1016/j.bmc.2008.07.073; Cheon CH, 2008, J AM CHEM SOC, V130, P9246, DOI 10.1021/ja8041542; Garcia-Garcia P, 2009, ANGEW CHEM INT EDIT, V48, P4363, DOI 10.1002/anie.200901768; Hatano M, 2008, J AM CHEM SOC, V130, P16858, DOI 10.1021/ja806875c; HOUK KN, 1983, J MOL STRUC-THEOCHEM, V12, P197, DOI 10.1016/0166-1280(83)85020-9; Hultzsch KC, 2005, ORG BIOMOL CHEM, V3, P1819, DOI 10.1039/b418521h; Hultzsch KC, 2005, ADV SYNTH CATAL, V347, P367, DOI 10.1002/adsc.200404261; KABACHNIK MI, 1960, TETRAHEDRON, V9, P10, DOI 10.1016/0040-4020(60)80048-8; Leavitt CM, 2008, INORG CHEM, V47, P3056, DOI 10.1021/ic7020897; Li ZG, 2006, ORG LETT, V8, P4175, DOI 10.1021/ol0610035; Liu C, 2007, ORG LETT, V9, P1935, DOI 10.1021/ol070483c; MacMillan DWC, 2008, NATURE, V455, P304, DOI 10.1038/nature07367; MASTRYUKOVA TA, 1971, ZH OBSHCH KHIM+, V41, P1938; MEBAH JMN, 1992, PHOSPHORUS SULFUR, V73, P49, DOI 10.1080/10426509208034430; MUELLER WH, 1966, J ORG CHEM, V31, P1894, DOI 10.1021/jo01344a051; Mutel V., 2005, European patent, Patent No. [1,299 383, 1299383]; Nakashima D, 2006, J AM CHEM SOC, V128, P9626, DOI 10.1021/ja062508t; NORMAN GR, 1952, J AM CHEM SOC, V74, P161, DOI 10.1021/ja01121a040; OBUSHAK ND, 1987, ZH OBSHCH KHIM+, V57, P1078; Pousse G, 2009, TETRAHEDRON, V65, P10617, DOI 10.1016/j.tet.2009.10.068; Roesky PW, 2003, ANGEW CHEM INT EDIT, V42, P2708, DOI 10.1002/anie.200301637; Rosenfeld DC, 2006, ORG LETT, V8, P4179, DOI 10.1021/ol061174+; Schlummer B, 2002, ORG LETT, V4, P1471, DOI 10.1021/ol025659j; Terada M, 2008, CHEM COMMUN, P4097, DOI 10.1039/b807577h; Uraguchi D, 2004, J AM CHEM SOC, V126, P5356, DOI 10.1021/ja0491533	30	150	150	2	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					245	+		10.1038/nature09723	http://dx.doi.org/10.1038/nature09723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	718RQ	21307938	Green Accepted, Green Submitted			2022-12-28	WOS:000287144200041
J	Miller, FG; Joffe, S				Miller, Franklin G.; Joffe, Steven			Equipoise and the Dilemma of Randomized Clinical Trials	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							METASTATIC COLORECTAL-CANCER; ESTROGEN PLUS PROGESTIN; THERAPEUTIC MISCONCEPTION; 1ST-LINE CHEMOTHERAPY; RESPONSE RATES; BREAST-CANCER; SURVIVAL; BENEFIT; MELANOMA; ETHICS		[Miller, Franklin G.] NIH, Dept Bioeth, Ctr Clin, Bethesda, MD 20892 USA; [Joffe, Steven] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Joffe, Steven] Childrens Hosp, Dept Med, Boston, MA 02115 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital	Miller, FG (corresponding author), NIH, Dept Bioeth, Ctr Clin, Bldg 10, Bethesda, MD 20892 USA.		Joffe, Steven/H-3941-2019	Joffe, Steven/0000-0002-0667-7384				Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; BERENSON A, 2006, NY TIMES        0215; Bruzzi P, 2005, J CLIN ONCOL, V23, P5117, DOI 10.1200/JCO.2005.02.106; Buchanan D, 2005, KENNEDY INST ETHIC J, V15, P161, DOI 10.1353/ken.2005.0010; Buyse M, 2000, LANCET, V356, P373, DOI 10.1016/S0140-6736(00)02528-9; Dedes KJ, 2009, EUR J CANCER, V45, P1397, DOI 10.1016/j.ejca.2008.12.016; ECHT DS, 1991, NEW ENGL J MED, V324, P781, DOI 10.1056/NEJM199103213241201; EINHORN LH, 1977, ANN INTERN MED, V87, P293, DOI 10.7326/0003-4819-87-3-293; Emanuel EJ, 2000, JAMA-J AM MED ASSOC, V283, P2701, DOI 10.1001/jama.283.20.2701; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; GIFFORD F, 1995, BIOETHICS, V9, P127, DOI 10.1111/j.1467-8519.1995.tb00306.x; GIFFORD F, 1986, J MED PHILOS, V11, P347, DOI 10.1093/jmp/11.4.347; Harmon A., 2010, NY TIMES 0918, pA1; Joffe S, 2008, HASTINGS CENT REP, V38, P30, DOI 10.1353/hcr.2008.0019; Johnson KR, 2006, LANCET ONCOL, V7, P741, DOI 10.1016/S1470-2045(06)70800-2; LEAVINGTHERAPYT.MD, 1983, Hastings Cent Rep, V13, P40; Livingstone E, 2010, EXPERT OPIN INV DRUG, V19, P1439, DOI 10.1517/13543784.2010.527945; Lui P, 2007, CANCER TREAT REV, V33, P665, DOI 10.1016/j.ctrv.2007.06.004; Manson JE, 2003, NEW ENGL J MED, V349, P523, DOI 10.1056/NEJMoa030808; Miller FG, 2003, NEW ENGL J MED, V348, P1383, DOI 10.1056/NEJMsb030228; Miller FG, 2003, HASTINGS CENT REP, V33, P19, DOI 10.2307/3528434; Miller FG, 2008, CLIN TRIALS, V5, P617, DOI 10.1177/1740774508097576; MISHRA R, 2004, BOSTON GLOBE    0701, pA1; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Moseley JB, 2002, NEW ENGL J MED, V347, P81, DOI 10.1056/NEJMoa013259; Pazdur R, 2000, J NATL CANCER I, V92, P1552, DOI 10.1093/jnci/92.19.1552; Rettig R. A., 2007, FALSE HOPE BONE MARR; Richardson PG, 2003, NEW ENGL J MED, V348, P2609, DOI 10.1056/NEJMoa030288; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Shanafelt TD, 2004, J CLIN ONCOL, V22, P1966, DOI 10.1200/JCO.2004.08.176; Stadtmauer EA, 2000, NEW ENGL J MED, V342, P1069, DOI 10.1056/NEJM200004133421501; Tang PA, 2007, J CLIN ONCOL, V25, P4562, DOI 10.1200/JCO.2006.08.1935; Tsimberidou AM, 2009, J CLIN ONCOL, V27, P6243, DOI 10.1200/JCO.2009.23.6018; Wilcox RA, 2008, J CLIN ONCOL, V26, P18, DOI 10.1200/JCO.2007.13.6259	35	116	116	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2011	364	5					476	480		10.1056/NEJMsb1011301	http://dx.doi.org/10.1056/NEJMsb1011301			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715LL	21288100				2022-12-28	WOS:000286885900016
J	Xian, Y; Holloway, RG; Noyes, K; Shah, MN; Friedman, B				Xian, Ying; Holloway, Robert G.; Noyes, Katia; Shah, Manish N.; Friedman, Bruce			Racial Differences in Mortality Among Patients With Acute Ischemic Stroke An Observational Study	ANNALS OF INTERNAL MEDICINE			English	Article							COMORBIDITY ADJUSTMENT; TREATMENT INTENSITY; HOSPITAL MORTALITY; CARE; END; DISPARITIES; POPULATION; ADMISSION; SURVIVAL; OUTCOMES	Background: Black patients are commonly believed to have higher stroke mortality. However, several recent studies have reported better survival in black patients with stroke. Objective: To examine racial differences in stroke mortality and explore potential reasons for these differences. Design: Observational cohort study. Setting: 164 hospitals in New York. Participants: 5319 black and 18 340 white patients aged 18 years or older who were hospitalized with acute ischemic stroke between January 2005 and December 2006. Measurements: Influence of race on mortality, examined by using propensity score analysis. Secondary outcomes were selected aspects of end-of-life treatment, use of tissue plasminogen activator, hospital spending, and length of stay. Patients were followed for mortality for 1 year after admission. Results: Overall in-hospital mortality was lower for black patients than for white patients (5.0% vs. 7.4%; P < 0.001), as was all-cause mortality at 30 days (6.1% vs. 11.4%; P < 0.001) and 1 year (16.5% vs. 24.4%; P < 0.001). After propensity score adjustment, black race was independently associated with lower inhospital mortality (odds ratio [OR], 0.77 [95% CI, 0.61 to 0.98]) and all-cause mortality up to 1 year (OR, 0.86 [CI, 0.77 to 0.96]). The adjusted hazard ratio was 0.87 (CI, 0.79 to 0.96). After adjustment for the probability of dying in the hospital, black patients with stroke were more likely to receive life-sustaining interventions (OR, 1.22 [CI, 1.09 to 1.38]) but less likely to be discharged to hospice (OR, 0.25 [CI, 0.14 to 0.46]). Limitations: The study used hospital administrative data that lacked a stroke severity measure. The study design precluded determination of causality. Conclusion: Among patients with acute ischemic stroke, black patients had lower mortality than white patients. This could be the result of differences in receipt of life-sustaining interventions and end-of-life care.	[Holloway, Robert G.] Univ Rochester, Dept Neurol, Sch Med & Dent, Rochester, NY 14642 USA; Duke Clin Res Inst, Durham, NC USA	University of Rochester; Duke University	Holloway, RG (corresponding author), Univ Rochester, Dept Neurol, Sch Med & Dent, 601 Elmwood Ave,Box 673, Rochester, NY 14642 USA.	Robert_Holloway@URMC.Rochester.edu	Xian, Ying/O-1956-2019	Shah, Manish/0000-0001-6331-1074; Xian, Ying/0000-0002-1237-1162	American Heart Association [0815772D]; National Center for Research Resources; National Institutes of Health (NIH) and the NIH Roadmap for Medical Research [1 UL1 RR024160-01]; Paul B. Beeson Career Development Award [NIA 1K23AG028942]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG028942] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health (NIH) and the NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Paul B. Beeson Career Development Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	By an American Heart Association Founders Affiliate Predoctoral Fellowship Award (0815772D) (Dr. Xian); the National Center for Research Resources, a component of the National Institutes of Health (NIH) and the NIH Roadmap for Medical Research (1 UL1 RR024160-01) (Drs. Holloway and Noyes); and a Paul B. Beeson Career Development Award (NIA 1K23AG028942) (Dr. Shah).	Bach PB, 2004, JAMA-J AM MED ASSOC, V292, P2765, DOI 10.1001/jama.292.22.2765; Barnato AE, 2007, J GEN INTERN MED, V22, P338, DOI 10.1007/s11606-006-0088-x; Barnato AE, 2010, MED CARE, V48, P125, DOI 10.1097/MLR.0b013e3181c161e4; Barnato AE, 2009, MED CARE, V47, P1098, DOI 10.1097/MLR.0b013e3181993191; Crawley L, 2000, JAMA-J AM MED ASSOC, V284, P2518, DOI 10.1001/jama.284.19.2518; Diringer MN, 2001, CRIT CARE MED, V29, P1792, DOI 10.1097/00003246-200109000-00023; Dupreez AE, 2008, J PALLIAT MED, V11, P1249, DOI 10.1089/jpm.2008.0124; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Ellis C, 2009, ETHNIC DIS, V19, P161; Epstein RM, 2010, HEALTH AFFAIR, V29, P1489, DOI 10.1377/hlthaff.2009.0888; Feng WW, 2009, STROKE, V40, P3096, DOI 10.1161/STROKEAHA.109.554535; Gillum RF, 1996, NEW ENGL J MED, V335, P1597, DOI 10.1056/NEJM199611213352110; Gillum RF, 1999, STROKE, V30, P1711, DOI 10.1161/01.STR.30.8.1711; Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c; Gorelick PB, 1998, STROKE, V29, P2656, DOI 10.1161/01.STR.29.12.2656; Griswold ME, 2010, ANN INTERN MED, V152, P393, DOI 10.7326/0003-4819-152-6-201003160-00010; Holloway RG, 2007, JAMA-J AM MED ASSOC, V298, P802, DOI 10.1001/jama.298.7.802; Holloway RG, 2010, J PALLIAT MED, V13, P407, DOI 10.1089/jpm.2009.0278; Iezzoni LI, 1996, MED DECIS MAKING, V16, P348, DOI 10.1177/0272989X9601600405; JENCKS SF, 1988, JAMA-J AM MED ASSOC, V260, P2240, DOI 10.1001/jama.260.15.2240; Johnston SC, 2001, STROKE, V32, P1061, DOI 10.1161/01.STR.32.5.1061; Jones MR, 2000, STROKE, V31, P563, DOI 10.1161/01.STR.31.3.563; Kelly A, 2008, STROKE, V39, P3367, DOI 10.1161/STROKEAHA.108.518738; Kissela B, 2004, STROKE, V35, P426, DOI 10.1161/01.STR.0000110982.74967.39; Kleindorfer D, 2006, STROKE, V37, P2473, DOI 10.1161/01.STR.0000242766.65550.92; KUHLEMEIER KV, 1994, STROKE, V25, P2126, DOI 10.1161/01.STR.25.11.2126; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Loggers ET, 2009, J CLIN ONCOL, V27, P5559, DOI 10.1200/JCO.2009.22.4733; OBRIEN LA, 1995, JAMA-J AM MED ASSOC, V274, P1775, DOI 10.1001/jama.274.22.1775; Pathak EB, 2009, NEUROEPIDEMIOLOGY, V32, P302, DOI 10.1159/000208795; Petty GW, 2000, STROKE, V31, P1062, DOI 10.1161/01.STR.31.5.1062; Polsky D, 2008, HEALTH SERV RES, V43, P1388, DOI 10.1111/j.1475-6773.2008.00837.x; Polsky D, 2007, MED CARE, V45, P1083, DOI 10.1097/MLR.0b013e3180ca960e; Rosenberg AL, 2003, ANN INTERN MED, V138, P882, DOI 10.7326/0003-4819-138-11-200306030-00009; Rubin DB, 1997, ANN INTERN MED, V127, P757, DOI 10.7326/0003-4819-127-8_Part_2-199710151-00064; Sacco RL, 2001, STROKE, V32, P1725, DOI 10.1161/01.STR.32.8.1725; Schwamm LH, 2010, CIRCULATION, V121, P1492, DOI 10.1161/CIRCULATIONAHA.109.881490; Stukenborg GJ, 2007, CIRCULATION, V116, P2960, DOI 10.1161/CIRCULATIONAHA.107.712323; Tuhrim Stanley, 2008, J Stroke Cerebrovasc Dis, V17, P226, DOI 10.1016/j.jstrokecerebrovasdis.2008.02.003; Volpp KG, 2007, HEALTH SERV RES, V42, P1613, DOI 10.1111/j.1475-6773.2006.00688.x; Wolfe CDA, 2005, BMJ-BRIT MED J, V331, P431, DOI 10.1136/bmj.38510.458218.8F; Zahuranec DB, 2007, NEUROLOGY, V68, P1651, DOI 10.1212/01.wnl.0000261906.93238.72; Zhu HF, 2008, NEUROLOGY, V71, P283, DOI 10.1212/01.wnl.0000318278.41347.94	45	42	42	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2011	154	3					152	+		10.7326/0003-4819-154-3-201102010-00004	http://dx.doi.org/10.7326/0003-4819-154-3-201102010-00004			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	713HY	21282694	Green Accepted			2022-12-28	WOS:000286729200002
J	Healey, F; Darowski, A; Lamont, T; Panesar, S; Poulton, S; Treml, J; Wiese, M				Healey, Frances; Darowski, Adam; Lamont, Tara; Panesar, Sukhmeet; Poulton, Susan; Treml, Jonathan; Wiese, Martin			Safety Alerts Essential care after an inpatient fall: summary of a safety report from the National Patient Safety Agency	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HOSPITALS		[Healey, Frances; Lamont, Tara; Panesar, Sukhmeet] Natl Patient Safety Agcy, London W1T 5HD, England; [Darowski, Adam] John Radcliffe Hosp, Oxford OX3 9DU, England; [Poulton, Susan] Queen Alexandra Hosp, Portsmouth PO6 3LY, Hants, England; [Treml, Jonathan] Queen Elizabeth Hosp, Univ Hosp Birmingham NHS Fdn Trust, Birmingham B15 2WB, W Midlands, England; [Wiese, Martin] Leicester Royal Infirm, Leicester LE1 5WW, Leics, England	University of Oxford; Portsmouth Hospitals NHS Trust; Queen Alexandra Hospital; University of Birmingham; University of Leicester	Healey, F (corresponding author), Natl Patient Safety Agcy, London W1T 5HD, England.							British Orthopaedic Association British Geriatric Society, 2007, BLUE BOOK GUID TREAT; National Institute for Health and Clinical Excellence, 2007, 56 NAT I HLTH CLIN E; National Patient Safety Agency, 2010, SLIPS TRIPS FALLS DA; National Patient Safety Agency, 2010, NPSA2011RRR001; Oliver D, 2010, CLIN GERIATR MED, V26, P645, DOI 10.1016/j.cger.2010.06.005; Patient Safety First, 2009, GUID RED HARM FALLS; Sari ABA, 2007, BMJ-BRIT MED J, V334, P79, DOI 10.1136/bmj.39031.507153.AE; Wiese MF, 2003, BMJ-BRIT MED J, V327, P782, DOI 10.1136/bmj.327.7418.782; Youde J, 2009, INJURY, V40, P1226, DOI 10.1016/j.injury.2009.06.167	9	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 28	2011	342								d329	10.1136/bmj.d329	http://dx.doi.org/10.1136/bmj.d329			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	715MR	21278215				2022-12-28	WOS:000286889100002
J	Bell, KJL; Kirby, A; Hayen, A; Irwig, L; Glasziou, P				Bell, Katy J. L.; Kirby, Adrienne; Hayen, Andrew; Irwig, Les; Glasziou, Paul			Monitoring adherence to drug treatment by using change in cholesterol concentration: secondary analysis of trial data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ELDERLY PATIENTS; STATIN THERAPY; HEART-DISEASE; MEDICATION; DETECT	Objective To estimate the accuracy of monitoring cholesterol concentration for detecting non-adherence to lipid lowering treatment. Design Secondary analysis of data on cholesterol concentration in the LIPID (long term intervention with pravastatin in ischaemic disease) study by using three measures of non-adherence: discontinuation of treatment, allocation to placebo arm, less than 80% of pills taken. Setting Randomised placebo controlled trial in Australia and New Zealand. Participants 9014 patients with previous coronary heart disease. Interventions Pravastatin 40 mg or placebo daily. Main outcome measures Sensitivity, specificity, area under the receiver operating characteristics (ROC) curve, post-test probability. Results Monitoring of cholesterol concentration had modest ability for detecting complete non-adherence. One year after the start of treatment, half (1957/3937) of the non-adherent patients and 6% (253/3944) of adherent patients had a rise in concentration of low density lipoprotein cholesterol. Accuracy was reasonable (area under the curve 0.89). Cholesterol monitoring, however, had weak ability for detecting partial non-adherence. One year after the start of treatment, 16%(34/213) of partially adherent and 4% (155/3585) of fully adherent patients had a rise in concentration of low density lipoprotein cholesterol. Accuracy was poor (area under the curve 0.65). For typical pre-test probabilities of non-adherence ranging from low (25%) to high (75%), the post-test probabilities indicate continuing uncertainty after lipid testing. A patient with no change in low density lipoprotein cholesterol concentration has a post-test probability of being completely non-adherent of between 67% and 95% and a post-test probability of being partially non-adherent of between 48% and 89%. A patient with a decrease in concentration of 1.0 mmol/L has a post-test probability of being completely non-adherent of between 7% and 40% and a post-test probability of being partially non-adherent of between 21% and 71%. Conclusions Monitoring concentration of low density lipoprotein (or total) cholesterol has modest ability to detect complete non-adherence or non-persistence with pravastatin treatment and weak ability to detect partial non-adherence. Results of monitoring should be considered as no more than an adjunct to careful discussion with patients about adherence.	[Bell, Katy J. L.; Hayen, Andrew; Irwig, Les] Univ Sydney, Sch Publ Hlth, STEP, Sydney, NSW 2006, Australia; [Kirby, Adrienne] Univ Sydney, NHMRC Clin Trials Ctr, Sydney, NSW 2006, Australia; [Glasziou, Paul] Bond Univ, Ctr Res Evidence Based Practice, Southport, Qld 4229, Australia	University of Sydney; University of Sydney; Bond University	Hayen, A (corresponding author), Univ Sydney, Sch Publ Hlth, STEP, Sydney, NSW 2006, Australia.	andrew.hayen@sydney.edu.au	Bell, Katy/B-9650-2013; Glasziou, Paul/A-7832-2008	Bell, Katy/0000-0002-0137-3218; Glasziou, Paul/0000-0001-7564-073X; Hayen, Andrew/0000-0003-4046-8030	Australian National Health and Medical Research Council [402764]; Bristol-Myers Squibb Pharmaceutical Research Institute; National Heart Foundation of Australia	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Bristol-Myers Squibb Pharmaceutical Research Institute(Bristol-Myers Squibb); National Heart Foundation of Australia(National Heart Foundation of Australia)	The authors have received funding from the Australian National Health and Medical Research Council (Program Grant No 402764). The LIPID trial was supported by a grant from the Bristol-Myers Squibb Pharmaceutical Research Institute and conducted under the auspices of the National Heart Foundation of Australia. The funders had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript.	Armitage J, 2007, LANCET, V370, P1781, DOI 10.1016/S0140-6736(07)60716-8; Bell KJL, 2008, BMJ-BRIT MED J, V336, P361, DOI 10.1136/bmj.39476.623611.25; Benner JS, 2005, AM J HEALTH-SYST PH, V62, P1468, DOI 10.2146/ajhp040419; Benner JS, 2002, JAMA-J AM MED ASSOC, V288, P455, DOI 10.1001/jama.288.4.455; Glasziou P, 2005, BMJ-BRIT MED J, V330, P644, DOI 10.1136/bmj.330.7492.644; Glasziou PP, 2008, ANN INTERN MED, V148, P656, DOI 10.7326/0003-4819-148-9-200805060-00005; HAYNES RB, 1980, GERIATRICS, V35, P91; HAYNES RB, 1980, HYPERTENSION, V2, P757, DOI 10.1161/01.HYP.2.6.757; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; KINLAY S, 1990, BRIT MED J, V300, P1545, DOI 10.1136/bmj.300.6739.1545; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; National Cholesterol Education Program (NCEP), 2002, CIRCULATION, V106, P3143; [National Heart Foundation of Australia Cardiac Society of Australia and New Zealand], 2005, POS STAT LIP MAN 200; National Institute for Health and Clinical Excellence, 2009, LIP MOD PRIM SEC CVD; Osterberg L, 2005, NEW ENGL J MED, V353, P487, DOI 10.1056/NEJMra050100; Schedlbauer A, 2004, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD004371.PUB2; Strychar IM, 1998, AM J PREV MED, V14, P103, DOI 10.1016/S0749-3797(97)00022-6; Takahashi O, 2010, HEART, V96, P448, DOI 10.1136/hrt.2009.172619; Tonkin A, 1998, NEW ENGL J MED, V339, P1349; Weymiller AJ, 2007, ARCH INTERN MED, V167, P1076, DOI 10.1001/archinte.167.10.1076	21	12	13	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2011	342								d12	10.1136/bmj.d12	http://dx.doi.org/10.1136/bmj.d12			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711PJ	21257657	Green Submitted, hybrid			2022-12-28	WOS:000286603600001
J	Benham, L; Guo, L; Turner, R				Benham, Laura; Guo, Lin; Turner, Richard			What is publication? The case of eltrombopag	LANCET			English	Editorial Material									[Benham, Laura; Guo, Lin; Turner, Richard] The Lancet, London NW1 7BY, England		Benham, L (corresponding author), The Lancet, London NW1 7BY, England.							Cheng G, 2011, LANCET, V377, P393, DOI 10.1016/S0140-6736(10)60959-2; Kuter DJ, 2008, LANCET, V371, P395, DOI 10.1016/S0140-6736(08)60203-2	2	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2011	377	9763					360	361		10.1016/S0140-6736(11)60024-X	http://dx.doi.org/10.1016/S0140-6736(11)60024-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	721ES	21277427				2022-12-28	WOS:000287337000007
J	Hoshino, I; Yokota, H; Fukunaga, T; Isozaki, Y				Hoshino, Isamu; Yokota, Hajime; Fukunaga, Toru; Isozaki, Yuka			Corkscrew oesophagus on virtual endoscopy	LANCET			English	Editorial Material									[Hoshino, Isamu; Fukunaga, Toru; Isozaki, Yuka] Numazu City Hosp, Dept Surg, Numazu, Shizuoka 4100302, Japan; [Yokota, Hajime] Numazu City Hosp, Dept Radiol, Numazu, Shizuoka 4100302, Japan		Hoshino, I (corresponding author), Numazu City Hosp, Dept Surg, Higashi Shiji 550, Numazu, Shizuoka 4100302, Japan.	i_hosino@yahoo.co.jp	Yokota, Hajime/ABI-7913-2020						0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 19	2011	377	9766					667	667		10.1016/S0140-6736(10)60675-7	http://dx.doi.org/10.1016/S0140-6736(10)60675-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	727DB	21315439	Bronze			2022-12-28	WOS:000287776600036
J	Pogach, L; Aron, DC				Pogach, Leonard; Aron, David C.			Sudden Acceleration of Diabetes Quality Measures	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MELLITUS		[Aron, David C.] Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Educ Off 14W, Cleveland, OH 44106 USA; [Pogach, Leonard] Vet Affairs New Jersey Healthcare Syst, E Orange, NJ USA; [Pogach, Leonard] Univ Med & Dent New Jersey, New Jersey Med Sch, Newark, NJ USA; [Aron, David C.] Case Western Reserve Univ, Cleveland, OH 44106 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Case Western Reserve University	Aron, DC (corresponding author), Louis Stokes Cleveland Dept Vet Affairs Med Ctr, Educ Off 14W, 10701 E Blvd, Cleveland, OH 44106 USA.	david.aron@va.gov						Kerr EA, 2008, ASSESSING QUALITY CA; [Anonymous], 2010, AL FORC MINN COMM SN; Aron D, 2009, JAMA-J AM MED ASSOC, V301, P210, DOI 10.1001/jama.2008.930; Bridges to Excellence (BTE), 2010, BRIDG EXC BTE; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; DeBord M, 2010, NY TIMES        0205; Ginsberg HN, 2010, NEW ENGL J MED, V362, P1563, DOI 10.1056/NEJMoa1001282; Pogach L, 2007, JAMA-J AM MED ASSOC, V297, P520, DOI 10.1001/jama.297.5.520	8	32	33	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2011	305	7					709	710		10.1001/jama.2011.153	http://dx.doi.org/10.1001/jama.2011.153			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721NH	21325188				2022-12-28	WOS:000287361100023
J	Grubina, R; Smith, SA				Grubina, Rozalina; Smith, Steven A.			Severe hypoglycemia was associated with increased risk for adverse clinical outcomes in type 2 diabetes	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Grubina, Rozalina; Smith, Steven A.] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Grubina, R (corresponding author), Mayo Clin, Rochester, MN 55905 USA.		Smith, Steven/HDM-9496-2022					[Anonymous], 2010, DIABETES CARE S1, V33, pS4, DOI DOI 10.2337/DC10-S004; Bonds DE, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b4909; Miller ME, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5444	3	0	0	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4							JC2-13	10.7326/0003-4819-154-4-201102150-02013	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-02013			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720VF	21320928				2022-12-28	WOS:000287310000012
J	Qaseem, A; Humphrey, LL; Chou, R; Snow, V; Shekelle, P				Qaseem, Amir; Humphrey, Linda L.; Chou, Roger; Snow, Vincenza; Shekelle, Paul		Amer Coll Phys	Use of Intensive Insulin Therapy for the Management of Glycemic Control in Hospitalized Patients: A Clinical Practice Guideline From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED CONTROLLED-TRIAL; GLUCOSE-INSULIN; DIABETES-MELLITUS; CARDIAC-SURGERY; ISCHEMIC-STROKE; HYPERGLYCEMIA; HYPOGLYCEMIA; MORTALITY; INFUSION	Description: The American College of Physicians (ACP) developed this guideline to present the evidence for the link between the use of intensive insulin therapy to achieve different glycemic targets and health outcomes in hospitalized patients with or without diabetes mellitus. Methods: Published literature on this topic was identified by using MEDLINE and the Cochrane Library. Additional articles were obtained from systematic reviews and the reference lists of pertinent studies, reviews, and editorials, as well as by consulting experts; unpublished studies on ClinicalTrials.gov were also identified. The literature search included studies published from 1950 through March 2009. Searches were limited to English-language publications. The primary outcomes of interest were short-term mortality and hypoglycemia. This guideline grades the evidence and recommendations by using the ACP clinical practice guidelines grading system. Recommendation 1: ACP recommends not using intensive insulin therapy to strictly control blood glucose in non-surgical intensive care unit (SICU)/medical intensive care unit (MICU) patients with or without diabetes mellitus (Grade: strong recommendation, moderate-quality evidence). Recommendation 2: ACP recommends not using intensive insulin therapy to normalize blood glucose in SICU/MICU patients with or without diabetes mellitus (Grade: strong recommendation, high-quality evidence). Recommendation 3: ACP recommends a target blood glucose level of 7.8 to 11.1 mmol/L (140 to 200 mg/dL) if insulin therapy is used in SICU/MICU patients (Grade: weak recommendation, moderate-quality evidence).	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Pfizer, Collegeville, PA USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Portland VA Med Ctr, Portland, OR USA; W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA	American College of Physicians; Pfizer; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org		Chou, Roger/0000-0001-9889-8610	ACP operating budget; Agency for Healthcare Research and Quality	ACP operating budget; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Financial support for the development of this guideline comes exclusively from the ACP operating budget.; Any financial and nonfinancial conflicts of interest of the group members were declared, discussed, and resolved. Dr. Vincenza Snow was an employee of the American College of Physicians at the time of the writing of this guideline. Dr. Snow: Employment: American College of Physicians, Pfizer. Dr. Shekelle: Grants/grants pending (money to institution): Agency for Healthcare Research and Quality; Royalties: UpToDate. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M10-2725.	Arabi YM, 2008, CRIT CARE MED, V36, P3190, DOI 10.1097/CCM.0b013e31818f21aa; BARCELLOS DS, 2007, REV BRAS CIR CARDIOV, V22, P275; Bilotta F, 2009, ANESTHESIOLOGY, V110, P611, DOI 10.1097/ALN.0b013e318198004b; Bruno A, 2008, STROKE, V39, P384, DOI 10.1161/STROKEAHA.107.493544; Butterworth J, 2005, J THORAC CARDIOV SUR, V130, P1319, DOI 10.1016/j.jtcvs.2005.02.049; Cheung NW, 2006, DIABETES CARE, V29, P765, DOI 10.2337/diacare.29.04.06.dc05-1894; Clement S, 2004, DIABETES CARE, V27, P553, DOI 10.2337/diacare.27.2.553; Datta Swati, 2007, Endocr Pract, V13, P225; de Azevedo JRA, 2007, ARQ NEURO-PSIQUIAT, V65, P733, DOI 10.1590/S0004-282X2007000500001; De la Rosa GD, 2008, CRIT CARE, V12, DOI 10.1186/cc7017; Desouza C, 2003, DIABETES CARE, V26, P1485, DOI 10.2337/diacare.26.5.1485; Dickerson Lori M, 2003, Ann Fam Med, V1, P29, DOI 10.1370/afm.2; Farah R, 2007, ISRAEL MED ASSOC J, V9, P140; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; FISCHER KF, 1986, NEW ENGL J MED, V315, P1245, DOI 10.1056/NEJM198611133152002; Gandhi GY, 2007, ANN INTERN MED, V146, P233, DOI 10.7326/0003-4819-146-4-200702200-00002; Garber AJ, 2006, DIABETES CARE, V29, P1955, DOI 10.2337/dc06-9913; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; Grey Neil J, 2004, Endocr Pract, V10 Suppl 2, P46; Ingels C, 2006, EUR HEART J, V27, P2716, DOI 10.1093/eurheartj/ehi855; Kansagara D, 2008, MANAGEMENT INPATIENT; Kansagara D, 2011, ANN INTERN MED, V154, P268, DOI 10.7326/0003-4819-154-4-201102150-00008; Kirdemir P, 2008, J CARDIOTHOR VASC AN, V22, P383, DOI 10.1053/j.jvca.2007.09.015; Krinsley J, 2007, CHEST, V132, P1, DOI 10.1378/chest.07-0834; Krinsley JS, 2003, MAYO CLIN PROC, V78, P1471, DOI 10.4065/78.12.1471; Lazar HL, 2004, CIRCULATION, V109, P1497, DOI 10.1161/01.CIR.0000121747.71054.79; Levetan CS, 1998, DIABETES CARE, V21, P246, DOI 10.2337/diacare.21.2.246; Li JY, 2006, TEX HEART I J, V33, P445; LINDSTROM T, 1992, DIABETIC MED, V9, P536, DOI 10.1111/j.1464-5491.1992.tb01834.x; Malmberg K, 2005, EUR HEART J, V26, P650, DOI 10.1093/eurheartj/ehi199; MALMBERG K, 1995, J AM COLL CARDIOL, V26, P57, DOI 10.1016/0735-1097(95)00126-K; Meijering S, 2006, CRIT CARE, V10, DOI 10.1186/cc3981; Montori VM, 2005, JAMA-J AM MED ASSOC, V294, P2203, DOI 10.1001/jama.294.17.2203; Nazer Lama H, 2007, Endocr Pract, V13, P137; NEEDHAM P, 2008, P NUTR SOC, V67, pE152; Oksanen T, 2007, INTENS CARE MED, V33, P2093, DOI 10.1007/s00134-007-0876-8; Preiser JC, 2007, INTENS CARE MED, V33, P570, DOI 10.1007/s00134-006-0485-y; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; Rasoul S, 2007, INT J CARDIOL, V122, P52, DOI 10.1016/j.ijcard.2006.11.037; Savioli M, 2009, CRIT CARE MED, V37, P424, DOI 10.1097/CCM.0b013e31819542da; Shilo S, 1998, J AM GERIATR SOC, V46, P978, DOI 10.1111/j.1532-5415.1998.tb02752.x; Smith A, 2002, J CARDIOTHOR VASC AN, V16, P413, DOI 10.1053/jcan.2002.125151; Spyer G, 2000, LANCET, V356, P1970, DOI 10.1016/S0140-6736(00)03322-5; Subramaniam B, 2009, ANESTHESIOLOGY, V110, P970, DOI 10.1097/ALN.0b013e3181a1005b; Svensson AM, 2005, EUR HEART J, V26, P1255, DOI 10.1093/eurheartj/ehi230; Umpierrez GE, 2002, J CLIN ENDOCR METAB, V87, P978, DOI 10.1210/jc.87.3.978; Umpierrez GE, 2007, DIABETES CARE, V30, P2181, DOI 10.2337/dc07-0295; Van den Berghe G, 2006, CRIT CARE MED, V34, P612, DOI 10.1097/01.CCM.0000201408.15502.24; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; Van den Berghe G, 2001, J CLIN ENDOCR METAB, V86, P3217, DOI 10.1210/jc.86.7.3217; Van den Berghe G, 2006, DIABETES, V55, P3151, DOI 10.2337/db06-0855; van der Horst ICC, 2003, J AM COLL CARDIOL, V42, P784, DOI 10.1016/S0735-1097(03)00830-1; Vriesendorp TM, 2006, CRIT CARE MED, V34, P96, DOI 10.1097/01.CCM.0000194536.89694.06; Walters MR, 2006, CEREBROVASC DIS, V22, P116, DOI 10.1159/000093239; Whitmer RA, 2009, JAMA-J AM MED ASSOC, V301, P1565, DOI 10.1001/jama.2009.460; Wilson M, 2007, DIABETES CARE, V30, P1005, DOI 10.2337/dc06-1964; Yang M, 2009, INT J NURS STUD, V46, P753, DOI 10.1016/j.ijnurstu.2009.01.004	59	214	235	0	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4					260	W81		10.7326/0003-4819-154-4-201102150-00007	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-00007			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720VF	21320941				2022-12-28	WOS:000287310000018
J	Seymour, J				Seymour, Jane			Historical keyword Hermaphrodite	LANCET			English	Editorial Material												jane.seymour@ucl.ac.uk							0	1	1	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 12	2011	377	9765					547	547		10.1016/S0140-6736(11)60188-8	http://dx.doi.org/10.1016/S0140-6736(11)60188-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	724DQ	21315935				2022-12-28	WOS:000287556700012
J	Martyn, C				Martyn, Christopher			Out of Hours Lactation wars	BRITISH MEDICAL JOURNAL			English	Editorial Material												cmartyn@bmj.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 9	2011	342								d835	10.1136/bmj.d835	http://dx.doi.org/10.1136/bmj.d835			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	722AZ	21307115				2022-12-28	WOS:000287402900008
J	Hemmelgarn, BR; Moist, LM; Lok, CE; Tonelli, M; Manns, BJ; Holden, RM; LeBlanc, M; Faris, P; Barre, P; Zhang, JG; Scott-Douglas, N				Hemmelgarn, Brenda R.; Moist, Louise M.; Lok, Charmaine E.; Tonelli, Marcello; Manns, Braden J.; Holden, Rachel M.; LeBlanc, Martine; Faris, Peter; Barre, Paul; Zhang, Jianguo; Scott-Douglas, Nairne		Prevention Dialysis Catheter Lumen	Prevention of Dialysis Catheter Malfunction with Recombinant Tissue Plasminogen Activator	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CENTRAL VENOUS CATHETERS; TUNNELED HEMODIALYSIS CATHETERS; TRISODIUM CITRATE 30-PERCENT; VASCULAR ACCESS; PRACTICE PATTERNS; HEPARIN; TRIAL; COMPLICATIONS; PROPHYLAXIS; MORTALITY	BACKGROUND The effectiveness of various solutions instilled into the central venous catheter lumens after each hemodialysis session (catheter locking solutions) to decrease the risk of catheter malfunction and bacteremia in patients undergoing hemodialysis is unknown. METHODS We randomly assigned 225 patients undergoing long-term hemodialysis in whom a central venous catheter had been newly inserted to a catheter-locking regimen of heparin (5000 U per milliliter) three times per week or recombinant tissue plasminogen activator (rt-PA) (1 mg in each lumen) substituted for heparin at the midweek session (with heparin used in the other two sessions). The primary outcome was catheter malfunction, and the secondary outcome was catheter-related bacteremia. The treatment period was 6 months; treatment assignments were concealed from the patients, investigators, and trial personnel. RESULTS A catheter malfunction occurred in 40 of the 115 patients assigned to heparin only (34.8%) and 22 of the 110 patients assigned to rt-PA (20.0%) - an increase in the risk of catheter malfunction by a factor of almost 2 among patients treated with heparin only as compared with those treated with rt-PA once weekly (hazard ratio, 1.91; 95% confidence interval [CI], 1.13 to 3.22; P=0.02). Catheter-related bacteremia occurred in 15 patients (13.0%) assigned to heparin only, as compared with 5 (4.5%) assigned to rt-PA (corresponding to 1.37 and 0.40 episodes per 1000 patient-days in the heparin and rt-PA groups, respectively; P=0.02). The risk of bacteremia from any cause was higher in the heparin group than in the rt-PA group by a factor of 3 (hazard ratio, 3.30; 95% CI, 1.18 to 9.22; P=0.02). The risk of adverse events, including bleeding, was similar in the two groups. CONCLUSIONS The use of rt-PA instead of heparin once weekly, as compared with the use of heparin three times a week, as a locking solution for central venous catheters significantly reduced the incidence of catheter malfunction and bacteremia.	[Hemmelgarn, Brenda R.] Univ Calgary, Foothills Med Ctr, Div Nephrol, Dept Med, Calgary, AB T2N 2T9, Canada; [Hemmelgarn, Brenda R.; Manns, Braden J.; Faris, Peter] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 2T9, Canada; [Hemmelgarn, Brenda R.; Tonelli, Marcello; Manns, Braden J.; Scott-Douglas, Nairne] Univ Alberta, Dept Med, Alberta Kidney Dis Network, Edmonton, AB, Canada; [Faris, Peter] Alberta Hlth Serv, Calgary, AB, Canada; [Moist, Louise M.] Univ Western Ontario, London Hlth Sci Ctr, London, ON, Canada; [Lok, Charmaine E.] Univ Toronto, Toronto Gen Hosp, Univ Hlth Network, Toronto, ON M5G 1L7, Canada; [Holden, Rachel M.] Queens Univ, Dept Med, Kingston, ON K7L 3N6, Canada; [LeBlanc, Martine] Univ Montreal, Dept Med, Hop Maison Neuve Rosemont, Montreal, PQ H3C 3J7, Canada; [Barre, Paul] McGill Univ, Dept Med, Montreal, PQ, Canada	University of Calgary; University of Calgary; University of Alberta; Alberta Health Services (AHS); University of Calgary; London Health Sciences Centre; Western University (University of Western Ontario); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Queens University - Canada; Universite de Montreal; McGill University	Hemmelgarn, BR (corresponding author), Univ Calgary, Foothills Med Ctr, Div Nephrol, Dept Med, 1403 29th St NW, Calgary, AB T2N 2T9, Canada.	brenda.hemmelgarn@albertahealthservices.ca	Faris, Peter/AAJ-3436-2020; Manns, Braden J/I-8942-2012; Tonelli, Marcello/B-3028-2009; Moist, Louise/G-3334-2011; Hemmelgarn, Brenda R./I-6894-2012	Faris, Peter/0000-0001-5208-817X; Tonelli, Marcello/0000-0002-0846-3187; Lok, Charmaine/0000-0001-5365-0064	Hoffmann-La Roche; Alberta Heritage Foundation for Medical Research; Canadian Institutes of Health Research; Amgen; Merck; Abbott Laboratories; Novartis	Hoffmann-La Roche(Hoffmann-La Roche); Alberta Heritage Foundation for Medical Research(Alberta Heritage Foundation for Medical ResearchGeneral Electric); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Amgen(Amgen); Merck(Merck & Company); Abbott Laboratories(Abbott Laboratories); Novartis(Novartis)	Supported by Hoffmann-La Roche. Drs. Hemmelgarn, Manns, and Tonelli were supported by awards from the Alberta Heritage Foundation for Medical Research and the Canadian Institutes of Health Research.; Drs. Hemmelgarn, Manns, Tonelli, Scott-Douglas, and Holden report receiving grant support from Amgen; Drs. Hemmelgarn and Manns, grant support from Merck; Dr. Tonelli, grant support from Abbott Laboratories; and Dr. Scott-Douglas, board membership fees from Amgen and lecture fees and travel expenses from Novartis. No other potential conflict of interest relevant to this article was reported.	Allon M, 2004, AM J KIDNEY DIS, V44, P779, DOI [10.1053/j.ajkd.2004.07.005, 10.1016/S0272-6386(04)01078-9]; Baskin JL, 2009, LANCET, V374, P159, DOI 10.1016/S0140-6736(09)60220-8; Clase CM, 2001, J THROMB THROMBOLYS, V11, P127, DOI 10.1023/A:1011272632286; Collins AJ, 2009, CLIN J AM SOC NEPHRO, V4, pS5, DOI 10.2215/CJN.05980809; Deitcher SR, 2002, J CLIN ONCOL, V20, P317, DOI 10.1200/JCO.20.1.317; Develter W, 2005, ARTIF ORGANS, V29, P399, DOI 10.1111/j.1525-1594.2005.29067.x; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Fellstrom BC, 2010, NEW ENGL J MED, V362, P1450; Hemmelgarn Brenda R, 2006, BMC Nephrol, V7, P8, DOI 10.1186/1471-2369-7-8; Jain G, 2009, CLIN J AM SOC NEPHRO, V4, P1787, DOI 10.2215/CJN.03920609; James MT, 2008, ANN INTERN MED, V148, P596, DOI 10.7326/0003-4819-148-8-200804150-00004; Kalmanti M, 2002, PEDIATR HEMAT ONCOL, V19, P173, DOI 10.1080/088800102753541323; Kethireddy S, 2008, J VASC ACCESS, V9, P51, DOI 10.1177/112972980800900109; Krishnasami Z, 2002, KIDNEY INT, V61, P1136, DOI 10.1046/j.1523-1755.2002.00201.x; Lee T, 2005, AM J KIDNEY DIS, V46, P501, DOI 10.1053/j.ajkd.2005.05.024; Little MA, 2002, AM J KIDNEY DIS, V39, P86, DOI 10.1053/ajkd.2002.29885; Little MA, 2001, NEPHROL DIAL TRANSPL, V16, P2194, DOI 10.1093/ndt/16.11.2194; Macrae Jennifer Marie, 2005, Hemodial Int, V9, P189, DOI 10.1111/j.1492-7535.2005.01131.x; Manns B, 2005, J AM SOC NEPHROL, V16, P201, DOI 10.1681/ASN.2004050355; McGee DC, 2003, NEW ENGL J MED, V348, P1123, DOI 10.1056/NEJMra011883; McIntyre CW, 2004, KIDNEY INT, V66, P801, DOI 10.1111/j.1523-1755.2004.00806.x; Mendelssohn DC, 2006, NEPHROL DIAL TRANSPL, V21, P721, DOI 10.1093/ndt/gfi281; Moist LM, 2008, CLIN J AM SOC NEPHRO, V3, P1726, DOI 10.2215/CJN.01240308; Mokrzycki MH, 2001, KIDNEY INT, V59, P1935, DOI 10.1046/j.1523-1755.2001.0590051935.x; *NAT I DIAB DIG KI, 2003, REN DAT SYST USRDS 2; Ponec D, 2001, J VASC INTERV RADIOL, V12, P951, DOI 10.1016/S1051-0443(07)61575-9; Ponikvar R, 2005, THER APHER DIAL, V9, P250, DOI 10.1111/j.1774-9987.2005.00265.x; Power A, 2009, AM J KIDNEY DIS, V53, P1034, DOI 10.1053/j.ajkd.2009.01.259; Saad TF, 2001, SEMIN DIALYSIS, V14, P446, DOI 10.1046/j.1525-139x.2001.00110.x; Saran R, 2003, KIDNEY INT, V64, P254, DOI 10.1046/j.1523-1755.2003.00064.x; Schenk P, 2000, AM J KIDNEY DIS, V35, P130, DOI 10.1016/S0272-6386(00)70311-8; Solomon LR, 2010, AM J KIDNEY DIS, V55, P1060, DOI 10.1053/j.ajkd.2009.11.025; Stas KJF, 2001, NEPHROL DIAL TRANSPL, V16, P1521, DOI 10.1093/ndt/16.7.1521-a; SWARTZ RD, 1994, J AM SOC NEPHROL, V4, P1719; Trerotola SO, 1997, RADIOLOGY, V203, P489, DOI 10.1148/radiology.203.2.9114110; Tumlin J, 2010, CLIN J AM SOC NEPHRO, V5, P631, DOI 10.2215/CJN.06520909; *VASC ACC WORK GRO, 2006, AM J KIDNEY DIS S, V48, pS248, DOI DOI 10.1053/J.AJKD.2006.04.040.MEDLINE; Weijmer MC, 2005, J AM SOC NEPHROL, V16, P2769, DOI 10.1681/ASN.2004100870; 1997, CAN COMMUN DIS RE S8, V23, P1	39	144	150	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2011	364	4					303	312		10.1056/NEJMoa1011376	http://dx.doi.org/10.1056/NEJMoa1011376			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711LH	21268722	Bronze			2022-12-28	WOS:000286592600005
J	Weatherall, DJ				Weatherall, David J.			Systems Biology and Red Cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Weatherall, David J.] Univ Oxford, Weatherall Inst Mol Med, Oxford, England; [Weatherall, David J.] John Radcliffe Hosp, Oxford OX3 9DU, England	University of Oxford; University of Oxford	Weatherall, DJ (corresponding author), Univ Oxford, Weatherall Inst Mol Med, Oxford, England.							Brenner S, 2010, PHILOS T R SOC B, V365, P207, DOI 10.1098/rstb.2009.0221; Higgins JM, 2010, P NATL ACAD SCI USA, V107, P20587, DOI 10.1073/pnas.1012747107; HORGAN J, 1996, END SCI LIMITS KNOWL; Ntaios G, 2007, ANN HEMATOL, V86, P487, DOI 10.1007/s00277-007-0302-x; WEATHERALL DJ, 2001, THALASSAEMIA SYNDROM, P345	5	14	14	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2011	364	4					376	377		10.1056/NEJMcibr1012683	http://dx.doi.org/10.1056/NEJMcibr1012683			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711LH	21268732				2022-12-28	WOS:000286592600016
J	Lu, JC; Unwin, DM; Deeming, DC; Jin, XS; Liu, YQ; Ji, QA				Lue, Junchang; Unwin, David M.; Deeming, D. Charles; Jin, Xingsheng; Liu, Yongqing; Ji, Qiang			An Egg-Adult Association, Gender, and Reproduction in Pterosaurs	SCIENCE			English	Article							EGGSHELL STRUCTURE; EVOLUTION; ONTOGENY	A sexually mature individual of Darwinopterus preserved together with an egg from the Jurassic of China provides direct evidence of gender in pterosaurs and insights into the reproductive biology of these extinct fliers. This new find and several other examples of Darwinopterus demonstrate that males of this pterosaur had a relatively small pelvis and a large cranial crest, whereas females had a relatively large pelvis and no crest. The ratio of egg mass to adult mass is relatively low, as in extant reptiles, and is comparable to values for squamates. A parchment-like eggshell points to burial and significant uptake of water after oviposition. This evidence for low parental investment contradicts the widespread assumption that reproduction in pterosaurs was like that of birds and shows that it was essentially like that of reptiles.	[Lue, Junchang; Liu, Yongqing; Ji, Qiang] Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China; [Unwin, David M.] Univ Leicester, Sch Museum Studies, Leicester LE1 7LF, Leics, England; [Deeming, D. Charles] Lincoln Univ, Dept Biol Sci, Lincoln LN2 2LG, England; [Jin, Xingsheng] Zhejiang Museum Nat Hist, Hangzhou 310012, Zhejiang, Peoples R China	Chinese Academy of Geological Sciences; University of Leicester; University of Lincoln	Lu, JC (corresponding author), Chinese Acad Geol Sci, Inst Geol, Beijing 100037, Peoples R China.	lujc2008@126.com; dmu1@le.ac.uk		Liu, Yongqing/0000-0002-9131-0172; Deeming, Denis Charles/0000-0002-9587-6149	National Natural Science Foundation of China [40872017, 90914003]; 973 Project [2006CB701405]; Ministry of Science and Technology [J1003, J0703]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 Project(National Basic Research Program of China); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	We thank X. M. Kang (Zhejiang Museum of Natural History, Hangzhou) for access to specimens and G. Birchard for access to his data set on reptile eggs. J.L. and Y.L. were supported by grants from the National Natural Science Foundation of China (40872017 and 90914003), the 973 Project (2006CB701405), and the Basic Outlay of Scientific Research Work from the Ministry of Science and Technology (J1003 and J0703); D.M.U. by the Royal Society and the University of Leicester; and D.C.D by the University of Lincoln.	Barrett Paul M., 2008, Zitteliana Reihe B, V28, P61; Bennett S.C., 1992, Journal of Vertebrate Paleontology, V12, P422; Bennett S. Christopher, 2003, Palaeontologische Zeitschrift, V77, P61; BENNETT SC, 1993, PALEOBIOLOGY, V19, P92, DOI 10.1017/S0094837300012331; BENNETT SC, 1995, J PALEONTOL, V69, P569, DOI 10.1017/S0022336000034946; BRAMWELL CD, 1974, PHILOS T R SOC B, V267, P503, DOI 10.1098/rstb.1974.0007; Chinsamy A, 2008, BIOL LETTERS, V4, P282, DOI 10.1098/rsbl.2008.0004; Chinsamy A, 2009, ANAT REC, V292, P1462, DOI 10.1002/ar.20990; Claessens LPAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004497; Codorniu L, 2004, CAN J EARTH SCI, V41, P9, DOI 10.1139/E03-080; Cogburn Larry A., 2000, P635, DOI 10.1016/B978-012747605-6/50026-2; de Ricqles AJ, 2000, ZOOL J LINN SOC-LOND, V129, P349, DOI 10.1006/zjls.1999.0239; Deeming DC, 2007, J ZOOL, V271, P78, DOI 10.1111/j.1469-7998.2006.00219.x; [段冶 DUAN Ye], 2009, [世界地质, World Geology], V28, P143; Grellet-Tinner Gerald, 2007, Historical Biology, V19, P273, DOI 10.1080/08912960701189800; Kunz Thomas H., 2000, P415, DOI 10.1016/B978-012195670-7/50011-4; Lu Junchang, 2009, Acta Geologica Sinica English Edition, V83, P1; Lu JC, 2010, P ROY SOC B-BIOL SCI, V277, P383, DOI 10.1098/rspb.2009.1603; Martill DM, 2006, PALAEONTOLOGY, V49, P925, DOI 10.1111/j.1475-4983.2006.00575.x; PADIAN K, 1993, AM J SCI, V293A, P91, DOI 10.2475/ajs.293.A.91; SHINE R, 1992, EVOLUTION, V46, P62, DOI 10.1111/j.1558-5646.1992.tb01985.x; Unwin D. M, 2005, PTEROSAURS DEEP TIME; Unwin D. M., 2006, 2005 HEYUAN INT DIN, P141; Unwin David M., 2008, Zitteliana Reihe B, V28, P199; Wang XL, 2004, NATURE, V429, P621, DOI 10.1038/429621a; Wellnhofer P, 1991, ILLUSTRATED ENCY PTE; Xu L., 2010, ACTA GEOSCI SINICA S, V31, P82	27	81	89	2	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					321	324		10.1126/science.1197323	http://dx.doi.org/10.1126/science.1197323			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252343				2022-12-28	WOS:000286636300034
J	Matsumoto, Y; Nakatsuji, S; Kuga, K; Karaki, Y; Horie, N; Shimura, Y; Sakakibara, T; Nevidomskyy, AH; Coleman, P				Matsumoto, Yosuke; Nakatsuji, Satoru; Kuga, Kentaro; Karaki, Yoshitomo; Horie, Naoki; Shimura, Yasuyuki; Sakakibara, Toshiro; Nevidomskyy, Andriy H.; Coleman, Piers			Quantum Criticality Without Tuning in the Mixed Valence Compound beta-YbAlB4	SCIENCE			English	Article							PHASE-TRANSITIONS; CRITICAL-POINTS; HEAVY	Fermi liquid theory, the standard theory of metals, has been challenged by a number of observations of anomalous metallic behavior found in the vicinity of a quantum phase transition. The breakdown of the Fermi liquid is accomplished by fine-tuning the material to a quantum critical point by using a control parameter such as the magnetic field, pressure, or chemical composition. Our high-precision magnetization measurements of the ultrapure f-electron-based superconductor beta-YbAlB4 demonstrate a scaling of its free energy that is indicative of zero-field quantum criticality without tuning in a metal. The breakdown of Fermi liquid behavior takes place in a mixed-valence state, which is in sharp contrast with other known examples of quantum critical f-electron systems that are magnetic Kondo lattice systems with integral valence.	[Matsumoto, Yosuke; Nakatsuji, Satoru; Kuga, Kentaro; Karaki, Yoshitomo; Horie, Naoki; Shimura, Yasuyuki; Sakakibara, Toshiro] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Nevidomskyy, Andriy H.; Coleman, Piers] Rutgers State Univ, Dept Phys & Astron, Ctr Mat Theory, Piscataway, NJ 08854 USA; [Nevidomskyy, Andriy H.] Rice Univ, Dept Phys & Astron, Houston, TX 77005 USA; [Coleman, Piers] Univ London, Dept Phys, Egham TW20 0EX, Surrey, England	University of Tokyo; Rutgers State University New Brunswick; Rice University; University of London; Royal Holloway University London	Nakatsuji, S (corresponding author), Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan.	satoru@issp.u-tokyo.ac.jp; coleman@physics.rutgers.edu	Matsumoto, Yosuke/N-6566-2018	Matsumoto, Yosuke/0000-0001-8522-7113; Nevidomskyy, Andriy/0000-0002-8684-7979; Nakatsuji, Satoru/0000-0001-9134-659X	Japan Society for the Promotion of Science [21684019]; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan [19052003, 20102007, 21102507]; NSF [DMR-NSF-0907179]; Global Centers of Excellence Program, MEXT, Japan; Toray Science and Technology Grant	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NSF(National Science Foundation (NSF)); Global Centers of Excellence Program, MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Toray Science and Technology Grant(Toray Industries, Inc.)	We thank H. Ishimoto, D. E. MacLaughlin, K. Miyake, T. Senthil, Q. Si, T. Tomita, K. Ueda, and S. Watanabe for useful discussions. This work is partially supported by grants-in-aid (21684019) from the Japan Society for the Promotion of Science; by grants-in-aid for Scientific Research on Priority Areas (19052003) and on Innovative Areas (20102007 and 21102507) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; by Global Centers of Excellence Program "the Physical Sciences Frontier," MEXT, Japan; by Toray Science and Technology Grant; and by a grant from NSF DMR-NSF-0907179 (P.C. and A.H.N.). P.C. and A.H.N. acknowledge the hospitality of the Aspen Physics Center.	Bianchi A, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.257001; Coleman P, 2001, J PHYS-CONDENS MAT, V13, pR723, DOI 10.1088/0953-8984/13/35/202; Cornelius AL, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.117201; Custers J, 2003, NATURE, V424, P524, DOI 10.1038/nature01774; DAYBELL MD, 1968, REV MOD PHYS, V40, P380, DOI 10.1103/RevModPhys.40.380; Doiron-Leyraud N, 2003, NATURE, V425, P595, DOI 10.1038/nature01968; Gegenwart P, 2008, NAT PHYS, V4, P186, DOI 10.1038/nphys892; GIAMARCHI T., 2004, INT SERIES MONOGRAPH; Grigera SA, 2001, SCIENCE, V294, P329, DOI 10.1126/science.1063539; Krellner C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.066401; Kuga K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.137004; Lohneysen H. v., 1996, J PHYS CONDENS MATT, V8, P9689; Macaluso RT, 2007, CHEM MATER, V19, P1918, DOI 10.1021/cm062244+; MILLIS AJ, 1993, PHYS REV B, V48, P7183, DOI 10.1103/PhysRevB.48.7183; Moriya T., 1985, SPIN FLUCTUATIONS IT; Nakatsuji S, 2008, NAT PHYS, V4, P603, DOI 10.1038/nphys1002; Nevidomskyy AH, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.147205; Nevidomskyy AH, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.077202; Okawa M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.247201; Paschen S, 2004, NATURE, V432, P881, DOI 10.1038/nature03129; SACHDEV S, 1994, Z PHYS B CON MAT, V94, P469, DOI 10.1007/BF01317409; Schroder A, 2000, NATURE, V407, P351, DOI 10.1038/35030039; Senthil T, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.216403; Senthil T, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.035103; Si QM, 2001, NATURE, V413, P804, DOI 10.1038/35101507; von Lohneysen H, 2007, REV MOD PHYS, V79, P1015, DOI 10.1103/RevModPhys.79.1015; Zhu LJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.066404	27	174	175	1	80	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					316	319		10.1126/science.1197531	http://dx.doi.org/10.1126/science.1197531			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252341	Green Submitted			2022-12-28	WOS:000286636300032
J	Nury, H; Van Renterghem, C; Weng, Y; Tran, A; Baaden, M; Dufresne, V; Changeux, JP; Sonner, JM; Delarue, M; Corringer, PJ				Nury, Hugues; Van Renterghem, Catherine; Weng, Yun; Tran, Alphonso; Baaden, Marc; Dufresne, Virginie; Changeux, Jean-Pierre; Sonner, James M.; Delarue, Marc; Corringer, Pierre-Jean			X-ray structures of general anaesthetics bound to a pentameric ligand-gated ion channel	NATURE			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; MOLECULAR-DYNAMICS; BINDING-SITE; ALLOSTERIC TRANSITIONS; CRYSTAL-STRUCTURES; GLYCINE RECEPTORS; GABA(A) RECEPTORS; HIGH-RESOLUTION; IDENTIFICATION; MODULATION	General anaesthetics have enjoyed long and widespread use but their molecular mechanism of action remains poorly understood. There is good evidence that their principal targets are pentameric ligand-gated ion channels(1,2) (pLGICs) such as inhibitory GABA(A) (gamma-aminobutyric acid) receptors and excitatory nicotinic acetylcholine receptors, which are respectively potentiated and inhibited by general anaesthetics. The bacterial homologue from Gloeobacter violaceus(3) (GLIC), whose X-ray structure was recently solved(4,5), is also sensitive to clinical concentrations of general anaesthetics(6). Here we describe the crystal structures of the complexes propofol/GLIC and desflurane/GLIC. These reveal a common general-anaesthetic binding site, which pre-exists in the apo-structure in the upper part of the transmembrane domain of each protomer. Both molecules establish van der Waals interactions with the protein; propofol binds at the entrance of the cavity whereas the smaller, more flexible, desflurane binds deeper inside. Mutations of some amino acids lining the binding site profoundly alter the ionic response of GLIC to protons, and affect its general-anaesthetic pharmacology. Molecular dynamics simulations, performed on the wild type (WT) and two GLIC mutants, highlight differences in mobility of propofol in its binding site and help to explain these effects. These data provide a novel structural framework for the design of general anaesthetics and of allosteric modulators of brain pLGICs.	[Nury, Hugues; Van Renterghem, Catherine; Dufresne, Virginie; Corringer, Pierre-Jean] Inst Pasteur, Grp Recepteurs Canaux, F-75015 Paris, France; [Nury, Hugues; Van Renterghem, Catherine; Dufresne, Virginie; Changeux, Jean-Pierre; Corringer, Pierre-Jean] CNRS, URA2182, F-75015 Paris, France; [Nury, Hugues; Delarue, Marc] Inst Pasteur, Unite Dynam Struct Macromol, F-75015 Paris, France; [Nury, Hugues; Delarue, Marc] CNRS, URA2185, F-75015 Paris, France; [Weng, Yun; Tran, Alphonso; Sonner, James M.] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Baaden, Marc] CNRS, UPR 9080, Inst Biol Physicochim, F-75005 Paris, France; [Changeux, Jean-Pierre] Coll France, F-75005 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); University of California System; University of California San Francisco; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France	Corringer, PJ (corresponding author), Inst Pasteur, Grp Recepteurs Canaux, F-75015 Paris, France.	delarue@pasteur.fr; pjcorrin@pasteur.fr	Baaden, Marc/C-6623-2008	Baaden, Marc/0000-0001-6472-0486; Nury, Hugues/0000-0002-3433-256X	Commission of the European Communities; Louis D. Foundation of the Institut de France; Network of European Neuroscience Institutes (ENI-NET); National Institutes of Health [NIGMS R01 GM069379]; Grand Equipement National de Calcul Intensif, Institut du Developpement et des Ressources en Informatique Scientifique (GENCI-IDRIS) [2009-072292]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069379] Funding Source: NIH RePORTER	Commission of the European Communities(European Commission); Louis D. Foundation of the Institut de France; Network of European Neuroscience Institutes (ENI-NET); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Grand Equipement National de Calcul Intensif, Institut du Developpement et des Ressources en Informatique Scientifique (GENCI-IDRIS); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Commission of the European Communities (Neurocypres project; to H.N.), the Louis D. Foundation of the Institut de France, the Network of European Neuroscience Institutes (ENI-NET) and a National Institutes of Health grant NIGMS R01 GM069379 (to J.M.S.). We thank J. Brallet for the gift of desflurane, the European Synchrotron Radiation Facility and Soleil staff for assistance during data collection, and G. Brannigan for providing propofol simulation parameters. Simulations were performed using high-performance computing resources from the Grand Equipement National de Calcul Intensif, Institut du Developpement et des Ressources en Informatique Scientifique (GENCI-IDRIS, grant 2009-072292).	Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; BARTH LG, 1959, J EMBRYOL EXP MORPH, V7, P210; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Bhattacharya AA, 2000, J BIOL CHEM, V275, P38731, DOI 10.1074/jbc.M005460200; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bricogne G, 2009, BUSTER VERSION 2 8 0; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; daCosta CJB, 2009, J BIOL CHEM, V284, P33841, DOI 10.1074/jbc.M109.048280; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Davis I. W., 2007, NUCLEIC ACIDS RES, V35, pW375; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; FRANKS NP, 1984, NATURE, V310, P599, DOI 10.1038/310599a0; Haeger S, 2010, NAT STRUCT MOL BIOL, V17, P90, DOI 10.1038/nsmb.1721; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; HUMPHREY W, 1996, J MOL GRAPH MODEL, V14, P33, DOI DOI 10.1016/0263-7855(96)00018-5; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Krause RM, 1998, MOL PHARMACOL, V53, P283, DOI 10.1124/mol.53.2.283; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; KUSANO K, 1982, J PHYSIOL-LONDON, V328, P143, DOI 10.1113/jphysiol.1982.sp014257; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Li GD, 2010, J BIOL CHEM, V285, P8615, DOI 10.1074/jbc.M109.074708; Lobo IA, 2005, INT REV NEUROBIOL, V65, P53, DOI 10.1016/S0074-7742(04)65003-3; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nievas GAF, 2008, J BIOL CHEM, V283, P21478, DOI 10.1074/jbc.M800345200; Nury H, 2010, P NATL ACAD SCI USA, V107, P6275, DOI 10.1073/pnas.1001832107; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; REVAH F, 1991, NATURE, V353, P846, DOI 10.1038/353846a0; RUBIN MM, 1966, J MOL BIOL, V21, P265, DOI 10.1016/0022-2836(66)90097-0; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Taly A, 2009, NAT REV DRUG DISCOV, V8, P733, DOI 10.1038/nrd2927; Trudell JR, 2004, J MOL GRAPH MODEL, V23, P39, DOI 10.1016/j.jmgm.2004.03.004; TUCKERMAN M, 1992, J CHEM PHYS, V97, P1990, DOI 10.1063/1.463137; Vedula LS, 2009, J BIOL CHEM, V284, P24176, DOI 10.1074/jbc.M109.017814; Villmann C, 2009, J NEUROSCI, V29, P2440, DOI 10.1523/JNEUROSCI.4400-08.2009; Violet JM, 1997, ANESTHESIOLOGY, V86, P866, DOI 10.1097/00000542-199704000-00017; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Zhang HM, 2009, FASEB J, V23, P2735, DOI 10.1096/fj.09-129908; Ziebell MR, 2004, J BIOL CHEM, V279, P17640, DOI 10.1074/jbc.M313886200	47	346	348	4	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					428	+		10.1038/nature09647	http://dx.doi.org/10.1038/nature09647			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248852				2022-12-28	WOS:000286385600059
J	Sheikh, M				Sheikh, Mubashar			Commitment and action to boost health workforce	LANCET			English	Editorial Material									WHO, Global Hlth Workforce Alliance, CH-1211 Geneva, Switzerland	World Health Organization	Sheikh, M (corresponding author), WHO, Global Hlth Workforce Alliance, CH-1211 Geneva, Switzerland.	sheikhm@who.int						Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; [Anonymous], 2007, TASK SHIFT GLOB REC; Bhutta ZA, 2010, LANCET, V375, P1137, DOI 10.1016/S0140-6736(10)60450-3; *GLOB HLTH WORKF A, 2008, KAMP DECL AG GLOB AC; Global Health Workforce Alliance, 2010, GLOBAL EXPERIENCE CO; High Level Taskforce on International Innovative Financing for Health Systems, 2009, CONSTR SCAL COSTS; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; United Nations Secretary General, 2010, GLOB STRAT WOM CHILD; WHO, 2010, INCREASING ACCESS TO HEALTH WORKERS IN REMOTE AND RURAL AREAS THROUGH IMPROVED RETENTION: GLOBAL POLICY RECOMMENDATIONS, P1; WHO, 2006, WORK TOG HLTH WORLD; World Health Organization, 2008, MIDL HLTH WORK STAT; World Health Organization, 2010, WHO GLOB COD PRACT I	12	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 7	2012	379	9810					E2	E4		10.1016/S0140-6736(11)60023-8	http://dx.doi.org/10.1016/S0140-6736(11)60023-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	873WC	21269676				2022-12-28	WOS:000298913000002
J	Lara-Tejero, M; Kato, J; Wagner, S; Liu, XY; Galan, JE				Lara-Tejero, Maria; Kato, Junya; Wagner, Samuel; Liu, Xiaoyun; Galan, Jorge E.			A Sorting Platform Determines the Order of Protein Secretion in Bacterial Type III Systems	SCIENCE			English	Article							CULTURED EPITHELIAL-CELLS; SALMONELLA-TYPHIMURIUM; SHIGELLA-FLEXNERI; NEEDLE LENGTH; YERSINIA-ENTEROCOLITICA; HOST-CELLS; INVASION; APPARATUS; ATPASE; TRANSLOCATION	Bacterial type III protein secretion systems deliver effector proteins into eukaryotic cells in order to modulate cellular processes. Central to the function of these protein-delivery machines is their ability to recognize and secrete substrates in a defined order. Here, we describe a mechanism by which a type III secretion system from the bacterial enteropathogen Salmonella enterica serovar Typhimurium can sort its substrates before secretion. This mechanism involves a cytoplasmic sorting platform that is sequentially loaded with the appropriate secreted proteins. The sequential loading of this platform, facilitated by customized chaperones, ensures the hierarchy in type III protein secretion. Given the presence of these machines in many important pathogens, these findings can serve as the bases for the development of novel antimicrobial strategies.	[Lara-Tejero, Maria; Kato, Junya; Wagner, Samuel; Liu, Xiaoyun; Galan, Jorge E.] Yale Univ, Sch Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Galan, JE (corresponding author), Yale Univ, Sch Med, Sect Microbial Pathogenesis, 295 Congress Ave, New Haven, CT 06536 USA.	jorge.galan@yale.edu		Kato, Junya/0000-0001-5432-157X	NIH [U54 AI0157158, AI30492]; International Human Frontiers Science Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030492, R37AI030492, R01AI030492] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Human Frontiers Science Program(Human Frontier Science Program); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the Galan laboratory for critical reading of this manuscript. This work was supported by NIH grant U54 AI0157158 (M.L.-T.), a long-term fellowship of the International Human Frontiers Science Program (S.W.), and NIH grant AI30492 (J.E.G.).	Alvarez-Martinez CE, 2009, MICROBIOL MOL BIOL R, V73, P775, DOI 10.1128/MMBR.00023-09; Boland A, 1996, EMBO J, V15, P5191, DOI 10.1002/j.1460-2075.1996.tb00904.x; Collazo CM, 1996, INFECT IMMUN, V64, P3524, DOI 10.1128/IAI.64.9.3524-3531.1996; Collazo CM, 1997, MOL MICROBIOL, V24, P747, DOI 10.1046/j.1365-2958.1997.3781740.x; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Edqvist PJ, 2003, J BACTERIOL, V185, P2259, DOI 10.1128/JB.185.7.2259-2266.2003; Feldman MF, 2003, FEMS MICROBIOL LETT, V219, P151, DOI 10.1016/S0378-1097(03)00042-9; Galan JE, 2005, CURR OPIN MICROBIOL, V8, P1, DOI 10.1016/j.mib.2004.12.015; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Gonzalez-Pedrajo B, 2006, MOL MICROBIOL, V60, P984, DOI 10.1111/j.1365-2958.2006.05149.x; GROISMAN EA, 1993, EMBO J, V12, P3779, DOI 10.1002/j.1460-2075.1993.tb06056.x; HKANSSON S, 1996, EMBO J, V15, P5812; Johnson S, 2008, FEMS MICROBIOL LETT, V286, P274, DOI 10.1111/j.1574-6968.2008.01284.x; Jouihri N, 2003, MOL MICROBIOL, V49, P755, DOI 10.1046/j.1365-2958.2003.03590.x; Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422; KANIGA K, 1995, J BACTERIOL, V177, P3965, DOI 10.1128/jb.177.14.3965-3971.1995; Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602; Kubori T, 2002, J BACTERIOL, V184, P4699, DOI 10.1128/JB.184.17.4699-4708.2002; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; Lara-Tejero M, 2009, INFECT IMMUN, V77, P2635, DOI 10.1128/IAI.00077-09; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; Minamino T, 2008, MOL BIOSYST, V4, P1105, DOI 10.1039/b808065h; Morita-Ishihara T, 2006, J BIOL CHEM, V281, P599, DOI 10.1074/jbc.M509644200; Pukatzki S, 2009, CURR OPIN MICROBIOL, V12, P11, DOI 10.1016/j.mib.2008.11.010; Riordan KE, 2008, J BACTERIOL, V190, P6204, DOI 10.1128/JB.00467-08; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Sorg JA, 2006, P NATL ACAD SCI USA, V103, P16490, DOI 10.1073/pnas.0605974103; Spaeth KE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000579; Sukhan A, 2001, J BACTERIOL, V183, P1159, DOI 10.1128/JB.183.4.1159-1167.2001; Tamano K, 2002, J BACTERIOL, V184, P1244, DOI 10.1128/JB.184.5.1244-1252.2002; Williams AW, 1996, J BACTERIOL, V178, P2960, DOI 10.1128/jb.178.10.2960-2970.1996; ZIERLER MK, 1995, INFECT IMMUN, V63, P4024, DOI 10.1128/IAI.63.10.4024-4028.1995	33	187	191	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1188	1191		10.1126/science.1201476	http://dx.doi.org/10.1126/science.1201476			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21292939	Green Accepted			2022-12-28	WOS:000287971200041
J	Ali, K; Harnden, A; Edge, JA				Ali, Keya; Harnden, Anthony; Edge, Julie A.			Practice Easily Missed? Type 1 diabetes in children	BRITISH MEDICAL JOURNAL			English	Editorial Material							MELLITUS					julie.edge@paediatrics.ox.ac.uk						Ali K, 2009, DIABETIC MED S1, V26, P34; Bui H, 2010, J PEDIATR-US, V156, P472, DOI 10.1016/j.jpeds.2009.10.001; Edge JA, 1999, ARCH DIS CHILD, V81, P318, DOI 10.1136/adc.81.4.318; PALOWICZ MM, 2008, PEDIAT ENDOCRINOL DI, V14, P7; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; PINKNEY JH, 1994, DIABETOLOGIA, V37, P70; Roche EF, 2005, PEDIATR DIABETES, V6, P75, DOI 10.1111/j.1399-543X.2005.00110.x; Royal College of Paediatrics and Child Health, 2009, GROW DIAB CHILDR YOU; Sundaram PCB, 2009, ARCH DIS CHILD, V94, P151, DOI 10.1136/adc.2007.133405; Vanelli M, 1999, DIABETES CARE, V22, P7, DOI 10.2337/diacare.22.1.7	10	12	12	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2011	342								d294	10.1136/bmj.d294	http://dx.doi.org/10.1136/bmj.d294			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725OZ	21325386				2022-12-28	WOS:000287656500023
J	Joynt, KE; Orav, EJ; Jha, AK				Joynt, Karen E.; Orav, E. John; Jha, Ashish K.			Thirty-Day Readmission Rates for Medicare Beneficiaries by Race and Site of Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-CARE; ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED CONTROLLED-TRIAL; CONGESTIVE-HEART-FAILURE; SAFETY-NET HOSPITALS; DUTY HOUR REFORM; BLACK PATIENTS; TRANSITIONS INTERVENTION; ADMINISTRATIVE DATA; RACIAL DISPARITIES	Context Understanding whether and why there are racial disparities in readmissions has implications for efforts to reduce readmissions. Objective To determine whether black patients have higher odds of readmission than white patients and whether these disparities are related to where black patients receive care. Design Using national Medicare data, we examined 30-day readmissions after hospitalization for acute myocardial infarction (MI), congestive heart failure (CHF), and pneumonia. We categorized hospitals in the top decile of proportion of black patients as minority-serving. We determined the odds of readmission for black patients compared with white patients at minority-serving vs non-minority-serving hospitals. Setting and Participants Medicare Provider Analysis Review files of more than 3.1 million Medicare fee-for-service recipients who were discharged from US hospitals in 2006-2008. Main Outcome Measure Risk-adjusted odds of 30-day readmission. Results Overall, black patients had higher readmission rates than white patients (24.8% vs 22.6%, odds ratio [OR], 1.13; 95% confidence interval [CI], 1.11-1.14; P<.001); patients from minority-serving hospitals had higher readmission rates than those from non-minority-serving hospitals (25.5% vs 22.0%, OR, 1.23; 95% CI, 1.20-1.27; P<.001). Among patients with acute MI and using white patients from non-minority-serving hospitals as the reference group (readmission rate 20.9%), black patients from minority-serving hospitals had the highest readmission rate (26.4%; OR, 1.35; 95% CI, 1.28-1.42), while white patients from minority-serving hospitals had a 24.6% readmission rate (OR, 1.23; 95% CI, 1.18-1.29) and black patients from non-minority-serving hospitals had a 23.3% readmission rate (OR, 1.20; 95% CI, 1.16-1.23; P<.001 for each); patterns were similar for CHF and pneumonia. The results were unchanged after adjusting for hospital characteristics including markers of caring for poor patients. Conclusion Among elderly Medicare recipients, black patients were more likely to be readmitted after hospitalization for 3 common conditions, a gap that was related to both race and to the site where care was received. JAMA. 2011;305(7):675-681 www.jama.com	[Joynt, Karen E.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Joynt, Karen E.; Jha, Ashish K.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Jha, Ashish K.] VA Boston Healthcare Syst, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Joynt, KE (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.	kjoynt@partners.org			National Institutes of Health, Brigham and Women's Hospital, Division of Cardiovascular Medicine [T32HL007604-24]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007604] Funding Source: NIH RePORTER	National Institutes of Health, Brigham and Women's Hospital, Division of Cardiovascular Medicine; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Joynt was supported by National Institutes of Health Training Grant T32HL007604-24, Brigham and Women's Hospital, Division of Cardiovascular Medicine.	Ayanian JZ, 1999, MED CARE, V37, P1260, DOI 10.1097/00005650-199912000-00009; AYANIAN JZ, 1993, JAMA-J AM MED ASSOC, V269, P2642, DOI 10.1001/jama.269.20.2642; Baicker K, 2004, HLTH AFF MILLWOOD S, pVAR33; Benatar D, 2003, ARCH INTERN MED, V163, P347, DOI 10.1001/archinte.163.3.347; Bourbeau J, 2003, ARCH INTERN MED, V163, P585, DOI 10.1001/archinte.163.5.585; Breslin TM, 2009, J CLIN ONCOL, V27, P3945, DOI 10.1200/JCO.2008.20.8546; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Culler SD, 2010, MED CARE, V48, P273, DOI 10.1097/MLR.0b013e3181c161ba; Deswal A, 2004, J AM COLL CARDIOL, V43, P778, DOI 10.1016/j.jacc.2003.10.033; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Fang J, 2008, J AM COLL CARDIOL, V52, P428, DOI 10.1016/j.jacc.2008.03.061; Gaskin DJ, 2008, HEALTH AFFAIR, V27, P518, DOI 10.1377/hlthaff.27.2.518; Givens JL, 2010, ARCH INTERN MED, V170, P427, DOI 10.1001/archinternmed.2009.547; Halm EA, 2009, STROKE, V40, P2493, DOI 10.1161/STROKEAHA.108.544866; Han B, 2006, MED CARE, V44, P731, DOI 10.1097/01.mlr.0000215858.37118.65; Hasnain-Wynia R, 2007, ARCH INTERN MED, V167, P1233, DOI 10.1001/archinte.167.12.1233; Healthcare Cost and Utilization Project (HCUP), COM SOFTW VERS 3 6; Hernandez AF, 2010, JAMA-J AM MED ASSOC, V303, P1716, DOI 10.1001/jama.2010.533; *I MED, 2002, UN TREATM CONFR RAC; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jha AK, 2005, NEW ENGL J MED, V353, P683, DOI 10.1056/NEJMsa050672; Jha AK, 2007, HEALTH AFFAIR, V26, P1104, DOI 10.1377/hlthaff.26.4.1104; Jha AK, 2007, ARCH INTERN MED, V167, P1177, DOI 10.1001/archinte.167.11.1177; Jha AK, 2007, AM HEART J, V153, P785, DOI 10.1016/j.ahj.2007.02.014; Kahn CN, 2006, HEALTH AFFAIR, V25, P148, DOI 10.1377/hlthaff.25.1.148; Kane RL, 2007, MED CARE, V45, P1195, DOI 10.1097/MLR.0b013e3181468ca3; Li B, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-12; Lucas FL, 2006, ANN SURG, V243, P281, DOI 10.1097/01.sla.0000197560.92456.32; Mayr FB, 2010, CRIT CARE MED, V38, P759, DOI 10.1097/CCM.0b013e3181c8fd58; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Niederman MS, 1998, CLIN THER, V20, P820, DOI 10.1016/S0149-2918(98)80144-6; Parry Carla, 2009, Home Health Care Serv Q, V28, P84, DOI 10.1080/01621420903155924; Pine M, 2007, JAMA-J AM MED ASSOC, V297, P71, DOI 10.1001/jama.297.1.71; Polsky D, 2008, HEALTH SERV RES, V43, P1388, DOI 10.1111/j.1475-6773.2008.00837.x; Sisk JE, 2006, ANN INTERN MED, V145, P273, DOI 10.7326/0003-4819-145-4-200608150-00007; Skinner J, 2005, CIRCULATION, V112, P2634, DOI 10.1161/CIRCULATIONAHA.105.543231; Southern DA, 2004, MED CARE, V42, P355, DOI 10.1097/01.mlr.0000118861.56848.ee; Tan EJ, 2003, J AM GERIATR SOC, V51, P246, DOI 10.1046/j.1532-5415.2003.51065.x; Trivedi AN, 2006, J AM COLL CARDIOL, V47, P417, DOI 10.1016/j.jacc.2005.08.068; U.S. Department of Health and Human Services, 2000, HLTH PEOPL 2010 UND; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P984, DOI 10.1001/jama.298.9.984; Volpp KG, 2007, JAMA-J AM MED ASSOC, V298, P975, DOI 10.1001/jama.298.9.975; Weller WE, 2007, J AM COLL SURGEONS, V204, P383, DOI 10.1016/j.jamcollsurg.2006.12.031; Werner RM, 2008, JAMA-J AM MED ASSOC, V299, P2180, DOI 10.1001/jama.299.18.2180; Zwanziger J, 2008, MED CARE RES REV, V65, P478, DOI 10.1177/1077558708315440	45	558	561	0	36	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2011	305	7					675	681		10.1001/jama.2011.123	http://dx.doi.org/10.1001/jama.2011.123			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	721NH	21325183	Green Accepted, Bronze			2022-12-28	WOS:000287361100018
J	Montgomery, BD				Montgomery, Brett D.			Pharmacist-physician hypertension comanagement reduced 24-hour ambulatory blood pressure	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Western Australia, Crawley, WA, Australia	University of Western Australia	Montgomery, BD (corresponding author), Univ Western Australia, Crawley, WA, Australia.							Clark CE, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3995; Conen D, 2008, J HYPERTENS, V26, P1290, DOI 10.1097/HJH.0b013e3282f97854; VICTOR RG, 2010, ARCH INTERN MED 1025	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4							JC2-9	10.7326/0003-4819-154-4-201102150-02009	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-02009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720VF	21320936				2022-12-28	WOS:000287310000008
J	Rowe, T; Frank, LR				Rowe, Timothy; Frank, Lawrence R.			The Disappearing Third Dimension	SCIENCE			English	Editorial Material								Three-dimensional computing is driving what many would call a revolution in scientific visualization. However, its power and advancement are held back by the absence of sustainable archives for raw data and derivative visualizations. Funding agencies, professional societies, and publishers each have unfulfilled roles in archive design and data management policy.	[Rowe, Timothy] Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA; [Frank, Lawrence R.] Univ Calif San Diego, Dept Radiol, San Diego, CA 92093 USA	University of Texas System; University of Texas Austin; University of California System; University of California San Diego	Rowe, T (corresponding author), Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA.	rowe@mail.utexas.edu; lfrank@ucsd.edu						Beckmann EC, 2006, BRIT J RADIOL, V79, P5, DOI 10.1259/bjr/29444122; CONROY GC, 1984, SCIENCE, V226, P456, DOI 10.1126/science.226.4673.456; Contreras JL, 2010, SCIENCE, V329, P393, DOI 10.1126/science.1189253; HESS C., 2007, UNDERSTANDING KNOWLE; Price BA, 1992, P 25 HAW INT C SYST, V2, P597; Rowe T. B., 1993, THRINAXODON DIGITAL	6	32	32	1	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					712	714		10.1126/science.1202828	http://dx.doi.org/10.1126/science.1202828			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21311010				2022-12-28	WOS:000287205700053
J	Sabeti, P				Sabeti, Pardis			The Landscape of Human Evolution	SCIENCE			English	Editorial Material									Harvard Univ, Cambridge, MA 02138 USA	Harvard University	Sabeti, P (corresponding author), Harvard Univ, Cambridge, MA 02138 USA.		Sabeti, Pardis/GQH-8610-2022						0	1	1	2	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					690	690		10.1126/science.1202570	http://dx.doi.org/10.1126/science.1202570			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21310997	Green Submitted			2022-12-28	WOS:000287205700041
J	Ku, L; Jones, K; Shin, P; Bruen, B; Hayes, K				Ku, Leighton; Jones, Karen; Shin, Peter; Bruen, Brian; Hayes, Katherine			The States' Next Challenge - Securing Primary Care for Expanded Medicaid Populations	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ku, Leighton; Jones, Karen; Shin, Peter; Bruen, Brian; Hayes, Katherine] George Washington Univ, Dept Hlth Policy, Washington, DC 20052 USA	George Washington University	Ku, L (corresponding author), George Washington Univ, Dept Hlth Policy, Washington, DC 20052 USA.		Potter, Joseph E/A-3122-2008	Bruen, Brian/0000-0001-6038-9917; Ku, Leighton/0000-0002-6154-9289				Bodenheimer T, 2010, HEALTH AFFAIR, V29, P799, DOI 10.1377/hlthaff.2010.0026; Holahan J., 2010, MEDICAID COVERAGE SP; Institute of Medicine, 2010, FUT NURS LEAD CHANG; Ku L, 2010, STRENGTHENING PRIMAR	4	79	79	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2011	364	6					493	495		10.1056/NEJMp1011623	http://dx.doi.org/10.1056/NEJMp1011623			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	718QH	21268720				2022-12-28	WOS:000287139900001
J	Burrage, D; Hassan, FU; Clarke, S				Burrage, D; Hassan, FU; Clarke, S			Case Report Neck lump in a young woman Medullary thyroid cancer was confirmed by fine needle aspiration	BRITISH MEDICAL JOURNAL			English	Editorial Material									Guys & St Thomas NHS Fdn, Nucl Med Dept, London SE1 9RT, England		Burrage, D (corresponding author), Guys & St Thomas NHS Fdn, Nucl Med Dept, London SE1 9RT, England.	d.burrage@doctors.org.uk	Hassan, Fahim/CAI-4651-2022; Hassan, Fahim/ABA-2256-2020					British Thyroid Association Royal College of Physicians., 2007, GUID MAN THYR CANC; COTE GJ, 2003, NEW ENGL J MED, V349, P16; KESTON JM, 2001, MANAGEMENT NODULAR T, V323, P293; Machens A, 2003, NEW ENGL J MED, V349, P1517, DOI 10.1056/NEJMoa012915; MEHANNA HM, 2009, BMJ, V338; Skinner MA, 2005, NEW ENGL J MED, V353, P1105, DOI 10.1056/NEJMoa043999; SPOUDEAS HA, 2005, NOVO NORDISK, P47	7	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 9	2011	342								d26	10.1136/bmj.d26	http://dx.doi.org/10.1136/bmj.d26			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722AZ	21307101				2022-12-28	WOS:000287402900018
J	Paley, J; Lilford, R				Paley, John; Lilford, Richard			Qualitative methods: an alternative view	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												r.j.lilford@bham.ac.uk						[Anonymous], 1996, ERROR GROWTH EXPT KN, DOI DOI 10.7208/CHICAGO/9780226511993.001.0001; Daston L., 2007, OBJECTIVITY; Giere R., 2006, SCI PERSPECTIVISM; Gilovich T., 2002, HEURISTICS BIASES PS, DOI [DOI 10.1017/CBO9780511808098.004, DOI 10.1017/CBO9780511808098]; Guba E., 1989, 4 GENERATION EVALUAT; Hedstrom P., 1998, SOCIAL MECH ANAL APP, P20; Hirstein W, 2005, PHILOS PSYCHOPATHOL, P1; Hodges BD, 2008, BRIT MED J, V337, pa879, DOI DOI 10.1136/BMJ.A879; Hurlburt R. T., 2007, PROPONENT MEETS SKEP; Kuper A, 2008, BMJ-BRIT MED J, V337, pa288, DOI DOI 10.1136/BMJ.A288; Kuper A, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1035; Lilford RJ, 1996, BRIT MED J, V313, P603; Lincoln Y, 1985, NATURALISTIC ENQUIRY; Lincoln Y., 2003, HDB QUALITATIVE RES; Lingard L, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.39602.690162.47; Loftus Elizabeth F, 1996, EYEWITNESS TESTIMONY; Metzinger Thomas, 2009, EGO TUNNEL SCI MIND; Munhall P. L., 2007, NURSING RES QUALITY, V4th; Paley J, 2010, NURS PHILOS, V11, P112, DOI 10.1111/j.1466-769X.2010.00436.x; Parahoo K., 2006, NURSING RES PRINCIPL; Reeves S., 2008, BMJ-BRIT MED J, V337, P631, DOI DOI 10.1136/BMJ.A288; Reeves S, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1020; Speziale H.S., 2007, QUALITATIVE RES NURS, V4th ed.; Wilson T. D., 2002, STRANGERS OURSELVES	24	24	24	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2011	342								d424	10.1136/bmj.d424	http://dx.doi.org/10.1136/bmj.d424			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	722AZ	21307109	Green Submitted			2022-12-28	WOS:000287402900014
J	Shaughnessy, AF				Shaughnessy, Allen F.			Drug Development Old drugs, new tricks	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												Allen.Shaughnessy@tufts.edu						Berry-Kravis E, 2009, J MED GENET, V46, P266, DOI 10.1136/jmg.2008.063701; BREN L, 2001, FDA MED REV LEAVES H; Campbell SF, 2000, CLIN SCI, V99, P255, DOI 10.1042/CS20000140; Campillos M, 2008, SCIENCE, V321, P263, DOI 10.1126/science.1158140; Frijters R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000943; Keiser MJ, 2009, NATURE, V462, P175, DOI 10.1038/nature08506; Rich RM, 2006, RETINA-J RET VIT DIS, V26, P495, DOI 10.1097/01.iae.0000225766.75009.3a; Rothwell PM, 2011, LANCET, V377, P31, DOI 10.1016/S0140-6736(10)62110-1; Silverman WA, 2002, PEDIATRICS, V110, P404, DOI 10.1542/peds.110.2.404; Sneader W, 2005, DRUG DISCOVERY: A HISTORY, P1, DOI 10.1002/0470015535; Yao LX, 2009, TRENDS BIOTECHNOL, V27, P531, DOI 10.1016/j.tibtech.2009.06.003	11	27	27	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2011	342								d741	10.1136/bmj.d741	http://dx.doi.org/10.1136/bmj.d741			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	722AZ	21307112				2022-12-28	WOS:000287402900009
J	Culyba, EK; Price, JL; Hanson, SR; Dhar, A; Wong, CH; Gruebele, M; Powers, ET; Kelly, JW				Culyba, Elizabeth K.; Price, Joshua L.; Hanson, Sarah R.; Dhar, Apratim; Wong, Chi-Huey; Gruebele, Martin; Powers, Evan T.; Kelly, Jeffery W.			Protein Native-State Stabilization by Placing Aromatic Side Chains in N-Glycosylated Reverse Turns	SCIENCE			English	Article							ASPARAGINE-LINKED GLYCOSYLATION; STABILITY; CARBOHYDRATE; CONFORMATION; ACYLPHOSPHATASE; GLYCANS; CONTEXT; CD2	N-glycosylation of eukaryotic proteins helps them fold and traverse the cellular secretory pathway and can increase their stability, although the molecular basis for stabilization is poorly understood. Glycosylation of proteins at naive sites (ones that normally are not glycosylated) could be useful for therapeutic and research applications but currently results in unpredictable changes to protein stability. We show that placing a phenylalanine residue two or three positions before a glycosylated asparagine in distinct reverse turns facilitates stabilizing interactions between the aromatic side chain and the first N-acetylglucosamine of the glycan. Glycosylating this portable structural module, an enhanced aromatic sequon, in three different proteins stabilizes their native states by -0.7 to -2.0 kilocalories per mole and increases cellular glycosylation efficiency.	[Culyba, Elizabeth K.; Price, Joshua L.; Hanson, Sarah R.; Wong, Chi-Huey; Powers, Evan T.; Kelly, Jeffery W.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Culyba, Elizabeth K.; Price, Joshua L.; Hanson, Sarah R.; Wong, Chi-Huey; Powers, Evan T.; Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Dhar, Apratim; Gruebele, Martin] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Gruebele, Martin] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Gruebele, Martin] Univ Illinois, Ctr Biophys & Computat Biol, Urbana, IL 61801 USA; [Kelly, Jeffery W.] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Scripps Research Institute	Powers, ET (corresponding author), Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.	epowers@scripps.edu; jkelly@scripps.edu		Price, Joshua/0000-0002-0116-0968; Powers, Evan/0000-0001-8185-8487	Skaggs Institute for Chemical Biology; Lita Annenberg Hazen Foundation; NIH [GM051105, F32 GM086039, AI072155]; NSF [MCB 1019958]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051105, F32GM086039] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1019958] Funding Source: National Science Foundation	Skaggs Institute for Chemical Biology; Lita Annenberg Hazen Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank R. A. Dwek, I. A. Wilson, J. C. Paulson, S. Deechongkit, and D. L. Powers for presubmission reviews and for helpful prepublication discussions. This work was supported in part by the Skaggs Institute for Chemical Biology, the Lita Annenberg Hazen Foundation, and by NIH grant GM051105 to J. W. K. and E. T. P. J. L. P. was supported in part by NIH postdoctoral fellowship F32 GM086039. A. D. and M. G. were supported by NSF grant MCB 1019958. S. R. H. and C.-H. W. were supported by NIH grant AI072155. The Scripps Research Institute has filed a provisional patent application covering the results described in this paper.	ANDREOTTI AH, 1993, J AM CHEM SOC, V115, P3352, DOI 10.1021/ja00061a053; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Chen MM, 2010, P NATL ACAD SCI USA, V107, P22528, DOI 10.1073/pnas.1015356107; Elliott S, 2004, J BIOL CHEM, V279, P16854, DOI 10.1074/jbc.M311095200; Geierhaas CD, 2004, J MOL BIOL, V343, P1111, DOI 10.1016/j.jmb.2004.08.100; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Hanson SR, 2009, P NATL ACAD SCI USA, V106, P3131, DOI 10.1073/pnas.0810318105; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; HOROVITZ A, 1992, J MOL BIOL, V224, P733, DOI 10.1016/0022-2836(92)90557-Z; IMPERIALI B, 1995, P NATL ACAD SCI USA, V92, P97, DOI 10.1073/pnas.92.1.97; IMPERIALI B, 1992, J AM CHEM SOC, V114, P7944, DOI 10.1021/ja00046a069; JONES EY, 1992, NATURE, V360, P232, DOI 10.1038/360232a0; KERN G, 1992, PROTEIN SCI, V1, P120; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Laughrey ZR, 2008, J AM CHEM SOC, V130, P14625, DOI 10.1021/ja803960x; Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880; PASTORE A, 1992, J MOL BIOL, V224, P427, DOI 10.1016/0022-2836(92)91005-A; Petrescu AJ, 2004, GLYCOBIOLOGY, V14, P103, DOI 10.1093/glycob/cwh008; Price JL, 2010, J AM CHEM SOC, V132, P15359, DOI 10.1021/ja106896t; Ranganathan R, 1997, CELL, V89, P875, DOI 10.1016/S0092-8674(00)80273-1; SIBANDA BL, 1989, J MOL BIOL, V206, P759, DOI 10.1016/0022-2836(89)90583-4; Walsh G, 2006, NAT BIOTECHNOL, V24, P1241, DOI 10.1038/nbt1252; Wang CQ, 1996, BIOCHEMISTRY-US, V35, P7299, DOI 10.1021/bi9517704; WORMALD MR, 1991, EUR J BIOCHEM, V198, P131, DOI 10.1111/j.1432-1033.1991.tb15995.x; WYSS DF, 1995, SCIENCE, V269, P1273, DOI 10.1126/science.7544493; Yamaguchi H, 1996, J BIOCHEM-TOKYO, V120, P474; Yeung RCY, 2006, ACTA CRYSTALLOGR F, V62, P80, DOI 10.1107/S174430910504145X; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	28	140	146	1	62	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					571	575		10.1126/science.1198461	http://dx.doi.org/10.1126/science.1198461			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292975	Green Accepted			2022-12-28	WOS:000286933600050
J	Farmer, A; Milne, R; Walley, T				Farmer, Andrew; Milne, Ruairidh; Walley, Tom			Uncertainties Page Research to decrease areas of clinical uncertainty	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												andrew.farmer@dphpc.ox.ac.uk		Milne, Ruairidh/0000-0002-5117-4380				Chalmers I, 2008, BRIT MED J, V337, DOI 10.1136/bmj.39555.392627.80; Clark AL, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d234; Cooksey D., 2006, REV UK HLTH RES FUND; Dumville JC, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b773; Farmer A, 2007, BMJ-BRIT MED J, V335, P132, DOI 10.1136/bmj.39247.447431.BE; Richardson W S, 1995, ACP J Club, V123, pA12; Shakur H, 2010, LANCET, V376, P23, DOI 10.1016/S0140-6736(10)60835-5; Walley T, 2010, LANCET, V375, P1063, DOI 10.1016/S0140-6736(10)60068-2	8	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 4	2011	342								d369	10.1136/bmj.d369	http://dx.doi.org/10.1136/bmj.d369			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	718PX	21296837				2022-12-28	WOS:000287138600011
J	Maramis, A; Nguyen, VT; Minas, H				Maramis, Albert; Nguyen Van Tuan; Minas, Harry			Mental health in southeast Asia	LANCET			English	Editorial Material									[Maramis, Albert] WHO Country Off Indonesia, Jakarta 12950, Indonesia; [Nguyen Van Tuan] Hanoi Med Univ, Dept Psychiat, Hanoi, Vietnam; [Nguyen Van Tuan] Natl Inst Mental Hlth, Hanoi, Vietnam; [Minas, Harry] Univ Melbourne, Melbourne Sch Populat Hlth, Ctr Int Mental Hlth, Parkville, Vic 3052, Australia	Hanoi Medical University; University of Melbourne	Maramis, A (corresponding author), WHO Country Off Indonesia, Jakarta 12950, Indonesia.	amaramis@indosat.net.id	Minas, Harry/O-8276-2019; Minas, Harry/F-7718-2010	Minas, Harry/0000-0003-1719-7367; 				Conde B, 2004, INT REV PSYCHIATR, V16, P159, DOI 10.1080/095402603100016; Deva MP, 2004, INT REV PSYCHIATR, V16, P167, DOI 10.1080/09540260310001635203; Hasan N, 2010, JAKARTA GLOBE   0223; Irmansyah I, 2009, Int J Ment Health Syst, V3, P14, DOI 10.1186/1752-4458-3-14; Minas Harry, 2009, Int J Ment Health Syst, V3, P8, DOI 10.1186/1752-4458-3-8; Minas Harry, 2008, Int J Ment Health Syst, V2, P8, DOI 10.1186/1752-4458-2-8; Ministry of Health Indonesia, 2010, NAT HLTH WORKSH IMPR; Patel V, 2008, LANCET, V372, P1354, DOI 10.1016/S0140-6736(08)61556-1; Siriwanarangsan P, 2004, INT REV PSYCHIATR, V16, P150, DOI 10.1080/09540260310001635195; Stockwell A, 2005, AUSTRALAS PSYCHIATRY, V13, P191, DOI 10.1080/j.1440-1665.2005.02187.x; UN Development Programme, 2006, IMP BAS PUBL SERV LI; UN Development Programme, 2010, HUM DEV REP 2010 REA; World Health Organization, 2005, MENT HLTH ATL	13	33	33	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2011	377	9767					700	702		10.1016/S0140-6736(10)62181-2	http://dx.doi.org/10.1016/S0140-6736(10)62181-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729JQ	21269680				2022-12-28	WOS:000287946000008
J	Navarra, SV; Guzman, RM; Gallacher, AE; Hall, S; Levy, RA; Jimenez, RE; Li, EKM; Thomas, M; Kim, HY; Leon, MG; Tanasescu, C; Nasonov, E; Lan, JL; Pineda, L; Zhong, ZJ; Freimuth, W; Petri, MA				Navarra, Sandra V.; Guzman, Renato M.; Gallacher, Alberto E.; Hall, Stephen; Levy, Roger A.; Jimenez, Renato E.; Li, Edmund K-M; Thomas, Mathew; Kim, Ho-Youn; Leon, Manuel G.; Tanasescu, Coman; Nasonov, Eugeny; Lan, Joung-Liang; Pineda, Lilia; Zhong, Z. John; Freimuth, William; Petri, Michelle A.		BLISS-52 Study Grp	Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial	LANCET			English	Article							LYMPHOCYTE STIMULATOR LEVELS; DISEASE-ACTIVITY; CLINICAL-TRIALS; EULAR RECOMMENDATIONS; BLYS; FLARES; BILAG; INDEX; CLASSIFICATION; ASSOCIATION	Background Systemic lupus erythematosus is a heterogeneous autoimmune disease that is associated with B-cell hyperactivity, autoantibodies, and increased concentrations of B-lymphocyte stimulator (BLyS). The efficacy and safety of the fully human monoclonal antibody belimumab (BLyS-specific inhibitor) was assessed in patients with active systemic lupus erythematosus. Methods Patients (aged >= 18 years) who were seropositive with scores of at least 6 on the Safety of Estrogens in Lupus Erythematosus National Assessment Systemic Lupus Erythematosus Disease Activity Index (SELENA-SLEDAI) were enrolled in a multicentre phase 3 study, which was done in Latin America, Asia-Pacific, and eastern Europe. Patients were randomly assigned by use of a central interactive voice response system in a 1:1:1 ratio to belimumab 1 mg/kg or 10 mg/kg, or placebo by intravenous infusion in 1 h on days 0, 14, and 28, and then every 28 days until 48 weeks, with standard of care. Patients, investigators, study coordinators, and sponsors were masked to treatment assignment. Primary efficacy endpoint was improvement in the Systemic Lupus Erythematosus Responder Index (SRI) at week 52 (reduction >= 4 points in SELENA-SLEDAI score; no new British Isles Lupus Assessment Group [BILAG] A organ domain score and no more than 1 new B organ domain score; and no worsening [<0.3 increase] in Physician's Global Assessment [PGA] score) versus baseline. Method of analysis was by modified intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00424476. Findings 867 patients were randomly assigned to belimumab 1 mg/kg (n=289) or 10 mg/kg (n=290), or placebo (n=288). 865 were treated and analysed in the belimumab (1 mg/kg, n=288; 10 mg/kg, n=290) and placebo groups (n=287). Significantly higher SRI rates were noted with belimumab 1 mg/kg (148 [51%], odds ratio 1.55 [95% CI 1.10-2.19]; p=0.0129) and 10 mg/kg (167 [58%], 1.83 [1.30-2.59]; p=0.0006) than with placebo (125 [44%]) at week 52. More patients had their SELENA-SLEDAI score reduced by at least 4 points during 52 weeks with belimumab 1 mg/kg (153 [53%], 1.51 [1.07-2.14]; p=0.0189) and 10 mg/kg (169 [58%], 1.71 [1.21-2.41]; p=0.0024) than with placebo (132 [46%]). More patients given belimumab 1 mg/kg (226 [78%], 1.38 [0.93-2.04]; p=0.1064) and 10 mg/kg (236 [81%], 1.62 [1.09-2.42]; p=0.0181) had no new BILAG A or no more than 1 new B flare than did those in the placebo group (210 [73%]). No worsening in PGA score was noted in more patients with belimumab 1 mg/kg (227 [79%], 1.68 [1.15-2.47]; p=0.0078) and 10 mg/kg (231 [80%], 1.74 [1.18-2.55]; p=0.0048) than with placebo (199 [69%]). Rates of adverse events were similar in the groups given belimumab 1 mg/kg and 10 mg/kg, and placebo: serious infection was reported in 22 (8%), 13 (4%), and 17 (6%) patients, respectively, and severe or serious hypersensitivity reactions on an infusion day were reported in two (<1%), two (<1%), and no patients, respectively. No malignant diseases were reported. Interpretation Belimumab has the potential to be the first targeted biological treatment that is approved specifically for systemic lupus erythematosus, providing a new option for the management of this important prototypic autoimmune disease.	[Petri, Michelle A.] Johns Hopkins Univ, Sch Med, Div Rheumatol, Baltimore, MD 21205 USA; [Navarra, Sandra V.] Univ Santo Tomas Hosp, Manila, Philippines; [Guzman, Renato M.] IDEARG, SaludCoop Clin, Bogota, Colombia; [Gallacher, Alberto E.] Hosp Britan Buenos Aires, Buenos Aires, DF, Argentina; [Hall, Stephen] Emeritus Res Cabrini Hosp, Malvern, Vic, Australia; [Levy, Roger A.] Univ Estado Rio de Janeiro, Hosp Univ Pedro Ernesto, Rio De Janeiro, Brazil; [Jimenez, Renato E.] Hosp Clin Vina del Mar, Vina Del Mar, Chile; [Li, Edmund K-M] Prince Wales Hosp, Hong Kong, Hong Kong, Peoples R China; [Thomas, Mathew] Kerala Inst Med Sci, Trivandrum, Kerala, India; [Kim, Ho-Youn] Catholic Univ Korea, Seoul St Marys Hosp, Seoul, South Korea; [Leon, Manuel G.] Inst Ginecol & Reprod, Lima, Peru; [Tanasescu, Coman] Spitalul Clin Colentina, Bucharest, Romania; [Nasonov, Eugeny] Sci Res Inst Rheumatol RAMS, State Inst, Moscow, Russia; [Lan, Joung-Liang] Taichung Vet Gen Hosp, Taichung, Taiwan; [Pineda, Lilia; Zhong, Z. John; Freimuth, William] Human Genome Sci, Rockville, MD USA	Johns Hopkins University; University of Santo Tomas; Hospital Britanico de Buenos Aires; Cabrini Health; Universidade do Estado do Rio de Janeiro; Chinese University of Hong Kong; Prince of Wales Hospital; Catholic University of Korea; Seoul St. Mary's Hospital; Russian Academy of Medical Sciences; Taichung Veterans General Hospital; GlaxoSmithKline; Human Genome Sciences Inc	Petri, MA (corresponding author), Johns Hopkins Univ, Sch Med, Div Rheumatol, 1830 E Monument St,Ste 7500, Baltimore, MD 21205 USA.	mpetri@jhmi.edu	Levy, Roger A/K-3087-2014	Levy, Roger A/0000-0001-6393-6031	Pfizer; Human Genome Sciences; GlaxoSmithKline	Pfizer(Pfizer); Human Genome Sciences(GlaxoSmithKline); GlaxoSmithKline(GlaxoSmithKline)	SVN has received a consulting fee or honorarium and support for travel to meetings for the study or otherwise from Human Genome Sciences; has received payment for development of educational presentations including service on speakers' bureaus, and has had travel or accommodations expenses covered or reimbursed by Merck, Pfizer, and Roche: and is President and Chief Executive Officer of Rheumatology Educational Trust Foundation, a non-profit, non-governmental organisation that administers the Lupus Inspired Advocacy Project. AEG has received a consulting fee or honorarium and support for travel to meetings for the study or otherwise from Human Genome Sciences. SH and his institution have received payment for conducting the trial from Human Genome Sciences. RAL has received a consulting fee or honorarium, and he and his institution have received financial support for participation in the study, and support for travel for subinvesugators to the investigators' meeting from Human Genome Sciences; is an advisory board member for Pfizer and Roche; is a consultant for Abbott, Bio-Rad, and Merck Sharp Dohme Pharma; has received a grant or has a grant pending from Pfizer: and has had travel or accommodations expenses covered or reimbursed by Abbott, Bio-Rad, Merck Sharp & Dohme, Novartis, and Pfizer. REJ and his institution have received a grant and he has received support for travel to meetings for the study or otherwise from Human Genome Sciences. CT and his institution have received a consulting fee or honorarium from GlaxoSmithKline and Human Genome Sciences. LP, ZJZ, and WE are employees of and own stock or stock options in Human Genome Sciences. MAP has received research support and support for travel to clinical trial meetings for the study from, and is a steering committee member and consultant for, Human Genome Sciences; is a member of the data monitoring board for GlaxoSmithKline and Human Genome Sciences; and her institution has received a grant or has a grant pending for clinical trials from Human Genome Sciences. The other authors declare that they have no conflicts of interest.; The study was supported by Human Genome Sciences and GlaxoSmithKline. Editorial support (writing assistance, assembling tables and figures, collating author comments, grammatical editing, and referencing) was provided by Geoff Marx of BioScience Communications, New York, NY, USA, and was funded by Human Genome Sciences and GlaxoSmithKline.	Baker KP, 2003, ARTHRITIS RHEUM-US, V48, P3253, DOI 10.1002/art.11299; Bernatsky S, 2006, ARTHRITIS RHEUM-US, V54, P2550, DOI 10.1002/art.21955; Bertsias G, 2008, LUPUS, V17, P437, DOI 10.1177/0961203308090031; Bertsias G, 2008, ANN RHEUM DIS, V67, P195, DOI 10.1136/ard.2007.070367; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; Camtbell R, 2008, ARTHRIT RHEUM-ARTHR, V59, P458, DOI 10.1002/art.23539; Cancro MP, 2009, J CLIN INVEST, V119, P1066, DOI 10.1172/JCI38010; Cervera R, 2003, MEDICINE, V82, P299, DOI 10.1097/01.md.0000091181.93122.55; Chatham WW, 2001, LUPUS, V10, P140, DOI 10.1191/096120301675075008; Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO;2-S; Collins CE, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1855; Dall'Era M, 2009, NAT REV RHEUMATOL, V5, P348, DOI 10.1038/nrrheum.2009.79; Doria A, 2008, AUTOIMMUN REV, V8, P24, DOI 10.1016/j.autrev.2008.07.019; Furie RA, 2009, ARTHRIT RHEUM-ARTHR, V61, P1143, DOI 10.1002/art.24698; Gladman DD, 2000, J RHEUMATOL, V27, P377; Gordon C, 2003, RHEUMATOLOGY, V42, P1372, DOI 10.1093/rheumatology/keg382; Halpern WG, 2006, TOXICOL SCI, V91, P586, DOI 10.1093/toxsci/kfj148; HAY EM, 1993, Q J MED, V86, P447; Ho A, 2001, ARTHRITIS RHEUM, V44, P2342, DOI 10.1002/1529-0131(200110)44:10<2342::AID-ART397>3.0.CO;2-8; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Isenberg DA, 2000, LUPUS, V9, P651, DOI 10.1191/096120300672904669; Kalunian K, 2009, CURR MED RES OPIN, V25, P1501, DOI 10.1185/03007990902929104; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Mariette X, 2003, ANN RHEUM DIS, V62, P168, DOI 10.1136/ard.62.2.168; Moore PA, 1999, SCIENCE, V285, P260, DOI 10.1126/science.285.5425.260; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; Petri M, 1999, LUPUS, V8, P685, DOI 10.1191/096120399680411281; Petri M, 2009, ARTHRITIS RHEUM S10, V60, pS774; Petri M, 2008, ARTHRITIS RHEUM, V58, P2453, DOI 10.1002/art.23678; Rahman A, 2008, NEW ENGL J MED, V358, P929, DOI 10.1056/NEJMra071297; Strand V, 2007, AUTOIMMUN REV, V6, P209, DOI 10.1016/j.autrev.2006.08.002; Thumboo J, 2007, ANN ACAD MED SINGAP, V36, P115; US Food and Drug Administration, 2005, GUID IND SYST LUP ER; Wallace DJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P1168, DOI 10.1002/art.24699; Ware JE, 1997, SF 36 HLTH SURVEY VE; Yee CS, 2007, ARTHRITIS RHEUM-US, V56, P4113, DOI 10.1002/art.23130; Zhang J, 2001, J IMMUNOL, V166, P6, DOI 10.4049/jimmunol.166.1.6; Zhu TY, 2009, ARTHRIT RHEUM-ARTHR, V61, P1159, DOI 10.1002/art.24725; Zonana-Nacach A, 2000, ARTHRITIS RHEUM, V43, P1801, DOI 10.1002/1529-0131(200008)43:8<1801::AID-ANR16>3.0.CO;2-O	39	1185	1282	1	142	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2011	377	9767					721	731		10.1016/S0140-6736(10)61354-2	http://dx.doi.org/10.1016/S0140-6736(10)61354-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729JQ	21296403				2022-12-28	WOS:000287946000029
J	Cowman, AF; Tonkin, CJ				Cowman, Alan F.; Tonkin, Christopher J.			A Tail of Division	SCIENCE			English	Editorial Material							ERYTHROCYTE INVASION; TOXOPLASMA-GONDII; PLAYS		[Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; Univ Melbourne, Dept Med Biol, Melbourne, Vic 3052, Australia	Walter & Eliza Hall Institute; University of Melbourne	Cowman, AF (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia.	cowman@wehi.edu.au; tonkin@wehi.edu.au	Tonkin, Christopher/K-6534-2019; Cowman, Alan F/C-7642-2013	Tonkin, Christopher/0000-0002-7036-6222; Cowman, Alan F/0000-0001-5145-9004				Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Buguliskis JS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000858; Herm-Gotz A, 2007, NAT METHODS, V4, P1003, DOI 10.1038/nmeth1134; Leykauf K, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000941; Mital J, 2005, MOL BIOL CELL, V16, P4341, DOI 10.1091/mbc.E05-04-0281; O'Donnell RA, 2006, J CELL BIOL, V174, P1023, DOI 10.1083/jcb.200604136; Richard D, 2010, J BIOL CHEM, V285, P14815, DOI 10.1074/jbc.M109.080770; Santos JM, 2011, SCIENCE, V331, P473, DOI 10.1126/science.1199284; Treeck M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000322; Triglia T, 2000, MOL MICROBIOL, V38, P706, DOI 10.1046/j.1365-2958.2000.02175.x; Urban S, 2003, MOL CELL, V11, P1425, DOI 10.1016/S1097-2765(03)00181-3	11	3	3	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2011	331	6016					409	410		10.1126/science.1201692	http://dx.doi.org/10.1126/science.1201692			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273475				2022-12-28	WOS:000286635900038
J	Dogariu, A; Michael, JB; Scully, MO; Miles, RB				Dogariu, Arthur; Michael, James B.; Scully, Marlan O.; Miles, Richard B.			High-Gain Backward Lasing in Air	SCIENCE			English	Article							ATOMIC OXYGEN; LASER FILAMENTATION; FLAMES; FLUORESCENCE; EXCITATION	The compelling need for standoff detection of hazardous gases and vapor indicators of explosives has motivated the development of a remotely pumped, high-gain air laser that produces lasing in the backward direction and can sample the air as the beam returns. We demonstrate that high gain can be achieved in the near-infrared region by pumping with a focused ultraviolet laser. The pumping mechanism is simultaneous resonant two-photon dissociation of molecular oxygen and resonant two-photon pumping of the atomic oxygen fragments. The high gain from the millimeter-length focal zone leads to equally strong lasing in the forward and backward directions. Further backward amplification is achieved with the use of earlier laser spark dissociation. Low-divergence backward air lasing provides possibilities for remote detection.	[Dogariu, Arthur; Michael, James B.; Scully, Marlan O.; Miles, Richard B.] Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA; [Scully, Marlan O.] Texas A&M Univ, Inst Quantum Sci & Engn, College Stn, TX 77843 USA	Princeton University; Texas A&M University System; Texas A&M University College Station	Dogariu, A (corresponding author), Princeton Univ, Dept Mech & Aerosp Engn, Princeton, NJ 08544 USA.	adogariu@princeton.edu	Michael, James/AAB-1219-2021; Michael, James/AAB-1789-2020	Michael, James/0000-0002-9666-114X; 	U.S. Office of Naval Research	U.S. Office of Naval Research(Office of Naval Research)	We gratefully acknowledge support from the U.S. Office of Naval Research under the Science Addressing Asymmetric Explosive Threats Program.	ALDEN M, 1982, OPT COMMUN, V42, P244, DOI 10.1016/0030-4018(82)90025-6; ALDEN M, 1989, OPT LETT, V14, P305, DOI 10.1364/OL.14.000305; BISCHEL WK, 1981, CHEM PHYS LETT, V82, P85, DOI 10.1016/0009-2614(81)85112-3; Buijsse B, 1998, J CHEM PHYS, V108, P7229, DOI 10.1063/1.476141; COOL TA, 1984, APPL OPTICS, V23, P1559, DOI 10.1364/AO.23.001559; Dogariu A., 2009, C LAS EL INT QUANT E; Frank JH, 2005, P COMBUST INST, V30, P1527, DOI 10.1016/j.proci.2004.08.151; GOLDSMITH JEM, 1987, APPL OPTICS, V26, P3566, DOI 10.1364/AO.26.003566; Kocharovsky V, 2005, P NATL ACAD SCI USA, V102, P7806, DOI 10.1073/pnas.0500534102; Luo Q, 2003, APPL PHYS B-LASERS O, V76, P337, DOI 10.1007/s00340-003-1115-9; Luo Q, 2004, OPT PHOTONICS NEWS, V15, P44, DOI 10.1364/OPN.15.9.000044; Miles RB, 2007, AIAA J, V45, P513, DOI 10.2514/1.28964; OWYOUNG A, 1978, IEEE J QUANTUM ELECT, V14, P192, DOI 10.1109/JQE.1978.1069760; Raizer Y. P., 1977, LASER INDUCED DISCHA; Smyth K.C., 1991, P COMBUST INST, V23, p1829e1837; Wrzesinski PJ, 2011, J RAMAN SPECTROSC, V42, P393, DOI 10.1002/jrs.2709; YOKELSON RJ, 1992, J CHEM PHYS, V97, P6153, DOI 10.1063/1.463724	17	199	206	5	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					442	445		10.1126/science.1199492	http://dx.doi.org/10.1126/science.1199492			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273482	Green Submitted			2022-12-28	WOS:000286635900047
J	Sundal, AV; Shepherd, A; Nienow, P; Hanna, E; Palmer, S; Huybrechts, P				Sundal, Aud Venke; Shepherd, Andrew; Nienow, Peter; Hanna, Edward; Palmer, Steven; Huybrechts, Philippe			Melt-induced speed-up of Greenland ice sheet offset by efficient subglacial drainage	NATURE			English	Article							MASS-BALANCE; SURFACE MELT; ACCELERATION; DYNAMICS; TRACKING; RUNOFF; MOTION	Fluctuations in surface melting are known to affect the speed of glaciers and ice sheets(1-7), but their impact on the Greenland ice sheet in a warming climate remains uncertain(8). Although some studies suggest that greater melting produces greater ice-sheet acceleration(7,9), others have identified a long-term decrease in Greenland's flow despite increased melting(3). Here we use satellite observations of ice motion recorded in a land-terminating sector of southwest Greenland to investigate the manner in which ice flow develops during years of markedly different melting. Although peak rates of ice speed-up are positively correlated with the degree of melting, mean summer flow rates are not, because glacier slowdown occurs, on average, when a critical run-off threshold of about 1.4 centimetres a day is exceeded. In contrast to the first half of summer, when flow is similar in all years, speed-up during the latter half is 62 +/- 16 per cent less in warmer years. Consequently, in warmer years, the period of fast ice flow is three times shorter and, overall, summer ice flow is slower. This behaviour is at odds with that expected from basal lubrication alone(7,9). Instead, it mirrors that of mountain glaciers(10-12), where melt-induced acceleration of flow ceases during years of high melting once subglacial drainage becomes efficient. A model of ice-sheet flow that captures switching between cavity and channel drainage modes(13) is consistent with the run-off threshold, fast-flow periods, and later-summer speeds we have observed. Simulations of the Greenland ice-sheet flow under climate warming scenarios should account for the dynamic evolution of subglacial drainage; a simple model of basal lubrication alone misses key aspects of the ice sheet's response to climate warming.	[Sundal, Aud Venke; Shepherd, Andrew; Palmer, Steven] Univ Leeds, Sch Earth & Environm, Leeds LS2 9JT, W Yorkshire, England; [Nienow, Peter] Univ Edinburgh, Sch Geosci, Edinburgh EH8 9XP, Midlothian, Scotland; [Hanna, Edward] Univ Sheffield, Dept Geog, Sheffield S10 2TN, S Yorkshire, England; [Huybrechts, Philippe] Vrije Univ Brussel, Dept Geog, B-1050 Brussels, Belgium	University of Leeds; University of Edinburgh; University of Sheffield; Vrije Universiteit Brussel	Shepherd, A (corresponding author), Univ Leeds, Sch Earth & Environm, Woodhouse Lane, Leeds LS2 9JT, W Yorkshire, England.	a.shepherd@leeds.ac.uk	Palmer, Steven/D-5170-2013; Hanna, Edward/W-5927-2019; Hanna, Edward/H-2219-2016; Huybrechts, Philippe/J-5278-2013	Hanna, Edward/0000-0002-8683-182X; Hanna, Edward/0000-0002-8683-182X; Huybrechts, Philippe/0000-0003-1406-0525; Palmer, Steven/0000-0003-3977-8509; Shepherd, Andrew/0000-0002-4914-1299	UK NERC National Centre for Earth Observation; EU [026]; Natural Environment Research Council [cpom20001, earth010006] Funding Source: researchfish; NERC [cpom20001] Funding Source: UKRI	UK NERC National Centre for Earth Observation(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EU(European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the UK NERC National Centre for Earth Observation, a Philip Leverhulme Prize to A.S. and by the EU FP7 Ice2Sea project (publ. no. 026). European Remote Sensing satellite synthetic aperture radar data were provided by the European Space Agency Vectra Consortium. We thank R. van de Wal for providing positive degree-day data.	Abdalati W, 2001, J GEOPHYS RES-ATMOS, V106, P33983, DOI 10.1029/2001JD900181; Bartholomaus TC, 2008, NAT GEOSCI, V1, P33, DOI 10.1038/ngeo.2007.52; Bartholomew I, 2010, NAT GEOSCI, V3, P408, DOI 10.1038/NGEO863; Bingham RG, 2003, ANN GLACIOL, V37, P181, DOI 10.3189/172756403781815762; Das SB, 2008, SCIENCE, V320, P778, DOI 10.1126/science.1153360; Hanna E, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005641; Hanna E, 2008, J CLIMATE, V21, P331, DOI 10.1175/2007JCLI1964.1; Janssens I, 2000, ANN GLACIOL-SER, V31, P133, DOI 10.3189/172756400781819941; Johannessen OM, 2005, SCIENCE, V310, P1013, DOI 10.1126/science.1115356; Joughin I, 2008, SCIENCE, V320, P781, DOI 10.1126/science.1153288; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; Mernild SH, 2010, J HYDROMETEOROL, V11, P3, DOI 10.1175/2009JHM1140.1; Palmer S.J., EARTH PLANE IN PRESS; Parizek BR, 2004, QUATERNARY SCI REV, V23, P1013, DOI 10.1016/j.quascirev.2003.12.024; Price SF, 2008, J GLACIOL, V54, P213, DOI 10.3189/002214308784886117; Pritchard H, 2005, J GEOPHYS RES-EARTH, V110, DOI 10.1029/2004JF000233; Rignot E, 2006, SCIENCE, V311, P986, DOI 10.1126/science.1121381; Ru┬thlisberger H., 1972, J GLACIOL, V11, P177, DOI [10.3189/S0022143000022188, DOI 10.1017/S0022143000022188]; Schoof C, 2005, P ROY SOC A-MATH PHY, V461, P609, DOI 10.1098/rspa.2004.1350; Schoof C, 2010, NATURE, V468, P803, DOI 10.1038/nature09618; Shepherd A, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL035758; Steffen K, 2001, J GEOPHYS RES-ATMOS, V106, P33951, DOI 10.1029/2001JD900161; Strozzi T, 2002, IEEE T GEOSCI REMOTE, V40, P2384, DOI 10.1109/TGRS.2002.805079; Truffer M, 2005, J GLACIOL, V51, P663, DOI 10.3189/172756505781829016; van de Wal RSW, 2008, SCIENCE, V321, P111, DOI 10.1126/science.1158540; Zwally HJ, 2002, SCIENCE, V297, P218, DOI 10.1126/science.1072708	26	234	238	2	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					522	U83		10.1038/nature09740	http://dx.doi.org/10.1038/nature09740			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270891				2022-12-28	WOS:000286596500030
J	Pornillos, O; Ganser-Pornillos, BK; Yeager, M				Pornillos, Owen; Ganser-Pornillos, Barbie K.; Yeager, Mark			Atomic-level modelling of the HIV capsid	NATURE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; C-TERMINAL DOMAIN; ROUS-SARCOMA-VIRUS; DIMERIZATION DOMAIN; IN-VITRO; STRUCTURE VALIDATION; ASSEMBLY PROPERTIES; PROTEIN; TYPE-1; CORE	The mature capsids of human immunodeficiency virus type 1 (HIV-1) and other retroviruses are fullerene shells, composed of the viral CA protein, that enclose the viral genome and facilitate its delivery into new host cells(1). Retroviral CA proteins contain independently folded amino (N)- and carboxy (C)-terminal domains (NTD and CTD) that are connected by a flexible linker(2-4). The NTD forms either hexameric or pentameric rings, whereas the CTD forms symmetric homodimers that connect the rings into a hexagonal lattice(3,5-13). We previously used a disulphide crosslinking strategy to enable isolation and crystallization of soluble HIV-1 CA hexamers(11,14). Here we use the same approach to solve the X-ray structure of the HIV-1 CA pentamer at 2.5 angstrom resolution. Two mutant CA proteins with engineered disulphides at different positions (P17C/T19C and N21C/A22C) converged onto the same quaternary structure, indicating that the disulphide-crosslinked proteins recapitulate the structure of the native pentamer. Assembly of the quasi-equivalent hexamers and pentamers requires remarkably subtle rearrangements in subunit interactions, and appears to be controlled by an electrostatic switch that favours hexamers over pentamers. This study completes the gallery of substructures describing the components of the HIV-1 capsid and enables atomic-level modelling of the complete capsid. Rigid-body rotations around two assembly interfaces appear sufficient to generate the full range of continuously varying lattice curvature in the fullerene cone.	[Pornillos, Owen; Ganser-Pornillos, Barbie K.; Yeager, Mark] Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Pornillos, Owen; Ganser-Pornillos, Barbie K.; Yeager, Mark] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA; [Yeager, Mark] Univ Virginia Hlth Syst, Dept Med, Div Cardiovasc Med, Charlottesville, VA 22908 USA	University of Virginia; Scripps Research Institute; University of Virginia	Yeager, M (corresponding author), Univ Virginia, Sch Med, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.	yeager@virginia.edu			US National Institutes of Health [R01-GM066087, P50-GM082545]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM082545, R01GM066087] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded by grants from the US National Institutes of Health to M.Y. (R01-GM066087 and P50-GM082545). X-ray diffraction data were collected at beamlines 22-BM and 22-ID at the Advanced Photon Source, Argonne National Laboratory. Initial crystal screening was performed with the assistance of S. Banumathi through the Collaborative Crystallography Program, Lawrence Berkeley National Laboratory at the Advanced Light Source. We thank J.E. Johnson and D. Borek for crystallographic advice; Y. Hua for assistance with molecular biology experiments; and I. A. Wilson, C. P. Hill and W. I. Sundquist for critical reading of the manuscript.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alcaraz LA, 2007, BIOPHYS J, V93, P1264, DOI 10.1529/biophysj.106.101089; Bailey GD, 2009, STRUCTURE, V17, P737, DOI 10.1016/j.str.2009.03.010; Bartonova V, 2008, J BIOL CHEM, V283, P32024, DOI 10.1074/jbc.M804230200; Berthet-Colominas C, 1999, EMBO J, V18, P1124, DOI 10.1093/emboj/18.5.1124; Byeon IJL, 2009, CELL, V139, P780, DOI 10.1016/j.cell.2009.10.010; CAMPBELL S, 1995, J VIROL, V69, P6487, DOI 10.1128/JVI.69.10.6487-6497.1995; Cardone G, 2009, NATURE, V457, P694, DOI 10.1038/nature07724; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; EHRLICH LS, 1992, J VIROL, V66, P4874, DOI 10.1128/JVI.66.8.4874-4883.1992; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gamble TR, 1997, SCIENCE, V278, P849, DOI 10.1126/science.278.5339.849; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Ganser-Pornillos BK, 2008, CURR OPIN STRUC BIOL, V18, P203, DOI 10.1016/j.sbi.2008.02.001; Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018; Ganser-Pornillos BK, 2004, J VIROL, V78, P2545, DOI 10.1128/JVI.78.5.2545-2552.2004; Gitti RK, 1996, SCIENCE, V273, P231, DOI 10.1126/science.273.5272.231; Gross I, 1997, EUR J BIOCHEM, V249, P592, DOI 10.1111/j.1432-1033.1997.t01-1-00592.x; Heymann JB, 2008, COMPUT MATH METHOD M, V9, P197, DOI 10.1080/17486700802168106; Hyun JK, 2010, J BIOL CHEM, V285, P15056, DOI 10.1074/jbc.M110.108209; Ivanov D, 2007, P NATL ACAD SCI USA, V104, P4353, DOI 10.1073/pnas.0609477104; Jin ZM, 1999, J MOL BIOL, V286, P83, DOI 10.1006/jmbi.1998.2443; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P826, DOI 10.1107/S0907444995014983; Li S, 2000, NATURE, V407, P409, DOI 10.1038/35030177; Mortuza GB, 2004, NATURE, V431, P481, DOI 10.1038/nature02915; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pornillos O, 2010, J MOL BIOL, V401, P985, DOI 10.1016/j.jmb.2010.06.042; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Reddy V, 2003, ACTA CRYSTALLOGR D, V59, P2200, DOI 10.1107/S0907444903020316; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; von Schwedler UK, 2003, J VIROL, V77, P5439, DOI 10.1128/JVI.77.9.5439-5450.2003; Wong HC, 2008, BIOCHEMISTRY-US, V47, P2289, DOI 10.1021/bi7022128; Worthylake DK, 1999, ACTA CRYSTALLOGR D, V55, P85, DOI 10.1107/S0907444998007689; Wriggers W, 1997, PROTEINS, V29, P1	37	274	278	0	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					424	+		10.1038/nature09640	http://dx.doi.org/10.1038/nature09640			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248851	Green Accepted			2022-12-28	WOS:000286385600058
J	Fowler, CD; Lu, Q; Johnson, PM; Marks, MJ; Kenny, PJ				Fowler, Christie D.; Lu, Qun; Johnson, Paul M.; Marks, Michael J.; Kenny, Paul J.			Habenular alpha 5 nicotinic receptor subunit signalling controls nicotine intake	NATURE			English	Article							INTRACRANIAL SELF-STIMULATION; BRAIN REWARD SYSTEMS; LUNG-CANCER; INTERPEDUNCULAR NUCLEUS; ACETYLCHOLINE-RECEPTORS; SUSCEPTIBILITY LOCUS; RISK; ASSOCIATION; RATS; ACTIVATION	Genetic variation in CHRN alpha 5, the gene encoding the alpha 5 nicotinic acetylcholine receptor subunit, increases vulnerability to tobacco addiction and lung cancer, but the underlying mechanisms are unknown. Here we report markedly increased nicotine intake in mice with a null mutation in Chrn alpha 5. This effect was 'rescued' in knockout mice by re-expressing alpha 5 subunits in the medial habenula (MHb), and recapitulated in rats through alpha 5 subunit knockdown in MHb. Remarkably, alpha 5 subunit knockdown in MHb did not alter the rewarding effects of nicotine but abolished the inhibitory effects of higher nicotine doses on brain reward systems. The MHb extends projections almost exclusively to the interpeduncular nucleus (IPN). We found diminished IPN activation in response to nicotine in alpha 5 knockout mice. Further, disruption of IPN signalling increased nicotine intake in rats. Our findings indicate that nicotine activates the habenulo-interpeduncular pathway through alpha 5-containing nAChRs, triggering an inhibitory motivational signal that acts to limit nicotine intake.	[Fowler, Christie D.; Lu, Qun; Johnson, Paul M.; Kenny, Paul J.] Scripps Res Inst Scripps Florida, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL 33458 USA; [Marks, Michael J.] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA	Scripps Research Institute; State University System of Florida; University of Florida; University of Colorado System; University of Colorado Boulder	Kenny, PJ (corresponding author), Scripps Res Inst Scripps Florida, Dept Mol Therapeut, Lab Behav & Mol Neurosci, Jupiter, FL 33458 USA.	pjkenny@scripps.edu	Fowler, Christie D/A-1754-2015	Fowler, Christie/0000-0003-2864-2163	National Institute on Drug Abuse [DA020686, DA026693, P30DA015663]; Florida Department of Health [07KN-06]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA020686, F32DA026693, P30DA015663] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Florida Department of Health; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Institute on Drug Abuse (DA020686 to P.J.K.; DA026693 to C.D.F.; P30DA015663 to M.J.M.) and The James and Esther King Biomedical Research Program, Florida Department of Health (07KN-06 to P.J.K.).	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Berrettine W, 2008, MOL PSYCHIATR, V13, P368, DOI 10.1038/sj.mp.4002154; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Brown RWB, 2007, J NEUROCHEM, V103, P204, DOI 10.1111/j.1471-4159.2007.04700.x; CORRIGALL WA, 1992, PSYCHOPHARMACOLOGY, V107, P285, DOI 10.1007/BF02245149; CORRIGALL WA, 1989, PSYCHOPHARMACOLOGY, V99, P473, DOI 10.1007/BF00589894; DONOVICK PJ, 1970, J COMP PHYSIOL PSYCH, V71, P376, DOI 10.1037/h0029114; Gavrilov Yu V, 2008, Neurosci Behav Physiol, V38, P189, DOI 10.1007/s11055-008-0028-9; Girod R, 2000, NEUROPHARMACOLOGY, V39, P2715, DOI 10.1016/S0028-3908(00)00145-3; Glick SD, 2006, EUR J PHARMACOL, V537, P94, DOI 10.1016/j.ejphar.2006.03.045; Grady SR, 2009, J NEUROSCI, V29, P2272, DOI 10.1523/JNEUROSCI.5121-08.2009; HENNINGFIELD JE, 1983, PHARMACOL BIOCHEM BE, V19, P989, DOI 10.1016/0091-3057(83)90405-7; HERKENHAM M, 1979, J COMP NEUROL, V187, P19, DOI 10.1002/cne.901870103; Hong LE, 2010, P NATL ACAD SCI USA, V107, P13509, DOI 10.1073/pnas.1004745107; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Hussain RJ, 2008, NEUROSCI LETT, V440, P270, DOI 10.1016/j.neulet.2008.06.001; HUSTONLYONS D, 1992, PHARMACOL BIOCHEM BE, V41, P755, DOI 10.1016/0091-3057(92)90223-3; Ikemoto S, 2006, J NEUROSCI, V26, P723, DOI 10.1523/JNEUROSCI.4542-05.2006; Jackson KJ, 2010, J PHARMACOL EXP THER, V334, P137, DOI 10.1124/jpet.110.165738; Kenny PJ, 2007, TRENDS PHARMACOL SCI, V28, P135, DOI 10.1016/j.tips.2007.01.008; Kenny PJ, 2009, NEUROPSYCHOPHARMACOL, V34, P266, DOI 10.1038/npp.2008.58; Kenny PJ, 2006, NEUROPSYCHOPHARMACOL, V31, P1203, DOI 10.1038/sj.npp.1300905; KORNETSKY C, 1979, ARCH GEN PSYCHIAT, V36, P289; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Laviolette SR, 2002, J NEUROSCI, V22, P8653; Le Foll B, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000230; Le Marchand L, 2008, CANCER RES, V68, P9137, DOI 10.1158/0008-5472.CAN-08-2271; Le Novere N, 2002, J NEUROBIOL, V53, P447, DOI 10.1002/neu.10153; Lecourtier L, 2004, EUR J NEUROSCI, V19, P2551, DOI 10.1111/j.0953-816X.2004.03356.x; Liu JZ, 2010, NAT GENET, V42, P436, DOI 10.1038/ng.572; LONDON ED, 1988, J NEUROSCI, V8, P3920; Lynch WJ, 1999, EXP CLIN PSYCHOPHARM, V7, P198, DOI 10.1037/1064-1297.7.3.198; Lynch WJ, 2001, EXP CLIN PSYCHOPHARM, V9, P131, DOI 10.1037//1064-1297.9.2.131; Marks MJ, 1999, J PHARMACOL EXP THER, V289, P1090; MARKS MJ, 1992, J NEUROSCI, V12, P2765; Maskos U, 2005, NATURE, V436, P103, DOI 10.1038/nature03694; Matsumoto M, 2007, NATURE, V447, P1111, DOI 10.1038/nature05860; Matta SG, 2007, PSYCHOPHARMACOLOGY, V190, P269, DOI 10.1007/s00213-006-0441-0; MCGEHEE DS, 1995, SCIENCE, V269, P1692, DOI 10.1126/science.7569895; Mokdad AH, 2004, JAMA-J AM MED ASSOC, V291, P1238, DOI 10.1001/jama.291.10.1238; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Picciotto MR, 1998, NATURE, V391, P173, DOI 10.1038/34413; Qin C, 2009, NEUROSCIENCE, V161, P827, DOI 10.1016/j.neuroscience.2009.03.085; Rauhut AS, 2008, PHARMACOL BIOCHEM BE, V90, P598, DOI 10.1016/j.pbb.2008.05.002; RISNER ME, 1983, J PHARMACOL EXP THER, V224, P319; RUSSELL MAH, 1975, BRIT MED J, V2, P414, DOI 10.1136/bmj.2.5968.414; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Salas R, 2003, MOL PHARMACOL, V63, P1059, DOI 10.1124/mol.63.5.1059; Salas R, 2009, J NEUROSCI, V29, P3014, DOI 10.1523/JNEUROSCI.4934-08.2009; SCHAEFER GJ, 1986, NEUROPHARMACOLOGY, V25, P125, DOI 10.1016/0028-3908(86)90033-X; Schlaelpfer IR, 2008, BIOL PSYCHIAT, V63, P1039, DOI 10.1016/j.biopsych.2007.10.024; Shoaib M, 2002, NEUROPHARMACOLOGY, V42, P530, DOI 10.1016/S0028-3908(01)00194-0; STOLERMAN IP, 1995, PSYCHOPHARMACOLOGY, V117, P2, DOI 10.1007/BF02245088; Tapper AR, 2004, SCIENCE, V306, P1029, DOI 10.1126/science.1099420; Wang YF, 2010, CARCINOGENESIS, V31, P234, DOI 10.1093/carcin/bgp287	56	442	446	1	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 31	2011	471	7340					597	601		10.1038/nature09797	http://dx.doi.org/10.1038/nature09797			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	742NN	21278726	Green Accepted, Green Submitted			2022-12-28	WOS:000288951200034
J	Adzick, NS; Thom, EA; Spong, CY; Brock, JW; Burrows, PK; Johnson, MP; Howell, LJ; Farrell, JA; Dabrowiak, ME; Sutton, LN; Gupta, N; Tulipan, NB; D'Alton, ME; Farmer, DL				Adzick, N. Scott; Thom, Elizabeth A.; Spong, Catherine Y.; Brock, John W., III; Burrows, Pamela K.; Johnson, Mark P.; Howell, Lori J.; Farrell, Jody A.; Dabrowiak, Mary E.; Sutton, Leslie N.; Gupta, Nalin; Tulipan, Noel B.; D'Alton, Mary E.; Farmer, Diana L.		MOMS Investigators	A Randomized Trial of Prenatal versus Postnatal Repair of Myelomeningocele	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MATERNAL-FETAL SURGERY; IN-UTERO; HINDBRAIN HERNIATION; MODEL	BACKGROUND Prenatal repair of myelomeningocele, the most common form of spina bifida, may result in better neurologic function than repair deferred until after delivery. We compared outcomes of in utero repair with standard postnatal repair. METHODS We randomly assigned eligible women to undergo either prenatal surgery before 26 weeks of gestation or standard postnatal repair. One primary outcome was a composite of fetal or neonatal death or the need for placement of a cerebrospinal fluid shunt by the age of 12 months. Another primary outcome at 30 months was a composite of mental development and motor function. RESULTS The trial was stopped for efficacy of prenatal surgery after the recruitment of 183 of a planned 200 patients. This report is based on results in 158 patients whose children were evaluated at 12 months. The first primary outcome occurred in 68% of the infants in the prenatal-surgery group and in 98% of those in the postnatal-surgery group (relative risk, 0.70; 97.7% confidence interval [CI], 0.58 to 0.84; P<0.001). Actual rates of shunt placement were 40% in the prenatal-surgery group and 82% in the postnatal-surgery group (relative risk, 0.48; 97.7% CI, 0.36 to 0.64; P<0.001). Prenatal surgery also resulted in improvement in the composite score for mental development and motor function at 30 months (P = 0.007) and in improvement in several secondary outcomes, including hindbrain herniation by 12 months and ambulation by 30 months. However, prenatal surgery was associated with an increased risk of preterm delivery and uterine dehiscence at delivery. CONCLUSIONS Prenatal surgery for myelomeningocele reduced the need for shunting and improved motor outcomes at 30 months but was associated with maternal and fetal risks.	[Adzick, N. Scott] Childrens Hosp Philadelphia, Ctr Fetal Diag & Treatment, Philadelphia, PA 19104 USA; [Adzick, N. Scott; Johnson, Mark P.; Howell, Lori J.; Sutton, Leslie N.] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Thom, Elizabeth A.; Burrows, Pamela K.] George Washington Univ, Ctr Biostat, Washington, DC USA; [Spong, Catherine Y.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA; [Brock, John W., III; Dabrowiak, Mary E.; Tulipan, Noel B.] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Farrell, Jody A.; Gupta, Nalin; Farmer, Diana L.] Univ Calif San Francisco, Benioff Childrens Hosp, San Francisco, CA 94143 USA; [Farrell, Jody A.; Gupta, Nalin; Farmer, Diana L.] Univ Calif San Francisco, Sch Med, San Francisco, CA 94143 USA; [D'Alton, Mary E.] Columbia Univ Coll Phys & Surg, New York, NY 10032 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; George Washington University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Vanderbilt University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Columbia University	Adzick, NS (corresponding author), Childrens Hosp Philadelphia, Ctr Fetal Diag & Treatment, 34th St & Civ Ctr Blvd, Philadelphia, PA 19104 USA.	adzick@email.chop.edu	Drehmer, Jeremy/J-5873-2019	Drehmer, Jeremy/0000-0002-5022-5836; Sugarman, Jeremy/0000-0001-7022-8332; Cochrane, Douglas/0000-0002-4907-4583; Farmer, Diana/0000-0002-3530-5993	Eunice Kennedy Shriver National Institute of Child Health and Human Development [U10 HD041666, U01HD041665, U10 HD041667, U10 HD041669]; National Institutes of Health [UL1-RR-024134, UL1-RR-024131, UL1-RR-024975]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U10HD041666, U10HD041667, U01HD041665, U10HD041669] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR024978, UL1RR024131, KL2RR024977, UL1RR024975, UL1RR024134] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported by grants (U10 HD041666, U01HD041665, U10 HD041667, and U10 HD041669) from the Eunice Kennedy Shriver National Institute of Child Health and Human Development and by grants (UL1-RR-024134, UL1-RR-024131, and UL1-RR-024975) from the Clinical and Translational Science Awards, National Institutes of Health.	ADZICK NS, 1986, J PEDIATR SURG, V21, P477, DOI 10.1016/S0022-3468(86)80215-9; Bouchard S, 2003, J PEDIATR SURG, V38, P451, DOI 10.1053/jpsu.2003.50078; Boulet SL, 2008, BIRTH DEFECTS RES A, V82, P527, DOI 10.1002/bdra.20468; Caldarelli M, 1996, CHILD NERV SYST, V12, P748, DOI 10.1007/BF00261592; Danzer E, 2010, NEUROPEDIATRICS, V41, P140, DOI 10.1055/s-0030-1263164; Danzer E, 2008, NEUROPEDIATRICS, V39, P359, DOI 10.1055/s-0029-1202835; Danzer E, 2009, FETAL DIAGN THER, V25, P47, DOI 10.1159/000197359; Farrell JA, 1999, FETAL DIAGN THER, V14, P190, DOI 10.1159/000020918; HEFFEZ DS, 1993, NEUROSURGERY, V32, P1005, DOI 10.1227/00006123-199306000-00021; Hunt GM, 1997, DEV MED CHILD NEUROL, V39, P568; Johnson MP, 2006, AM J OBSTET GYNECOL, V194, P1145, DOI 10.1016/j.ajog.2006.01.072; Johnson MP, 2003, AM J OBSTET GYNECOL, V189, P482, DOI 10.1067/S0002-9378(03)00295-3; KORENROMP MJ, 1986, LANCET, V1, P917, DOI 10.1016/S0140-6736(86)91022-6; LAN KKG, 1983, BIOMETRIKA, V70, P659, DOI 10.2307/2336502; Manning SM, 2000, MENT RETARD DEV D R, V6, P6, DOI 10.1002/(SICI)1098-2779(2000)6:1<6::AID-MRDD2>3.0.CO;2-B; MEULI M, 1995, J PEDIATR SURG, V30, P1028, DOI 10.1016/0022-3468(95)90335-6; MEULI M, 1995, NAT MED, V1, P342, DOI 10.1038/nm0495-342; Mitchell LE, 2004, LANCET, V364, P1885, DOI 10.1016/S0140-6736(04)17445-X; OBRIEN PC, 1984, BIOMETRICS, V40, P1079, DOI 10.2307/2531158; Paek BW, 2000, AM J OBSTET GYNECOL, V183, P1119, DOI 10.1067/mob.2000.108867; Rintoul NE, 2002, PEDIATRICS, V109, P409, DOI 10.1542/peds.109.3.409; SHURTLEFF DB, 1994, CIBA F SYMP, V181, P270; Sival DA, 1997, EARLY HUM DEV, V50, P27, DOI 10.1016/S0378-3782(97)00090-X; Sutton LN, 1999, JAMA-J AM MED ASSOC, V282, P1826, DOI 10.1001/jama.282.19.1826; Tulipan N, 1999, PEDIATR NEUROSURG, V31, P183, DOI 10.1159/000028859; WEI LJ, 1978, J AM STAT ASSOC, V73, P559, DOI 10.2307/2286600; Wilson RD, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.029; Wilson RD, 2003, FETAL DIAGN THER, V18, P314, DOI 10.1159/000071972	28	1113	1134	1	78	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2011	364	11					993	1004		10.1056/NEJMoa1014379	http://dx.doi.org/10.1056/NEJMoa1014379			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735SX	21306277	Green Accepted			2022-12-28	WOS:000288439000005
J	Bansagi, T; Vanag, VK; Epstein, IR				Bansagi, Tamas, Jr.; Vanag, Vladimir K.; Epstein, Irving R.			Tomography of Reaction-Diffusion Microemulsions Reveals Three-Dimensional Turing Patterns	SCIENCE			English	Article							WAVES; DYNAMICS; GRADIENT; SYSTEMS; DESIGN; MODEL	Spatially periodic, temporally stationary patterns that emerge from instability of a homogeneous steady state were proposed by Alan Turing in 1952 as a mechanism for morphogenesis in living systems and have attracted increasing attention in biology, chemistry, and physics. Patterns found to date have been confined to one or two spatial dimensions. We used tomography to study the Belousov-Zhabotinsky reaction in a microemulsion in which the polar reactants are confined to aqueous nanodroplets much smaller than the scale of the stationary patterns. We demonstrate the existence of Turing patterns that can exist only in three dimensions, including curved surfaces, hexagonally packed cylinders, spots, and labyrinthine and lamellar patterns.	[Bansagi, Tamas, Jr.; Vanag, Vladimir K.; Epstein, Irving R.] Brandeis Univ, Dept Chem, Waltham, MA 02454 USA	Brandeis University	Epstein, IR (corresponding author), Brandeis Univ, Dept Chem, MS 015, Waltham, MA 02454 USA.	epstein@brandeis.edu		Vanag, Vladimir/0000-0002-9521-6650	NSF [CHE-0615507, CHE-0526866]; NSF Materials Research Science and Engineering Center [DMR-0820492]; U.S.-Hungarian Cooperative Grant; Radcliffe Institute	NSF(National Science Foundation (NSF)); NSF Materials Research Science and Engineering Center(National Science Foundation (NSF)); U.S.-Hungarian Cooperative Grant; Radcliffe Institute	We thank M. Hauser for helpful discussions, J. Carballido-Landeira for preliminary experiments, and F. Mello for assistance in constructing the tomography apparatus. This work was funded by the NSF under grants CHE-0615507, CHE-0526866, and NSF Materials Research Science and Engineering Center grant DMR-0820492 and a U.S.-Hungarian Cooperative Grant. I. R. E. thanks the Radcliffe Institute for a fellowship.	Augustin R, 2006, DEV BIOL, V296, P62, DOI 10.1016/j.ydbio.2006.04.003; Bansagi T, 2008, CHAOS, V18, DOI 10.1063/1.2896100; Callahan TK, 2004, PHYSICA D, V188, P65, DOI 10.1016/S0167-2789(03)00286-0; CASTETS V, 1990, PHYS REV LETT, V64, P2953, DOI 10.1103/PhysRevLett.64.2953; Coullet P, 2004, CHAOS, V14, P193, DOI 10.1063/1.1642311; DEKEPPER P, 1982, J PHYS CHEM-US, V86, P170, DOI 10.1021/j100391a007; DeWit A, 1997, P NATL ACAD SCI USA, V94, P12765, DOI 10.1073/pnas.94.24.12765; Dulos E, 1996, PHYSICA D, V98, P53, DOI 10.1016/0167-2789(96)00072-3; Horvath J, 2009, SCIENCE, V324, P772, DOI 10.1126/science.1169973; Jiang TX, 1999, DEVELOPMENT, V126, P4997; Jung HS, 1998, DEV BIOL, V196, P11, DOI 10.1006/dbio.1998.8850; Kak A.V., 1988, PRINCIPLES COMPUTERI, DOI DOI 10.1137/1.9780898719277.CH7; Kaminaga A, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1888386; Kondo S, 2010, SCIENCE, V329, P1616, DOI 10.1126/science.1179047; Leda M, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.066204; Leppanen T, 2003, INT J MOD PHYS B, V17, P5541, DOI 10.1142/S0217979203023240; Liu RT, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.011914; Maini PK, 2006, SCIENCE, V314, P1397, DOI 10.1126/science.1136396; Moore PK, 2009, CHAOS, V19, DOI 10.1063/1.3267509; NEWMAN SA, 1979, SCIENCE, V205, P662, DOI 10.1126/science.462174; OUYANG Q, 1991, NATURE, V352, P610, DOI 10.1038/352610a0; Shoji H, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.046212; Sick S, 2006, SCIENCE, V314, P1447, DOI 10.1126/science.1130088; Storb U, 2003, PHYS CHEM CHEM PHYS, V5, P2344, DOI 10.1039/b301790g; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; VANAG VK, 1994, J PHYS CHEM-US, V98, P1449, DOI 10.1021/j100056a013; Vanag VK, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.228301; Vanag VK, 2001, SCIENCE, V294, P835, DOI 10.1126/science.1064167; Winfree AT, 1996, CHAOS, V6, P617, DOI 10.1063/1.166208	29	117	117	4	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1309	1312		10.1126/science.1200815	http://dx.doi.org/10.1126/science.1200815			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21310963				2022-12-28	WOS:000288215200042
J	Anderson, SH; Kelly, D; Ladley, JJ; Molloy, S; Terry, J				Anderson, Sandra H.; Kelly, Dave; Ladley, Jenny J.; Molloy, Sue; Terry, Jon			Cascading Effects of Bird Functional Extinction Reduce Pollination and Plant Density	SCIENCE			English	Article							POLLEN LIMITATION; DISPERSAL; CONSEQUENCES	Reductions in bird numbers could hamper ecosystem services such as pollination, but experimental proof is lacking. We show that functional extinction of bird pollinators has reduced pollination, seed production, and plant density in the shrub Rhabdothamnus solandri (Gesneriaceae) on the North Island ("mainland") of New Zealand but not on three nearby island bird sanctuaries where birds remain abundant. Pollen limitation of fruit set is strong [pollen limitation index (PLI) = 0.69] and significant on the mainland but small (PLI = 0.15) and nonsignificant on islands. Seed production per flower on the mainland is reduced 84%. Mainland sites have similar adult densities, but 55% fewer juvenile plants per adult, than island sites. Seed addition experiments near adult R. solandri plants on the mainland found strong seed limitation 5 years after sowing for R. solandri but not for two other co-occurring woody species. This demonstrates a terrestrial trophic cascade.	[Kelly, Dave; Ladley, Jenny J.; Molloy, Sue; Terry, Jon] Univ Canterbury, Sch Biol Sci, Christchurch 8140, New Zealand; [Anderson, Sandra H.] Univ Auckland, Sch Biol Sci, Auckland 1010, New Zealand	University of Canterbury; University of Auckland	Kelly, D (corresponding author), Univ Canterbury, Sch Biol Sci, Private Bag 4800, Christchurch 8140, New Zealand.	dave.kelly@canterbury.ac.nz	Kelly, Dave/A-6129-2013	Kelly, Dave/0000-0002-9469-2161; Anderson, Sandra/0000-0002-6164-7380	Foundation for Research, Science and Technology [CO9X0004, CO9X0503]	Foundation for Research, Science and Technology(New Zealand Foundation for Research, Science and Technology)	W. Ji helped frequently with field work. Funding was provided by contracts (CO9X0004 and CO9X0503) from the Public Good Science Fund under the Foundation for Research, Science and Technology's Sustaining and Restoring Biodiversity program.	Allan H.H, 1961, FLORA NZ, VI; Ashman TL, 2004, ECOLOGY, V85, P2408, DOI 10.1890/03-8024; Beever R. E., 1983, AUCKLAND BOT SOC NEW, V38, P24; Bell B.D., 1991, P195; Christian CE, 2001, NATURE, V413, P635, DOI 10.1038/35098093; CLOUT MN, 1989, NEW ZEAL J ECOL, V12, P27; DIAMOND JM, 1984, NEW ZEAL J ECOL, V7, P37; Driskell A, 2007, AUST J ZOOL, V55, P73, DOI 10.1071/ZO07007; Heather B.D., 1996, FIELD GUIDE BIRDS NZ; Higgins P. J., 2001, HDB AUSTR NZ ANTARCT, V5; Innes J, 2010, NEW ZEAL J ECOL, V34, P86; JANZEN DH, 1974, NAT HIST, V83, P48; Kelly D, 2006, ECOL STUD-ANAL SYNTH, V186, P227; Kelly D, 2004, NEW ZEAL J BOT, V42, P89, DOI 10.1080/0028825X.2004.9512892; Kelly D, 2010, NEW ZEAL J ECOL, V34, P66; King CM., 2005, HDB NZ MAMMALS; Larson BMH, 2000, BIOL J LINN SOC, V69, P503, DOI 10.1111/j.1095-8312.2000.tb01221.x; Norton DA, 2009, SCIENCE, V325, P569, DOI 10.1126/science.1172978; Petrie D., 1902, T P R SOC NZ, V35, P321; Robertson AW, 1999, CONSERV BIOL, V13, P499, DOI 10.1046/j.1523-1739.1999.97471.x; Sekercioglu CH, 2006, TRENDS ECOL EVOL, V21, P464, DOI 10.1016/j.tree.2006.05.007; Sekercioglu CH, 2004, P NATL ACAD SCI USA, V101, P18042, DOI 10.1073/pnas.0408049101; Sharam GJ, 2009, SCIENCE, V325, P51, DOI 10.1126/science.1173805; STEADMAN DW, 2006, EXT BIOG TROP PAC, pR9; Traveset A, 2005, CONSERV BIOL, V19, P421, DOI 10.1111/j.1523-1739.2005.00019.x; [No title captured]	26	191	198	3	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1068	1071		10.1126/science.1199092	http://dx.doi.org/10.1126/science.1199092			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21292938				2022-12-28	WOS:000287699000064
J	Godfray, HCJ; Pretty, J; Thomas, SM; Warham, EJ; Beddington, JR				Godfray, H. C. J.; Pretty, J.; Thomas, S. M.; Warham, E. J.; Beddington, J. R.			Linking Policy on Climate and Food	SCIENCE			English	Editorial Material									[Thomas, S. M.; Warham, E. J.; Beddington, J. R.] Foresight, Govt Off Sci, London, England; [Godfray, H. C. J.] Univ Oxford, Oxford Martin Sch, Dept Zool, Oxford OX1 3PS, England; [Godfray, H. C. J.] Univ Oxford, Oxford Martin Sch, Inst Biodivers, Oxford OX1 3PS, England; [Pretty, J.] Univ Essex, Dept Biol Sci, Colchester CO4 3SQ, Essex, England	University of Oxford; University of Oxford; University of Essex	Thomas, SM (corresponding author), Foresight, Govt Off Sci, London, England.	sandy.thomas@bis.gsi.gov.uk	Pretty, Jules/D-4071-2012	Pretty, Jules/0000-0002-3897-6581				[Anonymous], JOINT STAT GLOB FOOD; [Anonymous], 5 NATL COMMUNICATION; [Anonymous], KYOTO PROTOCOL; [Anonymous], FAOSTAT; Batjes N. H., 1999, 401200031 DUTCH NAT; Bellarby J., 2008, COOL FARMING CLIMATE; Evans L., 1998, FEEDING 10 BILLION P; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Government Office of Science, 2011, FOR MIGR GLOB ENV CH; REDD+, REDD; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497	11	100	104	3	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1013	1014		10.1126/science.1202899	http://dx.doi.org/10.1126/science.1202899			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	726DM	21273449				2022-12-28	WOS:000287699000036
J	Widera, E; Steenpass, V; Marson, D; Sudore, R				Widera, Eric; Steenpass, Veronika; Marson, Daniel; Sudore, Rebecca			Finances in the Older Patient With Cognitive Impairment "He Didn't Want Me to Take Over"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; ELDER ABUSE; FUNCTIONAL ABILITIES; RISK-FACTORS; CAPACITY; DEMENTIA; AWARENESS; ADULTS; PERFORMANCE	Financial capacity can be defined as the ability to independently manage one's financial affairs in a manner consistent with personal self-interest. Financial capacity is essential for an individual to function independently in society; however, Alzheimer disease and other progressive dementias eventually lead to a complete loss of financial capacity. Many patients with cognitive impairment and their families seek guidance from their primary care clinician for help with financial impairment, yet most clinicians do not understand their role or know how to help. We review the prevalence and impact of diminished financial capacity in older adults with cognitive impairment. We also articulate the role of the primary care clinician, which includes (1) educating older adult patients and their families about the need for advance financial planning; (2) recognizing signs of possible impaired financial capacity; (3) assessing financial impairments in cognitively impaired adults; (4) recommending interventions to help patients maintain financial independence; and (5) knowing when and to whom to make medical and legal referrals. Clearly delineating the clinician's role regarding identification of financial impairment could establish for patients and families effective financial protections and limit the economic, psychological, and legal hardships of financial incapacity on patients with dementia and their families. JAMA. 2011;305(7):698-706 www.jama.com	[Widera, Eric; Sudore, Rebecca] Dept Vet Affairs Med Ctr, San Francisco, CA USA; [Widera, Eric; Steenpass, Veronika; Sudore, Rebecca] Univ Calif San Francisco, Div Geriatr, San Francisco, CA 94143 USA; [Marson, Daniel] Univ Alabama Birmingham, Dept Neurol, Birmingham, AL USA; [Marson, Daniel] Univ Alabama Birmingham, Alzheimers Dis Res Ctr, Birmingham, AL USA	University of California System; University of California San Francisco; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Widera, E (corresponding author), VA Med Ctr 181G, 4150 Clement St, San Francisco, CA 94121 USA.	eric.widera@ucsf.edu	Sudore, Rebecca/AAF-1635-2021		National Institutes of Health [HD053074, MH55247, AG021927, AG16582, AG24904, AG10483]; University of Alabama at Birmingham Research Foundation; Pfizer; Health Resources and Services Administration; Hartford Foundation as a Center of Excellence Faculty Scholar; National Institute on Aging [2R01 AG021927, 1P50 AG16582]; National Institute of Child Health and Human Development [1R01 HD053074]; US Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development; San Francisco Research Enhancement Award Program; SCAN Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD053074] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG021927, U01AG024904, R01AG021927, U01AG010483, P50AG016582] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Alabama at Birmingham Research Foundation; Pfizer(Pfizer); Health Resources and Services Administration(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); Hartford Foundation as a Center of Excellence Faculty Scholar; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); US Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development(US Department of Veterans Affairs); San Francisco Research Enhancement Award Program; SCAN Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Drs Widera and Steenpass report no disclosures. Dr Marson reports serving as a consultant to the American Bar Association and the American Psychological Association; previous service as a consultant to Medivation Inc and Rush University; receipt of research support from the National Institutes of Health and serving as the primary investigator (HD053074, MH55247, AG021927, AG16582, AG24904 [site primary investigator], and AG10483); receipt of royalty payments as the coinventor of the Capacity to Consent to Treatment Instrument, and anticipates receiving royalty payments in the future as the inventor of the Financial Capacity Instrument (both instruments are owned by the University of Alabama at Birmingham Research Foundation); and provision of expert consultation and testimony in multiple legal cases during the past 5 years. Dr Sudore reports funding in part by a Pfizer Fellowship in Clear Health Communication.; Dr Widera reports support by a Geriatrics Academic Career Award from the Health Resources and Services Administration and by the Hartford Foundation as a Center of Excellence Faculty Scholar. Dr Marson reports having served as the primary investigator and was supported in part by grants from the National Institute on Aging (2R01 AG021927 and 1P50 AG16582), and from the National Institute of Child Health and Human Development (1R01 HD053074). Dr Sudore reports having received support from the US Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Health Services Research and Development, the San Francisco Research Enhancement Award Program, and a Pfizer Fellowship in Clear Health Communication. The Care of the Aging Patient series is made possible by funding from The SCAN Foundation.	Alzheimer's Association, 2010, Alzheimers Dement, V6, P158, DOI 10.1016/j.jalz.2010.01.009; American Bar Association Commission on Law and Aging American Psychological Association, 2008, ASS OLD AD DIM CAP H; Aravanis S C, 1993, Arch Fam Med, V2, P371, DOI 10.1001/archfami.2.4.371; Baird A, 2006, CLIN NEUROPSYCHOL, V20, P649, DOI 10.1080/13854040590967072; Borson S, 2005, J AM GERIATR SOC, V53, P871, DOI 10.1111/j.1532-5415.2005.53269.x; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Earnst KS, 2001, AGING NEUROPSYCHOL C, V8, P109, DOI 10.1076/anec.8.2.109.839; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fulmer T, 2004, J AM GERIATR SOC, V52, P297, DOI 10.1111/j.1532-5415.2004.52074.x; Garre-Olmo J, 2009, J AM GERIATR SOC, V57, P815, DOI 10.1111/j.1532-5415.2009.02221.x; Griffith HR, 2003, NEUROLOGY, V60, P449, DOI 10.1212/WNL.60.3.449; GUTHEIL TG, 2000, CLIN HDB PSYCHIAT LA; Hinton L, 2007, J GEN INTERN MED, V22, P1487, DOI 10.1007/s11606-007-0317-y; Jogerst GJ, 2003, AM J PUBLIC HEALTH, V93, P2131, DOI 10.2105/AJPH.93.12.2131; KATZ S, 1963, JAMA-J AM MED ASSOC, V185, P914, DOI 10.1001/jama.1963.03060120024016; Kershaw M. M., 2004, PSYCHIAT PSYCHOL LAW, V11, P338, DOI [10.1375/pplt.2004.11.2.338, DOI 10.1375/PPLT.2004.11.2.338]; Lachs MS, 1997, GERONTOLOGIST, V37, P469, DOI 10.1093/geront/37.4.469; LACHS MS, 1995, NEW ENGL J MED, V332, P437, DOI 10.1056/NEJM199502163320706; LAWTON MP, 1969, GERONTOLOGIST, V9, P9, DOI 10.1093/geront/9.1.9; Loeb PA., 1996, INDEPENDENT LIVING S; LOEWENSTEIN DA, 1989, J GERONTOL, V44, pP114, DOI 10.1093/geronj/44.4.P114; Loewenstein DA, 2001, J GERONTOL B-PSYCHOL, V56, pP78, DOI 10.1093/geronb/56.2.P78; Marson D, 2008, ENCY PSYCHL LAW, P313; Marson DC, 2009, J AM GERIATR SOC, V57, P806, DOI 10.1111/j.1532-5415.2009.02202.x; Marson DC, 2000, ARCH NEUROL-CHICAGO, V57, P877, DOI 10.1001/archneur.57.6.877; Martin R, 2008, AM J GERIAT PSYCHIAT, V16, P209, DOI 10.1097/JGP.0b013e318157cb00; Met Life Mature Market Institute, 2009, MARK SURV LONG TERM; Moberg PJ, 2008, NEUROREHABILITATION, V23, P403; Moore DJ, 2007, J PSYCHIATR RES, V41, P97, DOI 10.1016/j.jpsychires.2005.10.008; Moye J, 2005, REHABIL PSYCHOL, V50, P207, DOI 10.1037/0090-5550.50.3.207; Moye J, 1996, J AGING STUD, V10, P27, DOI 10.1016/S0890-4065(96)90015-8; Mungas D, 1996, NEUROLOGY, V46, P700, DOI 10.1212/WNL.46.3.700; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; [National Center on Elder Abuse American Public Human Services Association], 1998, NAT ELD AB INC STUD; Nichols L.O., 2006, CLIN GERONTOLOGIST, V30, P39, DOI [10.1300/J018v30n01_04, DOI 10.1300/J018V30N01_04]; Okonkwo OC, 2008, AM J GERIAT PSYCHIAT, V16, P650, DOI 10.1097/JGP.0b013e31817e8a9d; Okonkwo OC, 2006, J AM GERIATR SOC, V54, P1745, DOI 10.1111/j.1532-5415.2006.00916.x; Okonkwo OC, 2009, J AM GERIATR SOC, V57, P978, DOI 10.1111/j.1532-5415.2009.02261.x; OVERMAN W, 1988, AM J PSYCHIAT, V145, P1495; Peres K, 2008, J AM GERIATR SOC, V56, P37, DOI 10.1111/j.1532-5415.2007.01499.x; Petersen RC, 2010, NEUROLOGY, V74, P201, DOI 10.1212/WNL.0b013e3181cb3e25; Petersen RC, 2009, ARCH NEUROL-CHICAGO, V66, P1447, DOI 10.1001/archneurol.2009.266; Raivio MM, 2008, J MED ETHICS, V34, P882, DOI 10.1136/jme.2008.025015; Razani J, 2007, J AM GERIATR SOC, V55, P1415, DOI 10.1111/j.1532-5415.2007.01307.x; Reed K, 2005, CLIN GERIATR MED, V21, P365, DOI 10.1016/j.cger.2004.11.004; Sabbagh MN, 2006, ARCH NEUROL-CHICAGO, V63, P1771, DOI 10.1001/archneur.63.12.1771; Sherod MG, 2009, J INT NEUROPSYCH SOC, V15, P258, DOI 10.1017/S1355617709090365; Smith T, 2007, CAN J PSYCHIAT, V52, P329, DOI 10.1177/070674370705200508; Social Security Administration, 2009, SSA PUBL, V13-11826; Stiegal LA, 2008, POWER ATTORNEY ABUSE; Triebel KL, 2009, NEUROLOGY, V73, P928, DOI 10.1212/WNL.0b013e3181b87971; Tueth MJ, 2000, AM J GERIAT PSYCHIAT, V8, P104, DOI 10.1176/appi.ajgp.8.2.104; Van Wielingen LE, 2004, AGING MENT HEALTH, V8, P374, DOI 10.1080/13607860410001709728; Wadley VG, 2003, J AM GERIATR SOC, V51, P1621, DOI 10.1046/j.1532-5415.2003.51514.x; Wald C, 2003, INT J GERIATR PSYCH, V18, P313, DOI 10.1002/gps.828; Wilber K H, 1995, J Aging Soc Policy, V7, P39, DOI 10.1300/J031v07n01_04; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x	57	75	76	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2011	305	7					698	706		10.1001/jama.2011.164	http://dx.doi.org/10.1001/jama.2011.164			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	721NH	21325186	Green Accepted			2022-12-28	WOS:000287361100021
J	Rayner, A				Rayner, Abi			Palliative oxygen and room air did not differ for relief of breathlessness in patients with refractory dyspnea	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									W Coast Dist Hlth Board, Greymouth, New Zealand		Rayner, A (corresponding author), W Coast Dist Hlth Board, Greymouth, New Zealand.								0	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4							JC2-2	10.7326/0003-4819-154-4-201102150-02002	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-02002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720VF	21320929				2022-12-28	WOS:000287310000001
J	Singh, J				Singh, Jaspal			Tiotropium plus beclomethasone was more effective than doubling beclomethasone for asthma	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Carolinas Med Ctr, Charlotte, NC 28203 USA	Carolinas Medical Center	Singh, J (corresponding author), Carolinas Med Ctr, Charlotte, NC 28203 USA.		Singh, Jasvinder/R-6172-2019	Singh, Jasvinder/0000-0003-3485-0006				*NAT ASTHM ED PREV, 2007, 085846 NIH NAT ASTHM; Salpeter SR, 2004, CHEST, V125, P2309, DOI 10.1378/chest.125.6.2309; Stempel DA, 2005, RESP MED, V99, P1263, DOI 10.1016/j.rmed.2005.03.002; Welte T, 2009, AM J RESP CRIT CARE, V180, P741, DOI 10.1164/rccm.200904-0492OC	4	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4							JC2-4	10.7326/0003-4819-154-4-201102150-02004	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-02004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720VF	21320931				2022-12-28	WOS:000287310000003
J	Dermitzakis, ET				Dermitzakis, Emmanouil T.			Genome Literacy	SCIENCE			English	Editorial Material									Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland	University of Geneva	Dermitzakis, ET (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.		Dermitzakis, Emmanouil/B-7687-2013					DERMITZAKIS ET, GENOME LITERACY	1	0	0	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					689	690		10.1126/science.1203237	http://dx.doi.org/10.1126/science.1203237			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21310993	Green Published			2022-12-28	WOS:000287205700039
J	Hung, CL; Zhang, XB; Gemelke, N; Chin, C				Hung, Chen-Lung; Zhang, Xibo; Gemelke, Nathan; Chin, Cheng			Observation of scale invariance and universality in two-dimensional Bose gases	NATURE			English	Article							SYMMETRY; SYSTEMS; ATOMS	The collective behaviour of a many-body system near a continuous phase transition is insensitive to the details of its microscopic physics; for example, thermodynamic observables follow generalized scaling laws near the phase transition(1). The Berezinskii-Kosterlitz-Thouless (BKT) phase transition(2,3) in two-dimensional Bose gases presents a particularly interesting case because the marginal dimensionality and intrinsic scaling symmetry(4) result in a broad fluctuation regime and an extended range of universal scaling behaviour. Studies of the BKT transition in cold atoms have stimulated great interest in recent years(5-10), but a clear demonstration of critical behaviour near the phase transition has remained elusive. Here we report in situ density and density-fluctuation measurements of two-dimensional Bose gases of caesium at different temperatures and interaction strengths, observing scale-invariant, universal behaviours. The extracted thermodynamic functions confirm the existence of a wide universal region near the BKT phase transition, and provide a sensitive test of the universality predicted by classical-field theory(11,12) and quantum Monte Carlo calculations(13). Our experimental results provide evidence for growing density-density correlations in the fluctuation region, and call for further explorations of universal phenomena in classical and quantum critical physics.	[Hung, Chen-Lung; Zhang, Xibo; Gemelke, Nathan; Chin, Cheng] Univ Chicago, James Franck Inst, Chicago, IL 60637 USA; [Hung, Chen-Lung; Zhang, Xibo; Gemelke, Nathan; Chin, Cheng] Univ Chicago, Dept Phys, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Hung, CL (corresponding author), Univ Chicago, James Franck Inst, 5640 S Ellis Ave, Chicago, IL 60637 USA.	clhung@uchicago.edu			NSF [PHY-0747907, NSF-MRSEC DMR-0213745]; Packard Foundation; Army Research Office; DARPA; Grainger Foundation	NSF(National Science Foundation (NSF)); Packard Foundation(The David & Lucile Packard Foundation); Army Research Office; DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Grainger Foundation	We thank Q. Zhou, B. Svistunov, T.-L. Ho, Y. Castin, C.-C. Chien, S. Tung, N. Prokof'ev, J. Freerick and D.-W. Wang for discussions. This work was supported by the NSF (grant numbers PHY-0747907, NSF-MRSEC DMR-0213745), the Packard Foundation, and a grant from the Army Research Office with funding from the DARPA OLE program. N. G. acknowledges support from the Grainger Foundation.	[Anonymous], 1983, FUNCTIONAL INTEGRALS; BEREZINSKII VL, 1972, SOV PHYS JETP-USSR, V34, P610; Bisset RN, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.033626; Chin C, 2010, REV MOD PHYS, V82, P1225, DOI 10.1103/RevModPhys.82.1225; Clade P, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.170401; Donner T, 2007, SCIENCE, V315, P1556, DOI 10.1126/science.1138807; Gemelke N, 2009, NATURE, V460, P995, DOI 10.1038/nature08244; Hadzibabic Z, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/4/045006; Hadzibabic Z, 2006, NATURE, V441, P1118, DOI 10.1038/nature04851; Ho T.-L., 2009, UNIVERSAL THERMOMETR; Holzmann M, 2007, P NATL ACAD SCI USA, V104, P1476, DOI 10.1073/pnas.0609957104; Holzmann M, 2010, PHYS REV A, V81, DOI 10.1103/PhysRevA.81.043622; Holzmann M, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.190402; Huang K., 1963, STAT MECH, P152; Hung CL, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.160403; Kosterlitz JM, 1973, J PHYS C SOLID STATE, V6, P1181, DOI 10.1088/0022-3719/6/7/010; Kruger P, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.040402; KUBO R, 1966, REP PROG PHYS, V29, P255, DOI 10.1088/0034-4885/29/1/306; Naraschewski M, 1999, PHYS REV A, V59, P4595, DOI 10.1103/PhysRevA.59.4595; Petrov DS, 2000, PHYS REV LETT, V84, P2551, DOI 10.1103/PhysRevLett.84.2551; Pitaevskii LP, 1997, PHYS REV A, V55, pR853, DOI 10.1103/PhysRevA.55.R853; Prokof'ev N, 2002, PHYS REV A, V66, DOI 10.1103/PhysRevA.66.043608; Prokof'ev N, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.270402; Rath SP, 2010, PHYS REV A, V82, DOI 10.1103/PhysRevA.82.013609; Reinaudi G, 2007, OPT LETT, V32, P3143, DOI 10.1364/OL.32.003143; Schweikhard V, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.030401; Simula TP, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.023618; Stanley HE, 1999, REV MOD PHYS, V71, pS358, DOI 10.1103/RevModPhys.71.S358; TODA M, 1983, STAT PHYS, V1; Tung S, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.230408	31	201	202	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2011	470	7333					236	+		10.1038/nature09722	http://dx.doi.org/10.1038/nature09722			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21270797	Green Submitted			2022-12-28	WOS:000287144200039
J	Lin, DY; Boyle, MP; Dollar, P; Lee, H; Lein, ES; Perona, P; Anderson, DJ				Lin, Dayu; Boyle, Maureen P.; Dollar, Piotr; Lee, Hyosang; Lein, E. S.; Perona, Pietro; Anderson, David J.			Functional identification of an aggression locus in the mouse hypothalamus	NATURE			English	Article							BRAIN-STIMULATION; FEMALE RATS; ANTERIOR HYPOTHALAMUS; VENTROMEDIAL NUCLEUS; VIOLENT AGGRESSION; AGONISTIC BEHAVIOR; RECEPTOR BLOCKADE; LORDOSIS REFLEX; NEURAL ACTIVITY; C-FOS	Electrical stimulation of certain hypothalamic regions in cats and rodents can elicit attack behaviour, but the exact location of relevant cells within these regions, their requirement for naturally occurring aggression and their relationship to mating circuits have not been clear. Genetic methods for neural circuit manipulation in mice provide a potentially powerful approach to this problem, but brain-stimulation-evoked aggression has never been demonstrated in this species. Here we show that optogenetic, but not electrical, stimulation of neurons in the ventromedial hypothalamus, ventrolateral subdivision (VMHvl) causes male mice to attack both females and inanimate objects, as well as males. Pharmacogenetic silencing of VMHvl reversibly inhibits inter-male aggression. Immediate early gene analysis and single unit recordings from VMHvl during social interactions reveal overlapping but distinct neuronal subpopulations involved in fighting and mating. Neurons activated during attack are inhibited during mating, suggesting a potential neural substrate for competition between these opponent social behaviours.	[Lin, Dayu; Lee, Hyosang; Anderson, David J.] CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; [Lin, Dayu; Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; [Boyle, Maureen P.; Lein, E. S.] Allen Inst Brain Sci, Seattle, WA 98103 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute; Allen Institute for Brain Science	Lin, DY (corresponding author), CALTECH, Div Biol 216 76, 1201 E Calif Blvd, Pasadena, CA 91125 USA.	dayu.lin@nyumc.org; wuwei@caltech.edu		Lin, Dayu/0000-0003-2006-0791; , Hyosang/0000-0002-3200-8678	Weston-Havens Foundation; Jane Coffin Childs Foundation	Weston-Havens Foundation; Jane Coffin Childs Foundation	We thank S. Ciocchi, S. Lin, Y. Ben-Shaul and A. Wang for advice on electrode and microdrive design; M. Gerfen and M. Vondrus for microdrive fabrication; M. P. Walsh, T. D. Heitzman and V. Rush for electronics support; A. Steele, R. Robbins, S. Ossorio, K. Gunapala, A. Paul, D. Oh, C. Kim and J. Nishiguchi for behaviour annotation and video scoring; H. Kim for technical assistance; W. E. Haubensak for teaching fibre-optic implant methods; J. T. Henderson for advice on stereotactic surgery; M. Kruk for advice on electrical stimulation experiments; K. Deisseroth for the Cre-dependent ChR2-EYFP AAV construct. M. Kruk, R. Mooney and R. Simerly for comments on the manuscripts; G. Mosconi for lab management and G. Mancuso for administrative support. This work was supported in part by the Weston-Havens Foundation and Jane Coffin Childs Foundation. D. J. A. is an Investigator of the Howard Hughes Medical Institute.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; BLANCHARD DC, 1988, ANNU REV PSYCHOL, V39, P43, DOI 10.1146/annurev.ps.39.020188.000355; Blanchard RJ, 2003, HORM BEHAV, V44, P161, DOI 10.1016/S0018-506X(03)00127-2; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Bragin A, 2000, J NEUROSCI METH, V98, P77, DOI 10.1016/S0165-0270(00)00193-X; Canteras NS, 2002, PHARMACOL BIOCHEM BE, V71, P481, DOI 10.1016/S0091-3057(01)00685-2; Delville Y, 2000, BRAIN BEHAV EVOLUT, V55, P53, DOI 10.1159/000006642; FERRIS CF, 1988, PHYSIOL BEHAV, V44, P235, DOI 10.1016/0031-9384(88)90144-8; Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093; Guzowski JF, 2001, CURR OPIN NEUROBIOL, V11, P579, DOI 10.1016/S0959-4388(00)00252-X; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Halasz J, 2008, BIOL PSYCHIAT, V63, P271, DOI 10.1016/j.biopsych.2007.04.022; Halasz J, 2009, EUR J PHARMACOL, V611, P35, DOI 10.1016/j.ejphar.2009.03.050; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hess W. R., 1943, HELVETICA PHYSIOL ET PHARMACOL ACTA, V1, P33; Hess W. R., 1928, PHYSIOLOGIE, V42, P554; Hrabovszky E, 2005, NEUROSCIENCE, V133, P657, DOI 10.1016/j.neuroscience.2005.03.042; KOLLACKWALKER S, 1995, NEUROSCIENCE, V66, P721, DOI 10.1016/0306-4522(94)00563-K; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; KRUK MR, 1991, NEUROSCI BIOBEHAV R, V15, P527, DOI 10.1016/S0149-7634(05)80144-7; KRUK MR, 1984, PROG BRAIN RES, V61, P303; KRUK MR, 1983, BRAIN RES, V260, P61, DOI 10.1016/0006-8993(83)90764-3; LAMMERS JHCM, 1988, BRAIN RES, V449, P311, DOI 10.1016/0006-8993(88)91046-3; LAMMERS JHCM, 1988, BRAIN RES, V449, P294, DOI 10.1016/0006-8993(88)91045-1; Lerchner W, 2007, NEURON, V54, P35, DOI 10.1016/j.neuron.2007.02.030; Li P, 2002, FEBS LETT, V528, P77, DOI 10.1016/S0014-5793(02)03245-3; Lonstein JS, 2002, NEUROSCI BIOBEHAV R, V26, P869, DOI 10.1016/S0149-7634(02)00087-8; Mongeau R, 2003, J NEUROSCI, V23, P3855; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Motta SC, 2009, P NATL ACAD SCI USA, V106, P4870, DOI 10.1073/pnas.0900939106; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Newman SW, 1999, ANN NY ACAD SCI, V877, P242, DOI 10.1111/j.1749-6632.1999.tb09271.x; OLIVIER B, 1974, BRAIN RES, V65, P521, DOI 10.1016/0006-8993(74)90241-8; OLIVIER B, 1977, AGGRESSIVE BEHAV, V3, P47, DOI 10.1002/1098-2337(1977)3:1<47::AID-AB2480030105>3.0.CO;2-H; Petrovich GD, 2001, BRAIN RES REV, V38, P247, DOI 10.1016/S0165-0173(01)00080-7; PFAFF DW, 1979, J PHYSIOL-LONDON, V288, P203; PFAFF DW, 1979, J PHYSIOL-LONDON, V288, P189; ROELING TAP, 1994, NEUROSCIENCE, V59, P1001, DOI 10.1016/0306-4522(94)90302-6; Siegel A, 1999, NEUROSCI BIOBEHAV R, V23, P359, DOI 10.1016/S0149-7634(98)00040-2; Simerly RB, 2002, ANNU REV NEUROSCI, V25, P507, DOI 10.1146/annurev.neuro.25.112701.142745; Slimko EM, 2002, J NEUROSCI, V22, P7373; Southwell AL, 2009, J NEUROSCI, V29, P13589, DOI 10.1523/JNEUROSCI.4286-09.2009; Swanson LW, 2000, BRAIN RES, V886, P113, DOI 10.1016/S0006-8993(00)02905-X; Taymans JM, 2007, HUM GENE THER, V18, P195, DOI 10.1089/hum.2006.178; Tinbergen N, 1951, STUDY INSTINCT; VANDERPOEL AM, 1983, PHYSIOL BEHAV, V31, P259, DOI 10.1016/0031-9384(83)90130-0; Veening JG, 2005, EUR J PHARMACOL, V526, P226, DOI 10.1016/j.ejphar.2005.09.041	47	533	542	3	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2011	470	7333					221	+		10.1038/nature09736	http://dx.doi.org/10.1038/nature09736			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307935	Green Accepted			2022-12-28	WOS:000287144200036
J	White, IR; Horton, NJ; Carpenter, J; Pocock, SJ				White, Ian R.; Horton, Nicholas J.; Carpenter, James; Pocock, Stuart J.			Strategy for intention to treat analysis in randomised trials with missing outcome data	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL-TRIALS					ian.white@mrc-bsu.cam.ac.uk	Horton, Nicholas/A-2493-2008	Horton, Nicholas/0000-0003-3332-4311; Carpenter, James/0000-0003-3890-6206; White, Ian/0000-0002-6718-7661	MRC [U.1052.00.006]; NIH [5R01MH054693-11]; ESRC [RES-063-27-0257]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054693] Funding Source: NIH RePORTER; Medical Research Council [MC_U105260558] Funding Source: researchfish; MRC [MC_U105260558] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	IRW was funded by MRC grant U.1052.00.006, NJH by NIH grant 5R01MH054693-11, and JC by ESRC Research Fellowship RES-063-27-0257.	Altman Douglas G, 2009, Open Med, V3, pe51; [Anonymous], 2001, COMMITTEE PROPRIETAR; Astrup A, 2009, LANCET, V374, P1606, DOI 10.1016/S0140-6736(09)61375-1; Carpenter J. R., 2008, MISSING DATA CLIN TR; Doody R, 2008, LANCET, V372, P1383, DOI 10.1016/S0140-6736(08)61582-2; Doody RS, 2008, LANCET, V372, P207, DOI 10.1016/S0140-6736(08)61074-0; European Medicines Agency, 2010, GUID MISS DAT CONF C; Hollis S, 2002, STAT MED, V21, P3823, DOI 10.1002/sim.1276; Kenward MG, 2001, STAT MODEL, V50, P15; Mackinnon A, 2008, LANCET, V372, P1382, DOI 10.1016/S0140-6736(08)61581-0; Moher D, 2010, BMJ-BRIT MED J, V2010, P340, DOI DOI 10.1136/BMJ.C869; National Research Council, 2010, PREVENTION TREATMENT; PEDUZZI P, 1993, STAT MED, V12, P1185, DOI 10.1002/sim.4780121102; Shih WCJ, 2002, CURR CONTR TRIALS C, V3, DOI 10.1186/1468-6708-3-4; Siddiqui O, 2009, J BIOPHARM STAT, V19, P227, DOI 10.1080/10543400802609797; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Ware JH, 2003, NEW ENGL J MED, V348, P2136, DOI 10.1056/NEJMe030054; White IR, 2007, CLIN TRIALS, V4, P125, DOI 10.1177/1740774507077849; Wittes J, 2009, J BIOPHARM STAT, V19, P957, DOI 10.1080/10543400903239825	19	504	507	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2011	342								d40	10.1136/bmj.d40	http://dx.doi.org/10.1136/bmj.d40			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V41KP	21300711	Green Published, Green Accepted			2022-12-28	WOS:000209545400001
J	Capotosti, F; Guernier, S; Lammers, F; Waridel, P; Cai, Y; Jin, JJ; Conaway, JW; Conaway, RC; Herr, W				Capotosti, Francesca; Guernier, Sophie; Lammers, Fabienne; Waridel, Patrice; Cai, Yong; Jin, Jingji; Conaway, Joan W.; Conaway, Ronald C.; Herr, Winship			O-GlcNAc Transferase Catalyzes Site-Specific Proteolysis of HCF-1	CELL			English	Article							N-ACETYLGLUCOSAMINE; COACTIVATOR HCF-1; TERMINAL SUBUNIT; PROTEINS; NUCLEAR; GLYCOSYLATION; COMPLEX; FAMILY; DOMAIN; VP16	The human epigenetic cell-cycle regulator HCF-1 undergoes an unusual proteolytic maturation process resulting in stably associated HCF-1(N) and HCF-1(C) subunits that regulate different aspects of the cell cycle. Proteolysis occurs at six centrally located HCF-1(PRO)-repeat sequences and is important for activation of HCF-1(C)-subunit functions in M phase progression. We show here that the HCF-1(PRO) repeat is recognized by O-linked beta-N-acetylglucosamine transferase (OGT), which both O-GlcNAcylates the HCF-1(N) subunit and directly cleaves the HCF-1(PRO) repeat. Replacement of the HCF-1(PRO) repeats by a heterologous proteolytic cleavage signal promotes HCF-1 proteolysis but fails to activate HCF-1(C)-subunit M phase functions. These results reveal an unexpected role of OGT in HCF-1 proteolytic maturation and an unforeseen nexus between OGT-directed O-GlcNAcylation and proteolytic maturation in HCF-1 cell-cycle regulation.	[Waridel, Patrice; Herr, Winship] Univ Lausanne, Ctr Integrat Genom, Fac Biol & Med, Prot Anal Facil, CH-1015 Lausanne, Switzerland; [Cai, Yong; Jin, Jingji; Conaway, Joan W.; Conaway, Ronald C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Conaway, Joan W.; Conaway, Ronald C.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66160 USA	University of Lausanne; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Herr, W (corresponding author), Univ Lausanne, Ctr Integrat Genom, Fac Biol & Med, Prot Anal Facil, CH-1015 Lausanne, Switzerland.	winship.herr@unil.ch	Herr, Winship/E-6491-2012	Herr, Winship/0000-0002-3606-4546; Conaway, Joan/0000-0002-2786-0663	Stowers Institute for Medical Research; Greater Kansas City Community Foundation; Swiss National Science Foundation; Oncosuisse; University of Lausanne	Stowers Institute for Medical Research; Greater Kansas City Community Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Oncosuisse; University of Lausanne	We thank T. M. Kristie and J.A. Hanover for the HCF-1nc and the bacterial OGT expression vectors, respectively; M. Boutros and A. Wilson for the HCF-1<INF>Delta PROrep2</INF> construct; R. S. Haltiwanger for the alpha-OGT antibody; E. Julien and D.J. Aufiero for the N13 and C18 antibodies; S. S. Taylor for the Flp-In-HeLa cells; M. Quadroni for advice with the mass spectrometry analysis; L. Capponi, P. L'Hote, and M. McLaird for technical support; and J.H. Reina for art design. We thank N. Hernandez, J. Michaud, and S. H. Verhelst for critical reading of the manuscript; and V. Zoete, O. Michielin, N. Hernandez, J. Muller, P. Schneider, and K. Struhl for discussion. This study was supported by the Stowers Institute for Medical Research and the Helen Nelson Medical Research Fund at the Greater Kansas City Community Foundation to J. W. C. and R. C. C. and by the Swiss National Science Foundation, Oncosuisse, and the University of Lausanne to W.H.	Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Cai Y, 2006, METHODS, V40, P312, DOI 10.1016/j.ymeth.2006.06.023; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Capotosti F, 2007, MOL CELL BIOL, V27, P7063, DOI 10.1128/MCB.00769-07; Clarke AJ, 2008, EMBO J, V27, P2780, DOI 10.1038/emboj.2008.186; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Gani OABSM, 2010, NAT PROD REP, V27, P489, DOI 10.1039/b923848b; Goto H, 1997, GENE DEV, V11, P726, DOI 10.1101/gad.11.6.726; Gross BJ, 2005, J AM CHEM SOC, V127, P14588, DOI 10.1021/ja0555217; HALTIWANGER RS, 1992, J BIOL CHEM, V267, P9005; Hanover JA, 2003, ARCH BIOCHEM BIOPHYS, V409, P287, DOI 10.1016/S0003-9861(02)00578-7; Hart GW, 2007, NATURE, V446, P1017, DOI 10.1038/nature05815; Hsieh JJD, 2003, CELL, V115, P293, DOI 10.1016/S0092-8674(03)00816-X; Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833; Julien E, 2004, MOL CELL, V14, P713, DOI 10.1016/j.molcel.2004.06.008; Julien E, 2003, EMBO J, V22, P2360, DOI 10.1093/emboj/cdg242; Konrad RJ, 2002, BIOCHEM BIOPH RES CO, V293, P207, DOI 10.1016/S0006-291X(02)00200-0; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kristie TM, 2010, BBA-GENE REGUL MECH, V1799, P257, DOI 10.1016/j.bbagrm.2009.08.003; KRISTIE TM, 1995, J BIOL CHEM, V270, P4387, DOI 10.1074/jbc.270.9.4387; Lazarus BD, 2006, GLYCOBIOLOGY, V16, P415, DOI 10.1093/glycob/cwj078; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Lubas WA, 2000, J BIOL CHEM, V275, P10983, DOI 10.1074/jbc.275.15.10983; Luciano RL, 2002, P NATL ACAD SCI USA, V99, P13403, DOI 10.1073/pnas.202200399; Luo Y, 2001, CELL, V106, P585, DOI 10.1016/S0092-8674(01)00479-2; Martinez-Fleites C, 2008, NAT STRUCT MOL BIOL, V15, P764, DOI 10.1038/nsmb.1443; Mazars R, 2010, J BIOL CHEM, V285, P13364, DOI 10.1074/jbc.M109.072579; Misaghi S, 2009, MOL CELL BIOL, V29, P2181, DOI 10.1128/MCB.01517-08; Nalivaeva NN, 2001, PROTEOMICS, V1, P735, DOI 10.1002/1615-9861(200106)1:6<735::AID-PROT735>3.0.CO;2-8; STARR CM, 1990, J BIOL CHEM, V265, P6868; TORRES CR, 1984, J BIOL CHEM, V259, P3308; Tyagi S, 2009, EMBO J, V28, P3185, DOI 10.1038/emboj.2009.258; Vogel JL, 2000, P NATL ACAD SCI USA, V97, P9425, DOI 10.1073/pnas.160266697; Vogel JL, 2006, P NATL ACAD SCI USA, V103, P6817, DOI 10.1073/pnas.0602109103; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Wells L, 2004, J BIOL CHEM, V279, P38466, DOI 10.1074/jbc.M406481200; Wells L, 2003, FEBS LETT, V546, P154, DOI 10.1016/S0014-5793(03)00641-0; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Wilson AC, 2000, MOL CELL BIOL, V20, P6721, DOI 10.1128/MCB.20.18.6721-6730.2000; WILSON AC, 1995, GENE DEV, V9, P2445, DOI 10.1101/gad.9.20.2445; WILSON AC, 1993, CELL, V74, P115, DOI 10.1016/0092-8674(93)90299-6; Wrabl JO, 2001, J MOL BIOL, V314, P365, DOI 10.1006/jmbi.2001.5151; Wysocka J, 2003, TRENDS BIOCHEM SCI, V28, P294, DOI 10.1016/S0968-0004(03)00088-4; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103; Yang XY, 2002, CELL, V110, P69, DOI 10.1016/S0092-8674(02)00810-3	46	164	164	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2011	144	3					376	388		10.1016/j.cell.2010.12.030	http://dx.doi.org/10.1016/j.cell.2010.12.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295698	Bronze			2022-12-28	WOS:000286973100010
J	Kitagawa, D; Vakonakis, I; Olieric, N; Hilbert, M; Keller, D; Olieric, V; Bortfeld, M; Erat, MC; Fluckiger, I; Gonczy, P; Steinmetz, MO				Kitagawa, Daiju; Vakonakis, Ioannis; Olieric, Natacha; Hilbert, Manuel; Keller, Debora; Olieric, Vincent; Bortfeld, Miriam; Erat, Michele C.; Flueckiger, Isabelle; Goenczy, Pierre; Steinmetz, Michel O.			Structural Basis of the 9-Fold Symmetry of Centrioles	CELL			English	Article							CENTROSOME DUPLICATION; BASAL BODY; C-ELEGANS; CAENORHABDITIS-ELEGANS; PROTEIN SPD-2; HUMAN-CELLS; SAS-6; PROCENTRIOLE; CYCLE; MECHANISMS	The centriole, and the related basal body, is an ancient organelle characterized by a universal 9-fold radial symmetry and is critical for generating cilia, flagella, and centrosomes. The mechanisms directing centriole formation are incompletely understood and represent a fundamental open question in biology. Here, we demonstrate that the centriolar protein SAS-6 forms rod-shaped homodimers that interact through their N-terminal domains to form oligomers. We establish that such oligomerization is essential for centriole formation in C. elegans and human cells. We further generate a structural model of the related protein Bld12p from C. reinhardtii, in which nine homodimers assemble into a ring from which nine coiled-coil rods radiate outward. Moreover, we demonstrate that recombinant Bld12p self-assembles into structures akin to the central hub of the cartwheel, which serves as a scaffold for centriole formation. Overall, our findings establish a structural basis for the universal 9-fold symmetry of centrioles.	[Kitagawa, Daiju; Keller, Debora; Flueckiger, Isabelle; Goenczy, Pierre] Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Sch Life Sci, ISREC, CH-1015 Lausanne, Switzerland; [Vakonakis, Ioannis; Hilbert, Manuel; Olieric, Vincent] Paul Scherrer Inst, Swiss Light Source, CH-5232 Villigen, Switzerland; [Olieric, Natacha; Hilbert, Manuel; Bortfeld, Miriam; Steinmetz, Michel O.] Paul Scherrer Inst, Biomol Res, CH-5232 Villigen, Switzerland; [Vakonakis, Ioannis; Erat, Michele C.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; University of Oxford	Gonczy, P (corresponding author), Ecole Polytech Fed Lausanne, Swiss Fed Inst Technol, Sch Life Sci, ISREC, CH-1015 Lausanne, Switzerland.	pierre.gonczy@epfl.ch	Olieric, Vincent/D-1078-2011; Steinmetz, Michel O/AAA-3349-2022	Olieric, Vincent/0000-0002-0533-7222; Steinmetz, Michel O/0000-0001-6157-3687; Olieric, Natacha/0000-0002-6273-390X; Gonczy, Pierre/0000-0002-6305-6883; Keller, Debora/0000-0002-5284-3195	JSPS; EMBO [ALTF-667-2007]; Wellcome Trust; FP7 Marie Curie Fellowship; Oncosuisse [OCS KLS 02024-02-2007]; ERC [AdG 233335]; Swiss National Foundation [CRSII3_125463]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); EMBO(European Molecular Biology Organization (EMBO)); Wellcome Trust(Wellcome TrustEuropean Commission); FP7 Marie Curie Fellowship; Oncosuisse; ERC(European Research Council (ERC)European Commission); Swiss National Foundation(Swiss National Science Foundation (SNSF))	We are grateful to Fritz Winkler (PSI) for help with the modeling and critical reading of the manuscript; to Vesna Oliveri, Ursula Sauder, and Gianni Morson (ZMB, University of Basel) for excellent support and access to the electron microscope; to Meitian Wang, Andrea Prota, and Daniel Frey (PSI) for help with crystallization and X-ray data collection; to Davide Demuras and Graham Knott (BioEM core facility, EPFL), as well as Petr Leiman (EPFL), for help with EM analysis; to Christine Wandrey (EPFL) for AUC analysis; to Coralie Busso (EPFL) for help in generating the C. elegans transgenic lines; to Diego Chiappe and Marc Moniatte (Proteomic core facility, EPFL) for mass spectrometry; and to Katayoun Afshar, Virginie Hachet, and Joachim Lingner for helpful comments on the manuscript. D. K. held postdoctoral fellowships from the JSPS and EMBO (ALTF-667-2007). I. V. was partly supported by the Wellcome Trust Career Development Fellowship program. M. C. E. was supported by a FP7 Marie Curie Fellowship. This work was supported also by grants to P. G. from Oncosuisse (OCS KLS 02024-02-2007) and from the ERC (AdG 233335) as well as by grants from the Swiss National Foundation to P. G. and M. S. (Sinergia CRSII3_125463). We are also indebted to Clemens Schulze-Briese (PSI) for generous support.	Azimzadeh J, 2010, CURR BIOL, V20, pR816, DOI 10.1016/j.cub.2010.08.010; Bach M, 2007, FEBS J, V274, P783, DOI 10.1111/j.1742-4658.2006.05623.x; Carvalho-Santos Z, 2010, J CELL SCI, V123, P1414, DOI 10.1242/jcs.064931; CAVALIER.T, 1974, J CELL SCI, V16, P529; Culver BP, 2009, MOL BIOL CELL, V20, P1865, DOI 10.1091/mbc.E08-08-0838; Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015; Dammermann A, 2008, J CELL BIOL, V180, P771, DOI 10.1083/jcb.200709102; Delattre M, 2004, NAT CELL BIOL, V6, P656, DOI 10.1038/ncb1146; DIRKSEN ER, 1991, BIOL CELL, V72, P31, DOI 10.1016/0248-4900(91)90075-X; FOWLER WE, 1983, J ULTRA MOL STRUCT R, V83, P319, DOI 10.1016/S0022-5320(83)90139-9; GAVIN RH, 1984, J CELL SCI, V66, P147; Gopalakrishnan J, 2010, J BIOL CHEM, V285, P8759, DOI 10.1074/jbc.M109.092627; Guichard P, 2010, EMBO J, V29, P1565, DOI 10.1038/emboj.2010.45; Hiraki M, 2007, CURR BIOL, V17, P1778, DOI 10.1016/j.cub.2007.09.021; Junop MS, 2000, EMBO J, V19, P5962, DOI 10.1093/emboj/19.22.5962; Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8; Khodjakov A, 2002, J CELL BIOL, V158, P1171, DOI 10.1083/jcb.200205102; Kilburn CL, 2007, J CELL BIOL, V178, P905, DOI 10.1083/jcb.200703109; Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X; Kitagawa D, 2009, DEV CELL, V17, P900, DOI 10.1016/j.devcel.2009.11.002; Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002; Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220; Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5; Loncarek J, 2009, MOL CELLS, V27, P135, DOI 10.1007/s10059-009-0017-z; Maeda I, 2001, CURR BIOL, V11, P171, DOI 10.1016/S0960-9822(01)00052-5; Marshall WF, 2000, CURR TOP DEV BIOL, V49, P187; Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046; Nigg EA, 2009, CELL, V139, P663, DOI 10.1016/j.cell.2009.10.036; O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5; Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012; Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318; Rodrigues-Martins A, 2007, CURR BIOL, V17, P1465, DOI 10.1016/j.cub.2007.07.034; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Steinmetz MO, 1998, EMBO J, V17, P1883, DOI 10.1093/emboj/17.7.1883; Stevens NR, 2010, DEV CELL, V19, P913, DOI 10.1016/j.devcel.2010.11.010; Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004; Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004; Yabe T, 2007, DEV BIOL, V312, P44, DOI 10.1016/j.ydbio.2007.08.054	38	248	253	3	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2011	144	3					364	375		10.1016/j.cell.2011.01.008	http://dx.doi.org/10.1016/j.cell.2011.01.008			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21277013	Green Published, hybrid, Green Accepted			2022-12-28	WOS:000286973100009
J	Reznicek, JE; Mason, WJ; Kaul, DR; Saint, S; Bloch, KC				Reznicek, Julie E.; Mason, William J.; Kaul, Daniel R.; Saint, Sanjay; Bloch, Karen C.			Avoiding a Rash Diagnosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WEST-NILE-VIRUS; ENCEPHALITIS; INFECTION; FEVER		[Bloch, Karen C.] Vanderbilt Univ, Med Ctr, Div Infect Dis, Dept Med, Nashville, TN 37232 USA; [Bloch, Karen C.] Vanderbilt Univ, Med Ctr, Dept Prevent Med, Nashville, TN 37232 USA; [Kaul, Daniel R.; Saint, Sanjay] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI USA; [Saint, Sanjay] Dept Vet Affairs Hlth Serv, Res & Dev Ctr Excellence, Ann Arbor, MI USA	Vanderbilt University; Vanderbilt University; University of Michigan System; University of Michigan	Bloch, KC (corresponding author), Vanderbilt Univ, Med Ctr, Div Infect Dis, Dept Med, A-2200 Med Ctr N, Nashville, TN 37232 USA.	karen.bloch@vanderbilt.edu	Saint, Sanjay/AAF-5126-2019; Bloch, Karen/AAE-1479-2020; Reznicek, Julie/ABD-4769-2020		Emerging Infections Program [U50/CCU416123-09]; Centers for Disease Control and Prevention	Emerging Infections Program; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Supported in part by the Emerging Infections Program cooperative agreement (U50/CCU416123-09) with the Centers for Disease Control and Prevention.	Anderson RC, 2004, J AM ACAD DERMATOL, V51, P820, DOI 10.1016/j.jaad.2004.05.031; Bakken Johan S., 2006, Morbidity and Mortality Weekly Report, V55, P1; Campbell GL, 2002, LANCET INFECT DIS, V2, P519, DOI 10.1016/S1473-3099(02)00368-7; Division of Vector-Borne Infectious Diseases CDC, LYM DIS STAT; Dumler JS, 2007, CLIN INFECT DIS, V45, pS45, DOI 10.1086/518146; Ferguson DD, 2005, CLIN INFECT DIS, V41, P1204, DOI 10.1086/444506; Lanciotti RS, 2000, J CLIN MICROBIOL, V38, P4066, DOI 10.1128/JCM.38.11.4066-4071.2000; LaScola B, 1997, J CLIN MICROBIOL, V35, P2715, DOI 10.1128/JCM.35.11.2715-2727.1997; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; Paddock CD, 2008, CLIN INFECT DIS, V47, P1188, DOI 10.1086/592254; Procop GW, 1997, ARCH PATHOL LAB MED, V121, P894; Roehrig JT, 2003, EMERG INFECT DIS, V9, P376, DOI 10.3201/eid0903.020531; Schutze GE, 2007, PEDIATR INFECT DIS J, V26, P475, DOI 10.1097/INF.0b013e318042b66c; Tilley PAG, 2006, J INFECT DIS, V193, P1361, DOI 10.1086/503577; Tyler KL, 2006, NEUROLOGY, V66, P361, DOI 10.1212/01.wnl.0000195890.70898.1f	15	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2011	364	5					466	472		10.1056/NEJMcps0906691	http://dx.doi.org/10.1056/NEJMcps0906691			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715LL	21288099				2022-12-28	WOS:000286885900014
J	Singarayer, JS; Valdes, PJ; Friedlingstein, P; Nelson, S; Beerling, DJ				Singarayer, Joy S.; Valdes, Paul J.; Friedlingstein, Pierre; Nelson, Sarah; Beerling, David J.			Late Holocene methane rise caused by orbitally controlled increase in tropical sources	NATURE			English	Article							LAST GLACIAL MAXIMUM; ATMOSPHERIC CO2 CONCENTRATIONS; PMIP2 COUPLED SIMULATIONS; ISOPRENE EMISSIONS; ICE CORE; CLIMATE; MODEL; MIDHOLOCENE; FEEDBACKS; RESPONSES	Considerable debate surrounds the source of the apparently 'anomalous'(1) increase of atmospheric methane concentrations since the mid-Holocene (5,000 years ago) compared to previous interglacial periods as recorded in polar ice core records(2). Proposed mechanisms for the rise in methane concentrations relate either to methane emissions from anthropogenic early rice cultivation(1,3) or an increase in natural wetland emissions from tropical(4) or boreal sources(5,6). Here we show that our climate and wetland simulations of the global methane cycle over the last glacial cycle (the past 130,000 years) recreate the ice core record and capture the late Holocene increase in methane concentrations. Our analyses indicate that the late Holocene increase results from natural changes in the Earth's orbital configuration, with enhanced emissions in the Southern Hemisphere tropics linked to precession-induced modification of seasonal precipitation. Critically, our simulations capture the declining trend in methane concentrations at the end of the last interglacial period (115,000-130,000 years ago) that was used to diagnose the Holocene methane rise as unique. The difference between the two time periods results from differences in the size and rate of regional insolation changes and the lack of glacial inception in the Holocene. Our findings also suggest that no early agricultural sources are required to account for the increase in methane concentrations in the 5,000 years before the industrial era.	[Singarayer, Joy S.; Valdes, Paul J.; Friedlingstein, Pierre; Nelson, Sarah] Univ Bristol, Sch Geog Sci, Bristol Res Initiat Dynam Global Environm, Bristol BS8 1SS, Avon, England; [Friedlingstein, Pierre] Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX4 4QF, Devon, England; [Beerling, David J.] Univ Sheffield, Dept Anim & Plant Sci, Sheffield S10 2TN, S Yorkshire, England	University of Bristol; University of Exeter; University of Sheffield	Singarayer, JS (corresponding author), Univ Bristol, Sch Geog Sci, Bristol Res Initiat Dynam Global Environm, Univ Rd, Bristol BS8 1SS, Avon, England.	joy.singarayer@bristol.ac.uk	Valdes, Paul/T-2004-2019; Friedlingstein, Pierre/H-2700-2014; Beerling, David J/C-2840-2009; Valdes, Paul/C-4129-2013	Valdes, Paul/0000-0002-1902-3283; Friedlingstein, Pierre/0000-0003-3309-4739; Beerling, David J/0000-0003-1869-4314; 	Royal Society; Leverhulme Trust; NERC [NE/E007600/1, NE/D001846/1] Funding Source: UKRI; Natural Environment Research Council [NE/D001846/1, NE/E007600/1] Funding Source: researchfish	Royal Society(Royal Society of London); Leverhulme Trust(Leverhulme Trust); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	J.S.S. and P.J.V. thank the BBC for commissioning the climate simulations for their TV series, The Incredible Human Journey. Thanks are also due to I. Woodward and M. Lomas for earlier SDGVM development. P.J.V. and D.J.B. acknowledge additional support through Royal Society-Wolfson Research Merit Awards and the Leverhulme Trust. J.S.S. thanks R. Bailey for comments.	Arneth A, 2008, ATMOS CHEM PHYS, V8, P4605, DOI 10.5194/acp-8-4605-2008; Arneth A, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030615; Beerling D. J., 2001, VEGETATION TERRESTRI; Beerling DJ, 1997, GLOBAL ECOL BIOGEOGR, V6, P439, DOI 10.2307/2997353; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; BLUNIER T, 1995, NATURE, V374, P46, DOI 10.1038/374046a0; Braconnot P, 2007, CLIM PAST, V3, P279, DOI 10.5194/cp-3-279-2007; Braconnot P, 2007, CLIM PAST, V3, P261, DOI 10.5194/cp-3-261-2007; Braconnot P, 2000, GLOBAL PLANET CHANGE, V26, P51, DOI 10.1016/S0921-8181(00)00033-3; Brook EJ, 2000, GLOBAL BIOGEOCHEM CY, V14, P559, DOI 10.1029/1999GB001182; Cao MK, 1996, J GEOPHYS RES-ATMOS, V101, P14399, DOI 10.1029/96JD00219; CATTLE H, 1995, PHILOS T R SOC A, V352, P201, DOI 10.1098/rsta.1995.0064; Chappellaz J, 1997, J GEOPHYS RES-ATMOS, V102, P15987, DOI 10.1029/97JD01017; Collins WJ, 1999, J GEOPHYS RES-ATMOS, V104, P26927, DOI 10.1029/1999JD900143; Fischer H, 2008, NATURE, V452, P864, DOI 10.1038/nature06825; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Gordon C, 2000, CLIM DYNAM, V16, P147, DOI 10.1007/s003820050010; GUENTHER A, 1995, J GEOPHYS RES-ATMOS, V100, P8873, DOI 10.1029/94JD02950; Hickler T, 2008, GLOBAL CHANGE BIOL, V14, P1531, DOI 10.1111/j.1365-2486.2008.01598.x; Indermuhle A, 2000, GEOPHYS RES LETT, V27, P735, DOI 10.1029/1999GL010960; KUTZBACH JE, 1988, SCIENCE, V241, P1043, DOI 10.1126/science.241.4869.1043; KUTZBACH JE, 1981, SCIENCE, V214, P59, DOI 10.1126/science.214.4516.59; Loulergue L, 2008, NATURE, V453, P383, DOI 10.1038/nature06950; Monnin E, 2001, SCIENCE, V291, P112, DOI 10.1126/science.291.5501.112; Parrenin F, 2007, CLIM PAST, V3, P485, DOI 10.5194/cp-3-485-2007; PARTON WJ, 1993, GLOBAL BIOGEOCHEM CY, V7, P785, DOI 10.1029/93GB02042; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pope VD, 2000, CLIM DYNAM, V16, P123, DOI 10.1007/s003820050009; Possell M, 2005, GLOBAL CHANGE BIOL, V11, P60, DOI 10.1111/j.1365-2486.2004.00889.x; Ruddiman WF, 2003, CLIMATIC CHANGE, V61, P261, DOI 10.1023/B:CLIM.0000004577.17928.fa; Ruddiman WF, 2001, QUATERNARY SCI REV, V20, P1769, DOI 10.1016/S0277-3791(01)00067-1; Ruddiman WF, 2007, REV GEOPHYS, V45, DOI 10.1029/2006RG000207; Ruddiman WF, 2008, QUATERNARY SCI REV, V27, P1291, DOI 10.1016/j.quascirev.2008.03.007; Running SW, 2004, BIOSCIENCE, V54, P547, DOI 10.1641/0006-3568(2004)054[0547:ACSMOG]2.0.CO;2; Schmidt GA, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL021083; Singarayer JS, 2010, QUATERNARY SCI REV, V29, P43, DOI 10.1016/j.quascirev.2009.10.011; Sitch S, 2008, GLOBAL CHANGE BIOL, V14, P2015, DOI 10.1111/j.1365-2486.2008.01626.x; Sowers T, 2010, QUATERNARY SCI REV, V29, P213, DOI 10.1016/j.quascirev.2009.05.023; Spahni R, 2005, SCIENCE, V310, P1317, DOI 10.1126/science.1120132; Stocker B., 2010, BIOGEOSCIENCES DISCU, V7, P921, DOI DOI 10.5194/BGD-7-921-2010; Valdes PJ, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021004; Woodward FI, 2008, ECOL LETT, V11, P1229, DOI 10.1111/j.1461-0248.2008.01240.x; WOODWARD FI, 1995, GLOBAL BIOGEOCHEM CY, V9, P471, DOI 10.1029/95GB02432; YIENGER JJ, 1995, J GEOPHYS RES-ATMOS, V100, P11447, DOI 10.1029/95JD00370	45	101	102	3	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					82	U91		10.1038/nature09739	http://dx.doi.org/10.1038/nature09739			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293375				2022-12-28	WOS:000286886400038
J	Kanchanachitra, C; Lindelow, M; Johnston, T; Hanvoravongchai, P; Lorenzo, FM; Nguyen, LH; Wilopo, SA; dela Rosa, JF				Kanchanachitra, Churnrurtai; Lindelow, Magnus; Johnston, Timothy; Hanvoravongchai, Piya; Lorenzo, Fely Marilyn; Nguyen Lan Huong; Wilopo, Siswanto Agus; dela Rosa, Jennifer Frances			Health in Southeast Asia 5 Human resources for health in southeast Asia: shortages, distributional challenges, and international trade in health services	LANCET			English	Article							NURSE MIGRATION; TOURISM	In this paper, we address the issues of shortage and maldistribution of health personnel in southeast Asia in the context of the international trade in health services. Although there is no shortage of health workers in the region overall, when analysed separately, five low-income countries have some deficit. All countries in southeast Asia face problems of maldistribution of health workers, and rural areas are often understaffed. Despite a high capacity for medical and nursing training in both public and private facilities, there is weak coordination between production of health workers and capacity for employment. Regional experiences and policy responses to address these challenges can be used to inform future policy in the region and elsewhere. A distinctive feature of southeast Asia is its engagement in international trade in health services. Singapore and Malaysia import health workers to meet domestic demand and to provide services to international patients. Thailand attracts many foreign patients for health services. This situation has resulted in the so-called brain drain of highly specialised staff from public medical schools to the private hospitals. The Philippines and Indonesia are the main exporters of doctors and nurses in the region. Agreements about mutual recognition of professional qualifications for three groups of health workers under the Association of Southeast Asian Nations Framework Agreement on Services could result in increased movement within the region in the future. To ensure that vital human resources for health are available to meet the needs of the populations that they serve, migration management and retention strategies need to be integrated into ongoing efforts to strengthen health systems in southeast Asia. There is also a need for improved dialogue between the health and trade sectors on how to balance economic opportunities associated with trade in health services with domestic health needs and equity issues.	[Kanchanachitra, Churnrurtai] Mahidol Univ, Inst Populat & Social Res, Salaya 73170, Nakhon Pathom, Thailand; [Lindelow, Magnus] World Bank, Viangchan, Laos; [Johnston, Timothy] World Bank, Phnom Penh, Cambodia; [Hanvoravongchai, Piya] Univ London, London Sch Hyg & Trop Med, London, England; [Lorenzo, Fely Marilyn; dela Rosa, Jennifer Frances] Univ Philippines, Manila, Philippines; [Nguyen Lan Huong] Minist Hlth, Hanoi, Vietnam; [Wilopo, Siswanto Agus] Gadjah Mada Univ, Yogyakarta, Indonesia	Mahidol University; The World Bank; The World Bank; University of London; London School of Hygiene & Tropical Medicine; University of the Philippines System; University of the Philippines Manila; Gadjah Mada University	Kanchanachitra, C (corresponding author), Mahidol Univ, Inst Populat & Social Res, Salaya 73170, Nakhon Pathom, Thailand.	prckc@mahidol.ac.th	Hanvoravongchai, Piya/A-1569-2012; Wilopo, Siswanto/AAJ-2092-2020; Wilopo, Siswanto/AAC-9417-2022	Hanvoravongchai, Piya/0000-0003-4256-1271; Wilopo, Siswanto Agus/0000-0003-1284-7228	China Medical Board; Rockefeller Foundation; Atlantic Philanthropies	China Medical Board; Rockefeller Foundation; Atlantic Philanthropies	The paper is part of a Series funded by the China Medical Board, the Rockefeller Foundation, and Atlantic Philanthropies. We thank the steering committee of this Series on health in southeast Asia, in particular Lincoln Chen and Suwit Wibulpolprasert for providing invaluable comments on the framework and draft paper. We also thank Theirs Theirs Htey (Department of Health, Myanmar) for providing information about the human resources for health situation in Myanmar, Manuel M Dayrit (WHO) and German Palabyab (Professional Regulation Commission, Republic of Philippines) for providing data for production capacity in the Philippines, Ann Robins (Human Resources for Health Advisor, WHO/Cambodia) for her contribution of data on human resources for health in Cambodia, and Khampasong Theppanya from the Department of Health (Ministry of Health, Laos) for assisting with data for the Laos health workforce. We also appreciate the comments from five anonymous reviewers who have greatly helped shape the content of the paper.	Anand S, 2004, LANCET, V364, P1603, DOI 10.1016/S0140-6736(04)17313-3; [Anonymous], U HLTH SCI STRAT PLA; [Anonymous], [No title captured]; Arunanondchai J, 2006, HEALTH PROMOT INT, V21, P59, DOI 10.1093/heapro/dal052; Bhargava A, 2010, MODELING EFFEC UNPUB; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; Chen L, 2004, LANCET, V364, P1984, DOI 10.1016/S0140-6736(04)17482-5; Chen LC, 2005, NEW ENGL J MED, V353, P1850, DOI 10.1056/NEJMe058188; Chongsuvivatwong V, 2011, LANCET, V377, P429, DOI 10.1016/S0140-6736(10)61507-3; Chornitz KM, 1998, 1888 WORLD BANK; Churnrurtai K, 2007, EXPLORING GENDER DIM, P153; Commission on Higher Education Philippines, 2009, DISTR GOV PRIV NURS; Connell J, 2006, TOURISM MANAGE, V27, P1093, DOI 10.1016/j.tourman.2005.11.005; Dela Rosa J, 2008, 3 AS PAC ACT ALL HUM; Department of Personnel and Organization, 2009, HUM RES HLTH REP 200; Doles C, 2010, B WORLD HEALTH ORGAN, V88, P321; Frehywot S, 2010, B WORLD HEALTH ORGAN, V88, P364, DOI 10.2471/BLT.09.071605; Hemmings J, 2008, REPROD HLTH MARGINS; Heywood PF, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-6; Human Resources Department Ministry of Health Cambodia, 2009, REP NEEDS ASS PUBL M; Institute of Health Policy and Development Studies, 2006, MIGR HLTH WORK COUNT; Jan S, 2005, B WORLD HEALTH ORGAN, V83, P771; Laurant M, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001271.pub2; Lehmann U, 2009, HUM RESOUR HEALTH, V7, DOI 10.1186/1478-4491-7-49; Levett, 2005, SYDNEY MORNING  1029, P27; Llorito DL, 2006, ASIA TIMES ONLI 0620; Lorenzo FME, 2007, HEALTH SERV RES, V42, P1406, DOI 10.1111/j.1475-6773.2007.00716.x; Mccoy D, 2008, HUM RESOUR HEALTH, V6, DOI 10.1186/1478-4491-6-16; Ministry of Health Human Resource Development Department Cambodia, HLTH WORKF DEV PLAN; Ministry of Health Laos PDR, 2007, HUM RES HLTH AN SIT; Ministry of Health-UNFPA, 2008, ASS SKILL BIRTH ATT; Na Ranong A, 2009, THAILAND MED HUB; Newman B.Y., 2006, OPTOMETRY, V77, P581; Noree T, 2008, ABUNDANT FEW SHORTAG; OECD, 2007, INT MIGR OUTL SOPEMI; Pachanee CA, 2006, HEALTH POLICY PLANN, V21, P310, DOI 10.1093/heapol/czl017; Pachanee CA, 2007, TRADE AND HEALTH: SEEKING COMMON GROUND, P151; Page SJ, 2009, TOURISM MANAGE, V30, P149, DOI 10.1016/j.tourman.2008.04.011; Patcharanarumol W, 2009, J INT DEV, V21, P212, DOI 10.1002/jid.1549; Perrin ME, 2007, INT NURS REV, V54, P219, DOI 10.1111/j.1466-7657.2007.00567.x; Philippines News Agency, 2009, GOV DOING GOOD JOB M; Philippines Overseas Employment Administration, OFW DEPL PER SKILL C; PRAKONGSAI P, 2003, DUAL PRACTICE PUBLIC; Robinson M, 2008, LANCET, V371, P691, DOI 10.1016/S0140-6736(08)60310-4; Sein TT, COVERAGE SKILL MIX B; Sherratt DR, 2006, COMPREHENSIVE MIDWIF; Smith RD, 2009, LANCET, V373, P593, DOI 10.1016/S0140-6736(08)61778-X; Srisuphan W, SUPPLY REQUIREMENT P; Suwannaki T, SUPPLY PROJECTION PH; Tangcharoensathien V, 2011, LANCET, V377, P863, DOI 10.1016/S0140-6736(10)61890-9; Task Force for Scaling Up Education and Training for Health Workers, 2008, SCAL SAV LIV; The Temasek Review, 2010, 2 OUT 3 DOCT SING AR; Thomas AE, 2005, STUDY GENDER ETHNIC; Uy V, 2008, NO NURS SURPL ONL UN; Vietnam Ministry of Health, 2009, HLTH STAT YB 2008; W.H. Organization, 2009, WORLD HLTH STAT 2009; WHO, 2010, INCREASING ACCESS TO HEALTH WORKERS IN REMOTE AND RURAL AREAS THROUGH IMPROVED RETENTION: GLOBAL POLICY RECOMMENDATIONS, P1; WHO, 2010, HUM RES HLTH OBS, P5; Woodman J., 2007, PATIENTS BORDERS EVE; World Health Organization (WHO), 2006, WORLD HLTH REP 2006; Yap J, 2009, MED TOURISM ASIAN CH	61	173	176	1	91	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB-MAR	2011	377	9767					769	781		10.1016/S0140-6736(10)62035-1	http://dx.doi.org/10.1016/S0140-6736(10)62035-1			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729JQ	21269674				2022-12-28	WOS:000287946000034
J	Guaita, A; Jones, M				Guaita, Antonio; Jones, Marc			A "Prosthetic" Approach for Individuals With Dementia?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COGNITIVE REHABILITATION; ALZHEIMERS-DISEASE; SYMPTOMS; MANAGEMENT		[Guaita, Antonio] Golgi Cenci Fdn, I-20081 Abbiategrasso, MI, Italy; [Jones, Marc] Moyra Jones Resources Ltd, New Westminster, BC, Canada		Guaita, A (corresponding author), Golgi Cenci Fdn, Piazza Golgi 11, I-20081 Abbiategrasso, MI, Italy.	a.guaita@golgiredaelli.it	Guaita, Antonio/Q-1787-2019	Guaita, Antonio/0000-0003-3954-5932				Clare L., 2003, COCHRANE DB SYST REV, V4, P1, DOI [https://doi.org/10.1002/14651858.CD003260, DOI 10.1002/14651858.CD003260]; Clare L, 2010, AM J GERIAT PSYCHIAT, V18, P928, DOI 10.1097/JGP.0b013e3181d5792a; Colombo M, 2007, ARCH GERONTOL GERIAT, V44, P113, DOI 10.1016/j.archger.2007.01.017; Friedrich MJ, 2009, JAMA-J AM MED ASSOC, V301, P2430, DOI 10.1001/jama.2009.809; Henneman WJP, 2009, NEUROLOGY, V72, P999, DOI 10.1212/01.wnl.0000344568.09360.31; Herrmann N, 2008, CAN MED ASSOC J, V179, P1279, DOI 10.1503/cmaj.070804; Jones M, 1999, GENTLECARE CHANGING; Rodda J, 2009, INT PSYCHOGERIATR, V21, P813, DOI 10.1017/S1041610209990354; Sink KM, 2005, JAMA-J AM MED ASSOC, V293, P596, DOI 10.1001/jama.293.5.596; Trumble WR, 2007, OXFORD ENGLISH DICT	10	3	3	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2011	305	4					402	403		10.1001/jama.2011.28	http://dx.doi.org/10.1001/jama.2011.28			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711MH	21266688				2022-12-28	WOS:000286595200026
J	de Costa, C; Miller, F				de Costa, Caroline; Miller, Francesca			The art of medicine American resurrection and the 1788 New York doctors' riot	LANCET			English	Editorial Material									[de Costa, Caroline; Miller, Francesca] James Cook Univ, Sch Med, Cairns, Qld 4870, Australia	James Cook University	de Costa, C (corresponding author), James Cook Univ, Sch Med, Cairns, Qld 4870, Australia.	caroline.decosta@jcu.edu.au							0	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 22	2011	377	9762					292	293		10.1016/S0140-6736(11)60083-4	http://dx.doi.org/10.1016/S0140-6736(11)60083-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	714ZO	21322844				2022-12-28	WOS:000286850400016
J	Darling, RC				Darling, R. Clement, III			Endovascular and Open Revascularization for Nonatherosclerotic Renal Artery Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FIBROMUSCULAR DYSPLASIA; ANGIOPLASTY; MANAGEMENT; STENOSIS; THERAPY	Objective: To evaluate the long-term outcome of endovascular and open treatment for nonatherosclerotic renal artery disease (NARAD). Design: Retrospective review. Setting: Academic institution. Patients: Fifty-five patients (47 women; mean age, 40 years) with NARAD. Underlying disease included Takayasu arteritis in 31 and fibromuscular dysplasia in 24. Interventions: Open revascularization and renal artery percutaneous transluminal angioplasty with or without stenting. Main Outcome Measures: Primary, primary assisted, and secondary patency rates; blood pressure; antihypertensive medication requirements; renal function; and mortality. Results: Seventy-nine renal interventions were performed, including 59 aortorenal bypass (16 ex vivo), 3 visceral-renal bypass, and 12 endovascular (8 percutaneous transluminal angioplasty and 4 stent placements) procedures, and 5 nephrectomies. There were no in-hospital deaths. During a mean follow-up of 75 months, 1-, 3-, and 5-year primary patency rates for any intervention were 87%, 75%, and 75%, respectively; primary assisted/secondary patency rates were 92%, 86%, and 86%, respectively. Endovascular interventions at 1, 3, and 5 years had primary patency rates of 73%, 49%, and 49%, respectively, and primary assisted/secondary patency rates of 83%, 83%, and 83%, respectively. For open revascularization, 1-, 3-, and 5-year primary patency rates were 91%, 80%, and 80%, respectively; primary assisted/secondary patency rates were 94%, 87%, and 87%, respectively. For both interventions, blood pressure and the number of antihypertensives used were reduced compared with preintervention values ( all P < .05). Serum creatinine level and estimated glomerular filtration rate were also improved after revascularization ( both P < .05). There were 6 deaths. Five-and 10-year actuarial survival rates were 94% and 78%, respectively. Conclusions: Endovascular and open management of NARAD confers long-term benefit for blood pressure, renal function, renal artery/graft patency, and survival. Open revascularization results in superior 1- and 5-year outcomes compared with endovascular management and provides the most durable outcome for NARAD. Arch Surg. 2010; 145(9):832-839	Inst Vasc Hlth & Dis, Div Vasc Surg, Albany, NY 12208 USA		Darling, RC (corresponding author), Inst Vasc Hlth & Dis, Div Vasc Surg, 43 New Scotland Ave,MC 157, Albany, NY 12208 USA.	darlingc@albanyvascular.com						Alhadad A, 2005, J HUM HYPERTENS, V19, P761, DOI 10.1038/sj.jhh.1001893; ANDERSON CA, 1995, J VASC SURG, V22, P207, DOI 10.1016/S0741-5214(95)70132-X; Barrier P, 2010, CARDIOVASC INTER RAD, V33, P270, DOI 10.1007/s00270-010-9818-x; Carmo M, 2005, ANN VASC SURG, V19, P208, DOI 10.1007/s10016-004-0164-9; Darling RC, 1999, ANN SURG, V230, P524, DOI 10.1097/00000658-199910000-00008; Ham SW, 2010, ARCH SURG-CHICAGO, V145, P832, DOI 10.1001/archsurg.2010.183; Kashyap VS, 2007, J VASC SURG, V45, P101, DOI 10.1016/j.jvs.2006.08.068; Kim HJ, 2008, KOREAN J RADIOL, V9, P38, DOI 10.3348/kjr.2008.9.1.38; Lacombe M, 2006, J VASC SURG, V44, P537, DOI 10.1016/j.jvs.2006.05.036; Sivamurthy N, 2004, J VASC SURG, V39, P565, DOI 10.1016/j.jvs.2003.09.024	10	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 19	2011	305	3					294	295		10.1001/jama.2010.2018	http://dx.doi.org/10.1001/jama.2010.2018			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	707YY	21249718				2022-12-28	WOS:000286328700025
J	DePaolo, RW; Abadie, V; Tang, F; Fehlner-Peach, H; Hall, JA; Wang, W; Marietta, EV; Kasarda, DD; Waldmann, TA; Murray, JA; Semrad, C; Kupfer, SS; Belkaid, Y; Guandalini, S; Jabri, B				DePaolo, R. W.; Abadie, V.; Tang, F.; Fehlner-Peach, H.; Hall, J. A.; Wang, W.; Marietta, E. V.; Kasarda, D. D.; Waldmann, T. A.; Murray, J. A.; Semrad, C.; Kupfer, S. S.; Belkaid, Y.; Guandalini, S.; Jabri, B.			Co-adjuvant effects of retinoic acid and IL-15 induce inflammatory immunity to dietary antigens	NATURE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; REGULATORY T-CELLS; GLUTEN SENSITIVITY; TRANSGENIC MICE; TGF-BETA; CLASS-I; DIFFERENTIATION; DISEASE; CYTOKINE; INTERLEUKIN-15	Under physiological conditions the gut-associated lymphoid tissues not only prevent the induction of a local inflammatory immune response, but also induce systemic tolerance to fed antigens(1,2). A notable exception is coeliac disease, where genetically susceptible individuals expressing human leukocyte antigen (HLA) HLA-DQ2 or HLA-DQ8 molecules develop inflammatory T-cell and antibody responses against dietary gluten, a protein present in wheat(3). The mechanisms underlying this dysregulated mucosal immune response to a soluble antigen have not been identified. Retinoic acid, a metabolite of vitamin A, has been shown to have a critical role in the induction of intestinal regulatory responses(4-6). Here we find in mice that in conjunction with IL-15, a cytokine greatly upregulated in the gut of coeliac disease patients(3,7), retinoic acid rapidly activates dendritic cells to induce JNK (also known as MAPK8) phosphorylation and release the proinflammatory cytokines IL-12p70 and IL-23. As a result, in a stressed intestinal environment, retinoic acid acted as an adjuvant that promoted rather than prevented inflammatory cellular and humoral responses to fed antigen. Altogether, these findings reveal an unexpected role for retinoic acid and IL-15 in the abrogation of tolerance to dietary antigens.	[DePaolo, R. W.; Abadie, V.; Tang, F.; Fehlner-Peach, H.; Wang, W.; Semrad, C.; Kupfer, S. S.; Jabri, B.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Hall, J. A.; Belkaid, Y.] NIAID, Mucosal Immunol Unit, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Hall, J. A.] Univ Penn, Immunol Grad Grp, Philadelphia, PA 19104 USA; [Marietta, E. V.] Mayo Clin, Dept Dermatol, Coll Med, Rochester, MN 55905 USA; [Marietta, E. V.] Mayo Clin, Dept Immunol, Coll Med, Rochester, MN 55905 USA; [Kasarda, D. D.] ARS, USDA, Western Reg Res Ctr, Albany, CA 94710 USA; [Waldmann, T. A.] NCI, Metab Branch, Bethesda, MD 20892 USA; [Murray, J. A.] Mayo Clin, Div Gastroenterol & Hepatol, Dept Med, Coll Med, Rochester, MN 55905 USA; [Guandalini, S.; Jabri, B.] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA; [Jabri, B.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Pennsylvania; Mayo Clinic; Mayo Clinic; United States Department of Agriculture (USDA); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic; University of Chicago; University of Chicago	Jabri, B (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	bjabri@bsd.uchicago.edu	Kupfer, Sonia S/ABD-9416-2021; Guandalini, Stefano/G-8084-2011; Waldmann, Thomas/AAT-5972-2021	Waldmann, Thomas/0000-0003-4500-6660; Belkaid, Yasmine/0000-0001-9962-3571; DePaolo, William/0000-0002-3880-4544; murray, joseph/0000-0003-1941-9090	Digestive Disease Research Core Center at the University of Chicago [DK42086, R01 DK67180, R01DK71003]; Crohn's and Colitis Foundation; University of Chicago Celiac Disease Center; NATIONAL CANCER INSTITUTE [K08CA142892, ZIASC004002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001132] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067180, R56DK071003, R01DK071003, P30DK042086] Funding Source: NIH RePORTER	Digestive Disease Research Core Center at the University of Chicago; Crohn's and Colitis Foundation; University of Chicago Celiac Disease Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank coeliac disease patients and their family members as well as the University of Chicago Celiac Disease Center for supporting our research. We thank B. Sally, L. M. Sollid and M. Musch for critical reading of the manuscript. We thank C. Ciszewski, B. Uzunparmak, and N. Grandison for their help with the collection and analysis of human biopsies. We thank M. Constantinides for technical assistance with mice breeding. We also thank the University of Chicago flow cytometry facility for technical assistance. D<SUP>d</SUP>-IL-15 transgenic mice were a gift from M. Caligiuri. RAR alpha-deficient mice were provided by P. Chambon and C. Benoist. This work was supported by the Digestive Disease Research Core Center at the University of Chicago (DK42086), R01 DK67180 (for B.J.), R01DK71003 (for J.A.M.), and the Crohn's and Colitis Foundation (for V.A.).	BERNARDI.JE, 1967, J BIOL CHEM, V242, P445; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Black KE, 2002, J IMMUNOL, V169, P5595, DOI 10.4049/jimmunol.169.10.5595; Bodd M, 2010, MUCOSAL IMMUNOL, V3, P594, DOI 10.1038/mi.2010.36; Caretto D, 2010, J IMMUNOL, V184, P30, DOI 10.4049/jimmunol.0903412; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; DePaolo RW, 2008, CELL HOST MICROBE, V4, P350, DOI 10.1016/j.chom.2008.09.004; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; Faria AMC, 2005, IMMUNOL REV, V206, P232, DOI 10.1111/j.0105-2896.2005.00280.x; Fehniger TA, 2001, J EXP MED, V193, P219, DOI 10.1084/jem.193.2.219; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gao Y, 2007, LEUKEMIA RES, V31, P455, DOI 10.1016/j.leukres.2006.07.004; Hill JA, 2008, IMMUNITY, V29, P758, DOI 10.1016/j.immuni.2008.09.018; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Hunt KA, 2008, NAT GENET, V40, P395, DOI 10.1038/ng.102; Jabri B, 2009, NAT REV IMMUNOL, V9, P858, DOI 10.1038/nri2670; Kraus TA, 2004, GASTROENTEROLOGY, V126, P1771, DOI 10.1053/j.gastro.2004.03.076; Lefrancois L, 2001, Curr Protoc Immunol, VChapter 3, DOI 10.1002/0471142735.im0319s17; Liu ZJ, 2000, J IMMUNOL, V164, P3608, DOI 10.4049/jimmunol.164.7.3608; Marietta E, 2004, J CLIN INVEST, V114, P1090, DOI 10.1172/JCI200421055; MARSH MN, 1992, GASTROENTEROLOGY, V102, P330, DOI 10.1016/0016-5085(92)91819-P; Mazzarella G, 2008, GASTROENTEROLOGY, V134, P1017, DOI 10.1053/j.gastro.2008.01.008; Mention JJ, 2003, GASTROENTEROLOGY, V125, P730, DOI 10.1016/S0016-5085(03)01047-3; Meresse B, 2004, IMMUNITY, V21, P357, DOI 10.1016/j.immuni.2004.06.020; Mohty M, 2003, BRIT J HAEMATOL, V122, P829, DOI 10.1046/j.1365-2141.2003.04489.x; Monteleone I, 2010, J IMMUNOL, V184, P2211, DOI 10.4049/jimmunol.0901919; Mora JR, 2008, NAT REV IMMUNOL, V8, P685, DOI 10.1038/nri2378; Mucida D, 2007, SCIENCE, V317, P256, DOI 10.1126/science.1145697; NILSEN EM, 1995, GUT, V37, P766, DOI 10.1136/gut.37.6.766; Reddy D, 2006, AM J GASTROENTEROL, V101, P1569, DOI 10.1111/j.1572-0241.2006.00632.x; Rochette-Egly Cecile, 2009, Nucl Recept Signal, V7, pe005, DOI 10.1621/nrs.07005; Stephensen CB, 2009, AM J CLIN NUTR, V90, P457, DOI 10.3945/ajcn.2009.28343; Tagaya Y, 1996, IMMUNITY, V4, P329, DOI 10.1016/S1074-7613(00)80246-0; Veldhoen M, 2006, IMMUNITY, V24, P179, DOI 10.1016/j.immuni.2006.01.001; Yokoyama S, 2009, P NATL ACAD SCI USA, V106, P15849, DOI 10.1073/pnas.0908834106	37	270	284	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 10	2011	471	7337					220	U110		10.1038/nature09849	http://dx.doi.org/10.1038/nature09849			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732FK	21307853	Green Accepted			2022-12-28	WOS:000288170200038
J	Choudhury, N; Walizer, L; Lisenkov, S; Bellaiche, L				Choudhury, Narayani; Walizer, Laura; Lisenkov, Sergey; Bellaiche, L.			Geometric frustration in compositionally modulated ferroelectrics	NATURE			English	Article							CHOLESTERIC BLUE PHASE; SUPERCONDUCTIVITY; SUPERLATTICES; MULTIFERROICS; CURVATURE; DIAGRAMS; GLASSES; PHYSICS; OXIDES; STATE	Geometric frustration is a broad phenomenon that results from an intrinsic incompatibility between some fundamental interactions and the underlying lattice geometry(1-7). Geometric frustration gives rise to new fundamental phenomena and is known to yield intriguing effects such as the formation of exotic states like spin ice, spin liquids and spin glasses(1-17). It has also led to interesting findings of fractional charge quantization and magnetic monopoles(5,6). Mechanisms related to geometric frustration have been proposed to understand the origins of relaxor and multiferroic behaviour, colossal magneto-capacitive coupling, and unusual and novel mechanisms of high-transition-temperature superconductivity(3-5,12,16). Although geometric frustration has been particularly well studied in magnetic systems in the past 20 years or so, its manifestation in the important class formed by ferroelectric materials (which are compounds with electric rather than magnetic dipoles) is basically unknown. Here we show, using a technique based on first principles, that compositionally graded ferroelectrics possess the characteristic 'fingerprints' associated with geometric frustration. These systems have a highly degenerate energy surface and display critical phenomena. They further reveal exotic orderings with novel stripe phases involving complex spatial organization. These stripes display spiral states, topological defects and curvature. Compositionally graded ferroelectrics can thus be considered the 'missing link' that brings ferroelectrics into the broad category of materials able to exhibit geometric frustration. Our ab initio calculations allow deep microscopic insight into this novel geometrically frustrated system.	[Choudhury, Narayani; Bellaiche, L.] Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA; [Walizer, Laura] Engineer Res & Dev Ctr, Vicksburg, MS 39180 USA; [Lisenkov, Sergey] Univ S Florida, Dept Phys, Tampa, FL 33620 USA	University of Arkansas System; University of Arkansas Fayetteville; United States Department of Defense; United States Army; U.S. Army Corps of Engineers; U.S. Army Engineer Research & Development Center (ERDC); State University System of Florida; University of South Florida	Choudhury, N (corresponding author), Univ Arkansas, Dept Phys, Fayetteville, AR 72701 USA.	narayani@uark.edu	Lisenkov, Sergey/C-4337-2012	Lisenkov, Sergey/0000-0003-4489-0028	US National Science Foundation; Office of Naval Research; Department of Energy; Direct For Computer & Info Scie & Enginr [0959124] Funding Source: National Science Foundation; EPSCoR [0918970] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Office of Naval Research(Office of Naval Research); Department of Energy(United States Department of Energy (DOE)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the US National Science Foundation, Office of Naval Research and Department of Energy. We gratefully acknowledge extensive use of the supercomputing resources of the University of Arkansas High Performance Computing Center as well as the Center for Piezoelectrics by Design, College of William and Mary, Virginia. We thank A. Apon, D. Chaffin, J. Pummill and E. J. Walter for computational support.	ANDERSON PW, 1987, SCIENCE, V235, P1196, DOI 10.1126/science.235.4793.1196; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Bin-Omran S, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.094119; Bousquet E, 2008, NATURE, V452, P732, DOI 10.1038/nature06817; Castelnovo C, 2008, NATURE, V451, P42, DOI 10.1038/nature06433; Cheong SW, 2007, NAT MATER, V6, P13, DOI 10.1038/nmat1804; Dawber M, 2005, REV MOD PHYS, V77, P1083, DOI 10.1103/RevModPhys.77.1083; Hagemann IS, 2000, PHYS REV B, V62, pR771, DOI 10.1103/PhysRevB.62.R771; Harris M, 1999, NATURE, V399, P311, DOI 10.1038/20562; Hemberger J, 2005, NATURE, V434, P364, DOI 10.1038/nature03348; Lai BK, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1890480; LAUGHLIN RB, 1988, SCIENCE, V242, P525, DOI 10.1126/science.242.4878.525; Lee HN, 2005, NATURE, V433, P395, DOI 10.1038/nature03261; Lee SH, 2002, NATURE, V418, P856, DOI 10.1038/nature00964; Libal A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.237004; Lisenkov S, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.020102; Moessner R, 2006, PHYS TODAY, V59, P24, DOI 10.1063/1.2186278; Mostovoy M, 2008, NAT MATER, V7, P269, DOI 10.1038/nmat2143; NARASIMHAN S, 1992, PHYS REV LETT, V69, P2455, DOI 10.1103/PhysRevLett.69.2455; Okatan MB, 2009, J APPL PHYS, V105, DOI 10.1063/1.3142385; Papanikolaou S, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.094406; Pertsev NA, 1998, PHYS REV LETT, V80, P1988, DOI 10.1103/PhysRevLett.80.1988; SETHNA JP, 1983, PHYS REV LETT, V51, P2198, DOI 10.1103/PhysRevLett.51.2198; SETHNA JP, 1985, PHYS REV B, V31, P6278, DOI 10.1103/PhysRevB.31.6278; VANDERBILT D, 1993, NATO ADV SCI INST SE, V240, P1; VEDMEDENKO EY, 2007, COMPETING INTERACTIO, P3; VILLAINGUILLOT S, 1995, PHYS REV B, V52, P6712, DOI 10.1103/PhysRevB.52.6712; Walizer L, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.144105; WEN XG, 1990, PHYS REV B, V41, P9377, DOI 10.1103/PhysRevB.41.9377	30	70	72	3	178	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 24	2011	470	7335					513	517		10.1038/nature09752	http://dx.doi.org/10.1038/nature09752			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21307851	Green Submitted			2022-12-28	WOS:000287652900037
J	Hackbarth, G; Boccuti, C				Hackbarth, Glenn; Boccuti, Cristina			Transforming Graduate Medical Education to Improve Health Care Value	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Hackbarth, Glenn; Boccuti, Cristina] Medicare Payment Advisory Commiss, Washington, DC USA		Hackbarth, G (corresponding author), Medicare Payment Advisory Commiss, Washington, DC USA.							[Anonymous], 2010, REP C MED PAYM POL, P39; Swensen SJ, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp0911199	2	46	48	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 24	2011	364	8					693	695		10.1056/NEJMp1012691	http://dx.doi.org/10.1056/NEJMp1012691			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	725NP	21306278				2022-12-28	WOS:000287652500001
J	McCartney, M				McCartney, Margaret			Medicine and the Media How useful are lifetime risks of disease?	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaretmccartney@doctors.org.uk	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				2011, COMP MATH MATH PHYS, V342, pD808, DOI DOI 10.1136/BMJ.D808	1	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2011	342								d1046	10.1136/bmj.d1046	http://dx.doi.org/10.1136/bmj.d1046			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	725OZ	21325383				2022-12-28	WOS:000287656500016
J	Ageno, W				Ageno, Walter			Fondaparinux reduced a composite of VTE complications or death in superficial leg-vein thrombosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Univ Insubria, Varese, Italy	University of Insubria	Ageno, W (corresponding author), Univ Insubria, Varese, Italy.							Decousus H, 2010, ANN INTERN MED, V152, P218, DOI 10.7326/0003-4819-152-4-201002160-00006; Di Nisio M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004982.pub3; Prandoni P, 2005, J THROMB HAEMOST, V3, P1152	3	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4							JC2-3	10.7326/0003-4819-154-4-201102150-02003	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-02003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720VF	21320930				2022-12-28	WOS:000287310000002
J	Popow, J; Englert, M; Weitzer, S; Schleiffer, A; Mierzwa, B; Mechtler, K; Trowitzsch, S; Will, CL; Luhrmann, R; Soll, D; Martinez, J				Popow, Johannes; Englert, Markus; Weitzer, Stefan; Schleiffer, Alexander; Mierzwa, Beata; Mechtler, Karl; Trowitzsch, Simon; Will, Cindy L.; Luehrmann, Reinhard; Soell, Dieter; Martinez, Javier			HSPC117 Is the Essential Subunit of a Human tRNA Splicing Ligase Complex	SCIENCE			English	Article							3'-TERMINAL PHOSPHATE CYCLASE; HELA-CELL EXTRACT; JUNCTION PHOSPHATE; FUNCTIONAL DOMAINS; LIGATION; PROTEIN; REVEALS; IDENTIFICATION; ENDONUCLEASE; PURIFICATION	Splicing of mammalian precursor transfer RNA (tRNA) molecules involves two enzymatic steps. First, intron removal by the tRNA splicing endonuclease generates separate 5' and 3' exons. In animals, the second step predominantly entails direct exon ligation by an elusive RNA ligase. Using activity-guided purification of tRNA ligase from HeLa cell extracts, we identified HSPC117, a member of the UPF0027 (RtcB) family, as the essential subunit of a tRNA ligase complex. RNA interference-mediated depletion of HSPC117 inhibited maturation of intron-containing pre-tRNA both in vitro and in living cells. The high sequence conservation of HSPC117/RtcB proteins is suggestive of RNA ligase roles of this protein family in various organisms.	[Englert, Markus; Soell, Dieter] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Popow, Johannes; Weitzer, Stefan; Mierzwa, Beata; Martinez, Javier] Austrian Acad Sci IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Schleiffer, Alexander] Res Inst Mol Pathol IMP IMBA, Bioinformat Dept, A-1030 Vienna, Austria; [Mechtler, Karl] Res Inst Mol Pathol IMP IMBA, Dept Prot Chem, A-1030 Vienna, Austria; [Trowitzsch, Simon; Will, Cindy L.; Luehrmann, Reinhard] Max Planck Inst Biophys Chem, Dept Cellular Biochem, D-37077 Gottingen, Germany; [Soell, Dieter] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Max Planck Society; Yale University	Soll, D (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, POB 6666, New Haven, CT 06520 USA.	dieter.soll@yale.edu; javier.martinez@imba.oeaw.ac.at	Mechtler, Karl/AAF-2717-2019; Trowitzsch, Simon/O-4957-2016; Mierzwa, Beata/A-6382-2016	Mechtler, Karl/0000-0002-3392-9946; Trowitzsch, Simon/0000-0001-9143-766X; Martinez, Javier/0000-0001-9152-7323; Schleiffer, Alexander/0000-0001-6251-2747; Mierzwa, Beata/0000-0002-2146-4352	European Commission [EURASNET-518238]; Fonds zur Forderung der wissenschaftlichen Forschung [W1207 RNA Biologie]; National Institute of General Medical Sciences; S.D. Prinz Max von und zu Liechtenstein	European Commission(European CommissionEuropean Commission Joint Research Centre); Fonds zur Forderung der wissenschaftlichen Forschung(Austrian Science Fund (FWF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); S.D. Prinz Max von und zu Liechtenstein	We thank H. Beier, T. Biederer, T. Clausen, A. Meinhart, A. F. Nielsen, R. Schroeder, K. Sheppard, T. Tuschl, and S. Westermann for reagents and helpful discussions; and G. Heyne, O. Kuzyk, G. Schmauss, and G. Stengl for technical assistance; and H. Urlaub for MS analysis of HSPC117 complexes. M.E. was a Feodor-Lynen Postdoctoral Fellow of the Alexander von Humboldt Stiftung (Bonn, Germany). Supported by grants from the European Commission (EURASNET-518238) (R.L.), the Fonds zur Forderung der wissenschaftlichen Forschung (W1207 RNA Biologie) (J.P.), and the National Institute of General Medical Sciences (D.S.). J.M. would like to especially acknowledge the generous financial contribution and support by S.D. Prinz Max von und zu Liechtenstein.	Abelson J, 1998, J BIOL CHEM, V273, P12685, DOI 10.1074/jbc.273.21.12685; APOSTOL BL, 1991, J BIOL CHEM, V266, P7445; Cao D, 2009, RNA, V15, P1971, DOI 10.1261/rna.1782209; Drewett V, 2001, NUCLEIC ACIDS RES, V29, P479, DOI 10.1093/nar/29.2.479; Englert M, 2005, NUCLEIC ACIDS RES, V33, P388, DOI 10.1093/nar/gki174; Englert M, 2011, P NATL ACAD SCI USA, V108, P1290, DOI 10.1073/pnas.1018307108; FILIPOWICZ W, 1983, CELL, V32, P547, DOI 10.1016/0092-8674(83)90474-9; FILIPOWICZ W, 1983, NUCLEIC ACIDS RES, V11, P1405, DOI 10.1093/nar/11.5.1405; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, pD3, DOI 10.1093/nar/gkh143; Genschik P, 1998, J BIOL CHEM, V273, P25516, DOI 10.1074/jbc.273.39.25516; Goyal K, 2008, PROTEINS, V70, P1206, DOI 10.1002/prot.21601; Harding HP, 2008, RNA, V14, P225, DOI 10.1261/rna.859908; KONARSKA M, 1981, NATURE, V293, P112, DOI 10.1038/293112a0; LASKI FA, 1983, J BIOL CHEM, V258, P1974; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Okada C, 2006, PROTEINS, V63, P1119, DOI 10.1002/prot.20912; Paushkin SV, 2004, CELL, V117, P311, DOI 10.1016/S0092-8674(04)00342-3; PERKINS KK, 1985, P NATL ACAD SCI USA, V82, P684, DOI 10.1073/pnas.82.3.684; PHIZICKY EM, 1986, J BIOL CHEM, V261, P2978; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Reid CE, 2000, P NATL ACAD SCI USA, V97, P424, DOI 10.1073/pnas.97.1.424; Sawaya R, 2003, J BIOL CHEM, V278, P43928, DOI 10.1074/jbc.M307839200; Trotta CR, 1997, CELL, V89, P849, DOI 10.1016/S0092-8674(00)80270-6; VICENTE O, 1988, EUR J BIOCHEM, V176, P431, DOI 10.1111/j.1432-1033.1988.tb14300.x; Wang LK, 2003, J BIOL CHEM, V278, P29454, DOI 10.1074/jbc.M304320200; Weitzer S, 2007, NATURE, V447, P222, DOI 10.1038/nature05777; ZILLMANN M, 1991, MOL CELL BIOL, V11, P5410, DOI 10.1128/MCB.11.11.5410; Zofallova L, 2000, RNA, V6, P1019, DOI 10.1017/S1355838200000613	28	154	165	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					760	764		10.1126/science.1197847	http://dx.doi.org/10.1126/science.1197847			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21311021	Green Submitted			2022-12-28	WOS:000287205700068
J	Stefansson, K				Stefansson, Kari			An Anniversary Party	SCIENCE			English	Editorial Material									deCode Genet, Reykjavik, Iceland		Stefansson, K (corresponding author), deCode Genet, Reykjavik, Iceland.		Stefansson, Kari/AAE-7187-2019						0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					691	691		10.1126/science.1203016	http://dx.doi.org/10.1126/science.1203016			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21311000				2022-12-28	WOS:000287205700043
J	Kuper, A; Marks, J				Kuper, Adam; Marks, Jonathan			Anthropologists unite!	NATURE			English	Editorial Material									[Marks, Jonathan] Univ N Carolina, Dept Anthropol, Charlotte, NC 28223 USA	University of North Carolina; University of North Carolina Charlotte	Kuper, A (corresponding author), London Sch Econ, Dept Anthropol, London WC2A 2AE, England.	adam.kuper@gmail.com						ALBERT B, 1989, CURR ANTHROPOL, V30, P637, DOI 10.1086/203793; Arnett JJ, 2008, AM PSYCHOL, V63, P602, DOI 10.1037/0003-066X.63.7.602; CHAGNON NA, 1988, SCIENCE, V239, P985, DOI 10.1126/science.239.4843.985; Freeman Derek, 1983, MARGARET MEAD MAKING; Herrnstein R., 1994, BELL CURVE INTELLIGE; Kuper A, 1999, CULTURE ANTHR ACCOUN; Mead M, 1964, COMING AGE SAMOA; Shankman Paul, 2009, TRASHING MARGARET ME; WADE N, 2010, NY TIMES        1213; Wade Nicholas, 2010, NY TIMES        1209	10	19	19	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2011	470	7333					166	168		10.1038/470166a	http://dx.doi.org/10.1038/470166a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	718RQ	21307914	Green Accepted			2022-12-28	WOS:000287144200016
J	Minc, N; Burgess, D; Chang, F				Minc, Nicolas; Burgess, David; Chang, Fred			Influence of Cell Geometry on Division-Plane Positioning	CELL			English	Article							CAENORHABDITIS-ELEGANS EMBRYO; MITOTIC SPINDLE ORIENTATION; FISSION YEAST; DYNAMIC MICROTUBULES; PRONUCLEAR MIGRATION; SHAPE; MECHANISM; CLEAVAGE; FORCES; LENGTH	The spatial organization of cells depends on their ability to sense their own shape and size. Here, we investigate how cell shape affects the positioning of the nucleus, spindle and subsequent cell division plane. To manipulate geometrical parameters in a systematic manner, we place individual sea urchin eggs into microfabricated chambers of defined geometry (e. g., triangles, rectangles, and ellipses). In each shape, the nucleus is positioned at the center of mass and is stretched by microtubules along an axis maintained through mitosis and predictive of the future division plane. We develop a simple computational model that posits that microtubules sense cell geometry by probing cellular space and orient the nucleus by exerting pulling forces that scale to microtubule length. This model quantitatively predicts division-axis orientation probability for a wide variety of cell shapes, even in multicellular contexts, and estimates scaling exponents for length-dependent microtubule forces.	[Burgess, David] Boston Coll, Dept Biol, Chestnut Hill, MA 02167 USA; [Minc, Nicolas; Burgess, David; Chang, Fred] Marine Biol Lab, Woods Hole, MA 02543 USA; [Minc, Nicolas; Chang, Fred] Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA	Boston College; Marine Biological Laboratory - Woods Hole; Columbia University	Minc, N (corresponding author), Inst Curie, UMR 144 CNRS IC, 26 Rue Ulm, F-75248 Paris 05, France.	nicolas.minc@curie.fr		Minc, Nicolas/0000-0002-5543-7950	National Institutes of Health (NIH) [GM069670, GM056836]; Ellison Senior Scholar award; CNRS; ANR [ANR-10PDOC-003-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056836, R01GM069670] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Senior Scholar award(Lawrence Ellison Foundation); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors acknowledge all members of the Chang and Burgess laboratories for discussions and technical assistance. We thank A. Boudaoud for careful reading of the manuscript and J. Brill for discussions. Microfabrication was made in the Columbia CEPSR clean room. Part of the microscopy was performed in the Microbiology Department confocal microscopy facility. This work, which was initiated at the Marine Biological Laboratory, was supported by National Institutes of Health (NIH) RO1 grants GM069670 and GM056836 and an Ellison Senior Scholar award to F. C. N.M. acknowledges support from the CNRS and an ANR "retour post-doctorants'' grant ANR-10PDOC-003-01. The authors dedicate this manuscript to the memory of Ray Rappaport.	Bettinger BT, 2004, NAT REV MOL CELL BIO, V5, P410, DOI 10.1038/nrm1370; BJERKNES M, 1986, SCIENCE, V234, P1413, DOI 10.1126/science.3787253; Cai DW, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000216; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Concha ML, 1998, DEVELOPMENT, V125, P983; Dahl KN, 2004, J CELL SCI, V117, P4779, DOI 10.1242/jcs.01357; Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; Foe VE, 2008, J CELL BIOL, V183, P457, DOI 10.1083/jcb.200807128; Gardner MK, 2008, CELL, V135, P894, DOI 10.1016/j.cell.2008.09.046; GOLDSTEIN B, 1995, J CELL BIOL, V129, P1071, DOI 10.1083/jcb.129.4.1071; Gonczy P, 1999, J CELL BIOL, V147, P135, DOI 10.1083/jcb.147.1.135; Gray D, 2004, CURR BIOL, V14, P397, DOI 10.1016/j.cub.2004.02.031; Grill SW, 2001, NATURE, V409, P630, DOI 10.1038/35054572; Grill SW, 2003, SCIENCE, V301, P518, DOI 10.1126/science.1086560; Grill SW, 2005, DEV CELL, V8, P461, DOI 10.1016/j.devcel.2005.03.014; Guyer M.F., 1900, THESIS U CHICAGO CHI; HAMAGUCHI MS, 1986, DEV GROWTH DIFFER, V28, P143, DOI 10.1111/j.1440-169x.1986.00143.x; Hara Y, 2009, CURR BIOL, V19, P1549, DOI 10.1016/j.cub.2009.07.050; HAYS TS, 1982, J CELL BIOL, V93, P374, DOI 10.1083/jcb.93.2.374; Hertwig O., 1884, PROBLEM BEFRUCHTUNG; Holy J, 1997, CELL TISSUE RES, V289, P285, DOI 10.1007/s004410050875; Howard J, 2006, PHYS BIOL, V3, P54, DOI 10.1088/1478-3975/3/1/006; Janson ME, 2007, CELL, V128, P357, DOI 10.1016/j.cell.2006.12.030; Jenkinson J.W., 1909, EXPT EMBRYOLOGY; Kimura A, 2005, DEV CELL, V8, P765, DOI 10.1016/j.devcel.2005.03.007; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Minc N, 2010, CURR BIOL, V20, P710, DOI 10.1016/j.cub.2010.02.047; Minc N, 2009, CURR BIOL, V19, P1096, DOI 10.1016/j.cub.2009.05.031; Minc N, 2009, CURR BIOL, V19, P83, DOI 10.1016/j.cub.2008.12.008; Moseley JB, 2010, CELL, V142, P189, DOI 10.1016/j.cell.2010.07.004; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; Rappaport R., 1996, CYTOKINESIS ANIMAL C; Reinsch S, 1998, J CELL SCI, V111, P2283; SCHATTEN G, 1986, EXP CELL RES, V166, P191, DOI 10.1016/0014-4827(86)90519-7; Schierenberg Einhard, 2006, WormBook, P1; Schuh M, 2008, CURR BIOL, V18, P1986, DOI 10.1016/j.cub.2008.11.022; Seetapun D, 2010, CURR BIOL, V20, P979, DOI 10.1016/j.cub.2010.04.040; Strauss B, 2006, DEVELOPMENT, V133, P3883, DOI 10.1242/dev.02578; Strickland L, 2004, METHOD CELL BIOL, V74, P371; Strickland LI, 2005, CURR BIOL, V15, P2249, DOI 10.1016/j.cub.2005.10.073; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Tischer C, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.5; Tran PT, 2001, J CELL BIOL, V153, P397, DOI 10.1083/jcb.153.2.397; Tsou MFB, 2003, J CELL BIOL, V160, P845, DOI 10.1083/jcb.200209079; Varga V, 2009, CELL, V138, P1174, DOI 10.1016/j.cell.2009.07.032; Vaziri A, 2007, J BIOMECH, V40, P2053, DOI 10.1016/j.jbiomech.2006.09.023; Velve-Casquillas G, 2010, NANO TODAY, V5, P28, DOI 10.1016/j.nantod.2009.12.001; Vogel SK, 2009, PLOS BIOL, V7, P918, DOI 10.1371/journal.pbio.1000087; von Dassow G, 2009, J CELL BIOL, V187, P831, DOI 10.1083/jcb.200907090; Wang SW, 1997, DEVELOPMENT, V124, P773; Wong GK, 1997, CELL MOTIL CYTOSKEL, V36, P30, DOI 10.1002/(SICI)1097-0169(1997)36:1<30::AID-CM3>3.0.CO;2-L; Wuhr M, 2009, CELL CYCLE, V8, P1115; Wuhr M, 2010, CURR BIOL, V20, P2040, DOI 10.1016/j.cub.2010.10.024	56	249	249	0	93	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 4	2011	144	3					414	426		10.1016/j.cell.2011.01.016	http://dx.doi.org/10.1016/j.cell.2011.01.016			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295701	Green Accepted, Bronze			2022-12-28	WOS:000286973100013
J	Riehle, MM; Guelbeogo, WM; Gneme, A; Eiglmeier, K; Holm, I; Bischoff, E; Garnier, T; Snyder, GM; Li, XZ; Markianos, K; Sagnon, N; Vernick, KD				Riehle, Michelle M.; Guelbeogo, Wamdaogo M.; Gneme, Awa; Eiglmeier, Karin; Holm, Inge; Bischoff, Emmanuel; Garnier, Thierry; Snyder, Gregory M.; Li, Xuanzhong; Markianos, Kyriacos; Sagnon, N'Fale; Vernick, Kenneth D.			A Cryptic Subgroup of Anopheles gambiae Is Highly Susceptible to Human Malaria Parasites	SCIENCE			English	Article							MULTILOCUS GENOTYPE DATA; DISEASE TRANSMISSION; MOLECULAR-FORMS; HOST SELECTION; MOSQUITOS; COMPLEX; INFERENCE; AFRICA; SPECIATION; CULICIDAE	Population subgroups of the African malaria vector Anopheles gambiae have not been comprehensively characterized owing to the lack of unbiased sampling methods. In the arid savanna zone of West Africa, where potential oviposition sites are scarce, widespread collection from larval pools in the peridomestic human habitat yielded a comprehensive genetic survey of local A. gambiae population subgroups, independent of adult resting behavior and ecological preference. A previously unknown subgroup of exophilic A. gambiae is sympatric with the known endophilic A. gambiae in this region. The exophilic subgroup is abundant, lacks differentiation into M and S molecular forms, and is highly susceptible to infection with wild Plasmodium falciparum. These findings might have implications for the epidemiology of malaria transmission and control.	[Riehle, Michelle M.; Eiglmeier, Karin; Holm, Inge; Bischoff, Emmanuel; Garnier, Thierry; Vernick, Kenneth D.] Inst Pasteur, Unit Insect Vector Genet & Genom, Dept Parasitol & Mycol,Dept Environm & Sustainabl, Unit Hosts Vectors & Pathogens URA 3012,CNRS, F-75015 Paris, France; [Riehle, Michelle M.; Snyder, Gregory M.; Vernick, Kenneth D.] Univ Minnesota, Dept Microbiol, St Paul, MN 55108 USA; [Guelbeogo, Wamdaogo M.; Gneme, Awa; Sagnon, N'Fale] Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso; [Li, Xuanzhong; Markianos, Kyriacos] Harvard Univ, Childrens Hosp Boston, Sch Med, Program Genom, Boston, MA 02115 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Boston Children's Hospital; Harvard Medical School	Vernick, KD (corresponding author), Inst Pasteur, Unit Insect Vector Genet & Genom, Dept Parasitol & Mycol,Dept Environm & Sustainabl, Unit Hosts Vectors & Pathogens URA 3012,CNRS, 28 Rue Docteur Roux, F-75015 Paris, France.	kenneth.vernick@pasteur.fr	Bischoff, Emmanuel/F-1197-2011; GNEME, Awa/M-3299-2015	Bischoff, Emmanuel/0000-0003-4655-4247; Markianos, Kyriacos/0000-0003-0214-6014; GNEME, Awa/0000-0003-2514-5313	National Institute of Allergy and Infectious Diseases, NIH [AI073685, AI042361]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073685, R01AI042361] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We acknowledge support from National Institute of Allergy and Infectious Diseases, NIH, to K.D.V., AI073685 and AI042361.	[Anonymous], 1993, MOSQUITO ECOLOGY FIE; BOCKARIE MJ, 1994, ANN TROP MED PARASIT, V88, P251, DOI 10.1080/00034983.1994.11812865; BRUCECHWATT LJ, 1966, B WORLD HEALTH ORGAN, V35, P405; Caputo B, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-182; Charlwood JD, 2000, AM J TROP MED HYG, V62, P726, DOI 10.4269/ajtmh.2000.62.726; COLUZZI M, 1977, NATURE, V266, P832, DOI 10.1038/266832a0; COLUZZI M, 1979, T ROY SOC TROP MED H, V73, P483, DOI 10.1016/0035-9203(79)90036-1; Coluzzi M., 1967, Parassitologia, V9, P73; Costantini Carlo, 2009, BMC Ecology, V9, P16, DOI 10.1186/1472-6785-9-16; della Torre A, 2001, INSECT MOL BIOL, V10, P9, DOI 10.1046/j.1365-2583.2001.00235.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Geissbuhler Y, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-126; Lehmann T, 2010, AM J TROP MED HYG, V83, P601, DOI 10.4269/ajtmh.2010.09-0779; Mitri C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000576; MOLINEAUX L, 1979, B WORLD HEALTH ORGAN, V57, P265; Odiere M, 2007, J MED ENTOMOL, V44, P14, DOI 10.1603/0022-2585(2007)44[14:SORAGA]2.0.CO;2; Oliveira E, 2008, J MED ENTOMOL, V45, P1057, DOI 10.1603/0022-2585(2008)45[1057:HLOHBM]2.0.CO;2; Pates H, 2005, ANNU REV ENTOMOL, V50, P53, DOI 10.1146/annurev.ento.50.071803.130439; Pritchard JK, 2000, GENETICS, V155, P945; REISEN WK, 1979, AM J TROP MED HYG, V28, P408, DOI 10.4269/ajtmh.1979.28.408; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Sharakhov IV, 2006, P NATL ACAD SCI USA, V103, P6258, DOI 10.1073/pnas.0509683103; Smits A, 1996, J MED ENTOMOL, V33, P545, DOI 10.1093/jmedent/33.4.545; Toure Y. T., 1998, Parassitologia (Rome), V40, P477; White BJ, 2010, MOL ECOL, V19, P925, DOI 10.1111/j.1365-294X.2010.04531.x; WHITE GB, 1974, T ROY SOC TROP MED H, V68, P278, DOI 10.1016/0035-9203(74)90035-2	27	102	104	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					596	598		10.1126/science.1196759	http://dx.doi.org/10.1126/science.1196759			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292978	Green Accepted			2022-12-28	WOS:000286933600057
J	Worsdorfer, B; Woycechowsky, KJ; Hilvert, D				Woersdoerfer, Bigna; Woycechowsky, Kenneth J.; Hilvert, Donald			Directed Evolution of a Protein Container	SCIENCE			English	Article							LUMAZINE SYNTHASE; CONSTRAINED SYNTHESIS; CONTRAST AGENTS; IRON-OXIDE; NANOPARTICLES; CAGE; ENCAPSULATION; DELIVERY; INTERIOR; RELEASE	Confinement of enzymes in protein nanocompartments represents a potentially powerful strategy for controlling catalytic activity in cells. By using a simple electrostatically based tagging system for protein encapsulation, we successfully sequestered HIV protease, a toxic enzyme when produced cytoplasmically, within an engineered lumazine synthase capsid. The growth advantage resulting from protecting the Escherichia coli host from the protease enabled directed evolution of improved capsids. After four rounds of mutagenesis and selection, we obtained a variant with a 5- to 10-fold higher loading capacity than the starting capsid, which permitted efficient growth even at high intracellular concentrations of HIV protease. The superior properties of the evolved capsid can be ascribed to multiple mutations that increase the net negative charge on its luminal surface and thereby enhance engineered Coulombic interactions between host and guest. Such structures could be used for diverse biotechnological applications in living cells.	[Woersdoerfer, Bigna; Woycechowsky, Kenneth J.; Hilvert, Donald] ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Hilvert, D (corresponding author), ETH, Organ Chem Lab, CH-8093 Zurich, Switzerland.	hilvert@org.chem.ethz.ch	Woycechowsky, Kenneth/K-5833-2015		Schweizerischer Nationalfond; ETH Zurich	Schweizerischer Nationalfond; ETH Zurich(ETH Zurich)	We thank B. Roschitzki at the Functional Genomics Center Zurich for collection of mass spectrometic data and assistance with data analysis; T. Ishikawa and M. Lucas at the Electron Microscopy Center of the ETH Zurich (EMEZ) for collecting the EM images and assistance with EM data analysis; H.-M. Fischer, F. Narberhaus, M. Neuenschwander, and F. Seebeck for contributive discussions; and P. Kast for careful reading of the manuscript. This work was supported in part by the Schweizerischer Nationalfond and the ETH Zurich. The supercharged GFP described in fig. S8 was obtained under a materials transfer agreement (MTA) with D. R. Liu at Harvard. An MTA would be required for sharing of materials used in the reported research.	Abbing A, 2004, J BIOL CHEM, V279, P27410, DOI 10.1074/jbc.M313612200; Aime S, 2002, ANGEW CHEM INT EDIT, V41, P1017, DOI 10.1002/1521-3773(20020315)41:6<1017::AID-ANIE1017>3.0.CO;2-P; Allen M, 2002, ADV MATER, V14, P1562, DOI 10.1002/1521-4095(20021104)14:21<1562::AID-ADMA1562>3.0.CO;2-D; de la Escosura A, 2009, J MATER CHEM, V19, P2274, DOI 10.1039/b815274h; DOUGLAS T, 1995, SCIENCE, V269, P54, DOI 10.1126/science.269.5220.54; Flenniken ML, 2005, CHEM COMMUN, P447, DOI 10.1039/b413435d; Flint S.J., 2020, PRINCIPLES VIROLOGY, V2; Hooker JM, 2007, NANO LETT, V7, P2207, DOI 10.1021/nl070512c; Ishii D, 2003, NATURE, V423, P628, DOI 10.1038/nature01663; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; KATZ RA, 1994, ANNU REV BIOCHEM, V63, P133, DOI 10.1146/annurev.bi.63.070194.001025; KIS K, 1995, J BIOL CHEM, V270, P16788, DOI 10.1074/jbc.270.28.16788; Klem MT, 2007, J AM CHEM SOC, V129, P197, DOI 10.1021/ja0667561; Knez M, 2003, NANO LETT, V3, P1079, DOI 10.1021/nl0342545; Liu XF, 2005, ACCOUNTS CHEM RES, V38, P167, DOI 10.1021/ar0302336; McMillan RA, 2005, J AM CHEM SOC, V127, P2800, DOI 10.1021/ja043827s; Neuenschwander M, 2007, NAT BIOTECHNOL, V25, P1145, DOI [10.1038/nbt1341, 10.1038/nbtl341]; Rebek J, 2005, ANGEW CHEM INT EDIT, V44, P2068, DOI 10.1002/anie.200462839; Saibil HR, 2008, CURR OPIN STRUC BIOL, V18, P35, DOI 10.1016/j.sbi.2007.11.006; Schaffer DV, 2008, ANNU REV BIOMED ENG, V10, P169, DOI 10.1146/annurev.bioeng.10.061807.160514; Seebeck FP, 2006, J AM CHEM SOC, V128, P4516, DOI 10.1021/ja058363s; Shenton W, 2001, ANGEW CHEM INT EDIT, V40, P442, DOI 10.1002/1521-3773(20010119)40:2<442::AID-ANIE442>3.0.CO;2-2; Sutter M, 2008, NAT STRUCT MOL BIOL, V15, P939, DOI 10.1038/nsmb.1473; Tanaka S, 2010, SCIENCE, V327, P81, DOI 10.1126/science.1179513; Uchida M, 2007, ADV MATER, V19, P1025, DOI 10.1002/adma.200601168; Uchida M, 2006, J AM CHEM SOC, V128, P16626, DOI 10.1021/ja0655690; Yamada T, 2003, NAT BIOTECHNOL, V21, P885, DOI 10.1038/nbt843; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Zhang XF, 2001, J MOL BIOL, V306, P1099, DOI 10.1006/jmbi.2000.4435; Zhang XF, 2006, J MOL BIOL, V362, P753, DOI 10.1016/j.jmb.2006.07.037; Zhou ZH, 2001, P NATL ACAD SCI USA, V98, P14802, DOI 10.1073/pnas.011597698	31	243	247	3	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					589	592		10.1126/science.1199081	http://dx.doi.org/10.1126/science.1199081			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292977				2022-12-28	WOS:000286933600055
J	Bottle, A; Jarman, B; Aylin, P				Bottle, Alex; Jarman, Brian; Aylin, Paul			Strengths and weaknesses of hospital standardised mortality ratios	BMJ-BRITISH MEDICAL JOURNAL			English	Article												robert.bottle@imperial.ac.uk	Aylin, Paul/A-1073-2014	Aylin, Paul/0000-0003-4589-1743; Bottle, Alex/0000-0001-9978-2011	National Institute of Health Research; NIHR Biomedical Research Centre funding scheme	National Institute of Health Research(National Institute for Health Research (NIHR)); NIHR Biomedical Research Centre funding scheme(National Institute for Health Research (NIHR))	The Dr Foster Unit is affiliated with the Centre for Patient Safety and Service Quality at Imperial College Healthcare NHS Trust, which is funded by the National Institute of Health Research. We are grateful for support from the NIHR Biomedical Research Centre funding scheme. We also thank Liz Robb and Nick Flatt for their helpful comments.	*AUD COMM, 2004, INF DAT QUAL NHS; Black N, 2010, BMJ-BRIT MED J, V340, P933; Bottle A, 2008, HEALTH SERV RES, V43, P10, DOI 10.1111/j.1475-6773.2007.00742.x; Campbell SE, 2001, J PUBLIC HEALTH MED, V23, P205, DOI 10.1093/pubmed/23.3.205; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Hayward RA, 2001, JAMA-J AM MED ASSOC, V286, P415, DOI 10.1001/jama.286.4.415; Healthcare Commission, 2009, INV MID STAFF NHS FD; Jarman B, 2005, BRIT MED J, V330, P329, DOI 10.1136/bmj.330.7487.329; Jarman B, 1999, BMJ-BRIT MED J, V318, P1515, DOI 10.1136/bmj.318.7197.1515; Jarman B, QUAL SAFETY IN PRESS; Kahn JM, 2007, CHEST, V131, P68, DOI 10.1378/chest.06-0741; Lilford R, 2004, LANCET, V363, P1147, DOI 10.1016/S0140-6736(04)15901-1; Lilford R, 2010, BMJ-BRIT MED J, V340, P955; Mohammed MA, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b780; National Audit Office, 2005, SAF PLAC PAT LEARN I; Nicholl J, 2007, J EPIDEMIOL COMMUN H, V61, P1010, DOI 10.1136/jech.2007.061747; Pine M, 2009, MED DECIS MAKING, V29, P69, DOI 10.1177/0272989X08323297; Robb E, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1234; Spiegelhalter DJ, 2005, QUAL SAF HEALTH CARE, V14, P347, DOI 10.1136/qshc.2005.013755; Wright J, 2006, J ROY SOC MED, V99, P303, DOI 10.1258/jrsm.99.6.303	20	42	43	2	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2011	342								c7116	10.1136/bmj.c7116	http://dx.doi.org/10.1136/bmj.c7116			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V41KY	21257655				2022-12-28	WOS:000209546300001
J	Amblard, A; Cooray, A; Serra, P; Altieri, B; Arumugam, V; Aussel, H; Blain, A; Bock, J; Boselli, A; Buat, V; Castro-Rodriguez, N; Cava, A; Chanial, P; Chapin, E; Clements, DL; Conley, A; Conversi, L; Dowell, CD; Dwek, E; Eales, S; Elbaz, D; Farrah, D; Franceschini, A; Gear, W; Glenn, J; Griffin, M; Halpern, M; Hatziminaoglou, E; Ibar, E; Isaak, K; Ivison, RJ; Khostovan, AA; Lagache, G; Levenson, L; Lu, N; Madden, S; Maffei, B; Mainetti, G; Marchetti, L; Marsden, G; Mitchell-Wynne, K; Nguyen, HT; O'Halloran, B; Oliver, SJ; Omont, A; Page, MJ; Panuzzo, P; Papageorgiou, A; Pearson, CP; Perez-Fournon, I; Pohlen, M; Rangwala, N; Roseboom, IG; Rowan-Robinson, M; Portal, MS; Schulz, B; Scott, D; Seymour, N; Shupe, DL; Smith, AJ; Stevens, JA; Symeonidis, M; Trichas, M; Tugwell, K; Vaccari, M; Valiante, E; Valtchanov, I; Vieira, JD; Vigroux, L; Wang, L; Ward, R; Wright, G; Xu, CK; Zemcov, M				Amblard, Alexandre; Cooray, Asantha; Serra, Paolo; Altieri, B.; Arumugam, V.; Aussel, H.; Blain, A.; Bock, J.; Boselli, A.; Buat, V.; Castro-Rodriguez, N.; Cava, A.; Chanial, P.; Chapin, E.; Clements, D. L.; Conley, A.; Conversi, L.; Dowell, C. D.; Dwek, E.; Eales, S.; Elbaz, D.; Farrah, D.; Franceschini, A.; Gear, W.; Glenn, J.; Griffin, M.; Halpern, M.; Hatziminaoglou, E.; Ibar, E.; Isaak, K.; Ivison, R. J.; Khostovan, A. A.; Lagache, G.; Levenson, L.; Lu, N.; Madden, S.; Maffei, B.; Mainetti, G.; Marchetti, L.; Marsden, G.; Mitchell-Wynne, K.; Nguyen, H. T.; O'Halloran, B.; Oliver, S. J.; Omont, A.; Page, M. J.; Panuzzo, P.; Papageorgiou, A.; Pearson, C. P.; Perez-Fournon, I.; Pohlen, M.; Rangwala, N.; Roseboom, I. G.; Rowan-Robinson, M.; Sanchez Portal, M.; Schulz, B.; Scott, Douglas; Seymour, N.; Shupe, D. L.; Smith, A. J.; Stevens, J. A.; Symeonidis, M.; Trichas, M.; Tugwell, K.; Vaccari, M.; Valiante, E.; Valtchanov, I.; Vieira, J. D.; Vigroux, L.; Wang, L.; Ward, R.; Wright, G.; Xu, C. K.; Zemcov, M.			Submillimetre galaxies reside in dark matter haloes with masses greater than 3 x 10(11) solar masses	NATURE			English	Article							HERSCHEL-SPIRE INSTRUMENT; STAR-FORMATION; NUMBER COUNTS; HERMES; REDSHIFT; SPITZER; ATLAS; BIAS	The extragalactic background light at far-infrared wavelengths(1-3) comes from optically faint, dusty, star-forming galaxies in the Universe with star formation rates of a few hundred solar masses per year(4). These faint, submillimetre galaxies are challenging to study individually because of the relatively poor spatial resolution of far-infrared telescopes(5,6). Instead, their average properties can be studied using statistics such as the angular power spectrum of the background intensity variations(7-10). A previous attempt(11) at measuring this power spectrum resulted in the suggestion that the clustering amplitude is below the level computed with a simple ansatz based on a halo model(12). Here we report excess clustering over the linear prediction at arcminute angular scales in the power spectrum of brightness fluctuations at 250, 350 and 500 mu m. From this excess, we find that submillimetre galaxies are located in dark matter haloes with a minimum mass, M-min, such that log(10)[M-min/M-circle dot] = 11.5(-0.2)(+0.7) at 350 mu m, where M-circle dot is the solar mass. This minimum dark matter halo mass corresponds to the most efficient mass scale for star formation in the Universe(13), and is lower than that predicted by semi-analytical models for galaxy formation(14).	[Amblard, Alexandre; Cooray, Asantha; Serra, Paolo; Khostovan, A. A.; Mitchell-Wynne, K.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA; [Altieri, B.; Conversi, L.; Sanchez Portal, M.; Valtchanov, I.] European Space Astron Ctr, Herschel Sci Ctr, Madrid 28691, Spain; [Arumugam, V.; Ivison, R. J.] Univ Edinburgh, Inst Astron, Royal Observ, Edinburgh EH9 3HJ, Midlothian, Scotland; [Aussel, H.; Elbaz, D.; Madden, S.; Panuzzo, P.] Univ Paris Diderot, CNRS, Lab AIM Paris Saclay, CEA DSM Irfu,CE Saclay, F-91191 Gif Sur Yvette, France; [Bock, J.; Dowell, C. D.; Levenson, L.; Nguyen, H. T.; Zemcov, M.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Boselli, A.; Buat, V.] Univ Aix Marseille, CNRS, OAMP, Lab Astrophys Marseille, F-13388 Marseille 13, France; [Castro-Rodriguez, N.; Cava, A.; Perez-Fournon, I.] Inst Astrofis Canarias, E-38200 San Cristobal la Laguna, Tenerife, Spain; [Castro-Rodriguez, N.; Cava, A.; Perez-Fournon, I.] Univ La Laguna, Dept Astrofis, E-38205 Tenerife, Spain; [Chanial, P.; Clements, D. L.; O'Halloran, B.; Rowan-Robinson, M.; Trichas, M.] Univ London Imperial Coll Sci Technol & Med, Blackett Lab, Astrophys Grp, London SW7 2AZ, England; [Chapin, E.; Halpern, M.; Marsden, G.; Scott, Douglas; Valiante, E.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V6T 1Z1, Canada; [Conley, A.; Glenn, J.; Rangwala, N.] Univ Colorado, Dept Astrophys & Planetary Sci, CASA UCB 389, Boulder, CO 80309 USA; [Dwek, E.] NASA, Goddard Space Flight Ctr, Observat Cosmol Lab, Greenbelt, MD 20771 USA; [Eales, S.; Gear, W.; Griffin, M.; Isaak, K.; Papageorgiou, A.; Pohlen, M.] Cardiff Univ, Cardiff Sch Phys & Astron, Cardiff CF24 3AA, S Glam, Wales; [Farrah, D.; Oliver, S. J.; Roseboom, I. G.; Smith, A. J.; Wang, L.; Ward, R.] Univ Sussex, Dept Phys & Astron, Ctr Astron, Brighton BN1 9QH, E Sussex, England; [Franceschini, A.; Mainetti, G.; Marchetti, L.; Vaccari, M.] Univ Padua, Dipartimento Astron, I-35122 Padua, Italy; [Hatziminaoglou, E.] ESO, D-85748 Garching, Germany; [Ibar, E.; Ivison, R. J.; Wright, G.] Royal Observ, UK Astron Technol Ctr, Edinburgh EH9 3HJ, Midlothian, Scotland; [Lagache, G.] Univ Paris 11, Inst Astrophys Spatiale, F-91405 Orsay, France; [Lagache, G.] CNRS, UMR 8617, F-91405 Orsay, France; [Lu, N.; Schulz, B.; Shupe, D. L.; Xu, C. K.] CALTECH, Jet Prop Lab, Infrared Proc & Anal Ctr, Pasadena, CA 91125 USA; [Maffei, B.] Univ Manchester, Sch Phys & Astron, Manchester M13 9PL, Lancs, England; [Omont, A.; Vigroux, L.] Univ Paris 06, CNRS, UMR7095, Inst Astrophys Paris, F-75014 Paris, France; [Page, M. J.; Pearson, C. P.; Seymour, N.; Symeonidis, M.] Rutherford Appleton Lab, Space Sci & Technol Dept, Didcot OX11 0QX, Oxon, England; [Tugwell, K.] Univ Coll London, Mullard Space Sci Lab, Dorking RH5 6NT, Surrey, England; [Pearson, C. P.] Univ Lethbridge, Inst Space Imaging Sci, Lethbridge, AB T1K 3M4, Canada; [Stevens, J. A.] Univ Hertfordshire, Ctr Astrophys Res, Hatfield AL10 9AB, Herts, England	University of California System; University of California Irvine; European Space Agency; University of Edinburgh; UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Instituto de Astrofisica de Canarias; Universidad de la Laguna; Imperial College London; University of British Columbia; University of Colorado System; University of Colorado Boulder; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Cardiff University; University of Sussex; University of Padua; University of Edinburgh; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Universite Paris Saclay; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); University of Manchester; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; University of London; University College London; University of Lethbridge; University of Hertfordshire	Cooray, A (corresponding author), Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA.	acooray@uci.edu	Castro-Rodríguez, Nieves/HHC-0597-2022; Symeonidis, Myrto/GNM-5974-2022; Dwek, Eli/C-3995-2012; amblard, alexandre/L-7694-2014; Vaccari, Mattia/R-3431-2016; Marchetti, Lucia/AAC-7835-2021; Perez-Fournon, Ismael/AAG-9049-2019; Seymour, Nicholas/M-4698-2017; Cava, Antonio/C-5274-2017; Elbaz, David/AAB-4141-2020; Ivison, R. J./G-4450-2011; Serra, Paolo/G-9678-2014; Ibar, Edo/AAI-5516-2020	amblard, alexandre/0000-0002-2212-5395; Vaccari, Mattia/0000-0002-6748-0577; Marchetti, Lucia/0000-0003-3948-7621; Perez-Fournon, Ismael/0000-0002-2807-6459; Seymour, Nicholas/0000-0003-3506-5536; Cava, Antonio/0000-0002-4821-1275; Elbaz, David/0000-0002-7631-647X; Ivison, R. J./0000-0001-5118-1313; Serra, Paolo/0000-0002-7609-3931; Conversi, Luca/0000-0002-6710-8476; Maffei, Bruno/0000-0002-2214-5329; Stevens, Jason/0000-0002-4010-8310; Shupe, David/0000-0003-4401-0430; Gear, Walter/0000-0001-6789-6196; Madden, Suzanne/0000-0003-3229-2899; Khostovan, Ali Ahmad/0000-0002-0101-336X; Altieri, Bruno/0000-0003-3936-0284	CSA (Canada); NAOC (China); CEA (France); CNES (France); CNRS (France); ASI (Italy); MCINN (Spain); SNSB (Sweden); STFC (UK); NASA (USA); STFC [ST/H00260X/1, PP/E005306/1, ST/I005765/1, ST/F007019/1, ST/G002630/1, ST/H001530/1, ST/F002858/1] Funding Source: UKRI; Science and Technology Facilities Council [PP/E005306/1, ST/G002630/1, ST/H00260X/1, ST/I005765/1, ST/F007019/1, ST/F002858/1] Funding Source: researchfish; UK Space Agency [ST/G003874/1, ST/F012373/1] Funding Source: researchfish	CSA (Canada); NAOC (China); CEA (France)(French Atomic Energy Commission); CNES (France)(Centre National D'etudes Spatiales); CNRS (France)(Centre National de la Recherche Scientifique (CNRS)); ASI (Italy)(Agenzia Spaziale Italiana (ASI)); MCINN (Spain); SNSB (Sweden); STFC (UK)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); NASA (USA)(National Aeronautics & Space Administration (NASA)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); UK Space Agency	SPIRE has been developed by a consortium of institutes led by Cardiff University (UK) and including the University of Lethbridge (Canada); NAOC (China); CEA and LAM (France); IFSI and the University of Padua (Italy); IAC (Spain); Stockholm Observatory (Sweden); Imperial College London, RAL, UCL-MSSL, UKATC and the University of Sussex (UK); and Caltech/JPL, IPAC and the University of Colorado (USA). This development has been supported by national funding agencies: CSA (Canada); NAOC (China); CEA, CNES and CNRS (France); ASI (Italy); MCINN (Spain); SNSB (Sweden); STFC (UK); and NASA (USA). We thank M. Viero for comments. A. A., A. Cooray, P. S., A. A. K., K.M.-W. and other US co-authors are supported by NASA funds for US participants in Herschel through an award from JPL.	Abergel A, 1996, ASTRON ASTROPHYS, V308, pL5; Amblard A, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014586; Amblard A, 2007, ASTROPHYS J, V670, P903, DOI 10.1086/522688; Bouche N, 2010, ASTROPHYS J, V718, P1001, DOI 10.1088/0004-637X/718/2/1001; Cooray A, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014597; Cooray A, 2002, PHYS REP, V372, P1, DOI 10.1016/S0370-1573(02)00276-4; Devlin MJ, 2009, NATURE, V458, P737, DOI 10.1038/nature07918; Dole H, 2006, ASTRON ASTROPHYS, V451, P417, DOI 10.1051/0004-6361:20054446; Dwek E, 1998, ASTROPHYS J, V508, P106, DOI 10.1086/306382; Fixsen DJ, 1998, ASTROPHYS J, V508, P123, DOI 10.1086/306383; Glenn J, 2010, MON NOT R ASTRON SOC, V409, P109, DOI 10.1111/j.1365-2966.2010.17781.x; Gonzalez J. E., 2010, MON NOT R ASTR UNPUB; Griffin MJ, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014519; Haiman Z, 2000, ASTROPHYS J, V530, P124, DOI 10.1086/308374; Hauser MG, 2001, ANNU REV ASTRON ASTR, V39, P249, DOI 10.1146/annurev.astro.39.1.249; Hughes DH, 1998, NATURE, V394, P241, DOI 10.1038/28328; Kennicutt RC, 1998, ANNU REV ASTRON ASTR, V36, P189, DOI 10.1146/annurev.astro.36.1.189; Knox L, 2001, ASTROPHYS J, V550, P7, DOI 10.1086/319732; Lagache G, 2007, ASTROPHYS J, V665, pL89, DOI 10.1086/521301; Lagache G, 2003, MON NOT R ASTRON SOC, V338, P555, DOI 10.1046/j.1365-8711.2003.05971.x; Maddox SJ, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014663; Marsden G, 2009, ASTROPHYS J, V707, P1729, DOI 10.1088/0004-637X/707/2/1729; Negrello M, 2007, MON NOT R ASTRON SOC, V377, P1557, DOI 10.1111/j.1365-2966.2007.11708.x; Nguyen HT, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014680; Oliver SJ, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014697; Pilbratt GL, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014759; Schlegel DJ, 1998, ASTROPHYS J, V500, P525, DOI 10.1086/305772; Swinyard BM, 2010, ASTRON ASTROPHYS, V518, DOI 10.1051/0004-6361/201014605; Valiante E, 2009, ASTROPHYS J, V701, P1814, DOI 10.1088/0004-637X/701/2/1814; Viero MP, 2009, ASTROPHYS J, V707, P1766, DOI 10.1088/0004-637X/707/2/1766	30	92	92	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					510	512		10.1038/nature09771	http://dx.doi.org/10.1038/nature09771			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21326201	Green Submitted			2022-12-28	WOS:000287652900036
J	Krum, H				Krum, Henry			Telemonitoring of fluid status in heart failure: CHAMPION	LANCET			English	Editorial Material							TRIAL		Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Monash Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia	Florey Institute of Neuroscience & Mental Health; Monash University	Krum, H (corresponding author), Monash Univ, Alfred Hosp, Dept Epidemiol & Prevent Med, Monash Ctr Cardiovasc Res & Educ Therapeut, Melbourne, Vic 3004, Australia.	henry.krum@med.monash.edu.au						ABRAHAM WT, 2011, LANCET          0210, DOI DOI 10.1016/S0140-6736(11)60101-3; ANKER SD, 2010, AM HEART ASS 2010 SC, P21829; Bourge RC, 2008, J AM COLL CARDIOL, V51, P1073, DOI 10.1016/j.jacc.2007.10.061; Chaudhry SI, 2010, NEW ENGL J MED, V363, P2301, DOI 10.1056/NEJMoa1010029; Porapakkham P, 2010, ARCH INTERN MED, V170, P507, DOI 10.1001/archinternmed.2010.35; Ritzema J, 2007, CIRCULATION, V116, P2952, DOI 10.1161/CIRCULATIONAHA.107.702191; Stevenson LW, 2005, JAMA-J AM MED ASSOC, V294, P1625	7	9	10	0	7	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 19	2011	377	9766					616	618		10.1016/S0140-6736(11)60164-5	http://dx.doi.org/10.1016/S0140-6736(11)60164-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	727DB	21315440				2022-12-28	WOS:000287776600006
J	Anoop, TM; George, KC				Anoop, T. M.; George, K. C.			Differential Clubbing and Cyanosis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Anoop, T. M.; George, K. C.] Kottayam Med Coll, Kottayam, Kerala, India		Anoop, TM (corresponding author), Kottayam Med Coll, Kottayam, Kerala, India.	dranooptm@yahoo.co.in	TM, Anoop/AAH-7443-2021	TM, Anoop/0000-0003-0567-5253					0	6	6	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2011	364	7					666	666		10.1056/NEJMicm1008597	http://dx.doi.org/10.1056/NEJMicm1008597			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722BW	21323544				2022-12-28	WOS:000287406000012
J	Kaufman, DS; Zietman, AL; Dahl, DM; Harisinghani, MG; Wu, CL				Kaufman, Donald S.; Zietman, Anthony L.; Dahl, Douglas M.; Harisinghani, Mukesh G.; Wu, Chin-Lee			Case 5-2011: A 65-Year-Old Man with Hematuria after Treatment for Prostate Cancer ANATOMICAL DIAGNOSIS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ADENOCARCINOMA; BRACHYTHERAPY; RADIOTHERAPY; OUTCOMES		[Kaufman, Donald S.] Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA; [Zietman, Anthony L.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Dahl, Douglas M.] Massachusetts Gen Hosp, Dept Urol, Boston, MA 02114 USA; [Harisinghani, Mukesh G.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Wu, Chin-Lee] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Kaufman, Donald S.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Zietman, Anthony L.] Harvard Univ, Sch Med, Dept Radiat Oncol, Boston, MA USA; [Dahl, Douglas M.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Harisinghani, Mukesh G.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Wu, Chin-Lee] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Kaufman, DS (corresponding author), Massachusetts Gen Hosp, Div Hematol Oncol, Boston, MA 02114 USA.		Harisinghani, Mukesh/G-1347-2010; Harisinghani, Mukesh/D-7590-2011					Adley Brian P., 2006, Int. braz j urol., V32, P681, DOI 10.1590/S1677-55382006000600009; AJCC, 2009, AJCC CANC STAG MAN; Aronowitz JN, 2002, INT J RADIAT ONCOL, V54, P712, DOI 10.1016/S0360-3016(02)02987-5; Brenner DJ, 2000, CANCER, V88, P398, DOI 10.1002/(SICI)1097-0142(20000115)88:2<398::AID-CNCR22>3.0.CO;2-V; Curtis MW, 2005, MODERN PATHOL, V18, P585, DOI 10.1038/modpathol.3800317; Potosky AL, 2000, JNCI-J NATL CANCER I, V92, P1582, DOI 10.1093/jnci/92.19.1582; Potters L, 2005, J UROLOGY, V173, P1562, DOI 10.1097/01.ju.0000154633.73092.8e; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Sunkoya AO, 2007, AM J SURG PATHOL, V31, P1323, DOI 10.1097/PAS.0b013e31802ff7c4; Tran KP, 1996, AM J SURG PATHOL, V20, P1346, DOI 10.1097/00000478-199611000-00005; Zelefsky MJ, 2007, INT J RADIAT ONCOL, V67, P327, DOI 10.1016/j.ijrobp.2006.08.056	11	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2011	364	7					667	675		10.1056/NEJMcpc1005310	http://dx.doi.org/10.1056/NEJMcpc1005310			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722BW	21323545				2022-12-28	WOS:000287406000014
J	Chamot-Rooke, J; Mikaty, G; Malosse, C; Soyer, M; Dumont, A; Gault, J; Imhaus, AF; Martin, P; Trellet, M; Clary, G; Chafey, P; Camoin, L; Nilges, M; Nassif, X; Dumenil, G				Chamot-Rooke, Julia; Mikaty, Guillain; Malosse, Christian; Soyer, Magali; Dumont, Audrey; Gault, Joseph; Imhaus, Anne-Flore; Martin, Patricia; Trellet, Mikael; Clary, Guilhem; Chafey, Philippe; Camoin, Luc; Nilges, Michael; Nassif, Xavier; Dumenil, Guillaume			Posttranslational Modification of Pili upon Cell Contact Triggers N. meningitidis Dissemination	SCIENCE			English	Article							NEISSERIA-MENINGITIDIS; IV PILI; EPITHELIAL-CELLS; GONORRHOEAE; PHOSPHOETHANOLAMINE; PHOSPHOCHOLINE; GENE	The Gram-negative bacterium Neisseria meningitidis asymptomatically colonizes the throat of 10 to 30% of the human population, but throat colonization can also act as the port of entry to the blood (septicemia) and then the brain (meningitis). Colonization is mediated by filamentous organelles referred to as type IV pili, which allow the formation of bacterial aggregates associated with host cells. We found that proliferation of N. meningitidis in contact with host cells increased the transcription of a bacterial gene encoding a transferase that adds phosphoglycerol onto type IV pili. This unusual posttranslational modification specifically released type IV pili-dependent contacts between bacteria. In turn, this regulated detachment process allowed propagation of the bacterium to new colonization sites and also migration across the epithelium, a prerequisite for dissemination and invasive disease.	[Mikaty, Guillain; Soyer, Magali; Dumont, Audrey; Imhaus, Anne-Flore; Martin, Patricia; Clary, Guilhem; Chafey, Philippe; Camoin, Luc; Nassif, Xavier; Dumenil, Guillaume] Univ Paris 05, Fac Med Paris Descartes, F-75006 Paris, France; [Chamot-Rooke, Julia; Malosse, Christian; Gault, Joseph] Ecole Polytech, Lab Mecanismes React, F-91128 Palaiseau, France; [Chamot-Rooke, Julia; Malosse, Christian; Gault, Joseph] CNRS, UMR7651, F-91128 Palaiseau, France; [Mikaty, Guillain; Martin, Patricia; Nassif, Xavier] INSERM, U1002, F-75015 Paris, France; [Soyer, Magali; Dumont, Audrey; Imhaus, Anne-Flore; Dumenil, Guillaume] Paris Cardiovasc Res Ctr, INSERM, U970, F-75015 Paris, France; [Trellet, Mikael; Nilges, Michael] Inst Pasteur, Unite Rech Associee CNRS 2185, Unite Bioinformat Struct, F-75015 Paris, France; [Clary, Guilhem; Chafey, Philippe; Camoin, Luc] CNRS, Inst Cochin, UMR 8104, F-75014 Paris, France; [Clary, Guilhem; Chafey, Philippe; Camoin, Luc] INSERM, U1016, F-75014 Paris, France; [Nassif, Xavier] Hop Necker Enfants Malad, AP HP, F-75015 Paris, France	UDICE-French Research Universities; Universite Paris Cite; Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Dumenil, G (corresponding author), Univ Paris 05, Fac Med Paris Descartes, F-75006 Paris, France.	guillaume.dumenil@inserm.fr	Camoin, Luc/AAB-3856-2019; Dumenil, Guillaume/N-3377-2019; Dumenil, Guillaume/F-7567-2015; Trellet, Mikael/A-9370-2017; Gault, Joseph/C-9623-2013; Nilges, Michael/E-4803-2011; Chamot-Rooke, Julia/F-3644-2014	Camoin, Luc/0000-0002-1230-4787; Dumenil, Guillaume/0000-0001-9174-9110; Dumenil, Guillaume/0000-0001-9174-9110; Trellet, Mikael/0000-0001-6337-581X; Gault, Joseph/0000-0001-7686-2983; Nilges, Michael/0000-0002-1451-8092; Nassif, Xavier/0000-0003-2855-3240; Chamot-Rooke, Julia/0000-0002-9427-543X	Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche; Agence Nationale de la Recherche [PCV08_319010, FRM INE20100118195]	Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche(Institut National de la Sante et de la Recherche Medicale (Inserm)Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	Authors thank M.-C. Prevost, S. Guadagnini, D. Lankar, J.-L. Beretti, M. Dupuis, G. Guilbaud for help with experiments and A.-M. Lennon, E. Camerer, S. Silva, and K. Melican for critical reading of the manuscript. This work was supported by Centre National de la Recherche Scientifique, Institut National de la Sante et de la Recherche (including Avenir program), and Agence Nationale de la Recherche grants PCV08_319010 and FRM INE20100118195.	Aas FE, 2006, J BIOL CHEM, V281, P27712, DOI 10.1074/jbc.M604324200; Chamot-Rooke J, 2007, P NATL ACAD SCI USA, V104, P14783, DOI 10.1073/pnas.0705335104; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Deghmane AE, 2000, EMBO J, V19, P1068, DOI 10.1093/emboj/19.5.1068; Hegge FT, 2004, P NATL ACAD SCI USA, V101, P10798, DOI 10.1073/pnas.0402397101; Ilver D, 1998, INFECT IMMUN, V66, P469, DOI 10.1128/IAI.66.2.469-473.1998; Jamet A, 2009, MICROBIOL-SGM, V155, P2288, DOI 10.1099/mic.0.027755-0; MARCEAU M, 1995, MOL MICROBIOL, V17, P855, DOI 10.1111/j.1365-2958.1995.mmi_17050855.x; Mikaty G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000314; Morelle S, 2003, J BACTERIOL, V185, P2618, DOI 10.1128/JB.185.8.2618-2627.2003; Pelicic V, 2008, MOL MICROBIOL, V68, P827, DOI 10.1111/j.1365-2958.2008.06197.x; Rusniok C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-10-r110; Stimson E, 1996, BIOCHEM J, V316, P29, DOI 10.1042/bj3160029; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; Warren MJ, 2003, INFECT IMMUN, V71, P6892, DOI 10.1128/IAI.71.12.6892-6898.2003	16	136	141	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					778	782		10.1126/science.1200729	http://dx.doi.org/10.1126/science.1200729			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21311024				2022-12-28	WOS:000287205700073
J	Lang, TD				Lang, Trudie			Advancing Global Health Research Through Digital Technology and Sharing Data	SCIENCE			English	Editorial Material							RESEARCH CAPACITY; MALARIA; COUNTRIES	The imperative for improving health in the world's poorest regions lies in research, yet there is no question that low participation, a lack of trained staff, and limited opportunities for data sharing in developing countries impede advances in medical practice and public health knowledge. Extensive studies are essential to develop new treatments and to identify better ways to manage healthcare issues. Recent rapid advances in availability and uptake of digital technologies, especially of mobile networks, have the potential to overcome several barriers to collaborative research in remote places with limited access to resources. Many research groups are already taking advantage of these technologies for data sharing and capture, and these initiatives indicate that increasing acceptance and use of digital technology could promote rapid improvements in global medical science.	Univ Oxford, Ctr Trop Med, Oxford OX3 7LJ, England	University of Oxford	Lang, TD (corresponding author), Univ Oxford, Ctr Trop Med, S Parks Rd, Oxford OX3 7LJ, England.	trudie.lang@ndm.ox.ac.uk		Lang, Trudie/0000-0003-2273-5975				Aikins AD, 2010, GLOBALIZATION HEALTH, V6, DOI 10.1186/1744-8603-6-5; Dondorp AM, 2010, LANCET, V376, P1647, DOI 10.1016/S0140-6736(10)61924-1; Fegan W, 2008, PLOS MED, V5, P347, DOI 10.1371/journal.pmed.0050006; Fischer BA, 2010, SCI ENG ETHICS, V16, P783, DOI 10.1007/s11948-010-9239-x; Guerin PJ, 2009, CURR OPIN INFECT DIS, V22, P593, DOI 10.1097/QCO.0b013e328332c4a7; Hay SI, 2006, PLOS MED, V3, P2204, DOI 10.1371/journal.pmed.0030473; Horton R, 2000, LANCET, V355, P2231, DOI 10.1016/S0140-6736(00)02414-4; Kanter AS, 2009, INT J MED INFORM, V78, P802, DOI 10.1016/j.ijmedinf.2009.08.002; Kowal P, 2010, GLOBAL HEALTH ACTION, V3, P11, DOI 10.3402/gha.v3i0.5302; Kwiatkowski D, 2008, NATURE, V456, P732, DOI 10.1038/nature07632; Lang TA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000619; Malin B, 2010, J INVEST MED, V58, P11, DOI 10.2310/JIM.0b013e3181c9b2ea; Mwaba P, 2010, LANCET, V375, P1874, DOI 10.1016/S0140-6736(10)60874-4; Noormohammad SF, 2010, INT J MED INFORM, V79, P204, DOI 10.1016/j.ijmedinf.2010.01.002; Parker M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000143; Pirmohamed M, 2007, BRIT MED J, V335, P462, DOI 10.1136/bmj.39323.586123.BE; Pisani E, 2010, B WORLD HEALTH ORGAN, V88, P462, DOI 10.2471/BLT.09.074393; WENGER E, 2000, HARVARD BUSINESS JAN, P139; Wertheim HFL, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000231; Whitworth J, 2010, B WORLD HEALTH ORGAN, V88, P467, DOI 10.2471/BLT.10.079202	20	44	48	1	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					714	717		10.1126/science.1199349	http://dx.doi.org/10.1126/science.1199349			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21311011				2022-12-28	WOS:000287205700054
J	Tamura, K; Nomura, N; Seki, R; Yonei-Tamura, S; Yokoyama, H				Tamura, Koji; Nomura, Naoki; Seki, Ryohei; Yonei-Tamura, Sayuri; Yokoyama, Hitoshi			Embryological Evidence Identifies Wing Digits in Birds as Digits 1, 2, and 3	SCIENCE			English	Article							PENTADACTYL GROUND-STATE; CHICK LIMB-BUD; SONIC-HEDGEHOG; VERTEBRATE LIMB; POLARIZING ACTIVITY; GENE-EXPRESSION; AVIAN HAND; HOX GENES; EVOLUTION; ZPA	The identities of the digits of the avian forelimb are disputed. Whereas paleontological findings support the position that the digits correspond to digits one, two, and three, embryological evidence points to digit two, three, and four identities. By using transplantation and cell-labeling experiments, we found that the posteriormost digit in the wing does not correspond to digit four in the hindlimb; its progenitor segregates early from the zone of polarizing activity, placing it in the domain of digit three specification. We suggest that an avian-specific shift uncouples the digit anlagen from the molecular mechanisms that pattern them, resulting in the imposition of digit one, two, and three identities on the second, third, and fourth anlagens.	[Tamura, Koji; Nomura, Naoki; Seki, Ryohei; Yonei-Tamura, Sayuri; Yokoyama, Hitoshi] Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Aoba Ku, Sendai, Miyagi 9808578, Japan	Tohoku University	Tamura, K (corresponding author), Tohoku Univ, Grad Sch Life Sci, Dept Dev Biol & Neurosci, Aoba Ku, Sendai, Miyagi 9808578, Japan.	tam@m.tohoku.ac.jp	Yokoyama, Hitoshi/F-5161-2015	Yokoyama, Hitoshi/0000-0003-4821-9506; Seki-Omura, Ryohei/0000-0002-3314-9237	Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Toray Science Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Toray Science Foundation(Toray Industries, Inc.)	We thank S. Kuratani for valuable discussions and comments on this study; R. Ladher, J. Fallon, H. Yajima, T. Suzuki, and D. Sipp for critical reading of this manuscript; and Y. Wakamatsu for supplying quail eggs. H.Y. was supported by Grant-in-Aid for Scientific Research on Innovative Areas. This work was supported by the Global Center of Excellence Program (J03) and grants from Japan Society for the Promotion of Science; the Ministry of Education, Culture, Sports, Science, and Technology of Japan; and the Toray Science Foundation.	Amano T, 2005, DEV DYNAM, V233, P326, DOI 10.1002/dvdy.20390; BURKE AC, 1995, DEVELOPMENT, V121, P333; Burke AC, 1997, SCIENCE, V278, P666, DOI 10.1126/science.278.5338.666; Chiang C, 2001, DEV BIOL, V236, P421, DOI 10.1006/dbio.2001.0346; Cohn MJ, 2002, BIOESSAYS, V24, P460, DOI 10.1002/bies.10088; Galis F, 2005, J EXP ZOOL PART B, V304B, P198, DOI 10.1002/jez.b.21042; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hinchliffe J. R., 1977, VERTEBRATE LIMB SOMI, P293; HINCHLIFFE JR, 1985, J EMBRYOL EXP MORPH, V86, P169; HONIG LS, 1985, J EMBRYOL EXP MORPH, V87, P163; Larsson HCE, 2010, J EXP ZOOL PART B, V314B, P571, DOI 10.1002/jez.b.21362; Larsson HCE, 2002, J EXP ZOOL, V294, P146, DOI 10.1002/jez.10153; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; ROWE DA, 1982, J EMBRYOL EXP MORPH, V68, P1; Sato K, 2007, DEVELOPMENT, V134, P1397, DOI 10.1242/dev.02822; Scherz PJ, 2007, DEV BIOL, V308, P343, DOI 10.1016/j.ydbio.2007.05.030; SUMMERBELL D, 1975, J EMBRYOL EXP MORPH, V33, P621; Summerbell D., 1977, VERTEBRATE LIMB SOMI, P41; Suzuki T, 2008, P NATL ACAD SCI USA, V105, P4185, DOI 10.1073/pnas.0707899105; Uejima A, 2010, DEV GROWTH DIFFER, V52, P223, DOI 10.1111/j.1440-169X.2009.01161.x; Vargas AO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003325; Vargas AO, 2005, J EXP ZOOL PART B, V304B, P206, DOI 10.1002/jez.b.21051; Wagner GP, 1999, P NATL ACAD SCI USA, V96, P5111, DOI 10.1073/pnas.96.9.5111; Welten MCM, 2005, EVOL DEV, V7, P18, DOI 10.1111/j.1525-142X.2005.05003.x; WILSON DJ, 1987, DEVELOPMENT, V99, P99; Wolpert L, 2007, PRINCIPLES DEV; Zeller R, 2009, NAT REV GENET, V10, P845, DOI 10.1038/nrg2681; Zhou ZH, 2004, NATURWISSENSCHAFTEN, V91, P455, DOI 10.1007/s00114-004-0570-4; Zhu JJ, 2008, DEV CELL, V14, P624, DOI 10.1016/j.devcel.2008.01.008	29	46	49	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					753	757		10.1126/science.1198229	http://dx.doi.org/10.1126/science.1198229			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21311019				2022-12-28	WOS:000287205700066
J	Raymond, E; Dahan, L; Raoul, JL; Bang, YJ; Borbath, I; Lombard-Bohas, C; Valle, J; Metrakos, P; Smith, D; Vinik, A; Chen, JS; Horsch, D; Hammel, P; Wiedenmann, B; Van Cutsem, E; Patyna, S; Lu, DR; Blanckmeister, C; Chao, R; Ruszniewski, P				Raymond, Eric; Dahan, Laetitia; Raoul, Jean-Luc; Bang, Yung-Jue; Borbath, Ivan; Lombard-Bohas, Catherine; Valle, Juan; Metrakos, Peter; Smith, Denis; Vinik, Aaron; Chen, Jen-Shi; Hoersch, Dieter; Hammel, Pascal; Wiedenmann, Bertram; Van Cutsem, Eric; Patyna, Shem; Lu, Dongrui Ray; Blanckmeister, Carolyn; Chao, Richard; Ruszniewski, Philippe			Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TYROSINE KINASE INHIBITOR; ANTITUMOR-ACTIVITY; SOMATOSTATIN ANALOGS; PHASE-II; STREPTOZOCIN; FLUOROURACIL; DOXORUBICIN; SURVIVAL; CHLOROZOTOCIN; EXPRESSION	Background: The multitargeted tyrosine kinase inhibitor sunitinib has shown activity against pancreatic neuroendocrine tumors in preclinical models and phase 1 and 2 trials. Methods: We conducted a multinational, randomized, double-blind, placebo-controlled phase 3 trial of sunitinib in patients with advanced, well-differentiated pancreatic neuroendocrine tumors. All patients had Response Evaluation Criteria in Solid Tumors-defined disease progression documented within 12 months before baseline. A total of 171 patients were randomly assigned (in a 1:1 ratio) to receive best supportive care with either sunitinib at a dose of 37.5 mg per day or placebo. The primary end point was progression-free survival; secondary end points included the objective response rate, overall survival, and safety. Results: The study was discontinued early, after the independent data and safety monitoring committee observed more serious adverse events and deaths in the placebo group as well as a difference in progression-free survival favoring sunitinib. Median progression-free survival was 11.4 months in the sunitinib group as compared with 5.5 months in the placebo group (hazard ratio for progression or death, 0.42; 95% confidence interval [CI], 0.26 to 0.66; P<0.001). A Cox proportional-hazards analysis of progression-free survival according to baseline characteristics favored sunitinib in all subgroups studied. The objective response rate was 9.3% in the sunitinib group versus 0% in the placebo group. At the data cutoff point, 9 deaths were reported in the sunitinib group (10%) versus 21 deaths in the placebo group (25%) (hazard ratio for death, 0.41; 95% CI, 0.19 to 0.89; P=0.02). The most frequent adverse events in the sunitinib group were diarrhea, nausea, vomiting, asthenia, and fatigue. Conclusions: Continuous daily administration of sunitinib at a dose of 37.5 mg improved progression-free survival, overall survival, and the objective response rate as compared with placebo among patients with advanced pancreatic neuroendocrine tumors. (Funded by Pfizer; ClinicalTrials.gov number, NCT00428597.) N Engl J Med 2011;364:501-13.	[Raymond, Eric] Hop Beaujon, AP HP, Serv Interhosp Cancerol, F-92118 Clichy, France; [Raymond, Eric; Hammel, Pascal; Ruszniewski, Philippe] Hop Beaujon, Serv Gastroenteropancreatol, F-92118 Clichy, France; [Dahan, Laetitia] Hop Enfants La Timone, Serv Oncol Digest, Marseille, France; [Dahan, Laetitia] Reseau Natl Tumeurs Endocrines, Provence Alpes Cote Azur, France; [Raoul, Jean-Luc] Univ Rennes, Eugene Marquis Ctr, Rennes, France; [Lombard-Bohas, Catherine] Hosp Civils Lyon, Hop Edouard Herriot, Lyon, France; [Smith, Denis] Hop St Andre, Bordeaux, France; [Bang, Yung-Jue] Seoul Natl Univ Hosp, Seoul 110744, South Korea; [Borbath, Ivan] Clin Univ St Luc, B-1200 Brussels, Belgium; [Valle, Juan] Christie Hosp Natl Hlth Serv Fdn Trust, Dept Med Oncol, Manchester, Lancs, England; [Metrakos, Peter] McGill Univ, Ctr Hosp, Montreal, PQ, Canada; [Vinik, Aaron] Eastern Virginia Med Sch, Strelitz Diabet Ctr, Norfolk, VA 23501 USA; [Vinik, Aaron] Eastern Virginia Med Sch, Neuroendocrine Unit, Norfolk, VA 23501 USA; [Chen, Jen-Shi] Chang Gung Mem Hosp, Tao Yuan, Taiwan; [Chen, Jen-Shi] Chang Gung Univ, Tao Yuan, Taiwan; [Hoersch, Dieter] Bad Berka Cent Clin, Clin Internal Med Gastroenterol & Endocrinol, Ctr Neuroendocrine Tumors, Bad Berka, Germany; [Wiedenmann, Bertram] Humboldt Univ, Charite Med Sch, Dept Gastroenterol & Hepatol, Berlin, Germany; [Van Cutsem, Eric] Univ Hosp Gasthuisberg, B-3000 Leuven, Belgium; [Patyna, Shem; Lu, Dongrui Ray; Chao, Richard] Pfizer Oncol, Dev, La Jolla, CA USA; [Blanckmeister, Carolyn] Pfizer Oncol, Emerging Markets, New York, NY USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; UNICANCER; Centre Eugene Marquis; Universite de Rennes; CHU Lyon; CHU Bordeaux; Seoul National University (SNU); Seoul National University Hospital; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Christie NHS Foundation Trust; Christie Hospital; McGill University; Eastern Virginia Medical School; Eastern Virginia Medical School; Chang Gung Memorial Hospital; Chang Gung University; Zentralklinik Bad Berka; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; KU Leuven; University Hospital Leuven; Pfizer; Pfizer	Raymond, E (corresponding author), Univ Paris 07, INSERM, U728, Serv Interhosp Cancerol Beaujon Bichat, 100 Blvd Gen Leclerc, F-92118 Clichy, France.	eric.raymond@bjn.aphp.fr	metrakos, peter/D-3726-2013; Bang, Yung Jue/J-2759-2012; Dahan, Laetitia LD/M-3441-2016; Chen, Jen-Shi/GLV-3349-2022; Van+Cutsem, Eric/ABE-1762-2021; Valle, Juan W/J-3571-2015	Bang, Yung Jue/0000-0001-6000-4597; Chen, Jen-Shi/0000-0001-9756-3974; Valle, Juan W/0000-0002-1999-0863; Hammel, Pascal/0000-0002-4630-4996; Raoul, Jean-Luc/0000-0001-6305-8953; LOMBARD-BOHAS, Catherine/0000-0003-3896-4588; Borbath, Ivan/0000-0001-7598-214X; Wiedenmann, Bertram/0000-0002-7890-2552	Pfizer; Novartis; Ansar; AstraZeneca; Eli Lilly; KV Pharmaceuticals; Merck; R. W. Johnson Pharmaceutical Research Institute; Sanofi-Aventis; Takeda; Tercica; Abbott; GlaxoSmithKline; Arcion Therapeutics; Merck Research; Bristol-Myers Squibb; Eisai; FoldRx; Exsulin; Ipsen; Covidien; Eckart; ITG; Merck Serono	Pfizer(Pfizer); Novartis(Novartis); Ansar; AstraZeneca(AstraZeneca); Eli Lilly(Eli Lilly); KV Pharmaceuticals; Merck(Merck & Company); R. W. Johnson Pharmaceutical Research Institute; Sanofi-Aventis(Sanofi-Aventis); Takeda(Takeda Pharmaceutical Company Ltd); Tercica; Abbott(Abbott Laboratories); GlaxoSmithKline(GlaxoSmithKline); Arcion Therapeutics; Merck Research; Bristol-Myers Squibb(Bristol-Myers Squibb); Eisai(Eisai Co Ltd); FoldRx; Exsulin; Ipsen(Ipsen); Covidien; Eckart; ITG; Merck Serono(Merck & Company)	Supported by Pfizer.; Dr. Raymond reports serving as a board member of and receiving grant support and payment for the development of educational presentations from Pfizer and Novartis; Dr. Bang, receiving consulting fees, grant support, and lecture fees from Pfizer; Dr. Borbath, receiving travel fees from Pfizer; Dr. Valle, receiving consulting fees from Pfizer; Dr. Metrakos, receiving consulting fees, lecture fees, and payment for the development of educational presentations from Novartis, and travel fees from Novartis and Pfizer; Dr. Vinik, receiving consulting fees from Ansar, AstraZeneca, Eli Lilly, KV Pharmaceuticals, Merck, Novartis, R. W. Johnson Pharmaceutical Research Institute, Sanofi-Aventis, Takeda, and Tercica, grant support from Abbott, GlaxoSmithKline, Sanofi-Aventis, Arcion Therapeutics, Eli Lilly, and Merck Research, and lecture fees from Abbott, Ansar, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Sanofi-Aventis, and Takeda, owning patents with Eli Lilly, Eisai, FoldRx, Pfizer, Exsulin, and receiving royalties from Eli Lilly, Eisai, FoldRx, Pfizer, and Exsulin, payments for the development of educational presentations from Eli Lilly, Eisai, FoldRx, Pfizer, and Exsulin, and travel fees from Eli Lilly, Eisai, FoldRx, Pfizer, and Exsulin; Dr. Horsch, serving as a board member of Pfizer, Novartis, and Ipsen, and receiving grant support from Novartis, Covidien, Eckart and Ziegler, and ITG, and lecture fees from Pfizer, Novartis, and Ipsen; Dr. Hammel, receiving consulting fees from Pfizer and Merck Serono; Dr. Wiedenmann, receiving consulting and lecture fees, payment for educational presentations, and travel fees from Pfizer; Dr. Van Cutsem, receiving grant support from Pfizer and Novartis; Dr. Ruszniewski, serving as a board member of and receiving consulting fees from Novartis, Pfizer, and Ipsen, grant support from Novartis and Ipsen, and travel fees from Ferring, AstraZeneca, and Novartis; and Drs. Patyna, Lu, Blanckmeister, and Chao, being full-time employees of and holding stock and stock options in Pfizer. No other potential conflict of interest relevant to this article was reported.	AARONSON NK, 1993, J NATL CANCER I, V85, P365, DOI 10.1093/jnci/85.5.365; Ballian N, 2009, HPB, V11, P422, DOI 10.1111/j.1477-2574.2009.00082.x; BUKOWSKI RM, 1992, J CLIN ONCOL, V10, P1914, DOI 10.1200/JCO.1992.10.12.1914; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Cheng PNM, 1999, CANCER, V86, P944, DOI 10.1002/(SICI)1097-0142(19990915)86:6<944::AID-CNCR8>3.3.CO;2-G; Escudier B, 2009, J CLIN ONCOL, V27, P4068, DOI 10.1200/JCO.2008.20.5476; Faivre S, 2006, J CLIN ONCOL, V24, P25, DOI 10.1200/JCO.2005.02.2194; Faivre S, 2007, NAT REV DRUG DISCOV, V6, P734, DOI 10.1038/nrd2380; Falconi M, 2006, NEUROENDOCRINOLOGY, V84, P196, DOI 10.1159/000098012; Fayers P, 2001, EORTC QLQ C30 SCORIN; Fjallskog ML, 2007, ACTA ONCOL, V46, P741, DOI 10.1080/02841860601048388; Fjallskog MLH, 2003, CLIN CANCER RES, V9, P1469; George S, 2009, EUR J CANCER, V45, P1959, DOI 10.1016/j.ejca.2009.02.011; Halfdanarson TR, 2008, ANN ONCOL, V19, P1727, DOI 10.1093/annonc/mdn351; Hansel D. E., 2003, Modern Pathology, V16, p120A; Inoue M, 2002, CANCER CELL, V1, P193, DOI 10.1016/S1535-6108(02)00031-4; Knigge U, 2008, SURG-J R COLL SURG E, V6, P232, DOI 10.1016/S1479-666X(08)80033-9; Kouvaraki MA, 2004, J CLIN ONCOL, V22, P4762, DOI 10.1200/JCO.2004.04.024; Kouvaraki MA, 2005, J CLIN ONCOL, V23, P248; Kulke MH, 2008, J CLIN ONCOL, V26, P3403, DOI 10.1200/JCO.2007.15.9020; Kwekkeboom DJ, 2005, J CLIN ONCOL, V23, P2754, DOI 10.1200/JCO.2005.08.066; McCollum AD, 2004, AM J CLIN ONCOL-CANC, V27, P485, DOI 10.1097/01.coc.0000135343.06038.eb; Mendel DB, 2003, CLIN CANCER RES, V9, P327; Modlin IM, 2010, ALIMENT PHARM THER, V31, P169, DOI 10.1111/j.1365-2036.2009.04174.x; MOERTEL CG, 1992, NEW ENGL J MED, V326, P519, DOI 10.1056/NEJM199202203260804; MOERTEL CG, 1980, NEW ENGL J MED, V303, P1189, DOI 10.1056/NEJM198011203032101; Oberg K, 2004, ANN ONCOL, V15, P966, DOI 10.1093/annonc/mdh216; Osoba D, 1998, J CLIN ONCOL, V16, P139, DOI 10.1200/JCO.1998.16.1.139; Pape UF, 2004, ANN NY ACAD SCI, V1014, P222, DOI 10.1196/annals.1294.025; Pietras K, 2005, J CLIN ONCOL, V23, P939, DOI 10.1200/JCO.2005.07.093; Rinke A, 2009, J CLIN ONCOL, V27, P4656, DOI 10.1200/JCO.2009.22.8510; Solcia E, 2000, HISTOLOGICAL TYPING; Theou-Anton N, 2009, DRUG SAFETY, V32, P717, DOI 10.2165/00002018-200932090-00003; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Valkema R, 2006, SEMIN NUCL MED, V36, P147, DOI 10.1053/j.semnuclmed.2006.01.001; Vinik A, 2010, 46 ANN M AM SOC CLIN; Vinik AI, 1997, CANC MED, P1605; Yao JC, 2011, NEW ENGL J MED, V364, P514, DOI 10.1056/NEJMoa1009290; Yao JC, 2010, J CLIN ONCOL, V28, P69, DOI 10.1200/JCO.2009.24.2669; Yao KA, 2001, SURGERY, V130, P677, DOI 10.1067/msy.2001.117377; Yao VJ, 2006, EJC SUPPL, V4, P27, DOI 10.1016/S1359-6349(06)70084-2	41	1757	1858	4	83	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2011	364	6					501	513		10.1056/NEJMoa1003825	http://dx.doi.org/10.1056/NEJMoa1003825			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718QH	21306237	Bronze			2022-12-28	WOS:000287139900004
J	Schooler, SS; Salau, B; Julien, MH; Ives, AR				Schooler, Shon S.; Salau, Buck; Julien, Mic H.; Ives, Anthony R.			Alternative stable states explain unpredictable biological control of Salvinia molesta in Kakadu	NATURE			English	Article							REGIME SHIFTS; ECOSYSTEMS; RESTORATION; ECOLOGY; COMMUNITIES; THRESHOLDS; TRANSIENTS; NITROGEN; GROWTH; FIELD	Suppression of the invasive plant Salvinia molesta by the salvinia weevil is an iconic example of successful biological control. However, in the billabongs (oxbow lakes) of Kakadu National Park, Australia, control is fitful and incomplete. By fitting a process-based nonlinear model to thirteen-year data sets from four billabongs, here we show that incomplete control can be explained by alternative stable states(1-4)-one state in which salvinia is suppressed and the other in which salvinia escapes weevil control. The shifts between states are associated with annual flooding events. In some years, high water flow reduces weevil populations, allowing the shift from a controlled to an uncontrolled state; in other years, benign conditions for weevils promote the return shift to the controlled state. In most described ecological examples, transitions between alternative stable states are relatively rare, facilitated by slow-moving environmental changes, such as accumulated nutrient loading or climate change(5,6). The billabongs of Kakadu give a different manifestation of alternative stable states that generate complex and seemingly unpredictable dynamics. Because shifts between alternative stable states are stochastic, they present a potential management strategy to maximize effective biological control: when the domain of attraction to the state of salvinia control is approached, augmentation of the weevil population or reduction of the salvinia biomass may allow the lower state to trap the system.	[Ives, Anthony R.] Univ Wisconsin, Dept Zool, Madison, WI 53706 USA; [Schooler, Shon S.; Julien, Mic H.] CSIRO Ecosyst Sci, Long Pocket Labs, Indooroopilly, Qld 4068, Australia; [Salau, Buck] Dept Environm Water Heritage & Arts, Jabiru, NT 0886, Australia	University of Wisconsin System; University of Wisconsin Madison; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Ives, AR (corresponding author), Univ Wisconsin, Dept Zool, Madison, WI 53706 USA.	arives@wisc.edu	Julien, Mic/B-6619-2009; Schooler, Shon/AAE-9369-2019; Ives, Anthony/A-5698-2008; Schooler, Shon/C-1860-2008	Ives, Anthony/0000-0001-9375-9523; 	Australian Department of Agriculture, Fisheries and Forestry; CSIRO; United States National Science Foundation through the North Temperate Lakes Long Term Ecological Research Network	Australian Department of Agriculture, Fisheries and Forestry(Australian GovernmentDepartment of Agriculture and Water Resources); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); United States National Science Foundation through the North Temperate Lakes Long Term Ecological Research Network	We thank S. Winderlich (Kakadu National Park) for facilitating data processing, and S. Cruickshank and G. Willis of the Northern Territory Department of Natural Resources, Environment, the Arts and Sport for providing gauging station data. M. Storrs, C. Murakami, F. Hunter, M. Hattand F. Baird provided field assistance. A. Bourne assisted with data interpretation, and P. Milewski provided value insight into the mathematical analyses. S.S.S. received funding from the Australian Department of Agriculture, Fisheries and Forestry and A.R.I. received funding from a CSIRO McMaster's Fellowship and United States National Science Foundation funds through the North Temperate Lakes Long Term Ecological Research Network and individual grants. S. R. Carpenter, Y. Buckley, and R. van Klinken provided comments on earlier versions of this manuscript.	Beisner BE, 2003, FRONT ECOL ENVIRON, V1, P376, DOI 10.2307/3868190; Carpenter SR, 2008, ECOL LETT, V11, P128, DOI 10.1111/j.1461-0248.2007.01131.x; FINLAYSON CM, 1984, AQUAT BOT, V18, P257, DOI 10.1016/0304-3770(84)90067-6; Firn J, 2010, J APPL ECOL, V47, P96, DOI 10.1111/j.1365-2664.2009.01741.x; Folke C, 2004, ANNU REV ECOL EVOL S, V35, P557, DOI 10.1146/annurev.ecolsys.35.021103.105711; Harvey A.C., 1989, FORECASTING STRUCTUR, DOI 10.1017/CBO9781107049994; Hastings A, 2004, TRENDS ECOL EVOL, V19, P39, DOI 10.1016/j.tree.2003.09.007; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Holmgren M, 2006, FRONT ECOL ENVIRON, V4, P87, DOI 10.1890/1540-9295(2006)004[0087:ECESAA]2.0.CO;2; Holmgren M, 2001, ECOSYSTEMS, V4, P151, DOI 10.1007/s100210000065; Julien MH, 2009, BIOLOGICAL CONTROL OF TROPICAL WEEDS USING ARTHROPODS, P378, DOI 10.1017/CBO9780511576348.019; KNOWLTON N, 1992, AM ZOOL, V32, P674; MAY RM, 1977, NATURE, V269, P471, DOI 10.1038/269471a0; ROOM PM, 1986, J APPL ECOL, V23, P1013, DOI 10.2307/2403952; ROOM PM, 1986, AQUAT BOT, V24, P213, DOI 10.1016/0304-3770(86)90058-6; ROOM PM, 1990, TRENDS ECOL EVOL, V5, P74, DOI 10.1016/0169-5347(90)90234-5; Scheffer M, 2001, NATURE, V413, P591, DOI 10.1038/35098000; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Scheffer M., 2020, CRITICAL TRANSITIONS, V16, DOI 10.2307/j.ctv173f1g1; Scheffer M, 2008, ECOSYSTEMS, V11, P226, DOI 10.1007/s10021-007-9118-8; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schmitz OJ, 2006, ECOSYSTEMS, V9, P659, DOI 10.1007/s10021-006-0006-4; Schroder A, 2005, OIKOS, V110, P3, DOI 10.1111/j.0030-1299.2005.13962.x; Storrs MJ, 1996, NO LANDSCAPES OCCASI, V1; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Suding KN, 2004, TRENDS ECOL EVOL, V19, P46, DOI 10.1016/j.tree.2003.10.005; SUTHERLAND JP, 1974, AM NAT, V108, P859, DOI 10.1086/282961; Van Geest GJ, 2007, ECOSYSTEMS, V10, P36, DOI 10.1007/s10021-006-9000-0	28	62	64	2	126	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2011	470	7332					86	89		10.1038/nature09735	http://dx.doi.org/10.1038/nature09735			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293376				2022-12-28	WOS:000286886400039
J	Skowronski, DM; Janjua, NZ; De Serres, G; Hottes, TS; Dickinson, JA; Crowcroft, N; Kwindt, TL; Tang, P; Charest, H; Fonseca, K; Gubbay, JB; Bastien, N; Li, Y; Petric, M				Skowronski, Danuta M.; Janjua, Naveed Z.; De Serres, Gaston; Hottes, Travis S.; Dickinson, James A.; Crowcroft, Natasha; Kwindt, Trijntje L.; Tang, Patrick; Charest, Hugues; Fonseca, Kevin; Gubbay, Jonathan B.; Bastien, Nathalie; Li, Yan; Petric, Martin			Effectiveness of AS03 adjuvanted pandemic H1N1 vaccine: case-control evaluation based on sentinel surveillance system in Canada, autumn 2009	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFLUENZA VACCINATION; NETWORK	Objective To assess the effectiveness of the pandemic influenza A/H1N1 vaccine used in Canada during autumn 2009. Design Test negative incident case-control study based on sentinel physician surveillance system. Setting Community based clinics contributing to sentinel networks in British Columbia, Alberta, Ontario, and Quebec, Canada. Participants 552 patients who presented to a sentinel site within seven days of onset of influenza-like illness during the primary analysis period between 8 November and 5 December 2009; participants were mostly (>80%) children and adults under 50 years old. Interventions Monovalent AS03 adjuvanted pandemic influenza A/H1N1 vaccine as the predominant formulation (>95%) distributed in Canada. Main outcome measures Vaccine effectiveness calculated as 1-(odds ratio for influenza in vaccinated (received pandemic H1N1 vaccine at least two weeks before onset of influenza-like illness) versus unvaccinated participants), with adjustment for age, comorbidity, province, timeliness of specimen collection, and week of illness onset. Sensitivity analyses explored the influence of varying analysis periods between 1 November and 31 December, receipt of trivalent seasonal influenza vaccine, and restriction to participants without comorbidity. Results During the primary analysis period, pandemic H1N1 was detected by reverse transcription polymerase chain reaction in 209/552 (38%) participants; rates were highest in children and young adults (40%) and lowest in people aged 65 or over (9%). Among the 209 cases, 35 (17%) reported comorbidity compared with 80/343 (23%) controls. Two (1%) cases had received pandemic H1N1 vaccine at least two weeks before the onset of illness, compared with 58/343 (17%) controls, all single dose. Adjusted vaccine effectiveness overall was 93% (95% confidence interval 69% to 98%). High estimates of vaccine protection-generally at least 90%-were maintained across most sensitivity analyses. Conclusions Although limited by a small number of vaccine failures, this study suggests that the monovalent AS03 adjuvanted vaccine used in Canada during autumn 2009 was highly effective in preventing medically attended, laboratory confirmed pandemic H1N1 illness, with reference in particular to a single dose in children and young adults.	[Skowronski, Danuta M.] British Columbia Ctr Dis Control, Epidemiol Serv, Vancouver, BC V5Z 4R4, Canada; [Skowronski, Danuta M.; Janjua, Naveed Z.] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [De Serres, Gaston; Charest, Hugues] Inst Natl Sante Publ Quebec, Quebec City, PQ, Canada; [Dickinson, James A.] Univ Calgary, Dept Family Med, Calgary, AB, Canada; [Dickinson, James A.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Crowcroft, Natasha] Ontario Agcy Hlth Protect & Promot, Toronto, ON, Canada; [Crowcroft, Natasha; Gubbay, Jonathan B.] Univ Toronto, Fac Med, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Tang, Patrick; Petric, Martin] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Fonseca, Kevin] Alberta Prov Lab, Calgary, AB, Canada; [Gubbay, Jonathan B.] Ontario Agcy Hlth Protect & Promot, Publ Hlth Lab, Toronto, ON, Canada; [Bastien, Nathalie; Li, Yan] Publ Hlth Agcy Canada, Natl Microbiol Lab, Winnipeg, MB, Canada	University of British Columbia; Institut national de sante publique du Quebec (INSPQ); University of Calgary; University of Calgary; University of Toronto; University of British Columbia; Public Health Agency of Canada	Skowronski, DM (corresponding author), British Columbia Ctr Dis Control, Epidemiol Serv, 655 W 12th Ave, Vancouver, BC V5Z 4R4, Canada.	danuta.skowronski@bccdc.ca	Zafar, Naveed/A-2712-2008; Gubbay, Jonathan/Q-8580-2019	Zafar, Naveed/0000-0001-5681-719X; Gubbay, Jonathan/0000-0003-0026-3786; Salway, Travis/0000-0002-5699-5444; Dickinson, James/0000-0003-3675-6865; Tang, Patrick/0000-0003-1583-5484	Canadian Institutes of Health Research [TPA-90193]; British Columbia Centre for Disease Control, Alberta Health and Wellness; Ontario Agency for Health Protection and Promotion; Ministere de la sante et des services sociaux du Quebec; Institut national de sante publique du Quebec; Canadian Institutes of Health Research; Public Health Agency of Canada; Michael Smith Foundation for Health Research; GlaxoSmithKline; Sanofi-Pasteur; Alberta Health and Wellness	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); British Columbia Centre for Disease Control, Alberta Health and Wellness; Ontario Agency for Health Protection and Promotion; Ministere de la sante et des services sociaux du Quebec; Institut national de sante publique du Quebec; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Public Health Agency of Canada; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); GlaxoSmithKline(GlaxoSmithKline); Sanofi-Pasteur; Alberta Health and Wellness	Funding for this study was provided by the Canadian Institutes of Health Research (ID: TPA-90193), the British Columbia Centre for Disease Control, Alberta Health and Wellness, the Ontario Agency for Health Protection and Promotion, the Ministere de la sante et des services sociaux du Quebec, and the Institut national de sante publique du Quebec. The funders did not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author at danuta.skowronski@bccdc.ca) and declare that they had no financial support from commercial entities for the submitted work. DMS was principal investigator on a clinical trial for which influenza vaccine was provided free by Sanofi-Pasteur and has received research grant funding related to influenza from the Canadian Institutes of Health Research, the Public Health Agency of Canada, and the Michael Smith Foundation for Health Research in the past 36 months. GDS has received research grants from GlaxoSmithKline and Sanofi-Pasteur for unrelated studies in the past 36 months. JBG has received a grant from GlaxoSmithKline to assess an unrelated influenza question. The Canadian Institutes of Health research grant provided salary support for TLK.	[Anonymous], 2005, Can Commun Dis Rep, V31, P181; [Anonymous], GUID DOC US PAND INF; Committee for Proprietary Medicinal Products [CPMP], 1997, CPMPBWP21496, P1; COX RJ, 1994, VACCINE, V12, P993, DOI 10.1016/0264-410X(94)90334-4; CSL Biotherapies Inc, 2009, PANV H1N1 VACC PANV; de Jong J C, 2003, Dev Biol (Basel), V115, P63; GlaxoSmithKline Inc, 2009, PROD MON FLUV 2009 2; GlaxoSmithKline Inc, 2009, PROD INF LEAFL INFL; GlaxoSmithKline Inc, 2010, PROD INF LEAFL AR H1; GlaxoSmithKline Inc, 2010, GSK STUD; Groenwold RHH, 2009, ANN EPIDEMIOL, V19, P432, DOI 10.1016/j.annepidem.2009.02.001; Jackson LA, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-71; National Advisory Committee on Immunization, 2009, CANADA COMMUNICABLE, P1; ORENSTEIN WA, 1985, B WORLD HEALTH ORGAN, V63, P1055; Public Health Agency of Canada, 2009, ADD OCT 21 2009 GUID; Sanofi Pasteur SA, 2010, PRODUCT MONOGRAPH VA; Simpson CR, 2010, HEALTH TECHNOL ASSES, V14, P323, DOI 10.3310/hta14340-05; Skowronski DM, 2007, VACCINE, V25, P2842, DOI 10.1016/j.vaccine.2006.10.002; Skowronski DM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000258; Skowronski DM, 2009, J INFECT DIS, V199, P168, DOI 10.1086/595862; Statistics Canada, 2005, CAN COMM HLTH SURV C; Statistics Canada, 2009, INFL IMM COV PROV AG; Valenciano M, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000388; Van Buynder PG, 2010, INFLUENZA OTHER RESP, V4, P171, DOI 10.1111/j.1750-2659.2010.00146.x; Waddington CS, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2649; WHO, 2009, REC COMP INFL VIR VA; Wichmann O, 2010, EURO SURVEILL, V15; World Health Organization, 2010, REC VIR INFL VACC US	28	79	81	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2011	342								c7297	10.1136/bmj.c7297	http://dx.doi.org/10.1136/bmj.c7297			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718PW	21292718	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000287138500001
J	Spiegel, D				Spiegel, David			Mind Matters in Cancer Survival	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							METASTATIC BREAST-CANCER; TRIAL		Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University	Spiegel, D (corresponding author), Stanford Univ, Sch Med, Dept Psychiat & Behav Sci, 401 Quarry Rd,Off 2325, Stanford, CA 94305 USA.	dspiegel@stanford.edu		Spiegel, David/0000-0002-9476-9173	NATIONAL CANCER INSTITUTE [R01CA118567] Funding Source: NIH RePORTER; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [P30AT005886] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH047226] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG018784] Funding Source: NIH RePORTER; NCCIH NIH HHS [1 P30 AT00 5886] Funding Source: Medline; NCI NIH HHS [1 R01 CA118567] Funding Source: Medline; NIA NIH HHS [P01 AG18784] Funding Source: Medline; NIMH NIH HHS [R01 MH47226] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCCIH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Andersen BL, 2008, CANCER-AM CANCER SOC, V113, P3450, DOI 10.1002/cncr.23969; Giese-Davis J, 2011, J CLIN ONCOL, V29, P413, DOI 10.1200/JCO.2010.28.4455; Goodwin PJ, 2001, NEW ENGL J MED, V345, P1719, DOI 10.1056/NEJMoa011871; HOUSE JS, 1988, SCIENCE, V241, P540, DOI 10.1037/0003-066X.59.8.676; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; PHILLIPS DP, 1990, JAMA-J AM MED ASSOC, V263, P1947, DOI 10.1001/jama.263.14.1947; Sephton SE, 2000, J NATL CANCER I, V92, P994, DOI 10.1093/jnci/92.12.994; SPIEGEL D, 1989, LANCET, V2, P888; Spiegel D, 2007, CANCER-AM CANCER SOC, V110, P1130, DOI 10.1002/cncr.22890; Temel JS, 2010, NEW ENGL J MED, V363, P733, DOI 10.1056/NEJMoa1000678	10	44	44	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2011	305	5					502	503		10.1001/jama.2011.69	http://dx.doi.org/10.1001/jama.2011.69			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	714LI	21285429	Green Accepted			2022-12-28	WOS:000286810700025
J	Turner, S				Turner, Steve			Case Report An asthmatic child with a troublesome cough The most likely diagnosis is pertussis, otherwise known as whooping cough, which is caused by the Gram negative bacterium Bordetella pertussis.	BRITISH MEDICAL JOURNAL			English	Editorial Material							INFECTION		[Turner, Steve] Univ Aberdeen, Royal Aberdeen Childrens Hosp, Aberdeen, Scotland	University of Aberdeen	Turner, S (corresponding author), Univ Aberdeen, Royal Aberdeen Childrens Hosp, Aberdeen, Scotland.	s.w.turner@abdn.ac.uk						ALTUNAIJI S, 2007, CD004404, V3; Halperin SA, 1999, PEDIATRICS, V104, DOI 10.1542/peds.104.4.e42; Harnden A, 2006, BRIT MED J, V333, P174, DOI 10.1136/bmj.38870.655405.AE; *HLTH PROT AG, 2010, HPA GUID PUBL HLTH M; *HLTH PROT AG, WHOOP COUGH PERT; Shields MD, 2008, THORAX, V63, P1, DOI 10.1136/thx.2007.077370; THEILEN U, 2008, BMJ-BRIT MED J, V337, P343; Yaari E, 1999, CHEST, V115, P1254, DOI 10.1378/chest.115.5.1254	8	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2011	342								c6846	10.1136/bmj.c6846	http://dx.doi.org/10.1136/bmj.c6846			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718PU	21289004				2022-12-28	WOS:000287138300009
J	Baker, CJ; Pickering, LK; Chilton, L; Cieslak, P; Coyne-Beasley, T; Duchin, J; Ehresmann, KR; Englund, J; Friedman, C; Jenkins, R; Judson, FN; Keitel, WA; Marcy, MS; Meissner, CH; Rosenbaum, S; Sawyer, MH; Temte, J				Baker, Carol J.; Pickering, Larry K.; Chilton, Lance; Cieslak, Paul; Coyne-Beasley, Tamera; Duchin, Jeffrey; Ehresmann, Kristen R.; Englund, Janet; Friedman, Carol; Jenkins, Renee; Judson, Franklyn N.; Keitel, Wendy A.; Marcy, Michael S.; Meissner, Cody H.; Rosenbaum, Sarah; Sawyer, Mark H.; Temte, Jonathan		Advisory Comm Immunization Practic	Recommended Adult Immunization Schedule: United States, 2011	ANNALS OF INTERNAL MEDICINE			English	Article									[Pickering, Larry K.] Ctr Dis Control & Prevent, Immunizat Serv Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Chilton, Lance] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA; [Cieslak, Paul] Oregon Publ Hlth Div, Portland, OR USA; [Coyne-Beasley, Tamera] Univ N Carolina, Chapel Hill, NC USA; [Duchin, Jeffrey] Univ Washington, Seattle, WA 98195 USA; [Ehresmann, Kristen R.] Minnesota Dept Hlth, St Paul, MN USA; [Englund, Janet] Childrens Hosp, Seattle, WA USA; [Englund, Janet] Reg Med Ctr, Seattle, WA USA; [Friedman, Carol] Ctr Dis Control & Prevent, ACIP Adult Immunizat Working Grp, Atlanta, GA USA; [Jenkins, Renee] Howard Univ, Coll Med, Washington, DC USA; [Judson, Franklyn N.] Univ Colorado, Denver, CO 80202 USA; [Marcy, Michael S.] So Calif Permanente Med Grp, Los Angeles, CA 90027 USA; [Meissner, Cody H.] Tufts Med Ctr, Boston, MA USA; [Rosenbaum, Sarah] George Washington Univ, Washington, DC USA; [Sawyer, Mark H.] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Temte, Jonathan] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA	Centers for Disease Control & Prevention - USA; University of New Mexico; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; Minnesota Department of Health (MHD); Seattle Children's Hospital; Centers for Disease Control & Prevention - USA; Howard University; University of Colorado System; University of Colorado Denver; Kaiser Permanente; Southern California Permanente Medical Group (SCPMG); Permanente Medical Groups; Tufts Medical Center; George Washington University; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison	Baker, CJ (corresponding author), Ctr Dis Control & Prevent, Immunizat Serv Div, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd NE,Mailstop E52, Atlanta, GA 30333 USA.	ams7@cdc.gov			Centers for Disease Control and Prevention; Novartis; Medimmune; ADMA; National Institutes of Health; Bill AMP; Melinda Gates Foundation; Exxon Mobil Research Club; Protein Sciences	Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Novartis(Novartis); Medimmune(AstraZenecaMedimmune); ADMA; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill AMP; Melinda Gates Foundation(CGIAR); Exxon Mobil Research Club(Exxon Mobil Corporation); Protein Sciences	To assure the integrity of the ACIP, the U. S. Department of Health and Human Services has taken steps to assure that there is technical compliance with ethics statutes and regulations regarding financial conflicts of interest. Concerns regarding the potential for the appearance of a conflict are addressed, or avoided altogether, through both pre- and postappointment considerations. Individuals with particular vaccine-related interests will not be considered for appointment to the committee. Potential nominees are screened for conflicts of interest and, if any are found, they are asked to divest or forgo certain vaccine-related activities. In addition, at the beginning of each ACIP meeting, each member is asked to declare his or her conflicts. Members with conflicts are not permitted to vote if the conflict involves the vaccine or biologic being voted upon. Members of the ACIP have disclosed the following: Dr. Chilton: Support to travel to meetings for the study or other purposes: Centers for Disease Control and Prevention. Dr. Coyne-Beasley: Consultancy: sanofi-pasteur; Payment for lectures including service on speakers bureaus: sanofi-pasteur. Dr. Ehresmann: Consulting fee or honorarium (money to institution): Centers for Disease Control and Prevention; Support to travel to meetings for the study or other purposes (money to institution): Centers for Disease Control and Prevention. Dr. Englund: Support to travel to meetings for the study or other purposes: Centers for Disease Control and Prevention; Grants/grants pending (money to institution): Novartis, Medimmune, ADMA; Other (money to institution): National Institutes of Health, Bill & Melinda Gates Foundation. Dr. Keitel: Consulting fee or honorarium: Centers for Disease Control and Prevention; Support to travel to meetings for the study or other purposes: Centers for Disease Control and Prevention; Grants/grants pending: Exxon Mobil Research Club; Grants/grants pending (money to institution): Novartis, Protein Sciences; Stock/stock options: Pfizer (since divested), Schering-Plough (since divested). Dr. Marcy: Consultancy: ACIP; Consultancy (money to institution): ACIP; Payment for development of educational presentations: Medical Education Speakers' Network, National Foundation for Infectious Diseases, Rady Children's Hospital San Diego, Phoenix Children's Hospital, Symposia Medicus. Dr. Rosenbaum: Consulting fee or honorarium: Centers for Disease Control and Prevention; Support to travel to meetings for the study or other purposes: Centers for Disease Control and Prevention. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=M10-2789.		0	13	13	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2011	154	3					168	+		10.7326/0003-4819-154-3-201102010-00006	http://dx.doi.org/10.7326/0003-4819-154-3-201102010-00006			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	713HY	21282696	Green Submitted			2022-12-28	WOS:000286729200004
J	Kaneko, H; Dridi, S; Tarallo, V; Gelfand, BD; Fowler, BJ; Cho, WG; Kleinman, ME; Ponicsan, SL; Hauswirth, WW; Chiodo, VA; Kariko, K; Yoo, JW; Lee, DK; Hadziahmetovic, M; Song, Y; Misra, S; Chaudhuri, G; Buaas, FW; Braun, RE; Hinton, DR; Zhang, Q; Grossniklaus, HE; Provis, JM; Madigan, MC; Milam, AH; Justice, NL; Albuquerque, RJC; Blandford, AD; Bogdanovich, S; Hirano, Y; Witta, J; Fuchs, E; Littman, DR; Ambati, BK; Rudin, CM; Chong, MMW; Provost, P; Kugel, JF; Goodrich, JA; Dunaief, JL; Baffi, JZ; Ambati, J				Kaneko, Hiroki; Dridi, Sami; Tarallo, Valeria; Gelfand, Bradley D.; Fowler, Benjamin J.; Cho, Won Gil; Kleinman, Mark E.; Ponicsan, Steven L.; Hauswirth, William W.; Chiodo, Vince A.; Kariko, Katalin; Yoo, Jae Wook; Lee, Dong-ki; Hadziahmetovic, Majda; Song, Ying; Misra, Smita; Chaudhuri, Gautam; Buaas, Frank W.; Braun, Robert E.; Hinton, David R.; Zhang, Qing; Grossniklaus, Hans E.; Provis, Jan M.; Madigan, Michele C.; Milam, Ann H.; Justice, Nikki L.; Albuquerque, Romulo J. C.; Blandford, Alexander D.; Bogdanovich, Sasha; Hirano, Yoshio; Witta, Jassir; Fuchs, Elaine; Littman, Dan R.; Ambati, Balamurali K.; Rudin, Charles M.; Chong, Mark M. W.; Provost, Patrick; Kugel, Jennifer F.; Goodrich, James A.; Dunaief, Joshua L.; Baffi, Judit Z.; Ambati, Jayakrishna			DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration	NATURE			English	Article							EMBRYONIC STEM-CELLS; MICRORNA BIOGENESIS; MOUSE OOCYTES; LDL RECEPTOR; RECOMBINATION; ARGONAUTE2; EXPRESSION; CANCER; SIRNAS; DIFFERENTIATION	Geographic atrophy (GA), an untreatable advanced form of age-related macular degeneration, results from retinal pigmented epithelium (RPE) cell degeneration. Here we show that the microRNA (miRNA)-processing enzyme DICER1 is reduced in the RPE of humans with GA, and that conditional ablation of Dicer1, but not seven other miRNA-processing enzymes, induces RPE degeneration in mice. DICER1 knockdown induces accumulation of Alu RNA in human RPE cells and Alu-like B1 and B2 RNAs in mouse RPE. Alu RNA is increased in the RPE of humans with GA, and this pathogenic RNA induces human RPE cytotoxicity and RPE degeneration in mice. Antisense oligonucleotides targeting Alu/B1/B2 RNAs prevent DICER1 depletion-induced RPE degeneration despite global miRNA downregulation. DICER1 degrades Alu RNA, and this digested Alu RNA cannot induce RPE degeneration in mice. These findings reveal a miRNA-independent cell survival function for DICER1 involving retrotransposon transcript degradation, show that Alu RNA can directly cause human pathology, and identify new targets for a major cause of blindness.	[Kaneko, Hiroki; Dridi, Sami; Tarallo, Valeria; Gelfand, Bradley D.; Fowler, Benjamin J.; Cho, Won Gil; Kleinman, Mark E.; Justice, Nikki L.; Albuquerque, Romulo J. C.; Blandford, Alexander D.; Bogdanovich, Sasha; Hirano, Yoshio; Baffi, Judit Z.; Ambati, Jayakrishna] Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA; [Cho, Won Gil] Yonsei Univ, Wonju Coll Med, Dept Anat, Wonju 220701, South Korea; [Ponicsan, Steven L.; Kugel, Jennifer F.; Goodrich, James A.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Hauswirth, William W.; Chiodo, Vince A.] Univ Florida, Dept Ophthalmol, Gainesville, FL 32610 USA; [Kariko, Katalin] Univ Penn, Sch Med, Dept Neurosurg, Philadelphia, PA 19104 USA; [Yoo, Jae Wook; Lee, Dong-ki] Sungkyunkwan Univ, Sch Chem Mat Sci BK21, Suwon 440746, South Korea; [Yoo, Jae Wook; Lee, Dong-ki] Sungkyunkwan Univ, Dept Chem, Suwon 440746, South Korea; [Hadziahmetovic, Majda; Song, Ying; Milam, Ann H.; Dunaief, Joshua L.] Univ Penn, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA; [Misra, Smita; Chaudhuri, Gautam] Meharry Med Coll, Dept Microbiol & Immunol, Nashville, TN 37208 USA; [Buaas, Frank W.; Braun, Robert E.] Jackson Lab, Bar Harbor, ME 04609 USA; [Hinton, David R.] Univ So Calif, Doheny Eye Inst, Arnold & Mabel Beckman Macular Res Ctr, Los Angeles, CA 90033 USA; [Zhang, Qing; Grossniklaus, Hans E.] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA; [Zhang, Qing; Grossniklaus, Hans E.] Emory Univ, Atlanta, GA 30322 USA; [Provis, Jan M.] Australian Natl Univ, ANU Med Sch, ARC Ctr Excellence Vis Sci, Canberra, ACT 0200, Australia; [Provis, Jan M.] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Madigan, Michele C.] Univ New S Wales, Sch Optometry & Vis Sci, Kensington, NSW 2033, Australia; [Madigan, Michele C.] Univ Sydney, Save Sight Inst, Sydney, NSW 2001, Australia; [Witta, Jassir] Univ Kentucky, Dept Internal Med, Lexington, KY 40506 USA; [Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Littman, Dan R.; Chong, Mark M. W.] NYU, Sch Med, Howard Hughes Med Inst, Kimmel Ctr Biol & Med,Skirball Inst, New York, NY 10016 USA; [Ambati, Balamurali K.] Univ Utah, Sch Med, Moran Eye Ctr, Dept Ophthalmol & Visual Sci, Salt Lake City, UT 84132 USA; [Ambati, Balamurali K.] Vet Affairs Salt Lake City Healthcare Syst, Dept Ophthalmol, Salt Lake City, UT 84148 USA; [Rudin, Charles M.] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Dept Oncol, Baltimore, MD 21231 USA; [Chong, Mark M. W.] Walter & Eliza Hall Inst Med Res, Autoimmun & Transplantat Div, Parkville, Vic 3052, Australia; [Provost, Patrick] Univ Laval, CHUL Res Ctr CHUQ, Quebec City, PQ G1K 7P4, Canada; [Provost, Patrick] Univ Laval, Fac Med, Quebec City, PQ G1K 7P4, Canada; [Ambati, Jayakrishna] Univ Kentucky, Dept Physiol, Lexington, KY 40506 USA; [Yoo, Jae Wook; Lee, Dong-ki] Sungkyunkwan Univ, Global Res Lab RNAi Med, Suwon 440746, South Korea	University of Kentucky; Yonsei University; University of Colorado System; University of Colorado Boulder; State University System of Florida; University of Florida; University of Pennsylvania; Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); University of Pennsylvania; Pennsylvania Medicine; Meharry Medical College; Jackson Laboratory; Doheny Eye Institute; University of Southern California; Emory University; Emory University; Australian National University; Australian National University; University of New South Wales Sydney; University of Sydney; University of Kentucky; Howard Hughes Medical Institute; Rockefeller University; Howard Hughes Medical Institute; New York University; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Johns Hopkins University; Johns Hopkins Medicine; Walter & Eliza Hall Institute; Laval University; Laval University; University of Kentucky; Sungkyunkwan University (SKKU)	Ambati, J (corresponding author), Univ Kentucky, Dept Ophthalmol & Visual Sci, Lexington, KY 40506 USA.	jamba2@email.uky.edu	Kaneko, Hiroki/AHA-2461-2022; Kaneko, Hiroki/O-7695-2015; Dridi, Sami/Q-8207-2019; Provost, Patrick/G-2786-2010; Gelfand, Brad/L-3926-2019; Fuchs, Elaine/G-1565-2016; Chong, Mark/H-6684-2016; Fowler, Benjamin/F-4987-2012; Provis, Jan/C-9529-2009; Rudin, Charles/R-2530-2019	Kaneko, Hiroki/0000-0003-0731-6465; Kaneko, Hiroki/0000-0003-0731-6465; Provost, Patrick/0000-0002-6099-6562; Chong, Mark/0000-0002-3701-7397; Provis, Jan/0000-0002-6405-2868; Rudin, Charles/0000-0001-5204-3465; hauswirth, william/0000-0002-3244-4947; Kleinman, Mark/0000-0001-8557-7949; Hirano, Yoshio/0000-0002-9173-0839; Tarallo, Valeria/0000-0002-6920-4402	National Eye Institute (NEI)/National Institutes of Health (NIH) [R01EY015422, R01EY018350, R01EY018836, R01EY020672, R21EY019778, RC1EY020442, R01EY017182, R01EY017950, R01HD027215, R21AI076757, P30EY06360, U10EY013729, R01EY011123, P30EY008571, R01GM068414, R01EY015240, P30EY003040, R01EY001545, T32HL091812]; Doris Duke Distinguished Clinical Scientist Award; Burroughs Wellcome Fund Clinical Scientist Award in Translational Research; Dr E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair; Research to Prevent Blindness Senior Scientist Investigator Awards; University of Kentucky Physician Scientist Award; International Retinal Research Foundation; American Health Assistance Foundation; VA Merit Award; Department of Defense; MEST, Korea; Arnold and Mabel Beckman Foundation; Macular Vision Research Foundation and Foundation Fighting Blindness; ARC Centres of Excellence [CE0561903]; Sydney Foundation for Medical Research; National Health and Medical Research Council, Australia [637228]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD027215] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [RC1EY020442, R01EY011123, U10EY013729, P30EY003040, R01EY001545, P30EY006360, R01EY017182, P30EY014800, R01EY018350, R01EY015422, P30EY008571, R01EY020672, R21EY019778, R01EY015240, R01EY017950, P30EY021721, R01EY018836] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL091812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI076757] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068414] Funding Source: NIH RePORTER	National Eye Institute (NEI)/National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Doris Duke Distinguished Clinical Scientist Award(Doris Duke Charitable Foundation (DDCF)); Burroughs Wellcome Fund Clinical Scientist Award in Translational Research(Burroughs Wellcome Fund); Dr E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair; Research to Prevent Blindness Senior Scientist Investigator Awards(Research to Prevent Blindness (RPB)); University of Kentucky Physician Scientist Award; International Retinal Research Foundation; American Health Assistance Foundation; VA Merit Award(US Department of Veterans Affairs); Department of Defense(United States Department of Defense); MEST, Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Arnold and Mabel Beckman Foundation; Macular Vision Research Foundation and Foundation Fighting Blindness; ARC Centres of Excellence(Australian Research Council); Sydney Foundation for Medical Research; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Chrenek, J. Garcia-Perez, T. Heidmann, C. Kanellopoulou, D. M. Livingston, J. V. Moran, R. F. Mullins, J. M. Nickerson, E. A. Pearce, A. Tarakhovsky, B. Vogelstein, V. E. Velculescu and D. J. Zack for providing mice, reagents or tissues; R. King, L. Xu, M. McConnell, C. Payne, G. R. Pattison, G. J. Jaffe, S. Medearis and C. Spee for technical assistance; and A. Sinai, R. Mohan, T. S. Khurana, R. A. Brekken, P. L. Deininger, S. Bondada, P. A. Pearson, A. M. Rao, G. S. Rao and K. Ambati for discussions. J. A. was supported by National Eye Institute (NEI)/National Institutes of Health (NIH) grants R01EY015422, R01EY018350, R01EY018836, R01EY020672, R21EY019778, RC1EY020442, the Doris Duke Distinguished Clinical Scientist Award, the Burroughs Wellcome Fund Clinical Scientist Award in Translational Research, and the Dr E. Vernon Smith and Eloise C. Smith Macular Degeneration Endowed Chair. Research to Prevent Blindness Senior Scientist Investigator Awards or departmental unrestricted grants supported J. A., H. E. G. and W. W. H.; J. Z. B. was supported by University of Kentucky Physician Scientist Award, International Retinal Research Foundation, and American Health Assistance Foundation; B. K. A. by VA Merit Award and Department of Defense; D.-k. L. by Global Research Laboratory program by MEST, Korea; D. R. H. by Arnold and Mabel Beckman Foundation; W. W. H. by Macular Vision Research Foundation and Foundation Fighting Blindness; J. M. P. by ARC Centres of Excellence Grant CE0561903; M. C. M. by Sydney Foundation for Medical Research. B. K. A was supported by NIH R01EY017182 and R01EY017950; R. E. B. by NIH R01HD027215; G. C. by NIH R21AI076757; H. E. G. by NIH P30EY06360; W. W. H. by NIH U10EY013729, R01EY011123, and P30EY008571; J. F. K. and J. A. G. by NIH R01GM068414; J. L. D. by NIH R01EY015240; D. R. H. by NIH P30EY003040 and R01EY001545; M. E. K. and S. B. by NIH T32HL091812. P. P. is a Senior Scholar from the Fonds de la Recherche en Sante du Quebec (FRSQ). M. M. W. C. is a QEII Fellow of the Australian Research Council and is supported by National Health and Medical Research Council, Australia Project Grant 637228. E. F. and D. R. L. are investigators of the Howard Hughes Medical Institute.	Alexander JJ, 2008, ADV EXP MED BIOL, V613, P121, DOI 10.1007/978-0-387-74904-4_13; Allen TA, 2004, NAT STRUCT MOL BIOL, V11, P816, DOI 10.1038/nsmb813; Ambati J, 2003, SURV OPHTHALMOL, V48, P257, DOI 10.1016/S0039-6257(03)00030-4; Babiarz JE, 2008, GENE DEV, V22, P2773, DOI 10.1101/gad.1705308; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chong MMW, 2008, J EXP MED, V205, P2449, DOI [10.1084/jem.20071219090508c, 10.1084/jem.20081219]; Chong MMW, 2010, GENE DEV, V24, P1951, DOI 10.1101/gad.1953310; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Damiani D, 2008, J NEUROSCI, V28, P4878, DOI 10.1523/JNEUROSCI.0828-08.2008; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; Diederichs S, 2007, CELL, V131, P1097, DOI 10.1016/j.cell.2007.10.032; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; Ferrara N, 2010, NAT MED, V16, P1107, DOI 10.1038/nm1010-1107; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hill DA, 2009, SCIENCE, V325, P965, DOI 10.1126/science.1174334; Iacovelli J, 2011, INVEST OPHTH VIS SCI, V52, P1378, DOI 10.1167/iovs.10-6347; Kaneda M, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-9; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kleinman ME, 2008, NATURE, V452, P591, DOI 10.1038/nature06765; Kohany O, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-474; Kumar MS, 2009, GENE DEV, V23, P2700, DOI 10.1101/gad.1848209; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; LEHRMAN MA, 1987, CELL, V48, P827, DOI 10.1016/0092-8674(87)90079-1; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nakagawa A, 2010, SCIENCE, V328, P327, DOI 10.1126/science.1182374; NICHOLLS RD, 1987, CELL, V49, P369, DOI 10.1016/0092-8674(87)90289-3; NYSTROMLAHTI M, 1995, NAT MED, V1, P1203, DOI 10.1038/nm1195-1203; O'Carroll D, 2007, GENE DEV, V21, P1999, DOI 10.1101/gad.1565607; Prades C, 1996, J MOL EVOL, V42, P37, DOI 10.1007/BF00163209; Saito Y, 2009, ONCOGENE, V28, P2738, DOI 10.1038/onc.2009.140; Saleh MC, 2006, NAT CELL BIOL, V8, P793, DOI 10.1038/ncb1439; Schaefer A, 2010, J EXP MED, V207, P1843, DOI 10.1084/jem.20100451; SCHONBORN J, 1991, NUCLEIC ACIDS RES, V19, P2993, DOI 10.1093/nar/19.11.2993; Shaikh TH, 1997, J MOL BIOL, V271, P222, DOI 10.1006/jmbi.1997.1161; Su H, 2009, GENE DEV, V23, P304, DOI 10.1101/gad.1749809; Takeda A, 2009, NATURE, V460, P225, DOI 10.1038/nature08151; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; WALLACE MR, 1991, NATURE, V353, P864, DOI 10.1038/353864a0; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Yang P, 2009, INVEST OPHTH VIS SCI, V50, P3473, DOI 10.1167/iovs.08-3202; Yang ZL, 2008, NEW ENGL J MED, V359, P1456, DOI 10.1056/NEJMoa0802437; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105	52	438	467	4	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					325	+		10.1038/nature09830	http://dx.doi.org/10.1038/nature09830			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21297615	Green Accepted			2022-12-28	WOS:000288444000034
J	Lebreton, A; Lakisic, G; Job, V; Fritsch, L; To, NT; Camejo, A; Mattei, PJ; Regnault, B; Nahori, MA; Cabanes, D; Gautreau, A; Ait-Si-Ali, S; Dessen, A; Cossart, P; Bierne, H				Lebreton, Alice; Lakisic, Goran; Job, Viviana; Fritsch, Lauriane; To Nam Tham; Camejo, Ana; Mattei, Pierre-Jean; Regnault, Beatrice; Nahori, Marie-Anne; Cabanes, Didier; Gautreau, Alexis; Ait-Si-Ali, Slimane; Dessen, Andrea; Cossart, Pascale; Bierne, Helene			A Bacterial Protein Targets the BAHD1 Chromatin Complex to Stimulate Type III Interferon Response	SCIENCE			English	Article							LISTERIA-MONOCYTOGENES; LAMBDA; INFECTION	Intracellular pathogens such as Listeria monocytogenes subvert cellular functions through the interaction of bacterial effectors with host components. Here we found that a secreted listerial virulence factor, LntA, could target the chromatin repressor BAHD1 in the host cell nucleus to activate interferon (IFN)-stimulated genes (ISGs). IFN-lambda expression was induced in response to infection of epithelial cells with bacteria lacking LntA; however, the BAHD1-chromatin associated complex repressed downstream ISGs. In contrast, in cells infected with lntA-expressing bacteria, LntA prevented BAHD1 recruitment to ISGs and stimulated their expression. Murine listeriosis decreased in BAHD1(+/-) mice or when lntA was constitutively expressed. Thus, the LntA-BAHD1 interplay may modulate IFN-lambda-mediated immune response to control bacterial colonization of the host.	[Lebreton, Alice; To Nam Tham; Nahori, Marie-Anne; Cossart, Pascale; Bierne, Helene] Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France; [Lebreton, Alice; To Nam Tham; Nahori, Marie-Anne; Cossart, Pascale; Bierne, Helene] INRA, USC2020, F-75015 Paris, France; [Lebreton, Alice; To Nam Tham; Nahori, Marie-Anne; Cossart, Pascale; Bierne, Helene] INSERM, U604, F-75015 Paris, France; [Lakisic, Goran; Gautreau, Alexis] CNRS, UPR3082, Lab Enzymol & Biochim Struct, F-91198 Gif Sur Yvette, France; [Job, Viviana; Mattei, Pierre-Jean; Dessen, Andrea] Inst Biol Struct, Bacterial Pathogenesis Grp, UMR 5075, CNRS CEA UJF, F-38027 Grenoble, France; [Fritsch, Lauriane; Ait-Si-Ali, Slimane] Univ Paris 07, CNRS, UMR7216, F-75013 Paris, France; [Camejo, Ana; Cabanes, Didier] Inst Mol & Cellular Biol, P-4150 Oporto, Portugal; [Regnault, Beatrice] Inst Pasteur, F-75015 Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; Universidade do Porto; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cossart, P (corresponding author), Inst Pasteur, Unite Interact Bacteries Cellules, F-75015 Paris, France.	pcossart@pasteur.fr; hbierne@pasteur.fr	Lebreton, Alice/M-8764-2015; Gautreau, Alexis/AAT-2751-2020; Cabanes, Didier/K-3917-2013; Cabanes, Didier/P-3052-2019	Lebreton, Alice/0000-0002-6643-902X; Gautreau, Alexis/0000-0002-2369-4362; Cabanes, Didier/0000-0002-4001-1332; Cabanes, Didier/0000-0002-4001-1332; REGNAULT, Beatrice/0000-0002-3914-1914; LAKISIC, Goran/0000-0002-0079-5072; Job, Viviana/0000-0001-8421-5292; Dessen, Andrea/0000-0001-6487-4020; Marie-Anne, Nahori/0000-0002-4066-4528; Bierne, Helene/0000-0002-0525-0848	Pasteur Institute, French National Institute for Agricultural Research (INRA); INSERM; The French National Research Agency (ANR)-European Research Area (ERA)-NET-PathoGenomics [SPATELIS]; French Ligue Nationale Contre le Cancer [LNCC RS10/75-76]; European Research Council [233348]; Region Rhone Alpes; Fundacao para a Ciencia e a Tecnologia (FCT) [PTDC-SAU/MII/65406/2006, SFRH/BD/29314/2006]; ERANET-PathoGenomics [SPATELIS]	Pasteur Institute, French National Institute for Agricultural Research (INRA); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); The French National Research Agency (ANR)-European Research Area (ERA)-NET-PathoGenomics(French National Research Agency (ANR)); French Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); European Research Council(European Research Council (ERC)European Commission); Region Rhone Alpes(Region Auvergne-Rhone-Alpes); Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); ERANET-PathoGenomics	We are very grateful to O. Dussurget for help in virulence assays. We thank E. Gouin for antibodies against LntA; J.-Y. Coppee for microarrays facilities at the IP Genopole; S. Jacquot and M. C. Birling at the Targeted Mutagenesis and Transgenesis department of the Mouse Clinical Institute (MCI/ICS), where the BAHD1<SUP>+/-</SUP> mouse line was generated. Work in the Cossart laboratory received financial support from the Pasteur Institute, French National Institute for Agricultural Research (INRA), INSERM, The French National Research Agency (ANR)-European Research Area (ERA)-NET-PathoGenomics (grant SPATELIS), French Ligue Nationale Contre le Cancer (LNCC RS10/75-76 Bierne), and European Research Council (Advanced Grant 233348). P.-J. M. received a Ph. D. fellowship from Region Rhone Alpes. Work in the Cabanes laboratory was supported by Fundacao para a Ciencia e a Tecnologia (FCT) (PTDC-SAU/MII/65406/2006; Ph. D. fellowship to A. C. SFRH/BD/29314/2006) and ERANET-PathoGenomics (grant SPATELIS). P. C. is an international research scholar of the Howard Hughes Medical Institute. The LntA molecular structure data are deposited at the Worldwide Protein Data Bank (http://www.wwpdb.org), ID no. 2xl4, structure factor file no. r2xl4sf.	Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bierne H, 2009, P NATL ACAD SCI USA, V106, P13826, DOI 10.1073/pnas.0901259106; Casola A, 2001, J VIROL, V75, P6428, DOI 10.1128/JVI.75.14.6428-6439.2001; Corr SC, 2009, CELL MICROBIOL, V11, P703, DOI 10.1111/j.1462-5822.2009.01294.x; Cossart P, 2008, MICROBES INFECT, V10, P1041, DOI 10.1016/j.micinf.2008.07.043; Donnelly RP, 2010, J INTERF CYTOK RES, V30, P555, DOI 10.1089/jir.2010.0078; Dussurget O, 2008, INT REV CEL MOL BIO, V270, P1, DOI 10.1016/S1937-6448(08)01401-9; Gallagher G, 2010, J INTERF CYTOK RES, V30, P603, DOI 10.1089/jir.2010.0081; Hamon MA, 2008, CELL HOST MICROBE, V4, P100, DOI 10.1016/j.chom.2008.07.009; Kamitani S, 2008, BIOCHEM BIOPH RES CO, V370, P366, DOI 10.1016/j.bbrc.2008.03.104; Lavigne M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000769; Lecuit M, 2005, CLIN MICROBIOL INFEC, V11, P430, DOI 10.1111/j.1469-0691.2005.01146.x; Li MC, 2009, J LEUKOCYTE BIOL, V86, P23, DOI [10.1189/JLB.1208761, 10.1189/jlb.1208761]; Mordstein M, 2010, J INTERF CYTOK RES, V30, P579, DOI 10.1089/jir.2010.0061; Nusinzon I, 2003, P NATL ACAD SCI USA, V100, P14742, DOI 10.1073/pnas.2433987100; Paschos K, 2010, TRENDS MICROBIOL, V18, P439, DOI 10.1016/j.tim.2010.07.003; Pulverer JE, 2010, J VIROL, V84, P8626, DOI 10.1128/JVI.00303-10; Tsuruma R, 2008, ONCOGENE, V27, P3054, DOI 10.1038/sj.onc.1210952	18	126	135	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 11	2011	331	6022					1319	1321		10.1126/science.1200120	http://dx.doi.org/10.1126/science.1200120			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	732UM	21252314	Green Submitted			2022-12-28	WOS:000288215200045
J	Hall, MA				Hall, Mark A.			Clearing Out the Underbrush in Constitutional Challenges to Health Insurance Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Wake Forest Univ, Sch Law, Winston Salem, NC 27109 USA	Wake Forest University	Hall, MA (corresponding author), Wake Forest Univ, Sch Law, Winston Salem, NC 27109 USA.			Hall, Mark A./0000-0001-6277-144X				HALL MA, COMMERCE CL IN PRESS; Hall MA, 2011, NEW ENGL J MED, V364, P295, DOI 10.1056/NEJMp1013234; JENSEN EM, N KY LAW RE IN PRESS; Mariner WK, 2011, NEW ENGL J MED, V364, P201, DOI 10.1056/NEJMp1014367; Rosenbaum S, 2010, NEW ENGL J MED, V362, P1952, DOI 10.1056/NEJMp1003890	5	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2011	364	9					793	795		10.1056/NEJMp1101252	http://dx.doi.org/10.1056/NEJMp1101252			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729DJ	21288088				2022-12-28	WOS:000287928400003
J	Funder, JW				Funder, John W.			The Genetics of Primary Aldosteronism	SCIENCE			English	Editorial Material							GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM; LOW-RENIN HYPERTENSION; FAMILIAL HYPERALDOSTERONISM; FIBROSIS; MICE		Monash Med Ctr, Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia	Monash University; Prince Henry's Institute of Medical Research	Funder, JW (corresponding author), Monash Med Ctr, Prince Henrys Inst Med Res, Clayton, Vic 3168, Australia.	john.funder@princehenrys.org	Gordon, Richard D/K-2555-2012; Stowasser, Michael/F-4121-2010					BRILLA CG, 1992, J LAB CLIN MED, V120, P893; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Davies LA, 2008, P NATL ACAD SCI USA, V105, P2203, DOI 10.1073/pnas.0712000105; Doi M, 2010, NAT MED, V16, P67, DOI 10.1038/nm.2061; GRECO RG, 1982, J CLIN ENDOCR METAB, V55, P1013, DOI 10.1210/jcem-55-5-1013; Gros R, 2011, HYPERTENSION, V57, P442, DOI 10.1161/HYPERTENSIONAHA.110.161653; Heitzmann D, 2008, EMBO J, V27, P179, DOI 10.1038/sj.emboj.7601934; Lafferty AR, 2000, J MED GENET, V37, P831, DOI 10.1136/jmg.37.11.831; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; Malagon-Rogers M, 2004, PEDIATR NEPHROL, V19, P235, DOI 10.1007/s00467-003-1339-2; Milliez P, 2005, J AM COLL CARDIOL, V45, P1243, DOI 10.1016/j.jacc.2005.01.015; YOUNG M, 1994, J CLIN INVEST, V93, P2578, DOI 10.1172/JCI117269	12	26	27	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					685	686		10.1126/science.1202887	http://dx.doi.org/10.1126/science.1202887			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21310991				2022-12-28	WOS:000287205700035
J	Dey, R; Dey, S				Dey, Rubi; Dey, Subhajeet			Limbal Dermoid.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dey, Rubi; Dey, Subhajeet] Sikkim Manipal Inst Med Sci, Gangtok, Sikkim, India	Sikkim Manipal University	Dey, R (corresponding author), Sikkim Manipal Inst Med Sci, Gangtok, Sikkim, India.		Dey, Subhajeet/AAC-3351-2021; Dey, Rubi/AAE-4473-2021	Dey, Subhajeet/0000-0001-6722-8067; Dey, Dr.Rubi/0000-0002-5413-574X					0	0	0	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2011	364	6					E9	E9		10.1056/NEJMicm1005854	http://dx.doi.org/10.1056/NEJMicm1005854			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718QH	21306235				2022-12-28	WOS:000287139900010
J	Shevenell, AE; Ingalls, AE; Domack, EW; Kelly, C				Shevenell, A. E.; Ingalls, A. E.; Domack, E. W.; Kelly, C.			Holocene Southern Ocean surface temperature variability west of the Antarctic Peninsula	NATURE			English	Article							SEA-ICE; SPATIOTEMPORAL VARIABILITY; ATMOSPHERIC CO2; PALMER-DEEP; CLIMATE; RECORD; MECHANISMS; VEGETATION; INSOLATION; ATLANTIC	The disintegration of ice shelves, reduced sea-ice and glacier extent, and shifting ecological zones observed around Antarctica(1,2) highlight the impact of recent atmospheric(3) and oceanic warming(4) on the cryosphere. Observations(1,2) and models(5,6) suggest that oceanic and atmospheric temperature variations at Antarctica's margins affect global cryosphere stability, ocean circulation, sea levels and carbon cycling. In particular, recent climate changes on the Antarctic Peninsula have been dramatic, yet the Holocene climate variability of this region is largely unknown, limiting our ability to evaluate ongoing changes within the context of historical variability and underlying forcing mechanisms. Here we show that surface ocean temperatures at the continental margin of the western Antarctic Peninsula cooled by 3-4 degrees C over the past 12,000 years, tracking the Holocene decline of local (65 degrees S) spring insolation. Our results, based on TEX(86) sea surface temperature (SST) proxy evidence from a marine sediment core, indicate the importance of regional summer duration as a driver of Antarctic seasonal sea-ice fluctuations(7). On millennial timescales, abrupt SST fluctuations of 2-4 degrees C coincide with globally recognized climate variability(8). Similarities between our SSTs, Southern Hemisphere westerly wind reconstructions(9) and El Nino/Southern Oscillation variability(10) indicate that present climate teleconnections between the tropical Pacific Ocean and the western Antarctic Peninsula(11) strengthened late in the Holocene epoch. We conclude that during the Holocene, Southern Ocean temperatures at the western Antarctic Peninsula margin were tied to changes in the position of the westerlies, which have a critical role in global carbon cycling(9,12).	[Shevenell, A. E.; Ingalls, A. E.; Kelly, C.] Univ Washington, Sch Oceanog, Seattle, WA 98195 USA; [Domack, E. W.] Hamilton Coll, Dept Geosci, Clinton, NY 13323 USA	University of Washington; University of Washington Seattle; Hamilton College	Shevenell, AE (corresponding author), UCL, Dept Geog, Gower St, London WC1E 6BT, England.	a.shevenell@ucl.ac.uk	shevenell, Amelia/A-4161-2009; Shevenell, Amelia/C-2757-2015	Shevenell, Amelia/0000-0002-6457-6530; Ingalls, Anitra/0000-0003-1953-7329	NSF [OPP-0620099, OPP-0732467]	NSF(National Science Foundation (NSF))	We thank R. Murray and K. Kryc for the ODP Hole 1098B samples, F. Lamy for the ODP Site 1233/GEOB3313 alkenone data set, S. Emerson, K. Kreutz, R. Dunbar, M. Maslin, R. Anderson, A. Newton, A. Pearson and A. Tudhope for discussions, and J. Sachs, O. Kawka and L. Truxal for assistance with alkenone measurements. This research used samples collected by the Ocean Drilling Program and the United States Antarctic Program. This research was supported by NSF grants OPP-0620099 (A. E. S. and A. E. I.) and OPP-0732467 (E.W.D.).	Anderson RF, 2009, SCIENCE, V323, P1443, DOI 10.1126/science.1167441; BARKER PF, 1999, P ODP INITIAL REPS, V178, pCH7; Bentley MJ, 2009, HOLOCENE, V19, P51, DOI 10.1177/0959683608096603; Conroy JL, 2008, QUATERNARY SCI REV, V27, P1166, DOI 10.1016/j.quascirev.2008.02.015; Cook AJ, 2005, SCIENCE, V308, P541, DOI 10.1126/science.1104235; Das SB, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD008790; Domack E, 2001, HOLOCENE, V11, P1, DOI 10.1191/095968301673881493; Gille ST, 2002, SCIENCE, V295, P1275, DOI 10.1126/science.1065863; Hall BL, 2010, GEOLOGY, V38, P635, DOI 10.1130/G30932.1; Huybers P, 2008, NAT GEOSCI, V1, P787, DOI 10.1038/ngeo311; Kaiser J, 2008, QUATERNARY SCI REV, V27, P2064, DOI 10.1016/j.quascirev.2008.08.025; Kim JH, 2008, GEOCHIM COSMOCHIM AC, V72, P1154, DOI 10.1016/j.gca.2007.12.010; Konneke M, 2005, NATURE, V437, P543, DOI 10.1038/nature03911; Laskar J, 2004, ASTRON ASTROPHYS, V428, P261, DOI 10.1051/0004-6361:20041335; Lubin D, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032170; Martinson DG, 2008, DEEP-SEA RES PT II, V55, P1964, DOI 10.1016/j.dsr2.2008.04.038; Mayewski PA, 2004, QUATERNARY RES, V62, P243, DOI 10.1016/j.yqres.2004.07.001; Monnin E, 2004, EARTH PLANET SC LETT, V224, P45, DOI 10.1016/j.epsl.2004.05.007; Moreno PI, 2010, GEOLOGY, V38, P727, DOI 10.1130/G30962.1; Murray AE, 1998, APPL ENVIRON MICROB, V64, P2585; Nielsen SHH, 2004, GEOLOGY, V32, P317, DOI 10.1130/G20334.1; Pahnke K, 2003, SCIENCE, V301, P948, DOI 10.1126/science.1084451; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Renssen H, 2005, HOLOCENE, V15, P951, DOI 10.1191/0959683605hl869ra; Schouten S, 2002, EARTH PLANET SC LETT, V204, P265, DOI 10.1016/S0012-821X(02)00979-2; Sjunneskog C, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2000PA000563; Stammerjohn SE, 2008, DEEP-SEA RES PT II, V55, P2041, DOI 10.1016/j.dsr2.2008.04.026; Steig EJ, 1998, SCIENCE, V282, P92, DOI 10.1126/science.282.5386.92; Steig EJ, 2009, NATURE, V457, P459, DOI 10.1038/nature07669; Stott L, 2004, NATURE, V431, P56, DOI 10.1038/nature02903; Wolff EW, 2009, NAT GEOSCI, V2, P206, DOI 10.1038/NGEO442; Yuan XJ, 2004, ANTARCT SCI, V16, P415, DOI 10.1017/S0954102004002238	32	143	150	3	94	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2011	470	7333					250	254		10.1038/nature09751	http://dx.doi.org/10.1038/nature09751			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307939				2022-12-28	WOS:000287144200042
J	McCartney, M				McCartney, Margaret			Medical Work Assessments Well enough to work?	BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				*AT OR, 2006, LIM EV BAS MED ACT; *CIT ADV SCOTL, 2010, WORK CAP ASS; *COMM SEL COMM, 2010, SUPP INC BEN CLAIM P; *FAC OCC MED, 2010, GOOD OCC MED PRACT; Harrington M., 2010, INDEPENDENT REV WORK; *MIND, 2010, NEW BEN WILL FAIL SP; [No title captured]	7	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2011	342								d599	10.1136/bmj.d599	http://dx.doi.org/10.1136/bmj.d599			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	718PU	21289006				2022-12-28	WOS:000287138300001
J	Lin, JS; Eder, M; Weinmann, S				Lin, Jennifer S.; Eder, Michelle; Weinmann, Sheila			Behavioral Counseling to Prevent Skin Cancer: A Systematic Review for the US Preventive Services Task Force	ANNALS OF INTERNAL MEDICINE			English	Article							CUTANEOUS MALIGNANT-MELANOMA; BASAL-CELL CARCINOMA; RANDOMIZED CONTROLLED-TRIAL; NON-HODGKIN-LYMPHOMA; RECEPTOR GENE POLYMORPHISMS; SUN PROTECTION BEHAVIORS; REGULAR SUNSCREEN USE; RISK-FACTORS; VITAMIN-D; ULTRAVIOLET-RADIATION	Background: More than 2 million cases of skin cancer are diagnosed annually in the United States, and melanoma incidence is increasing. Purpose: To assist the U.S. Preventive Services Task Force in updating its 2003 recommendation on behavioral counseling to prevent skin cancer. Data Sources: Existing systematic reviews, database searches through February 2010, and outside experts. Study Selection: English-language, primary care-relevant counseling trials to promote sun-protective behaviors and studies examining the association between sun-protective behaviors and skin cancer outcomes or potential adverse effects were included. Data Extraction: Each study was appraised by using design-specific quality criteria. Important study details were abstracted into evidence tables. Data Synthesis: 11 fair-or good-quality, randomized, controlled trials examined the counseling interventions' effect on sun-protective behaviors. In young women, appearance-focused behavioral interventions decrease indoor tanning and ultraviolet exposure. In young adolescents, computer support can decrease midday sun exposure and increase sunscreen use. Thirty-five mainly fair-quality observational studies examined the relationship between ultraviolet exposure or sunscreen use and skin cancer. Increasing intermittent sun exposure in childhood is associated with an increased risk for squamous cell carcinoma, basal cell carcinoma, and melanoma. Evidence suggests that regular or early use of indoor tanning may increase melanoma risk. On the basis of 1 fair-quality trial, regular sunscreen use can prevent squamous cell carcinoma, but it is yet unclear if it can prevent basal cell carcinoma or melanoma. Limitations: There are limited rigorous counseling trials. Observational studies are limited by the complexity of measuring ultraviolet exposure and sunscreen use, and inadequate adjustment for important confounders. Conclusion: Randomized, controlled trials suggest that primary care-relevant counseling can increase sun-protective behaviors and decrease indoor tanning.	[Lin, Jennifer S.] Kaiser Permanente NW, Ctr Hlth Res, Portland, OR 97227 USA	Kaiser Permanente	Lin, JS (corresponding author), Kaiser Permanente NW, Ctr Hlth Res, 3800 N Interstate Ave, Portland, OR 97227 USA.	jennifer.s.lin@kpchr.org			Oregon Evidence-based Practice Center [HHS-290-2007-10057-I]	Oregon Evidence-based Practice Center	By the Oregon Evidence-based Practice Center under contract to the Agency for Healthcare Research and Quality (contract HHS-290-2007-10057-I, task order 3).	ALTEKRUSE SF, 1975, SEER CANC STAT REV; American Cancer Society, SKIN CANC FACTS; Autier P, 2000, BRIT J CANCER, V83, P1243, DOI 10.1054/bjoc.2000.1429; Autier P, 1999, JNCI-J NATL CANCER I, V91, P1304, DOI 10.1093/jnci/91.15.1304; Autier P, 1999, LANCET, V354, P2163, DOI 10.1016/S0140-6736(05)77064-1; Autier P, 2007, INT J CANCER, V121, P1, DOI 10.1002/ijc.22745; Balk SJ, 2004, PEDIATRICS, V114, P1056, DOI 10.1542/peds.2004-1305; Bastuji-Garin S, 2002, BRIT J DERMATOL, V146, P24, DOI 10.1046/j.1365-2133.146.s61.9.x; Bataille W, 2005, EUR J CANCER, V41, P2141, DOI 10.1016/j.ejca.2005.04.038; Bauer J, 2005, INT J CANCER, V116, P755, DOI 10.1002/ijc.21081; Berwick M, 2006, FRONT BIOSCI-LANDMRK, V11, P1244, DOI 10.2741/1877; Berwick M, 1996, J NATL CANCER I, V88, P17, DOI 10.1093/jnci/88.1.17; Brot C, 2001, BRIT J NUTR, V86, pS97, DOI 10.1079/BJN2001345; Burgaz A, 2009, J INTERN MED, V266, P476, DOI 10.1111/j.1365-2796.2009.02125.x; Chang YM, 2009, INT J EPIDEMIOL, V38, P814, DOI 10.1093/ije/dyp166; Chen YC, 2010, CANCER CAUSE CONTROL, V21, P771, DOI 10.1007/s10552-010-9505-x; Chen YT, 1998, INT J EPIDEMIOL, V27, P758, DOI 10.1093/ije/27.5.758; Cho E, 2005, J CLIN ONCOL, V23, P2669, DOI 10.1200/JCO.2005.11.108; Clough-Gorr KM, 2008, CANCER CAUSE CONTROL, V19, P659, DOI 10.1007/s10552-008-9129-6; Coups EJ, 2008, AM J PREV MED, V34, P87, DOI 10.1016/j.amepre.2007.09.032; Crane LA, 2006, PREV MED, V42, P162, DOI 10.1016/j.ypmed.2005.11.007; Dennis LK, 2003, ANN INTERN MED, V139, P966, DOI 10.7326/0003-4819-139-12-200312160-00006; Dupuy A, 2005, ARCH DERMATOL, V141, P950, DOI 10.1001/archderm.141.8.950; Elwood JM, 1997, INT J CANCER, V73, P198, DOI 10.1002/(SICI)1097-0215(19971009)73:2<198::AID-IJC6>3.0.CO;2-R; English DR, 1998, INT J CANCER, V76, P628, DOI 10.1002/(SICI)1097-0215(19980529)76:5<628::AID-IJC3>3.0.CO;2-S; Fargnoli MC, 2004, MELANOMA RES, V14, P151, DOI 10.1097/00008390-200404000-00013; Gallagher R P, 1986, Recent Results Cancer Res, V102, P38; Gallagher RDP, 2000, JAMA-J AM MED ASSOC, V283, P2955, DOI 10.1001/jama.283.22.2955; Gallagher RP, 2005, CANCER EPIDEM BIOMAR, V14, P562, DOI 10.1158/1055-9965.EPI-04-0564; GALLAGHER RP, 1995, ARCH DERMATOL, V131, P164, DOI 10.1001/archderm.131.2.164; GALLAGHER RP, 1995, ARCH DERMATOL, V131, P157, DOI 10.1001/archderm.131.2.157; Gandini S, 2005, EUR J CANCER, V41, P2040, DOI 10.1016/j.ejca.2005.03.034; Gandini S, 2005, EUR J CANCER, V41, P45, DOI 10.1016/j.ejca.2004.10.016; Gandini S, 2005, EUR J CANCER, V41, P28, DOI 10.1016/j.ejca.2004.10.015; GARBE C, 1989, INT J DERMATOL, V28, P517, DOI 10.1111/j.1365-4362.1989.tb04604.x; Gefeller O, 2002, PHOTODERMATOL PHOTO, V18, P153, DOI 10.1034/j.1600-0781.2002.180310.x; Geller AC, 2002, PEDIATRICS, V109, P1009, DOI 10.1542/peds.109.6.1009; Geller AC, 2006, CANCER-AM CANCER SOC, V107, P806, DOI 10.1002/cncr.22050; Glanz K, 2008, ARCH DERMATOL, V144, P217, DOI 10.1001/archdermatol.2007.46; Glanz K, 2010, AM J PUBLIC HEALTH, V100, P735, DOI 10.2105/AJPH.2008.155705; Glazebrook C, 2006, PREV MED, V42, P449, DOI 10.1016/j.ypmed.2006.02.007; Gorham ED, 2007, ANN EPIDEMIOL, V17, P956, DOI 10.1016/j.annepidem.2007.06.008; Grant WB, 2007, J STEROID BIOCHEM, V103, P668, DOI 10.1016/j.jsbmb.2006.12.030; Green A, 1999, LANCET, V354, P723, DOI 10.1016/S0140-6736(98)12168-2; GREEN A, 1994, CONTROL CLIN TRIALS, V15, P512, DOI 10.1016/0197-2456(94)90008-6; Green A, 1996, AM J EPIDEMIOL, V144, P1034, DOI 10.1093/oxfordjournals.aje.a008875; GREEN AC, 1985, J NATL CANCER I, V74, P977; Green A, 2007, INT J CANCER, V120, P1116, DOI 10.1002/ijc.22453; Gritz ER, 2003, PEDIATR DERMATOL, V20, P16, DOI 10.1046/j.1525-1470.2003.03004.x; GRODSTEIN F, 1995, J NATL CANCER I, V87, P1061, DOI 10.1093/jnci/87.14.1061; Han JL, 2006, INT J EPIDEMIOL, V35, P1514, DOI 10.1093/ije/dyl197; Hartge P, 2006, CANCER CAUSE CONTROL, V17, P1045, DOI 10.1007/s10552-006-0040-8; Helfand M, 2003, AHRQ PUB B; Hillhouse J, 2008, CANCER-AM CANCER SOC, V113, P3257, DOI 10.1002/cncr.23922; HOLLY EA, 1995, AM J EPIDEMIOL, V141, P923, DOI 10.1093/oxfordjournals.aje.a117359; Hornung RL, 2007, PEDIATR DERMATOL, V24, P108, DOI 10.1111/j.1525-1470.2007.00353.x; Hughes AM, 2004, INT J CANCER, V110, P429, DOI 10.1002/ijc.20128; Hughes AM, 2004, INT J CANCER, V112, P865, DOI 10.1002/ijc.20470; Huncharek M, 2002, AM J PUBLIC HEALTH, V92, P1173, DOI 10.2105/AJPH.92.7.1173; Hunter David J., 1990, Annals of Epidemiology, V1, P13; IARC Working Group, 2008, IARC WORK GROUP REP, V5; IARC Working Group Reports, 1992, IARC MON EV CARC RIS, V55; John EM, 2005, CANCER RES, V65, P5470, DOI 10.1158/0008-5472.CAN-04-3134; John EM, 1999, CANCER EPIDEM BIOMAR, V8, P399; John EM, 2007, AM J EPIDEMIOL, V166, P1409, DOI 10.1093/aje/kwm259; Kampman E, 2000, CANCER CAUSE CONTROL, V11, P459, DOI 10.1023/A:1008914108739; Karagas MR, 2002, J NATL CANCER I, V94, P224, DOI 10.1093/jnci/94.3.224; Kasparian NA, 2009, J BEHAV MED, V32, P406, DOI 10.1007/s10865-009-9219-2; Koepsell T. D, 2003, EPIDEMIOLOGIC METHOD; KRICKER A, 1995, INT J CANCER, V60, P482, DOI 10.1002/ijc.2910600410; KRICKER A, 1991, INT J CANCER, V48, P650, DOI 10.1002/ijc.2910480504; KRICKER A, 1995, INT J CANCER, V60, P489, DOI 10.1002/ijc.2910600411; Lazovich D, 2008, ARCH DERMATOL, V144, P225, DOI 10.1001/archdermatol.2007.45; Le Marchand L, 2006, AM J EPIDEMIOL, V164, P232, DOI 10.1093/aje/kwj115; Lin J.S., 2011, AHRQ PUBLICATION; Linos E, 2009, J INVEST DERMATOL, V129, P1666, DOI 10.1038/jid.2008.423; Mahler HIM, 2007, HEALTH PSYCHOL, V26, P350, DOI 10.1037/0278-6133.26.3.350; Markovic SN, 2007, MAYO CLIN PROC, V82, P364; MARKS R, 1995, ARCH DERMATOL, V131, P415, DOI 10.1001/archderm.131.4.415; Milne E, 2007, AM J PUBLIC HEALTH, V97, P306, DOI 10.2105/AJPH.2005.080499; Nagore E, 2010, J EUR ACAD DERMATOL, V24, P50, DOI 10.1111/j.1468-3083.2009.03353.x; Neale RE, 2007, J AM ACAD DERMATOL, V56, P380, DOI 10.1016/j.jaad.2006.08.039; NELEMANS PJ, 1995, J CLIN EPIDEMIOL, V48, P1331, DOI 10.1016/0895-4356(95)00032-1; Norman GJ, 2007, ARCH PEDIAT ADOL MED, V161, P146, DOI 10.1001/archpedi.161.2.146; Oliveria SA, 2006, ARCH DIS CHILD, V91, P131, DOI 10.1136/adc.2005.086918; OSTERLIND A, 1988, INT J CANCER, V42, P319, DOI 10.1002/ijc.2910420303; Pandeya N, 2005, AM J EPIDEMIOL, V161, P748, DOI 10.1093/aje/kwi098; Parr CL, 2009, AM J EPIDEMIOL, V169, P257, DOI 10.1093/aje/kwn363; Patrick K, 2006, ARCH PEDIAT ADOL MED, V160, P128, DOI 10.1001/archpedi.160.2.128; Prochaska JO, 2005, PREV MED, V41, P406, DOI 10.1016/j.ypmed.2004.09.050; Prochaska JO, 2004, HEALTH PSYCHOL, V23, P503, DOI 10.1037/0278-6133.23.5.503; Purdue MP, 2008, J INVEST DERMATOL, V128, P2905, DOI 10.1038/jid.2008.159; Rosenberg DE, 2007, J ADOLESCENT HEALTH, V41, P472, DOI 10.1016/j.jadohealth.2007.05.018; Rosso S, 1998, MELANOMA RES, V8, P573, DOI 10.1097/00008390-199812000-00013; Rosso S, 1999, TUMORI, V85, P435, DOI 10.1177/030089169908500603; Saraiya M, 2004, AM J PREV MED, V27, P422, DOI 10.1016/j.amepre.2004.08.009; Shors AR, 2001, CANCER CAUSE CONTROL, V12, P599, DOI 10.1023/A:1011211615524; Smedby KE, 2005, JNCI-J NATL CANCER I, V97, P199, DOI 10.1093/jnci/dji022; Stapleton J, 2010, J BEHAV MED, V33, P181, DOI 10.1007/s10865-009-9246-z; Tabenkin M, 1999, ISRAEL MED ASSOC J, V1, P154; Turrisi R, 2008, ARCH DERMATOL, V144, P1521, DOI 10.1001/archderm.144.11.1521; US Preventive Services Task Force, 2008, AHRQ PUBL; van Dam RM, 1999, AM J EPIDEMIOL, V150, P459, DOI 10.1093/oxfordjournals.aje.a010034; van der Pols JC, 2006, CANCER EPIDEM BIOMAR, V15, P2546, DOI 10.1158/1055-9965.EPI-06-0352; Veierod MB, 2010, CANCER EPIDEM BIOMAR, V19, P111, DOI 10.1158/1055-9965.EPI-09-0567; Vlajinac HD, 2000, ACTA ONCOL, V39, P611; Walter SD, 1999, INT J EPIDEMIOL, V28, P418, DOI 10.1093/ije/28.3.418; WEINSTOCK MA, 1991, AM J EPIDEMIOL, V134, P462, DOI 10.1093/oxfordjournals.aje.a116117; Wells G., NEWCASTLE OTTAWA SCA; Westerdahl J, 2000, INT J CANCER, V87, P145, DOI 10.1002/1097-0215(20000701)87:1<145::AID-IJC22>3.0.CO;2-3; WESTERDAHL J, 1995, MELANOMA RES, V5, P59, DOI 10.1097/00008390-199502000-00007; Westerdahl J, 2000, BRIT J CANCER, V82, P1593; WESTERDAHL J, 1994, EUR J CANCER, V30A, P1647, DOI 10.1016/0959-8049(94)00337-5; WHITE E, 1994, AM J EPIDEMIOL, V139, P857, DOI 10.1093/oxfordjournals.aje.a117092; Worswick SD, 2008, PHOTOCHEM PHOTOBIOL, V84, P1462, DOI 10.1111/j.1751-1097.2008.00367.x; ZANETTI R, 1992, EUR J CANCER, V28A, P1172, DOI 10.1016/0959-8049(92)90480-P	116	99	100	0	28	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2011	154	3					190	+		10.7326/0003-4819-154-3-201102010-00009	http://dx.doi.org/10.7326/0003-4819-154-3-201102010-00009			24	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	713HY	21282699				2022-12-28	WOS:000286729200007
J	Fleming, DG; Arseneau, DJ; Sukhorukov, O; Brewer, JH; Mielke, SL; Schatz, GC; Garrett, BC; Peterson, KA; Truhlar, DG				Fleming, Donald G.; Arseneau, Donald J.; Sukhorukov, Oleksandr; Brewer, Jess H.; Mielke, Steven L.; Schatz, George C.; Garrett, Bruce C.; Peterson, Kirk A.; Truhlar, Donald G.			Kinetic Isotope Effects for the Reactions of Muonic Helium and Muonium with H-2	SCIENCE			English	Article							TRANSITION-STATE THEORY; POTENTIAL-ENERGY SURFACES; ATOM TRANSFER-REACTIONS; RATE CONSTANTS; HYDROGEN; APPROXIMATION; DYNAMICS; TESTS	The neutral muonic helium atom may be regarded as the heaviest isotope of the hydrogen atom, with a mass of similar to 4.1 atomic mass units (H-4.1), because the negative muon almost perfectly screens one proton charge. We report the reaction rate of H-4.1 with H-1(2) to produce (HH)-H-4.1-H-1 + H-1 at 295 to 500 kelvin. The experimental rate constants are compared with the predictions of accurate quantum-mechanical dynamics calculations carried out on an accurate Born-Huang potential energy surface and with previously measured rate constants of H-0.11 (where H-0.11 is shorthand for muonium). Kinetic isotope effects can be compared for the unprecedentedly large mass ratio of 36. The agreement with accurate quantum dynamics is quantitative at 500 kelvin, and variational transition-state theory is used to interpret the extremely low (large inverse) kinetic isotope effects in the 10(-4) to 10(-2) range.	[Fleming, Donald G.; Arseneau, Donald J.; Sukhorukov, Oleksandr] Univ British Columbia, TRIUMF, Vancouver, BC V6T 1Z1, Canada; [Fleming, Donald G.; Arseneau, Donald J.; Sukhorukov, Oleksandr] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada; [Sukhorukov, Oleksandr] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Brewer, Jess H.] Univ British Columbia, Dept Phys, Vancouver, BC V6T 1Z1, Canada; [Mielke, Steven L.; Truhlar, Donald G.] Univ Minnesota, Dept Chem, Minneapolis, MN 55455 USA; [Mielke, Steven L.; Truhlar, Donald G.] Univ Minnesota, Inst Supercomp, Minneapolis, MN 55455 USA; [Schatz, George C.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Garrett, Bruce C.] Pacific NW Natl Lab, Div Chem & Mat Sci, Richland, WA 99352 USA; [Peterson, Kirk A.] Washington State Univ, Dept Chem, Pullman, WA 99164 USA	University of British Columbia; University of British Columbia; University of Alberta; University of British Columbia; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Northwestern University; United States Department of Energy (DOE); Pacific Northwest National Laboratory; Washington State University	Fleming, DG (corresponding author), Univ British Columbia, TRIUMF, Vancouver, BC V6T 1Z1, Canada.	flem@triumf.ca; truhlar@umn.edu	Brewer, Jess H./B-2737-2013; Schatz, George C./ABF-1341-2020; Garrett, Bruce C/F-8516-2011; Peterson, Kirk A/HCH-8734-2022; Truhlar, Donald G./G-7076-2015; Mielke, Steven L/B-7533-2008	Brewer, Jess H./0000-0002-8211-1235; Truhlar, Donald G./0000-0002-7742-7294; Mielke, Steven L/0000-0002-1938-7503; Arseneau, Donald/0000-0002-0011-9592	Natural Sciences and Engineering Research Council of Canada; Office of Basic Energy Sciences of the U.S. Department of Energy (DOE); Air Force Office of Scientific Research	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Office of Basic Energy Sciences of the U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	We thank the Natural Sciences and Engineering Research Council of Canada, the Office of Basic Energy Sciences of the U.S. Department of Energy (DOE), and the Air Force Office of Scientific Research for their support of this work. Battelle operates the Pacific Northwest National Laboratory for DOE.	Arrhenius S., 1889, Z PHYS CHEM, V4U, P226, DOI [10.1515/zpch-1889-0416, DOI 10.1515/ZPCH-1889-0416]; Arseneau DJ, 2009, PHYSICA B, V404, P946, DOI 10.1016/j.physb.2008.11.130; Audi G, 2003, NUCL PHYS A, V729, P3, DOI 10.1016/j.nuclphysa.2003.11.001; BAER S, 1992, ACS SYM SER, V502, P111; Bernasconi C. F., 1986, INVESTIGATION RATES; BLAIS NC, 1981, J PHYS CHEM-US, V85, P1094, DOI 10.1021/j150609a003; Born M, 1927, ANN PHYS-BERLIN, V84, P0457; Born M., 1954, DYNAMICAL THEORY CRY; CHATFIELD DC, 1991, FARADAY DISCUSS, V91, P289, DOI 10.1039/dc9919100289; CHATFIELD DC, 1992, J PHYS CHEM-US, V96, P2414, DOI 10.1021/j100185a007; Dybala-Defratyka A, 2007, P NATL ACAD SCI USA, V104, P10774, DOI 10.1073/pnas.0702188104; Espinosa-Garcia J, 2008, PHYS CHEM CHEM PHYS, V10, P1277, DOI 10.1039/b714489j; GARRETT BC, 1983, J CHEM PHYS, V79, P4931, DOI 10.1063/1.445586; GARRETT BC, 1980, J PHYS CHEM-US, V84, P1730, DOI 10.1021/j100450a013; GARRETT BC, 1991, J PHYS CHEM-US, V95, P10374, DOI 10.1021/j100178a025; GARRETT BC, 1984, J CHEM PHYS, V81, P309, DOI 10.1063/1.447386; GARRETT BC, 1986, HYPERFINE INTERACT, V32, P779, DOI 10.1007/BF02394985; GARRETT BC, 1986, J AM CHEM SOC, V108, P3515, DOI 10.1021/ja00272a061; Kohen A., 2006, ISOTOPE EFFECTS CHEM; MARCUS RA, 1964, J CHEM PHYS, V41, P610, DOI 10.1063/1.1725935; Meana-Paneda R, 2010, J CHEM THEORY COMPUT, V6, P6, DOI 10.1021/ct900420e; MICHAEL JV, 1993, ANNU REV PHYS CHEM, V44, P429; Mielke SL, 2002, J CHEM PHYS, V116, P4142, DOI 10.1063/1.1432319; Mielke SL, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.063201; Mielke SL, 2009, J PHYS CHEM A, V113, P4479, DOI 10.1021/jp8110887; REID ID, 1987, J CHEM PHYS, V86, P5578, DOI 10.1063/1.452530; Senba M, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.042708; SOUDER PA, 1980, PHYS REV A, V22, P33, DOI 10.1103/PhysRevA.22.33; SUN Y, 1990, PHYS REV A, V41, P4857, DOI 10.1103/PhysRevA.41.4857; Tanaka T, 2010, CHEM PHYS LETT, V496, P248, DOI 10.1016/j.cplett.2010.07.070; TRUHLAR DG, 1971, J AM CHEM SOC, V93, P1840; TRUHLAR DG, 1980, ACCOUNTS CHEM RES, V13, P440, DOI 10.1021/ar50156a002; WALKER DC, 1981, J PHYS CHEM-US, V85, P3960, DOI 10.1021/j150626a003	33	74	75	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2011	331	6016					448	450		10.1126/science.1199421	http://dx.doi.org/10.1126/science.1199421			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273484				2022-12-28	WOS:000286635900049
J	Okazaki, R; Shibauchi, T; Shi, HJ; Haga, Y; Matsuda, TD; Yamamoto, E; Onuki, Y; Ikeda, H; Matsuda, Y				Okazaki, R.; Shibauchi, T.; Shi, H. J.; Haga, Y.; Matsuda, T. D.; Yamamoto, E.; Onuki, Y.; Ikeda, H.; Matsuda, Y.			Rotational Symmetry Breaking in the Hidden-Order Phase of URu2Si2	SCIENCE			English	Article							ELECTRON SUPERCONDUCTOR URU2SI2; FERMION SYSTEM URU2SI2; EXCITATIONS; SURFACE	A second-order phase transition is characterized by spontaneous symmetry breaking. The nature of the broken symmetry in the so-called "hidden-order" phase transition in the heavy-fermion compound URu2Si2, at transition temperature T-h = 17.5 K, has posed a long-standing mystery. We report the emergence of an in-plane anisotropy of the magnetic susceptibility below T-h, which breaks the four-fold rotational symmetry of the tetragonal URu2Si2. Two-fold oscillations in the magnetic torque under in-plane field rotation were sensitively detected in small pure crystals. Our findings suggest that the hidden-order phase is an electronic "nematic" phase, a translationally invariant metallic phase with spontaneous breaking of rotational symmetry.	[Okazaki, R.; Shibauchi, T.; Shi, H. J.; Ikeda, H.; Matsuda, Y.] Kyoto Univ, Dept Phys, Kyoto 6068502, Japan; [Haga, Y.; Matsuda, T. D.; Yamamoto, E.; Onuki, Y.] Japan Atom Energy Agcy, Adv Sci Res Ctr, Tokai, Ibaraki 3191195, Japan; [Onuki, Y.] Osaka Univ, Grad Sch Sci, Osaka 5600043, Japan	Kyoto University; Japan Atomic Energy Agency; Osaka University	Shibauchi, T (corresponding author), Kyoto Univ, Dept Phys, Kyoto 6068502, Japan.	shibauchi@scphys.kyoto-u.ac.jp	Haga, Yoshinori/C-7679-2011; Hiroaki, Ikeda/F-2635-2018; Matsuda, Tatsuma D/R-3494-2017; Okazaki, Ryuji/D-6902-2011; Matsuda, Yuji/ABH-7166-2020; Shibauchi, Takasada/B-9349-2008	Haga, Yoshinori/0000-0002-4605-5117; Okazaki, Ryuji/0000-0001-5234-4110; Matsuda, Yuji/0000-0001-9947-9418; Shibauchi, Takasada/0000-0001-5831-4924; Matsuda, Tatsuma/0000-0003-3805-5165; Ikeda, Hiroaki/0000-0002-9258-9478	Ministry of Education, Culture, Sports, Science Technology [20102002, 20102006]; Japan Society for the Promotion of Science; Grants-in-Aid for Scientific Research [23654118] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank D. F. Agterberg, A. V. Balatsky, A. Buzdin, H. Harima, R. Ikeda, K. Ishida, Y. Kohori, T. Sakakibara, A. Schofield, H. Shishido, M. Sigrist, T. Takimoto, A. Tanaka, P. Thalmeier, and Y. Yanase for helpful discussions. Supported by Grant-in-Aid for the Global COE program "The Next Generation of Physics, Spun from Universality and Emergence," Grant-in-Aid for Scientific Research on Innovative Areas "Heavy Electrons" (20102002, 20102006) from the Ministry of Education, Culture, Sports, Science & Technology, and Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science.	Amitsuka H, 2007, J MAGN MAGN MATER, V310, P214, DOI 10.1016/j.jmmm.2006.10.008; Behnia K, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.156405; Bernal OO, 2006, PHYSICA B, V378-80, P574, DOI 10.1016/j.physb.2006.01.547; Bernal OO, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.196402; Borzi RA, 2007, SCIENCE, V315, P214, DOI 10.1126/science.1134796; BROHOLM C, 1987, PHYS REV LETT, V58, P1467, DOI 10.1103/PhysRevLett.58.1467; Chandra P, 2002, NATURE, V417, P831, DOI 10.1038/nature00795; Cricchio F, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.107202; DELMORAL A, 1984, J MAGN MAGN MATER, V40, P331, DOI 10.1016/0304-8853(84)90326-3; Elgazzar S, 2009, NAT MATER, V8, P337, DOI [10.1038/nmat2395, 10.1038/NMAT2395]; Fradkin E, 2010, ANNU REV CONDEN MA P, V1, P153, DOI 10.1146/annurev-conmatphys-070909-103925; Harima H, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.033705; Haule K, 2009, NAT PHYS, V5, P796, DOI 10.1038/NPHYS1392; Ikeda H, 1998, PHYS REV LETT, V81, P3723, DOI 10.1103/PhysRevLett.81.3723; Kasahara Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.116402; Kiss A, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.054415; MAPLE MB, 1986, PHYS REV LETT, V56, P185, DOI 10.1103/PhysRevLett.56.185; Matsuda K, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.087203; Mineev VP, 2005, PHYS REV B, V72, DOI 10.1103/PhysRevB.72.014432; Okazaki R, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.084705; PALSTRA TTM, 1985, PHYS REV LETT, V55, P2727, DOI 10.1103/PhysRevLett.55.2727; RAMIREZ AP, 1992, PHYS REV LETT, V68, P2680, DOI 10.1103/PhysRevLett.68.2680; SANTINI P, 1994, PHYS REV LETT, V73, P1027, DOI 10.1103/PhysRevLett.73.1027; SCHOENES J, 1987, PHYS REV B, V35, P5375, DOI 10.1103/PhysRevB.35.5375; Shannon N, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.027213; Takagi S, 2007, J PHYS SOC JPN, V76, DOI 10.1143/JPSJ.76.033708; Varma CM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.036405; Vojta M, 2009, ADV PHYS, V58, P699, DOI 10.1080/00018730903122242; Wiebe CR, 2007, NAT PHYS, V3, P96, DOI 10.1038/nphys522	29	200	200	1	97	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					439	442		10.1126/science.1197358	http://dx.doi.org/10.1126/science.1197358			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273481	Green Submitted			2022-12-28	WOS:000286635900046
J	Munk-Olsen, T; Laursen, TM; Pedersen, CB; Lidegaard, O; Mortensen, PB				Munk-Olsen, Trine; Laursen, Thomas Munk; Pedersen, Carsten B.; Lidegaard, Ojvind; Mortensen, Preben Bo			Induced First-Trimester Abortion and Risk of Mental Disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEPRESSION; PREGNANCY; WOMEN; REGISTER; HOSPITALIZATION; FAMILY	BACKGROUND Concern has been expressed about potential harm to women's mental health in association with having an induced abortion, but it remains unclear whether induced abortion is associated with an increased risk of subsequent psychiatric problems. METHODS We conducted a population-based cohort study that involved linking information from the Danish Civil Registration system to the Danish Psychiatric Central Register and the Danish National Register of Patients. The information consisted of data for girls and women with no record of mental disorders during the 1995-2007 period who had a first-trimester induced abortion or a first childbirth during that period. We estimated the rates of first-time psychiatric contact (an inpatient admission or outpatient visit) for any type of mental disorder within the 12 months after the abortion or childbirth as compared with the 9-month period preceding the event. RESULTS The incidence rates of first psychiatric contact per 1000 person-years among girls and women who had a first abortion were 14.6 (95% confidence interval [CI], 13.7 to 15.6) before abortion and 15.2 (95% CI, 14.4 to 16.1) after abortion. The corresponding rates among girls and women who had a first childbirth were 3.9 (95% CI, 3.7 to 4.2) before delivery and 6.7 (95% CI, 6.4 to 7.0) post partum. The relative risk of a psychiatric contact did not differ significantly after abortion as compared with before abortion (P=0.19) but did increase after childbirth as compared with before childbirth (P<0.001). CONCLUSIONS The finding that the incidence rate of psychiatric contact was similar before and after a first-trimester abortion does not support the hypothesis that there is an increased risk of mental disorders after a first-trimester induced abortion.	[Munk-Olsen, Trine; Laursen, Thomas Munk; Pedersen, Carsten B.; Mortensen, Preben Bo] Aarhus Univ, Natl Ctr Register Based Res, Aarhus, Denmark; [Lidegaard, Ojvind] Univ Copenhagen, Rigshosp, Juliane Marie Ctr, Gynecol Clin, DK-2100 Copenhagen, Denmark	Aarhus University; Rigshospitalet; University of Copenhagen	Munk-Olsen, T (corresponding author), Univ Aarhus, Natl Ctr Register Based Res, Taasingegade 1, DK-8000 Aarhus C, Denmark.	tmo@ncrr.dk	Pedersen, Carsten Bøcker/B-8441-2013; Munk-olsen, Trine/AAS-3546-2021; Mortensen, Preben B/D-2358-2015; Laursen, Thomas Munk/AFQ-8066-2022	Pedersen, Carsten Bøcker/0000-0003-2077-8533; Munk-olsen, Trine/0000-0002-0786-7147; Mortensen, Preben B/0000-0002-5230-9865; Laursen, Thomas Munk/0000-0001-6934-1784	Susan Thompson Buffett Foundation; Danish Medical Research Council [09-063642/FSS]; Bayer Schering Pharma	Susan Thompson Buffett Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bayer Schering Pharma(Bayer AG)	Supported by grants from the Susan Thompson Buffett Foundation (to Dr. Munk-Olsen and Dr. Laursen) and the Danish Medical Research Council (09-063642/FSS, to Dr. Munk-Olsen).; Dr. Lidegaard reports receiving lecture fees and research funding from Bayer Schering Pharma. No other potential conflict of interest relevant to this article was reported.	Andersen P. K., 2012, STAT MODELS BASED CO; Andersen TF, 1999, DAN MED BULL, V46, P263; [Anonymous], 2007, LEGALT PROVOKEREDE A; Casey P, 2008, BRIT J PSYCHIAT, V193, P452, DOI 10.1192/bjp.bp.108.059550; Charles VE, 2008, CONTRACEPTION, V78, P436, DOI 10.1016/j.contraception.2008.07.005; Cohen LS, 2006, JAMA-J AM MED ASSOC, V295, P499, DOI 10.1001/jama.295.5.499; Coleman PK, 2009, J PSYCHIATR RES, V43, P770, DOI 10.1016/j.jpsychires.2008.10.009; DAGG PKB, 1991, AM J PSYCHIAT, V148, P578; Danish National Board of Health. Classification of Diseases, 1971, CLASS DIS EXT DAN LA; Dwyer Judith M, 2008, Aust New Zealand Health Policy, V5, P2, DOI 10.1186/1743-8462-5-2; Fergusson DM, 2009, BRIT J PSYCHIAT, V194, P377, DOI 10.1192/bjp.194.4.377b; Fergusson DM, 2008, BRIT J PSYCHIAT, V193, P444, DOI 10.1192/bjp.bp.108.056499; Fergusson DM, 2006, J CHILD PSYCHOL PSYC, V47, P16, DOI 10.1111/j.1469-7610.2005.01538.x; Gale S, 2003, J PSYCHOSOM OBST GYN, V24, P257, DOI 10.3109/01674820309074690; GILCHRIST AC, 1995, BRIT J PSYCHIAT, V167, P243, DOI 10.1192/bjp.167.2.243; Harlow BL, 2007, ARCH GEN PSYCHIAT, V64, P42, DOI 10.1001/archpsyc.64.1.42; Jakobsen KD, 2005, NORD J PSYCHIAT, V59, P209, DOI 10.1080/08039480510027698; Jones I, 2001, AM J PSYCHIAT, V158, P913, DOI 10.1176/appi.ajp.158.6.913; Jones I, 2008, ARCH GEN PSYCHIAT, V65, P356, DOI 10.1001/archpsyc.65.3.356-a; KENDELL RE, 1987, BRIT J PSYCHIAT, V150, P662, DOI 10.1192/bjp.150.5.662; KENDELL RE, 1987, BRIT J PSYCHIAT, V151, P135; KENDLER KS, 1990, PSYCHOL MED, V20, P311, DOI 10.1017/S0033291700017621; Kessing LV, 1998, EUR PSYCHIAT, V13, P392, DOI 10.1016/S0924-9338(99)80685-3; LAIRD N, 1981, J AM STAT ASSOC, V76, P231, DOI 10.2307/2287816; Laursen TM, 2005, ARCH GEN PSYCHIAT, V62, P841, DOI 10.1001/archpsyc.62.8.841; Lazzarini Z, 2008, NEW ENGL J MED, V359, P2189, DOI 10.1056/NEJMp0806742; Major B, 2000, ARCH GEN PSYCHIAT, V57, P777, DOI 10.1001/archpsyc.57.8.777; Major B, 2009, AM PSYCHOL, V64, P863, DOI 10.1037/a0017497; Munk-Olsen T, 2007, J CLIN PSYCHIAT, V68, P1947, DOI 10.4088/JCP.v68n1217; Munk-Olsen T, 2006, JAMA-J AM MED ASSOC, V296, P2582, DOI 10.1001/jama.296.21.2582; Munk-Olsen T, 2009, ARCH GEN PSYCHIAT, V66, P189, DOI 10.1001/archgenpsychiatry.2008.528; MunkJorgensen P, 1997, DAN MED BULL, V44, P82; OHara MW, 1996, INT REV PSYCHIATR, V8, P37, DOI 10.3109/09540269609037816; Pedersen CB, 2006, DAN MED BULL, V53, P441; Pedersen W, 2008, SCAND J PUBLIC HEALT, V36, P424, DOI 10.1177/1403494807088449; Reardon DC, 2002, BRIT MED J, V324, P151, DOI 10.1136/bmj.324.7330.151; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Schmiege S, 2005, BMJ-BRIT MED J, V331, P1303, DOI 10.1136/bmj.38623.532384.55; Steinberg JR, 2009, CONTRACEPTION, V79, P81, DOI 10.1016/j.contraception.2008.10.011; Thorp JM, 2003, OBSTET GYNECOL SURV, V58, P67, DOI 10.1097/00006254-200301000-00023; World Health Organization, 1994, WHO ICD 10 MENT BEH	41	108	109	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2011	364	4					332	339		10.1056/NEJMoa0905882	http://dx.doi.org/10.1056/NEJMoa0905882			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711LH	21268725				2022-12-28	WOS:000286592600008
J	Boltasseva, A; Atwater, HA				Boltasseva, Alexandra; Atwater, Harry A.			Low-Loss Plasmonic Metamaterials	SCIENCE			English	Editorial Material							INDEX; LIGHT		[Boltasseva, Alexandra] Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA; [Boltasseva, Alexandra] Purdue Univ, Birck Nanotechnol Ctr, W Lafayette, IN 47907 USA; [Atwater, Harry A.] CALTECH, Appl Phys & Kavli Nanosci Inst, Pasadena, CA 91125 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; California Institute of Technology	Boltasseva, A (corresponding author), Purdue Univ, Sch Elect & Comp Engn, W Lafayette, IN 47907 USA.	aeb@purdue.edu; haa@caltech.edu	Atwater, Harry A/H-2823-2014; Boltasseva, Alexandra/C-1674-2019	Atwater, Harry A/0000-0001-9435-0201; Boltasseva, Alexandra/0000-0001-8905-2605	ONR-MURI [N00014-10-1-0942]; U.S. Department of Energy [FG02-07ER46405]; AFOSR [FA9550-09 1 0673]	ONR-MURI(MURIOffice of Naval Research); U.S. Department of Energy(United States Department of Energy (DOE)); AFOSR(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	A.B. acknowledges support from ONR-MURI grant N00014-10-1-0942. H.A.A. acknowledges support from the U.S. Department of Energy under grant DOE DE-FG02-07ER46405 and AFOSR under grant FA9550-09 1 0673	Atwater HA, 2010, NAT MATER, V9, P205, DOI [10.1038/nmat2629, 10.1038/NMAT2629]; Blaber MG, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/14/144211; Bobb DA, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3237179; Engheta N, 2010, PHYS WORLD, V23, P31; Feigenbaum E, 2010, NANO LETT, V10, P2111, DOI 10.1021/nl1006307; Hoffman AJ, 2007, NAT MATER, V6, P946, DOI 10.1038/nmat2033; Jablan M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.245435; Jacob Z, 2006, OPT EXPRESS, V14, P8247, DOI 10.1364/OE.14.008247; Khurgin JB, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3425890; Lal S, 2007, NAT PHOTONICS, V1, P641, DOI 10.1038/nphoton.2007.223; Papasimakis N, 2010, OPT EXPRESS, V18, P8353, DOI 10.1364/OE.18.008353; Pendry JB, 2006, SCIENCE, V312, P1780, DOI 10.1126/science.1125907; Shalaev VM, 2008, SCIENCE, V322, P384, DOI 10.1126/science.1166079; Soukoulis CM, 2007, SCIENCE, V315, P47, DOI 10.1126/science.1136481; Taubner T, 2006, SCIENCE, V313, P1595, DOI 10.1126/science.1131025; West PR, 2010, LASER PHOTONICS REV, V4, P795, DOI 10.1002/lpor.200900055; Xiao SM, 2010, NATURE, V466, P735, DOI 10.1038/nature09278	17	1108	1135	20	522	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2011	331	6015					290	291		10.1126/science.1198258	http://dx.doi.org/10.1126/science.1198258			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252335				2022-12-28	WOS:000286636300023
J	Nalls, MA; Plagnol, V; Hernandez, DG; Sharma, M; Sheerin, UM; Saad, M; Simon-Sanchez, J; Schulte, C; Lesage, S; Sveinbjornsdottir, S; Arepalli, S; Barker, R; Ben-Shlomo, Y; Berendse, HW; Berg, D; Bhatia, K; de Bie, RMA; Biffi, A; Bloem, B; Bochdanovits, Z; Bonin, M; Bras, JM; Brockmann, K; Brooks, J; Burn, DJ; Charlesworth, G; Chen, HL; Chinnery, PF; Chong, S; Clarke, CE; Cookson, MR; Cooper, JM; Corvol, JC; Counsell, C; Damier, P; Dartigues, JF; Deloukas, P; Deuschl, G; Dexter, DT; van Dijk, KD; Dillman, A; Durif, F; Durr, A; Edkins, S; Evans, JR; Foltynie, T; Gao, JJ; Gardner, M; Gibbs, JR; Goate, A; Gray, E; Guerreiro, R; Gustafsson, O; Harris, C; van Hilten, JJ; Hofman, A; Hollenbeck, A; Holton, J; Hu, M; Huang, XM; Huber, H; Hudson, G; Hunt, SE; Huttenlocher, J; Illig, T; Jonsson, PV; Lambert, JC; Langford, C; Lees, A; Lichtner, P; Limousin, P; Lopez, G; Lorenz, D; McNeill, A; Moorby, C; Moore, M; Morris, HR; Morrison, KE; Mudanohwo, E; O'Sullivan, SS; Pearson, J; Perlmutter, JS; Petursson, H; Pollak, P; Post, B; Potter, S; Ravina, B; Revesz, T; Riess, O; Rivadeneira, F; Rizzu, P; Ryten, M; Sawcer, S; Schapira, A; Scheffer, H; Shaw, K; Shoulson, I; Sidransky, E; Smith, C; Spencer, CCA; Stefansson, H; Stockton, JD; Strange, A; Talbot, K; Tanner, CM; Tashakkori-Ghanbaria, A; Tison, F; Trabzuni, D; Traynor, BJ; Uitterlinden, AG; Velseboer, D; Vidailhet, M; Walker, R; van de Warrenburg, B; Wickremaratchi, M; Williams, N; Williams-Gray, CH; Winder-Rhodes, S; Stefansson, K; Martinez, M; Hardy, J; Heutink, P; Brice, A; Gasser, T; Singleton, AB; Wood, NW				Nalls, Michael A.; Plagnol, Vincent; Hernandez, Dena G.; Sharma, Manu; Sheerin, Una-Marie; Saad, Mohamad; Simon-Sanchez, Javier; Schulte, Claudia; Lesage, Suzanne; Sveinbjornsdottir, Sigurlaug; Arepalli, Sampath; Barker, Roger; Ben-Shlomo, Yoav; Berendse, Henk W.; Berg, Daniela; Bhatia, Kailash; de Bie, Rob M. A.; Biffi, Alessandro; Bloem, Bas; Bochdanovits, Zoltan; Bonin, Michael; Bras, Jose M.; Brockmann, Kathrin; Brooks, Janet; Burn, David J.; Charlesworth, Gavin; Chen, Honglei; Chinnery, Patrick F.; Chong, Sean; Clarke, Carl E.; Cookson, Mark R.; Cooper, J. Mark; Corvol, Jean Christophe; Counsell, Carl; Damier, Philippe; Dartigues, Jean-Francois; Deloukas, Panos; Deuschl, Guenther; Dexter, David T.; van Dijk, Karin D.; Dillman, Allissa; Durif, Frank; Duerr, Alexandra; Edkins, Sarah; Evans, Jonathan R.; Foltynie, Thomas; Gao, Jianjun; Gardner, Michelle; Gibbs, J. Raphael; Goate, Alison; Gray, Emma; Guerreiro, Rita; Gustafsson, Omar; Harris, Clare; van Hilten, Jacobus J.; Hofman, Albert; Hollenbeck, Albert; Holton, Janice; Hu, Michele; Huang, Xuemei; Huber, Heiko; Hudson, Gavin; Hunt, Sarah E.; Huttenlocher, Johanna; Illig, Thomas; Jonsson, Palmi V.; Lambert, Jean-Charles; Langford, Cordelia; Lees, Andrew; Lichtner, Peter; Limousin, Patricia; Lopez, Grisel; Lorenz, Delia; McNeill, Alisdair; Moorby, Catriona; Moore, Matthew; Morris, Huw R.; Morrison, Karen E.; Mudanohwo, Ese; O'Sullivan, Sean S.; Pearson, Justin; Perlmutter, Joel S.; Petursson, Hjoervar; Pollak, Pierre; Post, Bart; Potter, Simon; Ravina, Bernard; Revesz, Tamas; Riess, Olaf; Rivadeneira, Fernando; Rizzu, Patrizia; Ryten, Mina; Sawcer, Stephen; Schapira, Anthony; Scheffer, Hans; Shaw, Karen; Shoulson, Ira; Sidransky, Ellen; Smith, Colin; Spencer, Chris C. A.; Stefansson, Hreinn; Stockton, Joanna D.; Strange, Amy; Talbot, Kevin; Tanner, Carlie M.; Tashakkori-Ghanbaria, Avazeh; Tison, Francois; Trabzuni, Daniah; Traynor, Bryan J.; Uitterlinden, Andre G.; Velseboer, Daan; Vidailhet, Marie; Walker, Robert; van de Warrenburg, Bart; Wickremaratchi, Mirdhu; Williams, Nigel; Williams-Gray, Caroline H.; Winder-Rhodes, Sophie; Stefansson, Kari; Martinez, Maria; Hardy, John; Heutink, Peter; Brice, Alexis; Gasser, Thomas; Singleton, Andrew B.; Wood, Nicholas W.		Int Parkinson Dis Genomics Consort; Wellcome Trust Case-Control Consor	Imputation of sequence variants for identification of genetic risks for Parkinson's disease: a meta-analysis of genome-wide association studies	LANCET			English	Article							SYNAPTOTAGMIN-XI; COMMON; LOCI; SUSCEPTIBILITY; MUTATIONS; SUGGESTS; REGION; STK39; SNCA	Background Genome-wide association studies (GWAS) for Parkinson's disease have linked two loci (MAPT and SNCA) to risk of Parkinson's disease. We aimed to identify novel risk loci for Parkinson's disease. Methods We did a meta-analysis of datasets from five Parkinson's disease GWAS from the USA and Europe to identify loci associated with Parkinson's disease (discovery phase). We then did replication analyses of significantly associated loci in an independent sample series. Estimates of population-attributable risk were calculated from estimates from the discovery and replication phases combined, and risk-profile estimates for loci identified in the discovery phase were calculated. Findings The discovery phase consisted of 5333 case and 12 019 control samples, with genotyped and imputed data at 7 689 524 SNPs. The replication phase consisted of 7053 case and 9007 control samples. We identified 11 loci that surpassed the threshold for genome-wide significance (p<5x10(-8)). Six were previously identified loci (MAPT, SNCA, HLA-DRB5, BSTI, GAK and LRRK2) and five were newly identified loci (ACMSD, STK39, MCCC1/LAMP3, SYT11, and CCDC62/HIP1R). The combined population-attributable risk was 60.3% (95% CI 43.7-69-3). In the risk-profile analysis, the odds ratio in the highest quintile of disease risk was 2.51 (95% CI 2.23-2.83) compared with 1.00 in the lowest quintile of disease risk. Interpretation These data provide an insight into the genetics of Parkinson's disease and the molecular cause of the disease and could provide future targets for therapies.	[Nalls, Michael A.; Singleton, Andrew B.] NIA, Neurogenet Lab, NIH, Bethesda, MD 20837 USA; [Plagnol, Vincent; Wood, Nicholas W.] UCL Genet Inst, London, England; [Hernandez, Dena G.; Sheerin, Una-Marie; Bhatia, Kailash; Bras, Jose M.; Charlesworth, Gavin; Gardner, Michelle; Gibbs, J. Raphael; Guerreiro, Rita; Ryten, Mina; Trabzuni, Daniah; Hardy, John; Wood, Nicholas W.] UCL Inst Neurol, Dept Mol Neurosci, London, England; [Sharma, Manu] Univ Tubingen, Hertie Inst Clin Brain Res, Dept Neurodegenerat Dis, Tubingen, Germany; [Sharma, Manu] German Ctr Neurodegenerat Dis, DZNE, Tubingen, Germany; [Saad, Mohamad] CPTP, INSERM, U563, Toulouse, France; [Saad, Mohamad; Martinez, Maria] Univ Toulouse 3, F-31062 Toulouse, France; [Simon-Sanchez, Javier; Bochdanovits, Zoltan; Rizzu, Patrizia; Heutink, Peter] Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Sect Med Genom, Amsterdam, Netherlands; [Lesage, Suzanne; Corvol, Jean Christophe; Duerr, Alexandra] INSERM, UMR S975, Paris, France; [Lesage, Suzanne] Univ Paris 06, Ctr Rech, Inst Cerveau & Moelle Epiniere, Paris, France; [Lesage, Suzanne; Corvol, Jean Christophe; Duerr, Alexandra] CNRS, Paris, France; [Sveinbjornsdottir, Sigurlaug] Landspitali Univ Hosp, Dept Neurol, Reykjavik, Iceland; [Sveinbjornsdottir, Sigurlaug] MEHT Broomfield Hosp, Dept Neurol, Chelmsford, Essex, England; [Sveinbjornsdottir, Sigurlaug] Univ London, Queen Mary Coll, London, England; [Barker, Roger] Univ Cambridge, Addenbrookes Hosp, Dept Neurol, Cambridge CB2 2QQ, England; [Ben-Shlomo, Yoav] Univ Bristol, Dept Social Med, Bristol BS8 1TH, Avon, England; [Berendse, Henk W.; van Dijk, Karin D.] Vrije Univ Amsterdam Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Berendse, Henk W.; van Dijk, Karin D.] Vrije Univ Amsterdam Med Ctr, Alzheimers Ctr, Amsterdam, Netherlands; [de Bie, Rob M. A.; Velseboer, Daan] Univ Amsterdam, Acad Med Ctr, Dept Neurol, NL-1105 AZ Amsterdam, Netherlands; [Biffi, Alessandro] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Biffi, Alessandro] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Biffi, Alessandro] Broad Inst, Program Med & Populat Genet, Cambridge, MA USA; [Bloem, Bas; Post, Bart; van de Warrenburg, Bart] Radboud Univ Nijmegen, Med Ctr, Dept Neurol, NL-6525 ED Nijmegen, Netherlands; [Bonin, Michael; Petursson, Hjoervar; Riess, Olaf] Univ Tubingen, Inst Human Genet, Dept Med Genet, Tubingen, Germany; [Burn, David J.] Newcastle Univ, Clin Ageing Res Unit, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Chen, Honglei] NIEHS, Epidemiol Branch, NIH, Res Triangle Pk, NC USA; [Chinnery, Patrick F.; Hudson, Gavin] Newcastle Univ, Sch Med, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England; [Clarke, Carl E.; Moorby, Catriona; Morrison, Karen E.] Univ Birmingham, Sch Clin & Expt Med, Birmingham, W Midlands, England; [Clarke, Carl E.] Sandwell & W Birmingham Hosp NHS Trust, City Hosp, Dept Neurol, Birmingham, W Midlands, England; [Cooper, J. Mark; McNeill, Alisdair; Schapira, Anthony] UCL Inst Neurol, Dept Clin Neurosci, London, England; [Corvol, Jean Christophe] Hop La Pitie Salpetriere, INSERM, CIC 9503, Paris, France; [Counsell, Carl] Univ Aberdeen, Div Appl Hlth Sci, Populat Hlth Sect, Aberdeen, Scotland; [Damier, Philippe] CHU Nantes, CIC0004, Serv Neurol, F-44035 Nantes 01, France; [Dartigues, Jean-Francois] Univ Victor Segalen, INSERM, U897, Bordeaux, France; [Deloukas, Panos; Edkins, Sarah; Gray, Emma; Hunt, Sarah E.; Potter, Simon; Tashakkori-Ghanbaria, Avazeh] Wellcome Trust Sanger Inst, Cambridge, England; [Deuschl, Guenther] Univ Kiel, Univ Klinikum Schleswig Holstein, Neurol Klin, Kiel, Germany; [Dexter, David T.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Parkinsons Dis Res Grp, London, England; [Durif, Frank] Hop Gabriel Montpied, Serv Neurol, Clermont Ferrand, France; [Duerr, Alexandra] Hop La Pitie Salpetriere, AP HP, Paris, France; [Evans, Jonathan R.; Langford, Cordelia] Cambridge Ctr Brain Repair, Cambridge, England; [Gustafsson, Omar] Oslo Univ Hosp, deCODE Genet, N-0407 Oslo, Norway; [Gustafsson, Omar] Oslo Univ Hosp, Dept Psychiat, N-0407 Oslo, Norway; [van Hilten, Jacobus J.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Hofman, Albert; Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Hollenbeck, Albert] AARP, Washington, DC USA; [Holton, Janice] UCL Inst Neurol, Queen Sq Brain Bank Neurol Disorders, London, England; [Hu, Michele] John Radcliffe Hosp, Dept Clin Neurol, Oxford OX3 9DU, England; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurol, Hershey, PA 17033 USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Radiol, Hershey, PA 17033 USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Neurosurg, Hershey, PA 17033 USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Pharmacol, Hershey, PA 17033 USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Kinesiol, Hershey, PA 17033 USA; [Huang, Xuemei] Penn State Univ, Milton S Hershey Med Ctr, Dept Bioengn, Hershey, PA 17033 USA; [Illig, Thomas] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Epidemiol, Neuherberg, Germany; [Jonsson, Palmi V.] Landspitali Univ Hosp, Dept Geriatr, Reykjavik, Iceland; [Lambert, Jean-Charles] INSERM, U744, F-59045 Lille, France; [Lambert, Jean-Charles] Univ Lille Nord, Inst Pasteur Lille, Lille, France; [Lichtner, Peter] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Human Genet, Neuherberg, Germany; [Limousin, Patricia] Inst Neurol, Sobell Dept, Unit Funct Neurosurg, London WC1N 3BG, England; [Lopez, Grisel] NHGRI, Sect Mol Neurogenet, Med Genet Branch, NIH, Bethesda, MD USA; [Morris, Huw R.] Cardiff Univ, Sch Med, MRC, Ctr Neuropsychiat Genet & Genom, Cardiff, S Glam, Wales; [Morrison, Karen E.] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Dept Neurosci, Birmingham, W Midlands, England; [Mudanohwo, Ese] UCL Inst Neurol, Neurogenet Unit, London, England; [Perlmutter, Joel S.] Washington Univ, Dept Neurol Radiol & Neurobiol, St Louis, MO 63130 USA; [Pollak, Pierre] CHU Grenoble, Serv Neurol, F-38043 Grenoble, France; [Rivadeneira, Fernando; Uitterlinden, Andre G.] Erasmus Univ, Med Ctr, Dept Internal Med, Rotterdam, Netherlands; [Sawcer, Stephen] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Cambridge CB2 2QQ, England; [Scheffer, Hans] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Shoulson, Ira] Univ Rochester, Dept Neurol, Rochester, NY USA; [Smith, Colin; Walker, Robert] Univ Edinburgh, Dept Pathol, Edinburgh, Midlothian, Scotland; [Spencer, Chris C. A.; Strange, Amy] Wellcome Trust Ctr Human Genet, Oxford, England; [Talbot, Kevin] Univ Oxford, John Radcliffe Hosp, Dept Clin Neurol, Oxford OX3 9DU, England; [Tanner, Carlie M.] Parkinsons Inst & Clin Ctr, Dept Clin Res, Sunnyvale, CA USA; [Tison, Francois] Hop Haut Leveque, Serv Neurol, Pessac, France; [Vidailhet, Marie] Univ Paris 06, INSERM, UMR S975, CNRS,UMR 7225, F-75252 Paris 05, France; [Wickremaratchi, Mirdhu] Cardiff Univ, Dept Neurol, Cardiff, S Glam, Wales; [Williams-Gray, Caroline H.] Addenbrookes Hosp, Dept Neurol, Cambridge, England; [Winder-Rhodes, Sophie] Univ Cambridge, Dept Psychiat, Cambridge CB2 1TN, England; [Winder-Rhodes, Sophie] Univ Cambridge, MRC, Cambridge CB2 1TN, England; [Winder-Rhodes, Sophie] Univ Cambridge, Wellcome Trust Behav & Clin Neurosci Inst, Cambridge CB2 1TN, England; [Martinez, Maria] INSERM, U563, F-75654 Paris 13, France; [Brice, Alexis] Univ Paris 06, Pitie Salpetriere Hosp, AP HP, CNRS,UMR 7225,INSERM,UMR S975, F-75252 Paris 05, France	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of London; University College London; University of London; University College London; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Landspitali National University Hospital; Mid Essex Hospital Services NHS Trust; Broomfield Hospital; University of London; Queen Mary University London; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Bristol; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; University of Amsterdam; Academic Medical Center Amsterdam; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Radboud University Nijmegen; Eberhard Karls University of Tubingen; Newcastle University - UK; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Newcastle University - UK; University of Birmingham; University of Birmingham; University of London; University College London; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Aberdeen; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Wellcome Trust Sanger Institute; University of Kiel; Schleswig Holstein University Hospital; Imperial College London; CHU Clermont Ferrand; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Cambridge; University of Oslo; University of Oslo; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Erasmus University Rotterdam; Erasmus MC; American Association of Retired Persons (AARP); University of London; University College London; University of Oxford; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Landspitali National University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Cardiff University; University of Birmingham; University of London; University College London; Washington University (WUSTL); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Erasmus University Rotterdam; Erasmus MC; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Radboud University Nijmegen; University of Rochester; University of Edinburgh; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; CHU Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Cardiff University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Cambridge; University of Cambridge; University of Cambridge; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Singleton, AB (corresponding author), NIA, Neurogenet Lab, NIH, 35 Convent Dr, Bethesda, MD 20837 USA.	singleta@mail.nih.gov	Hardy, John/C-2451-2009; Talbot, Kevin/F-7361-2011; Gibbs, J. Raphael/A-3984-2010; Trabzuni, Daniah M/C-4034-2012; Deuschl, Gunther/A-7986-2010; Gasser, Thomas/GNH-5293-2022; O'Sullivan, Sean S/C-9333-2012; Brice, Alexis/A-2170-2009; LICEND, CEMND/F-1296-2015; Revesz, Tamas/A-8732-2010; Trabzuni, Daniah/AAI-2037-2021; Bloem, Bastiaan/H-8013-2014; Guerreiro, Rita J L/A-1327-2011; lambert, jean-charles/F-8787-2013; Bras, Jose MT/A-1428-2011; Hollenbeck, Albert/AAG-9461-2020; van de Warrenburg, Bart PC/D-1935-2010; Plagnol, Vincent/A-5667-2011; Hudson, Gavin/E-7117-2017; DARTIGUES, Jean François/T-4513-2019; Dexter, David Trevor/AAW-4222-2021; Martinez, Maria/B-3111-2013; Berg, Daniela/A-8728-2019; corvol, jean-christophe/I-6387-2012; Cooper, J Mark/D-5826-2013; Bloem, Bastiaan R/E-3812-2010; Lambert, jean-charles/A-9553-2014; Deloukas, Panos/B-2922-2013; Lees, Andrew J/A-6605-2009; Traynor, Bryan J/G-5690-2010; Wood, Nicholas W/C-2505-2009; Corvol, Jean-Christophe/F-2124-2017; Cookson, Mark/AAW-2516-2021; brice, alexis/AAE-8275-2019; Stefansson, Kari/AAE-7187-2019; Singleton, Andrew B/C-3010-2009; Holton, Janice L/F-6831-2011; Rivadeneira, Fernando/O-5385-2015; Schapira, Anthony H V/A-1245-2010; Scheffer, Hans/E-4644-2012; Charlesworth, Gavin/B-5895-2011; Sharma, Manu/AAX-2594-2020; Burn, David/ABD-6052-2021; Ryten, Mina/Q-8419-2016; mcneill, alisdair/B-1267-2012; Damier, Philippe/T-7829-2019; Ben-Shlomo, Yoav/ABD-2004-2021; Morris, Huw R/B-8527-2008	Hardy, John/0000-0002-3122-0423; Gibbs, J. Raphael/0000-0002-6985-0658; Trabzuni, Daniah M/0000-0003-4826-9570; Deuschl, Gunther/0000-0002-4176-9196; Gasser, Thomas/0000-0002-1069-1146; O'Sullivan, Sean S/0000-0002-0583-7956; Revesz, Tamas/0000-0003-2501-0259; Trabzuni, Daniah/0000-0003-4826-9570; Bloem, Bastiaan/0000-0002-6371-3337; lambert, jean-charles/0000-0003-0829-7817; van de Warrenburg, Bart PC/0000-0003-4412-1616; Martinez, Maria/0000-0003-2180-4537; Berg, Daniela/0000-0001-5796-5442; corvol, jean-christophe/0000-0001-7325-0199; Cooper, J Mark/0000-0002-3007-3054; Lambert, jean-charles/0000-0003-0829-7817; Deloukas, Panos/0000-0001-9251-070X; Lees, Andrew J/0000-0002-2476-4385; Wood, Nicholas W/0000-0002-9500-3348; Corvol, Jean-Christophe/0000-0001-7325-0199; Cookson, Mark/0000-0002-1058-3831; brice, alexis/0000-0002-0941-3990; Holton, Janice L/0000-0002-3882-5249; Rivadeneira, Fernando/0000-0001-9435-9441; Schapira, Anthony H V/0000-0002-3018-3966; Scheffer, Hans/0000-0002-2986-0915; Ben-Shlomo, Yoav/0000-0001-6648-3007; Morris, Huw R/0000-0002-5473-3774; Simon Sanchez, Javier/0000-0001-5141-5829; Bhatia, Kailash/0000-0001-8185-286X; Clarke, Carl/0000-0003-2478-3436; Chinnery, Patrick/0000-0002-7065-6617; van Hilten, Jacobus/0000-0002-7030-0362; Hu, Michele/0000-0001-6382-5841; Bras, Jose/0000-0001-8186-0333; Walker, Robert/0000-0001-7383-7846; Chen, Honglei/0000-0003-3446-7779; Schulte, Claudia/0000-0003-4006-1265; Morrison, Karen Elaine/0000-0003-0216-5717; Velseboer, Daan/0000-0003-1134-5461; Williams-Gray, Caroline/0000-0002-2648-9743; Heutink, Peter/0000-0001-5218-1737; Guerreiro, Rita/0000-0001-5879-3486; Hudson, Gavin/0000-0001-7210-2733; Plagnol, Vincent/0000-0002-5597-9215; Stefansson, Hreinn/0000-0002-9331-6666	deCODE; Eisai; Merck-Serono; Cephalon; Novartis; National Institute on Aging, National Institute of Neurological Disorders and Stroke, National Institute of Environmental Health Sciences; National Human Genome Research Institute of the National Institutes of Health, Department of Health and Human Services [Z01-AG000949-02, Z01-ES101986]; US Department of Defense [W81XWH-09-2-0128]; National Institutes of Health [NS057105, RA024992]; American Parkinson disease Association (APDA); Barnes Jewish Hospital Foundation; Greater St Louis Chapter of the APDA; Hersenstichting Nederland; Neuroscience Campus Amsterdam; section of medical genomics; Prinses Beatrix Fonds; Forschungszentrum fur Umwelt und Gesundheit; German National Genome Network (German Ministry for Education and Research) [01GS08134]; German Federal Ministry of Education and Research [NGFN 01GR0468]; Helmholtz Alliance Mental Health in an Ageing Society [HA-215]; Helmholtz Association; French National Agency of Research [ANR-08-MNP-012]; Landspitali University Hospital; Icelandic Research Council; European Community [PIAP-GA-2008-230596]; Wellcome Trust [083948/Z/07/Z]; Medical Research Council; Wellcome Trust disease centre [WT089698/Z/09/Z]; Parkinson's UK [8047, J-0804]; Medical Research Council [G0700943]; Department of Health's National Institute for Health Research Biomedical Research Centres; Wellcome Trust/Medical Research Council [WT089698]; Parkinson's Disease Consortium (UKPDC); MRC [G0701075, MC_G1000735, MC_PC_09003, G0700943, G1100616, G1100479, G0900627, G0802462, MC_G0901330] Funding Source: UKRI; Alzheimers Research UK [ART-PPG2011A-14] Funding Source: researchfish; Medical Research Council [G1100479, MC_G0901330, MC_G1000735, G0802462, MC_PC_09003, G0900627, G1100616, G0801418B, G0701075, G0400017] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10011] Funding Source: researchfish; Parkinson&quot;s UK [G-0907, J-0901, J-0804] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024992] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101986, ZIAES101986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041509, R01NS075321, P30NS057105, R01NS060722] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [Z01AG000949, ZIAAG000949] Funding Source: NIH RePORTER	deCODE; Eisai(Eisai Co Ltd); Merck-Serono(Merck & Company); Cephalon; Novartis(Novartis); National Institute on Aging, National Institute of Neurological Disorders and Stroke, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Environmental Health Sciences (NIEHS)NIH National Institute of Neurological Disorders & Stroke (NINDS)); National Human Genome Research Institute of the National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); US Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Parkinson disease Association (APDA); Barnes Jewish Hospital Foundation; Greater St Louis Chapter of the APDA; Hersenstichting Nederland; Neuroscience Campus Amsterdam; section of medical genomics; Prinses Beatrix Fonds; Forschungszentrum fur Umwelt und Gesundheit; German National Genome Network (German Ministry for Education and Research)(Federal Ministry of Education & Research (BMBF)); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Helmholtz Alliance Mental Health in an Ageing Society; Helmholtz Association(Helmholtz Association); French National Agency of Research(French National Research Agency (ANR)); Landspitali University Hospital; Icelandic Research Council; European Community(European Commission); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust disease centre(Wellcome Trust); Parkinson's UK(Parkinson's UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health's National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR)); Wellcome Trust/Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Wellcome Trust); Parkinson's Disease Consortium (UKPDC); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Parkinson&quot;s UK(Parkinson&apos;s UK); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	KSt has received grants from deCODE. JH has received consulting fees or honoraria from Eisai and his institute has received consulting fees or honoraria from Merck-Serono. TG has received consultancy fees from Cephalon and Merck-Serono; grants from Novartis; payments for lectures including service on speakers' bureaus from Boehringer Ingelheim, Merck-Serono, UCB, and Valeant; and holds patents NGFN2 and KASPP. MAN, VP, DGH, MSh, U-MS, MSa, JS-S, CS, SL, SS, KS, MM, PH, ABr, ABS, and NWW declare that they have no conflicts of interest.; This work was supported by the Intramural Research Programs of the National Institute on Aging, National Institute of Neurological Disorders and Stroke, National Institute of Environmental Health Sciences, and National Human Genome Research Institute of the National Institutes of Health, Department of Health and Human Services (project numbers Z01-AG000949-02 and Z01-ES101986). This work was also supported by the US Department of Defense (award number W81XWH-09-2-0128); National Institutes of Health (grants NS057105 and RA024992); American Parkinson disease Association (APDA); Barnes Jewish Hospital Foundation; Greater St Louis Chapter of the APDA; Hersenstichting Nederland; Neuroscience Campus Amsterdam; and the section of medical genomics, the Prinses Beatrix Fonds. The KORA (Cooperative Research in the Region of Augsburg) research platform was started and financed by the Forschungszentrum fur Umwelt und Gesundheit, which is funded by the German Federal Ministry of Education, Science, Research, and Technology and by the State of Bavaria. This study was also funded by the German National Genome Network (NGENplus number 01GS08134, German Ministry for Education and Research); by the German Federal Ministry of Education and Research (NGFN 01GR0468, PopGen); and 01EW0908 in the frame of ERA-NET NEURON and Helmholtz Alliance Mental Health in an Ageing Society (HA-215), which was funded by the Initiative and Networking Fund of the Helmholtz Association. The French GWAS work was supported by the French National Agency of Research (ANR-08-MNP-012). This study was also sponsored by the Landspitali University Hospital Research Fund (grant to SSv); Icelandic Research Council (grant to SSv); and European Community Framework Programme 7, People Programme, and IAPP on novel genetic and phenotypic markers of Parkinson's disease and Essential Tremor (MarkMD), contract number PIAP-GA-2008-230596 MarkMD (to HP and JHu). We used the Biowulf Linux cluster at the National Institutes of Health, Bethesda, MD, USA, and DNA panels, samples, and clinical data from the National Institute of Neurological Disorders and Stroke Human Genetics Resource Center DNA and Cell Line Repository. People who contributed samples are acknowledged in descriptions of every panel on the repository website. We thank The French Parkinson's Disease Genetics Study Group: Y Agid, M Anheim, A-M Bonnet, M Borg, A Brice, E Broussolle, J-C Corvol, P Damier, A Destee, A Darr, F Durif, S Klebe, E Lohmann, M Martinez, P Pollak, O Rascol, F Tison, C Tranchant, M Venn, F Viallet, and M Vidailhet. We also thank the members of the French 3C Consortium: Annick Alperovitch, Claudine Berr, Christophe Tzourio, and Philippe Amouyel for allowing us souse part of the 3C cohort; and D Zelenika for support in generating the genome-wide molecular data. We used genome-wide association data generated by the Wellcome Trust Case-Control Consortium 2 (WTCCC2) from UK patients with Parkinson's disease and UK control individuals from the 1958 Birth Cohort and National Blood Service. Genotyping of UK replication cases on ImmunoChip was part of the WTCCC2 project, which was funded by the Wellcome Trust (083948/Z/07/Z). UK population control data was made available through WTCCC1. This study was supported by the Medical Research Council and Wellcome Trust disease centre (grant WT089698/Z/09/Z to NW, J Ha, and ASc). This study was also supported by Parkinson's UK (grants 8047 and J-0804) and the Medical Research Council (G0700943). We thank Jeffrey Barrett for assistance with the design of the ImmunoChip.; DNA extration work that was done in the UK was undertaken at University College London Hospitals, University College London, who received a proportion of funding from the Department of Health's National Institute for Health Research Biomedical Research Centres funding. This study was supported in part by the Wellcome Trust/Medical Research Council Joint Call in Neurodegeneration award (WT089698) to the Parkinson's Disease Consortium (UKPDC), whose members are from the UCL Institute of Neurology, University of Sheffield, and the Medical Research Council Protein Phosphorylation Unit at the University of Dundee.	Cano P, 2007, HUM IMMUNOL, V68, P392, DOI 10.1016/j.humimm.2007.01.014; Cunnington MS, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-135; de Bakker PIW, 2008, HUM MOL GENET, V17, pR122, DOI 10.1093/hmg/ddn288; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Fung HC, 2006, LANCET NEUROL, V5, P911, DOI 10.1016/S1474-4422(06)70578-6; Garavaglia S, 2009, FEBS J, V276, P6615, DOI 10.1111/j.1742-4658.2009.07372.x; Gibbs JR, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000952; Glass AS, 2004, J NEURAL TRANSM-SUPP, P21; Hamza TH, 2010, NAT GENET, V42, P781, DOI 10.1038/ng.642; Handel AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010142; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Huynh DP, 2003, HUM MOL GENET, V12, P2587, DOI 10.1093/hmg/ddg269; Ioannidis JPA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000841; Li Y, 2009, ANNU REV GENOM HUM G, V10, P387, DOI 10.1146/annurev.genom.9.081307.164242; Lincoln MR, 2009, P NATL ACAD SCI USA, V106, P7542, DOI 10.1073/pnas.0812664106; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Malosio ML, 2004, J CELL SCI, V117, P743, DOI 10.1242/jcs.00934; Pankratz N, 2009, HUM GENET, V124, P593, DOI 10.1007/s00439-008-0582-9; Parker JA, 2007, J NEUROSCI, V27, P11056, DOI 10.1523/JNEUROSCI.1941-07.2007; Ramoz N, 2008, AM J MED GENET B, V147B, P1152, DOI 10.1002/ajmg.b.30739; Saad M, 2011, HUM MOL GENET, V20, P615, DOI 10.1093/hmg/ddq497; Satake W, 2009, NAT GENET, V41, P1303, DOI 10.1038/ng.485; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Simon-Sanchez J, 2011, EUR J HUM GENET, V19, P655, DOI 10.1038/ejhg.2010.254; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Singleton A, 2004, LANCET, V364, P1105, DOI 10.1016/S0140-6736(04)17117-1; Singleton AB, 2010, TRENDS GENET, V26, P438, DOI 10.1016/j.tig.2010.07.004; Spencer CCA, 2011, HUM MOL GENET, V20, P345, DOI 10.1093/hmg/ddq469; Team RC., 2022, LANG ENV STAT COMP; University of Michigan Center for Statistical Genetics, 1000G 2009 08 DOWNL; University of Michigan Centre for Statistical Genetics, MET MET HELP; Wang Y, 2009, P NATL ACAD SCI USA, V106, P226, DOI 10.1073/pnas.0808358106; Wersinger C, 2006, CURR MED CHEM, V13, P591, DOI 10.2174/092986706776055760; Willer CJ, 2010, BIOINFORMATICS, V26, P2190, DOI 10.1093/bioinformatics/btq340; Zollner S, 2007, AM J HUM GENET, V80, P605, DOI 10.1086/512821	35	675	692	3	139	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2011	377	9766					641	649		10.1016/S0140-6736(10)62345-8	http://dx.doi.org/10.1016/S0140-6736(10)62345-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	727DB	21292315	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000287776600033
J	Hellal, F; Hurtado, A; Ruschel, J; Flynn, KC; Laskowski, CJ; Umlauf, M; Kapitein, LC; Strikis, D; Lemmon, V; Bixby, J; Hoogenraad, CC; Bradke, F				Hellal, Farida; Hurtado, Andres; Ruschel, Joerg; Flynn, Kevin C.; Laskowski, Claudia J.; Umlauf, Martina; Kapitein, Lukas C.; Strikis, Dinara; Lemmon, Vance; Bixby, John; Hoogenraad, Casper C.; Bradke, Frank			Microtubule Stabilization Reduces Scarring and Causes Axon Regeneration After Spinal Cord Injury	SCIENCE			English	Article							TGF-BETA; FUNCTIONAL RECOVERY; GROWTH; PROLIFERATION; INHIBITION; ELEVATION; CAMP; CNS	Hypertrophic scarring and poor intrinsic axon growth capacity constitute major obstacles for spinal cord repair. These processes are tightly regulated by microtubule dynamics. Here, moderate microtubule stabilization decreased scar formation after spinal cord injury in rodents through various cellular mechanisms, including dampening of transforming growth factor-beta signaling. It prevented accumulation of chondroitin sulfate proteoglycans and rendered the lesion site permissive for axon regeneration of growth-competent sensory neurons. Microtubule stabilization also promoted growth of central nervous system axons of the Raphe-spinal tract and led to functional improvement. Thus, microtubule stabilization reduces fibrotic scarring and enhances the capacity of axons to grow.	[Hellal, Farida; Ruschel, Joerg; Flynn, Kevin C.; Laskowski, Claudia J.; Umlauf, Martina; Bradke, Frank] Max Planck Inst Neurobiol, Axonal Growth & Regenerat Grp, D-82152 Martinsried, Germany; [Hurtado, Andres] Johns Hopkins Univ, Hugo W Moser Res Inst Kennedy Krieger, Int Ctr Spinal Cord Injury, Dept Neurol, Baltimore, MD 21205 USA; [Kapitein, Lukas C.; Hoogenraad, Casper C.] Erasmus MC, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands; [Kapitein, Lukas C.; Hoogenraad, Casper C.] Univ Utrecht, Fac Sci, NL-3584 CH Utrecht, Netherlands; [Strikis, Dinara; Lemmon, Vance; Bixby, John] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Miami, FL 33136 USA	Max Planck Society; Johns Hopkins University; Erasmus University Rotterdam; Erasmus MC; Utrecht University; University of Miami	Bradke, F (corresponding author), Max Planck Inst Neurobiol, Axonal Growth & Regenerat Grp, Klopferspitz 18, D-82152 Martinsried, Germany.	fbradke@neuro.mpg.de	Hellal, Farida/AHC-2588-2022; Kapitein, Lukas C/J-4776-2016; Hellal, Farida/E-8533-2013; Lemmon, Vance/A-7410-2010; Hellal, Farida/D-1834-2015; Hoogenraad, Casper/B-8866-2011	Hellal, Farida/0000-0002-9344-1846; Kapitein, Lukas C/0000-0001-9418-6739; Lemmon, Vance/0000-0003-3550-7576; Hellal, Farida/0000-0002-9344-1846; Hoogenraad, Casper/0000-0002-2666-0758; Bixby, John/0000-0003-1633-5318; Ruschel, Joerg/0000-0002-4782-9786; Bradke, Frank/0000-0002-0345-3772	Max-Planck-Society; Deutsche Forschungsgemeinschaft; International Foundation for Paraplegia; Human Frontier Science Program; NIH; Netherlands Organization for Scientific Research (NWO); Netherlands Organization for Health Research and Development (ZonMW)-TOP; European Science Foundation; NWO-VICI; Marie Curie Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059866] Funding Source: NIH RePORTER	Max-Planck-Society(Max Planck SocietyFoundation CELLEX); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); International Foundation for Paraplegia; Human Frontier Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development (ZonMW)-TOP(Netherlands Organization for Health Research and Development); European Science Foundation(European Science Foundation (ESF)European Commission); NWO-VICI(Netherlands Organization for Scientific Research (NWO)); Marie Curie Fellowship(European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Hill for the SMAD2-PAGFP plasmid; A. Ullrich for the HaCaT cells; Ariad Pharmaceuticals for FKBP/FRB plasmids and Rapalog; G. Morfini for technical advice; K. Dornmair, M. Hubener, R. Klein, D. Neukirchen, M. Stiess, S. Tahirovic, and H. Wekerle for critically reading the manuscript; and V. Ha, T. Irl, D. F. Wendell, and R. Zenke for technical assistance. This work was supported by the Max-Planck-Society, Deutsche Forschungsgemeinschaft, International Foundation for Paraplegia, and Human Frontier Science Program (F.B.); NIH (J.B.); Netherlands Organization for Scientific Research (NWO)-Veni (L.C.K.); Netherlands Organization for Health Research and Development (ZonMW)-TOP, European Science Foundation Young Investigator Award, and NWO-VICI (C.C.H.); and a Marie Curie Fellowship (K.C.F.). The Max-Planck-Society has filed a patent on the use of Taxol after spinal cord injury.	Batut J, 2007, DEV CELL, V12, P261, DOI 10.1016/j.devcel.2007.01.010; BEHRMANN DL, 1992, J NEUROTRAUM, V9, P197, DOI 10.1089/neu.1992.9.197; Dergham P, 2002, J NEUROSCI, V22, P6570; Dill J, 2008, J NEUROSCI, V28, P8914, DOI 10.1523/JNEUROSCI.1178-08.2008; Dong CM, 2000, MOL CELL, V5, P27, DOI 10.1016/S1097-2765(00)80400-1; Erturk A, 2007, J NEUROSCI, V27, P9169, DOI 10.1523/JNEUROSCI.0612-07.2007; Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436; Hurtado A, 2008, BRAIN, V131, P2596, DOI 10.1093/brain/awn206; Jones LL, 2002, J NEUROSCI, V22, P2792, DOI 10.1523/JNEUROSCI.22-07-02792.2002; Kapitein LC, 2010, BIOPHYS J, V99, P2143, DOI 10.1016/j.bpj.2010.07.055; Klapka N, 2006, J NEUROTRAUM, V23, P422, DOI 10.1089/neu.2006.23.422; Laabs TL, 2007, J NEUROSCI, V27, P14494, DOI 10.1523/JNEUROSCI.2807-07.2007; LINDHOLM D, 1992, J CELL BIOL, V117, P395, DOI 10.1083/jcb.117.2.395; Liu XL, 2005, PLOS MED, V2, P1334, DOI 10.1371/journal.pmed.0020354; MOSES HL, 1987, J CELL PHYSIOL, P1, DOI 10.1002/jcp.1041330403; Neumann S, 2002, NEURON, V34, P885, DOI 10.1016/S0896-6273(02)00702-X; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; Qiu J, 2002, NEURON, V34, P895, DOI 10.1016/S0896-6273(02)00730-4; ROWINSKY EK, 1990, JNCI-J NATL CANCER I, V82, P1247, DOI 10.1093/jnci/82.15.1247; Schachtrup C, 2010, J NEUROSCI, V30, P5843, DOI 10.1523/JNEUROSCI.0137-10.2010; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Shearer MC, 2003, MOL CELL NEUROSCI, V24, P913, DOI 10.1016/j.mcn.2003.09.004; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Ylera B, 2009, CURR BIOL, V19, P930, DOI 10.1016/j.cub.2009.04.017	28	416	430	7	139	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 18	2011	331	6019					928	931		10.1126/science.1201148	http://dx.doi.org/10.1126/science.1201148			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21273450	Green Accepted, Green Published			2022-12-28	WOS:000287455100062
J	Ammar, T; Uchino, K				Ammar, Tamer; Uchino, Ken			Immediate surgery reduced long-term risk for nonperioperative stroke in severe asymptomatic carotid artery stenosis	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Ammar, Tamer; Uchino, Ken] Cleveland Clin, Cleveland, OH 44106 USA	Cleveland Clinic Foundation	Ammar, T (corresponding author), Cleveland Clin, Cleveland, OH 44106 USA.		Uchino, Ken/ABC-1611-2021	Uchino, Ken/0000-0001-9468-4172				GOLDSTEIN LB, 2010, STROKE          1206; Marquardt L, 2010, STROKE, V41, pE11, DOI 10.1161/STROKEAHA.109.561837; USPSTF, 2007, ANN INTERN MED, V147, P854, DOI 10.7326/0003-4819-147-12-200712180-00005; WALKER MD, 1995, JAMA-J AM MED ASSOC, V273, P1421, DOI 10.1001/jama.1995.03520420037035	4	0	0	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4							JC2-7	10.7326/0003-4819-154-4-201102150-02007	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-02007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720VF	21320934				2022-12-28	WOS:000287310000006
J	Molnar, P				Molnar, Peter			Jack Oliver (1923-2011) OBITUARY	NATURE			English	Biographical-Item									Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Molnar, P (corresponding author), Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA.	peter.molnar@colorado.edu							0	0	0	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2011	470	7333					176	176		10.1038/470176a	http://dx.doi.org/10.1038/470176a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307924	Bronze			2022-12-28	WOS:000287144200026
J	Bock, C; Kiskinis, E; Verstappen, G; Gu, HC; Boulting, G; Smith, ZD; Ziller, M; Croft, GF; Amoroso, MW; Oakley, DH; Gnirke, A; Eggan, K; Meissner, A				Bock, Christoph; Kiskinis, Evangelos; Verstappen, Griet; Gu, Hongcang; Boulting, Gabriella; Smith, Zachary D.; Ziller, Michael; Croft, Gist F.; Amoroso, Mackenzie W.; Oakley, Derek H.; Gnirke, Andreas; Eggan, Kevin; Meissner, Alexander			Reference Maps of Human ES and iPS Cell Variation Enable High-Throughput Characterization of Pluripotent Cell Lines	CELL			English	Article							EMBRYONIC STEM-CELLS; METHYLATION; DIFFERENTIATION; DERIVATION; MOUSE; BIOINFORMATICS; GENERATION; BIOLOGY	The developmental potential of human pluripotent stem cells suggests that they can produce disease-relevant cell types for biomedical research. However, substantial variation has been reported among pluripotent cell lines, which could affect their utility and clinical safety. Such cell-line-specific differences must be better understood before one can confidently use embryonic stem (ES) or induced pluripotent stem (iPS) cells in translational research. Toward this goal we have established genome-wide reference maps of DNA methylation and gene expression for 20 previously derived human ES lines and 12 human iPS cell lines, and we have measured the in vitro differentiation propensity of these cell lines. This resource enabled us to assess the epigenetic and transcriptional similarity of ES and iPS cells and to predict the differentiation efficiency of individual cell lines. The combination of assays yields a scorecard for quick and comprehensive characterization of pluripotent cell lines.	[Bock, Christoph; Kiskinis, Evangelos; Verstappen, Griet; Boulting, Gabriella; Smith, Zachary D.; Ziller, Michael; Eggan, Kevin; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Bock, Christoph; Verstappen, Griet; Gu, Hongcang; Smith, Zachary D.; Ziller, Michael; Gnirke, Andreas; Meissner, Alexander] Broad Inst, Cambridge, MA 02142 USA; [Bock, Christoph; Kiskinis, Evangelos; Verstappen, Griet; Boulting, Gabriella; Smith, Zachary D.; Ziller, Michael; Eggan, Kevin; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Bock, Christoph] Max Planck Inst Informat, D-66123 Saarbrucken, Germany; [Kiskinis, Evangelos; Boulting, Gabriella; Eggan, Kevin] Howard Hughes Med Inst, Chevy Chase, MD USA; [Boulting, Gabriella] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Oakley, Derek H.] Columbia Univ, Jenifer Estess Lab Stem Cell Res, Dept Pathol, Ctr Motor Neuron Biol & Dis MNC,Project ALS, New York, NY 10032 USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Oakley, Derek H.] Columbia Univ, Jenifer Estess Lab Stem Cell Res, Dept Neurol, Ctr Motor Neuron Biol & Dis MNC,Project ALS, New York, NY 10032 USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Oakley, Derek H.] Columbia Univ, Jenifer Estess Lab Stem Cell Res, Dept Neurosci, Ctr Motor Neuron Biol & Dis MNC,Project ALS, New York, NY 10032 USA; [Croft, Gist F.; Amoroso, Mackenzie W.; Oakley, Derek H.] Columbia Univ, CSCI, New York, NY 10032 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Max Planck Society; Howard Hughes Medical Institute; Harvard University; Columbia University; Columbia University; Columbia University; Columbia University	Eggan, K (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	keggan@scrb.harvard.edu; alexander_meissner@harvard.edu	Bock, Christoph/AAE-7618-2019; Oakley, Derek/ABA-4689-2020; Eggan, Kevin/P-7119-2018	Bock, Christoph/0000-0001-6091-3088; Oakley, Derek/0000-0002-6998-9510; Gu, Hongcang/0000-0002-1439-7606; Croft, Gist/0000-0002-9721-0148; Boulting, Gabriella/0000-0003-2012-1259; Mathis, Mackenzie/0000-0001-7368-4456	Alexander von Humboldt Foundation; NIH Roadmap Initiative on Epigenomics [U01ES017155]; Massachusetts Life Science Center (MLSC); Pew Charitable Trusts; Harvard Research Computing team; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017155] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH042191] Funding Source: NIH RePORTER	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NIH Roadmap Initiative on Epigenomics; Massachusetts Life Science Center (MLSC); Pew Charitable Trusts; Harvard Research Computing team; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to Christopher Henderson and Hynek Wichterle (Columbia University Motor Neuron Center, Project A.L.S./Jenifer Estess Laboratory for Stem Cell Research) for sharing fibroblast and iPS cell lines prior to publication and for many helpful discussions. We would also like to thank Tarjei Mikkelsen, Eleni Tomazou, Chad Cowan, Leon Plastek, and Tim Ahfeldt for their involvement in early pilot experiments; Patrick Boyle for technical assistance; the Harvard Research Computing team for support and computation time on the Odyssey cluster; and the members of the Eggan and Meissner labs for their comments on the manuscript. Furthermore, we acknowledge the members of the Broad Institute's Genome Sequencing Platform, Genetic Analysis Platform, and Epigenomics Initiative, including Ido Amit, Fontina Kelley, Kathleen Tibbetts, Tim Fennell, Supriya Gupta, Andrew Crenshaw, Charles Epstein, and Brad Bernstein. C. B. is supported by a Feodor Lynen Fellowship from the Alexander von Humboldt Foundation. E. K. is a fellow of the European Molecular Biology Organization. K. E. is an assistant investigator of the Stowers Medical Institute, a Howard Hughes Medical Institute early career scientist, and fellow of the MacArthur Foundation. The described work was funded by the NIH Roadmap Initiative on Epigenomics (U01ES017155), the Massachusetts Life Science Center (MLSC), and the Pew Charitable Trusts. A patent has been filed for the scorecard described in the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Bock C, 2010, NAT BIOTECHNOL, V28, P1106, DOI 10.1038/nbt.1681; Bock C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-r14; Bock C, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn122; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Boulting GL, 2011, NAT BIOTECHNOL, V29, P279, DOI 10.1038/nbt.1783; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Colman A, 2009, CELL STEM CELL, V5, P244, DOI 10.1016/j.stem.2009.08.010; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Daley GQ, 2010, J CLIN INVEST, V120, P8, DOI 10.1172/JCI41801; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hastie T., 2009, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-84858-7_7; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96; Kauffmann Audrey, 2009, Bioinformatics, V25, P415, DOI 10.1093/bioinformatics/btn647; Keshet I, 2006, NAT GENET, V38, P149, DOI 10.1038/ng1719; Kitchens RL, 2000, CHEM IMMUNOL, V74, P61; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Nistri A, 2006, J PHYSIOL-LONDON, V572, P323, DOI 10.1113/jphysiol.2005.100610; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rubin LL, 2008, CELL, V132, P549, DOI 10.1016/j.cell.2008.02.010; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tukey J. W., 1977, EXPLORATORY DATA ANA; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012	46	690	731	3	140	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2011	144	3					439	452		10.1016/j.cell.2010.12.032	http://dx.doi.org/10.1016/j.cell.2010.12.032			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295703	Green Accepted, Bronze			2022-12-28	WOS:000286973100015
J	Gregory, SM; Davis, BK; West, JA; Taxman, DJ; Matsuzawa, S; Reed, JC; Ting, JPY; Damania, B				Gregory, Sean M.; Davis, Beckley K.; West, John A.; Taxman, Debra J.; Matsuzawa, Shu-ichi; Reed, John C.; Ting, Jenny P. Y.; Damania, Blossom			Discovery of a Viral NLR Homolog that Inhibits the Inflammasome	SCIENCE			English	Article							SARCOMA-ASSOCIATED-HERPESVIRUS; PATTERN-RECOGNITION RECEPTORS; KAPOSIS-SARCOMA; CASPASE-1 ACTIVATION; MURAMYL DIPEPTIDE; DNA-SEQUENCES; INFECTION; GENE; HUMAN-HERPESVIRUS-8; DISEASE	The NLR (nucleotide binding and oligomerization, leucine-rich repeat) family of proteins senses microbial infections and activates the inflammasome, a multiprotein complex that promotes microbial clearance. Kaposi's sarcoma-associated herpesvirus (KSHV) is linked to several human malignancies. We found that KSHV Orf63 is a viral homolog of human NLRP1. Orf63 blocked NLRP1-dependent innate immune responses, including caspase-1 activation and processing of interleukins IL-1 beta and IL-18. KSHV Orf63 interacted with NLRP1, NLRP3, and NOD2. Inhibition of Orf63 expression resulted in increased expression of IL-1 beta during the KSHV life cycle. Furthermore, inhibition of NLRP1 was necessary for efficient reactivation and generation of progeny virus. The viral homolog subverts the function of cellular NLRs, which suggests that modulation of NLR-mediated innate immunity is important for the lifelong persistence of herpesviruses.	[Gregory, Sean M.; Davis, Beckley K.; West, John A.; Taxman, Debra J.; Ting, Jenny P. Y.; Damania, Blossom] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Gregory, Sean M.; West, John A.; Taxman, Debra J.; Ting, Jenny P. Y.; Damania, Blossom] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Matsuzawa, Shu-ichi; Reed, John C.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Damania, Blossom] Univ N Carolina, UNC Ctr AIDS Res, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Sanford Burnham Prebys Medical Discovery Institute; University of North Carolina; University of North Carolina Chapel Hill	Damania, B (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	damania@med.unc.edu			NIH [DE018281, CA096500, AI057157, AI077437, CA156330, AI56324, AI91967, T32-AI007419, T32-AI007001, 5R21CA131645, F32-AI78735]; American Heart Association [0640041N]; Burroughs Wellcome Fund; UNC; Crohn's & Colitis Foundation of America; NATIONAL CANCER INSTITUTE [R01CA156330, R01CA096500, R21CA131645] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI078735, T32AI007001, U19AI077437, R01AI091967, U54AI057157, T32AI007419, R01AI056324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018281] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Burroughs Wellcome Fund(Burroughs Wellcome Fund); UNC(Secretaria de Ciencia y Tecnologia (SECYT)); Crohn's & Colitis Foundation of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank S. Krall for assistance with tissue culture, Y. Matsuzawa for plasmid preparation, and D. Dittmer for proofreading. Supported by NIH grants DE018281 and CA096500, American Heart Association grant 0640041N, and a Burroughs Wellcome Fund grant (B.D.); NIH grants AI057157, AI077437, and CA156330 and the UNC University Cancer Research Fund (J.P.Y.T.); NIH grants AI56324 and AI91967 (J.C.R.); NIH training grants T32-AI007419 and T32-AI007001 (S.M.G.); the Crohn's & Colitis Foundation of America and NIH grant 5R21CA131645 (B.K.D.); and NIH grant F32-AI78735 (J.A.W.). B.D. is a Leukemia & Lymphoma Society Scholar and Burroughs Wellcome Fund Investigator in Infectious Disease. The NLRP1 and mutant NLRP1 expression plasmids as well as purified GST-NLRP1 protein were obtained from J.C.R. and require a material transfer agreement. The NLRP3, NOD1, NOD2, mutant NOD2, ASC, procaspase-1, and pro-IL-1 beta expression plasmids were obtained from J.P.Y.T. and also require a material transfer agreement. B.D., J.P.Y.T., and S.M.G. have filed a provisional patent on the KSHV Orf63 protein and/or any peptides derived from this protein in treatment for human disease.	Blasig C, 1997, J VIROL, V71, P7963, DOI 10.1128/JVI.71.10.7963-7968.1997; Boschan C, 2006, AM J MED GENET A, V140A, P883, DOI 10.1002/ajmg.a.31148; Bruey JM, 2007, CELL, V129, P45, DOI 10.1016/j.cell.2007.01.045; CESARMAN E, 1995, NEW ENGL J MED, V332, P1186, DOI 10.1056/NEJM199505043321802; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Coscoy L, 2007, NAT REV IMMUNOL, V7, P391, DOI 10.1038/nri2076; Damania B, 1996, GENE DEV, V10, P1369, DOI 10.1101/gad.10.11.1369; Damiano JS, 2004, BIOCHEM J, V381, P213, DOI 10.1042/BJ20031506; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Gregory SM, 2009, P NATL ACAD SCI USA, V106, P11725, DOI 10.1073/pnas.0905316106; Hake SB, 2000, MOL CELL BIOL, V20, P7716, DOI 10.1128/MCB.20.20.7716-7725.2000; Hlaing T, 2001, J BIOL CHEM, V276, P9230, DOI 10.1074/jbc.M009853200; Hsu LC, 2008, P NATL ACAD SCI USA, V105, P7803, DOI 10.1073/pnas.0802726105; Jin Y, 2007, NEW ENGL J MED, V356, P1216, DOI 10.1056/NEJMoa061592; Johnston JB, 2005, IMMUNITY, V23, P587, DOI 10.1016/j.immuni.2005.10.003; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Lequerre T, 2007, RHEUMATOLOGY, V46, P709, DOI 10.1093/rheumatology/kel399; Manji GA, 2002, J BIOL CHEM, V277, P11570, DOI 10.1074/jbc.M112208200; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Masters SL, 2009, ANNU REV IMMUNOL, V27, P621, DOI 10.1146/annurev.immunol.25.022106.141627; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Monini P, 1999, BLOOD, V93, P4044; Pauk J, 2000, NEW ENGL J MED, V343, P1369, DOI 10.1056/NEJM200011093431904; Poyet JL, 2001, J BIOL CHEM, V276, P28309, DOI 10.1074/jbc.C100250200; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Sun R, 1998, P NATL ACAD SCI USA, V95, P10866, DOI 10.1073/pnas.95.18.10866; Tanabe T, 2004, EMBO J, V23, P1587, DOI 10.1038/sj.emboj.7600175; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; West J, 2008, J VIROL, V82, P5440, DOI 10.1128/JVI.02590-07	29	156	169	1	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					330	334		10.1126/science.1199478	http://dx.doi.org/10.1126/science.1199478			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252346	Green Accepted, Green Submitted			2022-12-28	WOS:000286636300037
J	Boseley, S				Boseley, Sarah			Profile Carole Presern-versatile new Director of PMNCH	LANCET			English	Biographical-Item												sarah.boseley@guardian.co.uk							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2011	377	9763					373	373		10.1016/S0140-6736(11)60117-7	http://dx.doi.org/10.1016/S0140-6736(11)60117-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721ES	21277431				2022-12-28	WOS:000287337000014
J	Tangcharoensathien, V; Patcharanarumol, W; Ir, P; Aljunid, SM; Mukti, AG; Akkhavong, K; Banzon, E; Huong, DB; Thabrany, H; Mills, A				Tangcharoensathien, Viroj; Patcharanarumol, Walaiporn; Ir, Por; Aljunid, Syed Mohamed; Mukti, Ali Ghufron; Akkhavong, Kongsap; Banzon, Eduardo; Dung Boi Huong; Thabrany, Hasbullah; Mills, Anne			Health in Southeast Asia 6 Health-financing reforms in southeast Asia: challenges in achieving universal coverage	LANCET			English	Article							USER FEES; IMPROVING ACCESS; EQUITY-FUND; CARE; EXPERIENCE; PAYMENTS; POLICY; IMPOVERISHMENT; KNOWLEDGE; PROVIDERS	In this sixth paper of the Series, we review health-financing reforms in seven countries in southeast Asia that have sought to reduce dependence on out-of-pocket payments, increase pooled health finance, and expand service use as steps towards universal coverage. Laos and Cambodia, both resource-poor countries, have mostly relied on donor-supported health equity funds to reach the poor, and reliable funding and appropriate identification of the eligible poor are two major challenges for nationwide expansion. For Thailand, the Philippines, Indonesia, and Vietnam, social health insurance financed by payroll tax is commonly used for formal sector employees (excluding Malaysia), with varying outcomes in terms of financial protection. Alternative payment methods have different implications for provider behaviour and financial protection. Two alternative approaches for financial protection of the non-poor outside the formal sector have emerged contributory arrangements and tax-financed schemes with different abilities to achieve high population coverage rapidly. Fiscal space and mobilisation of payroll contributions are both important in accelerating financial protection. Expanding coverage of good-quality services and ensuring adequate human resources are also important to achieve universal coverage. As health-financing reform is complex, institutional capacity to generate evidence and inform policy is essential and should be strengthened.	[Tangcharoensathien, Viroj; Patcharanarumol, Walaiporn] Minist Publ Hlth, Int Hlth Policy Program, Nonthaburi 11000, Thailand; [Ir, Por] Minist Hlth, Siem Reap Prov Hlth Dept, Siem Reap, Cambodia; [Aljunid, Syed Mohamed] United Nations Univ, Kuala Lumpur, Malaysia; [Mukti, Ali Ghufron] Gadjah Mada Univ, Yogyakarta, Indonesia; [Akkhavong, Kongsap] Minist Hlth, Inst Publ Hlth, Viangchan, Laos; [Banzon, Eduardo] World Bank, Manila, Philippines; [Dung Boi Huong] Vietnam Hlth Econ Assoc, Hanoi, Vietnam; [Thabrany, Hasbullah] Univ Indonesia, W Java, Indonesia; [Mills, Anne] London Sch Hyg & Trop Med, London WC1, England	Ministry of Public Health - Thailand; Gadjah Mada University; The World Bank; University of Indonesia; University of London; London School of Hygiene & Tropical Medicine	Tangcharoensathien, V (corresponding author), Minist Publ Hlth, Int Hlth Policy Program, Tiwanon Rd, Nonthaburi 11000, Thailand.	viroj@ihpp.thaigov.net	Aljunid, Syed/J-6009-2014	Aljunid, Syed/0000-0002-0380-1335; Mills, Anne/0000-0001-9863-9950	China Medical Board; Rockefeller Foundation; Atlantic Philanthropies	China Medical Board; Rockefeller Foundation; Atlantic Philanthropies	This paper is part of a Series funded by the China Medical Board, Rockefeller Foundation, and Atlantic Philanthropies. We thank the China Medical Board and the Regional Steering Committee in convening various workshops.	Akashi H, 2004, SOC SCI MED, V58, P553, DOI 10.1016/S0277-9536(03)00240-5; [Anonymous], 2010, WORLD HLTH STAT 2010; [Anonymous], 2008, WORLD HLTH STAT 2008; Bureau of Health Economics and Financing, 2009, ANN HLTH FIN REP 200; Carrin G, 2008, B WORLD HEALTH ORGAN, V86, P857, DOI 10.2471/BLT.07.049387; Chee HL, 2008, SOC SCI MED, V66, P2145, DOI 10.1016/j.socscimed.2008.01.036; Chongsuvivatwong V, 2011, LANCET, V377, P429, DOI 10.1016/S0140-6736(10)61507-3; Department of Health, 2010, HLTH SECT REF AG MON; Economic Strategies Committee, 2010, FOST INCL GROWTH; Ezat WPS, 2009, MED HEALTH-KUALA LUM, V4, P53; Garrett L, 2009, LANCET, V374, P1294, DOI 10.1016/S0140-6736(09)61503-8; Gilson L, 1998, PHP PUBLICATION; Green A, 2000, INT J HEALTH PLAN M, V15, P39, DOI 10.1002/(SICI)1099-1751(200001/03)15:1<39::AID-HPM567>3.0.CO;2-9; Hardeman W, 2004, HEALTH POLICY PLANN, V19, P22, DOI 10.1093/heapol/czh003; Hayati N, 2010, J COMMUN HEALTH, V16, P60; International Health Policy Program, 2010, EFF PUBL HLTH INS SC; Ir P, 2010, HEALTH POLICY, V96, P200, DOI 10.1016/j.healthpol.2010.02.003; Jacobs B, 2004, HEALTH POLICY PLANN, V19, P310, DOI 10.1093/heapol/czh036; Jacobs B, 2006, HEALTH POLICY PLANN, V21, P27, DOI 10.1093/heapol/czj001; James CD, 2006, APPL HEALTH ECON HEA, V5, P137, DOI 10.2165/00148365-200605030-00001; Kawabata K, 2002, B WORLD HEALTH ORGAN, V80, P612; Kwon S, 2003, HEALTH POLICY PLANN, V18, P84, DOI 10.1093/heapol/18.1.84; Lane C, 2007, SCALING BETTER HLTH; Langenbrunner JC, 2009, DESIGNING AND IMPLEMENTING HEALTH CARE PROVIDER PAYMENT SYSTEMS: HOW-TO MANUALS, P1; Limwattananon S, 2007, B WORLD HEALTH ORGAN, V85, P600, DOI 10.2471/BLT.06.033720; Mills A, 2000, HEALTH POLICY, V51, P163, DOI 10.1016/S0168-8510(00)00059-2; National Statistical Coordinating Board, 2005, PHIL NAT HLTH ACC; National Statistical Coordinating Board, 2008, 2008 PHIL STAT YB; National Statistical Coordinating Board, 2007, PHIL NAT HLTH ACC; National Statistics Office, 2010, 2008 NAT DEM HLTH SU; Nitayarumphong S, 1998, ACHIEVING UNIVERSAL; Noirhomme M, 2007, HEALTH POLICY PLANN, V22, P246, DOI 10.1093/heapol/czm015; O'Donnell O, 2008, J HEALTH ECON, V27, P460, DOI 10.1016/j.jhealeco.2007.08.005; Organisation for Economic Co-operation and Development, PAR DECL ACCR AG ACT; Pannarunothai S, 2000, HEALTH POLICY PLANN, V15, P303, DOI 10.1093/heapol/15.3.303; Pannarunothai S, 1997, SOC SCI MED, V44, P1781, DOI 10.1016/S0277-9536(96)00287-0; Patcharanarumol W., 2008, THESIS U LONDON; Patcharanarumol W, 2009, J INT DEV, V21, P212, DOI 10.1002/jid.1549; PhilHealth, 2006, C EXT SOC HLTH INS I; Prakongsai P, 2009, ADV HEALTH ECON HEAL, V21, P57, DOI 10.1108/S0731-2199(2009)0000021006; Ranson MK, 2002, B WORLD HEALTH ORGAN, V80, P613; Sharifa Ezat WP, 2008, J COMMUNITY HLTH, V13, P11; Somanathan, 2009, HLTH FINANCING INDON; Somkotra T, 2008, SOC SCI MED, V67, P2027, DOI 10.1016/j.socscimed.2008.09.047; Tangcharoensathien V, 2004, B WORLD HEALTH ORGAN, V82, P750; Tangcharoensathien V, 1999, SOC SCI MED, V48, P913, DOI 10.1016/S0277-9536(98)00392-X; Tangcharoensathien V, 1990, THESIS U LONDON THAI; Tangcharoensathien V, 2010, BUILDING DECENT SOCIETIES: RETHINKING THE ROLE OF SOCIAL SECURITY IN DEVELOPMENT, P310; Tangcharoensathien V, 2005, SOC POLICY DEV CONTE, P257; Taskforce on Innovative International Financing for Health Systems, 2009, CONSTR SCAL COSTS; Thai working group on National Health Account, 2010, REP 1994 2008 NAT HL; Van Doorslaer E, 2007, HEALTH ECON, V16, P1159, DOI 10.1002/hec.1209; Wagstaff A, 2007, 4111 WORLD BANK; Wagstaff A., 2007, 4134 WPS WORLD BANK; Waters H, 2003, HEALTH POLICY PLANN, V18, P172, DOI 10.1093/heapol/czg022; WHO, 2010, ESS MED MON 2010; WHO, 2009, HLTH FIN STRAT AS PA; WHO, WHA5833 WHO; WHO, 2009, NAT HLTH ACC EST PHI; World Bank, WORLD DEV IND; World Bank, POV IND; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; Xu K, 2007, HEALTH AFFAIR, V26, P972, DOI 10.1377/hlthaff.26.4.972; Yip W, 2008, HEALTH AFFAIR, V27, P460, DOI 10.1377/hlthaff.27.2.460; Yon R., 2002, HLTH EC ISSUES MALAY, P87; Yon R B, 2001, Asia Pac J Public Health, V13, P54, DOI 10.1177/101053950101300112; Yu CP, 2006, INT J HEALTH PLAN M, V21, P193, DOI 10.1002/hpm.845; Yu CP, 2008, INT J EQUITY HEALTH, V7, DOI 10.1186/1475-9276-7-15	68	153	155	3	61	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 5	2011	377	9768					863	873		10.1016/S0140-6736(10)61890-9	http://dx.doi.org/10.1016/S0140-6736(10)61890-9			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	738GO	21269682	Green Accepted			2022-12-28	WOS:000288628500034
J	Iglehart, JK				Iglehart, John K.			Bundled Payment for ESRD - Including ESAs in Medicare's Dialysis Package	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Centers for Medicare & Medicaid Services (CMS) HHS, 2010, Fed Regist, V75, P49029; FIELDS R, 2010, PROPUBLICA      1109; *MED PAYM ADV COMM, 2001, REP C MED PAYM POL; ZHANG Y, 2010, HLTH SERV RES   1209, DOI DOI 10.1111/J.1475-6773.2010.01219.X	5	24	25	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2011	364	7					593	595		10.1056/NEJMp1014187	http://dx.doi.org/10.1056/NEJMp1014187			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	722BW	21323538	Bronze			2022-12-28	WOS:000287406000001
J	Baraniuk, RG				Baraniuk, Richard G.			More Is Less: Signal Processing and the Data Deluge	SCIENCE			English	Editorial Material								The data deluge is changing the operating environment of many sensing systems from data-poor to data-rich-so data-rich that we are in jeopardy of being overwhelmed. Managing and exploiting the data deluge require a reinvention of sensor system design and signal processing theory. The potential pay-offs are huge, as the resulting sensor systems will enable radically new information technologies and powerful new tools for scientific discovery.	Rice Univ, Dept Elect & Comp Engn, Houston, TX 77251 USA	Rice University	Baraniuk, RG (corresponding author), Rice Univ, Dept Elect & Comp Engn, POB 1892, Houston, TX 77251 USA.	richb@rice.edu	Baraniuk, Richard/ABA-1743-2020					Baraniuk RG, 2009, FOUND COMPUT MATH, V9, P51, DOI 10.1007/s10208-007-9011-z; Candes EJ, 2006, IEEE T INFORM THEORY, V52, P489, DOI 10.1109/TIT.2005.862083; Chatrchyan S, 2008, J INSTRUM, V3, DOI 10.1088/1748-0221/3/08/S08004; Donoho DL, 2006, IEEE T INFORM THEORY, V52, P1289, DOI 10.1109/TIT.2006.871582; Muthukrishnan S, 2005, FOUND TRENDS THEOR C, V1, P1, DOI 10.1561/0400000002; Reinsel, 2010, DIGITAL UNIVERSE DEC; Snavely N, 2006, ACM T GRAPHIC, V25, P835, DOI 10.1145/1141911.1141964; Tenenbaum JB, 2000, SCIENCE, V290, P2319, DOI 10.1126/science.290.5500.2319; U. S. National Academy of Engineering and Royal Academy of Engineering, 2010, FRONT ENG EU US S CA	9	152	167	0	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					717	719		10.1126/science.1197448	http://dx.doi.org/10.1126/science.1197448			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21311012				2022-12-28	WOS:000287205700055
J	Lane, J; Bertuzzi, S				Lane, Julia; Bertuzzi, Stefano			Measuring the Results of Science Investments	SCIENCE			English	Editorial Material									[Lane, Julia] Natl Sci Fdn, Arlington, VA 22230 USA; [Bertuzzi, Stefano] NIH, NIH Off Sci Policy Anal, Bethesda, MD 20892 USA	National Science Foundation (NSF); National Institutes of Health (NIH) - USA	Lane, J (corresponding author), Natl Sci Fdn, 4201 Wilson Blvd, Arlington, VA 22230 USA.	jlane@nsf.gov; stefano_bertuzzi@nih.gov		Lane, Julia/0000-0002-8139-2960				[Anonymous], 2010, WORKSH CHANG COND SC; [Anonymous], 2009, EUFORDIA CONCL REC; Arora A., 2010, CONTRIBUTIONS MEMORY, P91; Committee on National Statistics, 2010, DAT FED RES DEV INV; Cummings JN, 2005, SOC STUD SCI, V35, P703, DOI 10.1177/0306312705055535; Fleming L., 2009, GRANT COMMERCIALIZAT; Herr BW, 2009, INF VIS 2009 13 INT; Hicks D., 2010, WORKSH SCI SCI MEAS; Interagency Task Group on Science Policy, 2008, SCI SCI POL FED RES; Macilwain C, 2010, NATURE, V465, P682, DOI 10.1038/465682a; Macilwain C, 2010, NATURE, V463, P291, DOI 10.1038/463291a; Orszag Peter R., 2010, SCI TECHNOLOGY PRIOR; Rockwell S., 2009, RES MANAGE REV, V16, P28; Smith J., 2010, STRENGTHENING EVIDEN, V1, P59; Stokes D. E., 1997, PASTEURS QUADRANT BA	15	85	87	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					678	680		10.1126/science.1201865	http://dx.doi.org/10.1126/science.1201865			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21310987				2022-12-28	WOS:000287205700031
J	Plotkin, JB				Plotkin, Joshua B.			The Lives of Proteins	SCIENCE			English	Editorial Material							EXPRESSION; YEAST		[Plotkin, Joshua B.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Plotkin, Joshua B.] Univ Penn, Program Appl Math & Computat Sci, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Plotkin, JB (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	jplotkin@sas.upenn.edu	Plotkin, Joshua B/E-6947-2013					Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Eden E, 2011, SCIENCE, V331, P764, DOI 10.1126/science.1199784; Eldar A, 2010, NATURE, V467, P167, DOI 10.1038/nature09326; Fraser HB, 2004, PLOS BIOL, V2, P834, DOI 10.1371/journal.pbio.0020137; JAMIESON JD, 1967, J CELL BIOL, V34, P577, DOI 10.1083/jcb.34.2.577; LIU HP, 1992, GENETICS, V132, P665; Lu P, 2007, NAT BIOTECHNOL, V25, P117, DOI 10.1038/nbt1270; Patterson GH, 2002, SCIENCE, V297, P1873, DOI 10.1126/science.1074952; Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Thattai M, 2004, GENETICS, V167, P523, DOI 10.1534/genetics.167.1.523; Vogel C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.59; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489	14	10	10	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					683	684		10.1126/science.1202010	http://dx.doi.org/10.1126/science.1202010			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21310990				2022-12-28	WOS:000287205700034
J	Baker, M				Baker, Monya			GENOMES IN THREE DIMENSIONS	NATURE			English	Editorial Material							CHROMATIN; ORGANIZATION											Bau D, 2011, NAT STRUCT MOL BIOL, V18, P107, DOI 10.1038/nsmb.1936; Branco MR, 2006, PLOS BIOL, V4, P780, DOI 10.1371/journal.pbio.0040138; Carter D, 2002, NAT GENET, V32, P623, DOI 10.1038/ng1051; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Duan Z, 2010, NATURE, V465, P363, DOI 10.1038/nature08973; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Greil F, 2006, METHOD ENZYMOL, V410, P342, DOI 10.1016/S0076-6879(06)10016-6; Horike S, 2005, NAT GENET, V37, P31, DOI 10.1038/ng1491; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Meaburn KJ, 2009, J CELL BIOL, V187, P801, DOI 10.1083/jcb.200909127; Osborne CS, 2007, PLOS BIOL, V5, P1763, DOI 10.1371/journal.pbio.0050192; Roix JJ, 2003, NAT GENET, V34, P287, DOI 10.1038/ng1177; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Solovei I, 2009, CELL, V137, P356, DOI 10.1016/j.cell.2009.01.052; Tanizawa H, 2010, NUCLEIC ACIDS RES, V38, P8164, DOI 10.1093/nar/gkq955; Tolhuis B, 2002, MOL CELL, V10, P1453, DOI 10.1016/S1097-2765(02)00781-5; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891	20	19	20	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					289	294		10.1038/470289a	http://dx.doi.org/10.1038/470289a			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307943	Bronze			2022-12-28	WOS:000287144200050
J	Colbourne, JK; Pfrender, ME; Gilbert, D; Thomas, WK; Tucker, A; Oakley, TH; Tokishita, S; Aerts, A; Arnold, GJ; Basu, MK; Bauer, DJ; Caceres, CE; Carmel, L; Casola, C; Choi, JH; Detter, JC; Dong, QF; Dusheyko, S; Eads, BD; Frohlich, T; Geiler-Samerotte, KA; Gerlach, D; Hatcher, P; Jogdeo, S; Krijgsveld, J; Kriventseva, EV; Kultz, D; Laforsch, C; Lindquist, E; Lopez, J; Manak, JR; Muller, J; Pangilinan, J; Patwardhan, RP; Pitluck, S; Pritham, EJ; Rechtsteiner, A; Rho, M; Rogozin, IB; Sakarya, O; Salamov, A; Schaack, S; Shapiro, H; Shiga, Y; Skalitzky, C; Smith, Z; Souvorov, A; Sung, W; Tang, ZJ; Tsuchiya, D; Tu, H; Vos, H; Wang, M; Wolf, YI; Yamagata, H; Yamada, T; Ye, YZ; Shaw, JR; Andrews, J; Crease, TJ; Tang, HX; Lucas, SM; Robertson, HM; Bork, P; Koonin, EV; Zdobnov, EM; Grigoriev, IV; Lynch, M; Boore, JL				Colbourne, John K.; Pfrender, Michael E.; Gilbert, Donald; Thomas, W. Kelley; Tucker, Abraham; Oakley, Todd H.; Tokishita, Shinichi; Aerts, Andrea; Arnold, Georg J.; Basu, Malay Kumar; Bauer, Darren J.; Caceres, Carla E.; Carmel, Liran; Casola, Claudio; Choi, Jeong-Hyeon; Detter, John C.; Dong, Qunfeng; Dusheyko, Serge; Eads, Brian D.; Froehlich, Thomas; Geiler-Samerotte, Kerry A.; Gerlach, Daniel; Hatcher, Phil; Jogdeo, Sanjuro; Krijgsveld, Jeroen; Kriventseva, Evgenia V.; Kueltz, Dietmar; Laforsch, Christian; Lindquist, Erika; Lopez, Jacqueline; Manak, J. Robert; Muller, Jean; Pangilinan, Jasmyn; Patwardhan, Rupali P.; Pitluck, Samuel; Pritham, Ellen J.; Rechtsteiner, Andreas; Rho, Mina; Rogozin, Igor B.; Sakarya, Onur; Salamov, Asaf; Schaack, Sarah; Shapiro, Harris; Shiga, Yasuhiro; Skalitzky, Courtney; Smith, Zachary; Souvorov, Alexander; Sung, Way; Tang, Zuojian; Tsuchiya, Dai; Tu, Hank; Vos, Harmjan; Wang, Mei; Wolf, Yuri I.; Yamagata, Hideo; Yamada, Takuji; Ye, Yuzhen; Shaw, Joseph R.; Andrews, Justen; Crease, Teresa J.; Tang, Haixu; Lucas, Susan M.; Robertson, Hugh M.; Bork, Peer; Koonin, Eugene V.; Zdobnov, Evgeny M.; Grigoriev, Igor V.; Lynch, Michael; Boore, Jeffrey L.			The Ecoresponsive Genome of Daphnia pulex	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; GENES; EXPRESSION; DUPLICATIONS; EVOLUTION; MAGNA	We describe the draft genome of the microcrustacean Daphnia pulex, which is only 200 megabases and contains at least 30,907 genes. The high gene count is a consequence of an elevated rate of gene duplication resulting in tandem gene clusters. More than a third of Daphnia's genes have no detectable homologs in any other available proteome, and the most amplified gene families are specific to the Daphnia lineage. The coexpansion of gene families interacting within metabolic pathways suggests that the maintenance of duplicated genes is not random, and the analysis of gene expression under different environmental conditions reveals that numerous paralogs acquire divergent expression patterns soon after duplication. Daphnia-specific genes, including many additional loci within sequenced regions that are otherwise devoid of annotations, are the most responsive genes to ecological challenges.	[Colbourne, John K.; Gilbert, Donald; Choi, Jeong-Hyeon; Dong, Qunfeng; Eads, Brian D.; Lopez, Jacqueline; Patwardhan, Rupali P.; Rechtsteiner, Andreas; Smith, Zachary; Tang, Zuojian; Tsuchiya, Dai; Shaw, Joseph R.; Andrews, Justen; Tang, Haixu] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN 47405 USA; [Pfrender, Michael E.] Utah State Univ, Dept Biol, Logan, UT 84322 USA; [Gilbert, Donald; Tucker, Abraham; Casola, Claudio; Eads, Brian D.; Schaack, Sarah; Andrews, Justen; Lynch, Michael] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Thomas, W. Kelley; Tucker, Abraham; Bauer, Darren J.; Hatcher, Phil; Jogdeo, Sanjuro; Sung, Way] Univ New Hampshire, Hubbard Ctr Genome Studies, Durham, NH 03824 USA; [Oakley, Todd H.; Geiler-Samerotte, Kerry A.; Sakarya, Onur] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Tokishita, Shinichi; Shiga, Yasuhiro; Yamagata, Hideo] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Div Environm Sci, Lab Environm & Mol Biol, Tokyo 1920392, Japan; [Aerts, Andrea; Detter, John C.; Dusheyko, Serge; Lindquist, Erika; Pangilinan, Jasmyn; Pitluck, Samuel; Salamov, Asaf; Shapiro, Harris; Tu, Hank; Wang, Mei; Lucas, Susan M.; Grigoriev, Igor V.; Boore, Jeffrey L.] JGI, Dept Energy, Walnut Creek, CA 94598 USA; [Arnold, Georg J.; Froehlich, Thomas] Univ Munich, Gene Ctr, Lab Funct Genome Anal LAFUGA, D-82152 Planegg Martinsried, Germany; [Basu, Malay Kumar; Carmel, Liran; Rogozin, Igor B.; Souvorov, Alexander; Wolf, Yuri I.; Koonin, Eugene V.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Caceres, Carla E.] Univ Illinois, Sch Integrat Biol, Urbana, IL 61801 USA; [Gerlach, Daniel; Kriventseva, Evgenia V.; Zdobnov, Evgeny M.] Univ Geneva, Sch Med, CH-1211 Geneva, Switzerland; [Gerlach, Daniel; Kriventseva, Evgenia V.; Zdobnov, Evgeny M.] Swiss Inst Bioinformat, CH-1211 Geneva, Switzerland; [Krijgsveld, Jeroen; Vos, Harmjan] Univ Utrecht, Bijvoet Ctr Biomol Res, Biomol Mass Spectrometry & Prote Grp, NL-3584 CA Utrecht, Netherlands; [Krijgsveld, Jeroen; Vos, Harmjan] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CA Utrecht, Netherlands; [Krijgsveld, Jeroen; Vos, Harmjan] Univ Utrecht, Netherlands Prote Ctr, NL-3584 CA Utrecht, Netherlands; [Kueltz, Dietmar] Univ Calif Davis, Dept Anim Sci, Davis, CA 95616 USA; [Laforsch, Christian] Univ Munich, Dept Biol 2, D-82152 Planegg Martinsried, Germany; [Laforsch, Christian] Univ Munich, GeoBio Ctr Munich, D-82152 Planegg Martinsried, Germany; [Manak, J. Robert; Skalitzky, Courtney] Roche NimbleGen Inc, Gene Express, Madison, WI 53719 USA; [Muller, Jean; Yamada, Takuji; Bork, Peer] European Mol Biol Lab, Struct & Computat Biol Unit, D-69117 Heidelberg, Germany; [Pritham, Ellen J.; Schaack, Sarah] Univ Texas Arlington, Dept Biol, Arlington, TX 76019 USA; [Rho, Mina; Ye, Yuzhen; Tang, Haixu] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47408 USA; [Shaw, Joseph R.] Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN 47405 USA; [Crease, Teresa J.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Robertson, Hugh M.] Univ Illinois, Dept Entomol, Urbana, IL 61801 USA; [Zdobnov, Evgeny M.] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England; [Boore, Jeffrey L.] Genome Project Solut, Hercules, CA 94547 USA; [Boore, Jeffrey L.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	Indiana University System; Indiana University Bloomington; Utah System of Higher Education; Utah State University; Indiana University System; Indiana University Bloomington; University System Of New Hampshire; University of New Hampshire; University of California System; University of California Santa Barbara; Tokyo University of Pharmacy & Life Sciences; United States Department of Energy (DOE); Joint Genome Institute - JGI; University of Munich; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University of Illinois System; University of Illinois Urbana-Champaign; University of Geneva; Swiss Institute of Bioinformatics; Utrecht University; Utrecht University; Utrecht University; University of California System; University of California Davis; University of Munich; University of Munich; Roche Holding; European Molecular Biology Laboratory (EMBL); University of Texas System; University of Texas Arlington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Guelph; University of Illinois System; University of Illinois Urbana-Champaign; Imperial College London; University of California System; University of California Berkeley	Colbourne, JK (corresponding author), Indiana Univ, Ctr Genom & Bioinformat, 915 E 3rd St, Bloomington, IN 47405 USA.	jcolbour@indiana.edu	Crease, Teresa/E-2932-2015; Zdobnov, Evgeny/AAB-2745-2022; Muller, Jean/L-7412-2018; Choi, Jeong-Hyeon/E-3084-2010; Zdobnov, Evgeny M/K-1133-2012; Fröhlich, Thomas/C-6735-2011; Colbourne, John K/L-7748-2014; Krijgsveld, Jeroen/F-5974-2011; , DK/AAU-3163-2021; Bork, Peer/F-1813-2013; Choi, Justin/F-8792-2014; Pfrender, Micheal E./C-5065-2019	Crease, Teresa/0000-0001-8074-8024; Zdobnov, Evgeny/0000-0002-5178-1498; Muller, Jean/0000-0002-7682-559X; Fröhlich, Thomas/0000-0002-4709-3211; Colbourne, John K/0000-0002-6966-2972; Bork, Peer/0000-0002-2627-833X; Vos, Harmjan/0000-0002-4696-6068; Casola, Claudio/0000-0003-4853-1866; Rechtsteiner, Andreas/0000-0001-6031-1087; Krijgsveld, Jeroen/0000-0001-7549-9326; Wolf, Yuri/0000-0002-0247-8708; Gerlach, Daniel/0000-0001-9338-3765; Manak, John/0000-0002-6562-7694; Grigoriev, Igor/0000-0002-3136-8903; Rogozin, Igor/0000-0003-0802-4851; Oakley, Todd/0000-0002-4478-915X	Office of Science of the U.S. Department of Energy [DE-AC02-05CH11231]; Daphnia Genomics Consortium (DGC); NSF [0221837, 0328516]; NIH [R24GM07827401]; METACyt Initiative of Indiana University; Lilly Endowment, Inc.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699, R01ES019324] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM078274] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIALM000073] Funding Source: NIH RePORTER	Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); Daphnia Genomics Consortium (DGC); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); METACyt Initiative of Indiana University; Lilly Endowment, Inc.; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	We thank M. Frazer (JGI), P. Cherbas (CGB), R. Green, and T. Takova (Roche NimbleGen, Inc.). The work conducted by the U.S. Department of Energy Joint Genome Institute (JGI) was supported by the Office of Science of the U.S. Department of Energy under contract DE-AC02-05CH11231 and in collaboration with the Daphnia Genomics Consortium (DGC). This project was also supported by NSF grants 0221837 and 0328516 and NIH grant R24GM07827401. Coordination infrastructure for the DGC is provided by the Center for Genomics and Bioinformatics (CGB) at Indiana University, which is supported in part by the METACyt Initiative of Indiana University, funded in part through a major grant from the Lilly Endowment, Inc. Additional contributions and acknowledgments are provided in the SOM. Our work benefits from and contributes to the Daphnia Genomics Consortium. Daphnia pulex genome assembly version 1.1 and annotations are deposited at DNA Data Bank of Japan, European Molecular Biology Laboratory, and GenBank databases under accession ACJG00000000. ESTs (FE274839 to FE425949) are in GenBank. Microarray platforms GPL11200 to GPL11201 and data GSE25823 are deposited at National Center for Biotechnology Information Gene Expression Omnibus database.	Aparicio S, 2002, SCIENCE, V297, P1301, DOI 10.1126/science.1072104; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; CARPENTER SR, 1987, ECOLOGY, V68, P1863, DOI 10.2307/1939878; Casneuf T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r13; Colbourne John K., 1997, P163; Cristescu MEA, 2006, GENOMICS, V88, P415, DOI 10.1016/j.ygeno.2006.03.007; Gu ZL, 2004, NAT GENET, V36, P577, DOI 10.1038/ng1355; Hebert P.D.N., 1987, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V45, P439; Hoffmann FG, 2008, MOL BIOL EVOL, V25, P591, DOI 10.1093/molbev/msn004; Innan H, 2010, NAT REV GENET, V11, P97, DOI 10.1038/nrg2689; Katju V, 2006, MOL BIOL EVOL, V23, P1056, DOI 10.1093/molbev/msj114; Kimura S, 1999, J BIOL CHEM, V274, P10649, DOI 10.1074/jbc.274.15.10649; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Lercher MJ, 2003, GENOME RES, V13, P238, DOI 10.1101/gr.553803; Lynch Michael, 1994, P109; Martins J, 2007, ENVIRON INT, V33, P414, DOI 10.1016/j.envint.2006.12.006; Pena-Castillo L, 2007, GENETICS, V176, P7, DOI 10.1534/genetics.107.074468; Shaw JR, 2008, ADV EXP BIOL, V2, P165, DOI 10.1016/S1872-2423(08)00005-7; Storz UC, 1998, J COMP PHYSIOL A, V183, P709, DOI 10.1007/s003590050293; Taylor DJ, 1999, P ROY SOC B-BIOL SCI, V266, P791, DOI 10.1098/rspb.1999.0707; Tollrian R, 1998, ECOLOGY AND EVOLUTION OF INDUCIBLE DEFENSES, P177; Wang FY, 2009, VISION RES, V49, P1860, DOI 10.1016/j.visres.2009.04.023; Zeis B, 2008, COMP BIOCHEM PHYS A, V151, pS38, DOI 10.1016/j.cbpa.2008.05.141; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108	24	901	953	10	379	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					555	561		10.1126/science.1197761	http://dx.doi.org/10.1126/science.1197761			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292972	Green Submitted, Green Accepted			2022-12-28	WOS:000286933600046
J	Howell, P				Howell, Peter			Listen to the lessons of The King's Speech	NATURE			English	Editorial Material									UCL, London WC1E 6BT, England	University of London; University College London	Howell, P (corresponding author), UCL, London WC1E 6BT, England.	p.howell@ucl.ac.uk							0	0	0	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2011	470	7332					7	7		10.1038/470007a	http://dx.doi.org/10.1038/470007a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715LQ	21293331				2022-12-28	WOS:000286886400004
J	Seibert, MM; Ekeberg, T; Maia, FRNC; Svenda, M; Andreasson, J; Jonsson, O; Odic, D; Iwan, B; Rocker, A; Westphal, D; Hantke, M; DePonte, DP; Barty, A; Schulz, J; Gumprecht, L; Coppola, N; Aquila, A; Liang, MN; White, TA; Martin, A; Caleman, C; Stern, S; Abergel, C; Seltzer, V; Claverie, JM; Bostedt, C; Bozek, JD; Boutet, S; Miahnahri, AA; Messerschmidt, M; Krzywinski, J; Williams, G; Hodgson, KO; Bogan, MJ; Hampton, CY; Sierra, RG; Starodub, D; Andersson, I; Bajt, S; Barthelmess, M; Spence, JCH; Fromme, P; Weierstall, U; Kirian, R; Hunter, M; Doak, RB; Marchesini, S; Hau-Riege, SP; Frank, M; Shoeman, RL; Lomb, L; Epp, SW; Hartmann, R; Rolles, D; Rudenko, A; Schmidt, C; Foucar, L; Kimmel, N; Holl, P; Rudek, B; Erk, B; Homke, A; Reich, C; Pietschner, D; Weidenspointner, G; Struder, L; Hauser, G; Gorke, H; Ullrich, J; Schlichting, I; Herrmann, S; Schaller, G; Schopper, F; Soltau, H; Kuhnel, KU; Andritschke, R; Schroter, CD; Krasniqi, F; Bott, M; Schorb, S; Rupp, D; Adolph, M; Gorkhover, T; Hirsemann, H; Potdevin, G; Graafsma, H; Nilsson, B; Chapman, HN; Hajdu, J				Seibert, M. Marvin; Ekeberg, Tomas; Maia, Filipe R. N. C.; Svenda, Martin; Andreasson, Jakob; Joensson, Olof; Odic, Dusko; Iwan, Bianca; Rocker, Andrea; Westphal, Daniel; Hantke, Max; DePonte, Daniel P.; Barty, Anton; Schulz, Joachim; Gumprecht, Lars; Coppola, Nicola; Aquila, Andrew; Liang, Mengning; White, Thomas A.; Martin, Andrew; Caleman, Carl; Stern, Stephan; Abergel, Chantal; Seltzer, Virginie; Claverie, Jean-Michel; Bostedt, Christoph; Bozek, John D.; Boutet, Sebastien; Miahnahri, A. Alan; Messerschmidt, Marc; Krzywinski, Jacek; Williams, Garth; Hodgson, Keith O.; Bogan, Michael J.; Hampton, Christina Y.; Sierra, Raymond G.; Starodub, Dmitri; Andersson, Inger; Bajt, Sasa; Barthelmess, Miriam; Spence, John C. H.; Fromme, Petra; Weierstall, Uwe; Kirian, Richard; Hunter, Mark; Doak, R. Bruce; Marchesini, Stefano; Hau-Riege, Stefan P.; Frank, Matthias; Shoeman, Robert L.; Lomb, Lukas; Epp, Sascha W.; Hartmann, Robert; Rolles, Daniel; Rudenko, Artem; Schmidt, Carlo; Foucar, Lutz; Kimmel, Nils; Holl, Peter; Rudek, Benedikt; Erk, Benjamin; Hoemke, Andre; Reich, Christian; Pietschner, Daniel; Weidenspointner, Georg; Strueder, Lothar; Hauser, Guenter; Gorke, Hubert; Ullrich, Joachim; Schlichting, Ilme; Herrmann, Sven; Schaller, Gerhard; Schopper, Florian; Soltau, Heike; Kuehnel, Kai-Uwe; Andritschke, Robert; Schroeter, Claus-Dieter; Krasniqi, Faton; Bott, Mario; Schorb, Sebastian; Rupp, Daniela; Adolph, Marcus; Gorkhover, Tais; Hirsemann, Helmut; Potdevin, Guillaume; Graafsma, Heinz; Nilsson, Bjoern; Chapman, Henry N.; Hajdu, Janos			Single mimivirus particles intercepted and imaged with an X-ray laser	NATURE			English	Article							FREE-ELECTRON LASER; DIFFRACTION MICROSCOPY; VIROPHAGE	X-ray lasers offer new capabilities in understanding the structure of biological systems, complex materials and matter under extreme conditions(1-4). Very short and extremely bright, coherent X-ray pulses can be used to outrun key damage processes and obtain a single diffraction pattern from a large macromolecule, a virus or a cell before the sample explodes and turns into plasma(1). The continuous diffraction pattern of non-crystalline objects permits oversampling and direct phase retrieval(2). Here we show that high-quality diffraction data can be obtained with a single X-ray pulse from a noncrystalline biological sample, a single mimivirus particle, which was injected into the pulsed beam of a hard-X-ray free-electron laser, the Linac Coherent Light Source(5). Calculations indicate that the energy deposited into the virus by the pulse heated the particle to over 100,000 K after the pulse had left the sample. The reconstructed exit wavefront (image) yielded 32-nm full-period resolution in a single exposure and showed no measurable damage. The reconstruction indicates inhomogeneous arrangement of dense material inside the virion. We expect that significantly higher resolutions will be achieved in such experiments with shorter and brighter photon pulses focused to a smaller area. The resolution in such experiments can be further extended for samples available in multiple identical copies.	[Seibert, M. Marvin; Ekeberg, Tomas; Maia, Filipe R. N. C.; Svenda, Martin; Andreasson, Jakob; Joensson, Olof; Odic, Dusko; Iwan, Bianca; Rocker, Andrea; Westphal, Daniel; Hantke, Max; Caleman, Carl; Hajdu, Janos] Uppsala Univ, Dept Cell & Mol Biol, Lab Mol Biophys, SE-75124 Uppsala, Sweden; [DePonte, Daniel P.; Barty, Anton; Schulz, Joachim; Gumprecht, Lars; Coppola, Nicola; Aquila, Andrew; Liang, Mengning; White, Thomas A.; Martin, Andrew; Caleman, Carl; Stern, Stephan; Chapman, Henry N.] DESY, Ctr Free Electron Laser Sci, D-22607 Hamburg, Germany; [Stern, Stephan; Chapman, Henry N.] Univ Hamburg, D-22607 Hamburg, Germany; [Abergel, Chantal; Seltzer, Virginie; Claverie, Jean-Michel] Aix Marseille Univ, CNRS, UPR2589, Inst Microbiol & Mediterranee, F-13288 Marseille 9, France; [Bostedt, Christoph; Bozek, John D.; Boutet, Sebastien; Miahnahri, A. Alan; Messerschmidt, Marc; Krzywinski, Jacek; Williams, Garth] SLAC Natl Accelerator Lab, LCLS, Menlo Pk, CA 94025 USA; [Hodgson, Keith O.; Bogan, Michael J.; Hampton, Christina Y.; Sierra, Raymond G.; Starodub, Dmitri] SLAC Natl Accelerator Lab, PULSE Inst, Menlo Pk, CA 94025 USA; [Andersson, Inger] Swedish Univ Agr Sci, Uppsala Biomed Ctr, Dept Mol Biol, S-75124 Uppsala, Sweden; [Spence, John C. H.; Weierstall, Uwe; Kirian, Richard; Doak, R. Bruce] Arizona State Univ, Dept Phys, PSF470, Tempe, AZ 85287 USA; [Fromme, Petra; Hunter, Mark] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Marchesini, Stefano] Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Hau-Riege, Stefan P.; Frank, Matthias] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; [Shoeman, Robert L.; Lomb, Lukas; Rolles, Daniel; Foucar, Lutz; Schlichting, Ilme; Krasniqi, Faton; Bott, Mario] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Epp, Sascha W.; Rolles, Daniel; Rudenko, Artem; Schmidt, Carlo; Foucar, Lutz; Rudek, Benedikt; Erk, Benjamin; Hoemke, Andre; Strueder, Lothar; Ullrich, Joachim; Schlichting, Ilme; Krasniqi, Faton] Max Planck Adv Study Grp, Ctr Free Electron Laser Sci, D-22607 Hamburg, Germany; [Epp, Sascha W.; Rudenko, Artem; Schmidt, Carlo; Rudek, Benedikt; Erk, Benjamin; Hoemke, Andre; Ullrich, Joachim; Kuehnel, Kai-Uwe; Schroeter, Claus-Dieter] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Hartmann, Robert; Holl, Peter; Reich, Christian; Soltau, Heike] PNSensor GmbH, D-80803 Munich, Germany; [Kimmel, Nils; Pietschner, Daniel; Weidenspointner, Georg; Strueder, Lothar; Hauser, Guenter; Herrmann, Sven; Schaller, Gerhard; Schopper, Florian; Andritschke, Robert] Max Planck Inst Halbleiterlab, D-81739 Munich, Germany; [Kimmel, Nils; Pietschner, Daniel; Weidenspointner, Georg; Strueder, Lothar; Hauser, Guenter; Herrmann, Sven; Schaller, Gerhard; Schopper, Florian; Andritschke, Robert] Max Planck Inst Extraterr Phys, D-85741 Garching, Germany; [Strueder, Lothar] Univ Siegen, D-57068 Siegen, Germany; [Gorke, Hubert] Forschungszentrum Julich, Inst ZEL, D-52425 Julich, Germany; [Schorb, Sebastian; Rupp, Daniela; Adolph, Marcus; Gorkhover, Tais] Tech Univ Berlin, Inst Opt & Atomare Phys, D-10623 Berlin, Germany	Uppsala University; Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Swedish University of Agricultural Sciences; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Max Planck Society; Max Planck Society; Max Planck Society; PNSensor GmbH; Max Planck Society; Max Planck Society; Universitat Siegen; Helmholtz Association; Research Center Julich; Technical University of Berlin	Hajdu, J (corresponding author), Uppsala Univ, Dept Cell & Mol Biol, Lab Mol Biophys, Husargatan 3,Box 596, SE-75124 Uppsala, Sweden.	chantal.abergel@igs.cnrs-mrs.fr; janos.hajdu@xray.bmc.uu.se	Bozek, John D/E-9260-2010; Frank, Matthias/O-9055-2014; Claverie, Jean Michel/Z-2183-2019; Claverie, Jean-Michel/AAG-4889-2019; Rudenko, Artem/C-7412-2009; Gorkhover, Tais/K-8468-2012; Rupp, Daniela/AAD-7978-2021; Rudek, Benedikt/AAX-1278-2021; Bajt, Sasa/G-2228-2010; Bogan, Mike/I-6962-2012; Barty, Anton/K-5137-2014; Bajt, Sasa/O-4695-2019; Messerschmidt, Marc/F-3796-2010; FRS, Henry N Chapman/G-2153-2010; Jönsson, H Olof/O-8664-2017; Maia, Filipe R.N.C./C-3146-2014; Rupp, Daniela/P-7590-2016; Kirian, Richard/M-3750-2013; Marchesini, Stefano/GYR-1409-2022; Schlichting, Ilme/I-1339-2013; Marchesini, Stefano/A-6795-2009; Weierstall, Uwe/B-3568-2011; Williams, Garth/H-1606-2012; Rudek, Benedikt/A-5100-2017; Messerschmidt, Marc/Y-8929-2019	Bozek, John D/0000-0001-7486-7238; Claverie, Jean-Michel/0000-0003-1424-0315; Rudenko, Artem/0000-0002-9154-8463; Rupp, Daniela/0000-0002-6504-7956; Rudek, Benedikt/0000-0002-6404-4294; Bogan, Mike/0000-0001-9318-3333; Barty, Anton/0000-0003-4751-2727; Bajt, Sasa/0000-0002-7163-7602; Messerschmidt, Marc/0000-0002-8641-3302; FRS, Henry N Chapman/0000-0002-4655-1743; Jönsson, H Olof/0000-0002-2076-0918; Maia, Filipe R.N.C./0000-0002-2141-438X; Marchesini, Stefano/0000-0002-6798-2913; Messerschmidt, Marc/0000-0002-8641-3302; Stern, Stephan/0000-0001-9786-7513; Kirian, Richard/0000-0001-7197-3086; Frank, Matthias/0000-0002-5244-0791; Erk, Benjamin/0000-0001-8413-3588; MARTIN, ANDREW/0000-0003-3704-1829; Seibert, Mark Marvin/0000-0003-0251-0744; Aquila, Andrew/0000-0003-0358-2774; Abergel, Chantal/0000-0003-1875-4049; RUDENKO, Artem/0000-0001-6771-2510; Schulz, Joachim/0000-0002-9310-8832; Epp, Sascha/0000-0001-6366-9113; graafsma, heinz/0000-0003-2304-667X; Andreasson, Jakob/0000-0002-3202-2330	Swedish Research Councils; Swedish Foundation for International Cooperation in Research and Higher Education; Stiftelsen Olle Engkvist Byggmastare; Swedish University of Agricultural Sciences; Helmholtz Association [VH-VI-302]; DFG Cluster of Excellence at the Munich Centre for Advanced Photonics; Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [ANR-BLAN08-0089]; Hamburg Ministry of Science and Research; Hamburg School for Structure and Dynamics; Max Planck Society; US National Science Foundation [MCB 0919195, MCB-1021557]; US Department of Energy through the PULSE Institute; Joachim Herz Stiftung, Hamburg Initiative for Excellence in Research (LEXI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095583] Funding Source: NIH RePORTER; Direct For Biological Sciences [1021557] Funding Source: National Science Foundation	Swedish Research Councils(Swedish Research Council); Swedish Foundation for International Cooperation in Research and Higher Education; Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council); Swedish University of Agricultural Sciences; Helmholtz Association(Helmholtz Association); DFG Cluster of Excellence at the Munich Centre for Advanced Photonics(German Research Foundation (DFG)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); Hamburg Ministry of Science and Research; Hamburg School for Structure and Dynamics; Max Planck Society(Max Planck SocietyFoundation CELLEX); US National Science Foundation(National Science Foundation (NSF)); US Department of Energy through the PULSE Institute(United States Department of Energy (DOE)); Joachim Herz Stiftung, Hamburg Initiative for Excellence in Research (LEXI); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the following agencies: the Swedish Research Councils; the Swedish Foundation for International Cooperation in Research and Higher Education; Stiftelsen Olle Engkvist Byggmastare; the Swedish University of Agricultural Sciences; the Helmholtz Association (VH-VI-302); the DFG Cluster of Excellence at the Munich Centre for Advanced Photonics; the Centre National de la Recherche Scientifique; Agence Nationale de la Recherche (ANR-BLAN08-0089); the Hamburg Ministry of Science and Research and Joachim Herz Stiftung, as part of the Hamburg Initiative for Excellence in Research (LEXI); the Hamburg School for Structure and Dynamics; the Max Planck Society, the US National Science Foundation (grants MCB 0919195 and MCB-1021557); and the US Department of Energy, through the PULSE Institute. Portions of this research were carried out at the Linac Coherent Light Source, a National User Facility operated by Stanford University on behalf of the US Department of Energy, Office of Basic Energy Sciences. We are grateful to B. Hedman and N. Timneanu for their help and to the scientific and technical staff of the LCLS for their outstanding facility and support.	Bergh M, 2008, Q REV BIOPHYS, V41, P181, DOI 10.1017/S003358350800471X; Bogan MJ, 2008, NANO LETT, V8, P310, DOI 10.1021/nl072728k; Bortel G, 2009, J STRUCT BIOL, V166, P226, DOI 10.1016/j.jsb.2009.01.005; Bozek JD, 2009, EUR PHYS J-SPEC TOP, V169, P129, DOI 10.1140/epjst/e2009-00982-y; Byrne D, 2009, GENOME RES, V19, P1233, DOI 10.1101/gr.091561.109; Chapman HN, 2006, NAT PHYS, V2, P839, DOI 10.1038/nphys461; Claverie JM, 2010, TRENDS GENET, V26, P431, DOI 10.1016/j.tig.2010.07.003; Claverie JM, 2009, ANNU REV GENET, V43, P49, DOI 10.1146/annurev-genet-102108-134255; DePonte DP, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/19/195505; Ding Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.254801; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/NPHOTON.2010.176, 10.1038/nphoton.2010.176]; Fung R, 2009, NAT PHYS, V5, P64, DOI [10.1038/nphys1129, 10.1038/NPHYS1129]; Hau-Riege SP, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.064801; Huldt G, 2003, J STRUCT BIOL, V144, P219, DOI 10.1016/j.jsb.2003.09.025; La Scola B, 2003, SCIENCE, V299, P2033; La Scola B, 2008, NATURE, V455, P100, DOI 10.1038/nature07218; Loh NTD, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026705; Luke DR, 2005, INVERSE PROBL, V21, P37, DOI 10.1088/0266-5611/21/1/004; Maia FRNC, 2010, J APPL CRYSTALLOGR, V43, P1535, DOI 10.1107/S0021889810036083; Maia FRNC, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.031905; Marchesini S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.140101; Nagler B, 2009, NAT PHYS, V5, P693, DOI 10.1038/NPHYS1341; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Perkins TT, 1997, SCIENCE, V276, P2016, DOI 10.1126/science.276.5321.2016; Raoult D, 2004, SCIENCE, V306, P1344, DOI 10.1126/science.1101485; Seibert MM, 2010, J PHYS B-AT MOL OPT, V43, DOI 10.1088/0953-4075/43/19/194015; Shapiro D, 2005, P NATL ACAD SCI USA, V102, P15343, DOI 10.1073/pnas.0503305102; Song CY, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.158101; Steinbrener J, 2010, OPT EXPRESS, V18, P18598, DOI 10.1364/OE.18.018598; Struder L, 2010, NUCL INSTRUM METH A, V614, P483, DOI 10.1016/j.nima.2009.12.053; Thibault P, 2006, ACTA CRYSTALLOGR A, V62, P248, DOI 10.1107/S0108767306016515; Xiao C, 2009, PLOS BIOL, V7, P958, DOI 10.1371/journal.pbio.1000092; Young L, 2010, NATURE, V466, P56, DOI 10.1038/nature09177	33	649	666	6	305	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2011	470	7332					78	U86		10.1038/nature09748	http://dx.doi.org/10.1038/nature09748			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293374	Green Accepted, Green Published			2022-12-28	WOS:000286886400037
J	Kim, NH; Kim, M; Lee, S; Yun, NR; Kim, KH; Park, SW; Kim, HB; Kim, NJ; Kim, EC; Park, WB; Oh, MD				Kim, Nak-Hyun; Kim, Moonsuk; Lee, Shinwon; Yun, Na Ra; Kim, Kye-Hyung; Park, Sang Won; Kim, Hong Bin; Kim, Nam-Joong; Kim, Eui-Chong; Park, Wan Beom; Oh, Myoung-don			Effect of Routine Sterile Gloving on Contamination Rates in Blood Culture A Cluster Randomized Trial	ANNALS OF INTERNAL MEDICINE			English	Article							VENIPUNCTURE SITE DISINFECTION; POVIDONE-IODINE; CHLORHEXIDINE GLUCONATE; CLINICAL-SIGNIFICANCE; SKIN PREPARATION; TINCTURE; ANTISEPSIS	Background: Blood culture contamination leads to inappropriate or unnecessary antibiotic use. However, practical guidelines are inconsistent about the routine use of sterile gloving in collection of blood for culture. Objective: To determine whether the routine use of sterile gloving before venipuncture reduces blood culture contamination rates. Design: Cluster randomized, assessor-blinded, crossover trial (ClinicalTrials.gov registration number: NCT00973063). Setting: Single-center trial involving medical wards and the intensive care unit. Participants: 64 interns in charge of collection of blood for culture were randomly assigned to routine-to-optional or optional-to-routine sterile gloving groups for 1854 adult patients who needed blood cultures. Intervention: During routine sterile gloving, the interns wore sterile gloves every time before venipuncture, but during optional sterile gloving, sterile gloves were worn only if needed. Measurements: Isolates from single positive blood cultures were classified as likely contaminant, possible contaminant, or true pathogen. Contamination rates were compared by using generalized mixed models. Results: A total of 10 520 blood cultures were analyzed: 5265 from the routine sterile gloving period and 5255 from the optional sterile gloving period. When possible contaminants were included, the contamination rate was 0.6% in routine sterile gloving and 1.1% in optional sterile gloving (adjusted odds ratio, 0.57 [95% CI, 0.37 to 0.87]; P = 0.009). When only likely contaminants were included, the contamination rate was 0.5% in routine sterile gloving and 0.9% in optional sterile gloving (adjusted odds ratio, 0.51 [CI, 0.31 to 0.83]; P = 0.007). Limitation: Blood cultures from the emergency department, surgical wards, and pediatric wards were not assessed. Conclusion: Routine sterile gloving before venipuncture may reduce blood culture contamination.	[Kim, Nak-Hyun; Kim, Moonsuk; Lee, Shinwon; Yun, Na Ra; Kim, Kye-Hyung; Park, Sang Won; Kim, Hong Bin; Kim, Nam-Joong; Kim, Eui-Chong; Park, Wan Beom; Oh, Myoung-don] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 110744, South Korea	Seoul National University (SNU)	Park, WB (corresponding author), Seoul Natl Univ, Coll Med, Dept Internal Med, 28 Yongon Dong, Seoul 110744, South Korea.	wbpark1@snu.ac.kr	Park, Wan Beom/AGO-0374-2022; Bin Kim, Hong/J-5452-2012; Park, Sang Won/J-5485-2012; Kim, Nam-Joong/J-2735-2012; Park, Wan Beom/GLU-9886-2022	Park, Wan Beom/0000-0003-0022-9625; Bin Kim, Hong/0000-0001-6262-372X; Park, Sang Won/0000-0002-0550-1897; Oh, Myoung-don/0000-0002-2344-7695; Kim, Nak-Hyun/0000-0003-1134-1364; Lee, Shinwon/0000-0001-7652-7093	Medical Research Collaborating Center at Seoul National University Hospital	Medical Research Collaborating Center at Seoul National University Hospital	The authors thank the Medical Research Collaborating Center at Seoul National University Hospital for their support for statistical analyses.	BATES DW, 1991, JAMA-J AM MED ASSOC, V265, P365, DOI 10.1001/jama.265.3.365; CHANDRASEKAR PH, 1994, ARCH INTERN MED, V154, P841, DOI 10.1001/archinte.154.8.841; Clinical and Laboratory Standards Institute, 2007, M47A CLSI; Eskira S, 2006, CLIN MICROBIOL INFEC, V12, P818, DOI 10.1111/j.1469-0691.2006.01446.x; Hall KK, 2006, CLIN MICROBIOL REV, V19, P788, DOI 10.1128/CMR.00062-05; JUMAA PA, 1994, J HOSP INFECT, V27, P167, DOI 10.1016/0195-6701(94)90124-4; Lee Ching-Chi, 2007, Journal of Microbiology Immunology and Infection, V40, P438; Little JR, 1999, AM J MED, V107, P119, DOI 10.1016/S0002-9343(99)00197-7; MACGREGOR RR, 1972, ARCH INTERN MED, V130, P84, DOI 10.1001/archinte.130.1.84; Marlowe L, 2010, INFECT CONT HOSP EP, V31, P171, DOI 10.1086/650201; Mimoz O, 1999, ANN INTERN MED, V131, P834, DOI 10.7326/0003-4819-131-11-199912070-00006; Norberg A, 2003, JAMA-J AM MED ASSOC, V289, P726, DOI 10.1001/jama.289.6.726; Ramsook C, 2000, INFECT CONT HOSP EP, V21, P649, DOI 10.1086/501708; SPITALNIC SJ, 1995, CLIN INFECT DIS, V21, P1103, DOI 10.1093/clinids/21.5.1103; STRAND CL, 1993, JAMA-J AM MED ASSOC, V269, P1004, DOI 10.1001/jama.269.8.1004; Suwanpimolkul G, 2008, J INFECTION, V56, P354, DOI 10.1016/j.jinf.2008.03.001; Trautner BW, 2002, INFECT CONT HOSP EP, V23, P397, DOI 10.1086/502073; VIAGAPPAN M, 1995, J HOSP INFECT, V30, P217, DOI 10.1016/S0195-6701(95)90317-8; Weinbaum FI, 1997, J CLIN MICROBIOL, V35, P563, DOI 10.1128/JCM.35.3.563-565.1997; Weinstein MP, 1997, CLIN INFECT DIS, V24, P584, DOI 10.1093/clind/24.4.584; Weinstein MP, 1996, CLIN INFECT DIS, V23, P40, DOI 10.1093/clinids/23.1.40; YORK MK, 1990, J CLIN MICROBIOL, V28, P2114, DOI 10.1128/JCM.28.9.2114-2116.1990	22	40	42	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2011	154	3					145	+		10.7326/0003-4819-154-3-201102010-00003	http://dx.doi.org/10.7326/0003-4819-154-3-201102010-00003			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	713HY	21282693				2022-12-28	WOS:000286729200001
J	Chin, MH; Goldmann, D				Chin, Marshall H.; Goldmann, Don			Meaningful Disparities Reduction Through Research and Translation Programs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH-CARE; QUALITY IMPROVEMENT; ETHNIC DISPARITIES; INTERVENTIONS		[Chin, Marshall H.] Univ Chicago, Gen Internal Med Sect, Dept Med, Ctr Diabet Res & Training, Chicago, IL 60637 USA; [Chin, Marshall H.] Robert Wood Johnson Fdn, Finding Answers Dispar Res Change Natl Program Of, Chicago, IL USA; [Goldmann, Don] Inst Healthcare Improvement, Cambridge, MA USA; [Goldmann, Don] Childrens Hosp, Boston, MA 02115 USA; [Goldmann, Don] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA	University of Chicago; Robert Wood Johnson Foundation (RWJF); Institute for Healthcare Improvement; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Chin, MH (corresponding author), Univ Chicago, Gen Internal Med Sect, Dept Med, Ctr Diabet Res & Training, 5841 S Maryland Ave,MC 2007, Chicago, IL 60637 USA.	mchin@medicine.bsd.uchicago.edu			AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [T32HS000084, T32HS000063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092949, K24DK071933] Funding Source: NIH RePORTER; AHRQ HHS [T32 HS00063, T32 HS00084] Funding Source: Medline; NIDDK NIH HHS [K24 DK071933, P30 DK092949] Funding Source: Medline	AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		[Anonymous], 2001, CROSSING QUALITY CHA, DOI DOI 10.17226/10027; [Anonymous], AHRQ PUBL; Berwick DM, 2002, HEALTH AFFAIR, V21, P80, DOI 10.1377/hlthaff.21.3.80; Chin MH, 2007, MED CARE RES REV, V64, p7S, DOI 10.1177/1077558707305413; Chin MH, 2006, QUAL SAF HEALTH CARE, V15, P79, DOI 10.1136/qshc.2006.017749; Davidoff F, 2008, QUAL SAF HEALTH CARE, V17, P3, DOI 10.1136/qshc.2008.029066; Fisher TL, 2007, MED CARE RES REV, V64, p243S, DOI 10.1177/1077558707305414; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; *NOT HS, 2003, NOTHS03010; Ulmer C, 2010, FUTURE DIRECTIONS NA	10	20	20	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2011	305	4					404	405		10.1001/jama.2011.26	http://dx.doi.org/10.1001/jama.2011.26			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711MH	21266689				2022-12-28	WOS:000286595200027
J	Kamerow, D				Kamerow, Douglas			Yankee Doodling Guns don't kill crowds, people with semi-automatics do	BRITISH MEDICAL JOURNAL			English	Editorial Material									RTI Int, Res Triangle Pk, NC USA	Research Triangle Institute	Kamerow, D (corresponding author), RTI Int, Res Triangle Pk, NC USA.	dkamerow@rti.org		Kamerow, Douglas/0000-0001-7000-9957					0	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 25	2011	342								d477	10.1136/bmj.d477	http://dx.doi.org/10.1136/bmj.d477			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	715LX	21266435				2022-12-28	WOS:000286887100009
J	Sung, CC; Chen, YS; Lin, SH				Sung, Chih-Chien; Chen, Yi-Shin; Lin, Shih-Hua			Family paralysis	LANCET			English	Editorial Material							GITELMANS-SYNDROME		[Sung, Chih-Chien; Lin, Shih-Hua] Triserv Gen Hosp, Natl Def Med Ctr, Dept Med, Div Nephrol, Taipei 114, Taiwan; [Chen, Yi-Shin] Taichung Buddhist Tzu Chi Gen Hosp, Dept Med, Div Nephrol, Taichung, Taiwan	National Defense Medical Center; Tri-Service General Hospital; Buddhist Tzu Chi General Hospital	Lin, SH (corresponding author), Triserv Gen Hosp, Natl Def Med Ctr, Dept Med, Div Nephrol, 325,Sect 2,Cheng Kung Rd, Taipei 114, Taiwan.	l521116@ndmctsgh.edu.tw						Cruz DN, 2001, KIDNEY INT, V59, P710, DOI 10.1046/j.1523-1755.2001.059002710.x; Lin SH, 2005, J CLIN ENDOCR METAB, V90, P2500, DOI 10.1210/jc.2004-1905; Lin SH, 2004, ARCH INTERN MED, V164, P1561, DOI 10.1001/archinte.164.14.1561; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Venance SL, 2006, BRAIN, V129, P8, DOI 10.1093/brain/awh639	5	1	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 22	2011	377	9762					352	352		10.1016/S0140-6736(10)61356-6	http://dx.doi.org/10.1016/S0140-6736(10)61356-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	714ZO	21256383				2022-12-28	WOS:000286850400032
J	Stanescu, HC; Arcos-Burgos, M; Medlar, A; Bockenhauer, D; Kottgen, A; Dragomirescu, L; Voinescu, C; Patel, N; Pearce, K; Hubank, M; Stephens, HAF; Laundy, V; Padmanabhan, S; Zawadzka, A; Hofstra, JM; Coenen, MJH; den Heijer, M; Kiemeney, LALM; Bacq-Daian, D; Stengel, B; Powis, SH; Brenchley, P; Feehally, J; Rees, AJ; Debiec, H; Wetzels, JFM; Ronco, P; Mathieson, PW; Kleta, R				Stanescu, Horia C.; Arcos-Burgos, Mauricio; Medlar, Alan; Bockenhauer, Detlef; Kottgen, Anna; Dragomirescu, Liviu; Voinescu, Catalin; Patel, Naina; Pearce, Kerra; Hubank, Mike; Stephens, Henry A. F.; Laundy, Valerie; Padmanabhan, Sandosh; Zawadzka, Anna; Hofstra, Julia M.; Coenen, Marieke J. H.; den Heijer, Martin; Kiemeney, Lambertus A. L. M.; Bacq-Daian, Delphine; Stengel, Benedicte; Powis, Stephen H.; Brenchley, Paul; Feehally, John; Rees, Andrew J.; Debiec, Hanna; Wetzels, Jack F. M.; Ronco, Pierre; Mathieson, Peter W.; Kleta, Robert			Risk HLA-DQA1 and PLA(sub 2)R1 Alleles in Idiopathic Membranous Nephropathy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CLASS-II GENES; GLOMERULONEPHRITIS; RECEPTOR; ANTIGEN; SUSCEPTIBILITY; DETERMINANTS; AUTOIMMUNITY; LOCI	Background: Idiopathic membranous nephropathy is a major cause of the nephrotic syndrome in adults, but its etiologic basis is not fully understood. We investigated the genetic basis of biopsy-proven cases of idiopathic membranous nephropathy in a white population. Methods: We performed independent genomewide association studies of single-nucleotide polymorphisms (SNPs) in patients with idiopathic membranous nephropathy from three populations of white ancestry (75 French, 146 Dutch, and 335 British patients). The patients were compared with racially matched control subjects; population stratification and quality controls were carried out according to standard criteria. Associations were calculated by means of a chi-square basic allele test; the threshold for significance was adjusted for multiple comparisons (with the Bonferroni method). Results: In a joint analysis of data from the 556 patients studied (398 men), we identified significant alleles at two genomic loci associated with idiopathic membranous nephropathy. Chromosome 2q24 contains the gene encoding M-type phospholipase A(sub 2) receptor (PLA(sub 2)R1) (SNP rs4664308, P=8.6 x 10(sup -29)), previously shown to be the target of an autoimmune response. Chromosome 6p21 contains the gene encoding HLA complex class II HLA-DQ alpha chain 1 (HLA-DQA1) (SNP rs2187668, P=8.0 x 10(sup -93)). The association with HLA-DQA1 was significant in all three populations (P=1.8 x 10(sup -9), P=5.6 x 10(sup -27), and P=5.2 x 10(sup -36) in the French, Dutch, and British groups, respectively). The odds ratio for idiopathic membranous nephropathy with homozygosity for both risk alleles was 78.5 (95% confidence interval, 34.6 to 178.2). Conclusions: An HLA-DQA1 allele on chromosome 6p21 is most closely associated with idiopathic membranous nephropathy in persons of white ancestry. This allele may facilitate an autoimmune response against targets such as variants of PLA2R1. Our findings suggest a basis for understanding this disease and illuminate how adaptive immunity is regulated by HLA. N Engl J Med 2011;364:616-26.	[Stanescu, Horia C.; Medlar, Alan; Bockenhauer, Detlef; Voinescu, Catalin; Patel, Naina; Stephens, Henry A. F.; Powis, Stephen H.; Kleta, Robert] UCL, Royal Free Hosp, Ctr Nephrol, London NW3 2PF, England; [Stanescu, Horia C.; Bockenhauer, Detlef; Patel, Naina; Pearce, Kerra; Hubank, Mike; Kleta, Robert] UCL, Inst Child Hlth, London NW3 2PF, England; [Kleta, Robert] UCL, Dept Physiol, London NW3 2PF, England; [Kleta, Robert] UCL, Genet Inst, London NW3 2PF, England; [Bockenhauer, Detlef; Kleta, Robert] Great Ormond St Hosp Sick Children, London, England; [Stephens, Henry A. F.] Anthony Nolan Trust, London, England; [Laundy, Valerie; Mathieson, Peter W.] Univ Bristol, Acad Renal Unit, Bristol, Avon, England; [Padmanabhan, Sandosh] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Zawadzka, Anna] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Brenchley, Paul] Univ Manchester, Sch Biomed, Manchester, Lancs, England; [Feehally, John] Univ Leicester, John Walls Renal Unit, Leicester, Leics, England; [Feehally, John] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England; [Arcos-Burgos, Mauricio] NHGRI, NIH, Bethesda, MD 20892 USA; [Kottgen, Anna] Univ Hosp Freiburg, Div Renal, Freiburg, Germany; [Kottgen, Anna] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Dragomirescu, Liviu] Univ Bucharest, Dept Syst Ecol, Bucharest, Romania; [Hofstra, Julia M.; Wetzels, Jack F. M.] Radboud Univ Nijmegen, Med Ctr, Dept Nephrol, NL-6525 ED Nijmegen, Netherlands; [Coenen, Marieke J. H.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands; [Hubank, Mike; Kiemeney, Lambertus A. L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Epidemiol Biostat & Hlth Technol Assessment, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus A. L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Urol, NL-6525 ED Nijmegen, Netherlands; [Kiemeney, Lambertus A. L. M.] Radboud Univ Nijmegen, Med Ctr, Dept Endocrinol, NL-6525 ED Nijmegen, Netherlands; [Bacq-Daian, Delphine] CEA, Inst Genom, Ctr Natl Genotypage, Evry, France; [Stengel, Benedicte] Univ Paris Sud, INSERM, UMR S 1018, Villejuif, France; [Debiec, Hanna; Ronco, Pierre] Univ Paris 06, Tenon Hosp, AP HP, INSERM,UMR S 702, Paris, France; [Rees, Andrew J.] Med Univ Vienna, Clin Inst Pathol, Vienna, Austria	University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of Bristol; University of Glasgow; University of Oxford; Wellcome Centre for Human Genetics; University of Manchester; University of Leicester; University of Leicester; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Freiburg; Johns Hopkins University; University of Bucharest; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; CEA; UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Medical University of Vienna	Kleta, R (corresponding author), UCL, Royal Free Hosp, Ctr Nephrol, Rowland Hill St, London NW3 2PF, England.	r.kleta@ucl.ac.uk	Padmanabhan, Sandosh/S-3963-2016; Ronco, Pierre/AAC-8390-2022; Coenen, Marieke/A-2159-2010; Hubank, Michael JF/C-1837-2008; Stengel, Benedicte/G-5730-2015; Bockenhauer, Detlef/C-5951-2008; Kiemeney, Lambertus A./D-3357-2009; Bockenhauer, Detlef/AAF-6495-2020; Kottgen, Anna/D-2920-2012; Hofstra, Julia/A-4171-2015; Vargas Alfonso, Alba Lucia/E-1581-2015; Debiec, Hanna/AAL-8144-2021; Wetzels, Jack F.M./A-1720-2014; den Heijer, Martin/J-8036-2015; Arcos-Burgos, Mauricio/H-1326-2017	Coenen, Marieke/0000-0001-8796-2031; Hubank, Michael JF/0000-0002-2901-0742; Stengel, Benedicte/0000-0001-9469-0804; Bockenhauer, Detlef/0000-0001-5878-941X; Kiemeney, Lambertus A./0000-0002-2368-1326; Bockenhauer, Detlef/0000-0001-5878-941X; Vargas Alfonso, Alba Lucia/0000-0001-7984-0560; Debiec, Hanna/0000-0002-8946-8245; Wetzels, Jack F.M./0000-0002-0650-6921; Padmanabhan, Sandosh/0000-0003-3869-5808; Brenchley, Paul/0000-0003-1290-9919; den Heijer, Martin/0000-0003-3620-5617; Voinescu, Catalin/0000-0002-3636-8689; Arcos-Burgos, Mauricio/0000-0002-8529-0574	David and Elaine Potter Charitable Foundation; St Peter's Trust for Kidney, Bladder and Prostate Research; Special Trustees of Great Ormond Street Hospital; Kids Kidney Research UK; Medical Research Council (MRC) at the Centre for Integrated Genomic Medical Research, University of Manchester; MRC [G0000934]; Wellcome Trust [068545/Z/02]; National Institute for Health Research Manchester Biomedical Research Centre; Kidney Research UK; Dutch Kidney Foundation; French Ministry of Health [PHRC AOM 00022]; Ministry of Environment [EN00D08]; Ministry of Research [01P0513]; Biomedecine Agency; Agence Nationale pour la Recherche [ANR-07-Physio-016-01]; European Community [HEALTH-F2-2007-201590]; Fondation pour la Recherche Medicale; Association pour l'Utilisation du Rein Artificiel; Assistance Publique-Hopitaux de Paris; Medical Research Council [G9721265, G0000934] Funding Source: researchfish; Great Ormond Street Hospital Childrens Charity [V0901] Funding Source: researchfish; MRC [G9721265] Funding Source: UKRI	David and Elaine Potter Charitable Foundation; St Peter's Trust for Kidney, Bladder and Prostate Research; Special Trustees of Great Ormond Street Hospital; Kids Kidney Research UK(Kidney Research UK (KRUK)); Medical Research Council (MRC) at the Centre for Integrated Genomic Medical Research, University of Manchester(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); National Institute for Health Research Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); Kidney Research UK(Kidney Research UK (KRUK)); Dutch Kidney Foundation; French Ministry of Health; Ministry of Environment(Ministry of Environment (ME), Republic of Korea); Ministry of Research(Ministry of Research and Technology of the Republic of Indonesia (RISTEK)); Biomedecine Agency; Agence Nationale pour la Recherche(French National Research Agency (ANR)); European Community(European Commission); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Association pour l'Utilisation du Rein Artificiel; Assistance Publique-Hopitaux de Paris; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Great Ormond Street Hospital Childrens Charity; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants from the David and Elaine Potter Charitable Foundation (to Drs. Powis and Kleta), St Peter's Trust for Kidney, Bladder and Prostate Research (to Drs. Bockenhauer, Powis, and Kleta), the Special Trustees of Great Ormond Street Hospital (to Dr. Bockenhauer), Kids Kidney Research UK (to Drs. Bockenhauer and Kleta), Medical Research Council (MRC) at the Centre for Integrated Genomic Medical Research, University of Manchester; grants from the MRC (G0000934) and the Wellcome Trust (068545/Z/02); the National Institute for Health Research Manchester Biomedical Research Centre (to Dr. Brenchley); and the MRC and Kidney Research UK, as part of the MRC/Kidney Research UK National DNA Bank for Glomerulonephritis, for the collection of the British idiopathic membranous nephropathy DNA samples; grants from the Dutch Kidney Foundation (Nierstichting Nederland OW 08, to Drs. Wetzels and Hofstra); grants from the French Ministry of Health (PHRC AOM 00022), the Ministry of Environment (Decision d'aide EN00D08), the Ministry of Research (Decision d'aide 01P0513), and the Biomedecine Agency (AO Recherche et Greffes 2005); grants from the Agence Nationale pour la Recherche (ANR-07-Physio-016-01), Coordination Theme 1 (Health) of the European Community's 7th Framework Program (HEALTH-F2-2007-201590), Fondation pour la Recherche Medicale, and Association pour l'Utilisation du Rein Artificiel (to Drs. Ronco and Debiec), and a Contrat d'Interface from Assistance Publique-Hopitaux de Paris (to Dr. Debiec).	ABE S, 1986, J CLIN PATHOL, V39, P1193, DOI 10.1136/jcp.39.11.1193; AUSTIN HA, 1992, ANN INTERN MED, V116, P672, DOI 10.7326/0003-4819-116-8-672; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beck LH, 2010, KIDNEY INT, V77, P765, DOI 10.1038/ki.2010.34; Beck LH, 2009, NEW ENGL J MED, V361, P11, DOI 10.1056/NEJMoa0810457; BERTHOUX FC, 1990, PRESSE MED, V19, P990; Bockenhauer D, 2008, NEPHRON CLIN PRACT, V108, pC10, DOI 10.1159/000112466; Boilard E, 2003, FASEB J, V17, P1068, DOI 10.1096/fj.02-0938com; CAMERON J S, 1965, Guys Hosp Rep, V114, P101; Debiec H, 2002, NEW ENGL J MED, V346, P2053, DOI 10.1056/NEJMoa012895; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; DYER PA, 1992, NEPHROL DIAL TRANSPL, V7, P42; East L, 2002, BBA-GEN SUBJECTS, V1572, P364, DOI 10.1016/S0304-4165(02)00319-7; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Glassock RJ, 2010, AM J KIDNEY DIS, V56, P157, DOI 10.1053/j.ajkd.2010.01.008; Glassock RJ, 2009, NEW ENGL J MED, V361, P81, DOI 10.1056/NEJMe0903343; Hofstra JM, 2010, NEPHROL DIAL TRANSPL, V25, P1760, DOI 10.1093/ndt/gfq017; Jin Y, 2010, NEW ENGL J MED, V362, P1686, DOI 10.1056/NEJMoa0908547; Kalluri R, 1997, J CLIN INVEST, V100, P2263, DOI 10.1172/JCI119764; KLOUDA PT, 1979, LANCET, V2, P770, DOI 10.1016/S0140-6736(79)92118-4; Lefaucheur C, 2006, KIDNEY INT, V70, P1510, DOI 10.1038/sj.ki.5001790; Li SJ, 2010, CLIN J AM SOC NEPHRO, V5, P439, DOI 10.2215/CJN.07571009; Lincoln MR, 2009, P NATL ACAD SCI USA, V106, P7542, DOI 10.1073/pnas.0812664106; Llorca O, 2008, CELL MOL LIFE SCI, V65, P1302, DOI 10.1007/s00018-007-7497-9; Moranne O, 2008, QJM-INT J MED, V101, P215, DOI 10.1093/qjmed/hcm142; OGAHARA S, 1992, KIDNEY INT, V41, P175, DOI 10.1038/ki.1992.24; Pedchenko V, 2010, NEW ENGL J MED, V363, P343, DOI 10.1056/NEJMoa0910500; PELLETIER L, 1987, SPRINGER SEMIN IMMUN, V9, P359; Petukhova L, 2010, NATURE, V466, P113, DOI 10.1038/nature09114; Ponticelli C, 2007, J NEPHROL, V20, P268; Powis SH, 2003, OX MG MED G, V48, P417; Prunotto M, 2010, J AM SOC NEPHROL, V21, P507, DOI 10.1681/ASN.2008121259; Rees A, 2009, NAT REV NEPHROL, V5, P617, DOI 10.1038/nrneph.2009.167; Ronco P, 2010, J AM SOC NEPHROL, V21, P564, DOI 10.1681/ASN.2009121220; Salant DJ, 2009, NEPHRON PHYSIOL, V112, pP11, DOI 10.1159/000212068; SHORT CD, 1984, BRIT MED J, V289, P1500, DOI 10.1136/bmj.289.6457.1500; SOLLID LM, 2002, COELIAC DIS DISSECTI; VAUGHAN RW, 1989, TISSUE ANTIGENS, V34, P261, DOI 10.1111/j.1399-0039.1989.tb01741.x; Waldman M, 2009, NAT REV NEPHROL, V5, P469, DOI 10.1038/nrneph.2009.101; Wetzels JFM, 2007, KIDNEY INT, V72, P632, DOI 10.1038/sj.ki.5002374	40	338	376	3	57	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2011	364	7					616	626		10.1056/NEJMoa1009742	http://dx.doi.org/10.1056/NEJMoa1009742			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722BW	21323541	Green Published, Bronze			2022-12-28	WOS:000287406000007
J	Arie, S				Arie, Sophie			Vaccines Global HPV vaccination	BRITISH MEDICAL JOURNAL			English	Editorial Material												ariesophie@yahoo.co.uk						Center for Disease Control, 2011, VACC IMM; World Health Organization/Information Commissioner's Office Information Centre on HPV and Cervical Cancer (HPV Information Centre), 2010, HUM PAP REL CANC SUM; World Health Organization (WHO), 2008, HUM PAP HPV VACC BAC	3	8	8	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2011	342								d1042	10.1136/bmj.d1042	http://dx.doi.org/10.1136/bmj.d1042			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	725OZ	21325382				2022-12-28	WOS:000287656500013
J	DeMets, DL; Califf, RM				DeMets, David L.; Califf, Robert M.			A Historical Perspective on Clinical Trials Innovation and Leadership Where Have the Academics Gone?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[DeMets, David L.] Univ Wisconsin, Dept Biostat & Med Informat, Clin Sci Ctr K6 446, Madison, WI 53792 USA; [Califf, Robert M.] Duke Translat Med Inst, Durham, NC USA; [Califf, Robert M.] Duke Univ, Sch Med, Durham, NC USA	University of Wisconsin System; University of Wisconsin Madison; Duke University; Duke University	DeMets, DL (corresponding author), Univ Wisconsin, Dept Biostat & Med Informat, Clin Sci Ctr K6 446, 600 Highland Ave, Madison, WI 53792 USA.	demets@biostat.wisc.edu						[Anonymous], 1988, CONTROL CLIN TRIALS, V9, P137; Clancy C, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001235; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Eisenstein EL, 2008, CLIN TRIALS, V5, P75, DOI 10.1177/1740774507087551; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; Fisher MR, 2001, DRUG INF J, V35, P115, DOI 10.1177/009286150103500113; Friedmen LM, 2010, FUNDAMENTALS OF CLINICAL TRIALS, FOURTH EDITION, P1; Olsen L, 2007, I MED ROUNDT EV BAS; Psaty BM, 2003, JAMA-J AM MED ASSOC, V289, P2128, DOI 10.1001/jama.289.16.2128; The Coronary Drug Project Research Group, 1973, CIRCULATION, V47, P11	10	49	49	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2011	305	7					713	714		10.1001/jama.2011.175	http://dx.doi.org/10.1001/jama.2011.175			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	721NH	21325190				2022-12-28	WOS:000287361100025
J	Sen Gupta, P; Green, AN; Chowdhury, TA				Sen Gupta, Piya; Green, Andrea N.; Chowdhury, Tahseen A.			Practice 10-Minute Consultation Hypoglycaemia	BRITISH MEDICAL JOURNAL			English	Editorial Material												psengupta79@doctors.net.uk		Sen Gupta, Piya/0000-0002-2800-7365					0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2011	342								d567	10.1136/bmj.d567	http://dx.doi.org/10.1136/bmj.d567			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	725OZ	21325388				2022-12-28	WOS:000287656500017
J	Macilwain, C				Macilwain, Colin			Pharmaceutical industry must take its medicine	NATURE			English	Editorial Material												cfmworldview@gmail.com							0	3	3	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2011	470	7333					141	141		10.1038/470141a	http://dx.doi.org/10.1038/470141a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	718RQ	21307893	Bronze			2022-12-28	WOS:000287144200004
J	Glick, S				Glick, Shimon			Personal View Withholding versus withdrawal of life support: is there an ethical difference?	BRITISH MEDICAL JOURNAL			English	Editorial Material							ASSISTED SUICIDE; EUTHANASIA; END; ATTITUDES		Ben Gurion Univ Negev, Joyce & Irving Goldman Sch Med, Lord Rabbi Immanuel Jakobovits Ctr Jewish Med Eth, IL-84105 Beer Sheva, Israel	Ben Gurion University	Glick, S (corresponding author), Ben Gurion Univ Negev, Joyce & Irving Goldman Sch Med, Lord Rabbi Immanuel Jakobovits Ctr Jewish Med Eth, IL-84105 Beer Sheva, Israel.	gshimon@bgu.ac.il						Abramson N, 1998, SOUTHERN MED J, V91, P637, DOI 10.1097/00007611-199807000-00006; Dickenson DL, 2000, J MED ETHICS, V26, P254, DOI 10.1136/jme.26.4.254; Elliott C, 1996, BRIT MED J, V313, P1088; Grossman D., 2000, PSYCHOL EFFECTS COMB; Hopkins PD, 1997, HASTINGS CENT REP, V27, P29, DOI 10.2307/3528666; Meisel A, 2000, JAMA-J AM MED ASSOC, V284, P2495, DOI 10.1001/jama.284.19.2495; Ravitsky V, 2005, BRIT MED J, V330, P415, DOI 10.1136/bmj.330.7488.415; RAVITSKY V, 2008, J JEWISH MED ETHICS, V6, P13; Rebagliato M, 2000, JAMA-J AM MED ASSOC, V284, P2451, DOI 10.1001/jama.284.19.2451	9	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 9	2011	342								d728	10.1136/bmj.d728	http://dx.doi.org/10.1136/bmj.d728			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	722AZ	21307111				2022-12-28	WOS:000287402900017
J	van Griensven, J; Boelaert, M				van Griensven, Johan; Boelaert, Marleen			Combination therapy for visceral leishmaniasis	LANCET			English	Editorial Material							LIPOSOMAL AMPHOTERICIN-B; DRUG-RESISTANCE		[van Griensven, Johan] Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium; [Boelaert, Marleen] Inst Trop Med, Dept Publ Hlth, B-2000 Antwerp, Belgium	Institute of Tropical Medicine (ITM); Institute of Tropical Medicine (ITM)	van Griensven, J (corresponding author), Inst Trop Med, Dept Clin Sci, B-2000 Antwerp, Belgium.	jvangriensven@itg.be	Lynen, Lutgarde/A-1212-2014; Boelaert, Marleen/E-2698-2012	Lynen, Lutgarde/0000-0001-7183-4895; Boelaert, Marleen/0000-0001-8051-6776				Alvar J, 2006, ADV PARASIT, V61, P223, DOI 10.1016/S0065-308X(05)61006-8; Berman JD, 1998, B WORLD HEALTH ORGAN, V76, P25; Bryceson A, 2001, TROP MED INT HEALTH, V6, P928, DOI 10.1046/j.1365-3156.2001.00795.x; Chappuis F, 2007, NAT REV MICROBIOL, V5, P873, DOI 10.1038/nrmicro1748; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; Hailu A, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000709; Meheus F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000818; Sundar S, 2010, NEW ENGL J MED, V362, P504, DOI 10.1056/NEJMoa0903627; Sunder S, 2011, LANCET          0120, DOI 10.1016/S0140-6736(10)62050-8; van Griensven J, 2010, LANCET INFECT DIS, V10, P184, DOI 10.1016/S1473-3099(10)70011-6	10	23	23	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 5	2011	377	9764					443	444		10.1016/S0140-6736(10)62237-4	http://dx.doi.org/10.1016/S0140-6736(10)62237-4			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721TX	21255829				2022-12-28	WOS:000287381800005
J	Hudson, T				Hudson, Tom			Genomics and Clinical Relevance	SCIENCE			English	Editorial Material									Ontario Inst Canc Res, Toronto, ON, Canada	Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates	Hudson, T (corresponding author), Ontario Inst Canc Res, Toronto, ON, Canada.								0	2	5	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					547	547		10.1126/science.1202572	http://dx.doi.org/10.1126/science.1202572			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292965				2022-12-28	WOS:000286933600040
J	Agwu, AL; Jang, SS; Korthuis, PT; Araneta, MRG; Gebo, KA				Agwu, Allison L.; Jang, Susie S.; Korthuis, P. Todd; Araneta, Maria Rosario G.; Gebo, Kelly A.			Pregnancy Incidence and Outcomes in Vertically and Behaviorally HIV-Infected Youth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Agwu, Allison L.; Gebo, Kelly A.] Johns Hopkins Univ, Baltimore, MD 21218 USA; [Jang, Susie S.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Korthuis, P. Todd] Oregon Hlth & Sci Univ, Portland, OR 97201 USA; [Araneta, Maria Rosario G.] Univ Calif San Diego, San Diego, CA 92103 USA	Johns Hopkins University; Harvard University; Beth Israel Deaconess Medical Center; Oregon Health & Science University; University of California System; University of California San Diego	Agwu, AL (corresponding author), Johns Hopkins Univ, Baltimore, MD 21218 USA.	kgebo@jhmi.edu	Gebo, Kelly/AHA-7533-2022	Gebo, Kelly/0000-0003-4010-398X; Korthuis, Philip/0000-0001-5556-3597	NCRR NIH HHS [KL2 RR025006-01, 1KL2RR025006-01, KL2 RR025006] Funding Source: Medline; NIAID NIH HHS [1K23AI084549] Funding Source: Medline; NIA NIH HHS [R01 AG026250-01A2, R01 AG026250] Funding Source: Medline; NIDA NIH HHS [K23-DA019809, K23 DA019809, K23 DA019809-04] Funding Source: Medline; PHS HHS [290-01-0012] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K23AI084549] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026250] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K23DA019809] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; Chen XK, 2007, INT J EPIDEMIOL, V36, P368, DOI 10.1093/ije/dyl284; Fleishman JA, 2005, MED CARE, V43, P40; Gortmaker SL, 2001, NEW ENGL J MED, V345, P1522, DOI 10.1056/NEJMoa011157; Ventura Stephanie J, 2008, Natl Vital Stat Rep, V56, P1	5	26	26	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2011	305	5					468	470		10.1001/jama.2011.79	http://dx.doi.org/10.1001/jama.2011.79			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	714LI	21285423	Green Accepted			2022-12-28	WOS:000286810700017
J	Bird, SM; Goldacre, B; Strang, J				Bird, Sheila M.; Goldacre, Ben; Strang, John			Personal View We should push for evidence based sentencing in criminal justice	BRITISH MEDICAL JOURNAL			English	Editorial Material							CONTROLLED-TRIAL; PRISON; METHADONE		[Bird, Sheila M.] MRC Biostat Unit, Cambridge, England; [Goldacre, Ben] London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London, England; [Strang, John] Kings Coll London, London WC2R 2LS, England; [Strang, John] Natl Addict Ctr, London, England	MRC Biostatistics Unit; University of London; London School of Hygiene & Tropical Medicine; University of London; King's College London; University of London; King's College London	Bird, SM (corresponding author), MRC Biostat Unit, Cambridge, England.	sheila.bird@mrc-bsu.cam.ac.uk	Strang, John/H-5460-2011	Strang, John/0000-0002-5413-2725; Goldacre, Ben/0000-0002-5127-4728	MRC [MC_U105260794] Funding Source: UKRI; Medical Research Council [MC_U105260794, U.1052.00.002.00001.01] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bird AG, 1997, BRIT MED J, V315, P21, DOI 10.1136/bmj.315.7099.21; Bird SM, 2009, LANCET, V373, P1231, DOI 10.1016/S0140-6736(09)60707-8; Bird SM, 2004, LANCET, V364, P1457, DOI 10.1016/S0140-6736(04)17230-9; Bird SM, 2008, HOWARD J CRIMINAL JU, V47, P343; Bohannon J, 2009, SCIENCE, V325, P1614, DOI 10.1126/science.325_1614; Committee on Data and Research for Policy on Illegal Drugs, 2001, INF AM POL ILL DRUGS; Dolan KA, 2003, DRUG ALCOHOL DEPEN, V72, P59, DOI 10.1016/S0376-8716(03)00187-X; Farrington DP, 2006, CRIME JUSTICE, V34, P55, DOI 10.1086/500057; FIENBERG S, 1976, EVALUATION, V3, P124; Fienberg SE, 2005, STAT SCI, V20, P249, DOI 10.1214/088342305000000223; Fitz-Gibbon C, 2004, J R STAT SOC A STAT, V167, P1, DOI 10.1046/j.0964-1998.2003.02047.x; Henderson M, 2007, BMJ-BRIT MED J, V334, P133, DOI 10.1136/bmj.39014.503692.55; Howells C, 2002, DRUG ALCOHOL DEPEN, V67, P169, DOI 10.1016/S0376-8716(02)00024-8; Kariminia A, 2007, MED J AUSTRALIA, V187, P387, DOI 10.5694/j.1326-5377.2007.tb01307.x; Maynard Alan, 1997, NONRANDOM REFLECTION; McDonald SA, 2009, STAT METHODS MED RES, V18, P271, DOI 10.1177/0962280208094690; MCDOUGALL C, 2009, MINISTRY JUSTICE RES, V409; Merrall ELC, 2010, ADDICTION, V105, P1545, DOI 10.1111/j.1360-0443.2010.02990.x; Shapland J., 2008, MINISTRY JUSTICE RES, V10	19	6	6	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2011	342								d612	10.1136/bmj.d612	http://dx.doi.org/10.1136/bmj.d612			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	718PU	21289007				2022-12-28	WOS:000287138300007
J	Martinez, FD; Chinchilli, VM; Morgan, WJ; Boehmer, SJ; Lemanske, RF; Mauger, DT; Strunk, RC; Szefler, SJ; Zeiger, RS; Bacharier, LB; Bade, E; Covar, RA; Friedman, NJ; Guilbert, TW; Heidarian-Raissy, H; Kelly, HW; Malka-Rais, J; Mellon, MH; Sorkness, CA; Taussig, L				Martinez, Fernando D.; Chinchilli, Vernon M.; Morgan, Wayne J.; Boehmer, Susan J.; Lemanske, Robert F., Jr.; Mauger, David T.; Strunk, Robert C.; Szefler, Stanley J.; Zeiger, Robert S.; Bacharier, Leonard B.; Bade, Elizabeth; Covar, Ronina A.; Friedman, Noah J.; Guilbert, Theresa W.; Heidarian-Raissy, Hengameh; Kelly, H. William; Malka-Rais, Jonathan; Mellon, Michael H.; Sorkness, Christine A.; Taussig, Lynn			Use of beclomethasone dipropionate as rescue treatment for children with mild persistent asthma (TREXA): a randomised, double-blind, placebo-controlled trial	LANCET			English	Article							PRESCHOOL-CHILDREN; CHILDHOOD ASTHMA; PEDIATRIC ASTHMA; FACTORIAL TRIALS; YOUNG-CHILDREN; SINGLE INHALER; MAINTENANCE; BUDESONIDE/FORMOTEROL; CORTICOSTEROIDS; EXACERBATIONS	Background Daily inhaled corticosteroids are an effective treatment for mild persistent asthma, but some children have exacerbations even with good day-to-day control, and many discontinue treatment after becoming asymptomatic. We assessed the effectiveness of an inhaled corticosteroid (beclomethasone dipropionate) used as rescue treatment. Methods In this 44-week, randomised, double-blind, placebo-controlled trial we enrolled children and adolescents with mild persistent asthma aged 5-18 years from five clinical centres in the USA. A computer-generated randomisation sequence, stratified by clinical centre and age group, was used to randomly assign participants to one of four treatment groups: twice daily beclomethasone with beclomethasone plus albuterol as rescue (combined group); twice daily beclomethasone with placebo plus albuterol as rescue (daily bedomethasone group); twice daily placebo with beclomethasone plus albuterol as rescue (rescue beclomethasone group); and twice daily placebo with placebo plus albuterol as rescue (placebo group). Twice daily beclomethasone treatment was one puff of beclomethasone (40 mu g per puff) or placebo given in the morning and evening. Rescue beclomethasone treatment was two puffs of beclomethasone or placebo for each two puffs of albuterol (180 mu g) needed for symptom relief. The primary outcome was time to first exacerbation that required oral corticosteroids. A secondary outcome measured linear growth. Analysis was by intention toll-eat. This study is registered with clinicaltrials.gov, number NCT00394329. Results 843 children and adolescents were enrolled into this trial, of whom 288 were assigned to one of four treatment groups; combined (n=71), daily beclomethasone (n=72), rescue beclomethasone (n=71), and placebo (n=74)-555 individuals were excluded during the run-in, according to predefined criteria. Compared with the placebo group (49%, 95% CI 37-61), the frequency of exacerbations was lower in the daily (28%, 18-40, p=0.03), combined (31%, 21-43, p=0.07), and rescue (35%, 24-47, p=0.07) groups. Frequency of treatment failure was 23% (95% CI 14-43) in the placebo group, compared with 5.6% (1.6-14) in the combined (p=0.012), 2.8% (0-10) in the daily (p=0-009), and 8.5% (2-15) in the rescue (p=0.024) groups. Compared with the placebo group, linear growth was 1.1 cm (SD 0.3) less in the combined and daily arms (p<0.0001), but not the rescue group (p=0.26). Only two individuals had severe adverse events; one in the daily bedomethasone group had viral meningitis and one in the combined group had bronchitis. Interpretation Children with mild persistent asthma should not be treated with rescue albuterol alone and the most effective treatment to prevent exacerbations is daily inhaled corticosteroids. Inhaled corticosteroids as rescue medication with albuterol might be an effective step-down strategy for children with well controlled, mild asthma because it is more effective at reducing exacerbations than is use of rescue albuterol alone. Use of daily inhaled corticosteroid treatment and related side-effects such as growth impairment can therefore be avoided.	[Martinez, Fernando D.; Morgan, Wayne J.] Univ Arizona, Coll Med, Arizona Resp Ctr, Tucson, AZ 85724 USA; [Chinchilli, Vernon M.; Boehmer, Susan J.; Mauger, David T.] Penn State Hershey Coll Med, Dept Publ Hlth Sci, Hershey, PA USA; [Lemanske, Robert F., Jr.; Guilbert, Theresa W.; Sorkness, Christine A.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA; [Strunk, Robert C.; Bacharier, Leonard B.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Szefler, Stanley J.; Covar, Ronina A.; Malka-Rais, Jonathan] Natl Jewish Hlth, Denver, CO USA; [Zeiger, Robert S.; Friedman, Noah J.; Mellon, Michael H.] Kaiser Permanente, Dept Allergy, La Jolla, CA USA; [Zeiger, Robert S.; Friedman, Noah J.; Mellon, Michael H.] Univ Calif San Diego, La Jolla, CA 92093 USA; [Bade, Elizabeth] Univ Wisconsin, Aurora UW Med Grp, Milwaukee, WI 53201 USA; [Heidarian-Raissy, Hengameh; Kelly, H. William] Univ New Mexico, Albuquerque, NM 87131 USA; [Taussig, Lynn] Univ Denver, Denver, CO USA	University of Arizona; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL); National Jewish Health; Kaiser Permanente; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Milwaukee; University of New Mexico; University of Denver	Martinez, FD (corresponding author), Univ Arizona, Coll Med, Arizona Resp Ctr, 1501 N Campbell,Room 2349, Tucson, AZ 85724 USA.	fernando@arc.arizona.edu		Szefler, Stanley/0000-0002-6911-3199; Guilbert, Theresa/0000-0002-6932-712X; Zeiger, Robert/0000-0001-5788-5063; Bacharier, Leonard/0000-0003-0432-2704	GlaxoSmithKline; MedImmune; AstraZeneca; Genentech; Novartis; Cystic Fibrosis Foundation; MAP Pharmaceuticals; Gray Consulting; Smith Research; Merck Childhood Asthma Network; Quintiles/Innovax; RC Horowitz and Co; Scienomics Group; Pharmaxis; Biocryst; Watermark; Parexel; Schering; Boehringer-Ingelheim; Ross (Division of Abbott); Aerocrine AB; Schering Plough; Aerocrine; Genentech/Novartis; Merck/Schering Plough; Altus Pharmaceuticals; Inspire Pharmaceuticals; MAP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U10HL064307] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); MedImmune(AstraZenecaMedimmune); AstraZeneca(AstraZeneca); Genentech(Roche HoldingGenentech); Novartis(Novartis); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); MAP Pharmaceuticals; Gray Consulting; Smith Research; Merck Childhood Asthma Network; Quintiles/Innovax; RC Horowitz and Co; Scienomics Group; Pharmaxis; Biocryst; Watermark; Parexel; Schering; Boehringer-Ingelheim(Boehringer Ingelheim); Ross (Division of Abbott); Aerocrine AB(HOGANAS ABStatisticon AB); Schering Plough(Merck & CompanySchering Plough Corporation); Aerocrine; Genentech/Novartis(Roche HoldingGenentech); Merck/Schering Plough(Merck & CompanySchering Plough Corporation); Altus Pharmaceuticals; Inspire Pharmaceuticals; MAP; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	FDM is a board member at Medlmmune and Merck, has received consulting fees from GlaxoSmithKline, and MedImmune, honoraria from Merck, and pending grant support from AstraZeneca. WJM has received consulting fees from Genentech, Novartis, and Cystic Fibrosis Foundation, honoraria from Vertex Pharmaceuticals and Phadia AB, and pending grant support from Novartis. RFL has received consulting fees from MAP Pharmaceuticals, Gray Consulting, Smith Research, Merck Childhood Asthma Network, Novartis, Quintiles/Innovax, RC Horowitz and Co, AstraZeneca, and Scienomics Group, and has pending grand support from Pharmaxis. RFL has also received honoraria from Merck; AstraZeneca; Doembecher Children's Hospital; Washington University; Medicus Group; Park Nicolet Institute; American College of Allergy, Asthma and Immunology; LA Allergy Society; Michigan Allergy/Asthma Society; Medical College of Wisconsin; Toronto Allergy Society; Fund for Medical Research and Education (Detroit); Children's Hospital of Minnesota; Detroit Beauromont Hospital; University of Illinois; Canadian Society of Allergy and Clinical Immunology; New York Presbyterian Hospital; SRA; and Western Society of Allergy, Asthma and Immunology. DTM has received consulting fees from Biocryst, Watermark, and Parexel, and honoraria from Roche. SJS has received consulting fees from Merck, Genentech, Schering, Boehringer-Ingelheim, and Novartis; honoraria from Merck; and research grants from GlaxoSmithKline and Ross (Division of Abbott). RSZ has received consulting fees from Aerocrine AB, AstraZeneca, Genentech, GlaxoSmithKline, Merck, and Schering Plough, and has a pending grant support from Genentech, GlaxoSmithKine, and Merck. LBB has received consulting fees from Aerocrine, GlaxoSmithKline, Genentech, Novartis, Merck, and Schering Plough, and honoraria from Aerocrine, AstraZeneca, Genentech, GlaxoSmithKline, Merck, Novartis, and Schering Plough. TWG has received consulting fees from GlaxoSmithKline, AstraZeneca, Genentech/Novartis, Merck/Schering Plough, and MAP Pharmaceuticals; honoraria from GlaxoSmithKline, AstraZeneca, Merck, Peerpoint Medical Education Institute, Antidote CME programs, Schering-Plough, Novartis, and American Academy of Allergy, Asthma, and Immunology; and pending grant support from Altus Pharmaceuticals and Inspire Pharmaceuticals. HWK has received consulting fees from AstraZeneca, GlaxoSmithKline, MAP, Merck, and Novartis, and honoraria from AstraZeneca. MHM has received consulting fees from AstraZeneca, and honoraria from AstraZeneca and Schering Plough. CAS has received consulting fees from GlaxoSmithKline, Schering Plough, and AstraZeneca, and has pending grant support from Schering Plough, Pharmaxis, and Sandoz. All other authors declare that they have no conflicts of interest.	Bacharier LB, 2008, J ALLERGY CLIN IMMUN, V122, P1127, DOI 10.1016/j.jaci.2008.09.029; Bisgaard H, 2006, CHEST, V130, P1733, DOI 10.1378/chest.130.6.1733; Boushey HA, 2005, NEW ENGL J MED, V352, P1519, DOI 10.1056/NEJMoa042552; Burgess SW, 2008, RESPIROLOGY, V13, P559, DOI 10.1111/j.1440-1843.2008.01292.x; Ducharme FM, 2009, NEW ENGL J MED, V360, P339, DOI 10.1056/NEJMoa0808907; FitzGerald JM, 2004, THORAX, V59, P550, DOI 10.1136/thx.2003.014936; Global Strategy for Asthma Management and Prevention, 2009, GLOB STRAT ASTHM MAN; Guilbert TW, 2006, NEW ENGL J MED, V354, P1985, DOI 10.1056/NEJMoa051378; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Jones SL, 2001, AM J RESP CRIT CARE, V164, P738, DOI 10.1164/ajrccm.164.5.2012125; LUBSEN J, 1994, EUR HEART J, V15, P585, DOI 10.1093/oxfordjournals.eurheartj.a060552; Martinez FD, 2009, PEDIATRICS, V123, pS146, DOI 10.1542/peds.2008-2233D; McAlister FA, 2003, JAMA-J AM MED ASSOC, V289, P2545, DOI 10.1001/jama.289.19.2545; National Asthma Education and Prevention Program, 2007, GUID DIAGN MAN ASTHM; O'Byrne PM, 2005, AM J RESP CRIT CARE, V171, P129, DOI 10.1164/rccm.200407-884OC; Papi A, 2007, NEW ENGL J MED, V356, P2040, DOI 10.1056/NEJMoa063861; Pedersen S, 2002, PEDIATRICS, V109, DOI 10.1542/peds.109.6.e92; Pijnenburg MW, 2005, THORAX, V60, P215, DOI 10.1136/thx.2004.023374; Plint AC, 2009, NEW ENGL J MED, V360, P2079, DOI 10.1056/NEJMoa0900544; Rabe KF, 2006, CHEST, V129, P246, DOI 10.1378/chest.129.2.246; Simons FER, 1997, NEW ENGL J MED, V337, P1659, DOI 10.1056/NEJM199712043372304; Sorkness CA, 2007, J ALLERGY CLIN IMMUN, V119, P64, DOI 10.1016/j.jaci.2006.09.042; Szefler S, 2000, NEW ENGL J MED, V343, P1054; Turpeinen M, 2008, ARCH DIS CHILD, V93, P654, DOI 10.1136/adc.2007.116632; Verberne AAPH, 1998, AM J RESP CRIT CARE, V158, P213, DOI 10.1164/ajrccm.158.1.9706048	25	214	228	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2011	377	9766					650	657		10.1016/S0140-6736(10)62145-9	http://dx.doi.org/10.1016/S0140-6736(10)62145-9			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	727DB	21324520	Green Published, Green Accepted			2022-12-28	WOS:000287776600034
J	Ward, CV; Kimbel, WH; Johanson, DC				Ward, Carol V.; Kimbel, William H.; Johanson, Donald C.			Complete Fourth Metatarsal and Arches in the Foot of Australopithecus afarensis	SCIENCE			English	Article							HADAR FORMATION; EVOLUTION; JOINT; FOOTPRINTS; WALKING; TARSAL; FEET	The transition to full-time terrestrial bipedality is a hallmark of human evolution. A key correlate of human bipedalism is the development of longitudinal and transverse arches of the foot that provide a rigid propulsive lever and critical shock absorption during striding bipedal gait. Evidence for arches in the earliest well-known Australopithecus species, A. afarensis, has long been debated. A complete fourth metatarsal of A. afarensis was recently discovered at Hadar, Ethiopia. It exhibits torsion of the head relative to the base, a direct correlate of a transverse arch in humans. The orientation of the proximal and distal ends of the bone reflects a longitudinal arch. Further, the deep, flat base and tarsal facets imply that its midfoot had no ape-like midtarsal break. These features show that the A. afarensis foot was functionally like that of modern humans and support the hypothesis that this species was a committed terrestrial biped.	[Ward, Carol V.] Univ Missouri, Dept Pathol & Anat Sci, Columbia, MO 65212 USA; [Kimbel, William H.; Johanson, Donald C.] Arizona State Univ, Sch Human Evolut & Social Change, Inst Human Origins, Tempe, AZ 85287 USA	University of Missouri System; University of Missouri Columbia; Arizona State University; Arizona State University-Tempe	Ward, CV (corresponding author), Univ Missouri, Dept Pathol & Anat Sci, M263 Med Sci Bldg, Columbia, MO 65212 USA.	wardcv@missouri.edu		Ward, Carol/0000-0001-6255-9668	NSF [NSF SBR-9601025, NSF BCS-0333296]; University of Missouri Research Board and University of Missouri Research Council; Institute of Human Origins at Arizona State University	NSF(National Science Foundation (NSF)); University of Missouri Research Board and University of Missouri Research Council; Institute of Human Origins at Arizona State University	The authors thank the members of the Hadar Research Project (1990-2004) and the Hadar Paleoanthropology Field School (2007 and 2009) for their dedication and hard work, and the directors and staff of the National Museum of Ethiopia, Cleveland Museum of Natural History, and National Museums of Kenya for facilitating the analytical research reported here. Fieldwork permissions were kindly granted by the Authority for Research and Conservation of Cultural Heritage, Ethiopian Ministry of Culture and Tourism, and the Culture and Tourism Bureau of the Afar Regional State government. We thank J. DeSilva, J. M. Plavcan, and G. Schwartz for helpful comments. The analytical research was supported by NSF (grants NSF SBR-9601025 and NSF BCS-0333296), the University of Missouri Research Board and University of Missouri Research Council, and the Institute of Human Origins at Arizona State University.	Aiello L, 1990, INTRO HUMAN EVOLUTIO; ALEXANDER RM, 1991, J EXP BIOL, V160, P55; Bennett MR, 2009, SCIENCE, V323, P1197, DOI 10.1126/science.1168132; Berillon G., 2003, Human Evolution, V18, P113, DOI 10.1007/BF02436280; D'Aout K, 2002, AM J PHYS ANTHROPOL, V119, P37, DOI 10.1002/ajpa.10112; DAY MH, 1964, NATURE, V201, P969, DOI 10.1038/201969a0; Deloison Yvette, 2003, Biometrie Humaine et Anthropologie, V21, P189; DeSilva J., 2009, AM J PHYS ANTHROPOL, V141, P1; Elftman H, 1935, AM J PHYS ANTHROPOL, V20, P69, DOI 10.1002/ajpa.1330200109; GEBO DL, 1992, AM J PHYS ANTHROPOL, V89, P29, DOI 10.1002/ajpa.1330890105; GOMBERG DN, 1984, AM J PHYS ANTHROPOL, V63, P164; Hamrick MW, 1996, J MORPHOL, V230, P113; Harcourt-Smith W.E., 2002, THESIS U COLL LONDON; Harcourt-Smith WE, 2005, AM J PHYS ANTHROPOL, P112; Harcourt-Smith WEH, 2004, J ANAT, V204, P403, DOI 10.1111/j.0021-8782.2004.00296.x; HICKS JH, 1953, J ANAT, V87, P345; Kapandji I. A., 1985, PHYSL JOINTS; KER RF, 1987, NATURE, V325, P147, DOI 10.1038/325147a0; KIDD RS, 1993, AUST PODIATR, V27, P35; Kimbel WH, 2009, YEARB PHYS ANTHROPOL, V52, P2, DOI 10.1002/ajpa.21183; Klenerman L., 2006, HUMAN FOOT COMPANION; LAMY P, 1986, J HUM EVOL, V15, P31, DOI 10.1016/S0047-2484(86)80063-X; LATIMER B, 1990, AM J PHYS ANTHROPOL, V83, P13, DOI 10.1002/ajpa.1330830103; LATIMER BM, 1982, AM J PHYS ANTHROPOL, V57, P701, DOI 10.1002/ajpa.1330570412; LEWIS OJ, 1980, J ANAT, V130, P833; Lovejoy CO, 2009, SCIENCE, V326, DOI 10.1126/science.1175832; Morton DJ, 1924, AM J PHYS ANTHROPOL, V7, P1, DOI 10.1002/ajpa.1330070114; SAMMARCO GJ, 1989, BASIC BIOMECHANICS M, P163; SARMIENTO E, 1991, AM J PHYS ANTHR S, V12, P157; STERN JT, 1983, AM J PHYS ANTHROPOL, V60, P279, DOI 10.1002/ajpa.1330600302; Tuttle R.H., 1991, Human Evolution, V6, P193, DOI 10.1007/BF02438142; Vereecke E, 2003, AM J PHYS ANTHROPOL, V120, P373, DOI 10.1002/ajpa.10163; Vereecke EE, 2008, J EXP BIOL, V211, P3661, DOI 10.1242/jeb.018754; WALTER RC, 1994, GEOLOGY, V22, P6, DOI 10.1130/0091-7613(1994)022<0006:AOLATF>2.3.CO;2; WHITE TD, 1987, AM J PHYS ANTHROPOL, V72, P485, DOI 10.1002/ajpa.1330720409; Zipfel B, 2009, AM J PHYS ANTHROPOL, V140, P532, DOI 10.1002/ajpa.21103	36	118	122	2	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					750	753		10.1126/science.1201463	http://dx.doi.org/10.1126/science.1201463			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21311018				2022-12-28	WOS:000287205700065
J	Lemos, CA; Camargo, A				Lemos-Junior, Celso Augusto; Camargo, Alessandra			Sialolith of the Submandibular Salivary Gland.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lemos-Junior, Celso Augusto; Camargo, Alessandra] Univ Sao Paulo, Sao Paulo, Brazil	Universidade de Sao Paulo	Lemos, CA (corresponding author), Univ Sao Paulo, Sao Paulo, Brazil.		CAMARGO, LMA/B-4156-2009; Lemos, Celso/G-7249-2012	CAMARGO, LMA/0000-0001-9486-6195; Lemos, Celso/0000-0002-3372-6719					0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2011	364	6					551	551		10.1056/NEJMicm1008310	http://dx.doi.org/10.1056/NEJMicm1008310			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718QH	21306241				2022-12-28	WOS:000287139900009
J	Moses, H; Martin, JB				Moses, Hamilton, III; Martin, Joseph B.			Biomedical Research and Health Advances.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							OF-INTEREST; REVOLUTION; SCIENCE		[Moses, Hamilton, III] Alerion Inst, N Garden, VA USA; [Martin, Joseph B.] Harvard Univ, Sch Med, Boston, MA USA; [Moses, Hamilton, III] Johns Hopkins Sch Med, Baltimore, MD USA	Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins Medicine	Moses, H (corresponding author), Alerion Inst, N Garden, VA USA.							Agre P, 2010, SCIENCE, V327, P921, DOI 10.1126/science.1188231; [Anonymous], 2009, ROAD ENTRPR EC RES P; [Anonymous], 2010, NY TIMES        0621, pA24; [Anonymous], 2007, CRIS CONF; [Anonymous], 2009, ECONOMIST       0625, P13; Bush, 1945, SCI THE ENDLESS FRON, DOI DOI 10.1016/j.techsoc.2019.03.007; Buxton M, 2004, B WORLD HEALTH ORGAN, V82, P733; Callahan D, 2009, TAMING THE BELOVED BEAST: HOW MEDICAL TECHNOLOGY COSTS ARE DESTROYING OUR HEALTH CARE SYSTEM, P1; CARMICHAEL M, 2010, NEWSWEEK        0515; Collins F, 2010, NATURE, V464, P674, DOI 10.1038/464674a; Council of Medical Specialty Societies, COD INT CO; Dorsey ER, 2010, JAMA-J AM MED ASSOC, V303, P137, DOI 10.1001/jama.2009.1987; Dorsey ER, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007015; Fuchs V, 2003, BROOKINGS REV, V21, P44; Goodwin I, 2000, PHYS TODAY, V53, P53, DOI 10.1063/1.883037; Hemenway D, 2010, NEW ENGL J MED, V362, P1657, DOI 10.1056/NEJMp1001784; Higgins MJ, 2009, SCIENCE, V326, P370, DOI 10.1126/science.1176116; Koh HK, 2010, AM J PUBLIC HEALTH, V100, pS9, DOI 10.2105/AJPH.2010.191379; Ledford H, 2010, NATURE, V464, P1258, DOI 10.1038/4641258a; Lo B, 2009, CONFLICT INTEREST ME; Marmot MG, 2009, JAMA-J AM MED ASSOC, V301, P1169, DOI 10.1001/jama.2009.363; Martin JB, 2010, NEUROLOGY, V74, P2016, DOI 10.1212/WNL.0b013e3181e398e8; McArthur JH, 1997, JAMA-J AM MED ASSOC, V277, P985, DOI 10.1001/jama.277.12.985; Moses H, 2005, JAMA-J AM MED ASSOC, V294, P1333, DOI 10.1001/jama.294.11.1333; Moses H, 2009, JAMA-J AM MED ASSOC, V302, P1001, DOI 10.1001/jama.2009.1262; Moses HI, 2002, NEW ENGL J MED, V347, P1371, DOI 10.1056/NEJMsb021319; Munos B, 2010, CLIN PHARMACOL THER, V87, P534, DOI 10.1038/clpt.2010.26; Munos BH, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000155; Murphy K, 2003, PERSPECT BIOL MED, V46, pS108, DOI 10.1353/pbm.2003.0048; Nagarkar Purushottam A, 2010, Pharos Alpha Omega Alpha Honor Med Soc, V73, P13; Orszag PR, 2010, NEW ENGL J MED, V363, P601, DOI 10.1056/NEJMp1006571; Paul SM, 2010, NAT REV DRUG DISCOV, V9, P203, DOI 10.1038/nrd3078; Pekarsky B, 2010, PHARMACOECONOMICS, V28, P1, DOI 10.2165/11318770-000000000-00000; PETROSKI H, 2010, ESSENTIAL ENG WHY SC; Rockey SJ, 2010, JAMA-J AM MED ASSOC, V303, P2400, DOI 10.1001/jama.2010.774; Stiglitz J, 2010, WALL STREET J   0416; Stuart TE, 2007, RES POLICY, V36, P477, DOI 10.1016/j.respol.2007.02.016; Wadman M, 2010, NAT REV DRUG DISCOV, V9, P1, DOI 10.1038/nrd3143; Weinberg RA, 2010, NATURE, V464, P678, DOI 10.1038/464678a; Wood AJJ, 2006, NEW ENGL J MED, V355, P2712; Wood AJJ, 2006, NEW ENGL J MED, V355, P618, DOI 10.1056/NEJMsb055203; Zinner DE, 2009, JAMA-J AM MED ASSOC, V302, P969, DOI 10.1001/jama.2009.1265	42	29	30	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2011	364	6					567	571		10.1056/NEJMsb1007634	http://dx.doi.org/10.1056/NEJMsb1007634			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718QH	21306245				2022-12-28	WOS:000287139900014
J	Sinha, B; Koster, D; Ruez, R; Gonnord, P; Bastiani, M; Abankwa, D; Stan, RV; Butler-Browne, G; Vedie, B; Johannes, L; Morone, N; Parton, RG; Raposo, G; Sens, P; Lamaze, C; Nassoy, P				Sinha, Bidisha; Koester, Darius; Ruez, Richard; Gonnord, Pauline; Bastiani, Michele; Abankwa, Daniel; Stan, Radu V.; Butler-Browne, Gillian; Vedie, Benoit; Johannes, Ludger; Morone, Nobuhiro; Parton, Robert G.; Raposo, Graca; Sens, Pierre; Lamaze, Christophe; Nassoy, Pierre			Cells Respond to Mechanical Stress by Rapid Disassembly of Caveolae	CELL			English	Article							SIGNAL-REGULATED KINASE; MEMBRANE TENSION; DEPENDENT ACTIVATION; ENDOTHELIAL-CELLS; IN-VITRO; PROTEIN; ENDOCYTOSIS; MUTATIONS; MUSCLE; GENE	The functions of caveolae, the characteristic plasma membrane invaginations, remain debated. Their abundance in cells experiencing mechanical stress led us to investigate their role in membrane-mediated mechanical response. Acute mechanical stress induced by osmotic swelling or by uniaxial stretching results in a rapid disappearance of caveolae, in a reduced caveolin/Cavin1 interaction, and in an increase of free caveolins at the plasma membrane. Tether-pulling force measurements in cells and in plasma membrane spheres demonstrate that caveola flattening and disassembly is the primary actin-and ATP-independent cell response that buffers membrane tension surges during mechanical stress. Conversely, stress release leads to complete caveola reassembly in an actin-and ATP-dependent process. The absence of a functional caveola reservoir in myotubes from muscular dystrophic patients enhanced membrane fragility under mechanical stress. Our findings support a new role for caveolae as a physiological membrane reservoir that quickly accommodates sudden and acute mechanical stresses.	[Ruez, Richard; Gonnord, Pauline; Johannes, Ludger; Raposo, Graca; Lamaze, Christophe] CNRS UMR144, F-75248 Paris 05, France; [Sinha, Bidisha; Koester, Darius; Nassoy, Pierre] Univ Paris 06, CNRS UMR168, F-75248 Paris 05, France; [Sinha, Bidisha; Koester, Darius; Nassoy, Pierre] Inst Curie, Ctr Rech, Chim Phys Lab, F-75248 Paris 05, France; [Ruez, Richard; Gonnord, Pauline; Johannes, Ludger; Lamaze, Christophe] Inst Curie, Ctr Rech, Lab Traf Signalisat & Ciblage Intracellulaires, F-75248 Paris 05, France; [Raposo, Graca] PICT IBiSA Inst Curie, F-75248 Paris 05, France; [Raposo, Graca] Inst Curie, Ctr Rech, Lab Struct & Compartiments Membranaires, F-75248 Paris 05, France; [Sens, Pierre] ESPCI, CNRS UMR 7083, F-75231 Paris 05, France; [Bastiani, Michele; Abankwa, Daniel; Parton, Robert G.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Bastiani, Michele; Abankwa, Daniel; Parton, Robert G.] Ctr Microscopy & Microanal, Brisbane, Qld 4072, Australia; [Stan, Radu V.] Dartmouth Med Sch, Lebanon, NH 03756 USA; [Butler-Browne, Gillian] UM76 UPMC, Hop La Pitie Salpetriere, Inst Myol, CNRS AIM,Inserm U974,UMR7215, F-75651 Paris 13, France; [Vedie, Benoit] Hop Europeen Georges Pompidou, Biochim Lab, F-75015 Paris, France; [Morone, Nobuhiro] Natl Ctr Neurol & Psychiat, Natl Inst Neurosci, Dept Ultrastruct Res, Kodaira, Tokyo 1878502, Japan	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI); University of Queensland; University of Queensland; Dartmouth College; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; National Center for Neurology & Psychiatry - Japan	Lamaze, C (corresponding author), CNRS UMR144, F-75248 Paris 05, France.	christophe.lamaze@curie.fr; pierre.nassoy@curie.fr	Johannes, Ludger/W-8593-2019; Köster, Darius Vasco/Y-1387-2019; Nassoy, Pierre/AAC-2606-2019; Mouly, Gillian/G-6595-2017; Parton, Robert G/C-5673-2009; Ruez, Richard/A-3479-2013; Bastiani, Michele/J-1823-2014; sens, pierre/C-3537-2011; Johannes, Ludger/M-9778-2017; Stan, Radu/AAE-7574-2021; Lamaze, Christophe/M-4912-2017	Johannes, Ludger/0000-0002-2168-0004; Köster, Darius Vasco/0000-0001-8530-5476; Parton, Robert G/0000-0002-7494-5248; Ruez, Richard/0000-0001-5187-2210; Bastiani, Michele/0000-0001-6752-4157; sens, pierre/0000-0003-4523-3791; Johannes, Ludger/0000-0002-2168-0004; Stan, Radu/0000-0003-2969-1725; Raposo, graca/0000-0001-9590-1298; Abankwa, Daniel/0000-0003-2769-0745; LAMAZE, Christophe/0000-0001-5430-2707; Nassoy, Pierre/0000-0003-4615-9431; butler-browne, gillian/0000-0002-3431-242X; Morone, Nobuhiro/0000-0002-7672-158X	Institut Curie (PIC Division Cellulaire, Polarite et Cancer); Agence Nationale pour la Recherche; Fondation de France; Association Francaise contre les Myopathies; National Health and Medical Research Council of Australia; Australian Research Council; NIH [HL83249, HL92085]; Institut Curie; Association pour la Recherche sur le Cancer; NATIONAL CANCER INSTITUTE [P30CA023108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092085, R01HL083249] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [23310087] Funding Source: KAKEN	Institut Curie (PIC Division Cellulaire, Polarite et Cancer); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation de France(Fondation de France); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Institut Curie; Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Institut Curie (PIC Division Cellulaire, Polarite et Cancer), Agence Nationale pour la Recherche, Fondation de France (programme tumeurs), Association Francaise contre les Myopathies, the National Health and Medical Research Council of Australia and the Australian Research Council (R. G. P. and D. A.), and NIH grants HL83249 and HL92085 (R. V. S.). Microscopy (M. B.) was performed at the ACRF/IMB Dynamic Imaging Centre for Cancer Biology. D. K. was funded by a doctorate fellowship from the Institut Curie, and B. S. was funded by postdoctoral fellowships from the Institut Curie and the Association pour la Recherche sur le Cancer. D. A. is a fellow of the Swiss National Science Foundation (PA00A-111446) and is indebted to K. Alexandrov for support. The authors gratefully acknowledge the Nikon Imaging Centre at Institut Curie and the CNRS consortium CellTis. We thank F. Perez for the pDendra2-C plasmid, A. Helenius for the Cav1-EGFP plasmid and MEF cells, and F. Pinaud for Cav1-EGFP HeLa. We are also grateful to M. Piel and N. Carpi for help in micropatterning and P. Bassereau for access to the confocal microscope coupled to optical tweezers. We thank C. Viaris and C. Blouin for carefully reading the manuscript, and we are indebted to A. Bigot for providing human muscle cells. We would like to thank Eurobiobank and Pr. C. Minette for giving access to primary cells to isolate the immortalized Cav3 cell line. C. L. wishes to dedicate this work to the memory of his father, Robert Lamaze, and to all patients suffering from pancreatic cancer.	Abankwa D, 2008, EMBO J, V27, P727, DOI 10.1038/emboj.2008.10; Boyd NL, 2003, AM J PHYSIOL-HEART C, V285, pH1113, DOI 10.1152/ajpheart.00302.2003; Chen CS, 1997, SCIENCE, V276, P1425, DOI 10.1126/science.276.5317.1425; Cuvelier D, 2005, BIOPHYS J, V88, P2714, DOI 10.1529/biophysj.104.056473; D'Alessandro M, 2002, J CELL SCI, V115, P4341, DOI 10.1242/jcs.00120; Dai J, 1995, COLD SPRING HARB SYM, V60, P567, DOI 10.1101/SQB.1995.060.01.060; Dai JW, 1999, BIOPHYS J, V77, P3363, DOI 10.1016/S0006-3495(99)77168-7; Dai JW, 1998, J NEUROSCI, V18, P6681; Dai JW, 1997, J GEN PHYSIOL, V110, P1, DOI 10.1085/jgp.110.1.1; Dimova R, 2006, J PHYS-CONDENS MAT, V18, pS1151, DOI 10.1088/0953-8984/18/28/S04; DULHUNTY AF, 1975, J PHYSIOL-LONDON, V250, P513, DOI 10.1113/jphysiol.1975.sp011068; Hansen CG, 2009, NAT CELL BIOL, V11, P807, DOI 10.1038/ncb1887; Hayashi YK, 2009, J CLIN INVEST, V119, P2623, DOI 10.1172/JCI38660; Henley JR, 1998, J CELL BIOL, V141, P85, DOI 10.1083/jcb.141.1.85; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Jansa P, 2001, NUCLEIC ACIDS RES, V29, P423, DOI 10.1093/nar/29.2.423; Kawamura S, 2003, J BIOL CHEM, V278, P31111, DOI 10.1074/jbc.M300725200; Kirkham M, 2008, J CELL SCI, V121, P2075, DOI 10.1242/jcs.024588; Kozera L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008312; KURZCHALIA TV, 1992, J CELL BIOL, V118, P1003, DOI 10.1083/jcb.118.5.1003; Lang F, 1998, PHYSIOL REV, V78, P247, DOI 10.1152/physrev.1998.78.1.247; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Merlini L, 2002, J NEUROL NEUROSUR PS, V73, P65, DOI 10.1136/jnnp.73.1.65; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Morris CE, 2001, J MEMBRANE BIOL, V179, P79, DOI 10.1007/s002320010040; Murata T, 2007, J BIOL CHEM, V282, P16631, DOI 10.1074/jbc.M607948200; Nabi IR, 2003, J CELL BIOL, V161, P673, DOI 10.1083/jcb.200302028; PALADE GE, 1953, J HISTOCHEM CYTOCHEM, V1, P188, DOI 10.1177/1.4.188; Park H, 1998, J BIOL CHEM, V273, P32304, DOI 10.1074/jbc.273.48.32304; Park H, 2000, AM J PHYSIOL-HEART C, V278, pH1285, DOI 10.1152/ajpheart.2000.278.4.H1285; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pelkmans L, 2004, CELL, V118, P767, DOI 10.1016/j.cell.2004.09.003; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Pinaud F, 2009, TRAFFIC, V10, P691, DOI 10.1111/j.1600-0854.2009.00902.x; PRESCOTT L, 1976, TISSUE CELL, V8, P241, DOI 10.1016/0040-8166(76)90050-1; Richter T, 2008, TRAFFIC, V9, P893, DOI 10.1111/j.1600-0854.2008.00733.x; Rizzo V, 2003, AM J PHYSIOL-HEART C, V285, pH1720, DOI 10.1152/ajpheart.00344.2002; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Scherer PE, 1996, P NATL ACAD SCI USA, V93, P131, DOI 10.1073/pnas.93.1.131; Sedding DG, 2005, CIRC RES, V96, P635, DOI 10.1161/01.RES.0000160610.61306.0f; Sens P, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031918; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Sorre B, 2009, P NATL ACAD SCI USA, V106, P5622, DOI 10.1073/pnas.0811243106; Stan RV, 2005, BBA-MOL CELL RES, V1746, P334, DOI 10.1016/j.bbamcr.2005.08.008; Tagawa A, 2005, J CELL BIOL, V170, P769, DOI 10.1083/jcb.200506103; Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890; Woodman SE, 2004, NEUROLOGY, V62, P538, DOI 10.1212/WNL.62.4.538; YAMADA E, 1955, J BIOPHYS BIOCHEM CY, V1, P445, DOI 10.1083/jcb.1.5.445	51	567	568	6	97	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 4	2011	144	3					402	413		10.1016/j.cell.2010.12.031	http://dx.doi.org/10.1016/j.cell.2010.12.031			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295700	Bronze, Green Accepted			2022-12-28	WOS:000286973100012
J	Yucel, G; Oro, AE				Yucel, Gozde; Oro, Anthony E.			Cell Migration: GSK3 beta Steers the Cytoskeleton's Tip	CELL			English	Editorial Material							SYNTHASE KINASE 3; ACF7	Directed cell migration polarizes the cytoskeleton, allowing the cell to move toward migratory cues. In this issue, Wu et al. (2011) demonstrate that the glycogen synthase kinase 3 beta (GSK3 beta) controls microtubule architecture and polarized movement of skin stem cells during wound healing in mammals by regulating the microtubule crosslinking protein ACF7.	[Yucel, Gozde; Oro, Anthony E.] Program Epithelial Biol, Stanford, CA 94305 USA; [Yucel, Gozde; Oro, Anthony E.] Stanford Univ, Sch Med, Stanford, CA 94305 USA	Stanford University	Oro, AE (corresponding author), Program Epithelial Biol, CCSR 2145C,269 Campus Dr, Stanford, CA 94305 USA.	oro@stanford.edu		Oro, Anthony/0000-0002-6261-138X	NIAMS NIH HHS [R01 AR052785] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052785] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Roper K, 2002, J CELL SCI, V115, P4215, DOI 10.1242/jcs.00157; Sun T, 2009, DEV GROWTH DIFFER, V51, P735, DOI 10.1111/j.1440-169X.2009.01141.x; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Wu XY, 2011, CELL, V144, P341, DOI 10.1016/j.cell.2010.12.033; Zaoui K, 2010, P NATL ACAD SCI USA, V107, P18517, DOI 10.1073/pnas.1000975107	10	12	13	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2011	144	3					319	321		10.1016/j.cell.2011.01.023	http://dx.doi.org/10.1016/j.cell.2011.01.023			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295692	Green Accepted, Bronze			2022-12-28	WOS:000286973100002
J	Van Dover, CL				Van Dover, Cindy Lee			Tighten regulations on deep-sea mining	NATURE			English	Editorial Material									Duke Univ, Nicholas Sch Environm, Div Marine Sci & Conservat, Beaufort, NC 28516 USA	Duke University	Van Dover, CL (corresponding author), Duke Univ, Nicholas Sch Environm, Div Marine Sci & Conservat, Beaufort, NC 28516 USA.	clv3@duke.edu		Van Dover, Cindy/0000-0001-9845-8391				Coffey Natural Systems, 2008, ENV IMP STAT SOLW 1, P226; GJERDE KM, 2008, MARINE SERIES IUCN, V1; Gleason M, 2010, OCEAN COAST MANAGE, V53, P52, DOI 10.1016/j.ocecoaman.2009.12.001; Jankowski P, 2007, INDEPENDENT TECHNICA; SPIESS FN, 1980, SCIENCE, V207, P1421, DOI 10.1126/science.207.4438.1421; VANDOVER CL, 2011, ISA TECHNICAL STUDY, V8	6	97	98	2	71	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2011	470	7332					31	33		10.1038/470031a	http://dx.doi.org/10.1038/470031a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715LQ	21293351	Bronze			2022-12-28	WOS:000286886400013
J	Pronovost, PJ; Marsteller, JA				Pronovost, Peter J.; Marsteller, Jill A.			A Physician Management Infrastructure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Pronovost, Peter J.; Marsteller, Jill A.] Bloomberg Sch Publ Hlth, Dept Anesthesiol & Crit Care Med, Qual & Safety Res Grp, Baltimore, MD USA; [Pronovost, Peter J.; Marsteller, Jill A.] Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA; [Pronovost, Peter J.] Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA; [Pronovost, Peter J.] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University	Pronovost, PJ (corresponding author), Johns Hopkins Qual & Safety Res Grp, 1909 Thames St,2nd Floor, Baltimore, MD 21231 USA.	ppronovo@jhmi.edu						Darzi A, 2009, NEW ENGL J MED, V361, DOI 10.1056/NEJMp0905707; Heifetz RA., 1994, LEADERSHIP EASY ANSW; Nelson EC, 2008, JT COMM J QUAL PATIE, V34, P367, DOI 10.1016/S1553-7250(08)34047-1; Pronovost PJ, 2010, JAMA-J AM MED ASSOC, V304, P204, DOI 10.1001/jama.2010.979; Pronovost PJ, 2009, ACAD MED, V84, P1651, DOI 10.1097/ACM.0b013e3181bce0ee; Pronovost PJ, 2008, JT COMM J QUAL PATIE, V34, P342, DOI 10.1016/S1553-7250(08)34043-4; Shortell SM, 2007, JAMA-J AM MED ASSOC, V298, P673, DOI 10.1001/jama.298.6.673; Timmel J, 2010, JT COMM J QUAL PATIE, V36, P252, DOI 10.1016/S1553-7250(10)36040-5; Wachter RM, 2010, HEALTH AFFAIR, V29, P165, DOI 10.1377/hlthaff.2009.0785	9	10	10	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2011	305	5					500	501		10.1001/jama.2011.71	http://dx.doi.org/10.1001/jama.2011.71			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	714LI	21285428				2022-12-28	WOS:000286810700024
J	Kendall, T; Cape, J; Chan, M; Taylor, C				Kendall, Tim; Cape, John; Chan, Melissa; Taylor, Clare		Guideline Dev Grp	Guidelines Management of generalised anxiety disorder in adults: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY-CARE; PREVALENCE		[Kendall, Tim; Chan, Melissa; Taylor, Clare] Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London E1 8AA, England; [Kendall, Tim; Cape, John] UCL, London WC1E 7HB, England; [Kendall, Tim] Sheffield Hlth & Social Care NHS Fdn Trust, Sheffield S10 3TH, S Yorkshire, England; [Cape, John] Camden & Islington NHS Fdn Trust, St Pancras Hosp, London NW1 0PE, England	University of London; University College London; University of London; University College London	Kendall, T (corresponding author), Royal Coll Psychiatrists, Natl Collaborating Ctr Mental Hlth, London E1 8AA, England.	tim.kendall@shsc.nhs.uk	John, Cape/B-9039-2009	John, Cape/0000-0003-3108-7228				Arroll B, 2009, PRIMARY CARE MENTAL, P147; Bitran S, 2009, NEW OXFORD TXB PSYCH, P729; Brugha T, 2009, ADULT PSYCHIAT MORBI; Culpepper L, 2009, J CLIN PSYCHIAT, V70, P20, DOI 10.4088/JCP.s.7002.04; Dugas M. J., 2007, COGNITIVE BEHAV TREA, P1; Layard R, 2006, BRIT MED J, V332, P1030, DOI 10.1136/bmj.332.7548.1030; National Institute for Health and Clinical Excellence, 2009, CLIN GUID; National Institute for Health and Clinical Excellence, 2011, CLIN GUID; National Institute for Health and Clinical Excellence, 2004, CLIN GUID; Rickels K, 2001, J CLIN PSYCHIAT, V62, P4; Roy-Byrne PP, 2008, GEN HOSP PSYCHIAT, V30, P208, DOI 10.1016/j.genhosppsych.2007.12.006; Roy-Byrne PP, 2004, J CLIN PSYCHIAT, V65, P20; Sareen J, 2006, ARCH INTERN MED, V166, P2109, DOI 10.1001/archinte.166.19.2109; Tyrer P, 2006, LANCET, V368, P2156, DOI 10.1016/S0140-6736(06)69865-6; Wittchen HU, 2002, DEPRESS ANXIETY, V16, P162, DOI 10.1002/da.10065; Wittchen HU, 2002, J CLIN PSYCHIAT, V63, P24	16	8	8	0	12	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2011	342								c7460	10.1136/bmj.c7460	http://dx.doi.org/10.1136/bmj.c7460			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715ME	21270081	Green Published			2022-12-28	WOS:000286887800009
J	Baris, E; Mollahaliloglu, S; Aydin, S				Baris, Enis; Mollahaliloglu, Salih; Aydin, Sabahattin			Healthcare in Turkey: from laggard to leader	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Baris, Enis] World Bank, Washington, DC 20433 USA	The World Bank	Baris, E (corresponding author), World Bank, Room H9-271,1818 H St NW, Washington, DC 20433 USA.	ebaris@worldbank.org		Aydin, Sabahattin/0000-0001-6374-817X				AKDAG R, 2009, TRANSFORMATION PROGR; [Anonymous], 2008, OECD REV HLTH SYST T; Garrett L, 2009, LANCET, V374, P1294, DOI 10.1016/S0140-6736(09)61503-8; Hacettepe University Institute of Population Studies, 2009, 2008 TURK DEM HLTH S; Ministry of Health, 2003, HLTH TRANSF PROGR; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P717; OECD, 2009, HLTH GLANC 2009 OECD; *ORG EC COOP DEV, 2007, OECD HLTH DAT 2007; Savas BS, 2002, HEALTHCARE SYSTEMS T; Travis P, 2004, LANCET, V364, P900, DOI 10.1016/S0140-6736(04)16987-0; W.H. Organization, 2009, WORLD HLTH STAT 2009; WHO, 2009, EUROPEAN HEALTH REPORT 2009: HEALTH AND HEALTH SYSTEMS, P1; WHO, 2010, TRENDS MAT MORT 1990; *WORLD BANK, 2004, TURK HLTH TRANS PROJ, V1; *WORLD BANK, 2004, TURK HLTH TRANS PROJ, V2; *WORLD BANK, 2010, IMPL COMPL RES REP T; World Bank, 2010, 48627TR WORLD BANK; World Bank, 2003, TURK REF HLTH SECT I, V2; World Bank, 2003, TURK REF HLTH SECT I, V1; World Health Organization, 2005, HLTH MILL DEV GOALS; Yardim MS, 2010, HEALTH POLICY, V94, P26, DOI 10.1016/j.healthpol.2009.08.006; You D., 2010, LEVELS TRENDS CHILD	22	34	34	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2011	342								c7456	10.1136/bmj.c7456	http://dx.doi.org/10.1136/bmj.c7456			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711PJ	21257656				2022-12-28	WOS:000286603600006
J	Rebbeck, CA; Leroi, AM; Burt, A				Rebbeck, Clare A.; Leroi, Armand M.; Burt, Austin			Mitochondrial Capture by a Transmissible Cancer	SCIENCE			English	Article							EVOLUTION; ORIGIN		[Rebbeck, Clare A.; Leroi, Armand M.; Burt, Austin] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Ascot SL5 7PY, Berks, England	Imperial College London	Burt, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, Silwood Pk, Ascot SL5 7PY, Berks, England.	a.burt@imperial.ac.uk		rebbeck, clare/0000-0002-2502-9622; Burt, Austin/0000-0001-5146-9640	Natural Environmental Research Council (NERC); Breakthrough Breast Cancer Research Centre, part of the Institute of Cancer Research (ICR)	Natural Environmental Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Breakthrough Breast Cancer Research Centre, part of the Institute of Cancer Research (ICR)	We thank E. C. Yeoh, J. Gilchrist, A. Ortega-Pacheco, B. Rivera, N. Trakrantungsie, and H. Ververidis for providing CTVT samples and A. Ashworth and C. Isacke. Supported by the Natural Environmental Research Council (NERC) and the Breakthrough Breast Cancer Research Centre, part of the Institute of Cancer Research (ICR). GenBank accession numbers for sequence data are given in table S1. Data were deposited at Dryad: DOI 10.5061/dryad.8081.	Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Irion DN, 2003, J HERED, V94, P81, DOI 10.1093/jhered/esg004; Mozos E, 1996, VET PATHOL, V33, P257, DOI 10.1177/030098589603300301; Murgia C, 2006, CELL, V126, P477, DOI 10.1016/j.cell.2006.05.051; Rebbeck CA, 2009, EVOLUTION, V63, P2340, DOI 10.1111/j.1558-5646.2009.00724.x; Savolainen P, 2002, SCIENCE, V298, P1610, DOI 10.1126/science.1073906; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103	8	74	78	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					303	303		10.1126/science.1197696	http://dx.doi.org/10.1126/science.1197696			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252340				2022-12-28	WOS:000286636300028
J	Trinidad, SB; Fullerton, SM; Ludman, EJ; Jarvik, GP; Larson, EB; Burke, W				Trinidad, S. B.; Fullerton, S. M.; Ludman, E. J.; Jarvik, G. P.; Larson, E. B.; Burke, W.			Research Practice and Participant Preferences: The Growing Gulf	SCIENCE			English	Editorial Material							MEDICINE; PRIVACY; BIOBANK; SAMPLES; VIEWS; TRIBE		[Trinidad, S. B.; Fullerton, S. M.; Burke, W.] Univ Washington, Dept Bioeth & Humanities, Seattle, WA 98185 USA; [Ludman, E. J.; Larson, E. B.] Grp Hlth Res Inst, Seattle, WA 98101 USA; [Jarvik, G. P.] Univ Washington, Div Med Genet, Dept Med, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Trinidad, SB (corresponding author), Univ Washington, Dept Bioeth & Humanities, Seattle, WA 98185 USA.	sbtrini@uw.edu	Fullerton, Stephanie Malia/H-8696-2019; Jarvik, Gail P/N-6476-2014	Fullerton, Stephanie Malia/0000-0002-0938-6048; Jarvik, Gail P/0000-0002-6710-8708; Trinidad, Susan Brown/0000-0002-5956-6557	NHGRI NIH HHS [U01 HG006375, U01-HG-004610, U01 HG004610, U01 HG004610-01] Funding Source: Medline; NIA NIH HHS [U01 AG006781] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006375, U01HG004610] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG006781] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], U01HG004610 NIH NAT; Boyer Bert B, 2005, Int J Circumpolar Health, V64, P281; Brothers KB, 2010, AM J BIOETHICS, V10, P15, DOI 10.1080/15265161.2010.492891; Capriccioso R., 2010, INDIAN COUNTRY  0421; Couzin-Frankel J, 2010, SCIENCE, V328, P1218, DOI 10.1126/science.328.5983.1218; Couzin-Frankel J, 2010, SCIENCE, V328, P558, DOI 10.1126/science.328.5978.558; Driver C., 2010, MAILONOLINE     0524; Fullerton SM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000361; Gellman R, 2010, AM J BIOETHICS, V10, P28, DOI 10.1080/15265161.2010.492892; HARMON A, 2010, NY TIMES        0425, pWK1; Harmon A., 2010, NY TIMES 0918, pA1; Johnsson L, 2010, EUR J HUM GENET, V18, P1261, DOI 10.1038/ejhg.2010.106; Kaufman D, 2008, GENET MED, V10, P331, DOI 10.1097/GIM.0b013e31818bb3ab; Kohane IS, 2007, SCIENCE, V316, P836, DOI 10.1126/science.1135489; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Lemke AA, 2010, PUBLIC HEALTH GENOM, V13, P368, DOI 10.1159/000276767; Ludman EJ, 2010, J EMPIR RES HUM RES, V5, P9, DOI 10.1525/jer.2010.5.3.9; McCarty CA, 2008, AM J MED GENET A, V146A, P3026, DOI 10.1002/ajmg.a.32559; Mello MM, 2010, NEW ENGL J MED, V363, P204, DOI 10.1056/NEJMp1005203; National Institutes of Health (NIH), 2003, NOTOD03032 NIH HHS; NIH, 2007, NOTOD07088 NIH HHS; Pentz RD, 2006, AM J MED GENET A, V140A, P733, DOI 10.1002/ajmg.a.31154; Pulley JM, 2008, CELL TISSUE BANK, V9, P55, DOI 10.1007/s10561-007-9051-2; Ramshaw E., 2010, TEXAS TRIBUNE 0222 TEXAS TRIBUNE 0222; Rothstein MA, 2010, AM J BIOETHICS, V10, P3, DOI 10.1080/15265161.2010.494215; Secko DM, 2009, SOC SCI MED, V68, P781, DOI 10.1016/j.socscimed.2008.11.020; Skloot R., 2010, IMMORTAL LIFE HENRIE; Storing B.C., 2010, CBC NEWS        0512; Trinidad SB, 2010, GENET MED, V12, P486, DOI 10.1097/GIM.0b013e3181e38f9e; U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES, 2008, GUID RES INV COD PRI; Yarborough M, 2009, ACAD MED, V84, P472, DOI 10.1097/ACM.0b013e31819a8aa6	31	78	78	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					287	288		10.1126/science.1199000	http://dx.doi.org/10.1126/science.1199000			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712BF	21252333	Green Accepted			2022-12-28	WOS:000286636300021
J	Driver, JA; Logroscino, G; Lu, LD; Gaziano, JM; Kurth, T				Driver, Jane A.; Logroscino, Giancarlo; Lu, Linda; Gaziano, J. Michael; Kurth, Tobias			Use of non-steroidal anti-inflammatory drugs and risk of Parkinson's disease: nested case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; PHYSICIANS HEALTH; BETA-CAROTENE; COMORBIDITY; PROTECT; CANCER; NEUROPROTECTION; SALICYLATE; ADJUSTMENT; MORTALITY	Objective To evaluate the relation between Parkinson's disease and prior use of non-steroidal anti-inflammatory drugs (NSAIDs) in a large cohort of men. Design Case-control analysis nested in the Physicians' Health Study. Participants 22 007 male physicians aged 40-84 years without indications for or contraindications to regular NSAID use and free of Parkinson's disease at baseline. Cases and controls were matched by age alone or by age and scores for confounders (comorbidity and indicators of NSAID use). Up to five controls were matched to each of 616 cases by age and 565 cases by age and confounder scores. Setting United States. Main outcome measures Odds of having been exposed to prior non-aspirin NSAID or aspirin use by participants with Parkinson's disease and by their controls in each case-control set. Results Participants who had ever used non-aspirin NSAIDs had an increased risk of Parkinson's disease (odds ratio 1.28 (95% CI 1.05 to 1.56) in the age matched group but not in the group also matched on confounder scores (odds ratio 1.17 (0.94 to 1.46)). There was an increased risk of Parkinson's disease in men who had 12 years of regular non-aspirin NSAID use (odds ratio 1.35 (1.07 to 1.70)), a finding that remained significant after matching for confounder scores as well (odds ratio 1.35 (1.05 to 1.75)). In contrast, the significant association of use of non-aspirin NSAIDs for >= 5 years (odds ratio 1.48 (1.05 to 2.09)) in the age matched group was entirely attenuated in the group also matched on confounder scores (1.03 (0.70 to 1.53)). There was also a suggestion that men who regularly used aspirin had an increased risk of Parkinson's disease. Positive associations between non-aspirin NSAID or aspirin and risk of Parkinson's disease tended to disappear when analyses were limited to drug use >= 5 years before the disease diagnosis. Conclusions This case-control study did not find evidence that NSAID use reduces Parkinson's disease risk. The positive associations observed between NSAID use and Parkinson's disease might have been due to confounding by indication as the use was clustered in the few years before disease diagnosis.	[Driver, Jane A.; Lu, Linda; Gaziano, J. Michael] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Aging,Dept Med, Boston, MA 02120 USA; [Driver, Jane A.; Gaziano, J. Michael] VA Boston Healthcare Syst, Geriatr Res Educ & Clin Ctr, Boston, MA USA; [Driver, Jane A.; Gaziano, J. Michael] VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res Informat Ctr, Boston, MA USA; [Logroscino, Giancarlo] Univ Bari, Dept Neurol & Psychiat Sci, Bari, Italy; [Gaziano, J. Michael; Kurth, Tobias] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02120 USA; [Kurth, Tobias] INSERM, Neuroepidemiol U708, Paris, France; [Kurth, Tobias] Univ Paris 06, Paris, France	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Universita degli Studi di Bari Aldo Moro; Harvard University; Brigham & Women's Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Driver, JA (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Aging,Dept Med, 1620 Tremont St, Boston, MA 02120 USA.	jdriver@partners.org	Kurth, Tobias/A-9243-2012; LOGROSCINO, GIANCARLO/K-5148-2016	Kurth, Tobias/0000-0001-7169-2620; LOGROSCINO, GIANCARLO/0000-0003-0423-3242	Parkinson's Disease Foundation; National Cancer Institute [CA-34944, CA-40360, CA-097193]; National Heart, Lung, and Blood Institute, Bethesda, MD [HL-26490, HL-34595]; Hartford Foundation; Harvard Medical School; Veteran's Administration; Amyotrophic Lateral Sclerosis Association, Italian Ministry of Health; Apulia Region; Italian Ministry of Universities; National Institutes of Health; BASF; DSM Pharmaceuticals; Wyeth Pharmaceuticals; McNeil Consumer Products; Pliva; French National Research Agency; US National Institutes of Health; Merck; Migraine Research Foundation; Parkinson's Research Foundation; NATIONAL CANCER INSTITUTE [R01CA097193, R01CA040360] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL034595] Funding Source: NIH RePORTER	Parkinson's Disease Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Hartford Foundation; Harvard Medical School; Veteran's Administration(US Department of Veterans Affairs); Amyotrophic Lateral Sclerosis Association, Italian Ministry of Health(Ministry of Health, Italy); Apulia Region; Italian Ministry of Universities(Ministry of Education, Universities and Research (MIUR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BASF(BASF); DSM Pharmaceuticals; Wyeth Pharmaceuticals(Wyeth); McNeil Consumer Products; Pliva(Teva Pharmaceutical Industries); French National Research Agency(French National Research Agency (ANR)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck(Merck & Company); Migraine Research Foundation; Parkinson's Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research is funded by a grant from the Parkinson's Disease Foundation. The Physicians' Health Study is supported by grants CA-34944, CA-40360, and CA-097193 from the National Cancer Institute and grants HL-26490 and HL-34595 from the National Heart, Lung, and Blood Institute, Bethesda, MD. The study sponsor had no role in study design; data collection, analysis, or interpretation; writing the article; or the decision to submit it for publication. The researchers are independent from funders and sponsors.; All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare: JAD has support from the Parkinson's Disease Foundation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work. We report a full disclosure for the past five years for each of the authors. JAD has a research grant from the Parkinson's Disease Foundation, the Hartford Foundation, Harvard Medical School, and a Career Development Award from the Veteran's Administration. LL has nothing to disclose. GL has received research funding from the Amyotrophic Lateral Sclerosis Association, Italian Ministry of Health, the Apulia Region, and special funding from the Italian Ministry of Universities and has received honorariums from Pfizer, Novartis, Glaxo, and Lilly Pharmaceutical for speaking engagements. JMG has received investigator initiated research funding and support as principal investigator from National Institutes of Health, BASF, DSM Pharmaceuticals, Wyeth Pharmaceuticals, McNeil Consumer Products, and Pliva; received honoraria from Bayer and Pfizer for speaking engagements; and is a consultant for Bayer, McNeil Consumer Products, Wyeth Pharmaceuticals, Merck, Nutraquest, and GlaxoSmithKline. TK has received investigator initiated research funding from the French National Research Agency, the US National Institutes of Health, Merck, the Migraine Research Foundation, and the Parkinson's Research Foundation; is a consultant to i3 Drug Safety and World Health Information Science Consultants, LLC; and has received honoraria from the American Academy of Neurology, Genzyme, Merck, and Pfizer for educational lectures.	Administration on Aging, 2005, PROF OLD AM 2005; Asmis TR, 2008, J CLIN ONCOL, V26, P54, DOI 10.1200/JCO.2007.12.8322; Aubin N, 1998, J NEUROCHEM, V71, P1635, DOI 10.1046/j.1471-4159.1998.71041635.x; Bornebroek M, 2007, NEUROEPIDEMIOLOGY, V28, P193, DOI 10.1159/000108110; Bower JH, 2006, NEUROLOGY, V67, P494, DOI 10.1212/01.wnl.0000227906.99570.cc; Breitner JCS, 2009, NEUROLOGY, V72, P1899, DOI 10.1212/WNL.0b013e3181a18691; Camargo CA, 1997, ARCH INTERN MED, V157, P79, DOI 10.1001/archinte.157.1.79; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen H, 2005, NEUROLOGY, V64, P664, DOI 10.1212/01.WNL.0000151960.28687.93; Chen HL, 2005, ANN NEUROL, V58, P963, DOI 10.1002/ana.20682; Chen HL, 2003, ARCH NEUROL-CHICAGO, V60, P1059, DOI 10.1001/archneur.60.8.1059; Christen WG, 2000, ANN EPIDEMIOL, V10, P125, DOI 10.1016/S1047-2797(99)00042-3; Driver JA, 2008, NEUROLOGY, V70, P1423, DOI 10.1212/01.wnl.0000310414.85144.ee; Driver JA, 2007, CANCER CAUSE CONTROL, V18, P705, DOI 10.1007/s10552-007-9005-9; Ford B, 2009, NAT REV NEUROL, V5, P242, DOI 10.1038/nrneurol.2009.50; Frigerio R, 2005, NEUROLOGY, V65, P1575, DOI 10.1212/01.wnl.0000184520.21744.a2; Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c; Hancock DB, 2007, ARCH NEUROL-CHICAGO, V64, P576, DOI 10.1001/archneur.64.4.576; Hennekens CH, 1996, NEW ENGL J MED, V334, P1145, DOI 10.1056/NEJM199605023341801; HENNEKENS CH, 1989, NEW ENGL J MED, V321, P129, DOI 10.1056/nejm198907203210301; Hernan MA, 2006, NEUROLOGY, V66, P1097, DOI 10.1212/01.wnl.0000204446.82823.28; Hunot S, 2003, ANN NEUROL, V53, pS49, DOI 10.1002/ana.10481; KOLLER WC, 1984, NEUROLOGY, V34, P957, DOI 10.1212/WNL.34.7.957; Kurth T, 2006, AM J EPIDEMIOL, V163, P262, DOI 10.1093/aje/kwj047; McGeer PL, 2003, ANN NEUROL, V54, P599, DOI 10.1002/ana.10728; Mohanakumar KP, 2000, BRAIN RES, V864, P281, DOI 10.1016/S0006-8993(00)02189-2; Nagatsu T, 2000, ADV RES NEURODEGENER, V8, P277; Powers KM, 2008, MOVEMENT DISORD, V23, P88, DOI 10.1002/mds.21782; ROYER GL, 1984, AM J MED, V77, P25, DOI 10.1016/S0002-9343(84)80015-7; SANDYK R, 1982, S AFR MED J, V61, P3; Schiess M, 2003, ARCH NEUROL-CHICAGO, V60, P1043, DOI 10.1001/archneur.60.8.1043; Snider SR, 1987, HDB PARKINSON DISEAS, P171; Teismann P, 2001, SYNAPSE, V39, P167, DOI 10.1002/1098-2396(200102)39:2<167::AID-SYN8>3.0.CO;2-U; Ton TG, 2006, MOVEMENT DISORD, V21, P964, DOI 10.1002/mds.20856; Wahner AD, 2007, NEUROLOGY, V69, P1836, DOI 10.1212/01.wnl.0000279519.99344.ad; Yates LB, 2008, ARCH INTERN MED, V168, P284, DOI 10.1001/archinternmed.2007.77	36	50	52	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2011	342								d198	10.1136/bmj.d198	http://dx.doi.org/10.1136/bmj.d198			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711PE	21252104	Green Published, hybrid			2022-12-28	WOS:000286603100002
J	Ross, J; Grahame, R				Ross, Juliette; Grahame, Rodney			Easily Missed? Joint hypermobility syndrome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CRITERIA; POPULATION; TESTS; AGE					rodney.grahame@uclh.nhs.uk						Adib N, 2005, RHEUMATOLOGY, V44, P744, DOI 10.1093/rheumatology/keh557; BEIGHTON P, 1973, ANN RHEUM DIS, V32, P413, DOI 10.1136/ard.32.5.413; Beighton P, 1998, AM J MED GENET, V77, P31, DOI 10.1002/(SICI)1096-8628(19980428)77:1<31::AID-AJMG8>3.3.CO;2-P; Bravo JF, 2006, ARTHRITIS RHEUM, V54, P515, DOI 10.1002/art.21557; BRIDGES AJ, 1992, ANN RHEUM DIS, V51, P793, DOI 10.1136/ard.51.6.793; Coady D, 2004, RHEUMATOLOGY, V43, P633, DOI 10.1093/rheumatology/keh138; Daniel HC, 2010, HYPERMOBILITY FIBROM; DAVIDOVITCH M, 1994, J CHILD NEUROL, V9, P417, DOI 10.1177/088307389400900417; DePaepe A, 1996, AM J MED GENET, V62, P417, DOI 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R; DIAZ MA, 1993, BRIT J RHEUMATOL, V32, P120; Ferrell WR, 2004, ARTHRITIS RHEUM-US, V50, P3323, DOI 10.1002/art.20582; Grahame R, 2006, ANN RHEUM DIS, V65, P263; Grahame R, 2000, J RHEUMATOL, V27, P1777; Grahame R, 2001, RHEUMATOLOGY, V40, P559, DOI 10.1093/rheumatology/40.5.559; Grahame R., 2010, HYPERMOBILITY FIBROM; Grahame R, 2009, CURR PAIN HEADACHE R, V13, P427, DOI 10.1007/s11916-009-0070-5; Hakim A, 2003, BEST PRACT RES CL RH, V17, P989, DOI 10.1016/j.berh.2003.08.001; Hudson N, 1995, BRIT J RHEUMATOL, V34, P1157; Juul-Kristensen B, 2007, RHEUMATOLOGY, V46, P1835, DOI 10.1093/rheumatology/kem290; Maillard S, 2010, HYPERMOBILITY FIBROM; McCulloch R, 2010, HYPERMOBILITY FIBROM; NORTON PA, 1995, OBSTET GYNECOL, V85, P225, DOI 10.1016/0029-7844(94)00386-R; Remvig L, 2007, J RHEUMATOL, V34, P804; Remvig L, 2007, J RHEUMATOL, V34, P798; RUNOW A, 1983, ACTA ORTHOP SCAND, V54, P1, DOI 10.3109/17453678309154170; Slmmonds JV, 2007, MANUAL THER, V12, P298, DOI 10.1016/j.math.2007.05.001; Tinkle BT, 2009, AM J MED GENET A, V149A, P2368, DOI 10.1002/ajmg.a.33070; WYNNEDAVIES R, 1971, P ROY SOC MED, V64, P689, DOI 10.1177/003591577106400649; Zarate N, 2010, NEUROGASTROENT MOTIL, V22, DOI 10.1111/j.1365-2982.2009.01421.x	29	54	56	0	11	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 20	2011	342								c7167	10.1136/bmj.c7167	http://dx.doi.org/10.1136/bmj.c7167			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711PE	21252103				2022-12-28	WOS:000286603100008
J	Schroeder, BO; Wu, ZH; Nuding, S; Groscurth, S; Marcinowski, M; Beisner, J; Buchner, J; Schaller, M; Stange, EF; Wehkamp, J				Schroeder, Bjoern O.; Wu, Zhihong; Nuding, Sabine; Groscurth, Sandra; Marcinowski, Moritz; Beisner, Julia; Buchner, Johannes; Schaller, Martin; Stange, Eduard F.; Wehkamp, Jan			Reduction of disulphide bonds unmasks potent antimicrobial activity of human beta-defensin 1	NATURE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; IMMUNE-RESPONSES; PEPTIDES; THIOREDOXIN; ASSOCIATION; BETA-DEFENSIN-1; DISEASE; ASSAYS; COLON	Human epithelia are permanently challenged by bacteria and fungi, including commensal and pathogenic microbiota(1,2). In the gut, the fraction of strict anaerobes increases from proximal to distal, reaching 99% of bacterial species in the colon(3). At colonic mucosa, oxygen partial pressure is below 25% of airborne oxygen content, moreover microbial metabolism causes reduction to a low redox potential of -200 mV to -300 mV in the colon(4). Defensins, characterized by three intramolecular disulphide-bridges, are key effector molecules of innate immunity that protect the host from infectious microbes and shape the composition of microbiota at mucosal surfaces(5-8). Human beta-defensin 1 (hBD-1) is one of the most prominent peptides of its class but despite ubiquitous expression by all human epithelia, comparison with other defensins suggested only minor antibiotic killing activity(9,10). Whereas much is known about the activity of antimicrobial peptides in aerobic environments, data about reducing environments are limited. Herein we show that after reduction of disulphide-bridges hBD-1 becomes a potent antimicrobial peptide against the opportunistic pathogenic fungus Candida albicans and against anaerobic, Gram-positive commensals of Bifidobacterium and Lactobacillus species. Reduced hBD-1 differs structurally from oxidized hBD-1 and free cysteines in the carboxy terminus seem important for the bactericidal effect. In vitro, the thioredoxin (TRX) system(11) is able to reduce hBD-1 and TRX co-localizes with reduced hBD-1 in human epithelia. Hence our study indicates that reduced hBD-1 shields the healthy epithelium against colonisation by commensal bacteria and opportunistic fungi. Accordingly, an intimate interplay between redox-regulation and innate immune defence seems crucial for an effective barrier protecting human epithelia.	[Schroeder, Bjoern O.; Nuding, Sabine; Beisner, Julia; Wehkamp, Jan] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; [Schroeder, Bjoern O.; Nuding, Sabine; Beisner, Julia; Wehkamp, Jan] Univ Tubingen, D-72076 Tubingen, Germany; [Wu, Zhihong] Univ Hosp Schleswig Holstein, Dept Dermatol, D-24105 Kiel, Germany; [Groscurth, Sandra] Max Planck Inst Dev Biol, Dept Prot Evolut 1, D-72076 Tubingen, Germany; [Marcinowski, Moritz; Buchner, Johannes] Tech Univ Munich, Dept Chem, Ctr Integrated Prot Sci Munich, D-85747 Garching, Germany; [Schaller, Martin] Univ Tubingen Hosp, Dept Dermatol, D-72076 Tubingen, Germany; [Stange, Eduard F.; Wehkamp, Jan] Robert Bosch Krankenhaus, Dept Internal Med 1, D-70376 Stuttgart, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; University of Kiel; Schleswig Holstein University Hospital; Max Planck Society; Technical University of Munich; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Bosch; Robert Bosch Krankenhaus	Wehkamp, J (corresponding author), Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany.	jan.wehkamp@ikp-stuttgart.de	Buchner, Johannes/A-2651-2010; Schroeder, Bjoern O/F-3353-2011; Wehkamp, Jan/B-7319-2011; Wu, Zhihong/AAK-3433-2020; hongbo, yi/G-9615-2011; Wu, Zhihong/G-3569-2011	Schroeder, Bjoern O/0000-0002-6716-8284; Buchner, Johannes/0000-0003-1282-7737; Wehkamp, Jan/0000-0001-6788-841X	Deutsche Forschungsgemeinschaft [WE 436/1-1, SCH 897/1-3, SFB685]; Robert-Bosch Foundation (Stuttgart, Germany)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Robert-Bosch Foundation (Stuttgart, Germany)	We thank M. Katajew, H. Loffler, C. Martensen-Kerl, C. Mehrens, J. Quitzau and A. Rose for technical assistance, B. Fehrenbacher for performing electron microscopy and H.-P. Kreichgauer, C. Schafer, O. Muller, K. R. Herrlinger and M. Escher for collecting biopsies. Furthermore we thank M. Schwab for discussions and support, C. L. Bevins and J.-M. Schroder for discussions and reading of the manuscript and Ardeypharm GmbH for providing anaerobic bacterial strains and L. Zabel for providing C. albicans strains. This work was supported by Deutsche Forschungsgemeinschaft (WE 436/1-1, SCH 897/1-3 and SFB685) and the Robert-Bosch Foundation (Stuttgart, Germany). J. W. is an Emmy Noether Scholar of Deutsche Forschungsgemeinschaft.	Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; BENSCH KW, 1995, FEBS LETT, V368, P331, DOI 10.1016/0014-5793(95)00687-5; Bevins C L, 2003, Contrib Microbiol, V10, P106; GANZ T, 1994, CURR OPIN IMMUNOL, V6, P584, DOI 10.1016/0952-7915(94)90145-7; Harder J, 2007, J ENDOTOXIN RES, V13, P317, DOI 10.1177/0968051907088275; HOLMGREN A, 1984, METHOD ENZYMOL, V107, P295; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Hooper LV, 2001, SCIENCE, V291, P881, DOI 10.1126/science.291.5505.881; Jurevic RJ, 2003, J CLIN MICROBIOL, V41, P90, DOI 10.1128/JCM.41.1.90-96.2003; Kocsis AK, 2008, SCAND J GASTROENTERO, V43, P299, DOI 10.1080/00365520701682615; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Macpherson AJ, 2004, NAT REV IMMUNOL, V4, P478, DOI 10.1038/nri1373; Nagy E, 2010, DRUGS, V70, P841, DOI 10.2165/11534490-000000000-00000; Nizet V, 2009, NAT REV IMMUNOL, V9, P609, DOI 10.1038/nri2607; Nuding S, 2006, J MICROBIOL METH, V65, P335, DOI 10.1016/j.mimet.2005.08.004; Nuding S, 2009, MICROBES INFECT, V11, P384, DOI 10.1016/j.micinf.2009.01.001; Ozturk A, 2010, J DENT RES, V89, P631, DOI 10.1177/0022034510364491; Peschel A, 2006, NAT REV MICROBIOL, V4, P529, DOI 10.1038/nrmicro1441; Peyrin-Biroulet L, 2010, P NATL ACAD SCI USA, V107, P8772, DOI 10.1073/pnas.0905745107; Round JL, 2009, NAT REV IMMUNOL, V9, P313, DOI 10.1038/nri2515; Schaefer AS, 2010, GENES IMMUN, V11, P45, DOI 10.1038/gene.2009.75; Schroeder B. O., 2011, PROTOCOL EXCHANGE, DOI [10.1038/protex.2010.204, DOI 10.1038/PROTEX.2010.204]; Schroder JM, 2010, METHODS MOL BIOL, V618, P15, DOI 10.1007/978-1-60761-594-1_2; Scudiero O, 2010, ANTIMICROB AGENTS CH, V54, P2312, DOI 10.1128/AAC.01550-09; Sido B, 2005, EUR J IMMUNOL, V35, P408, DOI 10.1002/eji.200424500; Singh PK, 1998, P NATL ACAD SCI USA, V95, P14961, DOI 10.1073/pnas.95.25.14961; Tamaki H, 2006, GASTROENTEROLOGY, V131, P1110, DOI 10.1053/j.gastro.2006.08.023; Taylor K, 2008, BIOPOLYMERS, V90, P1, DOI 10.1002/bip.20900; Tollin M, 2003, PEPTIDES, V24, P523, DOI 10.1016/S0196-9781(03)00114-1; WILSON M, 2005, MICROBIAL INHABITANT, P251; Wu Z., 2011, PROTOCOL EXCHANGE, DOI [10.1038/protex.2010.205, DOI 10.1038/PROTEX.2010.205]; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a	32	342	359	2	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					419	+		10.1038/nature09674	http://dx.doi.org/10.1038/nature09674			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248850				2022-12-28	WOS:000286385600057
J	Dunlop, N				Dunlop, Nic			The art of medicine Dying in isolation	LANCET			English	Editorial Material									Panos Pictures, London EC1Y 0TH, England		Dunlop, N (corresponding author), Panos Pictures, London EC1Y 0TH, England.								0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN-FEB	2011	377	9763					374	375		10.1016/S0140-6736(11)60118-9	http://dx.doi.org/10.1016/S0140-6736(11)60118-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	721ES	21312393	Bronze			2022-12-28	WOS:000287337000015
J	Dans, A; Ng, N; Varghese, C; Tai, ES; Firestone, R; Bonita, R				Dans, Antonio; Ng, Nawi; Varghese, Cherian; Tai, E. Shyong; Firestone, Rebecca; Bonita, Ruth			Health in Southeast Asia 4 The rise of chronic non-communicable diseases in southeast Asia: time for action	LANCET			English	Article							CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; LOW-INCOME; COUNTRIES; PREVALENCE; BURDEN; PREVENTION; SMOKING; OBESITY; COSTS	Southeast Asia faces an epidemic of chronic non-communicable diseases, now responsible for 60% of deaths in the region. The problem stems from environmental factors that promote tobacco use, unhealthy diet, and inadequate physical activity. Disadvantaged populations are the hardest hit, with death rates inversely proportional to a country's gross national income. Families shoulder the financial burden, but entire economies suffer as well. Although attempts to control non-communicable diseases are increasing, more needs to be done. Health-care systems need to be redesigned to deliver chronic care that is founded on existing primary health-care facilities, but supported by good referral systems. Surveillance of key modifiable risk factors is needed to monitor the magnitude of the problem and to study the effects of interventions. All branches of government and all sectors of society have to get involved in establishing environments that are conducive to healthy living. The Association of Southeast Asian Nations is in a unique position to make a united stand against chronic non-communicable diseases in the region. Inaction will affect millions of lives often, the lives of those who have the least.	[Dans, Antonio] Univ Philippines, Coll Med, Dept Med, Manila 1000, Philippines; [Ng, Nawi] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Ng, Nawi] Gadjah Mada Univ, Fac Med, Dept Publ Hlth, Yogyakarta, Indonesia; [Varghese, Cherian] WHO, Western Pacific Reg Off, Manila, Philippines; [Tai, E. Shyong] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Div Endocrinol, Singapore 117595, Singapore; [Firestone, Rebecca] China Med Board, Cambridge, MA USA; [Firestone, Rebecca] Harvard Global Equ Initiat, Cambridge, MA USA; [Bonita, Ruth] Univ Auckland, Sch Populat Hlth, Auckland 1, New Zealand	University of the Philippines System; University of the Philippines Manila; Umea University; Gadjah Mada University; WHO Western Pacific Regional Office; World Health Organization; National University of Singapore; University of Auckland	Dans, A (corresponding author), Univ Philippines, Coll Med, Dept Med, Manila 1000, Philippines.	tdans@skybroadband.com.ph	Ng, Nawi/F-8373-2011; Tai, E Shyong/J-9831-2013	Ng, Nawi/0000-0003-0556-1483; Tai, E Shyong/0000-0003-2929-8966	AstraZeneca; Boehringer Ingelheim; Pfizer; China Medical Board; Rockefeller Foundation; Atlantic Philanthropies	AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); Pfizer(Pfizer); China Medical Board; Rockefeller Foundation; Atlantic Philanthropies	RF receives honoraria for her work with the China Medical Board. AD reports receiving a research grant from AstraZeneca, related to a study that involves a statin. He also received a research grant and honoraria for lectures from Boehringer Ingelheim, related to a study on an angiotensin-converting enzyme inhibitor. EST is a member of several advisory boards on dyslipidaemia for Merck Sharpe and Dohme, on liraglutide for Novo Nordisk Pharma, and on diabetes for AstraZeneca and Bristol-Myers Squibb. He is the recipient of a research grant from Pfizer, and has received honoraria for lectures from Merck Schering-Plough, GlaxoSmithKline, and Abbott Manufacturing. NN, CV, and RB declare that they have no conflicts of interest.; The paper is part of a Series funded by the China Medical Board, the Rockefeller Foundation, and Atlantic Philanthropies. China Medical Board organised the writing teams, set standards and directions, then monitored progress and compliance with deadlines. None of the funders were involved in data collection, analysis, or write-up. No honoraria were paid for writing of this paper, and the final responsibility for submission belonged to the authors. Views expressed in this report are those of the authors and are not the policies or positions of the organisations that they represent. We thank Leanne Riley from the Department of Chronic Diseases and Health Promotion of the World Health Organization in Geneva, Switzerland, for her untiring help in developing table 2 from various country reports.	Abegunde DO, 2007, LANCET, V370, P1929, DOI 10.1016/S0140-6736(07)61696-1; Alwan A, 2010, LANCET, V376, P1861, DOI 10.1016/S0140-6736(10)61853-3; [Anonymous], WHO GLOB INFOBASE; [Anonymous], 2005, PREV CHRON DIS VIT I; Armstrong Thimothy, 2003, ETHNIC DIS, V13, P2; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Asia Pacific Cohort Collaboration, 2007, DIABETOLOGIA, V50, P2289, DOI 10.1007/s00125-007-0801-2; Barr Victoria J, 2003, Hosp Q, V7, P73; Barzi F, 2005, ANN EPIDEMIOL, V15, P405, DOI 10.1016/j.annepidem.2005.01.005; Bhalla V, 2006, SMJ Singapore Medical Journal, V47, P841; Bill & Melinda Gates Foundation, FUND GRANTS COMB TOB; Bloomberg Initiative, TOB CONTR GRANTS; Chongsuvivatwong V, 2011, LANCET, V377, P429, DOI 10.1016/S0140-6736(10)61507-3; Department of Health Republic of the Philippines, 2009, PREV CONTR CHRON LIF; ERC, 2007, WORLD CIG 1 2007 REP; Ezzati M, 2004, COMP QUANTIFICATION; Food and Agricultural Organization of the United Nations, 2006, DOUBL BURD MALN CAS; globalEDGE, FOOD BAV IND STATS; Huxley R, 2006, BMJ-BRIT MED J, V332, P73, DOI 10.1136/bmj.38678.389583.7C; Institute of Medicine, 2010, PROM CARD HLTH DEV W; Johnston SC, 2009, LANCET NEUROL, V8, P345, DOI 10.1016/S1474-4422(09)70023-7; Karthikeyan G, 2009, J AM COLL CARDIOL, V53, P244, DOI 10.1016/j.jacc.2008.09.041; Khor GL, 2008, ASIA PAC J CLIN NUTR, V17, P111; Lawes CMM, 2004, DIABETES CARE, V27, P2836; Lee CMY, 2007, OBES REV, V8, P191, DOI 10.1111/j.1467-789X.2006.00292.x; Leowski J, 2009, HEALTH POLICY, V92, P43, DOI 10.1016/j.healthpol.2009.02.003; Levy DT, 2008, TOB CONTROL, V17, P53, DOI 10.1136/tc.2007.022319; Lim SS, 2007, LANCET, V370, P2054, DOI 10.1016/S0140-6736(07)61699-7; Lock K, 2010, LANCET, V376, P1699, DOI 10.1016/S0140-6736(10)61352-9; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mbanya JC, 2011, LANCET, V377, P536, DOI 10.1016/S0140-6736(10)61891-0; Mhurchu CN, 2004, INT J EPIDEMIOL, V33, P751, DOI 10.1093/ije/dyh163; Nakamura K, 2008, STROKE, V39, P1694, DOI 10.1161/STROKEAHA.107.496752; Ng Nawi, 2009, Glob Health Action, V2, DOI [10.3402/gha.v2i0.1984, 10.3402/gha.v2i0.1985]; Nguyen MD, 2007, PUBLIC HEALTH NUTR, V10, P115, DOI 10.1017/S1368980007224085; Parr CL, 2010, LANCET ONCOL, V11, P741, DOI 10.1016/S1470-2045(10)70141-8; Porapakkham Y, 2008, SINGAP MED J, V49, P868; Rampal L, 2007, ASIA PAC J CLIN NUTR, V16, P561; Ruiz AJ, 2004, MED NUTR THERAPY FIL; Samb B, 2010, LANCET, V376, P1785, DOI 10.1016/S0140-6736(10)61353-0; Stein AD, 2005, MATERN CHILD NUTR, V1, P177, DOI 10.1111/j.1740-8709.2005.00021.x; Sun Q, 2009, INT J EQUITY HEALTH, V8, DOI 10.1186/1475-9276-8-42; Tanchoco CC, 2003, ASIA PAC J CLIN NUTR, V12, P271; UN Development Programme, 2005, HUM DEV REP 2005; UN ESCAP/ADB/UNDP, 2007, MILL DEV GOALS PROGR; United Nations Population Division, WORLD POP PROSP 2008; WHO, PROJ MORT BURD DIS 2; WHO Regional Office for the South-East Asia, 2009, STRENGTH PARTN INT P; WHO Regional Office for Western Pacific, 2009, W PAC REG ACT PLAN N; World Health Organization, 2008, The global burden of disease: 2004 update; World Health Organization, 2004, GLOB STRAT DIET PHYS; World Health Organization, 2008, 2008 2013 ACT PLAN G; World Health Organization, 2003, WHO FRAM CONV TOB CO; World Health Organization, 2009, WHO REP GLOB TOB EP; World Health Organization, 2002, WHO CVD RISK MAN PAC; World Health Organization (WHO), STEPWISE APPR SURV S; Yoon KH, 2006, LANCET, V368, P1681, DOI 10.1016/S0140-6736(06)69703-1; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	60	166	169	1	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2011	377	9766					680	689		10.1016/S0140-6736(10)61506-1	http://dx.doi.org/10.1016/S0140-6736(10)61506-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	727DB	21269677				2022-12-28	WOS:000287776600038
J	Pitsuwan, S				Pitsuwan, Surin			Challenges in infection in ASEAN	LANCET			English	Editorial Material									ASEAN Secretariat, Jakarta 12110, Indonesia		Pitsuwan, S (corresponding author), ASEAN Secretariat, Jakarta 12110, Indonesia.	fellasari.surasman@asean.org						Association of Southeast Asian Nations, 2010, SE AS REG MULT PAND; Association of Southeast Asian Nations, 2009, ASEAN SOC CULT COMM; Association of Southeast Asian Nations, 2010, HLTH PEOPL HLTH ASEA; Association of Southeast Asian Nations, 1967, CHART ASS SE AS NAT; Coker R, 2006, LANCET, V368, P886, DOI 10.1016/S0140-6736(06)69209-X; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; East Asia and Pacific Region World Bank, 2005, E AS UPD; Information Centre on Emerging Infectious Diseases in the ASEAN Plus Three Countries, 2008, PREP M ASEAN PLUS 3; Rushton J, 2005, WORLD POULTRY SCI J, V61, P491, DOI 10.1079/WPS200570; WHO, 2010, CUM NUMB CONF HUM CA	10	7	7	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 19	2011	377	9766					619	621		10.1016/S0140-6736(10)62143-5	http://dx.doi.org/10.1016/S0140-6736(10)62143-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	727DB	21269683				2022-12-28	WOS:000287776600008
J	Gagne, JJ; Choudhry, NK				Gagne, Joshua J.; Choudhry, Niteesh K.			How Many "Me-Too" Drugs Is Too Many?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BRAND-NAME DRUGS		[Gagne, Joshua J.] Brigham & Womens Hosp, Dept Med, Boston, MA 02120 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Choudhry, NK (corresponding author), Brigham & Womens Hosp, Dept Med, 1620 Tremont St,Ste 3030, Boston, MA 02120 USA.	nchoudhry@partners.org	Mendoza, Elvia/A-9361-2012					Avorn J, 2005, POWERFUL MED BENEFIT; Cannon CP, 2004, NEW ENGL J MED, V350, P1495, DOI 10.1056/NEJMoa040583; Choudhry NK, 2009, CIRCULATION, V119, P365, DOI 10.1161/CIRCULATIONAHA.108.829655; Congressional Budget Office, 1998, INCR COMP GEN DRUGS; Haas JS, 2005, ANN INTERN MED, V142, P891, DOI 10.7326/0003-4819-142-11-200506070-00006; Kesselheim AS, 2008, JAMA-J AM MED ASSOC, V300, P2514, DOI 10.1001/jama.2008.758; Moran DW, 2000, HEALTH AFFAIR, V19, P63, DOI 10.1377/hlthaff.19.2.63; REDELMEIER DA, 1995, JAMA-J AM MED ASSOC, V273, P302, DOI 10.1001/jama.273.4.302; US Food and Drug Administration, 2010, FY 2009 PDUFA FIN RE	9	54	55	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2011	305	7					711	712		10.1001/jama.2011.152	http://dx.doi.org/10.1001/jama.2011.152			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721NH	21325189				2022-12-28	WOS:000287361100024
J	Sabatino, CP				Sabatino, Charles P.			Damage Prevention and Control for Financial Incapacity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Amer Bar Assoc, Commiss Law & Aging, Washington, DC 20005 USA		Sabatino, CP (corresponding author), Amer Bar Assoc, Commiss Law & Aging, 740 15th St NW, Washington, DC 20005 USA.	charles.sabatino@americanbar.org						American Bar Association American Psychological Association, ASS OLD AD DIM CAP H; *CA BANK ASS, SPOT ELD FIN AB; *FIN IND REG AUTH, ELELC158 FIN IND REG; STIEGEL LA, 2008, POWER ATTORNEY ABUSE, P8; *VA POL I STAT U C, 2009, BROK TRUST ELD FAM F	5	7	8	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2011	305	7					707	708		10.1001/jama.2011.187	http://dx.doi.org/10.1001/jama.2011.187			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721NH	21325187				2022-12-28	WOS:000287361100022
J	Watts, G				Watts, Geoff			Cohort Studies In for the long haul	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk			Medical Research Council [MC_U123092720] Funding Source: Medline; MRC [MC_U123092720] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Acad. Med. Sci, 2007, ID ENV CAUS DIS SHOU; ACHESON D, 1998, REPORT INDEPENDENT I; Centre for Longitudinal Studies, COH STUD; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; International Agency for Research on Cancer World Health Organization, EPIC PROJ; Marmot M., 2014, STRATEGIC REV HLTH I; Medical Research Council, NAT SURV HLTH DEV; National Acadamies, 1945, AT BOMB CAS COMM; UCL Research Department of Epidemiology and Public Health, WHIT 2 STUD; WALD N, 1991, LANCET, V338, P131	10	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2011	342								d942	10.1136/bmj.d942	http://dx.doi.org/10.1136/bmj.d942			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725OU	21324993				2022-12-28	WOS:000287655900016
J	Fox, P; Hendler, J				Fox, Peter; Hendler, James			Changing the Equation on Scientific Data Visualization	SCIENCE			English	Editorial Material								An essential facet of the data deluge is the need for different types of users to apply visualizations to understand how data analyses and queries relate to each other. Unfortunately, visualization too often becomes an end product of scientific analysis, rather than an exploration tool that scientists can use throughout the research life cycle. However, new database technologies, coupled with emerging Web-based technologies, may hold the key to lowering the cost of visualization generation and allow it to become a more integral part of the scientific process.	[Fox, Peter; Hendler, James] Rensselaer Polytech Inst, Troy, NY 12180 USA	Rensselaer Polytechnic Institute	Hendler, J (corresponding author), Rensselaer Polytech Inst, Troy, NY 12180 USA.	hendler@cs.rpi.edu	; Fox, Peter/E-9989-2013	Hendler, James/0000-0003-3056-1960; Fox, Peter/0000-0002-1009-7163				BIZER C, 2008, P 17 INT C WORLD WID; Card S. K., 1999, READINGS INFORM VISU; CRUZNEIRA C, 1992, COMMUN ACM, V35, P64, DOI 10.1145/129888.129892; Hey T., 2009, 4 PARADIGM DATA INTE; Lengler R., PERIODIC TABLE VISUA; Magoulas R., 2009, INTRO BIG DATA RELEA; Perer A., 2008, ACM C HUM FACT COMP; *UCAR NCAR, 2000, ROB AG COMPR INF INF; Williams GT, 2010, J WEB SEMANT, V8, P365, DOI 10.1016/j.websem.2010.08.002	9	95	99	2	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					705	708		10.1126/science.1197654	http://dx.doi.org/10.1126/science.1197654			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21311008				2022-12-28	WOS:000287205700051
J	Karpicke, JD; Blunt, JR				Karpicke, Jeffrey D.; Blunt, Janell R.			Retrieval Practice Produces More Learning than Elaborative Studying with Concept Mapping	SCIENCE			English	Article							LONG-TERM RETENTION; MEMORY; WORDS; TESTS; TEXT	Educators rely heavily on learning activities that encourage elaborative studying, whereas activities that require students to practice retrieving and reconstructing knowledge are used less frequently. Here, we show that practicing retrieval produces greater gains in meaningful learning than elaborative studying with concept mapping. The advantage of retrieval practice generalized across texts identical to those commonly found in science education. The advantage of retrieval practice was observed with test questions that assessed comprehension and required students to make inferences. The advantage of retrieval practice occurred even when the criterial test involved creating concept maps. Our findings support the theory that retrieval practice enhances learning by retrieval-specific mechanisms rather than by elaborative study processes. Retrieval practice is an effective tool to promote conceptual learning about science.	[Karpicke, Jeffrey D.; Blunt, Janell R.] Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Karpicke, JD (corresponding author), Purdue Univ, Dept Psychol Sci, W Lafayette, IN 47907 USA.	karpicke@purdue.edu			National Science Foundation [0941170]	National Science Foundation(National Science Foundation (NSF))	This research was supported by a grant from the National Science Foundation (0941170). We thank C. Ballas, B. Byrer, H. Cannon, and B. Etchison for help with this research.	Anderson L. W., 2000, TAXONOMY LEARNING TE; Bjork R.A., 1975, INFORM PROCESSING CO, P123; Bransford JD., 2000, PEOPLE LEARN; Carpenter SK, 2007, PSYCHON B REV, V14, P474, DOI 10.3758/BF03194092; COOK LK, 1988, J EDUC PSYCHOL, V80, P448, DOI 10.1037/0022-0663.80.4.448; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; Donovan M. S., 2005, STUDENTS LEARN SCI C; Dunlosky J., 2009, METACOGNITION; Duschl R.A., 2005, TAKING SCI SCH LEARN; HUNT RR, 1993, J MEM LANG, V32, P421, DOI 10.1006/jmla.1993.1023; Karpicke JD, 2008, SCIENCE, V319, P966, DOI 10.1126/science.1152408; Karpicke JD, 2007, J MEM LANG, V57, P151, DOI 10.1016/j.jml.2006.09.004; Karpicke JD, 2010, J MEM LANG, V62, P227, DOI 10.1016/j.jml.2009.11.010; Karpicke JD, 2010, MEM COGNITION, V38, P116, DOI 10.3758/MC.38.1.116; Mayer RE, 2008, LEARNING WITH ANIMATION: RESEARCH IMPLICATIONS FOR DESIGN, P30; McDaniel MA, 1989, EDUC PSYCHOL REV, V1, P113, DOI 10.1007/BF01326639; McDaniel MA, 2009, PSYCHOL SCI, V20, P516, DOI 10.1111/j.1467-9280.2009.02325.x; Nairne J. S., 2006, DISTINCTIVENESS MEMO, P27; Nairne JS, 2002, MEMORY, V10, P389, DOI 10.1080/09658210244000216; Nesbit JC, 2006, REV EDUC RES, V76, P413, DOI 10.3102/00346543076003413; Novak J. D, 1984, LEARNING LEARN; Novak JD, 2005, RES SCI EDUC, V35, P23, DOI 10.1007/s11165-004-3431-4; Pashler H, 2007, PSYCHON B REV, V14, P187, DOI 10.3758/BF03194050; Pyc MA, 2009, J MEM LANG, V60, P437, DOI 10.1016/j.jml.2009.01.004; RAAIJMAKERS JGW, 1981, PSYCHOL REV, V88, P93, DOI 10.1037/0033-295X.88.2.93; Roediger HL, 2006, PSYCHOL SCI, V17, P249, DOI 10.1111/j.1467-9280.2006.01693.x	27	470	487	16	341	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					772	775		10.1126/science.1199327	http://dx.doi.org/10.1126/science.1199327			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21252317				2022-12-28	WOS:000287205700071
J	Royal, CDM				Royal, Charmaine D. M.			My Genome, My Identity, My Health	SCIENCE			English	Editorial Material									[Royal, Charmaine D. M.] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA; [Royal, Charmaine D. M.] Duke Univ, Dept African & African Amer Studies, Durham, NC USA	Duke University; Duke University	Royal, CDM (corresponding author), Duke Univ, Inst Genome Sci & Policy, Durham, NC 27710 USA.								0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					690	691		10.1126/science.1203123	http://dx.doi.org/10.1126/science.1203123			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21310996				2022-12-28	WOS:000287205700042
J	Berger, MF; Lawrence, MS; Demichelis, F; Drier, Y; Cibulskis, K; Sivachenko, AY; Sboner, A; Esgueva, R; Pflueger, D; Sougnez, C; Onofrio, R; Carter, SL; Park, K; Habegger, L; Ambrogio, L; Fennell, T; Parkin, M; Saksena, G; Voet, D; Ramos, AH; Pugh, TJ; Wilkinson, J; Fisher, S; Winckler, W; Mahan, S; Ardlie, K; Baldwin, J; Simons, JW; Kitabayashi, N; MacDonald, TY; Kantoff, PW; Chin, L; Gabriel, SB; Gerstein, MB; Golub, TR; Meyerson, M; Tewari, A; Lander, ES; Getz, G; Rubin, MA; Garraway, LA				Berger, Michael F.; Lawrence, Michael S.; Demichelis, Francesca; Drier, Yotam; Cibulskis, Kristian; Sivachenko, Andrey Y.; Sboner, Andrea; Esgueva, Raquel; Pflueger, Dorothee; Sougnez, Carrie; Onofrio, Robert; Carter, Scott L.; Park, Kyung; Habegger, Lukas; Ambrogio, Lauren; Fennell, Timothy; Parkin, Melissa; Saksena, Gordon; Voet, Douglas; Ramos, Alex H.; Pugh, Trevor J.; Wilkinson, Jane; Fisher, Sheila; Winckler, Wendy; Mahan, Scott; Ardlie, Kristin; Baldwin, Jennifer; Simons, Jonathan W.; Kitabayashi, Naoki; MacDonald, Theresa Y.; Kantoff, Philip W.; Chin, Lynda; Gabriel, Stacey B.; Gerstein, Mark B.; Golub, Todd R.; Meyerson, Matthew; Tewari, Ashutosh; Lander, Eric S.; Getz, Gad; Rubin, Mark A.; Garraway, Levi A.			The genomic complexity of primary human prostate cancer	NATURE			English	Article							GENE FUSIONS; ANDROGEN RECEPTOR; TUMOR-SUPPRESSOR; HUMAN BREAST; PTEN; MUTATION; PATHWAY; REARRANGEMENTS; IMMUNOTHERAPY; TMPRSS2-ERG	Prostate cancer is the second most common cause of male cancer deaths in the United States. However, the full range of prostate cancer genomic alterations is incompletely characterized. Here we present the complete sequence of seven primary human prostate cancers and their paired normal counterparts. Several tumours contained complex chains of balanced (that is, 'copy-neutral') rearrangements that occurred within or adjacent to known cancer genes. Rearrangement breakpoints were enriched near open chromatin, androgen receptor and ERG DNA binding sites in the setting of the ETS gene fusion TMPRSS2-ERG, but inversely correlated with these regions in tumours lacking ETS fusions. This observation suggests a link between chromatin or transcriptional regulation and the genesis of genomic aberrations. Three tumours contained rearrangements that disrupted CADM2, and four harboured events disrupting either PTEN (unbalanced events), a prostate tumour suppressor, or MAGI2 (balanced events), a PTEN interacting protein not previously implicated in prostate tumorigenesis. Thus, genomic rearrangements may arise from transcriptional or chromatin aberrancies and engage prostate tumorigenic mechanisms.	[Demichelis, Francesca; Esgueva, Raquel; Pflueger, Dorothee; Park, Kyung; Kitabayashi, Naoki; MacDonald, Theresa Y.; Rubin, Mark A.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Berger, Michael F.; Lawrence, Michael S.; Cibulskis, Kristian; Sivachenko, Andrey Y.; Sougnez, Carrie; Onofrio, Robert; Carter, Scott L.; Ambrogio, Lauren; Fennell, Timothy; Parkin, Melissa; Saksena, Gordon; Voet, Douglas; Ramos, Alex H.; Pugh, Trevor J.; Wilkinson, Jane; Fisher, Sheila; Winckler, Wendy; Mahan, Scott; Ardlie, Kristin; Baldwin, Jennifer; Chin, Lynda; Gabriel, Stacey B.; Golub, Todd R.; Meyerson, Matthew; Lander, Eric S.; Getz, Gad; Garraway, Levi A.] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; [Berger, Michael F.; Lawrence, Michael S.; Cibulskis, Kristian; Sivachenko, Andrey Y.; Sougnez, Carrie; Onofrio, Robert; Carter, Scott L.; Ambrogio, Lauren; Fennell, Timothy; Parkin, Melissa; Saksena, Gordon; Voet, Douglas; Ramos, Alex H.; Pugh, Trevor J.; Wilkinson, Jane; Fisher, Sheila; Winckler, Wendy; Mahan, Scott; Ardlie, Kristin; Baldwin, Jennifer; Chin, Lynda; Gabriel, Stacey B.; Golub, Todd R.; Meyerson, Matthew; Lander, Eric S.; Getz, Gad; Garraway, Levi A.] MIT, Cambridge, MA 02142 USA; [Demichelis, Francesca] Weill Cornell Med Coll, Inst Computat Biomed, New York, NY 10021 USA; [Drier, Yotam] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel; [Sboner, Andrea; Gerstein, Mark B.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Sboner, Andrea; Habegger, Lukas; Gerstein, Mark B.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT 06520 USA; [Ramos, Alex H.; Pugh, Trevor J.; Kantoff, Philip W.; Chin, Lynda; Meyerson, Matthew; Lander, Eric S.; Garraway, Levi A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Pugh, Trevor J.; Kantoff, Philip W.; Chin, Lynda; Meyerson, Matthew; Garraway, Levi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Simons, Jonathan W.] Prostate Canc Fdn, Santa Monica, CA 90401 USA; [Chin, Lynda] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Gerstein, Mark B.] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [Golub, Todd R.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Golub, Todd R.; Meyerson, Matthew; Garraway, Levi A.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Tewari, Ashutosh] Weill Cornell Med Coll, Inst Prostate Canc, Dept Urol, New York, NY 10065 USA; [Tewari, Ashutosh] Weill Cornell Med Coll, Lefrak Ctr Robot Surg, New York, NY 10065 USA; [Tewari, Ashutosh] New York Presbyterian Hosp, New York, NY 10065 USA; [Lander, Eric S.] 9 Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA	Cornell University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Cornell University; Weizmann Institute of Science; Yale University; Yale University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Yale University; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Cornell University; Cornell University; NewYork-Presbyterian Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute	Rubin, MA (corresponding author), Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA.	rubinma@med.cornell.edu; levi_garraway@dfci.harvard.edu	Lawrence, Michael/AAC-8202-2020; Cibulskis, Kristian/AAC-7380-2019; Meyerson, Matthew L/E-7123-2012; Pugh, Trevor/Y-2535-2019; Demichelis, Francesca/J-9829-2016; Sboner, Andrea/C-6487-2008; Drier, Yotam/K-5208-2012	Pugh, Trevor/0000-0002-8073-5888; Demichelis, Francesca/0000-0002-8266-8631; Sboner, Andrea/0000-0001-6915-3070; Drier, Yotam/0000-0003-1725-2995; Rubin, Mark/0000-0002-8321-9950; Meyerson, Matthew/0000-0002-9133-8108; Simons, Jonathan/0000-0001-7660-0748; Cibulskis, Kristian/0000-0003-1343-1582; Kantoff, Philip/0000-0001-7275-0597	Prostate Cancer Foundation/Movember; Howard Hughes Medical Institute; National Human Genome Research Institute; Kohlberg Foundation; National Cancer Institute (NCI); NCI Early Detection Research Network; National Institutes of Health; Department of Defense; Dana-Farber/Harvard Cancer Center [2 P50 CA090381-11]; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE [P50CA090381, R33CA126674] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002750] Funding Source: NIH RePORTER	Prostate Cancer Foundation/Movember; Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Kohlberg Foundation; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI Early Detection Research Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); Dana-Farber/Harvard Cancer Center; Starr Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank R. Leung and all members of the Broad Institute Sequencing Platform. This work was supported by the Prostate Cancer Foundation/Movember (T. R. G., M. A. R., L. A. G.), the Howard Hughes Medical Institute (T. R. G.), the National Human Genome Research Institute (S. B. G., E. S. L.), the Kohlberg Foundation (P. W. K., L. A. G.), the National Cancer Institute (NCI; F. D., M. A. R., M. M.), the NCI Early Detection Research Network (M. A. R.), the National Institutes of Health (L. A. G.), the Department of Defense (F. D.), the Dana-Farber/Harvard Cancer Center Prostate Cancer SPORE grant 2 P50 CA090381-11 (P. W. K.), and the Starr Cancer Consortium (M. F. B., F. D., M. A. R., L.A.G.).	Attard G, 2008, J CLIN ONCOL, V26, P4563, DOI 10.1200/JCO.2007.15.9749; Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Berger MF, 2010, GENOME RES, V20, P413, DOI 10.1101/gr.103697.109; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Carver BS, 2009, NAT GENET, V41, P619, DOI 10.1038/ng.370; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Haffner MC, 2010, NAT GENET, V42, P668, DOI 10.1038/ng.613; Han B, 2009, MODERN PATHOL, V22, P1083, DOI 10.1038/modpathol.2009.69; Helgeson BE, 2008, CANCER RES, V68, P73, DOI 10.1158/0008-5472.CAN-07-5352; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kan ZY, 2010, NATURE, V466, P869, DOI 10.1038/nature09208; Kantoff PW, 2010, NEW ENGL J MED, V363, P411, DOI 10.1056/NEJMoa1001294; Kantoff PW, 2010, J CLIN ONCOL, V28, P1099, DOI 10.1200/JCO.2009.25.0597; King JC, 2009, NAT GENET, V41, P524, DOI 10.1038/ng.371; Krum SA, 2008, MOL ENDOCRINOL, V22, P2393, DOI 10.1210/me.2008-0100; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; Lee W, 2010, NATURE, V465, P473, DOI 10.1038/nature09004; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lin BY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006589; Lin CR, 2009, CELL, V139, P1069, DOI 10.1016/j.cell.2009.11.030; Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pearl LH, 2008, BIOCHEM J, V410, P439, DOI 10.1042/BJ20071640; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Tomlins SA, 2006, CANCER RES, V66, P3396, DOI 10.1158/0008-5472.CAN-06-0168; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Tomlins SA, 2007, NATURE, V448, P595, DOI 10.1038/nature06024; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Vazquez F, 2001, J BIOL CHEM, V276, P48627, DOI 10.1074/jbc.C100556200; VISAKORPI T, 1995, NAT GENET, V9, P401, DOI 10.1038/ng0495-401; Wu XY, 2000, P NATL ACAD SCI USA, V97, P4233, DOI 10.1073/pnas.97.8.4233; Yang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000264; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zhang CL, 2002, MOL CELL BIOL, V22, P7302, DOI 10.1128/MCB.22.20.7302-7312.2002	50	921	954	2	82	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					214	220		10.1038/nature09744	http://dx.doi.org/10.1038/nature09744			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307934	Green Accepted, hybrid, Green Submitted, Green Published			2022-12-28	WOS:000287144200035
J	Myers, MG; Godwin, M; Dawes, M; Kiss, A; Tobe, SW; Grant, FC; Kaczorowski, J				Myers, Martin G.; Godwin, Marshall; Dawes, Martin; Kiss, Alexander; Tobe, Sheldon W.; Grant, F. Curry; Kaczorowski, Janusz			Conventional versus automated measurement of blood pressure in primary care patients with systolic hypertension: randomised parallel design controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							MEASUREMENTS-WILL; OFFICE; DEVICE; VALIDATION; ALGORITHM; REDUCE	Objective To compare the quality and accuracy of manual office blood pressure and automated office blood pressure using the awake ambulatory blood pressure as a gold standard. Design Multi-site cluster randomised controlled trial. Setting Primary care practices in five cities in eastern Canada. Participants 555 patients with systolic hypertension and no serious comorbidities under the care of 88 primary care physicians in 67 practices in the community. Interventions Practices were randomly allocated to either ongoing use of manual office blood pressure (control group) or automated office blood pressure (intervention group) using the BpTRU device. The last routine manual office blood pressure (mm Hg) was obtained from each patient's medical record before enrolment. Office blood pressure readings were compared before and after enrolment in the intervention and control groups; all readings were also compared with the awake ambulatory blood pressure. Main outcome measure Difference in systolic blood pressure between awake ambulatory blood pressure minus automated office blood pressure and awake ambulatory blood pressure minus manual office blood pressure. Results Cluster randomisation allocated 31 practices (252 patients) to manual office blood pressure and 36 practices (303 patients) to automated office blood pressure measurement. The most recent routine manual office blood pressure (149.5 (SD 10.8)/81.4 (8.3)) was higher than automated office blood pressure (135.6 (17.3)/77.7 (10.9)) (P<0.001). In the control group, routine manual office blood pressure before enrolment (149.9 (10.7)/81.8 (8.5)) was reduced to 141.4 (14.6)/80.2 (9.5) after enrolment (P<0.001/P=0.01), but the reduction in the intervention group from manual office to automated office blood pressure was significantly greater (P<0.001/P=0.02). On the first study visit after enrolment, the estimated mean difference for the intervention group between the awake ambulatory systolic/diastolic blood pressure and automated office blood pressure (-2.3 (95% confidence interval -0.31 to -4.3)/-3.3 (-2.7 to -4.4)) was less (P=0.006/P=0.26) than the difference in the control group between the awake ambulatory blood pressure and the manual office blood pressure (-6.5 (-4.3 to -8.6)/-4.3 (-2.9 to -5.8)). Systolic/diastolic automated office blood pressure showed a stronger (P<0.001) within group correlation (r=0.34/r=0.56) with awake ambulatory blood pressure after enrolment compared with manual office blood pressure versus awake ambulatory blood pressure before enrolment (r=0.10/r=0.40); the mean difference in r was 0.24 (0.12 to 0.36)/0.16 (0.07 to 0.25)). The between group correlation comparing diastolic automated office blood pressure and awake ambulatory blood pressure (r=0.56) was stronger (P<0.001) than that for manual office blood pressure versus awake ambulatory blood pressure (r=0.30); the mean difference in r was 0.26 (0.09 to 0.41). Digit preference with readings ending in zero was substantially reduced by use of automated office blood pressure. Conclusion In compliant, otherwise healthy, primary care patients with systolic hypertension, introduction of automated office blood pressure measurement into routine primary care significantly reduced the white coat response compared with the ongoing use of manual office blood pressure measurement. The quality and accuracy of automated office blood pressure in relation to the awake ambulatory blood pressure was also significantly better when compared with manual office blood pressure.	[Myers, Martin G.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Schulich Heart Ctr, Div Cardiol,Dept Med, Toronto, ON M4N 3M5, Canada; [Godwin, Marshall] Mem Univ Newfoundland, Dept Family Med, St John, NF, Canada; [Dawes, Martin] McGill Univ, Dept Family Med, Montreal, PQ H3A 2T5, Canada; [Kiss, Alexander] Sunnybrook Hlth Sci Ctr, Dept Res Design & Biostat, Toronto, ON M4N 3M5, Canada; [Grant, F. Curry] Quinte Hlth Care, Stroke Prevent Clin, Belleville, ON, Canada; [Kaczorowski, Janusz] Univ British Columbia, Dept Family Practice, Vancouver, BC V5Z 1M9, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; Memorial University Newfoundland; McGill University; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of British Columbia	Myers, MG (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Schulich Heart Ctr, Div Cardiol,Dept Med, A-202,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	martin.myers@sunnybrook.ca	dawes, martin/B-1750-2013; Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285; Dawes, Martin/0000-0003-3624-2477	Heart and Stroke Foundation of Ontario [ESA5745]	Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	The study was supported by Grant ESA5745 from the Heart and Stroke Foundation of Ontario.	Beckett Linda, 2005, BMC Cardiovasc Disord, V5, P18, DOI 10.1186/1471-2261-5-18; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Giles TD, 2008, J CLIN HYPERTENS, V10, P257, DOI 10.1111/j.1751-7176.2008.08084.x; Godwin M, 2011, FAM PRACT, V28, P110, DOI 10.1093/fampra/cmq067; Head Geoffrey A, 2010, BMJ, V340, pc1104, DOI 10.1136/bmj.c1104; Ishikawa J, 2009, J HYPERTENS, V27, pS4; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Myers MG, 2010, BLOOD PRESS MONIT, V15, P300, DOI 10.1097/MBP.0b013e328340d128; Myers MG, 2010, J HYPERTENS, V28, P703, DOI 10.1097/HJH.0b013e328335d091; Myers MG, 2010, HYPERTENSION, V55, P195, DOI 10.1161/HYPERTENSIONAHA.109.141879; Myers MG, 2009, BLOOD PRESS MONIT, V14, P108, DOI 10.1097/MBP.0b013e32832c5167; Myers MG, 2009, BLOOD PRESS MONIT, V14, P45, DOI 10.1097/MBP.0b013e32831e314f; Myers MG, 2008, BLOOD PRESS MONIT, V13, P333, DOI 10.1097/MBP.0b013e3283104247; Myers MG, 2009, J HYPERTENS, V27, P280, DOI 10.1097/HJH.0b013e32831b9e6b; Myers MG, 2006, BLOOD PRESS MONIT, V11, P59, DOI 10.1097/01.mbp.0000200481.64787.c0; Myers MG, 2003, AM J HYPERTENS, V16, P494, DOI 10.1016/S0895-7061(03)00058-X; O'Brien E, 2002, BLOOD PRESS MONIT, V7, P37, DOI 10.1097/00126097-200202000-00007; O'Brien E, 2008, HYPERTENSION, V51, P1435, DOI 10.1161/HYPERTENSIONAHA.107.100008; OBRIEN E, 1991, J HYPERTENS, V9, pS332; Parati G, 2009, HYPERTENSION, V54, P181, DOI 10.1161/HYPERTENSIONAHA.108.122853; PICKERING TG, 1988, JAMA-J AM MED ASSOC, V259, P225, DOI 10.1001/jama.259.2.225; Pickering Thomas G., 2005, Hypertension (Baltimore), V45, P142; Pickering TG, 2008, J HYPERTENS, V26, P2259, DOI 10.1097/HJH.0b013e32831313c4; REEVES RA, 1995, JAMA-J AM MED ASSOC, V273, P1211, DOI 10.1001/jama.1995.03520390071036; Sala C, 2006, AM J HYPERTENS, V19, P713, DOI 10.1016/j.amjhyper.2005.08.021; Scientific Committee on Emerging and Newly Identified Health Risks, 2009, MERC SPHYGM HEALTHC; Staessen JA, 1997, JAMA-J AM MED ASSOC, V278, P1065, DOI 10.1001/jama.278.13.1065; Stergiou GS, 2008, BLOOD PRESS MONIT, V13, P299, DOI 10.1097/MBP.0b013e3283057af6; Stergiou GS, 2010, HYPERTENSION, V55, P1301, DOI 10.1161/HYPERTENSIONAHA.110.150771; Verdecchia P, 1999, Blood Press Monit, V4, P303, DOI 10.1097/00126097-199912000-00004; Verdecchia P, 2009, HYPERTENSION, V54, P188, DOI 10.1161/HYPERTENSIONAHA.108.122861; White WB, 2001, BLOOD PRESS MONIT, V6, P107, DOI 10.1097/00126097-200104000-00007; Wright JM, 2001, BLOOD PRESS MONIT, V6, P161, DOI 10.1097/00126097-200106000-00008	34	195	196	1	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2011	342								d286	10.1136/bmj.d286	http://dx.doi.org/10.1136/bmj.d286			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722AF	21300709	Green Published, hybrid, Green Submitted, Green Accepted			2022-12-28	WOS:000287400200001
J	Despres, JP				Despres, Jean-Pierre			CRP: star trekking the galaxy of risk markers	LANCET			English	Editorial Material							C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; ABDOMINAL OBESITY; CHOLESTEROL; EVENTS; WOMEN		[Despres, Jean-Pierre] Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ G1V 4G5, Canada; [Despres, Jean-Pierre] Univ Laval, Dept Social & Prevent Med, Div Kinesiol, Quebec City, PQ, Canada	Laval University	Despres, JP (corresponding author), Ctr Rech Inst Univ Cardiol & Pneumol Quebec, Quebec City, PQ G1V 4G5, Canada.	jean-pierre.despres@criucpq.ulaval.ca						Arsenault BJ, 2010, CIRCULATION, V122; Buckley DI, 2009, ANN INTERN MED, V151, P483, DOI 10.7326/0003-4819-151-7-200910060-00009; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Despres JP, 2009, LANCET, V373, P1147, DOI 10.1016/S0140-6736(09)60448-7; Detrano R, 2008, NEW ENGL J MED, V358, P1336, DOI 10.1056/NEJMoa072100; Genest J, 2009, CAN J CARDIOL, V25, P567, DOI 10.1016/S0828-282X(09)70715-9; Gupta S, 2010, JACC-CARDIOVASC IMAG, V3, P605, DOI 10.1016/j.jcmg.2010.03.005; Heart Protection Study Collaborative Group, 2011, LANCET          0128, DOI [10.1016/S0140-6736(10)62174-5, DOI 10.1016/S0140-6736(10)62174-5]; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Lemieux I, 2001, ARTERIOSCL THROM VAS, V21, P961, DOI 10.1161/01.ATV.21.6.961; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 2010, AM J CARDIOL, V106, P204, DOI 10.1016/j.amjcard.2010.03.018; Ridker PM, 1998, CIRCULATION, V97, P2007, DOI 10.1161/01.CIR.97.20.2007; Sever PS, 2010, AM HEART ASS SCI SES	16	4	5	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2011	377	9764					441	442		10.1016/S0140-6736(10)62316-1	http://dx.doi.org/10.1016/S0140-6736(10)62316-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	721TX	21277015				2022-12-28	WOS:000287381800004
J	Ebert, D				Ebert, Dieter			A Genome for the Environment	SCIENCE			English	Editorial Material							DAPHNIA; REVEALS		[Ebert, Dieter] Univ Basel, Inst Zool, CH-4059 Basel, Switzerland; [Ebert, Dieter] Wissensch Kolleg Berlin, D-14193 Berlin, Germany	University of Basel	Ebert, D (corresponding author), Univ Basel, Inst Zool, Vesalgasse 1, CH-4059 Basel, Switzerland.	dieter.ebert@unibas.ch	Ebert, Dieter/B-5502-2009; Ebert, Dieter/P-6134-2019	Ebert, Dieter/0000-0003-2653-3772; Ebert, Dieter/0000-0003-2653-3772				Ben-Ami F, 2010, AM NAT, V175, P106, DOI 10.1086/648672; Colbourne JK, 2011, SCIENCE, V331, P555, DOI 10.1126/science.1197761; Decaestecker E, 2007, NATURE, V450, P870, DOI 10.1038/nature06291; Laforsch C, 2004, P NATL ACAD SCI USA, V101, P15911, DOI 10.1073/pnas.0404860101; Laforsch C, 2000, ARCH HYDROBIOL, V149, P587; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Metchnikoff M. E., 1884, VIRCHOWS ARCH PATHOL, V9, P177; Moenickes S, 2010, J EXP BIOL, V213, P408, DOI 10.1242/jeb.031914; Ohno S., 1970, EVOLUTION GENE DUPLI; Shaw JR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-477; Tollrian R, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-51; Weismann A, 1885, CONTINUITAT KEIMPLAS; Woltereck R., 1909, VERH DTSCH ZOOL GES, V19, P110, DOI DOI 10.1007/BF01876686	13	63	66	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					539	540		10.1126/science.1202092	http://dx.doi.org/10.1126/science.1202092			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292957	Green Submitted			2022-12-28	WOS:000286933600031
J	Frey, BS				Frey, Bruno S.			Happy People Live Longer	SCIENCE			English	Editorial Material									[Frey, Bruno S.] Univ Warwick, Warwick Business Sch, Coventry CV4 7AL, W Midlands, England; [Frey, Bruno S.] Univ Zurich, Dept Econ, CH-8032 Zurich, Switzerland	University of Warwick; University of Zurich	Frey, BS (corresponding author), Univ Warwick, Warwick Business Sch, Coventry CV4 7AL, W Midlands, England.	bruno.frey@econ.uzh.ch	Frey, Bruno/AAW-9103-2021	tester22, sciencv/0000-0002-2791-7842; Holland, Sherri/0000-0003-2860-0668				Danner DD, 2001, J PERS SOC PSYCHOL, V80, P804, DOI 10.1037/0022-3514.80.5.804; DIENER E, 2010, SSRN WORKING PAPER; Frey B, 2002, HAPPINESS EC; Frey B., 2008, MY FRIEND JAMAL; HOWELL RT, 2007, PSYCHOL REV, V1, P83; Layard R., 2005, PROSPECT, V108; Rozanski A, 1999, CIRCULATION, V99, P2192, DOI 10.1161/01.CIR.99.16.2192; Veenhoven R, 2008, J HAPPINESS STUD, V9, P449, DOI 10.1007/s10902-006-9042-1	8	33	36	0	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					542	543		10.1126/science.1201060	http://dx.doi.org/10.1126/science.1201060			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292959				2022-12-28	WOS:000286933600033
J	Venter, JC				Venter, J. Craig			The Human Genome at 10: Successes and Challenges	SCIENCE			English	Editorial Material									[Venter, J. Craig] J Craig Venter Inst, Rockville, MD USA; [Venter, J. Craig] J Craig Venter Inst, San Diego, CA USA; [Venter, J. Craig] Synthet Genom Inc, La Jolla, CA USA	J. Craig Venter Institute; J. Craig Venter Institute	Venter, JC (corresponding author), J Craig Venter Inst, Rockville, MD USA.								0	18	19	0	18	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					546	547		10.1126/science.1202812	http://dx.doi.org/10.1126/science.1202812			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292962				2022-12-28	WOS:000286933600038
J	Stone, JH				Stone, John H.			BLISS! Lupus learns its lessons	LANCET			English	Editorial Material							ERYTHEMATOSUS; INDEX		Harvard Univ, Massachusetts Gen Hosp, Sch Med, Rheumatol Unit, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Stone, JH (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Rheumatol Unit, Boston, MA 02114 USA.	jhstone@partners.org						Furie RA, 2009, ARTHRIT RHEUM-ARTHR, V61, P1143, DOI 10.1002/art.24698; HAY EM, 1993, Q J MED, V86, P447; Navarra SV, 2011, LANCET, V377, P721, DOI 10.1016/S0140-6736(10)61354-2; Petri M, 2005, NEW ENGL J MED, V353, P2550, DOI 10.1056/NEJMoa051135; *US DEP HHS, 2010, GUID IND SYST LUP ER; Wallace DJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P1168, DOI 10.1002/art.24699	6	4	4	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB-MAR	2011	377	9767					693	694		10.1016/S0140-6736(10)61546-2	http://dx.doi.org/10.1016/S0140-6736(10)61546-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729JQ	21296404				2022-12-28	WOS:000287946000004
J	Wilson, JF				Wilson, Jennifer F			The Polycystic Ovary Syndrome	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							IMPAIRED GLUCOSE-TOLERANCE; INSULIN-RESISTANCE; RANDOMIZED-TRIAL; ANDROGEN EXCESS; OBESE WOMEN; WEIGHT-LOSS; PREVALENCE; METFORMIN; HORMONE; INFERTILITY						Wilson, Jennifer/Q-3623-2019					Alexander CJ, 2009, REV OBSTET GYNECOL, V2, P232; *AM ASS CLIN ENDO, 2005, ENDOCR PRACT, V11, P12; Azziz R, 2003, OBSTET GYNECOL, V101, P995, DOI 10.1016/S0029-7844(02)02725-4; Azziz R, 2009, FERTIL STERIL, V91, P456, DOI 10.1016/j.fertnstert.2008.06.035; Baillargeon JP, 2005, J CLIN ENDOCR METAB, V90, P3863, DOI 10.1210/jc.2004-1958; Balen A, 2002, HUM REPROD, V17, P2219, DOI 10.1093/humrep/17.9.2219; Balen A, 2001, HUM REPROD UPDATE, V7, P522, DOI 10.1093/humupd/7.6.522; Balen AH, 2007, BMJ-BRIT MED J, V335, P663, DOI 10.1136/bmj.39335.462303.80; Balen AH, 2003, HUM REPROD UPDATE, V9, P505, DOI 10.1093/humupd/dmg044; BALEN AH, 1995, HUM REPROD, V10, P2107, DOI 10.1093/oxfordjournals.humrep.a136243; Barber TM, 2006, CLIN ENDOCRINOL, V65, P137, DOI 10.1111/j.1365-2265.2006.02587.x; Barnard L, 2007, HUM REPROD, V22, P2279, DOI 10.1093/humrep/dem108; Bayram N, 2004, BMJ-BRIT MED J, V328, P192, DOI 10.1136/bmj.328.7433.192; Boomsma CM, 2008, SEMIN REPROD MED, V26, P72, DOI 10.1055/s-2007-992927; CARMINA E, 1992, AM J OBSTET GYNECOL, V167, P1807, DOI 10.1016/0002-9378(92)91779-A; Carmina E, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.03.008; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; COSTELLO M, 2007, COCHRANE DATABASE SY, V24; Crosignani PG, 2003, HUM REPROD, V18, P1928, DOI 10.1093/humrep/deg367; Diamanti-Kandarakis E, 2003, J CLIN ENDOCR METAB, V88, P1927, DOI 10.1210/jc.2002-021528; Driscoll DA, 2003, SEMIN REPROD MED, V21, P301; Ehrmann DA, 2005, NEW ENGL J MED, V352, P1223, DOI 10.1056/NEJMra041536; Ehrmann DA, 1999, DIABETES CARE, V22, P141, DOI 10.2337/diacare.22.1.141; Ewens KG, 2010, J CLIN ENDOCR METAB, V95, P2306, DOI 10.1210/jc.2009-2703; FARQUHAR C, 2005, COCHRANE DATABASE SY; FRANKS S, 1993, ANN NY ACAD SCI, V687, P112; GEORGE K, 2005, LANCET, V366, P1059; Goodarzi MO, 2005, FERTIL STERIL, V84, P766, DOI 10.1016/j.fertnstert.2005.03.051; Harborne L, 2003, LANCET, V361, P1894, DOI 10.1016/S0140-6736(03)13493-9; Huber-Buchholz MM, 1999, J CLIN ENDOCR METAB, V84, P1470, DOI 10.1210/jc.84.4.1470; Hudecova M, 2009, HUM REPROD, V24, P1176, DOI 10.1093/humrep/den482; Johnson NP, 2010, HUM REPROD, V25, P1675, DOI 10.1093/humrep/deq100; Kerchner A, 2009, FERTIL STERIL, V91, P207, DOI 10.1016/j.fertnstert.2007.11.022; Koskinen P, 1996, FERTIL STERIL, V65, P517, DOI 10.1016/S0015-0282(16)58146-1; Legro RS, 2007, CLIN OBSTET GYNECOL, V50, P295, DOI 10.1097/GRF.0b013e31803057ed; Legro RS, 2007, NEW ENGL J MED, V356, P551, DOI 10.1056/NEJMoa063971; Legro RS, 1999, J CLIN ENDOCR METAB, V84, P165, DOI 10.1210/jc.84.1.165; Legro RS, 1999, ENDOCRIN METAB CLIN, V28, P379, DOI 10.1016/S0889-8529(05)70075-X; Lord J, 2006, BJOG-INT J OBSTET GY, V113, P1203, DOI 10.1111/j.1471-0528.2006.00973.x; March WA, 2010, HUM REPROD, V25, P544, DOI 10.1093/humrep/dep399; Martin KA, 2008, J CLIN ENDOCR METAB, V93, P1105, DOI 10.1210/jc.2007-2437; Menke MN, 2007, CURR OPIN OBSTET GYN, V19, P355, DOI 10.1097/GCO.0b013e328220e877; Moran LJ, 2010, HUM REPROD UPDATE, V16, P347, DOI 10.1093/humupd/dmq001; Nestler JE, 2008, NEW ENGL J MED, V358, P47, DOI 10.1056/NEJMct0707092; Norman RJ, 2007, LANCET, V370, P685, DOI 10.1016/S0140-6736(07)61345-2; Pasquali R, 2000, J CLIN ENDOCR METAB, V85, P2767, DOI 10.1210/jc.85.8.2767; Rittmaster RS, 1999, ENDOCRIN METAB CLIN, V28, P409, DOI 10.1016/S0889-8529(05)70077-3; ROBINSON S, 1992, BRIT J OBSTET GYNAEC, V99, P232, DOI 10.1111/j.1471-0528.1992.tb14505.x; Salley KES, 2007, J CLIN ENDOCR METAB, V92, P4546, DOI 10.1210/jc.2007-1549; Shapiro J, 2007, NEW ENGL J MED, V357, P1620, DOI 10.1056/NEJMcp072110; Stamets K, 2004, FERTIL STERIL, V81, P630, DOI 10.1016/j.fertnstert.2003.08.023; Stoll BA, 1999, BRIT J OBSTET GYNAEC, V106, P402, DOI 10.1111/j.1471-0528.1999.tb08290.x; Tang T, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003053.pub4; Tasali E, 2008, SLEEP MED CLIN, V3, P37, DOI 10.1016/j.jsmc.2007.11.001; *THESS ESHRE ASRM, 2008, HUMAN REPROD, V3, P462; Thomson RL, 2009, HUM REPROD, V24, P1976, DOI 10.1093/humrep/dep101; van Hooff MHA, 1999, HUM REPROD, V14, P2223, DOI 10.1093/humrep/14.9.2223; Welt CK, 2006, J CLIN ENDOCR METAB, V91, P4361, DOI 10.1210/jc.2006-1191; Wild RA, 2010, J CLIN ENDOCR METAB, V95, P2038, DOI 10.1210/jc.2009-2724; Zawadzki J, 1992, POLYCYSTIC OVARY SYN, P377	60	8	8	2	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2011	154	3							ITC2	10.7326/0003-4819-154-3-201102010-01002	http://dx.doi.org/10.7326/0003-4819-154-3-201102010-01002			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	713HY	21282692				2022-12-28	WOS:000286729200018
J	Locke, DP; Hillier, LW; Warren, WC; Worley, KC; Nazareth, LV; Muzny, DM; Yang, SP; Wang, ZY; Chinwalla, AT; Minx, P; Mitreva, M; Cook, L; Delehaunty, KD; Fronick, C; Schmidt, H; Fulton, LA; Fulton, RS; Nelson, JO; Magrini, V; Pohl, C; Graves, TA; Markovic, C; Cree, A; Dinh, HH; Hume, J; Kovar, CL; Fowler, GR; Lunter, G; Meader, S; Heger, A; Ponting, CP; Marques-Bonet, T; Alkan, C; Chen, L; Cheng, Z; Kidd, JM; Eichler, EE; White, S; Searle, S; Vilella, AJ; Chen, YA; Flicek, P; Ma, JA; Raney, B; Suh, B; Burhans, R; Herrero, J; Haussler, D; Faria, R; Fernando, O; Darre, F; Farre, D; Gazave, E; Oliva, M; Navarro, A; Roberto, R; Capozzi, O; Archidiacono, N; Della Valle, G; Purgato, S; Rocchi, M; Konkel, MK; Walker, JA; Ullmer, B; Batzer, MA; Smit, AFA; Hubley, R; Casola, C; Schrider, DR; Hahn, MW; Quesada, V; Puente, XS; Ordonez, GR; Lopez-Otin, C; Vinar, T; Brejova, B; Ratan, A; Harris, RS; Miller, W; Kosiol, C; Lawson, HA; Taliwal, V; Martins, AL; Siepel, A; RoyChoudhury, A; Ma, X; Degenhardt, J; Bustamante, CD; Gutenkunst, RN; Mailund, T; Dutheil, JY; Hobolth, A; Schierup, MH; Ryder, OA; Yoshinaga, Y; de Jong, PJ; Weinstock, GM; Rogers, J; Mardis, ER; Gibbs, RA; Wilson, RK				Locke, Devin P.; Hillier, LaDeana W.; Warren, Wesley C.; Worley, Kim C.; Nazareth, Lynne V.; Muzny, Donna M.; Yang, Shiaw-Pyng; Wang, Zhengyuan; Chinwalla, Asif T.; Minx, Pat; Mitreva, Makedonka; Cook, Lisa; Delehaunty, Kim D.; Fronick, Catrina; Schmidt, Heather; Fulton, Lucinda A.; Fulton, Robert S.; Nelson, Joanne O.; Magrini, Vincent; Pohl, Craig; Graves, Tina A.; Markovic, Chris; Cree, Andy; Dinh, Huyen H.; Hume, Jennifer; Kovar, Christie L.; Fowler, Gerald R.; Lunter, Gerton; Meader, Stephen; Heger, Andreas; Ponting, Chris P.; Marques-Bonet, Tomas; Alkan, Can; Chen, Lin; Cheng, Ze; Kidd, Jeffrey M.; Eichler, Evan E.; White, Simon; Searle, Stephen; Vilella, Albert J.; Chen, Yuan; Flicek, Paul; Ma, Jian; Raney, Brian; Suh, Bernard; Burhans, Richard; Herrero, Javier; Haussler, David; Faria, Rui; Fernando, Olga; Darre, Fleur; Farre, Domenec; Gazave, Elodie; Oliva, Meritxell; Navarro, Arcadi; Roberto, Roberta; Capozzi, Oronzo; Archidiacono, Nicoletta; Della Valle, Giuliano; Purgato, Stefania; Rocchi, Mariano; Konkel, Miriam K.; Walker, Jerilyn A.; Ullmer, Brygg; Batzer, Mark A.; Smit, Arian F. A.; Hubley, Robert; Casola, Claudio; Schrider, Daniel R.; Hahn, Matthew W.; Quesada, Victor; Puente, Xose S.; Ordonez, Gonzalo R.; Lopez-Otin, Carlos; Vinar, Tomas; Brejova, Brona; Ratan, Aakrosh; Harris, Robert S.; Miller, Webb; Kosiol, Carolin; Lawson, Heather A.; Taliwal, Vikas; Martins, Andre L.; Siepel, Adam; RoyChoudhury, Arindam; Ma, Xin; Degenhardt, Jeremiah; Bustamante, Carlos D.; Gutenkunst, Ryan N.; Mailund, Thomas; Dutheil, Julien Y.; Hobolth, Asger; Schierup, Mikkel H.; Ryder, Oliver A.; Yoshinaga, Yuko; de Jong, Pieter J.; Weinstock, George M.; Rogers, Jeffrey; Mardis, Elaine R.; Gibbs, Richard A.; Wilson, Richard K.			Comparative and demographic analysis of orang-utan genomes	NATURE			English	Article							LOW NUCLEOTIDE DIVERSITY; RETROTRANSPOSONS; CHIMPANZEES; EVOLUTION; HUMANS; ANCESTOR; SEQUENCE	'Orang-utan' is derived from a Malay term meaning 'man of the forest' and aptly describes the southeast Asian great apes native to Sumatra and Borneo. The orang-utan species, Pongo abelii (Sumatran) and Pongo pygmaeus (Bornean), are the most phylogenetically distant great apes from humans, thereby providing an informative perspective on hominid evolution. Here we present a Sumatran orang-utan draft genome assembly and short read sequence data from five Sumatran and five Bornean orang-utan genomes. Our analyses reveal that, compared to other primates, the orang-utan genome has many unique features. Structural evolution of the orang-utan genome has proceeded much more slowly than other great apes, evidenced by fewer rearrangements, less segmental duplication, a lower rate of gene family turnover and surprisingly quiescent Alu repeats, which have played a major role in restructuring other primate genomes. We also describe a primate polymorphic neocentromere, found in both Pongo species, emphasizing the gradual evolution of orang-utan genome structure. Orang-utans have extremely low energy usage for a eutherian mammal(1), far lower than their hominid relatives. Adding their genome to the repertoire of sequenced primates illuminates new signals of positive selection in several pathways including glycolipid metabolism. From the population perspective, both Pongo species are deeply diverse; however, Sumatran individuals possess greater diversity than their Bornean counterparts, and more species-specific variation. Our estimate of Bornean/Sumatran speciation time, 400,000 years ago, is more recent than most previous studies and underscores the complexity of the orang-utan speciation process. Despite a smaller modern census population size, the Sumatran effective population size (Ne) expanded exponentially relative to the ancestral Ne after the split, while Bornean Ne declined over the same period. Overall, the resources and analyses presented here offer new opportunities in evolutionary genomics, insights into hominid biology, and an extensive database of variation for conservation efforts.	[Locke, Devin P.; Hillier, LaDeana W.; Warren, Wesley C.; Yang, Shiaw-Pyng; Wang, Zhengyuan; Chinwalla, Asif T.; Minx, Pat; Mitreva, Makedonka; Cook, Lisa; Delehaunty, Kim D.; Fronick, Catrina; Schmidt, Heather; Fulton, Lucinda A.; Fulton, Robert S.; Nelson, Joanne O.; Magrini, Vincent; Pohl, Craig; Graves, Tina A.; Markovic, Chris; Weinstock, George M.; Mardis, Elaine R.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Ctr, St Louis, MO 63108 USA; [Worley, Kim C.; Nazareth, Lynne V.; Muzny, Donna M.; Cree, Andy; Dinh, Huyen H.; Hume, Jennifer; Kovar, Christie L.; Fowler, Gerald R.; Rogers, Jeffrey; Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Lunter, Gerton; Meader, Stephen; Heger, Andreas; Ponting, Chris P.] Univ Oxford, MRC, Funct Genom Unit, Oxford OX1 3QX, England; [Lunter, Gerton; Meader, Stephen; Heger, Andreas; Ponting, Chris P.] Univ Oxford, Dept Physiol Anat & Genet, Oxford OX1 3QX, England; [Lunter, Gerton] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Marques-Bonet, Tomas; Alkan, Can; Chen, Lin; Cheng, Ze; Kidd, Jeffrey M.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA 98195 USA; [Marques-Bonet, Tomas; Faria, Rui; Fernando, Olga; Darre, Fleur; Farre, Domenec; Gazave, Elodie; Oliva, Meritxell; Navarro, Arcadi] Univ Pompeu Fabra, PRBB, CSIC, IBE, Barcelona 08003, Spain; [Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [White, Simon; Searle, Stephen] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Vilella, Albert J.; Chen, Yuan; Flicek, Paul; Herrero, Javier] European Bioinformat Inst, Cambridge CB10 1SD, England; [Ma, Jian; Raney, Brian; Suh, Bernard; Haussler, David] Univ Calif Santa Cruz, Ctr Biomol Sci & Engn, Santa Cruz, CA 95064 USA; [Burhans, Richard; Ratan, Aakrosh; Harris, Robert S.; Miller, Webb] Penn State Univ, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA; [Faria, Rui] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, P-4485661 Vairao, Portugal; [Fernando, Olga] Univ Nova Lisboa, Inst Tecnol Quim & Biol, P-2780157 Oeiras, Portugal; [Navarro, Arcadi] ICREA, Barcelona 08003, Spain; [Navarro, Arcadi] PRBB, INB, Barcelona 08003, Spain; [Roberto, Roberta; Capozzi, Oronzo; Archidiacono, Nicoletta; Rocchi, Mariano] Univ Bari, Dept Biol, I-70125 Bari, Italy; [Della Valle, Giuliano; Purgato, Stefania] Univ Bologna, Dept Biol, I-40126 Bologna, Italy; [Konkel, Miriam K.; Walker, Jerilyn A.; Batzer, Mark A.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Ullmer, Brygg] Louisiana State Univ, Dept Comp Sci, Ctr Computat & Technol, Baton Rouge, LA 70803 USA; [Smit, Arian F. A.; Hubley, Robert] Inst Syst Biol, Seattle, WA 98103 USA; [Casola, Claudio; Schrider, Daniel R.; Hahn, Matthew W.] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Casola, Claudio; Schrider, Daniel R.; Hahn, Matthew W.] Indiana Univ, Sch Informat & Comp, Bloomington, IN 47405 USA; [Quesada, Victor; Puente, Xose S.; Ordonez, Gonzalo R.; Lopez-Otin, Carlos] Univ Oviedo, Dept Bioquim & Biol Mol, Inst Univ Oncol, E-33006 Oviedo, Spain; [Vinar, Tomas; Brejova, Brona] Comenius Univ, Fac Math Phys & Informat, Bratislava 84248, Slovakia; [Kosiol, Carolin] Vetmeduni Vienna, Inst Populat Genet, A-1210 Vienna, Austria; [Lawson, Heather A.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA; [Taliwal, Vikas; Martins, Andre L.; Siepel, Adam; Ma, Xin; Degenhardt, Jeremiah] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY 14853 USA; [RoyChoudhury, Arindam] Columbia Univ, Dept Biostat, New York, NY 10032 USA; [Bustamante, Carlos D.] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Gutenkunst, Ryan N.] Univ Arizona, Dept Mol & Cellular Biol, Tucson, AZ 85721 USA; [Mailund, Thomas; Dutheil, Julien Y.; Hobolth, Asger; Schierup, Mikkel H.] Aarhus Univ, Bioinformat Res Ctr, DK-8000 Aarhus C, Denmark; [Ryder, Oliver A.] San Diego Zoos Inst Conservat Res, Escondido, CA 92027 USA; [Yoshinaga, Yuko; de Jong, Pieter J.] Childrens Hosp Oakland, Res Inst, Oakland, CA 94609 USA	Washington University (WUSTL); Baylor College of Medicine; University of Oxford; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Washington; University of Washington Seattle; Consejo Superior de Investigaciones Cientificas (CSIC); Pompeu Fabra University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Wellcome Trust Sanger Institute; European Molecular Biology Laboratory (EMBL); University of California System; University of California Santa Cruz; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Universidade do Porto; Universidade Nova de Lisboa; ICREA; Pompeu Fabra University; Universita degli Studi di Bari Aldo Moro; University of Bologna; Louisiana State University System; Louisiana State University; Louisiana State University System; Louisiana State University; Institute for Systems Biology (ISB); Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Comenius University Bratislava; University of Veterinary Medicine Vienna; Washington University (WUSTL); Cornell University; Columbia University; Stanford University; University of Arizona; Aarhus University; Zoological Society of San Diego; Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Locke, DP (corresponding author), Washington Univ, Sch Med, Genome Ctr, 4444 Forest Pk Ave, St Louis, MO 63108 USA.	dlocke@wustl.edu; wwarren@wustl.edu	Wang, Zhengyuan/GWV-6069-2022; Marques-Bonet, Tomas/ABF-3734-2020; Navarro, Arcadi/F-1592-2011; Schierup, Mikkel Heide/AAM-4997-2020; Dutheil, Julien Yann/K-5479-2016; Faria, Rui/AAE-5418-2019; Farre, Domenec/K-8010-2014; López-Otín, Carlos/AAB-2106-2020; Mardis, Elaine/W-2202-2019; Brejova, Brona/I-3718-2014; Puente, Xosé S./ADB-0672-2022; Ma, Jian/A-9838-2008; Wilson, Richard K./AAF-4139-2019; Lunter, Gerton/H-4939-2016; Alkan, Can/D-2982-2009; Magrini, Vincent/AAT-5830-2020; Weinstock, George M/C-6314-2013; Schierup, Mikkel H/F-1675-2010; Raney, Brian/ABE-6267-2020; Herrero, Javier/H-6971-2019; Faria, Rui/F-8778-2012; Ponting, Chris/AAV-2621-2021; Marques-Bonet, Tomas/I-4618-2014; wang, zhengyuan/HGA-0435-2022; Quesada, Víctor/B-6557-2014; Vinar, Tomas/I-3695-2014	Marques-Bonet, Tomas/0000-0002-5597-3075; Navarro, Arcadi/0000-0003-2162-8246; Schierup, Mikkel Heide/0000-0002-5028-1790; Dutheil, Julien Yann/0000-0001-7753-4121; Faria, Rui/0000-0001-6635-685X; Farre, Domenec/0000-0001-8553-1983; López-Otín, Carlos/0000-0001-6964-1904; Brejova, Brona/0000-0002-9483-1766; Puente, Xosé S./0000-0001-9525-1483; Ma, Jian/0000-0002-4202-5834; Wilson, Richard K./0000-0002-1992-1358; Alkan, Can/0000-0002-5443-0706; Magrini, Vincent/0000-0002-2019-4872; Weinstock, George M/0000-0002-2997-4592; Schierup, Mikkel H/0000-0002-5028-1790; Herrero, Javier/0000-0001-7313-717X; Faria, Rui/0000-0001-6635-685X; Marques-Bonet, Tomas/0000-0002-5597-3075; wang, zhengyuan/0000-0002-8447-9674; Quesada, Víctor/0000-0002-8398-3457; Vinar, Tomas/0000-0003-3898-3447; CAPOZZI, Oronzo/0000-0002-7443-6777; Worley, Kim/0000-0002-0282-1000; Casola, Claudio/0000-0003-4853-1866; Kidd, Jeffrey/0000-0002-9631-1465; Hobolth, Asger/0000-0003-4056-1286; Flicek, Paul/0000-0002-3897-7955; Mitreva, Makedonka/0000-0001-9572-3436; Locke, Devin/0000-0002-2527-0475; Hahn, Matthew/0000-0002-5731-8808; White, Simon/0000-0001-6375-2363; Bustamante, Carlos D./0000-0002-4187-7920; Siepel, Adam/0000-0002-3557-7219; Heger, Andreas/0000-0001-7720-0447; Ponting, Chris/0000-0003-0202-7816; Lawson, Heather/0000-0002-3550-5485; Chinwalla, Asif/0000-0001-7831-3996; Gazave, Elodie/0000-0002-6972-7051; Lunter, Gerton/0000-0002-3798-2058; Mailund, Thomas/0000-0001-6206-9239; archidiacono, nicoletta/0000-0002-1439-9521; Rocchi, Mariano/0000-0002-9451-5616; Vilella, Albert/0000-0002-2005-2516	National Human Genome Research Institute (NHGRI) [U54 HG003079, U54 HG003273]; National Institutes of Health [R01 GM59290, PO1 AG022064, HG002385, HG002238]; National Science Foundation [DBI-0644111]; David and Lucile Packard Foundation; Cornell University; UK Medical Research Council; Marie Curie Fellowship; Ministerio de Ciencia e Innovacion-Spain (MCI-Spain); Fundacion M. Botin; MCI-Spain [BFU2006-15413-C02-01, BFU2009-13409-C02-02]; Spanish National Institute for Bioinformatics (INAB); Fundacao para a Ciencia e a Tecnologia (Portugal) [SFRH/BPD/26384/2006, SFRH/BD/15856/2005]; PRIN; CEGBA; Commission of the European Communities [IRG-224885, IRG-231025]; MRC [MC_U137761446, G0501331] Funding Source: UKRI; Medical Research Council [MC_U137761446, G0501331] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003079, R01HG002385, U54HG003273, R01HG002939, R01HG002238] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022064] Funding Source: NIH RePORTER; ICREA Funding Source: Custom	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Cornell University; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Marie Curie Fellowship(European Commission); Ministerio de Ciencia e Innovacion-Spain (MCI-Spain)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion M. Botin; MCI-Spain; Spanish National Institute for Bioinformatics (INAB); Fundacao para a Ciencia e a Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); CEGBA; Commission of the European Communities(European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ICREA(ICREA)	The orang-utan genome project was funded by the National Human Genome Research Institute (NHGRI), including grants U54 HG003079 (R.K.W.) and U54 HG003273 (R.A.G), with further support from National Institutes of Health R01 GM59290 (M.A.B.), PO1 AG022064 (M.A.B.), HG002385 (E.E.E.) and HG002238 (W.M.), National Science Foundation DBI-0644111 (A.S. and B.B.), David and Lucile Packard Foundation (A.S., V.T. and T.V.), Cornell University Provost's Fellowship (A.L.M.), UK Medical Research Council (C.P.P., G.L., S.M. and A.H.), Marie Curie Fellowship (T.M.-B.), Ministerio de Ciencia e Innovacion-Spain (MCI-Spain) and Fundacion M. Botin (V.Q., X.S.P., G.R.O. and C.L.-O.), MCI-Spain BFU2006-15413-C02-01 and BFU2009-13409-C02-02 (A.N.), Spanish National Institute for Bioinformatics (INAB) and Fundacao para a Ciencia e a Tecnologia (Portugal), SFRH/BPD/26384/2006 (R.F.) and SFRH/BD/15856/2005 (O.F.), PRIN and CEGBA (M.R., N.A. and G.D.V.), and the Commission of the European Communities IRG-224885 (T.V.), IRG-231025 (B.B.). We thank the Gladys Porter Zoo, and S. O'Brien and S. Paabo for use of orang-utan samples. D.P.L. thanks S. D. McGrath, A. Wollam, R. M. Abbott and L. Chemnick for technical assistance. We acknowledge all the important work that could not be cited owing to space limitations. Resources for exploring the orang-utan genome are available at UCSC (http://genome.ucsc.edu), Ensembl (http://www.ensembl.org), NCBI (http://ncbi.nlm.nih.gov) and The Genome Center at Washington University (http://genome.wustl.edu/genomes/view/pongo_abelii/).	Alcaide M, 2009, HEREDITY, V102, P190, DOI 10.1038/hdy.2008.107; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Hahn MW, 2007, GENETICS, V177, P1941, DOI 10.1534/genetics.107.080077; Hobolth A, 2007, PLOS GENET, V3, P294, DOI 10.1371/journal.pgen.0030007; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Kulpa DA, 2006, NAT STRUCT MOL BIOL, V13, P655, DOI 10.1038/nsmb1107; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee J, 2007, GENE, V390, P18, DOI 10.1016/j.gene.2006.08.029; LI WH, 1991, GENETICS, V129, P513; Liu G, 2003, GENOME RES, V13, P358, DOI 10.1101/gr.923303; Makino CL, 2004, J GEN PHYSIOL, V123, P729, DOI 10.1085/jgp.200308994; Marques-Bonet T, 2009, NATURE, V457, P877, DOI 10.1038/nature07744; Meijaard E, 2007, CURR BIOL, V17, pR540, DOI 10.1016/j.cub.2007.05.016; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Patterson N, 2006, NATURE, V441, P1103, DOI 10.1038/nature04789; Pontzer H, 2010, P NATL ACAD SCI USA, V107, P14048, DOI 10.1073/pnas.1001031107; SEUANEZ H, 1976, CYTOGENET CELL GENET, V17, P26, DOI 10.1159/000130684; Singleton I., 2004, ORANGUTAN POPULATION; Stanyon R, 2008, CHROMOSOME RES, V16, P17, DOI 10.1007/s10577-007-1209-z; van Noordwijk MA, 2005, AM J PHYS ANTHROPOL, V127, P79, DOI 10.1002/ajpa.10426; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Wade CM, 2009, SCIENCE, V326, P865, DOI 10.1126/science.1178158; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Yi SJ, 2002, MOL BIOL EVOL, V19, P2191, DOI 10.1093/oxfordjournals.molbev.a004043; Yu N, 2003, GENETICS, V164, P1511	30	367	379	2	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 27	2011	469	7331					529	533		10.1038/nature09687	http://dx.doi.org/10.1038/nature09687			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270892	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000286596500032
J	McDermott, U; Downing, JR; Stratton, MR				McDermott, Ultan; Downing, James R.; Stratton, Michael R.			GENOMIC MEDICINE Genomics and the Continuum of Cancer Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CELL LUNG-CANCER; GENE-EXPRESSION; ACQUIRED-RESISTANCE; POLY(ADP-RIBOSE) POLYMERASE; IMATINIB MESYLATE; MUTATIONS; BREAST; RECURRENCE; GEFITINIB; PREDICT		[McDermott, Ultan; Stratton, Michael R.] Wellcome Trust Sanger Inst, Cambridge, England; [McDermott, Ultan; Stratton, Michael R.] Inst Canc Res, Surrey, England; [Downing, James R.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA	Wellcome Trust Sanger Institute; University of London; Institute of Cancer Research - UK; St Jude Children's Research Hospital	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England.	mrs@sanger.ac.uk	Downing, James R./N-8102-2018	McDermott, Ultan/0000-0001-9032-4700				Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Antonescu CR, 2005, CLIN CANCER RES, V11, P4182, DOI 10.1158/1078-0432.CCR-04-2245; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bender RA, 2009, SEMIN ONCOL, V36, P38, DOI 10.1053/j.seminoncol.2008.10.002; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; DeMatteo RP, 2000, ANN SURG, V231, P51, DOI 10.1097/00000658-200001000-00008; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Dutt A, 2008, P NATL ACAD SCI USA, V105, P8713, DOI 10.1073/pnas.0803379105; Emery CM, 2009, P NATL ACAD SCI USA, V106, P20411, DOI 10.1073/pnas.0905833106; Engelman JA, 2008, CURR OPIN GENET DEV, V18, P73, DOI 10.1016/j.gde.2008.01.004; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Hindorff LA, CATALOG PUBLISHED GE; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Kerr D, 2009, J CLIN ONCOL, V27; Kwak EL, 2009, J CLIN ONCOL, V27; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Leary RJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000702; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lo SS, 2010, J CLIN ONCOL, V28, P1671, DOI 10.1200/JCO.2008.20.2119; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maheswaran S, 2008, NEW ENGL J MED, V359, P366, DOI 10.1056/NEJMoa0800668; Mass Robert D, 2005, Clin Breast Cancer, V6, P240, DOI 10.3816/CBC.2005.n.026; McBride DJ, 2010, GENE CHROMOSOME CANC, V49, P1062, DOI 10.1002/gcc.20815; McCabe N, 2006, CANCER RES, V66, P8109, DOI 10.1158/0008-5472.CAN-06-0140; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; NOWELL PC, 1960, SCIENCE, V132, P1497; O'Brien SG, 2003, NEW ENGL J MED, V348, P994, DOI 10.1056/NEJMoa022457; O'Connell MJ, 2010, J CLIN ONCOL, V28, P3937, DOI 10.1200/JCO.2010.28.9538; O'Hare T, 2007, BLOOD, V110, P2242, DOI 10.1182/blood-2007-03-066936; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Pleasance ED, 2010, NATURE, V463, P184, DOI 10.1038/nature08629; Press RD, 2006, BLOOD, V107, P4250, DOI 10.1182/blood-2005-11-4406; Rosenwald A, 2002, NEW ENGL J MED, V346, P1937, DOI 10.1056/NEJMoa012914; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Stephens P, 2004, NATURE, V431, P525, DOI 10.1038/431525b; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	55	226	236	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2011	364	4					340	350		10.1056/NEJMra0907178	http://dx.doi.org/10.1056/NEJMra0907178			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711LH	21268726	Bronze			2022-12-28	WOS:000286592600009
J	Henry, SG				Henry, Stephen G.			The Tyranny of Reality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												henrstep@umich.edu							0	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2011	305	4					338	339		10.1001/jama.2011.9	http://dx.doi.org/10.1001/jama.2011.9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711MH	21266675				2022-12-28	WOS:000286595200001
J	McCartney, G; Garnham, L; Gunson, D; Collins, C				McCartney, Gerry; Garnham, Lisa; Gunson, Darryl; Collins, Chik			Competing Interests When do your politics become a competing interest?	BRITISH MEDICAL JOURNAL			English	Editorial Material												gmccartney@nhs.net	Garnham, Lisa/GVS-7878-2022; Collins, Chik/AAE-6905-2021	Collins, Chik/0000-0003-3906-0695; McCartney, Gerry/0000-0001-6341-3521; Garnham, Lisa/0000-0001-9242-8095					0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 25	2011	342								d269	10.1136/bmj.d269	http://dx.doi.org/10.1136/bmj.d269			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	715LX	21266420				2022-12-28	WOS:000286887100029
J	Crimmins, SM; Dobrowski, SZ; Greenberg, JA; Abatzoglou, JT; Mynsberge, AR				Crimmins, Shawn M.; Dobrowski, Solomon Z.; Greenberg, Jonathan A.; Abatzoglou, John T.; Mynsberge, Alison R.			Changes in Climatic Water Balance Drive Downhill Shifts in Plant Species' Optimum Elevations	SCIENCE			English	Article							VEGETATION DISTRIBUTION; CALIFORNIA; 20TH-CENTURY; PHENOLOGY; MIGRATION; USA	Uphill shifts of species' distributions in response to historical warming are well documented, which leads to widespread expectations of continued uphill shifts under future warming. Conversely, downhill shifts are often considered anomalous and unrelated to climate change. By comparing the altitudinal distributions of 64 plant species between the 1930s and the present day within California, we show that climate changes have resulted in a significant downward shift in species' optimum elevations. This downhill shift is counter to what would be expected given 20th-century warming but is readily explained by species' niche tracking of regional changes in climatic water balance rather than temperature. Similar downhill shifts can be expected to occur where future climate change scenarios project increases in water availability that outpace evaporative demand.	[Crimmins, Shawn M.; Dobrowski, Solomon Z.; Mynsberge, Alison R.] Univ Montana, Coll Forestry & Conservat, Dept Forest Management, Missoula, MT 59812 USA; [Greenberg, Jonathan A.] Univ Calif Davis, Ctr Spatial Technol & Remote Sensing, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Abatzoglou, John T.] Univ Idaho, Dept Geog, Coll Sci, Moscow, ID 83844 USA	University of Montana System; University of Montana; University of California System; University of California Davis; Idaho; University of Idaho	Dobrowski, SZ (corresponding author), Univ Montana, Coll Forestry & Conservat, Dept Forest Management, Missoula, MT 59812 USA.	solomon.dobrowski@cfc.umt.edu	Dobrowski, Solomon Z/Q-7132-2019; Abatzoglou, John T/ABE-6134-2020; Crimmins, Shawn/C-6972-2012; Crimmins, Shawn/M-1809-2013; Abatzoglou, John T/C-7635-2012	Dobrowski, Solomon Z/0000-0003-2561-3850; Abatzoglou, John T/0000-0001-7599-9750; Abatzoglou, John T/0000-0001-7599-9750; Greenberg, Jonathan/0000-0001-8435-9077	NSF [BCS-0819430, BCS-0819493, EPS-0814387]; U.S. Department of Agriculture Forest Service's (USFS's) Rocky Mountain Research Station [JV11221635-201]	NSF(National Science Foundation (NSF)); U.S. Department of Agriculture Forest Service's (USFS's) Rocky Mountain Research Station(United States Department of Agriculture (USDA)United States Forest Service)	Supported by NSF (BCS-0819430 to S.Z.D. and BCS-0819493 to J.A.G.). J.T.A. was supported by NSF's Experimental Program to Stimulate Competitive Research (EPSCoR) (EPS-0814387). A.R.M. was supported by U.S. Department of Agriculture Forest Service's (USFS's) Rocky Mountain Research Station (JV11221635-201). We thank C. Daly for providing interpolated climate data; M. Kelly for Vegetation Type Mapping project data; C. Ramirez (Region 5 USFS Remote Sensing Lab) for the USFS Forest Inventory and Analysis data (plot locations were not provided to the authors); J. Thorne for compiling modern data sources; and S. Running for helpful comments on the manuscript.	Archaux F, 2004, IBIS, V146, P138, DOI 10.1111/j.1474-919X.2004.00246.x; Cleland EE, 2007, TRENDS ECOL EVOL, V22, P357, DOI 10.1016/j.tree.2007.04.003; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Doi H, 2008, AGR FOREST METEOROL, V148, P512, DOI 10.1016/j.agrformet.2007.10.002; Eckert Andrew J., 2007, Madrono, V54, P117, DOI 10.3120/0024-9637(2007)54[117:EAEEOS]2.0.CO;2; Hickling R, 2005, GLOBAL CHANGE BIOL, V11, P502, DOI 10.1111/j.1365-2486.2005.00904.x; IPCC Apndice, 2007, AR4 CLIMATE CHANGE 2; Konvicka M, 2003, GLOBAL ECOL BIOGEOGR, V12, P403, DOI 10.1046/j.1466-822X.2003.00053.x; Lawler JJ, 2009, ECOLOGY, V90, P588, DOI 10.1890/08-0823.1; Lenihan JM, 2003, ECOL APPL, V13, P1667, DOI 10.1890/025295; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Lenoir J, 2010, ECOGRAPHY, V33, P295, DOI 10.1111/j.1600-0587.2010.06279.x; Millar CI, 2004, ARCT ANTARCT ALP RES, V36, P181, DOI 10.1657/1523-0430(2004)036[0181:ROSCIT]2.0.CO;2; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Oppel S, 2008, CONDOR, V110, P296, DOI 10.1525/cond.2008.8502; Parmesan C, 1999, NATURE, V399, P579, DOI 10.1038/21181; Popy S, 2010, J BIOGEOGR, V37, P57, DOI 10.1111/j.1365-2699.2009.02197.x; Stephenson NL, 1998, J BIOGEOGR, V25, P855, DOI 10.1046/j.1365-2699.1998.00233.x; STEPHENSON NL, 1990, AM NAT, V135, P649, DOI 10.1086/285067; Van Buskirk J, 2009, GLOBAL CHANGE BIOL, V15, P760, DOI 10.1111/j.1365-2486.2008.01751.x; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wieslander A.E., 1935, MADRONO, V3, P140; Wieslander A. E, 1935, J FOREST, V33, P877, DOI DOI 10.1093/JOF/33.10.877; Zhang K, 2009, J HYDROL, V379, P92, DOI 10.1016/j.jhydrol.2009.09.047	24	386	399	6	252	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					324	327		10.1126/science.1199040	http://dx.doi.org/10.1126/science.1199040			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252344				2022-12-28	WOS:000286636300035
J	Lister, R; Pelizzola, M; Kida, YS; Hawkins, RD; Nery, JR; Hon, G; Antosiewicz-Bourget, J; O'Malley, R; Castanon, R; Klugman, S; Downes, M; Yu, R; Stewart, R; Ren, B; Thomson, JA; Evans, RM; Ecker, JR				Lister, Ryan; Pelizzola, Mattia; Kida, Yasuyuki S.; Hawkins, R. David; Nery, Joseph R.; Hon, Gary; Antosiewicz-Bourget, Jessica; O'Malley, Ronan; Castanon, Rosa; Klugman, Sarit; Downes, Michael; Yu, Ruth; Stewart, Ron; Ren, Bing; Thomson, James A.; Evans, Ronald M.; Ecker, Joseph R.			Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells	NATURE			English	Article							DNA METHYLATION; DIFFERENTIATION; GENES; MICE	Induced pluripotent stem cells (iPSCs) offer immense potential for regenerative medicine and studies of disease and development. Somatic cell reprogramming involves epigenomic reconfiguration, conferring iPSCs with characteristics similar to embryonic stem (ES) cells. However, it remains unknown how complete the reestablishment of ES-cell-like DNA methylation patterns is throughout the genome. Here we report the first whole-genome profiles of DNA methylation at single-base resolution in five human iPSC lines, along with methylomes of ES cells, somatic cells, and differentiated iPSCs and ES cells. iPSCs show significant reprogramming variability, including somatic memory and aberrant reprogramming of DNA methylation. iPSCs share megabase-scale differentially methylated regions proximal to centromeres and telomeres that display incomplete reprogramming of non-CG methylation, and differences in CG methylation and histone modifications. Lastly, differentiation of iPSCs into trophoblast cells revealed that errors in reprogramming CG methylation are transmitted at a high frequency, providing an iPSC reprogramming signature that is maintained after differentiation.	[Lister, Ryan; Pelizzola, Mattia; Nery, Joseph R.; O'Malley, Ronan; Castanon, Rosa; Ecker, Joseph R.] Salk Inst Biol Studies, Genome Anal Lab, La Jolla, CA 92037 USA; [Kida, Yasuyuki S.; Downes, Michael; Yu, Ruth; Evans, Ronald M.] Salk Inst Biol Studies, Howard Hughes Med Inst, Gene Express Lab, La Jolla, CA 92037 USA; [Hawkins, R. David; Hon, Gary; Klugman, Sarit; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Antosiewicz-Bourget, Jessica; Stewart, Ron; Thomson, James A.] Morgridge Inst Res, Madison, WI 53707 USA; [Antosiewicz-Bourget, Jessica; Stewart, Ron; Thomson, James A.] Genome Ctr Wisconsin, Madison, WI 53706 USA; [Ren, Bing] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Thomson, James A.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Thomson, James A.] Univ Wisconsin, Dept Anat, Madison, WI 53706 USA	Salk Institute; Howard Hughes Medical Institute; Salk Institute; Ludwig Institute for Cancer Research; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ecker, JR (corresponding author), Salk Inst Biol Studies, Genome Anal Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ecker@salk.edu	kida, yasuyuki S/J-1718-2018; Nery, Joseph/AAE-8422-2019; Evans, Ronald/AAF-4001-2019; Ecker, Joseph R/B-9144-2008; Lister, Ryan/B-5168-2012	kida, yasuyuki S/0000-0002-9972-293X; Nery, Joseph/0000-0003-0153-5659; Evans, Ronald/0000-0002-9986-5965; Ecker, Joseph R/0000-0001-5799-5895; Lister, Ryan/0000-0001-6637-7239; Pelizzola, Mattia/0000-0001-6672-9636	California Institute; Catharina Foundation; American Cancer Society; Japan Society for the Promotion of Science; Mary K. Chapman Foundation; National Science Foundation (NSF) [NSF 0726408]; National Institutes of Health (NIH) [U01 ES017166, U01 1U01ES017166-01, DK062434]; California Institute for Regenerative Medicine [RB2-01530]; Morgridge Institute for Research; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK062434] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER	California Institute; Catharina Foundation; American Cancer Society(American Cancer Society); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Mary K. Chapman Foundation; National Science Foundation (NSF)(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Morgridge Institute for Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank L. Zhang and G. Schroth for assistance with MethylC-Seq library sequencing. R.L. is supported by a California Institute for Regenerative Medicine Training Grant. M.P. is supported by a Catharina Foundation postdoctoral fellowship. R.D.H. is supported by an American Cancer Society Postdoctoral Fellowship. Y.K. is supported by the Japan Society for the Promotion of Science. This work was supported by grants from the following: Mary K. Chapman Foundation, the National Science Foundation (NSF) (NSF 0726408), the National Institutes of Health (NIH) (U01 ES017166, U01 1U01ES017166-01, DK062434), the California Institute for Regenerative Medicine (RB2-01530), the Morgridge Institute for Research and the Howard Hughes Medical Institute. We thank the NIH Roadmap Reference Epigenome Consortium (http://www.roadmapepigenomics.org/). This study was carried out as part of the NIH Roadmap Epigenomics Program.	Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chen PY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-203; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Chodavarapu RK, 2010, NATURE, V466, P388, DOI 10.1038/nature09147; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Erhardt A, 2011, MOL PSYCHIATR, V16, P647, DOI 10.1038/mp.2010.41; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laurent L, 2010, GENOME RES, V20, P320, DOI 10.1101/gr.101907.109; Li MZ, 2006, DEV BIOL, V292, P555, DOI 10.1016/j.ydbio.2006.01.033; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; O'Malley RC, 2007, NAT PROTOC, V2, P2910, DOI 10.1038/nprot.2007.425; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Sugii S, 2010, P NATL ACAD SCI USA, V107, P3558, DOI 10.1073/pnas.0910172106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yilmaz Gokhan, 2010, Exp Transl Stroke Med, V2, P11, DOI 10.1186/2040-7378-2-11; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	37	1110	1168	3	320	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 3	2011	471	7336					68	U84		10.1038/nature09798	http://dx.doi.org/10.1038/nature09798			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729BY	21289626	Green Accepted, Green Published			2022-12-28	WOS:000287924100035
J	Berkowitz, SA; Miller, ED				Berkowitz, Scott A.; Miller, Edward D.			Accountable Care at Academic Medical Centers - Lessons from Johns Hopkins	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Berkowitz, Scott A.; Miller, Edward D.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA	Johns Hopkins University	Berkowitz, SA (corresponding author), Johns Hopkins Univ, Sch Med, Baltimore, MD 21218 USA.							JAFFE S, 2010, WASHINGTON POST 1220; McClellan M, 2010, HEALTH AFFAIR, V29, P982, DOI 10.1377/hlthaff.2010.0194; Tallia AF, 2010, ACAD MED, V85, P766, DOI 10.1097/ACM.0b013e3181d0ed8c; *U PA SCH NURS PHI, LIV IND ELD	4	23	23	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2011	364	7								10.1056/NEJMp1100076	http://dx.doi.org/10.1056/NEJMp1100076			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	722BW	21288089				2022-12-28	WOS:000287406000005
J	Tishler, LW				Tishler, Lori Wiviott			The Pavilion	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												ltishler@partners.org							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2011	305	7					653	654		10.1001/jama.2011.112	http://dx.doi.org/10.1001/jama.2011.112			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721NH	21325176				2022-12-28	WOS:000287361100001
J	Kansagara, D; Fu, RW; Freeman, M; Wolf, F; Helfand, M				Kansagara, Devan; Fu, Rongwei; Freeman, Michele; Wolf, Fawn; Helfand, Mark			Intensive Insulin Therapy in Hospitalized Patients: A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							CRITICALLY-ILL PATIENTS; BLOOD-GLUCOSE CONTROL; TIGHT GLYCEMIC CONTROL; ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED CONTROLLED-TRIAL; PREDICTIVE CONTROL ALGORITHM; CLINICAL-PRACTICE GUIDELINES; DEPENDENT DIABETES-MELLITUS; CARDIAC SURGICAL-PROCEDURES; STERNAL WOUND-INFECTION	Background: The benefits and harms of intensive insulin therapy (IIT) titrated to strict glycemic targets in hospitalized patients remain uncertain. Purpose: To evaluate the benefits and harms of IIT in hospitalized patients. Data Sources: MEDLINE and Cochrane Database of Systematic Reviews from 1950 to January 2010, reference lists, experts, and unpublished sources. Study Selection: English-language randomized, controlled trials comparing protocols titrated to strict or less strict glycemic targets. Data Extraction: Two reviewers independently abstracted data from each study on sample, setting, glycemic control interventions, glycemic targets, mean glucose levels achieved, and outcomes. Results were grouped by patient population or setting. A random-effects model was used to combine trial data on short-term mortality (<= 28 days), long-term mortality (90 or 180 days), infection, length of stay, and hypoglycemia. The Grading of Recommendations Assessment, Development, and Evaluation system was used to rate the overall body of evidence for each outcome. Data Synthesis: In a meta-analysis of 21 trials in intensive care unit, perioperative care, myocardial infarction, and stroke or brain injury settings, IIT did not affect short-term mortality (relative risk, 1.00 [95% CI, 0.94 to 1.07]). No consistent evidence showed that IIT reduced long-term mortality, infection rates, length of stay, or the need for renal replacement therapy. No evidence of benefit from IIT was reported in any hospital setting, although the best evidence for lack of benefit was in intensive care unit settings. Data combined from 10 trials showed that IIT was associated with a high risk for severe hypoglycemia (relative risk, 6.00 [CI, 4.06 to 8.87]; P < 0.001). Risk for IIT-associated hypoglycemia was increased in all hospital settings. Limitations: Methodological shortcomings and inconsistencies limit the data in perioperative care, myocardial infarction, and stroke or brain injury settings. Differences in insulin protocols and patient and hospital characteristics may affect generalizability across treatment settings. Conclusion: No consistent evidence demonstrates that IIT targeted to strict glycemic control compared with less strict glycemic control improves health outcomes in hospitalized patients. Furthermore, IIT is associated with an increased risk for severe hypoglycemia.	[Kansagara, Devan] Oregon Hlth & Sci Univ, Portland Vet Affairs Med Ctr, Portland, OR 97239 USA; Oregon Hlth & Sci Univ, Portland Diabet & Endocrinol Ctr, Portland, OR 97239 USA	Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; VA Portland Health Care System; Oregon Health & Science University	Kansagara, D (corresponding author), Oregon Hlth & Sci Univ, Portland Vet Affairs Med Ctr, 3710 SW US Vet Hosp Rd,Mailcode R&D 71, Portland, OR 97239 USA.	kansagar@ohsu.edu			Department of Veterans Affairs, Veterans Health Administration [ESP 05-225, 01-0206]; American College of Physicians	Department of Veterans Affairs, Veterans Health Administration(US Department of Veterans Affairs); American College of Physicians	Financial Support: By the Department of Veterans Affairs, Veterans Health Administration (VHA Project ESP 05-225, VA #01-0206). The American College of Physicians provided funding for the preparation of this manuscript.	Ahmann AJ, 2008, J HOSP MED, V3, pS42, DOI 10.1002/jhm.366; Arabi YM, 2008, CRIT CARE MED, V36, P3190, DOI 10.1097/CCM.0b013e31818f21aa; Aragon D, 2006, AM J CRIT CARE, V15, P370, DOI 10.4037/ajcc2006.15.4.370; Balkin M, 2007, DIABETES-METAB RES, V23, P49, DOI 10.1002/dmrr.673; BARCELLOS DS, 2007, REV BRAS CIR CARDIOV, V22, P275; Beilman Greg J, 2005, Diabetes Technol Ther, V7, P823, DOI 10.1089/dia.2005.7.823; Bell DA, 2005, BRIT J NEUROSURG, V19, P21, DOI 10.1080/02688690500089423; Biffl W, 2007, J TRAUMA, V62, P1375; Bilotta F, 2009, ANESTHESIOLOGY, V110, P611, DOI 10.1097/ALN.0b013e318198004b; Bistrian BR, 2006, CRIT CARE MED, V34, P1525, DOI 10.1097/01.CCM.0000216704.54446.FD; Bland DK, 2005, AM J CRIT CARE, V14, P370; Blunt M, 2008, BR J INTENSIVE CARE, V18, P121; Bochicchio GV, 2005, AM SURGEON, V71, P171; Braithwaite SS, 2006, DIABETES TECHNOL THE, V8, P476, DOI 10.1089/dia.2006.8.476; Brozek JL, 2009, ALLERGY, V64, P669, DOI 10.1111/j.1398-9995.2009.01973.x; Bruno A, 2008, STROKE, V39, P384, DOI 10.1161/STROKEAHA.107.493544; Butterworth J, 2005, J THORAC CARDIOV SUR, V130, P1319, DOI 10.1016/j.jtcvs.2005.02.049; Button E, 2006, CRIT CARE NURS CLIN, V18, P257; Button Elaine, 2006, Crit Care Nurs Clin North Am, V18, P257, DOI 10.1016/j.ccell.2006.01.001; Capes SE, 2000, LANCET, V355, P773, DOI 10.1016/S0140-6736(99)08415-9; Capes SE, 2001, STROKE, V32, P2426, DOI 10.1161/hs1001.096194; Carvalho G, 2004, ANESTH ANALG, V99, P319, DOI 10.1213/01.ANE.0000121769.62638.EB; Chaney MA, 1999, ANESTH ANALG, V89, P1091, DOI 10.1213/00000539-199911000-00004; Chant C, 2005, PHARMACOTHERAPY, V25, P352, DOI 10.1592/phco.25.3.352.61594; Chee F, 2003, IEEE T INF TECHNOL B, V7, P419, DOI 10.1109/TITB.2003.821326; Cheung NW, 2006, DIABETES CARE, V29, P765, DOI 10.2337/diacare.29.04.06.dc05-1894; Clayton SB, 2006, CRIT CARE MED, V34, P2974, DOI 10.1097/01.CCM.0000248906.10399.CF; Clement S, 2004, DIABETES CARE, V27, P553, DOI 10.2337/diacare.27.2.553; Cochran A, 2008, J BURN CARE RES, V29, P187, DOI 10.1097/BCR.0b013e318160d066; Datta Swati, 2007, Endocr Pract, V13, P225; Davis ED, 2005, DIABETES EDUCATOR, V31, P818, DOI 10.1177/0145721705283077; de Azevedo JRA, 2007, ARQ NEURO-PSIQUIAT, V65, P733, DOI 10.1590/S0004-282X2007000500001; De la Rosa GD, 2008, CRIT CARE, V12, DOI 10.1186/cc7017; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DeSantis Anthony J, 2006, Endocr Pract, V12, P491; Dickerson Lori M, 2003, Ann Fam Med, V1, P29, DOI 10.1370/afm.2; Dilkhush D, 2005, AM J HEALTH-SYST PH, V62, P2260, DOI 10.2146/ajhp040590; Dortch MJ, 2008, JPEN-PARENTER ENTER, V32, P18, DOI 10.1177/014860710803200118; Eigsti J, 2006, DIMENS CRIT CARE NUR, V25, P62, DOI 10.1097/00003465-200603000-00004; Elinav H, 2007, CURR MED RES OPIN, V23, P757, DOI 10.1185/030079907X178748; Farah R, 2007, ISRAEL MED ASSOC J, V9, P140; Finfer S, 2009, NEW ENGL J MED, V360, P1283, DOI 10.1056/NEJMoa0810625; Finney SJ, 2003, JAMA-J AM MED ASSOC, V290, P2041, DOI 10.1001/jama.290.15.2041; FISCHER KF, 1986, NEW ENGL J MED, V315, P1245, DOI 10.1056/NEJM198611133152002; Furnary AP, 2006, SEMIN THORAC CARDIOV, V18, P339, DOI 10.1053/j.semtcvs.2007.01.004; Furnary AP, 1999, ANN THORAC SURG, V67, P352, DOI 10.1016/S0003-4975(99)00014-4; Furnary AP, 2003, J THORAC CARDIOV SUR, V125, P1007, DOI 10.1067/mtc.2003.181; Gandhi GY, 2007, ANN INTERN MED, V146, P233, DOI 10.7326/0003-4819-146-4-200702200-00002; Goldberg PA, 2004, J CARDIOTHOR VASC AN, V18, P690, DOI 10.1053/j.jvca.2004.08.003; GOLDBERG PA, 2005, DIABETES SPECTRUM, V18, P28; Gonzalez-Michaca L, 2002, ARCH MED RES, V33, P48, DOI 10.1016/S0188-4409(01)00354-X; Gray CS, 2007, LANCET NEUROL, V6, P397, DOI 10.1016/S1474-4422(07)70080-7; Grey Neil J, 2004, Endocr Pract, V10 Suppl 2, P46; Griesdale DEG, 2009, CAN MED ASSOC J, V180, P821, DOI 10.1503/cmaj.090206; Harris RP, 2001, AM J PREV MED, V20, P21, DOI 10.1016/S0749-3797(01)00261-6; Hemmerling TM, 2001, J CLIN ANESTH, V13, P293, DOI 10.1016/S0952-8180(01)00276-8; Heyland DK, 2003, JPEN-PARENTER ENTER, V27, P355, DOI 10.1177/0148607103027005355; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hirshberg E, 2008, CHEST, V133, P1328, DOI 10.1378/chest.07-2702; Hovorka R, 2007, J CLIN ENDOCR METAB, V92, P2960, DOI 10.1210/jc.2007-0434; *I HLTH CAR IMPR, 2008, IMPL EFF GLUC CONTR; Iapichino G, 2008, INTENS CARE MED, V34, P1843, DOI 10.1007/s00134-008-1158-9; Ingels C, 2006, EUR HEART J, V27, P2716, DOI 10.1093/eurheartj/ehi855; Inzucchi SE, 2009, NEW ENGL J MED, V360, P1346, DOI 10.1056/NEJMe0901507; IWAMOTO G, COMP TRIAL COMPUTER; Juneja R, 2007, DIABETES TECHNOL THE, V9, P232, DOI 10.1089/dia.2006.0015; Kanji S, 2005, CRIT CARE MED, V33, P2778, DOI 10.1097/01.CCM.0000189939.10881.60; Kanji S, 2004, INTENS CARE MED, V30, P804, DOI 10.1007/s00134-004-2252-2; Kansagara D, 2008, MANAGEMENT INPATIENT; Kirdemir P, 2008, J CARDIOTHOR VASC AN, V22, P383, DOI 10.1053/j.jvca.2007.09.015; Korytkowski MT, 2009, DIABETES CARE, V32, P594, DOI 10.2337/dc08-1436; Kosiborod M, 2009, JAMA-J AM MED ASSOC, V301, P1556, DOI 10.1001/jama.2009.496; Kreisel SH, 2009, CEREBROVASC DIS, V27, P167, DOI 10.1159/000185608; Krinsley J, 2007, CHEST, V132, P1, DOI 10.1378/chest.07-0834; Krinsley JS, 2006, SEMIN THORAC CARDIOV, V18, P317, DOI 10.1053/j.semtcvs.2006.12.003; Ku SY, 2005, JT COMM J QUAL PATIE, V31, P141, DOI 10.1016/S1553-7250(05)31019-1; LACHERADE JC, MULTICENTRE RANDOMIZ; Lazar HL, 2004, CIRCULATION, V109, P1497, DOI 10.1161/01.CIR.0000121747.71054.79; Levetan CS, 1998, DIABETES CARE, V21, P246, DOI 10.2337/diacare.21.2.246; Li JY, 2006, TEX HEART I J, V33, P445; Lien Lillian F, 2005, Endocr Pract, V11, P240; Malmberg K, 2005, EUR HEART J, V26, P650, DOI 10.1093/eurheartj/ehi199; MALMBERG K, 1995, J AM COLL CARDIOL, V26, P57, DOI 10.1016/0735-1097(95)00126-K; Markovitz Lawrence J, 2002, Endocr Pract, V8, P10; McCowen KC, 2001, CRIT CARE CLIN, V17, P107, DOI 10.1016/S0749-0704(05)70154-8; McMullin J, 2007, J CRIT CARE, V22, P112, DOI 10.1016/j.jcrc.2006.08.002; Meijering S, 2006, CRIT CARE, V10, DOI 10.1186/cc3981; Metchick LN, 2002, AM J MED, V113, P317, DOI 10.1016/S0002-9343(02)01213-5; Miriam A, 2004, ANESTH ANALG, V99, P598, DOI 10.1213/01.ANE.0000122824.21065.CA; Mitchell Imogen, 2006, Crit Care Resusc, V8, P289; Nazer Lama H, 2007, Endocr Pract, V13, P137; Oksanen T, 2007, INTENS CARE MED, V33, P2093, DOI 10.1007/s00134-007-0876-8; Osburne RC, 2006, DIABETES EDUCATOR, V32, P394, DOI 10.1177/0145721706288072; Pachler C, 2008, INTENS CARE MED, V34, P1224, DOI 10.1007/s00134-008-1033-8; Plank J, 2006, DIABETES CARE, V29, P271, DOI 10.2337/diacare.29.02.06.dc05-1689; Pomposelli JJ, 1998, JPEN-PARENTER ENTER, V22, P77, DOI 10.1177/014860719802200277; Preiser JC, 2007, INTENS CARE MED, V33, P570, DOI 10.1007/s00134-006-0485-y; Preiser JC, 2009, INTENS CARE MED, V35, P1738, DOI 10.1007/s00134-009-1585-2; Quinn JA, 2006, PHARMACOTHERAPY, V26, P1410, DOI 10.1592/phco.26.10.1410; Rasoul S, 2007, INT J CARDIOL, V122, P52, DOI 10.1016/j.ijcard.2006.11.037; RaucoulesAime M, 1996, BRIT J ANAESTH, V76, P198, DOI 10.1093/bja/76.2.198; Rea RS, 2007, AM J HEALTH-SYST PH, V64, P385, DOI 10.2146/ajhp060014; Reed CC, 2007, J AM COLL SURGEONS, V204, P1048, DOI 10.1016/j.jamcollsurg.2006.12.047; Rood E, 2005, J AM MED INFORM ASSN, V12, P172, DOI 10.1197/jamia.M1598; Rowen M, 2007, CORONARY ARTERY DIS, V18, P405, DOI 10.1097/MCA.0b013e328224bb02; Saager L, 2008, J CARDIOTHOR VASC AN, V22, P377, DOI 10.1053/j.jvca.2007.09.013; Savioli M, 2009, CRIT CARE MED, V37, P424, DOI 10.1097/CCM.0b013e31819542da; Scalea TM, 2007, ANN SURG, V246, P605, DOI 10.1097/SLA.0b013e318155a789; Shaw Geoffrey M, 2006, Crit Care Resusc, V8, P90; Shilo S, 1998, J AM GERIATR SOC, V46, P978, DOI 10.1111/j.1532-5415.1998.tb02752.x; SIMMONS D, 1994, DIABETES EDUCATOR, V20, P422, DOI 10.1177/014572179402000510; Smith A, 2002, J CARDIOTHOR VASC AN, V16, P413, DOI 10.1053/jcan.2002.125151; Smith SM, 2007, DIABETES CARE, V30, P2503, DOI 10.2337/dc07-0865; Wiener RS, 2008, JAMA-J AM MED ASSOC, V300, P933, DOI 10.1001/jama.300.8.933; Subramaniam B, 2009, ANESTHESIOLOGY, V110, P970, DOI 10.1097/ALN.0b013e3181a1005b; Svensson AM, 2005, EUR HEART J, V26, P1255, DOI 10.1093/eurheartj/ehi230; Tamaki M, 2008, DIABETES RES CLIN PR, V81, P296, DOI 10.1016/j.diabres.2008.03.021; Taylor BE, 2006, J AM COLL SURGEONS, V202, P1, DOI 10.1016/j.jamcollsurg.2005.09.015; Theilen Brenda M, 2008, Endocr Pract, V14, P185; Toschlog EA, 2007, J TRAUMA, V62, P1370, DOI 10.1097/TA.0b013e318047b7dc; Treggiari MM, 2008, CRIT CARE, V12, DOI 10.1186/cc6807; Turchin A, 2009, DIABETES CARE, V32, P1153, DOI 10.2337/dc08-2127; Umpierrez GE, 2002, J CLIN ENDOCR METAB, V87, P978, DOI 10.1210/jc.87.3.978; UMPIERREZ GE, COMP TRIAL COMPUTER; Umpierrez GE, 2007, DIABETES CARE, V30, P2181, DOI 10.2337/dc07-0295; Van den Berghe G, 2006, CRIT CARE MED, V34, P612, DOI 10.1097/01.CCM.0000201408.15502.24; Van den Berghe G, 2006, NEW ENGL J MED, V354, P449, DOI 10.1056/NEJMoa052521; Van den Berghe G, 2001, NEW ENGL J MED, V345, P1359, DOI 10.1056/NEJMoa011300; van der Horst ICC, 2003, J AM COLL CARDIOL, V42, P784, DOI 10.1016/S0735-1097(03)00830-1; van Wezel HB, 2006, J CLIN ENDOCR METAB, V91, P4144, DOI 10.1210/jc.2006-1199; Vogelzang M, 2008, INTENS CARE MED, V34, P1421, DOI 10.1007/s00134-008-1091-y; Vogelzang Mathijs, 2005, BMC Med Inform Decis Mak, V5, P38, DOI 10.1186/1472-6947-5-38; Vriesendorp TM, 2006, CRIT CARE MED, V34, P96, DOI 10.1097/01.CCM.0000194536.89694.06; Walters MR, 2006, CEREBROVASC DIS, V22, P116, DOI 10.1159/000093239; Whitmer RA, 2009, JAMA-J AM MED ASSOC, V301, P1565, DOI 10.1001/jama.2009.460; Wilson M, 2007, DIABETES CARE, V30, P1005, DOI 10.2337/dc06-1964; Wong XW, 2006, MED ENG PHYS, V28, P665, DOI 10.1016/j.medengphy.2005.10.015; Yang M, 2009, INT J NURS STUD, V46, P753, DOI 10.1016/j.ijnurstu.2009.01.004; Zerr KJ, 1997, ANN THORAC SURG, V63, P356; Zimmerman CR, 2004, ANN PHARMACOTHER, V38, P1123, DOI 10.1345/aph.1E018	141	136	145	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4					268	W89		10.7326/0003-4819-154-4-201102150-00008	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-00008			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720VF	21320942				2022-12-28	WOS:000287310000019
J	Ramakrishnan, V				Ramakrishnan, V.			The Eukaryotic Ribosome	SCIENCE			English	Editorial Material							TRANSLATION INITIATION; INTERMEDIATE STATES; TRANSFER-RNA; MECHANISM		MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Cambridge CB2 0QH, England.	ramak@mrc-lmb.cam.ac.uk		Ramakrishnan, V/0000-0002-4699-2194	MRC [MC_U105184332] Funding Source: UKRI; Medical Research Council [MC_U105184332] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Agirrezabala X, 2008, MOL CELL, V32, P190, DOI 10.1016/j.molcel.2008.10.001; Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19748, DOI 10.1073/pnas.1009999107; Armache JP, 2010, P NATL ACAD SCI USA, V107, P19754, DOI 10.1073/pnas.1010005107; Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Ben-Shem A, 2010, SCIENCE, V330, P1203, DOI 10.1126/science.1194294; Frank J, 2010, ISR J CHEM, V50, P95, DOI 10.1002/ijch.201000010; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Julian P, 2008, P NATL ACAD SCI USA, V105, P16924, DOI 10.1073/pnas.0809587105; MOAZED D, 1989, NATURE, V342, P142, DOI 10.1038/342142a0; Rabl J, 2011, SCIENCE, V331, P730, DOI 10.1126/science.1198308; Schmeing TM, 2009, NATURE, V461, P1234, DOI 10.1038/nature08403; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Zhang W, 2009, SCIENCE, V325, P1014, DOI 10.1126/science.1175275	14	16	16	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					681	682		10.1126/science.1202093	http://dx.doi.org/10.1126/science.1202093			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21310988				2022-12-28	WOS:000287205700032
J	Green, ED; Guyer, MS				Green, Eric D.; Guyer, Mark S.		Natl Human Genome Res Inst	Charting a course for genomic medicine from base pairs to bedside	NATURE			English	Article							ABL TYROSINE KINASE; AMERICAN SOCIETY; MYELOID-LEUKEMIA; WIDE ASSOCIATION; GENE-MUTATIONS; DISEASE; INFORMATION; AUTOPHAGY; CARE; RISK	There has been much progress in genomics in the ten years since a draft sequence of the human genome was published. Opportunities for understanding health and disease are now unprecedented, as advances in genomics are harnessed to obtain robust foundational knowledge about the structure and function of the human genome and about the genetic contributions to human health and disease. Here we articulate a 2011 vision for the future of genomics research and describe the path towards an era of genomic medicine.	[Green, Eric D.; Guyer, Mark S.] NHGRI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Green, ED (corresponding author), NHGRI, NIH, 31 Ctr Dr, Bethesda, MD 20892 USA.	egreen@nhgri.nih.gov						Alexander RP, 2010, NAT REV GENET, V11, P559, DOI 10.1038/nrg2814; Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Angiolillo DJ, 2006, ARTERIOSCL THROM VAS, V26, P1895, DOI 10.1161/01.ATV.0000223867.25324.1a; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; Berg K, 2005, AM J HUM GENET, V77, P519; Berglund L, 2008, MOL CELL PROTEOMICS, V7, P2019, DOI 10.1074/mcp.R800013-MCP200; Bernstein BE, 2010, NAT BIOTECHNOL, V28, P1045, DOI 10.1038/nbt1010-1045; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bjorling E, 2008, MOL CELL PROTEOMICS, V7, P2028, DOI 10.1074/mcp.M800264-MCP200; Brest P, 2010, CURR MOL MED, V10, P486, DOI 10.2174/156652410791608252; Brooke BS, 2008, NEW ENGL J MED, V358, P2787, DOI 10.1056/NEJMoa0706585; Brufsky A, 2010, AM J CLIN ONCOL-CANC, V33, P186, DOI 10.1097/COC.0b013e318191bfb0; Buntin MB, 2010, HEALTH AFFAIR, V29, P1214, DOI 10.1377/hlthaff.2010.0503; Burke W, 2010, PUBLIC HEALTH GENOM, V13, P215, DOI 10.1159/000279623; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Caskey CT, 2010, ANNU REV MED, V61, P1, DOI 10.1146/annurev-med-011209-132719; Chan JNY, 2010, TRENDS PHARMACOL SCI, V31, P82, DOI 10.1016/j.tips.2009.11.002; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Collins FS, 2003, NATURE, V422, P835, DOI 10.1038/nature01626; Collins FS, 2004, NATURE, V429, P475, DOI 10.1038/nature02628; Contreras JL, 2010, SCIENCE, V329, P393, DOI 10.1126/science.1189253; Couzin-Frankel J, 2010, SCIENCE, V328, P558, DOI 10.1126/science.328.5978.558; D'Hulst C, 2009, J MED GENET, V46, P577, DOI 10.1136/jmg.2008.064667; Del Fiol Guilherme, 2006, AMIA Annu Symp Proc, P904; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Dietz HC, 2010, NEW ENGL J MED, V363, P852, DOI 10.1056/NEJMra0907180; Druker BJ, 2001, NEW ENGL J MED, V344, P1038, DOI 10.1056/NEJM200104053441402; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; DULBECCO R, 1986, SCIENCE, V231, P1055, DOI 10.1126/science.3945817; Ewing SWF, 2009, ADDICT BIOL, V14, P356, DOI 10.1111/j.1369-1600.2009.00149.x; Feinberg AP, 2010, NAT BIOTECHNOL, V28, P1049, DOI 10.1038/nbt1010-1049; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Freedman ML, 2006, P NATL ACAD SCI USA, V103, P14068, DOI 10.1073/pnas.0605832103; Frueh FW, 2008, PHARMACOTHERAPY, V28, P992, DOI 10.1592/phco.28.8.992; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Goetz MP, 2007, BREAST CANCER RES TR, V101, P113, DOI 10.1007/s10549-006-9428-0; Grasemann H, 2010, EXPERT OPIN EMERG DR, V15, P653, DOI 10.1517/14728214.2010.517746; Gulcher JR, 2000, NEW ENGL J MED, V342, P1827, DOI 10.1056/NEJM200006153422411; Harris L, 2007, J CLIN ONCOL, V25, P5287, DOI 10.1200/JCO.2007.14.2364; Henderson GE, 2007, PLOS MED, V4, P1735, DOI 10.1371/journal.pmed.0040324; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hiraki S, 2010, OBSTET GYN CLIN N AM, V37, P11, DOI 10.1016/j.ogc.2010.01.002; Hudson KL, 2008, NEW ENGL J MED, V358, P2661, DOI 10.1056/NEJMp0803964; Hudson TJ, 2010, NATURE, V464, P993, DOI 10.1038/nature08987; Jain KK, 2007, CLIN CHEM, V53, P2002, DOI 10.1373/clinchem.2007.090795; Kao WHL, 2008, NAT GENET, V40, P1185, DOI 10.1038/ng.232; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Kohane IS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000809; Kuczynski J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-210; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Levy PA, 2010, J DEV BEHAV PEDIATR, V31, P622, DOI 10.1097/DBP.0b013e3181eedf01; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Loukides G, 2010, P NATL ACAD SCI USA, V107, P7898, DOI 10.1073/pnas.0911686107; Ludman EJ, 2010, J EMPIR RES HUM RES, V5, P9, DOI 10.1525/jer.2010.5.3.9; Mailman MD, 2007, NAT GENET, V39, P1181, DOI 10.1038/ng1007-1181; Manolio TA, 2010, JAMA-J AM MED ASSOC, V304, P2290, DOI 10.1001/jama.2010.1686; Manolio TA, 2010, NEW ENGL J MED, V363, P166, DOI 10.1056/NEJMra0905980; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Margulies EH, 2007, GENOME RES, V17, P760, DOI 10.1101/gr.6034307; McBride CM, 2010, AM J PREV MED, V38, P556, DOI 10.1016/j.amepre.2010.01.027; McGuire AL, 2008, NAT REV GENET, V9, P152, DOI 10.1038/nrg2302; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyerson M, 2010, NAT REV GENET, V11, P685, DOI 10.1038/nrg2841; Miller DT, 2010, AM J HUM GENET, V86, P749, DOI 10.1016/j.ajhg.2010.04.006; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Murphy S, 2009, GENOME RES, V19, P1675, DOI 10.1101/gr.094615.109; Murphy SN, 2010, J AM MED INFORM ASSN, V17, P124, DOI 10.1136/jamia.2009.000893; Natl. Res. Council, 1988, MAPP SEQ HUM GEN; Need AC, 2009, TRENDS GENET, V25, P489, DOI 10.1016/j.tig.2009.09.012; Oita I, 2010, ANAL BIOANAL CHEM, V398, P239, DOI 10.1007/s00216-010-3857-7; Paik S, 2004, NEW ENGL J MED, V351, P2817, DOI 10.1056/NEJMoa041588; Panel on antiretroviral guidelines for adults and adolescents, 2009, GUID US ANT AG HIV 1, P1, DOI DOI 10.1111/J.1468-1293.2008.00636.X; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Ramos E, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-29; Rieder MJ, 2005, NEW ENGL J MED, V352, P2285, DOI 10.1056/NEJMoa044503; Rioux JD, 2007, NAT GENET, V39, P596, DOI 10.1038/ng2032; Ritchie MD, 2010, AM J HUM GENET, V86, P560, DOI 10.1016/j.ajhg.2010.03.003; Robinson CJ, 2010, MICROBIOL MOL BIOL R, V74, P453, DOI 10.1128/MMBR.00014-10; Rotimi CN, 2010, NEW ENGL J MED, V363, P1551, DOI 10.1056/NEJMra0911564; Roy S, 2010, SCIENCE, V330, P1787, DOI 10.1126/science.1198374; Sankar P, 2004, JAMA-J AM MED ASSOC, V291, P2985, DOI 10.1001/jama.291.24.2985; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Shiwaku K, 2003, INT J OBESITY, V27, P1028, DOI 10.1038/sj.ijo.0802375; Simon R, 2008, CLIN CANCER RES, V14, P5984, DOI 10.1158/1078-0432.CCR-07-4531; Smushkin G, 2010, CURR OPIN CLIN NUTR, V13, P471, DOI 10.1097/MCO.0b013e32833a558d; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stein LD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-207; Stover PJ, 2010, CURR OPIN LIPIDOL, V21, P136, DOI 10.1097/MOL.0b013e3283377395; Stuart D, 2009, CURR OPIN CELL BIOL, V21, P304, DOI 10.1016/j.ceb.2009.02.001; Thorisson GA, 2003, NUCLEIC ACIDS RES, V31, P124, DOI 10.1093/nar/gkg052; Toronto Int Data Release Workshop, 2009, NATURE, V461, P168, DOI 10.1038/461168a; Tozzi V, 2010, ANTIVIR RES, V85, P190, DOI 10.1016/j.antiviral.2009.09.001; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Van Limbergen J, 2009, ANNU REV GENOM HUM G, V10, P89, DOI 10.1146/annurev-genom-082908-150013; Wolf SM, 2008, J LAW MED ETHICS, V36, P219, DOI 10.1111/j.1748-720X.2008.00266.x; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710	103	617	633	1	89	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					204	213		10.1038/nature09764	http://dx.doi.org/10.1038/nature09764			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307933	Bronze			2022-12-28	WOS:000287144200034
J	Yao, JC; Shah, MH; Ito, T; Bohas, CL; Wolin, EM; Van Cutsem, E; Hobday, TJ; Okusaka, T; Capdevila, J; de Vries, EGE; Tomassetti, P; Pavel, ME; Hoosen, S; Haas, T; Lincy, J; Lebwohl, D; Oberg, K				Yao, James C.; Shah, Manisha H.; Ito, Tetsuhide; Bohas, Catherine Lombard; Wolin, Edward M.; Van Cutsem, Eric; Hobday, Timothy J.; Okusaka, Takuji; Capdevila, Jaume; de Vries, Elisabeth G. E.; Tomassetti, Paola; Pavel, Marianne E.; Hoosen, Sakina; Haas, Tomas; Lincy, Jeremie; Lebwohl, David; Oberg, Kjell		RAD001 Adv Neuroendocrine Tumors T	Everolimus for Advanced Pancreatic Neuroendocrine Tumors.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ISLET-CELL-CARCINOMA; ANTITUMOR-ACTIVITY; ENDOCRINE TUMORS; SOLID TUMORS; PHASE-II; STREPTOZOCIN; DOXORUBICIN; FLUOROURACIL; COMBINATION; EFFICACY	Background: Everolimus, an oral inhibitor of mammalian target of rapamycin (mTOR), has shown antitumor activity in patients with advanced pancreatic neuroendocrine tumors, in two phase 2 studies. We evaluated the agent in a prospective, randomized, phase 3 study. Methods: We randomly assigned 410 patients who had advanced, low-grade or intermediate-grade pancreatic neuroendocrine tumors with radiologic progression within the previous 12 months to receive everolimus, at a dose of 10 mg once daily (207 patients), or placebo (203 patients), both in conjunction with best supportive care. The primary end point was progression-free survival in an intention-to-treat analysis. In the case of patients in whom radiologic progression occurred during the study, the treatment assignments could be revealed, and patients who had been randomly assigned to placebo were offered open-label everolimus. Results: The median progression-free survival was 11.0 months with everolimus as compared with 4.6 months with placebo (hazard ratio for disease progression or death from any cause with everolimus, 0.35; 95% confidence interval [CI], 0.27 to 0.45; P<0.001), representing a 65% reduction in the estimated risk of progression or death. Estimates of the proportion of patients who were alive and progression-free at 18 months were 34% (95% CI, 26 to 43) with everolimus as compared with 9% (95% CI, 4 to 16) with placebo. Drug-related adverse events were mostly grade 1 or 2 and included stomatitis (in 64% of patients in the everolimus group vs. 17% in the placebo group), rash (49% vs. 10%), diarrhea (34% vs. 10%), fatigue (31% vs. 14%), and infections (23% vs. 6%), which were primarily upper respiratory. Grade 3 or 4 events that were more frequent with everolimus than with placebo included anemia (6% vs. 0%) and hyperglycemia (5% vs. 2%). The median exposure to everolimus was longer than exposure to placebo by a factor of 2.3 (38 weeks vs. 16 weeks). Conclusions: Everolimus, as compared with placebo, significantly prolonged progression-free survival among patients with progressive advanced pancreatic neuroendocrine tumors and was associated with a low rate of severe adverse events. (Funded by Novartis Oncology; RADIANT-3 ClinicalTrials.gov number, NCT00510068.) N Engl J Med 2011;364:514-23.	[Yao, James C.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Shah, Manisha H.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Ito, Tetsuhide] Kyushu Univ, Grad Sch Med Sci, Fukuoka 812, Japan; [Bohas, Catherine Lombard] Hosp Civils Lyon, Hop Edouard Herriot, Lyon, France; [Wolin, Edward M.] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Van Cutsem, Eric] Univ Hosp Gasthuisberg, B-3000 Louvain, Belgium; [Hobday, Timothy J.] Mayo Clin, Rochester, MN USA; [Okusaka, Takuji] Natl Canc Ctr, Tokyo, Japan; [Capdevila, Jaume] Vall dHebron Univ Hosp, Barcelona, Spain; [de Vries, Elisabeth G. E.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Tomassetti, Paola] Univ Hosp St Orsola, Bologna, Italy; [Pavel, Marianne E.] Charite, D-13353 Berlin, Germany; [Hoosen, Sakina; Haas, Tomas; Lincy, Jeremie; Lebwohl, David] Novartis Oncol, Florham Pk, NJ USA; [Oberg, Kjell] Univ Uppsala Hosp, Uppsala, Sweden	University of Texas System; UTMD Anderson Cancer Center; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Kyushu University; CHU Lyon; Cedars Sinai Medical Center; KU Leuven; University Hospital Leuven; Mayo Clinic; National Cancer Center - Japan; Hospital Universitari Vall d'Hebron; University of Groningen; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Novartis; Uppsala University; Uppsala University Hospital	Yao, JC (corresponding author), Univ Texas MD Anderson Canc Ctr, 1515 Holcombe Blvd,Box 426, Houston, TX 77030 USA.	jyao@mdanderson.org	Oberg, Kjell/AAG-7118-2019; Van+Cutsem, Eric/ABE-1762-2021	de Vries, Elisabeth/0000-0002-8949-7425	Novartis Oncology; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER	Novartis Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by Novartis Oncology.	Bajetta Emilio, 2003, Expert Rev Anticancer Ther, V3, P631, DOI 10.1586/14737140.3.5.631; BRODER LE, 1973, ANN INTERN MED, V79, P108, DOI 10.7326/0003-4819-79-1-108; Bushnell W, 2009, C CLIN CANC RES WASH; Cheng PNM, 1999, CANCER, V86, P944, DOI 10.1002/(SICI)1097-0142(19990915)86:6<944::AID-CNCR8>3.3.CO;2-G; CHERNICOFF D, 1979, CANCER TREAT REP, V63, P795; Delaunoit T, 2004, EUR J CANCER, V40, P515, DOI 10.1016/j.ejca.2003.09.035; Jensen RI, 2008, CANCER-AM CANCER SOC, V113, P1807, DOI 10.1002/cncr.23648; Kouvaraki MA, 2004, J CLIN ONCOL, V22, P4762, DOI 10.1200/JCO.2004.04.024; McCollum AD, 2004, AM J CLIN ONCOL-CANC, V27, P485, DOI 10.1097/01.coc.0000135343.06038.eb; Missiaglia E, 2010, J CLIN ONCOL, V28, P245, DOI 10.1200/JCO.2008.21.5988; MOERTEL CG, 1992, NEW ENGL J MED, V326, P519, DOI 10.1056/NEJM199202203260804; MOERTEL CG, 1980, NEW ENGL J MED, V303, P1189, DOI 10.1056/NEJM198011203032101; Moreno A, 2008, ENDOCR-RELAT CANCER, V15, P257, DOI 10.1677/ERC-07-0202; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; O'Donnell A, 2008, J CLIN ONCOL, V26, P1588, DOI 10.1200/JCO.2007.14.0988; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Ramanathan RK, 2001, ANN ONCOL, V12, P1139, DOI 10.1023/A:1011632713360; Raymond E, 2011, NEW ENGL J MED, V364, P501, DOI 10.1056/NEJMoa1003825; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; von Wichert G, 2000, CANCER RES, V60, P4573; Yao JC, 2008, J CLIN ONCOL, V26, P4311, DOI 10.1200/JCO.2008.16.7858; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Yao JC, 2007, ANN SURG ONCOL, V14, P3492, DOI 10.1245/s10434-007-9566-6; Yao JC, 2010, J CLIN ONCOL, V28, P69, DOI 10.1200/JCO.2009.24.2669; Yao JC, 2008, CANC PRINCIPLES PRAC, P1702	25	2030	2127	3	94	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2011	364	6					514	523		10.1056/NEJMoa1009290	http://dx.doi.org/10.1056/NEJMoa1009290			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718QH	21306238	Green Accepted			2022-12-28	WOS:000287139900005
J	Hansen, CJ; Bourke, M; Bridges, NT; Byrne, S; Colon, C; Diniega, S; Dundas, C; Herkenhoff, K; McEwen, A; Mellon, M; Portyankina, G; Thomas, N				Hansen, C. J.; Bourke, M.; Bridges, N. T.; Byrne, S.; Colon, C.; Diniega, S.; Dundas, C.; Herkenhoff, K.; McEwen, A.; Mellon, M.; Portyankina, G.; Thomas, N.			Seasonal Erosion and Restoration of Mars' Northern Polar Dunes	SCIENCE			English	Article							SUBLIMATION-DRIVEN ACTIVITY; HIRISE OBSERVATIONS; DEPOSITS	Despite radically different environmental conditions, terrestrial and martian dunes bear a strong resemblance, indicating that the basic processes of saltation and grainfall (sand avalanching down the dune slipface) operate on both worlds. Here, we show that martian dunes are subject to an additional modification process not found on Earth: springtime sublimation of Mars' CO2 seasonal polar caps. Numerous dunes in Mars' north polar region have experienced morphological changes within a Mars year, detected in images acquired by the High-Resolution Imaging Science Experiment on the Mars Reconnaissance Orbiter. Dunes show new alcoves, gullies, and dune apron extension. This is followed by remobilization of the fresh deposits by the wind, forming ripples and erasing gullies. The widespread nature of these rapid changes, and the pristine appearance of most dunes in the area, implicates active sand transport in the vast polar erg in Mars' current climate.	[Hansen, C. J.; Bourke, M.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Bourke, M.] Univ Oxford, Sch Geog & Environm, Oxford OX1 3QY, England; [Bridges, N. T.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 20723 USA; [Byrne, S.; Dundas, C.; McEwen, A.] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Colon, C.] Rutgers State Univ, Dept Earth & Environm Sci, Newark, NJ 07102 USA; [Diniega, S.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Herkenhoff, K.] US Geol Survey, Flagstaff, AZ 86001 USA; [Mellon, M.] Univ Colorado, Lab Atmospher & Space Phys, Boulder, CO 80309 USA; [Portyankina, G.; Thomas, N.] Univ Bern, Space Res & Planetol Div, CH-0132 Bern, Switzerland	University of Oxford; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Arizona; Rutgers State University Newark; Rutgers State University New Brunswick; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); United States Department of the Interior; United States Geological Survey; University of Colorado System; University of Colorado Boulder; University of Bern	Hansen, CJ (corresponding author), Planetary Sci Inst, Tucson, AZ 85719 USA.	cjhansen@psi.edu	Byrne, Shane/B-8104-2012; Bridges, Nathan T/D-6341-2016; Bourke, Mary/I-4387-2012; Mellon, Michael/C-3456-2016	Bourke, Mary/0000-0002-0424-0322; Dundas, Colin/0000-0003-2343-7224	Jet Propulsion Laboratory, California Institute of Technology; NASA	Jet Propulsion Laboratory, California Institute of Technology; NASA(National Aeronautics & Space Administration (NASA))	This work was partially supported by the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA.	Aharonson O., 2004, 35 LUN PLAN SCI C 15; Balme M, 2008, GEOMORPHOLOGY, V101, P703, DOI 10.1016/j.geomorph.2008.03.011; Bourke MC, 2008, GEOMORPHOLOGY, V94, P247, DOI 10.1016/j.geomorph.2007.05.012; Bourke M. C., 2009, P LUNAR PLANET SCI C, V40, P1748; CUTTS JA, 1973, J GEOPHYS RES, V78, P4139, DOI 10.1029/JB078i020p04139; Diniega S, 2010, GEOLOGY, V38, P1047, DOI 10.1130/G31287.1; Dundas C. M., 2009, GEOPHYS RES LETT, V37; Gardin E, 2010, J GEOPHYS RES-PLANET, V115, DOI 10.1029/2009JE003515; Hansen C., 2010, P LUNAR PLANET SCI C, V41, P1533; Hansen CJ, 2010, ICARUS, V205, P283, DOI 10.1016/j.icarus.2009.07.021; Hansen C. J., 2008, B AM ASTRON SOC, V40, P409; Hayward RK, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2007JE002943; Kereszturi A, 2010, ICARUS, V207, P149, DOI 10.1016/j.icarus.2009.10.012; Kereszturi A, 2009, ICARUS, V201, P492, DOI 10.1016/j.icarus.2009.01.014; Kieffer H. H., 2000, LUNAR PLANETARY I CO, P1057; Kieffer HH, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2006JE002816; Malin M. C., 2005, NASA JPL PLANETARY P; Malin MC, 2001, J GEOPHYS RES-PLANET, V106, P23429, DOI 10.1029/2000JE001455; Matsuo K, 2009, ICARUS, V202, P90, DOI 10.1016/j.icarus.2009.02.023; MCCAULEY JF, 1972, ICARUS, V17, P289, DOI 10.1016/0019-1035(72)90003-6; McEwen AS, 2007, J GEOPHYS RES-PLANET, V112, DOI 10.1029/2005JE002605; Mellon MT, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003417; Mohlmann D, 2010, ICARUS, V207, P654, DOI 10.1016/j.icarus.2010.01.002; Piqueux S, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2002JE002007; Piqueux S, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003009; Portyankina G, 2010, ICARUS, V205, P311, DOI 10.1016/j.icarus.2009.08.029; Putzig N., 2010, P LUNAR PLANET SCI C, V41, P1533; Schatz V, 2006, J GEOPHYS RES-PLANET, V111, DOI 10.1029/2005JE002514; Silvestro S., 2010, 2 INT DUN C LPI CONT, V1552, P65; Thomas N, 2010, ICARUS, V205, P296, DOI 10.1016/j.icarus.2009.05.030; TSOAR H, 1979, J GEOPHYS RES, V84, P8167, DOI 10.1029/JB084iB14p08167; WARD AW, 1983, ICARUS, V55, P420, DOI 10.1016/0019-1035(83)90112-4	32	117	118	0	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					575	578		10.1126/science.1197636	http://dx.doi.org/10.1126/science.1197636			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292976				2022-12-28	WOS:000286933600051
J	Kim, JJ				Kim, Jane J.			FOCUS ON RESEARCH Weighing the Benefits and Costs of HPV Vaccination of Young Men	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HUMAN-PAPILLOMAVIRUS VACCINATION		Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Kim, JJ (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.							Brisson M, 2009, PUBLIC HEALTH GENOM, V12, P343, DOI 10.1159/000214924; Chaturvedi AK, 2010, J ADOLESCENT HEALTH, V46, pS20, DOI 10.1016/j.jadohealth.2010.01.016; Hoy T, 2009, CURR MED RES OPIN, V25, P2343, DOI 10.1185/03007990903136378; Kim JJ, 2010, LANCET INFECT DIS, V10, P845, DOI 10.1016/S1473-3099(10)70219-X; Palefsky JM, 2010, P 26 INT PAP C MONTR	5	22	23	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2011	364	5					393	395		10.1056/NEJMp1012246	http://dx.doi.org/10.1056/NEJMp1012246			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	715LL	21288093				2022-12-28	WOS:000286885900002
J	Prasad, A; Herrmann, J				Prasad, Abhiram; Herrmann, Joerg			CURRENT CONCEPTS Myocardial Infarction Due to Percutaneous Coronary Intervention	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							CREATINE KINASE-MB; TROPONIN-I ELEVATION; LONG-TERM MORTALITY; CARDIAC ENZYME ELEVATION; DRUG-ELUTING STENTS; PROGNOSTIC-SIGNIFICANCE; ADVERSE OUTCOMES; PERIPROCEDURAL MYONECROSIS; INTRAVASCULAR ULTRASOUND; UNIVERSAL DEFINITION		[Prasad, Abhiram] Mayo Clin, Dept Internal Med, Rochester, MN 55905 USA; Mayo Clin, Div Cardiovasc Dis, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Prasad, A (corresponding author), Mayo Clin, Dept Internal Med, 200 1st St SW, Rochester, MN 55905 USA.	prasad.abhiram@mayo.edu		Prasad, Abhiram/0000-0001-9252-5602				Abdelmeguid AE, 1996, CIRCULATION, V94, P1528, DOI 10.1161/01.CIR.94.7.1528; Ajani AE, 2004, AM J CARDIOL, V93, P313, DOI 10.1016/j.amjcard.2003.10.010; Akkerhuis KM, 2002, CIRCULATION, V105, P554, DOI 10.1161/hc0502.104278; Alcock RF, 2010, INT J CARDIOL, V140, P66, DOI 10.1016/j.ijcard.2008.11.005; Andron M, 2008, J INVASIVE CARDIOL, V20, P108; Bahrmann P, 2007, CIRCULATION, V115, P600, DOI 10.1161/CIRCULATIONAHA.106.660779; Bhatt DL, 2009, NEW ENGL J MED, V361, P2330, DOI 10.1056/NEJMoa0908629; Bhatt DL, 2005, CIRCULATION, V112, P906, DOI 10.1161/CIRCULATIONAHA.104.483297; Blankenship JC, 2006, AM J CARDIOL, V97, P1591, DOI 10.1016/j.amjcard.2005.12.050; Brener SJ, 2002, J AM COLL CARDIOL, V40, P1961, DOI 10.1016/S0735-1097(02)02538-X; Brener SJ, 2002, EUR HEART J, V23, P869, DOI 10.1053/euhj.2001.2976; Cai QJ, 2007, AM J CARDIOL, V99, P616, DOI 10.1016/j.amjcard.2006.09.108; Cantor WJ, 2002, J AM COLL CARDIOL, V39, P1738, DOI 10.1016/S0735-1097(02)01877-6; Cavallini C, 2005, EUR HEART J, V26, P1494, DOI 10.1093/eurheartj/ehi173; Cavallini C, 2010, CIRC-CARDIOVASC INTE, V3, P431, DOI 10.1161/CIRCINTERVENTIONS.110.957712; Chaitman BR, 2009, CIRCULATION, V120, P2529, DOI 10.1161/CIRCULATIONAHA.109.913111; Cutlip DE, 2005, CIRCULATION, V112, P916, DOI 10.1161/CIRCULATIONAHA.104.478347; Dangas G, 2002, AM J CARDIOL, V89, P586, DOI 10.1016/S0002-9149(01)02299-8; De Labriolle A, 2009, AM J CARDIOL, V103, P639, DOI 10.1016/j.amjcard.2008.10.044; Di Sciascio G, 2009, J AM COLL CARDIOL, V54, P558, DOI 10.1016/j.jacc.2009.05.028; Ellis SG, 2002, CIRCULATION, V106, P1205, DOI 10.1161/01.CIR.0000028146.71416.2E; Feldman DN, 2009, AM J CARDIOL, V104, P1210, DOI 10.1016/j.amjcard.2009.06.032; Fuchs S, 2000, AM J CARDIOL, V85, P1077, DOI 10.1016/S0002-9149(00)00699-8; Heeschen C, 1999, CIRCULATION, V100, P1509, DOI 10.1161/01.CIR.100.14.1509; Herrmann J, 2002, CIRCULATION, V106, P2180, DOI 10.1161/01.CIR.0000037520.89770.5E; Herrmann J, 2005, EUR HEART J, V26, P2493, DOI 10.1093/eurheartj/ehi455; Herrmann J, 2002, HEART, V87, P549, DOI 10.1136/heart.87.6.549; Herrmann J, 2001, CIRCULATION, V103, P2339; Hong MK, 1999, CIRCULATION, V100, P2400, DOI 10.1161/01.CIR.100.24.2400; Hong YJ, 2009, JACC-CARDIOVASC IMAG, V2, P458, DOI 10.1016/j.jcmg.2008.12.020; Hubacek J, 2009, CAN J CARDIOL, V25, pE42, DOI 10.1016/S0828-282X(09)70483-0; Jang JS, 2008, INT J CARDIOL, V129, P368, DOI 10.1016/j.ijcard.2007.07.125; Jeremias A, 2008, CIRCULATION, V118, P632, DOI 10.1161/CIRCULATIONAHA.107.752428; Jeremias AU, 2004, J AM COLL CARDIOL, V44, P1210, DOI 10.1016/j.jacc.2004.06.051; Kini A, 1999, J AM COLL CARDIOL, V34, P663, DOI 10.1016/S0735-1097(99)00298-3; Kini AS, 2004, AM J CARDIOL, V93, P18, DOI 10.1016/j.amjcard.2003.09.006; Kizer JR, 2003, EUR HEART J, V24, P1314, DOI 10.1016/S0195-668X(03)00258-6; Kong TQ, 1997, JAMA-J AM MED ASSOC, V277, P461, DOI 10.1001/jama.277.6.461; KUGELMASS AD, 1994, AM J CARDIOL, V74, P748, DOI 10.1016/0002-9149(94)90427-8; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Mandadi VR, 2004, AM J CARDIOL, V93, P747, DOI 10.1016/j.amjcard.2003.11.070; Miller WL, 2006, EUR HEART J, V27, P1061, DOI 10.1093/eurheartj/ehi760; Nallamothu BK, 2003, AM J CARDIOL, V91, P1272, DOI 10.1016/S0002-9149(03)00283-2; Natarajan MK, 2004, AM J CARDIOL, V93, P750, DOI 10.1016/j.amjcard.2003.11.069; Nienhuis MB, 2008, CATHETER CARDIO INTE, V71, P318, DOI 10.1002/ccd.21345; Porto I, 2006, CIRCULATION, V114, P662, DOI 10.1161/CIRCULATIONAHA.105.593210; Prasad A, 2008, CIRC-CARDIOVASC INTE, V1, P10, DOI 10.1161/CIRCINTERVENTIONS.108.765610; Prasad A, 2006, J AM COLL CARDIOL, V48, P1765, DOI 10.1016/j.jacc.2006.04.102; Prasad A, 2009, J AM COLL CARDIOL, V54, P477, DOI 10.1016/j.jacc.2009.03.063; Saucedo JF, 2000, J AM COLL CARDIOL, V35, P1134, DOI 10.1016/S0735-1097(00)00513-1; SMITH SC, 2006, CIRCULATION, V113, pE847; Srinivasan M, 2009, CIRCULATION, V119, P1311, DOI 10.1161/CIRCULATIONAHA.108.831453; Stone GW, 2001, CIRCULATION, V104, P642, DOI 10.1161/hc3101.093902; Testa L, 2009, QJM-INT J MED, V102, P369, DOI 10.1093/qjmed/hcp005; Thygesen K, 2007, EUR HEART J, V28, P2525; Uetani T, 2008, EUR HEART J, V29, P1714, DOI 10.1093/eurheartj/ehn248; van Gaal WJ, 2009, INT J CARDIOL, V135, P60, DOI 10.1016/j.ijcard.2008.03.033; Wang TY, 2008, J AM COLL CARDIOL, V51, P2068, DOI 10.1016/j.jacc.2008.01.054	58	191	198	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2011	364	5					453	464		10.1056/NEJMra0912134	http://dx.doi.org/10.1056/NEJMra0912134			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715LL	21288097				2022-12-28	WOS:000286885900010
J	Greaves, SJ; Rose, RA; Oliver, TAA; Glowacki, DR; Ashfold, MNR; Harvey, JN; Clark, IP; Greetham, GM; Parker, AW; Towrie, M; Orr-Ewing, AJ				Greaves, Stuart J.; Rose, Rebecca A.; Oliver, Thomas A. A.; Glowacki, David R.; Ashfold, Michael N. R.; Harvey, Jeremy N.; Clark, Ian P.; Greetham, Gregory M.; Parker, Anthony W.; Towrie, Michael; Orr-Ewing, Andrew J.			Vibrationally Quantum-State-Specific Reaction Dynamics of H Atom Abstraction by CN Radical in Solution	SCIENCE			English	Article							ROOM-TEMPERATURE LIQUIDS; BIMOLECULAR REACTIONS; HCN; RELAXATION; SPECTROSCOPY; COMPLEXES	Solvent collisions can often mask initial disposition of energy to the products of solution-phase chemical reactions. Here, we show with transient infrared absorption spectra obtained with picosecond time resolution that the nascent HCN products of reaction of CN radicals with cyclohexane in chlorinated organic solvents exhibit preferential excitation of one quantum of the C-H stretching mode and up to two quanta of the bending mode. On time scales of approximately 100 to 300 picoseconds, the HCN products undergo relaxation to the vibrational ground state by coupling to the solvent bath. Comparison with reactions of CN radicals with alkanes in the gas phase, known to produce HCN with greater C-H stretch and bending mode excitation (up to two and approximately six quanta, respectively), indicates partial damping of the nascent product vibrational motion by the solvent. The transient infrared spectra therefore probe solvent-induced modifications to the reaction free energy surface and chemical dynamics.	[Greaves, Stuart J.; Rose, Rebecca A.; Oliver, Thomas A. A.; Glowacki, David R.; Ashfold, Michael N. R.; Harvey, Jeremy N.; Orr-Ewing, Andrew J.] Univ Bristol, Sch Chem, Bristol BS8 1TS, Avon, England; [Clark, Ian P.; Greetham, Gregory M.; Parker, Anthony W.; Towrie, Michael] Rutherford Appleton Lab, Cent Laser Facil, Harwell Sci & Technol Facil Council, Didcot OX11 0QX, Oxon, England	University of Bristol; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Orr-Ewing, AJ (corresponding author), Univ Bristol, Sch Chem, Cantocks Close, Bristol BS8 1TS, Avon, England.	a.orr-ewing@bris.ac.uk	Greaves, Stuart/D-9213-2011; Harvey, Jeremy/AAC-6433-2019; Parker, Anthony W./G-5445-2011; Oliver, Tom/A-6432-2012; Harvey, Jeremy N/E-8848-2010	Greaves, Stuart/0000-0002-5238-7150; Harvey, Jeremy/0000-0002-1728-1596; Parker, Anthony W./0000-0003-3094-9762; Harvey, Jeremy N/0000-0002-1728-1596; Towrie, Mike/0000-0002-1305-701X; Orr-Ewing, Andrew/0000-0001-5551-9609; Oliver, Tom/0000-0003-3979-7857; Clark, Ian/0000-0002-0105-4743; ashfold, michael/0000-0001-5762-7048	Science and Technology Facilities Council (STFC); UK Biotechnology and Biological Sciences Research Council (STFC) [ST/501784]; Engineering and Physical Sciences Research Council [EP/G00224X]; Leverhulme Trust; Royal Society; Wolfson Foundation; EPSRC [EP/G00224X/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/G00224X/1] Funding Source: researchfish	Science and Technology Facilities Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)Science and Technology Development Fund (STDF)); UK Biotechnology and Biological Sciences Research Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Leverhulme Trust(Leverhulme Trust); Royal Society(Royal Society of London); Wolfson Foundation; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	Measurements were made at the Central Laser Facility, Rutherford Appleton Laboratory, with financial support for the ULTRA laser complex from the Science and Technology Facilities Council (STFC) and UK Biotechnology and Biological Sciences Research Council (STFC Facility Grant ST/501784). Funding for the Bristol group was provided by the Engineering and Physical Sciences Research Council Programme Grant EP/G00224X. We thank the Leverhulme Trust for an Early Career Research Fellowship (S.J.G.) and the Royal Society and the Wolfson Foundation for a Research Merit Award (A.J.O.E.).	Althorpe SC, 2003, ANNU REV PHYS CHEM, V54, P493, DOI 10.1146/annurev.physchem.54.011002.103750; Bethardy GA, 1996, J CHEM PHYS, V105, P4533, DOI 10.1063/1.472537; BETHARDY GA, 1995, J CHEM PHYS, V102, P7966, DOI 10.1063/1.468995; BOTSCHWINA P, 1983, CHEM PHYS, V81, P73, DOI 10.1016/0301-0104(83)85303-8; Bragg AE, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.233005; Cahoon JF, 2008, SCIENCE, V319, P1820, DOI 10.1126/science.1154041; COPELAND LR, 1992, J CHEM PHYS, V96, P5817, DOI 10.1063/1.462681; Crowther AC, 2008, J PHYS CHEM A, V112, P12081, DOI 10.1021/jp8064079; Crowther AC, 2009, J PHYS CHEM A, V113, P3758, DOI 10.1021/jp8084099; Elles CG, 2006, ANNU REV PHYS CHEM, V57, P273, DOI 10.1146/annurev.physchem.57.032905.104538; Greaves SJ, 2010, PHYS CHEM CHEM PHYS, V12, P9129, DOI 10.1039/c001233e; Greetham GM, 2010, APPL SPECTROSC, V64, P1311, DOI 10.1366/000370210793561673; HERZBERG G, 1945, MOL SPECTRA MOL STRU, pR2; Huang C, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2968547; Levine RD, 2005, MOL REACTION DYNAMIC, DOI 10.1017/CBO9780511614125; Linstrom P. J., NIST STANDARD REFERE; Mohammed OF, 2005, SCIENCE, V310, P83, DOI 10.1126/science.1117756; MORRIS VR, 1994, CHEM PHYS LETT, V220, P448, DOI 10.1016/0009-2614(94)00212-6; Moskun AC, 2006, SCIENCE, V311, P1907, DOI 10.1126/science.1123738; Moskun AC, 2003, J CHEM PHYS, V119, P4500, DOI 10.1063/1.1591726; OWRUTSKY JC, 1994, ANNU REV PHYS CHEM, V45, P519, DOI 10.1146/annurev.pc.45.100194.002511; POLANYI JC, 1972, ACCOUNTS CHEM RES, V5, P161, DOI 10.1021/ar50053a001; RAFTERY D, 1994, J CHEM PHYS, V101, P8572, DOI 10.1063/1.468052; RAFTERY D, 1993, CHEM PHYS LETT, V201, P513, DOI 10.1016/0009-2614(93)85110-A; Sheps L, 2006, J PHYS CHEM A, V110, P3087, DOI 10.1021/jp0543835; Voth GA, 1996, J PHYS CHEM-US, V100, P13034, DOI 10.1021/jp960317e	27	72	73	2	104	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 18	2011	331	6023					1423	1426		10.1126/science.1197796	http://dx.doi.org/10.1126/science.1197796			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	736OM	21292937	Green Submitted			2022-12-28	WOS:000288504000037
J	Cortazar, D; Kunz, C; Selfridge, J; Lettieri, T; Saito, Y; MacDougall, E; Wirz, A; Schuermann, D; Jacobs, AL; Siegrist, F; Steinacher, R; Jiricny, J; Bird, A; Schar, P				Cortazar, Daniel; Kunz, Christophe; Selfridge, Jim; Lettieri, Teresa; Saito, Yusuke; MacDougall, Eilidh; Wirz, Annika; Schuermann, David; Jacobs, Angelika L.; Siegrist, Fredy; Steinacher, Roland; Jiricny, Josef; Bird, Adrian; Schaer, Primo			Embryonic lethal phenotype reveals a function of TDG in maintaining epigenetic stability	NATURE			English	Article							THYMINE-DNA GLYCOSYLASE; BASE-EXCISION; STEM-CELLS; METHYLATION; PROMOTER; REPAIR; GENE; 5-METHYLCYTOSINE; MLL; DEMETHYLATION	Thymine DNA glycosylase (TDG) is a member of the uracil DNA glycosylase (UDG) superfamily of DNA repair enzymes. Owing to its ability to excise thymine when mispaired with guanine, it was proposed to act against the mutability of 5-methylcytosine (5-mC) deamination in mammalian DNA(1). However, TDG was also found to interact with transcription factors(2,3), histone acetyltransferases(4) and de novo DNA methyltransferases(5,6), and it has been associated with DNA demethylation in gene promoters following activation of transcription(7-9), altogether implicating an engagement in gene regulation rather than DNA repair. Here we use a mouse genetic approach to determine the biological function of this multifaceted DNA repair enzyme. We find that, unlike other DNA glycosylases, TDG is essential for embryonic development, and that this phenotype is associated with epigenetic aberrations affecting the expression of developmental genes. Fibroblasts derived from Tdg null embryos (mouse embryonic fibroblasts, MEFs) show impaired gene regulation, coincident with imbalanced histone modification and CpG methylation at promoters of affected genes. TDG associates with the promoters of such genes both in fibroblasts and in embryonic stem cells (ESCs), but epigenetic aberrations only appear upon cell lineage commitment. We show that TDG contributes to the maintenance of active and bivalent chromatin throughout cell differentiation, facilitating a proper assembly of chromatin-modifying complexes and initiating base excision repair to counter aberrant de novo methylation. We thus conclude that TDG-dependent DNA repair has evolved to provide epigenetic stability in lineage committed cells.	[Cortazar, Daniel; Kunz, Christophe; Saito, Yusuke; Wirz, Annika; Schuermann, David; Jacobs, Angelika L.; Steinacher, Roland; Schaer, Primo] Univ Basel, Inst Biochem & Genet, Dept Biomed, CH-4048 Basel, Switzerland; [Selfridge, Jim; MacDougall, Eilidh; Bird, Adrian] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Lettieri, Teresa; Jiricny, Josef] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland; [Siegrist, Fredy] F Hoffmann La Roche Ltd, Global Preclin Safety, Pharmaceut Res, CH-4058 Basel, Switzerland	University of Basel; University of Edinburgh; University of Zurich; Roche Holding	Schar, P (corresponding author), Univ Basel, Inst Biochem & Genet, Dept Biomed, CH-4048 Basel, Switzerland.	primo.schaer@unibas.ch	Schär, Primo/G-5967-2012; Siegrist, Fredy/A-8230-2013; Schuermann, David/AAC-4075-2019	Schär, Primo/0000-0003-1843-6147; Schuermann, David/0000-0003-2904-1378; Kunz, Christophe/0000-0002-0511-3915; Bird, Adrian/0000-0002-8600-0372; SELFRIDGE, JIM/0000-0003-2473-4386; Lettieri, Teresa/0000-0002-3363-9666	Swiss National Science Foundation [3100A0-108436, 3100A0-122574/]; Association For International Cancer Research [01-330]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Association For International Cancer Research	We thank D. Klewe-Nebenius for preparations of mouse primary fibroblast, and F. Mohn and D. Schubeler for discussions and assistance in the setup and evaluation of the ChIP experiments. The work was supported by project grants from the Swiss National Science Foundation (3100A0-108436; 3100A0-122574/) and the Association For International Cancer Research (01-330).	Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; Chen DS, 2003, J BIOL CHEM, V278, P38586, DOI 10.1074/jbc.M304286200; Cheng YY, 2007, BRIT J CANCER, V97, P895, DOI 10.1038/sj.bjc.6603968; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Erfurth FE, 2008, P NATL ACAD SCI USA, V105, P7517, DOI 10.1073/pnas.0800090105; Furuta J, 2006, CANCER RES, V66, P6080, DOI 10.1158/0008-5472.CAN-06-0157; Gallais R, 2007, MOL ENDOCRINOL, V21, P2085, DOI 10.1210/me.2006-0490; Gallinari P, 1996, NATURE, V383, P735, DOI 10.1038/383735a0; Hardeland U, 2000, J BIOL CHEM, V275, P33449, DOI 10.1074/jbc.M005095200; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Kunz C, 2009, PLOS BIOL, V7, P967, DOI 10.1371/journal.pbio.1000091; Li YQ, 2007, NUCLEIC ACIDS RES, V35, P390, DOI 10.1093/nar/gkl1052; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Pasini D, 2010, NUCLEIC ACIDS RES, V38, P4958, DOI 10.1093/nar/gkq244; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Um S, 1998, J BIOL CHEM, V273, P20728, DOI 10.1074/jbc.273.33.20728; Wang PF, 2009, MOL CELL BIOL, V29, P6074, DOI 10.1128/MCB.00924-09; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Yu BD, 1998, P NATL ACAD SCI USA, V95, P10632, DOI 10.1073/pnas.95.18.10632; Zhu B, 2000, P NATL ACAD SCI USA, V97, P5135, DOI 10.1073/pnas.100107597; Zhu B, 2001, P NATL ACAD SCI USA, V98, P5031, DOI 10.1073/pnas.091097298	29	274	283	1	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 17	2011	470	7334					419	U210		10.1038/nature09672	http://dx.doi.org/10.1038/nature09672			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21278727				2022-12-28	WOS:000287409100047
J	Barer, D				Barer, David			B-vitamin supplements did not reduce vascular events in patients with recent stroke or TIA	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							HOMOCYSTEINE		Queen Elizabeth Hosp, Gateshead, England		Barer, D (corresponding author), Queen Elizabeth Hosp, Sheriff Hill, Gateshead, England.		Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328				Armitage JM, 2010, JAMA-J AM MED ASSOC, V303, P2486, DOI 10.1001/jama.2010.840; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015, DOI 10.1001/jama.288.16.2015; Marti-Carvajal AJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006786.pub2	3	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4							JC2-8	10.7326/0003-4819-154-4-201102150-02008	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-02008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720VF	21320935				2022-12-28	WOS:000287310000007
J	Prasad, N; Ghiya, BC; Bumb, RA; Kaushal, H; Saboskar, AA; Lezama-Davila, CM; Salotra, P; Satoskar, AR				Prasad, Neha; Ghiya, Bhikiam C.; Bumb, Ram A.; Kaushal, Himanshu; Saboskar, Anjali A.; Lezama-Davila, Claudio M.; Salotra, Poonam; Satoskar, Abhay R.			Heat, Oriental sore, and HIV	LANCET			English	Editorial Material							LEISHMANIA-TROPICA		[Prasad, Neha; Ghiya, Bhikiam C.; Bumb, Ram A.] SP Med Coll, Dept Dermatol STD & Leprosy, Bikaner, Rajasthan, India; [Kaushal, Himanshu; Salotra, Poonam] Inst Pathol ICMR, New Delhi, India; [Saboskar, Anjali A.; Lezama-Davila, Claudio M.; Satoskar, Abhay R.] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Saboskar, Anjali A.; Lezama-Davila, Claudio M.; Satoskar, Abhay R.] Ohio State Univ, Dept Microbiol, Columbus, OH 43210 USA	Ohio State University; Ohio State University	Bumb, RA (corresponding author), H-3,PBM Hosp Campus, Bikaner, Rajasthan, India.	dr_bumb@rediffmail.com; abhay.satoskar@osumc.edu	Satoskar, Abhay/AAB-7748-2019; Kaushal, Himanshu/AAY-9369-2020	Kaushal, Dr. Himanshu/0000-0003-0935-9039; Salotra, Poonam/0000-0002-4057-4872				Chio CM, 2002, AM J CLIN DERMATOL, V3, P91; MAGILL AJ, 1993, NEW ENGL J MED, V328, P1383, DOI 10.1056/NEJM199305133281904; Niamba P, 2006, ANN DERMATOL VENER, V133, P537, DOI 10.1016/S0151-9638(06)70958-9; Reithinger R, 2005, CLIN INFECT DIS, V40, P1148, DOI 10.1086/428736; Schonian G, 2003, DIAGN MICR INFEC DIS, V47, P349, DOI 10.1016/S0732-8893(03)00093-2	5	15	15	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2011	377	9765					610	610		10.1016/S0140-6736(10)61495-X	http://dx.doi.org/10.1016/S0140-6736(10)61495-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724DQ	21315946				2022-12-28	WOS:000287556700031
J	Matsuoka, RL; Nguyen-Ba-Charvet, KT; Parray, A; Badea, TC; Chedotal, A; Kolodkin, AL				Matsuoka, Ryota L.; Nguyen-Ba-Charvet, Kim T.; Parray, Aijaz; Badea, Tudor C.; Chedotal, Alain; Kolodkin, Alex L.			Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina	NATURE			English	Article							GANGLION-CELLS; PLEXIN-A4; RESPONSES; REQUIREMENT; EXPRESSION; DSCAM	In the vertebrate retina, establishment of precise synaptic connections among distinct retinal neuron cell types is critical for processing visual information and for accurate visual perception. Retinal ganglion cells (RGCs), amacrine cells and bipolar cells establish stereotypic neurite arborization patterns to form functional neural circuits in the inner plexiform layer (IPL)(1-3), a laminar region that is conventionally divided into five major parallel sublaminae(1,2). However, the molecular mechanisms governing distinct retinal subtype targeting to specific sublaminae within the IPL remain to be elucidated. Here we show that the transmembrane semaphorin Sema6A signals through its receptor PlexinA4 (PlexA4) to control lamina-specific neuronal stratification in the mouse retina. Expression analyses demonstrate that Sema6A and PlexA4 proteins are expressed in a complementary fashion in the developing retina: Sema6A in most ON sublaminae and PlexA4 in OFF sublaminae of the IPL. Mice with null mutations in PlexA4 or Sema6A exhibit severe defects in stereotypic lamina-specific neurite arborization of tyrosine hydroxylase (TH)-expressing dopaminergic amacrine cells, intrinsically photosensitive RGCs (ipRGCs) and calbindin-positive cells in the IPL. Sema6A and PlexA4 genetically interact in vivo for the regulation of dopaminergic amacrine cell laminar targeting. Therefore, neuronal targeting to subdivisions of the IPL in the mammalian retina is directed by repulsive transmembrane guidance cues present on neuronal processes.	[Matsuoka, Ryota L.; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Badea, Tudor C.] Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; [Matsuoka, Ryota L.; Badea, Tudor C.; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Nguyen-Ba-Charvet, Kim T.; Parray, Aijaz; Chedotal, Alain] INSERM, UMR S968, Inst Vis, F-75012 Paris, France; [Nguyen-Ba-Charvet, Kim T.; Parray, Aijaz; Chedotal, Alain] Univ Paris 06, UMR S968, Inst Vis, F-75012 Paris, France; [Nguyen-Ba-Charvet, Kim T.; Parray, Aijaz; Chedotal, Alain] CNRS, UMR 7210, Inst Vis, F-75012 Paris, France	Johns Hopkins University; Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Kolodkin, AL (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	kolodkin@jhmi.edu	Chedotal, Alain/F-2750-2017; Nguyen-Ba-Charvet, Kim/J-3507-2017; Matsuoka, Ryota L./K-5439-2019; Badea, Tudor Constantin/B-1654-2018	Chedotal, Alain/0000-0001-7577-3794; Nguyen-Ba-Charvet, Kim/0000-0001-5398-0872; Matsuoka, Ryota L./0000-0001-6214-2889; Badea, Tudor Constantin/0000-0003-3086-6713	Nakajima Foundation; Fondation pour la Recherche Medicale (FRM); Fondation Retina France; Paris School of Neuroscience (ENP);  [R01 NS35165]; NATIONAL EYE INSTITUTE [ZIAEY000504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS035165, R37NS035165] Funding Source: NIH RePORTER	Nakajima Foundation; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); Fondation Retina France; Paris School of Neuroscience (ENP); ; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K.-W. Yau for the C-terminal melanopsin antibody, F. Suto for the PlexA4 antibody, B. Howell for the Dab-1 antibody, Y. Yoshida for the PlexA1<SUP>-/-</SUP> eyes, P. Mombaerts for the PlexB1<SUP>-/-</SUP> and PlexB3<SUP>-/-</SUP> mice (unpublished), C. Gu for the PlexD1<SUP>-/flox</SUP>; nestin cre (unpublished) eyes and M. Tessier-Lavigne for the PlexA4<SUP>-/-</SUP> mice. We also thank J. Nathans, S. Hattar, K. Mandai and M. Riccomagno for comments on the manuscript and discussions, and members of the Kolodkin laboratory for assistance. This work was supported by R01 NS35165 to A. L. K., a predoctoral fellowship from the Nakajima Foundation to R. L. M., the Fondation pour la Recherche Medicale (Programme equipe FRM) to A. C., the Fondation Retina France to K. T. N.-B.-C., and a PhD fellowship from the Paris School of Neuroscience (ENP) to A. P. A. L. K. is an investigator of the Howard Hughes Medical Institute.	Cheng HJ, 2001, NEURON, V32, P249, DOI 10.1016/S0896-6273(01)00478-0; de Winter F, 2004, INVEST OPHTH VIS SCI, V45, P4554, DOI 10.1167/iovs.04-0173; FAMIGLIETTI EV, 1976, SCIENCE, V194, P193, DOI 10.1126/science.959847; Friedel RH, 2007, J NEUROSCI, V27, P3921, DOI 10.1523/JNEUROSCI.4710-06.2007; Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514; Fuerst PG, 2010, GENESIS, V48, P578, DOI 10.1002/dvg.20662; Giger RJ, 2000, NEURON, V25, P29, DOI 10.1016/S0896-6273(00)80869-7; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hattar S, 2002, SCIENCE, V295, P1065, DOI 10.1126/science.1069609; Huberman AD, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001743; Kay JN, 2004, DEVELOPMENT, V131, P1331, DOI 10.1242/dev.01040; Kerjan G, 2005, NAT NEUROSCI, V8, P1516, DOI 10.1038/nn1555; Leighton PA, 2001, NATURE, V410, P174, DOI 10.1038/35065539; Pasterkamp RJ, 2003, NATURE, V424, P398, DOI 10.1038/nature01790; Pires SS, 2009, J NEUROSCI, V29, P12332, DOI 10.1523/JNEUROSCI.2036-09.2009; Rockhill RL, 2000, P NATL ACAD SCI USA, V97, P2303, DOI 10.1073/pnas.030413497; RODIECK RW, 1991, VISUAL NEUROSCI, V6, P95, DOI 10.1017/S095252380001049X; Ruenker AE, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-34; Sanes JR, 2010, NEURON, V66, P15, DOI 10.1016/j.neuron.2010.01.018; Stacy RC, 2003, J COMP NEUROL, V456, P154, DOI 10.1002/cne.10509; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Suto F, 2007, NEURON, V53, P535, DOI 10.1016/j.neuron.2007.01.028; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Viney TJ, 2007, CURR BIOL, V17, P981, DOI 10.1016/j.cub.2007.04.058; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8; Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; Yoshida Y, 2006, NEURON, V52, P775, DOI 10.1016/j.neuron.2006.10.032; Zhang DQ, 2008, P NATL ACAD SCI USA, V105, P14181, DOI 10.1073/pnas.0803893105	30	149	149	0	21	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					259	+		10.1038/nature09675	http://dx.doi.org/10.1038/nature09675			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21270798	Green Accepted			2022-12-28	WOS:000287144200044
J	Jones, CE; Naidoo, S; De Beer, C; Esser, M; Kampmann, B; Hesseling, AC				Jones, Christine E.; Naidoo, Shalena; De Beer, Corena; Esser, Monika; Kampmann, Beate; Hesseling, Anneke C.			Maternal HIV Infection and Antibody Responses Against Vaccine-Preventable Diseases in Uninfected Infants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PNEUMOCOCCAL CONJUGATE VACCINE; PLACENTAL MALARIA; MEASLES-VIRUS; PERTUSSIS ANTIBODIES; CHILD-MORTALITY; IMMUNIZATION; PREVALENCE; MORBIDITY; AVIDITY; SERUM	Context Altered immune responses might contribute to the high morbidity and mortality observed in human immunodeficiency virus (HIV)-exposed uninfected infants. Objective To study the association of maternal HIV infection with maternal-and infant-specific antibody levels to Haemophilus influenzae type b (Hib), pneumococcus, Bordetella pertussis antigens, tetanus toxoid, and hepatitis B surface antigen. Design, Setting, and Participants A community-based cohort study in Khayelitsha, Western Cape Province, South Africa, between March 3, 2009, and April 28, 2010, of 109 HIV-infected and uninfected women and their infants. Serum samples from 104 women and 100 infants were collected at birth and samples from 93 infants were collected at 16 weeks. Main Outcome Measure Level of specific antibody in mother-infant pairs at delivery and in infants at 16 weeks, determined by enzyme-linked immunosorbent assays. Results At birth, HIV-exposed uninfected infants (n=46) had lower levels of specific antibodies than unexposed infants (n=54) did to Hib (0.37 [interquartile range {IQR}, 0.22-0.67] mg/L vs 1.02 [IQR, 0.34-3.79] mg/L; P<.001), pertussis (16.07 [IQR, 8.87-30.43] Food and Drug Administration [FDA] U/mL vs 36.11 [IQR, 20.41-76.28] FDA U/mL; P<.001), pneumococcus (17.24 [IQR, 11.33-40.25] mg/L vs 31.97 [IQR, 18.58-61.80] mg/L; P=.02), and tetanus (0.08 [IQR, 0.03-0.39] IU/mL vs 0.24 [IQR, 0.08-0.92] IU/mL; P=.006). Compared with HIV-uninfected women (n=58), HIV-infected women (n=46) had lower specific antibody levels to Hib (0.67 [IQR, 0.16-1.54] mg/L vs 1.34 [IQR, 0.15-4.82] mg/L; P=.009) and pneumococcus (33.47 [IQR, 4.03-69.43] mg/L vs 50.84 [IQR, 7.40-118.00] mg/L; P=.03); however, no differences were observed for antipertussis or antitetanus antibodies. HIV-exposed uninfected infants (n=38) compared with HIV-unexposed infants (n=55) had robust antibody responses following vaccination, with higher antibody responses to pertussis (270.1 [IQR, 84.4-355.0] FDA U/mL vs 91.7 [IQR, 27.9-168.4] FDA U/mL; P=.006) and pneumoccocus (47.32 [IQR, 32.56-77.80] mg/L vs 14.77 [IQR, 11.06-41.08] mg/L; P=.001). Conclusion Among South African infants, antenatal HIV exposure was associated with lower specific antibody responses in exposed uninfected infants compared with unexposed infants at birth, but with robust responses following routine vaccination. JAMA. 2011; 305(6): 576-584	[Jones, Christine E.; Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Acad Dept Pediat, London W2 1PG, England; [Jones, Christine E.; Kampmann, Beate] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Kampmann, Beate] Med Res Council UK Gambia, Fajara, Gambia; [Naidoo, Shalena; De Beer, Corena; Esser, Monika] Univ Stellenbosch, Dept Pathol, Cape Town, South Africa; [De Beer, Corena; Esser, Monika] Tygerberg Hosp, Natl Hlth Lab Serv, Cape Town, South Africa; [Hesseling, Anneke C.] Univ Stellenbosch, Dept Pediat & Child Hlth, Desmond Tutu TB Ctr, Cape Town, South Africa	Imperial College London; University of Cape Town; University of London; London School of Hygiene & Tropical Medicine; Stellenbosch University; University of Cape Town; Tygerberg Hospital; Stellenbosch University	Jones, CE (corresponding author), Univ London Imperial Coll Sci Technol & Med, Acad Dept Pediat, St Marys Campus,Norfolk Pl, London W2 1PG, England.	christine.jones@imperial.ac.uk	Jones, Chrissie/GXG-4400-2022	Jones, Christine/0000-0003-1523-2368	European Society for Pediatric Infectious Diseases; Thrasher Research Foundation; Wellcome Trust; National Institute for Health Research, England; Elizabeth Glaser Pediatric AIDS Foundation; Medical Research Council [MC_UP_A900_1115, MC_UP_A900_1122] Funding Source: researchfish; MRC [MC_UP_A900_1122, MC_UP_A900_1115] Funding Source: UKRI	European Society for Pediatric Infectious Diseases; Thrasher Research Foundation; Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research, England(National Institute for Health Research (NIHR)); Elizabeth Glaser Pediatric AIDS Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the European Society for Pediatric Infectious Diseases (Dr Jones), the Thrasher Research Foundation (Dr Jones), the Wellcome Trust (Dr Kampmann), National Institute for Health Research, England (Dr Kampmann), and Elizabeth Glaser Pediatric AIDS Foundation (Dr Hesseling).	AGBARAKWE AE, 1995, J CLIN PATHOL, V48, P206, DOI 10.1136/jcp.48.3.206; ALBRECHT P, 1977, J PEDIATR-US, V91, P715, DOI 10.1016/S0022-3476(77)81021-4; [Anonymous], 2007, Wkly Epidemiol Rec, V82, P193; [Anonymous], 2005, Wkly Epidemiol Rec, V80, P279; Bisgard KM, 2004, PEDIATR INFECT DIS J, V23, P985, DOI 10.1097/01.inf.0000145263.37198.2b; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Caceres VM, 2000, CLIN INFECT DIS, V31, P110, DOI 10.1086/313926; *CDCP, 2005, MMWR-MORBID MORTAL W, V54, P1283; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P1050; Cumberland P, 2007, J INFECT DIS, V196, P550, DOI 10.1086/519845; de Moraes-Pinto MI, 1998, ARCH DIS CHILD-FETAL, V79, pF202, DOI 10.1136/fn.79.3.F202; DUCLOS P, 2009, J AM COLL CARDIOL, V9, pS2; Dworkin MS, 2001, CLIN INFECT DIS, V32, P794, DOI 10.1086/319218; ENGLUND JA, 1995, PEDIATRICS, V96, P580; Farquhar C, 2005, JAIDS-J ACQ IMM DEF, V40, P494, DOI 10.1097/01.qai.0000168179.68781.95; Healy CM, 2006, CURR OPIN INFECT DIS, V19, P271, DOI 10.1097/01.qco.0000224822.65599.5b; Healy CM, 2004, J INFECT DIS, V190, P335, DOI 10.1086/421033; Hesseling AC, 2009, B WORLD HEALTH ORGAN, V87, P505, DOI 10.2471/BLT.08.055657; Joint United Nations Programme on HIV/AIDS, 2011, GLOB REP UNAIDS REP; KNUF M, 2008, J PEDIAT, V152, pE1; KNUF M, 2008, J PEDIAT, V152, P660; Knuf M, 2008, J PEDIATR-US, V152, P655, DOI 10.1016/j.jpeds.2007.09.034; Koyanagi A, 2011, PEDIATR INFECT DIS J, V30, P45, DOI 10.1097/INF.0b013e3181ecbf7e; Kuhn L, 2005, CLIN INFECT DIS, V41, P1654, DOI 10.1086/498029; Kurikka S, 1996, PEDIATR INFECT DIS J, V15, P530, DOI 10.1097/00006454-199606000-00011; Madhi SA, 2005, VACCINE, V23, P5517, DOI 10.1016/j.vaccine.2005.07.038; Madhi SA, 2005, PEDIATR INFECT DIS J, V24, P410, DOI 10.1097/01.inf.0000160942.84169.14; Madhi SA, 2010, J INFECT DIS, V202, P355, DOI 10.1086/653704; Marinda E, 2007, PEDIATR INFECT DIS J, V26, P519, DOI 10.1097/01.inf.0000264527.69954.4c; McNally LM, 2007, LANCET, V369, P1440, DOI 10.1016/S0140-6736(07)60670-9; MUSHER DM, 1990, J INFECT DIS, V161, P728, DOI 10.1093/infdis/161.4.728; Nair N, 2009, J INFECT DIS, V200, P1031, DOI 10.1086/605648; Ned RM, 2008, J INFECT DIS, V198, P1609, DOI 10.1086/593066; Nuttall JJ, 2008, INT J INFECT DIS, V12, pE99, DOI 10.1016/j.ijid.2008.06.014; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Plotkin SA, 2008, CLIN INFECT DIS, V47, P401, DOI 10.1086/589862; SARVAS H, 1992, J INFECT DIS, V165, P977, DOI 10.1093/infdis/165.5.977; Scott S, 2005, J INFECT DIS, V191, P1854, DOI 10.1086/429963; Scott S, 2007, CLIN INFECT DIS, V45, P1417, DOI 10.1086/522989; Siegrist CA, 2003, VACCINE, V21, P3406, DOI 10.1016/S0264-410X(03)00342-6; *U CAP TOWN CTR IN, COMPR TB HIV SERV PR; *U CAP TOWN CTR IN, PROV HIV TB CAR PRIM; *WHO, 2006, WKLY EPIDEMIOL REC, V81, P198	43	170	172	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2011	305	6					576	584		10.1001/jama.2011.100	http://dx.doi.org/10.1001/jama.2011.100			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	717XI	21304083				2022-12-28	WOS:000287080500022
J	Edgeworth, JA; Farmer, M; Sicilia, A; Tavares, P; Beck, J; Campbell, T; Lowe, J; Mead, S; Rudge, P; Collinge, J; Jackson, GS				Edgeworth, Julie Ann; Farmer, Michael; Sicilia, Anita; Tavares, Paul; Beck, Jonathan; Campbell, Tracy; Lowe, Jessica; Mead, Simon; Rudge, Peter; Collinge, John; Jackson, Graham S.			Detection of prion infection in variant Creutzfeldt-Jakob disease: a blood-based assay	LANCET			English	Article							TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES; PROTEIN; TRANSFUSION; COMPONENTS; DIAGNOSIS; PATIENT	Background Variant Creutzfeldt-Jakob disease (vCJD) is a fatal neurodegenerative disorder originating from exposure to bovine-spongiform-encephalopathy-like prions. Prion infections are associated with long and clinically silent incubations. The number of asymptomatic individuals with vCJD prion infection is unknown, posing risk to others via blood transfusion, blood products, organ or tissue grafts, and contaminated medical instruments. We aimed to establish the sensitivity and specificity of a blood-based assay for detection of vCJD prion infection. Methods We developed a solid-state binding matrix to capture and concentrate disease-associated prion proteins and coupled this method to direct immunodetection of surface-bound material. Quantitative assay sensitivity was assessed with a serial dilution series of 10(-7) to 10(-10) of vCJD prion-infected brain homogenate into whole human blood, with a baseline control of normal human brain homogenate in whole blood (10(-6)). To establish the sensitivity and specificity of the assay for detection of endogenous vCJD, we analysed a masked panel of 190 whole blood samples from 21 patients with vCJD, 27 with sporadic CJD, 42 with other neurological diseases, and 100 normal controls. Samples were masked and numbered by individuals independent of the assay and analysis. Each sample was tested twice in independent assay runs; only samples that were reactive in both runs were scored as positive overall. Findings We were able to distinguish a 10(-10) dilution of exogenous vCJD prion-infected brain from a 10(-6) dilution of normal brain (mean chemiluminescent signal, 1.3x10(5) [SD 1.1x10(4)] for vCJD vs 9.9x10(4)[4.5x10(3)] for normal brain; p<0.0001)-an assay sensitivity that was orders of magnitude higher than any previously reported. 15 samples in the masked panel were scored as positive. All 15 samples were from patients with vCJD, showing an assay sensitivity for vCJD of 71.4% (95% CI 47.8-88.7) and a specificity of 100% (95% Cis between 97.8% and 100%). Interpretation These initial studies provide a prototype blood test for diagnosis of vCJD in symptomatic individuals, which could allow development of large-scale screening tests for asymptomatic vCJD prion infection.	[Edgeworth, Julie Ann; Farmer, Michael; Sicilia, Anita; Tavares, Paul; Beck, Jonathan; Campbell, Tracy; Lowe, Jessica; Mead, Simon; Collinge, John; Jackson, Graham S.] UCL Inst Neurol, Dept Neurodegenerat Dis, MRC, Prion Unit, London WC1N 3BG, England; [Mead, Simon; Rudge, Peter; Collinge, John] Natl Hosp Neurol & Neurosurg, Natl Prion Clin, London WC1N 3BG, England	University of London; University College London; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Collinge, J (corresponding author), UCL Inst Neurol, Dept Neurodegenerat Dis, MRC, Prion Unit, London WC1N 3BG, England.	j.collinge@prion.ucl.ac.uk; g.s.jackson@prion.ucl.ac.uk	Mead, Simon/E-9414-2011	Mead, Simon/0000-0002-4326-1468; Jackson, Graham/0000-0002-3125-2011	UK Medical Research Council; Department of Health (England); University College London Hospital NHS Foundation Trust; Department of Health's NIHR Biomedical Research Centres; MRC [MC_U123170362, MC_U123160657] Funding Source: UKRI; Medical Research Council [MC_U123160657, MC_U123170362] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health (England); University College London Hospital NHS Foundation Trust; Department of Health's NIHR Biomedical Research Centres(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the patients and families affected by prion and other neurodegenerative diseases for their kind and generous support of these studies; our neurological and other clinical colleagues across the UK for referring patients, particularly colleagues at the National CJD Surveillance Centre in Edinburgh with whom we coordinate patient referral and research under a national protocol; present and past staff of the National Prion Clinic and Dementia Research Centre at the National Hospital for Neurology and Neurosurgery and of the MRC Prion Unit for many years of work collecting, documenting, and curating our sample collections (in particular, we thank Andrew Thompson, Ana Lukic, Chris Carswell, Michelle Gorham, Liz Ford, Imogen Eastwood, Steve Wroe, Daffyd Thomas, Angus Kennedy, Tom Webb, Dune Siddique, Suvankar Pal, Gary Adamson, James Uphill, Mark Poulter, Huda Al-Doujaily, Sabeena Chaudary, Gosala Gopalakrishnan, Nick Fox, Jason Warren, Martin Rossor, Jonathan Rohrer, Natalie Ryan, Colin Mahoney, and Suzie Barker); Paul Bassett of the UCL Biomedical Research Unit for statistical advice and analysis; Ray Young for preparation of the figures; and Jonathan Wadsworth for his critical reading of the report and assistance with preparing the panel of masked samples. This research was funded by the UK Medical Research Council. The Department of Health (England) funds the National Prion Monitoring Cohort study. Some of the work was undertaken at University College London Hospital NHS Foundation Trust, which received a proportion of funding from the Department of Health's NIHR Biomedical Research Centres funding scheme.	BARCIKOWSKA M, 1995, HISTOPATHOLOGY, V26, P445; Brown P, 1999, TRANSFUSION, V39, P1169, DOI 10.1046/j.1537-2995.1999.39111169.x; Brown P, 1998, TRANSFUSION, V38, P810, DOI 10.1046/j.1537-2995.1998.38998408999.x; Clewley JP, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1442; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 1999, LANCET, V354, P317, DOI 10.1016/S0140-6736(99)05128-4; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2006, LANCET, V367, P2068, DOI 10.1016/S0140-6736(06)68930-7; Collinge J, 2009, LANCET NEUROL, V8, P334, DOI 10.1016/S1474-4422(09)70049-3; Cronier S, 2008, BIOCHEM J, V416, P297, DOI 10.1042/BJ20081235; de Marco MF, 2010, J PATHOL, V222, P380, DOI 10.1002/path.2767; Duncan RE, 2005, J MED ETHICS, V31, P625, DOI 10.1136/jme.2005.011965; Edgeworth JA, 2009, P NATL ACAD SCI USA, V106, P3479, DOI 10.1073/pnas.0813342106; Ghani AC, 2002, CR BIOL, V325, P37, DOI 10.1016/S1631-0691(02)01389-6; Gregori L, 2004, LANCET, V364, P529, DOI 10.1016/S0140-6736(04)16812-8; Gregori L, 2006, LANCET, V368, P2226, DOI 10.1016/S0140-6736(06)69897-8; Health Protection Analytical Team Department of Health, 2008, 1006 SEAC DEP HLTH H; Hewitt PE, 2006, VOX SANG, V91, P348, DOI 10.1111/j.1423-0410.2006.00837.x; Hewitt PE, 2006, VOX SANG, V91, P221, DOI 10.1111/j.1423-0410.2006.00833.x; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; Hilton DA, 2004, J PATHOL, V203, P733, DOI 10.1002/path.1580; Llewelyn CA, 2004, LANCET, V363, P417, DOI 10.1016/S0140-6736(04)15486-X; Minor PD, 2004, VOX SANG, V86, P164, DOI 10.1111/j.0042-9007.2004.00411.x; National Prion Clinic, 2009, NATL PRION CLIN; Pastrana MA, 2006, BIOCHEMISTRY-US, V45, P15710, DOI 10.1021/bi0615442; Peden A, 2010, HAEMOPHILIA, V16, P296, DOI 10.1111/j.1365-2516.2009.02181.x; Peden AH, 2004, LANCET, V364, P527, DOI 10.1016/S0140-6736(04)16811-6; Poser S, 1999, BRAIN, V122, P2345, DOI 10.1093/brain/122.12.2345; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Saa P, 2006, SCIENCE, V313, P92, DOI 10.1126/science.1129051; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Spongiform Encephalopathy Advisory Committee, 2010, 1042 SEAC; Spongiform Encephalopathy Advisory Committee, 2008, 1002 SEAC; Tattum MH, 2010, TRANSFUSION, V50, P2619, DOI 10.1111/j.1537-2995.2010.02731.x; Tattum MH, 2010, TRANSFUSION, V50, P996, DOI 10.1111/j.1537-2995.2010.02595.x; Tzaban S, 2002, BIOCHEMISTRY-US, V41, P12868, DOI 10.1021/bi025958g; Wadsworth JDF, 2007, GUT, V56, P90, DOI 10.1136/gut.2006.091637; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4; Wroe SJ, 2006, LANCET, V368, P2061, DOI 10.1016/S0140-6736(06)69835-8; Zerr I, 2009, BRAIN, V132, P2659, DOI 10.1093/brain/awp191; Zobeley E, 1999, MOL MED, V5, P240, DOI 10.1007/BF03402121	41	130	135	0	29	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2011	377	9764					487	493		10.1016/S0140-6736(10)62308-2	http://dx.doi.org/10.1016/S0140-6736(10)62308-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721TX	21295339				2022-12-28	WOS:000287381800029
J	Sundar, S; Sinha, PK; Rai, M; Verma, DK; Nawin, K; Alam, S; Chakravarty, J; Vaillant, M; Verma, N; Pandey, K; Kumari, P; Lal, CS; Arora, R; Sharma, B; Ellis, S; Strub-Wourgaft, N; Balasegaram, M; Olliaro, P; Das, P; Modabber, F				Sundar, Shyam; Sinha, Prabhat Kumar; Rai, Madhukar; Verma, Deepak Kumar; Nawin, Kumar; Alam, Shanawwaj; Chakravarty, Jaya; Vaillant, Michel; Verma, Neena; Pandey, Krishna; Kumari, Poonam; Lal, Chandra Shekhar; Arora, Rakesh; Sharma, Bhawna; Ellis, Sally; Strub-Wourgaft, Nathalie; Balasegaram, Manica; Olliaro, Piero; Das, Pradeep; Modabber, Farrokh			Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial	LANCET			English	Article							LIPOSOMAL AMPHOTERICIN-B; COMBINATION THERAPIES; ORAL MILTEFOSINE; DRUG-RESISTANCE; IN-VITRO; SINGLE; PAROMOMYCIN; DONOVANI	Background Improved treatment approaches are needed for visceral leishmaniasis. We assessed the efficacy and safety of three potential short-course combination treatments compared with the standard monotherapy in India. Methods Standard treatment (1 mg/kg amphotericin B infusion on alternate days for 30 days, total dose 15 mg/kg) was compared with three drug combinations (single injection of 5 mg/kg liposomal amphotericin B and 7-day 50 mg oral miltefosine or single 10-day 11 mg/kg intramuscular paromomycin; or 10 days each of miltefosine and paromomycin) in an open-label, parallel-group, non-inferiority, randomised controlled trial in two hospital sites in Bihar, India. Patients aged 5-60 years with parasitologically confirmed visceral leishmaniasis were randomly assigned one of the four treatments by the trial statistician by use of a computer-generated list. Clinical assessments were done at the end of treatment (15 days on combination treatment; 31 days for standard treatment) and after 45 days and 6 months. The primary endpoint was definitive cure (defined as no sign or symptom of visceral leishmaniasis and parasitologically cured to the last follow-up). Analyses were done both by intention to treat and per protocol. This trial is registered with ClinicalTrials.gov, number NCT00696969. Findings Between June, 2008, and July, 2009, 634 patients were assigned amphotericin B (n=157), liposomal amphotericin B with miltefosine (n=160) or paromomycin (n=158), or miltefosine and paromomycin (n=159). 618 patients were in the per-protocol population. There were two relapses in each group. The numbers with definitive cure at 6 months for the intention-to-treat population were 146 (cure rate 93.0%; CI 87.5-96.3) for amphotericin B, 156 (97.5%; 93.3-99.2) for liposomal amphotericin B and miltefosine, 154 (97.5%; 93.24-99.2) for liposomal amphotericin B and paromomycin, and 157(98-7%; 95.1-99.8) for miltefosine and paromomycin. All combinations were non-inferior to the standard treatment, in both the intention-to-treat and per-protocol populations. Patients in the combination groups had fewer adverse events than did those assigned standard treatment. Interpretation Combination treatments for visceral leishmaniasis are efficacious and safe, and decrease the duration of therapy, thereby encouraging adherence and reducing emergence of drug-resistant parasites.	[Sundar, Shyam; Rai, Madhukar; Verma, Deepak Kumar; Alam, Shanawwaj; Chakravarty, Jaya; Kumari, Poonam; Arora, Rakesh] Banaras Hindu Univ, Inst Med Sci, Dept Med, Kala Azar Med Res Ctr, Varanasi 221005, Uttar Pradesh, India; [Sinha, Prabhat Kumar; Nawin, Kumar; Verma, Neena; Pandey, Krishna; Lal, Chandra Shekhar; Das, Pradeep] Indian Council Med Res, Rajendra Mem Res Inst Med Sci, Patna, Bihar, India; [Vaillant, Michel] Ctr Etud Sante, Ctr Rech Publ Sante, Luxembourg, Luxembourg; [Sharma, Bhawna; Ellis, Sally; Strub-Wourgaft, Nathalie; Balasegaram, Manica; Modabber, Farrokh] Drugs Neglected Dis Initiat, Geneva, Switzerland; [Olliaro, Piero] WHO, WHO Special Programme Res & Training Trop Dis, World Bank, United Nations Dev Programme,UNICEF, CH-1211 Geneva, Switzerland	Banaras Hindu University (BHU); Indian Council of Medical Research (ICMR); ICMR - Rajendra Memorial Research Institute of Medical Sciences (RMRI); Luxembourg Institute of Health; The World Bank; World Health Organization	Sundar, S (corresponding author), 6 SK Gupta Nagar, Varanasi 221005, Uttar Pradesh, India.	drshyamsundar@hotmail.com	vaillant, michel/H-5635-2019	vaillant, michel/0000-0003-4714-8128	Bharat Serum and Vaccine Ltd; Paladin Labs; Institute for One World Health; GlaxoSmithKline; DNDi; Indian Council of Medical Research; Medecins Sans Frontieres; Spanish Agency of International Cooperation for Development; UK Department for International Development; Starr International Foundation in Switzerland	Bharat Serum and Vaccine Ltd; Paladin Labs; Institute for One World Health; GlaxoSmithKline(GlaxoSmithKline); DNDi; Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); Medecins Sans Frontieres; Spanish Agency of International Cooperation for Development; UK Department for International Development; Starr International Foundation in Switzerland	SS has received grant support for clinical trials and travel funds to attend scientific meetings from Paladin Labs, Institute for One World Health, and GlaxoSmithKline, and his institute has received grants from Bharat Serum and Vaccine Ltd. MR has received travel funds from Paladin Labs to attend a scientific meeting. BS, SE, NSW, MS, MB, and FM are employees of, and MV consultant to, the Drugs for Neglected Diseases initiative (DNDi). All other authors declare that they have no conflicts of interest.; We thank B Pecoul, N K Ganguly, S Bhattacharya, M Vray, M Boelaert, S Chang, J Alvar, H Murray, K Weerasuriya, S D Seth, I Ribeiro, and C Royce for their inputs in the concept, protocol design, execution, and review of the manuscript, as well as their support and evaluation of the trial: F Giovannini for assistance in redaction of the manuscript; and P Smith, C P Thakur, R A Pandey, and N K Arora (members of the Data Safety Monitoring Board). This work was jointly supported by DNDi and the Indian Council of Medical Research. We thank Gilead for donating AmBisome used in this study. DNDi would like to thank the following donors for their commitment to the mission and vision of DNDi and for their support of this project, which without their support could not have been accomplished: Medecins Sans Frontieres, the Spanish Agency of International Cooperation for Development, the UK Department for International Development, and the Starr International Foundation in Switzerland. The opinions expressed in this paper are those of the authors and might not reflect those of their employing organisations.	[Anonymous], 2009, RES SUPP EL VISC LEI; Bern C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000599; Chappuis F, 2006, BMJ-BRIT MED J, V333, P723, DOI 10.1136/bmj.38917.503056.7C; CHULAY JD, 1983, AM J TROP MED HYG, V32, P475, DOI 10.4269/ajtmh.1983.32.475; KOHR RL, 1974, J EXP EDUC, V43, P61, DOI 10.1080/00220973.1974.10806305; Laniado-Laborin R, 2009, REV IBEROAM MICOL, V26, P223, DOI 10.1016/j.riam.2009.06.003; Maarouf M, 1998, PARASITE, V5, P167, DOI 10.1051/parasite/1998052167; Meheus F, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000818; Olliaro P, 2009, TROP MED INT HEALTH, V14, P918, DOI 10.1111/j.1365-3156.2009.02306.x; Olliaro PL, 2005, LANCET INFECT DIS, V5, P763, DOI 10.1016/S1473-3099(05)70296-6; Rijal S, 2007, MICROBES INFECT, V9, P529, DOI 10.1016/j.micinf.2007.01.009; Saint-Pierre-Chazalet A, 2009, J ANTIMICROB CHEMOTH, V64, P993, DOI 10.1093/jac/dkp321; Seifert K, 2006, ANTIMICROB AGENTS CH, V50, P73, DOI 10.1128/AAC.50.1.73-79.2006; SUNCLAR S, 2002, CLIN DIEGO LAB IMMUN, V9, P951; Sundar S, 2002, NEW ENGL J MED, V347, P1739, DOI 10.1056/NEJMoa021556; Sundar S, 2001, TROP MED INT HEALTH, V6, P849, DOI 10.1046/j.1365-3156.2001.00778.x; Sundar S, 2001, BRIT MED J, V323, P419, DOI 10.1136/bmj.323.7310.419; SUNDAR S, 1994, BRIT MED J, V308, P307, DOI 10.1136/bmj.308.6924.307; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Sundar S, 2008, CLIN INFECT DIS, V47, P1000, DOI 10.1086/591972; Sundar S, 2007, NEW ENGL J MED, V356, P2571, DOI 10.1056/NEJMoa066536; Sundar S, 2010, NEW ENGL J MED, V362, P504, DOI 10.1056/NEJMoa0903627; Sundar Shyam, 2007, Ther Clin Risk Manag, V3, P733; van Griensven J, 2010, LANCET INFECT DIS, V10, P184, DOI 10.1016/S1473-3099(10)70011-6	24	228	231	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2011	377	9764					477	486		10.1016/S0140-6736(10)62050-8	http://dx.doi.org/10.1016/S0140-6736(10)62050-8			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721TX	21255828				2022-12-28	WOS:000287381800028
J	deMenocal, PB				deMenocal, Peter B.			Climate and Human Evolution	SCIENCE			English	Editorial Material							EAST-AFRICA; PLIOPLEISTOCENE; ECOSYSTEMS; NEOGENE; PERIOD; MA		Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA	Columbia University	deMenocal, PB (corresponding author), Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA.	peter@ldeo.columbia.edu	demenocal, peter/B-1386-2013	demenocal, peter/0000-0002-7191-717X				Blois JL, 2009, ANNU REV EARTH PL SC, V37, P181, DOI 10.1146/annurev.earth.031208.100055; Bobe R, 2004, PALAEOGEOGR PALAEOCL, V207, P399, DOI 10.1016/j.palaeo.2003.09.033; Bobe Rene, 2009, P173, DOI 10.1007/978-1-4020-9980-9_15; Cerling TE, 1992, PALAEOGEOGR PALAEOCL, V97, P241, DOI 10.1016/0031-0182(92)90211-M; Dart RA, 1925, NATURE, V115, P195, DOI 10.1038/115195a0; DARWIN C, 2003, ORIGIN SPECIES MEANS, pCH3; DeConto RM, 2003, NATURE, V421, P245, DOI 10.1038/nature01290; deMenocal P, 2000, QUATERNARY SCI REV, V19, P347, DOI 10.1016/S0277-3791(99)00081-5; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; Feakins SJ, 2005, GEOLOGY, V33, P977, DOI 10.1130/G21814.1; Kingston JD, 2007, YEARB PHYS ANTHROPOL, V50, P20, DOI 10.1002/ajpa.20733; Kingston JD, 2007, J HUM EVOL, V53, P487, DOI 10.1016/j.jhevol.2006.12.007; Lourens LJ, 1996, PALEOCEANOGRAPHY, V11, P391, DOI 10.1029/96PA01125; Maslin Mark A., 2009, P151, DOI 10.1007/978-1-4020-9980-9_13; National Research Council, 2010, UND CLIM INFL HUM EV; Potts R, 1998, YEARB PHYS ANTHROPOL, V41, P93; Reed KE, 1997, J HUM EVOL, V32, P289, DOI 10.1006/jhev.1996.0106; Semaw S, 2003, J HUM EVOL, V45, P169, DOI 10.1016/S0047-2484(03)00093-9; Trauth MH, 2005, SCIENCE, V309, P2051, DOI 10.1126/science.1112964; van Dam JA, 2006, NATURE, V443, P687, DOI 10.1038/nature05163; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P385; Wynn JG, 2004, AM J PHYS ANTHROPOL, V123, P106, DOI 10.1002/ajpa.10317; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	23	159	163	6	96	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					540	542		10.1126/science.1190683	http://dx.doi.org/10.1126/science.1190683			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292958				2022-12-28	WOS:000286933600032
J	Sokol, DK				Sokol, Daniel K.			Ethics Man "Make the care of your patient your first concern"	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Sokol, DK (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	daniel.sokol@talk21.com						General Medical Council, 2006, GOOD MED PRACT; Sokol DK, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b165; Wynia MK, 2000, JAMA-J AM MED ASSOC, V283, P1858, DOI 10.1001/jama.283.14.1858	3	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2011	342								d646	10.1136/bmj.d646	http://dx.doi.org/10.1136/bmj.d646			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	718PU	21289008				2022-12-28	WOS:000287138300002
J	Hankey, GJ				Hankey, Graeme J.			Lowering blood pressure in acute stroke: the SCAST trial	LANCET			English	Editorial Material							CEREBRAL-HEMORRHAGE TRIAL; ISCHEMIC-STROKE; GUIDELINES; MANAGEMENT; REDUCTION; ASSOCIATION; THERAPY		[Hankey, Graeme J.] Royal Perth Hosp, Dept Neurol, Stroke Unit, Perth, WA 6000, Australia; [Hankey, Graeme J.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA 6009, Australia	Royal Perth Hospital; University of Western Australia; University of Western Australia	Hankey, GJ (corresponding author), Royal Perth Hosp, Dept Neurol, Stroke Unit, Perth, WA 6000, Australia.	gjhankey@cyllene.uwa.edu.au	Hankey, Graeme J/H-4968-2014	Hankey, Graeme J/0000-0002-6044-7328				Adams HP, 2007, STROKE, V38, P1655, DOI 10.1161/STROKEAHA.107.181486; Anderson CS, 2008, LANCET NEUROL, V7, P391, DOI 10.1016/S1474-4422(08)70069-3; Aries MJH, 2010, STROKE, V41, P2697, DOI 10.1161/STROKEAHA.110.594168; Delcourt C, 2010, INT J STROKE, V5, P110, DOI 10.1111/j.1747-4949.2010.00415.x; Geeganage C, 2008, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD000039.PUB2; Geeganage C, 2011, STROKE, V42, P491, DOI 10.1161/STROKEAHA.110.596163; Geeganage C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002839.pub2; Hacke W, 2008, CEREBROVASC DIS, V25, P457, DOI 10.1159/000131083; Morgenstern LB, 2010, STROKE, V41, P2108, DOI 10.1161/STR.0b013e3181ec611b; Oliveira J, 2003, NEUROLOGY, V61, P1047, DOI 10.1212/01.WNL.0000092498.75010.57; Potter JF, 2009, LANCET NEUROL, V8, P48, DOI 10.1016/S1474-4422(08)70263-1; Robinson TG, 2010, LANCET NEUROL, V9, P767, DOI 10.1016/S1474-4422(10)70163-0; Sandset EC, 2011, LANCET, V377, P741, DOI 10.1016/S0140-6736(11)60104-9; Schrader J, 2003, STROKE, V34, P1699, DOI 10.1161/01.STR.0000075777.18006.89; Thomas D, 2006, INT J STROKE, V1, P245, DOI 10.1111/j.1747-4949.2006.00059.x	15	11	12	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB-MAR	2011	377	9767					696	698		10.1016/S0140-6736(11)60163-3	http://dx.doi.org/10.1016/S0140-6736(11)60163-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	729JQ	21316753				2022-12-28	WOS:000287946000006
J	Thomsen, L; Frankenhuis, WE; Ingold-Smith, M; Carey, S				Thomsen, Lotte; Frankenhuis, Willem E.; Ingold-Smith, McCaila; Carey, Susan			Big and Mighty: Preverbal Infants Mentally Represent Social Dominance	SCIENCE			English	Article							SIZE	Human infants face the formidable challenge of learning the structure of their social environment. Previous research indicates that infants have early-developing representations of intentional agents, and of cooperative social interactions, that help meet that challenge. Here we report five studies with 144 infant participants showing that 10- to 13-month-old, but not 8-month-old, infants recognize when two novel agents have conflicting goals, and that they use the agents' relative size to predict the outcome of the very first dominance contests between them. These results suggest that preverbal infants mentally represent social dominance and use a cue that covaries with it phylogenetically, and marks it metaphorically across human cultures and languages, to predict which of two agents is likely to prevail in a conflict of goals.	[Thomsen, Lotte; Ingold-Smith, McCaila; Carey, Susan] Harvard Univ, Dept Psychol, Lab Dev Studies, Cambridge, MA 02138 USA; [Thomsen, Lotte] Univ Copenhagen, Dept Psychol, DK-1353 Copenhagen K, Denmark; [Frankenhuis, Willem E.] Univ Calif Los Angeles, Dept Anthropol, Ctr Behav Evolut & Culture, Los Angeles, CA 90095 USA	Harvard University; University of Copenhagen; University of California System; University of California Los Angeles	Thomsen, L (corresponding author), Harvard Univ, Dept Psychol, Lab Dev Studies, William James Hall,33 Kirkland St, Cambridge, MA 02138 USA.	lthomsen@fas.harvard.edu			Harvard University; Winkler Foundation; National Danish Science Foundation; NIH/NICHD [ROI HD038338]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD038338] Funding Source: NIH RePORTER	Harvard University; Winkler Foundation; National Danish Science Foundation; NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research formed part of L.T.'s doctoral dissertation. It was supported by Harvard University and Winkler Foundation dissertation fellowships, together with a postdoctoral fellowship and an early-career award from the National Danish Science Foundation to L.T., and a NIH/NICHD grant (2 ROI HD038338) to S.C. We thank L. Schultz and the MIT Play Lab in the Boston Children's Museum for lending us their lab space; J. Cotton, M. Renno, and B. Walker-Meade for help in data collection; S. Grum-Thomsen for help with graphics; and A. Fiske, J. Sidanius, T. Teasdale, and two anonymous reviewers for helpful feedback on an earlier draft.	Aureli F., 2000, NATURAL CONFLICT RES; BROWN JH, 1986, NATURE, V324, P248, DOI 10.1038/324248a0; Buston P, 2003, NATURE, V424, P145, DOI 10.1038/424145a; Call J, 2004, DEVELOPMENTAL SCI, V7, P488, DOI 10.1111/j.1467-7687.2004.00368.x; Carey S., 2009, ORIGIN CONCEPTS; Clutton-Brock TH, 2006, NATURE, V444, P1065, DOI 10.1038/nature05386; Csibra G, 2003, COGNITIVE SCI, V27, P111, DOI 10.1207/s15516709cog2701_4; DARWIN C, 1982, ORIGIN SPECIES; Fiske A.P., 1991, STRUCTURES SOCIAL LI; Fiske AP, 2004, RELATIONAL MODELS THEORY: CONTEMPORARY OVERVIEW, P61; Fiske AP, 2000, PERS SOC PSYCHOL REV, V4, P76, DOI 10.1207/S15327957PSPR0401_7; Gergely G, 2002, NATURE, V415, P755, DOI 10.1038/415755a; GERGELY G, 1995, COGNITION, V56, P165, DOI 10.1016/0010-0277(95)00661-H; Hamlin JK, 2007, NATURE, V450, P557, DOI 10.1038/nature06288; Johnson SC, 2003, PHILOS T R SOC B, V358, P549, DOI 10.1098/rstb.2002.1237; Kuhlmeier V, 2003, PSYCHOL SCI, V14, P402, DOI 10.1111/1467-9280.01454; Lakoff G., 1980, METAPHORS WE LIVE; McGrew W. C., 1972, ETHOLOGICAL STUDY CH; Melis AP, 2006, SCIENCE, V311, P1297, DOI 10.1126/science.1123007; Over H, 2009, PSYCHOL SCI, V20, P1189, DOI 10.1111/j.1467-9280.2009.02419.x; Phillips W, 2009, DEVELOPMENTAL SCI, V12, P938, DOI 10.1111/j.1467-7687.2009.00840.x; Richerson P. J., 2006, NOT BY GENES ALONE; Saxe R, 2005, PSYCHOL SCI, V16, P995, DOI 10.1111/j.1467-9280.2005.01649.x; Schubert TW, 2008, EMBODIED GROUNDING: SOCIAL, COGNITIVE, AFFECTIVE, AND NEUROSCIENTIFIC APPROACHES, P160; Sidanius J., 1999, SOCIAL DOMINANCE; Silk JB, 2007, SCIENCE, V317, P1347, DOI 10.1126/science.1140734; SLUCKIN AM, 1977, CHILD DEV, V48, P917; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Woodward AL, 1998, COGNITION, V69, P1, DOI 10.1016/S0010-0277(98)00058-4	29	216	218	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					477	480		10.1126/science.1199198	http://dx.doi.org/10.1126/science.1199198			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712BB	21273490	Green Accepted			2022-12-28	WOS:000286635900057
J	Garfield, AS; Cowley, M; Smith, FM; Moorwood, K; Stewart-Cox, JE; Gilroy, K; Baker, S; Xia, J; Dalley, JW; Hurst, LD; Wilkinson, LS; Isles, AR; Ward, A				Garfield, Alastair S.; Cowley, Michael; Smith, Florentia M.; Moorwood, Kim; Stewart-Cox, Joanne E.; Gilroy, Kerry; Baker, Sian; Xia, Jing; Dalley, Jeffrey W.; Hurst, Laurence D.; Wilkinson, Lawrence S.; Isles, Anthony R.; Ward, Andrew			Distinct physiological and behavioural functions for parental alleles of imprinted Grb10	NATURE			English	Article							GENE-EXPRESSION; MOUSE; ACETYLCHOLINE; METHYLATION; DISRUPTION; DOMINANCE; GROWTH; MODEL; LEADS; MICE	Imprinted genes, defined by their preferential expression of a single parental allele, represent a subset of the mammalian genome and often have key roles in embryonic development(1), but also postnatal functions including energy homeostasis(2) and behaviour(3,4). When the two parental alleles are unequally represented within a social group (when there is sex bias in dispersal and/or variance in reproductive success)(5,6), imprinted genes may evolve to modulate social behaviour, although so far no such instance is known. Predominantly expressed from the maternal allele during embryogenesis, Grb10 encodes an intracellular adaptor protein that can interact with several receptor tyrosine kinases and downstream signalling molecules(7). Here we demonstrate that within the brain Grb10 is expressed from the paternal allele from fetal life into adulthood and that ablation of this expression engenders increased social dominance specifically among other aspects of social behaviour, a finding supported by the observed increase in allogrooming by paternal Grb10-deficient animals. Grb10 is, therefore, the first example of an imprinted gene that regulates social behaviour. It is also currently alone in exhibiting imprinted expression from each of the parental alleles in a tissue-specific manner, as loss of the peripherally expressed maternal allele leads to significant fetal and placental overgrowth. Thus Grb10 is, so far, a unique imprinted gene, able to influence distinct physiological processes, fetal growth and adult behaviour, owing to actions of the two parental alleles in different tissues.	[Garfield, Alastair S.; Cowley, Michael; Smith, Florentia M.; Moorwood, Kim; Stewart-Cox, Joanne E.; Hurst, Laurence D.; Ward, Andrew] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Garfield, Alastair S.; Cowley, Michael; Smith, Florentia M.; Moorwood, Kim; Stewart-Cox, Joanne E.; Hurst, Laurence D.; Ward, Andrew] Univ Bath, Ctr Regenerat Med, Bath BA2 7AY, Avon, England; [Garfield, Alastair S.; Gilroy, Kerry; Baker, Sian; Wilkinson, Lawrence S.; Isles, Anthony R.] Cardiff Univ, Sch Med, Neurosci & Mental Hlth Res Inst, MRC,Ctr Neuropsychiat Genet & Genom,Behav Genet G, Cardiff CF14 4XN, S Glam, Wales; [Garfield, Alastair S.; Gilroy, Kerry; Baker, Sian; Wilkinson, Lawrence S.; Isles, Anthony R.] Cardiff Univ, Sch Psychol, Neurosci & Mental Hlth Res Inst, MRC,Ctr Neuropsychiat Genet & Genom,Behav Genet G, Cardiff CF14 4XN, S Glam, Wales; [Xia, Jing; Dalley, Jeffrey W.] Univ Cambridge, Behav & Clin Neurosci Inst, Cambridge CB2 3EB, England; [Xia, Jing; Dalley, Jeffrey W.] Univ Cambridge, Dept Expt Psychol, Cambridge CB2 3EB, England; [Dalley, Jeffrey W.] Univ Cambridge, Addenbrookes Hosp, Dept Psychiat, Cambridge CB2 2QQ, England	University of Bath; University of Bath; Cardiff University; Cardiff University; University of Cambridge; University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Ward, A (corresponding author), Univ Bath, Dept Biol & Biochem, Claverton Down, Bath BA2 7AY, Avon, England.	bssaw@bath.ac.uk	Cowley, Mike/B-9425-2013; Hurst, Laurence/F-9215-2010	Hurst, Laurence/0000-0002-1002-1054; Moorwood, Kim/0000-0003-0943-6161; Dalley, Jeffrey/0000-0002-2282-3660; Isles, Anthony/0000-0002-7587-5712; Garfield, Alastair/0000-0002-9628-6140; Ward, Andrew/0000-0001-8311-5695; Cowley, Michael/0000-0001-8564-4224	Biotechnology and Biological Sciences Research Council; Medical Research Council; Wellcome Trust; Medical Research Council [G0001354B, G0300415, G1000183B, G0001354, G0801418B] Funding Source: researchfish; MRC [G0300415] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank S. Wonnacott for reagents, the University of Bath Biological Services Unit and S. Routley for technical assistance, I. Jones and P. Mitchell for advice and C. Tickle for comments on the manuscript. We acknowledge funding of the work from the Biotechnology and Biological Sciences Research Council, Medical Research Council, Wellcome Trust and external benefactors.	Ainscough JFX, 1997, DEVELOPMENT, V124, P3621; Arnaud P, 2003, HUM MOL GENET, V12, P1005, DOI 10.1093/hmg/ddg110; Bennett WR, 2003, DEVELOPMENT, V130, P1079, DOI 10.1242/dev.00333; Blagitko N, 2000, HUM MOL GENET, V9, P1587, DOI 10.1093/hmg/9.11.1587; Charalambous M, 2003, P NATL ACAD SCI USA, V100, P8292, DOI 10.1073/pnas.1532175100; Charalambous M, 2010, DEV BIOL, V337, P1, DOI 10.1016/j.ydbio.2009.10.011; Dalley JW, 2001, J NEUROSCI, V21, P4908, DOI 10.1523/JNEUROSCI.21-13-04908.2001; Davies W, 2005, NEUROSCI BIOBEHAV R, V29, P421, DOI 10.1016/j.neubiorev.2004.11.007; Doe CM, 2009, HUM MOL GENET, V18, P2140, DOI 10.1093/hmg/ddp137; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Gregg C, 2010, SCIENCE, V329, P643, DOI 10.1126/science.1190830; Haig D, 2000, ANN NY ACAD SCI, V907, P149, DOI 10.1111/j.1749-6632.2000.tb06621.x; Hikichi T, 2003, NUCLEIC ACIDS RES, V31, P1398, DOI 10.1093/nar/gkg232; Holt LJ, 2005, BIOCHEM J, V388, P393, DOI 10.1042/BJ20050216; Isles AR, 2006, PHILOS T R SOC B, V361, P2229, DOI 10.1098/rstb.2006.1942; Isles AR, 2001, NATURE, V409, P783, DOI 10.1038/35057323; Kaplan JR, 2002, NEUROPSYCHOPHARMACOL, V26, P431, DOI 10.1016/S0893-133X(01)00344-X; Keverne B, 2009, BIOESSAYS, V31, P1318, DOI 10.1002/bies.200900074; Kozlov SV, 2007, NAT GENET, V39, P1266, DOI 10.1038/ng2114; Monk D, 2009, HUM MOL GENET, V18, P3066, DOI 10.1093/hmg/ddp248; MORALES MA, 1995, P NATL ACAD SCI USA, V92, P11819, DOI 10.1073/pnas.92.25.11819; Nagy A., 2003, MANIPULATING MOUSE E; Nevison CM, 2003, P ROY SOC B-BIOL SCI, V270, P1957, DOI 10.1098/rspb.2003.2452; Plagge A, 2005, MOL CELL BIOL, V25, P3019, DOI 10.1128/MCB.25.8.3019-3026.2005; Przydzial MJ, 2010, BEHAV BRAIN RES, V206, P313, DOI 10.1016/j.bbr.2009.09.017; RALEIGH MJ, 1991, BRAIN RES, V559, P181, DOI 10.1016/0006-8993(91)90001-C; Reik W, 2001, NAT REV GENET, V2, P21, DOI 10.1038/35047554; Rousseau SJ, 2005, NEUROPHARMACOLOGY, V49, P59, DOI 10.1016/j.neuropharm.2005.01.030; Sanz LA, 2008, EMBO J, V27, P2523, DOI 10.1038/emboj.2008.142; Sarna JR, 2000, BEHAV BRAIN RES, V108, P39, DOI 10.1016/S0166-4328(99)00137-0; Smith FM, 2006, CYTOGENET GENOME RES, V113, P279, DOI 10.1159/000090843; Smith FM, 2007, MOL CELL BIOL, V27, P5871, DOI 10.1128/MCB.02087-06; Spencer CM, 2005, GENES BRAIN BEHAV, V4, P420, DOI 10.1111/j.1601-183X.2005.00123.x; Ubeda F, 2010, EVOLUTION, V64, P2587, DOI 10.1111/j.1558-5646.2010.01015.x; Wolf JB, 2006, PLOS BIOL, V4, P2238, DOI 10.1371/journal.pbio.0040380; Yamasaki-Ishizaki Y, 2007, MOL CELL BIOL, V27, P732, DOI 10.1128/MCB.01329-06	36	141	144	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					534	U101		10.1038/nature09651	http://dx.doi.org/10.1038/nature09651			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270893	Green Accepted			2022-12-28	WOS:000286596500033
J	Sullivan, P; Goldmann, D				Sullivan, Paul; Goldmann, Don			The Promise of Comparative Effectiveness Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLINICAL-TRIALS		[Sullivan, Paul; Goldmann, Don] Inst Healthcare Improvement, Cambridge, MA USA; [Goldmann, Don] Childrens Hosp Boston, Dept Pediat, Boston, MA USA; [Goldmann, Don] Harvard Univ, Sch Med, Boston, MA USA	Institute for Healthcare Improvement; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Sullivan, P (corresponding author), Sallford Royal Fdn Trust, Dept Qual Improvement, Stolt Lane, Salford M6 8HD, Lancs, England.	paul.sullivan@srft.nhs.uk						Berry DA, 2005, STROKE, V36, P1621, DOI 10.1161/01.STR.0000170637.02692.14; Chow SC, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-11; Davidoff F, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3152; Horn SD, 2010, STUD HEALTH TECHNOL, V151, P446, DOI 10.3233/978-1-60750-476-4-446; Luce BR, 2009, ANN INTERN MED, V151, P206, DOI 10.7326/0003-4819-151-3-200908040-00126; Schneeweiss S, 2007, CLIN PHARMACOL THER, V82, P143, DOI 10.1038/sj.clpt.6100249; Steinbrook R, 2009, NEW ENGL J MED, V360, P1057, DOI 10.1056/NEJMp0900665; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Woolf SH, 2008, JAMA-J AM MED ASSOC, V299, P211, DOI 10.1001/jama.2007.26; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	10	69	69	0	6	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2011	305	4					400	401		10.1001/jama.2011.12	http://dx.doi.org/10.1001/jama.2011.12			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711MH	21266687				2022-12-28	WOS:000286595200025
J	Barnes, MJ; Powrie, F				Barnes, Michael J.; Powrie, Fiona			The Gut's Clostridium Cocktail	SCIENCE			English	Editorial Material							SEGMENTED FILAMENTOUS BACTERIA; INTESTINAL MICROBIOTA; T-CELLS; INFLAMMATION		[Barnes, Michael J.; Powrie, Fiona] Univ Oxford, Translat Gastroenterol Unit, Oxford OX3 9DU, England	University of Oxford	Barnes, MJ (corresponding author), Univ Oxford, Translat Gastroenterol Unit, Oxford OX3 9DU, England.	fiona.powrie@path.ox.ac.uk		Barnes, Michael/0000-0003-0846-3352	Wellcome Trust [095688] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Cerf-Bensussan N, 2010, NAT REV IMMUNOL, V10, P735, DOI 10.1038/nri2850; Gaboriau-Routhiau V, 2009, IMMUNITY, V31, P677, DOI 10.1016/j.immuni.2009.08.020; Hill DA, 2010, ANNU REV IMMUNOL, V28, P623, DOI 10.1146/annurev-immunol-030409-101330; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Round JL, 2010, P NATL ACAD SCI USA, V107, P12204, DOI 10.1073/pnas.0909122107; Rubtsov YP, 2008, IMMUNITY, V28, P546, DOI 10.1016/j.immuni.2008.02.017; Smith K, 2007, SEMIN IMMUNOL, V19, P59, DOI 10.1016/j.smim.2006.10.002; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Stepankova R, 2007, INFLAMM BOWEL DIS, V13, P1202, DOI 10.1002/ibd.20221; Thornton AM, 2010, J IMMUNOL, V184, P3433, DOI 10.4049/jimmunol.0904028; Uhlig HH, 2006, J IMMUNOL, V177, P5852, DOI 10.4049/jimmunol.177.9.5852; Wlodarska M, 2010, MUCOSAL IMMUNOL, V3, P100, DOI 10.1038/mi.2009.135; Wu HJ, 2010, IMMUNITY, V32, P815, DOI 10.1016/j.immuni.2010.06.001	16	19	25	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2011	331	6015					289	290		10.1126/science.1201291	http://dx.doi.org/10.1126/science.1201291			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252334				2022-12-28	WOS:000286636300022
J	Ensign, SA				Ensign, Scott A.			Another Microbial Pathway for Acetate Assimilation	SCIENCE			English	Editorial Material									Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Ensign, SA (corresponding author), Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA.	ensigns@cc.usu.edu						ALBERS H, 1976, ARCH MICROBIOL, V111, P45, DOI 10.1007/BF00446548; Candela T, 2006, MOL MICROBIOL, V60, P1091, DOI 10.1111/j.1365-2958.2006.05179.x; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; GOTTSCHAL JC, 1980, ARCH MICROBIOL, V126, P33, DOI 10.1007/BF00421888; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Khomyakova M, 2011, SCIENCE, V331, P334, DOI 10.1126/science.1196544; KORNBERG HL, 1957, NATURE, V179, P988, DOI 10.1038/179988a0; KORNBERG HL, 1960, J GEN MICROBIOL, V23, P511, DOI 10.1099/00221287-23-3-511; Oren A., 2002, HALOPHILIC MICROORGA	9	9	9	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2011	331	6015					294	295		10.1126/science.1201252	http://dx.doi.org/10.1126/science.1201252			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252338				2022-12-28	WOS:000286636300026
J	Kravchuk, T; Reznikov, M; Tichonov, P; Avidor, N; Meir, Y; Bekkerman, A; Alexandrowicz, G				Kravchuk, T.; Reznikov, M.; Tichonov, P.; Avidor, N.; Meir, Y.; Bekkerman, A.; Alexandrowicz, G.			A Magnetically Focused Molecular Beam of Ortho-Water	SCIENCE			English	Article							SPIN CONVERSION; SYSTEM	Like dihydrogen, water exists as two spin isomers, ortho and para, with the nuclear magnetic moments of the hydrogen atoms either parallel or antiparallel. The ratio of the two spin isomers and their physical properties play an important role in a wide variety of research fields, ranging from astrophysics to nuclear magnetic resonance (NMR). Unlike ortho and para H-2, however, the two water isomers remain challenging to separate, and as a consequence, very little is currently known about their different physical properties. Here, we report the formation of a magnetically focused molecular beam of ortho-water. The beam we formed also had a particular spin projection. Thus, in the presence of holding magnetic fields, the water molecules are hyperpolarized, laying the foundation for ultrasensitive NMR experiments in the future.	[Kravchuk, T.; Reznikov, M.; Tichonov, P.; Avidor, N.; Meir, Y.; Bekkerman, A.; Alexandrowicz, G.] Technion Israel Inst Technol, Schulich Fac Chem, IL-32000 Technion, Haifa, Israel	Technion Israel Institute of Technology	Kravchuk, T (corresponding author), Technion Israel Inst Technol, Schulich Fac Chem, IL-32000 Technion, Haifa, Israel.		Kravchuk, Tatyana/AAZ-6310-2020	Kravchuk, Tatyana/0000-0002-3206-002X; Alexandrowicz, Gil/0000-0003-3203-5577; Avidor, Nadav/0000-0002-3928-2493	German Israeli Foundation	German Israeli Foundation(German-Israeli Foundation for Scientific Research and Development)	The authors thank U. Even and A. Jardine for their invaluable advice and assistance in this project. Funding was received from the German Israeli Foundation for scientific research and development.	Chapovsky PL, 1999, ANNU REV PHYS CHEM, V50, P315, DOI 10.1146/annurev.physchem.50.1.315; Encrenaz T, 2008, ANNU REV ASTRON ASTR, V46, P57, DOI 10.1146/annurev.astro.46.060407.145229; Estermann I, 1937, PHYS REV, V52, P0535, DOI 10.1103/PhysRev.52.535; Farkas A., 1935, ORTHOHYDROGEN PARAHY; Fouquet P, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1896945; Gershnabel E, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.063416; Hillenkamp M, 2003, J CHEM PHYS, V118, P8699, DOI 10.1063/1.1568331; Jardine AP, 2004, SCIENCE, V304, P1790, DOI 10.1126/science.1098490; Jardine AP, 2001, REV SCI INSTRUM, V72, P3834, DOI 10.1063/1.1405794; KAENDERS WG, 1995, NATURE, V375, P214, DOI 10.1038/375214a0; Kapralov PO, 2008, B LEBEDEV PHYS INST+, V35, P221, DOI 10.3103/S1068335608070075; Konyukhov V. K., 2007, Bulletin of the Lebedev Physics Institute, V34, P154, DOI 10.3103/S1068335607050053; Lebehot A., 2001, ATOMIC MOL BEAMS STA; Limbach HH, 2006, CHEMPHYSCHEM, V7, P551, DOI 10.1002/cphc.200500559; Moro R, 2007, PHYS REV A, V75, DOI 10.1103/PhysRevA.75.013415; Scoles G., 1988, ATOMIC MOL BEAM METH; Tikhonov VI, 2002, SCIENCE, V296, P2363, DOI 10.1126/science.1069513; TOENNIES JP, 1977, J CHEM PHYS, V66, P3965, DOI 10.1063/1.434448; Townes CH., 1955, MICROWAVE SPECTROSCO, V1; Turro NJ, 2010, ACCOUNTS CHEM RES, V43, P335, DOI 10.1021/ar900223d	20	53	54	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					319	321		10.1126/science.1200433	http://dx.doi.org/10.1126/science.1200433			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252342				2022-12-28	WOS:000286636300033
J	Churchman, LS; Weissman, JS				Churchman, L. Stirling; Weissman, Jonathan S.			Nascent transcript sequencing visualizes transcription at nucleotide resolution	NATURE			English	Article							RNA-POLYMERASE-II; ACTIVE PROMOTERS; BIDIRECTIONAL PROMOTERS; DIVERGENT TRANSCRIPTION; HUMAN GENOME; HISTONE H3; IN-VIVO; POL II; ELONGATION; METHYLATION	Recent studies of transcription have revealed a level of complexity not previously appreciated even a few years ago, both in the intricate use of post-initiation control and the mass production of rapidly degraded transcripts. Dissection of these pathways requires strategies for precisely following transcripts as they are being produced. Here we present an approach (native elongating transcript sequencing, NET-seq), based on deep sequencing of 3' ends of nascent transcripts associated with RNA polymerase, to monitor transcription at nucleotide resolution. Application of NET-seq in Saccharomyces cerevisiae reveals that although promoters are generally capable of divergent transcription, the Rpd3S deacetylation complex enforces strong directionality to most promoters by suppressing antisense transcript initiation. Our studies also reveal pervasive polymerase pausing and backtracking throughout the body of transcripts. Average pause density shows prominent peaks at each of the first four nucleosomes, with the peak location occurring in good agreement with in vitro biophysical measurements. Thus, nucleosome-induced pausing represents a major barrier to transcriptional elongation in vivo.	[Churchman, L. Stirling; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Churchman, L. Stirling; Weissman, Jonathan S.] Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA.	weissman@cmp.ucsf.edu		Weissman, Jonathan/0000-0003-2445-670X	Damon Runyon Cancer Research Foundation [DRG-1997-08]; Howard Hughes Medical Institute	Damon Runyon Cancer Research Foundation; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank C. Guthrie, N. Krogan, S. Luo, G. Schroth, J. Steitz and K. Yamamoto for advice and discussions; D. Breslow, P. Fordyce, A. Frost, J. Huff, M. Kampmann and M. Pufall for critical comments on the manuscript; C. Chu and N. Ingolia for help with sequencing and analysis; and S. Rouskin for help developing the ligation protocol. This research was supported by the Damon Runyon Cancer Research Foundation (DRG-1997-08 to L.S.C.) and by the Howard Hughes Medical Institute (to J.S.W.)	Arigo JT, 2006, MOL CELL, V23, P841, DOI 10.1016/j.molcel.2006.07.024; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; CAI H, 1987, J BIOL CHEM, V262, P298; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; IZBAN MG, 1992, J BIOL CHEM, V267, P13647; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; KASSAVETIS GA, 1981, J BIOL CHEM, V256, P2777; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kim TH, 2005, NATURE, V436, P876, DOI 10.1038/nature03877; Kireeva ML, 2009, P NATL ACAD SCI USA, V106, P8900, DOI 10.1073/pnas.0900407106; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Kulish D, 2001, MOL CELL BIOL, V21, P4162, DOI 10.1128/MCB.21.13.4162-4168.2001; LANGMEAD B, 2009, GENOME BIOL, V10, pR25, DOI DOI 10.1186/gb-2009-10-11-r134; Lefrancois P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-37; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; MARKHAM R, 1952, BIOCHEM J, V52, P552, DOI 10.1042/bj0520552; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747; Nudler E, 1997, CELL, V89, P33, DOI 10.1016/S0092-8674(00)80180-4; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Reines D, 1999, CURR OPIN CELL BIOL, V11, P342, DOI 10.1016/S0955-0674(99)80047-7; Rodriguez-Gil A, 2010, NUCLEIC ACIDS RES, V38, P4651, DOI 10.1093/nar/gkq215; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Seila AC, 2009, CELL CYCLE, V8, P2557, DOI 10.4161/cc.8.16.9305; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Sigurdsson S, 2010, MOL CELL, V38, P202, DOI 10.1016/j.molcel.2010.02.026; Unrau PJ, 1998, NATURE, V395, P260, DOI 10.1038/26193; Vasiljeva L, 2008, NAT STRUCT MOL BIOL, V15, P795, DOI 10.1038/nsmb.1468; Weiner A, 2010, GENOME RES, V20, P90, DOI 10.1101/gr.098509.109; Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728	45	531	537	3	104	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					368	+		10.1038/nature09652	http://dx.doi.org/10.1038/nature09652			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248844	Green Accepted			2022-12-28	WOS:000286385600045
J	Hilbert, M; Lopez, P				Hilbert, Martin; Lopez, Priscila			The World's Technological Capacity to Store, Communicate, and Compute Information	SCIENCE			English	Article								We estimated the world's technological capacity to store, communicate, and compute information, tracking 60 analog and digital technologies during the period from 1986 to 2007. In 2007, humankind was able to store 2.9 x 10(20) optimally compressed bytes, communicate almost 2 x 10(21) bytes, and carry out 6.4 x 10(18) instructions per second on general-purpose computers. General-purpose computing capacity grew at an annual rate of 58%. The world's capacity for bidirectional telecommunication grew at 28% per year, closely followed by the increase in globally stored information (23%). Humankind's capacity for unidirectional information diffusion through broadcasting channels has experienced comparatively modest annual growth (6%). Telecommunication has been dominated by digital technologies since 1990 (99.9% in digital format in 2007), and the majority of our technological memory has been in digital format since the early 2000s (94% digital in 2007).	[Hilbert, Martin] Univ So Calif, Annenberg Sch Commun, Los Angeles, CA 90089 USA; [Lopez, Priscila] Open Univ Catalonia, Informat & Commun Sci Dept, Barcelona 08018, Spain	University of Southern California; UOC Universitat Oberta de Catalunya	Hilbert, M (corresponding author), Univ So Calif, Annenberg Sch Commun, Los Angeles, CA 90089 USA.	mhilbert@usc.edu	Hilbert, Martin/E-7845-2010	Hilbert, Martin/0000-0003-0809-6361	United Nations ECLAC (in Chile)	United Nations ECLAC (in Chile)	We thank the Information Society Program of United Nations ECLAC (in Chile) for its support; T. Coughlin, J. McCallum, D. Franz, M. Gonzalez, C. Vasquez, L. Adleman, M. Castells, and the statisticians from UPU (Universal Post Union) and ITU (International Telecommunications Union); as well as numerous colleagues who motivated us by doubting the feasibility of this undertaking.	[Anonymous], 1977, INFORM EC DEFINITION; Bell D., 1973, COMING POST-IND SOC; Bohn RE, 2009, MUCH INFORM 2009 REP; Brynjolfsson E., 2009, WIRED INNOVATION INF; Castells M., 2009, RISE NETWORK SOC INF, V1; Castells Manuel, 2000, END MILLENNIUM INFOR, V3; Chen X, 2002, BIOINFORMATICS, V18, P1696, DOI 10.1093/bioinformatics/18.12.1696; Cormen TH, 2003, INTRO ALGORITHMS; Coughlin T., 2007, DIGITAL STORAGE TECH; Faostat, 2010, FORESSTAT; Forester T., 1985, INFORM TECHNOLOGY RE; Freeman C., 2002, TIME GOES IND REVOLU; Gantz J. F., 2008, DIVERSE EXPLODING DI; Gardiner B., 2007, WIRED MAG; Global Technology Team, 2006, TECHN Q1 2006 GLOB T; International Federation of the Phonographic Industry (IFPI), REC IND WORLD SAL 19; International Telecommunication Union (ITU), 2020, WORLD TEL ICT IND DA; Ito Y., 1981, MASS COMMUNICATION R, V2, P671; Lesk M., 1997, MUCH INFORM IS THERE; Lloyd S, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.237901; Longbottom R., 2006, COMPUTER SPEED CLAIM; Lyman P, 2003, MUCH INFORM 2003; Masuda Y., 1980, INFORM SOC POSTINDUS; McCallum J., 2002, COMPUTER ENG HDB, P136; MOORE GE, 1995, P SOC PHOTO-OPT INS, V2439, P2, DOI 10.1117/12.209195; PEREZ C, 1983, FUTURES, V15, P357, DOI 10.1016/0016-3287(83)90050-2; POOL ID, 1983, SCIENCE, V221, P609, DOI 10.1126/science.221.4611.609; Porter J., 2005, DISK TREND REPORTS 1; SAHAL D, 1985, RES POLICY, V14, P61, DOI 10.1016/0048-7333(85)90015-0; SHANNON CE, 1948, BELL SYST TECH J, V27, P379, DOI 10.1002/j.1538-7305.1948.tb01338.x; Thomas MC, 2006, ELEMENTS INFORM THEO; TOP500, 2009, TOP500 LIST REL; Turing AM, 1937, P LOND MATH SOC, V42, P230, DOI 10.1112/plms/s2-42.1.230; Universal Postal Union (UPU), 2007, POST STAT	34	702	747	10	211	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 1	2011	332	6025					60	65		10.1126/science.1200970	http://dx.doi.org/10.1126/science.1200970			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	743EJ	21310967				2022-12-28	WOS:000289000000036
J	Al-Majed, NS; McAlister, FA; Bakal, JA; Ezekowitz, JA				Al-Majed, Nawaf S.; McAlister, Finlay A.; Bakal, Jeffrey A.; Ezekowitz, Justin A.			Meta-analysis: Cardiac Resynchronization Therapy for Patients With Less Symptomatic Heart Failure	ANNALS OF INTERNAL MEDICINE			English	Review							IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; VENTRICULAR SYSTOLIC DYSFUNCTION; DEVICE THERAPY; ATRIAL-FIBRILLATION; RANDOMIZED-TRIAL; FOCUSED UPDATE; ESC GUIDELINES; PACED PATIENTS; TASK-FORCE; ASSOCIATION	Background: Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in patients with advanced symptoms of heart failure. Purpose: To assess the benefits and harms of CRT in patients with advanced heart failure and those with less symptomatic disease. Data Sources: A search of electronic databases (1950 to December 2010), hand-searching of reference lists, and unpublished data from principal investigators. Searches were not limited to the English language. Study Selection: Randomized, controlled trials of CRT compared with usual care and right or left ventricular pacing in adults with heart failure and a left ventricular ejection fraction of 0.40 or less. Data Extraction: Two reviewers performed independent study selection, data abstraction, and quality assessment by using the Cochrane tool for assessing risk for bias. Data Synthesis: There were 9082 patients in 25 trials. In patients with New York Heart Association (NYHA) class I and II symptoms, CRT reduced all-cause mortality (6 trials, 4572 participants; risk ratio [RR], 0.83 [95% CI, 0.72 to 0.96]) and heart failure hospitalizations (4 trials, 4349 participants; RR, 0.71 [CI, 0.57 to 0.87]) without improving functional outcomes or quality of life. In patients with NYHA class III or IV symptoms, CRT improved functional outcomes and reduced both all-cause mortality (19 trials, 4510 participants; RR, 0.78 [CI, 0.67 to 0.91]) and heart failure hospitalizations (11 trials, 2663 participants; RR, 0.65 [CI, 0.50 to 0.86]). The implant success rate was 94.4%; peri-implantation deaths occurred in 0.3% of trial participants, mechanical complications in 3.2%, lead problems in 6.2%, and infections in 1.4%. Limitation: Subgroup analyses were underpowered and lack data for persons with NYHA class I symptoms, atrial fibrillation, chronic kidney disease, or right bundle branch block. Conclusion: Cardiac resynchronization therapy is beneficial for patients with reduced left ventricular ejection fraction, symptoms of heart failure, and prolonged QRS, regardless of NYHA class.	[McAlister, Finlay A.; Ezekowitz, Justin A.] Walter Mackenzie Ctr, Edmonton, AB T6G 2B7, Canada; [Al-Majed, Nawaf S.] Univ Alberta, Dept Med, Edmonton, AB T6G 2B7, Canada; [Bakal, Jeffrey A.] Univ Alberta, Edmonton, AB T6G 2M8, Canada	University of Alberta; University of Alberta; University of Alberta	Ezekowitz, JA (corresponding author), Walter Mackenzie Ctr, 8440 112 St, Edmonton, AB T6G 2B7, Canada.	justin.ezekowitz@ualberta.ca	Bakal, Jeff/ABE-4051-2021; McAlister, Finlay/C-4151-2013; Ezekowitz, Justin A/C-4579-2013	McAlister, Finlay/0000-0001-7435-3341; Ezekowitz, Justin A/0000-0002-2724-4086; Bakal, Jeffrey/0000-0002-3658-2554	New Investigator program of the Canadian Institutes of Health Research; Alberta Heritage Foundation for Medical Research (AHFMR)	New Investigator program of the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research)	Dr. Ezekowitz is supported by the New Investigator program of the Canadian Institutes of Health Research and by the Alberta Heritage Foundation for Medical Research (AHFMR). Dr. McAlister holds a Senior Health Scholar Award from AHFMR.	Abraham WT, 2004, CIRCULATION, V110, P2864, DOI 10.1161/01.CIR.0000146336.92331.D1; Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Auricchio A, 2002, J AM COLL CARDIOL, V39, P2026, DOI 10.1016/S0735-1097(02)01895-8; Auricchio A, 2003, J AM COLL CARDIOL, V42, P2109, DOI 10.1016/j.jacc.2003.04.003; Beshai JF, 2007, NEW ENGL J MED, V357, P2461, DOI 10.1056/NEJMoa0706695; Bleeker GB, 2006, J AM COLL CARDIOL, V48, P2243, DOI 10.1016/j.jacc.2006.07.067; Boriani G, 2010, AM HEART J, V159, P1052, DOI 10.1016/j.ahj.2010.03.008; Bristow MR, 2004, NEW ENGL J MED, V350, P2140, DOI 10.1056/NEJMoa032423; Bueno H, 2010, JAMA-J AM MED ASSOC, V303, P2141, DOI 10.1001/jama.2010.748; Cazeau S, 2001, NEW ENGL J MED, V344, P873, DOI 10.1056/NEJM200103223441202; Chakeabarti S, 2010, J CARD FAIL, V16, pS53, DOI 10.1016/j.cardfail.2010.04.004; Chung ES, 2010, EUR J HEART FAIL, V12, P581, DOI 10.1093/eurjhf/hfq009; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Curtis AB, 2009, AM HEART J, V158, P956, DOI 10.1016/j.ahj.2009.10.011; Curtis JP, 2009, JAMA-J AM MED ASSOC, V301, P1661, DOI 10.1001/jama.2009.547; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dickstein K, 2008, EUR HEART J, V29, P2388, DOI 10.1093/eurheartj/ehn309; Dickstein K, 2010, EUR J HEART FAIL, V12, P1143, DOI [10.1093/eurjhf/hfq192, 10.1093/europace/euq392]; Dickstein K, 2009, EUR HEART J, V30, P2450, DOI 10.1093/eurheartj/ehp359; EZEKOWITZ JA, 2010, EUR J HEART FAIL; Ezekowitz JA, 2007, ANN INTERN MED, V147, P251, DOI 10.7326/0003-4819-147-4-200708210-00007; Fein AS, 2010, J AM COLL CARDIOL, V56, P766, DOI 10.1016/j.jacc.2010.05.025; FILHO MM, 2010, J CARD FAIL, V16, P293; Fornwalt BK, 2010, CIRCULATION, V121, P1985, DOI 10.1161/CIRCULATIONAHA.109.910778; Fox M, 2007, Health Technol Assess, V11, piii; Fox M, 2007, HLTH TECHNOL ASSESS, V11; Freeman JV, 2010, J AM COLL CARDIOL, V56, P1133, DOI 10.1016/j.jacc.2010.07.007; Gasparini M, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.08.018; Higgins J., 2009, COCHRANE HDB SYSTEMA; Higgins SL, 2003, J AM COLL CARDIOL, V42, P1454, DOI 10.1016/S0735-1097(03)01042-8; Hoppe UC, 2006, CIRCULATION, V114, P18, DOI 10.1161/CIRCULATIONAHA.106.614560; Howlett JG, 2009, CAN J CARDIOL, V25, P85, DOI 10.1016/S0828-282X(09)70477-5; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Kindermann M, 2006, J AM COLL CARDIOL, V47, P1927, DOI 10.1016/j.jacc.2005.12.056; Landolina M, 2007, AM J CARDIOL, V100, P1007, DOI 10.1016/j.amjcard.2007.04.043; Leclercq C, 2002, EUR HEART J, V23, P1780, DOI 10.1053/euhj.2002.3232; Leclercq C, 2007, PACE, V30, pS23; Linde C, 2008, J AM COLL CARDIOL, V52, P1834, DOI 10.1016/j.jacc.2008.08.027; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lubitz SA, 2010, EUR J HEART FAIL, V12, P360, DOI 10.1093/eurjhf/hfq029; Maass AH, 2010, EUR J HEART FAIL, V12, P527, DOI 10.1093/eurjhf/hfq084; McAlister FA, 2006, EUR HEART J, V27, P323, DOI 10.1093/eurheartj/ehi446; McAlister FA, 2008, CIRCULATION, V118, P901, DOI 10.1161/CIRCULATIONAHA.108.800722; McAlister FA, 2007, JAMA-J AM MED ASSOC, V297, P2502, DOI 10.1001/jama.297.22.2502; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; Piccini JP, 2008, CIRCULATION, V118, P926, DOI 10.1161/CIRCULATIONAHA.108.773838; Piepoli MF, 2008, PACE, V31, P701, DOI 10.1111/j.1540-8159.2008.01073.x; Rao RK, 2007, CIRCULATION, V115, P2136, DOI 10.1161/CIRCULATIONAHA.106.634444; RECTOR TS, 1993, CIRCULATION, V87, P71; Shenkman HJ, 2002, CHEST, V122, P528, DOI 10.1378/chest.122.2.528; Solomon SD, 2010, CIRCULATION, V122, P985, DOI 10.1161/CIRCULATIONAHA.110.955039; Sutton MSJ, 2009, CIRCULATION, V120, P1858, DOI 10.1161/CIRCULATIONAHA.108.818724; Sutton MGS, 2006, CIRCULATION, V113, P266, DOI 10.1161/CIRCULATIONAHA.104.520817; Tang ASL, 2010, NEW ENGL J MED, V363, P2385, DOI 10.1056/NEJMoa1009540; THIBAULT B, 2010, HEART RHYTHM SOC 31A; U.S. Food and Drug Administration, 2005, ST JUD FRONT CARD RE; U.S. Food and Drug Administration, 2005, SUMM SAF EFF DAT; Upadhyay GA, 2008, J AM COLL CARDIOL, V52, P1239, DOI 10.1016/j.jacc.2008.06.043; *USFDA, 2009, MULT AUT DEF IMPL TR; van Geldorp IE, 2010, EUROPACE, V12, P223, DOI 10.1093/europace/eup378; Viechtbauer W, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i03; Yao GQ, 2007, EUR HEART J, V28, P42, DOI 10.1093/eurheartj/ehl382; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685; Yu CM, 2006, J AM COLL CARDIOL, V48, P2251, DOI 10.1016/j.jacc.2006.07.054	65	92	98	1	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 15	2011	154	6					401	+		10.7326/0003-4819-154-6-201103150-00313	http://dx.doi.org/10.7326/0003-4819-154-6-201103150-00313			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	734WA	21320922				2022-12-28	WOS:000288370000004
J	Chun, A; Leipzig, RM				Chun, Audrey; Leipzig, Rosanne M.			Review: Several bedside instruments are accurate for diagnosing delirium in hospitalized patients	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chun, Audrey; Leipzig, Rosanne M.] Mt Sinai Sch Med, New York, NY USA	Icahn School of Medicine at Mount Sinai	Chun, A (corresponding author), Mt Sinai Sch Med, New York, NY USA.							Inouye S. K., 2003, CONFUSION ASSESSMENT; Inouye SK, 2006, NEW ENGL J MED, V354, P1157, DOI 10.1056/NEJMra052321; Wei LA, 2008, J AM GERIATR SOC, V56, P823, DOI 10.1111/j.1532-5415.2008.01674.x	3	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4							JC2-12	10.7326/0003-4819-154-4-201102150-02012	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-02012			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720VF	21320927				2022-12-28	WOS:000287310000011
J	Overpeck, JT; Meehl, GA; Bony, S; Easterling, DR				Overpeck, Jonathan T.; Meehl, Gerald A.; Bony, Sandrine; Easterling, David R.			Climate Data Challenges in the 21st Century	SCIENCE			English	Editorial Material							SIMULATION; MODEL	Climate data are dramatically increasing in volume and complexity, just as the users of these data in the scientific community and the public are rapidly increasing in number. A new paradigm of more open, user-friendly data access is needed to ensure that society can reduce vulnerability to climate variability and change, while at the same time exploiting opportunities that will occur.	[Overpeck, Jonathan T.] Univ Arizona, Inst Environm, Tucson, AZ 85721 USA; [Meehl, Gerald A.] Natl Ctr Atmospher Res, Boulder, CO 80307 USA; [Bony, Sandrine] Univ Paris 06, CNRS, Inst Pierre Simon Laplace, Meteorol Dynam Lab, Paris, France; [Easterling, David R.] NOAA, Natl Climat Data Ctr, Asheville, NC USA	University of Arizona; National Center Atmospheric Research (NCAR) - USA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Saclay; National Center Atmospheric Research (NCAR) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Overpeck, JT (corresponding author), Univ Arizona, Inst Environm, 845 N Pk Ave,Suite 532, Tucson, AZ 85721 USA.	jto@email.arizona.edu	Bony, Sandrine/AAG-5804-2019	Bony, Sandrine/0000-0002-4791-4438				Chepfer H, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034207; Covey C, 2003, GLOBAL PLANET CHANGE, V37, P103, DOI 10.1016/S0921-8181(02)00193-5; Easterling D.R., 2008, WEATHER CLIM EXTREME, P117; Folland C. K., 2006, TEMPERATURE TRENDS L, P119; Hansen J, 2010, REV GEOPHYS, V48, DOI 10.1029/2010RG000345; Haynes JM, 2007, B AM METEOROL SOC, V88, P1723, DOI 10.1175/BAMS-88-11-1723; Held IM, 2005, B AM METEOROL SOC, V86, P1609, DOI 10.1175/BAMS-86-11-1609; Hibbard K. A., 2007, EOS T, V88, P217, DOI DOI 10.1029/2007EO200002; Jansen E, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P433; Lemos MC, 2005, GLOBAL ENVIRON CHANG, V15, P57, DOI 10.1016/j.gloenvcha.2004.09.004; Meehl G.A., 1997, EOS T AM GEOPHYS UN, V78, P445, DOI [10.1029/97EO00276, DOI 10.1029/97EO00276]; Meehl GA, 2005, B AM METEOROL SOC, V86, P89, DOI 10.1175/BAMS-86-1-89; Meehl GA, 2000, B AM METEOROL SOC, V81, P413, DOI 10.1175/1520-0477(2000)081<0413:AITTIE>2.3.CO;2; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Moss RH, 2010, NATURE, V463, P747, DOI 10.1038/nature08823; National Research Council, 2004, CLIM DAT REC ENV SAT; Oouchi K, 2006, J METEOROL SOC JPN, V84, P259, DOI 10.2151/jmsj.84.259; Pulwarty R. S., 2009, INTEGRATED REGIONAL, P367; Reynolds RW, 2002, J CLIMATE, V15, P1609, DOI 10.1175/1520-0442(2002)015<1609:AIISAS>2.0.CO;2; Taylor KE, 2009, SUMMARY CMIP5 EXPT D; Williams DN, 2009, B AM METEOROL SOC, V90, P195, DOI 10.1175/2008BAMS2459.1	21	202	222	5	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					700	702		10.1126/science.1197869	http://dx.doi.org/10.1126/science.1197869			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21311006				2022-12-28	WOS:000287205700049
J	Vaccarella, M				Vaccarella, Maria			The art of medicine Narrative epileptology	LANCET			English	Editorial Material									Kings Coll London, Sch Arts & Humanities, Ctr Humanities & Hlth, London WC2R 2LS, England	University of London; King's College London; University College London	Vaccarella, M (corresponding author), Kings Coll London, Sch Arts & Humanities, Ctr Humanities & Hlth, London WC2R 2LS, England.	maria.vaccarella@kcl.ac.uk						Alcauskas M, 2008, NEUROLOGY, V70, P891, DOI 10.1212/01.wnl.0000304945.48551.13; Charon R., 2006, NARRATIVE MED HONORI; de Toffol B, 2008, PROUST IMPROVE YOUR; Frank AW., 2013, WOUNDED STORYTELLER; Gastaut H, 1978, EPILEPSIA, V78, P198; Heritage J, 2006, STUD INTERACT SOCIO, P1, DOI 10.1017/CBO9780511607172; Stirling J., 2010, REPRESENTING EPILEPS	7	12	12	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 5	2011	377	9764					460	461		10.1016/S0140-6736(11)60150-5	http://dx.doi.org/10.1016/S0140-6736(11)60150-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	721TX	21300595				2022-12-28	WOS:000287381800015
J	Lewis, SL; Brando, PM; Phillips, OL; van der Heijden, GMF; Nepstad, D				Lewis, Simon L.; Brando, Paulo M.; Phillips, Oliver L.; van der Heijden, Geertje M. F.; Nepstad, Daniel			The 2010 Amazon Drought	SCIENCE			English	Article							DEFORESTATION		[Lewis, Simon L.; Phillips, Oliver L.] Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England; [Brando, Paulo M.; Nepstad, Daniel] Inst Pesquisa Ambiental Amazonia, BR-66035170 Belem, Para, Brazil; [Brando, Paulo M.] Woods Hole Res Ctr, Falmouth, MA 02450 USA; [van der Heijden, Geertje M. F.] Univ Sheffield, Sheffield S10 2TN, S Yorkshire, England	University of Leeds; Woods Hole Research Center; University of Sheffield	Lewis, SL (corresponding author), Univ Leeds, Sch Geog, Leeds LS2 9JT, W Yorkshire, England.	s.l.lewis@leeds.ac.uk	Brando, Paulo M/C-4302-2012; Brando, Paulo/AAC-9396-2019; van der Heijden, Geertje/AAB-4102-2019; Phillips, Oliver/A-1523-2011	Brando, Paulo M/0000-0001-8952-7025; Brando, Paulo/0000-0001-8952-7025; van der Heijden, Geertje/0000-0002-2110-5173; Phillips, Oliver/0000-0002-8993-6168; Lewis, Simon/0000-0002-8066-6851	NERC [NE/I02982X/1, NE/D01025X/1, NE/D010306/1] Funding Source: UKRI; Natural Environment Research Council [NE/I02982X/1, NE/B504630/1, NE/D010306/1, NE/D01025X/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Aragao LEOC, 2007, GEOPHYS RES LETT, V34, DOI [10.1029/2006GL028946., 10.1029/2006GL028946]; Lewis SL, 2006, PHILOS T R SOC B, V361, P195, DOI 10.1098/rstb.2005.1711; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Marengo JA, 2008, J CLIMATE, V21, P495, DOI 10.1175/2007JCLI1600.1; Nogueira EM, 2008, FOREST ECOL MANAG, V255, P2963, DOI 10.1016/j.foreco.2008.02.002; Phillips OL, 2009, SCIENCE, V323, P1344, DOI 10.1126/science.1164033; Rammig A, 2010, NEW PHYTOL, V187, P694, DOI 10.1111/j.1469-8137.2010.03318.x	7	777	806	9	273	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					554	554		10.1126/science.1200807	http://dx.doi.org/10.1126/science.1200807			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292971				2022-12-28	WOS:000286933600045
J	Mayor, S				Mayor, Satyajit			Need Tension Relief Fast? Try Caveolae	CELL			English	Editorial Material								Caveolae are protein-driven membrane invaginations that regulate both the physical and chemical composition of the plasma membrane. Sinha et al. (2011) now show that caveolae are membrane reservoirs that are used to rapidly buffer against changes in membrane tension.	Natl Ctr Biol Sci TIFR, Bangalore 560065, Karnataka, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Mayor, S (corresponding author), Natl Ctr Biol Sci TIFR, Bellary Rd, Bangalore 560065, Karnataka, India.	mayor@ncbs.res.in						Evans E.A., 1980, MECH THERMODYNAMICS; Hill MM, 2008, CELL, V132, P113, DOI 10.1016/j.cell.2007.11.042; Hua SZ, 2010, AM J PHYSIOL-CELL PH, V298, pC1424, DOI 10.1152/ajpcell.00503.2009; Jansa P, 2001, NUCLEIC ACIDS RES, V29, P423, DOI 10.1093/nar/29.2.423; Parton RG, 2007, NAT REV MOL CELL BIO, V8, P185, DOI 10.1038/nrm2122; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sens P, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031918; Sheetz MP, 1996, TRENDS CELL BIOL, V6, P85, DOI 10.1016/0962-8924(96)80993-7; Sheetz MP, 2001, NAT REV MOL CELL BIO, V2, P392, DOI 10.1038/35073095; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Woodman SE, 2004, NEUROLOGY, V62, P538, DOI 10.1212/WNL.62.4.538	11	11	11	0	10	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 4	2011	144	3					323	324		10.1016/j.cell.2011.01.018	http://dx.doi.org/10.1016/j.cell.2011.01.018			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295694	Bronze			2022-12-28	WOS:000286973100004
J	Owens, DK; Qaseem, A; Chou, R; Shekelle, P				Owens, Douglas K.; Qaseem, Amir; Chou, Roger; Shekelle, Paul		Clinical Guidelines Comm Amer Coll	High-Value, Cost-Conscious Health Care: Concepts for Clinicians to Evaluate the Benefits, Harms, and Costs of Medical Interventions	ANNALS OF INTERNAL MEDICINE			English	Article							LOW-BACK-PAIN; AMERICAN-COLLEGE; PRACTICE GUIDELINES; GRADING QUALITY; UNITED-STATES; HIV; AHRQ; STRENGTH; LIFE; RECOMMENDATIONS	Health care costs in the United States are increasing unsustainably, and further efforts to control costs are inevitable and essential. Efforts to control expenditures should focus on the value, in addition to the costs, of health care interventions. Whether an intervention provides high value depends on assessing whether its health benefits justify its costs. High-cost interventions may provide good value because they are highly beneficial; conversely, low-cost interventions may have little or no value if they provide little benefit. Thus, the challenge becomes determining how to slow the rate of increase in costs while preserving high-value, high-quality care. A first step is to decrease or eliminate care that provides no benefit and may even be harmful. A second step is to provide medical interventions that provide good value: medical benefits that are commensurate with their costs. This article discusses 3 key concepts for understanding how to assess the value of health care interventions. First, assessing the benefits, harms, and costs of an intervention is essential to understand whether it provides good value. Second, assessing the cost of an intervention should include not only the cost of the intervention itself but also any downstream costs that occur because the intervention was performed. Third, the incremental cost-effectiveness ratio estimates the additional cost required to obtain additional health benefits and provides a key measure of the value of a health care intervention.	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; Stanford Univ, Stanford, CA 94305 USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; W Los Angeles Vet Affairs Med Ctr, Los Angeles, CA 90073 USA	American College of Physicians; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; West Los Angeles VA Medical Center	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org		Chou, Roger/0000-0001-9889-8610				[Anonymous], 2008, GUID METH TECHN APPR; Bendavid E, 2008, ARCH INTERN MED, V168, P1910, DOI 10.1001/archinternmed.2008.1; Boden WE, 2007, NEW ENGL J MED, V356, P1503, DOI 10.1056/NEJMoa070829; Braithwaite RS, 2008, MED CARE, V46, P349, DOI 10.1097/MLR.0b013e31815c31a7; Bravata DM, 2007, ANN INTERN MED, V147, P703, DOI 10.7326/0003-4819-147-10-200711200-00185; Brown AD, 1999, JAMA-J AM MED ASSOC, V281, P347, DOI 10.1001/jama.281.4.347; Brozek JL, 2009, ALLERGY, V64, P1109, DOI 10.1111/j.1398-9995.2009.02083.x; Brozek JL, 2009, ALLERGY, V64, P669, DOI 10.1111/j.1398-9995.2009.01973.x; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou R, 2011, ANN INTERN MED, V154, P181, DOI 10.7326/0003-4819-154-3-201102010-00008; Chou R, 2010, J CLIN EPIDEMIOL, V63, P502, DOI 10.1016/j.jclinepi.2008.06.007; DETSKY AS, 1990, ANN INTERN MED, V113, P147, DOI 10.7326/0003-4819-113-2-147; Eckman MH, 2009, ANN INTERN MED, V150, P73, DOI 10.7326/0003-4819-150-2-200901200-00005; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Fuchs VR, 2010, NEW ENGL J MED, V363, P704, DOI 10.1056/NEJMp0906597; Fuchs VR, 2009, JAMA-J AM MED ASSOC, V302, P2481, DOI 10.1001/jama.2009.1821; GAGE BF, 1995, JAMA-J AM MED ASSOC, V274, P1839, DOI 10.1001/jama.274.23.1839; Garber AM, 2010, HEALTH AFFAIR, V29, P1805, DOI 10.1377/hlthaff.2010.0647; Garber AM, 1997, J HEALTH ECON, V16, P1, DOI 10.1016/S0167-6296(96)00506-1; Gold MR, 1996, COST EFFECTIVENESS H; Guyatt GH, 2008, BRIT MED J, V336, P1170, DOI 10.1136/bmj.39504.506319.80; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P995, DOI 10.1136/bmj.39490.551019.BE; Guyatt GH, 2008, BMJ-BRIT MED J, V336, P1049, DOI 10.1136/bmj.39493.646875.AE; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Helfand M, 2010, J CLIN EPIDEMIOL, V63, P484, DOI 10.1016/j.jclinepi.2009.05.005; Hlatky MA, 2009, LANCET, V373, P1190, DOI 10.1016/S0140-6736(09)60552-3; Hutubessy Raymond, 2003, Cost Eff Resour Alloc, V1, P8, DOI 10.1186/1478-7547-1-8; Institute of Medicine, IN NAT PRIOR COMP EF; Khazeni N, 2009, ANN INTERN MED, V151, P829, DOI [10.7326/0000605-200912150-00157, 10.7326/0003-4819-151-12-200912150-00157]; Kirschner N, 2008, ANN INTERN MED, V148, P956, DOI 10.7326/0003-4819-148-12-200806170-00222; National Institute for Health and Clinical Excellence, COST SAV GUID; Owens DK, 1998, J GEN INTERN MED, V13, P716, DOI 10.1046/j.1525-1497.1998.00211.x; OWENS DK, 1995, ANN INTERN MED, V122, P641, DOI 10.7326/0003-4819-122-9-199505010-00001; Owens DK, 2010, J CLIN EPIDEMIOL, V63, P513, DOI 10.1016/j.jclinepi.2009.03.009; Paltiel AD, 2006, ANN INTERN MED, V145, P797, DOI 10.7326/0003-4819-145-11-200612050-00004; Paltiel AD, 2005, NEW ENGL J MED, V352, P586, DOI 10.1056/NEJMsa042088; Qaseem A, 2010, ANN INTERN MED, V153, P194, DOI 10.7326/0003-4819-153-3-201008030-00010; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; Sanders GD, 2005, NEW ENGL J MED, V353, P1471, DOI 10.1056/NEJMsa051989; Sanders GD, 2008, ANN INTERN MED, V148, P889, DOI 10.7326/0003-4819-148-12-200806170-00002; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Sharma M, 2009, COMP EFFECTIVENESS R; Slutsky J, 2010, J CLIN EPIDEMIOL, V63, P481, DOI 10.1016/j.jclinepi.2008.06.009; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; The Center for the Evaluation of Value and Risk in Health Tufts Medical Center, COST EFF AN CEA REG; Ubel PA, 2003, ARCH INTERN MED, V163, P1637, DOI 10.1001/archinte.163.14.1637; Walensky RP, 2007, CLIN INFECT DIS, V45, pS248, DOI 10.1086/522546; Weinstein MC, 2008, MED CARE, V46, P343, DOI 10.1097/MLR.0b013e31816a7144; Whitlock EP, 2010, J CLIN EPIDEMIOL, V63, P491, DOI 10.1016/j.jclinepi.2009.03.008	49	227	231	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2011	154	3					174	+		10.7326/0003-4819-154-3-201102010-00007	http://dx.doi.org/10.7326/0003-4819-154-3-201102010-00007			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	713HY	21282697				2022-12-28	WOS:000286729200005
J	Fox, A				Fox, Armando			Cloud Computing-What's in It for Me as a Scientist?	SCIENCE			English	Editorial Material									Univ Calif Berkeley, Dept Comp Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Fox, A (corresponding author), Univ Calif Berkeley, Dept Comp Sci, Berkeley, CA 94720 USA.	fox@cs.berkeley.edu						Armbrust M, 2010, COMMUN ACM, V53, P50, DOI 10.1145/1721654.1721672; Dean J, 2004, P 6 USENIX S OP SYST; EVANGELINOS C, 2008, 1 ACM WORKSH CLOUD C; FOSTER I, WHATS FASTER SUPERCO; Garfinkel S., 2007, TR0807 HARV U; HAMILTON J, 2008, 2 LARG SCAL DISTR SY; Walker E, 2008, MAGAZINE USENIX SAGE, V33, P18	7	44	48	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2011	331	6016					406	407		10.1126/science.1198981	http://dx.doi.org/10.1126/science.1198981			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273473				2022-12-28	WOS:000286635900036
J	Horsfall, LJ; Rait, G; Walters, K; Swallow, DM; Pereira, SP; Nazareth, I; Petersen, I				Horsfall, Laura J.; Rait, Greta; Walters, Kate; Swallow, Dallas M.; Pereira, Stephen P.; Nazareth, Irwin; Petersen, Irene			Serum Bilirubin and Risk of Respiratory Disease and Death	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEME OXYGENASE-1; POLYMORPHISMS; ASSOCIATION; POPULATION; PROMOTER; UGT1A1; GENOME; GENES	Context Serum total bilirubin levels in healthy patients reflect genetic and environmental factors that could influence the risk of developing respiratory disease. Objective To examine the relationship between bilirubin levels and respiratory disease. Design, Setting, and Participants Cohort study among 504 206 adults from a UK primary care research database (the Health Improvement Network) with serum bilirubin levels recorded but no evidence of hepatobiliary or hemolytic disease. Data were recorded between January 1988 and December 2008. Main Outcome Measures Incidence of chronic obstructive pulmonary disease (COPD), lung cancer, and all-cause mortality. Results Median bilirubin levels were 0.64 mg/dL (interquartile range, 0.47-0.88 mg/dL) in men and 0.53 mg/dL (interquartile range, 0.41-0.70 mg/dL) in women. There were 1341 cases of lung cancer, 5863 cases of COPD, and 23 103 deaths, with incidence rates of 2.5, 11.9, and 42.5 per 10 000 person-years, respectively. The incidence of lung cancer per 10 000 person-years in men was 5.0 (95% confidence interval [CI], 4.2-6.0) in the first decile category of bilirubin compared with 3.0 (95% CI, 2.3-3.8) in the fifth decile. The corresponding incidences for COPD in men were 19.5 (95% CI, 17.7-21.4) and 14.4 (95% CI, 12.7-16.2). The mortality rates per 10 000 person-years in men were 51.3 (95% CI, 48.5-54.2) in the first decile category compared with 38.1 (95% CI, 35.5-40.8) in the fifth decile. The associations were similar for women. After adjusting for other important health indicators, regression estimates for incidence rate of lung cancer per 0.1-mg/dL increase in bilirubin level were an 8% decrease (95% CI, 5%-11%) for men and an 11% decrease (95% CI, 7%-14%) for women. The regression estimate for COPD in men per 0.1-mg/dL increase in bilirubin level was a 6% decrease (95% CI, 5%-7%) and for mortality in men was a 3% decrease (95% CI, 2%-3%) after accounting for other health indicators. The results for COPD and mortality in women were very similar. Conclusion Among patients with normal-range bilirubin levels in primary care practices, relatively higher levels of bilirubin were associated with a lower risk of respiratory disease and all-cause mortality. JAMA. 2011;305(7):691-697 www.jama.com	[Horsfall, Laura J.; Rait, Greta; Walters, Kate; Nazareth, Irwin; Petersen, Irene] UCL, Res Dept Primary Care & Populat Hlth, London NW3 2PF, England; [Horsfall, Laura J.; Swallow, Dallas M.] UCL, Res Dept Genet Evolut & Environm, London NW3 2PF, England; [Pereira, Stephen P.] UCL, Inst Hepatol, London NW3 2PF, England; [Rait, Greta; Nazareth, Irwin] MRC, Gen Practice Res Framework, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Horsfall, LJ (corresponding author), UCL, Royal Free Hosp, Res Dept Primary Care & Populat Hlth, Rowland Hill St, London NW3 2PF, England.	laura.horsfall@ucl.ac.uk	Pereira, Stephen P/C-5639-2009; Petersen, Irene/I-2751-2012; Petersen, Irene/C-5702-2009	Pereira, Stephen P/0000-0003-0821-1809; Petersen, Irene/0000-0002-0037-7524; Rait, Greta/0000-0002-7216-7294; Nazareth, Irwin/0000-0003-2146-9628; Walters, Kate/0000-0003-2173-2430	National Institute for Health Research School for Primary Care Research; UK Medical Research Council [G0601726, G0900701]; Medical Research Council [G0601726, G0900701, MC_U122797165] Funding Source: researchfish; MRC [G0900701, MC_U122797165, G0601726] Funding Source: UKRI	National Institute for Health Research School for Primary Care Research; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Ms Horsfall completed this work as part of her post at the University College London Department of Primary Care and Population Health with additional funding from the National Institute for Health Research School for Primary Care Research. Dr Petersen received funding through grants G0601726 and G0900701 from the UK Medical Research Council.	Beutler E, 1998, P NATL ACAD SCI USA, V95, P8170, DOI 10.1073/pnas.95.14.8170; Booth N, 1994, Health Libr Rev, V11, P177; BOSMA PJ, 1995, NEW ENGL J MED, V333, P1171, DOI 10.1056/NEJM199511023331802; Bourke Alison, 2004, Inform Prim Care, V12, P171; Campbell MJ, 2009, STAT SQUARE ONE; Chen YH, 2008, DIABETES CARE, V31, P1615, DOI 10.2337/dc07-2126; Dave S, 2009, PHARMACOEPIDEM DR S, V18, P704, DOI 10.1002/pds.1770; Djousse L, 2001, AM J CARDIOL, V87, P1196, DOI 10.1016/S0002-9149(01)01494-1; Fredenburgh LE, 2007, AM J RESP CELL MOL, V36, P158, DOI 10.1165/rcmb.2006-0331TR; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Hong AL, 2007, DRUG METAB DISPOS, V35, P1254, DOI 10.1124/dmd.106.014183; Khan NF, 2010, BRIT J GEN PRACT, V60, DOI 10.3399/bjgp10X483562; Lewis JD, 2005, PHARMACOEPIDEM DR S, V14, P443, DOI 10.1002/pds.1115; Lin JP, 2006, CIRCULATION, V114, P1476, DOI 10.1161/CIRCULATIONAHA.106.633206; Lin JP, 2010, CLIN CHEM, V56, P1535, DOI 10.1373/clinchem.2010.151043; Lin R, 2009, HUM MUTAT, V30, P609, DOI 10.1002/humu.20895; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; Marston L, 2010, PHARMACOEPIDEM DR S, V19, P618, DOI 10.1002/pds.1934; Novotny L, 2003, EXP BIOL MED, V228, P568, DOI 10.1177/15353702-0322805-29; Office for National Statistics, 2005, CENS 2001 GEN REP EN; Premawardhena A, 2003, BLOOD CELL MOL DIS, V31, P98, DOI 10.1016/S1079-9796(03)00071-8; Rappaport SM, 2010, SCIENCE, V330, P460, DOI 10.1126/science.1192603; Royston P, 2006, STAT MED, V25, P127, DOI 10.1002/sim.2331; Ryter SW, 2007, AM J RESP CELL MOL, V36, P175, DOI 10.1165/rcmb.2006-0333TR; Temme EHM, 2001, CANCER CAUSE CONTROL, V12, P887, DOI 10.1023/A:1013794407325; Thanassoulis G, 2009, JAMA-J AM MED ASSOC, V301, P2386, DOI 10.1001/jama.2009.812; Van Hoydonck PGA, 2001, INT J EPIDEMIOL, V30, P1465; Wild CP, 2005, CANCER EPIDEM BIOMAR, V14, P1847, DOI 10.1158/1055-9965.EPI-05-0456; WILDING P, 1972, CLIN CHIM ACTA, V41, P375, DOI 10.1016/0009-8981(72)90534-7; Zucker SD, 2004, HEPATOLOGY, V40, P827, DOI 10.1002/hep.20407	31	143	151	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2011	305	7					691	697		10.1001/jama.2011.124	http://dx.doi.org/10.1001/jama.2011.124			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721NH	21325185	Bronze			2022-12-28	WOS:000287361100020
J	Finucane, MM; Stevens, GA; Cowan, MJ; Danaei, G; Lin, JK; Paciorek, CJ; Singh, GM; Gutierrez, HR; Lu, YA; Bahalim, AN; Farzadfar, F; Riley, LM; Ezzati, M				Finucane, Mariel M.; Stevens, Gretchen A.; Cowan, Melanie J.; Danaei, Goodarz; Lin, John K.; Paciorek, Christopher J.; Singh, Gitanjali M.; Gutierrez, Hialy R.; Lu, Yuan; Bahalim, Adil N.; Farzadfar, Farshad; Riley, Leanne M.; Ezzati, Majid		Global Burden Metab Risk Factors C	National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants	LANCET			English	Article							RISK-FACTORS; WEIGHT-LOSS; CARDIOVASCULAR-DISEASE; SOCIOECONOMIC-STATUS; OBESITY; OVERWEIGHT; PREVALENCE; METAANALYSIS; ADULTS; ASSOCIATION	Background Excess bodyweight is a major public health concern. However, few worldwide comparative analyses of long-term trends of body-mass index (BMI) have been done, and none have used recent national health examination surveys. We estimated worldwide trends in population mean BMI. Methods We estimated trends and their uncertainties of mean BMI for adults 20 years and older in 199 countries and territories. We obtained data from published and unpublished health examination surveys and epidemiological studies (960 country-years and 9.1 million participants). For each sex, we used a Bayesian hierarchical model to estimate mean BMI by age, country, and year, accounting for whether a study was nationally representative. Findings Between 1980 and 2008, mean BMI worldwide increased by 0.4 kg/m(2) per decade (95% uncertainty interval 0.2-0.6, posterior probability of being a true increase >0.999) for men and 0.5 kg/m(2) per decade (0.3-0.7, posterior probability >0.999) for women. National BMI change for women ranged from non-significant decreases in 19 countries to increases of more than 2.0 kg/m(2) per decade (posterior probabilities >0.99) in nine countries in Oceania. Male BMI increased in all but eight countries, by more than 2 kg/m(2) per decade in Nauru and Cook Islands (posterior probabilities >0.999). Male and female BMIs in 2008 were highest in some Oceania countries, reaching 33.9 kg/m(2) (32.8-35.0) for men and 35.0 kg/m(2) (33.6-36.3) for women in Nauru. Female BMI was lowest in Bangladesh (20.5 kg/m(2), 19.8-21.3) and male BMI in Democratic Republic of the Congo 19.9 kg/m(2) (18.2-21.5), with BMI less than 21.5 kg/m(2) for both sexes in a few countries in sub-Saharan Africa, and east, south, and southeast Asia. The USA had the highest BMI of high-income countries. In 2008, an estimated 1.46 billion adults (1.41-1.51 billion) worldwide had. BMI of 25 kg/m(2) or greater, of these 205 million men (193-217 million) and 297 million women (280-315 million) were obese. Interpretation Globally, mean BMI has increased since 1980. The trends since 1980, and mean population BMI in 2008, varied substantially between nations. Interventions and policies that can curb or reverse the increase, and mitigate the health effects of high BMI by targeting its metabolic mediators, are needed in most countries.	[Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London W2 1PG, England; [Finucane, Mariel M.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Danaei, Goodarz] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Lin, John K.; Singh, Gitanjali M.; Lu, Yuan; Farzadfar, Farshad; Ezzati, Majid] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Ezzati, Majid] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Stevens, Gretchen A.] WHO, Dept Hlth Stat & Informat, CH-1211 Geneva, Switzerland; [Cowan, Melanie J.; Riley, Leanne M.] WHO, Dept Chron Dis & Hlth Promot, CH-1211 Geneva, Switzerland; [Paciorek, Christopher J.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	Imperial College London; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; World Health Organization; World Health Organization; University of California System; University of California Berkeley	Ezzati, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, Med Fac Bldg,St Marys Campus,Norfolk Pl, London W2 1PG, England.	majid.ezzati@imperial.ac.uk	Dastgiri, Saeed/S-9077-2016; Tur, Josep Antoni/F-5576-2014; Bovet, Pascal/F-4477-2011; Sonestedt, Emily/I-3814-2016; Danaei, Goodarz/B-6085-2008; Veierød, Marit B/J-8229-2019; Sundström, Johan/A-6286-2009; Nsour, Mohannad Al/ABE-8741-2020; Miranda, J. Jaime/A-8482-2008; Stergiou, George/J-3083-2019; Colaus, PsyColaus/K-6607-2013; You, Qisheng/AAG-7153-2020; vioque, jesus/A-1066-2008; NSABIMANA, Samuel/U-5620-2017; Adewuya, Abiodun/N-4997-2017; Chen, Chien-Jen/N-4723-2019; Husseini, Abdullatif/E-8377-2015; Lim, Stephen S/B-4055-2012; Iats, Inct/K-2300-2013; Castetbon, Katia/F-2686-2017; Prabhakaran, Dorairaj/B-4147-2011; Zheng, Wei/O-3351-2013; BABU, BONTHA VEERRAJU/X-2096-2019; Serra-Majem, Lluis/I-6708-2019; Cífková, Renata/O-5731-2017; Panza, Francesco/M-6804-2017; Bjerregaard, Peter/ABD-8894-2020; Peres, Marco A/D-1623-2013; Reyes-Garcia, Victoria/C-4552-2008; Panza, Francesco/Y-2539-2019; Rampal, Lekhraj/G-6117-2010; Rampal, Sanjay/B-9691-2010; You, Qisheng/A-3619-2014; Marques-Vidal, Pedro/C-9449-2009; Pistelli, Francesco/Y-8270-2019	Dastgiri, Saeed/0000-0002-8129-9125; Tur, Josep Antoni/0000-0002-6940-0761; Bovet, Pascal/0000-0002-0242-4259; Sonestedt, Emily/0000-0002-0747-4562; Veierød, Marit B/0000-0002-2083-2758; Sundström, Johan/0000-0003-2247-8454; Nsour, Mohannad Al/0000-0003-1212-1611; Miranda, J. Jaime/0000-0002-4738-5468; Stergiou, George/0000-0002-6132-0038; You, Qisheng/0000-0003-0743-7320; vioque, jesus/0000-0002-2284-148X; Adewuya, Abiodun/0000-0002-7611-6953; Husseini, Abdullatif/0000-0001-8767-5956; Prabhakaran, Dorairaj/0000-0002-3172-834X; Zheng, Wei/0000-0003-1226-070X; BABU, BONTHA VEERRAJU/0000-0001-5096-2222; Serra-Majem, Lluis/0000-0002-9658-9061; Cífková, Renata/0000-0003-2765-3821; Panza, Francesco/0000-0002-7220-0656; Bjerregaard, Peter/0000-0001-7153-8447; Peres, Marco A/0000-0002-8329-2808; Reyes-Garcia, Victoria/0000-0002-2914-8055; Panza, Francesco/0000-0002-7220-0656; Rampal, Sanjay/0000-0002-0105-6407; You, Qisheng/0000-0003-0743-7320; Neovius, Martin/0000-0003-2300-3055; Farzadfar, Farshad/0000-0001-8288-4046; Holdsworth, Michelle/0000-0001-6028-885X; Mohanna, Salim/0000-0002-1486-3259; Pednekar, Mangesh/0000-0001-6266-5356; Torheim, Liv Elin/0000-0002-3161-1635; Rasmussen, Finn/0000-0001-7915-7809; Marques-Vidal, Pedro/0000-0002-4548-8500; Varo Cenarruzabeitia, Jose Javier/0000-0002-7756-0669; Hemmingsson, Tomas/0000-0001-6156-3964; Elliott, Paul/0000-0002-7511-5684; Pistelli, Francesco/0000-0001-5612-6364; Dinc Horasan, Gonul/0000-0001-9999-4102; Woodward, Mark/0000-0001-9800-5296; Lin, John/0000-0003-2490-4453	Harvard University; Bill & Melinda Gates Foundation; WHO; NATIONAL CANCER INSTITUTE [UM1CA182910] Funding Source: NIH RePORTER; MRC [G0801056] Funding Source: UKRI; Medical Research Council [G0801056B, G0801056] Funding Source: researchfish	Harvard University; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); WHO(World Health Organization); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JKL holds stock in Johnson & Johnson. CJP holds stock in Pfizer. GAS has received funding from Harvard University for travel purposes. ANB has received consulting fees or honoraria and support for travel to moorings for the study or other purposes from Harvard University. ME has chaired a session at the World Cardiology Congress, which was sponsored by the organiser. All other authors declare that they have no conflicts of interest.; Funding Bill & Melinda Gates Foundation and WHO.	Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Bleich S, 2008, ANNU REV PUBL HEALTH, V29, P273, DOI 10.1146/annurev.publhealth.29.020907.090954; Bogers RP, 2007, ARCH INTERN MED, V167, P1720, DOI 10.1001/archinte.167.16.1720; Brownell KD, 2009, NEW ENGL J MED, V361, P1599, DOI 10.1056/NEJMhpr0905723; Cervero R, 2009, INT J SUSTAIN TRANSP, V3, P203, DOI 10.1080/15568310802178314; Chu NF, 2005, OBES REV, V6, P271, DOI 10.1111/j.1467-789X.2005.00175.x; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Douketis JD, 2005, INT J OBESITY, V29, P1153, DOI 10.1038/sj.ijo.0802982; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Evans A, 2001, INT J EPIDEMIOL, V30, pS35, DOI 10.1093/ije/30.suppl_1.S35; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Farzadfar F, 2011, LANCET, V377, P578, DOI 10.1016/S0140-6736(10)62038-7; Fishman SM, 2004, COMP QUANTIFICATION, P39; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Franz MJ, 2007, J AM DIET ASSOC, V107, P1755, DOI 10.1016/j.jada.2007.07.017; Gardner CD, 2007, JAMA-J AM MED ASSOC, V297, P969, DOI 10.1001/jama.297.9.969; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gorber SC, 2007, OBES REV, V8, P307, DOI 10.1111/j.1467-789X.2007.00347.x; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Houterman S, 2001, INT J EPIDEMIOL, V30, P1063, DOI 10.1093/ije/30.5.1063; Jahns L, 2003, EUR J CLIN NUTR, V57, P1295, DOI 10.1038/sj.ejcn.1601691; James WPT, 2004, COMP QUANTIFICATION, P497; Keith SW, 2006, INT J OBESITY, V30, P1585, DOI 10.1038/sj.ijo.0803326; Kim DM, 2005, OBES REV, V6, P117, DOI 10.1111/j.1467-789X.2005.00173.x; Mendez MA, 2005, AM J CLIN NUTR, V81, P714; Mhurchu CN, 2004, INT J EPIDEMIOL, V33, P751, DOI 10.1093/ije/dyh163; Molarius A, 2000, AM J PUBLIC HEALTH, V90, P1260, DOI 10.2105/AJPH.90.8.1260; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Monteiro CA, 2007, AM J PUBLIC HEALTH, V97, P1808, DOI 10.2105/AJPH.2006.099630; Nguyen MD, 2007, PUBLIC HEALTH NUTR, V10, P115, DOI 10.1017/S1368980007224085; Nordmann AJ, 2006, ARCH INTERN MED, V166, P285, DOI 10.1001/archinte.166.3.285; Ogden Cynthia L, 2004, Adv Data, P1; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pelletier David L., 1998, Food and Nutrition Bulletin, V19, P223; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Popkin BM, 2006, OBESITY, V14, P1846, DOI 10.1038/oby.2006.213; Prentice A, 2004, NUTR REV, V62, pS98, DOI 10.1111/j.1753-4887.2004.tb00095.x; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Rennie KL, 2005, OBES REV, V6, P11, DOI 10.1111/j.1467-789X.2005.00164.x; Romon M, 2009, PUBLIC HEALTH NUTR, V12, P1735, DOI 10.1017/S1368980008004278; Roth J, 2004, OBES RES, V12, p88S, DOI 10.1038/oby.2004.273; Sassi F., 2009, OBESITY EPIDEMIC ANA; Schneider HJ, 2010, J CLIN ENDOCR METAB, V95, P1777, DOI 10.1210/jc.2009-1584; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wang H, 2007, INT J OBESITY, V31, P272, DOI 10.1038/sj.ijo.0803416; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Yoshiike N, 2002, Obes Rev, V3, P183, DOI 10.1046/j.1467-789X.2002.00070.x	49	2909	3023	7	478	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2011	377	9765					557	567		10.1016/S0140-6736(10)62037-5	http://dx.doi.org/10.1016/S0140-6736(10)62037-5			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	724DQ	21295846	Green Published, Green Accepted			2022-12-28	WOS:000287556700026
J	Chen, XB; Liu, L; Yu, PY; Mao, SS				Chen, Xiaobo; Liu, Lei; Yu, Peter Y.; Mao, Samuel S.			Increasing Solar Absorption for Photocatalysis with Black Hydrogenated Titanium Dioxide Nanocrystals	SCIENCE			English	Article							INITIO MOLECULAR-DYNAMICS; SURFACE SCIENCE	When used as a photocatalyst, titanium dioxide (TiO2) absorbs only ultraviolet light, and several approaches, including the use of dopants such as nitrogen, have been taken to narrow the band gap of TiO2. We demonstrated a conceptually different approach to enhancing solar absorption by introducing disorder in the surface layers of nanophase TiO2 through hydrogenation. We showed that disorder-engineered TiO2 nanocrystals exhibit substantial solar-driven photocatalytic activities, including the photo-oxidation of organic molecules in water and the production of hydrogen with the use of a sacrificial reagent.	[Chen, Xiaobo; Liu, Lei; Yu, Peter Y.; Mao, Samuel S.] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Chen, Xiaobo; Mao, Samuel S.] Univ Calif Berkeley, Dept Mech Engn, Berkeley, CA 94720 USA; [Liu, Lei; Yu, Peter Y.] Univ Calif Berkeley, Dept Phys, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Mao, SS (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA.	ssmao@lbl.gov	liu, lei/V-9822-2018; Chen, Xiaobo/AAC-5100-2019	liu, lei/0000-0002-9714-2130; Mao, Samuel/0000-0003-3287-8304	Office of Energy Efficiency and Renewable Energy of the U.S. Department of Energy; King Abdullah University of Science and Technology-University of California Academic Excellence Alliance; Office of Science, Office of Basic Energy Sciences of the U.S. Department of Energy	Office of Energy Efficiency and Renewable Energy of the U.S. Department of Energy(United States Department of Energy (DOE)); King Abdullah University of Science and Technology-University of California Academic Excellence Alliance; Office of Science, Office of Basic Energy Sciences of the U.S. Department of Energy(United States Department of Energy (DOE))	We thank M. S. Dresselhaus for encouragement, M. T. Lee and S. H. Shen for their assistance, and R. Greif for discussions and critical reading of the manuscript. This research has been supported by the Office of Energy Efficiency and Renewable Energy of the U.S. Department of Energy. S.S.M. and X.C. also acknowledge support from the King Abdullah University of Science and Technology-University of California Academic Excellence Alliance. TEM work was performed at the National Center for Electron Microscopy, which is supported by the Office of Science, Office of Basic Energy Sciences of the U.S. Department of Energy.	Asahi R, 2001, SCIENCE, V293, P269, DOI 10.1126/science.1061051; Chen XB, 2004, J PHYS CHEM B, V108, P15446, DOI 10.1021/jp0469160; Chen XB, 2008, J AM CHEM SOC, V130, P5018, DOI 10.1021/ja711023z; Chen X, 2007, CHEM REV, V107, P2891, DOI 10.1021/cr0500535; Chen XB, 2010, CHEM REV, V110, P6503, DOI 10.1021/cr1001645; Choi W., 1994, ANGEW CHEM, V106, P1148, DOI DOI 10.1002/ANGE.19941061014; Di Valentin C, 2009, J PHYS CHEM C, V113, P20543, DOI 10.1021/jp9061797; Diebold U, 2003, SURF SCI REP, V48, P53, DOI 10.1016/S0167-5729(02)00100-0; Fujishima A, 2008, SURF SCI REP, V63, P515, DOI 10.1016/j.surfrep.2008.10.001; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; HOFFMANN MR, 1995, CHEM REV, V95, P69, DOI 10.1021/cr00033a004; Khan SUM, 2002, SCIENCE, V297, P2243, DOI 10.1126/science.1075035; Kilic C, 2002, APPL PHYS LETT, V81, P73, DOI 10.1063/1.1482783; KRESSE G, 1993, PHYS REV B, V47, P558, DOI 10.1103/PhysRevB.47.558; Kresse G, 1996, COMP MATER SCI, V6, P15, DOI 10.1016/0927-0256(96)00008-0; KRESSE G, 1993, PHYS REV B, V48, P13115, DOI 10.1103/PhysRevB.48.13115; Kudo A, 2009, CHEM SOC REV, V38, P253, DOI 10.1039/b800489g; McCafferty E, 1998, SURF INTERFACE ANAL, V26, P549, DOI 10.1002/(SICI)1096-9918(199807)26:8<549::AID-SIA396>3.3.CO;2-H; Na-Phattalung S, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.125205; Tauc J., 1965, NONCRYSTALLINE SOLID; Thompson TL, 2006, CHEM REV, V106, P4428, DOI 10.1021/cr050172k; Van de Walle CG, 2000, PHYS REV LETT, V85, P1012, DOI 10.1103/PhysRevLett.85.1012; Yu PY, 2010, GRAD TEXTS PHYS, P1, DOI 10.1007/978-3-642-00710-1; Zuo F, 2010, J AM CHEM SOC, V132, P11856, DOI 10.1021/ja103843d	24	4775	4888	215	6131	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					746	750		10.1126/science.1200448	http://dx.doi.org/10.1126/science.1200448			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21252313				2022-12-28	WOS:000287205700064
J	El Saleeby, CM; Grottkau, BE; Friedmann, AM; Westra, SJ; Sohani, AR				El Saleeby, Chadi M.; Grottkau, Brian E.; Friedmann, Alison M.; Westra, Sjirk J.; Sohani, Aliyah R.			Case 4-2011: A 4-Year-Old Boy with Back Pain and Hypercalcemia B lymphoblastic leukemia, not otherwise specified	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BONE PAIN; LYMPHOMA; CHILDREN; CRLF2		[El Saleeby, Chadi M.] Massachusetts Gen Hosp, Dept Pediat, Div Pediat Hosp Med & Infect Dis, Boston, MA 02114 USA; [Grottkau, Brian E.] Massachusetts Gen Hosp, Dept Pediat, Div Pediat Orthoped Surg, Boston, MA 02114 USA; [Friedmann, Alison M.] Massachusetts Gen Hosp, Dept Pediat, Div Pediat Oncol, Boston, MA 02114 USA; [Westra, Sjirk J.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Sohani, Aliyah R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [El Saleeby, Chadi M.; Friedmann, Alison M.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Grottkau, Brian E.] Harvard Univ, Sch Med, Dept Surg, Boston, MA 02115 USA; [Westra, Sjirk J.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Sohani, Aliyah R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	El Saleeby, CM (corresponding author), Massachusetts Gen Hosp, Dept Pediat, Div Pediat Hosp Med & Infect Dis, Boston, MA 02114 USA.			Westra, Sjirk/0000-0002-9952-6891	Harvard Medical School Office of Continuing Education	Harvard Medical School Office of Continuing Education	This case was presented at the postgraduate course Primary Care Pediatrics, sponsored by the Harvard Medical School Office of Continuing Education.	APPELL RG, 1985, PEDIATR RADIOL, V15, P245, DOI 10.1007/BF02388765; Borowitz MJ, 2008, WHO CLASSIFICATION T, P171; Brown EM, 2000, ENDOCRIN METAB CLIN, V29, P503, DOI 10.1016/S0889-8529(05)70148-1; Ellis JA, 2002, CLIN J PAIN, V18, P262, DOI 10.1097/00002508-200207000-00007; Foster K, 2004, CLIN RADIOL, V59, P651, DOI 10.1016/j.crad.2004.02.001; Gallagher DJ, 1996, ORTHOP CLIN N AM, V27, P635; Grier HE, 1997, PEDIATR CLIN N AM, V44, P991, DOI 10.1016/S0031-3955(05)70541-1; Hagan JF, 2001, PEDIATRICS, V108, P793; Inukai T, 2007, LEUKEMIA, V21, P288, DOI 10.1038/sj.leu.2404496; JONSSON OG, 1990, J PEDIATR-US, V117, P233, DOI 10.1016/S0022-3476(05)80535-9; Kollars J, 2005, PEDIATRICS, V115, P974, DOI 10.1542/peds.2004-0804; Laor T, 2009, RADIOLOGY, V250, P28, DOI 10.1148/radiol.2501071322; LEBLANC A, 1984, CANCER, V54, P2132, DOI 10.1002/1097-0142(19841115)54:10<2132::AID-CNCR2820541013>3.0.CO;2-V; Mathur Mudit, 2003, Pediatr Crit Care Med, V4, P252, DOI 10.1097/01.PCC.0000059423.62268.02; MCKAY C, 1993, CANCER-AM CANCER SOC, V72, P256, DOI 10.1002/1097-0142(19930701)72:1<256::AID-CNCR2820720145>3.0.CO;2-D; Merkel S I, 1997, Pediatr Nurs, V23, P293; Miller DR, 1994, BLOOD DIS INFANCY CH, P660; MIZUTA T, 1987, J PEDIATR ORTHOPED, V7, P518, DOI 10.1097/01241398-198709000-00003; Mullighan CG, 2009, NAT GENET, V41, P1243, DOI 10.1038/ng.469; Mundy GR, 1997, AM J MED, V103, P134, DOI 10.1016/S0002-9343(97)80047-2; NIES BA, 1965, ANN INTERN MED, V62, P698, DOI 10.7326/0003-4819-62-4-698; Paakkonen M, 2010, CLIN ORTHOP RELAT R, V468, P861, DOI 10.1007/s11999-009-0936-1; PUGH MT, 1993, BRIT J RHEUMATOL, V32, P838; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; ROGALSKY RJ, 1986, J BONE JOINT SURG AM, V68A, P494, DOI 10.2106/00004623-198668040-00003; Russell LJ, 2009, BLOOD, V114, P2688, DOI 10.1182/blood-2009-03-208397; Shaw NJ, 2005, ARCH DIS CHILD, V90, P494, DOI 10.1136/adc.2003.036590; Smith M, 1996, J CLIN ONCOL, V14, P18, DOI 10.1200/JCO.1996.14.1.18; Sperling M, 2020, SPERLING PEDIAT ENDO, V5th; Steere AC, 2004, NAT REV IMMUNOL, V4, P143, DOI 10.1038/nri1267; Stewart AF, 2005, NEW ENGL J MED, V352, P373, DOI 10.1056/NEJMcp042806; Taylor EM, 2008, PAIN RES MANAG, V13, P25, DOI 10.1155/2008/478102; TENENBEIN M, 1990, AM J EMERG MED, V8, P208, DOI 10.1016/0735-6757(90)90324-S; Wada Ikuo, 2008, Clin Calcium, V18, P239, DOI CliCa0802239248; Wong DL, 2001, ESSENTIALS PEDIAT NU	35	7	7	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2011	364	6					552	562		10.1056/NEJMcpc1011318	http://dx.doi.org/10.1056/NEJMcpc1011318			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718QH	21306242				2022-12-28	WOS:000287139900012
J	Ross, DS				Ross, Douglas S.			Radioiodine Therapy for Hyperthyroidism.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MULTINODULAR TOXIC GOITER; DOSE I-131 THERAPY; GRAVES-DISEASE; RADIOACTIVE IODINE; ANTITHYROID DRUGS; THYROID-NODULES; FOLLOW-UP; CANCER INCIDENCE; OPHTHALMOPATHY; LONG	A 37-year-old woman presented with palpitations, tremulousness, shortness of breath, and a 9-kg (20-lb) weight loss, and received a diagnosis of Graves' hyperthyroidism. At the time of diagnosis, she had mild proptosis, no diplopia, and no signs of eye inflammation. Her thyroid gland was two times the normal size and non-nodular. Her initial serum triiodothyronine (T(3)) concentration was 655 ng per deciliter (9.2 nmol per liter), and her free thyroxine (T(4)) concentration was 5.7 ng per deciliter (73 pmol per liter). She was treated with methimazole for a year, and her thyroid tests became normal. She discontinued the methimazole 10 weeks before the current presentation with recurrent palpitations and tremulousness. Her serum T(3) concentration is 345 ng per deciliter (5.4 nmol per liter), and her free T(4) concentration is 2.8 ng per deciliter (36.0 pmol per liter). The patient does not smoke. She has a 3-year-old daughter and wishes to become pregnant again. Her endocrinologist recommends radioiodine ablation of her thyroid.	Massachusetts Gen Hosp, Thyroid Unit, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Ross, DS (corresponding author), Massachusetts Gen Hosp, Thyroid Unit, Boston, MA 02114 USA.							Abraham-Nordling M, 2005, THYROID, V15, P1279, DOI 10.1089/thy.2005.15.1279; Alexander EK, 2002, J CLIN ENDOCR METAB, V87, P1073, DOI 10.1210/jc.87.3.1073; Bahn RS, 2010, NEW ENGL J MED, V362, P726, DOI 10.1056/NEJMra0905750; Bartalena L, 1998, NEW ENGL J MED, V338, P73, DOI 10.1056/NEJM199801083380201; BARTALENA L, 1989, NEW ENGL J MED, V321, P1349, DOI 10.1056/NEJM198911163212001; BURCH HB, 1993, ENDOCRIN METAB CLIN, V22, P263, DOI 10.1016/S0889-8529(18)30165-8; Ceccarelli C, 2005, CLIN ENDOCRINOL, V62, P331, DOI 10.1111/j.1365-2265.2005.02218.x; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; CODACCIONI JL, 1988, J CLIN ENDOCR METAB, V67, P656, DOI 10.1210/jcem-67-4-656; Cooper DS, 2005, NEW ENGL J MED, V352, P905, DOI 10.1056/NEJMra042972; DOBYNS BM, 1953, J CLIN ENDOCR METAB, V13, P548, DOI 10.1210/jcem-13-5-548; Franklyn JA, 1999, LANCET, V353, P2111, DOI 10.1016/S0140-6736(98)12295-X; Franklyn JA, 1998, NEW ENGL J MED, V338, P712, DOI 10.1056/NEJM199803123381103; GOLDSTEIN R, 1983, NEW ENGL J MED, V309, P1473, DOI 10.1056/NEJM198312153092401; Hollowell JG, 2002, J CLIN ENDOCR METAB, V87, P489, DOI 10.1210/jc.87.2.489; HOLM LE, 1982, J NUCL MED, V23, P103; Holst JP, 2005, THYROID, V15, P1321, DOI 10.1089/thy.2005.15.1321; Imseis RE, 1998, J CLIN ENDOCR METAB, V83, P685, DOI 10.1210/jc.83.2.685; In H, 2009, J AM COLL SURGEONS, V209, P170, DOI 10.1016/j.jamcollsurg.2009.03.025; JARLOV AE, 1995, CLIN ENDOCRINOL, V43, P325, DOI 10.1111/j.1365-2265.1995.tb02039.x; Klein I, 2001, NEW ENGL J MED, V344, P501, DOI 10.1056/NEJM200102153440707; Kubota S, 2006, ENDOCR J, V53, P603, DOI 10.1507/endocrj.K06-057; Lai A, 2010, J CLIN ENDOCR METAB, V95, P1333, DOI 10.1210/jc.2009-2130; LAURBERG P, 1991, J INTERN MED, V229, P415, DOI 10.1111/j.1365-2796.1991.tb00368.x; Ljunggren JG, 1998, THYROID, V8, P653, DOI 10.1089/thy.1998.8.653; Metso S, 2007, CANCER, V110, P1875, DOI 10.1002/cncr.23041; Metso S, 2007, CANCER, V109, P1972, DOI 10.1002/cncr.22635; *NUCL REG COMM, PREC PROT CHILDR WHO; Nygaard B, 1999, THYROID, V9, P477, DOI 10.1089/thy.1999.9.477; Nygaard B, 1999, CLIN ENDOCRINOL, V50, P197, DOI 10.1046/j.1365-2265.1999.00635.x; Nygaard B, 1999, ARCH INTERN MED, V159, P1364, DOI 10.1001/archinte.159.12.1364; Parma J, 1997, J CLIN ENDOCR METAB, V82, P2695, DOI 10.1210/jc.82.8.2695; PETERS H, 1995, EUR J CLIN INVEST, V25, P186, DOI 10.1111/j.1365-2362.1995.tb01547.x; Porterfield JR, 2008, WORLD J SURG, V32, P1278, DOI 10.1007/s00268-008-9566-0; Read CH, 2004, J CLIN ENDOCR METAB, V89, P4229, DOI 10.1210/jc.2003-031223; Ron E, 1998, JAMA-J AM MED ASSOC, V280, P347, DOI 10.1001/jama.280.4.347; ROSS DS, 1984, ANN INTERN MED, V101, P488, DOI 10.7326/0003-4819-101-4-488; ROSS DS, 1994, THYROID, V4, P319, DOI 10.1089/thy.1994.4.319; Siegel JA, 2008, J NUCL MED, V49, p17N; Silva JE, 2008, THYROID, V18, P157, DOI 10.1089/thy.2007.0252; SRIDAMA V, 1984, NEW ENGL J MED, V311, P426, DOI 10.1056/NEJM198408163110702; TALLSTEDT L, 1992, NEW ENGL J MED, V326, P1733, DOI 10.1056/NEJM199206253262603; TIBALDI JM, 1986, AM J MED, V81, P619, DOI 10.1016/0002-9343(86)90547-4; Torring O, 1996, J CLIN ENDOCR METAB, V81, P2986, DOI 10.1210/jc.81.8.2986; Traisk F, 2009, J CLIN ENDOCR METAB, V94, P3700, DOI 10.1210/jc.2009-0747; UY HL, 1995, AM J MED, V99, P173, DOI 10.1016/S0002-9343(99)80137-5; Walter MA, 2007, BRIT MED J, V334, P514, DOI 10.1136/bmj.39114.670150.BE; Wang C, 1997, ENDOCRIN METAB CLIN, V26, P189, DOI 10.1016/S0889-8529(05)70240-1; Wartofsky L, 1991, Thyroid, V1, P129, DOI 10.1089/thy.1991.1.129	49	84	102	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2011	364	6					542	550		10.1056/NEJMct1007101	http://dx.doi.org/10.1056/NEJMct1007101			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718QH	21306240				2022-12-28	WOS:000287139900008
J	Schreiber, A; Stengel, F; Zhang, ZG; Enchev, RI; Kong, EH; Morris, EP; Robinson, CV; da Fonseca, PCA; Barford, D				Schreiber, Anne; Stengel, Florian; Zhang, Ziguo; Enchev, Radoslav I.; Kong, Eric H.; Morris, Edward P.; Robinson, Carol V.; da Fonseca, Paula C. A.; Barford, David			Structural basis for the subunit assembly of the anaphase-promoting complex	NATURE			English	Article							CRYSTAL-STRUCTURE; EVOLUTIONARY CONSERVATION; SACCHAROMYCES-CEREVISIAE; PROTEIN; COMPLEX/CYCLOSOME; EXPRESSION; INSIGHTS; CYCLIN; VISUALIZATION; PURIFICATION	The anaphase-promoting complex or cyclosome (APC/C) is an unusually large E3 ubiquitin ligase responsible for regulating defined cell cycle transitions. Information on how its 13 constituent proteins are assembled, and how they interact with co-activators, substrates and regulatory proteins is limited. Here, we describe a recombinant expression system that allows the reconstitution of holo APC/C and its sub-complexes that, when combined with electron microscopy, mass spectrometry and docking of crystallographic and homology-derived coordinates, provides a precise definition of the organization and structure of all essential APC/C subunits, resulting in a pseudo-atomic model for 70% of the APC/C. A lattice-like appearance of the APC/C is generated by multiple repeat motifs of most APC/C subunits. Three conserved tetratricopeptide repeat (TPR) subunits (Cdc16, Cdc23 and Cdc27) share related superhelical homo-dimeric architectures that assemble to generate a quasi-symmetrical structure. Our structure explains how this TPR sub-complex, together with additional scaffolding subunits (Apc1, Apc4 and Apc5), coordinate the juxtaposition of the catalytic and substrate recognition module (Apc2, Apc11 and Apc10 (also known as Doc1)), and TPR-phosphorylation sites, relative to co-activator, regulatory proteins and substrates.	[Schreiber, Anne; Zhang, Ziguo; Enchev, Radoslav I.; Kong, Eric H.; Morris, Edward P.; da Fonseca, Paula C. A.; Barford, David] Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, London SW3 6JB, England; [Stengel, Florian; Robinson, Carol V.] Univ Oxford, Dept Chem, Oxford OX1 3TA, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Oxford	Barford, D (corresponding author), Inst Canc Res, Chester Beatty Labs, Sect Struct Biol, 237 Fulham Rd, London SW3 6JB, England.	david.barford@icr.ac.uk		Morris, Edward/0000-0003-3544-0041; Zhang, Ziguo/0000-0002-7268-9631; robinson, carol/0000-0001-7829-5505; Schreiber, Anne/0000-0001-6766-2808; da Fonseca, Paula/0000-0001-8656-5747; Stengel, Florian/0000-0003-1447-4509	Cancer Research UK; EU [HEALTH-F4-2008-201648]	Cancer Research UK(Cancer Research UK); EU(European Commission)	This work was funded by a Cancer Research UK grant to D. B. and EU FP7 PROSPECTS (Proteomics Specification in Space and Time) Grant HEALTH-F4-2008-201648 to C. V. R. We thank F. Beuron for help with electron microscopy and Jing Yang for help with insect cell expression.	Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Au SWN, 2002, J MOL BIOL, V316, P955, DOI 10.1006/jmbi.2002.5399; Berger I, 2004, NAT BIOTECHNOL, V22, P1583, DOI 10.1038/nbt1036; da Fonseca PCA, 2011, NATURE, V470, P274, DOI 10.1038/nature09625; Dube P, 2005, MOL CELL, V20, P867, DOI 10.1016/j.molcel.2005.11.008; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Eytan E, 2006, P NATL ACAD SCI USA, V103, P2081, DOI 10.1073/pnas.0510695103; Fitzgerald DJ, 2007, STRUCTURE, V15, P275, DOI 10.1016/j.str.2007.01.016; Fitzgerald DJ, 2006, NAT METHODS, V3, P1021, DOI 10.1038/nmeth983; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gloeckner CJ, 2007, PROTEOMICS, V7, P4228, DOI 10.1002/pmic.200700038; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Hall MC, 2003, J BIOL CHEM, V278, P16698, DOI 10.1074/jbc.M213109200; Han D, 2009, J BIOL CHEM, V284, P15137, DOI 10.1074/jbc.M804887200; Hayes MJ, 2006, NAT CELL BIOL, V8, P607, DOI 10.1038/ncb1410; Heckman KL, 2007, NAT PROTOC, V2, P924, DOI 10.1038/nprot.2007.132; Hernandez H, 2007, NAT PROTOC, V2, P715, DOI 10.1038/nprot.2007.73; Herzog F, 2009, SCIENCE, V323, P1477, DOI 10.1126/science.1163300; HIRANO T, 1990, CELL, V60, P319, DOI 10.1016/0092-8674(90)90746-2; Izawa D, 2011, NAT CELL BIOL, V13, P223, DOI 10.1038/ncb2165; Kimata Y, 2008, MOL CELL, V32, P576, DOI 10.1016/j.molcel.2008.09.023; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Lupas A, 1997, TRENDS BIOCHEM SCI, V22, P195, DOI 10.1016/S0968-0004(97)01058-X; Matyskiela ME, 2009, MOL CELL, V34, P68, DOI 10.1016/j.molcel.2009.02.027; Mckay AR, 2006, J AM CHEM SOC, V128, P11433, DOI 10.1021/ja061468q; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; Oelschlaegel T, 2005, CELL, V120, P773, DOI 10.1016/j.cell.2005.01.032; Ohi MD, 2007, MOL CELL, V28, P871, DOI 10.1016/j.molcel.2007.10.003; Passmore LA, 2005, MOL CELL, V20, P855, DOI 10.1016/j.molcel.2005.11.003; Passmore LA, 2005, METHOD ENZYMOL, V398, P195, DOI 10.1016/S0076-6879(05)98017-8; Passmore LA, 2005, EMBO REP, V6, P873, DOI 10.1038/sj.embor.7400482; Passmore LA, 2003, EMBO J, V22, P786, DOI 10.1093/emboj/cdg084; Penczek PA, 2006, J STRUCT BIOL, V154, P168, DOI 10.1016/j.jsb.2006.01.003; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfleger CM, 2000, GENE DEV, V14, P655; Schwab M, 2001, EMBO J, V20, P5165, DOI 10.1093/emboj/20.18.5165; Schwickart M, 2004, MOL CELL BIOL, V24, P3562, DOI 10.1128/MCB.24.8.3562-3576.2004; SIKORSKI RS, 1993, MOL CELL BIOL, V13, P1212, DOI 10.1128/MCB.13.2.1212; SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z; Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552; Steen JAJ, 2008, P NATL ACAD SCI USA, V105, P6069, DOI 10.1073/pnas.0709807104; Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276; Taverner T, 2008, ACCOUNTS CHEM RES, V41, P617, DOI 10.1021/ar700218q; Thornton BR, 2006, GENE DEV, V20, P449, DOI 10.1101/gad.1396906; Thornton BR, 2006, GENE DEV, V20, P3069, DOI 10.1101/gad.1478306; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; Vodermaier HC, 2003, CURR BIOL, V13, P1459, DOI 10.1016/S0960-9822(03)00581-5; Wang J, 2009, NAT STRUCT MOL BIOL, V16, P987, DOI 10.1038/nsmb.1645; Warrens AN, 1997, GENE, V186, P29, DOI 10.1016/S0378-1119(96)00674-9; Wendt KS, 2001, NAT STRUCT BIOL, V8, P784, DOI 10.1038/nsb0901-784; Wolthuis R, 2008, MOL CELL, V30, P290, DOI 10.1016/j.molcel.2008.02.027; Zhang ZG, 2010, EMBO J, V29, P3733, DOI 10.1038/emboj.2010.247; Zhang ZG, 2010, J MOL BIOL, V397, P1316, DOI 10.1016/j.jmb.2010.02.045	56	135	142	1	49	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					227	+		10.1038/nature09756	http://dx.doi.org/10.1038/nature09756			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307936				2022-12-28	WOS:000287144200037
J	Arria, AM; O'Brien, MC				Arria, Amelia M.; O'Brien, Mary Claire			The "High" Risk of Energy Drinks	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							COLLEGE-STUDENTS; CAFFEINE INTAKE; ADOLESCENTS; CONSUMPTION		[Arria, Amelia M.] Univ Maryland, Sch Publ Hlth, Dept Family Sci, Ctr Young Adult Hlth & Dev, College Pk, MD 20742 USA; [Arria, Amelia M.] Treatment Res Inst, Philadelphia, PA USA; [O'Brien, Mary Claire] Wake Forest Univ, Sch Med, Dept Emergency Med, Winston Salem, NC 27109 USA	University System of Maryland; University of Maryland College Park; Wake Forest University	Arria, AM (corresponding author), Univ Maryland, Sch Publ Hlth, Dept Family Sci, Ctr Young Adult Hlth & Dev, 1142 Sch Publ Hlth Bldg, College Pk, MD 20742 USA.	aarria@umd.edu		Arria, Amelia/0000-0002-6360-9265	NIAAA NIH HHS [R01 AA014007, R01 AA014007-06A1, R01AA14007] Funding Source: Medline; NIDA NIH HHS [R01 DA014845-08, R01 DA014845, R01 DA014845-07, R01DA14845] Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA014007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014845] Funding Source: NIH RePORTER	NIAAA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ARRIA AM, COMMUNICATION; Arria AM, 2011, ALCOHOL CLIN EXP RES, V35, P1; Arria AM, 2010, J ADDICT MED, V4, P74, DOI 10.1097/ADM.0b013e3181aa8dd4; Ferreira SE, 2006, ALCOHOL CLIN EXP RES, V30, P598, DOI 10.1111/j.1530-0277.2006.00070.x; Greenwood DC, 2010, EUR J EPIDEMIOL, V25, P275, DOI 10.1007/s10654-010-9443-7; Miller KE, 2008, J ADOLESCENT HEALTH, V43, P490, DOI 10.1016/j.jadohealth.2008.03.003; O'Brien MC, 2008, ACAD EMERG MED, V15, P453, DOI 10.1111/j.1553-2712.2008.00085.x; Orbeta RL, 2006, J ADOLESCENT HEALTH, V38, P451, DOI 10.1016/j.jadohealth.2005.05.014; Reissig CJ, 2009, DRUG ALCOHOL DEPEN, V99, P1, DOI 10.1016/j.drugalcdep.2008.08.001; Savoca MR, 2005, AM J HYPERTENS, V18, P116, DOI 10.1016/j.amjhyper.2004.08.011	10	122	132	1	28	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2011	305	6					600	601		10.1001/jama.2011.109	http://dx.doi.org/10.1001/jama.2011.109			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	717XI	21266673	Green Accepted			2022-12-28	WOS:000287080500025
J	Myall, K; Sidney, J; Marsh, A				Myall, Katherine; Sidney, James; Marsh, Aidan			Mind the gap! An unusual metabolic acidosis	LANCET			English	Editorial Material							PYROGLUTAMIC ACIDURIA		[Myall, Katherine; Sidney, James; Marsh, Aidan] Frenchay Hosp, Dept Anaesthesia, Bristol BS16 1LE, Avon, England		Myall, K (corresponding author), Frenchay Hosp, Dept Anaesthesia, Bristol BS16 1LE, Avon, England.	katemyall@gmail.com						Croal BL, 1998, CLIN CHEM, V44, P336; Dempsey GA, 2000, CRIT CARE MED, V28, P1803, DOI 10.1097/00003246-200006000-00018; Peter JV, 2006, MED J AUSTRALIA, V185, P223, DOI 10.5694/j.1326-5377.2006.tb00537.x; PITT JJ, 1990, J INHERIT METAB DIS, V13, P755, DOI 10.1007/BF01799581	4	15	15	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 5	2011	377	9764					526	526		10.1016/S0140-6736(10)61383-9	http://dx.doi.org/10.1016/S0140-6736(10)61383-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721TX	21296238				2022-12-28	WOS:000287381800034
J	Coleman, JN; Lotya, M; O'Neill, A; Bergin, SD; King, PJ; Khan, U; Young, K; Gaucher, A; De, S; Smith, RJ; Shvets, IV; Arora, SK; Stanton, G; Kim, HY; Lee, K; Kim, GT; Duesberg, GS; Hallam, T; Boland, JJ; Wang, JJ; Donegan, JF; Grunlan, JC; Moriarty, G; Shmeliov, A; Nicholls, RJ; Perkins, JM; Grieveson, EM; Theuwissen, K; McComb, DW; Nellist, PD; Nicolosi, V				Coleman, Jonathan N.; Lotya, Mustafa; O'Neill, Arlene; Bergin, Shane D.; King, Paul J.; Khan, Umar; Young, Karen; Gaucher, Alexandre; De, Sukanta; Smith, Ronan J.; Shvets, Igor V.; Arora, Sunil K.; Stanton, George; Kim, Hye-Young; Lee, Kangho; Kim, Gyu Tae; Duesberg, Georg S.; Hallam, Toby; Boland, John J.; Wang, Jing Jing; Donegan, John F.; Grunlan, Jaime C.; Moriarty, Gregory; Shmeliov, Aleksey; Nicholls, Rebecca J.; Perkins, James M.; Grieveson, Eleanor M.; Theuwissen, Koenraad; McComb, David W.; Nellist, Peter D.; Nicolosi, Valeria			Two-Dimensional Nanosheets Produced by Liquid Exfoliation of Layered Materials	SCIENCE			English	Article							ELECTRICAL-CONDUCTIVITY; MOS2; NANOCOMPOSITES; GRAPHENE; PERFORMANCE; COMPOSITES; DEPOSITION; TELLURIDE; FILMS	If they could be easily exfoliated, layered materials would become a diverse source of two-dimensional crystals whose properties would be useful in applications ranging from electronics to energy storage. We show that layered compounds such as MoS(2), WS(2), MoSe(2), MoTe(2), TaSe(2), NbSe(2), NiTe(2), BN, and Bi(2)Te(3) can be efficiently dispersed in common solvents and can be deposited as individual flakes or formed into films. Electron microscopy strongly suggests that the material is exfoliated into individual layers. By blending this material with suspensions of other nanomaterials or polymer solutions, we can prepare hybrid dispersions or composites, which can be cast into films. We show that WS(2) and MoS(2) effectively reinforce polymers, whereas WS(2)/carbon nanotube hybrid films have high conductivity, leading to promising thermoelectric properties.	[Coleman, Jonathan N.; Lotya, Mustafa; O'Neill, Arlene; Bergin, Shane D.; King, Paul J.; Khan, Umar; Young, Karen; Gaucher, Alexandre; De, Sukanta; Smith, Ronan J.; Shvets, Igor V.; Arora, Sunil K.; Stanton, George; Wang, Jing Jing; Donegan, John F.] Trinity Coll Dublin, Sch Phys, Dublin D2, Ireland; [Coleman, Jonathan N.; Lotya, Mustafa; O'Neill, Arlene; Bergin, Shane D.; King, Paul J.; Khan, Umar; Young, Karen; Gaucher, Alexandre; De, Sukanta; Smith, Ronan J.; Shvets, Igor V.; Arora, Sunil K.; Stanton, George; Kim, Hye-Young; Lee, Kangho; Duesberg, Georg S.; Hallam, Toby; Boland, John J.; Wang, Jing Jing; Donegan, John F.] Trinity Coll Dublin, CRANN, Dublin D2, Ireland; [Kim, Hye-Young; Lee, Kangho; Duesberg, Georg S.; Hallam, Toby; Boland, John J.] Trinity Coll Dublin, Sch Chem, Dublin D2, Ireland; [Kim, Hye-Young; Lee, Kangho; Kim, Gyu Tae] Korea Univ, Sch Elect Engn, Seoul, South Korea; [Grunlan, Jaime C.; Moriarty, Gregory] Texas A&M Univ, Dept Mech Engn, College Stn, TX 77843 USA; [Shmeliov, Aleksey; Nicholls, Rebecca J.; Grieveson, Eleanor M.; Theuwissen, Koenraad; Nellist, Peter D.; Nicolosi, Valeria] Univ Oxford, Dept Mat, Oxford OX1 3PH, England; [Bergin, Shane D.; Perkins, James M.; McComb, David W.] Univ London Imperial Coll Sci Technol & Med, Dept Mat, London SW7 2AZ, England	Trinity College Dublin; Trinity College Dublin; Trinity College Dublin; Korea University; Texas A&M University System; Texas A&M University College Station; University of Oxford; Imperial College London	Coleman, JN (corresponding author), Trinity Coll Dublin, Sch Phys, Dublin D2, Ireland.	colemaj@tcd.ie; valeria.nicolosi@materials.ox.ac.uk	Kim, Gyu Tae/GPC-4902-2022; Bergin, Shane/C-7060-2011; Lee, Kangho/H-3879-2013; Shvets, Igor V/J-8710-2013; O'Neill, Arlene/F-2581-2013; Wang, Jing Jing J/F-8303-2010; Duesberg, Georg S/M-5946-2016; Grunlan, Jaime C/K-3242-2016; Nicolosi, Valeria/Y-2419-2019; Duesberg, Georg/AAA-7540-2020; Khan, Umar/ABG-7594-2020; Boland, John/AAB-8498-2022; Arora, Sunil/X-2238-2019; Wang, Jing Jing/C-6165-2009; Boland, John J/P-9740-2016; King, Paul/A-6766-2011; De, Sukanta/B-1822-2009; Arora, Sunil/B-8663-2008; Coleman, Jonathan N/B-8403-2011; McComb, David W/A-7808-2010	Bergin, Shane/0000-0003-1527-3004; Shvets, Igor V/0000-0001-7451-5435; Duesberg, Georg S/0000-0002-7412-700X; Grunlan, Jaime C/0000-0001-5241-9741; Duesberg, Georg/0000-0002-7412-700X; Boland, John/0000-0002-3229-8038; Arora, Sunil/0000-0002-4061-159X; Wang, Jing Jing/0000-0001-5721-7989; Boland, John J/0000-0002-3229-8038; Coleman, Jonathan N/0000-0001-9659-9721; Gallagher, Arlene/0000-0002-1745-6739; Donegan, John/0000-0002-5240-1434; Theuwissen, Koenraad/0000-0002-4085-8920; Nicolosi, Valeria/0000-0002-7637-4813; Lee, Kangho/0000-0002-6495-5231; Khan, Umar/0000-0002-2587-3604; Hallam, Toby/0000-0003-2327-6715	Irish Research Council for Science, Engineering & Technology (Embark Initiative); European Research Council; Science Foundation Ireland [07/IN.7/I1772]; Marie Curie grant [PIEF-GA-2008-220150]; Royal Academy of Engineering/Engineering and Physical Sciences Research Council; EPSRC [EP/F05677X/1, EP/H045090/1, EP/H046550/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F05677X/1, EP/H045090/1, EP/H046550/1] Funding Source: researchfish	Irish Research Council for Science, Engineering & Technology (Embark Initiative)(Irish Research Council for Science, Engineering and Technology); European Research Council(European Research Council (ERC)European Commission); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Marie Curie grant(European Commission); Royal Academy of Engineering/Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	The authors acknowledge the Irish Research Council for Science, Engineering & Technology (Embark Initiative), the European Research Council, and Science Foundation Ireland (grant number 07/IN.7/I1772) for financial support. V.N. acknowledges funding from the Marie Curie grant PIEF-GA-2008-220150 and the Royal Academy of Engineering/Engineering and Physical Sciences Research Council and thanks BegbrokeNano for their provision of research facilities.	Ayari A, 2007, J APPL PHYS, V101, DOI 10.1063/1.2407388; Benavente E, 2004, PHYS STATUS SOLIDI B, V241, P2444, DOI 10.1002/pssb.200304899; Bergin SD, 2008, ADV MATER, V20, P1876, DOI 10.1002/adma.200702451; Bergin SD, 2009, ACS NANO, V3, P2340, DOI 10.1021/nn900493u; BISSESUR R, 1993, J CHEM SOC CHEM COMM, V20, P1582; Clerc F, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/35/355002; Dresselhaus MS, 2007, ADV MATER, V19, P1043, DOI 10.1002/adma.200600527; Ellmer K, 1997, J CRYST GROWTH, V182, P389, DOI 10.1016/S0022-0248(97)00355-2; Frey GL, 2003, J AM CHEM SOC, V125, P5998, DOI 10.1021/ja020913o; Frindt RF, 1998, MOL CRYST LIQ CRYS A, V311, P367, DOI 10.1080/10587259808042412; GAMBLE FR, 1975, J CHEM PHYS, V63, P2544, DOI 10.1063/1.431645; Geim AK, 2009, SCIENCE, V324, P1530, DOI 10.1126/science.1158877; Gordon RA, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.125407; Hernandez Y, 2008, NAT NANOTECHNOL, V3, P563, DOI 10.1038/nnano.2008.215; JOENSEN P, 1986, MATER RES BULL, V21, P457, DOI 10.1016/0025-5408(86)90011-5; Khan U, 2010, CARBON, V48, P4035, DOI 10.1016/j.carbon.2010.07.008; Lee C, 2010, ACS NANO, V4, P2695, DOI 10.1021/nn1003937; LEMMON JP, 1995, ELECTROCHIM ACTA, V40, P2245, DOI 10.1016/0013-4686(95)00171-A; Liff SM, 2007, NAT MATER, V6, P76, DOI 10.1038/nmat1798; LIU C, 1984, THIN SOLID FILMS, V113, P165, DOI 10.1016/0040-6090(84)90025-7; Marseglia E. A., 1983, INT REV PHYS CHEM, V3, P177, DOI [10.1080/01442358309353343, DOI 10.1080/01442358309353343]; Matte HSSR, 2010, ANGEW CHEM INT EDIT, V49, P4059, DOI 10.1002/anie.201000009; Mishra SK, 1997, J PHYS-CONDENS MAT, V9, P461, DOI 10.1088/0953-8984/9/2/014; Nag A, 2010, ACS NANO, V4, P1539, DOI 10.1021/nn9018762; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Osada M, 2009, J MATER CHEM, V19, P2503, DOI 10.1039/b820160a; Ponomarev EA, 1996, THIN SOLID FILMS, V280, P86, DOI 10.1016/0040-6090(95)08204-2; Poudel B, 2008, SCIENCE, V320, P634, DOI 10.1126/science.1156446; Ruoff R, 2008, NAT NANOTECHNOL, V3, P10, DOI 10.1038/nnano.2007.432; Splendiani A, 2010, NANO LETT, V10, P1271, DOI 10.1021/nl903868w; Wilcoxon JP, 1997, J APPL PHYS, V81, P7934, DOI 10.1063/1.365367; WILSON JA, 1969, ADV PHYS, V18, P193, DOI 10.1080/00018736900101307; Xu BH, 2007, ELECTROCHIM ACTA, V52, P3028, DOI 10.1016/j.electacta.2006.09.046; Zhi CY, 2009, ADV MATER, V21, P2889, DOI 10.1002/adma.200900323	34	5335	5502	181	8791	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					568	571		10.1126/science.1194975	http://dx.doi.org/10.1126/science.1194975			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292974				2022-12-28	WOS:000286933600049
J	Sasaki, T; Matsuki, N; Ikegaya, Y				Sasaki, Takuya; Matsuki, Norio; Ikegaya, Yuji			Action-Potential Modulation During Axonal Conduction	SCIENCE			English	Article							HIPPOCAMPAL SYNAPSES; TRANSMITTER RELEASE; ASTROCYTES; RECEPTORS	Once initiated near the soma, an action potential (AP) is thought to propagate autoregeneratively and distribute uniformly over axonal arbors. We challenge this classic view by showing that APs are subject to waveform modulation while they travel down axons. Using fluorescent patch-clamp pipettes, we recorded APs from axon branches of hippocampal CA3 pyramidal neurons ex vivo. The waveforms of axonal APs increased in width in response to the local application of glutamate and an adenosine A(1) receptor antagonist to the axon shafts, but not to other unrelated axon branches. Uncaging of calcium in periaxonal astrocytes caused AP broadening through ionotropic glutamate receptor activation. The broadened APs triggered larger calcium elevations in presynaptic boutons and facilitated synaptic transmission to postsynaptic neurons. This local AP modification may enable axonal computation through the geometry of axon wiring.	[Sasaki, Takuya; Matsuki, Norio; Ikegaya, Yuji] Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo 1130033, Japan; [Ikegaya, Yuji] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan	University of Tokyo; Japan Science & Technology Agency (JST)	Ikegaya, Y (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Chem Pharmacol Lab, Tokyo 1130033, Japan.	ikegaya@mol.f.u-tokyo.ac.jp	Sasaki, Takuya/J-3283-2015	Ikegaya, Yuji/0000-0003-2260-8191	Ministry of Education, Culture, Sports, Science, and Technology of Japan [22115003, 22650080, 22680025]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Science Research (nos. 22115003, 22650080, and 22680025) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. T.S. collected experimental data and carried out the data analysis. Y.I. conceived the project and carried out the data analysis. T.S. and Y.I. wrote the manuscript. N.M. supervised the project and provided feedback on the manuscript.	Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055; Cunha RA, 2001, NEUROCHEM INT, V38, P107, DOI 10.1016/S0197-0186(00)00034-6; Engelman HS, 2004, NAT REV NEUROSCI, V5, P135, DOI 10.1038/nrn1297; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Henneberger C, 2010, NATURE, V463, P232, DOI 10.1038/nature08673; Ishikawa D, 2010, NEURAL NETWORKS, V23, P669, DOI 10.1016/j.neunet.2010.02.004; Jourdain P, 2007, NAT NEUROSCI, V10, P331, DOI 10.1038/nn1849; Kang J, 1998, NAT NEUROSCI, V1, P683, DOI 10.1038/3684; Kole MHP, 2007, NEURON, V55, P633, DOI 10.1016/j.neuron.2007.07.031; Liu QS, 2004, P NATL ACAD SCI USA, V101, P3172, DOI 10.1073/pnas.0306731101; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Schicker K W, 2008, Curr Mol Pharmacol, V1, P106; Shu YS, 2007, P NATL ACAD SCI USA, V104, P11453, DOI 10.1073/pnas.0702041104; Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720; Ventura R, 1999, J NEUROSCI, V19, P6897, DOI 10.1523/JNEUROSCI.19-16-06897.1999	15	148	151	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					599	601		10.1126/science.1197598	http://dx.doi.org/10.1126/science.1197598			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292979				2022-12-28	WOS:000286933600058
J	Wang, W; Barnaby, JY; Tada, Y; Li, H; Tor, M; Caldelari, D; Lee, DU; Fu, XD; Dong, XN				Wang, Wei; Barnaby, Jinyoung Yang; Tada, Yasuomi; Li, Hairi; Toer, Mahmut; Caldelari, Daniela; Lee, Dae-un; Fu, Xiang-Dong; Dong, Xinnian			Timing of plant immune responses by a central circadian regulator	NATURE			English	Article							DOWNY MILDEW RESISTANCE; PERONOSPORA-PARASITICA; CELL-DEATH; ARABIDOPSIS; RHYTHMS; GENES; TRANSCRIPTION; EXPRESSION; MUTANT; BAK1	The principal immune mechanism against biotrophic pathogens in plants is the resistance (R)-gene-mediated defence(1). It was proposed to share components with the broad-spectrum basal defence machinery(2). However, the underlying molecular mechanism is largely unknown. Here we report the identification of novel genes involved in R-gene-mediated resistance against downy mildew in Arabidopsis and their regulatory control by the circadian regulator, CIRCADIAN CLOCK-ASSOCIATED 1 (CCA1). Numerical clustering based on phenotypes of these gene mutants revealed that programmed cell death (PCD) is the major contributor to resistance. Mutants compromised in the R-gene-mediated PCD were also defective in basal resistance, establishing an interconnection between these two distinct defence mechanisms. Surprisingly, we found that these new defence genes are under circadian control by CCA1, allowing plants to 'anticipate' infection at dawn when the pathogen normally disperses the spores and time immune responses according to the perception of different pathogenic signals upon infection. Temporal control of the defence genes by CCA1 differentiates their involvement in basal and R-gene-mediated defence. Our study has revealed a key functional link between the circadian clock and plant immunity.	[Wang, Wei; Barnaby, Jinyoung Yang; Tada, Yasuomi; Caldelari, Daniela; Lee, Dae-un; Dong, Xinnian] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Li, Hairi; Fu, Xiang-Dong] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Toer, Mahmut] Univ Worcester, NPARU, Henwick Grove WR2 6AJ, Worcester, England	Duke University; University of California System; University of California San Diego; University of Worcester	Dong, XN (corresponding author), Duke Univ, Dept Biol, POB 90338, Durham, NC 27708 USA.	xdong@duke.edu	Wang, Wei/I-5230-2015; Wang, Wei/F-7425-2013; Tada, Yasuomi/M-5041-2014; Tor, Mahmut/AAF-6449-2020; Tor, Mahmut/AAU-4624-2020	Wang, Wei/0000-0002-3780-5158; Tor, Mahmut/0000-0002-4416-5048; Tada, Yasuomi/0000-0001-9900-069X; Barnaby, Jinyoung/0000-0001-6507-9985; LEE, DAEUN/0000-0002-8517-7010	NSF [MCB-0519898, HG004659]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank S. Brady for performing mixed model ANOVA of the data and advice on data analyses; J. Li for sharing the protocol for elf18 treatment, E. Tobin for providing the CCA1<INF>OE</INF> transgenic line, R. McClung for CCA1:LUC, LHY:LUC, ztl-4 lines. H. Lu for helpful discussion of the work, F. Ausubel, P. Benfey, S. Brady, J. Siedow and R. Mohan for critiquing the manuscript. This work was supported by a grant from NSF (MCB-0519898) to X.D. and a grant (HG004659) to X.-D.F.	Adam L, 1996, PLANT J, V9, P341, DOI 10.1046/j.1365-313X.1996.09030341.x; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Bryant PA, 2004, NAT REV IMMUNOL, V4, P457, DOI 10.1038/nri1369; CAO H, 1994, PLANT CELL, V6, P1583, DOI 10.1105/tpc.6.11.1583; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Donofrio NM, 2001, MOL PLANT MICROBE IN, V14, P439, DOI 10.1094/MPMI.2001.14.4.439; Harmer SL, 2000, SCIENCE, V290, P2110, DOI 10.1126/science.290.5499.2110; Harmer SL, 2005, PLANT CELL, V17, P1926, DOI 10.1105/tpc.105.033035; Heese A, 2007, P NATL ACAD SCI USA, V104, P12217, DOI 10.1073/pnas.0705306104; HOLUB EB, 1994, MOL PLANT MICROBE IN, V7, P223, DOI 10.1094/MPMI-7-0223; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kemmerling B, 2007, CURR BIOL, V17, P1116, DOI 10.1016/j.cub.2007.05.046; Lam E, 2001, NATURE, V411, P848, DOI 10.1038/35081184; McDowell JM, 2000, PLANT J, V22, P523, DOI 10.1046/j.1365-313x.2000.00771.x; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Roden LC, 2009, PLANT CELL, V21, P2546, DOI 10.1105/tpc.109.069922; Salome PA, 2005, PLANT CELL, V17, P791, DOI 10.1105/tpc.104.029504; Schaffer R, 1998, CELL, V93, P1219, DOI 10.1016/S0092-8674(00)81465-8; Slusarenko AJ, 2003, MOL PLANT PATHOL, V4, P159, DOI 10.1046/j.1364-3703.2003.00166.x; Suzuki R, 2006, BIOINFORMATICS, V22, P1540, DOI 10.1093/bioinformatics/btl117; Tamayo P, 2007, P NATL ACAD SCI USA, V104, P5959, DOI 10.1073/pnas.0701068104; Tao Y, 2003, PLANT CELL, V15, P317, DOI 10.1105/tpc.007591; Tor M, 2002, PLANT CELL, V14, P993, DOI 10.1105/tpc.001123; van der Biezen EA, 2002, PLANT J, V29, P439, DOI 10.1046/j.0960-7412.2001.01229.x; Wang ZY, 1998, CELL, V93, P1207, DOI 10.1016/S0092-8674(00)81464-6; Yeakley JM, 2002, NAT BIOTECHNOL, V20, P353, DOI 10.1038/nbt0402-353	27	307	326	8	176	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					110	U126		10.1038/nature09766	http://dx.doi.org/10.1038/nature09766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293378	Green Accepted			2022-12-28	WOS:000286886400044
J	Yeung, WCG; Rawlinson, WD; Craig, ME				Yeung, Wing-Chi G.; Rawlinson, William D.; Craig, Maria E.			Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies	BMJ-BRITISH MEDICAL JOURNAL			English	Review							BETA-CELL AUTOIMMUNITY; COXSACKIE-B-VIRUS; AUTOANTIBODY-POSITIVE SUBJECTS; BLOOD MONONUCLEAR-CELLS; RNA SEQUENCES; RISK-FACTOR; GENERAL-POPULATION; CHILDREN; ONSET; SERUM	Objective To review the association between current enterovirus infection diagnosed with molecular testing and development of autoimmunity or type 1 diabetes. Design Systematic review and meta-analysis of observational studies, analysed with random effects models. Data sources PubMed (until May 2010) and Embase (until May 2010), no language restrictions, studies in humans only; reference lists of identified articles; and contact with authors. Study eligibility criteria Cohort or case-control studies measuring enterovirus RNA or viral protein in blood, stool, or tissue of patients with pre-diabetes and diabetes, with adequate data to calculate an odds ratio and 95% confidence intervals. Results The 24 papers and two abstracts (all case-control studies) that met the eligibility criteria included 4448 participants. Study design varied greatly, with a high level of statistical heterogeneity. The two separate outcomes were diabetes related autoimmunity or type 1 diabetes. Meta-analysis showed a significant association between enterovirus infection and type 1 diabetes related autoimmunity (odds ratio 3.7, 95% confidence interval 2.1 to 6.8; heterogeneity X-2/df=1.3) and clinical type 1 diabetes (9.8, 5.5 to 17.4; X-2/df=3.2). Conclusions There is a clinically significant association between enterovirus infection, detected with molecular methods, and autoimmunity/type 1 diabetes. Larger prospective studies would be needed to establish a clear temporal relation between enterovirus infection and the development of autoimmunity and type 1 diabetes.	[Craig, Maria E.] Childrens Hosp, Inst Endocrinol & Diabet, Westmead, NSW 2145, Australia; [Yeung, Wing-Chi G.; Rawlinson, William D.] Univ New S Wales, Fac Med, Sydney, NSW 2052, Australia; [Rawlinson, William D.; Craig, Maria E.] Prince Wales Hosp, Virol Res POWH & UNSW Res Labs, Randwick, NSW 2031, Australia; [Craig, Maria E.] Univ Sydney, Discipline Paediat & Child Hlth, Sydney, NSW 2006, Australia	University of Sydney; University of New South Wales Sydney; University of Sydney	Craig, ME (corresponding author), Childrens Hosp, Inst Endocrinol & Diabet, Locked Bag 4001, Westmead, NSW 2145, Australia.	m.craig@unsw.edu.au		Yeung, Wing Chi Gigi/0000-0002-3387-3743; Rawlinson, William/0000-0003-0988-7827; Craig, Maria E/0000-0001-6004-576X				Al-Shaheeb A, 2010, DIABETES S1, V59, pA; Andreoletti L, 1997, J MED VIROL, V52, P121, DOI 10.1002/(SICI)1096-9071(199706)52:2&lt;121::AID-JMV1&gt;3.0.CO;2-5; [Anonymous], 2016, NEWCASTLEOTTAWA SCAL; Australian Government: National Health Medical Research Council (NHMRC), 2009, NHMRC ADD LEV EV GRA; Barker JM, 2004, J CLIN ENDOCR METAB, V89, P3896, DOI 10.1210/jc.2003-031887; Bener A, 2009, ACTA DIABETOL, V46, P183, DOI 10.1007/s00592-008-0071-6; Bessaoud K, 2006, DIABETIC MED, V23, P857, DOI 10.1111/j.1464-5491.2006.01925.x; BUESAGOMEZ J, 1994, J MED VIROL, V42, P193, DOI 10.1002/jmv.1890420217; Chong JW, 2007, PEDIATR DIABETES, V8, P67, DOI 10.1111/j.1399-5448.2007.00229.x; CLEMENTS GB, 1995, LANCET, V346, P221, DOI 10.1016/S0140-6736(95)91270-3; Couper JJ, 2009, DIABETES CARE, V32, P94, DOI 10.2337/dc08-0821; Coutant R, 2002, DIABETIC MED, V19, P968, DOI 10.1046/j.1464-5491.2002.00807_2.x; Craig ME, 2003, J INFECT DIS, V187, P1562, DOI 10.1086/374742; Dahlquist GG, 2004, DIABETES CARE, V27, P285, DOI 10.2337/diacare.27.1.285; Dotta F, 2007, P NATL ACAD SCI USA, V104, P5115, DOI 10.1073/pnas.0700442104; Filippi CM, 2008, DIABETES, V57, P2863, DOI 10.2337/db07-1023; FOULIS AK, 1990, DIABETOLOGIA, V33, P290, DOI 10.1007/BF00403323; FOY CA, 1995, DIABETIC MED, V12, P1002, DOI 10.1111/j.1464-5491.1995.tb00413.x; GAMBLE DR, 1969, BRIT MED J, V3, P627, DOI 10.1136/bmj.3.5671.627; Graves PM, 2003, DIABETES RES CLIN PR, V59, P51, DOI 10.1016/S0168-8227(02)00198-5; Green A, 2000, LANCET, V355, P873; Green A, 2001, DIABETOLOGIA, V44, pB3, DOI 10.1007/PL00002950; Green J, 2004, DIABETIC MED, V21, P507, DOI 10.1111/j.1464-5491.2004.01182.x; HADDEN DR, 1972, BMJ-BRIT MED J, V4, P729, DOI 10.1136/bmj.4.5842.729-a; HELFAND RF, 1995, J INFECT DIS, V172, P1206, DOI 10.1093/infdis/172.5.1206; Hiltunen M, 1997, J INFECT DIS, V175, P554, DOI 10.1093/infdis/175.3.554; Hober D, 2010, NAT REV ENDOCRINOL, V6, P279, DOI 10.1038/nrendo.2010.27; Hummel M, 2004, ANN INTERN MED, V140, P882, DOI 10.7326/0003-4819-140-11-200406010-00009; HYOTY H, 1995, DIABETES, V44, P652, DOI 10.2337/diabetes.44.6.652; Iturriza-Gomara M, 2006, J MED VIROL, V78, P243, DOI 10.1002/jmv.20533; Jacques J, 2008, J CLIN MICROBIOL, V46, P206, DOI 10.1128/JCM.01414-07; Juhela S, 2000, DIABETES, V49, P1308, DOI 10.2337/diabetes.49.8.1308; Kawashima H, 2004, J INFECTION, V49, P147, DOI 10.1016/j.jinf.2004.01.012; Kimpimaki T, 2001, J CLIN ENDOCR METAB, V86, P4782, DOI 10.1210/jc.86.10.4782; Lonnrot M, 2000, DIABETES, V49, P1314, DOI 10.2337/diabetes.49.8.1314; Lonnrot M, 2000, J MED VIROL, V61, P214, DOI 10.1002/(SICI)1096-9071(200006)61:2&lt;214::AID-JMV7&gt;3.0.CO;2-9; Luopajarvi K, 2008, PEDIATR DIABETES, V9, P434, DOI 10.1111/j.1399-5448.2008.00413.x; Maha M M, 2003, J Egypt Public Health Assoc, V78, P305; Moya-Suri V, 2005, J MED MICROBIOL, V54, P879, DOI 10.1099/jmm.0.46015-0; Nairn C, 1999, DIABETIC MED, V16, P509, DOI 10.1046/j.1464-5491.1999.00098.x; Oikarinen M, 2008, CLIN EXP IMMUNOL, V151, P71, DOI 10.1111/j.1365-2249.2007.03529.x; Patterson CC, 2009, LANCET, V373, P2027, DOI 10.1016/S0140-6736(09)60568-7; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; Rotbart HA, 2000, ARCH FAM MED, V9, P913, DOI 10.1001/archfami.9.9.913; Sadeharju K, 2003, CLIN EXP IMMUNOL, V132, P271, DOI 10.1046/j.1365-2249.2003.02147.x; Salminen K, 2003, J MED VIROL, V69, P91, DOI 10.1002/jmv.10260; Salminen KK, 2004, DIABETIC MED, V21, P156, DOI 10.1111/j.1464-5491.2004.01097.x; Sarmiento L, 2007, AUTOIMMUNITY, V40, P540, DOI 10.1080/08916930701523429; Schulte BM, 2010, VIRAL IMMUNOL, V23, P99, DOI 10.1089/vim.2009.0072; Taplin CE, 2005, MED J AUSTRALIA, V183, P243, DOI 10.5694/j.1326-5377.2005.tb07028.x; Toniolo A, 2010, AM SOC MICR M SAN DI; Tseng FC, 2007, J MED VIROL, V79, P1850, DOI 10.1002/jmv.21006; TUVEMO T, 1989, DIABETOLOGIA, V32, P745, DOI 10.1007/BF00274535; van Doornum GJJ, 2007, J MED VIROL, V79, P1868, DOI 10.1002/jmv.21031; WAGENKNECHT LE, 1991, AM J EPIDEMIOL, V133, P1024, DOI 10.1093/oxfordjournals.aje.a115811; Yin H, 2002, DIABETES, V51, P1964, DOI 10.2337/diabetes.51.6.1964; Ylipaasto P, 2004, DIABETOLOGIA, V47, P225, DOI 10.1007/s00125-003-1297-z; YOON JW, 1979, NEW ENGL J MED, V300, P1173, DOI 10.1056/NEJM197905243002102	58	311	315	0	47	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2011	342								d35	10.1136/bmj.d35	http://dx.doi.org/10.1136/bmj.d35			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718PW	21292721	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000287138500005
J	Muller, D				Muller, David			Haiti	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												david.muller@mssm.edu							0	5	5	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2011	305	5					447	448		10.1001/jama.2011.31	http://dx.doi.org/10.1001/jama.2011.31			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	714LI	21285416				2022-12-28	WOS:000286810700001
J	Armitage, SJ; Jasim, SA; Marks, AE; Parker, AG; Usik, VI; Uerpmann, HP				Armitage, Simon J.; Jasim, Sabah A.; Marks, Anthony E.; Parker, Adrian G.; Usik, Vitaly I.; Uerpmann, Hans-Peter			The Southern Route "Out of Africa": Evidence for an Early Expansion of Modern Humans into Arabia	SCIENCE			English	Article							PERSIAN-GULF; HOMO-SAPIENS; AGE; EVOLUTION	The timing of the dispersal of anatomically modern humans (AMH) out of Africa is a fundamental question in human evolutionary studies. Existing data suggest a rapid coastal exodus via the Indian Ocean rim around 60,000 years ago. We present evidence from Jebel Faya, United Arab Emirates, demonstrating human presence in eastern Arabia during the last interglacial. The tool kit found at Jebel Faya has affinities to the late Middle Stone Age in northeast Africa, indicating that technological innovation was not necessary to facilitate migration into Arabia. Instead, we propose that low eustatic sea level and increased rainfall during the transition between marine isotope stages 6 and 5 allowed humans to populate Arabia. This evidence implies that AMH may have been present in South Asia before the Toba eruption (1).	[Uerpmann, Hans-Peter] Univ Tubingen, Ctr Sci Archaeol, D-72070 Tubingen, Germany; [Armitage, Simon J.] Univ London, Dept Geog, Egham TW20 0EX, Surrey, England; [Jasim, Sabah A.] Govt Sharjah, Dept Culture & Informat, Directorate Antiqu, Sharjah, U Arab Emirates; [Marks, Anthony E.] So Methodist Univ, Dept Anthropol, Dallas, TX 75275 USA; [Parker, Adrian G.] Oxford Brookes Univ, Sch Social Sci & Law, Dept Geog & Anthropol, Oxford OX3 0BP, England; [Usik, Vitaly I.] Natl Acad Sci, Inst Archaeol, Archaeol Museum, UA-01030 Kiev, Ukraine	Eberhard Karls University of Tubingen; University of London; Royal Holloway University London; Southern Methodist University; Oxford Brookes University; National Academy of Sciences Ukraine; Institute of Archaeology, National Academy of Sciences of Ukraine	Uerpmann, HP (corresponding author), Univ Tubingen, Ctr Sci Archaeol, Rumelinstr 23, D-72070 Tubingen, Germany.	hans-peter.uerpmann@uni-tuebingen.de	Armitage, Simon J/K-7471-2015; Parker, Adrian/X-2596-2019; Parker, Adrian/T-3421-2019	Armitage, Simon J/0000-0003-1480-9188; Parker, Adrian/0000-0003-2989-7344	government of Sharjah; Heidelberg Academy of Sciences; Humboldt Foundation; Oxford Brookes University; German Science Foundation (Deutsche Forschungsgemeinschaft)	government of Sharjah; Heidelberg Academy of Sciences; Humboldt Foundation(Alexander von Humboldt Foundation); Oxford Brookes University; German Science Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG))	Funding information: We thank the government of Sharjah for funding the excavations and elements of the lab work at Tubingen. Funding was also provided by the Role of Culture in Early Expansions of Humans project (Heidelberg Academy of Sciences), Humboldt Foundation, Oxford Brookes University, and the German Science Foundation (Deutsche Forschungsgemeinschaft). Author responsibilities: S.J.A., OSL dating; S.A.J., excavation codirector; A.E.M. and V.I.U., lithic analysis; A.G.P., paleoenvironments; H.-P.U., codirector of excavations, director of laboratory analyses at Tubingen University. Special thanks are due to the third codirector, M. Uerpmann, for handling the logistics of the project.	Bailey G. N., 2007, COAST ARCH, V2, P127; Bar-Matthews M, 2003, GEOCHIM COSMOCHIM AC, V67, P3181, DOI 10.1016/S0016-7037(02)01031-1; Becker Cornelia, 2006, Munibe (Antropologia - Arkeologia), V57, P445; Burns SJ, 2001, GEOLOGY, V29, P623, DOI 10.1130/0091-7613(2001)029<0623:SEFOFC>2.0.CO;2; Derricourt R, 2005, J WORLD PREHIST, V19, P119, DOI 10.1007/s10963-006-9002-z; Faure H, 2002, GLOBAL PLANET CHANGE, V33, P47, DOI 10.1016/S0921-8181(02)00060-7; FIELD H, 1932, AJA, V36, P426; Fleitmann D, 2009, CR GEOSCI, V341, P633, DOI 10.1016/j.crte.2009.01.006; Forster P, 2005, SCIENCE, V308, P965, DOI 10.1126/science.1113261; Jacobs Z, 2007, EVOL ANTHROPOL, V16, P210, DOI 10.1002/evan.20150; Kivisild T, 2004, AM J HUM GENET, V75, P752, DOI 10.1086/425161; Klein RG, 2000, EVOL ANTHROPOL, V9, P17, DOI 10.1002/(SICI)1520-6505(2000)9:1<17::AID-EVAN3>3.0.CO;2-A; Lambeck K, 1996, EARTH PLANET SC LETT, V142, P43, DOI 10.1016/0012-821X(96)00069-6; Leuschner DC, 2003, PALAEOGEOGR PALAEOCL, V197, P83, DOI 10.1016/S0031-0182(03)00387-0; Marks AE, 2009, VERTEBR PALEOBIOL PA, P295, DOI 10.1007/978-90-481-2719-1_20; MARTINSON DG, 1987, QUATERNARY RES, V27, P1, DOI 10.1016/0033-5894(87)90046-9; MCBREARTY S, 1988, WORLD ARCHAEOL, V19, P388, DOI 10.1080/00438243.1988.9980048; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Mellars P, 2006, P NATL ACAD SCI USA, V103, P9381, DOI 10.1073/pnas.0510792103; Parker AG, 2009, VERTEBR PALEOBIOL PA, P39, DOI 10.1007/978-90-481-2719-1_3; Petit-Maire N, 2010, GLOBAL PLANET CHANGE, V72, P368, DOI 10.1016/j.gloplacha.2010.01.012; Petr M, 2009, LECT NOTES GEOINF CA, P1; Petraglia M, 2007, SCIENCE, V317, P114, DOI 10.1126/science.1141564; Preusser F, 2009, CR GEOSCI, V341, P621, DOI 10.1016/j.crte.2009.02.003; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Rose J.I., 2007, P SEMINAR ARABIAN ST, V37, P219; SARNTHEIN M, 1972, MAR GEOL, V12, P245, DOI 10.1016/0025-3227(72)90002-3; Shea JJ, 2008, QUATERNARY SCI REV, V27, P2253, DOI 10.1016/j.quascirev.2008.08.015; Siddall M, 2003, NATURE, V423, P853, DOI 10.1038/nature01690; Stringer C, 2000, NATURE, V405, P24, DOI 10.1038/35011166; Uerpmann H.-P., 1987, TUBINGER ATLAS V A S, V27; Uerpmann HP, 2009, VERTEBR PALEOBIOL PA, P205, DOI 10.1007/978-90-481-2719-1_15; Wildman DE, 2004, MOL PHYLOGENET EVOL, V32, P287, DOI 10.1016/j.ympev.2003.12.014	33	357	369	1	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					453	456		10.1126/science.1199113	http://dx.doi.org/10.1126/science.1199113			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273486				2022-12-28	WOS:000286635900051
J	Piovia-Scott, J; Spiller, DA; Schoener, TW				Piovia-Scott, Jonah; Spiller, David A.; Schoener, Thomas W.			Effects of Experimental Seaweed Deposition on Lizard and Ant Predation in an Island Food Web	SCIENCE			English	Article							RECENT CLIMATE-CHANGE; SPECIES INTERACTIONS; TROPHIC CASCADES; RESPONSES; SUBSIDIES; PREY; COMMUNITY; EVOLUTION; INVASION; IMPACTS	The effect of environmental change on ecosystems is mediated by species interactions. Environmental change may remove or add species and shift life-history events, altering which species interact at a given time. However, environmental change may also reconfigure multispecies interactions when both species composition and phenology remain intact. In a Caribbean island system, a major manifestation of environmental change is seaweed deposition, which has been linked to eutrophication, overfishing, and hurricanes. Here, we show in a whole-island field experiment that without seaweed two predators-lizards and ants-had a substantially greater-than-additive effect on herbivory. When seaweed was added to mimic deposition by hurricanes, no interactive predator effect occurred. Thus environmental change can substantially restructure food-web interactions, complicating efforts to predict anthropogenic changes in ecosystem processes.	[Piovia-Scott, Jonah] Univ Calif Davis, Sect Evolut & Ecol, Davis, CA 95616 USA; Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Piovia-Scott, J (corresponding author), Univ Calif Davis, Sect Evolut & Ecol, 1 Shields Ave, Davis, CA 95616 USA.	jpioviascott@ucdavis.edu	Piovia-Scott, Jonah/W-9308-2019		NSF; University of California Davis Center for Population Biology	NSF(National Science Foundation (NSF)); University of California Davis Center for Population Biology(University of California System)	We thank L. H. Yang, J. J. Stachowicz, M. L. Stanton, and three anonymous reviewers for comments on the manuscript; A. N. Wright and S. S. Porter for help in the field; L. Wong for help in the lab; and the Bahamas Ministry of Agriculture and Marine Resources for permission to conduct this research. This project was supported by grants from NSF and the University of California Davis Center for Population Biology to the authors.	Barton BT, 2009, ECOL LETT, V12, P1317, DOI 10.1111/j.1461-0248.2009.01386.x; Barton BT, 2009, ECOLOGY, V90, P2346, DOI 10.1890/08-2254.1; Baxter CV, 2004, ECOLOGY, V85, P2656, DOI 10.1890/04-138; Bender MA, 2010, SCIENCE, V327, P454, DOI 10.1126/science.1180568; Blomquist HL, 1943, AM J BOT, V30, P28, DOI 10.2307/2437389; Gilman SE, 2010, TRENDS ECOL EVOL, V25, P325, DOI 10.1016/j.tree.2010.03.002; Harmon JP, 2009, SCIENCE, V323, P1347, DOI 10.1126/science.1167396; Holt RD, 2008, ECOLOGY, V89, P671, DOI 10.1890/07-0348.1; Jackson JBC, 2008, P NATL ACAD SCI USA, V105, P11458, DOI 10.1073/pnas.0802812105; Leroux SJ, 2008, ECOL LETT, V11, P1147, DOI 10.1111/j.1461-0248.2008.01235.x; Marczak LB, 2007, ECOLOGY, V88, P140, DOI 10.1890/0012-9658(2007)88[140:MTLHAP]2.0.CO;2; Nakano S, 1999, ECOLOGY, V80, P2435; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Piovia-Scott J, 2011, J ECOL, V99, P327, DOI 10.1111/j.1365-2745.2010.01728.x; Polis GA, 1997, ANNU REV ECOL SYST, V28, P289, DOI 10.1146/annurev.ecolsys.28.1.289; Post E, 1999, NATURE, V401, P905, DOI 10.1038/44814; Sabo JL, 2002, ECOLOGY, V83, P1860, DOI 10.2307/3071770; Schoener TW, 1999, AM NAT, V153, P347, DOI 10.1086/303177; Sih A, 1998, TRENDS ECOL EVOL, V13, P350, DOI 10.1016/S0169-5347(98)01437-2; SPILLER DA, 1994, ECOLOGY, V75, P182, DOI 10.2307/1939393; Spiller DA, 2010, ECOLOGY, V91, P1424, DOI 10.1890/09-0715.1; Suttle KB, 2007, SCIENCE, V315, P640, DOI 10.1126/science.1136401; Takimoto G, 2009, AM NAT, V173, P200, DOI 10.1086/595759; Walther GR, 2010, PHILOS T R SOC B, V365, P2019, DOI 10.1098/rstb.2010.0021; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Wilmers CC, 2005, PLOS BIOL, V3, P571, DOI 10.1371/journal.pbio.0030092; Yang LM, 2010, THROMB RES, V125, pE159, DOI 10.1016/j.thromres.2009.10.017; Yang LH, 2010, ECOL LETT, V13, P1, DOI 10.1111/j.1461-0248.2009.01402.x	28	35	35	1	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2011	331	6016					461	463		10.1126/science.1200282	http://dx.doi.org/10.1126/science.1200282			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273487				2022-12-28	WOS:000286635900053
J	Shirey, PD; Lamberti, GA				Shirey, Patrick D.; Lamberti, Gary A.			Regulate trade in rare plants	NATURE			English	Editorial Material									[Shirey, Patrick D.; Lamberti, Gary A.] Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA	University of Notre Dame	Shirey, PD (corresponding author), Univ Notre Dame, Dept Biol Sci, Notre Dame, IN 46556 USA.	pshirey@nd.edu	Shirey, Patrick/A-3017-2010	Shirey, Patrick/0000-0001-5933-5022				BARLOW C, 2009, GAIA TURMOIL CLIMATE, pCH10; Ellstrand NC, 2010, BIOSCIENCE, V60, P384, DOI 10.1525/bio.2010.60.5.8; Goble DD, 1999, ENVIRON SCI POLICY, V2, P43, DOI DOI 10.1016/S1462-9011(98)00041-0; Marris E, 2009, NATURE, V459, P906, DOI 10.1038/459906a; Phelps J, 2010, SCIENCE, V330, P1752, DOI 10.1126/science.1195558; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; READ M, 1989, Oryx, V23, P127; Ricciardi A, 2009, TRENDS ECOL EVOL, V24, P248, DOI 10.1016/j.tree.2008.12.006; Richardson DM, 2009, P NATL ACAD SCI USA, V106, P9721, DOI 10.1073/pnas.0902327106; Shirey PD, 2010, CONSERV LETT, V3, P45, DOI 10.1111/j.1755-263X.2009.00083.x	10	7	7	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 27	2011	469	7331					465	467		10.1038/469465a	http://dx.doi.org/10.1038/469465a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	711MU	21270870	Bronze			2022-12-28	WOS:000286596500009
J	Altizer, S; Bartel, R; Han, BA				Altizer, Sonia; Bartel, Rebecca; Han, Barbara A.			Animal Migration and Infectious Disease Risk	SCIENCE			English	Review							LONG-DISTANCE MOVEMENTS; WEST NILE VIRUS; WILDEBEEST MIGRATION; NATURAL-POPULATIONS; IMMUNE FUNCTION; PREDATION RISK; HOST MIGRATION; SEA-TURTLES; PARASITE; DISPERSAL	Animal migrations are often spectacular, and migratory species harbor zoonotic pathogens of importance to humans. Animal migrations are expected to enhance the global spread of pathogens and facilitate cross-species transmission. This does happen, but new research has also shown that migration allows hosts to escape from infected habitats, reduces disease levels when infected animals do not migrate successfully, and may lead to the evolution of less-virulent pathogens. Migratory demands can also reduce immune function, with consequences for host susceptibility and mortality. Studies of pathogen dynamics in migratory species and how these will respond to global change are urgently needed to predict future disease risks for wildlife and humans alike.	[Altizer, Sonia; Bartel, Rebecca; Han, Barbara A.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Altizer, S (corresponding author), Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA.	saltizer@uga.edu	Han, Barbara A/H-9363-2015	Han, Barbara A/0000-0002-9948-3078	NSF [DEB-0643831]; Ruth L. Kirschstein National Research Service Award through the NIH	NSF(National Science Foundation (NSF)); Ruth L. Kirschstein National Research Service Award through the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	For helpful discussion and comments, we thank J. Antonovics, A. Davis, A. Dobson, V. Ezenwa, R. Hall, C. Lebarbenchon, A. Park, L. Ries, P. Rohani, P. R. Stephens, D. Streicker, and the Altizer/Ezenwa lab groups at the University of Georgia. This work was supported by an NSF grant (DEB-0643831) to S.A., a Ruth L. Kirschstein National Research Service Award through the NIH to R.B., an NSF Bioinformatics Postdoctoral Fellowship to B.A.H., and a National Center for Ecological Analysis and Synthesis working group on Migration Dynamics organized by S.A., L. Ries, and K. Oberhauser.	Ackery PR, 1984, MILKWEED BUTTERFLIES; Altizer SM, 2001, EVOL ECOL RES, V3, P611; Altizer SM, 2000, ECOL ENTOMOL, V25, P125, DOI 10.1046/j.1365-2311.2000.00246.x; ANDERSON E C, 1975, Journal of Wildlife Diseases, V11, P248; Bartel RA, 2011, ECOLOGY, V92, P342, DOI 10.1890/10-0489.1; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; Berger J, 2008, PLOS BIOL, V6, P1365, DOI 10.1371/journal.pbio.0060165; Bienen L, 2006, FRONT ECOL ENVIRON, V4, P319, DOI 10.1890/1540-9295(2006)4[319:AAEATB]2.0.CO;2; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; Blumenthal J.M., 2006, ENDANGER SPECIES RES, V2, P51, DOI [DOI 10.3354/ESR00044, 10.3354/esr002051]; Bowlin MS, 2010, INTEGR COMP BIOL, V50, P261, DOI 10.1093/icb/icq013; Boyce N. P., 1985, CAN TEC REP FISH AQU, V1450, P55; Bradley CA, 2005, ECOL LETT, V8, P290, DOI 10.1111/j.1461-0248.2005.00722.x; Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; Broderick AC, 2007, P ROY SOC B-BIOL SCI, V274, P1533, DOI 10.1098/rspb.2007.0211; BROWER LP, 1991, AM ZOOL, V31, P265; Buehler DM, 2008, AM NAT, V172, P783, DOI 10.1086/592865; Canaris AG, 2001, MEM I OSWALDO CRUZ, V96, P827, DOI 10.1590/S0074-02762001000600015; Carlsson-Graner U, 2002, OIKOS, V97, P97, DOI 10.1034/j.1600-0706.2002.970110.x; Clapham PJ, 1999, MAMMAL REV, V29, P35; Clopton RE, 2007, COMP PARASITOL, V74, P273, DOI 10.1654/4286.1; Corbet P.S., 1999, DRAGONFLIES BEHAVIOR; Cross PC, 2010, ECOL APPL, V20, P278, DOI 10.1890/08-2062.1; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; de Roode JC, 2010, EVOLUTION, V64, P502, DOI 10.1111/j.1558-5646.2009.00845.x; Dingle Hugh, 1996, P1; Dusek RJ, 2009, AM J TROP MED HYG, V81, P1151, DOI 10.4269/ajtmh.2009.09-0106; Ene A, 2005, J WILDLIFE DIS, V41, P489, DOI 10.7589/0090-3558-41.3.489; Epstein JH, 2009, J APPL ECOL, V46, P991, DOI 10.1111/j.1365-2664.2009.01699.x; Eraud C, 2005, FUNCT ECOL, V19, P110, DOI 10.1111/j.0269-8463.2005.00934.x; Figuerola J, 2000, EVOL ECOL, V14, P143, DOI 10.1023/A:1011009419264; FOLSTAD I, 1991, CAN J ZOOL, V69, P2423, DOI 10.1139/z91-340; Fyumagwa R. D., 2009, Tanzania Veterinary Journal, V26, P62; Gog J, 2002, P ROY SOC B-BIOL SCI, V269, P671, DOI 10.1098/rspb.2001.1667; GRNER HE, 1975, CRUSTACEORUM CATALOG, V5, P79; Gylfe A, 2000, NATURE, V403, P724, DOI 10.1038/35001663; Haig SM, 1998, CONSERV BIOL, V12, P749, DOI 10.1046/j.1523-1739.1998.97102.x; Halpin K, 2007, CLIN INFECT DIS, V44, P711, DOI 10.1086/511078; Harvell D, 2009, ECOLOGY, V90, P912, DOI 10.1890/08-0616.1; Hasselquist D, 2007, J EXP BIOL, V210, P1123, DOI 10.1242/jeb.02712; Hebblewhite M, 2007, OECOLOGIA, V152, P377, DOI 10.1007/s00442-007-0661-y; Hedenstrom A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000362; Henipavirus Ecology Research Group (HERG), 2006, P186; Hines AM, 2007, VET PARASITOL, V148, P350, DOI 10.1016/j.vetpar.2007.07.006; Holdo RM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000210; Holdo RM, 2009, AM NAT, V173, P431, DOI 10.1086/597229; Jensen T, 2002, SCIENCE, V297, P209, DOI 10.1126/science.1075343; Johnson PTJ, 2001, CAN J ZOOL, V79, P370, DOI 10.1139/cjz-79-3-370; Jones ME, 2008, P NATL ACAD SCI USA, V105, P10023, DOI 10.1073/pnas.0711236105; Kareiva P, 2000, SCIENCE, V290, P977, DOI 10.1126/science.290.5493.977; Keeling MJ, 2010, P NATL ACAD SCI USA, V107, P8866, DOI 10.1073/pnas.1000416107; Kiesecker JM, 2001, NATURE, V410, P681, DOI 10.1038/35070552; Kleijn D, 2010, P ROY SOC B-BIOL SCI, V277, P2041, DOI 10.1098/rspb.2010.0026; Koch V, 2006, BIOL CONSERV, V128, P327, DOI 10.1016/j.biocon.2005.09.038; Krauss S, 2010, P ROY SOC B-BIOL SCI, V277, P3373, DOI 10.1098/rspb.2010.1090; Krkosek M, 2007, P R SOC B, V274, P3141, DOI 10.1098/rspb.2007.1122; Krkosek M, 2010, FRONT ECOL ENVIRON, V8, P201, DOI 10.1890/080097; Kunz TH, 2003, BAT ECOLOGY, P3; Leroy EM, 2009, VECTOR-BORNE ZOONOT, V9, P723, DOI 10.1089/vbz.2008.0167; Levin PS, 2001, P ROY SOC B-BIOL SCI, V268, P1153, DOI 10.1098/rspb.2001.1634; Lewison RL, 2007, CONSERV BIOL, V21, P79, DOI 10.1111/j.1523-1739.2006.00592.x; Li WD, 2005, SCIENCE, V310, P676, DOI 10.1126/science.1118391; LOEHLE C, 1995, ECOLOGY, V76, P326, DOI 10.2307/1941192; Luschi P, 2003, OIKOS, V103, P293, DOI 10.1034/j.1600-0706.2003.12123.x; Mack D. E., 2000, BIRDS N AM, V540; McKinnon L, 2010, SCIENCE, V327, P326, DOI 10.1126/science.1183010; MCPEEK MA, 1992, AM NAT, V140, P1010, DOI 10.1086/285453; Messenger SL, 2002, CLIN INFECT DIS, V35, P738, DOI 10.1086/342387; MEYLAN AB, 1990, SCIENCE, V248, P724, DOI 10.1126/science.2333522; Minton Clive, 2010, Wader Study Group Bulletin, V117, P9; Moller AP, 2004, ECOLOGY, V85, P206, DOI 10.1890/02-0451; Moller AP, 1998, EVOL ECOL, V12, P945, DOI 10.1023/A:1006516222343; Morgan ER, 2007, ECOL MODEL, V200, P511, DOI 10.1016/j.ecolmodel.2006.09.002; Nagano C.D., 1993, Natural History Museum of Los Angeles County Science Series, P219; Niles LJ, 2009, BIOSCIENCE, V59, P153, DOI 10.1525/bio.2009.59.2.8; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Owen JC, 2008, CAN J ZOOL, V86, P638, DOI 10.1139/Z08-038; Owen J, 2006, ECOHEALTH, V3, P79, DOI 10.1007/s10393-006-0025-9; Owen JC, 2008, J ETHOL, V26, P383, DOI 10.1007/s10164-008-0092-1; Owen JC, 2006, CONDOR, V108, P389, DOI 10.1650/0010-5422(2006)108[389:SDIICO]2.0.CO;2; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Quinn T., 2005, THE BEHAVIOR AND ECO; Raidal SR, 1998, AUST VET J, V76, P415, DOI 10.1111/j.1751-0813.1998.tb12392.x; Rappole JH, 2000, EMERG INFECT DIS, V6, P319, DOI 10.3201/eid0604.000401; Rappole JH, 2003, J APPL MICROBIOL, V94, p47S; Restif O, 2001, J EVOLUTION BIOL, V14, P967, DOI 10.1046/j.1420-9101.2001.00355.x; Rice D. W., 1971, AM SOC MAMMALOGISTS, V3; RICE DW, 1998, MARINE MAMMALS OF TH, V4; Robinson WD, 2010, FRONT ECOL ENVIRON, V8, P354, DOI 10.1890/080179; Ruegg KC, 2002, P ROY SOC B-BIOL SCI, V269, P1375, DOI 10.1098/rspb.2002.2032; Russell CA, 2005, PLOS BIOL, V3, P382, DOI 10.1371/journal.pbio.0030088; Saino N, 2011, P ROY SOC B-BIOL SCI, V278, P835, DOI 10.1098/rspb.2010.1778; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Semlitsch RD, 2008, J WILDLIFE MANAGE, V72, P260, DOI 10.2193/2007-082; Serneels S, 2001, J BIOGEOGR, V28, P391, DOI 10.1046/j.1365-2699.2001.00557.x; SIMMONS AM, 1991, J ENTOMOL SCI, V26, P136, DOI 10.18474/0749-8004-26.1.136; Sinclair A., 1979, SERENGETI DYNAMICS E, P1; Sinclair ARE, 2007, CONSERV BIOL, V21, P580, DOI 10.1111/j.1523-1739.2007.00699.x; Svensson LME, 2007, J PARASITOL, V93, P1488, DOI 10.1645/GE-1064.1; Takekawa JY, 2010, AVIAN DIS, V54, P466, DOI 10.1637/8914-043009-Reg.1; Tidemann CR, 2004, J ZOOL, V263, P141, DOI 10.1017/S0952836904004960; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; Viboud C, 2006, SCIENCE, V312, P447, DOI 10.1126/science.1125237; Waldenstrom J, 2002, MOL ECOL, V11, P1545, DOI 10.1046/j.1365-294X.2002.01523.x; Weber TP, 2007, EMERG INFECT DIS, V13, P1139, DOI 10.3201/eid1308.070319; Webster MS, 2002, TRENDS ECOL EVOL, V17, P76, DOI 10.1016/S0169-5347(01)02380-1; White A, 2000, OIKOS, V89, P137, DOI 10.1034/j.1600-0706.2000.890115.x; Wikelski M, 2006, BIOL LETTERS, V2, P325, DOI 10.1098/rsbl.2006.0487; Wilcove D.S., 2008, NO WAY HOME DECLINE; 2000, FIRST ISOLATION OF L	110	550	572	19	519	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					296	302		10.1126/science.1194694	http://dx.doi.org/10.1126/science.1194694			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252339				2022-12-28	WOS:000286636300027
J	Flower, B; Armstrong-James, D; Dance, C; Bremner, F; Doherty, T				Flower, Barnaby; Armstrong-James, Darius; Dance, Claire; Bremner, Fion; Doherty, Tom			Blind, breathless, and paralysed from benign malaria	LANCET			English	Editorial Material									[Flower, Barnaby; Armstrong-James, Darius; Doherty, Tom] Univ Coll Hosp, Hosp Trop Dis, London WC1E 6JB, England; [Dance, Claire] Univ Coll Hosp, Dept Parasitol, London WC1E 6JB, England; [Bremner, Fion] Univ Coll Hosp, Dept Ophthalmol, London WC1E 6JB, England	University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University College London; University of London; University College London; University of London; University College London	Doherty, T (corresponding author), Univ Coll Hosp, Hosp Trop Dis, Mortimer Market Bldg,Capper St,Tottenham Court Rd, London WC1E 6JB, England.	tom.doherty@uclh.nhs.uk	Armstrong-James, Darius/AAX-4077-2020; Bremner, Fion/AAQ-8923-2020	Armstrong-James, Darius/0000-0002-1014-7343				Anstey NM, 2009, TRENDS PARASITOL, V25, P220, DOI 10.1016/j.pt.2009.02.003; Gallien S, 2006, J INFECTION, V54, pe1; Hayreh SS, 2009, PROG RETIN EYE RES, V28, P34, DOI 10.1016/j.preteyeres.2008.11.002; Sharma A, 2009, J VECTOR DIS, V46, P141; Tan LKK, 2008, LANCET INFECT DIS, V8, P449, DOI 10.1016/S1473-3099(08)70153-1	5	7	7	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2011	377	9763					438	438		10.1016/S0140-6736(10)61382-7	http://dx.doi.org/10.1016/S0140-6736(10)61382-7			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721ES	21277441				2022-12-28	WOS:000287337000033
J	Clarke, JG; Adashi, EY				Clarke, Jennifer G.; Adashi, Eli Y.			Perinatal Care for Incarcerated Patients A 25-Year-Old Woman Pregnant in Jail	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								More than 6 million men and 1 million women are under US correctional control, be it jail, prison, probation, or parole. On any given day, about 250 000 women and adolescent girls are behind bars, a number well in excess of those documented for all other sovereign nations. Moreover, women and girls represent the fastest-growing segment of the prison and jail populations. Approximately 75% of these women are mothers of minor children (leaving 200 000 children "motherless") and as many as 10 000 may be pregnant. Primarily designed for male offenders, the US correctional system is struggling to meet the specialized needs of its female inmates. Although incarceration during pregnancy is both stressful and dehumanizing, most studies paradoxically document better outcomes for pregnancies managed behind bars than for women of similar socioeconomic status whose pregnancies are managed in the community. Using the case of Ms A as a springboard for discussion, the issues, benefits, and challenges of caring for an incarcerated pregnant woman are addressed, as is the importance of family planning services to those about to be released. JAMA. 2011;305(9):923-929 www.jama.com	[Clarke, Jennifer G.; Adashi, Eli Y.] Brown Univ, Providence, RI 02906 USA	Brown University	Adashi, EY (corresponding author), Brown Univ, 272 George St, Providence, RI 02906 USA.	eli_adashi@brown.edu						American Bar Association, 2369 ABA; American Civil Liberties Union, STAT STAND PREGN REL; American Congress of Obstetricians and Gynecologists, 2005, OB GYNS ADDR HLTH NE; American Public Health Association, 2003, NEW MAN PROV GUID PR; Amnesty International, 1999, NOT PART MY SENT VIO; [Anonymous], 2009, PRISONERS 2008; BONCZAR T, PREVALENCE IMPRISONM; BREUNER CC, 1995, WESTERN J MED, V162, P328; Buergenthal Thomas, 1971, BUFFALO LAW REV, V21, P121; Centers for Disease Control and Prevention, 2001, WOM INJ DRUG US CRIM; Clarke JG, 2006, WOMEN HEALTH, V43, P111, DOI 10.1300/J013v43n02_07; Clarke Jennifer G, 2010, J Correct Health Care, V16, P133, DOI 10.1177/1078345809356533; Clarke JG, 2006, AM J PUBLIC HEALTH, V96, P840, DOI 10.2105/AJPH.2005.062869; Clarke JG, 2006, AM J PUBLIC HEALTH, V96, P834, DOI 10.2105/AJPH.2004.060236; DeVille KA, 1998, OBSTET GYN CLIN N AM, V25, P237, DOI 10.1016/S0889-8545(05)70367-3; Durrah TL, 2005, AM J PUBLIC HEALTH, V95, P1788, DOI 10.2105/AJPH.2004.056457; ELTON PJ, 1988, BRIT J HOSP MED, V39, P9; Fogel C I, 1992, West J Nurs Res, V14, P30, DOI 10.1177/019394599201400103; Fogel C I, 1993, J Obstet Gynecol Neonatal Nurs, V22, P33, DOI 10.1111/j.1552-6909.1993.tb01780.x; General Accounting Office, 1999, WOM PRIS ISS CHALL C; Glaze L.E., 2008, PARENTS PRISON THEIR; Harrison P., 2005, PRISONERS 2004; Hartney C., 2006, US RATES INCARCERATI; Howard DL, 2009, MATERN CHILD HLTH J, V13, P457, DOI 10.1007/s10995-008-0376-7; Institute on Women and Criminal Justice, 2009, MOTH INF IMPR; Jordan BK, 1996, ARCH GEN PSYCHIAT, V53, P513; Kline W, 2001, INBUILDING BETTER RA, P32; Knight M, 2005, BJOG-INT J OBSTET GY, V112, P1467, DOI 10.1111/j.1471-0528.2005.00749.x; Kyei-Aboagye K, 2000, J REPROD MED, V45, P190; Laughlin Harry H, 1922, EUGENICAL STERILIZAT; Macalino GE, 2004, AM J PUBLIC HEALTH, V94, P1218, DOI 10.2105/AJPH.94.7.1218; Martin SL, 1997, AM J PUBLIC HEALTH, V87, P1526, DOI 10.2105/AJPH.87.9.1526; Martin SL, 1997, PUBLIC HEALTH REP, V112, P340; Maruschak Laura M., 2006, MED PROBLEMS JAIL IN; Maruschak LM, 2006, MEDICAL PROBLEMS PRI; Maruschak LM, 2004, MED PROBLEMS PRISONE; Mauer M., 2003, COMP INT RATES INCAR; MILLER JM, 1995, AM J OBSTET GYNECOL, V172, P180, DOI 10.1016/0002-9378(95)90110-8; National Commission on Correctional Health Care, 2005, WOM HLTH CAR CORR SE; NCCD Center for Girls and Young Women, 2010, SHACKL PREGN WOM GIR; [Office of Civil Rights Department of Health and Human Services], 2002, STAND PRIV IND ID HL; Okie S, 2007, NEW ENGL J MED, V356, P105, DOI 10.1056/NEJMp068277; Pew Center on the States, 2009, ON 31 LONG REACH AM; Ramsay M, 2003, PRISONERS DRUG USE T; Sabol W. J., 2007, PRISON JAIL INMATES; Schirmer S., 2009, INCARCERATED PARENTS; Simpler AH, 2005, ADDICT RES THEORY, V13, P503, DOI 10.1080/16066350500151739; United Nations Department of Economic and Social Affairs, 2010, CONV EL ALL FORMS DI; US Department of Justice, 1996, PROGR STAT 6070 05 B; Willers DM, 2008, SEX TRANSM DIS, V35, P68, DOI 10.1097/OLQ.0b013e318154bdb2; William J, 2008, J CORRECT HLTH CARE, V14, P11	51	33	33	0	41	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 2	2011	305	9					923	929		10.1001/jama.2011.125	http://dx.doi.org/10.1001/jama.2011.125			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	728DP	21304069				2022-12-28	WOS:000287854700025
J	Liang, XF; Li, L; Liu, DW; Li, KL; Wu, WD; Zhu, BP; Wang, HQ; Luo, HM; Cao, LS; Zheng, JS; Yin, DP; Cao, L; Wu, BB; Bao, HH; Xu, DS; Yang, WZ; Wang, Y				Liang, Xiao-Feng; Li, Li; Liu, Da-Wei; Li, Ke-Li; Wu, Wen-Di; Zhu, Bao-Ping; Wang, Hua-Qing; Luo, Hui-Ming; Cao, Ling-Sheng; Zheng, Jing-Shan; Yin, Da-Peng; Cao, Lei; Wu, Bing-Bing; Bao, Hong-Hong; Xu, Di-Sha; Yang, Wei-Zhong; Wang, Yu			Safety of Influenza A (H1N1) Vaccine in Postmarketing Surveillance in China.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GUILLAIN-BARRE-SYNDROME; UNITED-STATES	Background: On September 21, 2009, China began administering vaccines, obtained from 10 different manufacturers, against 2009 pandemic influenza A (H1N1) virus infection in priority populations. We aimed to assess the safety of this vaccination program. Methods: We designed a plan for passive surveillance for adverse events after immunization with the influenza A (H1N1) vaccine. Physicians or vaccination providers were required to report the numbers of vaccinees and all adverse events to their local Center for Disease Control and Prevention (CDC), which then reported the data to the Chinese CDC through the online National Immunization Information System's National Adverse Event Following Immunization Surveillance System. Data were collected through March 21, 2010, and were verified and analyzed by the Chinese CDC. Results: A total of 89.6 million doses of vaccine were administered from September 21, 2009, through March 21, 2010, and 8067 vaccinees reported having an adverse event, for a rate of 90.0 per 1 million doses. The age-specific rates of adverse events ranged from 31.4 per 1 million doses among persons 60 years of age or older to 130.6 per 1 million doses among persons 9 years of age or younger, and the manufacturer-specific rates ranged from 4.6 to 185.4 per 1 million doses. A total of 6552 of the 8067 adverse events (81.2%; rate, 73.1 per 1 million doses) were verified as vaccine reactions; 1083 of the 8067 (13.4%; rate, 12.1 per 1 million doses) were rare and more serious (vs. common, minor events), most of which (1050) were allergic reactions. Eleven cases of the Guillain-Barre syndrome were reported, for a rate of 0.1 per 1 million doses, which is lower than the background rate in China. Conclusions: No pattern of adverse events that would be of concern was observed after the administration of influenza A (H1N1) vaccine, nor was there evidence of an increased risk of the Guillain-Barre syndrome. N Engl J Med 2011;364:638-47.	[Liang, Xiao-Feng; Li, Li; Liu, Da-Wei; Li, Ke-Li; Wu, Wen-Di; Wang, Hua-Qing; Luo, Hui-Ming; Cao, Ling-Sheng; Zheng, Jing-Shan; Yin, Da-Peng; Cao, Lei; Wu, Bing-Bing; Bao, Hong-Hong; Xu, Di-Sha; Yang, Wei-Zhong; Wang, Yu] Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing 100050, Peoples R China; [Zhu, Bao-Ping] Chinese Field Epidemiol Training Program, Beijing, Peoples R China	Chinese Center for Disease Control & Prevention	Wang, Y (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Immunizat Program, Beijing 100050, Peoples R China.	wangyu@chinacdc.cn		Zhu, Baoping/0000-0003-0065-0153				[Anonymous], PRELIMINARY REPORT A; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; *EUR MED AG, EUR MED AG REAFF EFF; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Haber P, 2004, JAMA-J AM MED ASSOC, V292, P2478, DOI 10.1001/jama.292.20.2478; Haber P, 2009, DRUG SAFETY, V32, P309, DOI 10.2165/00002018-200932040-00005; Izurieta HS, 2005, JAMA-J AM MED ASSOC, V294, P2720, DOI 10.1001/jama.294.21.2720; Lasky T, 1998, NEW ENGL J MED, V339, P1797, DOI 10.1056/NEJM199812173392501; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; Liu D., 2007, CHIN J VACCINES IMMU, V13, P505; *MIN HLTH PEOPL RE, 2009, GUID VACC PAND H1N1; Ministry of Health of the People's Republic of China, 2008, GUID ID ADV REACT IM; Ministry of Health of the People's Republic of China, 2005, CHIN STAND PROC VACC; SCHONBERGER LB, 1979, AM J EPIDEMIOL, V110, P105, DOI 10.1093/oxfordjournals.aje.a112795; *STAT FOOD DRUG AD, 2009, LIC PAND H1N1 VACC P; Vellozzi C, 2010, VACCINE, V28, P7248, DOI 10.1016/j.vaccine.2010.09.021; *WHO, 1999, WPROEPI9901; *WHO, 2000, SUPPL INF VACC SAF 2; WHO, 2009, 16 WHO; WU WD, 2009, CHIN J VACC IMNMUNIZ, V15, P481; Zhou Weigong, 2003, MMWR Surveill Summ, V52, P1; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535	22	92	99	0	15	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2011	364	7					638	647		10.1056/NEJMoa1008553	http://dx.doi.org/10.1056/NEJMoa1008553			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722BW	21288090	Bronze			2022-12-28	WOS:000287406000009
J	Danaei, G; Finucane, MM; Lin, JK; Singh, GM; Paciorek, CJ; Cowan, MJ; Farzadfar, F; Stevens, GA; Lim, SS; Riley, LM; Ezzati, M; Abdeen, Z; Agyemang, C; Al Nsour, M; Ali, MM; Ambady, R; Babu, BV; Barbagallo, CM; Barcelo, A; Barreto, SM; Barros, H; Bautista, LE; Bjerregaard, P; Bjorkelund, C; Bo, S; Bobak, M; Bonora, E; Botana, MA; Bovet, P; Breckenkamp, J; Breteler, MM; Broda, G; Brown, IJ; Bursztyn, M; de Leon, AC; Casiglia, E; Castetbon, K; Chatterji, S; Chen, ZM; Chen, CJ; Chua, L; Cifkova, R; Cobiac, LJ; Cooper, RS; Dankner, RS; Dong, GH; Elliott, P; Erem, C; Esteghamati, A; Fan, JG; Ferreccio, C; Firmo, JO; Fornes, NS; Fuchs, FD; Getz, L; Giampaoli, S; Gomez, LF; Graff-Iversen, S; Carvajal, RG; Gulliford, MC; Gupta, PC; Gureje, O; Hansen, TW; He, J; Heinrich, J; Hennis, A; Herrera, VM; Ho, SC; Ibrahim, MM; Ikeda, N; Jafar, TH; Joffres, MR; Jonas, JB; Kamadjeu, RM; Karalis, I; Kastarinen, MJ; Katz, J; Kelly, P; Khalilzadeh, O; Khang, YH; Kiechl, S; Kim, KW; Kobayashi, J; Kubinova, R; Kusuma, YS; Lam, TH; Lawes, CMM; Le, C; Lee, J; Lin, X; Lin, HH; Lin, CC; Liu, XQ; Lorbeer, R; Ma, S; Ma, GS; Magliano, DJ; Makdisse, M; Mancia, G; Mbanya, JCN; Miettola, J; Minh, HV; Miranda, JJ; Mohamed, MK; Mohan, V; Mokdad, AH; Morales, DD; Morgan, K; Muiesan, LM; Muntoni, S; Nabipour, I; Nangia, V; Neuhauser, H; Ninomiya, T; Olivieri, O; Onal, AE; Onat, A; Orostegui, M; Panagiotakos, DB; Panza, F; Pednekar, MS; Perez, C; Perez-Fernandez, R; Pichardo, R; Phua, HP; Plans, P; Poulter, N; Raitakari, OT; Rampal, S; Rampal, L; Redon, J; Revilla, L; Roaeid, RB; Rojas-Martinez, R; Sanisoglu, SY; Sans, S; Schelleman, H; Schneider, IJC; Silva, DAS; Silva, E; Simons, LA; Smith, M; Soebardi, S; Solfrizzi, V; Stein, AD; Stergiou, GS; Stessman, J; Suka, M; Tambs, K; Tesfaye, F; Thorogood, M; Tilvis, RS; Trenkwalder, P; Tuomilehto, JO; Tzourio, C; Vander Hoorn, S; Vanderpump, MP; Verschuren, M; Vioque, J; Waspadji, S; Wilhelmsen, L; Willeit, J; Woodward, M; Xavier, AJ; Xu, L; Yang, GH; Yeh, LC; Yoon, JS; You, QS; Zhou, M				Danaei, Goodarz; Finucane, Mariel M.; Lin, John K.; Singh, Gitanjali M.; Paciorek, Christopher J.; Cowan, Melanie J.; Farzadfar, Farshad; Stevens, Gretchen A.; Lim, Stephen S.; Riley, Leanne M.; Ezzati, Majid; Abdeen, Ziad; Agyemang, Charles; Al Nsour, Mohannad; Ali, Mohamed M.; Ambady, Ramachandran; Babu, Bontha V.; Barbagallo, Carlo M.; Barcelo, Alberto; Barreto, Sandhi M.; Barros, Henrique; Bautista, Leonelo E.; Bjerregaard, Peter; Bjoerkelund, Cecilia; Bo, Simona; Bobak, Martin; Bonora, Enzo; Botana, Manuel A.; Bovet, Pascal; Breckenkamp, Juergen; Breteler, Monique M.; Broda, Grazyna; Brown, Ian J.; Bursztyn, Michael; de Leon, Antonio Cabrera; Casiglia, Edoardo; Castetbon, Katia; Chatterji, Somnath; Chen, Zhengming; Chen, Chien-Jen; Chua, Lily; Cifkova, Renata; Cobiac, Linda J.; Cooper, Richard S.; Dankner, Rachel S.; Dong, Guang-Hui; Elliott, Paul; Erem, Cihangir; Esteghamati, Alireza; Fan, Jian-Gao; Ferreccio, Catterina; Firmo, Joselia O.; Fornes, Nelida S.; Fuchs, Flavio D.; Getz, Linn; Giampaoli, Simona; Gomez, Luis F.; Graff-Iversen, Sidsel; Carvajal, Ramiro Guerrero; Gulliford, Martin C.; Gupta, Prakash C.; Gureje, Oye; Hansen, Tine W.; He, Jiang; Heinrich, Joachim; Hennis, Anselm; Herrera, Victor M.; Ho, Suzanne C.; Ibrahim, M. Mohsen; Ikeda, Nayu; Jafar, Tazeen H.; Joffres, Michel R.; Jonas, Jost B.; Kamadjeu, Raoul M.; Karalis, Ioannis; Kastarinen, Mika J.; Katz, Joanne; Kelly, Paul; Khalilzadeh, Omid; Khang, Young-Ho; Kiechl, Stefan; Kim, Ki Woong; Kobayashi, Junji; Kubinova, Ruzena; Kusuma, Yadlapalli S.; Lam, Tai H.; Lawes, Carlene M. M.; Le, Cai; Lee, Jeannette; Lin, Xu; Lin, Hsien-Ho; Lin, Cheng-Chieh; Liu, Xiaoqing; Lorbeer, Roberto; Ma, Stefan; Ma, Guansheng; Magliano, Dianna J.; Makdisse, Marcia; Mancia, Giuseppe; Mbanya, Jean Claude N.; Miettola, Juhani; Minh, Hoang V.; Miranda, J. Jaime; Mohamed, Mostafa K.; Mohan, V.; Mokdad, Ali H.; Morales, Dante D.; Morgan, Karen; Muiesan, Lorenza M.; Muntoni, Sergio; Nabipour, Iraj; Nangia, Vinay; Neuhauser, Hannelore; Ninomiya, Toshiharu; Olivieri, Oliviero; Oenal, Ayse Emel; Onat, Altan; Orostegui, Myriam; Panagiotakos, Demosthenes B.; Panza, Francesco; Pednekar, Mangesh S.; Perez, Cynthia; Perez-Fernandez, Roman; Pichardo, Rafael; Phua, Hwee Pin; Plans, Pedro; Poulter, Neil; Raitakari, Olli T.; Rampal, Sanjay; Rampal, Lekhraj; Redon, Josep; Revilla, Luis; Roaeid, Ragab B.; Rojas-Martinez, Rosalba; Sanisoglu, Selim Y.; Sans, Susana; Schelleman, Hedi; Schneider, Ione J. C.; Silva, Diego Augusto Santos; Silva, Egle; Simons, Leon A.; Smith, Margaret; Soebardi, Suharko; Solfrizzi, Vincenzo; Stein, Aryeh D.; Stergiou, George S.; Stessman, Jochanan; Suka, Machi; Tambs, Kristian; Tesfaye, Fikru; Thorogood, Margaret; Tilvis, Reijo S.; Trenkwalder, Peter; Tuomilehto, Jaakko O.; Tzourio, Christophe; Vander Hoorn, Stephen; Vanderpump, Mark P.; Verschuren, Monique; Vioque, Jesus; Waspadji, Sarwono; Wilhelmsen, Lars; Willeit, Johann; Woodward, Mark; Xavier, Andre J.; Xu, Liang; Yang, Gonghuan; Yeh, Li-Chia; Yoon, Jin-Sang; You, Qisheng; Zhou, Maigeng		Global Burden Metab Risk Factors C	National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5.4 million participants	LANCET			English	Article							CARDIOVASCULAR RISK-FACTORS; HYPERTENSION CONTROL; EUROPEAN COUNTRIES; UNITED-STATES; PREVALENCE; AWARENESS; DISEASE; POPULATION; MONICA; GUIDELINES	Background Data for trends in blood pressure are needed to understand the effects of its dietary, lifestyle, and pharmacological determinants; set intervention priorities; and evaluate national programmes. However, few worldwide analyses of trends in blood pressure have been done. We estimated worldwide trends in population mean systolic blood pressure (SBP). Methods We estimated trends and their uncertainties in mean SBP for adults 25 years and older in 199 countries and territories. We obtained data from published and unpublished health examination surveys and epidemiological studies (786 country-years and 5.4 million participants). For each sex, we used a Bayesian hierarchical model to estimate mean SBP by age, country, and year, accounting for whether a study was nationally representative. Findings In 2008, age-standardised mean SBP worldwide was 128.1 mm Hg (95% uncertainty interval 126.7-129.4) in men and 124.4 mm Hg (123.0-125.9) in women. Globally, between 1980 and 2008, S BP decreased by 0.8 mm Hg per decade (-0.4 to 2.2, posterior probability of being a true decline=0.90) in men and 1.0 mm Hg per decade (-0.3 to 2.3, posterior probability=0.93) in women. Female SBP decreased by 3.5 mm Hg or more per decade in western Europe and Australasia (posterior probabilities >= 0.999). Male SBP fell most in high-income North America, by 2.8 mm Hg per decade (1.3-4.5, posterior probability >0.999), followed by Australasia and western Europe where it decreased by more than 2.0 mm Hg per decade (posterior probabilities >0.98). SBP rose in Oceania, east Africa, and south and southeast Asia for both sexes, and in west Africa for women, with the increases ranging 0.8-1.6 mm Hg per decade in men (posterior probabilities 0.72-0.91) and 1.0-2.7 mm Hg per decade for women (posterior probabilities 0.75-0.98). Female SBP was highest in some east and west African countries, with means of 135 mm Hg or greater. Male SBP was highest in Baltic and east and west African countries, where mean SBP reached 138 mm Hg or more. Men and women in western Europe had the highest SBP in high-income regions. Interpretation On average, global population SBP decreased slightly since 1980, but trends varied significantly across regions and countries. SBP is currently highest in low-income and middle-income countries. Effective population-based and personal interventions should be targeted towards low-income and middle-income countries.	[Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London W2 1PG, England; [Danaei, Goodarz] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Finucane, Mariel M.; Paciorek, Christopher J.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Lin, John K.; Singh, Gitanjali M.; Farzadfar, Farshad; Ezzati, Majid] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Ezzati, Majid] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Paciorek, Christopher J.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Cowan, Melanie J.; Riley, Leanne M.] WHO, Dept Chron Dis & Hlth Promot, CH-1211 Geneva, Switzerland; [Stevens, Gretchen A.] WHO, Dept Hlth Stat & Informat, CH-1211 Geneva, Switzerland; [Lim, Stephen S.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA	Imperial College London; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of California System; University of California Berkeley; World Health Organization; World Health Organization; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle	Ezzati, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, Med Fac Bldg,St Marys Campus,Norfolk Pl, London W2 1PG, England.	majid.ezzati@imperial.ac.uk	Gulliford, Martin C/I-8606-2018; Kim, Ki Woong/D-5801-2012; REDON, JOSEP/E-1719-2019; CHATTERJI, Somnath/ABE-6832-2020; Mokdad, Ali H./AAD-1232-2022; Tzourio, christophe/L-6344-2019; Bonora, Enzo/AAA-5300-2022; Stergiou, George/J-3083-2019; Xavier, André J/D-3287-2015; Bjerregaard, Peter/ABD-8894-2020; Woodward, Mark/L-6817-2017; Rampal, Sanjay/B-9691-2010; Barros, Henrique/A-5488-2008; Rampal, Lekhraj/G-6117-2010; Danaei, Goodarz/B-6085-2008; You, Qisheng/AAG-7153-2020; Lim, Stephen S/B-4055-2012; Heinrich, Joachim/N-1720-2013; Sans, Susana/ABD-5378-2021; Panagiotakos, Demosthenes/C-9776-2013; Bovet, Pascal/F-4477-2011; Perez-Fernandez, Roman/L-6342-2014; Tzourio, christophe/B-4015-2009; Önal, Ayşe Emel/AAC-8984-2020; Iats, Inct/K-2300-2013; Ma, Guansheng/AAD-6767-2020; Dong, Guanghui/AAN-4630-2020; vioque, jesus/A-1066-2008; He, Jiang/AAF-5303-2020; Castetbon, Katia/F-2686-2017; morgan, karen/C-3846-2012; Abdeen, Ziad/AAC-7889-2019; Chen, Chien-Jen/N-4723-2019; solfrizzi, vincenzo/AAL-3222-2020; Panagiotakos, Demosthenes/M-9167-2019; You, Qisheng/A-3619-2014; mohamed, mostafa/AFE-7371-2022; Miranda, J. Jaime/A-8482-2008; Firmo, Josélia Oliveira Araújo/AAD-6553-2022; Van Hoang, Minh/AET-0962-2022; Fuchs, Flávio D/L-5078-2016; Bo, Simona/AAC-1110-2019; Adewuya, Abiodun/N-4997-2017; Cífková, Renata/O-5731-2017; Breteler, Monique M.B./J-5058-2014; BABU, BONTHA VEERRAJU/X-2096-2019; Barreto, Sandhi M/D-2855-2014; Panza, Francesco/Y-2539-2019; Panagiotakos, Demosthenes/K-8294-2019; Makdisse, Marcia/AAY-9814-2020; Nsour, Mohannad Al/ABE-8741-2020; Schneider, Ione J.C./J-8762-2013; Redon, Josep/L-5997-2019; Raitakari, Olli/AAQ-7389-2021; Ikeda, Nayu/J-9890-2019; Herrera, Víctor/ABB-4480-2020; Silva, Diego Augusto Santos/AAB-9249-2020; Gureje, Oye/J-1183-2014; Silva, Diego/GRF-5446-2022; Barros, Henrique/Q-8609-2019; Panza, Francesco/M-6804-2017; Dankner, Rachel/Q-5245-2019; Mbanya, Jean Claude N/T-5147-2018	Gulliford, Martin C/0000-0003-1898-9075; Kim, Ki Woong/0000-0002-1103-3858; Mokdad, Ali H./0000-0002-4994-3339; Tzourio, christophe/0000-0002-6517-2984; Stergiou, George/0000-0002-6132-0038; Xavier, André J/0000-0002-8282-0939; Bjerregaard, Peter/0000-0001-7153-8447; Rampal, Sanjay/0000-0002-0105-6407; You, Qisheng/0000-0003-0743-7320; Heinrich, Joachim/0000-0002-9620-1629; Sans, Susana/0000-0002-0400-5197; Panagiotakos, Demosthenes/0000-0001-8583-153X; Bovet, Pascal/0000-0002-0242-4259; Perez-Fernandez, Roman/0000-0002-5894-0615; Tzourio, christophe/0000-0002-6517-2984; vioque, jesus/0000-0002-2284-148X; He, Jiang/0000-0002-8286-9652; morgan, karen/0000-0001-6193-1747; solfrizzi, vincenzo/0000-0002-8524-0315; Panagiotakos, Demosthenes/0000-0001-8583-153X; You, Qisheng/0000-0003-0743-7320; mohamed, mostafa/0000-0002-1421-2667; Miranda, J. Jaime/0000-0002-4738-5468; Firmo, Josélia Oliveira Araújo/0000-0001-5330-476X; Adewuya, Abiodun/0000-0002-7611-6953; Cífková, Renata/0000-0003-2765-3821; Breteler, Monique M.B./0000-0002-0626-9305; BABU, BONTHA VEERRAJU/0000-0001-5096-2222; Barreto, Sandhi M/0000-0001-7383-7811; Panza, Francesco/0000-0002-7220-0656; Nsour, Mohannad Al/0000-0003-1212-1611; Schneider, Ione J.C./0000-0001-6339-7832; Redon, Josep/0000-0001-8777-6773; Ikeda, Nayu/0000-0002-3424-1991; Herrera, Víctor/0000-0002-6295-1640; Silva, Diego Augusto Santos/0000-0002-0489-7906; Gureje, Oye/0000-0003-0094-5947; Barros, Henrique/0000-0003-4699-6571; Panza, Francesco/0000-0002-7220-0656; Dankner, Rachel/0000-0001-6454-6000; Elliott, Paul/0000-0002-7511-5684; Lin, John/0000-0003-2490-4453; Farzadfar, Farshad/0000-0001-8288-4046; Mbanya, Jean Claude N/0000-0001-9651-8653; Dong, Guang-Hui/0000-0002-2578-3369; Hoang Van, Minh/0000-0002-4749-5536; CASTETBON, Katia/0000-0002-1207-6729; Woodward, Mark/0000-0001-9800-5296; Pednekar, Mangesh/0000-0001-6266-5356; LIN, HSIEN-HO/0000-0002-7481-6016	Harvard University; Bill & Melinda Gates Foundation; WHO; Medical Research Council [G0801056B, G0801056] Funding Source: researchfish; MRC [G0801056] Funding Source: UKRI	Harvard University; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); WHO(World Health Organization); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	JKL holds stock in Johnson & Johnson. CJP holds stock in Pfizer. GAS has received funding from Harvard University for travel purposes. ME has chaired a session at the World Cardiology Congress, which was sponsored by the organiser. All other authors declare that they have no conflicts of interest.; Funding Bill & Melinda Gates Foundation and WHO.	Afridi I, 2003, J HYPERTENS, V21, P1983, DOI 10.1097/01.hjh.0000084751-37215.d2; Andersen UO, 2010, J HYPERTENS, V28, P1091, DOI 10.1097/HJH.0b013e328335fa81; Anderson CAM, 2010, J AM DIET ASSOC, V110, P736, DOI 10.1016/j.jada.2010.02.007; [Anonymous], 2009, GLOBAL HEALTH RISKS: MORTALITY AND BURDEN OF DISEASE ATTRIBUTABLE TO SELECTED MAJOR RISKS, P1; Antikainen RL, 2010, J HUM HYPERTENS, V24, P439, DOI 10.1038/jhh.2009.85; Bovet P, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-34; Campbell NRC, 2009, HYPERTENSION, V53, P128, DOI 10.1161/HYPERTENSIONAHA.108.119784; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cifkova R, 2010, ATHEROSCLEROSIS, V211, P676, DOI 10.1016/j.atherosclerosis.2010.04.007; Egan BM, 2010, JAMA-J AM MED ASSOC, V303, P2043, DOI 10.1001/jama.2010.650; Elliott P, 1996, BMJ-BRIT MED J, V312, P1249, DOI 10.1136/bmj.312.7041.1249; Evans A, 2001, INT J EPIDEMIOL, V30, pS35, DOI 10.1093/ije/30.suppl_1.S35; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Ezzati M, 2008, CIRCULATION, V117, P905, DOI 10.1161/CIRCULATIONAHA.107.732131; Fasce E, 2007, J HYPERTENS, V25, P1807, DOI 10.1097/HJH.0b013e328244e481; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Gupta R, 2004, J HUM HYPERTENS, V18, P73, DOI 10.1038/sj.jhh.1001633; Hajjar I, 2006, ANNU REV PUBL HEALTH, V27, P465, DOI 10.1146/annurev.publhealth.27.021405.102132; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; HOFFMEISTER H, 1994, PREV MED, V23, P197, DOI 10.1006/pmed.1994.1027; Ikeda N, 2008, B WORLD HEALTH ORGAN, V86, P978, DOI 10.2471/BLT.07.050195; Juonala M, 2004, J INTERN MED, V255, P457, DOI 10.1111/j.1365-2796.2004.01308.x; Kastarinen M, 2009, J HYPERTENS, V27, P1552, DOI 10.1097/HJH.0b013e32832c41cd; Kearney PM, 2005, LANCET, V365, P217, DOI 10.1016/S0140-6736(05)70151-3; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; Kuulasmaa K, 2000, LANCET, V355, P675, DOI 10.1016/S0140-6736(99)11180-2; Lanti M, 2005, AGING CLIN EXP RES, V17, P306; Law MR, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1665; Lawes CM, 2004, COMP QUANTIFICATION, P497; Lee K, 2010, ASIA PAC J CLIN NUTR, V19, P261; Lenfant C, 2002, ARCH INTERN MED, V162, P131, DOI 10.1001/archinte.162.2.131; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lopez A., 2001, GPE DISCUSSION PAPER; NEATON JD, 1992, ARCH INTERN MED, V152, P56, DOI 10.1001/archinte.152.1.56; Opie LH, 2009, CARDIOVASC J AFR, V20, P52; Osler M, 2000, J EPIDEMIOL COMMUN H, V54, P108, DOI 10.1136/jech.54.2.108; Primatesta P, 2006, J HYPERTENS, V24, P1187, DOI 10.1097/01.hjh.0000226210.95936.bc; Sheffer R, 2008, EUR J PUBLIC HEALTH, V18, P121, DOI 10.1093/eurpub/ckm083; VARTIAINEN E, 1994, INT J EPIDEMIOL, V23, P495, DOI 10.1093/ije/23.3.495; Venketasubramanian N, 1998, INT J EPIDEMIOL, V27, P15, DOI 10.1093/ije/27.1.15; Vlasoff T, 2008, EUR J PUBLIC HEALTH, V18, P666, DOI 10.1093/eurpub/ckn063; Wolf-Maier K, 2004, HYPERTENSION, V43, P10, DOI 10.1161/01.HYP.0000103630.72812.10; Wolf-Maier K, 2003, JAMA-J AM MED ASSOC, V289, P2363, DOI 10.1001/jama.289.18.2363	44	698	722	2	133	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2011	377	9765					568	577		10.1016/S0140-6736(10)62036-3	http://dx.doi.org/10.1016/S0140-6736(10)62036-3			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	724DQ	21295844				2022-12-28	WOS:000287556700027
J	Akil, H; Martone, ME; Van Essen, DC				Akil, Huda; Martone, Maryann E.; Van Essen, David C.			Challenges and Opportunities in Mining Neuroscience Data	SCIENCE			English	Editorial Material							MICROSCOPY; BRAIN	Understanding the brain requires a broad range of approaches and methods from the domains of biology, psychology, chemistry, physics, and mathematics. The fundamental challenge is to decipher the "neural choreography" associated with complex behaviors and functions, including thoughts, memories, actions, and emotions. This demands the acquisition and integration of vast amounts of data of many types, at multiple scales in time and in space. Here we discuss the need for neuroinformatics approaches to accelerate progress, using several illustrative examples. The nascent field of "connectomics" aims to comprehensively describe neuronal connectivity at either a macroscopic level (in long-distance pathways for the entire brain) or a microscopic level (among axons, dendrites, and synapses in a small brain region). The Neuroscience Information Framework (NIF) encompasses all of neuroscience and facilitates the integration of existing knowledge and databases of many types. These examples illustrate the opportunities and challenges of data mining across multiple tiers of neuroscience information and underscore the need for cultural and infrastructure changes if neuroinformatics is to fulfill its potential to advance our understanding of the brain.	[Akil, Huda] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Martone, Maryann E.] Univ Calif San Diego, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Van Essen, David C.] Washington Univ, Sch Med, Dept Anat & Neurobiol, St Louis, MO 63110 USA	University of Michigan System; University of Michigan; University of California System; University of California San Diego; Washington University (WUSTL)	Akil, H (corresponding author), Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA.	akil@umich.edu	Van Essen, David/ABA-8888-2020	Martone, Maryann/0000-0002-8406-3871	NIDA NIH HHS [P01 DA021633, 5P01-DA021633-02, P01 DA021633-01A2] Funding Source: Medline; NIMH NIH HHS [U54 MH091657, 1U54MH091657-01, R01 MH060974] Funding Source: Medline; NINDS NIH HHS [HHSN271200800035C] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH060974, U54MH091657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA021633] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Akil H, 2010, SCIENCE, V327, P1580, DOI 10.1126/science.1188654; Ascoli GA, 2006, NAT REV NEUROSCI, V7, P318, DOI 10.1038/nrn1885; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Bernard R, 2010, MOL PSYCHIAT    0413; Bjorklund A., 1983, HDB CHEM NEUROANATOM, VI; Briggman KL, 2006, CURR OPIN NEUROBIOL, V16, P562, DOI 10.1016/j.conb.2006.08.010; Bug WJ, 2008, NEUROINFORMATICS, V6, P175, DOI 10.1007/s12021-008-9032-z; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; CRICK F, 1993, NATURE, V361, P109, DOI 10.1038/361109a0; Deisseroth K, 2011, NAT METHODS, V8, P26, DOI 10.1038/NMETH.F.324; Gardner D, 2008, NEUROINFORMATICS, V6, P149, DOI 10.1007/s12021-008-9024-z; Grewe BF, 2009, CURR OPIN NEUROBIOL, V19, P520, DOI 10.1016/j.conb.2009.09.003; Gupta A, 2008, NEUROINFORMATICS, V6, P205, DOI 10.1007/s12021-008-9033-y; Hey T., 2009, 4 PARADIGM DATA INTE; Johansen-Berg H, 2009, ANNU REV NEUROSCI, V32, P75, DOI 10.1146/annurev.neuro.051508.135735; JohansenBerg H, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P1; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Marcus DS, 2007, NEUROINFORMATICS, V5, P11, DOI 10.1385/NI:5:1:11; Markram H, 2006, NAT REV NEUROSCI, V7, P153, DOI 10.1038/nrn1848; Martone ME, 2004, NAT NEUROSCI, V7, P467, DOI 10.1038/nn1229; Nicolson N., 1982, LETT V WOOLF; Pakkenberg B, 2003, EXP GERONTOL, V38, P95, DOI 10.1016/S0531-5565(02)00151-1; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Vincent JL, 2007, NATURE, V447, P83, DOI 10.1038/nature05758; Watson BO, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00029; World Health Organization (WHO), 2010, MENT HLTH DEV TARG P; Zhang DY, 2010, CEREB CORTEX, V20, P1187, DOI 10.1093/cercor/bhp182	27	116	118	2	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					708	712		10.1126/science.1199305	http://dx.doi.org/10.1126/science.1199305			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21311009	Green Accepted			2022-12-28	WOS:000287205700052
J	Dixon, JM; Khan, LR				Dixon, J. Michael; Khan, Lucy R.			Treatment of breast infection	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PERIDUCTAL MASTITIS; LACTATION MASTITIS; DUCT ECTASIA; WOMEN; ABSCESS; FEATURES					jmd@ed.ac.uk						ACOG, 2007, OBSTET GYNECOL, V109, P479; Anderson JE, 2004, PEDIATRICS, V113, pE360, DOI 10.1542/peds.113.4.e360; Arroyo R, 2010, CLIN INFECT DIS, V50, P1551, DOI 10.1086/652763; Berens PD, 2001, PEDIATR CLIN N AM, V48, P365, DOI 10.1016/S0031-3955(08)70030-0; Bharat A, 2009, WORLD J SURG, V33, P2582, DOI 10.1007/s00268-009-0170-8; BUNDRED NJ, 1985, BRIT J SURG, V72, P844, DOI 10.1002/bjs.1800721023; BUNDRED NJ, 1993, BRIT MED J, V307, P772, DOI 10.1136/bmj.307.6907.772; Carmichael AR, 2002, BREAST, V11, P88, DOI 10.1054/brst.2001.0313; Dener C, 2003, WORLD J SURG, V27, P130, DOI 10.1007/s00268-002-6563-6; Dixon JM, 1998, BREAST, V7, P216, DOI 10.1016/S0960-9776(98)90112-6; Dixon JM, 1998, BREAST, V7, P128, DOI 10.1016/S0960-9776(98)90021-2; Foxman B, 2002, AM J EPIDEMIOL, V155, P103, DOI 10.1093/aje/155.2.103; GALEA MH, 1989, AUST NZ J SURG, V59, P547, DOI 10.1111/j.1445-2197.1989.tb01629.x; HUGHES LE, 2000, BENIGN DISORDERS DIS, P230; Jahanfar S, 2009, COCHRANE DB SYST REV, V1; Janniger CK, 2005, AM FAM PHYSICIAN, V72, P833; Kvist LJ, 2005, BJOG-INT J OBSTET GY, V112, P1070, DOI 10.1111/j.1471-0528.2005.00659.x; MANSEL RE, 2009, BENIGN DISORDERS DIS, P273; Moazzez A, 2007, ARCH SURG-CHICAGO, V142, P881, DOI 10.1001/archsurg.142.9.881; Paviour S, 2002, CLIN INFECT DIS, V35, P1434, DOI 10.1086/344463; Rizzo M, 2009, AM J MED SCI, V338, P123, DOI 10.1097/MAJ.0b013e3181a9d0d3; Roberts K L, 1995, J Hum Lact, V11, P17, DOI 10.1177/089033449501100118; Schoenfeld EM, 2010, J EMERG MED, V38, P542, DOI [10.1016/j.jemermed.2008.11.021, 10.1016/j.jemermed.2008.09.036]; Thrush S, 2006, BRIT J SURG, V93, P251, DOI 10.1002/bjs.5312; Wilson JP, 2007, AM SURGEON, V73, P798	25	23	24	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2011	342								d396	10.1136/bmj.d396	http://dx.doi.org/10.1136/bmj.d396			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722BF	21317199				2022-12-28	WOS:000287403600005
J	Grima, JN; Attard, D; Gatt, R				Grima, Joseph N.; Attard, Daphne; Gatt, Ruben			Unusual Thermoelastic Properties of Methanol Monohydrate	SCIENCE			English	Editorial Material							NEGATIVE LINEAR COMPRESSIBILITY; THERMAL-EXPANSION; DESIGN		[Grima, Joseph N.; Attard, Daphne; Gatt, Ruben] Univ Malta, Fac Sci, Metamat Unit, Msida 2080, Msd, Malta	University of Malta	Grima, JN (corresponding author), Univ Malta, Fac Sci, Metamat Unit, Msida 2080, Msd, Malta.	joseph.grima@um.edu.mt; auxetic@um.edu.mt; ruben.gatt@um.edu.mt	Grima, Joseph N/AAO-5257-2020; Grima, Joseph/B-3492-2009	Grima, Joseph/0000-0001-5108-6551; Attard, Daphne/0000-0002-6288-5807				Baughman RH, 1998, SCIENCE, V279, P1522, DOI 10.1126/science.279.5356.1522; BAUGHMAN RH, 1993, NATURE, V365, P735, DOI 10.1038/365735a0; COLLINS EG, 1995, J GUID CONTROL DYNAM, V18, P208, DOI 10.2514/3.21371; Evans JSO, 1999, J CHEM SOC DALTON, P3317, DOI 10.1039/a904297k; EVANS KE, 1991, NATURE, V353, P124, DOI 10.1038/353124a0; Fortes AD, 2006, CHEM PHYS LETT, V431, P283, DOI 10.1016/j.cplett.2006.09.077; Fortes AD, 2011, SCIENCE, V331, P742, DOI 10.1126/science.1198640; Grima JN, 2007, P ROY SOC A-MATH PHY, V463, P1585, DOI 10.1098/rspa.2007.1841; Grima JN, 2008, PHYS STATUS SOLIDI B, V245, P2405, DOI 10.1002/pssb.200880267; Imre AR, 2008, J PHYS-CONDENS MAT, V20, DOI 10.1088/0953-8984/20/24/244104; Lakes R, 2008, PHYS STATUS SOLIDI B, V245, P545, DOI 10.1002/pssb.200777708; Marinkovic BA, 2009, CHEM MATER, V21, P2886, DOI 10.1021/cm900650c; Miller W, 2008, MECH MATER, V40, P351, DOI 10.1016/j.mechmat.2007.09.004; Sleight A. W., 2009, MCGRAW HILL YB SCI T, P246; Vandeperre L. J., 2003, MAT DEVICES SMART SY, VD11.4, P785; Weng CN, 2008, ADV MAT RES, V33-37, P807, DOI 10.4028/www.scientific.net/AMR.33-37.807; WETHERHOLD RC, 1995, COMPOS SCI TECHNOL, V53, P1, DOI 10.1016/0266-3538(94)00081-6	17	17	17	2	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					687	688		10.1126/science.1201564	http://dx.doi.org/10.1126/science.1201564			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21310992				2022-12-28	WOS:000287205700037
J	Gong, CG; Maquat, LE				Gong, Chenguang; Maquat, Lynne E.			lncRNAs transactivate STAU1-mediated mRNA decay by duplexing with 3 ' UTRs via Alu elements	NATURE			English	Article							THERMODYNAMIC PARAMETERS; NONCODING RNAS; EXPRESSION; PREDICTION; DATABASE; REPEATS; BINDING; PROTEIN; IMPACT	Staufen 1 (STAU1)-mediated messenger RNA decay (SMD) involves the degradation of translationally active mRNAs whose 3'-untranslated regions (39 UTRs) bind to STAU1, a protein that binds to double-stranded RNA(1,2). Earlier studies defined the STAU1-binding site within ADP-ribosylation factor 1 (ARF1) mRNA as a 19-base-pair stem with a 100-nucleotide apex(2). However, we were unable to identify comparable structures in the 3' UTRs of other targets of SMD. Here we show that STAU1-binding sites can be formed by imperfect base-pairing between an Alu element in the 3' UTR of an SMD target and another Alu element in a cytoplasmic, polyadenylated long non-coding RNA (lncRNA). An individual lncRNA can downregulate a subset of SMD targets, and distinct lncRNAs can downregulate the same SMD target. These are previously unappreciated functions of non-coding RNAs and Alu elements(3-5). Not all mRNAs that contain an Alu element in the 3' UTR are targeted for SMD even in the presence of a complementary lncRNA that targets other mRNAs for SMD. Most known trans-acting RNA effectors consist of fewer than 200 nucleotides, and these include small nucleolar RNAs and microRNAs. Our finding that the binding of STAU1 to mRNAs can be transactivated by lncRNAs uncovers an unexpected strategy that cells use to recruit proteins to mRNAs and mediate the decay of these mRNAs. We name these lncRNAs half-STAU1-binding site RNAs (1/2-sbsRNAs).	[Gong, Chenguang; Maquat, Lynne E.] Univ Rochester, Ctr RNA Biol, Rochester, NY 14642 USA; [Gong, Chenguang; Maquat, Lynne E.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Maquat, LE (corresponding author), Univ Rochester, Ctr RNA Biol, 601 Elmwood Ave, Rochester, NY 14642 USA.	lynne_maquat@urmc.rochester.edu	Gong, Chenguang/F-5791-2014	Maquat, Lynne/0000-0002-2789-2075	National Institutes of Health [GM074593]; Elon Huntington Hooker Graduate Student Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM074593, R01GM074593] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Elon Huntington Hooker Graduate Student Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Mathews and A. Grossfield for the use of computer clusters, D. Matthews for access to the program Structure 5.0, K. Nerhrke for fluorescence microscope time, S. de Lucas and J. Ortiz for anti-STAU1 antibodies, M. Gorospe for pcDNA3-MS2bsX12, S. Higgins and P. Higgins for HaCaT cells and advice on the scrape-injury repair assay, J. Wang for the initial BAG5 mRNA assays, and O. Isken, M. Gleghorn and D. Matthews for comments on the manuscript. This work was supported by the National Institutes of Health (GM074593 to L. E. M.) and an Elon Huntington Hooker Graduate Student Fellowship (C.G.).	ASHLEY CT, 1993, SCIENCE, V262, P563, DOI 10.1126/science.7692601; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Batzer MA, 2002, NAT REV GENET, V3, P370, DOI 10.1038/nrg798; Chen LL, 2008, EMBO J, V27, P1694, DOI 10.1038/emboj.2008.94; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Engstrom PG, 2006, PLOS GENET, V2, P564, DOI 10.1371/journal.pgen.0020047; Gong CG, 2009, GENE DEV, V23, P54, DOI 10.1101/gad.1717309; Hasler J, 2006, NUCLEIC ACIDS RES, V34, P5491, DOI 10.1093/nar/gkl706; Kapranov P, 2007, NAT REV GENET, V8, P413, DOI 10.1038/nrg2083; Kim HH, 2009, GENE DEV, V23, P1743, DOI 10.1101/gad.1812509; Kim YK, 2005, CELL, V120, P195, DOI 10.1016/j.cell.2004.11.050; Kim YK, 2007, EMBO J, V26, P2670, DOI 10.1038/sj.emboj.7601712; Kuwano Y, 2010, NUCLEIC ACIDS RES, V38, P225, DOI 10.1093/nar/gkp861; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Marion RM, 1999, MOL CELL BIOL, V19, P2212; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Pang KC, 2007, NUCLEIC ACIDS RES, V35, pD178, DOI 10.1093/nar/gkl926; Providence KM, 2008, ARCH DERMATOL RES, V300, P303, DOI 10.1007/s00403-008-0845-2; Walters RD, 2009, IUBMB LIFE, V61, P831, DOI 10.1002/iub.227; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; YULUG IG, 1995, GENOMICS, V27, P544, DOI 10.1006/geno.1995.1090; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	23	897	966	4	191	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					284	+		10.1038/nature09701	http://dx.doi.org/10.1038/nature09701			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307942	Green Accepted			2022-12-28	WOS:000287144200049
J	Gibson, WT; Veldhuis, JH; Rubinstein, B; Cartwright, HN; Perrimon, N; Brodland, GW; Nagpal, R; Gibson, MC				Gibson, William T.; Veldhuis, James H.; Rubinstein, Boris; Cartwright, Heather N.; Perrimon, Norbert; Brodland, G. Wayne; Nagpal, Radhika; Gibson, Matthew C.			Control of the Mitotic Cleavage Plane by Local Epithelial Topology	CELL			English	Article							REGULATES SPINDLE ORIENTATION; ORIENTED CELL-DIVISION; MECHANICAL SIGNALS; 1ST CLEAVAGE; DROSOPHILA; SHAPE; POLARITY; NUCLEUS; MITOSIS; MICROTUBULES	For nearly 150 years, it has been recognized that cell shape strongly influences the orientation of the mitotic cleavage plane (e. g., Hofmeister, 1863). However, we still understand little about the complex interplay between cell shape and cleavage-plane orientation in epithelia, where polygonal cell geometries emerge from multiple factors, including cell packing, cell growth, and cell division itself. Here, using mechanical simulations, we show that the polygonal shapes of individual cells can systematically bias the long-axis orientations of their adjacent mitotic neighbors. Strikingly, analyses of both animal epithelia and plant epidermis confirm a robust and nearly identical correlation between local cell topology and cleavage-plane orientation in vivo. Using simple mathematics, we show that this effect derives from fundamental packing constraints. Our results suggest that local epithelial topology is a key determinant of cleavage-plane orientation, and that cleavage-plane bias may be a widespread property of polygonal cell sheets in plants and animals.	[Gibson, William T.; Rubinstein, Boris; Cartwright, Heather N.; Gibson, Matthew C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Gibson, William T.; Nagpal, Radhika] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Gibson, William T.] Harvard Univ, Program Biophys, Cambridge, MA 02138 USA; [Veldhuis, James H.; Brodland, G. Wayne] Univ Waterloo, Dept Civil & Environm Engn, Waterloo, ON N2L 3G1, Canada; [Gibson, William T.; Perrimon, Norbert] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, Boston, MA 02115 USA; [Gibson, Matthew C.] Kansas Univ Med Ctr, Dept Anat & Cell Biol, Kansas City, MO 64110 USA	Stowers Institute for Medical Research; Harvard University; Harvard University; University of Waterloo; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Gibson, MC (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	mg2@stowers.org		Gibson, Matthew/0000-0001-5588-8842; Cartwright, Heather/0000-0001-6639-5808; Perrimon, Norbert/0000-0001-7542-472X	Stowers Institute for Medical Research; Burroughs Wellcome Fund; National Science Foundation; Natural Sciences and Engineering Research Council of Canada; Howard Hughes Medical Institute; NIH/NIGMS [T32 GM008313, 1029]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008313] Funding Source: NIH RePORTER	Stowers Institute for Medical Research; Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Science Foundation(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge support for this research from the Stowers Institute for Medical Research and the Burroughs Wellcome Fund (to M. C. G.), from the National Science Foundation (to R.N.), from the Natural Sciences and Engineering Research Council of Canada (to G. W. B.), and from the Howard Hughes Medical Institute (to N.P.). W. T. G. was supported in part by NIH/NIGMS Molecular Biophysics Training Grant #T32 GM008313 and CTC grant 1029 to M.C.G.	Aegerter-Wilmsen T, 2010, DEVELOPMENT, V137, P499, DOI 10.1242/dev.041731; Aldaz S, 2010, P NATL ACAD SCI USA, V107, P14217, DOI 10.1073/pnas.1008623107; Baena-Lopez LA, 2005, CURR BIOL, V15, P1640, DOI 10.1016/j.cub.2005.07.062; BLACK SD, 1988, DEV BIOL, V128, P65, DOI 10.1016/0012-1606(88)90267-9; Brodland GW, 2002, J BIOMECH, V35, P673, DOI 10.1016/S0021-9290(02)00006-4; Buschmann H, 2006, CURR BIOL, V16, P1938, DOI 10.1016/j.cub.2006.08.028; Chen HH, 2000, J BIOMECH ENG-T ASME, V122, P394, DOI 10.1115/1.1286563; COWAN R, 1988, J THEOR BIOL, V131, P33, DOI 10.1016/S0022-5193(88)80118-8; Dubertret B, 1998, PHYS REV E, V58, P6368, DOI 10.1103/PhysRevE.58.6368; Dubertret B, 1997, BIOPHYS J, V73, P38, DOI 10.1016/S0006-3495(97)78045-7; Fernandez-Minan A, 2007, CURR BIOL, V17, P683, DOI 10.1016/j.cub.2007.02.052; Fischer E, 2006, NAT GENET, V38, P21, DOI 10.1038/ng1701; FLANDERS DJ, 1990, J CELL BIOL, V110, P1111, DOI 10.1083/jcb.110.4.1111; Gallagher K, 1999, DEVELOPMENT, V126, P4623; Gibson MC, 2006, NATURE, V442, P1038, DOI 10.1038/nature05014; Gong Y, 2004, NATURE, V430, P689, DOI 10.1038/nature02796; GOODBODY KC, 1991, DEVELOPMENT, V113, P931; Gray D, 2004, CURR BIOL, V14, P397, DOI 10.1016/j.cub.2004.02.031; Hamant O, 2008, SCIENCE, V322, P1650, DOI 10.1126/science.1165594; Hofmeister W., 1863, JB WISSENSCHAFT BOT, V3, P259; Johnston CA, 2009, CELL, V138, P1150, DOI 10.1016/j.cell.2009.07.041; KATSUTA J, 1990, J CELL SCI, V95, P413; KORN RW, 1973, NEW PHYTOL, V72, P1357, DOI 10.1111/j.1469-8137.1973.tb02114.x; Kost B, 2002, CELL, V108, P9, DOI 10.1016/S0092-8674(01)00634-1; Lewis FT, 1928, ANAT REC, V38, P341, DOI 10.1002/ar.1090380305; Li W, 2009, CURR BIOL, V19, P1821, DOI 10.1016/j.cub.2009.09.023; LINTILHAC PM, 1984, NATURE, V307, P363, DOI 10.1038/307363a0; LLOYD CW, 1991, DEVELOPMENT, P55; Lynch TM, 1997, DEV BIOL, V181, P246, DOI 10.1006/dbio.1996.8462; Miri MF, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.031101; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765; PALEVITZ BA, 1987, J CELL BIOL, V104, P1515, DOI 10.1083/jcb.104.6.1515; Patel AB, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000412; PESHKIN MA, 1991, PHYS REV LETT, V67, P1803, DOI 10.1103/PhysRevLett.67.1803; PICKETTHEAPS JD, 1966, J CELL SCI, V1, P109; PRUSINKIEWICZ P, 1990, ALGORITHMIC BEAUTY P; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Rivier N, 1995, ACTA BIOTHEOR, V43, P403, DOI 10.1007/BF00713562; RIVIER N, 1982, J PHYS A-MATH GEN, V15, pL143, DOI 10.1088/0305-4470/15/3/012; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Segalen M, 2010, DEV CELL, V19, P740, DOI 10.1016/j.devcel.2010.10.004; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Siller KH, 2009, NAT CELL BIOL, V11, P365, DOI 10.1038/ncb0409-365; Sinnott EW, 1940, P NATL ACAD SCI USA, V26, P223, DOI 10.1073/pnas.26.4.223; Speicher S, 2008, CURR BIOL, V18, P831, DOI 10.1016/j.cub.2008.04.072; Strauss B, 2006, DEVELOPMENT, V133, P3883, DOI 10.1242/dev.02578; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Thery M, 2008, HFSP J, V2, P65, DOI 10.2976/1.2895661; Thery M, 2007, NATURE, V447, P493, DOI 10.1038/nature05786; TRAAS J, 1995, NATURE, V375, P676, DOI 10.1038/375676a0; Vanstraelen M, 2006, CURR BIOL, V16, P308, DOI 10.1016/j.cub.2005.12.035; Walker KL, 2007, CURR BIOL, V17, P1827, DOI 10.1016/j.cub.2007.09.063; Willemsen V, 2008, DEV CELL, V15, P913, DOI 10.1016/j.devcel.2008.09.019; Wright AJ, 2009, PLANT CELL, V21, P234, DOI 10.1105/tpc.108.062810	56	142	143	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2011	144	3					427	438		10.1016/j.cell.2010.12.035	http://dx.doi.org/10.1016/j.cell.2010.12.035			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295702	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000286973100014
J	Ampollini, L; Carbognani, P				Ampollini, Luca; Carbognani, Paolo			Madelung's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ampollini, Luca; Carbognani, Paolo] Univ Parma, I-43100 Parma, Italy	University of Parma	Ampollini, L (corresponding author), Univ Parma, I-43100 Parma, Italy.	lampollini@ao.pr.it		Ampollini, Luca/0000-0003-2225-299X					0	12	13	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2011	364	5					465	465		10.1056/NEJMicm1003531	http://dx.doi.org/10.1056/NEJMicm1003531			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715LL	21288098				2022-12-28	WOS:000286885900012
J	Benning, A; Ghaleb, M; Suokas, A; Dixon-Woods, M; Dawson, J; Barber, N; Franklin, BD; Girling, A; Hemming, K; Carmalt, M; Rudge, G; Naicker, T; Nwulu, U; Choudhury, S; Lilford, R				Benning, Amirta; Ghaleb, Maisoon; Suokas, Anu; Dixon-Woods, Mary; Dawson, Jeremy; Barber, Nick; Franklin, Bryony Dean; Girling, Alan; Hemming, Karla; Carmalt, Martin; Rudge, Gavin; Naicker, Thirumalai; Nwulu, Ugochi; Choudhury, Sopna; Lilford, Richard			Large scale organisational intervention to improve patient safety in four UK hospitals: mixed method evaluation	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ADVERSE EVENTS; QUALITY IMPROVEMENT; FRAMEWORK; EPISTEMOLOGY; DESIGN; CARE; PERFORMANCE; EXCELLENCE; MANAGEMENT	Objectives To conduct an independent evaluation of the first phase of the Health Foundation's Safer Patients Initiative (SPI), and to identify the net additional effect of SPI and any differences in changes in participating and non-participating NHS hospitals. Design Mixed method evaluation involving five substudies, before and after design. Setting NHS hospitals in United Kingdom. Participants Four hospitals (one in each country in the UK) participating in the first phase of the SPI (SPI1); 18 control hospitals. Intervention The SPI1 was a compound (multicomponent) organisational intervention delivered over 18 months that focused on improving the reliability of specific frontline care processes in designated clinical specialties and promoting organisational and cultural change. Results Senior staff members were knowledgeable and enthusiastic about SPI1. There was a small (0.08 points on a 5 point scale) but significant (P<0.01) effect in favour of the SPI1 hospitals in one of 11 dimensions of the staff questionnaire (organisational climate). Qualitative evidence showed only modest penetration of SPI1 at medical ward level. Although SPI1 was designed to engage staff from the bottom up, it did not usually feel like this to those working on the wards, and questions about legitimacy of some aspects of SPI1 were raised. Of the five components to identify patients at risk of deterioration-monitoring of vital signs (14 items); routine tests (three items); evidence based standards specific to certain diseases (three items); prescribing errors (multiple items from the British National Formulary); and medical history taking (11 items)-there was little net difference between control and SPI1 hospitals, except in relation to quality of monitoring of acute medical patients, which improved on average over time across all hospitals. Recording of respiratory rate increased to a greater degree in SPI1 than in control hospitals; in the second six hours after admission recording increased from 40% (93) to 69% (165) in control hospitals and from 37% (141) to 78% (296) in SPI1 hospitals (odds ratio for "difference in difference" 2.1, 99% confidence interval 1.0 to 4.3; P=0.008). Use of a formal scoring system for patients with pneumonia also increased over time (from 2% (102) to 23% (111) in control hospitals and from 2% (170) to 9% (189) in SPI1 hospitals), which favoured controls and was not significant (0.3, 0.02 to 3.4; P=0.173). There were no improvements in the proportion of prescription errors and no effects that could be attributed to SPI1 in non-targeted generic areas (such as enhanced safety culture). On some measures, the lack of effect could be because compliance was already high at baseline (such as use of steroids in over 85% of cases where indicated), but even when there was more room for improvement (such as in quality of medical history taking), there was no significant additional net effect of SPI1. There were no changes over time or between control and SPI1 hospitals in errors or rates of adverse events in patients in medical wards. Mortality increased from 11% (27) to 16% (39) among controls and decreased from17%(63) to 13% (49) among SPI1 hospitals, but the risk adjusted difference was not significant (0.5, 0.2 to 1.4; P=0.085). Poor care was a contributing factor in four of the 178 deaths identified by review of case notes. The survey of patients showed no significant differences apart from an increase in perception of cleanliness in favour of SPI1 hospitals. Conclusions The introduction of SPI1 was associated with improvements in one of the types of clinical process studied (monitoring of vital signs) and one measure of staff perceptions of organisational climate. There was no additional effect of SPI1 on other targeted issues nor on other measures of generic organisational strengthening.	[Benning, Amirta; Girling, Alan; Hemming, Karla; Rudge, Gavin; Naicker, Thirumalai; Choudhury, Sopna; Lilford, Richard] Univ Birmingham, Sch Hlth & Populat Sci, Edgbaston B15 2TT, W Midlands, England; [Franklin, Bryony Dean] Univ London, Sch Pharm, Dept Practice & Policy, Ctr Medicat Safety & Serv Qual, London WC1N 1AX, England; [Ghaleb, Maisoon] Univ Hertfordshire, Sch Pharm, Hatfield AL10 9AB, Herts, England; [Suokas, Anu] City Hosp Nottingham, Arthrit Res UK Pain Ctr, Nottingham NG5 1PB, England; [Dixon-Woods, Mary] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Dawson, Jeremy] Aston Univ, Aston Business Sch, Work & Org Psychol Grp, Birmingham B4 7ET, W Midlands, England; [Franklin, Bryony Dean] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Ctr Medicat Safety & Serv Qual, London W2 1NY, England; [Carmalt, Martin] Royal Orthopaed Hosp, Birmingham B31 2AP, W Midlands, England; [Nwulu, Ugochi] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Queen Elizabeth Med Ctr, Clin Invest Unit, Birmingham B15 2TH, W Midlands, England	University of Birmingham; University of London; University College London; University of London School of Pharmacy; University of Hertfordshire; Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Leicester; Aston University; Imperial College London; Royal Orthopaedic Hospital; Birmingham City University; University of Birmingham	Lilford, R (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Edgbaston B15 2TT, W Midlands, England.	r.j.lilford@bham.ac.uk	Girling, Alan J/A-7843-2012; Hemming, karla/AAB-3391-2021; Marques, Isabel Cristina/P-8319-2019; Nwulu, Ugochi/G-9245-2011; Chang, Shulan/H-2270-2011	Hemming, karla/0000-0002-2226-6550; Nwulu, Ugochi/0000-0002-4720-4751; Choudhury, Sopna Mannan/0000-0001-5017-6977; Nwulu, Ugochi/0000-0001-6372-176X; Suokas, Anu/0000-0002-4836-1230; Girling, Alan/0000-0003-2022-045X; Dixon-Woods, Mary/0000-0002-5915-0041; Franklin, Bryony/0000-0002-2892-1245	Health Foundation; NPSA; National Institute for Health Research Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country; Engineering and Physical Sciences Research Council, Multidisciplinary Assessment Technology Centre for Healthcare; National Institute of Health Research; EPSRC [EP/F063822/1] Funding Source: UKRI; MRC [G0800808] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F063822/1] Funding Source: researchfish; Medical Research Council [G0800808] Funding Source: researchfish	Health Foundation; NPSA; National Institute for Health Research Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country; Engineering and Physical Sciences Research Council, Multidisciplinary Assessment Technology Centre for Healthcare(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This study was funded by the Health Foundation and NPSA and sponsored for research governance purposes by the University of Birmingham. The study was designed independently by the researchers and was awarded after competitive tender. The researchers acted independently but worked collaboratively with the funder. The researchers independently collected, analysed, and interpreted the data and independently wrote this article. The funders were given the opportunity to provide comments before submission. All researchers had the opportunity to access participants' anonymised data. Competing interest: All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare financial support for the study by the Health Foundation, additional funding for the explicit case note review in control hospitals and the holistic case note review study from the National Patient Safety Agency, funding for KH from the National Institute for Health Research Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country, and AG by the Engineering and Physical Sciences Research Council, Multidisciplinary Assessment Technology Centre for Healthcare programme. The Centre for Medication Safety and Service Quality is affiliated with the Centre for Patient Safety and Service Quality at Imperial College Healthcare N HS Trust, which is funded by the National Institute of Health Research; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work .	[Anonymous], 2004, BTS GUID MAN COMM AC; Barber N, 2006, SAFER FASTER BETTER; Benn J, 2009, SOC SCI MED, V69, P1767, DOI 10.1016/j.socscimed.2009.09.051; Benning A, 2010, MIXED METHOD EVALUAT; Benning A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d199; Berwick DM, 2006, JAMA-J AM MED ASSOC, V295, P324, DOI 10.1001/jama.295.3.324; Bisognano C, 2005, TRUSTEE, V58, P12; Borrill C, 2000, BRIT J HLTH CARE, V6, P364, DOI DOI 10.12968/BJHC.2000.6.8.19300; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Brown C, 2008, QUAL SAF HEALTH CARE, V17, P158, DOI 10.1136/qshc.2007.023630; Brown C, 2008, QUAL SAF HEALTH CARE, V17, P170, DOI 10.1136/qshc.2007.023655; Brown C, 2008, QUAL SAF HEALTH CARE, V17, P163, DOI 10.1136/qshc.2007.023648; Brown C, 2008, QUAL SAF HEALTH CARE, V17, P178, DOI 10.1136/qshc.2007.023663; Brown C, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2764; Cook RI, 1994, HUMAN ERROR MED, P255; Cousins D, 1991, INT J PHARM PRACT, V1, P86; Deming EW., 1986, OUT CRISIS; Deparnuent of Health Expert Group, 2000, ORG MEM; Dixon-Woods M, 2010, QUAL SAF HEALTH CARE, V19, P74, DOI 10.1136/qshc.2008.029504; Dixon-Woods M, 2009, SOC SCI MED, V69, P362, DOI 10.1016/j.socscimed.2009.05.025; Friend JAR, 2001, THORAX, V56, P1, DOI 10.1136/thorax.56.1.1; GUZZO RA, 1985, PERS PSYCHOL, V38, P275, DOI 10.1111/j.1744-6570.1985.tb00547.x; Hackbarth A, 2006, HARD COUNT CALCULATI; Healthcare Commission, 2006, MAK SENS YOUR STAFF; Hillman KM, 2001, INTERN MED J, V31, P343, DOI 10.1046/j.1445-5994.2001.00077.x; Hutter BM, 2001, REGULATION RISK OCCU; Institute for Healthcare Improvement, 2005, 17 ANN NAT FOR QUAL; Kohn KT, 2000, ERR IS HUMAN BUILDIN; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Landon BE, 2004, ANN INTERN MED, V140, P887, DOI 10.7326/0003-4819-140-11-200406010-00010; Landon BE, 2007, NEW ENGL J MED, V356, P921, DOI 10.1056/NEJMsa062860; Leape LL, 2005, JAMA-J AM MED ASSOC, V293, P2384, DOI 10.1001/jama.293.19.2384; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Lilford R, 2004, LANCET, V363, P1147, DOI 10.1016/S0140-6736(04)15901-1; Lilford Richard, 2007, J Health Serv Res Policy, V12, P173, DOI 10.1258/135581907781543012; Lilford RJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4413; Macrae C, 2008, HEALTH RISK SOC, V10, P53, DOI 10.1080/13698570701782452; McQuillan P, 1998, BMJ-BRIT MED J, V316, P1853; Michie S, 2004, INT J MANAG REV, V5-6, P91, DOI 10.1111/j.1460-8545.2004.00098.x; Murphy E, 1998, HEALTH TECHNOL ASSES, V2, piii; Murray DM, 2003, EVALUATION REV, V27, P79, DOI 10.1177/0193841X02239019; Ogrinc G, 2008, QUAL SAF HEALTH CARE, V17, P13, DOI 10.1136/qshc.2008.029058; Reason J., 1990, HUMAN ERROR; Smith GB, 2006, RESUSCITATION, V71, P19, DOI 10.1016/j.resuscitation.2006.03.008; Strauss, 1967, DISCOVERY GROUNDED T; Varkey P, 2007, MAYO CLIN PROC, V82, P735, DOI 10.4065/82.6.735; Vincent C, 2001, BRIT MED J, V322, P517, DOI 10.1136/bmj.322.7285.517; Warrack BJ, 1999, TOTAL QUAL MANAGE, V10, pS779; West MA, 2006, J ORGAN BEHAV, V27, P983, DOI 10.1002/job.396; Wilson RM, 1995, MED J AUSTRALIA, V163, P458, DOI 10.5694/j.1326-5377.1995.tb124691.x; Woloshynowych M, 2003, QUAL SAF HEALTH CARE, V12, P411, DOI 10.1136/qhc.12.6.411	51	107	108	0	30	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2011	342								d195	10.1136/bmj.d195	http://dx.doi.org/10.1136/bmj.d195			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	718PW	21292719	Green Accepted, Green Submitted, Green Published, hybrid			2022-12-28	WOS:000287138500002
J	Chapman, HN; Fromme, P; Barty, A; White, TA; Kirian, RA; Aquila, A; Hunter, MS; Schulz, J; DePonte, DP; Weierstall, U; Doak, RB; Maia, FRNC; Martin, AV; Schlichting, I; Lomb, L; Coppola, N; Shoeman, RL; Epp, SW; Hartmann, R; Rolles, D; Rudenko, A; Foucar, L; Kimmel, N; Weidenspointner, G; Holl, P; Liang, MN; Barthelmess, M; Caleman, C; Boutet, S; Bogan, MJ; Krzywinski, J; Bostedt, C; Bajt, S; Gumprecht, L; Rudek, B; Erk, B; Schmidt, C; Homke, A; Reich, C; Pietschner, D; Struder, L; Hauser, G; Gorke, H; Ullrich, J; Herrmann, S; Schaller, G; Schopper, F; Soltau, H; Kuhnel, KU; Messerschmidt, M; Bozek, JD; Hau-Riege, SP; Frank, M; Hampton, CY; Sierra, RG; Starodub, D; Williams, GJ; Hajdu, J; Timneanu, N; Seibert, MM; Andreasson, J; Rocker, A; Jonsson, O; Svenda, M; Stern, S; Nass, K; Andritschke, R; Schroter, CD; Krasniqi, F; Bott, M; Schmidt, KE; Wang, XY; Grotjohann, I; Holton, JM; Barends, TRM; Neutze, R; Marchesini, S; Fromme, R; Schorb, S; Rupp, D; Adolph, M; Gorkhover, T; Andersson, I; Hirsemann, H; Potdevin, G; Graafsma, H; Nilsson, B; Spence, JCH				Chapman, Henry N.; Fromme, Petra; Barty, Anton; White, Thomas A.; Kirian, Richard A.; Aquila, Andrew; Hunter, Mark S.; Schulz, Joachim; DePonte, Daniel P.; Weierstall, Uwe; Doak, R. Bruce; Maia, Filipe R. N. C.; Martin, Andrew V.; Schlichting, Ilme; Lomb, Lukas; Coppola, Nicola; Shoeman, Robert L.; Epp, Sascha W.; Hartmann, Robert; Rolles, Daniel; Rudenko, Artem; Foucar, Lutz; Kimmel, Nils; Weidenspointner, Georg; Holl, Peter; Liang, Mengning; Barthelmess, Miriam; Caleman, Carl; Boutet, Sebastien; Bogan, Michael J.; Krzywinski, Jacek; Bostedt, Christoph; Bajt, Sasa; Gumprecht, Lars; Rudek, Benedikt; Erk, Benjamin; Schmidt, Carlo; Hoemke, Andre; Reich, Christian; Pietschner, Daniel; Strueder, Lothar; Hauser, Guenter; Gorke, Hubert; Ullrich, Joachim; Herrmann, Sven; Schaller, Gerhard; Schopper, Florian; Soltau, Heike; Kuehnel, Kai-Uwe; Messerschmidt, Marc; Bozek, John D.; Hau-Riege, Stefan P.; Frank, Matthias; Hampton, Christina Y.; Sierra, Raymond G.; Starodub, Dmitri; Williams, Garth J.; Hajdu, Janos; Timneanu, Nicusor; Seibert, M. Marvin; Andreasson, Jakob; Rocker, Andrea; Joensson, Olof; Svenda, Martin; Stern, Stephan; Nass, Karol; Andritschke, Robert; Schroeter, Claus-Dieter; Krasniqi, Faton; Bott, Mario; Schmidt, Kevin E.; Wang, Xiaoyu; Grotjohann, Ingo; Holton, James M.; Barends, Thomas R. M.; Neutze, Richard; Marchesini, Stefano; Fromme, Raimund; Schorb, Sebastian; Rupp, Daniela; Adolph, Marcus; Gorkhover, Tais; Andersson, Inger; Hirsemann, Helmut; Potdevin, Guillaume; Graafsma, Heinz; Nilsson, Bjoern; Spence, John C. H.			Femtosecond X-ray protein nanocrystallography	NATURE			English	Article							REFINEMENT	X-ray crystallography provides the vast majority of macromolecular structures, but the success of the method relies on growing crystals of sufficient size. In conventional measurements, the necessary increase in X-ray dose to record data from crystals that are too small leads to extensive damage before a diffraction signal can be recorded(1-3). It is particularly challenging to obtain large, well-diffracting crystals of membrane proteins, for which fewer than 300 unique structures have been determined despite their importance in all living cells. Here we present a method for structure determination where single-crystal X-ray diffraction 'snapshots' are collected from a fully hydrated stream of nanocrystals using femtosecond pulses from a hard-X-ray free-electron laser, the Linac Coherent Light Source(4). We prove this concept with nanocrystals of photosystem I, one of the largest membrane protein complexes(5). More than 3,000,000 diffraction patterns were collected in this study, and a three-dimensional data set was assembled from individual photosystem I nanocrystals (similar to 200 nm to 2 mm in size). We mitigate the problem of radiation damage in crystallography by using pulses briefer than the timescale of most damage processes(6). This offers a new approach to structure determination of macromolecules that do not yield crystals of sufficient size for studies using conventional radiation sources or are particularly sensitive to radiation damage.	[Chapman, Henry N.; Barty, Anton; White, Thomas A.; Aquila, Andrew; Schulz, Joachim; DePonte, Daniel P.; Martin, Andrew V.; Coppola, Nicola; Liang, Mengning; Caleman, Carl; Gumprecht, Lars; Stern, Stephan] DESY, Ctr Free Electron Laser Sci, D-22607 Hamburg, Germany; [Chapman, Henry N.; Nass, Karol] Univ Hamburg, D-22761 Hamburg, Germany; [Fromme, Petra; Hunter, Mark S.; Grotjohann, Ingo; Fromme, Raimund] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Kirian, Richard A.; Weierstall, Uwe; Doak, R. Bruce; Schmidt, Kevin E.; Wang, Xiaoyu; Spence, John C. H.] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Maia, Filipe R. N. C.; Hajdu, Janos; Timneanu, Nicusor; Seibert, M. Marvin; Andreasson, Jakob; Rocker, Andrea; Joensson, Olof; Svenda, Martin] Uppsala Univ, Dept Cell & Mol Biol, Lab Mol Biophys, SE-75124 Uppsala, Sweden; [Schlichting, Ilme; Epp, Sascha W.; Rolles, Daniel; Rudenko, Artem; Foucar, Lutz; Rudek, Benedikt; Erk, Benjamin; Schmidt, Carlo; Hoemke, Andre; Strueder, Lothar; Ullrich, Joachim; Krasniqi, Faton] Max Planck Adv Study Grp, Ctr Free Electron Laser Sci, D-22607 Hamburg, Germany; [Schlichting, Ilme; Lomb, Lukas; Shoeman, Robert L.; Rolles, Daniel; Foucar, Lutz; Krasniqi, Faton; Bott, Mario; Barends, Thomas R. M.] Max Planck Inst Med Res, D-69120 Heidelberg, Germany; [Epp, Sascha W.; Rudenko, Artem; Rudek, Benedikt; Erk, Benjamin; Schmidt, Carlo; Hoemke, Andre; Ullrich, Joachim; Kuehnel, Kai-Uwe; Schroeter, Claus-Dieter] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Hartmann, Robert; Holl, Peter; Reich, Christian; Soltau, Heike] PNSensor GmbH, D-81739 Munich, Germany; [Kimmel, Nils; Weidenspointner, Georg; Pietschner, Daniel; Strueder, Lothar; Hauser, Guenter; Herrmann, Sven; Schaller, Gerhard; Schopper, Florian; Andritschke, Robert] Max Planck Inst Halbleiterlab, D-81739 Munich, Germany; [Weidenspointner, Georg] Max Planck Inst Extraterr Phys, D-85741 Garching, Germany; [Boutet, Sebastien; Krzywinski, Jacek; Bostedt, Christoph; Messerschmidt, Marc; Bozek, John D.; Williams, Garth J.] SLAC Natl Accelerator Lab, LCLS, Menlo Pk, CA 94025 USA; [Bogan, Michael J.; Hampton, Christina Y.; Sierra, Raymond G.; Starodub, Dmitri] SLAC Natl Accelerator Lab, PULSE Inst, Menlo Pk, CA 94025 USA; [Gorke, Hubert] Forschungszentrum Julich, Inst ZEL, D-52425 Julich, Germany; [Hau-Riege, Stefan P.; Frank, Matthias] Lawrence Livermore Natl Lab, Livermore, CA 94551 USA; [Holton, James M.; Marchesini, Stefano] Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Neutze, Richard] Univ Gothenburg, Dept Chem Biochem & Biophys, SE-40530 Gothenburg, Sweden; [Schorb, Sebastian; Rupp, Daniela; Adolph, Marcus; Gorkhover, Tais] Tech Univ Berlin, Inst Opt & Atomare Phys, D-10623 Berlin, Germany; [Andersson, Inger] Swedish Univ Agr Sci, Uppsala Biomed Ctr, Dept Mol Biol, S-75124 Uppsala, Sweden	Helmholtz Association; Deutsches Elektronen-Synchrotron (DESY); University of Hamburg; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Uppsala University; Max Planck Society; Max Planck Society; Max Planck Society; PNSensor GmbH; Max Planck Society; Max Planck Society; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Helmholtz Association; Research Center Julich; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of Gothenburg; Technical University of Berlin; Swedish University of Agricultural Sciences	Chapman, HN (corresponding author), DESY, Ctr Free Electron Laser Sci, Notkestr 85, D-22607 Hamburg, Germany.	henry.chapman@desy.de	Bajt, Sasa/O-4695-2019; Rudek, Benedikt/AAX-1278-2021; FRS, Henry N Chapman/G-2153-2010; Marchesini, Stefano/GYR-1409-2022; Bajt, Sasa/G-2228-2010; Rupp, Daniela/P-7590-2016; Jönsson, H Olof/O-8664-2017; Kirian, Richard/M-3750-2013; Nass, Karol/K-1970-2012; Williams, Garth/H-1606-2012; Bogan, Mike/I-6962-2012; Barty, Anton/K-5137-2014; Fromme, Raimund/AAG-6578-2019; Rupp, Daniela/AAD-7978-2021; Frank, Matthias/O-9055-2014; Neutze, Richard/A-7573-2010; Rudenko, Artem/C-7412-2009; Maia, Filipe R.N.C./C-3146-2014; Fromme, Raimund/C-8885-2012; Timneanu, Nicusor/C-7691-2012; Messerschmidt, Marc/Y-8929-2019; Weierstall, Uwe/B-3568-2011; Rudek, Benedikt/A-5100-2017; Bozek, John D/E-9260-2010; Messerschmidt, Marc/F-3796-2010; Schlichting, Ilme/I-1339-2013; Gorkhover, Tais/K-8468-2012; Fromme, Raimund/W-5838-2019; Marchesini, Stefano/A-6795-2009	Bajt, Sasa/0000-0002-7163-7602; Rudek, Benedikt/0000-0002-6404-4294; FRS, Henry N Chapman/0000-0002-4655-1743; Jönsson, H Olof/0000-0002-2076-0918; Nass, Karol/0000-0001-8843-1566; Bogan, Mike/0000-0001-9318-3333; Barty, Anton/0000-0003-4751-2727; Rupp, Daniela/0000-0002-6504-7956; Neutze, Richard/0000-0003-0986-6153; Rudenko, Artem/0000-0002-9154-8463; Maia, Filipe R.N.C./0000-0002-2141-438X; Fromme, Raimund/0000-0003-4835-1080; Timneanu, Nicusor/0000-0001-7328-0400; Messerschmidt, Marc/0000-0002-8641-3302; Bozek, John D/0000-0001-7486-7238; Messerschmidt, Marc/0000-0002-8641-3302; Fromme, Raimund/0000-0003-4835-1080; Marchesini, Stefano/0000-0002-6798-2913; Andreasson, Jakob/0000-0002-3202-2330; Kirian, Richard/0000-0001-7197-3086; Fromme, Petra/0000-0003-0953-4909; Schulz, Joachim/0000-0002-9310-8832; Schmidt, Kevin/0000-0002-1597-9835; Seibert, Mark Marvin/0000-0003-0251-0744; Aquila, Andrew/0000-0003-0358-2774; Erk, Benjamin/0000-0001-8413-3588; Epp, Sascha/0000-0001-6366-9113; graafsma, heinz/0000-0003-2304-667X; Stern, Stephan/0000-0001-9786-7513; MARTIN, ANDREW/0000-0003-3704-1829; RUDENKO, Artem/0000-0001-6771-2510; Frank, Matthias/0000-0002-5244-0791	DOE through the PULSE Institute at the SLAC National Accelerator Laboratory; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Center for Bio-Inspired Solar Fuel Production; DOE, Office of Basic Energy Sciences [DE-SC0001016]; Hamburg Ministry of Science and Research; Joachim Herz Stiftung; Hamburg Initiative for Excellence in Research (LEXI); Hamburg School for Structure and Dynamics; Max Planck Society; US National Science Foundation [0417142, MCB-1021557]; US National Institutes of Health [1R01GM095583-01, 1U54GM094625-01]; Swedish Research Council; Swedish Foundation for International Cooperation in Research and Higher Education; Stiftelsen Olle Engkvist Byggmastare; DFG Cluster of Excellence at the Munich Centre for Advanced Photonics; CBST at the University of California [PHY 0120999]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM094599, R01GM095583, U54GM094625] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1021557] Funding Source: National Science Foundation	DOE through the PULSE Institute at the SLAC National Accelerator Laboratory; Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Center for Bio-Inspired Solar Fuel Production; DOE, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Hamburg Ministry of Science and Research; Joachim Herz Stiftung; Hamburg Initiative for Excellence in Research (LEXI); Hamburg School for Structure and Dynamics; Max Planck Society(Max Planck SocietyFoundation CELLEX); US National Science Foundation(National Science Foundation (NSF)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for International Cooperation in Research and Higher Education; Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council); DFG Cluster of Excellence at the Munich Centre for Advanced Photonics(German Research Foundation (DFG)); CBST at the University of California; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Experiments were carried out at the Linac Coherent Light Source and the Advanced Light Source, both National User Facilities operated respectively by Stanford University and the University of California on behalf of the US Department of Energy (DOE), Office of Basic Energy Sciences. We acknowledge support from the DOE through the PULSE Institute at the SLAC National Accelerator Laboratory; the Lawrence Livermore National Laboratory under contract DE-AC52-07NA27344; the Center for Bio-Inspired Solar Fuel Production, an Energy Frontier Research Center funded by the DOE, Office of Basic Energy Sciences (award DE-SC0001016); the Hamburg Ministry of Science and Research and the Joachim Herz Stiftung, as part of the Hamburg Initiative for Excellence in Research (LEXI); the Hamburg School for Structure and Dynamics; the Max Planck Society, for funding the development and operation of the CAMP instrument within the ASG at CFEL; the US National Science Foundation (awards 0417142 and MCB-1021557); the US National Institutes of Health (awards 1R01GM095583-01 (ROADMAP) and 1U54GM094625-01 (PSI: Biology)); the Swedish Research Council; the Swedish Foundation for International Cooperation in Research and Higher Education; Stiftelsen Olle Engkvist Byggmastare; the DFG Cluster of Excellence at the Munich Centre for Advanced Photonics; and the CBST at the University of California under cooperative agreement no. PHY 0120999. We acknowledge discussions with M. Rossmann, E. Snell, R. Stroud and A. Brunger, thank B. Hedman, E. Gullikson, F. Filsinger, A. Berg, H. Mahn and C. Kaiser for technical help and thank the staff of the LCLS for their support in carrying out these experiments.	Bergh M, 2008, Q REV BIOPHYS, V41, P181, DOI 10.1017/S003358350800471X; Bozek JD, 2009, EUR PHYS J-SPEC TOP, V169, P129, DOI 10.1140/epjst/e2009-00982-y; Chapman HN, 2007, NATURE, V448, P676, DOI 10.1038/nature06049; DePonte DP, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/19/195505; DePonte DP, 2009, MICRON, V40, P507, DOI 10.1016/j.micron.2008.12.009; Ding Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.254801; DUISENBERG AJM, 1992, J APPL CRYSTALLOGR, V25, P92, DOI 10.1107/S0021889891010634; Emma P, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.074801; Emma P, 2010, NAT PHOTONICS, V4, P641, DOI [10.1038/NPHOTON.2010.176, 10.1038/nphoton.2010.176]; Fromme P., 2009, CURR TOP MEMBR, V63, P192; Fung R, 2009, NAT PHYS, V5, P64, DOI [10.1038/nphys1129, 10.1038/NPHYS1129]; Hau-Riege SP, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.051906; HENDERSON R, 1995, Q REV BIOPHYS, V28, P171, DOI 10.1017/S003358350000305X; Hunter M. S., BIOPHYS J IN PRESS; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; Kirian RA, 2010, OPT EXPRESS, V18, P5713, DOI 10.1364/OE.18.005713; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Loh NTD, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.026705; Marchesini S, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.140101; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Owen RL, 2006, P NATL ACAD SCI USA, V103, P4912, DOI 10.1073/pnas.0600973103; Paithankar KS, 2009, J SYNCHROTRON RADIAT, V16, P152, DOI 10.1107/S0909049508040430; Praznikar J, 2009, ACTA CRYSTALLOGR D, V65, P921, DOI 10.1107/S0907444909021933; Riekel C, 2004, J SYNCHROTRON RADIAT, V11, P4, DOI 10.1107/S090904950302541X; Robinson I, 2009, NAT MATER, V8, P291, DOI [10.1038/nmat2400, 10.1038/NMAT2400]; ROSSMANN MG, 1979, J APPL CRYSTALLOGR, V12, P570, DOI 10.1107/S0021889879013273; SAYRE D, 1952, ACTA CRYSTALLOGR, V5, P843, DOI 10.1107/S0365110X52002276; Spence JCH, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.198102; Struder L, 2010, NUCL INSTRUM METH A, V614, P483, DOI 10.1016/j.nima.2009.12.053; WANG DN, 1991, J MOL BIOL, V217, P691, DOI 10.1016/0022-2836(91)90526-C; Willis B., 1975, THERMAL VIBRATIONS C, V92; Young L, 2010, NATURE, V466, P56, DOI 10.1038/nature09177; Zaefferer S, 2000, J APPL CRYSTALLOGR, V33, P10, DOI 10.1107/S0021889899010894	35	1482	1519	10	588	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					73	U81		10.1038/nature09750	http://dx.doi.org/10.1038/nature09750			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293373	Green Published, Green Accepted			2022-12-28	WOS:000286886400036
J	Jones, OM; Cunningham, C; Lindsey, I				Jones, Oliver M.; Cunningham, Christopher; Lindsey, Ian			The assessment and management of rectal prolapse, rectal intussusception, rectocoele, and enterocoele in adults	BMJ-BRITISH MEDICAL JOURNAL			English	Review							LAPAROSCOPIC VENTRAL RECTOPEXY; FECAL INCONTINENCE; OBSTRUCTED DEFECATION; CONSTIPATION; BIOFEEDBACK; RESECTION; LOPERAMIDE; OUTCOMES; BOWEL					oliver.jones@orh.nhs.uk	Cunningham, Christopher J L/P-4425-2014	Cunningham, Christopher J L/0000-0003-4904-447X				Abbott D, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3414; Association of Coloproctology of Great Britain and Ireland, RAND TRIAL RECT PROL; Bassotti G, 2004, BMJ-BRIT MED J, V328, P393, DOI 10.1136/bmj.328.7436.393; Boons P, 2010, COLORECTAL DIS, V12, P526, DOI 10.1111/j.1463-1318.2009.01859.x; Collinson R, 2010, COLORECTAL DIS, V12, P97, DOI 10.1111/j.1463-1318.2009.02049.x; D'Hoore A, 2006, SURG ENDOSC, V20, P1919, DOI 10.1007/s00464-005-0485-y; HALLAN RI, 1989, BRIT J SURG, V76, P973, DOI 10.1002/bjs.1800760934; Higgins PDR, 2004, AM J GASTROENTEROL, V99, P750, DOI 10.1111/j.1572-0241.2004.04114.x; Jarrett M, 2009, COLORECTAL DIS; Jayne DG, 2009, DIS COLON RECTUM, V52, P1205, DOI 10.1007/DCR.0b013e3181a9120f; Karulf RE, 2001, CURR PROB SURG, V38, P763; Khaikin M, 2006, WORLD J GASTROENTERO, V12, P3168, DOI 10.3748/wjg.v12.i20.3168; Koh CE, 2008, BRIT J SURG, V95, P1079, DOI 10.1002/bjs.6303; Lauti M, 2008, COLORECTAL DIS, V10, P553, DOI 10.1111/j.1463-1318.2007.01439.x; Lehur PA, 2008, DIS COLON RECTUM, V51, P1611, DOI 10.1007/s10350-008-9378-1; Madiba TE, 2005, ARCH SURG-CHICAGO, V140, P63, DOI 10.1001/archsurg.140.1.63; Madoff RD, 2004, LANCET, V364, P621, DOI 10.1016/S0140-6736(04)16856-6; Maher C, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004014.pub4; MARCIO J, 1993, DIS COLON RECTUM, V36, P77; MYERS JO, 1991, DIS COLON RECTUM, V34, P416, DOI 10.1007/BF02053694; NELSON R, 1995, JAMA-J AM MED ASSOC, V274, P559, DOI 10.1001/jama.274.7.559; Norton C, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002111.pub2; ORROM WJ, 1991, DIS COLON RECTUM, V34, P41, DOI 10.1007/BF02050205; Pescatori M, 2008, TECH COLOPROCTOL, V12, P7, DOI 10.1007/s10151-008-0391-0; Portier G, 2006, DIS COLON RECTUM, V49, P1136, DOI 10.1007/s10350-006-0616-0; READ M, 1982, DIGEST DIS SCI, V27, P807, DOI 10.1007/BF01391374; Ryhammer AM, 1997, INT J COLORECTAL DIS, V12, P225, DOI 10.1007/s003840050094; Sajid MS, 2010, COLORECTAL DIS, V12, P515, DOI 10.1111/j.1463-1318.2009.01886.x; SHORVON PJ, 1989, GUT, V30, P1737, DOI 10.1136/gut.30.12.1737; Slawik S, 2008, COLORECTAL DIS, V10, P138, DOI 10.1111/j.1463-1318.2007.01259.x; Tou S, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001758.pub2; Tsujinaka S, 2007, DIGEST SURG, V24, P46, DOI 10.1159/000100918; Wallner C, 2008, EUR UROL, V54, P1136, DOI 10.1016/j.eururo.2007.11.015; Wijffels N, 2010, COLORECTAL DIS; Yamana T, 2006, DIS COLON RECTUM, V49, P661, DOI 10.1007/s10350-006-0502-9	35	20	20	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2011	342								c7099	10.1136/bmj.c7099	http://dx.doi.org/10.1136/bmj.c7099			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718PR	21285185				2022-12-28	WOS:000287138000025
J	Spence, D				Spence, Des			From the Frontline Bad medicine: cardiology	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						Hingorani AD, 2011, BRIT MED J, V342, DOI 10.1136/bmj.c6244; NHS Information Centre, PRESCR DISP COMM ENG; Office for National Statistics, MORT CIRC DIS LEAD C; Taylor F, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub4	4	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 1	2011	342								d670	10.1136/bmj.d670	http://dx.doi.org/10.1136/bmj.d670			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	718PR	21285189				2022-12-28	WOS:000287138000005
J	Chen, DY; Stern, SA; Garcia-Osta, A; Saunier-Rebori, B; Pollonini, G; Bambah-Mukku, D; Blitzer, RD; Alberini, CM				Chen, Dillon Y.; Stern, Sarah A.; Garcia-Osta, Ana; Saunier-Rebori, Bernadette; Pollonini, Gabriella; Bambah-Mukku, Dhananjay; Blitzer, Robert D.; Alberini, Cristina M.			A critical role for IGF-II in memory consolidation and enhancement	NATURE			English	Article							GROWTH-FACTOR-II; LONG-TERM POTENTIATION; PROTEIN-SYNTHESIS; BINDING-PROTEIN; PERSISTENT DISRUPTION; RAT HIPPOCAMPUS; RECONSOLIDATION; RECEPTOR; GENE; MECHANISMS	We report that, in the rat, administering insulin-like growth factor II (IGF-II, also known as IGF2) significantly enhances memory retention and prevents forgetting. Inhibitory avoidance learning leads to an increase in hippocampal expression of IGF-II, which requires the transcription factor CCAAT enhancer binding protein beta and is essential for memory consolidation. Furthermore, injections of recombinant IGF-II into the hippocampus after either training or memory retrieval significantly enhance memory retention and prevent forgetting. To be effective, IGF-II needs to be administered within a sensitive period of memory consolidation. IGF-II-dependent memory enhancement requires IGF-II receptors, new protein synthesis, the function of activity-regulated cytoskeletal-associated protein and glycogen-synthase kinase 3 (GSK3). Moreover, it correlates with a significant activation of synaptic GSK3 beta and increased expression of GluR1 (also known as GRIA1) alpha-amino-3-hydroxy-5-methyl-4-isoxasolepropionic acid receptor subunits. In hippocampal slices, IGF-II promotes IGF-II receptor-dependent, persistent long-term potentiation after weak synaptic stimulation. Thus, IGF-II may represent a novel target for cognitive enhancement therapies.	[Chen, Dillon Y.; Stern, Sarah A.; Garcia-Osta, Ana; Pollonini, Gabriella; Bambah-Mukku, Dhananjay; Alberini, Cristina M.] Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA; [Saunier-Rebori, Bernadette; Blitzer, Robert D.] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Blitzer, Robert D.; Alberini, Cristina M.] Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Alberini, CM (corresponding author), Mt Sinai Sch Med, Dept Neurosci, New York, NY 10029 USA.	Cristina.Alberini@mssm.edu	Stern, Sarah/AAV-6019-2021; Garcia-Osta, Ana/H-1139-2017	Stern, Sarah/0000-0002-3033-8251; Garcia-Osta, Ana/0000-0001-6326-9064; Bambah-Mukku, Dhananjay/0000-0001-5822-6326	NARSAD [R01-MH065635, R01-MH074736]; Hirschl Foundation; Philoctetes Foundation [F31-MH816213, T32-MH087004, R21-DA29298, R01-GM054508]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054508] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065635, T32MH087004, R01MH074736] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA029298] Funding Source: NIH RePORTER	NARSAD(NARSAD); Hirschl Foundation; Philoctetes Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants R01-MH065635, R01-MH074736, NARSAD, the Hirschl Foundation and Philoctetes Foundation awarded to C.M.A., F31-MH816213 to D.Y.C., and T32-MH087004 to S.A.S.; R21-DA29298 and R01-GM054508 to R.D.B. We thank M. Baxter for assistance with statistical analyses. We thank J. Feng, J.-W. Koo and C.-Y. Lu for technical assistance. We thank A. Suzuki and A. Arguello for comments on the manuscript. We thank R. Miller and the Center for Comparative Medicine and Surgery Facility at Mount Sinai School of Medicine for technical support.	Alberini CM, 2006, CELL MOL LIFE SCI, V63, P999, DOI 10.1007/s00018-006-6025-7; Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; BAILEY CH, 1993, ANNU REV PHYSIOL, V55, P397, DOI 10.1146/annurev.ph.55.030193.002145; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Eisenberg M, 2004, EUR J NEUROSCI, V20, P3397, DOI 10.1111/j.1460-9568.2004.03818.x; Elizalde PV, 1998, J STEROID BIOCHEM, V67, P305, DOI 10.1016/S0960-0760(98)00123-X; Elkobi A, 2008, NAT NEUROSCI, V11, P1149, DOI 10.1038/nn.2190; Garcia-Osta A, 2006, J NEUROSCI, V26, P7919, DOI 10.1523/JNEUROSCI.1674-06.2006; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hawkes C, 2004, BRAIN RES REV, V44, P117, DOI 10.1016/j.brainresrev.2003.11.002; Kandel ER, 2001, BIOSCIENCE REP, V21, P565, DOI 10.1023/A:1014775008533; KAR S, 1993, J COMP NEUROL, V333, P375, DOI 10.1002/cne.903330306; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; KITRAKI E, 1993, INT J DEV NEUROSCI, V11, P1, DOI 10.1016/0736-5748(93)90029-D; LIANG KC, 1982, BEHAV BRAIN RES, V4, P237, DOI 10.1016/0166-4328(82)90002-X; Litvin O O, 2000, Neurosci Behav Physiol, V30, P671, DOI 10.1023/A:1026698700139; Lo JH, 2010, ENDOCRINOLOGY, V151, P2128, DOI 10.1210/en.2009-0960; Maviel T, 2004, SCIENCE, V305, P96, DOI 10.1126/science.1098180; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Milekic MH, 2007, LEARN MEMORY, V14, P504, DOI 10.1101/lm.598307; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; Milekic MH, 2006, J NEUROSCI, V26, P3010, DOI 10.1523/JNEUROSCI.4818-05.2006; Milner B, 1998, NEURON, V20, P445, DOI 10.1016/S0896-6273(00)80987-3; Muravieva EV, 2010, LEARN MEMORY, V17, P306, DOI 10.1101/lm.1794710; Nadel L, 2000, NAT REV NEUROSCI, V1, P209, DOI 10.1038/35044572; Nader K, 2000, NAT REV NEUROSCI, V1, P216, DOI 10.1038/35044580; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; NISSLEY SP, 1984, CLIN ENDOCRINOL META, V13, P43; PIETRZKOWSKI Z, 1992, CANCER RES, V52, P6447; Quesada A, 2004, J NEUROSCI RES, V75, P107, DOI 10.1002/jnr.10833; Russo VC, 2005, ENDOCR REV, V26, P916, DOI 10.1210/er.2004-0024; Scalia P, 2001, J CELL BIOCHEM, V82, P610, DOI 10.1002/jcb.1196; Shamblott MJ, 1998, MOL MAR BIOL BIOTECH, V7, P181; Silva AJ, 1998, ANNU REV NEUROSCI, V21, P127, DOI 10.1146/annurev.neuro.21.1.127; Slipczuk L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006007; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Taubenfeld SM, 2001, NAT NEUROSCI, V4, P813, DOI 10.1038/90520; Taubenfeld SM, 2001, J NEUROSCI, V21, P84, DOI 10.1523/JNEUROSCI.21-01-00084.2001; Tronel S, 2007, BIOL PSYCHIAT, V62, P33, DOI 10.1016/j.biopsych.2006.09.009; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; Tsokas P, 2005, J NEUROSCI, V25, P5833, DOI 10.1523/JNEUROSCI.0599-05.2005; VANDIJK MA, 1992, NUCLEIC ACIDS RES, V20, P3099, DOI 10.1093/nar/20.12.3099; Wei J, 2010, J BIOL CHEM, V285, P26369, DOI 10.1074/jbc.M110.121376; Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134; Xu CM, 2009, J NEUROCHEM, V111, P1357, DOI 10.1111/j.1471-4159.2009.06414.x	50	289	297	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					491	U63		10.1038/nature09667	http://dx.doi.org/10.1038/nature09667			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270887	Green Accepted			2022-12-28	WOS:000286596500024
J	Dyer, C				Dyer, Clare			Embryology New life for the HFEA?	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Dyer, C (corresponding author), BMJ, London WC1H 9JR, England.	ClareDyer@aol.com						Dillner L, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d185	1	0	0	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 25	2011	342								d439	10.1136/bmj.d439	http://dx.doi.org/10.1136/bmj.d439			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	715LX	21266423				2022-12-28	WOS:000286887100002
J	Pinnock, H; Kendall, M; Murray, SA; Worth, A; Levack, P; Porter, M; MacNee, W; Sheikh, A				Pinnock, Hilary; Kendall, Marilyn; Murray, Scott A.; Worth, Allison; Levack, Pamela; Porter, Mike; MacNee, William; Sheikh, Aziz			Living and dying with severe chronic obstructive pulmonary disease: multi-perspective longitudinal qualitative study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							END-STAGE COPD; PALLIATIVE CARE; CHRONIC ILLNESS; BIOGRAPHICAL DISRUPTION; LUNG-CANCER; OLDER AGE; OF-LIFE; COMMUNITY	Objectives To understand the perspectives of people with severe chronic obstructive pulmonary disease (COPD) as their illness progresses, and of their informal and professional carers, to inform provision of care for people living and dying with COPD. Design Up to four serial qualitative interviews were conducted with each patient and nominated carer over 18 months. Interviews were transcribed and analysed both thematically and as narratives. Participants 21 patients, and 13 informal carers (a family member, friend, or neighbour) and 18 professional carers (a key health or social care professional) nominated by the patients. Setting Primary and secondary care in Lothian, Tayside, and Forth Valley, Scotland, during 2007-9. Results Eleven patients died during the study period. Our final dataset comprised 92 interviews (23 conducted with patient and informal carer together). Severe symptoms that caused major disruption to normal life were described, often in terms implying acceptance of the situation as a "way of life" rather than an "illness." Patients and their informal carers adapted to and accepted the debilitating symptoms of a lifelong condition. Professional carers' familiarity with the patients' condition, typically over many years, and prognostic uncertainty contributed to the difficulty of recognising and actively managing end stage disease. Overall, patients told a "chaos narrative" of their illness that was indistinguishable from their life story, with no clear beginning and an unanticipated end described in terms comparable with attitudes to death in a normal elderly population. Conclusions Our findings challenge current assumptions underpinning provision of end of life care for people with COPD. The policy focus on identifying a time point for transition to palliative care has little resonance for people with COPD or their clinicians and is counter productive if it distracts from early phased introduction of supportive care. Careful assessment of possible supportive and palliative care needs should be triggered at key disease milestones along a lifetime journey with COPD, in particular after hospital admission for an exacerbation.	[Pinnock, Hilary] Univ Edinburgh, Allergy & Resp Res Grp, Ctr Populat Hlth Sci, GP Sect,Med Sch, Edinburgh EH8 9AG, Midlothian, Scotland; [Kendall, Marilyn; Murray, Scott A.] Univ Edinburgh, Ctr Populat Hlth Sci, Primary Palliat Care Res Grp, GP Sect, Edinburgh EH8 9AG, Midlothian, Scotland; [Levack, Pamela] Ninewells Hosp, NHS Tayside, Dundee DD1 9SY, Scotland; [MacNee, William] Univ Edinburgh, Queens Med Res Inst, MRC Ctr Inflammat Res, Edinburgh EH8 9AG, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh	Pinnock, H (corresponding author), Univ Edinburgh, Allergy & Resp Res Grp, Ctr Populat Hlth Sci, GP Sect,Med Sch, Doorway 3,Teviot Pl, Edinburgh EH8 9AG, Midlothian, Scotland.	hilary.pinnock@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056; MacNee, William/0000-0002-3692-1448	Chief Scientist's Office of the Scottish Government	Chief Scientist's Office of the Scottish Government	This study was supported by the Chief Scientist's Office of the Scottish Government. HP is supported by a primary care research career award from the Chief Scientist's Office of the Scottish Government.	Almagro P, 2002, CHEST, V121, P1441, DOI 10.1378/chest.121.5.1441; [Anonymous], 2004, SOL FACTS PALL CAR; Bury M, 1982, Sociol Health Illn, V4, P167, DOI 10.1111/1467-9566.ep11339939; Centers for Medicare & Medicaid Services, 2008, PUBL US DEP HLTH HUM; Charmaz K, 1983, Sociol Health Illn, V5, P168, DOI 10.1111/1467-9566.ep10491512; Christakis NA, 1996, NEW ENGL J MED, V335, P172, DOI 10.1056/NEJM199607183350306; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Connors AF, 1996, AM J RESP CRIT CARE, V154, P959, DOI 10.1164/ajrccm.154.4.8887592; Cornwell Jocelyn, 1984, HARD EARNED LIVES AC; Coventry PA, 2005, AGE AGEING, V34, P218, DOI 10.1093/ageing/afi054; Department of Health, 2008, NHS END LIF CAR STRA; Department of Health, 2010, CONS STRAT SERV CHRO; Diffen E, 2010, BBC NEWS        0322; Elofsson LC, 2004, PALLIATIVE MED, V18, P611, DOI 10.1191/0269216304pm922oa; Exley C, 2005, PALLIATIVE MED, V19, P76, DOI 10.1191/0269216305pm973oa; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Frank AW., 2013, WOUNDED STORYTELLER; Gore JM, 2000, THORAX, V55, P1000, DOI 10.1136/thorax.55.12.1000; Habraken JM, 2007, PATIENT EDUC COUNS, V68, P121, DOI 10.1016/j.pec.2007.05.011; Habraken JM, 2008, BRIT J GEN PRACT, V58, P844, DOI 10.3399/bjgp08X376186; Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419; Kendall M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4122; Lynn J, 2000, J AM GERIATR SOC, V48, pS91, DOI 10.1111/j.1532-5415.2000.tb03147.x; Malterud K, 2001, LANCET, V358, P483, DOI 10.1016/S0140-6736(01)05627-6; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Murray SA, 2005, BRIT MED J, V330, P611, DOI 10.1136/bmj.330.7492.611; Murray SA, 2002, BRIT MED J, V325, P929, DOI 10.1136/bmj.325.7370.929; Murray SA, 2005, BMJ-BRIT MED J, V330, P1007, DOI 10.1136/bmj.330.7498.1007; Murray SA, 2006, LANCET, V368, P901, DOI 10.1016/S0140-6736(06)69350-1; NHS End of Life Care Program, 2010, GOLD STAND FRAM; NHS Quality Improvement Scotland, 2010, CLIN STAND CHRON OBS; Pound P, 1998, SOCIOL HEALTH ILL, V20, P489, DOI 10.1111/1467-9566.00112; Reissman CatherineKohler., 1993, NARRATIVE ANAL; Rocker GM, 2007, J PALLIAT MED, V10, P783, DOI 10.1089/jpm.2007.9951; Sanders C, 2002, SOCIOL HEALTH ILL, V24, P227, DOI 10.1111/1467-9566.00292; Seamark DA, 2007, J ROY SOC MED, V100, P225, DOI 10.1258/jrsm.100.5.225; Seymour JE, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c4860; Sprangers MAG, 1999, SOC SCI MED, V48, P1507, DOI 10.1016/S0277-9536(99)00045-3; Williams B, 2009, QUAL HEALTH RES, V19, P1443, DOI 10.1177/1049732309348363; WILLIAMS G, 1984, SOCIOL HEALTH ILL, V6, P175, DOI 10.1111/1467-9566.ep10778250; Williams SJ, 2000, SOCIOL HEALTH ILL, V22, P40, DOI 10.1111/1467-9566.00191	41	203	205	0	49	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2011	342								d142	10.1136/bmj.d142	http://dx.doi.org/10.1136/bmj.d142			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	715LP	21262897	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000286886300001
J	Khomyakova, M; Bukmez, O; Thomas, LK; Erb, TJ; Berg, IA				Khomyakova, Maria; Buekmez, Oezlem; Thomas, Lorenz K.; Erb, Tobias J.; Berg, Ivan A.			A Methylaspartate Cycle in Haloarchaea	SCIENCE			English	Article							HALOPHILIC ARCHAEON; ISOCITRATE LYASE; MALATE SYNTHASE; METABOLISM; GLUTAMATE; ENZYMES	Access to novel ecological niches often requires adaptation of metabolic pathways to cope with new environments. For conversion to cellular building blocks, many substrates enter central carbon metabolism via acetyl-coenzyme A (acetyl-CoA). Until now, only two such pathways have been identified: the glyoxylate cycle and the ethylmalonyl-CoA pathway. Prokaryotes in the haloarchaea use a third pathway by which acetyl-CoA is oxidized to glyoxylate via the key intermediate methylaspartate. Glyoxylate condensation with another acetyl-CoA molecule yields malate, the final assimilation product. This cycle combines reactions that originally belonged to different metabolic processes in different groups of prokaryotes, which suggests lateral gene transfer and evolutionary tinkering of acetate assimilation. Moreover, it requires elevated intracellular glutamate concentrations, as well as coupling carbon assimilation with nitrogen metabolism.	[Khomyakova, Maria; Buekmez, Oezlem; Thomas, Lorenz K.; Erb, Tobias J.; Berg, Ivan A.] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany	University of Freiburg	Berg, IA (corresponding author), Univ Freiburg, Fak Biol, Schanzlestr 1, D-79104 Freiburg, Germany.	ivan.berg@biologie.uni-freiburg.de	Berg, Ivan/AAZ-3917-2020; Erb, Tobias/J-5214-2013; Khomyakova, Maria/E-6912-2014	Erb, Tobias/0000-0003-3685-0894; Berg, Ivan/0000-0002-1864-4969	Deutscher Akademischer Austausch Dienst; Deutsche Forschungsgemeinschaft; Evonik-Degussa GmbH	Deutscher Akademischer Austausch Dienst(Deutscher Akademischer Austausch Dienst (DAAD)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Evonik-Degussa GmbH	The authors thank G. Fuchs, Freiburg, for his constant support and the innumerable discussions and suggestions during this work and for his critical reading of the manuscript and N. Gad'on and C. Ebenau-Jehle, Freiburg, for growing cells and maintaining the laboratory. The work of M.K. was supported by the Deutscher Akademischer Austausch Dienst. This work was supported by the Deutsche Forschungsgemeinschaft and Evonik-Degussa GmbH.	Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Brasen C, 2001, ARCH MICROBIOL, V175, P360, DOI 10.1007/s002030100273; Buckel W., 1999, Chemistry and biochemistry of B12., P757; BUCKEL W, 1987, EUR J BIOCHEM, V164, P565, DOI 10.1111/j.1432-1033.1987.tb11164.x; Candela T, 2006, MOL MICROBIOL, V60, P1091, DOI 10.1111/j.1365-2958.2006.05179.x; Connaris H, 1999, BIOTECHNOL BIOENG, V64, P38, DOI 10.1002/(SICI)1097-0290(19990705)64:1<38::AID-BIT4>3.0.CO;2-7; Danson MJ, 2007, ARCHAEA: MOLECULAR AND CELLULAR BIOLOGY, P260; Daugherty M, 2001, J BACTERIOL, V183, P292, DOI 10.1128/JB.183.1.292-300.2001; Erb TJ, 2007, P NATL ACAD SCI USA, V104, P10631, DOI 10.1073/pnas.0702791104; Erb TJ, 2010, J BACTERIOL, V192, P1249, DOI 10.1128/JB.01267-09; Erb TJ, 2009, MOL MICROBIOL, V73, P992, DOI 10.1111/j.1365-2958.2009.06837.x; Falb M, 2008, EXTREMOPHILES, V12, P177, DOI 10.1007/s00792-008-0138-x; Hezayen FF, 2000, APPL MICROBIOL BIOT, V54, P319, DOI 10.1007/s002530000394; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Johnsen U, 2009, J BIOL CHEM, V284, P27290, DOI 10.1074/jbc.M109.003814; Kennedy SP, 2001, GENOME RES, V11, P1641, DOI 10.1101/gr.190201; KORNBERG HL, 1957, NATURE, V179, P988, DOI 10.1038/179988a0; LILLO JG, 1990, APPL ENVIRON MICROB, V56, P2517, DOI 10.1128/AEM.56.8.2517-2521.1990; Malki L, 2009, J BACTERIOL, V191, P5196, DOI 10.1128/JB.00297-09; OREN A, 1995, FEMS MICROBIOL LETT, V130, P91; Oren A., 2002, HALOPHILIC MICROORGA; Peyraud R, 2009, P NATL ACAD SCI USA, V106, P4846, DOI 10.1073/pnas.0810932106; Serrano JA, 1998, FEBS LETT, V434, P13, DOI 10.1016/S0014-5793(98)00911-9; Serrano JA, 2001, BBA-GENE STRUCT EXPR, V1520, P154, DOI 10.1016/S0167-4781(01)00263-9; Shimizu S., 1984, MICROBIAL GROWTH C1, P113; Tuininga JE, 1999, J BIOL CHEM, V274, P21023, DOI 10.1074/jbc.274.30.21023; Vuilleumier S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005584; Zarzycki J, 2009, P NATL ACAD SCI USA, V106, P21317, DOI 10.1073/pnas.0908356106	28	71	82	2	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					334	337		10.1126/science.1196544	http://dx.doi.org/10.1126/science.1196544			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252347				2022-12-28	WOS:000286636300038
J	Brock, DA; Douglas, TE; Queller, DC; Strassmann, JE				Brock, Debra A.; Douglas, Tracy E.; Queller, David C.; Strassmann, Joan E.			Primitive agriculture in a social amoeba	NATURE			English	Article							EVOLUTION; BACTERIA; COOPERATION; MUTUALISM	Agriculture has been a large part of the ecological success of humans(1). A handful of animals, notably the fungus-growing ants, termites and ambrosia beetles(2-4), have advanced agriculture that involves dispersal and seeding of food propagules, cultivation of the crop and sustainable harvesting(5). More primitive examples, which could be called husbandry because they involve fewer adaptations, include marine snails farming intertidal fungi(6) and damsel-fish farming algae(7). Recent work has shown that microorganisms are surprisingly like animals in having sophisticated behaviours such as cooperation, communication(8,9) and recognition(10,11), as well as many kinds of symbiosis(12-15). Here we show that the social amoeba Dictyostelium discoideum has a primitive farming symbiosis that includes dispersal and prudent harvesting of the crop. About one-third of wild-collected clones engage in husbandry of bacteria. Instead of consuming all bacteria in their patch, they stop feeding early and incorporate bacteria into their fruiting bodies. They then carry bacteria during spore dispersal and can seed a new food crop, which is a major advantage if edible bacteria are lacking at the new site. However, if they arrive at sites already containing appropriate bacteria, the costs of early feeding cessation are not compensated for, which may account for the dichotomous nature of this farming symbiosis. The striking convergent evolution between bacterial husbandry in social amoebas and fungus farming in social insects makes sense because multigenerational benefits of farming go to already established kin groups.	[Brock, Debra A.; Douglas, Tracy E.; Queller, David C.; Strassmann, Joan E.] Rice Univ, Dept Ecol & Evolutionary Biol, Houston, TX 77005 USA	Rice University	Brock, DA (corresponding author), Rice Univ, Dept Ecol & Evolutionary Biol, 6100 Main St, Houston, TX 77005 USA.	dbrock@rice.edu		Strassmann, Joan/0000-0003-0638-8440	US National Science Foundation; Division Of Environmental Biology [0816690, 1204352] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank J. Rudgers, G. Saxer Quance, L. Campbell, E. Ostrowski, O. Gilbert, A. Savage, J. Ahern, K. Crawford, S. Chamberlain, S. Read, D. Nguyen, K. Foster, H. Kaplan, D. Hatton and K. Boomsma for discussions and advice. This material is based on work supported by the US National Science Foundation.	Aanen DK, 2002, P NATL ACAD SCI USA, V99, P14887, DOI 10.1073/pnas.222313099; Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816; Benabentos R, 2009, CURR BIOL, V19, P567, DOI 10.1016/j.cub.2009.02.037; CLARK F. E., 1967, Soil Biology., P15; Crespi BJ, 2001, TRENDS ECOL EVOL, V16, P178, DOI 10.1016/S0169-5347(01)02115-2; Douglas AE, 1998, ANNU REV ENTOMOL, V43, P17, DOI 10.1146/annurev.ento.43.1.17; Farrell BD, 2001, EVOLUTION, V55, P2011, DOI 10.1111/j.0014-3820.2001.tb01318.x; Flowers JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001013; Fortunato A, 2003, MOL ECOL, V12, P1031, DOI 10.1046/j.1365-294X.2003.01792.x; Foster KR, 2004, NATURE, V431, P693, DOI 10.1038/nature02894; Gilbert OM, 2007, P NATL ACAD SCI USA, V104, P8913, DOI 10.1073/pnas.0702723104; Hata H, 2006, BIOL LETT-UK, V2, P593, DOI 10.1098/rsbl.2006.0528; HEIJNEN CE, 1993, APPL ENVIRON MICROB, V59, P743, DOI 10.1128/AEM.59.3.743-747.1993; HORN EG, 1971, ECOLOGY, V52, P475, DOI 10.2307/1937630; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Keller L, 2006, NAT REV MICROBIOL, V4, P249, DOI 10.1038/nrmicro1383; Kessin R.H., 2001, DICTYOSTELIUM EVOLUT; Matz C, 2005, TRENDS MICROBIOL, V13, P302, DOI 10.1016/j.tim.2005.05.009; Mehdiabadi NJ, 2006, NATURE, V442, P881, DOI 10.1038/442881a; Moran NA, 2005, J BACTERIOL, V187, P4229, DOI 10.1128/JB.187.12.4229-4237.2005; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Nadson G. A., 1899, SCRIPTA BOT HORTI U, V15, P188; Ostrowski EA, 2008, PLOS BIOL, V6, P2376, DOI 10.1371/journal.pbio.0060287; Raper K. B., 1984, DICTYOSTELIDS, P87; Raper KB, 1937, J AGRIC RES, V55, P0289; Santorelli LA, 2008, NATURE, V451, P1107, DOI 10.1038/nature06558; Sears CL, 2005, ANAEROBE, V11, P247, DOI 10.1016/j.anaerobe.2005.05.001; Silliman BR, 2003, P NATL ACAD SCI USA, V100, P15643, DOI 10.1073/pnas.2535227100; Skupienski F. X., 1920, THESIS U PARIS; Smith B.D., 1995, EMERGENCE AGR; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092	32	149	152	10	183	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					393	+		10.1038/nature09668	http://dx.doi.org/10.1038/nature09668			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248849				2022-12-28	WOS:000286385600051
J	Abraham, WT; Adamson, PB; Bourge, RC; Aaron, MF; Costanzo, MR; Stevenson, LW; Strickland, W; Neelagaru, S; Raval, N; Krueger, S; Weiner, S; Shavelle, D; Jeffries, B; Yadav, JS				Abraham, William T.; Adamson, Philip B.; Bourge, Robert C.; Aaron, Mark F.; Costanzo, Maria Rosa; Stevenson, Lynne W.; Strickland, Warren; Neelagaru, Suresh; Raval, Nirav; Krueger, Steven; Weiner, Stanislav; Shavelle, David; Jeffries, Bradley; Yadav, Jay S.		CHAMPION Trial Study Grp	Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial	LANCET			English	Article							LEFT ATRIAL PRESSURE; CARDIAC-RESYNCHRONIZATION; INITIAL-EXPERIENCE; IMPLANTABLE DEVICE; MANAGEMENT; DEFIBRILLATOR; ASSOCIATION; MULTICENTER; RATIONALE; OUTCOMES	Background Results of previous studies support the hypothesis that implantable haemodynamic monitoring systems might reduce rates of hospitalisation in patients with heart failure. We undertook a single-blind trial to assess this approach. Methods Patients with New York Heart Association (NYHA) class III heart failure, irrespective of the left ventricular ejection fraction, and a previous hospital admission for heart failure were enrolled in 64 centres in the USA. They were randomly assigned by use of a centralised electronic system to management with a wireless implantable haemodynamic monitoring (W-IHM) system (treatment group) or to a control group for at least 6 months. Only patients were masked to their assignment group. In the treatment group, clinicians used daily measurement of pulmonary artery pressures in addition to standard of care versus standard of care alone in the control group. The primary efficacy endpoint was the rate of heart-failure-related hospitalisations at 6 months. The safety endpoints assessed at 6 months were freedom from device-related or system-related complications (DSRC) and freedom from pressure-sensor failures. All analyses were by intention to treat. This trial is registered with ClinicalTrials.gov, number NCT00531661. Findings In 6 months, 83 heart-failure-related hospitalisations were reported in the treatment group (n=270) compared with 120 in the control group (n=280; rate 0.31 vs 0-44, hazard ratio [HR] 0.70, 95% CI 0.60-0.84, p<0.0001). During the entire follow-up (mean 15 months [SD 7]), the treatment group had a 39% reduction in heart-failure-related hospitalisation compared with the control group (153 vs 253, HR 0.64, 95% CI 0.55-0.75; p<0.0001). Eight patients had DSRC and overall freedom from DSRC was 98.6% (97-3-99.4) compared with a prespecified performance criterion of 80% (p<0.0001); and overall freedom from pressure-sensor failures was 100% (99-3-100.0). Interpretation Our results are consistent with, and extend, previous findings by definitively showing a significant and large reduction in hospitalisation for patients with NYHA class III heart failure who were managed with a wireless implantable haemodynamic monitoring system. The addition of information about pulmonary artery pressure to clinical signs and symptoms allows for improved heart failure management.	[Abraham, William T.] Ohio State Univ, Heart & Vasc Ctr, Columbus, OH 43210 USA; [Adamson, Philip B.] Oklahoma Heart Hosp, Oklahoma City, OK USA; [Adamson, Philip B.] Oklahoma Fdn Cardiovasc Res, Oklahoma City, OK USA; [Bourge, Robert C.] Univ Alabama Birmingham, Birmingham, AL USA; [Aaron, Mark F.] St Thomas Heart, Nashville, TN USA; [Costanzo, Maria Rosa] Midwest Heart Fdn, Lombard, IL USA; [Stevenson, Lynne W.] Brigham & Womens Hosp, Boston, MA 02115 USA; [Strickland, Warren] Huntsville Dist Mem Hosp, Huntsville, AL USA; NW Texas Hosp, Amarillo, TX USA; [Raval, Nirav] Piedmont Heart Inst, Atlanta, GA USA; [Krueger, Steven] Bryan Lincoln Gen Hosp Heart Inst, Lincoln, NE USA; [Weiner, Stanislav] Tyler Cardiovasc Consultants, Tyler, TX USA; [Shavelle, David] Univ So Calif, Los Angeles, CA USA; [Jeffries, Bradley; Yadav, Jay S.] CardioMEMS, Atlanta, GA USA	University System of Ohio; Ohio State University; University of Alabama System; University of Alabama Birmingham; Harvard University; Brigham & Women's Hospital; Piedmont Heart Institute; University of Southern California	Abraham, WT (corresponding author), Ohio State Univ, Heart & Vasc Ctr, 473 W 12th Ave,Room 110P, Columbus, OH 43210 USA.	william.abraham@osumc.edu		Goldberg, Lee/0000-0002-7906-9638; Jessup, Mariell/0000-0002-3010-0112	CardioMEMS, Atlanta, GA, USA	CardioMEMS, Atlanta, GA, USA	CardioMEMS, Atlanta, GA, USA, sponsored this study. We with to acknowledge the substantial contributions of key CHAMPION trial personnel-Susan Neville, Pam Cowart, Greg Ginn, John Henderson, Jordan Bauman, Melissa Webb, Kevin Corcoran, David Stern, Sandeep Yadav, Stephan Ogenstad, Rich Holcomb, and Spencer Kubo.	Abraham WT, 2002, NEW ENGL J MED, V346, P1845, DOI 10.1056/NEJMoa013168; Adams KF, 2005, AM HEART J, V149, P209, DOI 10.1016/j.ahj.2004.08.005; Adamson PB, 2003, J AM COLL CARDIOL, V41, P565, DOI 10.1016/S0735-1097(02)02896-6; Adamson PB, 2011, J CARD FAIL, V17, P3, DOI 10.1016/j.cardfail.2010.08.002; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bourge RC, 2008, J AM COLL CARDIOL, V51, P1073, DOI 10.1016/j.jacc.2007.10.061; Castro PF, 2007, J HEART LUNG TRANSPL, V26, P85, DOI 10.1016/j.healun.2006.10.006; Chaudhry SI, 2010, NEW ENGL J MED, V363, P2301, DOI 10.1056/NEJMoa1010029; Faris R, 2002, INT J CARDIOL, V82, P149, DOI 10.1016/S0167-5273(01)00600-3; Hoppe UC, 2009, HEART, V95, P1091, DOI 10.1136/hrt.2008.153486; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; Magalski A, 2002, J CARD FAIL, V8, P63, DOI 10.1054/jcaf.2002.32373; McAlister FA, 2004, J AM COLL CARDIOL, V44, P810, DOI 10.1016/j.jacc.2004.05.055; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Moss AJ, 2009, NEW ENGL J MED, V361, P1329, DOI 10.1056/NEJMoa0906431; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Pitt B, 1996, AM J CARDIOL, V78, P902; Poole-Wilson PA, 2003, LANCET, V362, P7, DOI 10.1016/S0140-6736(03)13800-7; Ritzema J, 2007, CIRCULATION, V116, P2952, DOI 10.1161/CIRCULATIONAHA.107.702191; Ritzema J, 2010, CIRCULATION, V121, P1086, DOI 10.1161/CIRCULATIONAHA.108.800490; Ross JS, 2010, CIRC-HEART FAIL, V3, P97, DOI 10.1161/CIRCHEARTFAILURE.109.885210; Russo MJ, 2008, J CARD FAIL, V14, P651, DOI 10.1016/j.cardfail.2008.06.005; Stevenson LW, 2005, JAMA-J AM MED ASSOC, V294, P1625; Taylor AL, 2004, NEW ENGL J MED, V351, P2049, DOI 10.1056/NEJMoa042934; Verdejo HE, 2007, J AM COLL CARDIOL, V50, P2375, DOI 10.1016/j.jacc.2007.06.061; Young JB, 2003, JAMA-J AM MED ASSOC, V289, P2685, DOI 10.1001/jama.289.20.2685; Zile MR, 2008, CIRCULATION, V118, P1433, DOI 10.1161/CIRCULATIONAHA.108.783910	29	937	972	3	80	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 19	2011	377	9766					658	666		10.1016/S0140-6736(11)60101-3	http://dx.doi.org/10.1016/S0140-6736(11)60101-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	727DB	21315441				2022-12-28	WOS:000287776600035
J	Kauffman, RP				Kauffman, Robert P.			Estrogen plus progestin increased long-term risk for invasive breast cancer in postmenopausal women	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									Texas Tech Univ, Sch Med, Amarillo, TX USA	Texas Tech University System; Texas Tech University	Kauffman, RP (corresponding author), Texas Tech Univ, Sch Med, Amarillo, TX USA.							RAGAZ J, 33 ANN SAN ANT BREAS; Shapiro S, 2007, CLIMACTERIC, V10, P2, DOI 10.1080/13697130701606754; Stanczyk FZ, 2003, J REPROD MED, V48, P485; Stefanick ML, 2006, JAMA-J AM MED ASSOC, V295, P1647, DOI 10.1001/jama.295.14.1647	4	0	0	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4							JC2-11	10.7326/0003-4819-154-4-201102150-02011	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-02011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720VF	21320926				2022-12-28	WOS:000287310000010
J	Wensley, F; Gao, P; Burgess, S; Kaptoge, S; Di Angelantonio, E; Shah, T; Engert, JC; Clarke, R; Davey-Smith, G; Nordestgaard, BG; Saleheen, D; Samani, NJ; Sandhu, M; Anand, S; Pepys, MB; Smeeth, L; Whittaker, J; Casas, JP; Thompson, SG; Hingorani, AD; Danesh, J; Eiriksdottir, G; Harris, TB; Launer, LJ; Gudnason, V; Folsom, AR; Andrews, G; Ballantyne, CM; Samani, NJ; Hall, AS; Braund, PS; Balmforth, AJ; Whincup, PH; Morris, R; Lawlor, DA; Lowe, GDO; Timpson, N; Ebrahim, S; Ben-Shlomo, Y; Davey-Smith, G; Timpson, N; Nordestgaard, BG; Tybjaerg-Hansen, A; Zacho, J; Brown, M; Sandhu, M; Ricketts, SL; Ashford, S; Lange, L; Reiner, A; Cushman, M; Tracy, R; Wu, C; Ge, J; Zou, Y; Sun, A; Hung, J; McQuillan, B; Thompson, P; Beilby, J; Warrington, N; Palmer, LJ; Wanner, C; Drechsler, C; Hoffmann, MM; Fowkes, FGR; Lowe, GDO; Tzoulaki, I; Kumari, M; Miller, M; Marmot, M; Onland-Moret, C; van der Schouw, YT; Boer, JM; Wijmenga, C; Ricketts, L; Ashford, S; Sandhu, M; Khaw, KT; Vasan, RS; Schnabel, RB; Yamamoto, JF; Benjamin, EJ; Schunkert, H; Erdmann, J; Konig, IR; Hengstenberg, C; Chiodini, B; Franzosi, MG; Pietri, S; Gori, F; Rudock, M; Liu, Y; Lohman, K; Harris, TB; Humphries, SE; Hamsten, A; Norman, PE; Hankey, GJ; Jamrozik, K; Palmer, LJ; Rimm, EB; Pai, JK; Psaty, BM; Heckbert, SR; Bis, JC; Yusuf, S; Anand, S; Engert, JC; Xie, C; Collins, R; Clarke, R; Bennett, D; Kooner, J; Chambers, J; Elliott, P; Marz, W; Kleber, ME; Bohm, BO; Winkelmann, BR; Melander, O; Berglund, G; Koenig, W; Thorand, B; Baumert, J; Peters, A; Rimm, EB; Manson, J; Pai, JK; Humphries, SE; Cooper, JA; Talmud, PJ; Ladenvall, P; Johansson, L; Jansson, JH; Hallmans, G; Reilly, MP; Qu, L; Li, M; Rader, DJ; Watkins, H; Clarke, R; Hopewell, J; Saleheen, D; Danesh, J; Frossard, P; Sattar, N; Robertson, M; Shepherd, J; Schaefer, E; Hofman, A; Witteman, JCM; Kardys, I; Dehghan, A; de Faire, U; Bennet, A; Gigante, B; Leander, K; Ben-Shlomo, Y; Davey-Smith, G; Timpson, N; Peters, B; Maitland-van der Zee, AH; de Boer, A; Klungel, O; Reiner, A; Manson, J; Greenland, P; Dai, J; Liu, S; Kumari, M; Brunner, E; Kivimaki, M; Marmot, M; Sattar, N; O'Reilly, D; Ford, I; Packard, CJ				Wensley, Frances; Gao, Pei; Burgess, Stephen; Kaptoge, Stephen; Di Angelantonio, Emanuele; Shah, Tina; Engert, James C.; Clarke, Robert; Davey-Smith, George; Nordestgaard, Borge G.; Saleheen, Danish; Samani, Nilesh J.; Sandhu, Manjinder; Anand, Sonia; Pepys, Mark B.; Smeeth, Liam; Whittaker, John; Casas, Juan Pablo; Thompson, Simon G.; Hingorani, Aroon D.; Danesh, John; Eiriksdottir, G.; Harris, T. B.; Launer, L. J.; Gudnason, V.; Folsom, A. R.; Andrews, G.; Ballantyne, C. M.; Samani, N. J.; Hall, A. S.; Braund, P. S.; Balmforth, A. J.; Whincup, P. H.; Morris, R.; Lawlor, D. A.; Lowe, G. D. O.; Timpson, N.; Ebrahim, S.; Ben-Shlomo, Y.; Davey-Smith, G.; Timpson, N.; Nordestgaard, B. G.; Tybjaerg-Hansen, A.; Zacho, J.; Brown, M.; Sandhu, M.; Ricketts, S. L.; Ashford, S.; Lange, L.; Reiner, A.; Cushman, M.; Tracy, R.; Wu, C.; Ge, J.; Zou, Y.; Sun, A.; Hung, J.; McQuillan, B.; Thompson, P.; Beilby, J.; Warrington, N.; Palmer, L. J.; Wanner, C.; Drechsler, C.; Hoffmann, M. M.; Fowkes, F. G. R.; Lowe, G. D. O.; Tzoulaki, I.; Kumari, M.; Miller, M.; Marmot, M.; Onland-Moret, C.; van der Schouw, Y. T.; Boer, J. M.; Wijmenga, C.; Ricketts, S. L.; Ashford, S.; Sandhu, M.; Khaw, K-T; Vasan, R. S.; Schnabel, R. B.; Yamamoto, J. F.; Benjamin, E. J.; Schunkert, H.; Erdmann, J.; Koenig, I. R.; Hengstenberg, C.; Chiodini, B.; Franzosi, M. G.; Pietri, S.; Gori, F.; Rudock, M.; Liu, Y.; Lohman, K.; Harris, T. B.; Humphries, S. E.; Hamsten, A.; Norman, P. E.; Hankey, G. J.; Jamrozik, K.; Palmer, L. J.; Rimm, E. B.; Pai, J. K.; Psaty, B. M.; Heckbert, S. R.; Bis, J. C.; Yusuf, S.; Anand, S.; Engert, J. C.; Xie, C.; Collins, R.; Clarke, R.; Bennett, D.; Kooner, J.; Chambers, J.; Elliott, P.; Maerz, W.; Kleber, M. E.; Boehm, B. O.; Winkelmann, B. R.; Melander, O.; Berglund, G.; Koenig, W.; Thorand, B.; Baumert, J.; Peters, A.; Rimm, E. B.; Manson, J.; Pai, J. K.; Humphries, S. E.; Cooper, J. A.; Talmud, P. J.; Ladenvall, P.; Johansson, L.; Jansson, J-H; Hallmans, G.; Reilly, M. P.; Qu, L.; Li, M.; Rader, D. J.; Watkins, H.; Clarke, R.; Hopewell, J.; Saleheen, D.; Danesh, J.; Frossard, P.; Sattar, N.; Robertson, M.; Shepherd, J.; Schaefer, E.; Hofman, A.; Witteman, J. C. M.; Kardys, I.; Dehghan, A.; de Faire, U.; Bennet, A.; Gigante, B.; Leander, K.; Ben-Shlomo, Y.; Davey-Smith, G.; Timpson, N.; Peters, B.; Maitland-van der Zee, A. H.; de Boer, A.; Klungel, O.; Reiner, A.; Manson, J.; Greenland, P.; Dai, J.; Liu, S.; Kumari, M.; Brunner, E.; Kivimaki, M.; Marmot, M.; Sattar, N.; O'Reilly, D.; Ford, I.; Packard, C. J.		C Reactive Prot Coronary Heart Dis; AGES; ARIC; BHF-FHS; BRHS; BWHHS; CAPS; CCHS CGPS CIHDS; CHAOS; CHS; CRPHANS; CUDAS CUPID; 4D; EAS; ELSA; EPICNL; EPICNOR; FRAMOFF; GERMIFS; GISSI-P; HEALTHABC; HIFMECH; HIMS; HPFS; HVHS; INTERHEART; ISIS; LOLIPOP; LURIC; MALMO; MONICAKORA; NHS; NPHSII; NSC; PENNCATH; PROCARDIS; PROMIS; PROSPER; ROTTERDAM; SHEEP; SPEED; UCP; WHIOS; WHITEII; WOSCOPS	Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data	BRITISH MEDICAL JOURNAL			English	Article							CARDIOVASCULAR-DISEASE; INSTRUMENTAL VARIABLES; MYOCARDIAL-INFARCTION; RISK; METAANALYSIS; ATHEROSCLEROSIS; MARKERS; GENE; POLYMORPHISMS; INFLAMMATION	Objective To use genetic variants as unconfounded proxies of C reactive protein concentration to study its causal role in coronary heart disease. Design Mendelian randomisation meta-analysis of individual participant data from 47 epidemiological studies in 15 countries. Participants 194 418 participants, including 46 557 patients with prevalent or incident coronary heart disease. Information was available on four CRP gene tagging single nucleotide polymorphisms (rs3093077, rs1205, rs1130864, rs1800947), concentration of C reactive protein, and levels of other risk factors. Main outcome measures Risk ratios for coronary heart disease associated with genetically raised C reactive protein versus risk ratios with equivalent differences in C reactive protein concentration itself, adjusted for conventional risk factors and variability in risk factor levels within individuals. Results CRP variants were each associated with up to 30% per allele difference in concentration of C reactive protein (P<10(-34)) and were unrelated to other risk factors. Risk ratios for coronary heart disease per additional copy of an allele associated with raised C reactive protein were 0.93 (95% confidence interval 0.87 to 1.00) for rs3093077; 1.00 (0.98 to 1.02) for rs1205; 0.98 (0.96 to 1.00) for rs1130864; and 0.99 (0.94 to 1.03) for rs1800947. In a combined analysis, the risk ratio for coronary heart disease was 1.00 (0.90 to 1.13) per 1 SD higher genetically raised natural log (ln) concentration of C reactive protein. The genetic findings were discordant with the risk ratio observed for coronary heart disease of 1.33 (1.23 to 1.43) per 1 SD higher circulating ln concentration of C reactive protein in prospective studies (P=0.001 for difference). Conclusion Human genetic data indicate that C reactive protein concentration itself is unlikely to be even a modest causal factor in coronary heart disease.	[Wensley, Frances; Gao, Pei; Kaptoge, Stephen; Di Angelantonio, Emanuele; Saleheen, Danish; Sandhu, Manjinder; Danesh, John] Univ Cambridge, Cambridge CB2 1TN, England; [Burgess, Stephen; Thompson, Simon G.] MRC Biostat Unit, Cambridge, England; [Shah, Tina; Pepys, Mark B.; Hingorani, Aroon D.] UCL, London WC1E 6BT, England; [Engert, James C.; Anand, Sonia] McGill Univ, Montreal, PQ H3A 2T5, Canada; [Clarke, Robert] Univ Oxford, Oxford OX1 2JD, England; [Davey-Smith, George] Univ Bristol, Bristol BS8 1TH, Avon, England; [Nordestgaard, Borge G.] Univ Copenhagen, DK-1168 Copenhagen, Denmark; [Samani, Nilesh J.] Univ Leicester, Leicester LE1 7RH, Leics, England; [Smeeth, Liam; Whittaker, John; Casas, Juan Pablo] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England	University of Cambridge; MRC Biostatistics Unit; University of London; University College London; McGill University; University of Oxford; University of Bristol; University of Copenhagen; University of Leicester; University of London; London School of Hygiene & Tropical Medicine	Wensley, F (corresponding author), Univ Cambridge, Cambridge CB2 1TN, England.	crpgenetics@phpc.cam.ac.uk	Gudnason, Vilmundur/K-6885-2015; Greenland, Philip/ABD-5528-2021; Fox, Laura J/C-6249-2016; Ford, Ian/ABE-6145-2020; Schnabel, Renate B/ABE-6668-2021; Ben-Shlomo, Yoav/ABD-2004-2021; Tzoulaki, Ioanna/ABE-6269-2020; Hall, Alistair/K-1953-2019; Khaw, Kay-Tee/AAZ-3209-2021; Gao, Pei/AAF-3065-2019; Warrington, Nicole/P-4868-2014; Nordestgaard, Borge Gronne/ABF-1310-2020; Timpson, Nicholas John/O-7548-2015; van der Schouw, Yvonne T./F-8327-2014; , Bennett/O-7998-2019; Tzoulaki, Ioanna/C-1381-2008; Erdmann, Jeanette/P-7513-2014; Hankey, Graeme J/H-4968-2014; Liu, Simin/GSN-4159-2022; Li, Man/AAX-3400-2020; Bennett, Derrick/AAH-1220-2022; Gao, Pei/R-4794-2018; Erdmann, Jeanette/A-4417-2009; Norman, Paul E/C-5485-2013; Whittaker, John C/B-8609-2012; Marmot, M G/Y-3920-2019; Gigante, Bruna/I-9252-2012; Davey Smith, George/A-7407-2013; Onland-Moret, N. Charlotte/G-9185-2011; Leander, Karin/C-7261-2017; Bennett, Derrick/AFL-9254-2022; Brunner, Eric/H-2114-2011; Attrill, Lauren/V-1688-2018; McQuillan, Brendan/B-8271-2013; Schnabel, Renate B/F-6527-2014; Wijmenga, Cisca/AAE-7719-2019; König, Inke R/A-4544-2009; Ramachandran, Vasan/Y-2527-2019; Kivimaki, Mika/B-3607-2012; Miller, Michelle A/D-1840-2009; Palmer, Lyle John/N-1948-2019; Liu, Simin/I-3689-2014; Gudnason, Vilmundur/AAE-7126-2019; Thorand, Barbara/B-5349-2014; Ballantyne, Christie/A-6599-2008; DiAngelantonio, Emanuele/ABE-6852-2020; Dehghan, Abbas/ABE-7377-2020; Hengstenberg, Christian/U-5485-2019; Hoffmann, Michael M/D-4074-2015; Palmer, Lyle John/K-3196-2014; Maitland-van der Zee, Anke/I-9572-2016; Dehghan, Abbas/B-9896-2008; Smeeth, Liam/X-5862-2018	Gudnason, Vilmundur/0000-0001-5696-0084; Schnabel, Renate B/0000-0001-7170-9509; Ben-Shlomo, Yoav/0000-0001-6648-3007; Tzoulaki, Ioanna/0000-0002-4275-9328; Gao, Pei/0000-0001-8649-1290; Warrington, Nicole/0000-0003-4195-775X; Timpson, Nicholas John/0000-0002-7141-9189; van der Schouw, Yvonne T./0000-0002-4605-435X; Erdmann, Jeanette/0000-0002-4486-6231; Hankey, Graeme J/0000-0002-6044-7328; Li, Man/0000-0002-3839-0281; Bennett, Derrick/0000-0002-9170-8447; Gao, Pei/0000-0001-8649-1290; Norman, Paul E/0000-0003-3406-0506; Whittaker, John C/0000-0002-3529-2379; Marmot, M G/0000-0002-2431-6419; Davey Smith, George/0000-0002-1407-8314; Onland-Moret, N. Charlotte/0000-0002-2360-913X; Leander, Karin/0000-0002-1404-9222; Bennett, Derrick/0000-0002-9170-8447; Brunner, Eric/0000-0002-0595-4474; McQuillan, Brendan/0000-0002-2130-8114; Wijmenga, Cisca/0000-0002-5635-1614; König, Inke R/0000-0003-0504-6465; Ramachandran, Vasan/0000-0001-7357-5970; Kivimaki, Mika/0000-0002-4699-5627; Miller, Michelle A/0000-0002-6696-0923; Palmer, Lyle John/0000-0002-1628-3055; Liu, Simin/0000-0003-2098-3844; Gudnason, Vilmundur/0000-0001-5696-0084; Thorand, Barbara/0000-0002-8416-6440; Hoffmann, Michael M/0000-0001-8459-6080; Palmer, Lyle John/0000-0002-1628-3055; Hopewell, Jemma/0000-0002-3870-8018; Nordestgaard, Borge/0000-0002-1954-7220; Elliott, Paul/0000-0002-7511-5684; Hingorani, Aroon/0000-0001-8365-0081; Di Angelantonio, Emanuele/0000-0001-8776-6719; Ballantyne, Christie/0000-0002-6432-1730; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Koenig, Wolfgang/0000-0002-2064-9603; Burgess, Stephen/0000-0001-5365-8760; s, hema/0000-0002-3440-9475; Maitland-van der Zee, Anke/0000-0002-0414-3442; Yusuf, Salim/0000-0003-4776-5601; Talmud, Philippa/0000-0002-5560-1933; Whincup, Peter/0000-0002-5589-4107; Gigante, Bruna/0000-0003-4508-7990; Kumari, Meena/0000-0001-9716-1035; Melander, Olle/0000-0002-2581-484X; Shah, Tina/0000-0001-7724-7210; Morris, Richard/0000-0001-7240-4563; Wensley, Frances/0000-0003-4371-5340; Humphries, Stephen E/0000-0002-8221-6547; Lawlor, Debbie A/0000-0002-6793-2262; Dehghan, Abbas/0000-0001-6403-016X; Smeeth, Liam/0000-0002-9168-6022; Hall, Alistair/0000-0003-0306-7887; Cushman, Mary/0000-0002-7871-6143; Ricketts, Sally/0000-0002-5644-7958; Engert, James/0000-0001-8411-4790; Reilly, Muredach/0000-0002-3035-9386; Kleber, Marcus/0000-0003-0663-7275	British Heart Foundation [SP/08/007, FS05/125]; Rosetrees Foundation; British Heart Foundation [SP/08/007/23628, RG/07/008/23674, RG/08/008/25291, RG/08/014/24067, RG/08/013/25942] Funding Source: researchfish; Medical Research Council [G19/35, G7900510, G0100222, G0600705, MC_qA137933, G0601966, G8802774, MC_U105260792, G0401527, G1000143, G0801056, G0902037, G0801056B, G0801566, MC_U137686857, G0700931] Funding Source: researchfish; National Institute for Health Research [NF-SI-0510-10090] Funding Source: researchfish; MRC [MC_U105260792, G0601966, G0700931, MC_qA137933, G0600705, G0801566, MC_U137686857, G0902037] Funding Source: UKRI; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025741] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); Rosetrees Foundation(Rosetrees Trust); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The coordinating centre is supported by grant SP/08/007 from the British Heart Foundation. Various sources have supported recruitment, follow-up, and laboratory measurements in the contributing studies. Investigators of several of these studies have contributed to a list naming some of these funding sources, which can be found at http://ceu.phpc.cam.ac.uk/research/ccgc/studies/. AD Hingorani acknowledges support from the Rosetrees Foundation and the British Heart Foundation (FS05/125).	Anand SS, 2010, EUR HEART J, V31, P2092, DOI 10.1093/eurheartj/ehq242; Bisoendial RJ, 2010, EUR HEART J, V31, P2087, DOI 10.1093/eurheartj/ehq238; Burgess S, 2010, STAT MED, V29, P1298, DOI 10.1002/sim.3843; Carlson CS, 2005, AM J HUM GENET, V77, P64, DOI 10.1086/431366; Casas JP, 2008, J INTERN MED, V264, P295, DOI 10.1111/j.1365-2796.2008.02015.x; Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041; Cohen JC, 2006, NEW ENGL J MED, V354, P1264, DOI 10.1056/NEJMoa054013; Crossman DC, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-8; Danesh J, 2008, EUR J EPIDEMIOL, V23, P531, DOI 10.1007/s10654-008-9249-z; DEBEER FC, 1982, J EXP MED, V156, P230, DOI 10.1084/jem.156.1.230; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; Kaptoge S, 2007, AM J EPIDEMIOL, V166, P867, DOI 10.1093/aje/kwm191; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Kardys I, 2006, EUR HEART J, V27, P1331, DOI 10.1093/eurheartj/ehl018; Keavney B, 2006, INT J EPIDEMIOL, V35, P935, DOI 10.1093/ije/dyl114; Koike T, 2009, CIRCULATION, V120, P2088, DOI 10.1161/CIRCULATIONAHA.109.872796; Kovacs A, 2007, P NATL ACAD SCI USA, V104, P13768, DOI 10.1073/pnas.0706027104; Lachmann HJ, 2009, J EXP MED, V206, P1029, DOI 10.1084/jem.20082481; Lange LA, 2006, JAMA-J AM MED ASSOC, V296, P2703, DOI 10.1001/jama.296.22.2703; Lawlor DA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003011; Pai JK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001395; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pepys MB, 2006, NATURE, V440, P1217, DOI 10.1038/nature04672; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Smith GD, 2005, BMJ-BRIT MED J, V330, P1076, DOI 10.1136/bmj.330.7499.1076; Staiger D, 1997, ECONOMETRICA, V65, P557, DOI 10.2307/2171753; Taylor KE, 2005, ARTERIOSCL THROM VAS, V25, P1225, DOI 10.1161/01.ATV.0000164623.41250.28; Verzilli C, 2008, AM J HUM GENET, V82, P859, DOI 10.1016/j.ajhg.2008.01.016; Wood AM, 2009, STAT MED, V28, P1067, DOI 10.1002/sim.3530; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402; Zhang YX, 1999, ATHEROSCLEROSIS, V145, P375, DOI 10.1016/S0021-9150(99)00105-7	35	427	431	4	51	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2011	342								d548	10.1136/bmj.d548	http://dx.doi.org/10.1136/bmj.d548			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725OU	21325005	Green Submitted, Green Accepted, Green Published, hybrid			2022-12-28	WOS:000287655900007
J	Choi, M; Scholl, UI; Yue, P; Bjorklund, P; Zhao, BX; Nelson-Williams, C; Ji, WZ; Cho, YS; Patel, A; Men, CJ; Lolis, E; Wisgerhof, MV; Geller, DS; Mane, S; Hellman, P; Westin, G; Akerstrom, G; Wang, WH; Carling, T; Lifton, RP				Choi, Murim; Scholl, Ute I.; Yue, Peng; Bjoerklund, Peyman; Zhao, Bixiao; Nelson-Williams, Carol; Ji, Weizhen; Cho, Yoonsang; Patel, Aniruddh; Men, Clara J.; Lolis, Elias; Wisgerhof, Max V.; Geller, David S.; Mane, Shrikant; Hellman, Per; Westin, Gunnar; Akerstrom, Goran; Wang, Wenhui; Carling, Tobias; Lifton, Richard P.			K+ Channel Mutations in Adrenal Aldosterone-Producing Adenomas and Hereditary Hypertension	SCIENCE			English	Article							REMEDIABLE ALDOSTERONISM; ADRENOCORTICAL-CELLS; COLORECTAL CANCERS; GLOMERULOSA CELLS; POTASSIUM CHANNEL; MOLECULAR-BASIS; HUMAN BREAST; SELECTIVITY; IDENTIFICATION; CONDUCTION	Endocrine tumors such as aldosterone-producing adrenal adenomas (APAs), a cause of severe hypertension, feature constitutive hormone production and unrestrained cell proliferation; the mechanisms linking these events are unknown. We identify two recurrent somatic mutations in and near the selectivity filter of the potassium (K+) channel KCNJ5 that are present in 8 of 22 human APAs studied. Both produce increased sodium (Na+) conductance and cell depolarization, which in adrenal glomerulosa cells produces calcium (Ca2+) entry, the signal for aldosterone production and cell proliferation. Similarly, we identify an inherited KCNJ5 mutation that produces increased Na+ conductance in a Mendelian form of severe aldosteronism and massive bilateral adrenal hyperplasia. These findings explain pathogenesis in a subset of patients with severe hypertension and implicate loss of K+ channel selectivity in constitutive cell proliferation and hormone production.	[Choi, Murim; Scholl, Ute I.; Zhao, Bixiao; Nelson-Williams, Carol; Ji, Weizhen; Patel, Aniruddh; Men, Clara J.; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA; [Choi, Murim; Scholl, Ute I.; Zhao, Bixiao; Nelson-Williams, Carol; Ji, Weizhen; Patel, Aniruddh; Men, Clara J.; Lifton, Richard P.] Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Internal Med, New Haven, CT 06510 USA; [Yue, Peng; Wang, Wenhui] New York Med Coll, Dept Pharmacol, Valhalla, NY 10595 USA; [Bjoerklund, Peyman; Carling, Tobias] Yale Univ, Sch Med, Yale Endocrine Neoplasia Lab, Dept Surg, New Haven, CT 06510 USA; [Bjoerklund, Peyman; Carling, Tobias] Yale Univ, Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA; [Bjoerklund, Peyman; Hellman, Per; Westin, Gunnar; Akerstrom, Goran] Uppsala Univ, Dept Surg Sci, Uppsala, Sweden; [Cho, Yoonsang; Lolis, Elias] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Wisgerhof, Max V.] Henry Ford Hosp, Div Endocrinol, Detroit, MI 48202 USA; [Geller, David S.] Yale Univ, Sch Med, Nephrol Sect, West Haven, CT 06516 USA; [Geller, David S.] Vet Affairs Med Ctr, Dept Med, West Haven, CT 06516 USA; [Mane, Shrikant] Yale Univ, Sch Med, Yale Ctr Genome Anal, West Haven, CT 06516 USA	Howard Hughes Medical Institute; Yale University; Howard Hughes Medical Institute; Yale University; New York Medical College; Yale University; Yale University; Uppsala University; Yale University; Henry Ford Health System; Henry Ford Hospital; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System; Yale University	Lifton, RP (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT 06510 USA.	richard.lifton@yale.edu	Bjørklund, Geir/B-7319-2014; Hellman, Per/AAL-9817-2021; Choi, Murim/AAP-9120-2021; Björklund, Peyman/A-1509-2014	Bjørklund, Geir/0000-0003-2632-3935; Hellman, Per/0000-0002-5322-5073; Björklund, Peyman/0000-0002-9398-4496; Choi, Murim/0000-0002-9195-1455; Scholl, Ute/0000-0002-0309-8045; Zhao, Bixiao/0000-0002-1775-1690; Lolis, Elias/0000-0002-7902-7868; Patel, Aniruddh/0000-0001-7871-9638	National Institutes of Health (NIH) [DK54983]; Yale Center for Human Genetics and Genomics; Yale NIH O'Brien Center for Kidney Research; Yale NIH; Swedish Cancer Society; Swedish Research Council; Lions Cancer Fund, Uppsala; Fondation Leducq Transatlantic Network in Hypertension; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR060300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054983, P30DK079310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Center for Human Genetics and Genomics; Yale NIH O'Brien Center for Kidney Research; Yale NIH; Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Lions Cancer Fund, Uppsala; Fondation Leducq Transatlantic Network in Hypertension(Leducq Foundation); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the patients whose participation made this study possible and the staff of the Yale West Campus Genomics Center and the Endocrine Surgical Laboratory, Clinical Research Centre, University Hospital, Uppsala. Supported in part by the Fondation Leducq Transatlantic Network in Hypertension, National Institutes of Health (NIH) grant DK54983, the Yale Center for Human Genetics and Genomics, Yale NIH O'Brien Center for Kidney Research, and the Yale NIH Clinical Translational Science Award, and by the Swedish Cancer Society, the Swedish Research Council, and the Lions Cancer Fund, Uppsala. U.I.S. is a fellow of the Deutsche Forschungsgemeinschaft; B.Z. is an investigator of the Yale Medical Scientist Training Program; T.C. is a Doris Duke-Damon Runyon Clinical Investigator; R.P.L. is a paid scientific advisor to Merck and is an investigator of the Howard Hughes Medical Institute.	Calvo-Romero JM, 2000, POSTGRAD MED J, V76, P160, DOI 10.1136/pmj.76.893.160; Corey S, 1998, J BIOL CHEM, V273, P27499, DOI 10.1074/jbc.273.42.27499; Czirjak G, 2002, MOL ENDOCRINOL, V16, P621, DOI 10.1210/me.16.3.621; Dibb KM, 2003, J BIOL CHEM, V278, P49537, DOI 10.1074/jbc.M307723200; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Enyeart JJ, 2002, J BIOL CHEM, V277, P49186, DOI 10.1074/jbc.M207233200; Geller DS, 2008, J CLIN ENDOCR METAB, V93, P3117, DOI 10.1210/jc.2008-0594; Ghose RP, 1999, ANN INTERN MED, V131, P105, DOI 10.7326/0003-4819-131-2-199907200-00005; Gregerson KA, 2001, ENDOCRINOLOGY, V142, P2820, DOI 10.1210/en.142.7.2820; HAJNOCZKY G, 1992, ENDOCRINOLOGY, V130, P1637, DOI 10.1210/en.130.3.1637; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Kahl CR, 2003, ENDOCR REV, V24, P719, DOI 10.1210/er.2003-0008; KRAPIVINSKY G, 1995, NATURE, V374, P135, DOI 10.1038/374135a0; KUMAR V, 2009, ROBBINS COTRAN PATHO, pCH24; LIFTON RP, 1992, NATURE, V355, P262, DOI 10.1038/355262a0; Navarro B, 1996, SCIENCE, V272, P1950, DOI 10.1126/science.272.5270.1950; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pawlikowski M, 2001, Endocr Regul, V35, P139; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Rossi GP, 2006, J AM COLL CARDIOL, V48, P2293, DOI 10.1016/j.jacc.2006.07.059; Roux B, 2005, ANNU REV BIOPH BIOM, V34, P153, DOI 10.1146/annurev.biophys.34.040204.144655; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Tanabe A, 1998, J ENDOCRINOL INVEST, V21, P668, DOI 10.1007/BF03350796; Tao X, 2009, SCIENCE, V326, P1668, DOI 10.1126/science.1180310; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	25	669	699	2	63	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					768	772		10.1126/science.1198785	http://dx.doi.org/10.1126/science.1198785			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21311022	Green Published, Green Accepted			2022-12-28	WOS:000287205700070
J	Kephart, JO				Kephart, Jeffrey O.			Learning from Nature	SCIENCE			English	Editorial Material									IBM Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA	International Business Machines (IBM)	Kephart, JO (corresponding author), IBM Thomas J Watson Res Ctr, Yorktown Hts, NY 10598 USA.	kephart@us.ibm.com						Afek Y, 2011, SCIENCE, V331, P183, DOI 10.1126/science.1193210; Forrest S., 1994, IEEE S RES SEC PRIV, P202; Hebb D.O., 1949, ORG BEHAV NEUROPSYCH; Holland J.H., 1975, ADAPTATION NATURAL A, DOI DOI 10.7551/MITPRESS/1090.001.0001; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Kephart J., 1997, SCI AM, V276, P56; Kephart JO, 2003, COMPUTER, V36, P41, DOI 10.1109/MC.2003.1160055; KEPHART JO, 1995, P 14 INT JOINT C ART, P985	8	19	22	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					682	683		10.1126/science.1201003	http://dx.doi.org/10.1126/science.1201003			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21310989				2022-12-28	WOS:000287205700033
J	Schadt, E				Schadt, Eric			First Steps on a Long Road	SCIENCE			English	Editorial Material									Pacific Biosci Calif, Menlo Pk, CA USA		Schadt, E (corresponding author), Pacific Biosci Calif, Menlo Pk, CA USA.								0	3	3	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					691	691		10.1126/science.1203235	http://dx.doi.org/10.1126/science.1203235			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21310999				2022-12-28	WOS:000287205700044
J	Powell, T				Powell, Tia			Life Imitates Work	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												bioethics@montefiore.org							0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2011	305	6					542	543		10.1001/jama.2011.98	http://dx.doi.org/10.1001/jama.2011.98			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	717XI	21304072				2022-12-28	WOS:000287080500002
J	Hanover, JA				Hanover, John A.			A Versatile Sugar Transferase Makes the Cut	CELL			English	Editorial Material							CELL-PROLIFERATION; HCF-1	The nutrient sensor O-GlcNAc transferase modifies proteins with the O-GlcNAc moiety. In this issue, Capotosti et al. (2011) reveal that O-GlcNAc transferase not only glycosylates the cell-cycle regulator host cell factor 1 but activates it through proteolytic cleavage, providing a surprising link between metabolism and epigenetic regulation of the cell cycle.	NIDDK, Cellular & Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Hanover, JA (corresponding author), NIDDK, Cellular & Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	jah@helix.nih.gov			NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK060101, ZIADK060103] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Butkinaree C, 2010, BBA-GEN SUBJECTS, V1800, P96, DOI 10.1016/j.bbagen.2009.07.018; Capotosti F, 2011, CELL, V144, P376, DOI 10.1016/j.cell.2010.12.030; Davis DB, 2010, MOL ENDOCRINOL, V24, P1822, DOI 10.1210/me.2010-0082; Goto H, 1997, GENE DEV, V11, P726, DOI 10.1101/gad.11.6.726; Hanover JA, 2010, BBA-GEN SUBJECTS, V1800, P80, DOI 10.1016/j.bbagen.2009.07.017; Kristie TM, 2010, BBA-GENE REGUL MECH, V1799, P257, DOI 10.1016/j.bbagrm.2009.08.003; Love DC, 2010, SEMIN CELL DEV BIOL, V21, P646, DOI 10.1016/j.semcdb.2010.05.001; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Wang ZH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000526; Wysocka J, 2003, GENE DEV, V17, P896, DOI 10.1101/gad.252103	10	5	5	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 4	2011	144	3					321	323		10.1016/j.cell.2011.01.025	http://dx.doi.org/10.1016/j.cell.2011.01.025			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295693	Bronze			2022-12-28	WOS:000286973100003
J	Diep, CQ; Ma, DD; Deo, RC; Holm, TM; Naylor, RW; Arora, N; Wingert, RA; Bollig, F; Djordjevic, G; Lichman, B; Zhu, H; Ikenaga, T; Ono, F; Englert, C; Cowan, CA; Hukriede, NA; Handin, RI; Davidson, AJ				Diep, Cuong Q.; Ma, Dongdong; Deo, Rahul C.; Holm, Teresa M.; Naylor, Richard W.; Arora, Natasha; Wingert, Rebecca A.; Bollig, Frank; Djordjevic, Gordana; Lichman, Benjamin; Zhu, Hao; Ikenaga, Takanori; Ono, Fumihito; Englert, Christoph; Cowan, Chad A.; Hukriede, Neil A.; Handin, Robert I.; Davidson, Alan J.			Identification of adult nephron progenitors capable of kidney regeneration in zebrafish	NATURE			English	Article							TRANSGENIC ZEBRAFISH; GENES; MORPHOGENESIS; PRONEPHROS; REPORTER	Loss of kidney function underlies many renal diseases(1). Mammals can partly repair their nephrons (the functional units of the kidney), but cannot form new ones(2,3). By contrast, fish add nephrons throughout their lifespan and regenerate nephrons de novo after injury(4,5), providing a model for understanding how mammalian renal regeneration may be therapeutically activated. Here we trace the source of new nephrons in the adult zebrafish to small cellular aggregates containing nephron progenitors. Transplantation of single aggregates comprising 10-30 cells is sufficient to engraft adults and generate multiple nephrons. Serial transplantation experiments to test self-renewal revealed that nephron progenitors are long-lived and possess significant replicative potential, consistent with stem-cell activity. Transplantation of mixed nephron progenitors tagged with either green or red fluorescent proteins yielded some mosaic nephrons, indicating that multiple nephron progenitors contribute to a single nephron. Consistent with this, live imaging of nephron formation in transparent larvae showed that nephrogenic aggregates form by the coalescence of multiple cells and then differentiate into nephrons. Taken together, these data demonstrate that the zebrafish kidney probably contains self-renewing nephron stem/progenitor cells. The identification of these cells paves the way to isolating or engineering the equivalent cells in mammals and developing novel renal regenerative therapies.	[Diep, Cuong Q.; Ma, Dongdong; Deo, Rahul C.; Holm, Teresa M.; Naylor, Richard W.; Wingert, Rebecca A.; Cowan, Chad A.; Handin, Robert I.; Davidson, Alan J.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Ma, Dongdong; Handin, Robert I.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Wingert, Rebecca A.; Cowan, Chad A.; Handin, Robert I.; Davidson, Alan J.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Bollig, Frank; Englert, Christoph] Fritz Lipmann Inst, Leibniz Inst Age Res, D-07745 Jena, Germany; [Zhu, Hao] Dana Farber Canc Inst, Boston, MA 02115 USA; [Ikenaga, Takanori; Ono, Fumihito] NIAAA, Sect Model Synapt Syst, Lab Mol Physiol, NIH, Bethesda, MD 20892 USA; [Englert, Christoph] Friedrich Schiller Univ, D-07743 Jena, Germany; [Cowan, Chad A.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Hukriede, Neil A.] Univ Pittsburgh, Sch Med, Dept Dev Biol, Pittsburgh, PA 15260 USA; [Diep, Cuong Q.; Deo, Rahul C.; Holm, Teresa M.; Naylor, Richard W.; Arora, Natasha; Wingert, Rebecca A.; Djordjevic, Gordana; Lichman, Benjamin; Cowan, Chad A.; Davidson, Alan J.] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Leibniz Institut fur Alternsforschung - Fritz-Lipmann-Institut (FLI); Harvard University; Dana-Farber Cancer Institute; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); Friedrich Schiller University of Jena; Harvard University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Massachusetts General Hospital	Davidson, AJ (corresponding author), Univ Auckland, Sch Med Sci, Dept Mol Med & Pathol, Auckland 1142, New Zealand.	a.davidson@auckland.ac.nz	Ma, Diane/AAR-6749-2021; Zhu, Hao/L-5114-2013; Wilson, Matthew H/K-3193-2013; Wingert, Rebecca A/ABE-2786-2020	Zhu, Hao/0000-0002-8417-9698; Wingert, Rebecca A/0000-0003-3133-7549; Ma, Diane/0000-0001-7125-9587; Ikenaga, Takanori/0000-0002-7321-9703; ono, fumihito/0000-0001-7532-5262; Naylor, Richard/0000-0003-2901-7677; Englert, Christoph/0000-0002-5931-3189; Lichman, Benjamin/0000-0002-0033-1120	Harvard Stem Cell Institute; American Society of Nephrology; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [P50DK074030]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL098361] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P50DK074030, R01DK069403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000437] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; American Society of Nephrology; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We thank E. C. Liao for help with suturing, and R. Ethier and L. Gyr for zebrafish care. A.J.D. was supported by the Harvard Stem Cell Institute, the American Society of Nephrology and the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (P50DK074030).	Augusto J, 1996, DIS AQUAT ORGAN, V26, P49, DOI 10.3354/dao026049; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Elizondo MR, 2005, CURR BIOL, V15, P667, DOI 10.1016/j.cub.2005.02.050; Fogo AB, 2007, PEDIATR NEPHROL, V22, P2011, DOI 10.1007/s00467-007-0524-0; Georgas K, 2009, DEV BIOL, V332, P273, DOI 10.1016/j.ydbio.2009.05.578; GURDON JB, 1988, NATURE, V336, P772, DOI 10.1038/336772a0; Hall C, 2009, J LEUKOCYTE BIOL, V85, P751, DOI 10.1189/jlb.0708405; Hartman HA, 2007, DEV BIOL, V310, P379, DOI 10.1016/j.ydbio.2007.08.021; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Kramer-Zucker AG, 2005, DEV BIOL, V285, P316, DOI 10.1016/j.ydbio.2005.06.038; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Perner B, 2007, DEV BIOL, V309, P87, DOI 10.1016/j.ydbio.2007.06.022; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Reimschuessel R, 2001, ILAR J, V42, P285; Swanhart LM, 2010, INT J DEV BIOL, V54, P731, DOI 10.1387/ijdb.092969ls; Traver D, 2004, BLOOD, V104, P1298, DOI 10.1182/blood-2004-01-0100; Urasaki A, 2006, GENETICS, V174, P639, DOI 10.1534/genetics.106.060244; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Wingert RA, 2007, PLOS GENET, V3, P1922, DOI 10.1371/journal.pgen.0030189; Zhou WB, 2010, AM J PHYSIOL-RENAL, V299, pF1040, DOI 10.1152/ajprenal.00394.2010	23	200	208	0	35	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2011	470	7332					95	U108		10.1038/nature09669	http://dx.doi.org/10.1038/nature09669			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21270795	Green Accepted			2022-12-28	WOS:000286886400041
J	Mills, RE; Walter, K; Stewart, C; Handsaker, RE; Chen, K; Alkan, C; Abyzov, A; Yoon, SC; Ye, K; Cheetham, RK; Chinwalla, A; Conrad, DF; Fu, YT; Grubert, F; Hajirasouliha, I; Hormozdiari, F; Iakoucheva, LM; Iqbal, Z; Kang, SL; Kidd, JM; Konkel, MK; Korn, J; Khurana, E; Kural, D; Lam, HYK; Leng, J; Li, RQ; Li, YR; Lin, CY; Luo, RB; Mu, XJ; Nemesh, J; Peckham, HE; Rausch, T; Scally, A; Shi, XH; Stromberg, MP; Stutz, AM; Urban, AE; Walker, JA; Wu, JT; Zhang, YJ; Zhang, ZDD; Batzer, MA; Ding, L; Marth, GT; McVean, G; Sebat, J; Snyder, M; Wang, J; Ye, K; Eichler, EE; Gerstein, MB; Hurles, ME; Lee, C; McCarroll, SA; Korbel, JO				Mills, Ryan E.; Walter, Klaudia; Stewart, Chip; Handsaker, Robert E.; Chen, Ken; Alkan, Can; Abyzov, Alexej; Yoon, Seungtai Chris; Ye, Kai; Cheetham, R. Keira; Chinwalla, Asif; Conrad, Donald F.; Fu, Yutao; Grubert, Fabian; Hajirasouliha, Iman; Hormozdiari, Fereydoun; Iakoucheva, Lilia M.; Iqbal, Zamin; Kang, Shuli; Kidd, Jeffrey M.; Konkel, Miriam K.; Korn, Joshua; Khurana, Ekta; Kural, Deniz; Lam, Hugo Y. K.; Leng, Jing; Li, Ruiqiang; Li, Yingrui; Lin, Chang-Yun; Luo, Ruibang; Mu, Xinmeng Jasmine; Nemesh, James; Peckham, Heather E.; Rausch, Tobias; Scally, Aylwyn; Shi, Xinghua; Stromberg, Michael P.; Stuetz, Adrian M.; Urban, Alexander Eckehart; Walker, Jerilyn A.; Wu, Jiantao; Zhang, Yujun; Zhang, Zhengdong D.; Batzer, Mark A.; Ding, Li; Marth, Gabor T.; McVean, Gil; Sebat, Jonathan; Snyder, Michael; Wang, Jun; Ye, Kenny; Eichler, Evan E.; Gerstein, Mark B.; Hurles, Matthew E.; Lee, Charles; McCarroll, Steven A.; Korbel, Jan O.		1000 Genomes Project	Mapping copy number variation by population-scale genome sequencing	NATURE			English	Article							STRUCTURAL VARIATION; SEGMENTAL DUPLICATIONS; SHORT-READ; REARRANGEMENTS; COMMON; POLYMORPHISM; INSERTIONS; DELETIONS; SNPS	Genomic structural variants (SVs) are abundant in humans, differing from other forms of variation in extent, origin and functional impact. Despite progress in SV characterization, the nucleotide resolution architecture of most SVs remains unknown. We constructed a map of unbalanced SVs (that is, copy number variants) based on whole genome DNA sequencing data from 185 human genomes, integrating evidence from complementary SV discovery approaches with extensive experimental validations. Our map encompassed 22,025 deletions and 6,000 additional SVs, including insertions and tandem duplications. Most SVs (53%) were mapped to nucleotide resolution, which facilitated analysing their origin and functional impact. We examined numerous whole and partial gene deletions with a genotyping approach and observed a depletion of gene disruptions amongst high frequency deletions. Furthermore, we observed differences in the size spectra of SVs originating from distinct formation mechanisms, and constructed a map of SV hotspots formed by common mechanisms. Our analytical framework and SV map serves as a resource for sequencing-based association studies.	[Rausch, Tobias; Stuetz, Adrian M.; Korbel, Jan O.] European Mol Biol Lab, Genome Biol Res Unit, Heidelberg, Germany; [Mills, Ryan E.; Shi, Xinghua; Lee, Charles] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Mills, Ryan E.; Shi, Xinghua; Lee, Charles] Harvard Univ, Sch Med, Boston, MA USA; [Walter, Klaudia; Conrad, Donald F.; Scally, Aylwyn; Zhang, Yujun; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Stewart, Chip; Kural, Deniz; Stromberg, Michael P.; Wu, Jiantao; Marth, Gabor T.] Boston Coll, Dept Biol, Boston, MA USA; [Handsaker, Robert E.; Korn, Joshua; Nemesh, James; McCarroll, Steven A.] Harvard Univ, Broad Inst, Cambridge, MA 02138 USA; [Handsaker, Robert E.; Korn, Joshua; Nemesh, James; McCarroll, Steven A.] MIT, Cambridge, MA 02139 USA; [Chen, Ken; Chinwalla, Asif; Ding, Li] Washington Univ, Genome Ctr, St Louis, MO USA; [Alkan, Can; Kidd, Jeffrey M.; Eichler, Evan E.] Univ Washington, Sch Med, Dept Genome Sci, Seattle, WA USA; [Alkan, Can; Eichler, Evan E.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Abyzov, Alexej; Khurana, Ekta; Leng, Jing; Mu, Xinmeng Jasmine; Zhang, Zhengdong D.; Gerstein, Mark B.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT USA; [Yoon, Seungtai Chris] Mt Sinai Sch Med, Seaver Autism Ctr, New York, NY USA; [Yoon, Seungtai Chris] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Ye, Kai] Leiden Univ, Med Ctr, Dept Mol Epidemiol, Leiden, Netherlands; [Ye, Kai] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, Leiden, Netherlands; [Cheetham, R. Keira] Illumina Cambridge Ltd, Saffron Walden CB10 1XL, Essex, England; [Fu, Yutao; Peckham, Heather E.] Life Technol, Beverly, MA USA; [Grubert, Fabian; Lam, Hugo Y. K.; Urban, Alexander Eckehart; Snyder, Michael] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Hajirasouliha, Iman; Hormozdiari, Fereydoun] Simon Fraser Univ, Sch Comp Sci, Burnaby, BC V5A 1S6, Canada; [Iakoucheva, Lilia M.; Kang, Shuli; Sebat, Jonathan] Univ Calif San Diego, Inst Genom Med, Dept Cellular & Mol Med, Dept Psychiat, La Jolla, CA 92093 USA; [Iqbal, Zamin] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Konkel, Miriam K.; Walker, Jerilyn A.; Batzer, Mark A.] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA; [Khurana, Ekta; Gerstein, Mark B.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Li, Ruiqiang; Li, Yingrui; Luo, Ruibang; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Lin, Chang-Yun; Ye, Kenny] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Ding, Li] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [McVean, Gil] Univ Oxford, Dept Stat, Oxford OX3 7BN, England; [Wang, Jun] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Gerstein, Mark B.] Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA; [McCarroll, Steven A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Urban, Alexander Eckehart] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	European Molecular Biology Laboratory (EMBL); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Wellcome Trust Sanger Institute; Boston College; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; Yale University; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Illumina; Thermo Fisher Scientific; Stanford University; Simon Fraser University; University of California System; University of California San Diego; University of Oxford; Wellcome Centre for Human Genetics; Louisiana State University System; Louisiana State University; Yale University; Beijing Genomics Institute (BGI); Yeshiva University; Albert Einstein College of Medicine; Washington University (WUSTL); University of Oxford; University of Copenhagen; Yale University; Harvard University; Harvard Medical School; Stanford University	Korbel, JO (corresponding author), European Mol Biol Lab, Genome Biol Res Unit, Heidelberg, Germany.	jan.korbel@embl.de	Korbel, Jan O/G-6470-2012; Fang, Xiaodong/K-6743-2018; Handsaker, Bob/AAX-9095-2021; Chen, Wei/AAX-5994-2020; Rausch, Tobias/H-6511-2019; Mills, Ryan/F-4225-2010; Dahl, Andreas/E-3783-2017; Maestrini, Elena/K-7508-2012; Ye, Kai/GSD-9856-2022; Abyzov, Alexej/M-4284-2013; Khurana, Ekta/C-4933-2013; Abyzov, Alexej/AAT-4615-2020; Chen, Ken/A-1074-2009; Wilson, Richard K./AAF-4139-2019; Rosenstiel, Philip/A-5137-2009; Ye, Kai/B-3640-2012; Wang, Jun/A-7261-2013; Browning, Brian L/A-1178-2010; Cooper, David N/H-4384-2011; Li, Yingrui/K-1064-2015; Ye, Kenny/GSM-7731-2022; Sahinalp, Suleyman Cenk/X-7843-2018; Alkan, Can/D-2982-2009; Ye, Kenny/U-2341-2019; Chen, Ken/AAU-1432-2021; Mu, Xinmeng/P-2562-2016; Myers, Simon R/A-6792-2015; Tumian, Afidalina/J-4404-2014; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	Korbel, Jan O/0000-0002-2798-3794; Fang, Xiaodong/0000-0001-7061-3337; Handsaker, Bob/0000-0002-3128-3547; Chen, Wei/0000-0001-7196-8703; Rausch, Tobias/0000-0001-5773-5620; Mills, Ryan/0000-0003-3425-6998; Dahl, Andreas/0000-0002-2668-8371; Maestrini, Elena/0000-0001-5924-3179; Ye, Kai/0000-0002-2851-6741; Wilson, Richard K./0000-0002-1992-1358; Rosenstiel, Philip/0000-0002-9692-8828; Browning, Brian L/0000-0001-6454-6633; Cooper, David N/0000-0002-8943-8484; Sahinalp, Suleyman Cenk/0000-0002-5050-0682; Alkan, Can/0000-0002-5443-0706; Ye, Kenny/0000-0002-1466-855X; Chen, Ken/0000-0003-4013-5279; Mu, Xinmeng/0000-0002-8079-0828; Myers, Simon R/0000-0002-2585-9626; Tumian, Afidalina/0000-0003-2763-6677; Chinwalla, Asif/0000-0001-7831-3996; Wang, Jun/0000-0002-8540-8931; Palotie, Aarno/0000-0002-2527-5874; Keenan, Stephen/0000-0002-9141-7690; McLaren, William/0000-0001-6218-1116; Borodina, Tatiana/0000-0002-6978-016X; Iakoucheva, Lilia/0000-0002-4542-5219; Herrero, Javier/0000-0001-7313-717X; Kidd, Jeffrey/0000-0002-9631-1465; Keinan, Alon/0000-0002-9760-1122; Sebat, Jonathan/0000-0002-9087-526X; Abyzov, Alexej/0000-0001-5405-6729; Wang, Jun/0000-0002-2113-5874; Radhakrishnan, Rajesh/0000-0001-7170-699X; Haraksingh, Rajini/0000-0002-6644-8874; Zalunin, Vadim/0000-0002-7722-1958; Stuetz, Adrian/0000-0001-7650-3470; Keane, Thomas/0000-0001-7532-6898; Leinonen, Rasko/0000-0002-2639-7187; MCLELLAN, MICHAEL/0000-0002-2703-8784; Cibulskis, Kristian/0000-0003-1343-1582; Clarke, Laura/0000-0002-5989-6898; Sherry, Stephen/0000-0002-7982-076X; Iqbal, Zamin/0000-0001-8466-7547; MacArthur, Daniel/0000-0002-5771-2290; Kulesha, Eugene/0000-0002-4285-6232; Hinrichs, Angie/0000-0002-1697-1130; Hormozdiari, Fereydoun/0000-0003-2703-9274; Clark, Andrew/0000-0001-7159-8511; Kural, Deniz/0000-0002-8085-0771; Stone, Eric/0000-0002-2725-4209; Snyder, Michael/0000-0003-0784-7987; Schaffner, Stephen/0000-0001-6699-3568; Lin, Chang-Yun/0000-0001-7599-1214; Swerdlow, Harold/0000-0002-9510-160X; Walter, Klaudia/0000-0003-4448-0301; Balasubramanian, Shankar/0000-0002-0281-5815; Luo, Ruibang/0000-0001-9711-6533; Eberle, Michael/0000-0001-8965-1253; Bustamante, Carlos D./0000-0002-4187-7920	National Institutes of Health [RO1 GM59290, R01 HG004719, RC2 HG005552, P01 HG004120, U01 HG005209, P41 HG004221, RO1 GM081533, UO1 HG005209]; German Research Foundation (Deutsche Forschungsgemeinschaft); National Basic Research Program of China (973 program) [2011CB809200]; National Natural Science Foundation of China [30725008, 30890032, 30811130531, 30221004]; Chinese 863 program [2006AA02Z177, 2006AA02Z334, 2006AA02A302, 2009AA022707]; Shenzhen Municipal Government of China [JC200903190767A, JC200903190772A, ZYC200903240076A, CXB200903110066A, ZYC200903240077A, ZYC200903240080A]; Danish Natural Science Research Council; MRC [G0701805] Funding Source: UKRI; Medical Research Council [G1000758, G0701805, G1000758B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10212] Funding Source: researchfish; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005552, R01HG004719, U01HG005209, U54HG003273, ZIAHG000024, P41HG004221, U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081533, R01GM059290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH091350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R21AA022707] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese 863 program(National High Technology Research and Development Program of China); Shenzhen Municipal Government of China; Danish Natural Science Research Council(Danish Natural Science Research Council); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	We would like to acknowledge C. Hardy, R. Smith, A. De Witte and S. Giles for their assistance with validation. M.A.B.'s group was supported by a grant from the National Institutes of Health (RO1 GM59290) and G.T.M.'s group by grants R01 HG004719 and RC2 HG005552, also from the NIH. J.O.K.'s group was supported by an Emmy Noether Fellowship of the German Research Foundation (Deutsche Forschungsgemeinschaft). J.W.'s group was supported by the National Basic Research Program of China (973 program no. 2011CB809200), the National Natural Science Foundation of China (30725008; 30890032; 30811130531; 30221004), the Chinese 863 program (2006AA02Z177; 2006AA02Z334; 2006AA02A302; 2009AA022707), the Shenzhen Municipal Government of China (grants JC200903190767A; JC200903190772A; ZYC200903240076A; CXB200903110066A; ZYC200903240077A; ZYC200903240076A and ZYC200903240080A) and the Ole Romer grant from the Danish Natural Science Research Council. E.E.E.'s group was supported by grants P01 HG004120 and U01 HG005209 from the National Institutes of Health. C.L.'s group was supported by grants from the National Institutes of Health: P41 HG004221, RO1 GM081533 and UO1 HG005209 and X. S. was supported by a T32 fellowship award from the NIH. We thank the Genome Structural Variation Consortium (http://www.sanger.ac.uk/humgen/cnv/42mio/) and the International HapMap Consortium for making available microarray data. The authors acknowledge the individuals participating in the 1000 Genomes Project by providing samples, including the Yoruba people of Ibadan, Nigeria, the community at Beijing Normal University, the people of Tokyo, Japan, and the people of the Utah CEPH community. Furthermore, we thank R. Durbin and L. Steinmetz for comments on the manuscript.	Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Bailey JA, 2002, SCIENCE, V297, P1003, DOI 10.1126/science.1072047; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Conrad DF, 2010, NAT GENET, V42, P385, DOI 10.1038/ng.564; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Craddock N, 2010, NATURE, V464, P713, DOI 10.1038/nature08979; Hajirasouliha I, 2010, BIOINFORMATICS, V26, P1277, DOI 10.1093/bioinformatics/btq152; Harrow J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s4; Hasin-Brumshtein Y, 2009, TRENDS GENET, V25, P178, DOI 10.1016/j.tig.2009.02.002; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hormozdiari F, 2009, GENOME RES, V19, P1270, DOI 10.1101/gr.088633.108; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lam HYK, 2010, NAT BIOTECHNOL, V28, P47, DOI 10.1038/nbt.1600; Lee JA, 2007, CELL, V131, P1235, DOI 10.1016/j.cell.2007.11.037; Lee S, 2008, BIOINFORMATICS, V24, pI59, DOI 10.1093/bioinformatics/btn176; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Lupski JR, 1998, TRENDS GENET, V14, P417, DOI 10.1016/S0168-9525(98)01555-8; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McCarroll SA, 2008, NAT GENET, V40, P1107, DOI 10.1038/ng.215; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Medvedev P, 2009, NAT METHODS, V6, pS13, DOI [10.1038/NMETH.1374, 10.1038/nmeth.1374]; Mills RE, 2006, GENOME RES, V16, P1182, DOI 10.1101/gr.4565806; Pang AW, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-r52; Pinto D, 2010, NATURE, V466, P368, DOI 10.1038/nature09146; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2005, AM J HUM GENET, V77, P78, DOI 10.1086/431652; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Stankiewicz P, 2010, ANNU REV MED, V61, P437, DOI 10.1146/annurev-med-100708-204735; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109	44	771	824	5	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					59	65		10.1038/nature09708	http://dx.doi.org/10.1038/nature09708			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293372	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000286886400033
J	Lantos, J; Matlock, AM; Wendler, D				Lantos, John; Matlock, Ann Marie; Wendler, David			Clinician Integrity and Limits to Patient Autonomy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EMERGENCY CONTRACEPTION; DECISION-MAKING; HEALTH-CARE; CONSCIENCE; VALUES	A 28-year-old man with chronic granulomatous disease developed worsening respiratory status in the setting of chronic bacterial and fungal infections. The attending physician recommended transfer to the intensive care unit (ICU), but the patient declined. The patient understood that the nurses in the ICU have expertise in caring for patients with poor respiratory function. He also understood that he faced an increased risk of dying if he remained on the medical ward. At the same time, the patient was familiar with the nurses on the medical ward and felt comfortable there. Unsure of whether it was appropriate for clinicians to agree to provide less than optimal care for a critically ill patient, the clinicians on the medical ward requested a bioethics consultation. This article reviews the ethical issues that arise when patients ask clinicians to provide less than optimal care. Although it is well established that clinicians ought to respect patient autonomy, that obligation conflicted, in the present case, with the clinicians' sense of professional integrity. Future research on this vital but underexplored topic is needed to determine the extent to which clinicians' professional integrity places limits on the types of patient requests to which they should agree. JAMA. 2011;305(5):495-499 www.jama.com	[Lantos, John] Childrens Mercy Hosp, Childrens Mercy Bioeth Ctr, Kansas City, MO 64108 USA; [Matlock, Ann Marie; Wendler, David] NIH, Ctr Clin, Bethesda, MD 20892 USA	Children's Mercy Hospital; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Lantos, J (corresponding author), Childrens Mercy Hosp, Childrens Mercy Bioeth Ctr, 2401 Gilham Rd, Kansas City, MO 64108 USA.	jlantos@cmh.edu			Department of Bioethics at the National Institutes of Health Clinical Center; National Institutes of Health Clinical Center	Department of Bioethics at the National Institutes of Health Clinical Center; National Institutes of Health Clinical Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the Department of Bioethics at the National Institutes of Health Clinical Center.; The National Institutes of Health Clinical Center had no role in the design and conduct of the study, in the collection, management, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	BRETT AS, 1986, NEW ENGL J MED, V315, P1347, DOI 10.1056/NEJM198611203152109; Bridson J, 2003, BRIT MED J, V327, P1159, DOI 10.1136/bmj.327.7424.1159; Burns JP, 2007, CHEST, V132, P1987, DOI 10.1378/chest.07-1441; Childress JF., 2009, PRINCIPLE BIOMEDICAL; Curlin FA, 2007, NEW ENGL J MED, V356, P593, DOI 10.1056/NEJMsa065316; Entwistle VA, 2010, J GEN INTERN MED, V25, P741, DOI 10.1007/s11606-010-1292-2; Flynn DP, 2008, J MED ETHICS, V34, DOI 10.1136/jme.2007.021337; Flynn KE, 2006, SOC SCI MED, V63, P1158, DOI 10.1016/j.socscimed.2006.03.030; FORTENBERRY JD, 1988, J ADOLESCENT HEALTH, V9, P46, DOI 10.1016/0197-0070(88)90017-4; Mill JohnStuart., 2002, BASIC WRITINGS J STU; Quill TE, 1996, ANN INTERN MED, V125, P763, DOI 10.7326/0003-4819-125-9-199611010-00010; Towle A, 1999, BRIT MED J, V319, P766, DOI 10.1136/bmj.319.7212.766; Truog RD, 2010, NEW ENGL J MED, V362, P477, DOI 10.1056/NEJMp0908464; Upadhya KK, 2009, ARCH PEDIAT ADOL MED, V163, P944, DOI 10.1001/archpediatrics.2009.160; Wall LL, 2006, OBSTET GYNECOL, V107, P1148, DOI 10.1097/01.AOG.0000214951.46283.40; Weijer C, 1998, CAN MED ASSOC J, V159, P817; Wendler D, 2010, J MED ETHICS, V36, P66, DOI 10.1136/jme.2009.033001	17	35	35	0	8	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2011	305	5					495	499		10.1001/jama.2011.32	http://dx.doi.org/10.1001/jama.2011.32			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	714LI	21285427				2022-12-28	WOS:000286810700023
J	Appleby, J				Appleby, John			Data Briefing Does poor health justify NHS reform?	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Fund, London W1G 0AN, England		Appleby, J (corresponding author), Kings Fund, London W1G 0AN, England.	j.appleby@kingsfund.org.uk						*DEP HLTH, 2011, MIN BRIEF HLTH SOC C; *EUR, EUR SURV CANC PAT EU; *EUR 4, 2010, EUROCARE 4 DAT CANC; *OFF NAT STAT, 2010, CANC SURV CANC SURV; Organisation for Economic Co-operation and Development, 2010, HLTH DAT	5	14	14	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 27	2011	342								d566	10.1136/bmj.d566	http://dx.doi.org/10.1136/bmj.d566			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	715MM	21273272				2022-12-28	WOS:000286888600005
J	Weisfeldt, ML; Everson-Stewart, S; Sitlani, C; Rea, T; Aufderheide, TP; Atkins, DL; Bigham, B; Brooks, SC; Foerster, C; Gray, R; Ornato, JP; Powell, J; Kudenchuk, PJ; Morrison, LJ				Weisfeldt, Myron L.; Everson-Stewart, Siobhan; Sitlani, Colleen; Rea, Thomas; Aufderheide, Tom P.; Atkins, Dianne L.; Bigham, Blair; Brooks, Steven C.; Foerster, Christopher; Gray, Randal; Ornato, Joseph P.; Powell, Judy; Kudenchuk, Peter J.; Morrison, Laurie J.		Resuscitation Outcomes Consortium	Ventricular Tachyarrhythmias after Cardiac Arrest in Public versus at Home	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							AUTOMATED EXTERNAL DEFIBRILLATORS; ACCESS DEFIBRILLATION; CARDIOPULMONARY-RESUSCITATION; OUTCOMES; SURVIVAL; CPR; COMPRESSION; POPULATION; LOCATIONS	BACKGROUND The incidence of ventricular fibrillation or pulseless ventricular tachycardia as the first recorded rhythm after out-of-hospital cardiac arrest has unexpectedly declined. The success of bystander-deployed automated external defibrillators (AEDs) in public settings suggests that this may be the more common initial rhythm when out-of-hospital cardiac arrest occurs in public. We conducted a study to determine whether the location of the arrest, the type of arrhythmia, and the probability of survival are associated. METHODS Between 2005 and 2007, we conducted a prospective cohort study of out-of-hospital cardiac arrest in adults in 10 North American communities. We assessed the frequencies of ventricular fibrillation or pulseless ventricular tachycardia and of survival to hospital discharge for arrests at home as compared with arrests in public. RESULTS Of 12,930 evaluated out-of-hospital cardiac arrests, 2042 occurred in public and 9564 at home. For cardiac arrests at home, the incidence of ventricular fibrillation or pulseless ventricular tachycardia was 25% when the arrest was witnessed by emergency-medical-services (EMS) personnel, 35% when it was witnessed by a bystander, and 36% when a bystander applied an AED. For cardiac arrests in public, the corresponding rates were 38%, 60%, and 79%. The adjusted odds ratio for initial ventricular fibrillation or pulseless ventricular tachycardia in public versus at home was 2.28 (95% confidence interval [CI], 1.96 to 2.66; P<0.001) for bystander-witnessed arrests and 4.48 (95% CI, 2.23 to 8.97; P<0.001) for arrests in which bystanders applied AEDs. The rate of survival to hospital discharge was 34% for arrests in public settings with AEDs applied by bystanders versus 12% for arrests at home (adjusted odds ratio, 2.49; 95% CI, 1.03 to 5.99; P=0.04). CONCLUSIONS Regardless of whether out-of-hospital cardiac arrests are witnessed by EMS personnel or bystanders and whether AEDs are applied by bystanders, the proportion of arrests with initial ventricular fibrillation or pulseless ventricular tachycardia is much greater in public settings than at home. The incremental value of resuscitation strategies, such as the ready availability of an AED, may be related to the place where the arrest occurs.	[Weisfeldt, Myron L.] Johns Hopkins Univ, Baltimore, MD 21287 USA; [Everson-Stewart, Siobhan; Sitlani, Colleen; Rea, Thomas; Powell, Judy; Kudenchuk, Peter J.] Univ Washington, Seattle, WA 98195 USA; [Aufderheide, Tom P.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Atkins, Dianne L.] Univ Iowa, Iowa City, IA USA; [Bigham, Blair; Brooks, Steven C.; Foerster, Christopher; Morrison, Laurie J.] Univ Toronto, Toronto, ON, Canada; [Gray, Randal] Univ Alabama, Birmingham, AL USA; [Ornato, Joseph P.] Virginia Commonwealth Univ, Richmond, VA USA	Johns Hopkins University; University of Washington; University of Washington Seattle; Medical College of Wisconsin; University of Iowa; University of Toronto; University of Alabama System; University of Alabama Birmingham; Virginia Commonwealth University	Weisfeldt, ML (corresponding author), Johns Hopkins Univ, 1830 E Monument St,Suite 9026, Baltimore, MD 21287 USA.	mlw5@jhmi.edu	Morrison, Laurie Jean/A-6325-2012; Brooks, Steven/ABC-8078-2021; Atkins, Dianne/AFM-2981-2022; Brooks, Steven/N-4317-2015	Morrison, Laurie Jean/0000-0001-8369-9774; Brooks, Steven/0000-0002-4592-4974; Brown, Siobhan/0000-0002-4774-3122	National Heart, Lung, and Blood Institute [5U01 HL077863, HL077881, HL077871, HL077872, HL077866, HL077908, HL077867, HL077885, HL077887, HL077873, HL077865]; National Institute of Neurological Disorders and Stroke; U.S. Army Medical Research & Materiel Command; Canadian Institutes of Health Research-Institute of Circulatory and Respiratory Health; Defence Research and Development Canada; American Heart Association; Heart and Stroke Foundation of Canada; Philips and Physio-Control; Medtronic Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL077887, U01HL077873, U01HL077866, U01HL077865, U01HL077881, U01HL077872, U01HL077863, U01HL077867, U01HL077908, U01HL077885, U01HL077871] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); U.S. Army Medical Research & Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); Canadian Institutes of Health Research-Institute of Circulatory and Respiratory Health(Canadian Institutes of Health Research (CIHR)); Defence Research and Development Canada; American Heart Association(American Heart Association); Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Philips and Physio-Control; Medtronic Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Supported by cooperative agreements with 10 regional clinical centers and one data coordinating center (5U01 HL077863, HL077881, HL077871, HL077872, HL077866, HL077908, HL077867, HL077885, HL077887, HL077873, and HL077865) from the National Heart, Lung, and Blood Institute in partnership with the National Institute of Neurological Disorders and Stroke, the U.S. Army Medical Research & Materiel Command, the Canadian Institutes of Health Research-Institute of Circulatory and Respiratory Health, Defence Research and Development Canada, the American Heart Association, and the Heart and Stroke Foundation of Canada.; Dr. Atkins reports receiving support from the American Heart Association as the editor of the CPR Guidelines and having testified as an expert witness on pediatric defibrillation; Dr. Aufderheide, serving as a consultant for the Medtronic Foundation and Jolife; Dr. Ornato, being employed as the American editor of the journal Resuscitation; Dr. Rea, using AEDs supplied by Philips and Physio-Control and receiving funding on behalf of his institution, the University of Washington, from Philips and Physio-Control and the Medtronic Foundation; and Dr. Weisfeldt, receiving royalties both for himself and on behalf of his institution, the Johns Hopkins University School of Medicine, from a patent for a pacemaker. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2010, CIRCULATION, V121, pe46; Atkins DL, 2009, CIRCULATION, V120, P461, DOI 10.1161/CIRCULATIONAHA.109.883488; Bardy GH, 2005, NEW ENGL J MED, V352, P2146; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Bardy GH, 2008, NEW ENGL J MED, V358, P1793, DOI 10.1056/NEJMoa0801651; Becker L, 2008, RESUSCITATION, V79, P22, DOI 10.1016/j.resuscitation.2008.06.019; Caffrey SL, 2002, NEW ENGL J MED, V347, P1242, DOI 10.1056/NEJMoa020932; Cobb LA, 2002, JAMA-J AM MED ASSOC, V288, P3008, DOI 10.1001/jama.288.23.3008; Davis DP, 2007, PREHOSP EMERG CARE, V11, P369, DOI 10.1080/10903120701537147; Ewy GA, 2007, CIRCULATION, V116, P2525, DOI 10.1161/CIRCULATIONAHA.107.711820; Folke F, 2010, CIRCULATION, V122, P623, DOI 10.1161/CIRCULATIONAHA.109.924423; Folke F, 2009, CIRCULATION, V120, P510, DOI 10.1161/CIRCULATIONAHA.108.843755; Investigators TPADT., 2004, NEW ENGL J MED, V351, P637, DOI [10.1056/NEJMoa040566, DOI 10.1056/NEJMOA040566]; Iwami T, 2006, RESUSCITATION, V69, P221, DOI 10.1016/j.resuscitation.2005.08.018; MacDonald RD, 2001, ANN EMERG MED, V38, P262, DOI 10.1067/mem.2001.117953; Morrison LJ, 2008, RESUSCITATION, V78, P161, DOI 10.1016/j.resuscitation.2008.02.020; NICHOL G, 2008, JAMA-J AM MED ASSOC, V300, P1763; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Page RL, 2000, NEW ENGL J MED, V343, P1210, DOI 10.1056/NEJM200010263431702; Rea TD, 2001, CIRCULATION, V104, P2513, DOI 10.1161/hc4601.099468; Rea TD, 2010, NEW ENGL J MED, V363, P423, DOI 10.1056/NEJMoa0908993; Stolzenberg Brett T, 2002, Prehosp Emerg Care, V6, P65, DOI 10.1080/10903120290938814; Svensson L, 2010, NEW ENGL J MED, V363, P434, DOI 10.1056/NEJMoa0908991; Valenzuela TD, 2000, NEW ENGL J MED, V343, P1206, DOI 10.1056/NEJM200010263431701; Weisfeldt ML, 2010, NEW ENGL J MED, V363, P481, DOI 10.1056/NEJMe1006306; Weisfeldt ML, 2010, J AM COLL CARDIOL, V55, P1712, DOI 10.1016/j.jacc.2009.11.077	26	216	227	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2011	364	4					313	321		10.1056/NEJMoa1010663	http://dx.doi.org/10.1056/NEJMoa1010663			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711LH	21268723	Green Accepted, Green Published			2022-12-28	WOS:000286592600006
J	Hingorani, AD; Hemingway, H				Hingorani, Aroon D; Hemingway, Harry			How should we balance individual and population benefits of statins for preventing cardiovascular disease?	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hingorani, Aroon D] UCL, Dept Epidemiol & Publ Hlth, Clin Epidemiol Grp, London, England; [Hemingway, Harry] UCL, Dept Epidemiol & Publ Hlth, Genet Epidemiol Grp, London, England	University of London; University College London; University of London; University College London	Hingorani, AD (corresponding author), UCL, Dept Epidemiol & Publ Hlth, Genet Epidemiol Grp, London, England.	a.hingorani@ucl.ac.uk	Hemingway, Harry/C-1219-2009	Hemingway, Harry/0000-0003-2279-0624; Hingorani, Aroon/0000-0001-8365-0081	British Heart Foundation [FS05/125] Funding Source: Medline; Department of Health [RP-PG-0407-10314] Funding Source: Medline	British Heart Foundation(British Heart Foundation); Department of Health			0	12	13	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2011	342								c6244	10.1136/bmj.c6244	http://dx.doi.org/10.1136/bmj.c6244			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715ME	21270079				2022-12-28	WOS:000286887800015
J	Wells-Dang, A; Wells-Dang, G				Wells-Dang, Andrew; Wells-Dang, Giang			Civil society in ASEAN: a healthy development?	LANCET			English	Editorial Material									[Wells-Dang, Andrew] Univ Birmingham, Dept Polit Sci & Int Studies, Birmingham B15 2TT, W Midlands, England; [Wells-Dang, Giang] Act City, Hanoi, Vietnam	University of Birmingham	Wells-Dang, A (corresponding author), Univ Birmingham, Dept Polit Sci & Int Studies, Birmingham B15 2TT, W Midlands, England.	andrewwd@gmail.com						Alagappa Muthiah, 2004, CIVIL SOC POLITICAL; [Anonymous], 2010, I WANT HELP MY OWN P; Evans P, 1996, WORLD DEV, V24, P1119, DOI 10.1016/0305-750X(96)00021-6; LOESCHMANN H, 2006, ACTIVE CITIZENS POLI; *MIN HLTH GOV VIET, 2004, DEC PRIM MIN APPR NA; SCHAK DC, 2003, CIVIL SOC ASIA; *SOC REP VIETN, 2010, UNGASS COUNTR PROGR; Tantivess S, 2008, HEALTH POLICY PLANN, V23, P328, DOI 10.1093/heapol/czn023	8	3	3	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR 5	2011	377	9768					792	793		10.1016/S0140-6736(10)61923-X	http://dx.doi.org/10.1016/S0140-6736(10)61923-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	738GO	21269681				2022-12-28	WOS:000288628500008
J	Jiao, YC; Shi, CJ; Edil, BH; de Wilde, RF; Klimstra, DS; Maitra, A; Schulick, RD; Tang, LH; Wolfgang, CL; Choti, MA; Velculescu, VE; Diaz, LA; Vogelstein, B; Kinzler, KW; Hruban, RH; Papadopoulos, N				Jiao, Yuchen; Shi, Chanjuan; Edil, Barish H.; de Wilde, Roeland F.; Klimstra, David S.; Maitra, Anirban; Schulick, Richard D.; Tang, Laura H.; Wolfgang, Christopher L.; Choti, Michael A.; Velculescu, Victor E.; Diaz, Luis A., Jr.; Vogelstein, Bert; Kinzler, Kenneth W.; Hruban, Ralph H.; Papadopoulos, Nickolas			DAXX/ATRX, MEN1, and mTOR Pathway Genes Are Frequently Altered in Pancreatic Neuroendocrine Tumors	SCIENCE			English	Article							HISTONE METHYLTRANSFERASE COMPLEX; ENDOCRINE TUMORS; TUBEROUS SCLEROSIS; EXPRESSION; CANCER; ATRX; H3.3; LOCALIZATION; SUPPRESSOR; MUTATIONS	Pancreatic neuroendocrine tumors (PanNETs) are a rare but clinically important form of pancreatic neoplasia. To explore the genetic basis of PanNETs, we determined the exomic sequences of 10 nonfamilial PanNETs and then screened the most commonly mutated genes in 58 additional PanNETs. The most frequently mutated genes specify proteins implicated in chromatin remodeling: 44% of the tumors had somatic inactivating mutations in MEN1, which encodes menin, a component of a histone methyltransferase complex, and 43% had mutations in genes encoding either of the two subunits of a transcription/chromatin remodeling complex consisting of DAXX (death-domain-associated protein) and ATRX (alpha thalassemia/mental retardation syndrome X-linked). Clinically, mutations in the MEN1 and DAXX/ATRX genes were associated with better prognosis. We also found mutations in genes in the mTOR (mammalian target of rapamycin) pathway in 14% of the tumors, a finding that could potentially be used to stratify patients for treatment with mTOR inhibitors.	[Jiao, Yuchen; Velculescu, Victor E.; Diaz, Luis A., Jr.; Vogelstein, Bert; Kinzler, Kenneth W.; Papadopoulos, Nickolas] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet, Baltimore, MD 21231 USA; [Jiao, Yuchen; Velculescu, Victor E.; Diaz, Luis A., Jr.; Vogelstein, Bert; Kinzler, Kenneth W.; Papadopoulos, Nickolas] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; [Shi, Chanjuan; de Wilde, Roeland F.; Maitra, Anirban; Hruban, Ralph H.] Johns Hopkins Med Inst, Dept Pathol, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21231 USA; [Edil, Barish H.; Schulick, Richard D.; Wolfgang, Christopher L.; Choti, Michael A.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Surg, Baltimore, MD 21231 USA; [Klimstra, David S.; Tang, Laura H.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Maitra, Anirban; Hruban, Ralph H.] Johns Hopkins Med Inst, Sol Goldman Pancreat Canc Res Ctr, Dept Oncol, Baltimore, MD 21231 USA; [Diaz, Luis A., Jr.] Johns Hopkins Univ, Swim Amer Lab, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Memorial Sloan Kettering Cancer Center; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University	Kinzler, KW (corresponding author), Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet, Baltimore, MD 21231 USA.	kinzlke@jhmi.edu; rhruban@jhmi.edu; npapado1@jhmi.edu	Papadopoulos, Nickolas/K-7272-2012; Wolfgang, Christopher/HGD-0863-2022; Velculescu, Victor/ABF-4846-2020; jiao, yuchen/H-6313-2011	Velculescu, Victor/0000-0003-1195-438X; Diaz, Luis/0000-0002-7079-8914; Jiao, Yuchen/0000-0001-7917-8810	Caring for Carcinoid Foundation; Lustgarten Foundation for Pancreatic Cancer Research; Sol Goldman Pancreatic Cancer Research Center; Joseph L. Rabinowitz Fund for Pancreatic Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; Raymond and Beverly Sackler Research Foundation; American Associatoion for Cancer Research; National Institutes of Health [CA121113, P50CA062924, P01CA134292, R01CA113669]; NATIONAL CANCER INSTITUTE [R01CA121113, R01CA113669, P01CA134292, R37CA057345, P50CA062924, R01CA057345] Funding Source: NIH RePORTER	Caring for Carcinoid Foundation; Lustgarten Foundation for Pancreatic Cancer Research; Sol Goldman Pancreatic Cancer Research Center; Joseph L. Rabinowitz Fund for Pancreatic Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; Raymond and Beverly Sackler Research Foundation; American Associatoion for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Whalen for expert technical assistance. This work was supported by a research grant from the Caring for Carcinoid Foundation, by the Lustgarten Foundation for Pancreatic Cancer Research, the Sol Goldman Pancreatic Cancer Research Center, the Joseph L. Rabinowitz Fund for Pancreatic Cancer Research, the Virginia and D. K. Ludwig Fund for Cancer Research, the Raymond and Beverly Sackler Research Foundation, the American Associatoion for Cancer Research Stand Up To Cancer-Dream Team Translational Cancer Research Grant, and by National Institutes of Health grants CA121113, P50CA062924, P01CA134292, and R01CA113669. N.P. B.V., L.D., V.E.V., and K.W.K. are members of the Scientific Advisory Board of Inostics, a company that is developing technologies for the molecular diagnosis of cancer. N.P. B.V., L.D., V.E.V., and K.W.K. are co-founders of Inostics and Personal Genome Diagnostics and are members of their Scientific Advisory Boards. The authors are entitled to a share of the royalties received by the university on sales of products related to genes described in this manuscript. N.P., B.V., K.W.K., L.A.D., and V.E.V. own Inostics and Personal Genome Diagnostics stock, which is subject to certain restrictions under university policy. The terms of these arrangements are managed by Johns Hopkins University in accordance with its conflict-of-interest policies. D.S.K. is a paid advisor for Novartis, which produces drugs for treatment of neuroendocrine tumors.	Capelli P, 2009, ARCH PATHOL LAB MED, V133, P350, DOI 10.1043/1543-2165-133.3.350; Chung DC, 1998, CANCER RES, V58, P3706; Corbo V, 2010, ENDOCR-RELAT CANCER, V17, P771, DOI 10.1677/ERC-10-0028; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Ekeblad S, 2008, CLIN CANCER RES, V14, P7798, DOI 10.1158/1078-0432.CCR-08-0734; Floridia G, 2005, CANCER GENET CYTOGEN, V156, P23, DOI 10.1016/j.cancergencyto.2004.04.015; Francalanci P, 2003, AM J SURG PATHOL, V27, P1386, DOI 10.1097/00000478-200310000-00012; Fredrich M, 2009, EXP BRAIN RES, V195, P241, DOI 10.1007/s00221-009-1776-7; Gibbons RJ, 2008, HUM MUTAT, V29, P796, DOI 10.1002/humu.20734; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Grembecka J, 2010, J BIOL CHEM, V285, P40690, DOI 10.1074/jbc.M110.172783; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hruban RH, 2007, TUMORS PANCREAS ATLA, P191; Hu Wenwei, 2010, Genes Cancer, V1, P360; Hughes CM, 2004, MOL CELL, V13, P587, DOI 10.1016/S1097-2765(04)00081-4; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kim H, 2003, CANCER RES, V63, P6135; Krueger DA, 2010, NEW ENGL J MED, V363, P1801, DOI 10.1056/NEJMoa1001671; Law MJ, 2010, CELL, V143, P367, DOI 10.1016/j.cell.2010.09.023; Lewis PW, 2010, P NATL ACAD SCI USA, V107, P14075, DOI 10.1073/pnas.1008850107; Liu PX, 2009, NAT REV DRUG DISCOV, V8, P627, DOI 10.1038/nrd2926; Missiaglia E, 2010, J CLIN ONCOL, V28, P245, DOI 10.1200/JCO.2008.21.5988; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Perren A, 2000, AM J PATHOL, V157, P1097, DOI 10.1016/S0002-9440(10)64624-X; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Yao JC, 2010, ANN ONCOL, V21, P4; Yokoyama A, 2004, MOL CELL BIOL, V24, P5639, DOI 10.1128/MCB.24.13.5639-5649.2004	29	1175	1226	4	114	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 4	2011	331	6021					1199	1203		10.1126/science.1200609	http://dx.doi.org/10.1126/science.1200609			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	729SN	21252315	Green Accepted			2022-12-28	WOS:000287971200044
J	Swallows, MD; Bishof, M; Lin, YG; Blatt, S; Martin, MJ; Rey, AM; Ye, J				Swallows, Matthew D.; Bishof, Michael; Lin, Yige; Blatt, Sebastian; Martin, Michael J.; Rey, Ana Maria; Ye, Jun			Suppression of Collisional Shifts in a Strongly Interacting Lattice Clock	SCIENCE			English	Article							TONKS-GIRARDEAU GAS; OPTICAL LATTICE; ULTRACOLD FERMIONS; BOSONS; ATOMS	Optical lattice clocks with extremely stable frequency are possible when many atoms are interrogated simultaneously, but this precision may come at the cost of systematic inaccuracy resulting from atomic interactions. Density-dependent frequency shifts can occur even in a clock that uses fermionic atoms if they are subject to inhomogeneous optical excitation. However, sufficiently strong interactions can suppress collisional shifts in lattice sites containing more than one atom. We demonstrated the effectiveness of this approach with a strontium lattice clock by reducing both the collisional frequency shift and its uncertainty to the level of 10(-17). This result eliminates the compromise between precision and accuracy in a many-particle system; both will continue to improve as the number of particles increases.	[Swallows, Matthew D.; Bishof, Michael; Lin, Yige; Blatt, Sebastian; Martin, Michael J.; Rey, Ana Maria; Ye, Jun] Univ Colorado, Natl Inst Stand & Technol, Joint Inst Lab Astrophys, Boulder, CO 80309 USA; [Swallows, Matthew D.; Bishof, Michael; Lin, Yige; Blatt, Sebastian; Martin, Michael J.; Rey, Ana Maria; Ye, Jun] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Lin, Yige] Natl Inst Metrol, Beijing 100013, Peoples R China	National Institute of Standards & Technology (NIST) - USA; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; National Institute of Metrology China	Ye, J (corresponding author), Univ Colorado, Natl Inst Stand & Technol, Joint Inst Lab Astrophys, Boulder, CO 80309 USA.	ye@jila.colorado.edu	Martin, Michael/AAV-6857-2021; Blatt, Sebastian/F-8986-2012; Ye, Jun/C-3312-2011	Martin, Michael/0000-0002-6022-217X; Blatt, Sebastian/0000-0003-2466-9967; Ye, Jun/0000-0003-0076-2112	National Research Council; National Defense Science and Engineering Graduate fellowship; Army Research Office; Defense Advanced Research Projects Agency; National Institute of Standards and Technology; NSF Physics Frontier Center at JILA; Air Force Office of Scientific Research; Division Of Physics [0904017] Funding Source: National Science Foundation	National Research Council(Consiglio Nazionale delle Ricerche (CNR)); National Defense Science and Engineering Graduate fellowship; Army Research Office; Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA); NSF Physics Frontier Center at JILA(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Division Of Physics(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank C. Benko for technical assistance, and A. D. Ludlow and A. Gorshkov for useful discussions. Supported by a National Research Council postdoctoral fellowship (M.D.S.), a National Defense Science and Engineering Graduate fellowship (M.B.), and a grant from the Army Research Office with funding from the Defense Advanced Research Projects Agency OLE program, the National Institute of Standards and Technology, the NSF Physics Frontier Center at JILA, and the Air Force Office of Scientific Research.	Baym G, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.190407; Boyd MM, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.022510; Boyd MM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.083002; Campbell GK, 2009, SCIENCE, V324, P360, DOI 10.1126/science.1169724; DRESS WB, 1977, PHYS REV D, V15, P9, DOI 10.1103/PhysRevD.15.9; Gibble K, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.113202; GIRARDEAU M, 1960, J MATH PHYS, V1, P516, DOI 10.1063/1.1703687; Gupta S, 2003, SCIENCE, V300, P1723, DOI 10.1126/science.1085335; Haller E, 2009, SCIENCE, V325, P1224, DOI [10.1126/science.11758510, 10.1126/science.1175850]; Kinoshita T, 2004, SCIENCE, V305, P1125, DOI 10.1126/science.1100700; Lemke ND, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.063001; Ludlow AD, 2008, SCIENCE, V319, P1805, DOI 10.1126/science.1153341; Ludlow AD, 2007, OPT LETT, V32, P641, DOI 10.1364/OL.32.000641; Paredes B, 2004, NATURE, V429, P277, DOI 10.1038/nature02530; Punk M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.170404; Rey AM, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.260402; Saffman M, 2010, REV MOD PHYS, V82, P2313, DOI 10.1103/RevModPhys.82.2313; Swallows MD, 2010, IEEE T ULTRASON FERR, V57, P574, DOI 10.1109/TUFFC.2010.1449; Ye J, 2008, SCIENCE, V320, P1734, DOI 10.1126/science.1148259; Yu ZH, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.010801	23	129	134	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 25	2011	331	6020					1043	1046		10.1126/science.1196442	http://dx.doi.org/10.1126/science.1196442			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21292940	Green Submitted			2022-12-28	WOS:000287699000056
J	Wessels, MR				Wessels, Michael R.			Streptococcal Pharyngitis.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GROUP-A STREPTOCOCCI; APPROPRIATE ANTIBIOTIC USE; ANTIGEN-DETECTION TEST; COST-EFFECTIVENESS; DAILY AMOXICILLIN; RHEUMATIC-FEVER; THROAT CULTURE; CARRIER STATE; PENICILLIN; DIAGNOSIS	A 10-year-old girl presents with a sore throat and fever that has lasted for 1 day. She appears flushed and moderately ill. Physical examination reveals a temperature of 39 degrees C, tender bilateral anterior cervical lymph nodes that are 1 to 2 cm in the greatest dimension, and erythema and whitish-yellow exudate over enlarged tonsils and the posterior pharynx. A rapid antigen-detection test from a throat-swab specimen is positive for group A streptococcus. How should the patient be evaluated and treated?	[Wessels, Michael R.] Childrens Hosp Boston, Div Infect Dis, Boston, MA 02115 USA; [Wessels, Michael R.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Wessels, MR (corresponding author), Childrens Hosp Boston, Div Infect Dis, 300 Longwood Ave, Boston, MA 02115 USA.	michael.wessels@childrens.harvard.edu						Altamimi S., 2009, COCHRANE DB SYST REV, V1; Bisno AL, 2004, CLIN INFECT DIS, V38, P1535, DOI 10.1086/392520; Bisno AL, 2002, CLIN INFECT DIS, V35, P113, DOI 10.1086/340949; BLUMER JL, 1994, CLIN THER, V16, P604; BREESE BB, 1977, AM J DIS CHILD, V131, P514, DOI 10.1001/archpedi.1977.02120180028003; BRINK WR, 1951, AM J MED, V10, P300, DOI 10.1016/0002-9343(51)90274-4; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Casey JR, 2004, PEDIATRICS, V113, P866, DOI 10.1542/peds.113.4.866; CATANZARO FJ, 1954, AM J MED, V17, P749, DOI 10.1016/0002-9343(54)90219-3; Centor R M, 1981, Med Decis Making, V1, P239, DOI 10.1177/0272989X8100100304; CHAMOVITZ R, 1954, NEW ENGL J MED, V251, P466, DOI 10.1056/NEJM195409162511203; Clegg HW, 2006, PEDIATR INFECT DIS J, V25, P761, DOI 10.1097/01.inf.0000235678.46805.92; Cooper RJ, 2001, ANN INTERN MED, V134, P509, DOI 10.7326/0003-4819-134-6-200103200-00019; Del Mar CB, 2006, COCHRANE DB SYST REV, V4, DOI 10.1002/14651858.cd000023; DENNY FW, 1950, JAMA-J AM MED ASSOC, V143, P151, DOI 10.1001/jama.1950.02910370001001; DENNY FW, 1953, PEDIATRICS, V11, P7; Ebell MH, 2000, JAMA-J AM MED ASSOC, V284, P2912, DOI 10.1001/jama.284.22.2912; Edmonson MB, 2005, PEDIATRICS, V115, P280, DOI 10.1542/peds.2004-0907; Ehrlich JE, 2002, PREV MED, V35, P250, DOI 10.1006/pmed.2002.1062; Fox JW, 2006, J CLIN MICROBIOL, V44, P2593, DOI 10.1128/JCM.00797-06; Gerber MA, 2004, CLIN MICROBIOL REV, V17, P571, DOI 10.1128/CMR.17.3.571-580.2004; Gerber MA, 1999, PEDIATRICS, V104, P911, DOI 10.1542/peds.104.4.911; Gerber MA, 2009, CIRCULATION, V119, P1541, DOI 10.1161/CIRCULATIONAHA.109.191959; HING E, 2008, NAT HOSP AMBULATORY; KAPLAN EL, 1980, J PEDIATR-US, V97, P337, DOI 10.1016/S0022-3476(80)80178-8; Kim S, 2004, MICROB DRUG RESIST, V10, P300, DOI 10.1089/mdr.2004.10.300; KOMAROFF AL, 1986, J GEN INTERN MED, V1, P1, DOI 10.1007/BF02596317; KROBER MS, 1985, JAMA-J AM MED ASSOC, V253, P1271, DOI 10.1001/jama.253.9.1271; Lennon DR, 2008, ARCH DIS CHILD, V93, P474, DOI 10.1136/adc.2006.113506; LIEU TA, 1990, PEDIATRICS, V85, P246; Liu XR, 2009, PEDIATR PULM, V44, P436, DOI 10.1002/ppul.20976; Matthys J, 2007, ANN FAM MED, V5, P436, DOI 10.1370/afm.741; McIsaac WJ, 2004, JAMA-J AM MED ASSOC, V291, P1587, DOI 10.1001/jama.291.13.1587; McIsaac WJ, 2005, JAMA-J AM MED ASSOC, V294, P2700; Mishra S, 2008, INDIAN PEDIATR, V45, P565; Neuner JM, 2003, ANN INTERN MED, V139, P113, DOI 10.7326/0003-4819-139-2-200307150-00011; Pfoh E, 2008, PEDIATRICS, V121, P229, DOI 10.1542/peds.2007-0484; Pichichero ME, 2000, PEDIATR INFECT DIS J, V19, P917, DOI 10.1097/00006454-200009000-00035; POSES RM, 1985, JAMA-J AM MED ASSOC, V254, P925, DOI 10.1001/jama.254.7.925; RANDOLPH MF, 1985, J PEDIATR-US, V106, P870, DOI 10.1016/S0022-3476(85)80228-6; Robertson Katharine A, 2005, BMC Cardiovasc Disord, V5, P11, DOI 10.1186/1471-2261-5-11; Shulman ST, 2004, PEDIATRICS, V113, P1816, DOI 10.1542/peds.113.6.1816; SNELLMAN LW, 1993, PEDIATRICS, V91, P1166; Snow V, 2001, ANN INTERN MED, V134, P506, DOI 10.7326/0003-4819-134-6-200103200-00018; Tamayo J, 2005, J ANTIMICROB CHEMOTH, V56, P780, DOI 10.1093/jac/dki286; Tanz RR, 2009, PEDIATRICS, V124, P846, DOI 10.1542/peds.2009-1300; Tanz RR, 2009, PEDIATRICS, V123, P437, DOI 10.1542/peds.2008-0488; Tanz RR, 2004, CLIN INFECT DIS, V39, P1794, DOI 10.1086/426025; TANZ RR, 1991, J PEDIATR-US, V119, P123, DOI 10.1016/S0022-3476(05)81052-2; Tanz RR, 1998, PEDIATR ANN, V27, P281, DOI 10.3928/0090-4481-19980501-07; WANNAMAKER LW, 1951, AM J MED, V10, P673, DOI 10.1016/0002-9343(51)90336-1; WANNAMAKER LW, 1972, AM J DIS CHILD, V124, P352, DOI 10.1001/archpedi.1972.02110150050009	52	135	139	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2011	364	7					648	655		10.1056/NEJMcp1009126	http://dx.doi.org/10.1056/NEJMcp1009126			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722BW	21323542				2022-12-28	WOS:000287406000010
J	Kelley, AS; Ettner, SL; Morrison, RS; Du, QL; Wenger, NS; Sarkisian, CA				Kelley, Amy S.; Ettner, Susan L.; Morrison, R. Sean; Du, Qingling; Wenger, Neil S.; Sarkisian, Catherine A.			Determinants of Medical Expenditures in the Last 6 Months of Life	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; REGIONAL-VARIATIONS; PATIENT PREFERENCES; TREATMENT INTENSITY; END; DISABILITY; CANCER; DEATH; AGE; HOSPITALIZATION	Background: End-of-life medical expenditures exceed costs of care during other years, vary across regions, and are likely to be unsustainable. Identifying determinants of expenditure variation may reveal opportunities for reducing costs. Objective: To identify patient-level determinants of Medicare expenditures at the end of life and to determine the contributions of these factors to expenditure variation while accounting for regional characteristics. It was hypothesized that race or ethnicity, social support, and functional status are independently associated with treatment intensity and controlling for regional characteristics, and that individual characteristics account for a substantial proportion of expenditure variation. Design: Using data from the Health and Retirement Study, Medicare claims, and The Dartmouth Atlas of Health Care, relationships were modeled between expenditures and patient and regional characteristics. Setting: United States, 2000 to 2006. Participants: 2394 Health and Retirement Study decedents aged 65.5 years or older. Measurements: Medicare expenditures in the last 6 months of life were estimated in a series of 2-level multivariable regression models that included patient, regional, and patient and regional characteristics. Results: Decline in function (rate ratio [RR], 1.64 [95% CI, 1.46 to 1.83]); Hispanic ethnicity (RR, 1.50 [CI, 1.22 to 1.85]); black race (RR, 1.43 [CI, 1.25 to 1.64]); and certain chronic diseases, including diabetes (RR, 1.16 [CI, 1.06 to 1.27]), were associated with higher expenditures. Nearby family (RR, 0.90 [CI, 0.82 to 0.98]) and dementia (RR, 0.78 CI, 0.71 to 0.87]) were associated with lower expenditures, and advance care planning had no association. Regional characteristics, including end-of-life practice patterns (RR, 1.09 [CI, 1.06 to 1.14]) and hospital beds per capita (RR, 1.01 [CI, 1.00 to 1.02]), were associated with higher expenditures. Patient characteristics explained 10% of overall variance and retained statistically significant relationships with expenditures after regional characteristics were controlled for. Limitation: The study limitations include the decedent sample, proxy informants, and a large proportion of unexplained variation. Conclusion: Patient characteristics, such as functional decline, race or ethnicity, chronic disease, and nearby family, are important determinants of expenditures at the end of life, independent of regional characteristics.	[Kelley, Amy S.] Mt Sinai Sch Med, Dept Geriatr & Palliat Med, New York, NY 10029 USA; Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; James J Peters Vet Affairs Med Ctr, Bronx, NY USA; Vet Affairs Greater Los Angeles Healthcare Syst, Geriatr Res Educ Clin Ctr, Los Angeles, CA USA	Icahn School of Medicine at Mount Sinai; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Kelley, AS (corresponding author), Mt Sinai Sch Med, Dept Geriatr & Palliat Med, 1 Gustave L Levy Pl,Box 1070, New York, NY 10029 USA.	amy.kelley@mssm.edu			Brookdale Foundation; National Institute on Aging [K24 AG022345]; National Palliative Care Research Center; Veterans Affairs Greater Los Angeles Healthcare System Geriatric Research Education Clinical Center; NATIONAL INSTITUTE ON AGING [K24AG022345] Funding Source: NIH RePORTER	Brookdale Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Palliative Care Research Center; Veterans Affairs Greater Los Angeles Healthcare System Geriatric Research Education Clinical Center; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Grant Support: By the Brookdale Foundation. Dr. Kelley is a Brookdale Leadership in Aging Fellow. Dr. Morrison is the recipient of a MidCareer Investigator Award in Patient-Oriented Research (K24 AG022345) from the National Institute on Aging and is supported by the National Palliative Care Research Center. Dr. Sarkisian is supported by the Veterans Affairs Greater Los Angeles Healthcare System Geriatric Research Education Clinical Center.	[Anonymous], HLTH RETIREMENT STUD; Baicker K, 2004, HEALTH AFFAIR, V23, pW4184, DOI 10.1377/hlthaff.W4.184; Barnato AE, 2007, MED CARE, V45, P386, DOI 10.1097/01.mlr.0000255248.79308.41; Barnato AE, 2007, J GEN INTERN MED, V22, P338, DOI 10.1007/s11606-006-0088-x; Bhandari A, 2006, MED CARE RES REV, V63, P217, DOI 10.1177/1077558705285298; Bird Chloe E, 2002, J Palliat Med, V5, P705, DOI 10.1089/109662102320880525; Boyd CM, 2005, AM J MED, V118, P1225, DOI 10.1016/j.amjmed.2005.01.062; Boyd CM, 2005, JAMA-J AM MED ASSOC, V294, P716, DOI 10.1001/jama.294.6.716; Buccaneer Computer Systems and Services, 2009, CHRON COND DAT WAR U; Cortese D, 2007, HEALTH AFFAIR, V26, pW68, DOI 10.1377/hlthaff.26.1.w68; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Emanuel EJ, 2003, ANN INTERN MED, V138, P639, DOI 10.7326/0003-4819-138-8-200304150-00011; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fisher ES, 2003, PERSPECT BIOL MED, V46, P69, DOI 10.1353/pbm.2003.0004; Fisher LS, 2000, HEALTH SERV RES, V34, P1351; Fried LP, 2004, J GERONTOL A-BIOL, V59, P255; Gill TM, 2010, NEW ENGL J MED, V362, P1173, DOI 10.1056/NEJMoa0909087; Gill TM, 2004, JAMA-J AM MED ASSOC, V292, P2115, DOI 10.1001/jama.292.17.2115; Hanchate A, 2009, ARCH INTERN MED, V169, P493, DOI 10.1001/archinternmed.2008.616; Hogan C, 2001, HEALTH AFFAIR, V20, P188, DOI 10.1377/hlthaff.20.4.188; Hoover DR, 2002, HEALTH SERV RES, V37, P1625, DOI 10.1111/1475-6773.01113; Kelley AS, 2010, J PALLIAT MED, V13, P807, DOI 10.1089/jpm.2010.0007; Kelley AS, 2010, J AM GERIATR SOC, V58, P1109, DOI 10.1111/j.1532-5415.2010.02853.x; Levinsky NG, 2001, JAMA-J AM MED ASSOC, V286, P1349, DOI 10.1001/jama.286.11.1349; LUBITZ JD, 1993, NEW ENGL J MED, V328, P1092, DOI 10.1056/NEJM199304153281506; Phelps AC, 2009, JAMA-J AM MED ASSOC, V301, P1140, DOI 10.1001/jama.2009.341; Pritchard RS, 1998, J AM GERIATR SOC, V46, P1242, DOI 10.1111/j.1532-5415.1998.tb04540.x; Raudenbush SW, 2002, HIERARCHICAL LINEAR; REUBEN DB, 1992, AM J MED, V93, P663, DOI 10.1016/0002-9343(92)90200-U; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Shortell SM, 2008, JAMA-J AM MED ASSOC, V300, P95, DOI 10.1001/jama.300.1.95; Shugarman LR, 2007, J WOMENS HEALTH, V16, P214, DOI 10.1089/jwh.2006.0012; Shugarman LR, 2004, J GEN INTERN MED, V19, P127, DOI 10.1111/j.1525-1497.2004.30223.x; Skinner J, 2010, NEW ENGL J MED, V362, P569, DOI 10.1056/NEJMp1000448; Skinner J, 2009, HEALTH AFFAIR, V28, pW119, DOI 10.1377/hlthaff.28.1.w119; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Teno JM, 2007, J AM GERIATR SOC, V55, P189, DOI 10.1111/j.1532-5415.2007.01045.x; Virnig B A, 1999, J Palliat Med, V2, P23, DOI 10.1089/jpm.1999.2.23; Virnig BA, 2000, J AM GERIATR SOC, V48, P1117, DOI 10.1111/j.1532-5415.2000.tb04789.x; Welch LC, 2005, J AM GERIATR SOC, V53, P1145, DOI 10.1111/j.1532-5415.2005.53357.x; Wenger NS, 2000, J AM GERIATR SOC, V48, pS44, DOI 10.1111/j.1532-5415.2000.tb03140.x; Wennberg JE., DARTMOUTH ATLAS HLTH; Wennberg JE, 2009, HEALTH AFFAIR, V28, P103, DOI 10.1377/hlthaff.28.1.103; Werner RM, 2007, J GEN INTERN MED, V22, P1206, DOI 10.1007/s11606-007-0230-4; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Yasaitis L, 2009, HEALTH AFFAIR, V28, pW566, DOI 10.1377/hlthaff.28.4.w566; Zuckerman S, 2010, NEW ENGL J MED, V363, P54, DOI 10.1056/NEJMsa0909253	49	124	124	1	38	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4					235	W78		10.7326/0003-4819-154-4-201102150-00004	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-00004			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	720VF	21320939	Green Accepted			2022-12-28	WOS:000287310000015
J	Wang, J				Wang, Jun			Personal Genomes: For One and for All	SCIENCE			English	Editorial Material									Beijing Genome Inst, Beijing, Peoples R China	Beijing Genomics Institute (BGI)	Wang, J (corresponding author), Beijing Genome Inst, Beijing, Peoples R China.		Wang, Jun/B-9503-2016; Wang, Jun/C-8434-2016	Wang, Jun/0000-0002-2113-5874; Wang, Jun/0000-0002-8540-8931					0	4	4	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					690	690		10.1126/science.1202811	http://dx.doi.org/10.1126/science.1202811			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21310998				2022-12-28	WOS:000287205700040
J	Wu, L; Pan, LF; Wei, ZY; Zhang, MJ				Wu, Lin; Pan, Lifeng; Wei, Zhiyi; Zhang, Mingjie			Structure of MyTH4-FERM Domains in Myosin VIIa Tail Bound to Cargo	SCIENCE			English	Article							USHER-SYNDROME; UNCONVENTIONAL MYOSIN; HAIR BUNDLE; MUTATIONS; HARMONIN; DEAFNESS; PROTEIN; CELLS; CADHERIN-23; COHESION	The unconventional myosin VIIa (MYO7A) is one of the five proteins that form a network of complexes involved in formation of stereocilia. Defects in these proteins cause syndromic deaf-blindness in humans [Usher syndrome I (USH1)]. Many disease-causing mutations occur in myosin tail homology 4-protein 4.1, ezrin, radixin, moesin (MyTH4-FERM) domains in the myosin tail that binds to another USH1 protein, Sans. We report the crystal structure of MYO7A MyTH4-FERM domains in complex with the central domain (CEN) of Sans at 2.8 angstrom resolution. The MyTH4 and FERM domains form an integral structural and functional supramodule binding to two highly conserved segments (CEN1 and 2) of Sans. The MyTH4-FERM/CEN complex structure provides mechanistic explanations for known deafness-causing mutations in MYO7A MyTH4-FERM. The structure will also facilitate mechanistic and functional studies of MyTH4-FERM domains in other myosins.	[Wu, Lin; Pan, Lifeng; Wei, Zhiyi; Zhang, Mingjie] Hong Kong Univ Sci & Technol, Div Life Sci, Mol Neurosci Ctr, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China	Hong Kong University of Science & Technology	Zhang, MJ (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Mol Neurosci Ctr, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China.	mzhang@ust.hk	Wei, Zhiyi/C-4315-2014; Wei, Zhiyi/N-9995-2019; Wei, Zhiyi/B-5001-2010	Wei, Zhiyi/0000-0002-4446-6502; Wei, Zhiyi/0000-0002-4446-6502; Wei, Zhiyi/0000-0002-4446-6502; Zhang, Mingjie/0000-0001-9404-0190	Research Grant Council of Hong Kong [663808, 664009, 663610, CA07/08.SC01, SEG_HKUST06, AoE/B-15/01-II]	Research Grant Council of Hong Kong(Hong Kong Research Grants Council)	We thank T. Friediman for providing the mouse MYO7A cDNA construct, J. Yu and Y. Shang for the help in crystallography, Y. Zhao for the in-house x-ray diffractor, the BL17U1 of the Shanghai Synchrotron Radiation Facility for the beamline time, and A. Zhang for reading the manuscript. This work was supported by grants from the Research Grant Council of Hong Kong to M.Z. (663808, 664009, 663610, CA07/08.SC01, SEG_HKUST06, and AoE/B-15/01-II). The atomic coordinates and structure factors of the complex structure have been deposited in the Protein Data Bank under the accession code 3PVL. The superimposed final 10 NMR structures of the CEN2 peptide have been deposited in the Protein Data Bank under the accession code 2L7T.	Adato A, 2005, HUM MOL GENET, V14, P347, DOI 10.1093/hmg/ddi031; Ahmed ZM, 2003, CLIN GENET, V63, P431, DOI 10.1034/j.1399-0004.2003.00109.x; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; El-Amraoui A, 2005, J CELL SCI, V118, P4593, DOI 10.1242/jcs.02636; Jaijo T, 2007, J MED GENET, V44, DOI 10.1136/jmg.2006.045377; Lefevre G, 2008, DEVELOPMENT, V135, P1427, DOI 10.1242/dev.012922; Ouyang XM, 2005, HUM GENET, V116, P292, DOI 10.1007/s00439-004-1227-2; Probst FJ, 1998, SCIENCE, V280, P1444, DOI 10.1126/science.280.5368.1444; Reiners J, 2006, ADV EXP MED BIOL, V572, P349; Riazuddin S, 2008, HUM MUTAT, V29, P502, DOI 10.1002/humu.20677; Schwander M, 2010, J CELL BIOL, V190, P9, DOI 10.1083/jcb.201001138; Schwander M, 2009, J NEUROSCI, V29, P15810, DOI 10.1523/JNEUROSCI.4876-09.2009; Self T, 1998, DEVELOPMENT, V125, P557; Siemens J, 2002, P NATL ACAD SCI USA, V99, P14946, DOI 10.1073/pnas.232579599; Tepass U, 2009, CURR OPIN GENET DEV, V19, P357, DOI 10.1016/j.gde.2009.05.006; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Weil D, 2003, HUM MOL GENET, V12, P463, DOI 10.1093/hmg/ddg051; WELL D, 1995, NATURE, V374, P60, DOI 10.1038/374060a0	19	79	82	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					757	760		10.1126/science.1198848	http://dx.doi.org/10.1126/science.1198848			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21311020				2022-12-28	WOS:000287205700067
J	Spence, D				Spence, Des			From the Frontline Care less	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 9	2011	342								d877	10.1136/bmj.d877	http://dx.doi.org/10.1136/bmj.d877			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	722AZ	21307116				2022-12-28	WOS:000287402900002
J	Gregori, L				Gregori, Luisa			A prototype assay to detect vCJD-infected blood	LANCET			English	Editorial Material							CREUTZFELDT-JAKOB-DISEASE; INFECTIVITY		US FDA, Rockville, MD 20852 USA	US Food & Drug Administration (FDA)	Gregori, L (corresponding author), US FDA, Rockville, MD 20852 USA.	luisa.gregori@fda.hhs.gov						Brown P, 2001, J LAB CLIN MED, V137, P5, DOI 10.1067/mlc.2001.111951; Chen BA, 2010, NAT METHODS, V7, P519, DOI [10.1038/NMETH.1465, 10.1038/nmeth.1465]; EDGEWORTH JA, 2011, LANCET          0203, DOI DOI 10.1016/S0140-6736(10)62308-2; Edgeworth JA, 2009, P NATL ACAD SCI USA, V106, P3479, DOI 10.1073/pnas.0813342106; Gregori L, 2008, J VIROL METHODS, V149, P251, DOI 10.1016/j.jviromet.2008.01.028; Hewitt PE, 2006, VOX SANG, V91, P221, DOI 10.1111/j.1423-0410.2006.00833.x; *NAT BLOOD SERV SC, TRANSF MED EP REV; *NAT CREUTZF JAK D, 2010, VAR CREUTZF JAK DIS; Peden A, 2010, HAEMOPHILIA, V16, P296, DOI 10.1111/j.1365-2516.2009.02181.x; *UK HLTH PROT AG, 2007, HLTH PROT REP; Zobeley E, 1999, MOL MED, V5, P240, DOI 10.1007/BF03402121	11	11	11	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 5	2011	377	9764					444	446		10.1016/S0140-6736(11)60057-3	http://dx.doi.org/10.1016/S0140-6736(11)60057-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721TX	21295340				2022-12-28	WOS:000287381800006
J	Bolinger, JC; Traub, MC; Adachi, T; Barbara, PF				Bolinger, Joshua C.; Traub, Matthew C.; Adachi, Takuji; Barbara, Paul F.			Ultralong-Range Polaron-Induced Quenching of Excitons in Isolated Conjugated Polymers	SCIENCE			English	Article							SINGLE-MOLECULE SPECTROSCOPY; ENERGY MIGRATION; MEH-PPV; STATES; CHAIN	In conjugated polymers, radiative recombination of excitons (electron-hole pairs) competes with nonradiative thermal relaxation pathways. We visualized exciton quenching induced by hole polarons in single-polymer chains in a device geometry. The distance-scale for quenching was measured by means of a new subdiffraction, single-molecule technique-bias-modulated intensity centroid spectroscopy-which allowed the extraction of a mean centroid shift of 14 nanometers for highly ordered, single-polymer nanodomains. This shift requires energy transfer over distances an order of magnitude greater than previously reported for bulk conjugated polymers and far greater than predicted by the standard mechanism for exciton quenching, the unbiased diffusion of free excitons to quenching sites. Instead, multistep "energy funneling" to trapped, localized polarons is the probable mechanism for polaron-induced exciton quenching.	[Bolinger, Joshua C.; Traub, Matthew C.; Adachi, Takuji; Barbara, Paul F.] Univ Texas Austin, Ctr Nano & Mol Sci & Technol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Bolinger, JC (corresponding author), Univ Texas Austin, Ctr Nano & Mol Sci & Technol, Austin, TX 78712 USA.	jcb2873@mail.utexas.edu	Adachi, Takuji/T-8183-2018	Adachi, Takuji/0000-0002-0577-1926; Traub, Matthew/0000-0001-6425-2483	U.S. Department of Energy; Welch Foundation	U.S. Department of Energy(United States Department of Energy (DOE)); Welch Foundation(The Welch Foundation)	We acknowledge funding by the U.S. Department of Energy Basic Energy Sciences, Solar Photochemistry Program, and the Welch Foundation. Before his death in October 2010, Dr. Barbara was the director of the Center for Nano and Molecular Science and Technology at the University of Texas, Austin, TX 78712. J.C.B. was a research scientist for Dr. Barbara at the time. Submission of this manuscript was done by J.C.B. subsequent to Dr. Barbara's death.	Adachi T, 2010, J PHYS CHEM C, V114, P20896, DOI 10.1021/jp108546w; Adams DM, 1999, J PHYS CHEM A, V103, P10138, DOI 10.1021/jp992143h; Barbara PF, 2005, ACCOUNTS CHEM RES, V38, P602, DOI 10.1021/ar040141w; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bolinger J, 2008, J PHYS CHEM C, V112, P18608, DOI 10.1021/jp804901s; Bolinger JC, 2009, P NATL ACAD SCI USA, V106, P1342, DOI 10.1073/pnas.0811900106; Collini E, 2009, SCIENCE, V323, P369, DOI 10.1126/science.1164016; Dykstra TE, 2009, J PHYS CHEM B, V113, P656, DOI 10.1021/jp807249b; Hu DH, 2000, NATURE, V405, P1030, DOI 10.1038/35016520; Kim DY, 2006, SYNTHETIC MET, V156, P336, DOI 10.1016/j.synthmet.2005.12.019; Lim SH, 2003, J CHEM PHYS, V118, P4297, DOI 10.1063/1.1540093; Markov DE, 2005, J PHYS CHEM A, V109, P5266, DOI 10.1021/jp0509663; Moerner WE, 2007, P NATL ACAD SCI USA, V104, P12596, DOI 10.1073/pnas.0610081104; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Salleo A, 2003, J APPL PHYS, V94, P471, DOI 10.1063/1.1581352; Yu J, 2004, ISR J CHEM, V44, P127, DOI 10.1560/PHGE-RR3P-5P7V-DGCM; Yu J, 2000, SCIENCE, V289, P1327, DOI 10.1126/science.289.5483.1327	17	111	112	1	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					565	567		10.1126/science.1199140	http://dx.doi.org/10.1126/science.1199140			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292973				2022-12-28	WOS:000286933600048
J	Collins, FS				Collins, Francis S.			Faces of the Genome	SCIENCE			English	Editorial Material									NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Collins, FS (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000024] Funding Source: NIH RePORTER	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))			0	14	15	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					546	546		10.1126/science.1202894	http://dx.doi.org/10.1126/science.1202894			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292963	Green Published			2022-12-28	WOS:000286933600037
J	Przeworski, M				Przeworski, Molly			The Golden Age of Human Population Genetics	SCIENCE			English	Editorial Material									[Przeworski, Molly] Univ Chicago, Chicago, IL 60637 USA; [Przeworski, Molly] Howard Hughes Med Inst, Chevy Chase, MD USA	University of Chicago; Howard Hughes Medical Institute	Przeworski, M (corresponding author), Univ Chicago, Chicago, IL 60637 USA.				Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)			0	2	2	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					547	547		10.1126/science.1202571	http://dx.doi.org/10.1126/science.1202571			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292966				2022-12-28	WOS:000286933600039
J	Lissauer, JJ; Fabrycky, DC; Ford, EB; Borucki, WJ; Fressin, F; Marcy, GW; Orosz, JA; Rowe, JF; Torres, G; Welsh, WF; Batalha, NM; Bryson, ST; Buchhave, LA; Caldwell, DA; Carter, JA; Charbonneau, D; Christiansen, JL; Cochran, W; Desert, JM; Dunham, EW; Fanelli, MN; Fortney, JJ; Gautier, TN; Geary, JC; Gilliland, RL; Haas, MR; Hall, JR; Holman, MJ; Koch, DG; Latham, DW; Lopez, E; McCauliff, S; Miller, N; Morehead, RC; Quintana, EV; Ragozzine, D; Sasselov, D; Short, DR; Steffen, JH				Lissauer, Jack J.; Fabrycky, Daniel C.; Ford, Eric B.; Borucki, William J.; Fressin, Francois; Marcy, Geoffrey W.; Orosz, Jerome A.; Rowe, Jason F.; Torres, Guillermo; Welsh, William F.; Batalha, Natalie M.; Bryson, Stephen T.; Buchhave, Lars A.; Caldwell, Douglas A.; Carter, Joshua A.; Charbonneau, David; Christiansen, Jessie L.; Cochran, WilliamD.; Desert, Jean-Michel; Dunham, Edward W.; Fanelli, Michael N.; Fortney, Jonathan J.; Gautier, Thomas N., III; Geary, John C.; Gilliland, Ronald L.; Haas, Michael R.; Hall, Jennifer R.; Holman, Matthew J.; Koch, David G.; Latham, David W.; Lopez, Eric; McCauliff, Sean; Miller, Neil; Morehead, Robert C.; Quintana, Elisa V.; Ragozzine, Darin; Sasselov, Dimitar; Short, Donald R.; Steffen, Jason H.			A closely packed system of low-mass, low-density planets transiting Kepler-11	NATURE			English	Article							EXTRASOLAR PLANETS; SUPER-EARTHS; STARS; PERFORMANCE; EVAPORATION; ISOCHRONES; DYNAMICS; NEPTUNES; JUPITERS; SCIENCE	When an extrasolar planet passes in front of (transits) its star, its radius can be measured from the decrease in starlight and its orbital period from the time between transits. Multiple planets transiting the same star reveal much more: period ratios determine stability and dynamics, mutual gravitational interactions reflect planet masses and orbital shapes, and the fraction of transiting planets observed as multiples has implications for the planarity of planetary systems. But few stars have more than one known transiting planet, and none has more than three. Here we report Kepler spacecraft observations of a single Sun-like star, which we call Kepler-11, that reveal six transiting planets, five with orbital periods between 10 and 47 days and a sixth planet with a longer period. The five inner planets are among the smallest for which mass and size have both been measured, and these measurements imply substantial envelopes of light gases. The degree of coplanarity and proximity of the planetary orbits imply energy dissipation near the end of planet formation.	[Lissauer, Jack J.; Rowe, Jason F.; Caldwell, Douglas A.; Christiansen, Jessie L.; Quintana, Elisa V.] NASA, Ames Res Ctr, SETI Inst, Moffett Field, CA 94035 USA; [Fabrycky, Daniel C.; Fortney, Jonathan J.; Lopez, Eric; Miller, Neil] Univ Calif Santa Cruz, Univ Calif Observ, Lick Observ, Santa Cruz, CA 95064 USA; [Ford, Eric B.; Morehead, Robert C.] Univ Florida, Bryant Space Sci Ctr 211, Gainesville, FL 32611 USA; [Fressin, Francois; Torres, Guillermo; Carter, Joshua A.; Charbonneau, David; Desert, Jean-Michel; Geary, John C.; Holman, Matthew J.; Latham, David W.; Ragozzine, Darin; Sasselov, Dimitar] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Marcy, Geoffrey W.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Orosz, Jerome A.; Welsh, William F.; Short, Donald R.] San Diego State Univ, San Diego, CA 92182 USA; [Batalha, Natalie M.] San Jose State Univ, Dept Phys & Astron, San Jose, CA 95192 USA; [Buchhave, Lars A.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Cochran, WilliamD.] Univ Texas Austin, McDonald Observ, Austin, TX 78712 USA; [Dunham, Edward W.] Lowell Observ, Flagstaff, AZ 86001 USA; [Fanelli, Michael N.] NASA, Ames Res Ctr, Bay Area Environm Res Inst, Moffett Field, CA 94035 USA; [Gautier, Thomas N., III] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Gilliland, Ronald L.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Hall, Jennifer R.; McCauliff, Sean] NASA, Ames Res Ctr, Orbital Sci Corp, Moffett Field, CA 94035 USA; [Steffen, Jason H.] Fermilab Ctr Particle Astrophys, Batavia, IL 60510 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of California System; University of California Santa Cruz; State University System of Florida; University of Florida; Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of California System; University of California Berkeley; California State University System; San Diego State University; California State University System; San Jose State University; University of Copenhagen; Niels Bohr Institute; University of Texas System; University of Texas Austin; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Space Telescope Science Institute; National Aeronautics & Space Administration (NASA); NASA Ames Research Center	Lissauer, JJ (corresponding author), NASA, Ames Res Ctr, SETI Inst, Moffett Field, CA 94035 USA.	jack.lissauer@nasa.gov; fabrycky@ucolick.org	Ragozzine, Darin/C-4926-2013; Cochran, William D/M-4421-2014; Welsh, William/AAS-3445-2021; Ford, Eric B./AAB-5479-2019; Steffen, Jason H./A-4320-2013; Caldwell, Douglas A/L-7911-2014; Marcy, Geoff/AAC-6050-2019; Carter, Joshua A/A-8280-2013; Buchhave, Lars A./ABF-2000-2020; Fortney, Jonathan/F-8813-2014	Cochran, William D/0000-0001-9662-3496; Ford, Eric B./0000-0001-6545-639X; Caldwell, Douglas A/0000-0003-1963-9616; Buchhave, Lars A./0000-0003-1605-5666; Rowe, Jason/0000-0002-5904-1865; Morehead, Robert/0000-0002-2740-3673; Batalha, Natalie/0000-0002-7030-9519; Fabrycky, Daniel/0000-0003-3750-0183; Christiansen, Jessie/0000-0002-8035-4778; Fortney, Jonathan/0000-0002-9843-4354; Steffen, Jason/0000-0003-2202-3847	NASA [HF-51272.01-A, HF-51267.01-A]; STScl [NAS 5-26555]	NASA(National Aeronautics & Space Administration (NASA)); STScl	Kepler was competitively selected as the tenth Discovery mission. Funding for this mission is provided by NASA's Science Mission Directorate. We thank the many people who gave so generously of their time to make the Kepler mission a success. A. Dobrovolskis, T. J. Lee and D. Queloz provided constructive comments on the manuscript. D.C.F. and J.A.C. acknowledge NASA support through Hubble Fellowship grants HF-51272.01-A and HF-51267.01-A, respectively, awarded by STScl, operated by AURA under contract NAS 5-26555.	Agol E, 2005, MON NOT R ASTRON SOC, V359, P567, DOI 10.1111/j.1365-2966.2005.08922.x; BATALHA N, ASTROPHYS J IN PRESS, V728; Borucki WJ, 2010, SCIENCE, V327, P977, DOI 10.1126/science.1185402; BORUCKI WJ, ASTROPHYS J UNPUB; Brown TM, 2003, ASTROPHYS J, V593, pL125, DOI 10.1086/378310; Caldwell DA, 2010, ASTROPHYS J LETT, V713, pL92, DOI 10.1088/2041-8205/713/2/L92; Cumming A, 2008, PUBL ASTRON SOC PAC, V120, P531, DOI 10.1086/588487; des Etangs AL, 2007, ASTRON ASTROPHYS, V461, P1185, DOI 10.1051/0004-6361:20065014; des Etangs AL, 2010, ASTRON ASTROPHYS, V514, DOI 10.1051/0004-6361/200913347; Elkins-Tanton LT, 2008, ASTROPHYS J, V685, P1237, DOI 10.1086/591433; Girardi L, 2000, ASTRON ASTROPHYS SUP, V141, P371, DOI 10.1051/aas:2000126; GLADMAN B, 1993, ICARUS, V106, P247, DOI 10.1006/icar.1993.1169; Holman MJ, 2010, SCIENCE, V330, P51, DOI 10.1126/science.1195778; Holman MJ, 2005, SCIENCE, V307, P1288, DOI 10.1126/science.1107822; Howard AW, 2010, SCIENCE, V330, P653, DOI 10.1126/science.1194854; Jenkins JM, 2010, ASTROPHYS J LETT, V713, pL87, DOI 10.1088/2041-8205/713/2/L87; KOCH D, 1996, 1 INT C CIRC HAB ZON, V229; Koch DG, 2010, ASTROPHYS J LETT, V713, pL79, DOI 10.1088/2041-8205/713/2/L79; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; Miller N, 2009, ASTROPHYS J, V702, P1413, DOI 10.1088/0004-637X/702/2/1413; Miller-Ricci E, 2009, ASTROPHYS J, V690, P1056, DOI 10.1088/0004-637X/690/2/1056; Miralda-Escude J, 2002, ASTROPHYS J, V564, P1019, DOI 10.1086/324279; NETTELMANN N, 2010, ASTROPHYS J IN PRESS; Papaloizou JCB, 2010, MON NOT R ASTRON SOC, V405, P573, DOI 10.1111/j.1365-2966.2010.16477.x; Ragozzine D., 2010, ASTROPHYS J UNPUB; Rogers LA, 2010, ASTROPHYS J, V712, P974, DOI 10.1088/0004-637X/712/2/974; Rowe JF, 2010, ASTROPHYS J LETT, V713, pL150, DOI 10.1088/2041-8205/713/2/L150; Smith AW, 2009, ICARUS, V201, P381, DOI 10.1016/j.icarus.2008.12.027; Steffen JH, 2010, ASTROPHYS J, V725, P1226, DOI 10.1088/0004-637X/725/1/1226; Torres G, 2011, ASTROPHYS J, V727, DOI 10.1088/0004-637X/727/1/24; Valenti JA, 2005, ASTROPHYS J SUPPL S, V159, P141, DOI 10.1086/430500; Valenti JA, 1996, ASTRON ASTROPHYS SUP, V118, P595, DOI 10.1051/aas:1996222; Vidal-Madjar A, 2003, NATURE, V422, P143, DOI 10.1038/nature01448; Yi S, 2001, ASTROPHYS J SUPPL S, V136, P417, DOI 10.1086/321795	35	486	487	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2011	470	7332					53	58		10.1038/nature09760	http://dx.doi.org/10.1038/nature09760			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293371	Green Submitted			2022-12-28	WOS:000286886400032
J	Lipitz-Snyderman, A; Steinwachs, D; Needham, D; Colantuoni, E; Morlock, LL; Pronovos, PJ				Lipitz-Snyderman, Allison; Steinwachs, Donald; Needham, Dale M.; Colantuoni, Elizabeth; Morlock, Laura L; Pronovos, Peter J			Impact of a statewide intensive care unit quality improvement initiative on hospital mortality and length of stay: retrospective comparative analysis	BRITISH MEDICAL JOURNAL			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; BLOOD-STREAM INFECTIONS; CRITICALLY-ILL PATIENTS; ADVERSE EVENTS; PREVENTION; INTERVENTION; COST	Objective To evaluate whether implementation of the Michigan Keystone ICU project, a comprehensive statewide quality improvement initiative focused on reduction of infections, was associated with reductions in hospital mortality and length of stay for adults aged 65 or more admitted to intensive care units. Design Retrospective comparative study, using data from Medicare claims. Setting Michigan and Midwest region, United States. Population The study period (October 2001 to December 2006) spanned two years before the project was initiated to 22 months after its implementation. The study sample included hospital admissions for patients treated in 95 study hospitals in Michigan (238 937 total admissions)compared with 364 hospitals in the surrounding Midwest region (1 091 547 total admissions). Main outcome measures Hospital mortality and length of hospital stay. Results The overall trajectory of mortality outcomes differed significantly between the two groups upon implementation of the project (Wald test chi(2)=8.73,P=0.033). Reductions in mortality were significantly greater for the study group than for the comparison group 1-12 months (odds ratio 0.83, 95% confidence interval 0.79 to 0.87 v 0.88, 0.85 to 0.90, P=0.041) and 13-22 months (0.76, 0.72 to 0.81 v 0.84, 0.81 to 0.86, P=0.007) after implementation of the project. The overall trajectory of length of stay did not differ significantly between the groups upon implementation of the project (Wald test chi 2=2.05, P=0.560). Group differences in adjusted length of stay compared with baseline did not reach significance during implementation of the project(.0.45 days, 95% confidence interval -0.62 to -0.28 v -0.35, -0.52 to -0.19) or during post-implementation months 1-12 (-0.59, -0.80 to -0.37 v -0.42, -0.59 to -0.25) and 13-22 (-0.67, -0.91 to -0.43 v -0.54, -0.72 to -0.37). Conclusions Implementation of the Keystone ICU project was associated with a significant decrease in hospital mortality in Michigan compared with the surroundingarea. The project was not, however, sufficiently powered to show a significant difference in length of stay.	[Lipitz-Snyderman, Allison; Steinwachs, Donald; Morlock, Laura L] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA; [Needham, Dale M.] Johns Hopkins Sch Med, Div Pulm & Crit Care Med, Outcomes After Crit Illness & Surg Grp, Baltimore, MD USA; [Colantuoni, Elizabeth] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA; [Pronovos, Peter J] Johns Hopkins Univ, Dept Anesthesiol & Crit Care Med, Qual & Safety Res Grp, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University	Lipitz-Snyderman, A (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21205 USA.	alipitz@jhsph.edu						Angus DC, 2006, CRIT CARE MED, V34, P1016, DOI 10.1097/01.CCM.0000206105.05626.15; BERENHOLTZ S, 2010, INFECT CONTROL HOSP; Bosk CL, 2009, LANCET, V374, P444, DOI 10.1016/S0140-6736(09)61440-9; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; Elixhauser A., 1996, CLIN CLASSIFICATIONS; KHAUS WA, 1993, ANN INTERN MED, V118, P753; KNAUS WA, 1993, ANN INTERN MED, V118, P753, DOI 10.7326/0003-4819-118-10-199305150-00001; KOHN LT, 1999, ERR HUMAN BUILDING S; Melsen WG, 2009, CRIT CARE MED, V37, P2709, DOI 10.1097/CCM.0b013e3181ab8655; Mermel LA, 2000, ANN INTERN MED, V132, P391, DOI 10.7326/0003-4819-132-5-200003070-00009; PITTET D, 1994, JAMA-J AM MED ASSOC, V271, P1598, DOI 10.1001/jama.271.20.1598; POTTER L, 1997, P 5 ANN WESTERN USER; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2008, J CRIT CARE, V23, P207, DOI 10.1016/j.jcrc.2007.09.002; Pronovost PJ, 2006, HEALTH SERV RES, V41, P1599, DOI 10.1111/j.1475-6773.2006.00567.x; PRONOVOST PJ, 2010, BRIT MED J, P340; Safdar N, 2005, CRIT CARE MED, V33, P2184, DOI 10.1097/01.CCM.0000181731.53912.D9; Shorr AF, 2001, CHEST, V119, P228, DOI 10.1378/chest.119.1.228; Soufir L, 1999, INFECT CONT HOSP EP, V20, P396, DOI 10.1086/501639; Thomas EJ, 2000, BRIT MED J, V320, P741, DOI 10.1136/bmj.320.7237.741; Veenstra DL, 1999, JAMA-J AM MED ASSOC, V282, P554, DOI 10.1001/jama.282.6.554; Warren DK, 2006, INFECT CONT HOSP EP, V27, P662, DOI 10.1086/506184; Warren DK, 2006, CRIT CARE MED, V34, P2084, DOI 10.1097/01.CCM.0000227648.15804.2D	24	83	83	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 31	2011	342								d219	10.1136/bmj.d219	http://dx.doi.org/10.1136/bmj.d219			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718PN	21282262	Green Published, hybrid			2022-12-28	WOS:000287137500014
J	O'Neill, JS; Reddy, AB				O'Neill, John S.; Reddy, Akhilesh B.			Circadian clocks in human red blood cells	NATURE			English	Article							GENE-EXPRESSION; PEROXIREDOXINS; OSCILLATIONS; FEEDBACK; NADH; MECHANISMS; HEALTH; STATES; RHYTHM; DIMER	Circadian (similar to 24 hour) clocks are fundamentally important for coordinated physiology in organisms as diverse as cyanobacteria and humans. All current models of the molecular circadian clockwork in eukaryotic cells are based on transcription-translation feedback loops. Non-transcriptional mechanisms in the clockwork have been difficult to study in mammalian systems. We circumvented these problems by developing novel assays using human red blood cells, which have no nucleus (or DNA) and therefore cannot perform transcription. Our results show that transcription is not required for circadian oscillations in humans, and that non-transcriptional events seem to be sufficient to sustain cellular circadian rhythms. Using red blood cells, we found that peroxiredoxins, highly conserved antioxidant proteins, undergo similar to 24-hour redox cycles, which persist for many days under constant conditions (that is, in the absence of external cues). Moreover, these rhythms are entrainable (that is, tunable by environmental stimuli) and temperature-compensated, both key features of circadian rhythms. We anticipate that our findings will facilitate more sophisticated cellular clock models, highlighting the interdependency of transcriptional and non-transcriptional oscillations in potentially all eukaryotic cells.	[O'Neill, John S.; Reddy, Akhilesh B.] Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs,Dept Clin Neurosci, Cambridge CB2 0QQ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Reddy, AB (corresponding author), Univ Cambridge, Addenbrookes Hosp, Inst Metab Sci, Metab Res Labs,Dept Clin Neurosci, Cambridge CB2 0QQ, England.	areddy@cantab.net		O'Neill, John Stuart/0000-0003-2204-6096	Wellcome Trust [083643/Z/07/Z]; MRC Centre for Obesity and Related metabolic Disorders (MRC CORD); NIHR Cambridge Biomedical Research Centre	Wellcome Trust(Wellcome TrustEuropean Commission); MRC Centre for Obesity and Related metabolic Disorders (MRC CORD)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR))	This work was supported by the Wellcome Trust (083643/Z/07/Z), the MRC Centre for Obesity and Related metabolic Disorders (MRC CORD) and the NIHR Cambridge Biomedical Research Centre. We thank M. Jain and R. Edgar for discussions about the manuscript, A. Coles and J. Jones for providing access to samples, and G. van der Horst and F. Tamanini for providing access to Cry1 Cry2 knockout (and wild-type) mouse embryonic fibroblasts.	Barger LK, 2009, CURR NEUROL NEUROSCI, V9, P155, DOI 10.1007/s11910-009-0024-7; Barranco-Medina S, 2009, FEBS LETT, V583, P1809, DOI 10.1016/j.febslet.2009.05.029; BETZ A, 1965, ARCH BIOCHEM BIOPHYS, V109, P585, DOI 10.1016/0003-9861(65)90404-2; Cho CS, 2010, ANTIOXID REDOX SIGN, V12, P1235, DOI 10.1089/ars.2009.2701; Corellou F, 2009, PLANT CELL, V21, P3436, DOI 10.1105/tpc.109.068825; Dibner C, 2009, EMBO J, V28, P123, DOI 10.1038/emboj.2008.262; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; Dodd AN, 2007, SCIENCE, V318, P1789, DOI 10.1126/science.1146757; Dunlap JC, 1999, CELL, V96, P271, DOI 10.1016/S0092-8674(00)80566-8; Eelderink-Chen Z, 2010, P NATL ACAD SCI USA, V107, P2043, DOI 10.1073/pnas.0907902107; GHOSH AK, 1971, ARCH BIOCHEM BIOPHYS, V145, P319, DOI 10.1016/0003-9861(71)90042-7; Griffon N, 1998, PROTEIN SCI, V7, P673, DOI 10.1002/pro.5560070316; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Hastings MH, 2008, J NEUROENDOCRINOL, V20, P812, DOI 10.1111/j.1365-2826.2008.01715.x; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; HESS B, 1966, BIOCHEM BIOPH RES CO, V23, P102, DOI 10.1016/0006-291X(66)90276-2; HEWITT JA, 1972, P NATL ACAD SCI USA, V69, P203, DOI 10.1073/pnas.69.1.203; Hu T, 2009, BIOCHEMISTRY-US, V48, P608, DOI 10.1021/bi801880y; JACOBSEN MP, 1995, BBA-PROTEIN STRUCT M, V1246, P17, DOI 10.1016/0167-4838(94)00174-F; Johnson CH, 2008, CURR BIOL, V18, pR816, DOI 10.1016/j.cub.2008.07.012; JOHNSON CH, 1995, SCIENCE, V269, P1863, DOI 10.1126/science.7569925; Kennett EC, 2005, INT J BIOCHEM CELL B, V37, P1438, DOI 10.1016/j.biocel.2005.02.001; Kippert F, 2002, CURR BIOL, V12, pR47, DOI 10.1016/S0960-9822(01)00670-4; Lakin-Thomas PL, 2006, J BIOL RHYTHM, V21, P83, DOI 10.1177/0748730405286102; LATENKOV V P, 1986, Byulleten' Eksperimental'noi Biologii i Meditsiny, V101, P614; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; OGO S, 1989, J BIOL CHEM, V264, P11302; Qin XM, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000394; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Reddy AB, 2010, TRENDS CELL BIOL, V20, P36, DOI 10.1016/j.tcb.2009.10.005; Rhee SG, 2007, KIDNEY INT, V72, pS3, DOI 10.1038/sj.ki.5002380; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; Woelfle MA, 2004, CURR BIOL, V14, P1481, DOI 10.1016/j.cub.2004.08.023; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; WOOLUM JC, 1991, J BIOL RHYTHM, V6, P129, DOI 10.1177/074873049100600203; Wright KP, 2002, AM J PHYSIOL-REG I, V283, pR1370, DOI 10.1152/ajpregu.00205.2002; Yagita K, 2001, SCIENCE, V292, P278, DOI 10.1126/science.1059542; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031	45	542	560	4	144	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					498	U70		10.1038/nature09702	http://dx.doi.org/10.1038/nature09702			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270888	Green Accepted			2022-12-28	WOS:000286596500025
J	Shim, W; Braunschweig, AB; Liao, X; Chai, JN; Lim, JK; Zheng, GF; Mirkin, CA				Shim, Wooyoung; Braunschweig, Adam B.; Liao, Xing; Chai, Jinan; Lim, Jong Kuk; Zheng, Gengfeng; Mirkin, Chad A.			Hard-tip, soft-spring lithography	NATURE			English	Article							DIP-PEN NANOLITHOGRAPHY; AFM DATA-STORAGE; PARALLEL; MICROSCOPE; ARRAYS; NANOFABRICATION; NANOPLOTTER; POLYMERS; DENSITY	Nanofabrication strategies are becoming increasingly expensive and equipment-intensive, and consequently less accessible to researchers. As an alternative, scanning probe lithography has become a popular means of preparing nanoscale structures, in part owing to its relatively low cost and high resolution, and a registration accuracy that exceeds most existing technologies(1-6). However, increasing the throughput of cantilever-based scanning probe systems while maintaining their resolution and registration advantages has from the outset been a significant challenge(7-17). Even with impressive recent advances in cantilever array design, such arrays tend to be highly specialized for a given application, expensive, and often difficult to implement. It is therefore difficult to imagine commercially viable production methods based on scanning probe systems that rely on conventional cantilevers. Here we describe a low-cost and scalable cantilever-free tip-based nanopatterning method that uses an array of hard silicon tips mounted onto an elastomeric backing. This method-which we term hard-tip, soft-spring lithography-overcomes the throughput problems of cantilever-based scanning probe systems and the resolution limits imposed by the use of elastomeric stamps and tips: it is capable of delivering materials or energy to a surface to create arbitrary patterns of features with sub-50-nm resolution over centimetre-scale areas. We argue that hard-tip, soft-spring lithography is a versatile nanolithography strategy that should be widely adopted by academic and industrial researchers for rapid prototyping applications.	[Shim, Wooyoung; Liao, Xing; Mirkin, Chad A.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Shim, Wooyoung; Braunschweig, Adam B.; Liao, Xing; Chai, Jinan; Lim, Jong Kuk; Zheng, Gengfeng; Mirkin, Chad A.] Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA; [Braunschweig, Adam B.; Chai, Jinan; Lim, Jong Kuk; Zheng, Gengfeng; Mirkin, Chad A.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Northwestern University	Mirkin, CA (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, 2220 Campus Dr, Evanston, IL 60208 USA.	chadnano@northwestern.edu	Liao, Xing/M-1886-2013; Zheng, Gengfeng/G-7023-2011; Mirkin, Chad A/E-3911-2010	Liao, Xing/0000-0002-0405-1564; Zheng, Gengfeng/0000-0002-1803-6955; Mirkin, Chad/0000-0002-6634-7627	US Air Force Office of Scientific Research (AFOSR); US Defense Advanced Research Projects Agency (DARPA); US NSF; US Department of Defense; US NIH	US Air Force Office of Scientific Research (AFOSR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); US Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); US NSF(National Science Foundation (NSF)); US Department of Defense(United States Department of Defense); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	C.A.M. acknowledges the US Air Force Office of Scientific Research (AFOSR), the US Defense Advanced Research Projects Agency (DARPA) and the US NSF (NSEC program) for support of this research. C.A.M is grateful for a NSSEF Fellowship from the US Department of Defense. A.B.B is grateful for a NRSA fellowship from the US NIH. We thank Z. Zheng for discussions.	Braunschweig AB, 2009, NAT CHEM, V1, P353, DOI [10.1038/NCHEM.258, 10.1038/nchem.258]; Bullen D, 2004, APPL PHYS LETT, V84, P789, DOI 10.1063/1.1644317; EIGLER DM, 1990, NATURE, V344, P524, DOI 10.1038/344524a0; Gates BD, 2005, CHEM REV, V105, P1171, DOI 10.1021/cr030076o; Ginger DS, 2004, ANGEW CHEM INT EDIT, V43, P30, DOI 10.1002/anie.200300608; Hong SH, 2000, SCIENCE, V288, P1808, DOI 10.1126/science.288.5472.1808; Hong SH, 1999, SCIENCE, V286, P523, DOI 10.1126/science.286.5439.523; Huo FW, 2008, SCIENCE, V321, P1658, DOI 10.1126/science.1162193; Jang JW, 2007, SMALL, V3, P600, DOI 10.1002/smll.200600679; KUMAR A, 1993, APPL PHYS LETT, V63, P2002, DOI 10.1063/1.110628; Lenhert S, 2007, SMALL, V3, P71, DOI 10.1002/smll.200600431; LEUNG OM, 1992, SCIENCE, V255, P64, DOI 10.1126/science.255.5040.64; Liao X, 2010, NANO LETT, V10, P1335, DOI 10.1021/nl904200t; LIU JH, 1995, J MICROMECH MICROENG, V5, P18, DOI 10.1088/0960-1317/5/1/004; Mirkin CA, 2007, ACS NANO, V1, P79, DOI 10.1021/nn700228m; Nie ZH, 2008, NAT MATER, V7, P277, DOI 10.1038/nmat2109; Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661; Quate CF, 1997, SURF SCI, V386, P259, DOI 10.1016/S0039-6028(97)00305-1; Rosa LG, 2009, J PHYS-CONDENS MAT, V21, DOI 10.1088/0953-8984/21/48/483001; Saavedra HM, 2010, REP PROG PHYS, V73, DOI 10.1088/0034-4885/73/3/036501; Salaita K, 2005, SMALL, V1, P940, DOI 10.1002/smll.200500202; Salaita K, 2007, NAT NANOTECHNOL, V2, P145, DOI 10.1038/nnano.2007.39; Salaita K, 2006, ANGEW CHEM INT EDIT, V45, P7220, DOI 10.1002/anie.200603142; Tseng AA, 2005, J VAC SCI TECHNOL B, V23, P877, DOI 10.1116/1.1926293; Vettiger P, 2000, IBM J RES DEV, V44, P323, DOI 10.1147/rd.443.0323; Vettiger P, 1999, MICROELECTRON ENG, V46, P11, DOI 10.1016/S0167-9317(99)00006-4; Xia YN, 1998, ANGEW CHEM INT EDIT, V37, P550, DOI 10.1002/(SICI)1521-3773(19980316)37:5<550::AID-ANIE550>3.0.CO;2-G; Yun MH, 1998, J VAC SCI TECHNOL B, V16, P2844, DOI 10.1116/1.590282; Zhang M, 2002, NANOTECHNOLOGY, V13, P212, DOI 10.1088/0957-4484/13/2/315; Zheng Z, 2008, ANGEW CHEM INT EDIT, V47, P9951, DOI 10.1002/anie.200803834	30	147	154	5	218	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 27	2011	469	7331					516	521		10.1038/nature09697	http://dx.doi.org/10.1038/nature09697			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270890				2022-12-28	WOS:000286596500029
J	Torloni, MR; Daher, S; Betran, AP; Widmer, M; Montilla, P; Souza, JP; Merialdi, M				Torloni, Maria Regina; Daher, Silvia; Betran, Ana Pilar; Widmer, Mariana; Montilla, Pilar; Souza, Joao Paulo; Merialdi, Mario			Portrayal of caesarean section in Brazilian women's magazines: 20 year review	BRITISH MEDICAL JOURNAL			English	Review							PREGNANCY OUTCOMES; PERINATAL HEALTH; LATIN-AMERICA; GLOBAL SURVEY; DELIVERY; RATES	Objective To assess the quality and comprehensiveness of the information on caesarean section provided in Brazilian women's magazines. Design Review of articles published during 1988-2008 in top selling women's magazines. Setting Brazil, one of the countries with the highest caesarean section rates in the world. Data sources Women's magazines with the largest distribution during the study period, identified through the official national media indexing organisations. Selection criteria Articles with objective scientific information or advice, comments, opinions, or the experience of ordinary women or celebrities on delivery by caesarean section. Main outcome measures Sources of information mentioned by the author of the article, the accuracy and completeness of data presented on caesarean section, and alleged reasons why women would prefer to deliver though caesarean section. Results 118 articles were included. The main cited sources of information were health professionals (78% (n=92) of the articles). 71% (n=84) of the articles reported at least one benefit of caesarean section, and 82% (n=97) reported at least one short term maternal risk of caesarean section. The benefits most often attributed to delivery by caesarean section were reduction of pain and convenience for family or health professionals. The most frequently reported short term maternal risks of caesarean section were increased time to recover and that it is a less natural way of giving birth. Only one third of the articles mentioned any long term maternal risks or perinatal complications associated with caesarean section. Fear of pain was the main reported reason why women would prefer to deliver by caesarean section. Conclusions Most of the articles published in Brazilian women's magazines do not use optimal sources of information. The portrayal of caesarean section is mostly balanced, not explicitly in favour of one or another route of delivery, but incomplete and may be leading women to underestimate the maternal/perinatal risks associated with this route of delivery.	[Torloni, Maria Regina] Brazilian Cochrane Ctr, BR-04039001 Sao Paulo, Brazil; [Torloni, Maria Regina; Daher, Silvia] Univ Fed Sao Paulo, Dept Obstet, BR-04002400 Sao Paulo, Brazil; [Betran, Ana Pilar; Widmer, Mariana; Souza, Joao Paulo; Merialdi, Mario] WHO, Dept Reprod Hlth & Res, CH-1211 Geneva, Switzerland; [Montilla, Pilar] Osservatorio Nazl Salute Donna ON Da, Milan, Italy	Universidade Federal de Sao Paulo (UNIFESP); World Health Organization	Torloni, MR (corresponding author), Brazilian Cochrane Ctr, Rua Pedro de Toledo 598, BR-04039001 Sao Paulo, Brazil.	ginecologia@terra.com.br	DAHER, SILVIA/D-2180-2012; Souza, João Paulo/G-1982-2010	DAHER, SILVIA/0000-0001-5312-7804; Souza, João Paulo/0000-0002-2288-4244; montilla, pilar/0000-0002-5313-1560	World Health Organization	World Health Organization(World Health Organization)	World Health Organization.	Althabe F, 2006, BIRTH-ISS PERINAT C, V33, P270, DOI 10.1111/j.1523-536X.2006.00118.x; American College of Obstetricians and Gynecologists, 2007, OBSTET GYNECOL, V110, P1501, DOI [DOI 10.1097/01.AOG.0000291577.01569.4C, 10.1097/01.AOG.0000291577.01569.4c]; American College of Obstetricians and Gynecologists, 2000, EV CES DEL; Angeja ACE, 2006, BJOG-INT J OBSTET GY, V113, P1253, DOI 10.1111/j.1471-0528.2006.01069.x; Belizan JM, 2006, BIRTH-ISS PERINAT C, V33, P167, DOI 10.1111/j.0730-7659.2006.0098b.x; Belizan JM, 1999, BMJ-BRIT MED J, V319, P1397, DOI 10.1136/bmj.319.7222.1397; Betran AP, 2007, PAEDIATR PERINAT EP, V21, P98, DOI 10.1111/j.1365-3016.2007.00786.x; Brazil. Ministry of Health, 2008, PESQ NAC DEM SAUD CR; Fuglenes D, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.07.021; *GRUP MID SAO PAUL, 2010, MID DAD BRAS; GUNDERSON SA, 1986, ANN M TER SOC; Handfield B, 2006, AUST NZ J OBSTET GYN, V46, P379, DOI 10.1111/j.1479-828X.2006.00621.x; Hopkins K, 2000, SOC SCI MED, V51, P725, DOI 10.1016/S0277-9536(99)00480-3; Kalish RB, 2004, OBSTET GYNECOL, V103, P1137, DOI 10.1097/01.AOG.0000128118.37737.df; KIRAN TSU, 2002, J OBSTET GYNAECOL, V22, P363, DOI DOI 10.1080/01443610220141263; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; Moyer CA, 2001, INT J TECHNOL ASSESS, V17, P137, DOI 10.1017/S0266462301104125; National Collaborating Centre for Women's and Children's Health, 2004, CAES SECT; *NIH, 2006, STAT OF THE SCI C ST; OXMAN AD, 1993, J CLIN EPIDEMIOL, V46, P987, DOI 10.1016/0895-4356(93)90166-X; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7; Wallace LS, 2003, AM J HEALTH BEHAV, V27, P75, DOI 10.5993/AJHB.27.1.8; WESTON LC, 1985, WOMEN HEALTH, V10, P47	23	29	29	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 25	2011	342								d276	10.1136/bmj.d276	http://dx.doi.org/10.1136/bmj.d276			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	715LX	21266421	hybrid, Green Published			2022-12-28	WOS:000286887100008
J	Tan, W; Zhang, WZ; Strasner, A; Grivennikov, S; Cheng, JQ; Hoffman, RM; Karin, M				Tan, Wei; Zhang, Weizhou; Strasner, Amy; Grivennikov, Sergei; Cheng, Jin Q.; Hoffman, Robert M.; Karin, Michael			Tumour-infiltrating regulatory T cells stimulate mammary cancer metastasis through RANKL-RANK signalling	NATURE			English	Article							BREAST-CANCER; OSTEOCLAST DIFFERENTIATION; OSTEOPROTEGERIN-LIGAND; GLAND DEVELOPMENT; BONE METASTASES; PROSTATE-CANCER; EXPRESSION; ACTIVATION; DENOSUMAB; RECEPTOR	Inflammatory mechanisms influence tumorigenesis and metastatic progression even in cancers whose aetiology does not involve pre-existing inflammation or infection, such as breast and prostate cancers(1). For instance, prostate cancer metastasis is associated with the infiltration of lymphocytes into advanced tumours and the upregulation of two tumour-necrosis-factor family members: receptor activator of nuclear factor-kappa B (RANK) ligand (RANKL) and lymphotoxin(2). But the source of RANKL and its role in metastasis have not been established. RANKL and its receptor RANK control the proliferation of mammary lobuloalveolar cells during pregnancy(3) through inhibitor of nuclear factor-kappa B (I kappa B) kinase-alpha (IKK-alpha)(4), a protein kinase that is needed for the self-renewal of mammary cancer progenitors(5) and for prostate cancer metastasis(2). We therefore examined whether RANKL, RANK and IKK-alpha are also involved in mammary/breast cancer metastasis. Indeed, RANK signalling in mammary carcinoma cells that overexpress the proto-oncogene Erbb2 (also known as Neu)(6), which is frequently amplified in metastatic human breast cancers(7,8), was important for pulmonary metastasis. Metastatic spread of Erbb2-transformed carcinoma cells also required CD4(+)CD25(+) T cells, whose major pro-metastatic function was RANKL production. Most RANKL-producing T cells expressed forkhead box P3 (FOXP3), a transcription factor produced by regulatory T cells, and were located next to smooth muscle actin (SMA)(+) stromal cells in mouse and human breast cancers. The dependence of pulmonary metastasis on T cells was replaceable by exogenous RANKL, which also stimulated pulmonary metastasis of RANK(+) human breast cancer cells. These results are consistent with the adverse impact of tumour-infiltrating CD4(+) or FOXP3(+) T cells on human breast cancer prognosis(9,10) and suggest that the targeting of RANKL-RANK can be used in conjunction with the therapeutic elimination of primary breast tumours to prevent recurrent metastatic disease.	[Tan, Wei; Zhang, Weizhou; Strasner, Amy; Grivennikov, Sergei; Karin, Michael] Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, La Jolla, CA 92093 USA; [Tan, Wei; Zhang, Weizhou; Strasner, Amy; Grivennikov, Sergei; Karin, Michael] Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pathol, La Jolla, CA 92093 USA; [Cheng, Jin Q.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; H Lee Moffitt Cancer Center & Research Institute; University of California System; University of California San Diego; Anti Cancer Inc	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, 9500 Gilman Dr,Mail Code 0723, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Grivennikov, Sergei/AAE-7365-2019	Grivennikov, Sergei/0000-0003-2987-0555	National Institutes of Health (NIH); Susan G. Komen for the Cure; Crohn's and Colitis Foundation of America; NATIONAL CANCER INSTITUTE [R01CA132586, T32CA121938, R01CA127923] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Crohn's and Colitis Foundation of America; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. Coussens for discussions and suggestions, V. Temkin and G. He for advice, and H. Herschman for critical reading. Work was supported by the National Institutes of Health (NIH). W. T. and W.Z. were supported by postdoctoral fellowships from the Susan G. Komen for the Cure. A. S. was supported by NIH Asthma Research and Cancer Therapeutic training grants, and S. G. was supported by a research fellowship from the Crohn's and Colitis Foundation of America. M. K. is an American Cancer Society research professor.	Bates GJ, 2006, J CLIN ONCOL, V24, P5373, DOI 10.1200/JCO.2006.05.9584; Body JJ, 2010, J BONE MINER RES, V25, P440, DOI 10.1359/jbmr.090810; Bohling SD, 2008, MODERN PATHOL, V21, P1527, DOI 10.1038/modpathol.2008.160; Cao YX, 2007, P NATL ACAD SCI USA, V104, P15852, DOI 10.1073/pnas.0706728104; Cao YX, 2001, CELL, V107, P763, DOI 10.1016/S0092-8674(01)00599-2; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Dougall WC, 1999, GENE DEV, V13, P2412, DOI 10.1101/gad.13.18.2412; Ercolini AM, 2005, J EXP MED, V201, P1591, DOI 10.1084/jem.20042167; Fata JE, 2000, CELL, V103, P41, DOI 10.1016/S0092-8674(00)00103-3; Fizazi K, 2009, J CLIN ONCOL, V27, P1564, DOI 10.1200/JCO.2008.19.2146; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; GAO JL, 1993, J EXP MED, V177, P1421, DOI 10.1084/jem.177.5.1421; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Gonzalez-Suarez E, 2010, NATURE, V468, P103, DOI 10.1038/nature09495; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P3540, DOI 10.1073/pnas.96.7.3540; Jones DH, 2006, NATURE, V440, P692, DOI 10.1038/nature04524; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Kawai T, 2006, AM J PATHOL, V169, P987, DOI 10.2353/ajpath.2006.060180; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Luboshits G, 1999, CANCER RES, V59, P4681; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Ohara M, 2009, CANCER IMMUNOL IMMUN, V58, P441, DOI 10.1007/s00262-008-0570-x; Schramek D, 2010, NATURE, V468, P98, DOI 10.1038/nature09387; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; TIWARI RK, 1992, ANTICANCER RES, V12, P419	27	474	494	1	98	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					548	553		10.1038/nature09707	http://dx.doi.org/10.1038/nature09707			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21326202	Green Accepted			2022-12-28	WOS:000287652900045
J	Berry, JG; Hall, DE; Kuo, DZ; Cohen, E; Agrawal, R; Feudtner, C; Hall, M; Kueser, J; Kaplan, W; Neff, J				Berry, Jay G.; Hall, David E.; Kuo, Dennis Z.; Cohen, Eyal; Agrawal, Rishi; Feudtner, Chris; Hall, Matt; Kueser, Jacqueline; Kaplan, William; Neff, John			Hospital Utilization and Characteristics of Patients Experiencing Recurrent Readmissions Within Children's Hospitals	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COMPLEX CHRONIC CONDITIONS; DURABLE MEDICAL EQUIPMENT; WASHINGTON-STATE; CARE; PREVALENCE; EMERGENCY; PATTERNS	Context Early hospital readmission is emerging as an indicator of care quality. Some children with chronic illnesses may be readmitted on a recurrent basis, but there are limited data describing their rehospitalization patterns and impact. Objectives To describe the inpatient resource utilization, clinical characteristics, and admission reasons of patients recurrently readmitted to children's hospitals. Design, Setting, and Patients Retrospective cohort analysis of 317 643 patients (n=579 504 admissions) admitted to 37 US children's hospitals in 2003 with follow-up through 2008. Main Outcome Measure Maximum number of readmissions experienced by each child within any 365-day interval during the 5-year follow-up period. Results In the sample, 69 294 patients (21.8%) experienced at least 1 readmission within 365 days of a prior admission. Within a 365-day interval, 9237 patients (2.9%) experienced 4 or more readmissions; time between admissions was a median 37 days (interquartile range [IQR], 21-63). These patients accounted for 18.8% (109 155 admissions) of all admissions and 23.2% ($3.4 billion) of total inpatient charges for the study cohort during the entire follow-up period. Tests for trend indicated that as the number of readmissions increased from 0 to 4 or more, the prevalences increased for a complex chronic condition (from 22.3% [n=55 382/248 349] to 89.0% [n=8225/9237]; P<.001), technology assistance (from 5.3% [n=13 163] to 52.6% [n=4859]; P<.001), public insurance use (from 40.9% [n=101 575] to 56.3% [n=5202]; P<.001), and non-Hispanic black race (from 21.8% [n=54 140] to 34.4% [n=3181]; P<.001); and the prevalence decreased for readmissions associated with an ambulatory care-sensitive condition (from 23.1% [62 847/272 065] to 14.0% [15 282/109 155], P<.001). Of patients readmitted 4 or more times in a 365-day interval, 2633 (28.5%) were rehospitalized for a problem in the same organ system across all admissions during the interval. Conclusions Among a group of pediatric hospitals, 18.8% of admissions and 23.2% of inpatient charges were accounted for by the 2.9% of patients with frequent recurrent admissions. Many of these patients were rehospitalized recurrently for a problem in the same organ system. JAMA. 2011;305(7):682-690 www.jama.com	[Berry, Jay G.; Kaplan, William] Harvard Univ, Sch Med, Childrens Hosp, Div Gen Pediat, Boston, MA 02115 USA; [Hall, David E.] Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA; [Kuo, Dennis Z.] Univ Arkansas Med Sci, Arkansas Childrens Hosp, Dept Pediat, Little Rock, AR 72205 USA; [Cohen, Eyal] Univ Toronto, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Agrawal, Rishi] Northwestern Univ, Feinberg Sch Med, Childrens Mem Hosp, Chicago, IL 60611 USA; [Feudtner, Chris] Childrens Hosp Philadelphia, Div Gen Pediat, PolicyLab, Philadelphia, PA 19104 USA; [Feudtner, Chris] Childrens Hosp Philadelphia, Dept Med Eth, Philadelphia, PA 19104 USA; [Hall, David E.; Kueser, Jacqueline] Child Hlth Corp Amer, Shawnee Mission, KS USA; [Neff, John] Univ Washington, Seattle Childrens Hosp, Seattle, WA 98195 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Cincinnati Children's Hospital Medical Center; Arkansas Children's Hospital; University of Arkansas System; University of Arkansas Medical Sciences; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Seattle Children's Hospital; University of Washington; University of Washington Seattle	Berry, JG (corresponding author), Harvard Univ, Sch Med, Childrens Hosp, Div Gen Pediat, 300 Longwood Ave, Boston, MA 02115 USA.	jay.berry@childrens.harvard.edu	Dalla Zuanna, Teresa/G-3133-2015; Cohen, Eyal/K-2575-2014; Feudtner, Chris/AAI-1126-2019; Hall, Matt/AAT-1349-2021	Cohen, Eyal/0000-0003-0112-7188; Feudtner, Chris/0000-0002-5879-0434; Hall, Matt/0000-0001-7778-5887	Eunice Kennedy Shriver National Institute of Child Health and Human Development [K23 HD058092]; Arkansas Biosciences Institute National Health Center for Research Resources [KL2RR029883]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K23HD058092] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR029883] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Arkansas Biosciences Institute National Health Center for Research Resources; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Dr Berry was supported by the Eunice Kennedy Shriver National Institute of Child Health and Human Development career development award (K23 HD058092). Dr Kuo was supported by grant KL2RR029883 from the Arkansas Biosciences Institute National Health Center for Research Resources.	[Anonymous], CHILD HLTH CORPORATI; [Anonymous], PREV HOSP WIND PRIM; Beck Carolyn E, 2006, Paediatr Child Health, V11, P409; Berry JG, 2007, ARCH PEDIAT ADOL MED, V161, P38, DOI 10.1001/archpedi.161.1.38; Berry JG, 2009, PEDIATRICS, V124, P563, DOI 10.1542/peds.2008-3491; Berry SA, 2009, QUAL SAF HEALTH CARE, V18, P360, DOI 10.1136/qshc.2007.025056; Bhogal S, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005306.pub2; Bowles EJA, 2009, MED CARE, V47, P1091, DOI 10.1097/MLR.0b013e3181a7e569; Buescher PA, 2006, MATERN CHILD HLTH J, V10, P461, DOI 10.1007/s10995-006-0081-3; Carrns Ann, 2010, US News World Rep, V147, P22; Consumer Price Index, CONS PRIC IND; COYE MJ, 2008, HOSP HEALTH NETWORK, V82, pA10; Curtis P, GUARDIAN; Czaja AS, 2009, PEDIATRICS, V123, P849, DOI 10.1542/peds.2008-0856; Feudtner C, 2000, PEDIATRICS, V106, P205; Feudtner C, 2002, PEDIATRICS, V109, P656, DOI 10.1542/peds.109.4.656; Feudtner C, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.6.e99; Feudtner C, 2009, PEDIATRICS, V123, P286, DOI 10.1542/peds.2007-3395; Frei-Jones MJ, 2009, PEDIATR BLOOD CANCER, V53, P401, DOI 10.1002/pbc.22048; Frei-Jones MJ, 2009, PEDIATR BLOOD CANCER, V52, P481, DOI 10.1002/pbc.21854; Goodman DM, 2002, PEDIATRICS, V110, P583, DOI 10.1542/peds.110.3.583; Guterman S, 2010, HEALTH AFFAIR, V29, P1188, DOI 10.1377/hlthaff.2010.0442; Hansagi H, 2001, ANN EMERG MED, V37, P561, DOI 10.1067/mem.2001.111762; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Kne T, 1998, AM J EMERG MED, V16, P648, DOI 10.1016/S0735-6757(98)90166-8; Kripalani S, 2007, J HOSP MED, V2, P314, DOI 10.1002/jhm.228; Lubell Jennifer, 2007, Mod Healthc, V37, P37; Lye PS, 2010, PEDIATRICS, V126, P829, DOI 10.1542/peds.2010-1535; Mackie AS, 2008, AM HEART J, V155, P577, DOI 10.1016/j.ahj.2007.11.003; Massin MM, 2006, ACTA PAEDIATR, V95, P208, DOI 10.1080/08035250500346443; Medicare Payment Advisory Commission (U.S.), REP C PROM GREAT EFF; Millman M., 1993, ACCESS HLTH CARE AM; Moore Keith D, 2010, Healthc Financ Manage, V64, P57; Palfrey JS, 2004, PEDIATRICS, V113, P1507; PALFREY JS, 1994, PUBLIC HEALTH REP, V109, P226; Reynolds S, 1996, PEDIATR EMERG CARE, V12, P166, DOI 10.1097/00006565-199606000-00005; Rice KL, 2010, AM J RESP CRIT CARE, V182, P890, DOI 10.1164/rccm.200910-1579OC; Shah SS, 2008, NEUROSURGERY, V62, P1095, DOI 10.1227/01.neu.0000325871.60129.23; Simon TD, 2010, PEDIATRICS, V126, P647, DOI 10.1542/peds.2009-3266; Sneed RC, 2004, PEDIATRICS, V114, pE612, DOI 10.1542/peds.2004-1063; Sneed RC, 2001, PEDIATRICS, V107, P1283, DOI 10.1542/peds.107.6.1283; Srivastava R, 2005, PEDIATR CLIN N AM, V52, P1165, DOI 10.1016/j.pcl.2005.03.007; Srivastava R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4411; Stone BL, 2008, J PEDIATR REHAB MED, V1, P237; Turnock AC, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005074.pub2; Young NL, 2009, PHYS OCCUP THER PEDI, V29, P345, DOI 10.3109/01942630903245994	46	350	352	0	17	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 16	2011	305	7					682	690		10.1001/jama.2011.122	http://dx.doi.org/10.1001/jama.2011.122			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721NH	21325184	Bronze, Green Accepted			2022-12-28	WOS:000287361100019
J	Mardis, ER				Mardis, Elaine R.			A decade's perspective on DNA sequencing technology	NATURE			English	Article							HUMAN GENOME; STRUCTURAL VARIATION; COPY NUMBER; COLORECTAL CANCERS; HAPLOTYPE MAP; HUMAN BREAST; EVOLUTION; INHIBITORS; MUTATIONS; INSIGHTS	The decade since the Human Genome Project ended has witnessed a remarkable sequencing technology explosion that has permitted a multitude of questions about the genome to be asked and answered, at unprecedented speed and resolution. Here I present examples of how the resulting information has both enhanced our knowledge and expanded the impact of the genome on biomedical research. New sequencing technologies have also introduced exciting new areas of biological endeavour. The continuing upward trajectory of sequencing technology development is enabling clinical applications that are aimed at improving medical diagnosis and treatment.	Washington Univ, Sch Med, Dept Genet, Genome Ctr, St Louis, MO 63108 USA	Washington University (WUSTL)	Mardis, ER (corresponding author), Washington Univ, Sch Med, Dept Genet, Genome Ctr, St Louis, MO 63108 USA.	emardis@wustl.edu	Mardis, Elaine/W-2202-2019					Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/NMETH.1363, 10.1038/nmeth.1363]; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Finkbeiner SR, 2009, J VIROL, V83, P10836, DOI 10.1128/JVI.00998-09; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gilissen C, 2010, AM J HUM GENET, V87, P418, DOI 10.1016/j.ajhg.2010.08.004; Harismendy O, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r118; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Jones SJM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r82; Kidd JM, 2008, NATURE, V453, P56, DOI 10.1038/nature06862; Korbel JO, 2007, SCIENCE, V318, P420, DOI 10.1126/science.1149504; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Loh J, 2009, J VIROL, V83, P13019, DOI 10.1128/JVI.00638-09; Lupski JR, 2010, NEW ENGL J MED, V362, P1181, DOI 10.1056/NEJMoa0908094; Mardis ER, 2010, GENOME MED, V2, DOI 10.1186/gm205; Mardis ER, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-211; Mardis ER, 2009, GENOME MED, V1, DOI 10.1186/gm40; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Nelson KE, 2010, SCIENCE, V328, P994, DOI 10.1126/science.1183605; Ng SB, 2010, NAT GENET, V42, P790, DOI 10.1038/ng.646; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Presti RM, 2009, J VIROL, V83, P11599, DOI 10.1128/JVI.00677-09; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Roach JC, 2010, SCIENCE, V328, P636, DOI 10.1126/science.1186802; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sudmant PH, 2010, SCIENCE, V330, P641, DOI 10.1126/science.1197005; Tuzun E, 2005, NAT GENET, V37, P727, DOI 10.1038/ng1562; Warren WC, 2008, NATURE, V453, P175, DOI 10.1038/nature06936; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720	46	533	576	3	205	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					198	203		10.1038/nature09796	http://dx.doi.org/10.1038/nature09796			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307932				2022-12-28	WOS:000287144200033
J	Orchard, PJ; Wagner, JE				Orchard, Paul J.; Wagner, John E.			Leukodystrophy and Gene Therapy with a Dimmer Switch.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							TRANSPLANTATION; CELL		[Orchard, Paul J.] Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA; Univ Minnesota, Sch Med, Bone & Marrow Transplant Program, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Orchard, PJ (corresponding author), Univ Minnesota, Sch Med, Dept Pediat, Minneapolis, MN 55455 USA.							Escolar ML, 2005, NEW ENGL J MED, V352, P2069, DOI 10.1056/NEJMoa042604; FRATANTONI JC, 1968, SCIENCE, V162, P570, DOI 10.1126/science.162.3853.570; Gentner B, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001522; KRIVIT W, 1995, CELL TRANSPLANT, V4, P385, DOI 10.1016/0963-6897(95)00021-O; Krivit W, 1998, NEW ENGL J MED, V338, P1119, DOI 10.1056/NEJM199804163381605	5	10	10	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2011	364	6					572	573		10.1056/NEJMcibr1013082	http://dx.doi.org/10.1056/NEJMcibr1013082			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718QH	21306246				2022-12-28	WOS:000287139900015
J	Giuliano, AE; Hunt, KK; Ballman, KV; Beitsch, PD; Whitworth, PW; Blumencranz, PW; Leitch, AM; Saha, S; McCall, LM; Morrow, M				Giuliano, Armando E.; Hunt, Kelly K.; Ballman, Karla V.; Beitsch, Peter D.; Whitworth, Pat W.; Blumencranz, Peter W.; Leitch, A. Marilyn; Saha, Sukamal; McCall, Linda M.; Morrow, Monica			Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node Metastasis A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LYMPH-NODE; GENE-EXPRESSION; RADICAL-MASTECTOMY; BIOPSY VALIDATION; OLDER PATIENTS; FOLLOW-UP; SURVIVAL; SURGERY; COMPLICATIONS; HIGHLIGHTS	Context Sentinel lymph node dissection (SLND) accurately identifies nodal metastasis of early breast cancer, but it is not clear whether further nodal dissection affects survival. Objective To determine the effects of complete axillary lymph node dissection (ALND) on survival of patients with sentinel lymph node (SLN) metastasis of breast cancer. Design, Setting, and Patients The American College of Surgeons Oncology Group Z0011 trial, a phase 3 noninferiority trial conducted at 115 sites and enrolling patients from May 1999 to December 2004. Patients were women with clinical T1-T2 invasive breast cancer, no palpable adenopathy, and 1 to 2 SLNs containing metastases identified by frozen section, touch preparation, or hematoxylin-eosin staining on permanent section. Targeted enrollment was 1900 women with final analysis after 500 deaths, but the trial closed early because mortality rate was lower than expected. Interventions All patients underwent lumpectomy and tangential whole-breast irradiation. Those with SLN metastases identified by SLND were randomized to undergo ALND or no further axillary treatment. Those randomized to ALND underwent dissection of 10 or more nodes. Systemic therapy was at the discretion of the treating physician. Main Outcome Measures Overall survival was the primary end point, with a noninferiority margin of a 1-sided hazard ratio of less than 1.3 indicating that SLND alone is noninferior to ALND. Disease-free survival was a secondary end point. Results Clinical and tumor characteristics were similar between 445 patients randomized to ALND and 446 randomized to SLND alone. However, the median number of nodes removed was 17 with ALND and 2 with SLND alone. At a median follow-up of 6.3 years (last follow-up, March 4, 2010), 5-year overall survival was 91.8% (95% confidence interval [CI], 89.1%-94.5%) with ALND and 92.5% (95% CI, 90.0%-95.1%) with SLND alone; 5-year disease-free survival was 82.2% (95% CI, 78.3%-86.3%) with ALND and 83.9% (95% CI, 80.2%-87.9%) with SLND alone. The hazard ratio for treatment-related overall survival was 0.79 (90% CI, 0.56-1.11) without adjustment and 0.87 (90% CI, 0.62-1.23) after adjusting for age and adjuvant therapy. Conclusion Among patients with limited SLN metastatic breast cancer treated with breast conservation and systemic therapy, the use of SLND alone compared with ALND did not result in inferior survival.	[Giuliano, Armando E.] St Johns Hlth Ctr, John Wayne Canc Inst, Santa Monica, CA 90404 USA; [Hunt, Kelly K.] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Ballman, Karla V.] Mayo Clin Rochester, Rochester, MN USA; [Beitsch, Peter D.] Dallas Surg Grp, Dallas, TX USA; [Whitworth, Pat W.] Nashville Breast Ctr, Nashville, TN USA; [Blumencranz, Peter W.] Morton Plant Hosp, Clearwater, FL USA; [Leitch, A. Marilyn] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Saha, Sukamal] Michigan State Univ, McLaren Reg Med Ctr, Flint, MI USA; [McCall, Linda M.] Amer Coll Surg Oncol Grp, Durham, NC USA; [Morrow, Monica] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA	John Wayne Cancer Institute; University of Texas System; UTMD Anderson Cancer Center; Mayo Clinic; University of Texas System; University of Texas Southwestern Medical Center Dallas; Michigan State University; Michigan State University College of Human Medicine; Memorial Sloan Kettering Cancer Center	Giuliano, AE (corresponding author), St Johns Hlth Ctr, John Wayne Canc Inst, 2200 Santa Monica Blvd, Santa Monica, CA 90404 USA.	giulianoa@jwci.org			National Cancer Institute [U10 CA 76001]; NATIONAL CANCER INSTITUTE [P30CA016672, U10CA076001] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute grant U10 CA 76001 to the American College of Surgeons Oncology Group (ACOSOG).	ABE O, 1992, LANCET, V339, P71; Abe O, 2005, LANCET, V366, P2087; Abrams J S, 2001, Breast Cancer, V8, P298, DOI 10.1007/BF02967528; Albain KS, 2010, LANCET ONCOL, V11, P55, DOI 10.1016/S1470-2045(09)70314-6; Amanti C, 2009, TUMORI, V95, P153; [Anonymous], 1992, Lancet, V339, P1; Coutant C, 2009, J CLIN ONCOL, V27, P2800, DOI 10.1200/JCO.2008.19.7418; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; FISHER B, 1981, SURG GYNECOL OBSTET, V152, P765; FISHER B, 1977, CANCER-AM CANCER SOC, V39, P2827, DOI 10.1002/1097-0142(197706)39:6<2827::AID-CNCR2820390671>3.0.CO;2-I; FISHER B, 1989, NEW ENGL J MED, V320, P822, DOI 10.1056/NEJM198903303201302; Fisher B, 2002, NEW ENGL J MED, V347, P1233, DOI 10.1056/NEJMoa022152; Fleissig A, 2006, BREAST CANCER RES TR, V95, P279, DOI 10.1007/s10549-005-9025-7; Giuliano AE, 2010, ANN SURG, V252, P426, DOI 10.1097/SLA.0b013e3181f08f32; Goldhirsch A, 1998, J NATL CANCER I, V90, P1601, DOI 10.1093/jnci/90.21.1601; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; GRAVERSEN HP, 1988, EUR J SURG ONCOL, V14, P407; Greco M, 2000, ANN SURG, V232, P1, DOI 10.1097/00000658-200007000-00001; Halsted WS, 1907, ANN SURG, V46, P1, DOI 10.1097/00000658-190707000-00001; IVENS D, 1992, BRIT J CANCER, V66, P136, DOI 10.1038/bjc.1992.230; Kaji AH, 2010, ANN EMERG MED, V55, P408, DOI 10.1016/j.annemergmed.2010.01.024; LOTZE MT, 1981, ANN SURG, V193, P288, DOI 10.1097/00000658-198103000-00007; Lucci A, 2007, J CLIN ONCOL, V25, P3657, DOI 10.1200/JCO.2006.07.4062; Lyman GH, 2005, J CLIN ONCOL, V23, P7703, DOI 10.1200/JCO.2005.08.001; Martelli G, 2005, ANN SURG, V242, P1, DOI 10.1097/01.sla.0000167759.15670.14; Martelli G, 2011, ANN SURG ONCOL, V18, P125, DOI 10.1245/s10434-010-1217-7; Orr RK, 1999, ANN SURG ONCOL, V6, P109, DOI 10.1007/s10434-999-0109-1; Paik S, 2006, J CLIN ONCOL, V24, P3726, DOI 10.1200/JCO.2005.04.7985; Rescigno J, 2009, ANN SURG ONCOL, V16, P687, DOI 10.1245/s10434-008-0195-5; RUBINSTEIN LV, 1981, J CHRON DIS, V34, P469, DOI 10.1016/0021-9681(81)90007-2; Rudenstam CM, 2006, J CLIN ONCOL, V24, P337, DOI 10.1200/JCO.2005.01.5784; Rutgers EJT, 2008, J CLIN ONCOL, V26, P698, DOI 10.1200/JCO.2007.14.4667; Smith RA, 2007, CANCER-AM CANCER SOC, V109, P2205, DOI 10.1002/cncr.22671; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van la Parra RFD, 2009, ANN SURG ONCOL, V16, P1128, DOI 10.1245/s10434-009-0359-y; Veronesi U, 2005, ANN ONCOL, V16, P383, DOI 10.1093/annonc/mdi089; Veronesi U, 2003, NEW ENGL J MED, V349, P546, DOI 10.1056/NEJMoa012782; Veronesi U, 2010, ANN SURG, V251, P595, DOI 10.1097/SLA.0b013e3181c0e92a; YEOH EK, 1986, ACTA ONCOL, V25, P105, DOI 10.3109/02841868609136386	40	1991	2079	6	108	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2011	305	6					569	575		10.1001/jama.2011.90	http://dx.doi.org/10.1001/jama.2011.90			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	717XI	21304082	Green Accepted			2022-12-28	WOS:000287080500021
J	Basu, U; Meng, FL; Keim, C; Grinstein, V; Pefanis, E; Eccleston, J; Zhang, TT; Myers, D; Wasserman, CR; Wesemann, DR; Januszyk, K; Gregory, RI; Deng, HT; Lima, CD; Alt, FW				Basu, Uttiya; Meng, Fei-Long; Keim, Celia; Grinstein, Veronika; Pefanis, Evangelos; Eccleston, Jennifer; Zhang, Tingting; Myers, Darienne; Wasserman, Caitlyn R.; Wesemann, Duane R.; Januszyk, Kurt; Gregory, Richard I.; Deng, Haiteng; Lima, Christopher D.; Alt, Frederick W.			The RNA Exosome Targets the AID Cytidine Deaminase to Both Strands of Transcribed Duplex DNA Substrates	CELL			English	Article							CLASS SWITCH RECOMBINATION; CHROMOSOMAL R-LOOPS; PROTEIN-KINASE-A; POLYMERASE-II; SOMATIC HYPERMUTATION; MECHANISM; REGIONS; SEQUENCE; REPAIR; BREAKS	Activation-induced cytidine deaminase (AID) initiates immunoglobulin (Ig) heavy-chain (IgH) class switch recombination (CSR) and Ig variable region somatic hypermutation (SHM) in B lymphocytes by deaminating cytidines on template and nontemplate strands of transcribed DNA substrates. However, the mechanism of AID access to the template DNA strand, particularly when hybridized to a nascent RNA transcript, has been an enigma. We now implicate the RNA exosome, a cellular RNA-processing/degradation complex, in targeting AID to both DNA strands. In B lineage cells activated for CSR, the RNA exosome associates with AID, accumulates on IgH switch regions in an AID-dependent fashion, and is required for optimal CSR. Moreover, both the cellular RNA exosome complex and a recombinant RNA exosome core complex impart robust AID-and transcription-dependent DNA deamination of both strands of transcribed SHM substrates in vitro. Our findings reveal a role for noncoding RNA surveillance machinery in generating antibody diversity.	[Basu, Uttiya; Meng, Fei-Long; Eccleston, Jennifer; Zhang, Tingting; Myers, Darienne; Wasserman, Caitlyn R.; Wesemann, Duane R.; Alt, Frederick W.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Program Cellular & Mol Med,Dept Genet,Childrens H, Boston, MA 02115 USA; [Basu, Uttiya; Meng, Fei-Long; Eccleston, Jennifer; Zhang, Tingting; Myers, Darienne; Wasserman, Caitlyn R.; Wesemann, Duane R.; Alt, Frederick W.] Harvard Univ, Sch Med, Immune Dis Inst, Childrens Hosp Boston,Dept Genet, Boston, MA 02115 USA; [Basu, Uttiya; Keim, Celia; Grinstein, Veronika; Pefanis, Evangelos] Columbia Univ, Coll Phys & Surg, Dept Microbiol & Immunol, New York, NY 10032 USA; [Deng, Haiteng] Rockefeller Univ, Prote Res Ctr, New York, NY 10065 USA; [Gregory, Richard I.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Harvard Stem Cell Inst,Childrens Hosp Boston, Boston, MA 02115 USA; [Januszyk, Kurt; Lima, Christopher D.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA; [Deng, Haiteng] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Columbia University; Rockefeller University; Harvard University; Boston Children's Hospital; Harvard Medical School; Memorial Sloan Kettering Cancer Center; Tsinghua University	Basu, U (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Program Cellular & Mol Med,Dept Genet,Childrens H, 300 Longwood Ave, Boston, MA 02115 USA.	ub2121@columbia.edu; alt@enders.tch.harvard.edu		Meng, Feilong/0000-0003-0333-6872; Wesemann, Duane/0000-0002-6690-944X; Deng, Haiteng/0000-0001-9496-1280; Lima, Christopher/0000-0002-9163-6092	National Institute of Health [AI31541, GM079196]; Columbia University; Regeneron Pharmaceuticals; Cancer Biology training grant [CA09503-23]; Leukemia Research Foundation; NATIONAL CANCER INSTITUTE [T32CA009503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI077595, R01AI077595, U19AI031541, U01AI031541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079196] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Columbia University; Regeneron Pharmaceuticals(Regeneron); Cancer Biology training grant; Leukemia Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Bjoern Schwer, Jason Rodriguez, Stephen Goff, Bruce Stillman, and Tasuku Honjo for providing reagents and/or protocols. We also thank Bjoern Schwer and Cosmas Giallourakis for critically reading the manuscript. This work was supported by National Institute of Health grants AI31541 (to F. W. A.) and GM079196 (to K.J. and C. D. L.); by Trustees of Columbia University Faculty startup funds (to U. B.); and by funds from Regeneron Pharmaceuticals (in support of E. P.). F.-L. M. is a fellow of Cancer Research Institute of New York. C. K. was supported by a Cancer Biology training grant CA09503-23. K.J. is a fellow of the American Cancer Society (PF-10-236-01-RMC). U. B. is a Special Fellow of the Leukemia and Lymphoma Society of America and the recipient of a New Investigator Award from the Leukemia Research Foundation. F. W. A. is an Investigator of the Howard Hughes Medical Institute.	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Anderson JR, 2006, RNA, V12, P1810, DOI 10.1261/rna.144606; Andrulis ED, 2002, NATURE, V420, P837, DOI 10.1038/nature01181; Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Basu U, 2008, MOL CELL, V32, P285, DOI 10.1016/j.molcel.2008.08.019; Besmer E, 2006, MOL CELL BIOL, V26, P4378, DOI 10.1128/MCB.02375-05; Callahan KP, 2010, J BIOL CHEM, V285, P3540, DOI 10.1074/jbc.M109.058396; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; Chelico L, 2009, J BIOL CHEM, V284, P27761, DOI 10.1074/jbc.R109.052449; Cheng HL, 2009, P NATL ACAD SCI USA, V106, P2717, DOI 10.1073/pnas.0812304106; Daniels GA, 1995, NUCLEIC ACIDS RES, V23, P5006, DOI 10.1093/nar/23.24.5006; Di Nola JM, 2007, ANNU REV BIOCHEM, V76, P1, DOI 10.1146/annurev.biochem.76.061705.090740; Dickerson SK, 2003, J EXP MED, V197, P1291, DOI 10.1084/jem.20030481; Dzantiev L, 2004, MOL CELL, V15, P31, DOI 10.1016/j.molcel.2004.06.016; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; Genschel J, 2003, MOL CELL, V12, P1077, DOI 10.1016/S1097-2765(03)00428-3; Gomez-Gonzalez B, 2007, P NATL ACAD SCI USA, V104, P8409, DOI 10.1073/pnas.0702836104; Greimann JC, 2008, METHOD ENZYMOL, V448, P185, DOI 10.1016/S0076-6879(08)02610-4; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Huang FT, 2007, MOL CELL BIOL, V27, P5921, DOI 10.1128/MCB.00702-07; Huang FT, 2006, P NATL ACAD SCI USA, V103, P5030, DOI 10.1073/pnas.0506548103; Jensen TH, 2005, CELL, V121, P660, DOI 10.1016/j.cell.2005.05.018; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; LENNON GG, 1985, NATURE, V318, P475, DOI 10.1038/318475a0; Li XL, 2005, CELL, V122, P365, DOI 10.1016/j.cell.2005.06.008; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Liu M, 2009, TRENDS IMMUNOL, V30, P173, DOI 10.1016/j.it.2009.01.007; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Longerich S, 2006, CURR OPIN IMMUNOL, V18, P164, DOI 10.1016/j.coi.2006.01.008; LUTZKER S, 1988, MOL CELL BIOL, V8, P1849, DOI 10.1128/MCB.8.4.1849; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Maldonado E, 1996, NATURE, V381, P86, DOI 10.1038/381086a0; Maul RW, 2010, ADV IMMUNOL, V105, P159, DOI 10.1016/S0065-2776(10)05006-6; McBride KM, 2008, J EXP MED, V205, P2585, DOI 10.1084/jem.20081319; McBride KM, 2006, P NATL ACAD SCI USA, V103, P8798, DOI 10.1073/pnas.0603272103; Milstein C, 1998, P NATL ACAD SCI USA, V95, P8791, DOI 10.1073/pnas.95.15.8791; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Neuberger MS, 2003, TRENDS BIOCHEM SCI, V28, P305, DOI 10.1016/S0968-0004(03)00111-7; Oddone A, 2007, EMBO REP, V8, P63, DOI 10.1038/sj.embor.7400856; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Pasqualucci L, 2006, P NATL ACAD SCI USA, V103, P395, DOI 10.1073/pnas.0509969103; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Peled JU, 2008, ANNU REV IMMUNOL, V26, P481, DOI 10.1146/annurev.immunol.26.021607.090236; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Petersen S, 2001, NATURE, V414, P660, DOI 10.1038/414660a; Petersen-Mahrt SK, 2002, NATURE, V418, P99, DOI 10.1038/nature00862; Preker P, 2008, SCIENCE, V322, P1851, DOI 10.1126/science.1164096; Rajagopal D, 2009, J EXP MED, V206, P1237, DOI 10.1084/jem.20082514; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Ramiro AR, 2003, NAT IMMUNOL, V4, P452, DOI 10.1038/ni920; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Roy D, 2008, MOL CELL BIOL, V28, P50, DOI 10.1128/MCB.01251-07; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schrader CE, 2005, J EXP MED, V202, P561, DOI 10.1084/jem.20050872; Shen HM, 2005, MOL CELL BIOL, V25, P10815, DOI 10.1128/MCB.25.24.10815-10821.2005; Shen HM, 2004, P NATL ACAD SCI USA, V101, P12997, DOI 10.1073/pnas.0404974101; Shen HM, 2006, J IMMUNOL, V177, P5386, DOI 10.4049/jimmunol.177.8.5386; Shen V, 2006, CELL, V127, P1093, DOI 10.1016/j.cell.2006.11.035; Shinkura R, 2003, NAT IMMUNOL, V4, P435, DOI 10.1038/ni918; Sohail A, 2003, NUCLEIC ACIDS RES, V31, P2990, DOI 10.1093/nar/gkg464; Staals RHJ, 2010, EMBO J, V29, P2358, DOI 10.1038/emboj.2010.122; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; Tian M, 2000, J BIOL CHEM, V275, P24163, DOI 10.1074/jbc.M003343200; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; Wang LL, 2009, J EXP MED, V206, P1817, DOI 10.1084/jem.20081678; Wuerffel RA, 1997, J IMMUNOL, V159, P4139; Xue KM, 2006, J EXP MED, V203, P2085, DOI 10.1084/jem.20061067; Yang Shu Yuan, 2007, Adv Immunol, V94, P109, DOI 10.1016/S0065-2776(06)94004-8; Yu KF, 2003, DNA REPAIR, V2, P1163, DOI 10.1016/j.dnarep.2003.08.010; Yu KF, 2003, NAT IMMUNOL, V4, P442, DOI 10.1038/ni919; Zarrin AA, 2004, NAT IMMUNOL, V5, P1275, DOI 10.1038/ni1137	80	222	233	0	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2011	144	3					353	363		10.1016/j.cell.2011.01.001	http://dx.doi.org/10.1016/j.cell.2011.01.001			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21255825	Green Accepted, Bronze			2022-12-28	WOS:000286973100008
J	Cortada, X				Cortada, Xavier			Painting the Genome for the Public	SCIENCE			English	Editorial Material																			0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					548	548		10.1126/science.1203069	http://dx.doi.org/10.1126/science.1203069			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292969				2022-12-28	WOS:000286933600042
J	Wu, XY; Shen, QT; Oristian, DS; Lu, CP; Zheng, QS; Wang, HW; Fuchs, E				Wu, Xiaoyang; Shen, Qing-Tao; Oristian, Daniel S.; Lu, Catherine P.; Zheng, Qinsi; Wang, Hong-Wei; Fuchs, Elaine			Skin Stem Cells Orchestrate Directional Migration by Regulating Microtubule-ACF7 Connections through GSK3 beta	CELL			English	Article							ACTIN; HOMEOSTASIS; NETWORKS; PLAKIN; CDC42; ACF7	Homeostasis and wound healing rely on stem cells (SCs) whose activity and directed migration are often governed by Wnt signaling. In dissecting how this pathway integrates with the necessary downstream cytoskeletal dynamics, we discovered that GSK3 beta, a kinase inhibited by Wnt signaling, directly phosphorylates ACF7, a > 500 kDa microtubule-actin crosslinking protein abundant in hair follicle stem cells (HF-SCs). We map ACF7's GSK3 beta sites to the microtubule-binding domain and show that phosphorylation uncouples ACF7 from microtubules. Phosphorylation-refractile ACF7 rescues overall microtubule architecture, but phosphorylation-constitutive mutants do not. Neither mutant rescues polarized movement, revealing that phospho-regulation must be dynamic. This circuitry is physiologically relevant and depends upon polarized GSK3 beta inhibition at the migrating front of SCs/progeny streaming from HFs during wound repair. Moreover, only ACF7 and not GSK beta-refractile-ACF7 restore polarized microtubule-growth and SC-migration to ACF7 null skin. Our findings provide insights into how this conserved spectraplakin integrates signaling, cytoskeletal dynamics, and polarized locomotion of somatic SCs.	[Wu, Xiaoyang; Oristian, Daniel S.; Lu, Catherine P.; Zheng, Qinsi; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA; [Wu, Xiaoyang; Oristian, Daniel S.; Lu, Catherine P.; Zheng, Qinsi; Fuchs, Elaine] Rockefeller Univ, Lab Mammalian Cell Biol & Dev, New York, NY 10065 USA; [Shen, Qing-Tao; Wang, Hong-Wei] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Zheng, Qinsi] Weill Cornell Med Coll, Triinst Training Program Chem Biol, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University; Rockefeller University; Yale University; Cornell University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	fuchslb@rockefeller.edu	ZHENG, Qin/T-2925-2019; Fuchs, Elaine/G-1565-2016	Lu, Catherine/0000-0003-4593-327X	National Institutes of Health [R01-AR27883]; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027883, R37AR027883, R01AR050452] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We are grateful to M. Schober, Y.C. Hsu, E. Ezratty, and T. Chen for discussions and helpful comments and to J. Fernandez and H. Deng (Proteomics Center) for their technical assistance in mass spectrometry analysis. Valuable technical assistance was provided by N. Stokes, L. Polak, E. Wong, M Nikolova, J. Racelis, A. North, and S. Bhuvanendran. All mice used in this study were bred and maintained at the Rockefeller University Association for Assessment and Accreditation of Laboratory Animal Care International-accredited Comparative Biology Center (CBC) in accordance with institutional and National Institutes of Health guidelines. This work was supported by Grant R01-AR27883 from the National Institutes of Health. E. F. is an investigator of the Howard Hughes Medical Institute. X. W. was an American Association for Cancer Research Anna D. Barker Fellow in Basic Cancer Research and the recipient of a postdoctoral fellowship from the Jane Coffin Childs Memorial Fund for Medical Research.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Chen HJ, 2006, GENE DEV, V20, P1933, DOI 10.1101/gad.1411206; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fathke C, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-4; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Goryunov D, 2010, MOL CELL NEUROSCI, V44, P1, DOI 10.1016/j.mcn.2010.01.010; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jefferson JJ, 2004, NAT REV MOL CELL BIO, V5, P542, DOI 10.1038/nrm1425; Karakesisoglou I, 2000, J CELL BIOL, V149, P195, DOI 10.1083/jcb.149.1.195; Knipling L, 1999, CELL MOTIL CYTOSKEL, V43, P63, DOI 10.1002/(SICI)1097-0169(1999)43:1<63::AID-CM7>3.0.CO;2-Z; Kodama A, 2003, CELL, V115, P343, DOI 10.1016/S0092-8674(03)00813-4; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Matov A, 2010, NAT METHODS, V7, P761, DOI 10.1038/nmeth.1493; Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Rodriguez OC, 2003, NAT CELL BIOL, V5, P599, DOI 10.1038/ncb0703-599; Roper K, 2002, J CELL SCI, V115, P4215, DOI 10.1242/jcs.00157; Schiller Martin R, 2007, Curr Protoc Protein Sci, VChapter 2, DOI 10.1002/0471140864.ps0212s48; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Sun DM, 2001, J CELL SCI, V114, P161; Sun T, 2009, DEV GROWTH DIFFER, V51, P735, DOI 10.1111/j.1440-169X.2009.01141.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Wu XY, 2008, CELL, V135, P137, DOI 10.1016/j.cell.2008.07.045; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Yoshimura T, 2006, J NEUROSCI, V26, P10626, DOI 10.1523/JNEUROSCI.3824-06.2006; Zaoui K, 2010, P NATL ACAD SCI USA, V107, P18517, DOI 10.1073/pnas.1000975107	35	140	147	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2011	144	3					341	352		10.1016/j.cell.2010.12.033	http://dx.doi.org/10.1016/j.cell.2010.12.033			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295697	Bronze, Green Accepted			2022-12-28	WOS:000286973100007
J	Bajoghli, B; Guo, P; Aghaallaei, N; Hirano, M; Strohmeier, C; McCurley, N; Bockman, DE; Schorpp, M; Cooper, MD; Boehm, T				Bajoghli, Baubak; Guo, Peng; Aghaallaei, Narges; Hirano, Masayuki; Strohmeier, Christine; McCurley, Nathanael; Bockman, Dale E.; Schorpp, Michael; Cooper, Max D.; Boehm, Thomas			A thymus candidate in lampreys	NATURE			English	Article							VARIABLE LYMPHOCYTE RECEPTORS; EVOLUTION; DIVERSIFICATION; EPITHELIUM; RESPONSES; HAGFISH	Immunologists and evolutionary biologists have been debating the nature of the immune system of jawless vertebrates-lampreys and hagfish-since the nineteenth century. In the past 50 years, these fish were shown to have antibody-like responses and the capacity to reject allografts(1) but were found to lack the immunoglobulin-based adaptive immune system of jawed vertebrates(2). Recent work has shown that lampreys have lymphocytes that instead express somatically diversified antigen receptors that contain leucine-rich-repeats, termed variable lymphocyte receptors (VLRs)(3,4), and that the type of VLR expressed is specific to the lymphocyte lineage: T-like lymphocytes express type A VLR (VLRA) genes, and B-like lymphocytes express VLRB genes(5). These clonally diverse anticipatory antigen receptors are assembled from incomplete genomic fragments by gene conversion(6-9), which is thought to be initiated by either of two genes encoding cytosine deaminase(9), cytosine deaminase 1 (CDA1) in T-like cells and CDA2 in B-like cells(5). It is unknown whether jawless fish, like jawed vertebrates, have dedicated primary lymphoid organs, such as the thymus, where the development and selection of lymphocytes takes place(10,11). Here we identify discrete thymus-like lympho-epithelial structures, termed thymoids, in the tips of the gill filaments and the neighbouring secondary lamellae (both within the gill basket) of lamprey larvae. Only in the thymoids was expression of the orthologue of the gene encoding forkhead box N1 (FOXN1)(10), a marker of the thymopoietic microenvironment in jawed vertebrates(12), accompanied by expression of CDA1 and VLRA. This expression pattern was unaffected by immunization of lampreys or by stimulation with a T-cell mitogen. Non-functional VLRA gene assemblies were found frequently in the thymoids but not elsewhere, further implicating the thymoid as the site of development of T-like cells in lampreys. These findings suggest that the similarities underlying the dual nature of the adaptive immune systems in the two sister groups of vertebrates extend to primary lymphoid organs.	[Bajoghli, Baubak; Aghaallaei, Narges; Strohmeier, Christine; Schorpp, Michael; Boehm, Thomas] Max Planck Inst Immunobiol & Epigenet, Dept Dev Immunol, D-79108 Freiburg, Germany; [Guo, Peng; Hirano, Masayuki; McCurley, Nathanael; Cooper, Max D.] Emory Vaccine Ctr, Atlanta, GA 30329 USA; [Guo, Peng; Hirano, Masayuki; McCurley, Nathanael; Cooper, Max D.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Bockman, Dale E.] Med Coll Georgia, Dept Cellular Biol & Anat, Augusta, GA 30912 USA	Max Planck Society; Emory University; Emory University; University System of Georgia; Augusta University	Boehm, T (corresponding author), Max Planck Inst Immunobiol & Epigenet, Dept Dev Immunol, Stuebeweg 51, D-79108 Freiburg, Germany.	boehm@immunbio.mpg.de	Bajoghli, Baubak/AAF-8388-2020	Bajoghli, Baubak/0000-0002-7368-7523; Aghaallaei, Narges/0000-0002-9890-3229; Bajoghli, Baubak/0000-0003-1395-6362	Max Planck Society; Deutsche Forschungsgemeinschaft; National Institutes of Health; Georgia Research Alliance	Max Planck Society(Max Planck Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance	We thank C. Happe and M. Held for technical help, C. L. Turnbough Jr for providing B. anthracis spores and exosporia, and the Emory University School of Medicine core facility for flow cytometry for cell-sorting services. This work was supported by the Max Planck Society, the Deutsche Forschungsgemeinschaft, the National Institutes of Health and the Georgia Research Alliance.	Alder MN, 2008, NAT IMMUNOL, V9, P319, DOI 10.1038/ni1562; Alder MN, 2005, SCIENCE, V310, P1970, DOI 10.1126/science.1119420; Bajoghli B, 2009, CELL, V138, P186, DOI 10.1016/j.cell.2009.04.017; BOCKMAN DE, 1973, AM J ANAT, V136, P455, DOI 10.1002/aja.1001360406; Boehm T, 2007, NAT IMMUNOL, V8, P131, DOI 10.1038/ni1435; Cooper MD, 2006, CELL, V124, P815, DOI 10.1016/j.cell.2006.02.001; Espina V, 2006, NAT PROTOC, V1, P586, DOI 10.1038/nprot.2006.85; FINSTAD J, 1964, J EXP MED, V120, P1151, DOI 10.1084/jem.120.6.1151; Guo P, 2009, NATURE, V459, P796, DOI 10.1038/nature08068; Kasamatsu J, 2010, P NATL ACAD SCI USA, V107, P14304, DOI 10.1073/pnas.1001910107; Kishishita N, 2010, EMBO REP, V11, P126, DOI 10.1038/embor.2009.274; Mayer WE, 2002, P NATL ACAD SCI USA, V99, P14350, DOI 10.1073/pnas.212527499; Nagawa F, 2007, NAT IMMUNOL, V8, P206, DOI 10.1038/ni1419; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; Pancer Z, 2005, P NATL ACAD SCI USA, V102, P9224, DOI 10.1073/pnas.0503792102; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Rogozin IB, 2007, NAT IMMUNOL, V8, P647, DOI 10.1038/ni1463; Schaffer J., 1894, SBER K AKAD WISS, V103, P149; Wallin IE, 1917, AM J ANAT, V22, P127, DOI 10.1002/aja.1000220106	19	142	149	0	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					90	U101		10.1038/nature09655	http://dx.doi.org/10.1038/nature09655			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293377				2022-12-28	WOS:000286886400040
J	Chen, NM; Shih, SL				Chen, Naiming; Shih, Shin-Lin			Pseudomembranous Colitis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chen, Naiming; Shih, Shin-Lin] Mackay Mem Hosp, Taipei, Taiwan	Mackay Memorial Hospital	Chen, NM (corresponding author), Mackay Mem Hosp, Taipei, Taiwan.	b87401089@ntu.edu.tw							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2011	364	5					E8	E8		10.1056/NEJMicm1004244	http://dx.doi.org/10.1056/NEJMicm1004244			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715LL	21288092				2022-12-28	WOS:000286885900013
J	Chou, R; Qaseem, A; Owens, DK; Shekelle, P				Chou, Roger; Qaseem, Amir; Owens, Douglas K.; Shekelle, Paul		Clinical Guidelines Comm Amer Coll	Diagnostic Imaging for Low Back Pain: Advice for High-Value Health Care From the American College of Physicians	ANNALS OF INTERNAL MEDICINE			English	Article							RANDOMIZED CONTROLLED-TRIAL; LUMBAR SPINE; PATIENT EXPECTATIONS; CLINICAL-EVALUATION; PRACTICE PATTERNS; US; PREVALENCE; GUIDELINES; CANCER; COSTS	Diagnostic imaging is indicated for patients with low back pain only if they have severe progressive neurologic deficits or signs or symptoms that suggest a serious or specific underlying condition. In other patients, evidence indicates that routine imaging is not associated with clinically meaningful benefits but can lead to harms. Addressing inefficiencies in diagnostic testing could minimize potential harms to patients and have a large effect on use of resources by reducing both direct and downstream costs. In this area, more testing does not equate to better care. Implementing a selective approach to low back imaging, as suggested by the American College of Physicians and American Pain Society guideline on low back pain, would provide better care to patients, improve outcomes, and reduce costs.	[Qaseem, Amir] Amer Coll Physicians, Philadelphia, PA 19106 USA; Oregon Hlth & Sci Univ, Portland, OR 97201 USA; Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA USA; Stanford Univ, Palo Alto, CA 94304 USA; Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	American College of Physicians; Oregon Health & Science University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall W, Philadelphia, PA 19106 USA.	aqaseem@acponline.org		Chou, Roger/0000-0001-9889-8610	Wellpoint; Palladian Health; Consumers Union; Blue Cross Blue Shield Association; American Pain Society; Agency for Healthcare Research and Quality	Wellpoint; Palladian Health; Consumers Union; Blue Cross Blue Shield Association; American Pain Society; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Dr. Chou: Consulting fee or honorarium: Wellpoint, Palladian Health, Consumers Union, Blue Cross Blue Shield Association; Grants/grants pending: American Pain Society; Payment for manuscript preparation: American College of Physicians. Dr. Owens: Support for travel to meetings for the study or other purposes: American College of Physicians; Consultancy: Anthem/Wellpoint. Dr. Shekelle: Grants/grants pending: Agency for Healthcare Research and Quality; Royalties: UptoDate; Other: Unpaid advisor for a Wellpoint project that seeks to identify and certify high-quality back pain centers of excellence. Disclosures can also be viewed at www.acponline.org/authors/icmje/ConflictOflnterestForms.do?msNum=M10-1394. Any conflict of interest of the Clinical Guidelines Committee members was declared, discussed, and resolved.	American College of Physicians Foundation, 2011, HLTH TIPS LOW BACK P; American College of Radiology, 2008, ACR APPR CRIT LOW BA; [Anonymous], 1984, Can Med Assoc J, V130, P1542; [Anonymous], 2011, ANN INTERN MED, V154, P1; [Anonymous], 2009, 2009 MED REIMB FEE S; [Anonymous], 2009, BACKLETTER, V24, P50; Anthem Health Care Advisor, 2008, EST TOT COSTS INS BE; Ash LM, 2008, AM J NEURORADIOL, V29, P1098, DOI 10.3174/ajnr.A0999; Baras JD, 2009, HEALTH AFFAIR, V28, pW1133, DOI 10.1377/hlthaff.28.6.w1133; BODEN SD, 1990, J BONE JOINT SURG AM, V72A, P403, DOI 10.2106/00004623-199072030-00013; Buchbinder R, 2008, SPINE, V33, P74, DOI 10.1097/BRS.0b013e31815e39c8; Burton AK, 1999, SPINE, V24, P2484, DOI 10.1097/00007632-199912010-00010; Campbell EG, 2007, ANN INTERN MED, V147, P795, DOI 10.7326/0003-4819-147-11-200712040-00012; Carey TS, 2009, SPINE, V34, P718, DOI 10.1097/BRS.0b013e31819792b0; Carman KL, 2010, HEALTH AFFAIR, V29, P1400, DOI 10.1377/hlthaff.2009.0296; Carragee Eugene, 2006, Spine J, V6, P624, DOI 10.1016/j.spinee.2006.03.005; CHERKIN DC, 1994, ARTHRITIS RHEUM, V37, P15, DOI 10.1002/art.1780370104; CHOU R, 2009, EVALUATION MANAGEMEN; Chou R, 2007, ANN INTERN MED, V147, P478, DOI 10.7326/0003-4819-147-7-200710020-00006; Chou R, 2009, LANCET, V373, P463, DOI 10.1016/S0140-6736(09)60172-0; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; DEYO RA, 1992, JAMA-J AM MED ASSOC, V268, P760, DOI 10.1001/jama.268.6.760; DEYO RA, 1987, ARCH INTERN MED, V147, P141, DOI 10.1001/archinte.147.1.141; DEYO RA, 1988, J GEN INTERN MED, V3, P230, DOI 10.1007/BF02596337; Deyo RA, 2002, ANNU REV PUBL HEALTH, V23, P23, DOI 10.1146/annurev.publhealth.23.092101.134534; Deyo RA, 2006, SPINE, V31, P2724, DOI 10.1097/01.brs.0000244618.06877.cd; Deyo RA, 2009, J AM BOARD FAM MED, V22, P62, DOI 10.3122/jabfm.2009.01.080102; Di Iorio D, 2000, ARCH FAM MED, V9, P1015, DOI 10.1001/archfami.9.10.1015; Fazel R, 2009, NEW ENGL J MED, V361, P849, DOI 10.1056/NEJMoa0901249; Fisher ES, 1999, JAMA-J AM MED ASSOC, V281, P446, DOI 10.1001/jama.281.5.446; Freburger JK, 2009, ARCH INTERN MED, V169, P251, DOI 10.1001/archinternmed.2008.543; French SD, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006094.pub2; FRYBACK DG, 1991, MED DECIS MAKING, V11, P88, DOI 10.1177/0272989X9101100203; Gillan MGC, 2001, RADIOLOGY, V220, P393, DOI 10.1148/radiology.220.2.r01au06393; Gray DT, 2003, RADIOLOGY, V227, P669, DOI 10.1148/radiol.2273012213; Grimshaw JM, 2001, MED CARE, V39, pII2; GUYATT GH, 1986, CAN MED ASSOC J, V134, P587; HALL FM, 1976, RADIOLOGY, V120, P443, DOI 10.1148/120.2.443; HALPIN SFS, 1991, BRIT MED J, V303, P813, DOI 10.1136/bmj.303.6806.813; HART LG, 1995, SPINE, V20, P11, DOI 10.1097/00007632-199501000-00003; Henschke N, 2007, EUR SPINE J, V16, P1673, DOI 10.1007/s00586-007-0412-0; Henschke N, 2009, ARTHRITIS RHEUM-US, V60, P3072, DOI 10.1002/art.24853; Iglehart JK, 2009, NEW ENGL J MED, V360, P1030, DOI 10.1056/NEJMhpr0808703; Jarvik JG, 2002, ANN INTERN MED, V137, P586, DOI 10.7326/0003-4819-137-7-200210010-00010; Jarvik JG, 2003, JAMA-J AM MED ASSOC, V289, P2810, DOI 10.1001/jama.289.21.2810; Jarvik JJ, 2001, SPINE, V26, P1158, DOI 10.1097/00007632-200105150-00014; JENSEN MC, 1994, NEW ENGL J MED, V331, P69, DOI 10.1056/NEJM199407143310201; Joines JD, 2001, J GEN INTERN MED, V16, P14, DOI 10.1111/j.1525-1497.2001.00249.x; Kendrick D, 2001, BRIT MED J, V322, P400, DOI 10.1136/bmj.322.7283.400; Luo XM, 2004, SPINE, V29, P79, DOI 10.1097/01.BRS.0000105527.13866.0F; Lurie JD, 2003, SPINE, V28, P616, DOI 10.1097/00007632-200303150-00018; Martin BI, 2008, JAMA-J AM MED ASSOC, V299, P656, DOI 10.1001/jama.299.6.656; McPhillips-Tangum CA, 1998, J GEN INTERN MED, V13, P289, DOI 10.1046/j.1525-1497.1998.00093.x; Medicare Payment Advisory Commission, 2009, REP C IMPR INC MED P; NACHEMSON A L, 1976, Spine, V1, P59, DOI 10.1097/00007632-197603000-00009; Owens DK, 2011, ANN INTERN MED, V154, P174, DOI 10.7326/0003-4819-154-3-201102010-00007; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; Pham HH, 2009, ARCH INTERN MED, V169, P972, DOI 10.1001/archinternmed.2009.78; Rhodes LA, 1999, SOC SCI MED, V48, P1189, DOI 10.1016/S0277-9536(98)00418-3; ROCKEY PH, 1978, J FAM PRACTICE, V7, P455; Sackett DL, 2002, BRIT MED J, V324, P539, DOI 10.1136/bmj.324.7336.539; Schectman JM, 2003, J GEN INTERN MED, V18, P773, DOI 10.1046/j.1525-1497.2003.10205.x; Schers H, 2001, Spine (Phila Pa 1976), V26, pE348, DOI 10.1097/00007632-200108010-00013; Schunemann HJ, 2008, BMJ-BRIT MED J, V336, P1106, DOI 10.1136/bmj.39500.677199.AE; Smith-Bindman R, 2008, HEALTH AFFAIR, V27, P1491, DOI 10.1377/hlthaff.27.6.1491; Snowbeck C, 2005, PITTSBURGH POST 0611; Stewart WF, 2003, JAMA-J AM MED ASSOC, V290, P2443, DOI 10.1001/jama.290.18.2443; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; SuarezAlmazor ME, 1997, JAMA-J AM MED ASSOC, V277, P1782, DOI 10.1001/jama.277.22.1782; SWEDLOW A, 1992, NEW ENGL J MED, V327, P1502, DOI 10.1056/NEJM199211193272107; Underwood MR, 1995, BRIT J RHEUMATOL, V34, P1074; United States Government Accountability Office, 2008, GAO08452; vanTulder MW, 1997, SPINE, V22, P427, DOI 10.1097/00007632-199702150-00015; Verbeek J, 2004, SPINE, V29, P2309, DOI 10.1097/01.brs.0000142007.38256.7f; Verrilli D, 1996, JAMA-J AM MED ASSOC, V275, P1189, DOI 10.1001/jama.275.15.1189; Vroomen PCAJ, 2002, BRIT J GEN PRACT, V52, P119; Webster BS, 2010, J OCCUP ENVIRON MED, V52, P900, DOI 10.1097/JOM.0b013e3181ef7e53; Webster BS, 2005, J GEN INTERN MED, V20, P1132, DOI 10.1111/j.1525-1497.2005.0230.x; Weiner DK, 2006, PAIN MED, V7, P143, DOI 10.1111/j.1526-4637.2006.00112.x; WIESEL SW, 1984, SPINE, V9, P549, DOI 10.1097/00007632-198409000-00003; Williams CM, 2010, ARCH INTERN MED, V170, P271, DOI 10.1001/archinternmed.2009.507; Wilson IB, 2001, ARCH INTERN MED, V161, P256, DOI 10.1001/archinte.161.2.256	82	301	307	0	32	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2011	154	3					181	+		10.7326/0003-4819-154-3-201102010-00008	http://dx.doi.org/10.7326/0003-4819-154-3-201102010-00008			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	713HY	21282698				2022-12-28	WOS:000286729200006
J	Fries-Gaither, J; Lightle, K				Fries-Gaither, Jessica; Lightle, Kimberly			Penguins and Polar Bears Integrates Science and Literacy	SCIENCE			English	Editorial Material									[Fries-Gaither, Jessica; Lightle, Kimberly] Ohio State Univ, Sch Teaching & Learning, Coll Educ & Human Ecol, Columbus, OH 43210 USA	Ohio State University	Fries-Gaither, J (corresponding author), Ohio State Univ, Sch Teaching & Learning, Coll Educ & Human Ecol, 1929 Kenny Rd,Suite 400, Columbus, OH 43210 USA.	fries-gaither.1@osu.edu						BARBER J, 2006, 87 ANN M AM ED RES A; Cervetti G. N., 2005, READING WRITING SERV; CERVETTI GN, 2009, READING MORE READING, pCH4; Dorph R., 2007, STATUS SCI ED BAY AR; Duke N.K., 2003, READING WRITING INFO; Duschl R. A., 2007, TAKING SCI SCH LEARN, DOI DOI 10.17226/11625; MCMURRER J, 2008, INSTRUCTIONAL TIME E; Osborne J., 2002, CAMB J EDUC, V32, P203, DOI DOI 10.1080/03057640220147559; Palincsar AS, 2001, CARN S COGN, P151; Patrick H., 2009, YOUNG CHILDREN, V64, P32; TILSON JL, 2007, CONNECT, V21, P2; WOODRUFF SB, 2009, EVALUATION PENGUINS; WOODRUFF SB, 2010, EVALUATION PENGUINS	13	1	1	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2011	331	6016					413	414		10.1126/science.1196976	http://dx.doi.org/10.1126/science.1196976			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712BB	21273478				2022-12-28	WOS:000286635900041
J	Marteau, TM; Ogilvie, D; Roland, M; Suhrcke, M; Kelly, MP				Marteau, Theresa M.; Ogilvie, David; Roland, Martin; Suhrcke, Marc; Kelly, Michael P.			Judging nudging: can nudging improve population health?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CHRONIC DISEASES		[Marteau, Theresa M.; Roland, Martin] Univ Cambridge, Inst Publ Hlth, Behav & Hlth Res Unit, Cambridge CB2 0SR, England; [Ogilvie, David] MRC Epidemiol Unit, Cambridge, England; [Ogilvie, David] UKCRC Ctr Diet & Act Res, Inst Publ Hlth, Cambridge, England; [Suhrcke, Marc] Univ E Anglia, Sch Med Hlth Policy & Practice, Norwich NR4 7TJ, Norfolk, England; [Kelly, Michael P.] Natl Inst Hlth & Clin Excellence, Publ Hlth Excellence Ctr, London, England	University of Cambridge; University of Cambridge; University of East Anglia; National Institute for Health & Care Excellence	Marteau, TM (corresponding author), Univ Cambridge, Inst Publ Hlth, Behav & Hlth Res Unit, Cambridge CB2 0SR, England.	theresa.marteau@medschl.cam.ac.uk	Ogilvie, David/B-2444-2012; Suhrcke, Marc/AAE-9024-2019	Marteau, Theresa/0000-0003-3025-1129; Suhrcke, Marc/0000-0001-7263-8626; Roland, Martin/0000-0002-8533-3060; Ogilvie, David/0000-0002-0270-4672	ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_U106179474] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MC_U106179474] Funding Source: Medline; Department of Health [107/0001] Funding Source: Medline	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health		Anderson P, 2009, CURR OPIN PSYCHIATR, V22, P253, DOI 10.1097/YCO.0b013e328329ed75; [Anonymous], 2010, GROCERY CART CHOICE; ASH, 2010, SMOK FILL ROOM BIG T; Beaglehole R, 2010, LANCET, V376, P1619, DOI 10.1016/S0140-6736(10)61929-0; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; Capewell S, 2010, B WORLD HEALTH ORGAN, V88, P120, DOI 10.2471/BLT.08.057885; Cappuccio FP, 2010, HEART, V96, P1863, DOI 10.1136/hrt.2010.209023; Cecchini M, 2010, LANCET, V376, P1775, DOI 10.1016/S0140-6736(10)61514-0; Chernev A, 2011, J CONSUM PSYCHOL, V21, P178, DOI 10.1016/j.jcps.2010.08.002; Dolan P., 2010, MINDSPACE INFLUENCIN; Durkheim E, 1952, SUICIDE STUDY SOCIOL; Emberson J, 2004, EUR HEART J, V25, P484, DOI 10.1016/j.ehj.2003.11.012; Food Standards Agency, 2009, SALT RED TARG; Harris JL, 2009, HEALTH PSYCHOL, V28, P404, DOI 10.1037/a0014399; HART JT, 1971, LANCET, V1, P405, DOI 10.1016/S0140-6736(71)92410-X; Healthy People 2020, 2010, FDN HLTH MEAS REP HE; House of Commons Health Committee, 2010, ALC 1 REP SESS 2009; Just D, 2009, CHOICES, V29; Moreira MT, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006748.pub2; National Institute for Health and Clinical Excellence (NICE), 2010, NICE PUBL HLTH GUID; Organization WH, 2009, GLOB HLTH RISKS MORT; Pawson R., 1997, REALISTIC EVALUATION; Petticrew M, 2003, AM J PREV MED, V24, P2, DOI 10.1016/S0749-3797(02)00650-5; Rose G., 1992, STRATEGY PREVENTIVE; Ross L., 1977, ADV EXP SOC PSYCHOL, V10, P173, DOI DOI 10.1016/S0065-2601(08)60357-3; Ross L., 1991, PERSON SITUATION; Ruhm C., 2010, 16149 NBER; Sallis JF, 2009, AM J PREV MED, V36, P484, DOI 10.1016/j.amepre.2009.01.031; Sharma LL, 2010, AM J PUBLIC HEALTH, V100, P240, DOI 10.2105/AJPH.2009.160960; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Thaler RH, 2004, J POLIT ECON, V112, pS164, DOI 10.1086/380085; Thaler RH., 2021, NUDGE FINAL EDITION; Thomas S, 2008, TOB CONTROL, V17, DOI 10.1136/tc.2007.023911; Thorndike E, 1913, ED PSYCHOL BRIEFER C; Wansink B, 2006, J MARKETING RES, V43, P605, DOI 10.1509/jmkr.43.4.605; WHO Regional Committee for Europe, 2008, BEH CHANG STRAT HLTH; ZADEH LA, 1965, INFORM CONTROL, V8, P338, DOI 10.1016/S0019-9958(65)90241-X	37	297	297	10	148	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2011	342								d228	10.1136/bmj.d228	http://dx.doi.org/10.1136/bmj.d228			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	715LX	21266441	Green Submitted			2022-12-28	WOS:000286887100012
J	Strome, S				Strome, Susan			Toward Reprogramming Gonads to Brains	SCIENCE			English	Editorial Material							CAENORHABDITIS-ELEGANS; GERMLINE; CELLS		Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Strome, S (corresponding author), Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA.	sstrome@ucsc.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034059] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM034059] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ciosk R, 2006, SCIENCE, V311, P851, DOI 10.1126/science.1122491; Fay DS, 2007, DEV BIOL, V306, P1, DOI 10.1016/j.ydbio.2007.03.016; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Sarin S, 2009, DEVELOPMENT, V136, P2933, DOI 10.1242/dev.040204; Strome S, 2007, SCIENCE, V316, P392, DOI 10.1126/science.1140846; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tursun B, 2011, SCIENCE, V331, P304, DOI 10.1126/science.1199082; Uchida O, 2003, DEVELOPMENT, V130, P1215, DOI 10.1242/dev.00341; Unhavaithaya Y, 2002, CELL, V111, P991, DOI 10.1016/S0092-8674(02)01202-3; Wang D, 2005, NATURE, V436, P593, DOI 10.1038/nature04010; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015	12	0	0	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 21	2011	331	6015					292	293		10.1126/science.1201288	http://dx.doi.org/10.1126/science.1201288			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252336				2022-12-28	WOS:000286636300024
J	Kormendy, J; Bender, R				Kormendy, John; Bender, Ralf			Supermassive black holes do not correlate with dark matter haloes of galaxies	NATURE			English	Article							SPIRAL GALAXIES; FUNDAMENTAL RELATION; VELOCITY DISPERSION; STAR-CLUSTERS; QUASARS; MASS; SPECTROSCOPY; EVOLUTION; NUCLEI; ORIGIN	Supermassive black holes have been detected in all galaxies that contain bulge components when the galaxies observed were close enough that the searches were feasible. Together with the observation that bigger black holes live in bigger bulges(1-4), this has led to the belief that black-hole growth and bulge formation regulate each other(5). That is, black holes and bulges coevolve. Therefore, reports(6,7) of a similar correlation between black holes and the dark matter haloes in which visible galaxies are embedded have profound implications. Dark matter is likely to be non-baryonic, so these reports suggest that unknown, exotic physics controls black-hole growth. Here we show, in part on the basis of recent measurements(8) of bulgeless galaxies, that there is almost no correlation between dark matter and parameters that measure black holes unless the galaxy also contains a bulge. We conclude that black holes do not correlate directly with dark matter. They do not correlate with galaxy disks, either(9,10). Therefore, black holes coevolve only with bulges. This simplifies the puzzle of their coevolution by focusing attention on purely baryonic processes in the galaxy mergers that make bulges(11).	[Kormendy, John] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA; [Kormendy, John; Bender, Ralf] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Kormendy, John; Bender, Ralf] Univ Sternwarte, D-81679 Munich, Germany	University of Texas System; University of Texas Austin; Max Planck Society; University of Munich	Kormendy, J (corresponding author), Univ Texas Austin, Dept Astron, 1 Univ Stn, Austin, TX 78712 USA.	kormendy@astro.as.utexas.edu		Kormendy, John/0000-0001-9854-5217	National Science Foundation	National Science Foundation(National Science Foundation (NSF))	We thank S. Courteau for making available his surface photometry of NGC 801 (Supplementary Information) and J. Greene for helpful comments on the manuscript. The Hobby-Eberly Telescope (HET) is a joint project of the University of Texas at Austin, Pennsylvania State University, Stanford University, Ludwig-Maximilians-Universitat Munich and Georg-August-Universitat Gottingen. It is named in honour of its principal benefactors, W. P. Hobby and R. E. Eberly. This work was supported by the National Science Foundation.	Baes M, 2003, MON NOT R ASTRON SOC, V341, pL44, DOI 10.1046/j.1365-8711.2003.06680.x; Boker T, 2004, ASTRON J, V127, P105, DOI 10.1086/380231; Boker T, 1999, ASTRON J, V118, P831, DOI 10.1086/300985; Ferrarese L, 2000, ASTROPHYS J, V539, pL9, DOI 10.1086/312838; Ferrarese L, 2002, ASTROPHYS J, V578, P90, DOI 10.1086/342308; Gebhardt K, 2000, ASTROPHYS J, V539, pL13, DOI 10.1086/312840; Gebhardt K, 2001, ASTRON J, V122, P2469, DOI 10.1086/323481; Gultekin K, 2009, ASTROPHYS J, V698, P198, DOI 10.1088/0004-637X/698/1/198; GUNN JE, 1987, P IAU S, V117, P537; Ho L. C., 2004, ASTROPHYS SER; Ho LC, 1996, ASTROPHYS J, V472, P600, DOI 10.1086/178091; Ho LC, 2007, ASTROPHYS J, V668, P94, DOI 10.1086/521270; Hopkins PF, 2006, ASTROPHYS J SUPPL S, V163, P1, DOI 10.1086/499298; Komatsu E, 2009, ASTROPHYS J SUPPL S, V180, P330, DOI 10.1088/0067-0049/180/2/330; Kormendy J, 2004, ANNU REV ASTRON ASTR, V42, P603, DOI 10.1146/annurev.astro.42.053102.134024; KORMENDY J, 1993, ASTRON J, V105, P1793, DOI 10.1086/116555; KORMENDY J, 1995, ANNU REV ASTRON ASTR, V33, P581, DOI 10.1146/annurev.aa.33.090195.003053; Kormendy J., 1993, NEAREST ACTIVE GALAX, P197; Kormendy J, 2010, ASTROPHYS J, V723, P54, DOI 10.1088/0004-637X/723/1/54; RYDEN BS, 1987, ASTROPHYS J, V318, P15, DOI 10.1086/165349; SANCISI R, 1987, IAU S, V117, P67; SANDERS DB, 1988, ASTROPHYS J, V325, P74, DOI 10.1086/165983; Silk J, 1998, ASTRON ASTROPHYS, V331, pL1; Springel V, 2005, NATURE, V435, P629, DOI 10.1038/nature03597; TERLEVICH E, 1990, MON NOT R ASTRON SOC, V242, P271, DOI 10.1093/mnras/242.3.271; TOOMRE A, 1977, EVOLUTION GALAXIES S, P401; Tremaine S, 2002, ASTROPHYS J, V574, P740, DOI 10.1086/341002; VANALBADA TS, 1986, PHILOS T R SOC A, V320, P447; Walcher CJ, 2005, ASTROPHYS J, V618, P237, DOI 10.1086/425977; [No title captured]	31	109	110	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					377	380		10.1038/nature09695	http://dx.doi.org/10.1038/nature09695			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248846	Green Submitted			2022-12-28	WOS:000286385600047
J	Pellegrini, M; Calzascia, T; Toe, JG; Preston, SP; Lin, AE; Elford, AR; Shahinian, A; Lang, PA; Lang, KS; Morre, M; Assouline, B; Lahl, K; Sparwasser, T; Tedder, TF; Paik, JH; DePinho, RA; Basta, S; Ohashi, PS; Mak, TW				Pellegrini, Marc; Calzascia, Thomas; Toe, Jesse G.; Preston, Simon P.; Lin, Amy E.; Elford, Alisha R.; Shahinian, Arda; Lang, Philipp A.; Lang, Karl S.; Morre, Michel; Assouline, Brigitte; Lahl, Katharina; Sparwasser, Tim; Tedder, Thomas F.; Paik, Ji-hye; DePinho, Ronald A.; Basta, Sameh; Ohashi, Pamela S.; Mak, Tak W.			IL-7 Engages Multiple Mechanisms to Overcome Chronic Viral Infection and Limit Organ Pathology	CELL			English	Article							CD4(+) T-CELLS; IN-VIVO; LYMPHOID-TISSUE; HOST-DEFENSE; INTERLEUKIN-22; ACTIVATION; EXPANSION; INFLAMMATION; PERSISTENCE; HEPATOCYTES	Understanding the factors that impede immune responses to persistent viruses is essential in designing therapies for HIV infection. Mice infected with LCMV clone-13 have persistent high-level viremia and a dysfunctional immune response. Interleukin-7, a cytokine that is critical for immune development and homeostasis, was used here to promote immunity toward clone-13, enabling elucidation of the inhibitory pathways underlying impaired antiviral immune response. Mechanistically, IL-7 down-regulated a critical repressor of cytokine signaling, Socs3, resulting in amplified cytokine production, increased T cell effector function and numbers, and viral clearance. IL-7 enhanced thymic output to expand the naive T cell pool, including T cells that were not LCMV specific. Additionally, IL-7 promoted production of cytoprotective IL-22 that abrogated liver pathology. The IL-7-mediated effects were dependent on endogenous IL-6. These attributes of IL-7 have profound implications for its use as a therapeutic in the treatment of chronic viral diseases.	[Pellegrini, Marc; Calzascia, Thomas; Lin, Amy E.; Elford, Alisha R.; Shahinian, Arda; Lang, Philipp A.; Lang, Karl S.; Ohashi, Pamela S.; Mak, Tak W.] Univ Hlth Network, Dept Med Biophys, Campbell Family Canc Res Inst, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; [Pellegrini, Marc; Calzascia, Thomas; Lin, Amy E.; Elford, Alisha R.; Shahinian, Arda; Lang, Philipp A.; Lang, Karl S.; Ohashi, Pamela S.; Mak, Tak W.] Univ Hlth Network, Dept Immunol, Campbell Family Canc Res Inst, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada; [Pellegrini, Marc; Toe, Jesse G.; Preston, Simon P.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Pellegrini, Marc] Univ Melbourne, Dept Med Biol, Melbourne, Vic 3050, Australia; [Morre, Michel; Assouline, Brigitte] Cytheris Inc, F-92130 Issy Les Moulineaux, France; [Lahl, Katharina] Stanford Univ, Lab Immunol & Vasc Biol, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Sparwasser, Tim] Ctr Expt & Clin Infect Res, Inst Infect Immunol, TWINCORE, D-30625 Hannover, Germany; [Tedder, Thomas F.] Duke Univ, Dept Immunol, Med Ctr, Durham, NC 27708 USA; [Paik, Ji-hye; DePinho, Ronald A.] Harvard Univ, Sch Med, Belfer Inst Appl Canc Sci, Dept Med Oncol,Dept Med,Dana Farber Canc Inst, Boston, MA 02115 USA; [Paik, Ji-hye; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Dana Farber Canc Inst, Boston, MA 02115 USA; [Basta, Sameh] Queens Univ, Dept Microbiol & Immunol, Kingston, ON K7L 396, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Walter & Eliza Hall Institute; University of Melbourne; Stanford University; Duke University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Queens University - Canada	Ohashi, PS (corresponding author), Univ Hlth Network, Dept Med Biophys, Campbell Family Canc Res Inst, Ontario Canc Inst, Toronto, ON M5G 2C1, Canada.	pohashi@uhnres.utoronto.ca	Sparwasser, Tim/AAF-7085-2019; Pellegrini, Marc/F-7670-2014; Sparwasser, Tim D/AAA-4306-2022; Yang, Chen/G-1379-2010; Lin, Amy Erica/ABG-4745-2020; Lahl, Katharina/AAA-1909-2021; Lang, Karl S/R-2505-2016	Sparwasser, Tim/0000-0001-5645-902X; Lin, Amy Erica/0000-0002-0554-2832; Lahl, Katharina/0000-0003-4919-331X; Pellegrini, Marc/0000-0003-3627-3126; Ohashi, Pamela S./0000-0003-2915-9317; Lang, Karl/0000-0001-9783-7605; Preston, Simon/0000-0001-8969-8297; DePinho, Ronald/0000-0002-5625-577X; Calzascia, Thomas/0000-0001-8225-6744	Canadian Institute for Health Research [CIHR-MOP-106529]; Terry Fox Cancer Foundation National Cancer Institute of Canada; Boninchi Foundation (Geneva, Switzerland); National Cancer Institute of Canada; Irvington Institute with the Cancer Research Institute (New York, NY); Australian National Health and Medical Research Council; Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Health and Long Term Care (OMOHLTC)	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Terry Fox Cancer Foundation National Cancer Institute of Canada; Boninchi Foundation (Geneva, Switzerland); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Irvington Institute with the Cancer Research Institute (New York, NY); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario)	Dr. Mandana Nikpour assisted with statistical analyses. Marina Zaitseva contributed to the analysis of thymic emigrants; Alain Lamarre, Paul Jolicoeur, and Michel Nussenzweig provided reagents and mice. This work was supported by a Canadian Institute for Health Research grant to T. W. M. and P.S.O. (CIHR-MOP-106529) and a Terry Fox Cancer Foundation National Cancer Institute of Canada grant to T. W. M. T. C. was supported by the Boninchi Foundation (Geneva, Switzerland) and The Terry Fox Foundation through an award from the National Cancer Institute of Canada. M. P. was supported through an Irvington Institute Fellowship with the Cancer Research Institute (New York, NY) and an Australian National Health and Medical Research Council Fellowship. S. B receives support from the Natural Sciences and Engineering Research Council of Canada. P.S.O. holds a Canada Research Chair in autoimmunity and tumor immunity. This research was also funded, in part, by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC.	Aujla SJ, 2008, NAT MED, V14, P275, DOI 10.1038/nm1710; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; BATTEGAY M, 1991, J VIROL METHODS, V33, P191, DOI 10.1016/0166-0934(91)90018-U; Beq S, 2006, J IMMUNOL, V176, P914, DOI 10.4049/jimmunol.176.2.914; Bouaziz JD, 2007, P NATL ACAD SCI USA, V104, P20878, DOI 10.1073/pnas.0709205105; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brender C, 2007, BLOOD, V110, P2528, DOI 10.1182/blood-2006-08-041541; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Chase A, 2006, TRENDS PHARMACOL SCI, V27, P4, DOI 10.1016/j.tips.2005.11.005; Chu YW, 2004, BLOOD, V104, P1110, DOI 10.1182/blood-2003-10-3635; Colonna M, 2009, IMMUNITY, V31, P15, DOI 10.1016/j.immuni.2009.06.008; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Fry TJ, 2003, BLOOD, V101, P2294, DOI 10.1182/blood-2002-07-2297; Kittipatarin C, 2007, CYTOKINE, V39, P75, DOI 10.1016/j.cyto.2007.07.183; Klein C, 2005, J CLIN INVEST, V115, P860, DOI 10.1172/JCI200523640; Klenerman P, 2005, NAT IMMUNOL, V6, P873, DOI 10.1038/ni1241; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; Laurence A, 2008, NAT MED, V14, P247, DOI 10.1038/nm0308-247; Levy Y, 2009, J CLIN INVEST, V119, P997, DOI 10.1172/JCI38052; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Matter M, 2006, J EXP MED, V203, P2145, DOI 10.1084/jem.20060651; Nguyen LT, 2002, J EXP MED, V195, P423, DOI 10.1084/jem.20010032; Nugeyre MT, 2003, J IMMUNOL, V171, P4447, DOI 10.4049/jimmunol.171.8.4447; Ogura H, 2008, IMMUNITY, V29, P628, DOI 10.1016/j.immuni.2008.07.018; Ouyang WJ, 2008, IMMUNITY, V28, P454, DOI 10.1016/j.immuni.2008.03.004; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Pellegrini M, 2009, NAT MED, V15, P528, DOI 10.1038/nm.1953; Radaeva S, 2004, HEPATOLOGY, V39, P1332, DOI 10.1002/hep.20184; Rosenberg SA, 2006, J IMMUNOTHER, V29, P313, DOI 10.1097/01.cji.0000210386.55951.c2; Ruprecht CR, 2005, J EXP MED, V201, P1793, DOI 10.1084/jem.20050085; Sereti I, 2009, BLOOD, V113, P6304, DOI 10.1182/blood-2008-10-186601; Sportes C, 2008, J EXP MED, V205, P1701, DOI 10.1084/jem.20071681; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Sugimoto K, 2008, J CLIN INVEST, V118, P534, DOI [10.1172/JC133194, 10.1172/JCI33194]; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wilson EB, 2010, IMMUNOL RES, V48, P3, DOI 10.1007/s12026-010-8162-1; Yannoutsos N, 2001, J EXP MED, V194, P471, DOI 10.1084/jem.194.4.471; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Yu W, 1999, NATURE, V400, P682, DOI 10.1038/23287; Zenewicz LA, 2007, IMMUNITY, V27, P647, DOI 10.1016/j.immuni.2007.07.023; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	48	239	253	0	27	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 18	2011	144	4					601	613		10.1016/j.cell.2011.01.011	http://dx.doi.org/10.1016/j.cell.2011.01.011			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21295337	Bronze			2022-12-28	WOS:000287473100014
J	Losina, E; Walensky, RP; Reichmann, WM; Holt, HL; Gerlovin, H; Solomon, DH; Jordan, JM; Hunter, DJ; Suter, LG; Weinstein, AM; Paltiel, AD; Katz, JN				Losina, Elena; Walensky, Rochelle P.; Reichmann, William M.; Holt, Holly L.; Gerlovin, Hanna; Solomon, Daniel H.; Jordan, Joanne M.; Hunter, David J.; Suter, Lisa G.; Weinstein, Alexander M.; Paltiel, A. David; Katz, Jeffrey N.			Impact of Obesity and Knee Osteoarthritis on Morbidity and Mortality in Older Americans	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-LIFE; NUTRITION EXAMINATION SURVEY; HEALTH-STATE UTILITIES; BODY-MASS INDEX; NATIONAL-HEALTH; METABOLIC SYNDROME; PROSPECTIVE COHORT; UNITED-STATES; RISK-FACTORS; OVERWEIGHT	Background: Obesity and knee osteoarthritis are among the most frequent chronic conditions affecting Americans aged 50 to 84 years. Objective: To estimate quality-adjusted life-years lost due to obesity and knee osteoarthritis and health benefits of reducing obesity prevalence to levels observed a decade ago. Design: The U.S. Census and obesity data from national data sources were combined with estimated prevalence of symptomatic knee osteoarthritis to assign persons aged 50 to 84 years to 4 subpopulations: nonobese without knee osteoarthritis (reference group), nonobese with knee osteoarthritis, obese without knee osteoarthritis, and obese with knee osteoarthritis. The Osteoarthritis Policy Model, a computer simulation model of knee osteoarthritis and obesity, was used to estimate quality-adjusted life-year losses due to knee osteoarthritis and obesity in comparison with the reference group. Setting: United States. Participants: U.S. population aged 50 to 84 years. Measurements: Quality-adjusted life-years lost owing to knee osteoarthritis and obesity. Results: Estimated total losses of per-person quality-adjusted life-years ranged from 1.857 in nonobese persons with knee osteoarthritis to 3.501 for persons affected by both conditions, resulting in a total of 86.0 million quality-adjusted life-years lost due to obesity, knee osteoarthritis, or both. Quality-adjusted life-years lost due to knee osteoarthritis and/or obesity represent 10% to 25% of the remaining quality-adjusted survival of persons aged 50 to 84 years. Hispanic and black women had disproportionately high losses. Model findings suggested that reversing obesity prevalence to levels seen 10 years ago would avert 178 071 cases of coronary heart disease, 889 872 cases of diabetes, and 111 206 total knee replacements. Such a reduction in obesity would increase the quantity of life by 6 318 030 years and improve life expectancy by 7 812 120 quality-adjusted years in U. S. adults aged 50 to 84 years. Limitations: Comorbidity incidences were derived from prevalence estimates on the basis of life expectancy of the general population, potentially resulting in conservative underestimates. Calibration analyses were conducted to ensure comparability of model-based projections and data from external sources. Conclusion: The number of quality-adjusted life-years lost owing to knee osteoarthritis and obesity seems to be substantial, with black and Hispanic women experiencing disproportionate losses. Reducing mean body mass index to the levels observed a decade ago in this population would yield substantial health benefits.	[Losina, Elena] Boston Univ, Sch Publ Hlth, Brigham & Womens Hosp, Orthopaed & Arthrit Ctr Outcomes Res,Dept Orthopa, Boston, MA 02115 USA; Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Univ N Carolina, Chapel Hill, NC USA; Univ Sydney, Sydney, NSW 2006, Australia; Yale Univ, Sch Med, New Haven, CT USA	Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; University of North Carolina; University of North Carolina Chapel Hill; University of Sydney; Yale University	Losina, E (corresponding author), Boston Univ, Sch Publ Hlth, Brigham & Womens Hosp, Orthopaed & Arthrit Ctr Outcomes Res,Dept Orthopa, 75 Francis St,BC-4, Boston, MA 02115 USA.	Elosina@partners.org	Hunter, David J/A-4622-2010	Hunter, David J/0000-0003-3197-752X; Gerlovin, Hanna/0000-0002-6700-2129; Losina, ELENA/0000-0002-3424-0892; /0000-0002-1283-6329; Walensky, Rochelle P./0000-0002-8795-379X	National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR053112, K24 AR057827, K23 AR054095, P60 AR47782, T32 AR 055885, K24 AR 02123]; Arthritis Foundation; Arthritis Investigator Award; National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR057827, P60AR047782, K23AR054095, R01AR053112, T32AR055885, K24AR002123] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Arthritis Foundation; Arthritis Investigator Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	By the National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR053112, K24 AR057827, K23 AR054095, P60 AR47782, T32 AR 055885, and K24 AR 02123); an Arthritis Foundation Innovative Research grant (Dr. Losina); and an Arthritis Investigator Award (Dr. Suter).; Primary Funding Source: The National Institutes of Health and the Arthritis Foundation.	Abbate LM, 2006, OBESITY, V14, P1274, DOI 10.1038/oby.2006.145; Adams KF, 2006, NEW ENGL J MED, V355, P763, DOI 10.1056/NEJMoa055643; Ammar KA, 2008, AM HEART J, V156, P975, DOI 10.1016/j.ahj.2008.06.018; ANDERSON JJ, 1988, AM J EPIDEMIOL, V128, P179, DOI 10.1093/oxfordjournals.aje.a114939; Bender R, 1999, JAMA-J AM MED ASSOC, V281, P1498, DOI 10.1001/jama.281.16.1498; BOULT C, 1994, J GERONTOL, V49, pM28, DOI 10.1093/geronj/49.1.M28; Brazier J, 1998, J CLIN EPIDEMIOL, V51, P1115, DOI 10.1016/S0895-4356(98)00103-6; Calle EE, 1999, NEW ENGL J MED, V341, P1097, DOI 10.1056/NEJM199910073411501; *CDCP, 1997, HLTH DAT INT CHRON C; Centers for Disease Control and Prevention, 2008, NAT HLTH NUTR EX SUR; Centers for Disease Control and Prevention, 2006, NAT HLTH NUTR EX SUR; Cooper C, 2000, ARTHRITIS RHEUM, V43, P995, DOI 10.1002/1529-0131(200005)43:5<995::AID-ANR6>3.0.CO;2-1; Das UN, 2007, EUR HEART J, V28, P2953, DOI 10.1093/eurheartj/ehm472; DAVIS MA, 1988, AM J EPIDEMIOL, V127, P1019, DOI 10.1093/oxfordjournals.aje.a114878; Diehr P, 2001, MED CARE, V39, P670, DOI 10.1097/00005650-200107000-00004; Dieppe P, 1999, RHEUMATOLOGY, V38, P73, DOI 10.1093/rheumatology/38.1.73; Dillon CF, 2006, J RHEUMATOL, V33, P2271; Dominick Kelli L, 2004, Health Qual Life Outcomes, V2, P5; FELSON DT, 1988, ANN INTERN MED, V109, P18, DOI 10.7326/0003-4819-109-1-18; Felson DT, 1997, ARTHRITIS RHEUM, V40, P728, DOI 10.1002/art.1780400420; FELSON DT, 1990, SEMIN ARTHRITIS RHEU, V20, P42, DOI 10.1016/0049-0172(90)90046-I; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Finley CE, 2007, INT J OBESITY, V31, P292, DOI 10.1038/sj.ijo.0803395; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Fontaine KR, 2003, JAMA-J AM MED ASSOC, V289, P187, DOI 10.1001/jama.289.2.187; Harvey E L, 2002, Obes Rev, V3, P45, DOI 10.1046/j.1467-789X.2002.00053.x; Heo M, 2003, OBES RES, V11, P209, DOI 10.1038/oby.2003.33; Jordan JM, 2007, J RHEUMATOL, V34, P172; KEYFITZ N, 1975, BIOMETRICS, V31, P889, DOI 10.2307/2529814; Kreuter MW, 2003, HEALTH EDUC BEHAV, V30, P133, DOI 10.1177/1090198102251021; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; Lean MEJ, 1999, ARCH INTERN MED, V159, P837, DOI 10.1001/archinte.159.8.837; Lloyd A, 2006, BRIT J CANCER, V95, P683, DOI 10.1038/sj.bjc.6603326; Mann DM, 2006, PREV MED, V42, P66, DOI 10.1016/j.ypmed.2005.09.011; Mathers CD, 2002, GLOBAL BURDEN DIS 20; Mathias SD, 1997, QUAL LIFE RES, V6, P311, DOI 10.1023/A:1018475108460; McLernon DJ, 2008, MED DECIS MAKING, V28, P582, DOI 10.1177/0272989X08315240; Michaud Catherine M, 2006, Popul Health Metr, V4, P11, DOI 10.1186/1478-7954-4-11; Muennig P, 2006, AM J PUBLIC HEALTH, V96, P1662, DOI 10.2105/AJPH.2005.068874; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Nguyen NT, 2008, J AM COLL SURGEONS, V207, P928, DOI 10.1016/j.jamcollsurg.2008.08.022; Niu J, 2009, ARTHRIT RHEUM-ARTHR, V61, P329, DOI 10.1002/art.24337; OLIVERIA SA, 1995, ARTHRITIS RHEUM, V38, P1134, DOI 10.1002/art.1780380817; Parmet Sharon, 2003, JAMA, V289, P1068; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Quintana JM, 2006, ARCH INTERN MED, V166, P220, DOI 10.1001/archinte.166.2.220; Reichmann WM, 2009, ARTHRIT RHEUM-ARTHR, V61, P1046, DOI 10.1002/art.24839; Rothman AJ, 2006, J COMMUN, V56, pS202, DOI 10.1111/j.1460-2466.2006.00290.x; Sach TH, 2007, INT J OBESITY, V31, P189, DOI 10.1038/sj.ijo.0803365; Shirai K, 2004, CURR MED RES OPIN, V20, P295, DOI 10.1185/030079903125003008; Sowers M, 2000, OSTEOARTHR CARTILAGE, V8, P69, DOI 10.1053/joca.1999.0273; Todd Miller M, 2008, J Cardiometab Syndr, V3, P162, DOI 10.1111/j.1559-4572.2008.00004.x; Torrance GW, 1996, MED CARE, V34, P702, DOI 10.1097/00005650-199607000-00004; *US BUR CENS, 2010, NCEST200904HISPWANHB; Walter S, 2009, INT J OBESITY, V33, P1410, DOI 10.1038/ijo.2009.176; Wang Y, 2007, EPIDEMIOL REV, V29, P6, DOI 10.1093/epirev/mxm007; Winkelmayer WC, 2006, MED DECIS MAKING, V26, P247, DOI 10.1177/0272989X06288685; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013; Zhang YQ, 2010, CLIN GERIATR MED, V26, P355, DOI [10.1016/j.cger.2010.03.001, 10.1016/j.rdc.2012.10.004]	60	174	179	2	26	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4					217	W74		10.7326/0003-4819-154-4-201102150-00001	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-00001			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720VF	21320937	Green Accepted, Green Published			2022-12-28	WOS:000287310000013
J	Domanski, MJ; Mahaffey, K; Hasselblad, V; Brener, SJ; Smith, PK; Hillis, G; Engoren, M; Alexander, JH; Levy, JH; Chaitman, BR; Broderick, S; Mack, MJ; Pieper, KS; Farkouh, ME				Domanski, Michael J.; Mahaffey, Kenneth; Hasselblad, Vic; Brener, Sorin J.; Smith, Peter K.; Hillis, Graham; Engoren, Milo; Alexander, John H.; Levy, Jerrold H.; Chaitman, Bernard R.; Broderick, Samuel; Mack, Michael J.; Pieper, Karen S.; Farkouh, Michael E.			Association of Myocardial Enzyme Elevation and Survival Following Coronary Artery Bypass Graft Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HYDROGEN EXCHANGE INHIBITION; CREATINE-KINASE ELEVATION; ST-SEGMENT ELEVATION; RANDOMIZED-TRIAL; CARDIAC-SURGERY; MB ELEVATION; MORTALITY; RISK; REVASCULARIZATION; INTERVENTIONS	Context Several small studies have suggested that cardiac enzyme elevation in the 24 hours following coronary artery bypass graft (CABG) surgery is associated with worse prognosis, but a definitive study is not available. Also, the long-term prognostic impact of small increases of perioperative enzyme has not been reported. Objective To quantify the relationship between peak post-CABG elevation of biomarkers of myocardial damage and early, intermediate-, and long-term mortality, including determining whether there is a threshold below which elevations lack prognostic significance. Data Sources Studies (randomized clinical trials or registries) of patients undergoing CABG surgery in which postprocedural biomarker and mortality data were collected and included. A search of the PubMed database was performed in July 2008 using the search terms coronary artery bypass, troponin, CK-MB, and mortality. Study Selection Studies evaluating mortality and creatine kinase (CK-MB), troponin, or both were included. One study investigator declined to participate and 3 had insufficient data. Data Extraction Two independent reviewers determined study eligibility. The principal investigator from each eligible study was contacted to request his/her participation. Once institutional review board approval for the use of these data for this purpose was obtained, we requested patient-level data from each source. Data were examined to ensure that cardiac markers had been measured within 24 hours after CABG surgery, key baseline covariates, and mortality were available. Results A total of 18 908 patients from 7 studies were included. Follow-up varied from 3 months to 5 years. Mortality was found to be a monotonically increasing function of the CK-MB ratio. The 30-day mortality rates by categories of CK-MB ratio were 0.63% (95% confidence interval [CI], 0.36%-1.02%) for 0 to <1, 0.86%(95% CI, 0.49%-1.40%) for 1 to <2, 0.95% (95% CI, 0.72%-1.22%) for 2 to <5, 2.09% (95% CI, 1.69%-2.57%) for 5 to <10, 2.78%(95% CI, 2.12%-3.58%) for 10 to <20, and 7.06%(95% CI, 5.46%-8.96%) for 20 to >= 40. Of the variables considered, the CK-MB ratio was the strongest independent predictor of death to 30 days and remained significant even after adjusting for a wide range of baseline risk factors (chi(2)=143, P<.001; hazard ratio [HR] for each 5 point-increment above the upper limits of normal [ULN]=1.12; 95% CI, 1.10-1.14). This result was strongest at 30 days, but the adjusted association persisted from 30 days to 1 year (chi(2)=24; P < .001; HR for each 5-point increment above ULN=1.17; 95% CI, 1.10-1.24) and a trend was present from 1 year to 5 years (chi(2)=2.8; P=.10; HR for each 5-point increment above ULN=1.05; 95% CI, 0.99-1.11). Similar analyses using troponin as the marker of necrosis led to the same conclusions (chi(2)=142 for 0-30 days and chi(2)=40 for 30 days to 6 months, both P<.001; HR for each 50 points above the ULN=1.28; 95% CI, 1.23-1.33 and 1.15; 95% CI, 1.10-1.21, respectively). Conclusions Among patients who had undergone CABG surgery, elevation of CK-MB or troponin levels within the first 24 hours was independently associated with increased intermediate-and long-term risk of mortality. JAMA. 2011; 305(6): 585-591	[Domanski, Michael J.; Farkouh, Michael E.] Mt Sinai Cardiovasc Inst, New York, NY USA; [Mahaffey, Kenneth; Hasselblad, Vic; Smith, Peter K.; Alexander, John H.; Broderick, Samuel; Pieper, Karen S.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Brener, Sorin J.] New York Methodist Hosp, Brooklyn, NY USA; [Hillis, Graham] George Inst Int Hlth, Sydney, NSW, Australia; [Engoren, Milo] Mercy St Vincent Med Ctr, Toledo, OH USA; [Levy, Jerrold H.] Emory Univ, Sch Med, Atlanta, GA USA; [Chaitman, Bernard R.] St Louis Univ, Sch Med, St Louis, MO USA; [Mack, Michael J.] Baylor Healthcare Syst, Dallas, TX USA; [Farkouh, Michael E.] Univ Toronto, Univ Hlth Network, Toronto, ON, Canada; [Farkouh, Michael E.] Univ Toronto, Li Ka Shing Knowledge Inst, Toronto, ON, Canada	Icahn School of Medicine at Mount Sinai; Duke University; NewYork-Presbyterian Brooklyn Methodist Hospital; NewYork-Presbyterian Hospital; University of Sydney; Emory University; Saint Louis University; Baylor Health Care System; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Li Ka Shing Knowledge Institute	Domanski, MJ (corresponding author), Mt Sinai Sch Med, 1 Gustave L Levy Pl, New York, NY 10029 USA.	michael.domanski@mssm.edu	Alexander, John/GVS-7271-2022	Alexander, John/0000-0002-1444-2462				Abdelmeguid AE, 1996, AM HEART J, V131, P1097, DOI 10.1016/S0002-8703(96)90083-6; Alexander JH, 2000, JAMA-J AM MED ASSOC, V283, P347, DOI 10.1001/jama.283.3.347; Alexander JH, 2005, JAMA-J AM MED ASSOC, V294, P2446; Alexander JH, 2008, JAMA-J AM MED ASSOC, V299, P1777, DOI 10.1001/jama.299.15.joc80027; Alpert JS, 2000, J AM COLL CARDIOL, V36, P959, DOI 10.1016/S0735-1097(00)00804-4; American Heart Association, HEART DIS STROK STAT; Boyce SW, 2003, J THORAC CARDIOV SUR, V126, P420, DOI 10.1016/S0022-5223(03)00209-5; Brener SJ, 2002, J AM COLL CARDIOL, V40, P1961, DOI 10.1016/S0735-1097(02)02538-X; Califf RM, 1998, J AM COLL CARDIOL, V31, P241, DOI 10.1016/S0735-1097(97)00506-8; Costa MA, 2001, CIRCULATION, V104, P2689, DOI 10.1161/hc4701.099789; Croal BL, 2006, CIRCULATION, V114, P1468, DOI 10.1161/CIRCULATIONAHA.105.602370; Engoren MC, 2005, EUR J CARDIO-THORAC, V28, P114, DOI 10.1016/j.ejcts.2005.03.004; Fellahi JL, 2003, ANESTHESIOLOGY, V99, P270, DOI 10.1097/00000542-200308000-00007; Klatte K, 2001, J AM COLL CARDIOL, V38, P1070, DOI 10.1016/S0735-1097(01)01481-4; Kong TQ, 1997, JAMA-J AM MED ASSOC, V277, P461, DOI 10.1001/jama.277.6.461; Mahaffey KW, 2007, EUR HEART J, V28, P425, DOI 10.1093/eurheartj/ehl483; Mentzer RM, 2008, ANN THORAC SURG, V85, P1261, DOI 10.1016/j.athoracsur.2007.10.054; Newall N, 2006, ANN THORAC SURG, V81, P583, DOI 10.1016/j.athoracsur.2005.08.051; *PRIMO CABG 2, 2006, PEX FAILS RED DEATH; Ramsay J, 2005, J THORAC CARDIOV SUR, V129, P300, DOI 10.1016/j.jtcvs.2004.06.005; Rodriguez A, 2001, J AM COLL CARDIOL, V37, P51, DOI 10.1016/S0735-1097(00)01052-4; ROSENTHAL R, 1979, PSYCHOL BULL, V86, P638, DOI 10.1037/0033-2909.86.3.638; SAS Institute Inc, 1999, SAS STAT US GUID VER; Tardif JC, 2007, J THORAC CARDIOV SUR, V133, P1604, DOI 10.1016/j.jtcvs.2007.01.049; Topol EJ, 1997, JAMA-J AM MED ASSOC, V278, P479, DOI 10.1001/jama.278.6.479; Verrier ED, 2004, JAMA-J AM MED ASSOC, V291, P2319, DOI 10.1001/jama.291.19.2319	26	194	203	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2011	305	6					585	591		10.1001/jama.2011.99	http://dx.doi.org/10.1001/jama.2011.99			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	717XI	21304084	Bronze			2022-12-28	WOS:000287080500023
J	Pollock, AM; Price, D; Liebe, M				Pollock, Allyson M.; Price, David; Liebe, Moritz			Private finance initiatives during NHS austerity	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												allyson.pollock@ed.ac.uk		pollock, allyson/0000-0002-7388-3110				*CIT FIN, 2010, MAN PFI PPP PROJ CHA; CUTHBERT J, RESPONSE SCOTTISH FU; Department of Health, 2009, PRIOR CAP SCHEM APPR; Department of Health, 2010, CM7881; Gaffney D, 1999, BMJ-BRIT MED J, V319, P48, DOI 10.1136/bmj.319.7201.48; Gaffney D, 1999, BRIT MED J, V319, P116, DOI 10.1136/bmj.319.7202.116; HELLOWELL M, 2007, PRIV FIN PUBL DEF RE; HELLOWELL M, 2008, PUBLIC FINANCE  1031; Hellowell M, 2009, ECON AFFA, V29, P13, DOI 10.1111/j.1468-0270.2009.01861.x; *HM TREAS, 2003, M INV CHALL; HM Treasury, 2009, PREB REP SEC REC GRO; HM Treasury, 2009, PFI SIGN PROJ LIST; HM Treasury, 2009, BUDG 2009 BUILD BRIT; National Audit Office, 2010, PERF MAN HOSP PFI CO; National Audit Office, 2008, ALL MAN RISK MIN DEF; NORMAN J, 2011, FINANCIAL TIMES 0816; Pollock AM, 2008, PUBLIC MONEY MANAGE, V28, P173, DOI 10.1111/j.1467-9302.2008.00640.x; Pollock AM, 2002, BRIT MED J, V324, P1205, DOI 10.1136/bmj.324.7347.1205; Shaoul J, 2008, PUBLIC MONEY MANAGE, V28, P101, DOI 10.1111/j.1467-9302.2008.00628.x; Yescombe E.R., 2007, PUBLIC PRIVATE PARTN, P58, DOI [10.1016/B978-075068054-7.50029-0, DOI 10.1016/B978-075068054-7.50029-0]; [No title captured]	21	14	14	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 9	2011	342								d324	10.1136/bmj.d324	http://dx.doi.org/10.1136/bmj.d324			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	722AZ	21307102				2022-12-28	WOS:000287402900013
J	Acuin, CS; Khor, GL; Liabsuetrakul, T; Achadi, EL; Htay, TT; Firestone, R; Bhutta, ZA				Acuin, Cecilia S.; Khor, Geok Lin; Liabsuetrakul, Tippawan; Achadi, Endang L.; Htay, Thein Thein; Firestone, Rebecca; Bhutta, Zulfiqar A.			Health in Southeast Asia 2 Maternal, neonatal, and child health in southeast Asia: towards greater regional collaboration	LANCET			English	Article							ALMA-ATA; SURVIVAL; INTERVENTIONS; MORTALITY; NEWBORN; CARE; EPIDEMIOLOGY; COUNTRIES; REVIEWS; PROGRAM	Although maternal and child mortality are on the decline in southeast Asia, there are still major disparities, and greater equity is key to achieve the Millennium Development Goals. We used comparable cross-national data sources to document mortality trends from 1990 to 2008 and to assess major causes of maternal and child deaths. We present inequalities in intervention coverage by two common measures of wealth quintiles and rural or urban status. Case studies of reduction in mortality in Thailand and Indonesia indicate the varying extents of success and point to some factors that accelerate progress. We developed a Lives Saved Tool analysis for the region and for country subgroups to estimate deaths averted by cause and intervention. We identified three major patterns of maternal and child mortality reduction: early, rapid downward trends (Brunei, Singapore, Malaysia, and Thailand); initially high declines (sustained by Vietnam but faltering in the Philippines and Indonesia); and high initial rates with a downward trend (Laos, Cambodia, and Myanmar). Economic development seems to provide an important context that should be coupled with broader health-system interventions. Increasing coverage and consideration of the health-system context is needed, and regional support from the Association of Southeast Asian Nations can provide increased policy support to achieve maternal, neonatal, and child health goals.	[Acuin, Cecilia S.] Univ Philippines, Natl Inst Hlth, Inst Clin Epidemiol, Manila 1000, Philippines; [Khor, Geok Lin] Int Med Univ, Fac Med & Hlth, Kuala Lumpur 57000, Malaysia; [Liabsuetrakul, Tippawan] Prince Songkla Univ, Fac Med, Epidemiol Unit, Hat Yai, Songkhla, Thailand; [Achadi, Endang L.] Univ Indonesia, Fac Publ Hlth, Jakarta, Indonesia; [Achadi, Endang L.] Reg Ctr Community Nutr, SEAMEO TROPMED, Jakarta, Indonesia; [Firestone, Rebecca] China Med Board, Cambridge, MA USA; [Firestone, Rebecca] Harvard Global Equity Initiat, Boston, MA USA; [Bhutta, Zulfiqar A.] Aga Khan Univ, Dept Paediat & Child Hlth, Karachi, Pakistan	University of the Philippines System; University of the Philippines Manila; International Medical University Malaysia; Prince of Songkla University; University of Indonesia; Aga Khan University	Acuin, CS (corresponding author), Univ Philippines, Natl Inst Hlth, Inst Clin Epidemiol, Manila 1000, Philippines.	cesacuin@gmail.com		Khor, Geok Lin/0000-0002-4691-6319	Philippine government; UNICEF; United States Agency for International Development; WHO Regional Office for the Western Pacific; Institute of Gerontology; Universiti Putra Malaysia; International Life Sciences Institute SEA; SEAMEO TROPMED Regional Centre for Community Nutrition	Philippine government; UNICEF; United States Agency for International Development(United States Agency for International Development (USAID)); WHO Regional Office for the Western Pacific; Institute of Gerontology; Universiti Putra Malaysia; International Life Sciences Institute SEA; SEAMEO TROPMED Regional Centre for Community Nutrition	CSA is employed by the University of the Philippines, National Institutes of Health and has received consultancy fees from projects with the Philippine government, UNICEF, United States Agency for International Development, and WHO Regional Office for the Western Pacific. GLK has received consultancy fees from the Institute of Gerontology, Universiti Putra Malaysia, International Life Sciences Institute SEA, SEAMEO TROPMED Regional Centre for Community Nutrition, and is employed by the International Medical University, Malaysia. All other authors have no conflicts of interest.	Abu Bakar S, 1999, B WORLD HEALTH ORGAN, V77, P190; Ahmed MU, 2005, GOOD BAD PRACTICES; [Anonymous], 2010, COUNTD 2015; [Anonymous], 2010, WORLD HLTH STAT 2010; ASEAN Regional Programme for Disaster Management, REG STRAT DIS RED; Association of Southeast Asian Nations, 2010, 10 ASEAN HLTH MIN M; Azwar A, 2004, EVOLUTION SAFE MOTHE; Bhutta ZA, 2008, LANCET, V372, P972, DOI 10.1016/S0140-6736(08)61407-5; Bhutta ZA, 2008, LANCET, V371, P417, DOI 10.1016/S0140-6736(07)61693-6; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Boerma JT, 2008, LANCET, V371, P1259, DOI 10.1016/S0140-6736(08)60560-7; Boschi-Pinto C, 2010, INT J EPIDEMIOL, V39, P3, DOI 10.1093/ije/dyq018; Bryce J, 2010, INT J EPIDEMIOL, V39, P40, DOI 10.1093/ije/dyq020; Bureau of Policy and Strategy Ministry of Public Health, 2009, HLTH POL THAIL; Campbell OMR, 2006, LANCET, V368, P1284, DOI 10.1016/S0140-6736(06)69381-1; Chongsuvivatwong V, 2011, LANCET, V377, P429, DOI 10.1016/S0140-6736(10)61507-3; Chopra M, 2009, LANCET, V374, P835, DOI 10.1016/S0140-6736(09)61123-5; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; Darmstadt GL, 2005, LANCET, V365, P977, DOI 10.1016/S0140-6736(05)71088-6; Department of International Health, LIST LIV SAV TOOL EV; Fiszbein A, 2009, CONDITIONAL CASH TRA; Friberg IK, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000295; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; GWATKIN DR, 2007, SOCIOECONOMIC DIFFER; Hazel E, 2010, INT J EPIDEMIOL, V39, P32, DOI 10.1093/ije/dyq019; Health Policy and Strategy Institute, MEAS HLTH SYST PERF; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Jones G, 2003, LANCET, V362, P65, DOI 10.1016/S0140-6736(03)13811-1; Kerber KJ, 2007, LANCET, V370, P1358, DOI 10.1016/S0140-6736(07)61578-5; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Lawn JE, 2005, LANCET, V365, P891, DOI 10.1016/S0140-6736(05)71048-5; Limwattananon S, 2010, B WORLD HEALTH ORGAN, V88, P420, DOI 10.2471/BLT.09.068791; Ministry of Health Indonesia, NAT HLTH SURV 1980 2; National Statistics Office, 2006, MON SIT CHILDR WOM T; Ploslcy WD, 2009, LIVES SAVED TOOL COM; Pramualratana P., 2002, HLTH INSURANCE SYSTE; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rohde J, 2008, LANCET, V372, P950, DOI 10.1016/S0140-6736(08)61405-1; Stover J, 2010, INT J EPIDEMIOL, V39, P7, DOI 10.1093/ije/dyq016; Tangcharoensathien V, 2011, LANCET, V377, P863, DOI 10.1016/S0140-6736(10)61890-9; *TRIP COR GROUP, 2008, POST NARG JOINT ASS; UN Country Team Malaysia, 2005, MAL SUCC CHALL; United Nations Children's Fund (UNICEF), MULT IND CLUST SURV; Van Lerberghe W, 2001, STUDIES HLTH SERVICE, V17, P7; Victora CG, 2010, INT J EPIDEMIOL, V39, P1, DOI 10.1093/ije/dyq044; Victors CG, 2010, BMC PREGNANCY CHI S1, V10, pS4; Walker N, 2010, INT J EPIDEMIOL, V39, P21, DOI 10.1093/ije/dyq036; WHO, 2010, TRENDS MAT MORT 1990; WHO SEARO, 2004, IMPR MAT NEWB CHILD; WIBULPOLPRASERT S, 1991, HEALTH POLICY PLANN, V6, P354, DOI 10.1093/heapol/6.4.354; Wibulpolprasert S., 2007, THAILAND HLTH PROFIL; World Bank, WORLD DEV IND DAT; You D., 2010, LEVELS TRENDS CHILD	53	56	57	0	39	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2011	377	9764					516	525		10.1016/S0140-6736(10)62049-1	http://dx.doi.org/10.1016/S0140-6736(10)62049-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721TX	21269675	Bronze, Green Published			2022-12-28	WOS:000287381800033
J	Shetty, P				Shetty, Priya			Profile Dagfinn Hoybraten-new Board Chair of GAVI Alliance	LANCET			English	Biographical-Item												priya4876@gmail.com							0	1	1	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 5	2011	377	9764					459	459		10.1016/S0140-6736(11)60149-9	http://dx.doi.org/10.1016/S0140-6736(11)60149-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721TX	21296226				2022-12-28	WOS:000287381800014
J	Bulger, M; Groudine, M				Bulger, Michael; Groudine, Mark			Functional and Mechanistic Diversity of Distal Transcription Enhancers	CELL			English	Review							BETA-GLOBIN LOCUS; I HYPERSENSITIVE SITES; CONTROL REGION; GENE-EXPRESSION; ACTIVE GENES; HISTONE MODIFICATIONS; PROMOTER INTERACTIONS; RNA GENE; CHROMATIN; CTCF	Biological differences among metazoans and between cell types in a given organism arise in large part due to differences in gene expression patterns. Gene-distal enhancers are key contributors to these expression patterns, exhibiting both sequence diversity and cell type specificity. Studies of long-range interactions indicate that enhancers are often important determinants of nuclear organization, contributing to a general model for enhancer function that involves direct enhancer-promoter contact. However, mechanisms for enhancer function are emerging that do not fit solely within such a model, suggesting that enhancers as a class of DNA regulatory element may be functionally and mechanistically diverse.	[Bulger, Michael] Univ Rochester, Dept Pediat, Ctr Pediat Biomed Res, Rochester, NY 14627 USA; [Groudine, Mark] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Groudine, Mark] Univ Washington, Dept Radiat Oncol, Seattle, WA 98105 USA	University of Rochester; Fred Hutchinson Cancer Center; University of Washington; University of Washington Seattle	Bulger, M (corresponding author), Univ Rochester, Dept Pediat, Ctr Pediat Biomed Res, Rochester, NY 14627 USA.	michael_bulger@urmc.rochester.edu	Li, Yapeng/N-1042-2017	Li, Yapeng/0000-0002-5042-6881	NHLBI NIH HHS [R01 HL065440, R01 HL65440] Funding Source: Medline; NIDDK NIH HHS [R01 DK070687, R37 DK44746, R37 DK044746] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065440] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070687, R37DK044746] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Amano T, 2009, DEV CELL, V16, P47, DOI 10.1016/j.devcel.2008.11.011; Andrulis ED, 1998, NATURE, V394, P592, DOI 10.1038/29100; BANERJI J, 1981, CELL, V27, P299, DOI 10.1016/0092-8674(81)90413-X; BANERJI J, 1983, CELL, V33, P729, DOI 10.1016/0092-8674(83)90015-6; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bender MA, 2000, MOL CELL, V5, P387, DOI 10.1016/S1097-2765(00)80433-5; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blackwood EM, 1998, SCIENCE, V281, P60, DOI 10.1126/science.281.5373.60; Blow MJ, 2010, NAT GENET, V42, P806, DOI 10.1038/ng.650; Branco MR, 2007, TRENDS CELL BIOL, V17, P127, DOI 10.1016/j.tcb.2006.12.006; Brown JM, 2008, J CELL BIOL, V182, P1083, DOI 10.1083/jcb.200803174; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Butler JEF, 2001, GENE DEV, V15, P2515, DOI 10.1101/gad.924301; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Calhoun VC, 2003, P NATL ACAD SCI USA, V100, P9878, DOI 10.1073/pnas.1233791100; Calhoun VC, 2002, P NATL ACAD SCI USA, V99, P9243, DOI 10.1073/pnas.142291299; Chan YF, 2010, SCIENCE, V327, P302, DOI 10.1126/science.1182213; Chaturvedi CP, 2009, P NATL ACAD SCI USA, V106, P18303, DOI 10.1073/pnas.0906769106; Cosma MP, 1999, CELL, V97, P299, DOI 10.1016/S0092-8674(00)80740-0; Crawford GE, 2006, NAT METHODS, V3, P503, DOI 10.1038/NMETH888; Cremer T, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003889; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; CULLEN KE, 1993, SCIENCE, V261, P203, DOI 10.1126/science.8327891; de Bruin D, 2001, NATURE, V409, P109, DOI 10.1038/35051119; de Laat W, 2008, CURR TOP DEV BIOL, V82, P117, DOI 10.1016/S0070-2153(07)00005-1; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; deKok YJM, 1996, HUM MOL GENET, V5, P1229, DOI 10.1093/hmg/5.9.1229; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; Dobi KC, 2007, MOL CELL BIOL, V27, P5575, DOI 10.1128/MCB.00459-07; Dorsett D, 1999, CURR OPIN GENET DEV, V9, P505, DOI 10.1016/S0959-437X(99)00002-7; Dostie J, 2006, GENOME RES, V16, P1299, DOI 10.1101/gr.5571506; Drissen R, 2004, GENE DEV, V18, P2485, DOI 10.1101/gad.317004; ELGIN SCR, 1988, J BIOL CHEM, V263, P19259; Emison ES, 2005, NATURE, V434, P857, DOI 10.1038/nature03467; Ferrai C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000588; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Francastel C, 1999, CELL, V99, P259, DOI 10.1016/S0092-8674(00)81657-8; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; GROSS DS, 1988, ANNU REV BIOCHEM, V57, P159, DOI 10.1146/annurev.bi.57.070188.001111; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Hardison R, 1997, GENE, V205, P73, DOI 10.1016/S0378-1119(97)00474-5; Hare EE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000106; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Ho YG, 2002, MOL CELL, V9, P291, DOI 10.1016/S1097-2765(02)00447-1; Ho YG, 2006, MOL CELL, V23, P365, DOI 10.1016/j.molcel.2006.05.041; Holmes SG, 1996, GENE DEV, V10, P1021, DOI 10.1101/gad.10.8.1021; Hou CH, 2010, P NATL ACAD SCI USA, V107, P3651, DOI 10.1073/pnas.0912087107; Iborra FJ, 1996, J CELL SCI, V109, P1427; Juven-Gershon T, 2008, GENE DEV, V22, P2823, DOI 10.1101/gad.1698108; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kim A, 2007, MOL CELL BIOL, V27, P2980, DOI 10.1128/MCB.02337-06; Kim E, 2007, NUCLEIC ACIDS RES, V35, P125, DOI 10.1093/nar/gkl924; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kleinjan DA, 2005, AM J HUM GENET, V76, P8, DOI 10.1086/426833; Koch CM, 2007, GENOME RES, V17, P691, DOI 10.1101/gr.5704207; Koch F, 2008, TRENDS BIOCHEM SCI, V33, P265, DOI 10.1016/j.tibs.2008.04.006; Krebs JE, 1999, GENE DEV, V13, P1412, DOI 10.1101/gad.13.11.1412; Kurukuti S, 2006, P NATL ACAD SCI USA, V103, P10684, DOI 10.1073/pnas.0600326103; Leach KM, 2001, MOL CELL BIOL, V21, P2629, DOI 10.1128/MCB.21.8.2629-2640.2001; Lettice LA, 2003, HUM MOL GENET, V12, P1725, DOI 10.1093/hmg/ddg180; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Liber D, 2010, CELL STEM CELL, V7, P114, DOI 10.1016/j.stem.2010.05.020; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; McGaughey DM, 2008, GENOME RES, V18, P252, DOI 10.1101/gr.6929408; Melnikova L, 2008, CHROMOSOMA, V117, P137, DOI 10.1007/s00412-007-0132-6; Miele A, 2008, MOL BIOSYST, V4, P1046, DOI 10.1039/b803580f; Miele Adriana, 2008, V464, P105; Moen PT, 2004, MOL BIOL CELL, V15, P197, DOI 10.1091/mbc.e03-06-0388; MOON AM, 1990, P NATL ACAD SCI USA, V87, P7693, DOI 10.1073/pnas.87.19.7693; Moreau P., 1981, NUCLEIC ACIDS RES, V9, P6047; MORROW BE, 1993, MOL CELL BIOL, V13, P1283, DOI 10.1128/MCB.13.2.1283; NEIGEBORN L, 1990, NUCLEIC ACIDS RES, V18, P4179, DOI 10.1093/nar/18.14.4179; Noonan JP, 2010, ANNU REV GENOM HUM G, V11, P1, DOI 10.1146/annurev-genom-082509-141651; Noonan JP, 2009, CURR OPIN GENET DEV, V19, P557, DOI 10.1016/j.gde.2009.10.002; Noordermeer D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000016; Odom DT, 2007, NAT GENET, V39, P730, DOI 10.1038/ng2047; Ohtsuki S, 1998, GENE DEV, V12, P547, DOI 10.1101/gad.12.4.547; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Pant V, 2004, MOL CELL BIOL, V24, P3497, DOI 10.1128/MCB.24.8.3497-3504.2004; Petrascheck M, 2005, NUCLEIC ACIDS RES, V33, P3743, DOI 10.1093/nar/gki689; Phillips JE, 2009, CELL, V137, P1194, DOI 10.1016/j.cell.2009.06.001; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Prabhakar S, 2006, SCIENCE, V314, P786, DOI 10.1126/science.1130738; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; Rada-Iglesias A, 2011, NATURE, V470, P279, DOI 10.1038/nature09692; Ragoczy T, 2003, CHROMOSOME RES, V11, P513, DOI 10.1023/A:1024939130361; Ragoczy T, 2006, GENE DEV, V20, P1447, DOI 10.1101/gad.1419506; Rebeiz M, 2009, SCIENCE, V326, P1663, DOI 10.1126/science.1178357; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Rollins RA, 1999, GENETICS, V152, P577; Rubio ED, 2008, P NATL ACAD SCI USA, V105, P8309, DOI 10.1073/pnas.0801273105; Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547; Sagai T, 2005, DEVELOPMENT, V132, P797, DOI 10.1242/dev.01613; Sawado T, 2003, GENE DEV, V17, P1009, DOI 10.1101/gad.1072303; Schmidt D, 2010, SCIENCE, V328, P1036, DOI 10.1126/science.1186176; Schoenfelder S, 2010, NAT GENET, V42, P53, DOI 10.1038/ng.496; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Splinter E, 2006, GENE DEV, V20, P2349, DOI 10.1101/gad.399506; STAMATOYANNOPOULOS JA, 1995, EMBO J, V14, P106, DOI 10.1002/j.1460-2075.1995.tb06980.x; Sutherland H, 2009, NAT REV GENET, V10, P457, DOI 10.1038/nrg2592; Swanson CI, 2010, DEV CELL, V18, P359, DOI 10.1016/j.devcel.2009.12.026; Taddei A, 2007, CURR OPIN CELL BIOL, V19, P305, DOI 10.1016/j.ceb.2007.04.012; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Vakoc CR, 2005, MOL CELL, V17, P453, DOI 10.1016/j.molcel.2004.12.028; Valenzuela L, 2008, MOL CELL BIOL, V28, P1924, DOI 10.1128/MCB.01647-07; Visel A, 2009, NATURE, V461, P199, DOI 10.1038/nature08451; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730; Wai H, 2001, MOL CELL BIOL, V21, P5541, DOI 10.1128/MCB.21.16.5541-5553.2001; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Wilson MD, 2008, SCIENCE, V322, P434, DOI 10.1126/science.1160930; WU C, 1980, NATURE, V286, P854, DOI 10.1038/286854a0; Xi HL, 2007, PLOS GENET, V3, P1377, DOI 10.1371/journal.pgen.0030136; Xu H, 2001, CURR OPIN MICROBIOL, V4, P138, DOI 10.1016/S1369-5274(00)00179-X; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Xu M, 2008, J CELL BIOL, V181, P615, DOI 10.1083/jcb.200710053; Yusufzai TM, 2004, MOL CELL, V13, P291, DOI 10.1016/S1097-2765(04)00029-2; Zhao Z, 2006, NAT GENET, V38, P1341, DOI 10.1038/ng1891; Zhu XG, 2007, NUCLEIC ACIDS RES, V35, P5532, DOI 10.1093/nar/gkm595; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	126	573	595	4	84	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2011	144	3					327	339		10.1016/j.cell.2011.01.024	http://dx.doi.org/10.1016/j.cell.2011.01.024			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295696	Green Accepted, Bronze			2022-12-28	WOS:000286973100006
J	Benning, A; Dixon-Woods, M; Nwulu, U; Ghaleb, M; Dawson, J; Barber, N; Franklin, BD; Girling, A; Hemming, K; Carmalt, M; Rudge, G; Naicker, T; Kotecha, A; Derrington, MC; Lilford, R				Benning, Amirta; Dixon-Woods, Mary; Nwulu, Ugochi; Ghaleb, Maisoon; Dawson, Jeremy; Barber, Nick; Franklin, Bryony Dean; Girling, Alan; Hemming, Karla; Carmalt, Martin; Rudge, Gavin; Naicker, Thirumalai; Kotecha, Amit; Derrington, M. Clare; Lilford, Richard			Multiple component patient safety intervention in English hospitals: controlled evaluation of second phase	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CARE-NATIONAL-AUDIT; FRAMEWORK; ADMISSIONS; MORTALITY; ADULT; UNITS; WORK	Objective To independently evaluate the impact of the second phase of the Health Foundation's Safer Patients Initiative (SPI2) on a range of patient safety measures. Design A controlled before and after design. Five substudies: survey of staff attitudes; review of case notes from high risk (respiratory) patients in medical wards; review of case notes from surgical patients; indirect evaluation of hand hygiene by measuring hospital use of handwashing materials; measurement of outcomes (adverse events, mortality among high risk patients admitted to medical wards, patients' satisfaction, mortality in intensive care, rates of hospital acquired infection). Setting NHS hospitals in England. Participants Nine hospitals participating in SPI2 and nine matched control hospitals. Intervention The SPI2 intervention was similar to the SPI1, with somewhat modified goals, a slightly longer intervention period, and a smaller budget per hospital. Results One of the scores (organisational climate) showed a significant (P=0.009) difference in rate of change over time, which favoured the control hospitals, though the difference was only 0.07 points on a five point scale. Results of the explicit case note reviews of high risk medical patients showed that certain practices improved over time in both control and SPI2 hospitals (and none deteriorated), but there were no significant differences between control and SPI2 hospitals. Monitoring of vital signs improved across control and SPI2 sites. This temporal effect was significant for monitoring the respiratory rate at both the six hour (adjusted odds ratio 2.1, 99% confidence interval 1.0 to 4.3; P=0.010) and 12 hour (2.4, 1.1 to 5.0; P=0.002) periods after admission. There was no significant effect of SPI for any of the measures of vital signs. Use of a recommended system for scoring the severity of pneumonia improved from 1.9% (1/52) to 21.4% (12/56) of control and from 2.0% (1/50) to 41.7% (25/60) of SPI2 patients. This temporal change was significant (7.3, 1.4 to 37.7; P=0.002), but the difference in difference was not significant (2.1, 0.4 to 11.1; P=0.236). There were no notable or significant changes in the pattern of prescribing errors, either over time or between control and SPI2 hospitals. Two items of medical history taking (exercise tolerance and occupation) showed significant improvement over time, across both control and SPI2 hospitals, but no additional SPI2 effect. The holistic review showed no significant changes in error rates either over time or between control and SPI2 hospitals. The explicit case note review of perioperative care showed that adherence rates for two of the four perioperative standards targeted by SPI2 were already good at baseline, exceeding 94% for antibiotic prophylaxis and 98% for deep vein thrombosis prophylaxis. Intraoperative monitoring of temperature improved over time in both groups, but this was not significant (1.8, 0.4 to 7.6; P=0.279), and there were no additional effects of SPI2. A dramatic rise in consumption of soap and alcohol hand rub was similar in control and SPI2 hospitals (P=0.760 and P=0.889, respectively), as was the corresponding decrease in rates of Clostridium difficile and meticillin resistant Staphylococcus aureus infection (P=0.652 and P=0.693, respectively). Mortality rates of medical patients included in the case note reviews in control hospitals increased from 17.3% (42/ 243) to 21.4% (24/112), while in SPI2 hospitals they fell from 10.3% (24/233) to 6.1% (7/114) (P=0.043). Fewer than 8% of deaths were classed as avoidable; changes in proportions could not explain the divergence of overall death rates between control and SPI2 hospitals. There was no significant difference in the rate of change in mortality in intensive care. Patients' satisfaction improved in both control and SPI2 hospitals on all dimensions, but again there were no significant changes between the two groups of hospitals. Conclusions Many aspects of care are already good or improving across the NHS in England, suggesting considerable improvements in quality across the board. These improvements are probably due to contemporaneous policy activities relating to patient safety, including those with features similar to the SPI, and the emergence of professional consensus on some clinical processes. This phenomenon might have attenuated the incremental effect of the SPI, making it difficult to detect. Alternatively, the full impact of the SPI might be observable only in the longer term. The conclusion of this study could have been different if concurrent controls had not been used.	[Benning, Amirta; Girling, Alan; Hemming, Karla; Rudge, Gavin; Naicker, Thirumalai; Lilford, Richard] Univ Birmingham, Sch Hlth & Populat Sci, Edgbaston B15 2TT, W Midlands, England; [Dixon-Woods, Mary] Univ Leicester, Dept Hlth Sci, Leicester LE1 7RH, Leics, England; [Nwulu, Ugochi] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp, Clin Invest Unit, Birmingham B15 2TH, W Midlands, England; [Franklin, Bryony Dean] Univ London, Sch Pharm, Dept Practice & Policy, Ctr Medicat Safety & Serv Qual, London WC1N 1AX, England; [Ghaleb, Maisoon] Univ Hertfordshire, Sch Pharm, Hatfield AL10 9AB, Herts, England; [Dawson, Jeremy] Aston Univ, Aston Business Sch, Work & Org Psychol Grp, Birmingham B4 7ET, W Midlands, England; [Franklin, Bryony Dean] Imperial Coll Healthcare NHS Trust, St Marys Hosp, Ctr Medicat Safety & Serv Qual, London W2 1NY, England; [Carmalt, Martin; Kotecha, Amit] Royal Orthopaed Hosp, Birmingham B31 2AP, W Midlands, England	University of Birmingham; University of Leicester; University of Birmingham; University of London; University College London; University of London School of Pharmacy; University of Hertfordshire; Aston University; Imperial College London; Royal Orthopaedic Hospital	Lilford, R (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Edgbaston B15 2TT, W Midlands, England.	r.j.lilford@bham.ac.uk	Hemming, karla/AAB-3391-2021; Girling, Alan J/A-7843-2012; Nwulu, Ugochi/G-9245-2011	Hemming, karla/0000-0002-2226-6550; Nwulu, Ugochi/0000-0002-4720-4751; Nwulu, Ugochi/0000-0001-6372-176X; Franklin, Bryony/0000-0002-2892-1245; Girling, Alan/0000-0003-2022-045X; Dixon-Woods, Mary/0000-0002-5915-0041	Health Foundation; National Patient Safety Agency; National Institute for Health Research Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country; Engineering and Physical Sciences Research Council, Multidisciplinary Assessment of Technology Centre for Healthcare; National Institute of Health Research; Engineering and Physical Sciences Research Council [EP/F063822/1] Funding Source: researchfish; Medical Research Council [G0800808] Funding Source: researchfish; EPSRC [EP/F063822/1] Funding Source: UKRI; MRC [G0800808] Funding Source: UKRI	Health Foundation; National Patient Safety Agency; National Institute for Health Research Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country; Engineering and Physical Sciences Research Council, Multidisciplinary Assessment of Technology Centre for Healthcare(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Institute of Health Research(National Institute for Health Research (NIHR)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Health Foundation and the National Patient Safety Agency. KH was funded by the National Institute for Health Research Collaborations for Leadership in Applied Health Research and Care for Birmingham and Black Country, and AG by the Engineering and Physical Sciences Research Council, Multidisciplinary Assessment of Technology Centre for Healthcare programme. The Centre for Medication Safety and Service Quality is affiliated with the Centre for Patient Safety and Service Quality at Imperial College Healthcare NHS Trust, which is funded by the National Institute of Health Research. The evaluation was sponsored for research governance purposes by the University of Birmingham. The study was designed independently by the researchers. The researchers acted independently but worked collaboratively with the funder. The researchers independently collected, analysed and interpreted the data. The researchers wrote this article independently. The funders were given the opportunity to provide comments before submission. All researchers (apart from CD) had the opportunity to access participant anonymised data.	Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Bate P., 2008, ORG QUALITY IMPROVEM; Benning A, 2010, CONTROLLED EVALUATIO; Benning A, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d195; Borrill C, 2000, BRIT J HLTH CARE, V6, P364, DOI DOI 10.12968/BJHC.2000.6.8.19300; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; British Orthopaedic Association, 2006, PRIM TOT HIP REPL GU; Brown C, 2008, QUAL SAF HEALTH CARE, V17, P163, DOI 10.1136/qshc.2007.023648; Campbell SE, 2001, INT J QUAL HEALTH C, V13, P309, DOI 10.1093/intqhc/13.4.309; Davidoff F, 2009, JAMA-J AM MED ASSOC, V302, P2580, DOI 10.1001/jama.2009.1845; Department of Health, 2010, BEDS OP OV ENGL; Department of Health, 2007, SAV LIV RED INF DEL; Dixon-Woods M, 2010, QUAL SAF HEALTH CARE, V19, P74, DOI 10.1136/qshc.2008.029504; EPSTEIN S, 1995, SCI TECHNOL HUM VAL, V20, P408, DOI 10.1177/016224399502000402; Gallivan S, 2008, DRUG SAFETY, V31, P637, DOI 10.2165/00002018-200831080-00001; GUZZO RA, 1985, PERS PSYCHOL, V38, P275, DOI 10.1111/j.1744-6570.1985.tb00547.x; Harrison DA, 2006, CRIT CARE MED, V34, P1378, DOI 10.1097/01.CCM.0000216702.94014.75; Harrison DA, 2004, CRIT CARE, V8, pR99, DOI 10.1186/cc2834; Harrison DA, 2007, CRIT CARE MED, V35, P1091, DOI 10.1097/01.CCM.0000259468.24532.44; Healthcare Commission, 2006, MAK SENS YOUR STAFF; Hillman K, 2005, LANCET, V365, P2091; House of Commons Health Committee, 2009, 6 HOUS COMM HLTH COM; Institute for Healthcare Improvement, 2007, GUID PREV SURG SIT I; Keogh-Brown M, 2007, HEALTH TECHNOL ASSES, V11, P1; Leape LL, 2005, JAMA-J AM MED ASSOC, V293, P2384, DOI 10.1001/jama.293.19.2384; Lilford Richard, 2007, J Health Serv Res Policy, V12, P173, DOI 10.1258/135581907781543012; LILFORD RJ, 2010, BMJ-BRIT MED J, V341, pC4413, DOI DOI 10.1136/BMJ.C4413; Michie S, 2004, INT J MANAG REV, V5-6, P91, DOI 10.1111/j.1460-8545.2004.00098.x; National Institute for Health and Clinical Excellence, 2008, 65 NAT I HLTH CLIN E; National Institute for Health and Clinical Excellence, 2010, 74 NAT I HLTH CLIN E; National Institute for Health and Clinical Excellence, 2007, CG50  NAT I HLTH CLI; National Patient Safety Agency, 2010, CLEAN CAMP; SACKS H, 1982, AM J MED, V72, P233, DOI 10.1016/0002-9343(82)90815-4; Slaughter MJ, 2001, J INT ECON, V55, P203, DOI 10.1016/S0022-1996(00)00087-8; Stone S, 2007, J HOSP INFECT, V66, P293, DOI 10.1016/j.jhin.2007.04.011; West MA, 2006, J ORGAN BEHAV, V27, P983, DOI 10.1002/job.396	36	75	78	0	26	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 3	2011	342								d199	10.1136/bmj.d199	http://dx.doi.org/10.1136/bmj.d199			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	718PW	21292720	Green Accepted, Green Submitted, Green Published, hybrid			2022-12-28	WOS:000287138500003
J	Letessier, A; Millot, GA; Koundrioukoff, S; Lachages, AM; Vogt, N; Hansen, RS; Malfoy, B; Brison, O; Debatisse, M				Letessier, Anne; Millot, Gael A.; Koundrioukoff, Stephane; Lachages, Anne-Marie; Vogt, Nicolas; Hansen, R. Scott; Malfoy, Bernard; Brison, Olivier; Debatisse, Michelle			Cell-type-specific replication initiation programs set fragility of the FRA3B fragile site	NATURE			English	Article							DNA-REPLICATION; MOLECULAR-BASIS; ORIGIN CHOICE; COMMON; GENOME; FORK; CANCER; CHROMOSOMES; INSTABILITY; INDUCTION	Common fragile sites have long been identified by cytogeneticists as chromosomal regions prone to breakage upon replication stress(1). They are increasingly recognized to be preferential targets for oncogene-induced DNA damage in pre-neoplastic lesions(2) and hotspots for chromosomal rearrangements in various cancers(3). Common fragile site instability was attributed to the fact that they contain sequences prone to form secondary structures that may impair replication fork movement, possibly leading to fork collapse resulting in DNA breaks(4). Here we show, in contrast to this view, that the fragility of FRA3B-the most active common fragile site in human lymphocytes-does not rely on fork slowing or stalling but on a paucity of initiation events. Indeed, in lymphoblastoid cells, but not in fibroblasts, initiation events are excluded from a FRA3B core extending approximately 700 kilobases, which forces forks coming from flanking regions to cover long distances in order to complete replication. We also show that origins of the flanking regions fire in mid-S phase, leaving the site incompletely replicated upon fork slowing. Notably, FRA3B instability is specific to cells showing this particular initiation pattern. The fact that both origin setting(5,6) and replication timing are highly plastic(7,8) in mammalian cells explains the tissue specificity of common fragile site instability we observed. Thus, we propose that common fragile sites correspond to the latest initiation-poor regions to complete replication in a given cell type. For historical reasons, common fragile sites have been essentially mapped in lymphocytes(1). Therefore, common fragile site contribution to chromosomal rearrangements in tumours should be reassessed after mapping fragile sites in the cell type from which each tumour originates.	[Letessier, Anne; Millot, Gael A.; Koundrioukoff, Stephane; Lachages, Anne-Marie; Vogt, Nicolas; Malfoy, Bernard; Brison, Olivier; Debatisse, Michelle] Inst Curie, Ctr Rech, F-75248 Paris, France; [Letessier, Anne; Millot, Gael A.; Koundrioukoff, Stephane; Lachages, Anne-Marie; Vogt, Nicolas; Malfoy, Bernard; Brison, Olivier; Debatisse, Michelle] Univ Paris 06, F-75005 Paris, France; [Letessier, Anne; Millot, Gael A.; Koundrioukoff, Stephane; Lachages, Anne-Marie; Vogt, Nicolas; Malfoy, Bernard; Brison, Olivier; Debatisse, Michelle] CNRS, UMR 3244, F-75248 Paris, France; [Hansen, R. Scott] Univ Washington, Div Med Genet, Dept Med, Sch Med, Seattle, WA 98195 USA	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; University of Washington; University of Washington Seattle	Debatisse, M (corresponding author), Inst Curie, Ctr Rech, 26 Rue Ulm, F-75248 Paris, France.	michelle.debatisse@curie.fr	Millot, Gael/AAO-7115-2020; Letessier, Anne/M-3431-2017	Letessier, Anne/0000-0002-1894-4072; Lachages, Anne-Marie/0000-0003-1771-1880	ARC(Association pour la recherche sur le cancer); La Ligue Nationale contre le Cancer (LNCC); INCa (Institut National du Cancer) [2009-1-PLBIO-10-IC-1]; PIC Replication, Instabilite Chromosomique et Cancer (Institut Curie)	ARC(Association pour la recherche sur le cancer)(Fondation ARC pour la Recherche sur le Cancer); La Ligue Nationale contre le Cancer (LNCC); INCa (Institut National du Cancer)(Institut National du Cancer (INCA) France); PIC Replication, Instabilite Chromosomique et Cancer (Institut Curie)	We thank E. Blackburn for critical reading of the manuscript. We thank Genomic Vision for making the DNA combing technology available to us. We acknowledge the Nikon Imaging Centre at Institut Curie-CNRS. We thank C. Rouzaud for help in combing experiments. A.L. is supported by a grant from the ARC(Association pour la recherche sur le cancer). The M.D. team is supported by La Ligue Nationale contre le Cancer (LNCC) (Equipe Labellisee EL2008. LNCC/MD), INCa (Institut National du Cancer) (2009-1-PLBIO-10-IC-1) and the PIC Replication, Instabilite Chromosomique et Cancer (Institut Curie).	Anglana M, 2003, CELL, V114, P385, DOI 10.1016/S0092-8674(03)00569-5; Bielinsky AK, 2003, CELL CYCLE, V2, P307, DOI 10.4161/cc.2.4.435; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Cha RS, 2002, SCIENCE, V297, P602, DOI 10.1126/science.1071398; Courbet S, 2008, NATURE, V455, P557, DOI 10.1038/nature07233; Dazy S, 2006, EMBO REP, V7, P806, DOI 10.1038/sj.embor.7400736; Durkin SG, 2008, P NATL ACAD SCI USA, V105, P246, DOI 10.1073/pnas.0708097105; Durkin SG, 2007, ANNU REV GENET, V41, P169, DOI 10.1146/annurev.genet.41.042007.165900; El Achkar E, 2005, P NATL ACAD SCI USA, V102, P18069, DOI 10.1073/pnas.0506497102; Farkash-Amar S, 2008, GENOME RES, V18, P1562, DOI 10.1101/gr.079566.108; Gregoire D, 2006, EMBO REP, V7, P812, DOI 10.1038/sj.embor.7400758; Hansen RS, 2010, P NATL ACAD SCI USA, V107, P139, DOI 10.1073/pnas.0912402107; Helmrich A, 2006, GENOME RES, V16, P1222, DOI 10.1101/gr.5335506; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Huebner K, 2003, BRIT J CANCER, V88, P1501, DOI 10.1038/sj.bjc.6600937; Labit H, 2008, BIOTECHNIQUES, V45, P649, DOI 10.2144/000113002; Le Beau MM, 1998, HUM MOL GENET, V7, P755, DOI 10.1093/hmg/7.4.755; Lebofsky R, 2006, MOL BIOL CELL, V17, P5337, DOI 10.1091/mbc.E06-04-0298; Masai H, 2010, ANNU REV BIOCHEM, V79, P89, DOI 10.1146/annurev.biochem.052308.103205; Michalet X, 1997, SCIENCE, V277, P1518, DOI 10.1126/science.277.5331.1518; Negrini S, 2010, NAT REV MOL CELL BIO, V11, P220, DOI 10.1038/nrm2858; O'Keefe LV, 2006, CANCER LETT, V232, P37, DOI 10.1016/j.canlet.2005.07.041; Palumbo E., 2010, CHROMOSOMA; Pichiorri F, 2008, J CELL BIOCHEM, V104, P1525, DOI 10.1002/jcb.21560; R Development Core Team, 2006, R LANG ENV STAT COMP; Rothstein R, 2000, GENE DEV, V14, P1; Ryba T, 2010, GENOME RES, V20, P761, DOI 10.1101/gr.099655.109; Schwartz M, 2006, CANCER LETT, V232, P13, DOI 10.1016/j.canlet.2005.07.039; SUTHERLAND GR, 1995, CURR OPIN GENET DEV, V5, P323, DOI 10.1016/0959-437X(95)80046-8; Tourriere H, 2007, DNA REPAIR, V6, P900, DOI 10.1016/j.dnarep.2007.02.004; Tsantoulis PK, 2008, ONCOGENE, V27, P3256, DOI 10.1038/sj.onc.1210989	32	303	304	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 3	2011	470	7332					120	U138		10.1038/nature09745	http://dx.doi.org/10.1038/nature09745			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21258320				2022-12-28	WOS:000286886400046
J	Schoener, TW				Schoener, Thomas W.			The Newest Synthesis: Understanding the Interplay of Evolutionary and Ecological Dynamics	SCIENCE			English	Review							RAPID EVOLUTION; POPULATION-GROWTH; GENETIC DIVERSITY; EFFECT SIZE; TIME; SELECTION; COEVOLUTION; COMMUNITIES; ECOSYSTEMS; DEMOGRAPHY	The effect of ecological change on evolution has long been a focus of scientific research. The reverse-how evolutionary dynamics affect ecological traits-has only recently captured our attention, however, with the realization that evolution can occur over ecological time scales. This newly highlighted causal direction and the implied feedback loop-eco-evolutionary dynamics-is invigorating both ecologists and evolutionists and blurring the distinction between them. Despite some recent relevant studies, the importance of the evolution-to-ecology pathway across systems is still unknown. Only an extensive research effort involving multiple experimental approaches-particularly long-term field experiments-over a variety of ecological communities will provide the answer.	Univ Calif Davis, Davis, CA 95616 USA	University of California System; University of California Davis	Schoener, TW (corresponding author), Univ Calif Davis, 1 Shields Ave, Davis, CA 95616 USA.	twschoener@ucdavis.edu			NSF	NSF(National Science Foundation (NSF))	I thank S. P. Ellner, G. F. Fussmann, N. G. Hairston Jr., and J. B. Losos for very helpful comments. Supported by grants from NSF.	Abrams PA, 1997, EVOLUTION, V51, P1742, DOI 10.1111/j.1558-5646.1997.tb05098.x; Abrams PA, 2000, ANNU REV ECOL SYST, V31, P79, DOI 10.1146/annurev.ecolsys.31.1.79; Bailey JK, 2009, PHILOS T R SOC B, V364, P1607, DOI 10.1098/rstb.2008.0336; Bassar RD, 2010, P NATL ACAD SCI USA, V107, P3616, DOI 10.1073/pnas.0908023107; Becks L, 2010, ECOL LETT, V13, P989, DOI 10.1111/j.1461-0248.2010.01490.x; Brockhurst MA, 2007, EVOLUTION, V61, P1238, DOI 10.1111/j.1558-5646.2007.00087.x; Bull JJ, 2006, AM NAT, V167, pE39, DOI 10.1086/499374; Carroll SP, 2007, FUNCT ECOL, V21, P387, DOI 10.1111/j.1365-2435.2007.01289.x; CHITTY DENNIS, 1960, CANADIAN JOUR ZOOL, V38, P99, DOI 10.1139/z60-011; Coulson T, 2006, P ROY SOC B-BIOL SCI, V273, P547, DOI 10.1098/rspb.2005.3357; Coulson T, 2010, J ANIM ECOL, V79, P1226, DOI 10.1111/j.1365-2656.2010.01734.x; Darimont CT, 2009, P NATL ACAD SCI USA, V106, P952, DOI 10.1073/pnas.0809235106; Duffy MA, 2009, ECOLOGY, V90, P1441, DOI 10.1890/08-1130.1; Estes S, 2007, AM NAT, V169, P227, DOI 10.1086/510633; Ezard THG, 2009, PHILOS T R SOC B, V364, P1491, DOI 10.1098/rstb.2009.0006; Fussmann GF, 2007, FUNCT ECOL, V21, P465, DOI 10.1111/j.1365-2435.2007.01275.x; GINGERICH PD, 1983, SCIENCE, V222, P159, DOI 10.1126/science.222.4620.159; Grant P. R., 2008, WHY SPECIES MULTIPLY; Hairston NG, 2005, ECOL LETT, V8, P1114, DOI 10.1111/j.1461-0248.2005.00812.x; Haloin JR, 2008, ANN NY ACAD SCI, V1133, P87, DOI 10.1196/annals.1438.003; Harmon LJ, 2009, NATURE, V458, P1167, DOI 10.1038/nature07974; Hendry AP, 1999, EVOLUTION, V53, P1637, DOI 10.1111/j.1558-5646.1999.tb04550.x; Hoekstra HE, 2001, P NATL ACAD SCI USA, V98, P9157, DOI 10.1073/pnas.161281098; Hughes AR, 2008, ECOL LETT, V11, P609, DOI 10.1111/j.1461-0248.2008.01179.x; Johnson MTJ, 2009, PHILOS T R SOC B, V364, P1593, DOI 10.1098/rstb.2008.0334; Kerr B, 2006, NATURE, V442, P75, DOI 10.1038/nature04864; Kinnison MT, 2007, FUNCT ECOL, V21, P444, DOI 10.1111/j.1365-2435.2007.01278.x; Kokko H, 2007, ECOL LETT, V10, P773, DOI 10.1111/j.1461-0248.2007.01086.x; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.2307/2408842; Lennon JT, 2008, ECOL LETT, V11, P1178, DOI 10.1111/j.1461-0248.2008.01225.x; LOSOS JB, 1994, ANNU REV ECOL SYST, V25, P467, DOI 10.1146/annurev.es.25.110194.002343; Olsen EM, 2004, NATURE, V428, P932, DOI 10.1038/nature02430; Ozgul A, 2010, NATURE, V466, P482, DOI 10.1038/nature09210; Palkovacs EP, 2009, PHILOS T R SOC B, V364, P1617, DOI 10.1098/rstb.2009.0016; Pearse DE, 2009, J HERED, V100, P515, DOI 10.1093/jhered/esp040; Pelletier F, 2009, PHILOS T R SOC B, V364, P1483, DOI 10.1098/rstb.2009.0027; Pelletier F, 2007, SCIENCE, V315, P1571, DOI 10.1126/science.1139024; PIMENTEL D, 1961, AM NAT, V95, P65, DOI 10.1086/282160; Reznick D., 2004, EVOLUTIONARY CONSERV; Reznick DN, 2001, GENETICA, V112, P183, DOI 10.1023/A:1013352109042; Saccheri I, 2006, TRENDS ECOL EVOL, V21, P341, DOI 10.1016/j.tree.2006.03.018; Siepielski AM, 2009, ECOL LETT, V12, P1261, DOI 10.1111/j.1461-0248.2009.01381.x; SLOBODKIN LAWRENCE B., 1961; Stenseth N. C., 1993, BIOL LEMMINGS, P62; Strauss SY, 2008, ECOL LETT, V11, P199, DOI 10.1111/j.1461-0248.2007.01128.x; TAPER ML, 1985, ECOLOGY, V66, P355, DOI 10.2307/1940385; Terhorst CP, 2010, ECOLOGY, V91, P629, DOI 10.1890/09-1481.1; Thompson JN, 1998, TRENDS ECOL EVOL, V13, P329, DOI 10.1016/S0169-5347(98)01378-0; Whitham TG, 2006, NAT REV GENET, V7, P510, DOI 10.1038/nrg1877	49	649	658	7	589	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					426	429		10.1126/science.1193954	http://dx.doi.org/10.1126/science.1193954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273479				2022-12-28	WOS:000286635900043
J	Bouwens, RJ; Illingworth, GD; Labbe, I; Oesch, PA; Trenti, M; Carollo, CM; van Dokkum, PG; Franx, M; Stiavelli, M; Gonzalez, V; Magee, D; Bradley, L				Bouwens, R. J.; Illingworth, G. D.; Labbe, I.; Oesch, P. A.; Trenti, M.; Carollo, C. M.; van Dokkum, P. G.; Franx, M.; Stiavelli, M.; Gonzalez, V.; Magee, D.; Bradley, L.			A candidate redshift z approximate to 10 galaxy and rapid changes in that population at an age of 500 Myr	NATURE			English	Article							LYMAN-BREAK GALAXIES; STELLAR MASS DENSITY; ULTRA DEEP FIELD; STAR-FORMING GALAXIES; LUMINOSITY FUNCTION; SPECTROSCOPIC CONFIRMATION; EVOLUTION; REIONIZATION; EPOCH; Z-SIMILAR-TO-5	Searches for very-high-redshift galaxies over the past decade have yielded a large sample of more than 6,000 galaxies existing just 900-2,000 million years (Myr) after the Big Bang (redshifts 6 > z > 3; ref. 1). The Hubble Ultra Deep Field (HUDF09) data(2,3) have yielded the first reliable detections of z approximate to 8 galaxies(3-9) that, together with reports of a c-ray burst at z approximate to 8.2 (refs 10, 11), constitute the earliest objects reliably reported to date. Observations of z approximate to 7-8 galaxies suggest substantial star formation at z > 9-10 (refs 12, 13). Here we use the full two-year HUDF09 data to conduct an ultra-deep search for z approximate to 10 galaxies in the heart of the reionization epoch, only 500 Myr after the Big Bang. Not only do we find one possible z approximate to 10 galaxy candidate, but we show that, regardless of source detections, the star formation rate density is much smaller (similar to 10%) at this time than it is just similar to 200 Myr later at z approximate to 8. This demonstrates how rapid galaxy build-up was at z approximate to 10, as galaxies increased in both luminosity density and volume density from z approximate to 10 to z approximate to 8. The 100-200 Myr before z approximate to 10 is clearly a crucial phase in the assembly of the earliest galaxies.	[Bouwens, R. J.; Illingworth, G. D.; Gonzalez, V.; Magee, D.] Univ Calif Santa Cruz, Dept Astron, Santa Cruz, CA 95064 USA; [Bouwens, R. J.; Franx, M.] Leiden Univ, Leiden Observ, NL-2333 Leiden, Netherlands; [Labbe, I.] Carnegie Observ, Pasadena, CA 91101 USA; [Oesch, P. A.; Carollo, C. M.] Swiss Fed Inst Technol, Inst Astron, CH-8093 Zurich, Switzerland; [Trenti, M.] Univ Colorado, Ctr Astrophys & Space Astron, Boulder, CO 80303 USA; [van Dokkum, P. G.] Yale Univ, Dept Astron, New Haven, CT 06520 USA; [Stiavelli, M.; Bradley, L.] Space Telescope Sci Inst, Baltimore, MD 21218 USA	University of California System; University of California Santa Cruz; Leiden University; Leiden University - Excl LUMC; Carnegie Institution for Science; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Colorado System; University of Colorado Boulder; Yale University; Space Telescope Science Institute	Bouwens, RJ (corresponding author), Univ Calif Santa Cruz, Dept Astron, Santa Cruz, CA 95064 USA.	bouwens@ucolick.org	Labbe, Ivo/AAZ-2544-2020; Labbe, Ivo/B-1408-2016; Gonzalez, Valentino/F-7021-2015	Labbe, Ivo/0000-0002-2057-5376; Bradley, Larry/0000-0002-7908-9284; Stiavelli, Massimo/0000-0001-9935-6047; Magee, Daniel/0000-0002-6668-2011; Oesch, Pascal/0000-0001-5851-6649; Gonzalez, Valentino/0000-0002-3120-0510; Trenti, Michele/0000-0001-9391-305X; Illingworth, Garth/0000-0002-8096-2837	NASA; Swiss National Science Foundation; Science and Technology Facilities Council [ST/H00243X/1] Funding Source: researchfish	NASA(National Aeronautics & Space Administration (NASA)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We are grateful to all those at NASA, STScI and throughout the community who have worked to make the Hubble Space Telescope the observatory that it is today, and we acknowledge the importance of the servicing missions and those who organised them. We acknowledge our program coordinator W. Januszewski for his care in helping to set up our program and observing configuration. We acknowledge support from NASA and the Swiss National Science Foundation.	Beckwith SVW, 2006, ASTRON J, V132, P1729, DOI 10.1086/507302; Bouwens R, 1998, ASTROPHYS J, V506, P557, DOI 10.1086/306258; Bouwens RJ, 2007, ASTROPHYS J, V670, P928, DOI 10.1086/521811; Bouwens RJ, 2009, ASTROPHYS J, V705, P936, DOI 10.1088/0004-637X/705/1/936; Bouwens R. J., 2010, ASTROPHYS J UNPUB; Bouwens RJ, 2008, ASTROPHYS J, V686, P230, DOI 10.1086/590103; Bunker AJ, 2010, MON NOT R ASTRON SOC, V409, P855, DOI 10.1111/j.1365-2966.2010.17350.x; Fan XH, 2002, ASTRON J, V123, P1247, DOI 10.1086/339030; Finkelstein SL, 2010, ASTROPHYS J, V719, P1250, DOI 10.1088/0004-637X/719/2/1250; Gonzalez V, 2010, ASTROPHYS J, V713, P115, DOI 10.1088/0004-637X/713/1/115; Komatsu E., 2010, ASTROPHYS J IN PRESS; Labbe I, 2010, ASTROPHYS J LETT, V708, pL26, DOI 10.1088/2041-8205/708/1/L26; Lehnert MD, 2010, NATURE, V467, P940, DOI 10.1038/nature09462; McLure RJ, 2009, MON NOT R ASTRON SOC, V395, P2196, DOI 10.1111/j.1365-2966.2009.14677.x; Oesch PA, 2010, ASTROPHYS J LETT, V709, pL16, DOI 10.1088/2041-8205/709/1/L16; Popesso P, 2009, ASTRON ASTROPHYS, V494, P443, DOI 10.1051/0004-6361:200809617; Reddy NA, 2009, ASTROPHYS J, V692, P778, DOI 10.1088/0004-637X/692/1/778; Robertson BE, 2010, NATURE, V468, P49, DOI 10.1038/nature09527; Salvaterra R, 2009, NATURE, V461, P1258, DOI 10.1038/nature08445; Schiminovich D, 2005, ASTROPHYS J, V619, pL47, DOI 10.1086/427077; Steidel CC, 2003, ASTROPHYS J, V592, P728, DOI 10.1086/375772; Steidel CC, 1996, ASTROPHYS J, V462, pL17, DOI 10.1088/1538-4357/462/1/L17; Tanvir NR, 2009, NATURE, V461, P1254, DOI 10.1038/nature08459; Trenti M, 2008, ASTROPHYS J, V676, P767, DOI 10.1086/528674; Vanzella E, 2009, ASTROPHYS J, V695, P1163, DOI 10.1088/0004-637X/695/2/1163; Yan HJ, 2010, RES ASTRON ASTROPHYS, V10, P867, DOI 10.1088/1674-4527/10/9/003; Yoshida M, 2006, ASTROPHYS J, V653, P988, DOI 10.1086/508621	30	227	227	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					504	507		10.1038/nature09717	http://dx.doi.org/10.1038/nature09717			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270889	Green Submitted			2022-12-28	WOS:000286596500026
J	Fukuda, S; Toh, H; Hase, K; Oshima, K; Nakanishi, Y; Yoshimura, K; Tobe, T; Clarke, JM; Topping, DL; Suzuki, T; Taylor, TD; Itoh, K; Kikuchi, J; Morita, H; Hattori, M; Ohno, H				Fukuda, Shinji; Toh, Hidehiro; Hase, Koji; Oshima, Kenshiro; Nakanishi, Yumiko; Yoshimura, Kazutoshi; Tobe, Toru; Clarke, Julie M.; Topping, David L.; Suzuki, Tohru; Taylor, Todd D.; Itoh, Kikuji; Kikuchi, Jun; Morita, Hidetoshi; Hattori, Masahira; Ohno, Hiroshi			Bifidobacteria can protect from enteropathogenic infection through production of acetate	NATURE			English	Article							ENTEROHEMORRHAGIC ESCHERICHIA-COLI; SMOOTH-MUSCLE-CELLS; SHIGA-TOXIN; ARABIDOPSIS-THALIANA; GENOME SEQUENCE; GENE-EXPRESSION; LONGUM NCC2705; GUT MICROBIOTA; PPAR-ALPHA; MICE	The human gut is colonized with a wide variety of microorganisms, including species, such as those belonging to the bacterial genus Bifidobacterium, that have beneficial effects on human physiology and pathology(1-3). Among the most distinctive benefits of bifidobacteria are modulation of host defence responses and protection against infectious diseases(4-6). Nevertheless, the molecular mechanisms underlying these effects have barely been elucidated. To investigate these mechanisms, we used mice associated with certain bifidobacterial strains and a simplified model of lethal infection with enterohaemorrhagic Escherichia coli O157:H7, together with an integrated 'omics' approach. Here we show that genes encoding an ATP-binding-cassette-type carbohydrate transporter present in certain bifidobacteria contribute to protecting mice against death induced by E. coli O157:H7. We found that this effect can be attributed, at least in part, to increased production of acetate and that translocation of the E. coli O157:H7 Shiga toxin from the gut lumen to the blood was inhibited. We propose that acetate produced by protective bifidobacteria improves intestinal defence mediated by epithelial cells and thereby protects the host against lethal infection.	[Fukuda, Shinji; Hase, Koji; Nakanishi, Yumiko; Ohno, Hiroshi] RIKEN Res Ctr Allergy & Immunol, Lab Epithelial Immunobiol, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Fukuda, Shinji; Nakanishi, Yumiko; Kikuchi, Jun; Ohno, Hiroshi] Yokohama City Univ, Grad Sch Nanobiosci, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Toh, Hidehiro; Taylor, Todd D.] RIKEN Adv Sci Inst, MetaSyst Res Team, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Oshima, Kenshiro; Hattori, Masahira] Univ Tokyo, Grad Sch Frontier Sci, Chiba 2778561, Japan; [Nakanishi, Yumiko; Kikuchi, Jun] RIKEN Plant Sci Ctr, Adv NMR Metab Res Team, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; [Yoshimura, Kazutoshi; Itoh, Kikuji] Univ Tokyo, Grad Sch Agr & Life Sci, Bunkyo Ku, Tokyo 1138657, Japan; [Tobe, Toru] Osaka Univ, Grad Sch Med, Suita, Osaka 5650871, Japan; [Clarke, Julie M.; Topping, David L.] CSIRO Food & Nutr Sci, Adelaide, SA 5000, Australia; [Suzuki, Tohru] Gifu Univ, United Grad Sch Agr Sci, Gifu 5011193, Japan; [Kikuchi, Jun] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Morita, Hidetoshi] Azabu Univ, Sch Vet Med, Kanagawa 2298501, Japan; [Ohno, Hiroshi] Chiba Univ, Grad Sch Med, Chuo Ku, Chiba 2608670, Japan	RIKEN; Yokohama City University; RIKEN; University of Tokyo; RIKEN; University of Tokyo; Osaka University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Gifu University; Nagoya University; Azabu University; Chiba University	Ohno, H (corresponding author), RIKEN Res Ctr Allergy & Immunol, Lab Epithelial Immunobiol, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan.	hattori@k.u-tokyo.ac.jp; ohno@rcai.riken.jp	Ohno, Hiroshi/L-7899-2014; Clarke, Julie M/H-6762-2013; topping, david l/H-7969-2013; Kikuchi, Jun/O-4725-2019; Hattori, Masahira/AAD-3785-2019; Taylor, Todd/A-7121-2009; Hattori, Masahira/C-6958-2016; Kikuchi, Jun/M-5512-2015	Ohno, Hiroshi/0000-0001-8776-9661; Clarke, Julie M/0000-0003-4676-0366; topping, david l/0000-0002-8481-9384; Kikuchi, Jun/0000-0002-6809-394X; Taylor, Todd/0000-0003-4247-6253; Hattori, Masahira/0000-0001-9467-0344; Kikuchi, Jun/0000-0002-6809-394X; Fukuda, Shinji/0000-0001-5161-9880; Hase, Koji/0000-0001-9550-2334	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency; Danone Institute of Japan; Institute for Fermentation, Osaka; Kieikai Research Foundation; Naito Foundation; Nestle Nutrition Council, Japan; Japan Science Society; Yakult Bio-Science Foundation; Academic Frontier Project for Private Universities (Matching Fund Subsidy); Private University Scientific Foundation	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Danone Institute of Japan(Danone Nutricia); Institute for Fermentation, Osaka(Institute for Fermentation (IFO)); Kieikai Research Foundation(Kieikai Research Foundation); Naito Foundation(Naito Memorial Foundation); Nestle Nutrition Council, Japan; Japan Science Society; Yakult Bio-Science Foundation; Academic Frontier Project for Private Universities (Matching Fund Subsidy)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Private University Scientific Foundation	We thank H. Kitamura and M. E. Mariotti-Ferrandiz for discussions and for reading the manuscript; T. Morita for suggestions; and C. Nishigaki, M. Ohmae, Y. Chiba, T. Kato, H. Shima, A. Nakano, K. Sakaguchi, K. Furuya, C. Yoshino, H. Inaba, E. Iioka, K. Motomura and Y. Hattori for technical support. This research was supported in part by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan: a Grant-in-Aid for Scientific Research on Priority Areas 'Comprehensive Genomics' (M.H.), 'Membrane Traffic' (H.O.) and 'Matrix of Infectious Phenomena' (K.H.); Young Scientists (S.F., K.H. and J.K.); Challenging Exploratory Research (J.K.); Scientific Research (H.O.); and Scientific Research on Innovative Areas 'Intracellular Logistics' (H.O.). This work was also supported in part by a RIKEN President's Special Research Grant (J.K.); a RIKEN DRI Research Grant (S.F.); a CREST grant from the Japan Science and Technology Agency (J.K.); the Danone Institute of Japan (H.O.); the Institute for Fermentation, Osaka (S.F.); the Kieikai Research Foundation (S.F.); the Naito Foundation (S.F.); the Nestle Nutrition Council, Japan (S.F.); the Sasakawa Scientific Research Grant from the Japan Science Society (S.F. and Y.N.); the Yakult Bio-Science Foundation (S.F.); the Academic Frontier Project for Private Universities (Matching Fund Subsidy (H.M.)); and the Private University Scientific Foundation (H.M.).	Akiyama Kenji, 2008, In Silico Biology, V8, P339; Annison G, 2003, J NUTR, V133, P3523, DOI 10.1093/jn/133.11.3523; Antonio V, 2003, BIOCHEM J, V376, P351, DOI 10.1042/BJ20030098; Asahara T, 2004, INFECT IMMUN, V72, P2240, DOI 10.1128/IAI.72.4.2240-2247.2004; Chikayama E, 2010, ANAL CHEM, V82, P1653, DOI 10.1021/ac9022023; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Delerive P, 2000, J BIOL CHEM, V275, P36703, DOI 10.1074/jbc.M004045200; Eaton KA, 2008, INFECT IMMUN, V76, P3054, DOI 10.1128/IAI.01626-07; Fukuda S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004893; Gagnon M, 2006, INT J FOOD MICROBIOL, V111, P26, DOI 10.1016/j.ijfoodmicro.2006.04.041; Garmendia J, 2005, INFECT IMMUN, V73, P2573, DOI 10.1128/IAI.73.5.2573-2585.2005; Gordon D, 2001, GENOME RES, V11, P614, DOI 10.1101/gr.171401; Hase K, 2005, DNA RES, V12, P127, DOI 10.1093/dnares/12.2.127; Hase K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003033; Hijikata A, 2007, BIOINFORMATICS, V23, P2934, DOI 10.1093/bioinformatics/btm430; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jia W, 2008, NAT REV DRUG DISCOV, V7, P123, DOI 10.1038/nrd2505; Kikuchi J, 2004, PLANT CELL PHYSIOL, V45, P1099, DOI 10.1093/pcp/pch117; Kitajima H, 2002, ARCH DIS CHILD, V87, P335, DOI 10.1136/adc.87.4.335; Kles KA, 2006, GASTROENTEROLOGY, V130, pS100, DOI 10.1053/j.gastro.2005.11.048; KONGMUANG U, 1987, J CLIN MICROBIOL, V25, P115, DOI 10.1128/JCM.25.1.115-118.1987; Kurokawa K, 2007, DNA RES, V14, P169, DOI 10.1093/dnares/dsm018; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; Li JL, 2005, J BIOL CHEM, V280, P7427, DOI 10.1074/jbc.M411473200; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Mazmanian SK, 2006, NAT REV IMMUNOL, V6, P849, DOI 10.1038/nri1956; Morita T, 2004, J GASTROEN HEPATOL, V19, P303, DOI 10.1111/j.1440-1746.2003.03208.x; Nakamura T, 2002, BIOSCI BIOTECH BIOCH, V66, P2362, DOI 10.1271/bbb.66.2362; Parche S, 2007, J MOL MICROB BIOTECH, V12, P9, DOI 10.1159/000096455; Picard C, 2005, ALIMENT PHARM THER, V22, P495, DOI 10.1111/j.1365-2036.2005.02615.x; Saulnier DMA, 2009, CURR OPIN BIOTECH, V20, P135, DOI 10.1016/j.copbio.2009.01.002; Schell MA, 2002, P NATL ACAD SCI USA, V99, P14422, DOI 10.1073/pnas.212527599; Schuller S, 2004, CELL MICROBIOL, V6, P289, DOI 10.1046/j.1462-5822.2004.00370.x; Sekiyama Y, 2010, ANAL CHEM, V82, P1643, DOI 10.1021/ac9019076; Sela DA, 2008, P NATL ACAD SCI USA, V105, P18964, DOI 10.1073/pnas.0809584105; Sethi S, 2002, BLOOD, V100, P1340, DOI 10.1182/blood-2002-01-0316; Sonnenburg JL, 2006, PLOS BIOL, V4, P2213, DOI 10.1371/journal.pbio.0040413; Staels B, 1998, NATURE, V393, P790, DOI 10.1038/31701; Tarr PI, 2005, LANCET, V365, P1073, DOI 10.1016/S0140-6736(05)71144-2; Tedelind S, 2007, WORLD J GASTROENTERO, V13, P2826, DOI 10.3748/wjg.v13.i20.2826; Tian C, 2007, J BIOL CHEM, V282, P18532, DOI 10.1074/jbc.M700549200; Ventura M, 2009, NAT REV MICROBIOL, V7, P61, DOI 10.1038/nrmicro2047; Yasui K, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn884; Yoshimura K, 2010, ANTON LEEUW INT J G, V97, P107, DOI 10.1007/s10482-009-9391-y; Yuan J, 2006, MOL CELL PROTEOMICS, V5, P1105, DOI 10.1074/mcp.M500410-MCP200; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883	47	1401	1698	19	433	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 27	2011	469	7331					543	U791		10.1038/nature09646	http://dx.doi.org/10.1038/nature09646			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270894				2022-12-28	WOS:000286596500035
J	Xian, Y; Holloway, RG; Chan, PS; Noyes, K; Shah, MN; Ting, HH; Chappel, AR; Peterson, ED; Friedman, B				Xian, Ying; Holloway, Robert G.; Chan, Paul S.; Noyes, Katia; Shah, Manish N.; Ting, Henry H.; Chappel, Andre R.; Peterson, Eric D.; Friedman, Bruce			Association Between Stroke Center Hospitalization for Acute Ischemic Stroke and Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ACUTE MYOCARDIAL-INFARCTION; REDUCE MORTALITY; TRAUMA CENTERS; CARE; OUTCOMES; QUALITY; COMPARE; DISEASE; BIAS	Context Although stroke centers are widely accepted and supported, little is known about their effect on patient outcomes. Objective To examine the association between admission to stroke centers for acute ischemic stroke and mortality. Design, Setting, and Participants Observational study using data from the New York Statewide Planning and Research Cooperative System. We compared mortality for patients admitted with acute ischemic stroke (n = 30 947) between 2005 and 2006 at designated stroke centers and nondesignated hospitals using differential distance to hospitals as an instrumental variable to adjust for potential prehospital selection bias. Patients were followed up for mortality for 1 year after the index hospitalization through 2007. To assess whether our findings were specific to stroke, we also compared mortality for patients admitted with gastrointestinal hemorrhage (n = 39 409) or acute myocardial infarction (n = 40 024) at designated stroke centers and nondesignated hospitals. Main Outcome Measure Thirty-day all-cause mortality. Results Among 30 947 patients with acute ischemic stroke, 15 297 (49.4%) were admitted to designated stroke centers. Using the instrumental variable analysis, admission to designated stroke centers was associated with lower 30-day all-cause mortality (10.1% vs 12.5%; adjusted mortality difference, -2.5%; 95% confidence interval [CI], -3.6% to -1.4%; P<.001) and greater use of thrombolytic therapy (4.8% vs 1.7%; adjusted difference, 2.2%; 95% CI, 1.6% to 2.8%; P<.001). Differences in mortality also were observed at 1-day, 7-day, and 1-year follow-up. The outcome differences were specific for stroke, as stroke centers and nondesignated hospitals had similar 30-day all-cause mortality rates among those with gastrointestinal hemorrhage (5.0% vs 5.8%; adjusted mortality difference, +0.3%; 95% CI, -0.5% to 1.0%; P=.50) or acute myocardial infarction (10.5% vs 12.7%; adjusted mortality difference, +0.1%; 95% CI, -0.9% to 1.1%; P=.83). Conclusion Among patients with acute ischemic stroke, admission to a designated stroke center was associated with modestly lower mortality and more frequent use of thrombolytic therapy. JAMA. 2011;305(4):373-380 www.jama.com	[Xian, Ying; Peterson, Eric D.] Duke Clin Res Inst, Durham, NC 27705 USA; [Holloway, Robert G.; Noyes, Katia; Shah, Manish N.; Chappel, Andre R.; Friedman, Bruce] Univ Rochester, Rochester, NY USA; [Chan, Paul S.] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Ting, Henry H.] Mayo Clin, Rochester, MN USA	Duke University; University of Rochester; Saint Luke's Mid America Heart Institute; Mayo Clinic	Xian, Y (corresponding author), Duke Clin Res Inst, 2400 Pratt St, Durham, NC 27705 USA.	ying.xian@duke.edu	Peterson, Eric David/ABF-5033-2021; Xian, Ying/O-1956-2019	Xian, Ying/0000-0002-1237-1162; Shah, Manish/0000-0001-6331-1074	Schering Plough; Bristol-Myers Squibb; Merck/Schering Plough; Sanofi Aventis; Saint Judes; American Heart Association (AHA) [0815772D]; Agency for Healthcare Research and Quality (AHRQ) [U18HS016964]; National Heart, Lung, and Blood Institute [K23HL102224]; National Institute on Aging [1K23AG028942]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS016964] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL102224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K23AG028942] Funding Source: NIH RePORTER	Schering Plough(Merck & CompanySchering Plough Corporation); Bristol-Myers Squibb(Bristol-Myers Squibb); Merck/Schering Plough(Merck & CompanySchering Plough Corporation); Sanofi Aventis(Sanofi-Aventis); Saint Judes; American Heart Association (AHA)(American Heart Association); Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Holloway reported being a consultant for Milliman Guidelines, reviewing neurology guidelines. Dr Peterson reported receiving research grants from Schering Plough, Bristol-Myers Squibb, Merck/Schering Plough, Sanofi Aventis, and Saint Judes and being a consultant/advisory board member to Pfizer and Bayer Corp. No other disclosures were reported.; This study was funded in part by a predoctoral fellowship 0815772D from the American Heart Association (AHA) Founders Affiliate (Dr Xian). This study received infrastructure support from the Agency for Healthcare Research and Quality (AHRQ) (U18HS016964). Dr Chan is supported by a Career Development Grant Award (K23HL102224) from the National Heart, Lung, and Blood Institute. Dr Shah is supported by the Paul B. Beeson Career Development Award (National Institute on Aging 1K23AG028942).	Agency for Healthcare Research and Quality, 2006, INP QUAL IND OV; Alberts MJ, 2010, STROKE, V41, P1100, DOI 10.1161/STROKEAHA.110.582148; Alberts MJ, 2000, JAMA-J AM MED ASSOC, V283, P3102, DOI 10.1001/jama.283.23.3102; [Anonymous], NEW YORK STATE EMT A; Austin PC, 2009, COMMUN STAT-SIMUL C, V38, P1228, DOI 10.1080/03610910902859574; Beck CA, 2003, HEALTH SERV RES, V38, P1423, DOI 10.1111/j.1475-6773.2003.00186.x; Bhattacharya J, 2006, STAT MED, V25, P389, DOI 10.1002/sim.2226; Bravata DM, 2010, ARCH INTERN MED, V170, P804, DOI 10.1001/archinternmed.2010.92; Douglas VC, 2005, NEUROLOGY, V64, P422, DOI 10.1212/01.WNL.0000150903.38639.E1; Fonarow GC, 2010, CIRCULATION, V122, P2459, DOI 10.1161/CIR.0b013e3182011a81; Goldstein LB, 2004, STROKE, V35, P1941, DOI 10.1161/01.STR.0000135225.80898.1c; Goldstein LB, 2003, NEUROLOGY, V61, P792, DOI 10.1212/01.WNL.0000082724.77447.3A; Greene H., 2003, ECONOMETRIC ANAL; Gropen TI, 2006, NEUROLOGY, V67, P88, DOI 10.1212/01.wnl.0000223622.13641.6d; Holloway RG, 2007, JAMA-J AM MED ASSOC, V298, P802, DOI 10.1001/jama.298.7.802; Langhorne P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000197.pub3; Lattimore SU, 2003, STROKE, V34, pE55, DOI 10.1161/01.STR.0000073789.12120.F3; Lichtman JH, 2009, STROKE, V40, pE127; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; McConnell KJ, 2005, HEALTH SERV RES, V40, P435, DOI 10.1111/j.1475-6773.2005.0u367.x; Meretoja A, 2010, STROKE, V41, pE361; Mitchell JB, 1996, STROKE, V27, P1937, DOI 10.1161/01.STR.27.11.1937; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; Peterson ED, 2006, JAMA-J AM MED ASSOC, V295, P1912, DOI 10.1001/jama.295.16.1912; Pracht EE, 2007, MED CARE RES REV, V64, P83, DOI 10.1177/1077558706296241; ROSENBAUM PR, 1984, J AM STAT ASSOC, V79, P516, DOI 10.2307/2288398; Stradling D, 2007, NEUROLOGY, V68, P469, DOI 10.1212/01.wnl.0000252930.82140.65; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; U.S. Department of Agriculture, MEAS RUR RUR URB COM; *US DEP HHS, HOSP COMP	31	234	235	1	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2011	305	4					373	380		10.1001/jama.2011.22	http://dx.doi.org/10.1001/jama.2011.22			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	711MH	21266684	Green Accepted, Bronze			2022-12-28	WOS:000286595200022
J	Kirby, T				Kirby, Tony			Rethy Chhem: from war-torn Cambodia to the IAEA Profile	LANCET			English	Biographical-Item												tony.kirby@lancet.com							0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 22	2011	377	9762					291	291		10.1016/S0140-6736(11)60082-2	http://dx.doi.org/10.1016/S0140-6736(11)60082-2			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	714ZO	21256373				2022-12-28	WOS:000286850400015
J	Wan, XH; Nakatani, H; Ueno, K; Asamizuya, T; Cheng, K; Tanaka, K				Wan, Xiaohong; Nakatani, Hironori; Ueno, Kenichi; Asamizuya, Takeshi; Cheng, Kang; Tanaka, Keiji			The Neural Basis of Intuitive Best Next-Move Generation in Board Game Experts	SCIENCE			English	Article							BASAL GANGLIA; CORTICOSTRIATAL PROJECTIONS; EPISODIC MEMORY; PARIETAL CORTEX; ABACUS EXPERTS; CHESS EXPERTS; BRAIN; CONNECTIONS; ACTIVATION; AREAS	The superior capability of cognitive experts largely depends on quick automatic processes. To reveal their neural bases, we used functional magnetic resonance imaging to study brain activity of professional and amateur players in a board game named shogi. We found two activations specific to professionals: one in the precuneus of the parietal lobe during perception of board patterns, and the other in the caudate nucleus of the basal ganglia during quick generation of the best next move. Activities at these two sites covaried in relevant tasks. These results suggest that the precuneus-caudate circuit implements the automatic, yet complicated, processes of board-pattern perception and next-move generation in board game experts.	[Wan, Xiaohong; Nakatani, Hironori; Cheng, Kang; Tanaka, Keiji] RIKEN Brain Sci Inst, Cognit Brain Mapping Lab, Wako, Saitama 3510198, Japan; [Ueno, Kenichi; Asamizuya, Takeshi; Cheng, Kang] RIKEN Brain Sci Inst, Support Unit Funct Magnet Resonance Imaging, Wako, Saitama 3510198, Japan	RIKEN; RIKEN	Tanaka, K (corresponding author), RIKEN Brain Sci Inst, Cognit Brain Mapping Lab, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	keiji@riken.jp	Cheng, Kang/A-6448-2016; Wan, Xiaohong/B-3753-2013; Ueno, Kenichi/A-9395-2014; Tanaka, Keiji/N-5917-2015	Tanaka, Keiji/0000-0002-1910-3427; Asamizuya, Takeshi/0000-0003-1004-6435	Fujitsu Laboratories; Ministry of Education, Culture, Sports, Science and Technology of Japan [19700312]	Fujitsu Laboratories; Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the Fujitsu Laboratories and a grant-in-aid for Young Scientists from the Ministry of Education, Culture, Sports, Science and Technology of Japan (19700312, X.W.). We thank the Japan Shogi Association for cooperation and T. Ito, K. Okuma, and T. Kawatsuma for discussion.	ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Amidzic O, 2001, NATURE, V412, P603, DOI 10.1038/35088119; Atherton M, 2003, COGNITIVE BRAIN RES, V16, P26, DOI 10.1016/S0926-6410(02)00207-0; Berns GS, 1998, J COGNITIVE NEUROSCI, V10, P108, DOI 10.1162/089892998563815; Cabeza R, 2008, NAT REV NEUROSCI, V9, P613, DOI 10.1038/nrn2459; Campitelli G, 2007, INT J NEUROSCI, V117, P1641, DOI 10.1080/00207450601041955; CAVADA C, 1991, NEUROSCIENCE, V42, P683, DOI 10.1016/0306-4522(91)90037-O; CHARNESS N, 1981, J EXP PSYCHOL HUMAN, V7, P467, DOI 10.1037/0096-1523.7.2.467; CHASE WG, 1973, COGNITIVE PSYCHOL, V4, P55, DOI 10.1016/0010-0285(73)90004-2; Crinion J, 2006, SCIENCE, V312, P1537, DOI 10.1126/science.1127761; de Groot A. D., 1946, DENKEN VANDENSCHAKER; Dolan RJ, 1997, NATURE, V389, P596, DOI 10.1038/39309; Ericsson KA, 1996, ANNU REV PSYCHOL, V47, P273, DOI 10.1146/annurev.psych.47.1.273; Gaser C, 2003, J NEUROSCI, V23, P9240; Gobet F, 1996, COGNITIVE PSYCHOL, V31, P1, DOI 10.1006/cogp.1996.0011; Gobet F, 2004, MOVES IN MIND: THE PSYCHOLOGY OF BOARD GAMES; Gobet F, 1994, ADV COMPUTER CHESS, V7, P35; Grahn JA, 2008, PROG NEUROBIOL, V86, P141, DOI 10.1016/j.pneurobio.2008.09.004; Graybiel AM, 2008, ANNU REV NEUROSCI, V31, P359, DOI 10.1146/annurev.neuro.29.051605.112851; Han S, 2010, J NEUROSCI, V30, P4767, DOI 10.1523/JNEUROSCI.3077-09.2010; Hanakawa T, 2003, NEUROIMAGE, V19, P296, DOI 10.1016/S1053-8119(03)00050-8; HOLDING DH, 1989, AM J PSYCHOL, V102, P103, DOI 10.2307/1423119; HOLDING DH, 1979, SIMULAT GAMING, V10, P207, DOI 10.1177/104687817901000205; KEMP JM, 1970, BRAIN, V93, P525, DOI 10.1093/brain/93.3.525; Leichnetz GR, 2001, ANAT RECORD, V263, P215, DOI 10.1002/ar.1082; Lieberman MD, 2000, PSYCHOL BULL, V126, P109, DOI 10.1037/0033-2909.126.1.109; Maguire EA, 2000, P NATL ACAD SCI USA, V97, P4398, DOI 10.1073/pnas.070039597; Mishkin M., 1984, NEUROBIOL LEARN MEM, P65, DOI DOI 10.1523/JNEUROSCI.0840-16.2016; NICHELLI P, 1994, NATURE, V369, P191, DOI 10.1038/369191a0; ONOFRJ M, 1995, NEUROSCI LETT, V198, P169, DOI 10.1016/0304-3940(95)11985-6; Ouchi Y, 2005, COGNITIVE BRAIN RES, V23, P164, DOI 10.1016/j.cogbrainres.2004.10.004; Packard MG, 2002, ANNU REV NEUROSCI, V25, P563, DOI 10.1146/annurev.neuro.25.112701.142937; Poldrack RA, 1999, NEUROPSYCHOLOGY, V13, P564, DOI 10.1037/0894-4105.13.4.564; Saariluoma P, 2004, EUR J COGN PSYCHOL, V16, P753, DOI 10.1080/09541440340000501; SAARILUOMA P, 1992, PSYCHOL RES-PSYCH FO, V54, P17, DOI 10.1007/BF01359219; Saariluoma P., 1995, CHESS PLAYERS THINKI; SELEMON LD, 1985, J NEUROSCI, V5, P776; Tanaka S, 2002, NEUROREPORT, V13, P2187, DOI 10.1097/00001756-200212030-00005; Volke HJ, 2002, J PSYCHOPHYSIOL, V16, P23, DOI 10.1027//0269-8803.16.1.23; Wagner AD, 2005, TRENDS COGN SCI, V9, P445, DOI 10.1016/j.tics.2005.07.001; YETERIAN EH, 1995, J COMP NEUROL, V352, P436, DOI 10.1002/cne.903520309; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	42	84	86	0	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					341	346		10.1126/science.1194732	http://dx.doi.org/10.1126/science.1194732			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712BF	21252348				2022-12-28	WOS:000286636300040
J	Guizetti, J; Schermelleh, L; Mantler, J; Maar, S; Poser, I; Leonhardt, H; Muller-Reichert, T; Gerlich, DW				Guizetti, Julien; Schermelleh, Lothar; Maentler, Jana; Maar, Sandra; Poser, Ina; Leonhardt, Heinrich; Mueller-Reichert, Thomas; Gerlich, Daniel W.			Cortical Constriction During Abscission Involves Helices of ESCRT-III-Dependent Filaments	SCIENCE			English	Article							MEDIATED ABSCISSION; CYTOKINESIS; MIDBODY; MACHINERY; ALIX; SCISSION; SPASTIN; CELLS	After partitioning of cytoplasmic contents by cleavage furrow ingression, animal cells remain connected by an intercellular bridge, which subsequently splits by abscission. Here, we examined intermediate stages of abscission in human cells by using live imaging, three-dimensional structured illumination microscopy, and electron tomography. We identified helices of 17-nanometer-diameter filaments, which narrowed the cortex of the intercellular bridge to a single stalk. The endosomal sorting complex required for transport (ESCRT)-III co-localized with constriction zones and was required for assembly of 17-nanometer-diameter filaments. Simultaneous spastin-mediated removal of underlying microtubules enabled full constriction at the abscission site. The identification of contractile filament helices at the intercellular bridge has broad implications for the understanding of cell division and of ESCRT-III-mediated fission of large membrane structures.	[Mueller-Reichert, Thomas] Tech Univ Dresden, Med Fac Carl Gustav Carus, Med Theoret Ctr, D-01307 Dresden, Germany; [Guizetti, Julien; Maar, Sandra; Gerlich, Daniel W.] Swiss Fed Inst Technol Zurich ETHZ, Dept Biol, Inst Biochem, CH-8093 Zurich, Switzerland; [Guizetti, Julien; Mueller-Reichert, Thomas; Gerlich, Daniel W.] Marine Biol Lab, Woods Hole, MA 02543 USA; [Schermelleh, Lothar; Leonhardt, Heinrich] Univ Munich, Ctr Integrated Prot Sci Munich, Dept Biol, D-82152 Planegg Martinsried, Germany; [Maentler, Jana; Poser, Ina] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Swiss Federal Institutes of Technology Domain; ETH Zurich; Marine Biological Laboratory - Woods Hole; University of Munich; Max Planck Society	Muller-Reichert, T (corresponding author), Tech Univ Dresden, Med Fac Carl Gustav Carus, Med Theoret Ctr, Fetscherstr 74, D-01307 Dresden, Germany.	mueller-reichert@tu-dresden.de; daniel.gerlich@bc.biol.ethz.ch	Leonhardt, Heinrich/B-2791-2014; Gerlich, Daniel Wolfram W/A-6991-2016; Schermelleh, Lothar/H-4588-2019; Guizetti, Julien/AAF-3793-2020	Gerlich, Daniel Wolfram W/0000-0003-1637-3365; Schermelleh, Lothar/0000-0002-1612-9699; Guizetti, Julien/0000-0002-8762-4259; Guizetti, Julien/0000-0002-7735-4689	Swiss National Science Foundation [3100A0-114120]; ETH-TH; European Science Foundation; Evelyn and Melvin Spiegel Fund; Human Frontier Science Program [RGP 0034/2010]; Deutsche Forschungsgemeinschaft [MU 1423/2-1, MU 1423/3-1, SFB TR5]; BioImaging Network; Nanosystems Initiative Munich; European Commission [241548]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH-TH; European Science Foundation(European Science Foundation (ESF)European Commission); Evelyn and Melvin Spiegel Fund; Human Frontier Science Program(Human Frontier Science Program); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); BioImaging Network; Nanosystems Initiative Munich; European Commission(European CommissionEuropean Commission Joint Research Centre)	We thank A. E. Smith, M. Petronczki, P. Steigemann, M. Glotzer, and Y. Barral for comments on the manuscript; S. Prugnaller, A. Boden, G. Fabig, E. Seemann, A. Maiser, J. Neumann, L. Kerr, G. Csucs, and the ETHZ Light Microscopy and RNAi Screening Centres for technical support; U. Rothbauer, J. Gertsch, I. Mellman, B. Pfeiffer, and K. H. Altmann for providing reagents; and A. A. Hyman for support and reagents. This work was supported by Swiss National Science Foundation research grant 3100A0-114120, an ETH-TH grant, a European Young Investigators award of the European Science Foundation to D. W. G., MBL Research Fellowships by the Evelyn and Melvin Spiegel Fund to D. W. G. and T. M. R., a Human Frontier Science Program grant (RGP 0034/2010) to T. M. R., and grants from the Deutsche Forschungsgemeinschaft (MU 1423/2-1 and MU 1423/3-1 to T. M. R. and SFB TR5 to H. L. and L. S.) and from the BioImaging Network and the Nanosystems Initiative Munich to L. S. and H. L. Work in the Hyman and Gerlich laboratories is supported by European Commission grant agreement 241548 (MitoSys).	Ang AL, 2003, J CELL BIOL, V163, P339, DOI 10.1083/jcb.200307046; Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Carlton JG, 2008, P NATL ACAD SCI USA, V105, P10541, DOI 10.1073/pnas.0802008105; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Connell JW, 2009, TRAFFIC, V10, P42, DOI 10.1111/j.1600-0854.2008.00847.x; Darenfed H, 2005, BIOCHEM CELL BIOL, V83, P711, DOI 10.1139/O05-164; Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425; Ghazi-Tabatabai S, 2008, STRUCTURE, V16, P1345, DOI 10.1016/j.str.2008.06.010; Gromley A, 2005, CELL, V123, P75, DOI 10.1016/j.cell.2005.07.027; Hanson PI, 2008, J CELL BIOL, V180, P389, DOI 10.1083/jcb.200707031; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Lata S, 2008, SCIENCE, V321, P1354, DOI 10.1126/science.1161070; Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042; Montagnac G, 2008, CURR OPIN CELL BIOL, V20, P454, DOI 10.1016/j.ceb.2008.03.011; Morita E, 2007, EMBO J, V26, P4215, DOI 10.1038/sj.emboj.7601850; MULLINS JM, 1977, J CELL BIOL, V73, P672, DOI 10.1083/jcb.73.3.672; Pires R, 2009, STRUCTURE, V17, P843, DOI 10.1016/j.str.2009.04.007; Saksena S, 2009, CELL, V136, P97, DOI 10.1016/j.cell.2008.11.013; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Shan B, 1999, P NATL ACAD SCI USA, V96, P5686, DOI 10.1073/pnas.96.10.5686; Steigemann P, 2009, TRENDS CELL BIOL, V19, P606, DOI 10.1016/j.tcb.2009.07.008; Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020; Wollert T, 2009, NATURE, V458, P172, DOI 10.1038/nature07836; Yang D, 2008, NAT STRUCT MOL BIOL, V15, P1278, DOI 10.1038/nsmb.1512	26	323	331	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 25	2011	331	6024					1616	1620		10.1126/science.1201847	http://dx.doi.org/10.1126/science.1201847			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	739XH	21310966				2022-12-28	WOS:000288754500059
J	Nikolova, EN; Kim, E; Wise, AA; O'Brien, PJ; Andricioaei, I; Al-Hashimi, HM				Nikolova, Evgenia N.; Kim, Eunae; Wise, Abigail A.; O'Brien, Patrick J.; Andricioaei, Ioan; Al-Hashimi, Hashim M.			Transient Hoogsteen base pairs in canonical duplex DNA	NATURE			English	Article							DOUBLE-HELICAL DNA; NUCLEIC-ACIDS; TATA BOX; MOLECULAR-STRUCTURE; GENERALIZED BORN; SPIN RELAXATION; PROTEIN; NMR; DYNAMICS; PROTON	Sequence-directed variations in the canonical DNA double helix structure that retain Watson-Crick base-pairing have important roles in DNA recognition, topology and nucleosome positioning. By using nuclear magnetic resonance relaxation dispersion spectroscopy in concert with steered molecular dynamics simulations, we have observed transient sequence-specific excursions away from Watson-Crick base-pairing at CA and TA steps inside canonical duplex DNA towards low-populated and short-lived A.T and G.C Hoogsteen base pairs. The observation of Hoogsteen base pairs in DNA duplexes specifically bound to transcription factors and in damaged DNA sites implies that the DNA double helix intrinsically codes for excited state Hoogsteen base pairs as a means of expanding its structural complexity beyond that which can be achieved based on Watson-Crick base-pairing. The methods presented here provide a new route for characterizing transient low-populated nucleic acid structures, which we predict will be abundant in the genome and constitute a second transient layer of the genetic code.	[Nikolova, Evgenia N.; Wise, Abigail A.; Al-Hashimi, Hashim M.] Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA; [Kim, Eunae; Andricioaei, Ioan] Univ Calif Irvine, Dept Chem, Irvine, CA 92697 USA; [O'Brien, Patrick J.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of California System; University of California Irvine; University of Michigan System; University of Michigan	Al-Hashimi, HM (corresponding author), Univ Michigan, Dept Chem & Biophys, 930 N Univ Ave, Ann Arbor, MI 48109 USA.	andricio@uci.edu; hashimi@umich.edu		Nikolova, Evgenia/0000-0003-0365-2939	NSF [MCB 0644278, CHE-0918817]; NIH [R01GM089846]; Rackham International; University of Michigan; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089846] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rackham International; University of Michigan(University of Michigan System); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. L. Hansen, S. Horowitz and J. Feigon for valuable discussions and suggestions, A. V. Kurochkin for NMR expertise, and C. L. Brooks III for access to a supercomputing cluster. We gratefully acknowledge the Michigan Economic Development Cooperation and the Michigan Technology Tri-Corridor for support in the purchase of a 600 MHz spectrometer. This work was supported by NSF CAREER awards (MCB 0644278 to HMA and CHE-0918817 to I. A.) and an NIH grant (R01GM089846). E.N.N. acknowledges support by a Rackham International and Predoctoral Fellowship awarded by the University of Michigan.	Abrescia NGA, 2004, BIOCHEMISTRY-US, V43, P4092, DOI 10.1021/bi0355140; Abrescia NGA, 2002, P NATL ACAD SCI USA, V99, P2806, DOI 10.1073/pnas.052675499; Aishima J, 2002, NUCLEIC ACIDS RES, V30, P5244, DOI 10.1093/nar/gkf661; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Chocholousova J, 2006, J PHYS CHEM B, V110, P17240, DOI 10.1021/jp0627675; Coman D, 2005, BIOPHYS J, V89, P3285, DOI 10.1529/biophysj.105.065763; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Denisov VP, 1996, NAT STRUCT BIOL, V3, P505, DOI 10.1038/nsb0696-505; Feig M, 2004, J COMPUT CHEM, V25, P265, DOI 10.1002/jcc.10378; FERRY JD, 1953, J APPL PHYS, V24, P911, DOI 10.1063/1.1721401; FISCHER S, 1992, CHEM PHYS LETT, V194, P252, DOI 10.1016/0009-2614(92)85543-J; Frisch M.J., 2016, GAUSSIAN16 REV B01; Ghosal G, 2006, BIOCHEM BIOPH RES CO, V343, P1, DOI 10.1016/j.bbrc.2006.02.148; GILBERT DE, 1989, P NATL ACAD SCI USA, V86, P3006, DOI 10.1073/pnas.86.9.3006; GREENE KL, 1995, J BIOMOL NMR, V5, P333; GUERON M, 1987, NATURE, V328, P89, DOI 10.1038/328089a0; Hansen AL, 2009, J AM CHEM SOC, V131, P3818, DOI 10.1021/ja8091399; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hoopes BC, 1998, J MOL BIOL, V277, P1015, DOI 10.1006/jmbi.1998.1651; HOOVER WG, 1985, PHYS REV A, V31, P1695, DOI 10.1103/PhysRevA.31.1695; IZATT RM, 1971, CHEM REV, V71, P439, DOI 10.1021/cr60273a002; Johnson JE, 2008, J AM CHEM SOC, V130, P16757, DOI 10.1021/ja805759z; Kitayner M, 2010, NAT STRUCT MOL BIOL, V17, P423, DOI 10.1038/nsmb.1800; Korzhnev DM, 2008, ACCOUNTS CHEM RES, V41, P442, DOI 10.1021/ar700189y; Korzhnev DM, 2010, SCIENCE, V329, P1312, DOI 10.1126/science.1191723; Koudelka GB, 2006, PROG NUCLEIC ACID RE, V81, P143, DOI 10.1016/S0079-6603(06)81004-4; Lee MS, 2003, J COMPUT CHEM, V24, P1348, DOI 10.1002/jcc.10272; Lu LH, 2010, NUCLEIC ACIDS RES, V38, P4415, DOI 10.1093/nar/gkq129; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Meyer T, 1997, J BIOL CHEM, V272, P30709, DOI 10.1074/jbc.272.49.30709; Miloushev VZ, 2005, J MAGN RESON, V177, P221, DOI 10.1016/j.jmr.2005.07.023; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; NOSE S, 1984, J CHEM PHYS, V81, P511, DOI 10.1063/1.447334; Olson WK, 2001, J MOL BIOL, V313, P229, DOI 10.1006/jmbi.2001.4987; Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t; Palmer AG, 2006, CHEM REV, V106, P1700, DOI 10.1021/cr0404287; PARDI A, 1982, BIOCHEMISTRY-US, V21, P6567, DOI 10.1021/bi00268a038; Patikoglou GA, 1999, GENE DEV, V13, P3217, DOI 10.1101/gad.13.24.3217; Perez A, 2007, J AM CHEM SOC, V129, P14739, DOI 10.1021/ja0753546; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Powell SW, 2001, BIOCHEMISTRY-US, V40, P11065, DOI 10.1021/bi010890a; RECORD MT, 1981, ANNU REV BIOCHEM, V50, P997, DOI 10.1146/annurev.bi.50.070181.005025; Richmond TJ, 2003, NATURE, V423, P145, DOI 10.1038/nature01595; Rohs R, 2009, NATURE, V461, P1248, DOI 10.1038/nature08473; Saiz L, 2006, CURR OPIN STRUC BIOL, V16, P344, DOI 10.1016/j.sbi.2006.05.008; Sau AK, 1995, FEBS LETT, V377, P301, DOI 10.1016/0014-5793(95)01362-8; SEAMAN FC, 1993, BIOCHEMISTRY-US, V32, P12577, DOI 10.1021/bi00210a005; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; SegersNolten GMJ, 1997, BIOCHEMISTRY-US, V36, P13241, DOI 10.1021/bi971326w; Shajani Z, 2008, BIOCHEMISTRY-US, V47, P7617, DOI 10.1021/bi7020469; Shanmugam G, 2008, CHEM RES TOXICOL, V21, P1795, DOI 10.1021/tx8001466; Song K, 2009, J CHEM THEORY COMPUT, V5, P3105, DOI 10.1021/ct9001575; Travers AA, 2004, PHILOS T R SOC A, V362, P1423, DOI 10.1098/rsta.2004.1390; UGHETTO G, 1985, NUCLEIC ACIDS RES, V13, P2305, DOI 10.1093/nar/13.7.2305; WANG AHJ, 1979, NATURE, V282, P680, DOI 10.1038/282680a0; WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0; Xu XP, 2000, J PHYS CHEM B, V104, P5641, DOI 10.1021/jp0007538; Yang H, 2008, FEBS LETT, V582, P1629, DOI 10.1016/j.febslet.2008.04.013	58	224	228	0	97	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 24	2011	470	7335					498	U84		10.1038/nature09775	http://dx.doi.org/10.1038/nature09775			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	725NT	21270796	Green Submitted, Green Accepted			2022-12-28	WOS:000287652900034
J	Finnegan, S; Bergmann, K; Eiler, JM; Jones, DS; Fike, DA; Eisenman, I; Hughes, NC; Tripati, AK; Fischer, WW				Finnegan, Seth; Bergmann, Kristin; Eiler, John M.; Jones, David S.; Fike, David A.; Eisenman, Ian; Hughes, Nigel C.; Tripati, Aradhna K.; Fischer, Woodward W.			The Magnitude and Duration of Late Ordovician-Early Silurian Glaciation	SCIENCE			English	Article							SURFACE TEMPERATURES; ISOTOPIC EVIDENCE; MASS EXTINCTION; CO2; CONSTRAINTS; ICE	Understanding ancient climate changes is hampered by the inability to disentangle trends in ocean temperature from trends in continental ice volume. We used carbonate "clumped" isotope paleothermometry to constrain ocean temperatures, and thereby estimate ice volumes, through the Late Ordovician-Early Silurian glaciation. We find tropical ocean temperatures of 32 degrees to 37 degrees C except for short-lived cooling by similar to 5 degrees C during the final Ordovician stage. Evidence for ice sheets spans much of the study interval, but the cooling pulse coincided with a glacial maximum during which ice volumes likely equaled or exceeded those of the last (Pleistocene) glacial maximum. This cooling also coincided with a large perturbation of the carbon cycle and the Late Ordovician mass extinction.	[Finnegan, Seth; Bergmann, Kristin; Eiler, John M.; Eisenman, Ian; Tripati, Aradhna K.; Fischer, Woodward W.] CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA; [Jones, David S.; Fike, David A.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Eisenman, Ian] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; [Hughes, Nigel C.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Tripati, Aradhna K.] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Dept Earth & Space Sci, Los Angeles, CA 90095 USA; [Tripati, Aradhna K.] Univ Calif Los Angeles, Inst Geophys & Planetary Phys, Dept Atmospher & Ocean Sci, Los Angeles, CA 90095 USA	California Institute of Technology; Washington University (WUSTL); University of Washington; University of Washington Seattle; University of California System; University of California Riverside; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Finnegan, S (corresponding author), CALTECH, Div Geol & Planetary Sci, Pasadena, CA 91125 USA.	sethf@caltech.edu	Fike, David A/D-3634-2011; Jones, David Stewart/P-3210-2019; Tripati, Aradhna/C-9419-2011; Eisenman, Ian/B-9329-2009	Fike, David A/0000-0003-2848-0328; Jones, David Stewart/0000-0001-8478-3599; Tripati, Aradhna/0000-0002-1695-1754; Eisenman, Ian/0000-0003-0190-2869; /0000-0002-6106-2059	Agouron Institute; NSF Division of Earth Sciences	Agouron Institute(Pfizer); NSF Division of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank T. Raub, M. Rohrssen, and B. Gaines for assistance with field and lab work; D. Boulet and Societe des etablissements de plein air du Quebec (SEPAQ) Anticosti for permission to work in Anticosti National Park; and B. Hunda for supplying samples. This work was funded by an Agouron Institute award to W.W.F. and D.A.F. and NSF Division of Earth Sciences awards to W.W.F. and J.M.E.	Berner RA, 2006, GEOCHIM COSMOCHIM AC, V70, P5653, DOI 10.1016/j.gca.2005.11.032; Bornemann A, 2008, SCIENCE, V319, P189, DOI 10.1126/science.1148777; BRAND U, 1980, J SEDIMENT PETROL, V50, P1219; BRENCHLEY PJ, 1994, GEOLOGY, V22, P295, DOI 10.1130/0091-7613(1994)022<0295:BAIEFA>2.3.CO;2; Brenchley PJ, 2003, GEOL SOC AM BULL, V115, P89, DOI 10.1130/0016-7606(2003)115<0089:HRSISO>2.0.CO;2; Came RE, 2007, NATURE, V449, P198, DOI 10.1038/nature06085; Cocks LRM, 2002, J GEOL SOC LONDON, V159, P631, DOI 10.1144/0016-764901-118; Desrochers A, 2010, PALAEOGEOGR PALAEOCL, V296, P248, DOI 10.1016/j.palaeo.2010.02.017; FRAKES LA, 1996, CLIMATE MODES PHANER; Herrmann AD, 2004, PALAEOGEOGR PALAEOCL, V206, P59, DOI 10.1016/j.palaeo.2003.12.019; Hints L, 2010, EST J EARTH SCI, V59, P1, DOI 10.3176/earth.2010.1.01; Le Heron DP, 2009, J GEOL SOC LONDON, V166, P277, DOI 10.1144/0016-76492008-087; MARSHALL JD, 1990, J GEOL SOC LONDON, V147, P1, DOI 10.1144/gsjgs.147.1.0001; Puceat E, 2010, EARTH PLANET SC LETT, V298, P135, DOI 10.1016/j.epsl.2010.07.034; Raymond A, 2004, J GEOL, V112, P655, DOI 10.1086/424580; Saltzman MR, 2005, GEOLOGY, V33, P109, DOI 10.1130/G21219.1; SAVIN SM, 1977, ANNU REV EARTH PL SC, V5, P319, DOI 10.1146/annurev.ea.05.050177.001535; Schouten S, 2003, GEOLOGY, V31, P1069, DOI 10.1130/G19876.1; Sepkoski J. J., 2002, B AM PALEONTOL, V363, P560; Sheehan PM, 2001, ANNU REV EARTH PL SC, V29, P331, DOI 10.1146/annurev.earth.29.1.331; Shields GA, 2003, GEOCHIM COSMOCHIM AC, V67, P2005, DOI 10.1016/S0016-7037(02)01116-X; Stouffer RJ, 2003, CLIM DYNAM, V20, P759, DOI 10.1007/s00382-002-0302-4; Tripati A, 2005, NATURE, V436, P341, DOI 10.1038/nature03874; Trotter JA, 2008, SCIENCE, V321, P550, DOI 10.1126/science.1155814; Waelbroeck C, 2009, NAT GEOSCI, V2, P127, DOI 10.1038/NGEO411	25	332	363	13	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 18	2011	331	6019					903	906		10.1126/science.1200803	http://dx.doi.org/10.1126/science.1200803			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722SO	21273448				2022-12-28	WOS:000287455100055
J	Van Aert, S; Batenburg, KJ; Rossell, MD; Erni, R; Van Tendeloo, G				Van Aert, Sandra; Batenburg, Kees J.; Rossell, Marta D.; Erni, Rolf; Van Tendeloo, Gustaaf			Three-dimensional atomic imaging of crystalline nanoparticles	NATURE			English	Article							GUINIER-PRESTON ZONES; INTERNAL STRUCTURE; ELECTRON; TOMOGRAPHY; PROSPECTS; IMAGES	Determining the three-dimensional (3D) arrangement of atoms in crystalline nanoparticles is important for nanometre-scale device engineering and also for applications involving nanoparticles, such as optoelectronics or catalysis. A nanoparticle's physical and chemical properties are controlled by its exact 3D morphology, structure and composition(1). Electron tomography enables the recovery of the shape of a nanoparticle from a series of projection images(2-4). Although atomic-resolution electron microscopy has been feasible for nearly four decades, neither electron tomography nor any other experimental technique has yet demonstrated atomic resolution in three dimensions. Here we report the 3D reconstruction of a complex crystalline nanoparticle at atomic resolution. To achieve this, we combined aberration-corrected scanning transmission electron microscopy(5-7), statistical parameter estimation theory(8,9) and discrete tomography(10,11). Unlike conventional electron tomography, only two images of the target-a silver nanoparticle embedded in an aluminium matrix-are sufficient for the reconstruction when combined with available knowledge about the particle's crystallographic structure. Additional projections confirm the reliability of the result. The results we present help close the gap between the atomic resolution achievable in two-dimensional electron micrographs and the coarser resolution that has hitherto been obtained by conventional electron tomography.	[Van Aert, Sandra; Van Tendeloo, Gustaaf] Univ Antwerp, B-2020 Antwerp, Belgium; [Batenburg, Kees J.] Ctr Wiskunde & Informat, NL-1098 XG Amsterdam, Netherlands; [Batenburg, Kees J.] Univ Antwerp, IBBT Vis Lab, B-2610 Antwerp, Belgium; [Rossell, Marta D.] Swiss Fed Inst Technol, Dept Mat, CH-8093 Zurich, Switzerland; [Erni, Rolf] Empa, Swiss Fed Labs Mat Sci & Technol, Ctr Electron Microscopy, CH-8600 Dubendorf, Switzerland	University of Antwerp; University of Antwerp; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA)	Van Aert, S (corresponding author), Univ Antwerp, Groenenborgerlaan 171, B-2020 Antwerp, Belgium.	sandra.vanaert@ua.ac.be	Van Aert, Sandra/G-9144-2011; Erni, Rolf/P-7435-2014; Van Aert, Sandra/B-7913-2017; Rossell, Marta D/E-9785-2017	Erni, Rolf/0000-0003-2391-5943; Van Aert, Sandra/0000-0001-9603-8764; Rossell, Marta D/0000-0001-8610-8853	Office of Science, Office of Basic Energy Sciences of the US Department of Energy [DE-AC02-05CH11231]; European Union [026019 ESTEEM]	Office of Science, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE)); European Union(European Commission)	Part of this work was performed at the National Center for Electron Microscopy (LBNL) which is supported by the Office of Science, Office of Basic Energy Sciences of the US Department of Energy under contract number DE-AC02-05CH11231. Financial support from the European Union for the Framework 6 programme under a contract for an Integrated Infrastructure Initiative (reference 026019 ESTEEM) is acknowledged.	Arslan I, 2005, SCIENCE, V309, P2195, DOI 10.1126/science.1116745; Batenburg KJ, 2009, ULTRAMICROSCOPY, V109, P730, DOI 10.1016/j.ultramic.2009.01.009; Batenburg KJ, 2007, J MATH IMAGING VIS, V27, P175, DOI 10.1007/s10851-006-9798-2; Batson PE, 2002, NATURE, V418, P617, DOI 10.1038/nature00972; CREWE AV, 1968, J APPL PHYS, V39, P5861, DOI 10.1063/1.1656079; den Dekker AJ, 2005, ULTRAMICROSCOPY, V104, P83, DOI 10.1016/j.ultramic.2005.03.001; DUBEY PA, 1991, ACTA METALL MATER, V39, P1161, DOI 10.1016/0956-7151(91)90204-E; Dwyer C, 2010, ULTRAMICROSCOPY, V110, P952, DOI 10.1016/j.ultramic.2010.01.007; Erni R, 2003, PHIL MAG LETT, V83, P599, DOI 10.1080/09500830310001600347; Erni R, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.096101; Haider M, 1998, NATURE, V392, P768, DOI 10.1038/33823; Hartel P, 1996, ULTRAMICROSCOPY, V63, P93, DOI 10.1016/0304-3991(96)00020-4; HILLYARD S, 1995, ULTRAMICROSCOPY, V58, P6, DOI 10.1016/0304-3991(94)00173-K; Jinschek JR, 2008, ULTRAMICROSCOPY, V108, P589, DOI 10.1016/j.ultramic.2007.10.002; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; Kisielowski C, 2008, MICROSC MICROANAL, V14, P469, DOI 10.1017/S1431927608080902; Klenov DO, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1947910; Krivanek OL, 2010, NATURE, V464, P571, DOI 10.1038/nature08879; Li ZY, 2008, NATURE, V451, P46, DOI 10.1038/nature06470; Malik A, 1996, ACTA MATER, V44, P4845, DOI 10.1016/S1359-6454(96)00129-2; MALIS T, 1988, J ELECTRON MICR TECH, V8, P193, DOI 10.1002/jemt.1060080206; McLachlan G., 2000, WILEY SER PROB STAT; Midgley PA, 2009, NAT MATER, V8, P271, DOI 10.1038/nmat2406; Muller H, 2006, MICROSC MICROANAL, V12, P442, DOI 10.1017/S1431927606060600; Nellist PD, 2000, ADV IMAG ELECT PHYS, V113, P147, DOI 10.1016/S1076-5670(00)80013-0; Olson GB, 2000, SCIENCE, V288, P993, DOI 10.1126/science.288.5468.993; Pennycook S. J., 2004, MICROSC MICROANAL, V10, P1172; Van Aert S, 2009, ULTRAMICROSCOPY, V109, P1236, DOI 10.1016/j.ultramic.2009.05.010; van Benthem K, 2006, ULTRAMICROSCOPY, V106, P1062, DOI 10.1016/j.ultramic.2006.04.020; Xin HL, 2009, J ELECTRON MICROSC, V58, P157, DOI 10.1093/jmicro/dfn029	30	391	392	4	320	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					374	377		10.1038/nature09741	http://dx.doi.org/10.1038/nature09741			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21289625	Green Published			2022-12-28	WOS:000287409100037
J	McKee, M; Cole, K; Hurst, L; Aldridge, RW; Horton, R				McKee, Martin; Cole, Katie; Hurst, Louise; Aldridge, Robert W.; Horton, Richard			Observations Medicine and the Media The other Twitter revolution: how social media are helping to monitor the NHS reforms	BRITISH MEDICAL JOURNAL			English	Editorial Material									[McKee, Martin; Cole, Katie] London Sch Hyg & Trop Med, London, England; [Hurst, Louise] UCL, Dept Epidemiol & Publ Hlth, London WC1E 6BT, England; [Aldridge, Robert W.] UCL, Dept Infect & Populat Hlth, Ctr Infect Dis Epidemiol, London WC1E 6BT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; University College London	McKee, M (corresponding author), London Sch Hyg & Trop Med, London, England.	martin.mckee@lshtm.ac.uk	Mckee, Martin/E-6673-2018; McKee, Marc D/E-2187-2011	Mckee, Martin/0000-0002-0121-9683; McKee, Marc D/0000-0001-8349-965X; Aldridge, Robert/0000-0003-0542-0816	National Institute for Health Research [ACF-2009-18-028] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Appleby J, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d566; COWPER A, 2010, SUPER WEDNESDAY POLI; COWPER A, 2011, ACCOUNTABILITY MATTE; Goldacre B., 2011, GUARDIAN; Organisation for Economic Co-operation and Development, 2010, IMPR VAL HLTH CAR ME; PEEDELL C, 2011, O LETWIN NEW POLL TA; 2011, HLTH IND LOBBYING TO	7	9	9	0	11	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2011	342								d948	10.1136/bmj.d948	http://dx.doi.org/10.1136/bmj.d948			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	725OZ	21325389	Green Accepted			2022-12-28	WOS:000287656500022
J	Kmetik, KS; O'Toole, MF; Bossley, H; Brutico, CA; Fischer, G; Grund, SL; Gulotta, BM; Hennessey, M; Kahn, S; Murphy, KM; Pacheco, T; Pawlson, LG; Schaeffer, J; Schwamberger, PA; Scholle, SH; Wozniak, G				Kmetik, Karen S.; O'Toole, Michael F.; Bossley, Heidi; Brutico, Carmen A.; Fischer, Gary; Grund, Sherry L.; Gulotta, Bridget M.; Hennessey, Mark; Kahn, Stasia; Murphy, Karen M.; Pacheco, Ted; Pawlson, L. Greg; Schaeffer, John; Schwamberger, Patricia A.; Scholle, Sarah H.; Wozniak, Gregory			Exceptions to Outpatient Quality Measures for Coronary Artery Disease in Electronic Health Records	ANNALS OF INTERNAL MEDICINE			English	Article							ASSOCIATION TASK-FORCE; PRACTICE GUIDELINES COMMITTEE; AMERICAN-HEART-ASSOCIATION; COLLEGE-OF-CARDIOLOGY; ACC/AHA GUIDELINES; MYOCARDIAL-INFARCTION; PRIMARY-CARE; PERFORMANCE; MANAGEMENT; ANGINA	Background: Physicians report outpatient quality measures from data in electronic health records to facilitate care improvement and qualify for incentive payments. Objective: To determine the frequency and validity of exceptions to quality measures and to test a system for classifying the reasons for these exceptions. Design: Cross-sectional observational study. Setting: 5 internal medicine or cardiology practices. Participants: 47 075 patients with coronary artery disease between 2006 and 2007. Measurements: Counts of adherence with and exceptions to 4 quality measures, on the basis of automatic reports of recommended drug therapy by computer software and separate manual reviews of electronic health records. Results: 3.5% of patients who had a drug recommended had an exception to the drug and were not prescribed it (95% CI, 3.4% to 3.7%). Clinicians did prescribe the recommended drug for many other patients with exceptions. In 538 randomly selected records, 92.6% (CI, 90.3% to 94.9%) of the exceptions reported automatically by computer software were also exceptions during manual review. Most medical exceptions were clinical contraindications, drug allergies, or drug intolerances. In 592 randomly selected records, an unreported exception or a drug prescription was found during manual review for 74.6% (CI, 71.1% to 78.1%) of patients for whom automatic reporting recorded a quality failure. Limitation: The study used a convenience sample of practices, nonstandardized data extraction methods, only drug-related quality measures, and no financial incentives. Conclusion: Exceptions to recommended therapy occur infrequently and are usually valid. Physicians frequently prescribed drugs even when exceptions were present. Automated reports of quality failure often miss critical information.	[Kmetik, Karen S.] Amer Med Assoc, Chicago, IL 60654 USA; Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; Iowa Fdn Med Care, Des Moines, IA USA; Fox Prairie Med Grp, St Charles, IL USA; N Ohio Heart Ctr, Avon, OH USA; Natl Comm Qual Assurance, Washington, DC USA; Midwest Heart Specialists, Lombard, IL USA; Phys Hlth Alliance, Scranton, PA USA	American Medical Association; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Kmetik, KS (corresponding author), Amer Med Assoc, 515 N State St, Chicago, IL 60654 USA.	karen.kmetik@ama-assn.org			Agency for Healthcare Research and Quality [R18 HS 017160]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS017160] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Grant Support: By the Agency for Healthcare Research and Quality (R18 HS 017160).	[Anonymous], 2001, NIH PUBL; Antman Elliott M, 2004, J Am Coll Cardiol, V44, P671, DOI 10.1016/j.jacc.2004.07.002; Antman EM, 2009, CIRCULATION, V119, P1180, DOI 10.1161/CIRCULATIONAHA.109.856757; Baker DW, 2007, ANN INTERN MED, V146, P270, DOI 10.7326/0003-4819-146-4-200702200-00006; Brailer DJ, 2010, HEALTH AFFAIR, V29, P586, DOI 10.1377/hlthaff.2010.0274; Braunwald E, 2000, J AM COLL CARDIOL, V36, P970, DOI 10.1016/S0735-1097(00)00889-5; Centers for Medicare & Medicaidi Servies, 2010, FED REGISTER, V75, P44313; Cochran W.G., 2007, SAMPLING TECHNIQUES; Conway PH, 2009, JAMA-J AM MED ASSOC, V301, P763, DOI 10.1001/jama.2009.103; *CTR MED MED SERV, 2010, PHYS QUAL REP IN; *CTR MED MED SERV, 2008, EL HLTH REC DEM CLIN; *CTR MED MED SERV, 2009, DOCT OFF QUAL INF TE; *CTR MED MED SERV, 2000, MED PHYS GROUP PRACT; *CTR MED MED SERV, 2010, ALT REP MECH; *CTR MED MED SERV, 2006, MED CAR MAN PERF DEM; Doran T, 2008, NEW ENGL J MED, V359, P274, DOI 10.1056/NEJMsa0800310; Eagle KA, 1999, J AM COLL CARDIOL, V34, P1262, DOI 10.1016/S0735-1097(99)00389-7; FERGUSON J, 2009, HIT STANDARD COMMITT; Garber AM, 2005, HEALTH AFFAIR, V24, P174, DOI 10.1377/hlthaff.24.1.174; Gibbons RJ, 1999, J AM COLL CARDIOL, V33, P2092, DOI 10.1016/S0735-1097(99)00150-3; Linder JA, 2009, MED CARE, V47, P208, DOI 10.1097/MLR.0b013e318189375f; McDonald R, 2009, ANN FAM MED, V7, P121, DOI 10.1370/afm.946; Pedhazur EJ, 1991, MEASUREMENT DESIGN A; Persell SD, 2006, ARCH INTERN MED, V166, P2272, DOI 10.1001/archinte.166.20.2272; Persell SD, 2010, ANN INTERN MED, V152, P225, DOI 10.7326/0003-4819-152-4-201002160-00007; *PHYS CONS PERF IM, 2010, PHYS CONS PERF IMPR; *PHYS CONS PERF IM, 2007, PHYS CONS PERF IMPR; Ryan TJ, 1999, J AM COLL CARDIOL, V34, P890, DOI 10.1016/S0735-1097(99)00351-4; Tanguay JF, 2003, J AM COLL CARDIOL, V41, p404A	29	17	17	0	4	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 15	2011	154	4					227	W77		10.7326/0003-4819-154-4-201102150-00003	http://dx.doi.org/10.7326/0003-4819-154-4-201102150-00003			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	720VF	21320938				2022-12-28	WOS:000287310000014
J	Richman, BD; Schulman, KA				Richman, Barak D.; Schulman, Kevin A.			A Cautious Path Forward on Accountable Care Organizations	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Schulman, Kevin A.] Duke Univ, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA; [Schulman, Kevin A.] Duke Univ, Sch Med, Dept Med, Durham, NC 27715 USA; [Richman, Barak D.] Duke Univ, Sch Law, Durham, NC 27715 USA; [Richman, Barak D.; Schulman, Kevin A.] Duke Univ, Hlth Sector, Management Program, Fuqua Sch Business, Durham, NC 27715 USA	Duke University; Duke University; Duke University; Duke University	Schulman, KA (corresponding author), Duke Univ, Duke Clin Res Inst, POB 17969, Durham, NC 27715 USA.	kevin.schulman@duke.edu						Bastian H, 2010, PLOS MED, V7, pe1000326, DOI 10.1371/journal.pmed.1000326; Berenson RA, 2010, HEALTH AFFAIR, V29, P699, DOI 10.1377/hlthaff.2009.0715; Elhauge E., 2010, FRAGMENTATION US HLT, DOI 10.1093/acprof:oso/9780195390131.001.0001; ENTHOVEN AC, 2005, HLTH AFF MILLWOOD S; Greaney TL, 1997, AM J LAW MED, V23, P191; Ioannidis JPA, 2005, PLOS MED, V2, pe124, DOI 10.1371/journal.pmed.0020124; Kent DM, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-85; Landrigan CP, 2010, NEW ENGL J MED, V363, P2573	8	25	25	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 9	2011	305	6					602	603		10.1001/jama.2011.111	http://dx.doi.org/10.1001/jama.2011.111			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	717XI	21304085	Green Published			2022-12-28	WOS:000287080500026
J	Jasny, BR; Zahn, LM				Jasny, Barbara R.; Zahn, Laura M.			GENOME-SEQUENCING ANNIVERSARY A Celebration of the Genome, Part I	SCIENCE			English	Editorial Material																			0	4	4	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					546	546		10.1126/science.331.6017.546-a	http://dx.doi.org/10.1126/science.331.6017.546-a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292964				2022-12-28	WOS:000286933600036
J	Yadon, AN; Tsukiyama, T				Yadon, Adam N.; Tsukiyama, Toshio			SnapShot: Chromatin Remodeling: ISWI	CELL			English	Editorial Material							TRANSCRIPTION		[Yadon, Adam N.; Tsukiyama, Toshio] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA	Fred Hutchinson Cancer Center	Yadon, AN (corresponding author), Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA.				NICHD NIH HHS [T32HD007183] Funding Source: Medline; NIGMS NIH HHS [R01 GM058465] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007183] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058465] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bowman GD, 2010, CURR OPIN STRUC BIOL, V20, P73, DOI 10.1016/j.sbi.2009.12.002; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dang WW, 2007, MOL CELL BIOL, V27, P8306, DOI 10.1128/MCB.01351-07; Gangaraju VK, 2009, MOL CELL, V35, P58, DOI 10.1016/j.molcel.2009.05.013; Whitehouse I, 2007, NATURE, V450, P1031, DOI 10.1038/nature06391; Yadon AN, 2010, MOL CELL BIOL, V30, P5110, DOI 10.1128/MCB.00602-10	6	46	47	0	15	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 4	2011	144	3					454	U154	454.e1	10.1016/j.cell.2011.01.019	http://dx.doi.org/10.1016/j.cell.2011.01.019			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295704	Bronze			2022-12-28	WOS:000286973100016
J	Louie, TJ; Miller, MA; Mullane, KM; Weiss, K; Lentnek, A; Golan, Y; Gorbach, S; Sears, P; Shue, YK				Louie, Thomas J.; Miller, Mark A.; Mullane, Kathleen M.; Weiss, Karl; Lentnek, Arnold; Golan, Yoav; Gorbach, Sherwood; Sears, Pamela; Shue, Youe-Kong		OPT-80-003 Clinical Study Grp	Fidaxomicin versus Vancomycin for Clostridium difficile Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RESTRICTION-ENDONUCLEASE ANALYSIS; IN-VITRO ACTIVITIES; MOLECULAR ANALYSIS; UNITED-STATES; OPT-80; METRONIDAZOLE; DIARRHEA; COLITIS; DISEASE; INCREASE	BACKGROUND Clostridium difficile infection is a serious diarrheal illness associated with substantial morbidity and mortality. Patients generally have a response to oral vancomycin or metronidazole; however, the rate of recurrence is high. This phase 3 clinical trial compared the efficacy and safety of fidaxomicin with those of vancomycin in treating C. difficile infection. METHODS Adults with acute symptoms of C. difficile infection and a positive result on a stool toxin test were eligible for study entry. We randomly assigned patients to receive fidaxomicin (200 mg twice daily) or vancomycin (125 mg four times daily) orally for 10 days. The primary end point was clinical cure (resolution of symptoms and no need for further therapy for C. difficile infection as of the second day after the end of the course of therapy). The secondary end points were recurrence of C. difficile infection (diarrhea and a positive result on a stool toxin test within 4 weeks after treatment) and global cure (i.e., cure with no recurrence). RESULTS A total of 629 patients were enrolled, of whom 548 (87.1%) could be evaluated for the per-protocol analysis. The rates of clinical cure with fidaxomicin were noninferior to those with vancomycin in both the modified intention-to-treat analysis (88.2% with fidaxomicin and 85.8% with vancomycin) and the per-protocol analysis (92.1% and 89.8%, respectively). Significantly fewer patients in the fidaxomicin group than in the vancomycin group had a recurrence of the infection, in both the modified intention-to-treat analysis (15.4% vs. 25.3%, P = 0.005) and the per-protocol analysis (13.3% vs. 24.0%, P = 0.004). The lower rate of recurrence was seen in patients with non-North American Pulsed Field type 1 strains. The adverse-event profile was similar for the two therapies. CONCLUSIONS The rates of clinical cure after treatment with fidaxomicin were noninferior to those after treatment with vancomycin. Fidaxomicin was associated with a significantly lower rate of recurrence of C. difficile infection associated with non-North American Pulsed Field type 1 strains.	[Louie, Thomas J.] Univ Calgary, Foothills Hosp, Dept Med & Microbiol, Div Infect Dis, Calgary, AB T2N 4J8, Canada; [Miller, Mark A.] McGill Univ, Montreal, PQ, Canada; [Weiss, Karl] Univ Montreal, Montreal, PQ, Canada; [Mullane, Kathleen M.] Univ Chicago, Chicago, IL 60637 USA; [Lentnek, Arnold] Wellstar Infect Dis, Marietta, GA USA; [Golan, Yoav; Gorbach, Sherwood] Tufts Med Ctr, Boston, MA USA; [Gorbach, Sherwood; Sears, Pamela; Shue, Youe-Kong] Optimer Pharmaceut, San Diego, CA USA	University of Calgary; McGill University; Universite de Montreal; University of Chicago; Tufts Medical Center	Louie, TJ (corresponding author), Univ Calgary, Foothills Hosp, Dept Med & Microbiol, Div Infect Dis, 1403 29 St NW, Calgary, AB T2N 4J8, Canada.	thomas.louie@albertahealthservices.ca	Silverman, Michael/J-3776-2014	Silverman, Michael/0000-0002-0389-7656	Optimer Pharmaceuticals; Merck; Cubist Pharmaceuticals; ViroPharma; Cempra; Iroko Pharmaceuticals; Salix Pharmaceuticals; Abbott; Bayer; Pfizer; Genzyme	Optimer Pharmaceuticals; Merck(Merck & Company); Cubist Pharmaceuticals; ViroPharma; Cempra; Iroko Pharmaceuticals; Salix Pharmaceuticals; Abbott(Abbott Laboratories); Bayer(Bayer AG); Pfizer(Pfizer); Genzyme(Sanofi-AventisGenzyme Corporation)	Drs. Louie, Miller, Mullane, Weiss, Lentnek, and Golan report that their respective institutions received per-case funding from Optimer Pharmaceuticals to support patient expenses. Drs. Louie, Miller, Mullane, and Golan report receiving support from Optimer Pharmaceuticals for travel to meetings for the conduct of the clinical trial or presentation of the results of the clinical trial, and Drs. Louie, Miller, and Mullane report receiving honoraria from Optimer Pharmaceuticals for participation in additional meetings related to investigative planning for fidaxomicin. In addition, Dr. Louie reports receiving honoraria or consulting fees from Merck, Cubist Pharmaceuticals, ViroPharma, Cempra, and Iroko Pharmaceuticals, and being listed on a fidaxomicin patent; Dr. Miller, receiving honoraria or consulting fees from Merck, Iroko Pharmaceuticals, and Salix Pharmaceuticals; Dr. Weiss, receiving honoraria or consulting fees from Abbott, Bayer, Pfizer, and Genzyme; Dr. Shue, being an employee of and owning stock options in Optimer Pharmaceuticals; Dr. Sears, being an employee of and owning stock options in Optimer Pharmaceuticals and being listed as an inventor on a fidaxomicin patent; and Dr. Gorbach, being a part-time employee of Optimer Pharmaceuticals, receiving honoraria from and owning stock options in Cempra, and holding a patent on lactobacillus GG probiotic and beta-glucan. No other potential conflict of interest relevant to this article was reported.	Ackermann G, 2004, ANTIMICROB AGENTS CH, V48, P2280, DOI 10.1128/AAC.48.6.2280-2282.2004; Al-Nassir WN, 2008, ANTIMICROB AGENTS CH, V52, P2403, DOI 10.1128/AAC.00090-08; Bartlett JG, 2008, CLIN INFECT DIS, V46, P1489, DOI 10.1086/587654; BOLTON RP, 1986, GUT, V27, P1169, DOI 10.1136/gut.27.10.1169; Chernak E., 2005, Morbidity and Mortality Weekly Report, V54, P1201; CLABOTS CR, 1993, J CLIN MICROBIOL, V31, P1870, DOI 10.1128/JCM.31.7.1870-1875.1993; Cloud J, 2009, CLIN GASTROENTEROL H, V7, P868, DOI 10.1016/j.cgh.2009.05.018; Credito KL, 2004, ANTIMICROB AGENTS CH, V48, P4430, DOI 10.1128/AAC.48.11.4430-4434.2004; Dubberke ER, 2008, EMERG INFECT DIS, V14, P1031, DOI 10.3201/eid1407.070867; Finegold SA, 2004, ANTIMICROB AGENTS CH, V48, P4898, DOI 10.1128/AAC.48.12.4898-4902.2004; GERDING DN, 1995, INFECT CONT HOSP EP, V16, P459; Hecht DW, 2007, ANTIMICROB AGENTS CH, V51, P2716, DOI 10.1128/AAC.01623-06; JOHNSON S, 1989, J INFECT DIS, V159, P340, DOI 10.1093/infdis/159.2.340; Karlowsky JA, 2008, ANTIMICROB AGENTS CH, V52, P4163, DOI 10.1128/AAC.00476-08; Kelly CP, 2008, NEW ENGL J MED, V359; Kelly CP, 2010, NEW ENGL J MED, V363, P1585; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Kuijper E.J., 2008, EURO SURVEILL, V13; Loo VG, 2006, NEW ENGL J MED, V354, P2200; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Louie T, 2009, ANTIMICROB AGENTS CH, V53, P223, DOI 10.1128/AAC.01442-07; Louie TJ, 2009, ANTIMICROB AGENTS CH, V53, P261, DOI 10.1128/AAC.01443-07; MacCannell DR, 2006, J CLIN MICROBIOL, V44, P2147, DOI 10.1128/JCM.02563-05; Maroo S, 2006, GASTROENTEROLOGY, V130, P1311, DOI 10.1053/j.gastro.2006.02.044; McDonald LC, 2006, EMERG INFECT DIS, V12, P409, DOI 10.3201/eid1203.051064; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Morgan OW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001812; Musher DM, 2005, CLIN INFECT DIS, V40, P1586, DOI 10.1086/430311; Nelson R, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004610.pub3; Pepin J, 2005, CLIN INFECT DIS, V40, P1591, DOI 10.1086/430315; Pepin J, 2007, AM J GASTROENTEROL, V102, P2781, DOI 10.1111/j.1572-0241.2007.01539.x; Redelings MD, 2007, EMERG INFECT DIS, V13, P1417, DOI 10.3201/eid1309.061116; Rouphael NG, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.01.062; Sawabe E, 2007, EUR J CLIN MICROBIOL, V26, P695, DOI 10.1007/s10096-007-0355-8; Shue YK, 2008, ANTIMICROB AGENTS CH, V52, P1391, DOI 10.1128/AAC.01045-07; Tannock GW, 2010, MICROBIOL-SGM, V156, P3354, DOI 10.1099/mic.0.042010-0; Zar FA, 2007, CLIN INFECT DIS, V45, P302, DOI 10.1086/519265; Zilberberg MD, 2008, EMERG INFECT DIS, V14, P929, DOI 10.3201/eid1406.071447	38	1038	1090	2	91	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2011	364	5					422	431		10.1056/NEJMoa0910812	http://dx.doi.org/10.1056/NEJMoa0910812			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715LL	21288078				2022-12-28	WOS:000286885900007
J	Neogi, T				Neogi, Tuhina			Gout	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							EVIDENCE BASED RECOMMENDATIONS; URIC-ACID LEVELS; RECURRENT GOUT; DOUBLE-BLIND; INCIDENT GOUT; URATE LEVELS; ACUTE FLARES; TASK-FORCE; PHASE-II; RISK	A 54-year-old man with crystal-proven gout has a history of four attacks during the previous year. Despite receiving 300 mg of allopurinol daily, his serum urate level is 7.2 mg per deciliter (428 mu mol per liter). He is moderately obese and has hypertension, for which he receives hydrochlorothiazide, and his serum creatinine level is 1.0 mg per deciliter (88 mu mol per liter). How should his case be managed?	Boston Univ, Sch Med, Clin Epidemiol Sect, Res & Training Unit, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02118 USA	Boston University; Boston University	Neogi, T (corresponding author), Boston Univ, Sch Med, Clin Epidemiol Unit, 650 Albany St,Suite X-200, Boston, MA 02118 USA.	tneogi@bu.edu	Neogi, Tuhina/AAM-1110-2020	Neogi, Tuhina/0000-0002-9515-1711				Arromdee E, 2002, J RHEUMATOL, V29, P2403; AXELROD D, 1988, ARTHRITIS RHEUM-US, V31, P803, DOI 10.1002/art.1780310618; Becker MA, 2005, NEW ENGL J MED, V353, P2450, DOI 10.1056/NEJMoa050373; Becker MA, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2978; Borstad GC, 2004, J RHEUMATOL, V31, P2429; Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4; Choi HK, 2004, LANCET, V363, P1277, DOI 10.1016/S0140-6736(04)16000-5; Choi HK, 2004, NEW ENGL J MED, V350, P1093, DOI 10.1056/NEJMoa035700; Choi HK, 2005, ANN INTERN MED, V143, P499, DOI 10.7326/0003-4819-143-7-200510040-00009; Choi HK, 2008, BMJ-BRIT MED J, V336, P309, DOI 10.1136/bmj.39449.819271.BE; Choi HK, 2007, ARTHRITIS RHEUM, V56, P2049, DOI 10.1002/art.22712; Choi Hyon K., 2010, JAMA (Journal of the American Medical Association), V304, P2270, DOI 10.1001/jama.2010.1638; Choi HK, 2009, ARCH INTERN MED, V169, P502, DOI 10.1001/archinternmed.2008.606; Dalbeth N, 2006, J RHEUMATOL, V33, P1646; Dalbeth N, 2010, ANN RHEUM DIS, V69, P1677, DOI 10.1136/ard.2009.124230; Dehghan A, 2008, LANCET, V372, P1953, DOI 10.1016/S0140-6736(08)61343-4; Fam AG, 2001, ARTHRITIS RHEUM-US, V44, P231, DOI 10.1002/1529-0131(200101)44:1<231::AID-ANR30>3.0.CO;2-7; Feig DI, 2008, NEW ENGL J MED, V359, P1811, DOI 10.1056/NEJMra0800885; Feig DI, 2010, NEW ENGL J MED, V362, P2235; GUTMAN AB, 1973, ARTHRITIS RHEUM-US, V16, P431, DOI 10.1002/art.1780160402; Huang HY, 2005, ARTHRITIS RHEUM, V52, P1843, DOI 10.1002/art.21105; Hunter DJ, 2006, J RHEUMATOL, V33, P1714; Hunter DJ, 2006, J RHEUMATOL, V33, P1341; Janssens HJEM, 2008, LANCET, V371, P1854, DOI 10.1016/S0140-6736(08)60799-0; Janssens HJ, 2008, COCHRANE DB SYST REV, V2; Jordan KM, 2007, RHEUMATOLOGY, V46, P1372, DOI 10.1093/rheumatology/kem056a; Kutzing MK, 2008, J PHARMACOL EXP THER, V324, P1, DOI 10.1124/jpet.107.129031; Lawrence RC, 2008, ARTHRITIS RHEUM, V58, P26, DOI 10.1002/art.23176; LOEB JN, 1972, ARTHRITIS RHEUM-US, V15, P189, DOI 10.1002/art.1780150209; Man CY, 2007, ANN EMERG MED, V49, P670, DOI 10.1016/j.annemergmed.2006.11.014; Mandell Brian F, 2010, Cleve Clin J Med, V77 Suppl 2, pS2, DOI 10.3949/ccjm.77.s2.01; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mikuls TR, 2004, ARTHRITIS RHEUM-US, V50, P937, DOI 10.1002/art.20102; Neogi T, 2006, J RHEUMATOL, V33, P104; Neogi T, 2010, ARTHRITIS RHEUM-US, V62, P2845, DOI 10.1002/art.27635; Perez-Ruiz F, 2007, ARTHRIT RHEUM-ARTHR, V57, P1324, DOI 10.1002/art.23007; Perez-Ruiz F, 2006, ARTHRIT RHEUM-ARTHR, V55, P786, DOI 10.1002/art.22232; Reinders MK, 2009, ANN RHEUM DIS, V68, P892, DOI 10.1136/ard.2008.091462; Reinders MK, 2009, ANN RHEUM DIS, V68, P51, DOI 10.1136/ard.2007.083071; Rodriguez G, 2010, ANN RHEUM DIS, V69, P2090, DOI 10.1136/ard.2010.130013; Schlesinger N, 2002, J RHEUMATOL, V29, P331; So A, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2143; So A, 2010, ARTHRITIS RHEUM-US, V62, P3064, DOI 10.1002/art.27600; Sundy JS, 2008, ARTHRITIS RHEUM, V58, P2882, DOI 10.1002/art.23810; Sutaria S, 2006, RHEUMATOLOGY, V45, P1422, DOI 10.1093/rheumatology/kel071; Takahashi S, 2003, ANN RHEUM DIS, V62, P572, DOI 10.1136/ard.62.6.572; Taniguchi A, 2005, ARTHRITIS RHEUM-US, V52, P2576, DOI 10.1002/art.21242; Terkeltaub R, 2009, ANN RHEUM DIS, V68, P1613, DOI 10.1136/ard.2009.108936; Terkeltaub RA, 2010, ARTHRITIS RHEUM-US, V62, P1060, DOI 10.1002/art.27327; Wallace KL, 2004, J RHEUMATOL, V31, P1582; Zhang W, 2006, ANN RHEUM DIS, V65, P1312, DOI 10.1136/ard.2006.055269; Zhang W, 2006, ANN RHEUM DIS, V65, P1301, DOI 10.1136/ard.2006.055251; Zhang YQ, 2006, AM J MED, V119, DOI 10.1016/j.amjmed.2006.01.020	53	335	350	3	100	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2011	364	5					443	452		10.1056/NEJMcp1001124	http://dx.doi.org/10.1056/NEJMcp1001124			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715LL	21288096				2022-12-28	WOS:000286885900009
J	Pei, HD; Zhang, L; Luo, KT; Qin, YX; Chesi, M; Fei, F; Bergsagel, PL; Wang, LW; You, ZS; Lou, ZK				Pei, Huadong; Zhang, Lindsey; Luo, Kuntian; Qin, Yuxin; Chesi, Marta; Fei, Frances; Bergsagel, P. Leif; Wang, Liewei; You, Zhongsheng; Lou, Zhenkun			MMSET regulates histone H4K20 methylation and 53BP1 accumulation at DNA damage sites	NATURE			English	Article							WOLF-HIRSCHHORN-SYNDROME; DOUBLE-STRAND BREAKS; MULTIPLE-MYELOMA; PROTEIN; METHYLTRANSFERASE; CHECKPOINT; MDC1; RECRUITMENT; REPAIR; DOMAIN	p53-binding protein 1 (53BP1) is known to be an important mediator of the DNA damage response(1), with dimethylation of histone H4 lysine 20 (H4K20me2) critical to the recruitment of 53BP1 to double-strand breaks (DSBs)(2,3). However, it is not clear how 53BP1 is specifically targeted to the sites of DNA damage, as the overall level of H4K20me2 does not seem to increase following DNA damage. It has been proposed that DNA breaks may cause exposure of methylated H4K20 previously buried within the chromosome; however, experimental evidence for such a model is lacking. Here we found that H4K20 methylation actually increases locally upon the induction of DSBs and that methylation of H4K20 at DSBs is mediated by the histone methyltransferase MMSET (also known as NSD2 or WHSC1) in mammals. Downregulation of MMSET significantly decreases H4K20 methylation at DSBs and the subsequent accumulation of 53BP1. Furthermore, we found that the recruitment of MMSET to DSBs requires the gamma H2AX-MDC1 pathway; specifically, the interaction between the MDC1 BRCT domain and phosphorylated Ser 102 of MMSET. Thus, we propose that a pathway involving gamma H2AX-MDC1-MMSET regulates the induction of H4K20 methylation on histones around DSBs, which, in turn, facilitates 53BP1 recruitment.	[Pei, Huadong; Luo, Kuntian; Lou, Zhenkun] Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA; [Zhang, Lindsey; Fei, Frances; You, Zhongsheng] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Qin, Yuxin; Wang, Liewei] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Chesi, Marta; Bergsagel, P. Leif] Mayo Clin Arizona, Ctr Comprehens Canc, Scottsdale, AZ 85259 USA	Mayo Clinic; Washington University (WUSTL); Mayo Clinic; Mayo Clinic; Mayo Clinic Phoenix	Lou, ZK (corresponding author), Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA.	lou.zhenkun@mayo.edu	Bergsagel, Peter Leif/A-7842-2011; Pei, Huadong/C-9625-2013; You, Zhongsheng/F-5404-2012	Bergsagel, Peter Leif/0000-0003-1523-7388; Fei, Yueyang/0000-0001-9439-9136; You, Zhongsheng/0000-0002-9719-8791	Richard Schulze Family Foundation; NIH [CA130996, CA151329]; American Cancer Society [IRG-58-010-52]; Siteman Career Award in Breast Cancer Research; NATIONAL CANCER INSTITUTE [R01CA133966, R01CA151329, R01CA136671, R01CA130996] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG020686, R01AG020686] Funding Source: NIH RePORTER	Richard Schulze Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Siteman Career Award in Breast Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank M. Jasin for providing HeLa DR-GFP cells, and S. Baylin for providing MDA-MB-231 cells with inducible I-SceI expression. We thank M. Goldberg, X. Yu and M. Stucki for providing MDC1 and BRCA1 constructs. We thank M. Huen for providing 53BP1 expression constructs. We thank J. D. Licht for providing MMSET antibodies and B. Ho Park for providing MMSET shRNAs. This work was supported by the Richard Schulze Family Foundation and the NIH (CA130996 and CA151329; Z.L.), a grant from the American Cancer Society (IRG-58-010-52; Z.Y.) and a Siteman Career Award in Breast Cancer Research (Z.Y.).	Bekker-Jensen S, 2005, J CELL BIOL, V170, P201, DOI 10.1083/jcb.200503043; Bergemann AD, 2005, TRENDS GENET, V21, P188, DOI 10.1016/j.tig.2005.01.008; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Celeste A, 2003, NAT CELL BIOL, V5, P675, DOI 10.1038/ncb1004; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; Du LL, 2006, GENE DEV, V20, P1583, DOI 10.1101/gad.1422606; Fang J, 2002, CURR BIOL, V12, P1086, DOI 10.1016/S0960-9822(02)00924-7; FitzGerald JE, 2009, BIOCHEM SOC T, V37, P897, DOI 10.1042/BST0370897; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Kim JY, 2008, MOL CELL BIOL, V28, P2023, DOI 10.1128/MCB.02130-07; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Lee MS, 2005, J BIOL CHEM, V280, P32053, DOI 10.1074/jbc.C500273200; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Marango J, 2008, BLOOD, V111, P3145, DOI 10.1182/blood-2007-06-092122; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Moynahan ME, 2001, MOL CELL, V7, P263, DOI 10.1016/S1097-2765(01)00174-5; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Sanders SL, 2004, CELL, V119, P603, DOI 10.1016/j.cell.2004.11.009; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schotta G, 2008, GENE DEV, V22, P2048, DOI 10.1101/gad.476008; Stec I, 1998, HUM MOL GENET, V7, P1071, DOI 10.1093/hmg/7.7.1071; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Wang B, 2002, SCIENCE, V298, P1435, DOI 10.1126/science.1076182; You ZS, 2009, MOL CELL, V36, P954, DOI 10.1016/j.molcel.2009.12.002; Yu XC, 2003, SCIENCE, V302, P639, DOI 10.1126/science.1088753	30	308	319	0	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 3	2011	470	7332					124	U144		10.1038/nature09658	http://dx.doi.org/10.1038/nature09658			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715LQ	21293379	Green Accepted			2022-12-28	WOS:000286886400047
J	Berkman, MB; Plutzer, E				Berkman, Michael B.; Plutzer, Eric			Defeating Creationism in the Courtroom, But Not in the Classroom	SCIENCE			English	Editorial Material							EVOLUTION; STANDARDS		[Berkman, Michael B.; Plutzer, Eric] Penn State Univ, Dept Polit Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Plutzer, E (corresponding author), Penn State Univ, Dept Polit Sci, University Pk, PA 16802 USA.	Plutzer@psu.edu		Plutzer, Eric/0000-0002-5456-7227				Berkman M., 2010, EVOLUTION CREATIONIS; Berkman MB, 2009, PERSPECT POLIT, V7, P485, DOI 10.1017/S153759270999082X; Berkman MB, 2008, PLOS BIOL, V6, P920, DOI 10.1371/journal.pbio.0060124; Branch G, 2010, ANNU REV GENOM HUM G, V11, P317, DOI 10.1146/annurev-genom-082509-141815; Donnelly LA, 2007, J RES SCI TEACH, V44, P236, DOI 10.1002/tea.20150; Moore R, 2002, BIOSCIENCE, V52, P378, DOI 10.1641/0006-3568(2002)052[0378:TEDSSM]2.0.CO;2; National Center for Education Statistics, 2005, NAT ASS ED PROGR 200; National Research Council (NRC), 1996, NAT SCI ED STAND; Plutzer E, 2008, PUBLIC OPIN QUART, V72, P540, DOI 10.1093/poq/nfn034; Rutledge ML, 2002, AM BIOL TEACH, V64, P21, DOI 10.1662/0002-7685(2002)064[0021:HSBTKS]2.0.CO;2	10	72	75	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					404	405		10.1126/science.1198902	http://dx.doi.org/10.1126/science.1198902			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	712BB	21273472				2022-12-28	WOS:000286635900035
J	Hardie, DG				Hardie, D. Grahame			Why Starving Cells Eat Themselves	SCIENCE			English	Editorial Material							ACTIVATED PROTEIN-KINASE; AUTOPHAGY; PHOSPHORYLATION; RAPTOR		Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland	University of Dundee	Hardie, DG (corresponding author), Univ Dundee, Coll Life Sci, Dundee DD1 5EH, Scotland.	d.g.hardie@dundee.ac.uk	Hardie, David/Z-1979-2019	Hardie, Grahame/0000-0002-8373-7379				Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; CLARK SL, 1957, J BIOPHYS BIOCHEM CY, V3, P349, DOI 10.1083/jcb.3.3.349; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Scott JW, 2002, J MOL BIOL, V317, P309, DOI 10.1006/jmbi.2001.5316; TSUKADA M, 1993, FEBS LETT, V333, P169, DOI 10.1016/0014-5793(93)80398-E; Wang Z, 2001, MOL CELL BIOL, V21, P5742, DOI 10.1128/MCB.21.17.5742-5752.2001; Wilson WA, 1996, CURR BIOL, V6, P1426, DOI 10.1016/S0960-9822(96)00747-6; Xiao B, 2007, NATURE, V449, P496, DOI 10.1038/nature06161	12	15	15	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2011	331	6016					410	411		10.1126/science.1201691	http://dx.doi.org/10.1126/science.1201691			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273476				2022-12-28	WOS:000286635900039
J	Chen, Q; Bae, SC; Granick, S				Chen, Qian; Bae, Sung Chul; Granick, Steve			Directed self-assembly of a colloidal kagome lattice	NATURE			English	Article							CRYSTALLIZATION; NANOPARTICLES; COMPLEX; GROWTH	A challenging goal in materials chemistry and physics is spontaneously to form intended superstructures from designed building blocks. In fields such as crystal engineering(1) and the design of porous materials(2-4), this typically involves building blocks of organic molecules, sometimes operating together with metallic ions or clusters. The translation of such ideas to nanoparticles and colloidal-sized building blocks would potentially open doors to new materials and new properties(5-7), but the pathways to achieve this goal are still undetermined. Here we show how colloidal spheres can be induced to self-assemble into a complex predetermined colloidal crystal-in this case a colloidal kagome lattice(8-12)-through decoration of their surfaces with a simple pattern of hydrophobic domains. The building blocks are simple micrometre-sized spheres with interactions (electrostatic repulsion in the middle, hydrophobic attraction at the poles, which we call 'triblock Janus') that are also simple, but the self-assembly of the spheres into an open kagome structure contrasts with previously known close-packed periodic arrangements of spheres(13-15). This open network is of interest for several theoretical reasons(8-10). With a view to possible enhanced functionality, the resulting lattice structure possesses two families of pores, one that is hydrophobic on the rims of the pores and another that is hydrophilic. This strategy of 'convergent' self-assembly from easily fabricated(16) colloidal building blocks encodes the target supracolloidal architecture, not in localized attractive spots but instead in large redundantly attractive regions, and can be extended to form other supracolloidal networks.	[Chen, Qian; Bae, Sung Chul; Granick, Steve] Univ Illinois, Dept Mat Sci & Engn, Urbana, IL 61801 USA; [Granick, Steve] Univ Illinois, Dept Chem, Urbana, IL 61801 USA; [Granick, Steve] Univ Illinois, Dept Phys, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Granick, S (corresponding author), Univ Illinois, Dept Mat Sci & Engn, 1304 W Green St, Urbana, IL 61801 USA.	sgranick@illinois.edu	Chen, Qian/A-6535-2011; Chen, Qian/E-9624-2014; Bae, Sung C/A-3423-2008	Bae, Sung C/0000-0002-9765-6801; Chen, Qian/0000-0002-1968-441X	US Department of Energy, Division of Materials Science through the Frederick Seitz Materials Research Laboratory at the University of Illinois at Urbana-Champaign [DE-FG02-07ER46471]; Div Of Chem, Bioeng, Env, & Transp Sys [0853737] Funding Source: National Science Foundation	US Department of Energy, Division of Materials Science through the Frederick Seitz Materials Research Laboratory at the University of Illinois at Urbana-Champaign(United States Department of Energy (DOE)); Div Of Chem, Bioeng, Env, & Transp Sys(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the US Department of Energy, Division of Materials Science, under award number DE-FG02-07ER46471 through the Frederick Seitz Materials Research Laboratory at the University of Illinois at Urbana-Champaign. For equipment, we acknowledge the National Science Foundation, CBET-0853737. We thank K. Chen for help with particle tracking.	Anderson VJ, 2002, NATURE, V416, P811, DOI 10.1038/416811a; Atwood JL, 2002, NAT MATER, V1, P91, DOI 10.1038/nmat740; Desiraju GR, 2007, ANGEW CHEM INT EDIT, V46, P8342, DOI 10.1002/anie.200700534; Doppelbauer G, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/10/104105; Gasser U, 2001, SCIENCE, V292, P258, DOI 10.1126/science.1058457; Ghosh A, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.248305; Giacometti A, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3415490; Glettner B, 2008, ANGEW CHEM INT EDIT, V47, P9063, DOI 10.1002/anie.200802957; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Grunbaum B., 1987, TILINGS PATTERNS; Hong L, 2008, LANGMUIR, V24, P621, DOI 10.1021/la7030818; Kraft DJ, 2009, SOFT MATTER, V5, P3823, DOI 10.1039/b910593j; Li C, 2010, CHEM MATER, V22, P476, DOI 10.1021/cm9031946; Liu HJ, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.018101; Liu K, 2010, SCIENCE, V329, P197, DOI 10.1126/science.1189457; Mann S, 2009, NAT MATER, V8, P781, DOI [10.1038/NMAT2496, 10.1038/nmat2496]; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508; Pawar AB, 2008, LANGMUIR, V24, P355, DOI 10.1021/la703005z; Schlickum U, 2008, J AM CHEM SOC, V130, P11778, DOI 10.1021/ja8028119; Shevchenko EV, 2006, NATURE, V439, P55, DOI 10.1038/nature04414; Souslov A, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.205503; Sun QF, 2010, SCIENCE, V328, P1144, DOI 10.1126/science.1188605; van der Marck SC, 1998, J PHYS A-MATH GEN, V31, P3449, DOI 10.1088/0305-4470/31/15/010; Xia YN, 2003, ADV FUNCT MATER, V13, P907, DOI 10.1002/adfm.200300002; Yaghi OM, 2003, NATURE, V423, P705, DOI 10.1038/nature01650; Yethiraj A, 2003, NATURE, V421, P513, DOI 10.1038/nature01328	28	960	976	20	829	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					381	384		10.1038/nature09713	http://dx.doi.org/10.1038/nature09713			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248847	Green Submitted			2022-12-28	WOS:000286385600048
J	Clark, PC; Glover, SCO; Smith, RJ; Greif, TH; Klessen, RS; Bromm, V				Clark, Paul C.; Glover, Simon C. O.; Smith, Rowan J.; Greif, Thomas H.; Klessen, Ralf S.; Bromm, Volker			The Formation and Fragmentation of Disks Around Primordial Protostars	SCIENCE			English	Article							1ST STARS; CDM UNIVERSE; ACCRETION; BINARIES; SYSTEMS; REDSHIFT	The very first stars to form in the universe heralded an end to the cosmic dark ages and introduced new physical processes that shaped early cosmic evolution. Until now, it was thought that these stars lived short, solitary lives, with only one extremely massive star, or possibly a very wide binary system, forming in each dark-matter minihalo. Here we describe numerical simulations that show that these stars were, to the contrary, often members of tight multiple systems. Our results show that the disks that formed around the first young stars were unstable to gravitational fragmentation, possibly producing small binary and higher-order systems that had separations as small as the distance between Earth and the Sun.	[Clark, Paul C.; Glover, Simon C. O.; Smith, Rowan J.; Klessen, Ralf S.] Univ Heidelberg, Zentrum Astron, Inst Theoret Astrophys, D-69120 Heidelberg, Germany; [Greif, Thomas H.] Max Planck Inst Astrophys, D-85748 Garching, Germany; [Klessen, Ralf S.] Stanford Univ, Kavli Inst Particle Astrophys & Cosmol, Menlo Pk, CA 94025 USA; [Bromm, Volker] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA; [Bromm, Volker] Univ Texas Austin, Texas Cosmol Ctr, Austin, TX 78712 USA	Ruprecht Karls University Heidelberg; Max Planck Society; Stanford University; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Clark, PC (corresponding author), Univ Heidelberg, Zentrum Astron, Inst Theoret Astrophys, Albert Ueberle Str 2, D-69120 Heidelberg, Germany.	pcc@ita.uni-heidelberg.de	Smith, Rowan/GOH-1182-2022	Smith, Rowan/0000-0002-0820-1814; Glover, Simon/0000-0001-6708-1317; Klessen, Ralf Stephan/0000-0002-0560-3172	Baden-Wurttemberg Stiftung [P-LS-SPII/18]; Heidelberg University, German Excellence Initiative; NSF [AST-0708795, AST-1009928]; NASA [NNX 08-AL43G, 09-AJ33G]; Texas Advanced Computing Center [AST090003]	Baden-Wurttemberg Stiftung; Heidelberg University, German Excellence Initiative; NSF(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); Texas Advanced Computing Center	We acknowledge financial support from the Baden-Wurttemberg Stiftung via their program International Collaboration II (grant P-LS-SPII/18), a Frontier grant of Heidelberg University sponsored by the German Excellence Initiative, NSF grants AST-0708795 and AST-1009928, and NASA through Astrophysics Theory and Fundamental Physics Program grants NNX 08-AL43G and 09-AJ33G (V. B.). This research used the Ranger system at the Texas Advanced Computing Center (TeraGrid award AST090003).	Abel T, 2002, SCIENCE, V295, P93, DOI 10.1126/science.1063991; Bate MR, 1997, MON NOT R ASTRON SOC, V285, P33, DOI 10.1093/mnras/285.1.33; Bromm V, 2006, ASTROPHYS J, V642, P382, DOI 10.1086/500799; Bromm V, 2002, ASTROPHYS J, V564, P23, DOI 10.1086/323947; Bromm V, 2004, NEW ASTRON, V9, P353, DOI 10.1016/j.newast.2003.12.006; Gammie CF, 2001, ASTROPHYS J, V553, P174, DOI 10.1086/320631; Krumholz MR, 2009, SCIENCE, V323, P754, DOI 10.1126/science.1165857; Lodato G, 2005, MON NOT R ASTRON SOC, V358, P1489, DOI 10.1111/j.1365-2966.2005.08875.x; Machida MN, 2008, ASTROPHYS J, V677, P813, DOI 10.1086/533434; Mckee CF, 2008, ASTROPHYS J, V681, P771, DOI 10.1086/587434; O'Shea BW, 2007, ASTROPHYS J, V654, P66, DOI 10.1086/509250; Peters T, 2010, ASTROPHYS J, V711, P1017, DOI 10.1088/0004-637X/711/2/1017; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; Stacy A, 2010, MON NOT R ASTRON SOC, V403, P45, DOI 10.1111/j.1365-2966.2009.16113.x; Tan JC, 2004, ASTROPHYS J, V603, P383, DOI 10.1086/381490; Turk MJ, 2009, SCIENCE, V325, P601, DOI 10.1126/science.1173540; Yoshida N, 2008, SCIENCE, V321, P669, DOI 10.1126/science.1160259; Yoshida N, 2006, ASTROPHYS J, V652, P6, DOI 10.1086/507978	19	290	290	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 25	2011	331	6020					1040	1042		10.1126/science.1198027	http://dx.doi.org/10.1126/science.1198027			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	726DM	21292936	Green Submitted			2022-12-28	WOS:000287699000055
J	Tang, YC; Williams, BR; Siegel, JJ; Amon, A				Tang, Yun-Chi; Williams, Bret R.; Siegel, Jake J.; Amon, Angelika			Identification of Aneuploidy-Selective Antiproliferation Compounds	CELL			English	Article							ACTIVATED PROTEIN-KINASE; CELL-DEATH; AUTOPHAGY; HSP90; PROLIFERATION; TUMORIGENESIS; INSTABILITY; METABOLISM; PHENOTYPES; INHIBITORS	Aneuploidy, an incorrect chromosome number, is a hallmark of cancer. Compounds that cause lethality in aneuploid, but not euploid, cells could therefore provide new cancer therapies. We have identified the energy stress-inducing agent AICAR, the protein folding inhibitor 17-AAG, and the autophagy inhibitor chloroquine as exhibiting this property. AICAR induces p53-mediated apoptosis in primary mouse embryonic fibroblasts (MEFs) trisomic for chromosome 1, 13, 16, or 19. AICAR and 17-AAG, especially when combined, also show efficacy against aneuploid human cancer cell lines. Our results suggest that compounds that interfere with pathways that are essential for the survival of aneuploid cells could serve as a new treatment strategy against a broad spectrum of human tumors.	[Tang, Yun-Chi; Williams, Bret R.; Siegel, Jake J.; Amon, Angelika] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Tang, Yun-Chi; Williams, Bret R.; Siegel, Jake J.; Amon, Angelika] MIT, Howard Hughes Med Inst, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Amon, A (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	angelika@mit.edu	Tang, Yun-Chi/GRE-8205-2022	tang, yun qi/0000-0001-9385-2787; Amon, Angelika/0000-0001-9837-0314	Howard Hughes Medical Institute; Curt W. and Kathy Marble Cancer Research Fund; Human Frontier Science Program Fellowship	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Curt W. and Kathy Marble Cancer Research Fund; Human Frontier Science Program Fellowship(Human Frontier Science Program)	We thank H.-C. Chang and M. vander Heiden for discussions; M. Hemann for the LMS vectors and shp53.1224; D. Sabatini for torin1; J.M. van Deursen for Bub1b<SUP>H/H</SUP> mice; P. Zhang for Cdc20<SUP>AAA</SUP> MEF cells; and E. Vazile in the Koch Institute Microscopy facility for assistance. We are grateful to M. Dunham, M. Hemann, J. Lees, D. Sabatini, F. Solomon, and members of the Amon lab for their critical reading of the manuscript. This work was supported by grants from the Howard Hughes Medical Institute and the Curt W. and Kathy Marble Cancer Research Fund. Y.-C.T. is supported by the Human Frontier Science Program Fellowship.	Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Antonarakis SE, 2004, NAT REV GENET, V5, P725, DOI 10.1038/nrg1448; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Baker DJ, 2004, NAT GENET, V36, P744, DOI 10.1038/ng1382; BHATTACHARYYA NP, 1994, P NATL ACAD SCI USA, V91, P6319, DOI 10.1073/pnas.91.14.6319; Burton TR, 2009, CELL DEATH DIFFER, V16, P515, DOI 10.1038/cdd.2008.185; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Georgakis GV, 2006, EXP HEMATOL, V34, P1670, DOI 10.1016/j.exphem.2006.07.002; Hardie DG, 2007, NAT REV MOL CELL BIO, V8, P774, DOI 10.1038/nrm2249; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Larson PS, 2006, J PATHOL, V209, P307, DOI 10.1002/path.1973; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li M, 2010, P NATL ACAD SCI USA, V107, P14188, DOI 10.1073/pnas.1005960107; Li M, 2009, J CELL BIOL, V185, P983, DOI 10.1083/jcb.200904020; Lin HY, 2006, AM J MED GENET A, V140A, P945, DOI 10.1002/ajmg.a.31173; LINDSLEY DL, 1972, GENETICS, V71, P157; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, ANNU REV NUTR, V27, P19, DOI 10.1146/annurev.nutr.27.061406.093749; MOERMAN P, 1988, HUM GENET, V80, P349, DOI 10.1007/BF00273650; Niwa O, 2006, YEAST, V23, P937, DOI 10.1002/yea.1411; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; SEGAL DJ, 1974, J CELL PHYSIOL, V83, P85, DOI 10.1002/jcp.1040830112; Shih IM, 2001, CANCER RES, V61, P818; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Taldone T, 2008, CURR OPIN PHARMACOL, V8, P370, DOI 10.1016/j.coph.2008.06.015; TAMAI KT, 1994, MOL CELL BIOL, V14, P8155, DOI 10.1128/MCB.14.12.8155; Thompson SL, 2010, J CELL BIOL, V188, P369, DOI 10.1083/jcb.200905057; Tomasini R, 2008, TRENDS CELL BIOL, V18, P244, DOI 10.1016/j.tcb.2008.03.003; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Torres EM, 2010, CELL, V143, P71, DOI 10.1016/j.cell.2010.08.038; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; Young JC, 2001, J CELL BIOL, V154, P267, DOI 10.1083/jcb.200104079	44	245	249	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 18	2011	144	4					499	512		10.1016/j.cell.2011.01.017	http://dx.doi.org/10.1016/j.cell.2011.01.017			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	722ZC	21315436	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000287473100006
J	Philippe, H; Brinkmann, H; Copley, RR; Moroz, LL; Nakano, H; Poustka, AJ; Wallberg, A; Peterson, KJ; Telford, MJ				Philippe, Herve; Brinkmann, Henner; Copley, Richard R.; Moroz, Leonid L.; Nakano, Hiroaki; Poustka, Albert J.; Wallberg, Andreas; Peterson, Kevin J.; Telford, Maximilian J.			Acoelomorph flatworms are deuterostomes related to Xenoturbella	NATURE			English	Article							PHYLOGENETIC DISTRIBUTION; BASAL POSITION; SEQUENCES; PHYLUM; NEMERTODERMATIDA; MICRORNAS; EVOLUTION; ALIGNMENT; SUPPORTS; PACKAGE	Xenoturbellida and Acoelomorpha are marine worms with contentious ancestry. Both were originally associated with the flatworms (Platyhelminthes), but molecular data have revised their phylogenetic positions, generally linking Xenoturbellida to the deuterostomes(1,2) and positioning the Acoelomorpha as the most basally branching bilaterian group(s)(3-6). Recent phylogenomic data suggested that Xenoturbellida and Acoelomorpha are sister taxa and together constitute an early branch of Bilateria(7). Here we assemble three independent data sets-mitochondrial genes, a phylogenomic data set of 38,330 amino-acid positions and new microRNA (miRNA) complements-and show that the position of Acoelomorpha is strongly affected by a long-branch attraction (LBA) artefact. When we minimize LBA we find consistent support for a position of both acoelomorphs and Xenoturbella within the deuterostomes. The most likely phylogeny links Xenoturbella and Acoelomorpha in a clade we call Xenacoelomorpha. The Xenacoelomorpha is the sister group of the Ambulacraria (hemichordates and echinoderms). We show that analyses of miRNA complements(8) have been affected by character loss in the acoels and that both groups possess one miRNA and the gene Rsb66 otherwise specific to deuterostomes. In addition, Xenoturbella shares one miRNA with the ambulacrarians, and two with the acoels. This phylogeny makes sense of the shared characteristics of Xenoturbellida and Acoelomorpha, such as ciliary ultrastructure and diffuse nervous system, and implies the loss of various deuterostome characters in the Xenacoelomorpha including coelomic cavities, through gut and gill slits.	[Telford, Maximilian J.] UCL, Dept Genet Evolut & Environm, London WC1E 6BT, England; [Philippe, Herve; Brinkmann, Henner] Univ Montreal, Dept Biochim, Ctr Robert Cedergren, Montreal, PQ H3C 3J7, Canada; [Copley, Richard R.] Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Moroz, Leonid L.] Univ Florida, Whitney Lab Marine Biosci, St Augustine, FL 32080 USA; [Moroz, Leonid L.] Univ Florida, Dept Neurosci, St Augustine, FL 32080 USA; [Moroz, Leonid L.] Univ Florida, Whitney Lab Marine Biosci, Gainesville, FL 32080 USA; [Moroz, Leonid L.] Univ Florida, Dept Neurosci, Gainesville, FL 32080 USA; [Nakano, Hiroaki] Univ Gothenburg, Dept Marine Ecol Kristineberg, S-45034 Fiskebackskil, Sweden; [Poustka, Albert J.] Max Planck Inst Mol Genet, Evolut & Dev Grp, D-14195 Berlin, Germany; [Wallberg, Andreas] Uppsala Univ, Dept Systemat Biol, Evolutionary Biol Ctr, Uppsala, Sweden; [Peterson, Kevin J.] Dartmouth Coll, Dept Biol, Hanover, NH 03755 USA	University of London; University College London; Universite de Montreal; University of Oxford; Wellcome Centre for Human Genetics; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Gothenburg; Max Planck Society; Uppsala University; Dartmouth College	Telford, MJ (corresponding author), UCL, Dept Genet Evolut & Environm, Darwin Bldg,Gower St, London WC1E 6BT, England.	m.telford@ucl.ac.uk	Telford, Maximilian J/B-7178-2008; Peterson, Kevin J/A-2188-2009	Telford, Maximilian J/0000-0002-3749-5620; Moroz, Leonid/0000-0002-1333-3176; Wallberg, Andreas/0000-0002-9081-9663	Canada Research Chairs; Natural Sciences and Engineering Research Council; Reseau Quebecois de Calcul de Haute Performance; Biotechnology and Biological Sciences Research Council; National Science Foundation; NASA Ames; Wellcome Trust [075491/Z/04]; Max-Planck Society for the Advancement of Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039103] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA030118] Funding Source: NIH RePORTER; Division Of Computer and Network Systems [0821622] Funding Source: National Science Foundation	Canada Research Chairs(Canada Research ChairsCGIAR); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Reseau Quebecois de Calcul de Haute Performance; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Science Foundation(National Science Foundation (NSF)); NASA Ames(National Aeronautics & Space Administration (NASA)); Wellcome Trust(Wellcome TrustEuropean Commission); Max-Planck Society for the Advancement of Sciences; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Division Of Computer and Network Systems(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	We thank N. Lartillot for reading the manuscript, W. Sterrer for helping collect material, and E. Sperling for help with small RNA library construction. H. P. is funded by Canada Research Chairs, Natural Sciences and Engineering Research Council and Reseau Quebecois de Calcul de Haute Performance for computational resources: more than 220,000 central processing unit (CPU)-hours were used producing at least 7 tonnes of CO<INF>2</INF> excluding grey energy. R. R. C. and M.J.T. were part-funded by the Biotechnology and Biological Sciences Research Council SYNTAX scheme. K.J.P. is supported by the National Science Foundation and NASA Ames. R. R. C. was also supported by a Wellcome Trust core award, grant number 075491/Z/04. A.J.P. was supported by the Max-Planck Society for the Advancement of Sciences e. V. A. W. was funded by Inez Johanssons Stiftelse and Stiftelsen Lars Hiertas Minne.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Baguna J, 2008, PHILOS T R SOC B, V363, P1481, DOI 10.1098/rstb.2007.2238; Birney E, 2004, GENOME RES, V14, P988, DOI 10.1101/gr.1865504; Blanquart S, 2008, MOL BIOL EVOL, V25, P842, DOI 10.1093/molbev/msn018; Bourlat SJ, 2006, NATURE, V444, P85, DOI 10.1038/nature05241; Bourlat SJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-107; Bourlat SJ, 2003, NATURE, V424, P925, DOI 10.1038/nature01851; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Egger B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005502; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; FRANZEN A, 1987, ZOOL SCR, V16, P9, DOI 10.1111/j.1463-6409.1987.tb00046.x; Hejnol A, 2008, PHILOS T R SOC B, V363, P1493, DOI 10.1098/rstb.2007.2239; Hejnol A, 2009, P ROY SOC B-BIOL SCI, V276, P4261, DOI 10.1098/rspb.2009.0896; Hrdy I, 2004, NATURE, V432, P618, DOI 10.1038/nature03149; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Lartillot N, 2004, MOL BIOL EVOL, V21, P1095, DOI 10.1093/molbev/msh112; Lartillot N, 2008, PHILOS T R SOC B, V363, P1463, DOI 10.1098/rstb.2007.2236; Lartillot N, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S4; Lartillot N, 2009, BIOINFORMATICS, V25, P2286, DOI 10.1093/bioinformatics/btp368; Lundin K, 2001, BELG J ZOOL, V131, P153; Nielsen C, 2010, EVOL DEV, V12, P241, DOI 10.1111/j.1525-142X.2010.00408.x; Papillon D, 2004, MOL BIOL EVOL, V21, P2122, DOI 10.1093/molbev/msh229; PARDOS F, 1988, ACTA ZOOL-STOCKHOLM, V69, P1, DOI 10.1111/j.1463-6395.1988.tb00895.x; Peterson KJ, 2005, PALEOBIOLOGY, V31, P36, DOI 10.1666/0094-8373(2005)031[0036:TAMOEA]2.0.CO;2; PHILIPPE H, 1993, NUCLEIC ACIDS RES, V21, P5264, DOI 10.1093/nar/21.22.5264; Philippe H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000717; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Roure B., BMC EVOL BI IN PRESS; Roure B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S2; Ruiz-Trillo I, 2004, MOL PHYLOGENET EVOL, V33, P321, DOI 10.1016/j.ympev.2004.06.002; Ruiz-Trillo I, 2002, P NATL ACAD SCI USA, V99, P11246, DOI 10.1073/pnas.172390199; Ruiz-Trillo I, 1999, SCIENCE, V283, P1919, DOI 10.1126/science.283.5409.1919; Ruppert EE, 2005, CAN J ZOOL, V83, P8, DOI 10.1139/Z04-158; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Sempere LF, 2007, EVOL DEV, V9, P409, DOI 10.1111/j.1525-142X.2007.00180.x; Sempere LF, 2006, J EXP ZOOL PART B, V306B, P575, DOI 10.1002/jez.b.21118; Sperling EA, 2008, ANIMAL EVOLUTION: GENOMES, FOSSILS, AND TREES, P157; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Telford MJ, 2008, GENESIS, V46, P580, DOI 10.1002/dvg.20414; Telford MJ, 2003, P ROY SOC B-BIOL SCI, V270, P1077, DOI 10.1098/rspb.2003.2342; Tyler S, 2001, INTERRELATIONSHIPS P, P3; Westblad E., 1949, ARK ZOOL, V1, P3; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x	47	303	322	3	121	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					255	+		10.1038/nature09676	http://dx.doi.org/10.1038/nature09676			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307940	Green Accepted			2022-12-28	WOS:000287144200043
J	Yan, H; Choe, HS; Nam, SW; Hu, YJ; Das, S; Klemic, JF; Ellenbogen, JC; Lieber, CM				Yan, Hao; Choe, Hwan Sung; Nam, SungWoo; Hu, Yongjie; Das, Shamik; Klemic, James F.; Ellenbogen, James C.; Lieber, Charles M.			Programmable nanowire circuits for nanoprocessors	NATURE			English	Article							LOGIC; ARRAYS	A nanoprocessor constructed from intrinsically nanometre-scale building blocks is an essential component for controlling memory, nanosensors and other functions proposed for nanosystems assembled from the bottom up(1-3). Important steps towards this goal over the past fifteen years include the realization of simple logic gates with individually assembled semiconductor nanowires and carbon nanotubes(1,4-8), but with only 16 devices or fewer and a single function for each circuit. Recently, logic circuits also have been demonstrated that use two or three elements of a one-dimensional memristor array(9), although such passive devices without gain are difficult to cascade. These circuits fall short of the requirements for a scalable, multifunctional nanoprocessor(10,11) owing to challenges in materials, assembly and architecture on the nanoscale. Here we describe the design, fabrication and use of programmable and scalable logic tiles for nanoprocessors that surmount these hurdles. The tiles were built from programmable, non-volatile nanowire transistor arrays. Ge/Si core/shell nanowires(12) coupled to designed dielectric shells yielded single-nanowire, non-volatile field-effect transistors (FETs) with uniform, programmable threshold voltages and the capability to drive cascaded elements. We developed an architecture to integrate the programmable nanowire FETs and define a logic tile consisting of two interconnected arrays with 496 functional configurable FET nodes in an area of similar to 960 mu m(2). The logic tile was programmed and operated first as a full adder with a maximal voltage gain of ten and input-output voltage matching. Then we showed that the same logic tile can be reprogrammed and used to demonstrate full-subtractor, multiplexer, demultiplexer and clocked D-latch functions. These results represent a significant advance in the complexity and functionality of nanoelectronic circuits built from the bottom up with a tiled architecture that could be cascaded to realize fully integrated nanoprocessors with computing, memory and addressing capabilities.	[Yan, Hao; Hu, Yongjie; Lieber, Charles M.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Choe, Hwan Sung] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA; [Nam, SungWoo; Lieber, Charles M.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Das, Shamik; Klemic, James F.; Ellenbogen, James C.] Mitre Corp, Nanosyst Grp, Mclean, VA 22102 USA	Harvard University; Harvard University; Harvard University; MITRE Corporation	Das, S (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	sdas@mitre.org; cml@cmliris.harvard.edu	Nam, SungWoo/D-5345-2011; Hu, Yongjie/A-8308-2013; Nam, SungWoo/C-1745-2015	Nam, SungWoo/0000-0002-9719-7203; Hu, Yongjie/0000-0001-7225-1130	National Security Science and Engineering Faculty; MITRE Corporation; US government's Nano-Enabled Technology Initiative; MITRE	National Security Science and Engineering Faculty; MITRE Corporation; US government's Nano-Enabled Technology Initiative; MITRE	We thank D. Bell and N. Antoniou for transmission electron microscopy sample preparation and imaging, Q. Qing for assistance with electrical measurements and J. L. Huang, X. Duan and X. Jiang for helpful discussions. C. M. L. acknowledges support from a National Security Science and Engineering Faculty Fellow award and a contract from the MITRE Corporation. S. D., J. F. K. and J. C. E. acknowledge support by the US government's Nano-Enabled Technology Initiative and the MITRE Innovation Program.	Bachtold A, 2001, SCIENCE, V294, P1317, DOI 10.1126/science.1065824; Borghetti J, 2010, NATURE, V464, P873, DOI 10.1038/nature08940; Cui Y, 2001, SCIENCE, V291, P851, DOI 10.1126/science.291.5505.851; Das S, 2005, LECT NOTES PHYS, V680, P479; Das S, 2007, IEEE T CIRCUITS-I, V54, P2528, DOI 10.1109/TCSI.2007.907864; DeHon A, 2003, IEEE T NANOTECHNOL, V2, P23, DOI 10.1109/TNANO.2003.808508; Huang Y, 2001, SCIENCE, V294, P1313, DOI 10.1126/science.1066192; Javey A, 2002, NAT MATER, V1, P241, DOI 10.1038/nmat769; Javey A, 2007, NANO LETT, V7, P773, DOI 10.1021/nl063056l; Liu J, 2010, SEMICOND SCI TECH, V25, DOI 10.1088/0268-1242/25/5/055013; Lu W, 2008, IEEE T ELECTRON DEV, V55, P2859, DOI 10.1109/TED.2008.2005158; Lu W, 2007, NAT MATER, V6, P841, DOI 10.1038/nmat2028; Nam S, 2009, P NATL ACAD SCI USA, V106, P21035, DOI 10.1073/pnas.0911713106; Sakamoto W., 2009, P EL DEV M 2009, DOI [10.1109/IEDM.2009.5424211, DOI 10.1109/IEDM.2009.5424211]; Sedra A. S., 2004, MICROELECTRONICS CIR, P1014; Snider G, 2004, NANOTECHNOLOGY, V15, P881, DOI 10.1088/0957-4484/15/8/003; Sze S.M., 1981, PHYS SEMICONDUCTOR D, P438; Whang D, 2003, NANO LETT, V3, P1255, DOI 10.1021/nl0345062; Xia QF, 2009, NANO LETT, V9, P3640, DOI 10.1021/nl901874j; Xiang J, 2006, NATURE, V441, P489, DOI 10.1038/nature04796; Zhong ZH, 2003, SCIENCE, V302, P1377, DOI 10.1126/science.1090899	21	436	447	15	538	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					240	244		10.1038/nature09749	http://dx.doi.org/10.1038/nature09749			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307937				2022-12-28	WOS:000287144200040
J	Pelsser, LM; Frankena, K; Toorman, J; Savelkoul, HF; Dubois, AE; Pereira, RR; Haagen, TA; Rommelse, NN; Buitelaar, JK				Pelsser, Lidy M.; Frankena, Klaas; Toorman, Jan; Savelkoul, Huub F.; Dubois, Anthony E.; Pereira, Rob Rodrigues; Haagen, Ton A.; Rommelse, Nanda N.; Buitelaar, Jan K.			Effects of a restricted elimination diet on the behaviour of children with attention-deficit hyperactivity disorder (INCA study): a randomised controlled trial	LANCET			English	Article							DEFICIT/HYPERACTIVITY DISORDER; FOLLOW-UP; FOOD-ADDITIVES; RECURRENT DEPRESSION; OLIGOANTIGENIC DIET; COGNITIVE THERAPY; ADHD; SYMPTOMS; ALLERGY; MTA	Background The effects of a restricted elimination diet in children with attention-deficit hyperactivity disorder (ADHD) have mainly been investigated in selected subgroups of patients. We aimed to investigate whether there is a connection between diet and behaviour in an unselected group of children. Methods The Impact of Nutrition on Children with ADHD (INCA) study was a randomised controlled trial that consisted of an open-label phase with masked measurements followed by a double-blind crossover phase. Patients in the Netherlands and Belgium were enrolled via announcements in medical health centres and through media announcements. Randomisation in both phases was individually done by random sampling. In the open-label phase (first phase), children aged 4-8 years who were diagnosed with ADHD were randomly assigned to 5 weeks of a restricted elimination diet (diet group) or to instructions for a healthy diet (control group). Thereafter, the clinical responders (those with an improvement of at least 40% on the ADHD rating scale [ARS]) from the diet group proceeded with a 4-week double-blind crossover food challenge phase (second phase), in which high-IgG or low-IgG foods (classified on the basis of every child's individual IgG blood test results) were added to the diet. During the first phase, only the assessing paediatrician was masked to group allocation. During the second phase (challenge phase), all persons involved were masked to challenge allocation Primary endpoints were the change in ARS score between baseline and the end of the first phase (masked paediatrician) and between the end of the first phase and the second phase (double-blind), and the abbreviated Conners' scale (ACS) score (unmasked) between the same timepoints. Secondary endpoints included food-specific IgG levels at baseline related to the behaviour of the diet group responders after IgG-based food challenges. The primary analyses were intention to treat for the first phase and per protocol for the second phase. INCA is registered as an International Standard Randomised Controlled Trial, number ISRCTN 76063113. Findings Between Nov 4,2008, and Sept 29,2009,100 children were enrolled and randomly assigned to the control group (n=50) or the diet group (n=50). Between baseline and the end of the first phase, the difference between the diet group and the control group in the mean ARS total score was 23.7 (95% CI 18.6-28.8; p<0.0001) according to the masked ratings. The difference between groups in the mean ACS score between the same timepoints was 11.8 (95% CI 9.2-14.5; p<0.0001). The ARS total score increased in clinical responders after the challenge by 20.8 (95% CI 14.3-27.3; p<0.0001) and the ACS score increased by 11.6 (7.7-15.4; p<0.0001). In the challenge phase, after challenges with either high-IgG or low-IgG foods, relapse of ADHD symptoms occurred in 19 of 30 (63%) children, independent of the IgG blood levels. There were no harms or adverse events reported in both phases. Interpretation A strictly supervised restricted elimination diet is a valuable instrument to assess whether ADHD is induced by food. The prescription of diets on the basis of IgG blood tests should be discouraged.	[Pelsser, Lidy M.] ADHD Res Ctr, NL-5624 JE Eindhoven, Netherlands; [Frankena, Klaas; Savelkoul, Huub F.] Wageningen Univ, Quantitat Vet Epidemiol Grp, Wageningen, Netherlands; [Frankena, Klaas; Savelkoul, Huub F.] Wageningen Univ, Cell Biol & Immunol Grp, Wageningen, Netherlands; [Toorman, Jan] Catharina Hosp, Eindhoven, Netherlands; [Dubois, Anthony E.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Child Clin, NL-9713 AV Groningen, Netherlands; [Pereira, Rob Rodrigues] Maasstad Hosp, Rotterdam, Netherlands; [Haagen, Ton A.] VieCuri Med Ctr, Venlo, Netherlands; [Rommelse, Nanda N.; Buitelaar, Jan K.] Radboud Univ Nijmegen, Med Ctr, Dept Psychiat, NL-6525 ED Nijmegen, Netherlands; [Rommelse, Nanda N.; Buitelaar, Jan K.] Radboud Univ Nijmegen, Med Ctr, Dept Cognit Neurosci, NL-6525 ED Nijmegen, Netherlands; [Rommelse, Nanda N.; Buitelaar, Jan K.] Radboud Univ Nijmegen, Med Ctr, Karakter Child & Adolescent Psychiat Univ Ctr, NL-6525 ED Nijmegen, Netherlands	Wageningen University & Research; Wageningen University & Research; Catharina Hospital; University of Groningen; Maasstad Hospital; VieCuri Medical Center; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	Pelsser, LM (corresponding author), ADHD Res Ctr, Liviuslaan 49, NL-5624 JE Eindhoven, Netherlands.	lmjpelsser@adhdresearchcentre.nl	Rommelse, Nanda NJ/D-4872-2009; Buitelaar, Jan K/E-4584-2012; FRANKENA, KLAAS/K-6920-2012; Savelkoul, Huub FJ/F-6026-2012; Buitelaar, J.K./AAY-7522-2020	Rommelse, Nanda NJ/0000-0002-1711-0359; Buitelaar, Jan K/0000-0001-8288-7757; Pelsser, Lidy/0000-0002-8474-5151	Foundation of Child and Behaviour; Foundation Nuts Ohra; Foundation for Children's Welfare Stamps Netherlands; KF Hein foundation	Foundation of Child and Behaviour; Foundation Nuts Ohra; Foundation for Children's Welfare Stamps Netherlands; KF Hein foundation	This study was supported by grants from the Foundation of Child and Behaviour, Foundation Nuts Ohra, Foundation for Children's Welfare Stamps Netherlands, and the KF Hein foundation. We thank Marjan de Boer (Dutch Food Allergy Organisation) for her contribution to the advisory board and expert advice; and Karin van Geene, Gerrie Raats, and Petrie van Meijel for their kind and valuable contributions. We thank the staff of Catharina Hospital Eindhoven for their commitment, and all parents, guardians, children, and teachers who participated in the INCA study.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arnold LE, 1999, J ATTEN DISORD, V3, P30; Beyer K, 2005, CURR OPIN ALLERGY CL, V5, P261, DOI 10.1097/01.all.0000168792.27948.f9; Biederman J, 2005, LANCET, V366, P237, DOI 10.1016/S0140-6736(05)66915-2; Biederman J, 2008, J DEV BEHAV PEDIATR, V29, P501, DOI 10.1097/DBP.0b013e318190b290; Bockting CLH, 2009, J CLIN PSYCHIAT, V70, P1621, DOI 10.4088/JCP.08m04784blu; Bockting CLH, 2005, J CONSULT CLIN PSYCH, V73, P647, DOI 10.1037/0022-006X.73.4.647; BORIS M, 1994, ANN ALLERGY, V72, P462; BUITELAAR JK, 1995, J AM ACAD CHILD PSY, V34, P1025, DOI 10.1097/00004583-199508000-00012; CARTER CM, 1993, ARCH DIS CHILD, V69, P564, DOI 10.1136/adc.69.5.564; Chang C, 2004, HANDBOOK OF NUTRITION AND IMMUNITY, P153; CONNERS CK, 1976, PEDIATRICS, V58, P154; Dawson G, 2010, PEDIATRICS, V125, pE17, DOI 10.1542/peds.2009-0958; DUPAUL GJ, 1991, J CLIN CHILD PSYCHOL, V20, P245, DOI 10.1207/s15374424jccp2003_3; EGGER J, 1985, LANCET, V1, P540; Elia Josephine, 2008, Child Adolesc Psychiatry Ment Health, V2, P15, DOI 10.1186/1753-2000-2-15; Goodman R, 1999, J ABNORM CHILD PSYCH, V27, P17, DOI 10.1023/A:1022658222914; Heuer L, 2008, AUTISM RES, V1, P275, DOI 10.1002/aur.42; Hill P, 2001, ARCH DIS CHILD, V84, P404, DOI 10.1136/adc.84.5.404; Jensen PS, 2007, J AM ACAD CHILD PSY, V46, P989, DOI 10.1097/chi.0b013e3180686d48; Jensen PS, 1999, ARCH GEN PSYCHIAT, V56, P1073; Johansson SGO, 2004, J ALLERGY CLIN IMMUN, V113, P832, DOI 10.1016/j.jaci.2003.12.591; JONES B, 1989, DESIGN ANAL CROSSOVE; KAPLAN BJ, 1989, PEDIATRICS, V83, P7; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; McCann D, 2007, LANCET, V370, P1560, DOI 10.1016/S0140-6736(07)61306-3; McManus R, 2010, LANCET, V376, P163, DOI 10.1016/S0140-6736(10)60964-6; Molina BSG, 2009, J AM ACAD CHILD PSY, V48, P484, DOI 10.1097/CHI.0b013e31819c23d0; Mullin GE, 2010, NUTR CLIN PRACT, V25, P192, DOI 10.1177/0884533610362696; National Institute for Health and Clinical Excellence, 2008, NICE CLIN GUID, V72; Pelsser LM, 2010, EUR J PEDIATR, V169, P1129, DOI 10.1007/s00431-010-1196-5; Pelsser LMJ, 2009, PEDIAT ALLERG IMM-UK, V20, P107, DOI 10.1111/j.1399-3038.2008.00749.x; Pelsser LMJ, 2009, EUR CHILD ADOLES PSY, V18, P12, DOI 10.1007/s00787-008-0695-7; Schmidt MH, 1997, EUR CHILD ADOLES PSY, V6, P88; SchulteKorne G, 1996, Z KINDER JUG-PSYCH, V24, P176; Shrout P E, 1998, Stat Methods Med Res, V7, P301, DOI 10.1191/096228098672090967; Stevenson J, 2010, AM J PSYCHIAT, V167, P1108, DOI 10.1176/appi.ajp.2010.09101529; Strobel S, 2005, HUMAN NUTR, P493; van den Hoofdakker BJ, 2010, J PEDIATR PSYCHOL, V35, P317, DOI 10.1093/jpepsy/jsp060; Walkup JT, 2008, NEW ENGL J MED, V359, P2753, DOI 10.1056/NEJMoa0804633; Weaver FM, 2009, JAMA-J AM MED ASSOC, V301, P63, DOI 10.1001/jama.2008.929	41	121	122	0	146	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2011	377	9764					494	503		10.1016/S0140-6736(10)62227-1	http://dx.doi.org/10.1016/S0140-6736(10)62227-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	721TX	21296237				2022-12-28	WOS:000287381800030
J	Djuranovic, S; Nahvi, A; Green, R				Djuranovic, Sergej; Nahvi, Ali; Green, Rachel			A Parsimonious Model for Gene Regulation by miRNAs	SCIENCE			English	Review							MEDIATED TRANSLATIONAL REPRESSION; MESSENGER-RNA DEGRADATION; STRUCTURAL BASIS; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; LET-7 MICRORNA; GW182 PROTEINS; HUMAN-CELLS; PAZ DOMAIN; HUMAN AGO2	MicroRNAs (miRNAs) and small interfering RNAs (siRNAs) act with the Argonaute family of proteins to regulate target messenger RNAs (mRNAs) posttranscriptionally. SiRNAs typically induce endonucleolytic cleavage of mRNA with near-perfect complementarity. For targets with less complementarity, both translational repression and mRNA destabilization mechanisms have been implicated in miRNA-mediated gene repression, although the timing, coupling, and relative importance of these events have not been determined. Here, we review gene-specific and global approaches that probe miRNA function and mechanism, looking for a unifying model. More systematic analyses of the molecular specificities of the core components coupled with analysis of the relative timing of the different events will ultimately shed light on the mechanism of miRNA-mediated repression.	[Djuranovic, Sergej; Nahvi, Ali; Green, Rachel] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Howard Hughes Medical Institute; Johns Hopkins University	Green, R (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.	ragreen@jhmi.edu		Djuranovic, Sergej/0000-0002-9417-0822	HHMI; Life Sciences Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059425] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); Life Sciences Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Coller, G. Seydoux, R. Strack, and K. Wehner for critical comments. Supported by HHMI and Life Sciences Research Foundation (A.N.).	Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Boland A, 2010, EMBO REP, V11, P522, DOI 10.1038/embor.2010.81; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Chendrimada TP, 2007, NATURE, V447, P823, DOI 10.1038/nature05841; Coller J, 2005, CELL, V122, P875, DOI 10.1016/j.cell.2005.07.012; Ding XC, 2009, EMBO J, V28, P213, DOI 10.1038/emboj.2008.275; Djuranovic S, 2010, NAT STRUCT MOL BIOL, V17, P144, DOI 10.1038/nsmb.1736; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Fabian MR, 2009, MOL CELL, V35, P868, DOI 10.1016/j.molcel.2009.08.004; Fabian MR, 2010, ANNU REV BIOCHEM, V79, P351, DOI 10.1146/annurev-biochem-060308-103103; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Frank F, 2010, NATURE, V465, P818, DOI 10.1038/nature09039; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hendrickson DG, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000238; Huttelmaier S, 2005, NATURE, V438, P512, DOI 10.1038/nature04115; Ingolia NT, 2009, SCIENCE, V324, P218, DOI 10.1126/science.1168978; Isken O, 2007, GENE DEV, V21, P1833, DOI 10.1101/gad.1566807; Iwasaki S, 2009, MOL CELL, V34, P58, DOI 10.1016/j.molcel.2009.02.010; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Kiriakidou M, 2007, CELL, V129, P1141, DOI 10.1016/j.cell.2007.05.016; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777; Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514; Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Miyoshi K, 2009, RNA, V15, P1282, DOI 10.1261/rna.1541209; Nahvi A, 2009, RNA, V15, P814, DOI 10.1261/rna.1565109; Nissan T, 2008, RNA, V14, P1480, DOI 10.1261/rna.1072808; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Ostareck DH, 2001, CELL, V104, P281, DOI 10.1016/S0092-8674(01)00212-4; Parker JS, 2006, TRENDS BIOCHEM SCI, V31, P622, DOI 10.1016/j.tibs.2006.09.010; Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462; Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031; Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Schwartz DC, 1999, MOL CELL BIOL, V19, P5247; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tritschler F, 2010, NAT REV MOL CELL BIO, V11, P379, DOI 10.1038/nrm2885; Wakiyama M, 2007, GENE DEV, V21, P1857, DOI 10.1101/gad.1566707; Wang BB, 2008, P NATL ACAD SCI USA, V105, P5343, DOI 10.1073/pnas.0801102105; Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Yang Y, 2010, MOL BIOSYST, V6, P1873, DOI 10.1039/c004401f; Zdanowicz A, 2009, MOL CELL, V35, P881, DOI 10.1016/j.molcel.2009.09.009; Zekri L, 2009, MOL CELL BIOL, V29, P6220, DOI 10.1128/MCB.01081-09	59	391	406	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 4	2011	331	6017					550	553		10.1126/science.1191138	http://dx.doi.org/10.1126/science.1191138			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	715ZE	21292970	Green Accepted			2022-12-28	WOS:000286933600044
J	Dev, SP; Hillmer, MD; Ferri, M				Dev, Shelly P.; Hillmer, Melinda D.; Ferri, Mauricio			Arterial Puncture for Blood Gas Analysis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RADIAL-ARTERY; ALLEN TEST; PREOPERATIVE ASSESSMENT		[Dev, Shelly P.; Hillmer, Melinda D.; Ferri, Mauricio] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, Toronto, ON M4N 3M5, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center	Dev, SP (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Crit Care Med, 2075 Bayview Ave,Suite D-112, Toronto, ON M4N 3M5, Canada.							Agrifoglio M, 2005, ANN THORAC SURG, V79, P570, DOI 10.1016/j.athoracsur.2004.07.034; Barone JE, 2006, J TRAUMA, V61, P468, DOI 10.1097/01.ta.0000229815.43871.59; HALPERN AA, 1978, J BONE JOINT SURG AM, V60, P1136, DOI 10.2106/00004623-197860080-00026; Ruengsakulrach P, 2001, J THORAC CARDIOV SUR, V121, P526, DOI 10.1067/mtc.2001.112468	4	19	21	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2011	364	5					E7	E9		10.1056/NEJMvcm0803851	http://dx.doi.org/10.1056/NEJMvcm0803851			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715LL	21288091				2022-12-28	WOS:000286885900011
J	Wachterman, MW; Marcantonio, ER; Davis, RB; McCarthy, EP				Wachterman, Melissa W.; Marcantonio, Edward R.; Davis, Roger B.; McCarthy, Ellen P.			Association of Hospice Agency Profit Status With Patient Diagnosis, Location of Care, and Length of Stay	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICARE; ENROLLMENT; LIFE; HOME; END	Context Medicare's per diem payment structure may create financial incentives to select patients who require less resource-intensive care and have longer hospice stays. For-profit and nonprofit hospices may respond differently to financial incentives. Objective To compare patient diagnosis and location of care between for-profit and nonprofit hospices and examine whether number of visits per day and length of stay vary by diagnosis and profit status. Design, Setting, and Patients Cross-sectional study using data from the 2007 National Home and Hospice Care Survey. Nationally representative sample of 4705 patients discharged from hospice. Main Outcome Measures Diagnosis and location of care (home, nursing home, hospital, residential hospice, or other) by hospice profit status. Hospice length of stay and number of visits per day by various hospice personnel. Results For-profit hospices (1087 discharges from 145 agencies), compared with nonprofit hospices (3618 discharges from 524 agencies), had a lower proportion of patients with cancer (34.1%; 95% CI, 29.9%-38.6%, vs 48.4%; 95% CI, 45.0%-51.8%) and a higher proportion of patients with dementia (17.2%; 95% CI, 14.1%-20.8%, vs 8.4%; 95% CI, 6.6%-10.6%) and other noncancer diagnoses (48.7%; 95% CI, 43.2%-54.1%, vs 43.2%; 95% CI, 40.0%-46.5%; adjusted P<.001). After adjustment for demographic, clinical, and agency characteristics, there was no significant difference in location of care by profit status. For-profit hospices compared with nonprofit hospices had a significantly longer length of stay (median, 20 days; interquartile range [IQR], 6-88, vs 16 days; IQR, 5-52 days; adjusted P=.01) and were more likely to have patients with stays longer than 365 days (6.9%; 95% CI, 5.0%-9.4%, vs 2.8%; 95% CI, 2.0%-4.0%) and less likely to have patients with stays of less than 7 days (28.1%; 95% CI, 23.9%-32.7%, vs 34.3%; 95% CI, 31.3%-37.3%; P=.005). Compared with cancer patients, those with dementia or other diagnoses had fewer visits per day from nurses (0.50 visits; IQR, 0.32-0.87, vs 0.37 visits; IQR, 0.20-0.78, and 0.41 visits; IQR, 0.26-0.79, respectively; adjusted P=.002) and social workers (0.15 visits; IQR, 0.07-0.31, vs 0.11 visits; IQR, 0.04-0.27, and 0.14 visits; IQR, 0.07-0.31, respectively; adjusted P<.001). Conclusion Compared with nonprofit hospice agencies, for-profit hospice agencies had a higher percentage of patients with diagnoses associated with lower-skilled needs and longer lengths of stay. JAMA. 2011;305(5):472-479 www.jama.com	[Wachterman, Melissa W.; Marcantonio, Edward R.; Davis, Roger B.; McCarthy, Ellen P.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Gen Med & Primary Care, Boston, MA 02115 USA; [Marcantonio, Edward R.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Gerontol, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Wachterman, MW (corresponding author), Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med,Div Gen Med & Primary Care, 330 Brookline Ave, Boston, MA 02115 USA.	mwachter@bidmc.harvard.edu	Marcantonio, Edward R/U-3929-2017	Marcantonio, Edward R/0000-0002-2911-4250	Health Resources and Services Administration of the Department of Health and Human Services [6T32HP12706-02-01]; NATIONAL INSTITUTE ON AGING [K24AG035075] Funding Source: NIH RePORTER	Health Resources and Services Administration of the Department of Health and Human Services(United States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Wachterman received support from grant 6T32HP12706-02-01 from the Health Resources and Services Administration of the Department of Health and Human Services to support the Harvard Medical School Fellowship Program in General Medicine and Primary Care.	Campbell DE, 2004, ANN INTERN MED, V140, P269, DOI 10.7326/0003-4819-140-4-200402170-00009; Carlson MDA, 2004, MED CARE, V42, P432, DOI 10.1097/01.mlr.0000124246.86156.54; Carney K, 1989, Nurs Econ, V7, P41; *CDCP, NAT HOM HOSP CAR SUR; CHEUNG L, 2001, COSTS HOSPICE CARE A; Christakis N A, 1998, Hosp J, V13, P71; Christakis NA, 1996, NEW ENGL J MED, V335, P172, DOI 10.1056/NEJM199607183350306; Fitch K, 2003, 1 LAST DAYS HOSPICE; Fox E, 1999, JAMA-J AM MED ASSOC, V282, P1638, DOI 10.1001/jama.282.17.1638; Gruneir A, 2006, J PAIN SYMPTOM MANAG, V32, P478, DOI 10.1016/j.jpainsymman.2006.05.026; HACKBARTH GM, INCREASING VALUE MED; HACKBARTH GM, 2008, REF DEL SYST MEDPAC; Huskamp HA, 2001, HEALTH AFFAIR, V20, P204, DOI 10.1377/hlthaff.20.3.204; Lindrooth RC, 2007, J HEALTH ECON, V26, P342, DOI 10.1016/j.jhealeco.2006.09.003; Lorenz Karl A, 2002, J Palliat Med, V5, P507, DOI 10.1089/109662102760269742; Lynn J, 1997, New Horiz, V5, P56; Lynn J, 1996, Duquesne Law Rev, V35, P311; National Association for Home Care and Hospice, 2009, HOSP FACTS STAT; *NHPCO, 2010, NHPCO FACTS FIG HOSP; Nicosia N, 2009, HEALTH CARE FINANC R, V30, P47; O'Neill SM, 2008, J PALLIAT MED, V11, P1002, DOI 10.1089/jpm.2007.0252; NATL HOME HOSPICE CA	22	82	82	1	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2011	305	5					472	479		10.1001/jama.2011.70	http://dx.doi.org/10.1001/jama.2011.70			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	714LI	21285424	Green Accepted, Bronze			2022-12-28	WOS:000286810700020
J	Romley, JA; Jena, AB; Goldman, DP				Romley, John A.; Jena, Anupam B.; Goldman, Dana P.			Hospital Spending and Inpatient Mortality: Evidence From California An Observational Study	ANNALS OF INTERNAL MEDICINE			English	Article							REGIONAL-VARIATIONS; HEALTH-CARE; QUALITY; INTENSITY; SURVIVAL; OUTCOMES; ALWAYS	Background: Evidence shows that high Medicare spending is not associated with better health outcomes at a regional level and that high spending in hospitals is not associated with better process quality. The relationship between hospital spending and inpatient mortality is less well understood. Objective: To determine the association between hospital spending and risk-adjusted inpatient mortality. Design: Retrospective cohort study. Setting: Database of discharge records from 1999 to 2008 for 208 California hospitals included in The Dartmouth Atlas of Health Care. Patients: 2 545 352 patients hospitalized during 1999 to 2008 with 1 of 6 major medical conditions. Measurements: Inpatient mortality rates among patients admitted to hospitals with varying levels of end-of-life hospital spending. Results: For each of 6 diagnoses at admission-acute myocardial infarction, congestive heart failure, acute stroke, gastrointestinal hemorrhage, hip fracture, and pneumonia-patient admission to higher-spending hospitals was associated with lower risk-adjusted inpatient mortality. During 1999 to 2003, for example, patients admitted with acute myocardial infarction to California hospitals in the highest quintile of hospital spending had lower inpatient mortality than did those admitted to hospitals in the lowest quintile (odds ratio, 0.862 [95% CI, 0.742 to 0.983]). Predicted inpatient deaths would increase by 1831 if all patients admitted with acute myocardial infarction were cared for in hospitals in the lowest quintile of spending rather than the highest. The association between hospital spending and inpatient mortality did not vary by region or hospital size. Limitation: Unobserved predictors of mortality create uncertainty about whether greater inpatient hospital spending leads to lower inpatient mortality. Conclusion: Hospitals that spend more have lower inpatient mortality for 6 common medical conditions.	Univ So Calif, Leonard D Schaeffer Ctr Hlth Policy & Econ, Dept Neurol, Los Angeles, CA 90089 USA; Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA USA	University of Southern California; Harvard University; Harvard Medical School; Massachusetts General Hospital	Romley, JA (corresponding author), Univ So Calif, Schaeffer Ctr, Dept Neurol, 650 Childs Way, Los Angeles, CA 90089 USA.		Goldman, Dana P/E-7667-2013	Goldman, Dana P/0000-0001-8498-6396	National Institute on Aging [1R03AG031990-A1]; Roybal Center for Health Policy Simulation [P30AG024968]; NATIONAL INSTITUTE ON AGING [P30AG024968, R03AG031990] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Roybal Center for Health Policy Simulation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr. Romley received support from the National Institute on Aging (1R03AG031990-A1), and Dr. Goldman was supported by the Roybal Center for Health Policy Simulation (P30AG024968).	Agency for Healthcare Quality and Research, 2007, GUID INP QUAL IND QU; American Hospital Association, 2001, 2001 ANN SURV DAT; Bach PB, 2010, NEW ENGL J MED, V362, P569, DOI 10.1056/NEJMp0909947; Barnato AE, 2010, MED CARE, V48, P125, DOI 10.1097/MLR.0b013e3181c161e4; Bradley EH, 2006, JAMA-J AM MED ASSOC, V296, P72, DOI 10.1001/jama.296.1.72; Chandra A, 2007, J POLIT ECON, V115, P103, DOI 10.1086/512249; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Fisher ES, 2003, NEW ENGL J MED, V349, P1665, DOI 10.1056/NEJMe038149; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Landrum MB, 2008, HEALTH AFFAIR, V27, P159, DOI 10.1377/hlthaff.27.1.159; Lin DY, 1998, BIOMETRICS, V54, P948, DOI 10.2307/2533848; Ong MK, 2009, CIRC-CARDIOVASC QUAL, V2, P548, DOI 10.1161/CIRCOUTCOMES.108.825612; Rubin D. B., 2004, MULTIPLE IMPUTATION; Skinner J, 2010, NEW ENGL J MED, V362, P569, DOI 10.1056/NEJMp1000448; Skinner J, 2009, HEALTH AFFAIR, V28, pW119, DOI 10.1377/hlthaff.28.1.w119; Song YJ, 2010, NEW ENGL J MED, V363, P45, DOI 10.1056/NEJMsa0910881; Van Buuren S, 1999, STAT MED, V18, P681, DOI 10.1002/(SICI)1097-0258(19990330)18:6<681::AID-SIM71>3.0.CO;2-R; Weinstein MC, 2010, NEW ENGL J MED, V362, P460, DOI 10.1056/NEJMsb0911104; WENNBERG JE, 2004, HLTH AFF MILLWOOD S, pVAR5; Wennberg JE, 2008, TRACKING CARE PATIEN; Wennberg JE, 2005, HLTH AFF MILLWOOD S; Wennberg JE., 1996, DARTMOUTH ATLAS HLTH, P15; Werner RM, 2006, JAMA-J AM MED ASSOC, V296, P2694, DOI 10.1001/jama.296.22.2694; Yasaitis L, 2009, HEALTH AFFAIR, V28, pW566, DOI 10.1377/hlthaff.28.4.w566; Zuckerman S, 2010, NEW ENGL J MED, V363, P54, DOI 10.1056/NEJMsa0909253	27	72	72	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	2011	154	3					160	+		10.7326/0003-4819-154-3-201102010-00005	http://dx.doi.org/10.7326/0003-4819-154-3-201102010-00005			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	713HY	21282695	Green Accepted			2022-12-28	WOS:000286729200003
J	Croucher, NJ; Harris, SR; Fraser, C; Quail, MA; Burton, J; van der Linden, M; Mcgee, L; von Gottberg, A; Song, JH; Ko, KS; Pichon, B; Baker, S; Parry, CM; Lambertsen, LM; Shahinas, D; Pillai, DR; Mitchell, TJ; Dougan, G; Tomasz, A; Klugman, KP; Parkhill, J; Hanage, WP; Bentley, SD				Croucher, Nicholas J.; Harris, Simon R.; Fraser, Christophe; Quail, Michael A.; Burton, John; van der Linden, Mark; McGee, Lesley; von Gottberg, Anne; Song, Jae Hoon; Ko, Kwan Soo; Pichon, Bruno; Baker, Stephen; Parry, Christopher M.; Lambertsen, Lotte M.; Shahinas, Dea; Pillai, Dylan R.; Mitchell, Timothy J.; Dougan, Gordon; Tomasz, Alexander; Klugman, Keith P.; Parkhill, Julian; Hanage, William P.; Bentley, Stephen D.			Rapid Pneumococcal Evolution in Response to Clinical Interventions	SCIENCE			English	Article							RESISTANT STREPTOCOCCUS-PNEUMONIAE; ANTIBIOTIC-RESISTANCE; INTERCONTINENTAL SPREAD; UNITED-STATES; SEROTYPE 19A; 23F CLONE; EMERGENCE; DISEASE; TRANSFORMATION; SEQUENCE	Epidemiological studies of the naturally transformable bacterial pathogen Streptococcus pneumoniae have previously been confounded by high rates of recombination. Sequencing 240 isolates of the PMEN1 (Spain(23F)-1) multidrug-resistant lineage enabled base substitutions to be distinguished from polymorphisms arising through horizontal sequence transfer. More than 700 recombinations were detected, with genes encoding major antigens frequently affected. Among these were 10 capsule-switching events, one of which accompanied a population shift as vaccine-escape serotype 19A isolates emerged in the USA after the introduction of the conjugate polysaccharide vaccine. The evolution of resistance to fluoroquinolones, rifampicin, and macrolides was observed to occur on multiple occasions. This study details how genomic plasticity within lineages of recombinogenic bacteria can permit adaptation to clinical interventions over remarkably short time scales.	[Croucher, Nicholas J.; Harris, Simon R.; Quail, Michael A.; Burton, John; Dougan, Gordon; Parkhill, Julian; Bentley, Stephen D.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Fraser, Christophe; Hanage, William P.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London W2 1PG, England; [van der Linden, Mark] Rhein Westfal TH Aachen, Univ Hosp, Inst Med Microbiol, Natl Reference Ctr Streptococci, D-52074 Aachen, Germany; [McGee, Lesley; Klugman, Keith P.] Ctr Dis Control & Prevent, Resp Dis Branch, Atlanta, GA 30333 USA; [von Gottberg, Anne; Klugman, Keith P.] Natl Hlth Lab Serv, Natl Inst Communicable Dis, Resp & Meningeal Pathogens Res Unit, ZA-2000 Johannesburg, South Africa; [von Gottberg, Anne; Klugman, Keith P.] Univ Witwatersrand, ZA-2000 Johannesburg, South Africa; [Song, Jae Hoon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea; [Song, Jae Hoon] Asia Pacific Fdn Infect Dis, Seoul, South Korea; [Ko, Kwan Soo] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, South Korea; [Pichon, Bruno] Hlth Protect Agcy Ctr Infect, Resp & Syst Infect Lab, London NW9 5HT, England; [Baker, Stephen; Parry, Christopher M.] Oxford Univ Clin Res Unit, Wellcome Trust Major Overseas Programme, Hosp Trop Dis, Ho Chi Minh City, Vietnam; [Lambertsen, Lotte M.] Statens Serum Inst, Dept Microbiol Surveillance & Res, DK-2300 Copenhagen S, Denmark; [Shahinas, Dea; Pillai, Dylan R.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1V2, Canada; [Shahinas, Dea; Pillai, Dylan R.] Ontario Agcy Hlth Protect & Promot, Toronto, ON M5G 1V2, Canada; [Mitchell, Timothy J.] Univ Glasgow, Inst Infect Immun & Inflammat, Glasgow G12 8TA, Lanark, Scotland; [Tomasz, Alexander] Rockefeller Univ, Microbiol Lab, New York, NY 10021 USA; [Klugman, Keith P.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Klugman, Keith P.] Emory Univ, Sch Med, Div Infect Dis, Atlanta, GA 30322 USA; [Hanage, William P.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Wellcome Trust Sanger Institute; Imperial College London; RWTH Aachen University; RWTH Aachen University Hospital; Centers for Disease Control & Prevention - USA; National Health Laboratory Service; National Institute for Communicable Diseases (NICD); University of Witwatersrand; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Health Protection Agency; Statens Serum Institut; University of Toronto; University of Glasgow; Rockefeller University; Emory University; Rollins School Public Health; Emory University; Harvard University; Harvard T.H. Chan School of Public Health	Bentley, SD (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 1SA, England.	sdb@sanger.ac.uk	Parkhill, Julian/G-4703-2011; Hanage, Bill/CAF-1813-2022; Song, Jae Hoon/C-9602-2011; Fraser, Christophe/A-8109-2008; Quail, michael/ABE-6131-2020; Harris, Simon R/K-1318-2013; Tomasz, Alexander/B-9939-2011; van der Linden, Mark/B-9305-2009	Parkhill, Julian/0000-0002-7069-5958; Fraser, Christophe/0000-0003-2399-9657; Harris, Simon R/0000-0003-1512-6194; van der Linden, Mark/0000-0002-6574-4313; Baker, Stephen/0000-0003-1308-5755; Tomasz, Alexander/0000-0003-1520-1983; Mitchell, Timothy/0000-0002-8309-5556; Ko, Kwan Soo/0000-0002-0978-1937; Croucher, Nicholas/0000-0001-6303-8768; Lambertsen, Lotte/0000-0001-6409-6337; von Gottberg, Anne/0000-0002-0243-7455	Wellcome Trust; MRC [G0800596] Funding Source: UKRI; Medical Research Council [G0600719B, G0800596] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the participating surveillance networks, listed in table S1, and the core informatics, library-making, and sequencing teams at the Wellcome Trust Sanger Institute. Attending authors were grateful for the opportunity to discuss this project at the Permafrost conference. Sequence accession codes are given in tables S1 and S2. This work was funded by the Wellcome Trust.	Ardanuy C, 2009, J ANTIMICROB CHEMOTH, V64, P507, DOI 10.1093/jac/dkp210; Bentley SD, 2006, PLOS GENET, V2, P262, DOI 10.1371/journal.pgen.0020031; BUUHOI A, 1980, J BACTERIOL, V143, P313; Colijn C, 2010, J R SOC INTERFACE, V7, P905, DOI 10.1098/rsif.2009.0400; Corso A, 1998, MICROB DRUG RESIST, V4, P325, DOI 10.1089/mdr.1998.4.325; Croucher NJ, 2009, J BACTERIOL, V191, P1480, DOI 10.1128/JB.01343-08; Dagan R, 2008, LANCET INFECT DIS, V8, P785, DOI 10.1016/S1473-3099(08)70281-0; Del Grosso M, 2007, ANTIMICROB AGENTS CH, V51, P4184, DOI 10.1128/AAC.00598-07; Del Grosso M, 2006, ANTIMICROB AGENTS CH, V50, P3361, DOI 10.1128/AAC.00277-06; Feil EJ, 2000, GENETICS, V154, P1439; Ferrandiz MJ, 2005, ANTIMICROB AGENTS CH, V49, P2237, DOI 10.1128/AAC.49.6.2237-2245.2005; Hanage WP, 2009, SCIENCE, V324, P1454, DOI 10.1126/science.1171908; Harris SR, 2010, SCIENCE, V327, P469, DOI 10.1126/science.1182395; Holt KE, 2008, NAT GENET, V40, P987, DOI 10.1038/ng.195; KLUGMAN KP, 1994, EUR J CLIN MICROBIOL, V13, P171, DOI 10.1007/BF01982193; McCool TL, 2003, INFECT IMMUN, V71, P5724, DOI 10.1128/IAI.71.10.5724-5732.2003; McGee L, 1997, MICROB DRUG RESIST, V3, P253, DOI 10.1089/mdr.1997.3.253; McGee L, 2001, J CLIN MICROBIOL, V39, P2565, DOI 10.1128/JCM.39.7.2565-2571.2001; Moore MR, 2008, J INFECT DIS, V197, P1016, DOI 10.1086/528996; MUNOZ R, 1991, J INFECT DIS, V164, P302, DOI 10.1093/infdis/164.2.302; Munoz-Almagro C, 2008, CLIN INFECT DIS, V46, P174, DOI 10.1086/524660; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Parry CM, 2002, ANTIMICROB AGENTS CH, V46, P3512, DOI 10.1128/AAC.46.11.3512-3517.2002; Pestova EV, 1998, J BACTERIOL, V180, P2701, DOI 10.1128/JB.180.10.2701-2710.1998; Pletz MWR, 2006, EMERG INFECT DIS, V12, P1462, DOI 10.3201/eid1209.051400; Romero P, 2007, PLASMID, V58, P51, DOI 10.1016/j.plasmid.2006.12.006; Rose L, 2008, J INFECT DIS, V198, P375, DOI 10.1086/589775; SHAW JH, 1985, J BACTERIOL, V164, P782, DOI 10.1128/JB.164.2.782-796.1985; Tarasi A, 1997, MICROB DRUG RESIST, V3, P105, DOI 10.1089/mdr.1997.3.105; Trzcinski K, 2004, J BACTERIOL, V186, P3447, DOI 10.1128/JB.186.11.3447-3452.2004	31	643	661	0	141	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					430	434		10.1126/science.1198545	http://dx.doi.org/10.1126/science.1198545			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273480	Green Accepted			2022-12-28	WOS:000286635900044
J	Rosebeck, S; Madden, L; Jin, XH; Gu, SF; Apel, IJ; Appert, A; Hamoudi, RA; Noels, H; Sagaert, X; Van Loo, P; Baens, M; Du, MQ; Lucas, PC; McAllister-Lucas, LM				Rosebeck, Shaun; Madden, Lisa; Jin, Xiaohong; Gu, Shufang; Apel, Ingrid J.; Appert, Alex; Hamoudi, Rifat A.; Noels, Heidi; Sagaert, Xavier; Van Loo, Peter; Baens, Mathijs; Du, Ming-Qing; Lucas, Peter C.; McAllister-Lucas, Linda M.			Cleavage of NIK by the API2-MALT1 Fusion Oncoprotein Leads to Noncanonical NF-kappa B Activation	SCIENCE			English	Article							T-CELL-ACTIVATION; MALT LYMPHOMA; MARGINAL ZONE; CHROMOSOMAL TRANSLOCATION; UBIQUITIN LIGASE; BINDING-SITE; KINASE; PATHWAYS; TNF; TRAF2	Proper regulation of nuclear factor kappa B (NF-kappa B) transcriptional activity is required for normal lymphocyte function, and deregulated NF-kappa B signaling can facilitate lymphomagenesis. We demonstrate that the API2-MALT1 fusion oncoprotein created by the recurrent t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma induces proteolytic cleavage of NF-kappa B-inducing kinase (NIK) at arginine 325. NIK cleavage requires the concerted actions of both fusion partners and generates a C-terminal NIK fragment that retains kinase activity and is resistant to proteasomal degradation. The resulting deregulated NIK activity is associated with constitutive noncanonical NF-kappa B signaling, enhanced B cell adhesion, and apoptosis resistance. Our study reveals the gain-of-function proteolytic activity of a fusion oncoprotein and highlights the importance of the noncanonical NF-kappa B pathway in B lymphoproliferative disease.	[Jin, Xiaohong; Apel, Ingrid J.; Lucas, Peter C.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Rosebeck, Shaun; Madden, Lisa; Gu, Shufang; McAllister-Lucas, Linda M.] Univ Michigan, Dept Pediat & Communicable Dis, Ann Arbor, MI 48109 USA; [Appert, Alex; Hamoudi, Rifat A.; Du, Ming-Qing] Univ Cambridge, Addenbrookes Hosp, Dept Pathol, Div Mol Histopathol, Cambridge CB2 0QQ, England; [Noels, Heidi; Van Loo, Peter; Baens, Mathijs] Catholic Univ Louvain, Ctr Human Genet, Human Genome Lab, B-3000 Louvain, Belgium; [Noels, Heidi; Van Loo, Peter; Baens, Mathijs] Flanders Inst Biotechnol VIB, Dept Mol & Dev Genet, Human Genome Lab, B-3000 Louvain, Belgium; [Sagaert, Xavier] Catholic Univ Louvain, Dept Pathol, Sect Morphol & Mol Pathol, B-3000 Louvain, Belgium	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Universite Catholique Louvain; Flanders Institute for Biotechnology (VIB); Universite Catholique Louvain	Lucas, PC (corresponding author), Univ Michigan, Dept Pathol, 1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	plucas@umich.edu; lindaluc@umich.edu	Noels, Heidi/AAQ-2622-2020; Van Loo, Peter/A-3287-2012	Du, Ming-Qing/0000-0002-1017-5045; Lucas, Peter/0000-0003-4880-7172; Hamoudi, Rifat/0000-0002-1402-0868; Van Loo, Peter/0000-0003-0292-1949	Nancy Newton Loeb Pediatric Cancer Research; Helen L. Kay Pediatric Cancer Research Award; National Institute of Child Health and Human Development, NIH [T32-HD07513]; National Heart, Lung, and Blood Institute, NIH [T32-HL007622-21A2]; Research Foundation-Flanders (FWO); Belgian Foundation against Cancer; Shirley K. Schlafer Foundation; Elizabeth Caroline Crosby Fund; University of Michigan Comprehensive Cancer Center [G007839]; Leukemia and Lymphoma Research UK; National Cancer Institute NIH [R01CA124540]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007513] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA124540] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007622, R01HL082914] Funding Source: NIH RePORTER	Nancy Newton Loeb Pediatric Cancer Research; Helen L. Kay Pediatric Cancer Research Award; National Institute of Child Health and Human Development, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung, and Blood Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Research Foundation-Flanders (FWO)(FWO); Belgian Foundation against Cancer; Shirley K. Schlafer Foundation; Elizabeth Caroline Crosby Fund; University of Michigan Comprehensive Cancer Center; Leukemia and Lymphoma Research UK(Leukemia and Lymphoma Society); National Cancer Institute NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank M. Dyer for the SSK41 cells, R. Renne for the BJAB Tet-On cells, and G. Nunez for several expression plasmids. A Material Transfer Agreement is required for use of the SSK41 cells expressing API2-MALT1. Microarray data from MALT lymphoma tumor collections are Minimum Information About a Microarray Experiment (MIAME) compliant and are available online at the Gene Expression Omnibus (GEO) with accession number GSE25527 for collection no. 1 and accession number GSE25550 for collection no. 2 (www.ncbi.nlm.nih.gov/projects/geo/). L. M. is a recipient of the Nancy Newton Loeb Pediatric Cancer Research and Helen L. Kay Pediatric Cancer Research Awards and received support from National Institute of Child Health and Human Development, NIH, T32-HD07513. L.M. and S.R. were both supported by National Heart, Lung, and Blood Institute, NIH, T32-HL007622-21A2. M.B. is supported by grants from the Research Foundation-Flanders (FWO) and Belgian Foundation against Cancer. H.N. was an aspirant of the FWO-Vlaanderen. X.S. is a Senior Clinical Investigator of FWO-Vlaanderen, and P.V.L. is a postdoctoral researcher of the FWO. This work was supported by the Shirley K. Schlafer Foundation, the Elizabeth Caroline Crosby Fund, and grants from the University of Michigan Comprehensive Cancer Center (G007839), Leukemia and Lymphoma Research UK, and National Cancer Institute NIH (R01CA124540).	Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Baens M, 2006, CANCER RES, V66, P5270, DOI 10.1158/0008-5472.CAN-05-4590; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Chen JL, 2008, BLOOD, V111, P1677, DOI 10.1182/blood-2007-04-083808; Coornaert B, 2008, NAT IMMUNOL, V9, P263, DOI 10.1038/ni1561; Enzler T, 2006, IMMUNITY, V25, P403, DOI 10.1016/j.immuni.2006.07.010; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Guo F, 2007, BLOOD, V110, P2381, DOI 10.1182/blood-2007-02-075143; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Lopez-Giral S, 2004, J LEUKOCYTE BIOL, V76, P462, DOI 10.1189/jlb.1203652; Lucas PC, 2007, ONCOGENE, V26, P5643, DOI 10.1038/sj.onc.1210342; Lucas PC, 2001, J BIOL CHEM, V276, P19012, DOI 10.1074/jbc.M009984200; Luftig M, 2004, P NATL ACAD SCI USA, V101, P141, DOI 10.1073/pnas.2237183100; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; McAllister-Lucas LM, 2008, NAT IMMUNOL, V9, P231, DOI 10.1038/ni0308-231; Nie YC, 2004, J EXP MED, V200, P1145, DOI 10.1084/jem.20041185; Noels H, 2007, J BIOL CHEM, V282, P10180, DOI 10.1074/jbc.M611038200; Petersen SL, 2007, CANCER CELL, V12, P445, DOI 10.1016/j.ccr.2007.08.029; Rebeaud F, 2008, NAT IMMUNOL, V9, P272, DOI 10.1038/ni1568; Sanchez-Izquierdo D, 2003, BLOOD, V101, P4539, DOI 10.1182/blood-2002-10-3236; Sasaki Y, 2008, P NATL ACAD SCI USA, V105, P10883, DOI 10.1073/pnas.0805186105; Song HY, 1997, P NATL ACAD SCI USA, V94, P9792, DOI 10.1073/pnas.94.18.9792; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Thome M, 2008, NAT REV IMMUNOL, V8, P495, DOI 10.1038/nri2338; Uren AG, 2000, MOL CELL, V6, P961, DOI 10.1016/S1097-2765(05)00086-9; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Witzel II, 2010, BIOCHEM SOC T, V38, P217, DOI 10.1042/BST0380217; Woodland RT, 2008, BLOOD, V111, P750, DOI 10.1182/blood-2007-03-077222; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhou HL, 2005, CANCER CELL, V7, P425, DOI 10.1016/j.ccr.2005.04.012	32	111	127	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					468	472		10.1126/science.1198946	http://dx.doi.org/10.1126/science.1198946			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273489	Green Accepted			2022-12-28	WOS:000286635900055
J	Tarakji, KG; Sabik, JF; Bhudia, SK; Batizy, LH; Blackstone, EH				Tarakji, Khaldoun G.; Sabik, Joseph F., III; Bhudia, Sunil K.; Batizy, Lillian H.; Blackstone, Eugene H.			Temporal Onset, Risk Factors, and Outcomes Associated With Stroke After Coronary Artery Bypass Grafting	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OFF-PUMP; CARDIAC-SURGERY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; AXILLARY ARTERY; ON-PUMP; PREDICTORS; MORBIDITY; CANNULATION; SURVIVAL; TERM	Context Stroke is a devastating and potentially preventable complication of coronary artery bypass graft (CABG) surgery. Better understanding of the timing and risk factors for stroke associated with CABG are needed. Objectives To investigate temporal trends in stroke after CABG and to identify stroke risk factors and association with longitudinal outcomes. Design, Setting, and Patients Prospective study conducted from 1982 through 2009 at a single US academic medical center among 45 432 consecutive patients (mean age, 63 [SD, 10] years) undergoing isolated primary or reoperative CABG surgery. Strokes occurring following CABG were recorded prospectively and classified as having occurred intraoperatively or postoperatively. Complications and survival after stroke were assessed in propensity-matched groups. Intervention CABG performed using 4 different operative strategies (off-pump, on-pump with beating heart, on-pump with arrested heart, on-pump with hypothermic circulatory arrest). Main Outcome Measures Hospital complications; late survival. Results Among 45 432 patients undergoing CABG surgery, 705 (1.6% [95% confidence interval {CI}, 1.4%-1.7%]) experienced a stroke. The prevalence of stroke peaked in 1988 at 2.6% (95% CI, 1.9%-3.4%), then declined at 4.69% (95% CI, 4.68%-4.70%) per year (P=.04), despite increasing patient comorbidity. Overall, 279 strokes (40%) occurred intraoperatively and 409 (58%) occurred postoperatively (timing indeterminate in 17 patients). Postoperative stroke peaked at 40 hours, decreasing to 0.055%/d (95% CI, 0.047%-0.065%) by day 6. Risk factors for both intraoperative and postoperative stroke included older age (odds ratio, 8.5 [95% CI, 3.2-22]) and variables representing arteriosclerotic burden. Intraoperative stroke rates were lowest in off-pump CABG (0.14% [95% CI, 0.029%-0.40%]) and on-pump beating-heart CABG (0% [95% CI, 0%-1.6%]), intermediate with on-pump arrested-heart CABG (0.50% [95% CI, 0.41%-0.61%]), and highest with on-pump CABG with hypothermic circulatory arrest (5.3% [95% CI, 2.0%-11%]). Patients with stroke had worse adjusted hospital outcomes, longer intensive care and postoperative stays, and worse downstream survival (mean, 11 [SD, 8.6] years). Conclusion Among patients undergoing CABG surgery at a single center over the past 30 years, the occurrence of stroke declined despite an increasing patient risk profile, and more than half of strokes occurred postoperatively rather than intraoperatively. JAMA. 2011;305(4):381-390 www.jama.com	[Sabik, Joseph F., III; Bhudia, Sunil K.; Blackstone, Eugene H.] Cleveland Clin, Dept Thorac & Cardiovasc Surg, Cleveland, OH 44195 USA; [Tarakji, Khaldoun G.] Cleveland Clin, Dept Cardiovasc Med, Inst Heart & Vasc, Cleveland, OH 44195 USA; [Batizy, Lillian H.; Blackstone, Eugene H.] Cleveland Clin, Dept Quantitat Hlth Sci, Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation	Sabik, JF (corresponding author), Cleveland Clin, Dept Thorac & Cardiovasc Surg, 9500 Euclid Ave,Desk J4-1, Cleveland, OH 44195 USA.	sabikj@ccf.org	Bhudia, Sunil/AAF-8325-2020; Bhudia, Sunil K/A-3150-2011	Bhudia, Sunil K/0000-0002-6660-3141	Cleveland Clinic Department of Thoracic and Cardiovascular Surgery	Cleveland Clinic Department of Thoracic and Cardiovascular Surgery	This study was funded in part by the Cleveland Clinic Department of Thoracic and Cardiovascular Surgery and the Kenneth Gee and Paula Shaw, PhD, Chair in Heart Research, held by Dr Blackstone.	BLACKSTONE EH, 1986, J AM STAT ASSOC, V81, P615, DOI 10.2307/2288989; BLAUTH CI, 1992, J THORAC CARDIOV SUR, V103, P1104; BOYLE CA, 1990, AM J EPIDEMIOL, V131, P160, DOI 10.1093/oxfordjournals.aje.a115470; Breiman L, 1996, MACH LEARN, V24, P123, DOI 10.1007/BF00058655; Brown PP, 2008, ANN THORAC SURG, V85, P1980, DOI 10.1016/j.athoracsur.2008.01.053; Charlson ME, 2007, J CARDIAC SURG, V22, P465, DOI 10.1111/j.1540-8191.2007.00471.x; DavilaRoman VG, 1996, J AM COLL CARDIOL, V28, P942, DOI 10.1016/S0735-1097(96)00263-X; Filsoufi F, 2008, ANN THORAC SURG, V85, P862, DOI 10.1016/j.athoracsur.2007.10.060; Fuchs S, 2002, CIRCULATION, V106, P86, DOI 10.1161/01.CIR.0000020678.16325.E0; GOLD JP, 1995, J THORAC CARDIOV SUR, V110, P1302, DOI 10.1016/S0022-5223(95)70053-6; Hamon M, 2008, CIRCULATION, V118, P678, DOI 10.1161/CIRCULATIONAHA.108.784504; Hogue CW, 1999, CIRCULATION, V100, P642, DOI 10.1161/01.CIR.100.6.642; Koch CG, 2006, ANN THORAC SURG, V82, P1747, DOI 10.1016/j.athoracsur.2006.05.045; Lim E, 2006, J THORAC CARDIOV SUR, V132, P1409, DOI 10.1016/j.jtcvs.2006.08.012; MOODY DM, 1990, ANN NEUROL, V28, P477, DOI 10.1002/ana.410280403; Myers WO, 1999, J AM COLL CARDIOL, V33, P488, DOI 10.1016/S0735-1097(98)00563-4; Newman MF, 1996, CIRCULATION, V94, P74; Newman TB, 1997, J AM MED INFORM ASSN, V4, P233, DOI 10.1136/jamia.1997.0040233; Nishiyama K, 2009, ANN THORAC SURG, V87, P1839, DOI 10.1016/j.athoracsur.2009.02.061; Normand SLT, 2001, J CLIN EPIDEMIOL, V54, P387, DOI 10.1016/S0895-4356(00)00321-8; Peel GK, 2004, J AM COLL CARDIOL, V43, P752, DOI 10.1016/j.jacc.2003.09.047; Puskas JD, 2008, ANN THORAC SURG, V86, P1139, DOI 10.1016/j.athoracsur.2008.05.073; Roach GW, 1996, NEW ENGL J MED, V335, P1857, DOI 10.1056/NEJM199612193352501; Rosenberger P, 2008, ANN THORAC SURG, V85, P548, DOI 10.1016/j.athoracsur.2007.08.061; Sabik JF, 2004, ANN THORAC SURG, V77, P1315, DOI 10.1016/j.athoracsur.2003.08.056; Sabik JF, 2002, J THORAC CARDIOV SUR, V124, P698, DOI 10.1067/mtc.2002.121975; SABIK JF, 1995, J THORAC CARDIOV SUR, V109, P885, DOI 10.1016/S0022-5223(95)70312-8; Salazar JD, 2001, ANN THORAC SURG, V72, P1195, DOI 10.1016/S0003-4975(01)02929-0; Sedrakyan A, 2006, STROKE, V37, P2759, DOI 10.1161/01.STR.0000245081.52877.f2; Shroyer AL, 2009, NEW ENGL J MED, V361, P1827, DOI 10.1056/NEJMoa0902905; Society of Thoracic Surgeons National Adult Cardiac Database, SOC THOR SURG NAT AD; Stamou SC, 2001, STROKE, V32, P1508, DOI 10.1161/01.STR.32.7.1508; Svensson LG, 2004, ANN THORAC SURG, V78, P1274, DOI 10.1016/j.athoracsur.2004.04.063; Wilson MJ, 2000, ANN THORAC SURG, V70, P25, DOI 10.1016/S0003-4975(00)01256-X	34	215	227	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 26	2011	305	4					381	390		10.1001/jama.2011.37	http://dx.doi.org/10.1001/jama.2011.37			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711MH	21266685				2022-12-28	WOS:000286595200023
J	Woodcock, J; Griffin, JP; Behrman, RE				Woodcock, Janet; Griffin, Joseph P.; Behrman, Rachel E.			Development of Novel Combination Therapies	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Woodcock, Janet] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Griffin, Joseph P.; Behrman, Rachel E.] US FDA, Off Med Policy, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Woodcock, J (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							AD L, 2010, SCIENCE, V328, P137; Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; *FOOD DRUG ADM, 2010, GUID IND CH IN PRESS; *FOOD DRUG ADM, 2010, GUID IND CO IN PRESS	4	198	202	2	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 17	2011	364	11					985	987		10.1056/NEJMp1101548	http://dx.doi.org/10.1056/NEJMp1101548			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	735SX	21323535				2022-12-28	WOS:000288439000001
J	Evans, JA; Foster, JG				Evans, James A.; Foster, Jacob G.			Metaknowledge	SCIENCE			English	Editorial Material							KNOWLEDGE; PUBLICATION; SCIENCE; TEAMS	The growth of electronic publication and informatics archives makes it possible to harvest vast quantities of knowledge about knowledge, or "metaknowledge." We review the expanding scope of metaknowledge research, which uncovers regularities in scientific claims and infers the beliefs, preferences, research tools, and strategies behind those regularities. Metaknowledge research also investigates the effect of knowledge context on content. Teams and collaboration networks, institutional prestige, and new technologies all shape the substance and direction of research. We argue that as metaknowledge grows in breadth and quality, it will enable researchers to reshape science-to identify areas in need of reexamination, reweight former certainties, and point out new paths that cut across revealed assumptions, heuristics, and disciplinary boundaries.	[Evans, James A.; Foster, Jacob G.] Univ Chicago, Dept Sociol, Chicago, IL 60637 USA	University of Chicago	Evans, JA (corresponding author), Univ Chicago, Dept Sociol, Chicago, IL 60637 USA.	jevans@uchicago.edu						[Anonymous], COCHR COLL REV HDB; Armstrong EM, 2006, J HEALTH POLIT POLIC, V31, P729, DOI 10.1215/03616878-2006-002; Barnhardt R, 2005, ANTHROPOL EDUC QUART, V36, P8, DOI 10.1525/aeq.2005.36.1.008; Besteman, 2008, TRANSFORMING CAPE TO; Bollen J, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006022, 10.1371/journal.pone.0004803]; Cetina Karin Knorr, 1999, EPISTEMIC CULTURES S; Coffey Patrick, 2008, CATHEDRALS SCI PERSO; Cokol M, 2005, NAT BIOTECHNOL, V23, P1243, DOI 10.1038/nbt1005-1243; Cokol M, 2007, EMBO REP, V8, P422, DOI 10.1038/sj.embor.7400970; Cokol M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-406; COLLINS HM, 1974, SCI STUD, V4, P165, DOI 10.1177/030631277400400203; Collins Randall, 1998, SOCIOLOGY PHILOSOPHI; Cronin B., 2000, WEB KNOWLEDGE FESTSC; Dovring K, 1954, PUBLIC OPIN QUART, V18, P389, DOI 10.1086/266531; Evangelou E, 2005, FASEB J, V19, P1943, DOI 10.1096/fj.05-4784lsf; Evans JA, 2008, SCIENCE, V321, P395, DOI 10.1126/science.1150473; Evans JA, 2010, SOC STUD SCI, V40, P757, DOI 10.1177/0306312710379931; Evans JA, 2009, SCIENCE, V323, P1025, DOI 10.1126/science.1154562; Foote R, 2007, SCIENCE, V318, P410, DOI 10.1126/science.1141754; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Gerber AS, 2008, SOCIOL METHOD RES, V37, P3, DOI 10.1177/0049124108318973; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Glass G.V., 1979, EDUC EVAL POLICY AN, V1, P2, DOI [10.3102/01623737001001002, DOI 10.3102/01623737001001002]; Greenberg Steven A, 2009, BMJ, V339, pb2680, DOI 10.1136/bmj.b2680; Griffiths TL, 2004, P NATL ACAD SCI USA, V101, P5228, DOI 10.1073/pnas.0307752101; Harris Mark, 2007, WAYS KNOWING NEW APP, P1; Hedges LV, 1992, STAT SCI, V7, P246, DOI DOI 10.1214/SS/1177011364; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Hunter J. E., 2004, METHODS METAANALYSIS; Ioannidis JPA, 2005, JAMA-J AM MED ASSOC, V294, P218, DOI 10.1001/jama.294.2.218; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Ioannidis JPA, 2005, J CLIN EPIDEMIOL, V58, P543, DOI 10.1016/j.jclinepi.2004.10.019; Jones BF, 2008, SCIENCE, V322, P1259, DOI 10.1126/science.1158357; Kevles Dan, 1978, PHYS HIST SCI COMMUN; Krieger CJ, 2004, NUCLEIC ACIDS RES, V32, pD438, DOI 10.1093/nar/gkh100; Kuhn T, 1977, ESSENTIAL TENSION SE, DOI [DOI 10.7208/9780226217239-014, DOI 10.7208/CHICAGO/9780226217239.001.0001]; Lenoir T, 1997, I SCI CULTURAL PRODU; Leskovec J., 2009, P 15 ASS COMP MACH S; Mane KK, 2004, P NATL ACAD SCI USA, V101, P5287, DOI 10.1073/pnas.0307626100; MARTIN E, 1991, SIGNS, V16, P485, DOI 10.1086/494680; Michel JB, 2011, SCIENCE, V331, P176, DOI 10.1126/science.1199644; Newman MEJ, 2004, P NATL ACAD SCI USA, V101, P5200, DOI 10.1073/pnas.0307545100; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.016131; O'Rourke K, 2007, J ROY SOC MED, V100, P579, DOI 10.1258/jrsm.100.12.579; Pearson K, 1904, BRIT MED J, V3, P1243; Pratt J., 1940, EXTRA SENSORY PERCEP; Renear AH, 2009, SCIENCE, V325, P828, DOI 10.1126/science.1157784; Rzhetsky A, 2006, P NATL ACAD SCI USA, V103, P4940, DOI 10.1073/pnas.0600591103; Rzhetsky A, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000061; Shwed U, 2010, AM SOCIOL REV, V75, P817, DOI 10.1177/0003122410388488; SOLOMON M, 1992, PHILOS SCI, V59, P439, DOI 10.1086/289680; Stigler, 1986, HIST STAT MEASUREMEN; Swanson DR, 1997, ARTIF INTELL, V91, P183, DOI 10.1016/S0004-3702(97)00008-8; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; Wuchty S, 2007, SCIENCE, V316, P1036, DOI 10.1126/science.1136099	55	168	174	4	150	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					721	725		10.1126/science.1201765	http://dx.doi.org/10.1126/science.1201765			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21311014				2022-12-28	WOS:000287205700057
J	Kahn, SD				Kahn, Scott D.			On the Future of Genomic Data	SCIENCE			English	Editorial Material							GENETIC DIAGNOSIS	Many of the challenges in genomics derive from the informatics needed to store and analyze the raw sequencing data that is available from highly multiplexed sequencing technologies. Because single week-long sequencing runs today can produce as much data as did entire genome centers a few years ago, the need to process terabytes of information has become de rigueur for many labs engaged in genomic research. The availability of deep (and large) genomic data sets raises concerns over information access, data security, and subject/patient privacy that must be addressed for the field to continue its rapid advances.	Illumina, San Diego, CA 92121 USA	Illumina	Kahn, SD (corresponding author), Illumina, 9885 Towne Ctr Dr, San Diego, CA 92121 USA.							Aldhous P., 2008, PLOS GENET; Choi M, 2009, P NATL ACAD SCI USA, V106, P19096, DOI 10.1073/pnas.0910672106; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/NNANO.2009.12, 10.1038/nnano.2009.12]; Fritz MHY, 2011, GENOME RES, V21, P734, DOI 10.1101/gr.114819.110; Homer N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000167; Karow J., 2009, GENOMEWEB       0728; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Mayer A. N., 2010, GENET MED; Morgan JE, 2010, HUM MUTAT, V31, P484, DOI 10.1002/humu.21216; Tucker T, 2009, AM J HUM GENET, V85, P142, DOI 10.1016/j.ajhg.2009.06.022; Vasta V, 2009, GENOME MED, V1, DOI 10.1186/gm100; WORTHEY EA, 2010, GENET MED	12	159	165	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					728	729		10.1126/science.1197891	http://dx.doi.org/10.1126/science.1197891			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21311016				2022-12-28	WOS:000287205700059
J	King, G				King, Gary			Ensuring the Data-Rich Future of the Social Sciences	SCIENCE			English	Editorial Material								Massive increases in the availability of informative social science data are making dramatic progress possible in analyzing, understanding, and addressing many major societal problems. Yet the same forces pose severe challenges to the scientific infrastructure supporting data sharing, data management, informatics, statistical methodology, and research ethics and policy, and these are collectively holding back progress. I address these changes and challenges and suggest what can be done.	Harvard Univ, Inst Quantitat Social Sci, Cambridge, MA 02138 USA	Harvard University	King, G (corresponding author), Harvard Univ, Inst Quantitat Social Sci, 1737 Cambridge St, Cambridge, MA 02138 USA.	king@harvard.edu						Aggarwal CC, 2008, ADV DATABASE SYST, V34, P1, DOI 10.1007/978-0-387-70992-5; Altman Micah, 2007, D-Lib Magazine, V13, DOI 10.1045/march2007-altman; Anderson RG, 2008, J ECON METHODOL, V15, P99, DOI 10.1080/13501780801915574; Blair Ann M., 2010, TOO MUCH KNOW MANAGI; Hopkins DJ, 2010, AM J POLIT SCI, V54, P229, DOI 10.1111/j.1540-5907.2009.00428.x; KING G, 1995, PS, V28, P494, DOI 10.2307/420317; King G, 2006, PS-POLIT SCI POLIT, V39, P119; King G., 2009, FUTURE POLITICAL SCI, P91; King G, 2007, SOCIOL METHOD RES, V36, P173, DOI 10.1177/0049124107306660; KOSHLAND DE, 1995, SCIENCE, V267, P1575, DOI 10.1126/science.7886434; Mackie C., 2000, IMPROVING ACCESS CON; Stodden V., 2009, INT J COMMUNICATIONS, P1; Sweeney L, 1997, J LAW MED ETHICS, V25, P98, DOI 10.1111/j.1748-720X.1997.tb01885.x; WEINTRAUB H, 1995, SCIENCE, V267, P1609; White RF, 2007, INDEP REV, V11, P547	15	227	229	3	79	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					719	721		10.1126/science.1197872	http://dx.doi.org/10.1126/science.1197872			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21311013	Green Submitted			2022-12-28	WOS:000287205700056
J	Mathews, DJH; Graff, GD; Saha, K; Winickoff, DE				Mathews, Debra J. H.; Graff, Gregory D.; Saha, Krishanu; Winickoff, David E.			Access to Stem Cells and Data: Persons, Property Rights, and Scientific Progress	SCIENCE			English	Editorial Material								Many fields have struggled to develop strategies, policies, or structures to optimally manage data, materials, and intellectual property rights (IPRs). There is growing recognition that the field of stem cell science, in part because of its complex IPRs landscape and the importance of cell line collections, may require collective action to facilitate basic and translational research. Access to pluripotent stem cell lines and the information associated with them is critical to the progress of stem cell science, but simple notions of access are substantially complicated by shifting boundaries between what is considered information versus material, person versus artifact, and private property versus the public domain.	[Mathews, Debra J. H.] Johns Hopkins Berman Inst Bioeth, Baltimore, MD 21205 USA; [Graff, Gregory D.] Colorado State Univ, Dept Agr & Resource Econ, Ft Collins, CO 80523 USA; [Saha, Krishanu] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Winickoff, David E.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA	Johns Hopkins University; Colorado State University; Massachusetts Institute of Technology (MIT); Whitehead Institute; University of California System; University of California Berkeley	Mathews, DJH (corresponding author), Johns Hopkins Berman Inst Bioeth, Deering Hall 208,1809 Ashland Ave, Baltimore, MD 21205 USA.	dmathews@jhu.edu	Saha, Krishanu/J-3980-2014	Saha, Krishanu/0000-0003-2837-0858; Graff, Gregory/0000-0002-9140-0901; Mathews, Debra/0000-0002-4897-7617				[Anonymous], 2009, NATURE, V461, P145, DOI 10.1038/461145a; Bergman K, 2007, NAT BIOTECHNOL, V25, P419, DOI 10.1038/nbt0407-419; Field D, 2009, SCIENCE, V326, P234, DOI 10.1126/science.1180598; Fullerton SM, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000361; Kohane IS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000809; Mello MM, 2010, NEW ENGL J MED, V363, P204, DOI 10.1056/NEJMp1005203; Nelson B, 2009, NATURE, V461, P160, DOI 10.1038/461160a; Schofield PN, 2009, NATURE, V461, P171, DOI 10.1038/461171a; Skloot R., 2010, IMMORTAL LIFE HENRIE; Stacey G, 2006, REGEN MED, V1, P139, DOI 10.2217/17460751.1.1.139; The Hinxton Group, 2011, POL PRACT GOV DAT MA; Winickoff, 2009, YALE J HLTH POLICY L, V9, P52	12	21	22	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 11	2011	331	6018					725	727		10.1126/science.1201382	http://dx.doi.org/10.1126/science.1201382			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	719LH	21311015				2022-12-28	WOS:000287205700058
J	Hess, M; Sczyrba, A; Egan, R; Kim, TW; Chokhawala, H; Schroth, G; Luo, SJ; Clark, DS; Chen, F; Zhang, T; Mackie, RI; Pennacchio, LA; Tringe, SG; Visel, A; Woyke, T; Wang, Z; Rubin, EM				Hess, Matthias; Sczyrba, Alexander; Egan, Rob; Kim, Tae-Wan; Chokhawala, Harshal; Schroth, Gary; Luo, Shujun; Clark, Douglas S.; Chen, Feng; Zhang, Tao; Mackie, Roderick I.; Pennacchio, Len A.; Tringe, Susannah G.; Visel, Axel; Woyke, Tanja; Wang, Zhong; Rubin, Edward M.			Metagenomic Discovery of Biomass-Degrading Genes and Genomes from Cow Rumen	SCIENCE			English	Article							IONIC LIQUIDS; PAN-GENOME; ONE-CELL; SWITCHGRASS; CELLULOSE; BACTERIAL; BIOFUELS; TIME	The paucity of enzymes that efficiently deconstruct plant polysaccharides represents a major bottleneck for industrial-scale conversion of cellulosic biomass into biofuels. Cow rumen microbes specialize in degradation of cellulosic plant material, but most members of this complex community resist cultivation. To characterize biomass-degrading genes and genomes, we sequenced and analyzed 268 gigabases of metagenomic DNA from microbes adherent to plant fiber incubated in cow rumen. From these data, we identified 27,755 putative carbohydrate-active genes and expressed 90 candidate proteins, of which 57% were enzymatically active against cellulosic substrates. We also assembled 15 uncultured microbial genomes, which were validated by complementary methods including single-cell genome sequencing. These data sets provide a substantially expanded catalog of genes and genomes participating in the deconstruction of cellulosic biomass.	[Hess, Matthias; Sczyrba, Alexander; Egan, Rob; Chen, Feng; Zhang, Tao; Pennacchio, Len A.; Tringe, Susannah G.; Visel, Axel; Woyke, Tanja; Wang, Zhong; Rubin, Edward M.] Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA; [Hess, Matthias; Sczyrba, Alexander; Egan, Rob; Chen, Feng; Zhang, Tao; Pennacchio, Len A.; Tringe, Susannah G.; Visel, Axel; Woyke, Tanja; Wang, Zhong; Rubin, Edward M.] Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; [Kim, Tae-Wan; Chokhawala, Harshal; Clark, Douglas S.] Univ Calif Berkeley, Energy Biosci Inst, Berkeley, CA 94720 USA; [Clark, Douglas S.] Univ Calif Berkeley, Dept Chem & Biomol Engn, Berkeley, CA 94720 USA; [Schroth, Gary; Luo, Shujun] Illumina Inc, Hayward, CA 94545 USA; [Mackie, Roderick I.] Univ Illinois, Inst Genom Biol, Dept Anim Sci, Urbana, IL 61801 USA; [Mackie, Roderick I.] Univ Illinois, Energy Biosci Inst, Urbana, IL 61801 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Illumina; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Rubin, EM (corresponding author), Joint Genome Inst, Dept Energy, Walnut Creek, CA 94598 USA.	emrubin@lbl.gov	Hess, Matthias/R-3006-2017; Wang, Zhong/E-7897-2011; Wang, Zhong/J-3244-2019; Hess, Matthias/B-1783-2012; Visel, Axel/A-9398-2009	Hess, Matthias/0000-0003-0321-0380; Wang, Zhong/0000-0002-6307-0458; Visel, Axel/0000-0002-4130-7784; Sczyrba, Alexander/0000-0002-4405-3847; Pennacchio, Len/0000-0002-8748-3732	Office of Science of the U.S. Department of Energy [DE-AC02-05CH112]; U.S. Department of Energy [DE-AC02-05CH11231]; Energy Biosciences Institute at the University of California, Berkeley	Office of Science of the U.S. Department of Energy(United States Department of Energy (DOE)); U.S. Department of Energy(United States Department of Energy (DOE)); Energy Biosciences Institute at the University of California, Berkeley	We thank J. Bristow, P. Hugenholtz, F. Warnecke, and K. Mavrommatis for critical discussions and reading the manuscript. We acknowledge technical support by the JGI production team, L. M. Sczyrba, M. Harmon-Smith, J. Froula, J. Martin, C. Wright, A. Lipzen, J. Zhao, S. Malfatti and Stefan Bauer. We thank P. D'Haeseleer for sequences extracted from the CAZy database, Jonas Lovaas Gjerstad for the picture of the fistulated cow, T. Shinkei, T. Yannarell, J. Kim and staff at the Dairy Farm, Department of Animal Sciences for assistance with the maintenance of the fistulated cows, nylon bag experiments and lab procedures carried out at the University of Illinois. The work conducted by the U.S. Department of Energy Joint Genome Institute was supported in part by the Office of Science of the U.S. Department of Energy under contract DE-AC02-05CH112 and U.S. Department of Energy under contract DE-AC02-05CH11231 (cow rumen metagenomics data analysis and informatics). Supported by a research grant from the Energy Biosciences Institute at the University of California, Berkeley (M.H.). Data are available at the NCBI Short Read Archive under accession number SRA023560 and GenBank accession numbers HQ706005-HQ706094. Complete data can also be accessed through the Web site of the DOE Joint Genome Institute (www.jgi.doe.gov).	Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Blanch HW, 2008, ACS CHEM BIOL, V3, P17, DOI 10.1021/cb700267s; Brulc JM, 2009, P NATL ACAD SCI USA, V106, P1948, DOI 10.1073/pnas.0806191105; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Demura T, 2010, CURR OPIN PLANT BIOL, V13, P299, DOI 10.1016/j.pbi.2010.03.002; Ferrer M, 2005, ENVIRON MICROBIOL, V7, P1996, DOI 10.1111/j.1462-2920.2005.00920.x; Kelly WJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011942; Krause DO, 2003, FEMS MICROBIOL REV, V27, P663, DOI 10.1016/S0168-6445(03)00072-X; Lapierrel P, 2009, TRENDS GENET, V25, P107, DOI 10.1016/j.tig.2008.12.004; Li LL, 2009, BIOTECHNOL BIOFUELS, V2, DOI 10.1186/1754-6834-2-10; Liu ZZ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm541; Martin HG, 2006, NAT BIOTECHNOL, V24, P1263, DOI 10.1038/nbt1247; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; MEYER JHF, 1986, APPL ENVIRON MICROB, V51, P622, DOI 10.1128/AEM.51.3.622-629.1986; Parrish DJ, 2009, METHODS MOL BIOL, V581, P27, DOI 10.1007/978-1-60761-214-8_2; Pope PB, 2010, P NATL ACAD SCI USA, V107, P14793, DOI 10.1073/pnas.1005297107; Rincon MT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012476; Rubin EM, 2008, NATURE, V454, P841, DOI 10.1038/nature07190; Sanderson K, 2006, NATURE, V444, P673, DOI 10.1038/444673a; Stepanauskas R, 2007, P NATL ACAD SCI USA, V104, P9052, DOI 10.1073/pnas.0700496104; Teeling H, 2004, ENVIRON MICROBIOL, V6, P938, DOI 10.1111/j.1462-2920.2004.00624.x; Uchiyama T, 2009, CURR OPIN BIOTECH, V20, P616, DOI 10.1016/j.copbio.2009.09.010; Wang FC, 2009, MICROBIOL RES, V164, P650, DOI 10.1016/j.micres.2008.12.002; Warnecke F, 2007, NATURE, V450, P560, DOI 10.1038/nature06269; Weimer PJ, 1996, J DAIRY SCI, V79, P1496, DOI 10.3168/jds.S0022-0302(96)76509-8; Wen F, 2009, CURR OPIN BIOTECH, V20, P412, DOI 10.1016/j.copbio.2009.07.001; Woyke T, 2006, NATURE, V443, P950, DOI 10.1038/nature05192; Woyke T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005299; Zhao H, 2010, BIOTECHNOL PROGR, V26, P127, DOI 10.1002/btpr.331; Zhao H, 2009, J BIOTECHNOL, V139, P47, DOI 10.1016/j.jbiotec.2008.08.009	30	851	947	20	546	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					463	467		10.1126/science.1200387	http://dx.doi.org/10.1126/science.1200387			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273488				2022-12-28	WOS:000286635900054
J	Mercieri, M; Mercieri, A				Mercieri, Marco; Mercieri, Angelo			A Photosensitive Dermatitis in the Intensive Care Unit	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Mercieri, Marco] Univ Roma La Sapienza, Rome, Italy; [Mercieri, Angelo] Azienda Osped Bolognini, Seriate, Italy	Sapienza University Rome	Mercieri, M (corresponding author), Univ Roma La Sapienza, Rome, Italy.	marco.mercieri@uniroma1.it		Mercieri, Marco/0000-0003-4321-6525					0	3	3	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 27	2011	364	4					361	361		10.1056/NEJMicm1003313	http://dx.doi.org/10.1056/NEJMicm1003313			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	711LH	21268728				2022-12-28	WOS:000286592600011
J	Khunti, K; Walker, N; Satter, N; Davies, M				Khunti, Kamlesh; Walker, Nicola; Satter, Naveed; Davies, Melanie			Unanswered questions over NHS health checks	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Khunti, Kamlesh; Walker, Nicola] Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England; [Satter, Naveed] BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland; [Davies, Melanie] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England	University of Leicester; University of Glasgow; University of Leicester	Khunti, K (corresponding author), Univ Leicester, Dept Hlth Sci, Leicester LE1 6TP, Leics, England.	kk22@le.ac.uk	/ABC-9527-2021	Davies, Melanie/0000-0002-9987-9371; Khunti, Kamlesh/0000-0003-2343-7099					0	16	16	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2011	342								c6312	10.1136/bmj.c6312	http://dx.doi.org/10.1136/bmj.c6312			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715ME	21270080	Green Accepted			2022-12-28	WOS:000286887800016
J	Winzenberg, T; Powell, S; Shaw, KA; Jones, G				Winzenberg, Tania; Powell, Sandi; Shaw, Kelly Anne; Jones, Graeme			Effects of vitamin D supplementation on bone density in healthy children: systematic review and meta-analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Review							PARATHYROID-HORMONE CONCENTRATIONS; SCHOOL-MILK INTERVENTION; AGED 10-12 YEARS; MINERAL DENSITY; D DEFICIENCY; HYPOVITAMINOSIS-D; ADOLESCENT GIRLS; 25-HYDROXYVITAMIN-D CONCENTRATIONS; PREPUBERTAL CHILDREN; SOUTHERN TASMANIA	Objective To determine the effectiveness of vitamin D supplementation for improving bone mineral density in children and adolescents and if effects vary with factors such as vitamin D dose and vitamin D status. Design Systematic review and meta-analysis. Data sources Cochrane Central Register of Controlled Trials, Medline (1966 to present), Embase (1980 to present), CINAHL (1982 to present), AMED (1985 to present), and ISI Web of Science (1945 to present), last updated on 9 August 2009, and hand searching of conference abstracts from key journals. Study selection Placebo controlled randomised controlled trials of vitamin D supplementation for at least three months in healthy children and adolescents (aged 1 month to <20 years) with bone density outcomes. Two authors independently assessed references for inclusion and study quality and extracted data. Data synthesis Standardised mean differences of the percentage change from baseline in bone mineral density of the forearm, hip, and lumbar spine and total body bone mineral content in treatment and control groups. Subgroup analyses were carried out by sex, pubertal stage, dose of vitamin D, and baseline serum vitamin D concentration. Compliance and allocation concealment were also considered as possible sources of heterogeneity. Results From 1653 potential references, six studies, totalling 343 participants receiving placebo and 541 receiving vitamin D, contributed data to meta-analyses. Vitamin D supplementation had no statistically significant effects on total body bone mineral content or on bone mineral density of the hip or forearm. There was a trend to a small effect on lumbar spine bone mineral density (standardised mean difference 0.15, 95% confidence interval -0.01 to 0.31; P=0.07). Effects were similar in studies of participants with high compared with low serum vitamin D levels, although there was a trend towards a larger effect with low vitamin D for total body bone mineral content (P=0.09 for difference). In studies with low serum vitamin D, significant effects on total body bone mineral content and lumbar spine bone mineral density were roughly equivalent to a 2.6% and 1.7% percentage point greater change from baseline in the supplemented group. Conclusions It is unlikely that vitamin D supplements are beneficial in children and adolescents with normal vitamin D levels. The planned subgroup analyses by baseline serum vitamin D level suggest that vitamin D supplementation of deficient children and adolescents could result in clinically useful improvements, particularly in lumbar spine bone mineral density and total body bone mineral content, but this requires confirmation.	[Winzenberg, Tania; Jones, Graeme] Univ Tasmania, Menzies Res Inst, Musculoskeletal Unit, Hobart, Tas 7000, Australia; [Powell, Sandi] Royal Hobart Hosp, Liverpool St Hobart, Tas, Australia; [Shaw, Kelly Anne] ASLaRC Aged Serv Unit, Coffs Harbour, Qld, Australia	University of Tasmania; Menzies Institute for Medical Research; Royal Hobart Hospital	Winzenberg, T (corresponding author), Univ Tasmania, Menzies Res Inst, Musculoskeletal Unit, Private Bag 23, Hobart, Tas 7000, Australia.	tania.winzenberg@utas.edu.au	Winzenberg, Tania/J-7522-2014	Winzenberg, Tania/0000-0002-4112-3491; , Deep/0000-0002-3375-6969	National Health and Medical Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	TW received a National Health and Medical Research Council training fellowship and GJ receives a National Health and Medical Research Council practitioner fellowship. The funding body had no input into any aspect of this study.	ALAHOUHALA M, 1988, ACTA PAEDIATR SCAND, V77, P89, DOI 10.1111/j.1651-2227.1988.tb10604.x; Alderson P, 2002, ADDITIONAL MODULE 1; Andersen R, 2008, BRIT J NUTR, V100, P197, DOI 10.1017/S000711450789430X; Burge R, 2007, J BONE MINER RES, V22, P465, DOI [10.1359/jbmr.061113, 10.1359/JBMR.061113]; Calvo MS, 2000, NUTRITION, V16, P564, DOI 10.1016/S0899-9007(00)00313-0; Cheng S, 2005, AM J CLIN NUTR, V82, P1115, DOI 10.1093/ajcn/82.5.1115; Cheng SL, 2003, AM J CLIN NUTR, V78, P485, DOI 10.1093/ajcn/78.3.485; Clutterbuck J, 1995, INT J ALTERNATIVE CO, V13, P19; Cohen J., 1988, STAT POWER ANAL BEHA; Compston J, 1998, NURS TIMES, V94, P47; Cranney Ann, 2007, Evid Rep Technol Assess (Full Rep), P1; CUMMINGS SR, 1993, LANCET, V341, P72, DOI 10.1016/0140-6736(93)92555-8; Das G, 2006, ARCH DIS CHILD, V91, P569, DOI 10.1136/adc.2005.077974; Du XQ, 2005, BRIT J NUTR, V94, P1038, DOI 10.1079/BJN20051584; Du XQ, 2004, BRIT J NUTR, V92, P159, DOI 10.1079/BJN20041118; Duhamel JF, 2000, ARCH PEDIATRIE, V7, P148, DOI 10.1016/S0929-693X(00)88084-7; El-Hajj Fuleihan G, 2001, PEDIATRICS, V107, DOI 10.1542/peds.107.4.e53; El-Hajj Fuleihan G, 2006, J CLIN ENDOCR METAB, V91, P405, DOI 10.1210/jc.2005-1436; El-Hajj Fuleihan G, 2004, J BONE MINER RES  S1, V19, pS13; El-Hajj Fuleihan G, 2007, NUTR ASPECTS OSTEOPO; FEHILY AM, 1992, AM J CLIN NUTR, V56, P579, DOI 10.1093/ajcn/56.3.579; FELICIANO ES, 1994, J TROP PEDIATRICS, V40, P162, DOI 10.1093/tropej/40.3.162; Flynn A, 2003, P NUTR SOC, V62, P851, DOI 10.1079/PNS2003301; Gilsanz V, 1998, EUR J RADIOL, V26, P177, DOI 10.1016/S0720-048X(97)00093-4; Gordon CM, 2004, ARCH PEDIAT ADOL MED, V158, P531, DOI 10.1001/archpedi.158.6.531; Goulding A, 1998, J BONE MINER RES, V13, P143, DOI 10.1359/jbmr.1998.13.1.143; Goulding A, 2001, J PEDIATR-US, V139, P509, DOI 10.1067/mpd.2001.116297; Guillemant J, 2001, OSTEOPOROSIS INT, V12, P875, DOI 10.1007/s001980170040; HANSEN MA, 1991, BMJ-BRIT MED J, V303, P961, DOI 10.1136/bmj.303.6808.961; HO ML, 1985, J PEDIATR-US, V107, P928, DOI 10.1016/S0022-3476(85)80192-X; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Johnell O, 2006, OSTEOPOROSIS INT, V17, P1726, DOI 10.1007/s00198-006-0172-4; Jones G, 1998, J CLIN ENDOCR METAB, V83, P4274, DOI 10.1210/jc.83.12.4274; Jones G, 2005, OSTEOPOROSIS INT, V16, P636, DOI 10.1007/s00198-004-1733-z; Jones G, 1999, EUR J CLIN NUTR, V53, P824, DOI 10.1038/sj.ejcn.1600858; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Lehtonen-Veromaa M, 1999, EUR J CLIN NUTR, V53, P746, DOI 10.1038/sj.ejcn.1600844; Lehtonen-Veromaa MKM, 2002, AM J CLIN NUTR, V76, P1446, DOI 10.1093/ajcn/76.6.1446; Looker AC, 2002, BONE, V30, P771, DOI 10.1016/S8756-3282(02)00692-0; Ma DQ, 2003, J CLIN ENDOCR METAB, V88, P1486, DOI 10.1210/jc.2002-021682; Marin F, 2006, J BONE MINER RES, V21, P1126, DOI 10.1359/JBMR.060417; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Matsumoto T, 2007, J STEROID BIOCHEM, V103, P584, DOI 10.1016/j.jsbmb.2006.12.088; Munns C, 2006, MED J AUSTRALIA, V185, P268, DOI 10.5694/j.1326-5377.2006.tb00558.x; Outila TA, 2001, AM J CLIN NUTR, V74, P206; PRENTICE A, 1994, AM J CLIN NUTR, V60, P837; Riis BJ, 1996, BONE, V19, P9, DOI 10.1016/8756-3282(96)00102-0; Rockell JEP, 2006, OSTEOPOROSIS INT, V17, P1382, DOI 10.1007/s00198-006-0118-x; Rockell JE, 2005, J NUTR, V135, P2602, DOI 10.1093/jn/135.11.2602; Sharma S, 2009, BJOG-INT J OBSTET GY, V116, P1678, DOI 10.1111/j.1471-0528.2009.02285.x; Tylavsky FA, 2006, J NUTR, V136, P1130, DOI 10.1093/jn/136.4.1130; VENKATARAMAN PS, 1992, AM J DIS CHILD, V146, P1302, DOI 10.1001/archpedi.1992.02160230060017; Viljakainen HT, 2006, J BONE MINER RES, V21, P836, DOI 10.1359/JBMR.060302; Winzenberg T, 2006, BMJ-BRIT MED J, V333, P775, DOI 10.1136/bmj.38950.561400.55; Winzenberg TM, 2008, COCHRANE DB SYST REV, V1; Winzenberg TM, 2010, COCHRANE DB SYST REV, V10; Winzenberg TM, 2006, COCHRANE DB SYST REV, V2; Zamora SA, 1999, J CLIN ENDOCR METAB, V84, P4541, DOI 10.1210/jc.84.12.4541; Zhu K, 2006, AM J CLIN NUTR, V83, P714, DOI 10.1093/ajcn.83.3.714	59	138	146	2	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2011	342								c7254	10.1136/bmj.c7254	http://dx.doi.org/10.1136/bmj.c7254			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715LX	21266418	Green Published, hybrid			2022-12-28	WOS:000286887100006
J	Coombes, RC; Kilburn, LS				Coombes, R. Charles; Kilburn, Lucy S.			Time to TEAM: exemestane, or tamoxifen then exemestane?	LANCET			English	Editorial Material									[Coombes, R. Charles] Univ London Imperial Coll Sci Technol & Med, Div Canc, London W12 0NN, England; [Kilburn, Lucy S.] Inst Canc Res, Sect Clin Trials, Clin Trials & Stat Unit, Surrey, England	Imperial College London; University of London; Institute of Cancer Research - UK	Coombes, RC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Canc, London W12 0NN, England.	c.coombes@imperial.ac.uk		Coombes, Raoul Charles/0000-0002-4811-1100; Kilburn, Lucy/0000-0002-1987-7545				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Bartlett WS, 2008, 31 ANN SAN ANT BREAS; Coates AS, 2007, J CLIN ONCOL, V25, P486, DOI 10.1200/JCO.2006.08.8617; Coombes RC, 2007, LANCET, V369, P559, DOI 10.1016/S0140-6736(07)60200-1; Coombes RC, 2004, NEW ENGL J MED, V350, P1081, DOI 10.1056/NEJMoa040331; Cuzick J, 2010, LANCET ONCOL, V11, P1135, DOI 10.1016/S1470-2045(10)70257-6; Dowsett M, 2010, J CLIN ONCOL, V28, P509, DOI 10.1200/JCO.2009.23.1274; Jones SE, 2008, 31 ANN SAN ANT BREAS; Mouridsen H, 2009, NEW ENGL J MED, V361, P766, DOI 10.1056/NEJMoa0810818; van de Velde CJH, 2011, LANCET, V377, P321, DOI 10.1016/S0140-6736(10)62312-4	10	2	2	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 22	2011	377	9762					280	281		10.1016/S0140-6736(11)60073-1	http://dx.doi.org/10.1016/S0140-6736(11)60073-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	714ZO	21256370				2022-12-28	WOS:000286850400007
J	Cang, H; Labno, A; Lu, CG; Yin, XB; Liu, M; Gladden, C; Liu, YM; Zhang, X				Cang, Hu; Labno, Anna; Lu, Changgui; Yin, Xiaobo; Liu, Ming; Gladden, Christopher; Liu, Yongmin; Zhang, Xiang			Probing the electromagnetic field of a 15-nanometre hotspot by single molecule imaging	NATURE			English	Article							ENHANCED RAMAN-SCATTERING; SURFACE-PLASMONS; SILVER ELECTRODE; DIFFRACTION-LIMIT; ENERGY-TRANSFER; MICROSCOPY; SPECTROSCOPY; PYRIDINE; LOCALIZATION; EXCITATION	When light illuminates a rough metallic surface, hotspots can appear, where the light is concentrated on the nanometre scale, producing an intense electromagnetic field. This phenomenon, called the surface enhancement effect(1,2), has a broad range of potential applications, such as the detection of weak chemical signals. Hotspots are believed to be associated with localized electromagnetic modes(3,4), caused by the randomness of the surface texture. Probing the electromagnetic field of the hotspots would offer much insight towards uncovering the mechanism generating the enhancement; however, it requires a spatial resolution of 1-2 nm, which has been a long-standing challenge in optics. The resolution of an optical microscope is limited to about half the wavelength of the incident light, approximately 200-300 nm. Although current state-of-the-art techniques, including near-field scanning optical microscopy(5), electron energy-loss spectroscopy(6), cathode luminescence imaging(7) and two-photon photoemission imaging(8) have subwavelength resolution, they either introduce a non-negligible amount of perturbation, complicating interpretation of the data, or operate only in a vacuum. As a result, after more than 30 years since the discovery of the surface enhancement effect(9-11), how the local field is distributed remains unknown. Here we present a technique that uses Brownian motion of single molecules to probe the local field. It enables two-dimensional imaging of the fluorescence enhancement profile of single hotspots on the surfaces of aluminium thin films and silver nanoparticle clusters, with accuracy down to 1.2 nm. Strong fluorescence enhancements, up to 54 and 136 times respectively, are observed in those two systems. This strong enhancement indicates that the local field, which decays exponentially from the peak of a hotspot, dominates the fluorescence enhancement profile.	[Cang, Hu; Yin, Xiaobo; Zhang, Xiang] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Cang, Hu; Labno, Anna; Lu, Changgui; Yin, Xiaobo; Liu, Ming; Gladden, Christopher; Liu, Yongmin; Zhang, Xiang] Univ Calif Berkeley, NSF Nano Scale Sci & Engn Ctr, Berkeley, CA 94720 USA; [Labno, Anna] Univ Calif Berkeley, Biophys Program, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; National Science Foundation (NSF); University of California System; University of California Berkeley; University of California System; University of California Berkeley	Zhang, X (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA.	xiang@berkeley.edu	Zhang, Xiang/F-6905-2011; Yin, Xiaobo/A-4142-2011; Liu, Yongmin/F-5322-2010	Liu, Ming/0000-0001-9849-1845; Liu, Yongmin/0000-0003-1084-6651; Zhang, Xiang/0000-0002-3272-894X	US Department of Energy Office of Science, Basic Energy Sciences and Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]	US Department of Energy Office of Science, Basic Energy Sciences and Lawrence Berkeley National Laboratory(United States Department of Energy (DOE))	We thank G. Bartal and A. Niv for discussions. This research was supported by the US Department of Energy Office of Science, Basic Energy Sciences and Lawrence Berkeley National Laboratory under contract no. DE-AC02-05CH11231.	ALBRECHT MG, 1977, J AM CHEM SOC, V99, P5215, DOI 10.1021/ja00457a071; Anger P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.113002; BETZIG E, 1992, SCIENCE, V257, P189, DOI 10.1126/science.257.5067.189; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; CHANCE RR, 1975, J CHEM PHYS, V62, P2245, DOI 10.1063/1.430748; CHANG CC, 1978, J ELECTROCHEM SOC, V125, pC136; CREIGHTON JA, 1979, J CHEM SOC FARAD T 2, V75, P790, DOI 10.1039/f29797500790; FLEISCHMANN M, 1974, CHEM PHYS LETT, V26, P163, DOI 10.1016/0009-2614(74)85388-1; GERSTEN J, 1980, J CHEM PHYS, V73, P3023, DOI 10.1063/1.440560; Hell S. W., 2009, SINGLE MOL SPECTROSC, P365; Hutchison JA, 2009, NANO LETT, V9, P995, DOI 10.1021/nl8030696; JEANMAIRE DL, 1977, J ELECTROANAL CHEM, V84, P1, DOI 10.1016/S0022-0728(77)80224-6; Kinkhabwala A, 2009, NAT PHOTONICS, V3, P654, DOI 10.1038/NPHOTON.2009.187; Kneipp K, 1997, PHYS REV LETT, V78, P1667, DOI 10.1103/PhysRevLett.78.1667; Kubo A, 2007, J PHYS B-AT MOL OPT, V40, pS259, DOI 10.1088/0953-4075/40/11/S02; Mortensen KI, 2010, NAT METHODS, V7, P377, DOI [10.1038/nmeth.1447, 10.1038/NMETH.1447]; MOSKOVITS M, 1978, J CHEM PHYS, V69, P4159, DOI 10.1063/1.437095; Nelayah J, 2007, NAT PHYS, V3, P348, DOI 10.1038/nphys575; Nie SM, 1997, SCIENCE, V275, P1102, DOI 10.1126/science.275.5303.1102; Roeffaers MBJ, 2009, ANGEW CHEM INT EDIT, V48, P9285, DOI 10.1002/anie.200904944; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sarychev AK, 1999, PHYS REV B, V60, P16389, DOI 10.1103/PhysRevB.60.16389; Seal K, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.206103; SHALAEV VM, 1988, Z PHYS D ATOM MOL CL, V10, P71, DOI 10.1007/BF01425582; Sharonov A, 2006, P NATL ACAD SCI USA, V103, P18911, DOI 10.1073/pnas.0609643104; Stockman MI, 2001, PHYS REV LETT, V87, part. no., DOI 10.1103/PhysRevLett.87.167401; Taminiau TH, 2008, NAT PHOTONICS, V2, P234, DOI 10.1038/nphoton.2008.32; Vesseur EJR, 2007, NANO LETT, V7, P2843, DOI 10.1021/nl071480w; WOKAUN A, 1983, J CHEM PHYS, V79, P509, DOI 10.1063/1.445550; Wu DM, 2008, NANO LETT, V8, P1159, DOI 10.1021/nl0733280	30	209	209	2	231	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 20	2011	469	7330					385	+		10.1038/nature09698	http://dx.doi.org/10.1038/nature09698			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248848				2022-12-28	WOS:000286385600049
J	Mintz-Hittner, HA; Kennedy, KA; Chuang, AZ				Mintz-Hittner, Helen A.; Kennedy, Kathleen A.; Chuang, Alice Z.		BEAT-ROP Cooperative Grp	Efficacy of Intravitreal Bevacizumab for Stage 3+Retinopathy of Prematurity.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ZONE-I RETINOPATHY; LASER TREATMENT; POSTERIOR RETINOPATHY; THRESHOLD RETINOPATHY; INJECTION; THERAPY; EYES; PHARMACOKINETICS; COMBINATION; AVASTIN	Background: Retinopathy of prematurity is a leading cause of childhood blindness worldwide. Peripheral retinal ablation with conventional (confluent) laser therapy is destructive, causes complications, and does not prevent all vision loss, especially in cases of retinopathy of prematurity affecting zone I of the eye. Case series in which patients were treated with vascular endothelial growth factor inhibitors suggest that these agents may be useful in treating retinopathy of prematurity. Methods: We conducted a prospective, controlled, randomized, stratified, multicenter trial to assess intravitreal bevacizumab monotherapy for zone I or zone II posterior stage 3+ (i.e., stage 3 with plus disease) retinopathy of prematurity. Infants were randomly assigned to receive intravitreal bevacizumab (0.625 mg in 0.025 ml of solution) or conventional laser therapy, bilaterally. The primary ocular outcome was recurrence of retinopathy of prematurity in one or both eyes requiring retreatment before 54 weeks' postmenstrual age. Results: We enrolled 150 infants (total sample of 300 eyes); 143 infants survived to 54 weeks' postmenstrual age, and the 7 infants who died were not included in the primary-outcome analyses. Retinopathy of prematurity recurred in 4 infants in the bevacizumab group (6 of 140 eyes [4%]) and 19 infants in the laser-therapy group (32 of 146 eyes [22%], P=0.002). A significant treatment effect was found for zone I retinopathy of prematurity (P=0.003) but not for zone II disease (P=0.27). Conclusions: Intravitreal bevacizumab monotherapy, as compared with conventional laser therapy, in infants with stage 3+ retinopathy of prematurity showed a significant benefit for zone I but not zone II disease. Development of peripheral retinal vessels continued after treatment with intravitreal bevacizumab, but conventional laser therapy led to permanent destruction of the peripheral retina. This trial was too small to assess safety. (Funded by Research to Prevent Blindness and others; ClinicalTrials.gov number, NCT00622726.) N Engl J Med 2011;364:603-15.	[Mintz-Hittner, Helen A.; Chuang, Alice Z.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Ophthalmol & Visual Sci, Houston, TX USA; [Kennedy, Kathleen A.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Pediat, Neonatal Perinatal Div, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Mintz-Hittner, HA (corresponding author), Robert Cizik Eye Clin, 6400 Fannin St,Suite 1800, Houston, TX 77030 USA.	helen.a.mintz-hittner@uth.tmc.edu			Research to Prevent Blindness; National Eye Institute [P30EY10608]; Hermann Eye Fund; Alfred W. Lasher III Professorship; University of Texas Health Science Center at Houston-Center for Clinical and Translational Science-Clinical Research Center [UL1 RR024148]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY010608] Funding Source: NIH RePORTER	Research to Prevent Blindness(Research to Prevent Blindness (RPB)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Hermann Eye Fund; Alfred W. Lasher III Professorship; University of Texas Health Science Center at Houston-Center for Clinical and Translational Science-Clinical Research Center; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Supported by grants from Research to Prevent Blindness, the National Eye Institute (Core Grant P30EY10608), and the Hermann Eye Fund (all to Drs. Mintz-Hittner and Chuang), as well as research funds from the Alfred W. Lasher III Professorship and a grant from the University of Texas Health Science Center at Houston-Center for Clinical and Translational Science-Clinical Research Center (Clinical and Translational Science Award Grant UL1 RR024148) (both to Dr. Mintz-Hittner).	Ahmed AE, 2010, MIDDLE EAST AFR J OP, V17, P264, DOI 10.4103/0974-9233.65500; ALTINSOY, 2010, OPHTHALMIC SURG 0309; Axer-Siegel R, 2000, BRIT J OPHTHALMOL, V84, P1383, DOI 10.1136/bjo.84.12.1383; BAKRI SJ, 2010, J AAPOS, V14, P2; Bakri SJ, 2007, OPHTHALMOLOGY, V114, P855, DOI 10.1016/j.ophtha.2007.01.017; Chung EJ, 2007, GRAEF ARCH CLIN EXP, V245, P1727, DOI 10.1007/s00417-007-0661-y; Dorta Paola, 2010, Retina, V30, pS24, DOI 10.1097/IAE.0b013e3181ca1457; Drenser Kimberly A, 2010, Retina, V30, pS37, DOI 10.1097/IAE.0b013e3181cb6151; Gilbert C, 2008, EARLY HUM DEV, V84, P77, DOI 10.1016/j.earlhumdev.2007.11.009; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684; Honda S, 2008, GRAEF ARCH CLIN EXP, V246, P1061, DOI 10.1007/s00417-008-0786-7; *INT COMM CLASS RE, 2006, ARCH OPHTHALMOL-CHIC, V124, P1669; Katz X, 2000, J AAPOS, V4, P373, DOI 10.1067/mpa.2000.107904; Kong L, 2008, ARCH OPHTHALMOL-CHIC, V126, P1161, DOI 10.1001/archophthalmol.2008.1; Krohne TU, 2008, AM J OPHTHALMOL, V146, P508, DOI 10.1016/j.ajo.2008.05.036; Kusaka S, 2008, BRIT J OPHTHALMOL, V92, P1450, DOI 10.1136/bjo.2008.140657; Kychenthal A, 2006, RETINA-J RET VIT DIS, V26, pS11, DOI 10.1097/01.iae.0000244285.79004.e6; Lad EM, 2008, BRIT J OPHTHALMOL, V92, P320, DOI 10.1136/bjo.2007.126201; Lad EM, 2010, BRIT J OPHTHALMOL, V94, P1268, DOI 10.1136/bjo.2007.126201corr1; LALWANI GA, 2009, RETINA, V29, P127; Lalwani GA, 2008, RETINA-J RET VIT DIS, V28, pS13, DOI 10.1097/IAE.0b013e3181644ad2; Law JC, 2010, J AAPOS, V14, P6, DOI 10.1016/j.jaapos.2009.10.011; Lee JY, 2010, GRAEF ARCH CLIN EXP, V248, P1257, DOI 10.1007/s00417-010-1375-0; Lichtenstein SJ, 2006, PEDIATRICS, V117, P572, DOI 10.1542/peds.2005-2749; Mintz-Hittner HA, 2008, RETINA-J RET VIT DIS, V28, P831, DOI 10.1097/IAE.0b013e318177f934; MINTZHITTNER HA, 1994, OPHTHALMOLOGY, V101, P548; MINTZHITTNER HA, 2008, GRAEFES ARCH CLIN EX, V246, P779; MINTZHITTNER HA, 2010, CLINICALTRIALS; Nazari H, 2010, GRAEF ARCH CLIN EXP, V248, P1713, DOI 10.1007/s00417-010-1430-x; O'Keefe M, 2003, ACTA OPHTHALMOL SCAN, V81, P614, DOI 10.1111/j.1395-3907.2003.00171.x; PALMER EA, 1988, ARCH OPHTHALMOL-CHIC, V106, P471; Quinn GE, 1996, OPHTHALMOLOGY, V103, P595, DOI 10.1016/S0161-6420(96)30647-7; Quiroz-Mercado H, 2008, RETINA-J RET VIT DIS, V28, pS19, DOI 10.1097/IAE.0b013e318159ec6b; Recsan Z, 2003, J PEDIAT OPHTH STRAB, V40, P204, DOI 10.3928/0191-3913-20030701-06; Repka MX, 2006, ARCH OPHTHALMOL-CHIC, V124, P24, DOI 10.1001/archopht.124.1.24; *SECT OPHTH AM AC, 2006, PEDIATRICS, V118, P1324; Smith LEH, 2008, INVEST OPHTH VIS SCI, V49, P5177, DOI 10.1167/iovs.08-2584; Spencer Rand, 2006, Trans Am Ophthalmol Soc, V104, P493; Travassos A, 2007, OPHTHAL SURG LAS IM, V38, P233, DOI 10.3928/15428877-20070501-09; Wu WC, 2011, OPHTHALMOLOGY, V118, P176, DOI 10.1016/j.ophtha.2010.04.018; Zepeda-Romero LC, 2010, EYE, V24, P931, DOI 10.1038/eye.2009.156	42	867	919	0	54	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 17	2011	364	7					603	615		10.1056/NEJMoa1007374	http://dx.doi.org/10.1056/NEJMoa1007374			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722BW	21323540	Green Accepted			2022-12-28	WOS:000287406000006
J	Spence, D				Spence, Des			From The Frontline Explaining the unexplainable	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk						2008, COMP MATH MATH PHYS, V336, P1124	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2011	342								d1039	10.1136/bmj.d1039	http://dx.doi.org/10.1136/bmj.d1039			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	725OZ	21325380				2022-12-28	WOS:000287656500011
J	Wilding, JPH; Hardy, K				Wilding, John P. H.; Hardy, Kevin			Therapeutics Glucagon-like peptide-1 analogues for type 2 diabetes	BRITISH MEDICAL JOURNAL			English	Editorial Material							METFORMIN-TREATED PATIENTS; TWICE-DAILY EXENATIDE; OPEN-LABEL TRIAL; GLYCEMIC CONTROL; RANDOMIZED-TRIAL; INSULIN GLARGINE; PARALLEL-GROUP; LIRAGLUTIDE; SULFONYLUREA; EXENDIN-4					j.p.h.wilding@liv.ac.uk	Wilding, John/ABB-6443-2020; Wilding, John PH/A-7106-2008	Wilding, John/0000-0003-2839-8404; Wilding, John PH/0000-0003-2839-8404				Buse JB, 2004, DIABETES CARE, V27, P2628, DOI 10.2337/diacare.27.11.2628; BUSE JB, 2002, TECHN APPR NAT I HLT, V203; Buse JB, 2010, DIABETES CARE, V33, P1300, DOI 10.2337/dc09-2260; Buse JB, 2009, LANCET, V374, P39, DOI 10.1016/S0140-6736(09)60659-0; DeFronzo RA, 2005, DIABETES CARE, V28, P1092, DOI 10.2337/diacare.28.5.1092; Garber A, 2009, LANCET, V373, P473, DOI 10.1016/S0140-6736(08)61246-5; Heine RJ, 2005, ANN INTERN MED, V143, P559, DOI 10.7326/0003-4819-143-8-200510180-00006; Kendall DM, 2005, DIABETES CARE, V28, P1083, DOI 10.2337/diacare.28.5.1083; Klonoff DC, 2008, CURR MED RES OPIN, V24, P275, DOI 10.1185/030079908X253870; Marre M, 2009, DIABETIC MED, V26, P268, DOI 10.1111/j.1464-5491.2009.02666.x; *MED HEALTHC PROD, 2009, DRUG SAF UPD, V2; *NAT I HLTH CLIN E, 2009, CLIN GUID NAT I HLTH, V87; Nathan DM, 2009, DIABETES CARE, V32, P193, DOI 10.2337/dc08-9025; Nauck MA, 2007, DIABETOLOGIA, V50, P259, DOI 10.1007/s00125-006-0510-2; Nauck M, 2009, DIABETES CARE, V32, P84, DOI 10.2337/dc08-1355; Pratley RE, 2010, LANCET, V375, P1447, DOI 10.1016/S0140-6736(10)60307-8; Ratner RE, 2006, DIABETES OBES METAB, V8, P419, DOI 10.1111/j.1463-1326.2006.00589.x; Ray JA, 2007, CURR MED RES OPIN, V23, P609, DOI 10.1185/030079907X178685; Riddle MC, 2006, DIABETES-METAB RES, V22, P483, DOI 10.1002/dmrr.646; Russell-Jones D, 2009, DIABETOLOGIA, V52, P2046, DOI 10.1007/s00125-009-1472-y; Yoon NM, 2009, CLIN THER, V31, P1511, DOI 10.1016/j.clinthera.2009.07.021; Zinman B, 2007, ANN INTERN MED, V146, P477, DOI 10.7326/0003-4819-146-7-200704030-00003; Zinman B, 2009, DIABETES CARE, V32, P1224, DOI 10.2337/dc08-2124	23	17	22	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 16	2011	342								d410	10.1136/bmj.d410	http://dx.doi.org/10.1136/bmj.d410			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	725OZ	21325387				2022-12-28	WOS:000287656500015
J	Farzadfar, F; Finucane, MM; Danaei, G; Pelizzari, PM; Cowan, MJ; Paciorek, CJ; Singh, GM; Lin, JK; Stevens, GA; Riley, LM; Ezzati, M				Farzadfar, Farshad; Finucane, Mariel M.; Danaei, Goodarz; Pelizzari, Pamela M.; Cowan, Melanie J.; Paciorek, Christopher J.; Singh, Gitanjali M.; Lin, John K.; Stevens, Gretchen A.; Riley, Leanne M.; Ezzati, Majid		Global Burden Metab Risk Factors C	National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3.0 million participants	LANCET			English	Article							CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; BODY-MASS INDEX; RISK-FACTORS; CARDIOVASCULAR RISK; 20-YEAR TRENDS; SECULAR TRENDS; PRIMARY-CARE; HYPERCHOLESTEROLEMIA; PREVALENCE	Background Data for trends in serum cholesterol are needed to understand the effects of its dietary, lifestyle, and pharmacological determinants; set intervention priorities; and evaluate national programmes. Previous analyses of trends in serum cholesterol were limited to a few countries, with no consistent and comparable global analysis. We estimated worldwide trends in population mean serum total cholesterol. Methods We estimated trends and their uncertainties in mean serum total cholesterol for adults 25 years and older in 199 countries and territories. We obtained data from published and unpublished health examination surveys and epidemiological studies (321 country-years and 3.0 million participants). For each sex, we used a Bayesian hierarchical model to estimate mean total cholesterol by age, country, and year, accounting for whether a study was nationally representative. Findings In 2008, age-standardised mean total cholesterol worldwide was 4.64 mmol/L (95% uncertainty interval 4.51-4.76) for men and 4.76 mmol/L (4.62-4.91) for women. Globally, mean total cholesterol changed little between 1980 and 2008, falling by less than 0.1 mmol/L per decade in men and women. Total cholesterol fell in the high-income region consisting of Australasia, North America, and western Europe, and in central and eastern Europe; the regional declines were about 0.2 mmol/L per decade for both sexes, with posterior probabilities of these being true declines 0.99 or greater. Mean total cholesterol increased in east and southeast Asia and Pacific by 0.08 mmol/L per decade (-0.06 to 0.22, posterior probability=0.86) in men and 0.09 mmol/L per decade (-0.07 to 0.26, posterior probability=0.86) in women. Despite converging trends, serum total cholesterol in 2008 was highest in the high. income region consisting of Australasia, North America, and western Europe; the regional mean was 5.24 mmol/L (5.08-5.39) for men and 5.23 mmol/L (5.03-5.43) for women. It was lowest in sub-Saharan Africa at 4.08 mmol/L (3.82-4.34) for men and 4.27 mmol/L (3.99-4.56) for women. Interpretation Nutritional policies and pharmacological interventions should be used to accelerate improvements in total cholesterol in regions with decline and to curb or prevent the rise in Asian populations and elsewhere. Population-based surveillance of cholesterol needs to be improved in low-income and middle-income countries.	[Ezzati, Majid] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, London W2 1PG, England; [Farzadfar, Farshad; Singh, Gitanjali M.; Lin, John K.; Ezzati, Majid] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Finucane, Mariel M.; Paciorek, Christopher J.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Danaei, Goodarz] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Ezzati, Majid] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Pelizzari, Pamela M.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Cowan, Melanie J.; Riley, Leanne M.] WHO, Dept Chron Dis & Hlth Promot, CH-1211 Geneva, Switzerland; [Stevens, Gretchen A.] WHO, Dept Hlth Stat & Informat, CH-1211 Geneva, Switzerland; [Paciorek, Christopher J.] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA	Imperial College London; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; World Health Organization; World Health Organization; University of California System; University of California Berkeley	Ezzati, M (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, MRC HPA Ctr Environm & Hlth, Med Fac Bldg,St Marys Campus,Norfolk Pl, London W2 1PG, England.	majid.ezzati@imperial.ac.uk	Miranda, J. Jaime/A-8482-2008; Cífková, Renata/O-5731-2017; Danaei, Goodarz/B-6085-2008; Bovet, Pascal/F-4477-2011; Colaus, PsyColaus/K-6607-2013; Rampal, Sanjay/B-9691-2010; Thomas, G. Neil/A-1879-2013; VOLPATO, STEFANO/H-2977-2014; Panza, Francesco/M-6804-2017; Chen, Chien-Jen/N-4723-2019; Castetbon, Katia/F-2686-2017; Bjerregaard, Peter/ABD-8894-2020; You, Qisheng/AAG-7153-2020; Lim, Stephen S/B-4055-2012; Panza, Francesco/Y-2539-2019; Nsour, Mohannad Al/ABE-8741-2020; Marques-Vidal, Pedro/C-9449-2009	Miranda, J. Jaime/0000-0002-4738-5468; Cífková, Renata/0000-0003-2765-3821; Bovet, Pascal/0000-0002-0242-4259; Rampal, Sanjay/0000-0002-0105-6407; Thomas, G. Neil/0000-0002-2777-1847; VOLPATO, STEFANO/0000-0003-4335-6034; Panza, Francesco/0000-0002-7220-0656; Bjerregaard, Peter/0000-0001-7153-8447; You, Qisheng/0000-0003-0743-7320; Panza, Francesco/0000-0002-7220-0656; Nsour, Mohannad Al/0000-0003-1212-1611; Woodward, Mark/0000-0001-9800-5296; Marques-Vidal, Pedro/0000-0002-4548-8500; Lin, John/0000-0003-2490-4453; Eggertsen, Robert/0000-0003-3807-3769; Farzadfar, Farshad/0000-0001-8288-4046; Pelizzari, Pamela/0000-0002-6992-9462; LIN, HSIEN-HO/0000-0002-7481-6016	Harvard University; Bill & Melinda Gates Foundation; WHO; Medical Research Council [G0801056B] Funding Source: researchfish	Harvard University; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); WHO(World Health Organization); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	JKL holds stock in Johnson & Johnson. CJP holds stock in Pfizer. GAS has received funding from Harvard University for travel purposes. ME has chaired a session at the World Cardiology Congress, which was sponsored by the organiser. All other authors declare that they have no conflicts of interest.; Funding Bill & Melinda Gates Foundation and WHO.	Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Arnett DK, 2005, CIRCULATION, V112, P3884, DOI 10.1161/CIRCULATIONAHA.105.549857; awes CMM, 2003, COMP QUANTIFICATION, P391; Ben Romdhane Habiba, 2005, Tunis Med, V83 Suppl 5, P8; Bovet P, 2009, CARDIOVASC DIABETOL, V8, DOI 10.1186/1475-2840-8-34; Bowden RG, 2006, PUBLIC HEALTH, V120, P572, DOI 10.1016/j.puhe.2006.03.005; Carroll MD, 2005, JAMA-J AM MED ASSOC, V294, P1773, DOI 10.1001/jama.294.14.1773; COHN JS, 1988, CLIN CHEM, V34, P2456; Danaei G, 2011, LANCET, V377, P568, DOI 10.1016/S0140-6736(10)62036-3; Eliasson M, 2006, J INTERN MED, V260, P551, DOI 10.1111/j.1365-2796.2006.01730.x; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Evans A, 2001, INT J EPIDEMIOL, V30, pS35, DOI 10.1093/ije/30.suppl_1.S35; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Ford ES, 2010, INT J CARDIOL, V140, P226, DOI 10.1016/j.ijcard.2008.11.033; Ford ES, 2003, CIRCULATION, V107, P2185, DOI 10.1161/01.CIR.0000066320.27195.B4; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; HOFFMEISTER H, 1994, PREV MED, V23, P197, DOI 10.1006/pmed.1994.1027; Houterman S, 2001, INT J EPIDEMIOL, V30, P1063, DOI 10.1093/ije/30.5.1063; JOOSSENS JV, 1977, LANCET, V1, P1069; Juonala M, 2004, J INTERN MED, V255, P457, DOI 10.1111/j.1365-2796.2004.01308.x; KEYS A, 1975, ATHEROSCLEROSIS, V22, P149, DOI 10.1016/0021-9150(75)90001-5; Khoo KL, 2003, ATHEROSCLEROSIS, V169, P1, DOI 10.1016/S0021-9150(03)00009-1; KNUIMAN JT, 1982, AM J EPIDEMIOL, V116, P631, DOI 10.1093/oxfordjournals.aje.a113446; Kotseva K, 2009, LANCET, V373, P929, DOI 10.1016/S0140-6736(09)60330-5; KROMHOUT D, 1995, PREV MED, V24, P308, DOI 10.1006/pmed.1995.1049; Kuklina EV, 2009, JAMA-J AM MED ASSOC, V302, P2104, DOI 10.1001/jama.2009.1672; LABARTHE DR, 1991, ANN NY ACAD SCI, V623, P108, DOI 10.1111/j.1749-6632.1991.tb43722.x; Langsted A, 2008, CIRCULATION, V118, P2047, DOI 10.1161/CIRCULATIONAHA.108.804146; Law M, 2000, AM J CLIN NUTR, V72, p1291S, DOI 10.1093/ajcn/72.5.1291s; LAW MR, 1994, EUR J CLIN NUTR, V48, P305; Lee MJ, 2002, PUBLIC HEALTH NUTR, V5, P197, DOI 10.1079/PHN2001294; Lewington S, 2007, LANCET, V370, P1829, DOI 10.1016/S0140-6736(07)61778-4; Lozano R, 2006, LANCET, V368, P1729, DOI 10.1016/S0140-6736(06)69566-4; Lyratzopoulos G, 2006, HEART, V92, P1198, DOI 10.1136/hrt.2005.081042; Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76; OKAYAMA A, 1995, J CLIN EPIDEMIOL, V48, P329, DOI 10.1016/0895-4356(94)00146-H; OKAYAMA A, 1993, INT J EPIDEMIOL, V22, P1038, DOI 10.1093/ije/22.6.1038; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; SJOL A, 1991, INT J EPIDEMIOL, V20, P105, DOI 10.1093/ije/20.1.105; Steinhagen-Thiessen E, 2008, CARDIOVASC DIABETOL, V7, DOI 10.1186/1475-2840-7-31; Sun Jia-yi, 2006, Zhonghua Nei Ke Za Zhi, V45, P980; Tolonen H, 2005, INT J EPIDEMIOL, V34, P181, DOI 10.1093/ije/dyi056; VARTIAINEN E, 1994, INT J EPIDEMIOL, V23, P495, DOI 10.1093/ije/23.3.495; WILSON PWF, 1989, AM J MED, V87, pS5, DOI 10.1016/S0002-9343(89)80593-5; Zatonski W, 2008, EUR J EPIDEMIOL, V23, P3, DOI 10.1007/s10654-007-9195-1; Zhang X, 2003, INT J EPIDEMIOL, V32, P563, DOI 10.1093/ije/dyg106	47	418	433	1	43	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 12	2011	377	9765					578	586		10.1016/S0140-6736(10)62038-7	http://dx.doi.org/10.1016/S0140-6736(10)62038-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	724DQ	21295847				2022-12-28	WOS:000287556700028
J	Ives, A; Ronet, C; Prevel, F; Ruzzante, G; Fuertes-Marraco, S; Schutz, F; Zangger, H; Revaz-Breton, M; Lye, LF; Hickerson, SM; Beverley, SM; Acha-Orbea, H; Launois, P; Fasel, N; Masina, S				Ives, Annette; Ronet, Catherine; Prevel, Florence; Ruzzante, Giulia; Fuertes-Marraco, Silvia; Schutz, Frederic; Zangger, Haroun; Revaz-Breton, Melanie; Lye, Lon-Fye; Hickerson, Suzanne M.; Beverley, Stephen M.; Acha-Orbea, Hans; Launois, Pascal; Fasel, Nicolas; Masina, Slavica			Leishmania RNA Virus Controls the Severity of Mucocutaneous Leishmaniasis	SCIENCE			English	Article							MUCOSAL LEISHMANIASIS; CUTANEOUS LEISHMANIASIS; INNATE IMMUNITY; BRAZILIENSIS; PATHOGENESIS; EXPRESSION; RESISTANCE; EVOLUTION; INFECTION; PARASITES	Mucocutaneous leishmaniasis is caused by infections with intracellular parasites of the Leishmania Viannia subgenus, including Leishmania guyanensis. The pathology develops after parasite dissemination to nasopharyngeal tissues, where destructive metastatic lesions form with chronic inflammation. Currently, the mechanisms involved in lesion development are poorly understood. Here we show that metastasizing parasites have a high Leishmania RNA virus-1 (LRV1) burden that is recognized by the host Toll-like receptor 3 (TLR3) to induce proinflammatory cytokines and chemokines. Paradoxically, these TLR3-mediated immune responses rendered mice more susceptible to infection, and the animals developed an increased footpad swelling and parasitemia. Thus, LRV1 in the metastasizing parasites subverted the host immune response to Leishmania and promoted parasite persistence.	[Ives, Annette; Ronet, Catherine; Prevel, Florence; Ruzzante, Giulia; Fuertes-Marraco, Silvia; Zangger, Haroun; Revaz-Breton, Melanie; Acha-Orbea, Hans; Fasel, Nicolas; Masina, Slavica] Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland; [Schutz, Frederic] Univ Lausanne, Swiss Inst Bioinformat, CH-1015 Dorigny, Switzerland; [Lye, Lon-Fye; Hickerson, Suzanne M.; Beverley, Stephen M.] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Launois, Pascal] WHO Immunol Res & Training Ctr, CH-1066 Epalinges, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics; University of Lausanne; Washington University (WUSTL)	Fasel, N (corresponding author), Univ Lausanne, Dept Biochem, CH-1066 Epalinges, Switzerland.	nicolas.fasel@unil.ch	Ronet, Catherine/O-6866-2017; Fasel, Nicolas/O-4253-2016; Marraco, Silvia A Fuertes/I-2481-2014	Ronet, Catherine/0000-0003-1479-2873; Fasel, Nicolas/0000-0003-0136-7245; Ives, Annette/0000-0002-7407-960X; Beverley, Stephen/0000-0001-5319-0811; Fuertes Marraco, Silvia A/0000-0002-3456-3317	FNRS [3100A0-116665/1, 310030-120325]; Foundation Pierre Mercier; NIH [A129646]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI029646] Funding Source: NIH RePORTER	FNRS(Fonds de la Recherche Scientifique - FNRS); Foundation Pierre Mercier; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We are grateful to N. Saravia (CIDEIM, Colombia) and Instituto Oswaldo Cruz, for L. guyanensis strains; S. Akira (Frontier Research center, Osaka University), P. Romero (LICR, Lausanne), and B. Ryffel (CNRS, Orleans) for knockout and mutant mice; M. Delorenzi (SIB, Lausanne) for bioinformatics expertise; F. Morgenthaler (Cellular Imaging Facility, Lausanne), S. Cawsey, and M.-A. Hartley for technical assistance; and J. Patterson and Y. T. Ro for the L.g. M4147 strains. This work was funded by FNRS grants 3100A0-116665/1 (N.F.) and 310030-120325 (P.L.), Foundation Pierre Mercier (S.M.), and NIH A129646 (S.M.B.). Microarray data are available within the Gene Expression Omnibus database (GSE21418) and at http://people.unil.ch/nicolasfasel/data-from-fasels-lab/.	Abou Fakher FH, 2009, J IMMUNOL, V182, P1386, DOI 10.4049/jimmunol.182.3.1386; Acestor N, 2006, J INFECT DIS, V194, P1160, DOI 10.1086/507646; Amato VS, 2008, ACTA TROP, V105, P1, DOI 10.1016/j.actatropica.2007.08.003; Arevalo J, 2007, J INFECT DIS, V195, P1846, DOI 10.1086/518041; BARRAL A, 1995, AM J TROP MED HYG, V53, P256, DOI 10.4269/ajtmh.1995.53.256; BARRAL A, 1995, AM J PATHOL, V147, P947; Ben-Othman R, 2008, MOL IMMUNOL, V45, P3222, DOI 10.1016/j.molimm.2008.02.019; Blackwell JM, 1999, PARASITOL TODAY, V15, P73, DOI 10.1016/S0169-4758(98)01355-6; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; CADD TL, 1993, J VIROL, V67, P5647, DOI 10.1128/JVI.67.9.5647-5650.1993; Castellucci L, 2006, J INFECT DIS, V194, P519, DOI 10.1086/505504; Cavassani KA, 2008, J EXP MED, V205, P2609, DOI 10.1084/jem.20081370; Doyle SL, 2006, BIOCHEM PHARMACOL, V72, P1102, DOI 10.1016/j.bcp.2006.07.010; Faria DR, 2005, INFECT IMMUN, V73, P7853, DOI 10.1128/IAI.73.12.7853-7859.2005; Gaze ST, 2006, SCAND J IMMUNOL, V63, P70, DOI 10.1111/j.1365-3083.2005.01707.x; GUILBRIDE L, 1992, MOL BIOCHEM PARASIT, V54, P101, DOI 10.1016/0166-6851(92)90099-6; Lang KS, 2006, J CLIN INVEST, V116, P2456, DOI 10.1172/JCI28349; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; MARTINEZ JE, 1992, T ROY SOC TROP MED H, V86, P392, DOI 10.1016/0035-9203(92)90233-3; Martinez JE, 2000, J PARASITOL, V86, P792, DOI 10.1645/0022-3395(2000)086[0792:CDITEA]2.0.CO;2; Ogg MM, 2003, AM J TROP MED HYG, V69, P309, DOI 10.4269/ajtmh.2003.69.309; PIRMEZ C, 1993, J CLIN INVEST, V91, P1390, DOI 10.1172/JCI116341; REY JA, 1990, AM J TROP MED HYG, V43, P623, DOI 10.4269/ajtmh.1990.43.623; Ro YT, 1997, J VIROL, V71, P8991, DOI 10.1128/JVI.71.12.8991-8998.1997; Salinas G, 1996, AM J TROP MED HYG, V54, P425, DOI 10.4269/ajtmh.1996.54.425; TRAVI B, 1988, J PARASITOL, V74, P1059, DOI 10.2307/3282237; Vargas-Inchaustegui DA, 2010, INFECT IMMUN, V78, P301, DOI 10.1128/IAI.00959-09; Vergel C, 2006, J INFECT DIS, V194, P503, DOI 10.1086/505583; Weigle K, 1996, CLIN DERMATOL, V14, P433, DOI 10.1016/0738-081X(96)00036-3; WIDMER G, 1989, P NATL ACAD SCI USA, V86, P5979, DOI 10.1073/pnas.86.15.5979	30	250	258	0	39	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 11	2011	331	6018					775	778		10.1126/science.1199326	http://dx.doi.org/10.1126/science.1199326			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	719LH	21311023	Green Accepted, Green Submitted			2022-12-28	WOS:000287205700072
J	Edwards, AM; Isserlin, R; Bader, GD; Frye, SV; Willson, TM; Yu, FH				Edwards, Aled M.; Isserlin, Ruth; Bader, Gary D.; Frye, Stephen V.; Willson, Timothy M.; Yu, Frank H.			Too many roads not taken	NATURE			English	Editorial Material							GENE; MUTATIONS		[Edwards, Aled M.] Univ Toronto, Toronto, ON M5G 1L7, Canada; [Isserlin, Ruth; Bader, Gary D.] Univ Toronto, Donnelly Ctr, Toronto, ON M5S 3E1, Canada; [Frye, Stephen V.] Univ N Carolina, Eshelman Sch Pharm, Ctr Integrat Chem Biol & Drug Discovery, Chapel Hill, NC 27599 USA; [Willson, Timothy M.] GlaxoSmithKline Inc, Res Triangle Pk, NC 27709 USA; [Yu, Frank H.] Seoul Natl Univ, Sch Dent, Program Neurobiol, Seoul 110749, South Korea; [Yu, Frank H.] Seoul Natl Univ, Sch Dent, Dent Res Inst, Seoul 110749, South Korea	University of Toronto; University of Toronto; University of North Carolina; University of North Carolina Chapel Hill; GlaxoSmithKline; Seoul National University (SNU); Seoul National University (SNU)	Edwards, AM (corresponding author), Univ Toronto, Toronto, ON M5G 1L7, Canada.	aled.edwards@utoronto.ca	feinstein, doug/M-9414-2019; Bader, Gary/C-1176-2009	Bader, Gary/0000-0003-0185-8861; Edwards, Aled/0000-0002-4782-6016; Yu, Frank/0000-0001-9306-1731				Achermann JC, 1999, NAT GENET, V22, P125, DOI 10.1038/9629; Fedorov O, 2010, NAT CHEM BIOL, V6, P166, DOI 10.1038/nchembio.297; Frye SV, 2010, NAT CHEM BIOL, V6, P159, DOI 10.1038/nchembio.296; Grueneberg DA, 2008, P NATL ACAD SCI USA, V105, P16472, DOI 10.1073/pnas.0808019105; ISSERLIN R, 2011, PREPRINT; Lee SL, 1996, SCIENCE, V273, P1219, DOI 10.1126/science.273.5279.1219; MUSCATELLI F, 1994, NATURE, V372, P672, DOI 10.1038/372672a0; Willson TM, 2002, MOL ENDOCRINOL, V16, P1135, DOI 10.1210/me.16.6.1135; Yamagata K, 1996, NATURE, V384, P458, DOI 10.1038/384458a0	9	257	259	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 10	2011	470	7333					163	165		10.1038/470163a	http://dx.doi.org/10.1038/470163a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	718RQ	21307913	Green Submitted			2022-12-28	WOS:000287144200015
J	Rajaraman, P; Simpson, J; Neta, G; de Gonzalez, AB; Ansell, P; Linet, MS; Ron, E; Roman, E				Rajaraman, Preetha; Simpson, Jill; Neta, Gila; de Gonzalez, Amy Berrington; Ansell, Pat; Linet, Martha S.; Ron, Elaine; Roman, Eve			Early life exposure to diagnostic radiation and ultrasound scans and risk of childhood cancer: case-control study	BRITISH MEDICAL JOURNAL			English	Article							ATOMIC-BOMB SURVIVORS; IONIZING-RADIATION; MULTIPLE-MYELOMA; OXFORD SURVEY; X-RAYS; LEUKEMIA; MALIGNANCIES; IRRADIATION; PREGNANCY; MORTALITY	Objective To examine childhood cancer risks associated with exposure to diagnostic radiation and ultrasound scans in utero and in early infancy (age 0-100 days). Design Case-control study. Setting England and Wales. Participants 2690 childhood cancer cases and 4858 age, sex, and region matched controls from the United Kingdom Childhood Cancer Study (UKCCS), born 1976-96. Main outcome measures Risk of all childhood cancer, leukaemia, lymphoma, and central nervous system tumours, measured by odds ratios. Results Logistic regression models conditioned on matching factors, with adjustment for maternal age and child's birth weight, showed no evidence of increased risk of childhood cancer with in utero exposure to ultrasound scans. Some indication existed of a slight increase in risk after in utero exposure to x rays for all cancers (odds ratio 1.l4, 95% confidence interval 0.90 to 1.45) and leukaemia (1.36, 0.91 to 2.02), but this was not statistically significant. Exposure to diagnostic x rays in early infancy (0-100 days) was associated with small, non-significant excess risks for all cancers and leukaemia, as well as increased risk of lymphoma (odds ratio 5.14, 1.27 to 20.78) on the basis of small numbers. Conclusions Although the results for lymphoma need to be replicated, all of the findings indicate possible risks of cancer from radiation at doses lower than those associated with commonly used procedures such as computed tomography scans, suggesting the need for cautious use of diagnostic radiation imaging procedures to the abdomen/pelvis of the mother during pregnancy and in children at very young ages.	[Rajaraman, Preetha; Neta, Gila; de Gonzalez, Amy Berrington; Linet, Martha S.; Ron, Elaine] NCI, Div Canc Epidemiol & Genet, NIH, DHHS, Bethesda, MD 20892 USA; [Simpson, Jill; Ansell, Pat; Roman, Eve] Univ York, Dept Hlth Sci, Epidemiol & Genet Unit, York YO10 5DD, N Yorkshire, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of York - UK	Rajaraman, P (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, DHHS, 6120 Execut Blvd, Bethesda, MD 20892 USA.	rajarama@mail.nih.gov	de gonzalez, amy berrington/L-7017-2017	de gonzalez, amy berrington/0000-0002-7332-8387; Roman, Eve/0000-0001-7603-3704	National Cancer Institute, National Institutes of Health, Department of Health and Human Services, USA; Leukaemia and Lymphoma Research; NATIONAL CANCER INSTITUTE [ZIACP010222] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health, Department of Health and Human Services, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukaemia and Lymphoma Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by intramural funds from the National Cancer Institute, National Institutes of Health, Department of Health and Human Services, USA. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organisations imply endorsement by the US government. The United Kingdom Childhood Cancer Study (UKCCS) is sponsored and administered by Leukaemia and Lymphoma Research. The UKCCS was conducted by 12 teams of investigators (10 clinical and epidemiological and two biological) based in university departments, research institutes, and the National Health Service in Scotland. Its work is coordinated by a management committee. The researchers are independent from the funders.	Berrington A, 2001, BRIT J RADIOL, V74, P507, DOI 10.1259/bjr.74.882.740507; BITHELL JF, 1975, BRIT J CANCER, V31, P271, DOI 10.1038/bjc.1975.62; Boulton A, 2000, BRIT J CANCER, V82, P1073; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Cardis E, 2007, RADIAT RES, V167, P396, DOI 10.1667/RR0553.1; CARTWRIGHT RA, 1984, LANCET, V2, P999; Committee to Assess Health Risks From Exposure to Low Levels of Ionizing Radiation Board on Radiation Effects Research Division on Earth and Life Studies National Research Council of the National Academies, 2006, HLTH RISKS EXP LOW L; Doll R, 1997, BRIT J RADIOL, V70, P130, DOI 10.1259/bjr.70.830.9135438; GRAHAM SAXON, 1966, NAT CANCER INST MONOGR, V19, P347; INSKIP PD, 1993, RADIAT RES, V135, P108, DOI 10.2307/3578404; Johnson KJ, 2008, BRIT J CANCER, V99, P545, DOI 10.1038/sj.bjc.6604516; Linet MS, 2009, PEDIATR RADIOL, V39, pS4, DOI 10.1007/s00247-008-1026-3; Mettler FA, 2008, HEALTH PHYS, V95, P502, DOI 10.1097/01.HP.0000326333.42287.a2; MOLE RH, 1990, BRIT J CANCER, V62, P152, DOI 10.1038/bjc.1990.249; MONSON RR, 1984, RAD CARCINOGENESIS E; PRESTON DL, 1994, RADIAT RES, V137, pS68, DOI 10.2307/3578893; Richardson D, 2009, RADIAT RES, V172, P368, DOI 10.1667/RR1801.1; Roman E, 2005, EUR J CANCER, V41, P749, DOI 10.1016/j.ejca.2004.11.006; Schulze-Rath R, 2008, RADIAT ENVIRON BIOPH, V47, P301, DOI 10.1007/s00411-008-0171-2; Shu XO, 2002, CANCER EPIDEM BIOMAR, V11, P177; SHU XO, 1994, BRIT J CANCER, V70, P531, DOI 10.1038/bjc.1994.340; SORAHAN T, 1995, BRIT J OBSTET GYNAEC, V102, P831, DOI 10.1111/j.1471-0528.1995.tb10851.x; STEWART A, 1958, BRIT MED J, V1, P1495, DOI 10.1136/bmj.1.5086.1495; STEWART A, 1956, LANCET, V2, P447; United Nations Scientific Committee on the Effects of Atomic Radiation, 2006, EFF ION RAD; Wakeford R, 2008, RADIAT PROT DOSIM, V132, P166, DOI 10.1093/rpd/ncn272	26	73	74	0	18	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 10	2011	342								d472	10.1136/bmj.d472	http://dx.doi.org/10.1136/bmj.d472			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	722BC	21310791	Green Published, hybrid			2022-12-28	WOS:000287403200003
J	Stevens, AJ; Jensen, JJ; Wyller, K; Kilgore, PC; Chatterjee, S; Rohrbaugh, ML				Stevens, Ashley J.; Jensen, Jonathan J.; Wyller, Katrine; Kilgore, Patrick C.; Chatterjee, Sabarni; Rohrbaugh, Mark L.			The Role of Public-Sector Research in the Discovery of Drugs and Vaccines.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background: Historically, public-sector researchers have performed the upstream, basic research that elucidated the underlying mechanisms of disease and identified promising points of intervention, whereas corporate researchers have performed the downstream, applied research resulting in the discovery of drugs for the treatment of diseases and have carried out development activities to bring them to market. However, the boundaries between the roles of the public and private sectors have shifted substantially since the dawn of the biotechnology era, and the public sector now has a much more direct role in the applied-research phase of drug discovery. Methods: We identified new drugs and vaccines approved by the Food and Drug Administration (FDA) that were discovered by public-sector research institutions (PSRIs) and classified them according to their therapeutic category and potential therapeutic effect. Results: We found that during the past 40 years, 153 new FDA-approved drugs, vaccines, or new indications for existing drugs were discovered through research carried out in PSRIs. These drugs included 93 small-molecule drugs, 36 biologic agents, 15 vaccines, 8 in vivo diagnostic materials, and 1 over-the-counter drug. More than half of these drugs have been used in the treatment or prevention of cancer or infectious diseases. PSRI-discovered drugs are expected to have a disproportionately large therapeutic effect. Conclusions: Public-sector research has had a more immediate effect on improving public health than was previously realized. N Engl J Med 2011;364:535-41.	[Stevens, Ashley J.; Jensen, Jonathan J.] Boston Univ, Sch Management, Inst Technol Entrepreneurship & Commercializat, Boston, MA 02215 USA; [Stevens, Ashley J.; Jensen, Jonathan J.] Boston Univ, Sch Management, Off Technol Dev, Boston, MA 02215 USA; [Wyller, Katrine] Norwegian Radium Hosp Res Fdn, Oslo, Norway; [Kilgore, Patrick C.] Boston Univ, Sch Law, Boston, MA 02215 USA; [Chatterjee, Sabarni; Rohrbaugh, Mark L.] NIH, Off Technol Transfer, Bethesda, MD 20892 USA	Boston University; Boston University; Boston University; National Institutes of Health (NIH) - USA	Stevens, AJ (corresponding author), Boston Univ, Sch Management, Inst Technol Entrepreneurship & Commercializat, 53 Bay State Rd, Boston, MA 02215 USA.	astevens@bu.edu	Kilgore, Paul E/L-1462-2013	Kilgore, Paul E/0000-0003-3214-4482; Rohrbaugh, Mark/0000-0002-6136-3337				Allen J., 2009, TOMORROWS TECHNOL TR, V1, P21; [Anonymous], 2002, ECONOMIST, P3; [Anonymous], VACC BLOOD BIOL; [Anonymous], 2009, GAO09742; Bremer H, 2009, PATENT TRADEMAR 0814; Cockburn I, 1997, 6018 NAT BUR EC RES; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; Food and Drug Administration, DRUG APPR DAT; Food and Drug Administration, OR BOOK APPR DRUG PR; Graham B, 1978, WASHINGTON POST 0408, pM2; KAITIN KI, 1993, J CLIN PHARMACOL, V33, P412, DOI 10.1002/j.1552-4604.1993.tb04680.x; Kneller R., 2010, NAT REV DRUG DISCOV, V9, P955; Kneller R, 2010, NAT REV DRUG DISCOV, V9, P867, DOI 10.1038/nrd3251; Loise V, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001481; National Institutes of Health, EN APPR FY 2008 FY 2; Sampat BN, 2009, AM J PUBLIC HEALTH, V99, P9, DOI 10.2105/AJPH.2007.128769; Toole AA, 2008, IMPACT PUBLIC BASIC; US Food and Drug Administration (FDA), DRUGS FDA GLOSS TERM; Zycher B, 2010, AM J THER, V17, P101, DOI 10.1097/MJT.0b013e3181ca7f10	19	142	142	0	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 10	2011	364	6					535	541		10.1056/NEJMsa1008268	http://dx.doi.org/10.1056/NEJMsa1008268			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	718QH	21306239	Bronze			2022-12-28	WOS:000287139900007
J	Kaczorowski, J; Chambers, LW; Dolovich, L; Paterson, JM; Karwalajtys, T; Gierman, T; Farrell, B; McDonough, B; Thabane, L; Tu, K; Zagorski, B; Goeree, R; Levitt, CA; Hogg, W; Laryea, S; Carter, MA; Cross, D; Sabaldt, RJ				Kaczorowski, Janusz; Chambers, Larry W.; Dolovich, Lisa; Paterson, J. Michael; Karwalajtys, Tina; Gierman, Tracy; Farrell, Barbara; McDonough, Beatrice; Thabane, Lehana; Tu, Karen; Zagorski, Brandon; Goeree, Ron; Levitt, Cheryl A.; Hogg, William; Laryea, Stephanie; Carter, Megan Ann; Cross, Dana; Sabaldt, Rolf J.			Improving cardiovascular health at population level: 39 community cluster randomised trial of Cardiovascular Health Awareness Program (CHAP)	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ADMINISTRATIVE DATA; HEART-FAILURE; CLINICAL-DATA; HYPERTENSION; DISEASE; RISK; ONTARIO; BURDEN	Objective To evaluate the effectiveness of the community based Cardiovascular Health Awareness Program (CHAP) on morbidity from cardiovascular disease. Design Community cluster randomised trial. Setting 39 mid-sized communities in Ontario, Canada, stratified by location and population size. Participants Community dwelling residents aged 65 years or over, family physicians, pharmacists, volunteers, community nurses, and local lead organisations. Intervention Communities were randomised to receive CHAP (n=20) or no intervention (n=19). In CHAP communities, residents aged 65 or over were invited to attend volunteer run cardiovascular risk assessment and education sessions held in community based pharmacies over a 10 week period; automated blood pressure readings and self reported risk factor data were collected and shared with participants and their family physicians and pharmacists. Main outcome measure Composite of hospital admissions for acute myocardial infarction, stroke, and congestive heart failure among all community residents aged 65 and over in the year before compared with the year after implementation of CHAP. Results All 20 intervention communities successfully implemented CHAP. A total of 1265 three hour long sessions were held in 129/145 (89%) pharmacies during the 10 week programme. 15 889 unique participants had a total of 27 358 cardiovascular assessments with the assistance of 577 peer volunteers. After adjustment for hospital admission rates in the year before the intervention, CHAP was associated with a 9% relative reduction in the composite end point (rate ratio 0.91, 95% confidence interval 0.86 to 0.97; P=0.002) or 3.02 fewer annual hospital admissions for cardiovascular disease per 1000 people aged 65 and over. Statistically significant reductions favouring the intervention communities were seen in hospital admissions for acute myocardial infarction (rate ratio 0.87, 0.79 to 0.97; P=0.008) and congestive heart failure (0.90, 0.81 to 0.99; P=0.029) but not for stroke (0.99, 0.88 to 1.12; P=0.89). Conclusions A collaborative, multi-pronged, community based health promotion and prevention programme targeted at older adults can reduce cardiovascular morbidity at the population level.	[Kaczorowski, Janusz] Univ British Columbia, Dept Family Practice, Vancouver, BC V6T 1Z3, Canada; [Kaczorowski, Janusz; Dolovich, Lisa; Karwalajtys, Tina; Levitt, Cheryl A.; Laryea, Stephanie] McMaster Univ, Dept Family Med, Hamilton, ON L8S 4L8, Canada; [Kaczorowski, Janusz] Child & Family Res Inst, Vancouver, BC, Canada; [Chambers, Larry W.; Farrell, Barbara; Hogg, William] Elisabeth Bruyere Res Inst, Inst Rech, Ottawa, ON, Canada; [Gierman, Tracy; Cross, Dana] Univ Ottawa, Acad Hlth Council, Ottawa, ON, Canada; [Dolovich, Lisa; Thabane, Lehana; Goeree, Ron] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON L8S 4L8, Canada; [Dolovich, Lisa; Sabaldt, Rolf J.] McMaster Univ, Dept Med, Hamilton, ON L8S 4L8, Canada; [Paterson, J. Michael; Tu, Karen; Zagorski, Brandon] Inst Clin Evaluat Sci, Toronto, ON, Canada; [Farrell, Barbara; Hogg, William] Univ Ottawa, Dept Family Med, Ottawa, ON K1N 6N5, Canada; [Hogg, William; Carter, Megan Ann] Univ Ottawa, Inst Populat Hlth, Ottawa, ON K1N 6N5, Canada	University of British Columbia; McMaster University; Child & Family Research Institute; University of Ottawa; University of Ottawa; McMaster University; McMaster University; University of Toronto; University of Ottawa; University of Ottawa	Kaczorowski, J (corresponding author), Univ British Columbia, Dept Family Practice, 320-5950 Univ Blvd, Vancouver, BC V6T 1Z3, Canada.	Janusz.kaczorowski@familymed.ubc.ca	Chambers, Larry W/AAI-4959-2020; Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285; Dolovich, Lisa/0000-0002-0061-6783; Tu, Karen/0000-0003-0883-4934	Canadian Stroke Network; Ontario Ministry of Health Promotion-Ontario Stroke System; Ontario Ministry of Health and Long-Term Care (MOHLTC)	Canadian Stroke Network; Ontario Ministry of Health Promotion-Ontario Stroke System; Ontario Ministry of Health and Long-Term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario)	The study was funded in part by the Canadian Stroke Network and the Ontario Ministry of Health Promotion-Ontario Stroke System. The Canadian Stroke Network is a part of the federal government supported "Networks of Centres of Excellence," whose purpose is to mobilise and support the best stroke research talent in Canada. The Government of Ontario, Ministry of Health Promotion, provided support for the mobilisation and implementation of CHAP, including salaries of the local CHAP coordinators in each of the 20 intervention communities. This study was supported by the Institute for Clinical Evaluative Sciences (ICES), a non-profit research corporation funded by the Ontario Ministry of Health and Long-Term Care (MOHLTC). The opinions, results, and conclusions are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred.	[Anonymous], 2005, PREV CHRON DIS VIT I; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Bibbins-Domingo K, 2010, NEW ENGL J MED, V362, P590, DOI 10.1056/NEJMoa0907355; Carter M, 2009, HEALTH PROMOT INT, V24, P325, DOI 10.1093/heapro/dap030; Chambers LW, 2005, CAN J PUBLIC HEALTH, V96, P294, DOI 10.1007/BF03405169; Flodgren G, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000125.pub4, 10.1002/14651858.CD000125]; Humphries KH, 2000, J CLIN EPIDEMIOL, V53, P343, DOI 10.1016/S0895-4356(99)00188-2; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Johns Hopkins University School of Hygiene and Public Health, 1997, J HOPK U ACG CAS MIX; Jones C, 2008, CAN J CARDIOL, V24, P561, DOI 10.1016/S0828-282X(08)70634-2; Kaczorowski J, 2008, PREV MED, V46, P537, DOI 10.1016/j.ypmed.2008.02.005; Karwalajtys T, 2009, J COMMUN HEALTH, V34, P336, DOI 10.1007/s10900-009-9149-5; Kralj B, 2000, ONTARIO MED REV, V67, P33; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Lee DS, 2005, MED CARE, V43, P182, DOI 10.1097/00005650-200502000-00012; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mackay DF, 2010, HEART, V96, P1525, DOI 10.1136/hrt.2010.199026; McCullough PA, 2002, J AM COLL CARDIOL, V39, P60, DOI 10.1016/S0735-1097(01)01700-4; Parker DR, 2005, PRIMARY CARE, V32, P865, DOI 10.1016/j.pop.2005.09.012; Pennant M, 2010, AM J EPIDEMIOL, V172, P501, DOI 10.1093/aje/kwq171; RODGERS A, 2002, WORLD HLTH REPORT 20; Rose G., 1992, STRATEGY PREVENTIVE; Sundararajan V, 2004, J CLIN EPIDEMIOL, V57, P1288, DOI 10.1016/j.jclinepi.2004.03.012; Thompson B, 2003, ANNU REV PUBL HEALTH, V24, P315, DOI 10.1146/annurev.publhealth.24.100901.140819; Tirschwell DL, 2002, STROKE, V33, P2465, DOI 10.1161/01.STR.0000032240.28636.BD; Tu K, 2002, AM J MED, V113, P52, DOI 10.1016/S0002-9343(02)01144-0; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; WHO, 2003, PREV REC HEART ATT S	29	100	104	0	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 7	2011	342								d442	10.1136/bmj.d442	http://dx.doi.org/10.1136/bmj.d442			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	722AF	21300712	hybrid, Green Submitted, Green Published			2022-12-28	WOS:000287400200003
J	Hassan, M; Tajunisah, I				Hassan, Mohd; Tajunisah, Iqbal			Valsalva haemorrhagic retinopathy after push-ups	LANCET			English	Editorial Material									[Hassan, Mohd; Tajunisah, Iqbal] Univ Malaya, Fac Med, Dept Ophthalmol, Kuala Lumpur 50603, Malaysia	Universiti Malaya	Tajunisah, I (corresponding author), Univ Malaya, Fac Med, Dept Ophthalmol, Kuala Lumpur 50603, Malaysia.	tajun69@yahoo.com	iqbal, tajunisah/U-8032-2017	iqbal, tajunisah/0000-0001-7474-7770					0	8	8	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 5	2011	377	9764					504	504		10.1016/S0140-6736(10)60677-0	http://dx.doi.org/10.1016/S0140-6736(10)60677-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	721TX	21255827				2022-12-28	WOS:000287381800031
J	Bjorndal, KA; Bowen, BW; Chaloupka, M; Crowder, LB; Heppell, SS; Jones, CM; Lutcavage, ME; Policansky, D; Solow, AR; Witherington, BE				Bjorndal, Karen A.; Bowen, Brian W.; Chaloupka, Milani; Crowder, Larry B.; Heppell, Selina S.; Jones, Cynthia M.; Lutcavage, Molly E.; Policansky, David; Solow, Andrew R.; Witherington, Blair E.			Better Science Needed for Restoration in the Gulf of Mexico	SCIENCE			English	Editorial Material							LOGGERHEAD SEA-TURTLE; CLIMATE-CHANGE; POPULATION; ECOSYSTEMS; MARINE; ECOLOGISTS		[Bjorndal, Karen A.] Univ Florida, Archie Carr Ctr Sea Turtle Res, Gainesville, FL 32611 USA; [Bjorndal, Karen A.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Bowen, Brian W.] Univ Hawaii, Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA; [Chaloupka, Milani] Univ Queensland, Ecol Modelling Serv Pty Ltd, St Lucia, Qld 4067, Australia; [Crowder, Larry B.] Duke Univ, Marine Lab, Ctr Marine Conservat, Beaufort, NC 28516 USA; [Heppell, Selina S.] Oregon State Univ, Dept Wildlife & Fisheries, Corvallis, OR 97331 USA; [Jones, Cynthia M.] Old Dominion Univ, Ctr Quantitat Fisheries Ecol, Norfolk, VA 23529 USA; [Lutcavage, Molly E.] Univ Massachusetts, Dept Environm Conservat, Large Pelag Res Ctr, Gloucester, MA 01930 USA; [Policansky, David] CNR, Washington, DC 20001 USA; [Witherington, Blair E.] Florida Fish & Wildlife Conservat Commiss, Melbourne Beach, FL 32951 USA; [Solow, Andrew R.] Woods Hole Oceanog Inst, Marine Policy Ctr, Woods Hole, MA 02543 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; University of Hawaii System; University of Queensland; Duke University; Oregon State University; Old Dominion University; University of Massachusetts System; Florida Fish & Wildlife Conservation Commission; Woods Hole Oceanographic Institution	Bjorndal, KA (corresponding author), Univ Florida, Archie Carr Ctr Sea Turtle Res, Gainesville, FL 32611 USA.	bjorndal@ufl.edu		Bjorndal, Karen/0000-0002-6286-1901				Bolker BM, 2007, MOL ECOL, V16, P685, DOI 10.1111/j.1365-294X.2006.03161.x; Bolten AB, 2011, FRONT ECOL ENVIRON, V9, P295, DOI 10.1890/090126; BOWEN BW, 1994, SCIENCE, V266, P713, DOI 10.1126/science.7973619; BOWEN BW, 1996, NOAA TECH MEMO NMFS, V396, P1; *BP, FUNDS BP INCLUDE  50; Carr MH, 2003, ECOL APPL, V13, pS90; Chaloupka M, 2003, LOGGERHEAD SEA TURTL, P274; Chaloupka M, 2008, J EXP MAR BIOL ECOL, V356, P136, DOI 10.1016/j.jembe.2007.12.009; Contreras JL, 2010, SCIENCE, V329, P393, DOI 10.1126/science.1189253; Ellison AM, 2010, FRONT ECOL ENVIRON, V8, P362, DOI 10.1890/080209; Finkelstein M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002480; Galuardi B, 2010, CAN J FISH AQUAT SCI, V67, P966, DOI 10.1139/F10-033; Graham B., 2011, NATL COMMISSION BP D; Harrison A., 2006, CONNECTIVITY CONSERV, V14, P213; Heppell SS, 2000, ECOLOGY, V81, P654, DOI 10.1890/0012-9658(2000)081[0654:LHAEPP]2.0.CO;2; Hoegh-Guldberg O, 2010, SCIENCE, V328, P1523, DOI 10.1126/science.1189930; Hoekstra JM, 2002, ECOL APPL, V12, P630, DOI 10.1890/1051-0761(2002)012[0630:ACROES]2.0.CO;2; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; Lehodey P, 2010, PROG OCEANOGR, V84, P69, DOI 10.1016/j.pocean.2009.09.008; LIMPUS CJ, 2010, CHALOUPKA LED DATA C; Lutcavage Molly E., 1997, P387; *NAT RES COUNC, 2010, ASS SEA IURTL STAT T; Nielsen J.L., 2009, TAGGING TRACKING MAR, V9; *OC POL TASK FORC, 2010, FIN REC INT OC POL T; Paine RT, 1996, ANNU REV ECOL SYST, V27, P197, DOI 10.1146/annurev.ecolsys.27.1.197; Selkoe KA, 2006, ECOL LETT, V9, P615, DOI 10.1111/j.1461-0248.2006.00889.x; Witherington B, 2009, ECOL APPL, V19, P30, DOI 10.1890/08-0434.1	27	56	61	4	71	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					537	538		10.1126/science.1199935	http://dx.doi.org/10.1126/science.1199935			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292956				2022-12-28	WOS:000286933600030
J	Cole-Turner, R				Cole-Turner, Ronald			What Defines Us?	SCIENCE			English	Editorial Material									Pittsburgh Theol Seminary, Pittsburgh, PA USA		Cole-Turner, R (corresponding author), Pittsburgh Theol Seminary, Pittsburgh, PA USA.								0	0	0	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					548	548		10.1126/science.1203070	http://dx.doi.org/10.1126/science.1203070			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292967				2022-12-28	WOS:000286933600041
J	Gibbs, RA				Gibbs, Richard A.			Bringing Genomics and Genetics Back Together	SCIENCE			English	Editorial Material									[Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Gibbs, RA (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.				NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NHGRI NIH HHS [U54 HG003273] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))			0	1	1	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 4	2011	331	6017					548	548		10.1126/science.1203017	http://dx.doi.org/10.1126/science.1203017			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	715ZE	21292968	Green Accepted			2022-12-28	WOS:000286933600043
J	Axon, RN; Williams, MV				Axon, R. Neal; Williams, Mark V.			Hospital Readmission as an Accountability Measure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INPATIENT CARE; QUALITY; ASSOCIATION		[Axon, R. Neal] Ralph H Johnson VAMC, Ctr Dis Prevent & Hlth Intervent Diverse Populat, Charleston, SC USA; [Axon, R. Neal] Med Univ S Carolina, Div Gen Internal Med & Geriatr, Charleston, SC USA; [Williams, Mark V.] Northwestern Univ, Feinberg Sch Med, Div Hosp Med, Chicago, IL 60611 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina; Northwestern University; Feinberg School of Medicine	Axon, RN (corresponding author), 135 Rutledge Ave,MSC 591, Charleston, SC 29425 USA.	axon@musc.edu		Williams, Mark V/0000-0001-6107-0457				[Anonymous], HOSP CAR OUTC EFF ME; ASHTON CM, 1995, ANN INTERN MED, V122, P415, DOI 10.7326/0003-4819-122-6-199503150-00003; Ashton CM, 1997, MED CARE, V35, P1044, DOI 10.1097/00005650-199710000-00006; Benbassat J, 2000, ARCH INTERN MED, V160, P1074, DOI 10.1001/archinte.160.8.1074; Chassin MR, 2010, NEW ENGL J MED, V363, P683, DOI 10.1056/NEJMsb1002320; Coleman EA, 2006, ARCH INTERN MED, V166, P1822, DOI 10.1001/archinte.166.17.1822; Gorodeski EZ, 2010, NEW ENGL J MED, V363, P297, DOI 10.1056/NEJMc1001882; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Keenan PS, 2008, CIRC-CARDIOVASC QUAL, V1, P29, DOI 10.1161/CIRCOUTCOMES.108.802686; *MED PAYM ADV COMM, 2007, MED PAYM POL	10	298	299	0	27	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 2	2011	305	5					504	505		10.1001/jama.2011.72	http://dx.doi.org/10.1001/jama.2011.72			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	714LI	21285430				2022-12-28	WOS:000286810700026
J	Radford, T				Radford, Tim			Of course scientists can communicate	NATURE			English	Editorial Material												tim.radford@guardian.co.uk							0	8	8	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 27	2011	469	7331					445	445		10.1038/469445a	http://dx.doi.org/10.1038/469445a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	711MU	21270851	Bronze			2022-12-28	WOS:000286596500001
J	Abdul-Wahab, A; Banerjee, P				Abdul-Wahab, A; Banerjee, P			Picture Quiz An odd eruption The most likely diagnosis is cutaneous sarcoidosis	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Hosp Lewisham, Dept Dermatol, London, England	University of London; King's College London	Abdul-Wahab, A (corresponding author), Univ Hosp Lewisham, Dept Dermatol, London, England.	alyawahab@gmail.com						Ball NJ, 2004, J CUTAN PATHOL, V31, P160, DOI 10.1111/j.0303-6987.2004.00157.x; COLLIN B, CLIN EXP DERMATOL; Doherty CB, 2008, DRUGS, V68, P1361, DOI 10.2165/00003495-200868100-00003; Katoh N, 2002, BRIT J DERMATOL, V147, P154, DOI 10.1046/j.1365-2133.2002.04727.x; Lodha S, 2009, CHEST, V136, P583, DOI 10.1378/chest.08-1527; VEIEN NK, 1987, J AM ACAD DERMATOL, V16, P534, DOI 10.1016/S0190-9622(87)70070-X	6	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2011	342								c6845	10.1136/bmj.c6845	http://dx.doi.org/10.1136/bmj.c6845			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715ME	21270091				2022-12-28	WOS:000286887800018
J	Notta, F; Mullighan, CG; Wang, JCY; Poeppl, A; Doulatov, S; Phillips, LA; Ma, J; Minden, MD; Downing, JR; Dick, JE				Notta, Faiyaz; Mullighan, Charles G.; Wang, Jean C. Y.; Poeppl, Armando; Doulatov, Sergei; Phillips, Letha A.; Ma, Jing; Minden, Mark D.; Downing, James R.; Dick, John E.			Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; INTRAFEMORAL TRANSPLANTATION; PANCREATIC-CANCER; CLONAL EVOLUTION; NUMBER; GENOME; HETEROGENEITY; DELETION; ENGRAFTMENT; METASTASIS	Many tumours are composed of genetically diverse cells; however, little is known about how diversity evolves or the impact that diversity has on functional properties. Here, using xenografting and DNA copy number alteration (CNA) profiling of human BCR-ABL1 lymphoblastic leukaemia, we demonstrate that genetic diversity occurs in functionally defined leukaemia-initiating cells and that many diagnostic patient samples contain multiple genetically distinct leukaemia-initiating cell subclones. Reconstructing the subclonal genetic ancestry of several samples by CNA profiling demonstrated a branching multi-clonal evolution model of leukaemogenesis, rather than linear succession. For some patient samples, the predominant diagnostic clone repopulated xenografts, whereas in others it was outcompeted by minor subclones. Reconstitution with the predominant diagnosis clone was associated with more aggressive growth properties in xenografts, deletion of CDKN2A and CDKN2B, and a trend towards poorer patient outcome. Our findings link clonal diversity with leukaemia-initiating-cell function and underscore the importance of developing therapies that eradicate all intratumoral subclones.	[Notta, Faiyaz; Wang, Jean C. Y.; Poeppl, Armando; Doulatov, Sergei; Dick, John E.] Ontario Canc Inst, Campbell Family Inst Canc Res, Div Stem Cell & Dev Biol, Toronto, ON M5G 1L7, Canada; [Notta, Faiyaz; Doulatov, Sergei; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada; [Mullighan, Charles G.; Phillips, Letha A.; Downing, James R.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA; [Wang, Jean C. Y.; Minden, Mark D.] Princess Margaret Hosp, Dept Med Oncol & Hematol, Toronto, ON M5G 2M9, Canada; [Wang, Jean C. Y.; Minden, Mark D.] Univ Toronto, Dept Med, Toronto, ON M5G 2M9, Canada; [Ma, Jing] St Jude Childrens Hosp, Hartwell Ctr Bioinformat & Biotechnol, Memphis, TN 38105 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; St Jude Children's Research Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; St Jude Children's Research Hospital	Dick, JE (corresponding author), Ontario Canc Inst, Campbell Family Inst Canc Res, Div Stem Cell & Dev Biol, Toronto, ON M5G 1L7, Canada.	jdick@uhnres.utoronto.ca	Mullighan, Charles/H-3253-2011; Downing, James R./N-8102-2018	Mullighan, Charles/0000-0002-1871-1850; Wang, Jean/0000-0001-7543-3917; Dick, John/0000-0002-9527-8317	Canadian Institutes for Health Research (CIHR); Pew Charitable Trusts; Stem Cell Network of Canadian National Centres of Excellence; Canadian Cancer Society; Terry Fox Foundation, Genome Canada through the Ontario Genomics Institute; Ontario Institute for Cancer Research; province of Ontario; Leukemia and Lymphoma Society; Canadian Institutes for Health Research; Canada Research Chair; American and Lebanese Syrian Associated Charities of St Jude Children's Research Hospital; Ontario Ministry of Health and Long Term Care (OMOHLTC)	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Pew Charitable Trusts; Stem Cell Network of Canadian National Centres of Excellence; Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Foundation, Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Institute for Cancer Research; province of Ontario; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); American and Lebanese Syrian Associated Charities of St Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario)	We would like to thank S. Minkin for statistical analysis of patient outcome, the Dick Laboratory and B. Neel for critical review of this manuscript, M. Cooper for editorial assistance, and P. A. Penttila, L. Jamieson, J. Yuan and S. Zhao for preparative flow cytometry. This work was supported by funds from Canadian Institutes for Health Research (CIHR) studentships (F.N., S.D.), the Pew Charitable Trusts (C.G.M.), The Stem Cell Network of Canadian National Centres of Excellence, the Canadian Cancer Society and the Terry Fox Foundation, Genome Canada through the Ontario Genomics Institute, Ontario Institute for Cancer Research with funds from the province of Ontario, the Leukemia and Lymphoma Society, the Canadian Institutes for Health Research, a Canada Research Chair, and the American and Lebanese Syrian Associated Charities of St Jude Children's Research Hospital. This research was funded in part by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC.	Barrett MT, 1999, NAT GENET, V22, P106, DOI 10.1038/8816; Bateman CM, 2010, BLOOD, V115, P3553, DOI 10.1182/blood-2009-10-251413; BRUCE WR, 1963, NATURE, V199, P79, DOI 10.1038/199079a0; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Dick JE, 2009, NAT BIOTECHNOL, V27, P44, DOI 10.1038/nbt0109-44; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Diehn M, 2009, SEMIN RADIAT ONCOL, V19, P78, DOI 10.1016/j.semradonc.2008.11.002; Ding L, 2010, NATURE, V464, P999, DOI 10.1038/nature08989; Greaves M, 2010, SEMIN CANCER BIOL, V20, P65, DOI 10.1016/j.semcancer.2010.03.002; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Li AH, 2003, BLOOD, V102, P4520, DOI 10.1182/blood-2003-05-1455; Lin M, 2004, BIOINFORMATICS, V20, P1233, DOI 10.1093/bioinformatics/bth069; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Notta F, 2010, BLOOD, V115, P3704, DOI 10.1182/blood-2009-10-249326; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Park SY, 2010, J CLIN INVEST, V120, P636, DOI 10.1172/JCI40724; Pearce DJ, 2006, BLOOD, V107, P1166, DOI 10.1182/blood-2005-06-2325; Pounds S, 2009, BIOINFORMATICS, V25, P315, DOI 10.1093/bioinformatics/btn624; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Tehranchi R, 2010, NEW ENGL J MED, V363, P1025, DOI 10.1056/NEJMoa0912228; Williams RT, 2007, GENE DEV, V21, P2283, DOI 10.1101/gad.1588607; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; Zuna J, 2004, CLIN CANCER RES, V10, P5355, DOI 10.1158/1078-0432.CCR-04-0584	34	360	374	0	31	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					362	+		10.1038/nature09733	http://dx.doi.org/10.1038/nature09733			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248843				2022-12-28	WOS:000286385600044
J	Cao, Y; Jin, XS; Huang, H; Derebe, MG; Levin, EJ; Kabaleeswaran, V; Pan, YP; Punta, M; Love, J; Weng, J; Quick, M; Ye, S; Kloss, B; Bruni, R; Martinez-Hackert, E; Hendrickson, WA; Rost, B; Javitch, JA; Rajashankar, KR; Jiang, YX; Zhou, M				Cao, Yu; Jin, Xiangshu; Huang, Hua; Derebe, Mehabaw Getahun; Levin, Elena J.; Kabaleeswaran, Venkataraman; Pan, Yaping; Punta, Marco; Love, James; Weng, Jun; Quick, Matthias; Ye, Sheng; Kloss, Brian; Bruni, Renato; Martinez-Hackert, Erik; Hendrickson, Wayne A.; Rost, Burkhard; Javitch, Jonathan A.; Rajashankar, Kanagalaghatta R.; Jiang, Youxing; Zhou, Ming			Crystal structure of a potassium ion transporter, TrkH	NATURE			English	Article							K+-UPTAKE SYSTEM; ESCHERICHIA-COLI; CATION-TRANSPORT; GLYCINE RESIDUES; LIGHT-SCATTERING; HIGH-AFFINITY; KTRAB SYSTEM; PROTEIN TRKA; CHANNEL; SELECTIVITY	The TrkH/TrkG/KtrB proteins mediate K+ uptake in bacteria and probably evolved from simple K+ channels by multiple gene duplications or fusions. Here we present the crystal structure of a TrkH from Vibrio parahaemolyticus. TrkH is a homodimer, and each protomer contains an ion permeation pathway. A selectivity filter, similar in architecture to those of K+ channels but significantly shorter, is lined by backbone and side-chain oxygen atoms. Functional studies showed that TrkH is selective for permeation of K+ and Rb+ over smaller ions such as Na+ or Li+. Immediately intracellular to the selectivity filter are an intramembrane loop and an arginine residue, both highly conserved, which constrict the permeation pathway. Substituting the arginine with an alanine significantly increases the rate of K+ flux. These results reveal the molecular basis of K+ selectivity and suggest a novel gating mechanism for this large and important family of membrane transport proteins.	[Cao, Yu; Huang, Hua; Levin, Elena J.; Kabaleeswaran, Venkataraman; Pan, Yaping; Weng, Jun; Zhou, Ming] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA; [Jin, Xiangshu] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Derebe, Mehabaw Getahun; Ye, Sheng; Jiang, Youxing] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Derebe, Mehabaw Getahun; Ye, Sheng; Jiang, Youxing] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Punta, Marco; Love, James; Kloss, Brian; Bruni, Renato; Rost, Burkhard] New York Struct Biol Ctr, NewYork Consortium Membrane Prot Struct, New York, NY 10027 USA; [Punta, Marco; Rost, Burkhard] Tech Univ Munich, Dept Comp Sci, D-85748 Munich, Germany; [Punta, Marco; Rost, Burkhard] Tech Univ Munich, Inst Adv Study, D-85748 Munich, Germany; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ, Ctr Mol Recognit, New York, NY 10032 USA; [Quick, Matthias; Javitch, Jonathan A.] Columbia Univ, Dept Psychiat, New York, NY 10032 USA; [Quick, Matthias] New York State Psychiat Inst & Hosp, Div Mol Therapeut, New York, NY 10032 USA; [Javitch, Jonathan A.] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, NE CAT, Adv Photon Source, Dept Chem & Chem Biol, Argonne, IL 60439 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Technical University of Munich; Technical University of Munich; Columbia University; Columbia University; New York State Psychiatry Institute; Columbia University; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Zhou, M (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, 630 W 168th St, New York, NY 10032 USA.	mz2140@columbia.edu	Punta, Marco/ABH-4698-2020; Cao, Yu/GNP-6653-2022; Rost, Burkhard/A-1908-2016	Punta, Marco/0000-0002-0050-0676; Cao, Yu/0000-0003-1409-2068; Rost, Burkhard/0000-0003-0179-8424; Kloss, Brian/0000-0003-0130-8739; Javitch, Jonathan/0000-0001-7395-2967; Jin, Xiangshu/0000-0002-6551-8850; Bruni, Renato/0000-0002-2312-0254; Martinez-Hackert, Erik/0000-0002-6182-7023	U.S. National Institutes of Health [HL086392, DK088057, GM05026-sub0007]; American Heart Association [0630148N]; National Institute of General Medical Sciences [GM05026]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK088057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Data for this study were measured at beamlines X4A, X4C, X25 and X29 of the National Synchrotron Light Source and the NE-CAT 24ID-C and E at the Advanced Photon Source. This work was supported by the U.S. National Institutes of Health (grants HL086392, DK088057 and GM05026-sub0007 to M. Z.) and the American Heart Association (0630148N to M. Z.). M. Z is a Pew Scholar in Biomedical Sciences. The New York Consortium on Membrane Protein Structure central facility is supported by grant GM05026 to W. A. H. aspart of the Protein Structure Initiative (PSI-2) established by the National Institute of General Medical Sciences. We thank B. Honig for support, K. Jung for providing E. coli LB650, and J. Morais-Cabral, S.-Y. Lee, H. R. Guy, C. L. Slayman and E. P. Bakker for discussions and comments on the manuscript. M. Z. is grateful to R. MacKinnon for advice and support throughout the project.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albright RA, 2007, J BIOL CHEM, V282, P35046, DOI 10.1074/jbc.M704260200; Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; Alkhuder K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008966; BAKKER EP, 1981, J BACTERIOL, V147, P820, DOI 10.1128/JB.147.3.820-826.1981; BOSSEMEYER D, 1989, J BIOL CHEM, V264, P16403; Cowtan K, 1999, ACTA CRYSTALLOGR D, V55, P1555, DOI 10.1107/S0907444999007416; Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Durell SR, 2000, BIOPHYS J, V78, P188, DOI 10.1016/S0006-3495(00)76584-2; Durell SR, 1999, BIOPHYS J, V77, P775, DOI 10.1016/S0006-3495(99)76931-6; Durell SR, 1999, BIOPHYS J, V77, P789, DOI 10.1016/S0006-3495(99)76932-8; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EPSTEIN W, 1971, J BACTERIOL, V108, P639, DOI 10.1128/JB.108.2.639-644.1971; Hanelt I, 2010, J BIOL CHEM, V285, P10318, DOI 10.1074/jbc.M109.089870; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Heginbotham L, 1998, J GEN PHYSIOL, V111, P741, DOI 10.1085/jgp.111.6.741; HENDRICKSON WA, 1991, SCIENCE, V254, P51, DOI 10.1126/science.1925561; Hille B., 2001, ION CHANNELS EXCITAB; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; Kato N, 2007, CHANNELS, V1, P161, DOI 10.4161/chan.4374; Kendrick BS, 2001, ANAL BIOCHEM, V299, P136, DOI 10.1006/abio.2001.5411; KROLL RG, 1981, BIOCHEM J, V198, P691, DOI 10.1042/bj1980691; LeMasurier M, 2001, J GEN PHYSIOL, V118, P303, DOI 10.1085/jgp.118.3.303; Li RA, 2001, J BIOL CHEM, V276, P11072, DOI 10.1074/jbc.M010862200; Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121; Love James, 2010, Journal of Structural and Functional Genomics, V11, P191, DOI 10.1007/s10969-010-9094-7; Maser P, 2002, P NATL ACAD SCI USA, V99, P6428, DOI 10.1073/pnas.082123799; MIKAMI A, 1989, NATURE, V340, P230, DOI 10.1038/340230a0; Morais-Cabral JH, 2001, NATURE, V414, P37, DOI 10.1038/35102000; Nakamura T, 1998, J BACTERIOL, V180, P3491, DOI 10.1128/JB.180.13.3491-3494.1998; NODA M, 1984, NATURE, V312, P121, DOI 10.1038/312121a0; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PLACK RH, 1980, J BIOL CHEM, V255, P3824; Punta Marco, 2009, Journal of Structural and Functional Genomics, V10, P255, DOI 10.1007/s10969-009-9071-1; Roosild TP, 2009, STRUCTURE, V17, P893, DOI 10.1016/j.str.2009.03.018; Roosild TP, 2002, CELL, V109, P781, DOI 10.1016/S0092-8674(02)00768-7; Roux B, 1999, SCIENCE, V285, P100, DOI 10.1126/science.285.5424.100; SCHLOSSER A, 1993, MOL MICROBIOL, V9, P533, DOI 10.1111/j.1365-2958.1993.tb01714.x; SCHLOSSER A, 1995, J BACTERIOL, V177, P1908, DOI 10.1128/jb.177.7.1908-1910.1995; SCHULTZ SG, 1963, J GEN PHYSIOL, V47, P329, DOI 10.1085/jgp.47.2.329; Shi N, 2006, NATURE, V440, P570, DOI 10.1038/nature04508; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Stary A, 2008, CHANNELS, V2, P210, DOI 10.4161/chan.2.3.6158; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; Stumpe S, 1997, ARCH MICROBIOL, V167, P126, DOI 10.1007/s002030050425; Tholema N, 2005, J BIOL CHEM, V280, P41146, DOI 10.1074/jbc.M507647200; Tholema N, 1999, FEBS LETT, V450, P217, DOI 10.1016/S0014-5793(99)00504-9; Zeng GF, 2004, J BIOL CHEM, V279, P3003, DOI 10.1074/jbc.M309760200; Zhou M, 2004, J MOL BIOL, V338, P839, DOI 10.1016/j.jmb.2004.03.020; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	53	101	106	0	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 17	2011	471	7338					336	+		10.1038/nature09731	http://dx.doi.org/10.1038/nature09731			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	735UE	21317882	Green Accepted			2022-12-28	WOS:000288444000036
J	Jost, TS				Jost, Timothy Stoltzfus			Can Congress Regulate "Inactivity" (and Make Americans Buy Health Insurance)?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA	Washington & Lee University	Jost, TS (corresponding author), Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA.							Hall MA, 2011, NEW ENGL J MED, V364, P793, DOI 10.1056/NEJMp1101252; JOST TM, 2011, HLTH AFFAIRS BL 0201	2	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 3	2011	364	9								10.1056/NEJMp1101400	http://dx.doi.org/10.1056/NEJMp1101400			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	729DJ	21323534				2022-12-28	WOS:000287928400004
J	Sahin, E; Colla, S; Liesa, M; Moslehi, J; Muller, FL; Guo, MR; Cooper, M; Kotton, D; Fabian, AJ; Walkey, C; Maser, RS; Tonon, G; Foerster, F; Xiong, R; Wang, YA; Shukla, SA; Jaskelioff, M; Martin, ES; Heffernan, TP; Protopopov, A; Ivanova, E; Mahoney, JE; Kost-Alimova, M; Perry, SR; Bronson, R; Liao, RL; Mulligan, R; Shirihai, OS; Chin, L; DePinho, RA				Sahin, Erguen; Colla, Simona; Liesa, Marc; Moslehi, Javid; Mueller, Florian L.; Guo, Mira; Cooper, Marcus; Kotton, Darrell; Fabian, Attila J.; Walkey, Carl; Maser, Richard S.; Tonon, Giovanni; Foerster, Friedrich; Xiong, Robert; Wang, Y. Alan; Shukla, Sachet A.; Jaskelioff, Mariela; Martin, Eric S.; Heffernan, Timothy P.; Protopopov, Alexei; Ivanova, Elena; Mahoney, John E.; Kost-Alimova, Maria; Perry, Samuel R.; Bronson, Roderick; Liao, Ronglih; Mulligan, Richard; Shirihai, Orian S.; Chin, Lynda; DePinho, Ronald A.			Telomere dysfunction induces metabolic and mitochondrial compromise	NATURE			English	Article							HEART-FAILURE; STEM-CELLS; DAMAGE; LEADS; PGC-1-ALPHA; MICE; COACTIVATORS; HOMEOSTASIS; BIOGENESIS; CARCINOMA	Telomere dysfunction activates p53-mediated cellular growth arrest, senescence and apoptosis to drive progressive atrophy and functional decline in high-turnover tissues. The broader adverse impact of telomere dysfunction across many tissues including more quiescent systems prompted transcriptomic network analyses to identify common mechanisms operative in haematopoietic stem cells, heart and liver. These unbiased studies revealed profound repression of peroxisome proliferator-activated receptor gamma, coactivator 1 alpha and beta (PGC-1 alpha and PGC-1 beta, also known as Ppargc1a and Ppargc1b, respectively) and the downstream network in mice null for either telomerase reverse transcriptase (Tert) or telomerase RNA component (Terc) genes. Consistent with PGCs as master regulators of mitochondrial physiology and metabolism, telomere dysfunction is associated with impaired mitochondrial biogenesis and function, decreased gluconeogenesis, cardiomyopathy, and increased reactive oxygen species. In the setting of telomere dysfunction, enforced Tert or PGC-1a expression or germline deletion of p53 (also known as Trp53) substantially restores PGC network expression, mitochondrial respiration, cardiac function and gluconeogenesis. We demonstrate that telomere dysfunction activates p53 which in turn binds and represses PGC-1 alpha and PGC-1 beta promoters, thereby forging a direct link between telomere and mitochondrial biology. We propose that this telomere-p53-PGC axis contributes to organ and metabolic failure and to diminishing organismal fitness in the setting of telomere dysfunction.	[Sahin, Erguen; Colla, Simona; Mueller, Florian L.; Maser, Richard S.; Tonon, Giovanni; Foerster, Friedrich; Xiong, Robert; Wang, Y. Alan; Shukla, Sachet A.; Jaskelioff, Mariela; Martin, Eric S.; Heffernan, Timothy P.; Protopopov, Alexei; Ivanova, Elena; Mahoney, John E.; Kost-Alimova, Maria; Perry, Samuel R.; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA; [Sahin, Erguen; Colla, Simona; Moslehi, Javid; Mueller, Florian L.; Maser, Richard S.; Tonon, Giovanni; Foerster, Friedrich; Jaskelioff, Mariela; Martin, Eric S.; Chin, Lynda; DePinho, Ronald A.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Liesa, Marc; Kotton, Darrell; Shirihai, Orian S.] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Moslehi, Javid; Liao, Ronglih; DePinho, Ronald A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Guo, Mira] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Cooper, Marcus] Univ Massachusetts, Div Cardiovasc Med, Worcester, MA 01605 USA; [Fabian, Attila J.; Mulligan, Richard; DePinho, Ronald A.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Walkey, Carl] Univ Melbourne, St Vincents Hosp, St Vincents Inst, Victoria 3065, Australia; [Walkey, Carl] Univ Melbourne, St Vincents Hosp, Dept Med, Victoria 3065, Australia; [Bronson, Roderick] Harvard Univ, Sch Med, Rodent Histopathol Lab, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Boston University; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; University of Massachusetts System; University of Massachusetts Worcester; Harvard University; Harvard Medical School; St Vincent's Hospital Melbourne; St. Vincent's Institute of Medical Research; University of Melbourne; St Vincent's Hospital Melbourne; University of Melbourne; Harvard University; Harvard Medical School	DePinho, RA (corresponding author), Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA 02115 USA.	ron_depinho@dfci.harvard.edu	Walkley, Carl/AAO-6021-2020; Maser, Richard/B-2970-2012; Tonon, Giovanni/J-9804-2018; Liesa, Marc/K-8590-2019	Walkley, Carl/0000-0002-4784-9031; Tonon, Giovanni/0000-0003-2973-5038; Liesa, Marc/0000-0002-5909-8570; Kotton, Darrell/0000-0002-9604-8476; Muller, Florian/0000-0001-7568-2948; DePinho, Ronald/0000-0002-5625-577X; Mahoney, John (Jed)/0000-0001-9414-9110; Ivanova, Elena/0000-0002-5069-4974; Colla, Simona/0000-0001-6583-8910; Shirihai, Orian/0000-0002-9502-2661	Deutsche Forschungsgemeinschaft; NIH National Cancer Institute; Robert A. and Renee E. Belfer Foundation; Ellison Foundation; American Cancer Society; Fundacion Ramon Areces; NATIONAL CANCER INSTITUTE [R01CA084628] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK063356, U24DK059635, R01DK056690, R01DK089185, R01DK035914, P30DK046200, P30DK079638] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Robert A. and Renee E. Belfer Foundation; Ellison Foundation(Lawrence Ellison Foundation); American Cancer Society(American Cancer Society); Fundacion Ramon Areces; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank C. Bianchi, J. Moriarty, K. Marmon and E. Thompson for excellent mouse husbandry and care. We are grateful to B. Spiegelman, P. Puigserver, J. E. Dominy and J. L. Estall for providing Ad-PGC-1 alpha and Ad-GFP virus and helpful comments on the manuscript. We thank G. I. Evan for the p53-ER construct. We appreciate input, critical comments and helpful discussions from many DePinho/Chin lab members, in particular A.-J. Chen, C. Khoo, R. Carrasco, A. Kimmelman, S. Quayle, D. Liu and R. Wiedemeyer. We acknowledge the services of the Mouse Metabolism Cores at Yale (NIH/NIDDK U24 DK-59635) and at Baylor College of Medicine (BCM) and the BCM Diabetes & Endocrinology Research Center (DERC) grant (P30 DK079638). E.S. was supported by the Deutsche Forschungsgemeinschaft and this work and R.A.D. are supported by R01 and U01 grants from the NIH National Cancer Institute and the Robert A. and Renee E. Belfer Foundation. R.A.D. was supported by an Ellison Foundation for Medical Research Senior Scholar and an American Cancer Society Research Professor award. M.L. is a recipient of a postdoctoral fellowship from Fundacion Ramon Areces.	Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Arnold AS, 2011, GERONTOLOGY, V57, P37, DOI 10.1159/000281883; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X; Conley KE, 2007, CURR OPIN CLIN NUTR, V10, P688, DOI 10.1097/MCO.0b013e3282f0dbfb; Erdmann N, 2004, P NATL ACAD SCI USA, V101, P6080, DOI 10.1073/pnas.0401580101; Farazi PA, 2003, CANCER RES, V63, P5021; Farazi PA, 2006, CANCER RES, V66, P4766, DOI 10.1158/0008-5472.CAN-05-4608; Finley LWS, 2009, AGEING RES REV, V8, P173, DOI 10.1016/j.arr.2009.03.003; Gardner JP, 2005, CIRCULATION, V111, P2171, DOI 10.1161/01.CIR.0000163550.70487.0B; Guarente L, 2008, CELL, V132, P171, DOI 10.1016/j.cell.2008.01.007; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Leri A, 2003, EMBO J, V22, P131, DOI 10.1093/emboj/cdg013; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Liu L, 2002, AGING CELL, V1, P40, DOI 10.1046/j.1474-9728.2002.00004.x; Maida Y, 2009, NATURE, V461, P230, DOI 10.1038/nature08283; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; Maser RS, 2002, SCIENCE, V297, P565, DOI 10.1126/science.297.5581.565; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Minamishima YA, 2008, BLOOD, V111, P3236, DOI 10.1182/blood-2007-10-117812; Miyagawa K, 2010, HYPERTENSION, V55, P738, DOI 10.1161/HYPERTENSIONAHA.109.141903; Pannicke U, 2009, NAT GENET, V41, P101, DOI 10.1038/ng.265; Passos JF, 2005, EXP GERONTOL, V40, P466, DOI 10.1016/j.exger.2005.04.006; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2; Sahin E, 2010, NATURE, V464, P520, DOI 10.1038/nature08982; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P35, DOI 10.1016/j.atherosclerosis.2009.12.021; Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Trifunovic A, 2004, NATURE, V429, P417, DOI 10.1038/nature02517; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wong KK, 2003, NATURE, V421, P643, DOI 10.1038/nature01385; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050	45	882	903	4	199	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 17	2011	470	7334					359	365		10.1038/nature09787	http://dx.doi.org/10.1038/nature09787			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	722CS	21307849	Green Accepted			2022-12-28	WOS:000287409100034
J	Hacking, JM; Muller, S; Buchan, IE				Hacking, John M.; Muller, Sara; Buchan, Iain E.			Trends in mortality from 1965 to 2008 across the English north-south divide: comparative observational study	BRITISH MEDICAL JOURNAL			English	Article							PREMATURE MORTALITY; GREAT-BRITAIN; INEQUALITIES; ENGLAND; HEALTH; DEPRIVATION; MIGRATION; WALES	Objective To compare all cause mortality between the north and south of England over four decades. Design Population wide comparative observational study of mortality. Setting Five northernmost and four southernmost English government office regions. Population All residents in each year from 1965 to 2008. Main outcome measures Death rate ratios of north over south England by age band and sex, and northern excess mortality (percentage of excess deaths in north compared with south, adjusted for age and sex and examined for annual trends, using Poisson regression). Results During 1965 to 2008 the northern excess mortality remained substantial, at an average of 13.8% (95% confidence interval 13.7% to 13.9%). This geographical inequality was significantly larger for males than for females (14.9%, 14.7% to 15.0% v 12.7%, 12.6% to 12.9%, P<0.001). The inequality decreased significantly but temporarily for both sexes from the early 80s to the late 90s, followed by a steep significant increase from 2000 to 2008. Inequality varied with age, being higher for ages 0-9 years and 40-74 years and lower for ages 10-39 years and over 75 years. Time trends also varied with age. The strongest trend over time by age group was the increase among the 20-34 age group, from no significant northern excess mortality in 1965-95 to 22.2% (18.7% to 26.0%) in 1996-2008. Overall, the north experienced a fifth more premature (<75 years) deaths than the south, which was significant: a pattern that changed only by a slight increase between 1965 and 2008. Conclusion Inequalities in all cause mortality in the north-south divide were severe and persistent over the four decades from 1965 to 2008. Males were affected more than females, and the variation across age groups was substantial. The increase in this inequality from 2000 to 2008 was notable and occurred despite the public policy emphasis in England over this period on reducing inequalities in health.	[Hacking, John M.] Manchester Joint Hlth Unit, Manchester M60 2LA, Lancs, England; [Muller, Sara; Buchan, Iain E.] Univ Manchester, Sch Community Based Med, Manchester M13 9PL, Lancs, England	University of Manchester	Hacking, JM (corresponding author), Manchester Joint Hlth Unit, Town Hall, Manchester M60 2LA, Lancs, England.	j.hacking@manchester.gov.uk; buchan@manchester.ac.uk	Buchan, Iain E/H-5767-2013	Buchan, Iain E/0000-0003-3392-1650	ESRC [ES/F029721/1] Funding Source: UKRI; Economic and Social Research Council [ES/F029721/1] Funding Source: researchfish	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))		Baker A.R.H., 2004, GEOGRAPHIES ENGLAND; Billinge Mark, 2004, GEOGRAPHIES ENGLAND, P88; Boyle P, 2004, PROG HUM GEOG, V28, P767, DOI 10.1191/0309132504ph518pr; Buchan I, 2009, 4 PARADIGM DATA INTE; Campbell B.M.S., 2004, GEOGRAPHIES ENGLAND, P145; Deacon L, 2007, INDICATIONS HLTH ENG; *DEP HLTH, 2008, HLTH PROF ENGL; Department of Health, 2009, TACKL HLTH IN 2006 8; Department of Health, 2007, WORLD CLASS COMM ASS; Department of Health, 2004, CHOOS HLTH MAK HLTH; Doran T, 2004, BMJ-BRIT MED J, V328, P1043, DOI 10.1136/bmj.328.7447.1043; Dorling Daniel, 2010, INJUSTICE; EAMES M, 1993, BRIT MED J, V307, P1097, DOI 10.1136/bmj.307.6912.1097; Gainsbury Sally, 2008, Health Serv J, V118, P12; Glasmeier A, 2008, CAMB J REG ECON SOC, V1, P1, DOI 10.1093/cjres/rsn004; Gordon E, 2008, HLTH STAT Q, V38, P6; Harding S, 2000, HLTH STAT Q, V6, P7; Harper R., 2001, SOCIAL CAPITAL REV L; Hills J, 2010, ANATOMY EC INEQUITY; HM Treasury, 2009, AUT PERF REP; House of Commons, 2003, RED REG DISP PROSP O; House of Commons Health Committee, 2009, 3 HC HLTH COMM; Howell Philip, 2004, GEOGRAPHIES ENGLAND, P64; Kmietowicz Z, 2006, BRIT MED J, V333, P774; Langford IH, 1996, SOC SCI MED, V42, P897, DOI 10.1016/0277-9536(95)00188-3; Law MR, 1998, J EPIDEMIOL COMMUN H, V52, P344, DOI 10.1136/jech.52.6.344; LECK I, 1989, COMMUNITY MED, V11, P102; Leyland AH, 2004, J EPIDEMIOL COMMUN H, V58, P296, DOI 10.1136/jech.2003.007278; Martin RL, 2004, GEOGRAPHIES ENGLAND, P15; Norman P, 2005, SOC SCI MED, V60, P2755, DOI 10.1016/j.socscimed.2004.11.008; Parkinson M, 2004, COMPETITIVE EUROPEAN; Siegler Veronique, 2008, Health Stat Q, P6; Smith D., 1994, N S BRITAINS EC SOCI; Thomas B, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3639; Wilkinson RG, 1997, BRIT MED J, V314, P591, DOI 10.1136/bmj.314.7080.591	35	70	70	0	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2011	342								d508	10.1136/bmj.d508	http://dx.doi.org/10.1136/bmj.d508			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	725OU	21325004	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000287655900006
J	Lander, ES				Lander, Eric S.			Initial impact of the sequencing of the human genome	NATURE			English	Review							HAPLOTYPE STRUCTURE; FETAL-HEMOGLOBIN; WIDE ASSOCIATION; SMALL MOLECULES; GENE; MUTATIONS; EXPRESSION; REVEALS; CANCER; LOCI	The sequence of the human genome has dramatically accelerated biomedical research. Here I explore its impact, in the decade since its publication, on our understanding of the biological functions encoded in the genome, on the biological basis of inherited diseases and cancer, and on the evolution and history of the human species. I also discuss the road ahead in fulfilling the promise of genomics for medicine.	[Lander, Eric S.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Lander, Eric S.] Harvard Univ, Cambridge Ctr 7, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Lander, ES (corresponding author), MIT, Broad Inst, Cambridge, MA 02142 USA.	lander@broadinstitute.org						Allen HL, 2010, NATURE, V467, P832, DOI 10.1038/nature09410; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bejerano G, 2006, NATURE, V441, P87, DOI 10.1038/nature04696; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bilguvar K, 2010, NATURE, V467, P207, DOI 10.1038/nature09327; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN, V518, P541; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Clamp M, 2007, P NATL ACAD SCI USA, V104, P19428, DOI 10.1073/pnas.0709013104; Clemons PA, 2010, P NATL ACAD SCI USA, V107, P18787, DOI 10.1073/pnas.1012741107; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Cowles CR, 2002, NAT GENET, V32, P432, DOI 10.1038/ng992; Daly MJ, 2001, NAT GENET, V29, P229, DOI 10.1038/ng1001-229; Davidson EH, 2006, REG GEN GEN REG; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; DULBECCO R, 1986, SCIENCE, V231, P1055, DOI 10.1126/science.3945817; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Galarneau G, 2010, NAT GENET, V42, P1049, DOI 10.1038/ng.707; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Gnerre S, 2011, P NATL ACAD SCI USA, V108, P1513, DOI 10.1073/pnas.1017351108; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Grossman SR, 2010, SCIENCE, V327, P883, DOI 10.1126/science.1183863; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Jonathan C, 2005, NAT GENET, V37, P161, DOI 10.1038/ng1509; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Jones S, 2010, SCIENCE, V330, P228, DOI 10.1126/science.1196333; Kapranov P, 2002, SCIENCE, V296, P916, DOI 10.1126/science.1068597; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lander ES, 1996, SCIENCE, V274, P536, DOI 10.1126/science.274.5287.536; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; McCarroll SA, 2010, NAT GENET, V42, P365, DOI 10.1038/ng0510-365; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mikkelsen TS, 2007, NATURE, V447, P167, DOI 10.1038/nature05805; Mikkelsen TS, 2005, NATURE, V437, P69, DOI 10.1038/nature04072; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Musunuru K, 2010, NATURE, V466, P714, DOI 10.1038/nature09266; Okou DT, 2007, NAT METHODS, V4, P907, DOI 10.1038/NMETH1109; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Park JH, 2010, NAT GENET, V42, P570, DOI 10.1038/ng.610; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Peck D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r61; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Perou CM, 1999, P NATL ACAD SCI USA, V96, P9212, DOI 10.1073/pnas.96.16.9212; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; Reich DE, 2001, TRENDS GENET, V17, P502, DOI 10.1016/S0168-9525(01)02410-6; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Risch N, 1996, SCIENCE, V273, P1516, DOI 10.1126/science.273.5281.1516; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sachidanandam R, 2001, NATURE, V409, P928, DOI 10.1038/35057149; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sebat J, 2009, TRENDS GENET, V25, P528, DOI 10.1016/j.tig.2009.10.004; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Stefansson H, 2009, NATURE, V460, P744, DOI 10.1038/nature08186; Stone JL, 2008, NATURE, V455, P237, DOI 10.1038/nature07239; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; Uda M, 2008, P NATL ACAD SCI USA, V105, P1620, DOI 10.1073/pnas.0711566105; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yarrow JC, 2003, COMB CHEM HIGH T SCR, V6, P279; Yassour M, 2009, P NATL ACAD SCI USA, V106, P3264, DOI 10.1073/pnas.0812841106; Yi X, 2010, SCIENCE, V329, P75, DOI 10.1126/science.1190371; Zappulla DC, 2006, COLD SPRING HARB SYM, V71, P217, DOI 10.1101/sqb.2006.71.011	100	659	689	2	220	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 10	2011	470	7333					187	197		10.1038/nature09792	http://dx.doi.org/10.1038/nature09792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	718RQ	21307931	Green Submitted			2022-12-28	WOS:000287144200032
J	Stefan, CJ; Manford, AG; Baird, D; Yamada-Hanff, J; Mao, YX; Emr, SD				Stefan, Christopher J.; Manford, Andrew G.; Baird, Daniel; Yamada-Hanff, Jason; Mao, Yuxin; Emr, Scott D.			Osh Proteins Regulate Phosphoinositide Metabolism at ER-Plasma Membrane Contact Sites	CELL			English	Article							OXYSTEROL-BINDING-PROTEIN; SAC1 LIPID PHOSPHATASE; ENDOPLASMIC-RETICULUM; YEAST SAC1; PHOSPHATIDYLINOSITOL 4-PHOSPHATE; GOLGI-COMPLEX; TRANSPORT; REQUIRES; 4-KINASE; MUTANTS	Sac1 phosphoinositide (PI) phosphatases are essential regulators of PI-signaling networks. Yeast Sac1, an integral endoplasmic reticulum (ER) membrane protein, controls PI4P levels at the ER, Golgi, and plasma membrane (PM). Whether Sac1 can act in trans and turn over PI4P at the Golgi and PM from the ER remains a paradox. We find that Sac1-mediated PI4P metabolism requires the oxysterol-binding homology (Osh) proteins. The PH domain-containing family member, Osh3, localizes to PM/ER membrane contact sites dependent upon PM PI4P levels. We reconstitute Osh protein-stimulated Sac1 PI phosphatase activity in vitro. We also show that the ER membrane VAP proteins, Scs2/Scs22, control PM PI4P levels and Sac1 activity in vitro. We propose that Osh3 functions at ER/PM contact sites as both a sensor of PM PI4P and an activator of the ER Sac1 phosphatase. Our findings further suggest that the conserved Osh proteins control PI metabolism at additional membrane contact sites.	[Stefan, Christopher J.; Manford, Andrew G.; Baird, Daniel; Yamada-Hanff, Jason; Mao, Yuxin; Emr, Scott D.] Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Emr, SD (corresponding author), Cornell Univ, Weill Inst Cell & Mol Biol, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	sde26@cornell.edu		Mao, Yuxin/0000-0002-5064-1397; Stefan, Christopher/0000-0002-4118-5721; Manford, Andrew/0000-0003-4472-9509	Weill Institute for Cell and Molecular Biology	Weill Institute for Cell and Molecular Biology	We thank C. Beh for strains and plasmids. We are grateful to S. Weys for technical assistance. We thank members of the S. D. E. laboratory, C. McMaster, and S. Henry for discussions, and A. Bretscher, C. Fromme, and D. Teis for comments on the manuscript. This work was supported by funds from the Weill Institute for Cell and Molecular Biology (S.D.E.).	Audhya A, 2000, MOL BIOL CELL, V11, P2673, DOI 10.1091/mbc.11.8.2673; Baird D, 2008, J CELL BIOL, V183, P1061, DOI 10.1083/jcb.200804003; Beh CT, 2004, J CELL SCI, V117, P2983, DOI 10.1242/jcs.01157; Blagoveshchenskaya A, 2008, J CELL BIOL, V180, P803, DOI 10.1083/jcb.200708109; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; D'Angelo G, 2008, J CELL SCI, V121, P1955, DOI 10.1242/jcs.023630; Fairn GD, 2007, P NATL ACAD SCI USA, V104, P15352, DOI 10.1073/pnas.0705571104; Faulhammer F, 2007, TRAFFIC, V8, P1554, DOI 10.1111/j.1600-0854.2007.00632.x; Foti M, 2001, MOL BIOL CELL, V12, P2396, DOI 10.1091/mbc.12.8.2396; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Guo SL, 1999, J BIOL CHEM, V274, P12990, DOI 10.1074/jbc.274.19.12990; Im YJ, 2005, NATURE, V437, P154, DOI 10.1038/nature03923; Kagiwada S, 2007, BIOCHEM BIOPH RES CO, V364, P870, DOI 10.1016/j.bbrc.2007.10.079; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Konrad G, 2002, J BIOL CHEM, V277, P10547, DOI 10.1074/jbc.M200090200; Lev S, 2010, NAT REV MOL CELL BIO, V11, P739, DOI 10.1038/nrm2971; Levine TP, 2001, MOL BIOL CELL, V12, P1633, DOI 10.1091/mbc.12.6.1633; Li XM, 2002, J CELL BIOL, V157, P63, DOI 10.1083/jcb.200201037; Liu Y, 2008, MOL BIOL CELL, V19, P3080, DOI 10.1091/mbc.E07-12-1290; Liu Y, 2010, PROG LIPID RES, V49, P201, DOI 10.1016/j.plipres.2009.12.001; Loewen CJR, 2007, J CELL BIOL, V179, P467, DOI 10.1083/jcb.200708205; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Manford A, 2010, EMBO J, V29, P1489, DOI 10.1038/emboj.2010.57; Nemoto Y, 2000, J BIOL CHEM, V275, P34293, DOI 10.1074/jbc.M003923200; Ngo MH, 2010, BIOCHEM J, V429, P13, DOI 10.1042/BJ20100263; Parrish WR, 2005, J CELL SCI, V118, P5589, DOI 10.1242/jcs.02649; Peretti D, 2008, MOL BIOL CELL, V19, P3871, DOI 10.1091/mbc.E08-05-0498; Raychaudhuri S, 2006, J CELL BIOL, V173, P107, DOI 10.1083/jcb.200510084; Rivas MP, 1999, MOL BIOL CELL, V10, P2235, DOI 10.1091/mbc.10.7.2235; Roy A, 2004, J BIOL CHEM, V279, P44683, DOI 10.1074/jbc.M401583200; Schulz TA, 2009, J CELL BIOL, V187, P889, DOI 10.1083/jcb.200905007; Tahirovic S, 2005, TRAFFIC, V6, P116, DOI 10.1111/j.1600-0854.2004.00255.x; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wei HC, 2003, CURR BIOL, V13, P1882, DOI 10.1016/j.cub.2003.09.056	35	330	341	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 4	2011	144	3					389	401		10.1016/j.cell.2010.12.034	http://dx.doi.org/10.1016/j.cell.2010.12.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	716MK	21295699	Bronze			2022-12-28	WOS:000286973100011
J	Alexander, MH				Alexander, Millard H.			Chemical Kinetics Under Test	SCIENCE			English	Editorial Material							TRANSITION-STATE THEORY; H+H-2		[Alexander, Millard H.] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Alexander, Millard H.] Univ Maryland, Inst Phys Sci & Technol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Alexander, MH (corresponding author), Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA.	mha@umd.edu						BIGELEISEN J, 1947, J CHEM PHYS, V15, P261, DOI 10.1063/1.1746492; Born M, 1927, ANN PHYS-BERLIN, V84, P0457; Che L, 2007, SCIENCE, V317, P1061, DOI 10.1126/science.1144984; Fleming DG, 2011, SCIENCE, V331, P448, DOI 10.1126/science.1199421; GARRETT BC, 1980, J PHYS CHEM-US, V84, P1730, DOI 10.1021/j100450a013; MICHAEL JV, 1990, SCIENCE, V249, P269, DOI 10.1126/science.249.4966.269; Mielke SL, 2002, J CHEM PHYS, V116, P4142, DOI 10.1063/1.1432319; Smith I.W.M., 1980, KINETICS DYNAMICS EL; SUN Y, 1990, PHYS REV A, V41, P4857, DOI 10.1103/PhysRevA.41.4857; TRUHLAR DG, 1980, ACCOUNTS CHEM RES, V13, P440, DOI 10.1021/ar50156a002; Wang XG, 2008, SCIENCE, V322, P573, DOI 10.1126/science.1163195; WESTON RE, 1967, SCIENCE, V158, P332, DOI 10.1126/science.158.3799.332	12	8	8	2	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 28	2011	331	6016					411	412		10.1126/science.1201509	http://dx.doi.org/10.1126/science.1201509			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273477				2022-12-28	WOS:000286635900040
J	Venkataramani, S; Jana, U; Dommaschk, M; Sonnichsen, FD; Tuczek, F; Herges, R				Venkataramani, S.; Jana, U.; Dommaschk, M.; Soennichsen, F. D.; Tuczek, F.; Herges, R.			Magnetic Bistability of Molecules in Homogeneous Solution at Room Temperature	SCIENCE			English	Article							INDUCED SPIN-CHANGE; TRANSITION-METAL-COMPLEXES; 1ST EVIDENCE; LIGHT; COORDINATION; PORPHYRINS; PHENYLAZOPYRIDINES; PHOTOMAGNETISM; PHOTOCHROMISM; MODULATION	Magnetic bistability, as manifested in the magnetization of ferromagnetic materials or spin crossover in transition metal complexes, has essentially been restricted to either bulk materials or to very low temperatures. We now present a molecular spin switch that is bistable at room temperature in homogeneous solution. Irradiation of a carefully designed nickel complex with blue-green light (500 nanometers) induces coordination of a tethered pyridine ligand and concomitant electronic rearrangement from a diamagnetic to a paramagnetic state in up to 75% of the ensemble. The process is fully reversible on irradiation with violet-blue light (435 nanometers). No fatigue or degradation is observed after several thousand cycles at room temperature under air. Preliminary data show promise for applications in magnetic resonance imaging.	[Venkataramani, S.; Jana, U.; Dommaschk, M.; Soennichsen, F. D.; Herges, R.] Univ Kiel, Otto Diels Inst Organ Chem, D-24118 Kiel, Germany; [Tuczek, F.] Univ Kiel, Inst Inorgan Chem, D-24118 Kiel, Germany	University of Kiel; University of Kiel	Herges, R (corresponding author), Univ Kiel, Otto Diels Inst Organ Chem, Olshaussenstr 40, D-24118 Kiel, Germany.	rherges@oc.uni-kiel.de	Sönnichsen, Frank D/D-8408-2011; Venkataramani, Sugumar/Q-5551-2019	Sönnichsen, Frank D/0000-0002-4539-3755; Venkataramani, Sugumar/0000-0002-6465-3655	Deutsche Forschungsgemeinschaft [SFB 677]; Alexander von Humboldt Foundation; Institut fur Physikalische Chemie, Universitat Kiel; Institut fur Anorganische Chemie, Universitat Kiel; Institut fur Neuroradiologie, Universitatsklinikum Schleswig-Holstein	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Institut fur Physikalische Chemie, Universitat Kiel; Institut fur Anorganische Chemie, Universitat Kiel; Institut fur Neuroradiologie, Universitatsklinikum Schleswig-Holstein	This work was supported by the Deutsche Forschungsgemeinschaft through SFB 677. We thank the Alexander von Humboldt Foundation for a research fellowship for S.V. We are also grateful for support from R. Siewertsen and F. Temps (Institut fur Physikalische Chemie, Universitat Kiel), G. Peters (Institut fur Anorganische Chemie, Universitat Kiel), and O. Jansen, C. Riedel and M. Helle (Institut fur Neuroradiologie, Universitatsklinikum Schleswig-Holstein). The Christian-Albrechts-Universitat zu Kiel and Universitatsklinikum Schleswig-Holstein have filed a patent application for the compound described herein as an MRI contrast agent.	Ahlrichs R, 2009, TURBOMOLE VERSION 6; [Anonymous], 2009, J MATER CHEM, V19, P1661; BERKESSEL A, 1990, ANGEW CHEM INT EDIT, V29, P106, DOI 10.1002/anie.199001061; Berliner L. J., 1993, NMR PARAMAGNETIC MOL; Boillot ML, 2009, INORG CHEM, V48, P4729, DOI 10.1021/ic802319c; Boillot M.-L., 1999, J CHEM, V1999, P19; Boillot ML, 1996, INORG CHEM, V35, P3975, DOI 10.1021/ic960015r; Boldog I, 2008, ANGEW CHEM INT EDIT, V47, P6433, DOI 10.1002/anie.200801673; BROWN EV, 1975, J AM CHEM SOC, V97, P621, DOI 10.1021/ja00836a025; Cotton F. A., 1999, ADV INORGANIC CHEM; Gutlich P., 2004, SPIN CROSSOVER TRANS, V1; Hasegawa Y, 2009, DALTON T, P280, DOI 10.1039/b817196n; Hirose S, 2000, B CHEM SOC JPN, V73, P2059, DOI 10.1246/bcsj.73.2059; KIM D, 1983, CHEM PHYS LETT, V98, P584, DOI 10.1016/0009-2614(83)80247-4; KIM D, 1983, CHEM PHYS, V75, P305, DOI 10.1016/0301-0104(83)85199-4; Knutsson L, 2010, MAGN RESON MATER PHY, V23, P1, DOI 10.1007/s10334-009-0190-2; Kolb JS, 2007, CR CHIM, V10, P125, DOI 10.1016/j.crci.2006.10.003; LaMar G. N., 1973, NMR PARAMAGNETIC MOL; Larionova J, 2008, ANGEW CHEM INT EDIT, V47, P8236, DOI 10.1002/anie.200802906; LAUFFER RB, 1987, CHEM REV, V87, P901, DOI 10.1021/cr00081a003; Letard JF, 2006, J MATER CHEM, V16, P2550, DOI 10.1039/b603473j; Matino F, 2010, CHEM COMMUN, V46, P6780, DOI 10.1039/c0cc00959h; Murray KS, 2004, TOP CURR CHEM, V233, P195, DOI 10.1007/b13536; Otsuki J, 2004, B CHEM SOC JPN, V77, P1537, DOI 10.1246/bcsj.77.1537; Otsuki J, 2004, CHEM LETT, V33, P356, DOI 10.1246/cl.2004.356; Otsuki J, 2010, COORDIN CHEM REV, V254, P2311, DOI 10.1016/j.ccr.2009.12.038; Renz F, 2000, ANGEW CHEM INT EDIT, V39, P3699, DOI 10.1002/1521-3773(20001016)39:20<3699::AID-ANIE3699>3.0.CO;2-Z; RODRIGUEZ J, 1990, J CHEM PHYS, V92, P5944, DOI 10.1063/1.458364; ROUX C, 1994, INORG CHEM, V33, P2273, DOI 10.1021/ic00088a033; Salitros I, 2009, MONATSH CHEM, V140, P695, DOI 10.1007/s00706-009-0128-4; Sato O, 2007, ANGEW CHEM INT EDIT, V46, P2152, DOI 10.1002/anie.200602205; Senechal-David K, 2008, DALTON T, P1932, DOI 10.1039/b715017b; Sour A, 1999, EUR J INORG CHEM, P2117; Stoll RS, 2009, J AM CHEM SOC, V131, P357, DOI 10.1021/ja807694s; Sugimoto H, 1999, J AM CHEM SOC, V121, P2325, DOI 10.1021/ja983960i; Sugimoto H., 2002, PERKIN T, V1, P1826; Suwa K, 2009, TETRAHEDRON LETT, V50, P2106, DOI 10.1016/j.tetlet.2009.02.126; Thies S, 2010, CHEM-EUR J, V16, P10074, DOI 10.1002/chem.201000603	38	411	414	5	297	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 28	2011	331	6016					445	448		10.1126/science.1201180	http://dx.doi.org/10.1126/science.1201180			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BB	21273483				2022-12-28	WOS:000286635900048
J	Koul, A; Arnoult, E; Lounis, N; Guillemont, J; Andries, K				Koul, Anil; Arnoult, Eric; Lounis, Nacer; Guillemont, Jerome; Andries, Koen			The challenge of new drug discovery for tuberculosis	NATURE			English	Review							MULTIDRUG-RESISTANT TUBERCULOSIS; NONREPLICATING MYCOBACTERIUM-TUBERCULOSIS; EARLY BACTERICIDAL ACTIVITY; PULMONARY TUBERCULOSIS; MURINE MODEL; PHARMACOKINETIC INTERACTIONS; PHYSICOCHEMICAL PROPERTIES; ANTITUBERCULOSIS AGENTS; DIARYLQUINOLINE TMC207; ATP HOMEOSTASIS	Tuberculosis (TB) is more prevalent in the world today than at any other time in human history. Mycobacterium tuberculosis, the pathogen responsible for TB, uses diverse strategies to survive in a variety of host lesions and to evade immune surveillance. A key question is how robust are our approaches to discovering new TB drugs, and what measures could be taken to reduce the long and protracted clinical development of new drugs. The emergence of multi-drug-resistant strains of M. tuberculosis makes the discovery of new molecular scaffolds a priority, and the current situation even necessitates the re-engineering and repositioning of some old drug families to achieve effective control. Whatever the strategy used, success will depend largely on our proper understanding of the complex interactions between the pathogen and its human host. In this review, we discuss innovations in TB drug discovery and evolving strategies to bring newer agents more quickly to patients.	[Koul, Anil; Lounis, Nacer; Andries, Koen] Johnson & Johnson, Janssen Res & Dev, Dept Antimicrobial Res, B-2340 Beerse, Belgium; [Arnoult, Eric; Guillemont, Jerome] Johnson & Johnson, Janssen Res & Dev, Dept Antimicrobial Res, F-27106 Val De Reuil, France	Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson	Koul, A (corresponding author), Johnson & Johnson, Janssen Res & Dev, Dept Antimicrobial Res, Turnhoutseweg 30, B-2340 Beerse, Belgium.	akoul@its.jnj.com	Duca, Gheorghe/AAF-9091-2021	Duca, Gheorghe/0000-0001-7265-6293				Agrawal D, 2009, INT J TUBERC LUNG D, V13, P79; Andries K, 2005, SCIENCE, V307, P223, DOI 10.1126/science.1106753; Andries K, 2010, ANTIMICROB AGENTS CH, V54, P4540, DOI 10.1128/AAC.00934-10; [Anonymous], 2010, SIMCA P 12; Bald D, 2010, FEMS MICROBIOL LETT, V308, P1, DOI 10.1111/j.1574-6968.2010.01959.x; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Beresford B, 2010, CLIN INFECT DIS, V50, pS178, DOI 10.1086/651489; Berry MPR, 2010, NATURE, V466, P973, DOI 10.1038/nature09247; Boshoff HIM, 2005, NAT REV MICROBIOL, V3, P70, DOI 10.1038/nrmicro1065; Burman WJ, 1999, CLIN INFECT DIS, V28, P419, DOI 10.1086/515174; Campbell EA, 2001, CELL, V104, P901, DOI 10.1016/S0092-8674(01)00286-0; CHAMBERS HF, 1995, ANTIMICROB AGENTS CH, V39, P2620, DOI 10.1128/AAC.39.12.2620; Chao MC, 2010, ANNU REV MICROBIOL, V64, P293, DOI 10.1146/annurev.micro.112408.134043; *CHEM COMP GROUP, MOE V 2009 10; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Conte JE, 2002, ANTIMICROB AGENTS CH, V46, P1475, DOI 10.1128/AAC.46.5.1475-1480.2002; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Dhar N, 2007, CURR OPIN MICROBIOL, V10, P30, DOI 10.1016/j.mib.2006.12.007; Dhar N, 2010, P NATL ACAD SCI USA, V107, P12275, DOI 10.1073/pnas.1003219107; Diacon AH, 2009, NEW ENGL J MED, V360, P2397, DOI 10.1056/NEJMoa0808427; Donald PR, 2008, TUBERCULOSIS, V88, pS75, DOI 10.1016/S1472-9792(08)70038-6; Dooley KE, 2009, LANCET INFECT DIS, V9, P737, DOI 10.1016/S1473-3099(09)70282-8; Drawz SM, 2010, CLIN MICROBIOL REV, V23, P160, DOI 10.1128/CMR.00037-09; Dye C, 2010, SCIENCE, V328, P856, DOI 10.1126/science.1185449; FELDMAN WH, 1947, AM REV TUBERC PULM, V56, P346; Fischbach MA, 2009, SCIENCE, V325, P1089, DOI 10.1126/science.1176667; Fortun J, 2005, J ANTIMICROB CHEMOTH, V56, P180, DOI 10.1093/jac/dki148; Gandhi NR, 2010, LANCET, V375, P1830, DOI 10.1016/S0140-6736(10)60410-2; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Hennessy A. J., 2010, PCT Int. Appl., Patent No. [WO 2010/046388, 2010046388]; Hett EC, 2008, MICROBIOL MOL BIOL R, V72, P126, DOI 10.1128/MMBR.00028-07; Hirano S, 2008, BIOORGAN MED CHEM, V16, P5123, DOI 10.1016/j.bmc.2008.03.020; Hugonnet JE, 2009, SCIENCE, V323, P1215, DOI 10.1126/science.1167498; Ibrahim M, 2009, AM J RESP CRIT CARE, V180, P553, DOI 10.1164/rccm.200807-1152OC; Keating LA, 2005, MOL MICROBIOL, V56, P163, DOI 10.1111/j.1365-2958.2005.04524.x; Khachi H, 2009, J ANTIMICROB CHEMOTH, V64, P871, DOI 10.1093/jac/dkp263; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Koul A, 2008, J BIOL CHEM, V283, P25273, DOI 10.1074/jbc.M803899200; Koul A, 2007, NAT CHEM BIOL, V3, P323, DOI 10.1038/nchembio884; Kumar D, 2010, CELL, V140, P731, DOI 10.1016/j.cell.2010.02.012; L'homme RFA, 2009, AIDS, V23, P863, DOI 10.1097/QAD.0b013e328329148e; Ma ZK, 2010, LANCET, V375, P2100, DOI 10.1016/S0140-6736(10)60359-9; MACIELAG M, 2005, 45 INT C ANT AG CHEM; Makarov V, 2009, SCIENCE, V324, P801, DOI 10.1126/science.1171583; Manjunatha Ujjini, 2009, Commun Integr Biol, V2, P215; Miller JR, 2009, P NATL ACAD SCI USA, V106, P1737, DOI 10.1073/pnas.0811275106; MITCHISON DA, 1993, AM REV RESPIR DIS, V147, P1062, DOI 10.1164/ajrccm/147.4.1062; Mitnick C, 2003, NEW ENGL J MED, V348, P119, DOI 10.1056/NEJMoa022928; Niemi M, 2003, CLIN PHARMACOKINET, V42, P819, DOI 10.2165/00003088-200342090-00003; O'Shea R, 2008, J MED CHEM, V51, P2871, DOI 10.1021/jm700967e; Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201; Pethe K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1060; Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006; Rao SPS, 2008, P NATL ACAD SCI USA, V105, P11945, DOI 10.1073/pnas.0711697105; RILEY RL, 1957, AM REV TUBERC PULM, V76, P931; Ritchie TJ, 2009, J CHEM INF MODEL, V49, P1025, DOI 10.1021/ci800429e; Ruslami R, 2010, ANTIMICROB AGENTS CH, V54, P1068, DOI 10.1128/AAC.00447-09; Russell DG, 2010, SCIENCE, V328, P852, DOI 10.1126/science.1184784; Rustomjee R, 2008, ANTIMICROB AGENTS CH, V52, P2831, DOI 10.1128/AAC.01204-07; Rustomjee R, 2008, INT J TUBERC LUNG D, V12, P128; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; Singh R, 2008, SCIENCE, V322, P1392, DOI 10.1126/science.1164571; Spigelman M, 2010, INT J TUBERC LUNG D, V14, P663; Stop TB Partnership, 2010, GLOB PLAN STOP TB 20; Szekely R, 2008, IMMUNOL LETT, V116, P225, DOI 10.1016/j.imlet.2007.12.005; Toure NO, 2007, REV MAL RESPIR, V24, P869, DOI 10.1016/S0761-8425(07)91389-3; Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384; Wallis RS, 2010, LANCET, V375, P1920, DOI 10.1016/S0140-6736(10)60359-5; Wallis RS, 2010, LANCET INFECT DIS, V10, P68, DOI 10.1016/S1473-3099(10)70003-7; Weinstein EA, 2005, P NATL ACAD SCI USA, V102, P4548, DOI 10.1073/pnas.0500469102; WHO, 2010, MULT EXT DRUG RES TU; Williams KN, 2009, ANTIMICROB AGENTS CH, V53, P1314, DOI 10.1128/AAC.01182-08; Working Group on New TB Drugs, 2010, GLOB TB DRUG PIP; Zhou B, 2010, P NATL ACAD SCI USA, V107, P4573, DOI 10.1073/pnas.0909133107	74	814	835	16	399	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 27	2011	469	7331					483	490		10.1038/nature09657	http://dx.doi.org/10.1038/nature09657			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	711MU	21270886				2022-12-28	WOS:000286596500023
J	Ogawa, T; Akahane, M; Koike, S; Tanabe, S; Mizoguchi, T; Imamura, T				Ogawa, Toshio; Akahane, Manabu; Koike, Soichi; Tanabe, Seizan; Mizoguchi, Tatsuhiro; Imamura, Tomoaki			Outcomes of chest compression only CPR versus conventional CPR conducted by lay people in patients with out of hospital cardiopulmonary arrest witnessed by bystanders: nationwide population based observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							AMERICAN-HEART-ASSOCIATION; EUROPEAN-RESUSCITATION-COUNCIL; SUDDEN CARDIAC-ARREST; BASIC LIFE-SUPPORT; HEALTH-PROFESSIONALS; STROKE-FOUNDATION; TASK-FORCE; STATEMENT; GUIDELINES; ATTITUDES	ABSTRACT Objective To compare the effectiveness of cardiopulmonary resuscitation (CPR) with chest compression only and conventional CPR on outcomes after cardiopulmonary arrest out of hospital. Design Nationwide population based observational study. Setting A nationwide emergency medical service system in Japan. Population All consecutive patients with out of hospital cardiopulmonary arrest, January 2005 to December 2007 in Japan, witnessed at the moment of collapse. Lay people attempted chest compression only CPR (n=20 707) or conventional CPR (mouth to mouth ventilation and chest compression) (n=19 328), and patients were transferred to hospital by ambulance. Main outcome measures Factors associated with better outcomes (assessed with chi superset of 2 superset of, multiple logistic regression analysis, odds ratios and their 95% confidence intervals): one month survival and neurologically favourable one month survival rates defined as category one (good cerebral performance) or two (moderate cerebral disability) of the cerebral performance categories. Results Conventional CPR was associated with better outcomes than chest compression only CPR, for both one month survival (adjusted odds ratio 1.17, 95% confidence interval 1.06 to 1.29) and neurologically favourable one month survival (1.17, 1.01 to 1.35). Neurologically favourable one month survival decreased with increasing age and with delays of up to 10 minutes in starting CPR for both conventional and chest compression only CPR. The benefit of conventional CPR over chest compression only CPR was significantly greater in younger people in non-cardiac cases (P=0.025) and with a delay in start of CPR after the event was witnessed in non-cardiac cases (P=0.015) and all cases combined (P=0.037). Conclusions Conventional CPR is associated with better outcomes than chest compression only CPR for selected patients with out of hospital cardiopulmonary arrest, such as those with arrests of non-cardiac origin and younger people, and people in whom there was delay in the start of CPR.	[Ogawa, Toshio; Akahane, Manabu; Imamura, Tomoaki] Nara Med Univ, Sch Med, Dept Publ Hlth Hlth Management & Policy, Kashihara 6348521, Nara, Japan; [Koike, Soichi] Univ Tokyo Hosp, Dept Planning Information & Management, Bunkyo Ku, Tokyo 1920364, Japan; [Tanabe, Seizan; Mizoguchi, Tatsuhiro] Emergency Life Saving Technique Acad Of Tokyo, Fdn Ambulance Serv Dev, Tokyo 1920364, Japan; Fire & Disaster Management Agcy, Ambulance Serv Planning Off, Chiyoda Ku, Tokyo 1008927, Japan	Nara Medical University; University of Tokyo	Ogawa, T (corresponding author), Nara Med Univ, Sch Med, Dept Publ Hlth Hlth Management & Policy, 840 Shijo Cho, Kashihara 6348521, Nara, Japan.	ogawat@naramed-u.ac.jp	Akahane, Manabu/GYD-5539-2022					[Anonymous], 2005, CIRCULATION, V112, pIV1, DOI 10.1161/CIRCULATIONAHA.105.166550; Arrich J, 2009, RESUSCITATION, V80, P876, DOI 10.1016/j.resuscitation.2009.04.045; Bohm K, 2007, CIRCULATION, V116, P2908, DOI 10.1161/CIRCULATIONAHA.107.710194; Caves ND, 2006, RESUSCITATION, V68, P93, DOI 10.1016/j.resuscitation.2005.05.014; Chamberlain D, 2005, RESUSCITATION, V67, P157, DOI 10.1016/j.resuscitation.2005.05.011; CUMMINS RO, 1991, CIRCULATION, V84, P960, DOI 10.1161/01.CIR.84.2.960; CUMMINS RO, 1991, CIRCULATION, V83, P1832, DOI 10.1161/01.CIR.83.5.1832; Holmberg M, 1999, AM J CARDIOL, V83, p88D; Hupfl M, 2010, LANCET, V376, P1552, DOI 10.1016/S0140-6736(10)61454-7; Iwami T, 2007, CIRCULATION, V116, P2900, DOI 10.1161/CIRCULATIONAHA.107.723411; Jacobs I, 2004, RESUSCITATION, V63, P233, DOI 10.1016/j.resuscitation.2004.09.008; Kitamura T, 2010, LANCET, V375, P1347, DOI 10.1016/S0140-6736(10)60064-5; LOCKE CJ, 1995, ARCH INTERN MED, V155, P938, DOI 10.1001/archinte.155.9.938; *MIN ED CULT SPORT, 2006, SPORTS SCI TECHNOL J; Nagao K, 2007, LANCET, V369, P920; Olasveengen TM, 2008, ACTA ANAESTH SCAND, V52, P914, DOI 10.1111/j.1399-6576.2008.01723.x; Ong MEH, 2008, RESUSCITATION, V78, P119, DOI 10.1016/j.resuscitation.2008.03.012; Rea TD, 2004, RESUSCITATION, V63, P17, DOI 10.1016/j.resuscitation.2004.03.025; Sayre MR, 2008, CIRCULATION, V117, P2162, DOI 10.1161/CIRCULATIONAHA.107.189380; Sayre MR, 2009, PREHOSP EMERG CARE, V13, P469, DOI 10.1080/10903120903144965; Steen PA, 2007, CIRCULATION, V116, P2514, DOI 10.1161/CIRCULATIONAHA.107.739086; Taniguchi T, 2007, RESUSCITATION, V75, P82, DOI 10.1016/j.resuscitation.2007.02.019; Vukmir RB, 2004, EMERG MED J, V21, P370, DOI 10.1136/emj.2003.008383	23	85	93	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2011	342								c7106	10.1136/bmj.c7106	http://dx.doi.org/10.1136/bmj.c7106			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715MM	21273279	Green Submitted, hybrid			2022-12-28	WOS:000286888600014
J	Oka, T; McCall, BJ				Oka, Takeshi; McCall, Benjamin J.			Disclosing Identities in Diffuse Interstellar Bands	SCIENCE			English	Editorial Material							ELECTRONIC-SPECTRUM; HD 183143; C3H2; PROPADIENYLIDENE; CHEMISTRY; H2CCC		[Oka, Takeshi] Univ Chicago, Dept Chem, Chicago, IL 60637 USA; [McCall, Benjamin J.] Univ Illinois, Dept Chem, Urbana, IL 61801 USA	University of Chicago; University of Illinois System; University of Illinois Urbana-Champaign	Oka, T (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	t-oka@uchicago.edu; bjmccall@illinois.edu	McCall, Benjamin J/A-3136-2008	OKA, TAKESHI/0000-0002-9434-8977; McCall, Benjamin/0000-0003-1022-7295				Achkasova E, 2006, J MOL SPECTROSC, V237, P70, DOI 10.1016/j.jms.2006.02.013; [Anonymous], 2010, SPECTR MOL IONS LAB; Birza P, 2005, J MOL SPECTROSC, V229, P276, DOI 10.1016/j.jms.2004.10.001; BROMAGE GE, 1987, Q J ROY ASTRON SOC, V28, P294; Cernicharo J, 1999, ASTRON ASTROPHYS, V351, P341; CERNICHARO J, 1991, ASTROPHYS J, V368, pL39, DOI 10.1086/185943; CODE AD, 1958, PUBL ASTRON SOC PAC, V70, P407, DOI 10.1086/127249; HERBIG GH, 1975, ASTROPHYS J, V196, P129, DOI 10.1086/153400; HERBIG GH, 1966, Z ASTROPHYS, V64, P512; HERBST E, 1995, ANNU REV PHYS CHEM, V46, P27, DOI 10.1146/annurev.physchem.46.1.27; Hobbs LM, 2009, ASTROPHYS J, V705, P32, DOI 10.1088/0004-637X/705/1/32; Lucas R, 2000, ASTRON ASTROPHYS, V358, P1069; Maier JP, 2011, ASTROPHYS J, V726, DOI 10.1088/0004-637X/726/1/41; Oka T, 2003, ASTROPHYS J, V582, P823, DOI 10.1086/344726; Thorburn JA, 2003, ASTROPHYS J, V584, P339, DOI 10.1086/345665	16	39	39	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 21	2011	331	6015					293	294		10.1126/science.1200144	http://dx.doi.org/10.1126/science.1200144			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	712BF	21252337				2022-12-28	WOS:000286636300025
J	Kormendy, J; Bender, R; Cornell, ME				Kormendy, John; Bender, R.; Cornell, M. E.			Supermassive black holes do not correlate with galaxy disks or pseudobulges	NATURE			English	Article							M-BH-SIGMA(ASTERISK) RELATION; MASS; CONSTRAINTS; ACCRETION; QUASARS; NUCLEI; BULGES; ORIGIN; SIGMA	The masses of supermassive black holes are known to correlate with the properties of the bulge components of their host galaxies(1-5). In contrast, they seem not to correlate with galaxy disks(1). Disk-grown 'pseudobulges' are intermediate in properties between bulges and disks(6); it has been unclear whether they do(1,5) or do not(7-9) correlate with black holes in the same way that bulges do. At stake in this issue are conclusions about which parts of galaxies coevolve with black holes(10), possibly by being regulated by energy feedback from black holes(11). Here we report pseudobulge classifications for galaxies with dynamically detected black holes and combine them with recent measurements of velocity dispersions in the biggest bulgeless galaxies(12). These data confirm that black holes do not correlate with disks and show that they correlate little or not at all with pseudobulges. We suggest that there are two different modes of black-hole feeding. Black holes in bulges grow rapidly to high masses when mergers drive gas infall that feeds quasar-like events. In contrast, small black holes in bulgeless galaxies and in galaxies with pseudobulges grow as low-level Seyfert galaxies. Growth of the former is driven by global processes, so the biggest black holes coevolve with bulges, but growth of the latter is driven locally and stochastically, and they do not coevolve with disks and pseudobulges.	[Kormendy, John; Cornell, M. E.] Univ Texas Austin, Dept Astron, Austin, TX 78712 USA; [Bender, R.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Bender, R.] Univ Sternwarte, D-81679 Munich, Germany	University of Texas System; University of Texas Austin; Max Planck Society; University of Munich	Kormendy, J (corresponding author), Univ Texas Austin, Dept Astron, 1 Univ Stn, Austin, TX 78712 USA.	kormendy@astro.as.utexas.edu		Kormendy, John/0000-0001-9854-5217	NASA; National Science Foundation (NSF)	NASA(National Aeronautics & Space Administration (NASA)); National Science Foundation (NSF)(National Science Foundation (NSF))	We acknowledge with pleasure our collaboration with N. Drory on work leading up to this paper. We thank N. Drory and J. Greene for helpful comments on the manuscript and J. Greene for communicating the maser black-hole detection results before publication. We also thank K. Gebhardt for permission to use M<INF>circle</INF> values for NGC 4736 and NGC 4826, and J. Jardel for permission to use his updated M<INF>circle</INF> value for NGC 4594 before publication. Some data used here were obtained with the Hobby-Eberly Telescope (HET), which is a joint project of the University of Texas at Austin, Pennsylvania State University, Stanford University, Ludwig-Maximilians-Universitat Munich and Georg-August-Universitat Gottingen. It is named in honour of its principal benefactors, W. P. Hobby and R. E. Eberly. We made extensive use of data from the Two Micron All Sky Survey, a joint project of the University of Massachusetts and the Infrared Processing and Analysis Center (IPAC)/California Institute of Technology funded by NASA and by the National Science Foundation (NSF). We also made extensive use of the NASA/IPAC Extragalactic Database (NED), which is operated by California Institute of Technology and the Jet Propulsion Laboratory under contract with NASA; of the HyperLeda database (http://leda.univ-lyon1.fr); and of the NASA Astrophysics Data System bibliographic services. Finally, we are grateful to the NSF for grant support.	Barth AJ, 2009, ASTROPHYS J, V690, P1031, DOI 10.1088/0004-637X/690/1/1031; Barth AJ, 2005, ASTROPHYS J, V619, pL151, DOI 10.1086/428365; Bentz MC, 2009, ASTROPHYS J LETT, V694, pL166, DOI 10.1088/0004-637X/694/2/L166; Ferrarese L, 2000, ASTROPHYS J, V539, pL9, DOI 10.1086/312838; Filippenko AV, 2003, ASTROPHYS J, V588, pL13, DOI 10.1086/375361; Gebhardt K, 2000, ASTROPHYS J, V539, pL13, DOI 10.1086/312840; Greene JE, 2006, ASTROPHYS J, V641, pL21, DOI 10.1086/500507; Greene JE, 2008, ASTROPHYS J, V688, P159, DOI 10.1086/592078; Greene JE, 2010, ASTROPHYS J, V721, P26, DOI 10.1088/0004-637X/721/1/26; Gultekin K, 2009, ASTROPHYS J, V698, P198, DOI 10.1088/0004-637X/698/1/198; Ho L. C., 2004, ASTROPHYS SER; Ho LC, 2008, ANNU REV ASTRON ASTR, V46, P475, DOI 10.1146/annurev.astro.45.051806.110546; Hopkins PF, 2006, ASTROPHYS J SUPPL S, V163, P1, DOI 10.1086/499298; Hopkins PF, 2006, ASTROPHYS J SUPPL S, V166, P1, DOI 10.1086/505753; Hopkins PF, 2010, MON NOT R ASTRON SOC, V407, P1529, DOI 10.1111/j.1365-2966.2010.17064.x; Hu J, 2008, MON NOT R ASTRON SOC, V386, P2242, DOI 10.1111/j.1365-2966.2008.13195.x; Kormendy J, 2004, ANNU REV ASTRON ASTR, V42, P603, DOI 10.1146/annurev.astro.42.053102.134024; Kormendy J, 2010, ASTROPHYS J, V723, P54, DOI 10.1088/0004-637X/723/1/54; Kumar P, 2010, MON NOT R ASTRON SOC, V404, P2170, DOI 10.1111/j.1365-2966.2010.16437.x; Nowak N, 2010, MON NOT R ASTRON SOC, V403, P646, DOI 10.1111/j.1365-2966.2009.16167.x; Peterson BM, 2005, ASTROPHYS J, V632, P799, DOI 10.1086/444494; SANDERS DB, 1988, ASTROPHYS J, V325, P74, DOI 10.1086/165983; Schawinski K, 2010, ASTROPHYS J, V711, P284, DOI 10.1088/0004-637X/711/1/284; Silk J, 1998, ASTRON ASTROPHYS, V331, pL1; Thornton CE, 2008, ASTROPHYS J, V686, P892, DOI 10.1086/591519; TOOMRE A, 1977, EVOLUTION GALAXIES S, P401; Tremaine S, 2002, ASTROPHYS J, V574, P740, DOI 10.1086/341002; Woo JH, 2010, ASTROPHYS J, V716, P269, DOI 10.1088/0004-637X/716/1/269; Yu QJ, 2002, MON NOT R ASTRON SOC, V335, P965, DOI 10.1046/j.1365-8711.2002.05532.x; [No title captured]	30	199	199	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 20	2011	469	7330					374	376		10.1038/nature09694	http://dx.doi.org/10.1038/nature09694			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	708SW	21248845	Green Submitted			2022-12-28	WOS:000286385600046
J	Chongsuvivatwong, V; Phua, KH; Yap, MT; Pocock, NS; Hashim, JH; Chhem, R; Wilopo, SA; Lopez, AD				Chongsuvivatwong, Virasakdi; Phua, Kai Hong; Yap, Mui Teng; Pocock, Nicola S.; Hashim, Jamal H.; Chhem, Rethy; Wilopo, Siswanto Agus; Lopez, Alan D.			Health in Southeast Asia 1 Health and health-care systems in southeast Asia: diversity and transitions	LANCET			English	Article							ECONOMIC-CRISIS; CLIMATE-CHANGE; HIV; MORTALITY; MALAYSIA; CHILDREN; IMPACT; FIRES	Southeast Asia is a region of enormous social, economic, and political diversity, both across and within countries, shaped by its history, geography, and position as a major crossroad of trade and the movement of goods and services. These factors have not only contributed to the disparate health status of the region's diverse populations, but also to the diverse nature of its health systems, which are at varying stages of evolution. Rapid but inequitable socioeconomic development, coupled with differing rates of demographic and epidemiological transitions, have accentuated health disparities and posed great public health challenges for national health systems, particularly the control of emerging infectious diseases and the rise of non-communicable diseases within ageing populations. While novel forms of health care are evolving in the region, such as corporatised public health-care systems (government owned, but operating according to corporate principles and with private-sector participation) and financing mechanisms to achieve universal coverage, there are key lessons for health reforms and decentralisation. New challenges have emerged with rising trade in health services, migration of the health workforce, and medical tourism. Juxtaposed between the emerging giant economies of China and India, countries of the region are attempting to forge a common regional identity, despite their diversity, to seek mutually acceptable and effective solutions to key regional health challenges. In this first paper in the Lancet Series on health in southeast Asia, we present an overview of key demographic and epidemiological changes in the region, explore challenges facing health systems, and draw attention to the potential for regional collaboration in health.	[Phua, Kai Hong; Pocock, Nicola S.] Natl Univ Singapore, Lee Kuan Yew Sch Publ Policy, Singapore 250772, Singapore; [Chongsuvivatwong, Virasakdi] Prince Songkla Univ, Hat Yai, Thailand; [Yap, Mui Teng] Inst Policy Studies, Singapore, Singapore; [Hashim, Jamal H.] United Nations Univ, Kuala Lumpur, Malaysia; [Hashim, Jamal H.] Univ Kebangsaan Malaysia, Kuala Lumpur, Malaysia; [Chhem, Rethy] Univ Western Ontario, Schulich Sch Med & Dent, London, ON, Canada; [Wilopo, Siswanto Agus] Gadjah Mada Univ, Yogyakarta, Indonesia; [Lopez, Alan D.] Univ Queensland, Brisbane, Qld, Australia	National University of Singapore; Prince of Songkla University; Universiti Kebangsaan Malaysia; Western University (University of Western Ontario); Gadjah Mada University; University of Queensland	Phua, KH (corresponding author), Natl Univ Singapore, Lee Kuan Yew Sch Publ Policy, 469C Bukit Timah Rd, Singapore 250772, Singapore.	spppkh@nus.edu.sg	Pocock, Nicola Suyin/ABB-5446-2020; Wilopo, Siswanto/AAJ-2092-2020; Wilopo, Siswanto/AAC-9417-2022; Lopez, Alan/AAA-2734-2022; Lopez, Alan D/F-1487-2010	Pocock, Nicola Suyin/0000-0002-2083-4171; Lopez, Alan D/0000-0001-5818-6512; Wilopo, Siswanto Agus/0000-0003-1284-7228	China Medical Board; Rockefeller Foundation; Atlantic Philanthropies	China Medical Board; Rockefeller Foundation; Atlantic Philanthropies	This paper is part of a Series funded by the China Medical Board, Rockefeller Foundation, and Atlantic Philanthropies.	Abella M, 2005, ASIA PACIFIC POPULAT, V20, P61; Acuin CS, 2011, LANCET; [Anonymous], 2009, SOC IND; ASEAN Secretariat, 2009, IMPL ROAD MAP ASEAN; Atoh M., 2004, JPN J POPUL, V2, P42; Awang M B, 2000, Respirology, V5, P183, DOI 10.1046/j.1440-1843.2000.00248.x; Barraclough S, 1999, HEALTH POLICY, V47, P53, DOI 10.1016/S0168-8510(99)00004-4; Barraclough S, 1997, INT J HEALTH SERV, V27, P643, DOI 10.2190/NTFT-QRBY-6VAJ-FMM9; Barraclough S, 2000, CONTEMP SE ASIA, V22, P340; Barraclough Simon, 2010, Glob Health Promot, V17, P40, DOI 10.1177/1757975909358243; Brauer M, 1998, ENVIRON SCI TECHNOL, V32, p404A, DOI 10.1021/es983677j; Chang SS, 2009, SOC SCI MED, V68, P1322, DOI 10.1016/j.socscimed.2009.01.010; Chavez JJ, 2007, GLOB SOC POLICY, V7, P358, DOI 10.1177/1468018107082239; Choprapawon C, 2005, Asia Pac J Public Health, V17, P110, DOI 10.1177/101053950501700209; City Mayors Statistics, LARG CIT WORLD LAND; Cleland J, COMPLETING FERTILITY; Coker RJ, 2011, LANCET, V377, P599, DOI 10.1016/S0140-6736(10)62004-1; Collin Jeff, 2010, Glob Health Promot, V17, P73, DOI 10.1177/1757975909358363; Costello MP, COMPLETING FERTILITY; Dans A, 2011, LANCET, V377, P680, DOI 10.1016/S0140-6736(10)61506-1; Emmanuel S C, 2000, Respirology, V5, P175, DOI 10.1046/j.1440-1843.2000.00247.x; Ezzati M, 2003, TOB CONTROL, V12, P79, DOI 10.1136/tc.12.1.79; Frankenberg E, 2005, DEMOGRAPHY, V42, P109, DOI 10.1353/dem.2005.0004; GOVINDASAMY P, 1992, POPUL DEV REV, V18, P243, DOI 10.2307/1973679; Hogan MC, 2010, LANCET, V375, P1609, DOI 10.1016/S0140-6736(10)60518-1; Hong P K, 2001, J Aging Soc Policy, V13, P169, DOI 10.1300/J031v13n02_12; Jones GW, 2009, ROUT RES PUB SOC POL, pXVII; Kanchanachitra C, 2011, LANCET, V377, P769, DOI 10.1016/S0140-6736(10)62035-1; Kilmarx PH, 1999, J ACQ IMMUN DEF SYND, V21, P313, DOI 10.1097/00126334-199908010-00009; Kovats RS, 2003, LANCET, V362, P1481, DOI 10.1016/S0140-6736(03)14695-8; Leete R, 2008, ETHOS            JUN, P88; Lin Vivian, 2010, Glob Health Promot, V17, P76, DOI 10.1177/1757975909358365; Lybecker KM, 2009, J LAW MED ETHICS, V37, P222, DOI 10.1111/j.1748-720X.2009.00367.x; Mertens TE, 1996, B WORLD HEALTH ORGAN, V74, P121; Mott JA, 2005, INT J HYG ENVIR HEAL, V208, P75, DOI 10.1016/j.ijheh.2005.01.018; Mujahid G, 2002, POPULATION AGEING E; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Phua Kai Hong, 2002, Asia Pac J Public Health, V14, P9; Phua KH, 1987, WORLD HEALTH FORUM, V8, P38; Phua KH, 1991, PRIVATIZATION RESTRU; Phua NH, 1999, RES HLTH CARE FINANC, V5, P113; Population Division of the Department of Economic and Social Affairs of the UN Secretariat, 2009, WORLD POP PROSP 2008; Population Reference Bureau, 2010, WORLD POP DAT SHEET; Population Reference Bureau, GRAPH BANK AG SPEED; Preker A., 2003, INNOVATIONS HLTH SER; Raguenaud ME, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-54; Rajaratnam JK, 2010, LANCET, V375, P1988, DOI 10.1016/S0140-6736(10)60703-9; Rajaratnam JK, 2010, LANCET, V375, P1704, DOI 10.1016/S0140-6736(10)60517-X; Reiter P, 2001, ENVIRON HEALTH PERSP, V109, P141, DOI 10.2307/3434853; Robinson W. C., 2007, GLOBAL FAMILY PLANNI, P421; Singh AR, 2009, GLOB SOC POLICY, V9, P5, DOI 10.1177/1468018109106877; Skeldon R, 1998, FUTURE LABOR MIGRATI; Statistics Singapore, 2010, KEY ANN IND; Tacconi L, 2003, FIRES INDONESIA CAUS; Tangcharoensathien V, 2000, SOC SCI MED, V51, P789, DOI 10.1016/S0277-9536(00)00061-7; Tangcharoensathien V, 2011, LANCET, V377, P863, DOI 10.1016/S0140-6736(10)61890-9; Thanawuth N, 2008, AIDS CARE, V20, P43, DOI 10.1080/09540120701439303; UN Educational Scientific and Cultural Organisation, REG OV E AS PAC; UN Population Fund, 2009, STAT WORLD POP; UN Statistics Division, 2010, SOC IND; UN-Habitat, 2006, STAT WORLDS CIT 2006, P27; United Nations Population Division, WORLD POP PROSP 2008; United States Geological Survey, 2009, EARTHQ GLOSS RING FI; Waters H, 2003, HEALTH POLICY PLANN, V18, P172, DOI 10.1093/heapol/czg022; WHO, 2009, PROM HLTH EQ EV POL; WHO, 2005, SOCHLTH INS SEL CAS; WHO, 2008, PAN INFL PREP SHAR I; World Bank, 2005, E ASIA DECENTRALIZES; World Health Organization, 2008, HLTH AS PAC; World Health Organization, 2006, PREV DIS HLTH ENV; World Health Organization (WHO), 2009, WORLD HLTH STAT; Zoubanov A, 2000, EXP GROUP M POL RESP	72	135	136	1	98	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2011	377	9763					429	437		10.1016/S0140-6736(10)61507-3	http://dx.doi.org/10.1016/S0140-6736(10)61507-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	721ES	21269685	Green Published, Bronze			2022-12-28	WOS:000287337000032
J	St Hilaire, C; Ziegler, SG; Markello, TC; Brusco, A; Groden, C; Gill, F; Carlson-Donohoe, H; Lederman, RJ; Chen, MY; Yang, D; Siegenthaler, MP; Arduino, C; Mancini, C; Freudenthal, B; Stanescu, HC; Zdebik, AA; Chaganti, RK; Nussbaum, RL; Kleta, R; Gahl, WA; Boehm, M				St Hilaire, Cynthia; Ziegler, Shira G.; Markello, Thomas C.; Brusco, Alfredo; Groden, Catherine; Gill, Fred; Carlson-Donohoe, Hannah; Lederman, Robert J.; Chen, Marcus Y.; Yang, Dan; Siegenthaler, Michael P.; Arduino, Carlo; Mancini, Cecilia; Freudenthal, Bernard; Stanescu, Horia C.; Zdebik, Anselm A.; Chaganti, R. Krishna; Nussbaum, Robert L.; Kleta, Robert; Gahl, William A.; Boehm, Manfred			NT5E Mutations and Arterial Calcifications	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONSPECIFIC ALKALINE-PHOSPHATASE; VASCULAR CALCIFICATION; MINERALIZATION; ADENOSINE; INFANCY; ENPP1; CELLS	BACKGROUND Arterial calcifications are associated with increased cardiovascular risk, but the genetic basis of this association is unclear. METHODS We performed clinical, radiographic, and genetic studies in three families with symptomatic arterial calcifications. Single-nucleotide-polymorphism analysis, targeted gene sequencing, quantitative polymerase-chain-reaction assays, Western blotting, enzyme measurements, transduction rescue experiments, and in vitro calcification assays were performed. RESULTS We identified nine persons with calcifications of the lower-extremity arteries and hand and foot joint capsules: all five siblings in one family, three siblings in another, and one patient in a third family. Serum calcium, phosphate, and vitamin D levels were normal. Affected members of Family 1 shared a single 22.4-Mb region of homozygosity on chromosome 6 and had a homozygous nonsense mutation (c.662C -> A, p.S221X) in NT5E, encoding CD73, which converts AMP to adenosine. Affected members of Family 2 had a homozygous missense mutation (c.1073G -> A, p.C358Y) in NT5E. The proband of Family 3 was a compound heterozygote for c.662C -> A and c.1609dupA (p.V537fsX7). All mutations found in the three families result in nonfunctional CD73. Cultured fibroblasts from affected members of Family 1 showed markedly reduced expression of NT5E messenger RNA, CD73 protein, and enzyme activity, as well as increased alkaline phosphatase levels and accumulated calcium phosphate crystals. Genetic rescue experiments normalized the CD73 and alkaline phosphatase activity in patients' cells, and adenosine treatment reduced the levels of alkaline phosphatase and calcification. CONCLUSIONS We identified mutations in NT5E in members of three families with symptomatic arterial and joint calcifications. This gene encodes CD73, which converts AMP to adenosine, supporting a role for this metabolic pathway in inhibiting ectopic tissue calcification.	[Markello, Thomas C.; Groden, Catherine; Gahl, William A.] NHGRI, NIH Undiagnosed Dis Program, NIH, Bethesda, MD 20892 USA; [St Hilaire, Cynthia; Lederman, Robert J.; Chen, Marcus Y.; Yang, Dan; Siegenthaler, Michael P.; Boehm, Manfred] NHLBI, NIH, Bethesda, MD 20892 USA; [Gill, Fred] NIH, Off Rare Dis Res, Ctr Clin, Bethesda, MD 20892 USA; [Brusco, Alfredo; Arduino, Carlo; Mancini, Cecilia] Direz Univ Med Genet, Azienda Osped Univ San Giovanni Battista, Turin, Italy; [Brusco, Alfredo; Arduino, Carlo; Mancini, Cecilia] Univ Turin, Dept Genet Biol & Biochem, Turin, Italy; [Freudenthal, Bernard; Stanescu, Horia C.; Zdebik, Anselm A.; Kleta, Robert] UCL, Dept Med, London WC1E 6BT, England; [Freudenthal, Bernard; Stanescu, Horia C.; Zdebik, Anselm A.; Kleta, Robert] UCL, Dept Physiol, London WC1E 6BT, England; [Chaganti, R. Krishna] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Nussbaum, Robert L.] Univ Calif San Francisco, Inst Human Genet, San Francisco, CA 94143 USA	National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); NIH National Center for Advancing Translational Sciences (NCATS); A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette; University of Turin; University of Turin; University of London; University College London; University of London; University College London; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Gahl, WA (corresponding author), NHGRI, NIH Undiagnosed Dis Program, NIH, 10 Ctr Dr,Bldg 10,Rm 10C-103, Bethesda, MD 20892 USA.	bgahl@helix.nih.gov	Riksen, Niels P/G-8260-2015; St. Hilaire, Cynthia/R-8205-2017; Mancini, Cecilia/AAB-7442-2019; St. Hilaire, Cynthia/I-4713-2014; Hofbauer, Lorenz C/G-2490-2010; Brusco, Alfredo/A-1811-2013; Rongen, Gerard A/C-1578-2018; lederman, robert j/C-6305-2009; Rongen, Gerard/AAJ-9694-2021	Riksen, Niels P/0000-0001-9197-8124; St. Hilaire, Cynthia/0000-0003-1871-6915; Hofbauer, Lorenz C/0000-0002-8691-8423; Brusco, Alfredo/0000-0002-8318-7231; lederman, robert j/0000-0003-1202-6673; Freudenthal, Bernard/0000-0003-4669-918X; Mancini, Cecilia/0000-0003-1282-0404	National Human Genome Research Institute (NHGRI); National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006079, ZICHL006019, ZIAHL006077, ZIAHL005062, ZIDHL006061] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814, T32GM007309] Funding Source: NIH RePORTER	National Human Genome Research Institute (NHGRI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by the Intramural Research Programs of the National Human Genome Research Institute (NHGRI) and the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.	Bing HT, 2006, J CELL BIOCHEM, V99, P1343, DOI 10.1002/jcb.20999; Bockenhauer D, 2009, NEW ENGL J MED, V360, P1960, DOI 10.1056/NEJMoa0810276; BOSTROM K, 1993, J CLIN INVEST, V91, P1800, DOI 10.1172/JCI116391; Castrop H, 2004, J CLIN INVEST, V114, P634, DOI 10.1172/JCI200421851; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Collin-Osdoby P, 2004, CIRC RES, V95, P1046, DOI 10.1161/01.RES.0000149165.99974.12; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Delomenede M, 2009, ACTA BIOCHIM POL, V56, P301; Harmey D, 2004, AM J PATHOL, V164, P1199, DOI 10.1016/S0002-9440(10)63208-7; HAYASHI E, 1985, BRIT J PHARMACOL, V84, P765, DOI 10.1111/j.1476-5381.1985.tb16159.x; HENTHORN PS, 1992, P NATL ACAD SCI USA, V89, P9924, DOI 10.1073/pnas.89.20.9924; Hessle L, 2002, P NATL ACAD SCI USA, V99, P9445, DOI 10.1073/pnas.142063399; Hoemann CD, 2009, PATHOL BIOL, V57, P318, DOI 10.1016/j.patbio.2008.06.004; Koszalka P, 2004, CIRC RES, V95, P814, DOI 10.1161/01.RES.0000144796.82787.6f; Lehto S, 1996, ARTERIOSCL THROM VAS, V16, P978, DOI 10.1161/01.ATV.16.8.978; LEVITIN J, 1945, RADIOLOGY, V44, P489, DOI 10.1148/44.5.489; Livak KJ, 1999, GENET ANAL-BIOMOL E, V14, P143, DOI 10.1016/S1050-3862(98)00019-9; Magnus-Levy A, 1914, DEUT MED WOCHENSCHR, V40, P1305, DOI 10.1055/s-0029-1190517; Mori Hideki, 1992, Heart and Vessels, V7, P211, DOI 10.1007/BF01744607; NORMAND J, 1995, IN VITRO CELL DEV-AN, V31, P447; NOSAKA H, 1974, YONAGO ACTA MED, V18, P191; Proudfoot D, 2000, CIRC RES, V87, P1055, DOI 10.1161/01.RES.87.11.1055; Ramjan KA, 2009, NAT CLIN PRACT ENDOC, V5, P167, DOI 10.1038/ncpendmet1067; Roberts S, 2007, J BONE MINER RES, V22, P617, DOI 10.1359/JBMR.070108; Rutsch F, 2003, NAT GENET, V34, P379, DOI 10.1038/ng1221; Rutsch F, 2008, CIRC-CARDIOVASC GENE, V1, P133, DOI 10.1161/CIRCGENETICS.108.797704; SHARP J, 1954, ANN RHEUM DIS, V13, P15, DOI 10.1136/ard.13.1.15; Shaw LJ, 2003, RADIOLOGY, V228, P826, DOI 10.1148/radiol.2283021006; Yang D, 2006, J CLIN INVEST, V116, P1913, DOI 10.1172/JCI27933	29	304	315	0	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 3	2011	364	5					432	442		10.1056/NEJMoa0912923	http://dx.doi.org/10.1056/NEJMoa0912923			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	715LL	21288095	Green Accepted, Green Published			2022-12-28	WOS:000286885900008
J	Riksen, NP; Rongen, GA				Riksen, Niels P.; Rongen, Gerard A.			NT5E Mutations and Arterial Calcifications	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							ECTO-5'-NUCLEOTIDASE		[Riksen, Niels P.; Rongen, Gerard A.] Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands	Radboud University Nijmegen	Riksen, NP (corresponding author), Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	n.riksen@aig.umcn.nl	Riksen, Niels P/G-8260-2015; St. Hilaire, Cynthia/R-8205-2017; Mancini, Cecilia/AAB-7442-2019; St. Hilaire, Cynthia/I-4713-2014; Hofbauer, Lorenz C/G-2490-2010; Brusco, Alfredo/A-1811-2013; Rongen, Gerard A/C-1578-2018; lederman, robert j/C-6305-2009; Rongen, Gerard/AAJ-9694-2021	Riksen, Niels P/0000-0001-9197-8124; St. Hilaire, Cynthia/0000-0003-1871-6915; Hofbauer, Lorenz C/0000-0002-8691-8423; Brusco, Alfredo/0000-0002-8318-7231; lederman, robert j/0000-0003-1202-6673; Freudenthal, Bernard/0000-0003-4669-918X; Mancini, Cecilia/0000-0003-1282-0404	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006079, ZICHL006019, ZIAHL006077, ZIAHL005062, ZIDHL006061] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007814, T32GM007309] Funding Source: NIH RePORTER	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Meijer P, 2010, HYPERTENSION, V56, P722, DOI 10.1161/HYPERTENSIONAHA.110.155689; Sanada S, 2004, CIRCULATION, V110, P2143, DOI 10.1161/01.CIR.0000143830.59419.73; Zernecke A, 2006, CIRCULATION, V113, P2120, DOI 10.1161/CIRCULATIONAHA.105.595249	4	304	315	0	41	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 21	2011	364	16					1579	1579		10.1056/NEJMoa0912923	http://dx.doi.org/10.1056/NEJMoa0912923			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	752VH	21288095	Green Published, Green Accepted			2022-12-28	WOS:000289722700025
J	Brown, RH; Al-Chalabi, A				Brown, Robert H.; Al-Chalabi, Ammar			Amyotrophic Lateral Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							FRONTOTEMPORAL LOBAR DEGENERATION; MOTOR-NEURON DISEASE; BAC TRANSGENIC MICE; REPEAT EXPANSION; SUPEROXIDE-DISMUTASE; NUCLEOCYTOPLASMIC TRANSPORT; ANTISENSE OLIGONUCLEOTIDE; PATHOLOGICAL FEATURES; HEXANUCLEOTIDE REPEAT; PROGRESSIVE MOTOR		[Brown, Robert H.] Univ Massachusetts, Sch Med, Dept Neurol, 55 Lake Ave N, Worcester, MA 01655 USA; [Al-Chalabi, Ammar] Kings Coll London, Maurice Wohl Clin Neurosci Inst, Dept Basic & Clin Neurosci, London, England	University of Massachusetts System; University of Massachusetts Worcester; University of London; King's College London	Brown, RH (corresponding author), Univ Massachusetts, Sch Med, Dept Neurol, 55 Lake Ave N, Worcester, MA 01655 USA.	robert.brown@umassmed.edu	Hardiman, Orla/Y-3441-2019; Al-Chalabi, Ammar/E-5361-2010	Hardiman, Orla/0000-0003-2610-1291; Turner, Martin/0000-0003-0267-3180; Shaw, Pamela/0000-0002-8925-2567; Veldink, Jan/0000-0001-5572-9657; van Es, Michael/0000-0002-7709-5883; Burrell, James/0000-0001-9638-2768; Al-Chalabi, Ammar/0000-0002-4924-7712; Sheu, Chau-Chyun/0000-0002-7979-3749; Kiernan, Matthew/0000-0001-9054-026X; Eisen, Andrew/0000-0002-1447-2725; Vucic, Steve/0000-0002-8323-873X; Chio, Adriano/0000-0001-9579-5341; Hsu, Chung-Yao/0000-0002-9880-5944	Voyager Therapeutics; GlaxoSmithKline; Cytokinetics; Medical Research Council [G0701923] Funding Source: Medline; Medical Research Council [G0600974, MR/L501529/1] Funding Source: Medline; Medical Research Council [MR/L501529/1] Funding Source: Medline; Motor Neurone Disease Association [ALCHALABI-TALBOT/APR14/926-794] Funding Source: Medline; Motor Neurone Disease Association [ALCHALABI-DOBSON/APR14/829-791] Funding Source: Medline	Voyager Therapeutics; GlaxoSmithKline(GlaxoSmithKline); Cytokinetics; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Motor Neurone Disease Association; Motor Neurone Disease Association	Dr. Brown reports holding equity in AviTx, Amylyx Pharmaceuticals, and ImStar Therapeutics, receiving fees for serving on an advisory board from Voyager Therapeutics, negotiating a collaborative agreement with WAVE Biosciences, holding patents and receiving royalties for patents on "Method for the diagnosis of familial amyotrophic lateral sclerosis" (US 5,843,641) and "Mice having a mutant SOD1 encoding transgene" (US 6,723,893), holding a patent for "Compounds and method for the diagnosis, treatment and prevention of cell death" (US 5,849,290), and holding a pending patent for "Use of synthetic microRNA for AAV-mediated silencing of SOD1 in ALS"; and Dr. Al-Chalabi reports receiving consulting fees from GlaxoSmithKline, providing unpaid consulting for Mitsubishi Tanabe Pharma, Treeway, Chronos Therapeutics, and Avanir Pharmaceuticals, receiving consulting fees and serving as principal investigator in an international commercial clinical trial of tirasemtiv in ALS for Cytokinetics, and serving as chief investigator of an international commercial clinical trial of levosimendan in ALS for Orion Pharma. No other potential conflict of interest relevant to this article was reported.	AI-Chalabi A, 2014, LANCET NEUROL, V13, P1108, DOI 10.1016/S1474-4422(14)70219-4; Al-Chalabi A, 2010, J NEUROL NEUROSUR PS, V81, P1324, DOI 10.1136/jnnp.2010.207464; Al-Chalabi A, 2016, LANCET NEUROL, V15, P1182, DOI 10.1016/S1474-4422(16)30199-5; Al-Chalabi A, 2013, NAT REV NEUROL, V9, P617, DOI 10.1038/nrneurol.2013.203; Al-Chalabi A, 2011, HUM HERED, V71, P281, DOI 10.1159/000330167; ALSGEN C, 2013, NEUROBIOL AGING, V0034; Arcila-Londono X, 2013, HAND CLINIC, V115, P429, DOI 10.1016/B978-0-444-52902-2.00024-2; Bang J, 2015, LANCET, V386, P1672, DOI 10.1016/S0140-6736(15)00461-4; Beard JD, 2016, ENVIRON INT, V91, P104, DOI 10.1016/j.envint.2016.02.014; Beghi E, 2011, AMYOTROPH LATERAL SC, V12, P1, DOI 10.3109/17482968.2010.502940; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Calvo A, 2016, J NEUROL NEUROSUR PS, V87, P1229, DOI 10.1136/jnnp-2016-313793; Chio A, 2013, NEUROEPIDEMIOLOGY, V41, P118, DOI 10.1159/000351153; Conte A, 2012, NEUROMUSCULAR DISORD, V22, P73, DOI 10.1016/j.nmd.2011.08.003; Cooper-Knock J, 2014, ACTA NEUROPATHOL, V127, P333, DOI 10.1007/s00401-014-1251-9; Cudkowicz ME, 1997, ANN NEUROL, V41, P210, DOI 10.1002/ana.410410212; Cudkowicz ME, 2013, LANCET NEUROL, V12, P1059, DOI 10.1016/S1474-4422(13)70221-7; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Diekstra FP, 2014, ANN NEUROL, V76, P120, DOI 10.1002/ana.24198; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Elden AC, 2010, NATURE, V466, P1069, DOI 10.1038/nature09320; Fecto F, 2011, ARCH NEUROL-CHICAGO, V68, P1440, DOI 10.1001/archneurol.2011.250; Fogh I, 2016, JAMA NEUROL, V73, P812, DOI 10.1001/jamaneurol.2016.1114; Freibaum BD, 2015, NATURE, V525, P129, DOI 10.1038/nature14974; Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Glass JD, 2016, NEUROLOGY, V87, P392, DOI 10.1212/WNL.0000000000002889; Gordon PH, 2006, NEUROLOGY, V66, P647, DOI 10.1212/01.wnl.0000200962.94777.71; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Ingre C, 2015, CLIN EPIDEMIOL, V7, P181, DOI 10.2147/CLEP.S37505; Jiang J, 2016, NEURON, V90, P535, DOI 10.1016/j.neuron.2016.04.006; Johnston CA, 2006, J NEUROL, V253, P1642, DOI 10.1007/s00415-006-0195-y; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; Kim HJ, 2013, NATURE, V495, P467, DOI 10.1038/nature11922; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lacomblez L, 2002, NEUROLOGY, V58, P1112, DOI 10.1212/WNL.58.7.1112; Lacorte E, 2016, NEUROSCI BIOBEHAV R, V66, P61, DOI 10.1016/j.neubiorev.2016.04.007; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Li W, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8201; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Liu YJ, 2016, NEURON, V90, P521, DOI 10.1016/j.neuron.2016.04.005; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; McCormick AL, 2008, NEUROLOGY, V70, P278, DOI 10.1212/01.wnl.0000297552.13219.b4; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Miller TM, 2013, LANCET NEUROL, V12, P435, DOI 10.1016/S1474-4422(13)70061-9; Mitchell JC, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0212-4; MULDER DW, 1986, NEUROLOGY, V36, P511, DOI 10.1212/WNL.36.4.511; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nicholson KA, 2015, NEUROTHERAPEUTICS, V12, P376, DOI 10.1007/s13311-015-0341-2; O'Rourke JG, 2015, NEURON, V88, P892, DOI 10.1016/j.neuron.2015.10.027; Pensato V, 2015, J NEUROL, V262, P1376, DOI 10.1007/s00415-015-7739-y; Peters OM, 2015, NEURON, V88, P902, DOI 10.1016/j.neuron.2015.11.018; Peters OM, 2015, J CLIN INVEST, V125, P2548, DOI 10.1172/JCI82693; Philips T, 2014, EXP NEUROL, V262, P111, DOI 10.1016/j.expneurol.2014.05.015; Pottier C, 2016, J NEUROCHEM, V138, P32, DOI 10.1111/jnc.13622; Pottier C, 2015, ACTA NEUROPATHOL, V130, P77, DOI 10.1007/s00401-015-1436-x; Puls I, 2003, NAT GENET, V33, P455, DOI 10.1038/ng1123; Ralph GS, 2005, NAT MED, V11, P429, DOI 10.1038/nm1205; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rezania K, 2013, NEUROL CLIN, V31, P219, DOI 10.1016/j.ncl.2012.09.014; Robberecht W, 2013, NAT REV NEUROSCI, V14, P248, DOI 10.1038/nrn3430; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Rowland LP, 2001, NEW ENGL J MED, V344, P1688, DOI 10.1056/NEJM200105313442207; Sareen D, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007529; Smith RA, 2006, J CLIN INVEST, V116, P2290, DOI 10.1172/JCI25424; Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584; Stoica L, 2016, ANN NEUROL, V79, P687, DOI 10.1002/ana.24618; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Therrien M, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0658-1; van Blitterswijk M, 2012, HUM MOL GENET, V21, P3776, DOI 10.1093/hmg/dds199; Van Hoecke A, 2012, NAT MED, V18, P1418, DOI 10.1038/nm.2901; van Rheenen W, 2016, NAT GENET, V48, P1043, DOI 10.1038/ng.3622; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Wang H, 2011, ARCH NEUROL-CHICAGO, V68, P207, DOI 10.1001/archneurol.2010.367; Wang M., 2016, SHOCK VIB, V2016, P1, DOI DOI 10.1016/J.FUE1.2016.07.061; Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x; Weisskopf MG, 2005, NEUROLOGY, V64, P32, DOI 10.1212/01.WNL.0000148649.17706.D9; Winter SM, 2000, J NEUROL, V247, P783, DOI 10.1007/s004150070093; Wu CH, 2012, NATURE, V488, P499, DOI 10.1038/nature11280; Yang CX, 2016, P NATL ACAD SCI USA, V113, pE6209, DOI 10.1073/pnas.1605964113; Zhang K, 2015, NATURE, V525, P56, DOI 10.1038/nature14973	86	1253	1292	21	186	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUL 13	2017	377	2					162	172		10.1056/NEJMra1603471	http://dx.doi.org/10.1056/NEJMra1603471			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA2PC	28700839	Green Published			2022-12-28	WOS:000405282300010
J	Brown, RH; Al-Chalabi, A				Brown, Robert H., Jr.; Al-Chalabi, Ammar			Amyotrophic Lateral Sclerosis REPLY	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter									[Brown, Robert H., Jr.] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA; [Al-Chalabi, Ammar] Kings Coll London, London, England	University of Massachusetts System; University of Massachusetts Worcester; University of London; King's College London	Brown, RH (corresponding author), Univ Massachusetts, Sch Med, Worcester, MA 01655 USA.	robert.brown@umassmed.edu	Hardiman, Orla/Y-3441-2019; Al-Chalabi, Ammar/E-5361-2010	Hardiman, Orla/0000-0003-2610-1291; Turner, Martin/0000-0003-0267-3180; Shaw, Pamela/0000-0002-8925-2567; Veldink, Jan/0000-0001-5572-9657; van Es, Michael/0000-0002-7709-5883; Burrell, James/0000-0001-9638-2768; Al-Chalabi, Ammar/0000-0002-4924-7712; Sheu, Chau-Chyun/0000-0002-7979-3749; Kiernan, Matthew/0000-0001-9054-026X; Eisen, Andrew/0000-0002-1447-2725; Vucic, Steve/0000-0002-8323-873X; Chio, Adriano/0000-0001-9579-5341; Hsu, Chung-Yao/0000-0002-9880-5944	Medical Research Council [G0701923] Funding Source: Medline; Medical Research Council [G0600974, MR/L501529/1] Funding Source: Medline; Medical Research Council [MR/L501529/1] Funding Source: Medline; Motor Neurone Disease Association [ALCHALABI-TALBOT/APR14/926-794] Funding Source: Medline; Motor Neurone Disease Association [ALCHALABI-DOBSON/APR14/829-791] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Motor Neurone Disease Association; Motor Neurone Disease Association			0	1253	1292	21	186	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	OCT 19	2017	377	16					1602	1602						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FK1LU	28700839				2022-12-28	WOS:000413243900029
